Citrus Sinensis ID: 014117

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430
Protein Sequence
MEMERVTEFPFSNLDRRPRKRARLGWDVPQAQVGLFCGQEVGNVTSFAPPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEccccccccEEEEccccccccccEEEEEEcccccEEEEEEEEccHHHHHHHHHHHHHHHHHHHcccccccEEEEcccccccccEEEEEccccccHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccccccccccccEEEccccccccccccccccccccccccccccccccEEEEEcccccccccccEEEEccccccccEEEEccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHHccccccccccccccccccccccccccccccccHHHHHHHcccccHHHHHHHHHHHccccccccccHHHHHcccccccccccc
Secondary Structure Prediction (SSPRO)
cccHEEEccccccccccccccccccccccHHHHcHHcccccccccccccccccccccccccccccccccccccccccccccccEEEEEcEEccccEEEEEEEEEcccEEEEEEEEccccEEEEEEEEcccHHHHHHHHHHHHHHHHHHHcccccEEEEEccccHcccccEEEEEEcccccHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEccccccEEEcccccccccccccccccccccccccEEccHHHcEEccEccccccccHHHccHHHHcccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHcccccccccccHHHHHHHcccccccccHHHHHcccccHHHHHHHHHHccccccccccHHHHHccHHHHHccccc
Coil and Loop (DISEMBL)
memervtefpfsnldrrprkrarlgwdvpqaqvglfcgqevgnvtsfapprapsdhvtssslfvkgvarngsppwreddkdghYMFALGENLTSRYKIhskmgegtfgqvLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAkhdkggnrcvqIRNWFDYRNHICIVFEKLGSSLYDFLrknnyrsfpIDLVREIARQLLECIAFMHDLCmihtdlkpenvLLVSseyikvpdyksslhtpkdssyfkrmpkssaikvidfgsttyerpdqnyivstrhyrapevilglgwtypcdiwsvGCILVELCTGEALFQTHENLEHLAMMERVlgplpqhmLKRVDRHAEKYVRrgrldwpegaasreSIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGllrydptdrltarealrhpfftrdhlrr
Flexible Loop (DISEMBL)
memervtefpfsnldrrprkrarlgwdvPQAQVGLFCGQEVGNVTSFApprapsdhvtssslfvkgvarngsppwreddkdGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQqlakhdkggnrcVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYikvpdyksslhtpkdssyfkrmpkssaikvidfgsttyerpdqnyivstrhYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYvrrgrldwpegaasresiksvMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTArealrhpfftrdhlrr
Low Complexity Region (SEG)
MEMERVTEFPFSNLDRRPRKRARLGWDVPQAQVGLFCGQEVGNVTSFAPPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR
Disordered region (IsUnstruct)
**********************RLGWDVPQAQVGLFCGQEVGNVTS***********************************GHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY********************AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWP**********SVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF*******
Disordered Region (DISOPRED)
*****************************************************************************DDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS*************MPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRL******************************HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD****
Disordered Region (DISEMBL)
*********PFSNLDRRPRKRARLGWDVPQAQVGLFCGQEVGNVTSFAPPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR
Disordered Region (DISPRO)
***ERVT*FPFSNLD******ARLGWDVPQAQVGLFCGQEVGNVTSFAPPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH***
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEMERVTEFPFSNLDRRPRKRARLGWDVPQAQVGLFCGQEVGNVTSFAPPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	430	2.2.26 [Sep-21-2011]
P51567	427	Serine/threonine-protein	yes	no	0.979	0.985	0.827	0.0
P51566	467	Serine/threonine-protein	no	no	0.988	0.910	0.706	1e-180
P51568	400	Serine/threonine-protein	no	no	0.897	0.965	0.600	1e-143
Q10156	690	Dual specificity protein	yes	no	0.867	0.540	0.427	1e-92
O35491	499	Dual specificity protein	yes	no	0.779	0.671	0.474	2e-89
P49760	499	Dual specificity protein	yes	no	0.781	0.673	0.472	2e-89
P49762	832	Serine/threonine-protein	no	no	0.793	0.409	0.455	8e-87
Q9HAZ1	481	Dual specificity protein	no	no	0.776	0.694	0.469	3e-85
O35493	481	Dual specificity protein	no	no	0.776	0.694	0.461	2e-83
P49759	484	Dual specificity protein	no	no	0.776	0.690	0.455	7e-83

>sp|P51567|AFC2_ARATH Serine/threonine-protein kinase AFC2 OS=Arabidopsis thaliana GN=AFC2 PE=1 SV=1

 Score =  745 bits (1924), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 355/429 (82%), Positives = 396/429 (92%), Gaps = 8/429 (1%)

Query: 1   MEMERVTEFPFSNLDRRPRKRARLGWDV-PQA---QVGLFCGQEVGNVTSFAPPRAPSDH 56
           MEMERV EFP +++DRRPRKRARLGWDV PQA   QVG+FCGQE+GN++SFA   APSD+
Sbjct: 1   MEMERVHEFPHTHMDRRPRKRARLGWDVLPQATKAQVGMFCGQEIGNISSFASSGAPSDN 60

Query: 57  VTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDR 116
             SSSL VKGVARNGSPPWREDDKDGHY+F LG++LT RYKI+SKMGEGTFGQVLECWDR
Sbjct: 61  --SSSLCVKGVARNGSPPWREDDKDGHYIFELGDDLTPRYKIYSKMGEGTFGQVLECWDR 118

Query: 117 ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 176
           ERKEMVA+KIVRG+KKYREAAMIEIE+LQQL KHDKGGNRCVQIRNWFDYRNHICIVFEK
Sbjct: 119 ERKEMVAVKIVRGVKKYREAAMIEIEMLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEK 178

Query: 177 LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 236
           LGSSLYDFLRKNNYRSFPIDLVREI  QLLEC+AFMHDL MIHTDLKPEN+LLVSS+Y+K
Sbjct: 179 LGSSLYDFLRKNNYRSFPIDLVREIGWQLLECVAFMHDLRMIHTDLKPENILLVSSDYVK 238

Query: 237 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG 296
           +P+YK S    +D  Y KR+PKSSAIKVIDFGSTTYER DQ YIVSTRHYRAPEVILGLG
Sbjct: 239 IPEYKGS-RLQRDVCY-KRVPKSSAIKVIDFGSTTYERQDQTYIVSTRHYRAPEVILGLG 296

Query: 297 WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR 356
           W+YPCD+WSVGCI+VELCTGEALFQTHENLEHLAMMERVLGP PQ MLK+VDRH+EKYVR
Sbjct: 297 WSYPCDVWSVGCIIVELCTGEALFQTHENLEHLAMMERVLGPFPQQMLKKVDRHSEKYVR 356

Query: 357 RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 416
           RGRLDWP+GA SR+S+K+V+KLPRLQNLIMQHVDHSAG+L +++QGLLR+DP++R+TARE
Sbjct: 357 RGRLDWPDGATSRDSLKAVLKLPRLQNLIMQHVDHSAGELINMVQGLLRFDPSERITARE 416

Query: 417 ALRHPFFTR 425
           ALRHPFF R
Sbjct: 417 ALRHPFFAR 425

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 1

>sp|P51566|AFC1_ARATH Serine/threonine-protein kinase AFC1 OS=Arabidopsis thaliana GN=AFC1 PE=2 SV=2

 Score =  632 bits (1630), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 303/429 (70%), Positives = 347/429 (80%), Gaps = 4/429 (0%)

Query: 1   MEMERVTEFPFSNLDRRPRKRARLGWDVPQAQVGLFCGQEVGNVTSFAPPRAPSDHVTS- 59
           +E +R  EFP   +D+RPRKR RL WD     +       V     +  P   S  V + 
Sbjct: 17  LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 76

Query: 60  --SSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRE 117
              ++F  G+ R GSPPWR DDKDGHY+F +G+ LT RY+I SKMGEGTFGQVLEC+D +
Sbjct: 77  VYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQILSKMGEGTFGQVLECFDNK 136

Query: 118 RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 177
            KE+VAIK++R I KYREAAMIEI+VLQ+L +HD GG+RCVQIRNWFDYRNHICIVFEKL
Sbjct: 137 NKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFEKL 196

Query: 178 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 237
           G SLYDFLRKN+YRSFPIDLVRE+ RQLLE +A+MHDL +IHTDLKPEN+LLVSSEYIK+
Sbjct: 197 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKI 256

Query: 238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGW 297
           PDYK      KD SYFK +PKSSAIK+IDFGSTT+E  D NYIVSTRHYRAPEVILG+GW
Sbjct: 257 PDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIVSTRHYRAPEVILGVGW 316

Query: 298 TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
            YPCD+WS+GCILVELC+GEALFQTHENLEHLAMMERVLGPLP HM+ R DR +EKY RR
Sbjct: 317 NYPCDLWSIGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVLRADRRSEKYFRR 376

Query: 358 G-RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 416
           G +LDWPEGA SR+S+K+V KLPRL NLIMQHVDHSAGDL  LLQGLLRYDPT+R  ARE
Sbjct: 377 GAKLDWPEGATSRDSLKAVWKLPRLPNLIMQHVDHSAGDLIDLLQGLLRYDPTERFKARE 436

Query: 417 ALRHPFFTR 425
           AL HPFFTR
Sbjct: 437 ALNHPFFTR 445

Activator of yeast transcription factor, STE12.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|P51568|AFC3_ARATH Serine/threonine-protein kinase AFC3 OS=Arabidopsis thaliana GN=AFC3 PE=2 SV=2

 Score =  508 bits (1308), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 251/418 (60%), Positives = 314/418 (75%), Gaps = 32/418 (7%)

Query: 11  FSNLDR-RPRKRARLGWDVPQAQVGLFCGQEVGNVTSFAPPRAPSDHVTSSSLFVKGVAR 69
           F ++D+ R RKR R+ WD   A+                 P A           +KG   
Sbjct: 6   FESMDKERVRKRPRMTWDEAPAE-----------------PEA-------KRAVIKGHGS 41

Query: 70  NG---SPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKI 126
           +G   SPP R+DD+DGHY+F+L +NLT RYKI SKMGEGTFG+VLECWDR+ KE VAIKI
Sbjct: 42  DGRILSPPLRDDDRDGHYVFSLRDNLTPRYKILSKMGEGTFGRVLECWDRDTKEYVAIKI 101

Query: 127 VRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLR 186
           +R IKKYR+AAMIEI+VLQ+L K DKG  RCVQ++NWFDYRNHICIVFEKLG SL+DFL+
Sbjct: 102 IRSIKKYRDAAMIEIDVLQKLVKSDKGRTRCVQMKNWFDYRNHICIVFEKLGPSLFDFLK 161

Query: 187 KNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 246
           +N Y +FP+ LVR+   QLLE +A+MH+L ++HTDLKPEN+LLVSSE +K+PD K S   
Sbjct: 162 RNKYSAFPLALVRDFGCQLLESVAYMHELQLVHTDLKPENILLVSSENVKLPDNKRS--- 218

Query: 247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSV 306
             + ++F+ +PKSSAIK+IDFGST  +    + IV TRHYR+PEVILGLGW+Y CD+WS+
Sbjct: 219 AANETHFRCLPKSSAIKLIDFGSTVCDNRIHHSIVQTRHYRSPEVILGLGWSYQCDLWSI 278

Query: 307 GCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEG 365
           GCIL ELCTGEALFQTH+NLEHLAMMER LGPLP+HM ++  R AEKY RRG RL+WPEG
Sbjct: 279 GCILFELCTGEALFQTHDNLEHLAMMERALGPLPEHMTRKASRGAEKYFRRGCRLNWPEG 338

Query: 366 AASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           A SRESI++V +L RL++++ +HVD++      LL GLL YDP++RLTA EAL HPFF
Sbjct: 339 ANSRESIRAVKRLDRLKDMVSKHVDNTRSRFADLLYGLLAYDPSERLTANEALDHPFF 396

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|Q10156|LKH1_SCHPO Dual specificity protein kinase lkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=lkh1 PE=1 SV=3

 Score =  340 bits (873), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 177/414 (42%), Positives = 255/414 (61%), Gaps = 41/414 (9%)

Query: 16  RRPRKRARLGWDVPQAQVGLFCGQEVGNVTSFAPPRAPSDHVTSSSLFVKGVARNGSPPW 75
           R P+KR R  W  P  +V       V + T+F P           S F            
Sbjct: 308 RPPKKRKRAAWP-PYKKVDRVNVPVVHDTTAFDP-----------STF------------ 343

Query: 76  REDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE 135
             DD DGHY         +RY +   +G GTFG+V++C+D+      AIK+ R I KYRE
Sbjct: 344 --DDDDGHYKVVPNSKFANRYTVVRLLGHGTFGKVIQCYDQSTGRHCAIKVTRAIPKYRE 401

Query: 136 AAMIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 194
           A++IE+ VLQ +A  D    N+C+Q+R++FDYR HICIV +  G S++DFL+ NNY  FP
Sbjct: 402 ASLIELRVLQTIAHSDPTNENKCIQLRDYFDYRKHICIVTDLFGWSVFDFLKNNNYIPFP 461

Query: 195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS--SEYIKVPDYKSSLHTPKDSSY 252
           +  ++ +++QL + +AF+H L ++HTDLKPENVLLVS  S  I++P Y++         Y
Sbjct: 462 LKHIQMLSQQLFKSVAFLHSLGLVHTDLKPENVLLVSNASRTIRLP-YRN---------Y 511

Query: 253 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 312
            +++  S  I++IDFGS T+E    + +VSTRHYRAPE+ILGLGW+YPCD+WS+GCILVE
Sbjct: 512 SQKVLNSCEIRLIDFGSATFEDEYHSSVVSTRHYRAPEIILGLGWSYPCDVWSIGCILVE 571

Query: 313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR-GRLDWPEGAASRES 371
           L TG+ALFQTHE+ EHL MME++LGP  ++M+ R  R ++++ +  G++ +P     ++S
Sbjct: 572 LFTGQALFQTHEDSEHLCMMEKILGPFDRNMISRSSRTSQRFFKSDGKVRYPLSNTPKKS 631

Query: 372 IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           I  +  L  L+ +        A  L  LL+ +  YDP  R+TA+EAL HPFFT+
Sbjct: 632 INYLQSLQTLEQIFAVSSPEVAL-LLDLLKKVFVYDPKRRITAKEALWHPFFTQ 684

Protein kinase that may act as a negative regulator of filamentous growth and flocculation. Appears to have a role in normal cell wall and septum formation and in cell seperation. May have antagonistic function in the regulation of beta-glucan distribution between the sites for cell wall and septum assembly.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|O35491|CLK2_MOUSE Dual specificity protein kinase CLK2 OS=Mus musculus GN=Clk2 PE=1 SV=2

 Score =  330 bits (845), Expect = 2e-89,   Method: Compositional matrix adjust.
 Identities = 166/350 (47%), Positives = 235/350 (67%), Gaps = 15/350 (4%)

Query: 77  EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYRE 135
           EDD +GH ++ +G+ L  RY+I S +GEGTFG+V++C D  R    VA+KI++ ++KY+E
Sbjct: 143 EDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGTQVALKIIKNVEKYKE 202

Query: 136 AAMIEIEVLQQLAKHD-KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 194
           AA +EI VL+++ + D    N CVQ+ +WFDY  H+CI FE LG S +DFL+ NNY  +P
Sbjct: 203 AARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYP 262

Query: 195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
           I  VR +A QL + + F+HD  + HTDLKPEN+L V+S+Y    +   +L   +D    +
Sbjct: 263 IHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----E 314

Query: 255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
           R  KS+A++V+DFGS T++    + IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E  
Sbjct: 315 RSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYY 374

Query: 315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
            G  LFQTH+N EHLAMMER+LGP+P  M+++  +  +KY  RGRLDW E  ++   ++ 
Sbjct: 375 VGFTLFQTHDNREHLAMMERILGPVPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRE 432

Query: 375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             K P  + L  +  DH    L  L++ +L Y+P  RLT  EAL+HPFF 
Sbjct: 433 NCK-PLRRYLTSEAEDHHQ--LFDLIENMLEYEPAKRLTLGEALQHPFFA 479

Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|P49760|CLK2_HUMAN Dual specificity protein kinase CLK2 OS=Homo sapiens GN=CLK2 PE=1 SV=1

 Score =  329 bits (844), Expect = 2e-89,   Method: Compositional matrix adjust.
 Identities = 166/351 (47%), Positives = 236/351 (67%), Gaps = 15/351 (4%)

Query: 77  EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYRE 135
           EDD +GH ++ +G+ L  RY+I S +GEGTFG+V++C D  R    VA+KI++ ++KY+E
Sbjct: 144 EDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKE 203

Query: 136 AAMIEIEVLQQLAKHD-KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 194
           AA +EI VL+++ + D    N CVQ+ +WFDY  H+CI FE LG S +DFL+ NNY  +P
Sbjct: 204 AARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYP 263

Query: 195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
           I  VR +A QL + + F+HD  + HTDLKPEN+L V+S+Y    +   +L   +D    +
Sbjct: 264 IHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----E 315

Query: 255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
           R  KS+A++V+DFGS T++    + IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E  
Sbjct: 316 RSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYY 375

Query: 315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
            G  LFQTH+N EHLAMMER+LGP+P  M+++  +  +KY  RGRLDW E  ++   ++ 
Sbjct: 376 VGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRE 433

Query: 375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
             K P  + L  +  +H    L  L++ +L Y+P  RLT  EAL+HPFF R
Sbjct: 434 NCK-PLRRYLTSEAEEHHQ--LFDLIESMLEYEPAKRLTLGEALQHPFFAR 481

Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|P49762|DOA_DROME Serine/threonine-protein kinase Doa OS=Drosophila melanogaster GN=Doa PE=1 SV=2

 Score =  321 bits (822), Expect = 8e-87,   Method: Compositional matrix adjust.
 Identities = 162/356 (45%), Positives = 231/356 (64%), Gaps = 15/356 (4%)

Query: 74  PWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY 133
           P  +DD DGH ++  G+ L  RYKI + +GEGTFG+V++  D ER   +A+KI++ ++KY
Sbjct: 457 PVIQDDADGHLIYHTGDILHHRYKIMATLGEGTFGRVVKVKDMERDYCMALKIIKNVEKY 516

Query: 134 REAAMIEIEVLQQLAKHDKGGNR-CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRS 192
           REAA +EI  L+++A+ D   +  CV++ +WFDY  H+CIVFE LG S++DFLR+NNY  
Sbjct: 517 REAAKLEINALEKIAQKDPHCDHLCVKMIDWFDYHGHMCIVFEMLGLSVFDFLRENNYEP 576

Query: 193 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 252
           +P+D VR +A QL   + F+HD  + HTDLKPEN+L V S+Y    ++K +         
Sbjct: 577 YPLDQVRHMAYQLCYSVKFLHDNRLTHTDLKPENILFVDSDYTSHYNHKINREV------ 630

Query: 253 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 312
             R  K++ +++IDFGS T++    + IVSTRHYRAPEVIL LGW+ PCD+WS+GCIL E
Sbjct: 631 --RRVKNTDVRLIDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCILFE 688

Query: 313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKR---VDRHAEKYVRRGRLDWPEGAASR 369
           L  G  LFQTH+N EHLAMMER+LG +P  M +      +   KY   G+LDW E +++ 
Sbjct: 689 LYLGITLFQTHDNREHLAMMERILGQIPYRMARNHTLYSKTKTKYFYHGKLDWDEKSSAG 748

Query: 370 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
             ++   K P     +    DH   +L  L++ +L Y+P+ R+T  EAL HPFF R
Sbjct: 749 RYVRDHCK-PLFLCQLSDSEDHC--ELFSLIKKMLEYEPSSRITLGEALHHPFFDR 801

Negative regulator of the copia retrotransposon element of the white (w) gene. In the eye, it is required for normal pigmentation, photoreceptor cell development and for organization of interommatidial bristles. Also essential for embryonic segmentation and differentiation of the nervous system. Functions in the control of alternative splicing by phosphorylating the argine/serine-rich splicing factors, SR proteins.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|Q9HAZ1|CLK4_HUMAN Dual specificity protein kinase CLK4 OS=Homo sapiens GN=CLK4 PE=1 SV=1

 Score =  316 bits (809), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 164/349 (46%), Positives = 232/349 (66%), Gaps = 15/349 (4%)

Query: 77  EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEM-VAIKIVRGIKKYRE 135
           EDD++GH +   G+ L +RY+I   +GEG FG+V+EC D     M VA+KIV+ + +YRE
Sbjct: 140 EDDEEGHLICQSGDVLRARYEIVDTLGEGAFGKVVECIDHGMDGMHVAVKIVKNVGRYRE 199

Query: 136 AAMIEIEVLQQLAKHDKGGN-RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 194
           AA  EI+VL+ L   D     RCVQ+  WFD+  H+CIVFE LG S YDF+++N++  F 
Sbjct: 200 AARSEIQVLEHLNSTDPNSVFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQ 259

Query: 195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
           ID +R++A Q+ + I F+H   + HTDLKPEN+L V S+Y  V  Y S +   +D    +
Sbjct: 260 IDHIRQMAYQICQSINFLHHNKLTHTDLKPENILFVKSDY--VVKYNSKM--KRD----E 311

Query: 255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
           R  K++ IKV+DFGS TY+    + +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E  
Sbjct: 312 RTLKNTDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 371

Query: 315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
            G  +FQTH++ EHLAMMER+LGP+PQHM+++  +   KY    +LDW E +++   ++ 
Sbjct: 372 LGFTVFQTHDSKEHLAMMERILGPIPQHMIQKTRK--RKYFHHNQLDWDEHSSAGRYVRR 429

Query: 375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             K   L+  ++ H D     L  L++ +L YDPT R+T  EAL+HPFF
Sbjct: 430 RCKP--LKEFMLCH-DEEHEKLFDLVRRMLEYDPTQRITLDEALQHPFF 475

Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates SRSF1 and SRSF3. Required for the regulation of alternative splicing of MAPT/TAU. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|O35493|CLK4_MOUSE Dual specificity protein kinase CLK4 OS=Mus musculus GN=Clk4 PE=1 SV=1

 Score =  309 bits (792), Expect = 2e-83,   Method: Compositional matrix adjust.
 Identities = 161/349 (46%), Positives = 230/349 (65%), Gaps = 15/349 (4%)

Query: 77  EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEM-VAIKIVRGIKKYRE 135
           EDD++GH +   G+ L +RY+I   +GEG FG+V+EC D     + VA+KIV+ + +YRE
Sbjct: 140 EDDEEGHLICQSGDVLRARYEIVDTLGEGAFGKVVECIDHGMDGLHVAVKIVKNVGRYRE 199

Query: 136 AAMIEIEVLQQLAKHDKGGN-RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 194
           AA  EI+VL+ L   D     RCVQ+  WFD+  H+CIVFE LG S YDF+++N++  F 
Sbjct: 200 AARSEIQVLEHLNSTDPNSVFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQ 259

Query: 195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
           ID +R++A Q+ + I F+H   + HTDLKPEN+L V S+Y  V  Y S +   +D    +
Sbjct: 260 IDHIRQMAYQICQSINFLHHNKLTHTDLKPENILFVKSDY--VVKYNSKM--KRD----E 311

Query: 255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
           R  K++ IKV+DFGS TY+    + +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E  
Sbjct: 312 RTLKNTDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 371

Query: 315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
            G  +FQTH++ EHLAMMER+LGP+P HM+++  +   KY    +LDW E +++   ++ 
Sbjct: 372 LGFTVFQTHDSKEHLAMMERILGPIPAHMIQKTRK--RKYFHHNQLDWDEHSSAGRYVRR 429

Query: 375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             K   L+  ++ H D     L  L++ +L YDP  R+T  EAL+HPFF
Sbjct: 430 RCKP--LKEFMLCH-DEEHEKLFDLVRRMLEYDPARRITLDEALQHPFF 475

Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates SRSF1 and SRSF3. Required for the regulation of alternative splicing of MAPT/TAU. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|P49759|CLK1_HUMAN Dual specificity protein kinase CLK1 OS=Homo sapiens GN=CLK1 PE=1 SV=2

 Score =  308 bits (788), Expect = 7e-83,   Method: Compositional matrix adjust.
 Identities = 159/349 (45%), Positives = 228/349 (65%), Gaps = 15/349 (4%)

Query: 77  EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYRE 135
           EDD++GH +   G+ L++RY+I   +GEG FG+V+EC D +     VA+KIV+ + +Y E
Sbjct: 142 EDDEEGHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCE 201

Query: 136 AAMIEIEVLQQLAKHDKGGN-RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 194
           AA  EI+VL+ L   D     RCVQ+  WF++  HICIVFE LG S YDF+++N +  F 
Sbjct: 202 AARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFR 261

Query: 195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
           +D +R++A Q+ + + F+H   + HTDLKPEN+L V S+Y +  + K      +D    +
Sbjct: 262 LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK----IKRD----E 313

Query: 255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
           R   +  IKV+DFGS TY+    + +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E  
Sbjct: 314 RTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 373

Query: 315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
            G  +F TH++ EHLAMMER+LGPLP+HM+++  +   KY    RLDW E +++   +  
Sbjct: 374 LGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRK--RKYFHHDRLDWDEHSSAGRYVSR 431

Query: 375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             K P  + ++ Q V+H    L  L+Q +L YDP  R+T REAL+HPFF
Sbjct: 432 RCK-PLKEFMLSQDVEHER--LFDLIQKMLEYDPAKRITLREALKHPFF 477

Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates: SRSF1, SRSF3 and PTPN1. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells and adenovirus E1A pre-mRNA.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	430
255540473	435	afc, putative [Ricinus communis] gi|2235	1.0	0.988	0.894	0.0
225456860	435	PREDICTED: serine/threonine-protein kina	0.997	0.986	0.891	0.0
224135977	427	predicted protein [Populus trichocarpa]	0.990	0.997	0.881	0.0
224121850	422	predicted protein [Populus trichocarpa]	0.981	1.0	0.875	0.0
363807284	430	uncharacterized protein LOC100804022 [Gl	0.993	0.993	0.870	0.0
363806778	430	uncharacterized protein LOC100804452 [Gl	0.993	0.993	0.877	0.0
147767048	421	hypothetical protein VITISV_035275 [Viti	0.965	0.985	0.864	0.0
449469580	433	PREDICTED: serine/threonine-protein kina	0.997	0.990	0.852	0.0
356508738	425	PREDICTED: serine/threonine-protein kina	0.981	0.992	0.856	0.0
356516617	425	PREDICTED: serine/threonine-protein kina	0.981	0.992	0.856	0.0

>gi|255540473|ref|XP_002511301.1| afc, putative [Ricinus communis] gi|223550416|gb|EEF51903.1| afc, putative [Ricinus communis]

 Score =  812 bits (2098), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 389/435 (89%), Positives = 409/435 (94%), Gaps = 5/435 (1%)

Query: 1   MEMERVTEFPFSNLDRRPRKRARLGWDVP---QAQVGLFCGQEVGNVTSFAPPRAPSDHV 57
           MEMERVTEFP  +LDRRPRKRARLGWDVP   +AQVG+FC QEVGNV S+A   A SDH 
Sbjct: 1   MEMERVTEFPLPHLDRRPRKRARLGWDVPLVPKAQVGMFCAQEVGNVASYASSGANSDHT 60

Query: 58  T-SSSLFVKGVA-RNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWD 115
           T SSS+F+KGVA RNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWD
Sbjct: 61  TTSSSVFLKGVAPRNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWD 120

Query: 116 RERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 175
           RERKEMVAIKIVRGIKKYREAAMIEI+VLQQL KHDKGGNRCVQIRNWFDYRNHICIVFE
Sbjct: 121 RERKEMVAIKIVRGIKKYREAAMIEIDVLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFE 180

Query: 176 KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 235
           KLG SLYDFLRKNNYRSFPIDLVREI RQLLECIAFMHDL +IHTDLKPEN+LLVS +Y+
Sbjct: 181 KLGPSLYDFLRKNNYRSFPIDLVREIGRQLLECIAFMHDLHLIHTDLKPENILLVSPDYV 240

Query: 236 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL 295
           KVPDYK S  +PKDSSYFKR+PKSSA+KVIDFGSTTYER DQNYIVSTRHYRAPEVILGL
Sbjct: 241 KVPDYKGSTRSPKDSSYFKRVPKSSAVKVIDFGSTTYERQDQNYIVSTRHYRAPEVILGL 300

Query: 296 GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV 355
           GW+YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKR+DRHAEKYV
Sbjct: 301 GWSYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRIDRHAEKYV 360

Query: 356 RRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 415
           RRGRLDWPEGA SRESIK+V+KLPRLQNL+MQHVDHSAGDL HLLQGLLRYDP+DRLTAR
Sbjct: 361 RRGRLDWPEGATSRESIKAVLKLPRLQNLVMQHVDHSAGDLIHLLQGLLRYDPSDRLTAR 420

Query: 416 EALRHPFFTRDHLRR 430
           EALRHPFF RDHLRR
Sbjct: 421 EALRHPFFARDHLRR 435

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456860|ref|XP_002279764.1| PREDICTED: serine/threonine-protein kinase AFC2 [Vitis vinifera] gi|297733679|emb|CBI14926.3| unnamed protein product [Vitis vinifera]

 Score =  808 bits (2088), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 388/435 (89%), Positives = 410/435 (94%), Gaps = 6/435 (1%)

Query: 1   MEM-ERVTEFPFSNLDRRPRKRARLGWDV----PQAQVGLFCGQEVGNVTSFAPPRAPSD 55
           MEM ERVTEFP +++DRRPRKR RLGWDV    P+AQ+G+FCGQEVGNV SFAP +A SD
Sbjct: 1   MEMVERVTEFPHTHMDRRPRKRPRLGWDVLPQAPKAQLGMFCGQEVGNVASFAPSKAHSD 60

Query: 56  HVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWD 115
             T+SS+FVKGVARNGSPPWREDDKDGHY+FALGENLTSRYKI+SKMGEGTFGQVLECWD
Sbjct: 61  Q-TTSSMFVKGVARNGSPPWREDDKDGHYIFALGENLTSRYKINSKMGEGTFGQVLECWD 119

Query: 116 RERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 175
           RERKEMVA+KIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE
Sbjct: 120 RERKEMVAVKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 179

Query: 176 KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 235
           KLG SLYDFLRKNNYRSFPIDLVREI RQLLEC+AFMHDL +IHTDLKPEN+LLVS EY+
Sbjct: 180 KLGPSLYDFLRKNNYRSFPIDLVREIGRQLLECVAFMHDLRLIHTDLKPENILLVSPEYV 239

Query: 236 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL 295
           KVPDYK S  +PKD SYFKR+PKSSAIKVIDFGSTTYER DQNYIVSTRHYRAPEVILGL
Sbjct: 240 KVPDYKVSSRSPKDGSYFKRVPKSSAIKVIDFGSTTYERQDQNYIVSTRHYRAPEVILGL 299

Query: 296 GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV 355
           GW+YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV
Sbjct: 300 GWSYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV 359

Query: 356 RRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 415
           RRGRLDWPEGA SRESIK+V+KLPRLQNLIMQHVDHSAGDL HLLQGLLRYDP+DRLTA 
Sbjct: 360 RRGRLDWPEGATSRESIKAVLKLPRLQNLIMQHVDHSAGDLIHLLQGLLRYDPSDRLTAL 419

Query: 416 EALRHPFFTRDHLRR 430
            ALRHPFFTRDHLRR
Sbjct: 420 GALRHPFFTRDHLRR 434

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224135977|ref|XP_002322208.1| predicted protein [Populus trichocarpa] gi|222869204|gb|EEF06335.1| predicted protein [Populus trichocarpa]

 Score =  795 bits (2053), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 378/429 (88%), Positives = 403/429 (93%), Gaps = 3/429 (0%)

Query: 1   MEMERVTEFPFSNLDRRPRKRARLGWDVPQAQVGLFCGQEVGNVTSFAPPRAPSDHVTSS 60
           MEME VT FP ++LDR PRKR R GWDVPQAQVG FCGQEVGNV S+A   A SDH  +S
Sbjct: 1   MEMEHVTIFPITHLDR-PRKRPRFGWDVPQAQVGNFCGQEVGNVASYASSGAISDH--TS 57

Query: 61  SLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKE 120
           SLFVKGVA+NGSPPWREDDKDGHYMFALG+NLTSRYKIH+KMGEGTFGQVLECWDRERKE
Sbjct: 58  SLFVKGVAQNGSPPWREDDKDGHYMFALGDNLTSRYKIHNKMGEGTFGQVLECWDRERKE 117

Query: 121 MVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSS 180
           MVAIKIVRGIKKY+EAAMIEIEVLQQL KHDKGGNRCVQIRNWFDYRNHICIVFEKLG S
Sbjct: 118 MVAIKIVRGIKKYKEAAMIEIEVLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEKLGPS 177

Query: 181 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 240
           LYDFLRKNNYRSFPID VREI RQLLEC+AFMHDL MIHTDLKPEN+LLVSS+Y+KVPDY
Sbjct: 178 LYDFLRKNNYRSFPIDHVREIGRQLLECVAFMHDLHMIHTDLKPENILLVSSDYVKVPDY 237

Query: 241 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYP 300
           K+S  +PKDSSY+KR+PKSSAIKVIDFGSTTYER DQNYIVSTRHYRAPEVILGLGW+YP
Sbjct: 238 KNSTRSPKDSSYYKRVPKSSAIKVIDFGSTTYERQDQNYIVSTRHYRAPEVILGLGWSYP 297

Query: 301 CDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRL 360
           CD+WSVGCILVELCTGEALFQTHENLEHLAMMERVLGP+PQ+MLKRVDRHAEK+VRRGRL
Sbjct: 298 CDVWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPMPQNMLKRVDRHAEKFVRRGRL 357

Query: 361 DWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
           DWPEGAASRESIK+V+KLPRLQNL+MQHVDHSAGDL HLLQGLLRYDP DRLTAREALRH
Sbjct: 358 DWPEGAASRESIKAVLKLPRLQNLVMQHVDHSAGDLIHLLQGLLRYDPMDRLTAREALRH 417

Query: 421 PFFTRDHLR 429
           PFF +DH R
Sbjct: 418 PFFAKDHRR 426

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224121850|ref|XP_002318688.1| predicted protein [Populus trichocarpa] gi|222859361|gb|EEE96908.1| predicted protein [Populus trichocarpa]

 Score =  783 bits (2022), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 372/425 (87%), Positives = 395/425 (92%), Gaps = 3/425 (0%)

Query: 1   MEMERVTEFPFSNLDRRPRKRARLGWDVPQAQVGLFCGQEVGNVTSFAPPRAPSDHVTSS 60
           ME+E VT FP ++LDR PRKRAR  WDVPQAQVG+FCGQEVGNV S+A   A SDH  +S
Sbjct: 1   MELEHVTVFPITHLDR-PRKRARFAWDVPQAQVGIFCGQEVGNVASYASSGAISDH--TS 57

Query: 61  SLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKE 120
           SLFVKGVARNGSPPWREDDKDGHYMFALG+NLTSRYKIHSKMGEGTFGQVLECWDRERKE
Sbjct: 58  SLFVKGVARNGSPPWREDDKDGHYMFALGDNLTSRYKIHSKMGEGTFGQVLECWDRERKE 117

Query: 121 MVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSS 180
           MVAIKIVRGIKKYREAAMIEIEVLQ L KHDKG NRCVQIRNWFDYRNHICIVFEKLG S
Sbjct: 118 MVAIKIVRGIKKYREAAMIEIEVLQNLGKHDKGSNRCVQIRNWFDYRNHICIVFEKLGPS 177

Query: 181 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 240
           LYDFLRKNNYRSFPIDLVREI RQLLEC+AFMHDL MIHTDLKPEN+LLVSS+Y+KVPDY
Sbjct: 178 LYDFLRKNNYRSFPIDLVREIGRQLLECVAFMHDLRMIHTDLKPENILLVSSDYVKVPDY 237

Query: 241 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYP 300
           K+S  +PKD SY+KR+PKSSAIKVIDFGSTTYER DQNYIVSTRHYRAPEVILGLGW+YP
Sbjct: 238 KNSSRSPKDISYYKRVPKSSAIKVIDFGSTTYERQDQNYIVSTRHYRAPEVILGLGWSYP 297

Query: 301 CDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRL 360
           CDIWS GCILVELCTGEALFQTHENLEHLAMMERVLGP+PQH+LKRVDRHA KYVRRGRL
Sbjct: 298 CDIWSAGCILVELCTGEALFQTHENLEHLAMMERVLGPMPQHILKRVDRHAGKYVRRGRL 357

Query: 361 DWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
           DWPEGAASRES+K+V+KLPRLQNL+MQHVD SAGDL HLLQGLLRYDP DRLTAREALRH
Sbjct: 358 DWPEGAASRESMKAVLKLPRLQNLVMQHVDQSAGDLIHLLQGLLRYDPLDRLTAREALRH 417

Query: 421 PFFTR 425
           PF  +
Sbjct: 418 PFLAK 422

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363807284|ref|NP_001242619.1| uncharacterized protein LOC100804022 [Glycine max] gi|255634850|gb|ACU17784.1| unknown [Glycine max]

 Score =  780 bits (2014), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/433 (87%), Positives = 401/433 (92%), Gaps = 6/433 (1%)

Query: 1   MEMERVTEFPFSNLDRRPRKRARLGWD---VPQAQVGLFCGQEVGNVTSFAPPRAPSDHV 57
           MEMERV EFP + +DRRPRKRARLGWD   VP+AQVGLFCGQ+VG ++SFAP R PS+H 
Sbjct: 1   MEMERVFEFPHTYMDRRPRKRARLGWDIPEVPKAQVGLFCGQDVGTISSFAPSRGPSEH- 59

Query: 58  TSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRE 117
           T+SSLFVK VARNGSPPWR+DDKDGHYMF LGENLTSRYKIH+KMGEGTFGQVLECWDRE
Sbjct: 60  TTSSLFVKPVARNGSPPWRDDDKDGHYMFTLGENLTSRYKIHTKMGEGTFGQVLECWDRE 119

Query: 118 RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 177
           RKEMVA+KIVRGIKKYREAAMIEIEVLQQL KHDKGGNRCVQIRNWFDYRNHICIVFEKL
Sbjct: 120 RKEMVAVKIVRGIKKYREAAMIEIEVLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEKL 179

Query: 178 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 237
           G SLYDFLRKNNYRSFPIDLVREI +QLLECIAFMHDL MIHTDLKPEN+LLVS EY+KV
Sbjct: 180 GPSLYDFLRKNNYRSFPIDLVREIGKQLLECIAFMHDLRMIHTDLKPENILLVSPEYVKV 239

Query: 238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGW 297
           PDYKSS  +    SYFKR+PKSSAIKVIDFGSTTYER DQNYIVSTRHYRAPEVILGLGW
Sbjct: 240 PDYKSSSRS--SCSYFKRVPKSSAIKVIDFGSTTYEREDQNYIVSTRHYRAPEVILGLGW 297

Query: 298 TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           +YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG LPQ M+KRVDRHAEKYVRR
Sbjct: 298 SYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGSLPQTMMKRVDRHAEKYVRR 357

Query: 358 GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 417
           GRLDWPEGA SRESIK+VMKLPRLQNL+MQHVD SAGDL HLLQGLLRYDP++RLTA+EA
Sbjct: 358 GRLDWPEGATSRESIKAVMKLPRLQNLVMQHVDRSAGDLIHLLQGLLRYDPSERLTAKEA 417

Query: 418 LRHPFFTRDHLRR 430
           LRH FF R+H RR
Sbjct: 418 LRHSFFMREHFRR 430

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363806778|ref|NP_001242280.1| uncharacterized protein LOC100804452 [Glycine max] gi|255635653|gb|ACU18176.1| unknown [Glycine max]

 Score =  780 bits (2013), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 380/433 (87%), Positives = 402/433 (92%), Gaps = 6/433 (1%)

Query: 1   MEMERVTEFPFSNLDRRPRKRARLGWD---VPQAQVGLFCGQEVGNVTSFAPPRAPSDHV 57
           MEMERV EFP +++DRRPRKRARLGWD   VP+AQVGLFCGQ+VG ++SFAP R PS++ 
Sbjct: 1   MEMERVFEFPHTHMDRRPRKRARLGWDIPEVPKAQVGLFCGQDVGTISSFAPSRGPSEN- 59

Query: 58  TSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRE 117
           T+SSLFVK VARNGSPPWR+DDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRE
Sbjct: 60  TTSSLFVKPVARNGSPPWRDDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRE 119

Query: 118 RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 177
           RKEMVA+KIVRGIKKYREAAMIEIEVLQQL KHDKGGNRCVQIRNWFDYRNHICIV EKL
Sbjct: 120 RKEMVAVKIVRGIKKYREAAMIEIEVLQQLGKHDKGGNRCVQIRNWFDYRNHICIVLEKL 179

Query: 178 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 237
           G SLYDFLRKNNYRSFPIDLVREI RQLLECIAFMHDL MIHTDLKPEN+LLVS EY+KV
Sbjct: 180 GPSLYDFLRKNNYRSFPIDLVREIGRQLLECIAFMHDLRMIHTDLKPENILLVSPEYVKV 239

Query: 238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGW 297
           PDYKSS  +   SSYFKR+PKSSAIKVIDFGSTTYER DQNYIVSTRHYRAPEVILGLGW
Sbjct: 240 PDYKSSSRS--PSSYFKRVPKSSAIKVIDFGSTTYEREDQNYIVSTRHYRAPEVILGLGW 297

Query: 298 TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           +YPCDIWSVGCILVELCTG ALFQTHENLEHLAMMERVLGPLPQ MLKRVDRHAEKYVRR
Sbjct: 298 SYPCDIWSVGCILVELCTGGALFQTHENLEHLAMMERVLGPLPQPMLKRVDRHAEKYVRR 357

Query: 358 GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 417
           GRLDWPEGA SRESIK+VM LPRLQNL+MQHVDHSAGDL HLLQGLLRYDP++RLTA+EA
Sbjct: 358 GRLDWPEGATSRESIKAVMNLPRLQNLVMQHVDHSAGDLIHLLQGLLRYDPSERLTAKEA 417

Query: 418 LRHPFFTRDHLRR 430
           LRH FF RD  RR
Sbjct: 418 LRHSFFMRDQFRR 430

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147767048|emb|CAN67679.1| hypothetical protein VITISV_035275 [Vitis vinifera]

 Score =  774 bits (1998), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 376/435 (86%), Positives = 397/435 (91%), Gaps = 20/435 (4%)

Query: 1   MEM-ERVTEFPFSNLDRRPRKRARLGWDV----PQAQVGLFCGQEVGNVTSFAPPRAPSD 55
           MEM ERVTEFP +++DRRPRKR RLGWDV    P+AQ+G+FCGQEVGNV SFAP +A SD
Sbjct: 1   MEMVERVTEFPHTHMDRRPRKRPRLGWDVLPQAPKAQLGMFCGQEVGNVASFAPSKAHSD 60

Query: 56  HVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWD 115
             T+SS+FVKGVARNGSPPWREDDKDGHY+FALGENLTSRYKI+SKMGEGTFGQVLECWD
Sbjct: 61  Q-TTSSMFVKGVARNGSPPWREDDKDGHYIFALGENLTSRYKINSKMGEGTFGQVLECWD 119

Query: 116 RERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 175
           RERKEMVA+KIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE
Sbjct: 120 RERKEMVAVKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 179

Query: 176 KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 235
           KLG SLYDFLRKNNYRSFPIDLVREI RQLLEC+AFMHDL +IHTDLKPEN+LLVS EY+
Sbjct: 180 KLGPSLYDFLRKNNYRSFPIDLVREIGRQLLECVAFMHDLRLIHTDLKPENILLVSPEYV 239

Query: 236 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL 295
           KVPDYK S  +PKD              VIDFGSTTYER DQNYIVSTRHYRAPEVILGL
Sbjct: 240 KVPDYKVSSRSPKD--------------VIDFGSTTYERQDQNYIVSTRHYRAPEVILGL 285

Query: 296 GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV 355
           GW+YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV
Sbjct: 286 GWSYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV 345

Query: 356 RRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 415
           RRGRLDWPEGA SRESIK+V+KLPRLQNLIMQHVDHSAGDL HLLQGLLRYDP+DRLTA 
Sbjct: 346 RRGRLDWPEGATSRESIKAVLKLPRLQNLIMQHVDHSAGDLIHLLQGLLRYDPSDRLTAJ 405

Query: 416 EALRHPFFTRDHLRR 430
            ALRHPFFTRDHLRR
Sbjct: 406 GALRHPFFTRDHLRR 420

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449469580|ref|XP_004152497.1| PREDICTED: serine/threonine-protein kinase AFC2-like [Cucumis sativus] gi|449487736|ref|XP_004157775.1| PREDICTED: serine/threonine-protein kinase AFC2-like [Cucumis sativus]

 Score =  773 bits (1996), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 370/434 (85%), Positives = 399/434 (91%), Gaps = 5/434 (1%)

Query: 1   MEMERVTEFPFSNLDRRPRKRARLGWDV----PQAQVGLFCGQEVGNVTSFAPPRAPSDH 56
           MEMER+ EFP ++LDRRPRKRARLGWDV    P+AQVG+ CGQE+ N+ SFA  RAPSDH
Sbjct: 1   MEMERMIEFPHTHLDRRPRKRARLGWDVVPEAPKAQVGICCGQEIANIPSFASTRAPSDH 60

Query: 57  VTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDR 116
            +S+ LFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDR
Sbjct: 61  -SSNPLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDR 119

Query: 117 ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 176
           E+KEMVAIKIVRGI+KYR+AAMIEIEVLQQL KHDKGGNRCVQIRNWFDYRNHICIVFEK
Sbjct: 120 EKKEMVAIKIVRGIRKYRDAAMIEIEVLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEK 179

Query: 177 LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 236
           LG SLYDFLRKNNYRSFPIDLVR+I RQLLEC+AFMHDL MIHTDLKPEN+LLVS +Y+K
Sbjct: 180 LGPSLYDFLRKNNYRSFPIDLVRDIGRQLLECVAFMHDLRMIHTDLKPENILLVSGDYVK 239

Query: 237 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG 296
           V DYK+   +P+DSS FKR+PKSSAIKVIDFGSTTY+R DQNYIVSTRHYRAPEVILGLG
Sbjct: 240 VHDYKNLSRSPRDSSNFKRVPKSSAIKVIDFGSTTYDRQDQNYIVSTRHYRAPEVILGLG 299

Query: 297 WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR 356
           W +PCDIWSVGCILVELC+GEALFQTHENLEHLAMMERVLGPLPQ MLK+VDRHAEKYVR
Sbjct: 300 WRFPCDIWSVGCILVELCSGEALFQTHENLEHLAMMERVLGPLPQEMLKKVDRHAEKYVR 359

Query: 357 RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 416
           RGRLDWPEGA SR+SIK+V KL RL NLIMQHVDHS G+L HL+QGLLRYDP  RLTARE
Sbjct: 360 RGRLDWPEGATSRDSIKAVQKLARLPNLIMQHVDHSGGELIHLVQGLLRYDPLLRLTARE 419

Query: 417 ALRHPFFTRDHLRR 430
           ALRHPFFTRD LRR
Sbjct: 420 ALRHPFFTRDSLRR 433

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356508738|ref|XP_003523111.1| PREDICTED: serine/threonine-protein kinase AFC2-like isoform 1 [Glycine max]

 Score =  767 bits (1981), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/433 (85%), Positives = 395/433 (91%), Gaps = 11/433 (2%)

Query: 1   MEMERVTEFPFSNLDRRPRKRARLGWDV---PQAQVGLFCGQEVGNVTSFAPPRAPSDHV 57
           MEMER+ EFP + +DR PRKRARLGWD+   P+AQVGLFCGQEV N++S+AP   P    
Sbjct: 1   MEMERIVEFPHTYMDRPPRKRARLGWDIAEAPKAQVGLFCGQEVENISSYAPSEHPP--- 57

Query: 58  TSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRE 117
             SSLF KGVARNGSPPWR+DDKDGHYMF LG+NLTSRYKIHSKMGEGTFGQVLECWDRE
Sbjct: 58  --SSLF-KGVARNGSPPWRDDDKDGHYMFELGDNLTSRYKIHSKMGEGTFGQVLECWDRE 114

Query: 118 RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 177
           RKEMVAIKIVRGIKKYREAAMIEIEVLQQL KHDKG NRCVQIRNWFDYRNHICIVFEKL
Sbjct: 115 RKEMVAIKIVRGIKKYREAAMIEIEVLQQLGKHDKGSNRCVQIRNWFDYRNHICIVFEKL 174

Query: 178 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 237
           G SLYDFLRKN+YRSFPIDLVREI  QLLEC+AFMHDL MIHTDLKPEN+LLVS EY+K+
Sbjct: 175 GPSLYDFLRKNSYRSFPIDLVREIGWQLLECVAFMHDLRMIHTDLKPENILLVSPEYLKI 234

Query: 238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGW 297
           PDYKS+  +P  SS+FKR+PKSSAIKVIDFGSTTYER DQ YIVSTRHYRAPEVILGLGW
Sbjct: 235 PDYKSTTRSP--SSFFKRVPKSSAIKVIDFGSTTYEREDQTYIVSTRHYRAPEVILGLGW 292

Query: 298 TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           +YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP+PQ MLKRVDRHAEKYVRR
Sbjct: 293 SYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPIPQQMLKRVDRHAEKYVRR 352

Query: 358 GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 417
           GRLDWPEGA SRESIK+VMKLPRLQNLIMQHVDHSAGDL HLLQGLLRYDP +RLTAR+A
Sbjct: 353 GRLDWPEGAISRESIKAVMKLPRLQNLIMQHVDHSAGDLIHLLQGLLRYDPFERLTARDA 412

Query: 418 LRHPFFTRDHLRR 430
           LRH FF RDHLRR
Sbjct: 413 LRHSFFMRDHLRR 425

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356516617|ref|XP_003526990.1| PREDICTED: serine/threonine-protein kinase AFC2-like [Glycine max]

 Score =  767 bits (1980), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/433 (85%), Positives = 395/433 (91%), Gaps = 11/433 (2%)

Query: 1   MEMERVTEFPFSNLDRRPRKRARLGWD---VPQAQVGLFCGQEVGNVTSFAPPRAPSDHV 57
           MEMER+ EFP + +DR PRKRARLGWD   VP+AQVGLFCGQEV N++SFAP   P    
Sbjct: 1   MEMERIVEFPHTYMDRPPRKRARLGWDIAEVPKAQVGLFCGQEVENISSFAPSEHPP--- 57

Query: 58  TSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRE 117
             SSLF KGVARNGSPPWR+DDKDGHYMF LG+NLTSRYKIH KMGEGTFGQVLECWDRE
Sbjct: 58  --SSLF-KGVARNGSPPWRDDDKDGHYMFELGDNLTSRYKIHGKMGEGTFGQVLECWDRE 114

Query: 118 RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 177
           RKEMVAIKIVRGIKKYREAAM+EIEVLQQL KHDKG NRCVQIRNWFDYRNHICIVFEKL
Sbjct: 115 RKEMVAIKIVRGIKKYREAAMVEIEVLQQLGKHDKGSNRCVQIRNWFDYRNHICIVFEKL 174

Query: 178 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 237
           G SLYDFLRKN+YRSFPIDLVREI  QLLEC+AFMHDL MIHTDLKPEN+LLVS EY+K+
Sbjct: 175 GPSLYDFLRKNSYRSFPIDLVREIGWQLLECVAFMHDLHMIHTDLKPENILLVSPEYLKI 234

Query: 238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGW 297
           PDYKS+  +P  SS+FKR+PKSSAIKVIDFGSTTYER DQ YIVSTRHYRAPEVILGLGW
Sbjct: 235 PDYKSTTRSP--SSFFKRVPKSSAIKVIDFGSTTYEREDQTYIVSTRHYRAPEVILGLGW 292

Query: 298 TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           +YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP+PQ MLKRVDRHAEKYVRR
Sbjct: 293 SYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPIPQQMLKRVDRHAEKYVRR 352

Query: 358 GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 417
           GRLDWPEGAASRESIK+VMKLPRLQN+IMQHVDHSAGDL HLLQGLLRYDP +RLTAR+A
Sbjct: 353 GRLDWPEGAASRESIKAVMKLPRLQNIIMQHVDHSAGDLIHLLQGLLRYDPFERLTARDA 412

Query: 418 LRHPFFTRDHLRR 430
           LRH FFTRD LRR
Sbjct: 413 LRHSFFTRDQLRR 425

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	430
TAIR|locus:2121984	427	FC2 "FUS3-complementing gene 2	0.979	0.985	0.827	1.4e-197
TAIR|locus:2084006	467	FC1 "FUS3-complementing gene 1	0.988	0.910	0.706	1.4e-165
TAIR|locus:2125622	400	AME3 [Arabidopsis thaliana (ta	0.855	0.92	0.640	9.1e-132
POMBASE|SPAC1D4.11c	690	lkh1 "dual specificity protein	0.783	0.488	0.463	1e-86
UNIPROTKB|E1B9Q2	500	CLK2 "Uncharacterized protein"	0.781	0.672	0.472	8.9e-86
UNIPROTKB|F1P919	612	CLK2 "Uncharacterized protein"	0.781	0.549	0.472	8.9e-86
UNIPROTKB|B1AVT0	497	CLK2 "Dual-specificity protein	0.781	0.676	0.472	8.9e-86
UNIPROTKB|P49760	499	CLK2 "Dual specificity protein	0.781	0.673	0.472	8.9e-86
UNIPROTKB|F1RLJ5	500	CLK2 "Uncharacterized protein"	0.781	0.672	0.472	8.9e-86
MGI|MGI:1098669	499	Clk2 "CDC-like kinase 2" [Mus	0.776	0.669	0.475	1.1e-85

TAIR|locus:2121984 FC2 "FUS3-complementing gene 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1913 (678.5 bits), Expect = 1.4e-197, P = 1.4e-197
 Identities = 355/429 (82%), Positives = 396/429 (92%)

Query:     1 MEMERVTEFPFSNLDRRPRKRARLGWDV-PQA---QVGLFCGQEVGNVTSFAPPRAPSDH 56
             MEMERV EFP +++DRRPRKRARLGWDV PQA   QVG+FCGQE+GN++SFA   APSD+
Sbjct:     1 MEMERVHEFPHTHMDRRPRKRARLGWDVLPQATKAQVGMFCGQEIGNISSFASSGAPSDN 60

Query:    57 VTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDR 116
               SSSL VKGVARNGSPPWREDDKDGHY+F LG++LT RYKI+SKMGEGTFGQVLECWDR
Sbjct:    61 --SSSLCVKGVARNGSPPWREDDKDGHYIFELGDDLTPRYKIYSKMGEGTFGQVLECWDR 118

Query:   117 ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 176
             ERKEMVA+KIVRG+KKYREAAMIEIE+LQQL KHDKGGNRCVQIRNWFDYRNHICIVFEK
Sbjct:   119 ERKEMVAVKIVRGVKKYREAAMIEIEMLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEK 178

Query:   177 LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 236
             LGSSLYDFLRKNNYRSFPIDLVREI  QLLEC+AFMHDL MIHTDLKPEN+LLVSS+Y+K
Sbjct:   179 LGSSLYDFLRKNNYRSFPIDLVREIGWQLLECVAFMHDLRMIHTDLKPENILLVSSDYVK 238

Query:   237 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG 296
             +P+YK S    +D  Y KR+PKSSAIKVIDFGSTTYER DQ YIVSTRHYRAPEVILGLG
Sbjct:   239 IPEYKGS-RLQRDVCY-KRVPKSSAIKVIDFGSTTYERQDQTYIVSTRHYRAPEVILGLG 296

Query:   297 WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR 356
             W+YPCD+WSVGCI+VELCTGEALFQTHENLEHLAMMERVLGP PQ MLK+VDRH+EKYVR
Sbjct:   297 WSYPCDVWSVGCIIVELCTGEALFQTHENLEHLAMMERVLGPFPQQMLKKVDRHSEKYVR 356

Query:   357 RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 416
             RGRLDWP+GA SR+S+K+V+KLPRLQNLIMQHVDHSAG+L +++QGLLR+DP++R+TARE
Sbjct:   357 RGRLDWPDGATSRDSLKAVLKLPRLQNLIMQHVDHSAGELINMVQGLLRFDPSERITARE 416

Query:   417 ALRHPFFTR 425
             ALRHPFF R
Sbjct:   417 ALRHPFFAR 425

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0004672 "protein kinase activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0006397 "mRNA processing" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0045727 "positive regulation of translation" evidence=RCA

TAIR|locus:2084006 FC1 "FUS3-complementing gene 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1611 (572.2 bits), Expect = 1.4e-165, P = 1.4e-165
 Identities = 303/429 (70%), Positives = 347/429 (80%)

Query:     1 MEMERVTEFPFSNLDRRPRKRARLGWDVPQAQVGLFCGQEVGNVTSFAPPRAPSDHVTS- 59
             +E +R  EFP   +D+RPRKR RL WD     +       V     +  P   S  V + 
Sbjct:    17 LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 76

Query:    60 --SSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRE 117
                ++F  G+ R GSPPWR DDKDGHY+F +G+ LT RY+I SKMGEGTFGQVLEC+D +
Sbjct:    77 VYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQILSKMGEGTFGQVLECFDNK 136

Query:   118 RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 177
              KE+VAIK++R I KYREAAMIEI+VLQ+L +HD GG+RCVQIRNWFDYRNHICIVFEKL
Sbjct:   137 NKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFEKL 196

Query:   178 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 237
             G SLYDFLRKN+YRSFPIDLVRE+ RQLLE +A+MHDL +IHTDLKPEN+LLVSSEYIK+
Sbjct:   197 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKI 256

Query:   238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGW 297
             PDYK      KD SYFK +PKSSAIK+IDFGSTT+E  D NYIVSTRHYRAPEVILG+GW
Sbjct:   257 PDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIVSTRHYRAPEVILGVGW 316

Query:   298 TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
              YPCD+WS+GCILVELC+GEALFQTHENLEHLAMMERVLGPLP HM+ R DR +EKY RR
Sbjct:   317 NYPCDLWSIGCILVELCSGEALFQTHENLEHLAMMERVLGPLPPHMVLRADRRSEKYFRR 376

Query:   358 G-RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 416
             G +LDWPEGA SR+S+K+V KLPRL NLIMQHVDHSAGDL  LLQGLLRYDPT+R  ARE
Sbjct:   377 GAKLDWPEGATSRDSLKAVWKLPRLPNLIMQHVDHSAGDLIDLLQGLLRYDPTERFKARE 436

Query:   417 ALRHPFFTR 425
             AL HPFFTR
Sbjct:   437 ALNHPFFTR 445

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005739 "mitochondrion" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0045727 "positive regulation of translation" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=TAS

TAIR|locus:2125622 AME3 [Arabidopsis thaliana (taxid:3702)]

 Score = 1292 (459.9 bits), Expect = 9.1e-132, P = 9.1e-132
 Identities = 241/376 (64%), Positives = 303/376 (80%)

Query:    52 APSDHVTSSSLFVKGVARNG---SPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFG 108
             AP++     ++ +KG   +G   SPP R+DD+DGHY+F+L +NLT RYKI SKMGEGTFG
Sbjct:    25 APAEPEAKRAV-IKGHGSDGRILSPPLRDDDRDGHYVFSLRDNLTPRYKILSKMGEGTFG 83

Query:   109 QVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 168
             +VLECWDR+ KE VAIKI+R IKKYR+AAMIEI+VLQ+L K DKG  RCVQ++NWFDYRN
Sbjct:    84 RVLECWDRDTKEYVAIKIIRSIKKYRDAAMIEIDVLQKLVKSDKGRTRCVQMKNWFDYRN 143

Query:   169 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL 228
             HICIVFEKLG SL+DFL++N Y +FP+ LVR+   QLLE +A+MH+L ++HTDLKPEN+L
Sbjct:   144 HICIVFEKLGPSLFDFLKRNKYSAFPLALVRDFGCQLLESVAYMHELQLVHTDLKPENIL 203

Query:   229 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRA 288
             LVSSE +K+PD K S     + ++F+ +PKSSAIK+IDFGST  +    + IV TRHYR+
Sbjct:   204 LVSSENVKLPDNKRSA---ANETHFRCLPKSSAIKLIDFGSTVCDNRIHHSIVQTRHYRS 260

Query:   289 PEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVD 348
             PEVILGLGW+Y CD+WS+GCIL ELCTGEALFQTH+NLEHLAMMER LGPLP+HM ++  
Sbjct:   261 PEVILGLGWSYQCDLWSIGCILFELCTGEALFQTHDNLEHLAMMERALGPLPEHMTRKAS 320

Query:   349 RHAEKYVRRG-RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 407
             R AEKY RRG RL+WPEGA SRESI++V +L RL++++ +HVD++      LL GLL YD
Sbjct:   321 RGAEKYFRRGCRLNWPEGANSRESIRAVKRLDRLKDMVSKHVDNTRSRFADLLYGLLAYD 380

Query:   408 PTDRLTAREALRHPFF 423
             P++RLTA EAL HPFF
Sbjct:   381 PSERLTANEALDHPFF 396

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0045727 "positive regulation of translation" evidence=RCA

POMBASE|SPAC1D4.11c lkh1 "dual specificity protein kinase Lkh1" [Schizosaccharomyces pombe (taxid:4896)]

 Score = 840 (300.8 bits), Expect = 1.0e-86, Sum P(2) = 1.0e-86
 Identities = 163/352 (46%), Positives = 237/352 (67%)

Query:    78 DDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA 137
             DD DGHY         +RY +   +G GTFG+V++C+D+      AIK+ R I KYREA+
Sbjct:   344 DDDDGHYKVVPNSKFANRYTVVRLLGHGTFGKVIQCYDQSTGRHCAIKVTRAIPKYREAS 403

Query:   138 MIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPID 196
             +IE+ VLQ +A  D    N+C+Q+R++FDYR HICIV +  G S++DFL+ NNY  FP+ 
Sbjct:   404 LIELRVLQTIAHSDPTNENKCIQLRDYFDYRKHICIVTDLFGWSVFDFLKNNNYIPFPLK 463

Query:   197 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS--SEYIKVPDYKSSLHTPKDSSYFK 254
              ++ +++QL + +AF+H L ++HTDLKPENVLLVS  S  I++P Y++         Y +
Sbjct:   464 HIQMLSQQLFKSVAFLHSLGLVHTDLKPENVLLVSNASRTIRLP-YRN---------YSQ 513

Query:   255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
             ++  S  I++IDFGS T+E    + +VSTRHYRAPE+ILGLGW+YPCD+WS+GCILVEL 
Sbjct:   514 KVLNSCEIRLIDFGSATFEDEYHSSVVSTRHYRAPEIILGLGWSYPCDVWSIGCILVELF 573

Query:   315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR-GRLDWPEGAASRESIK 373
             TG+ALFQTHE+ EHL MME++LGP  ++M+ R  R ++++ +  G++ +P     ++SI 
Sbjct:   574 TGQALFQTHEDSEHLCMMEKILGPFDRNMISRSSRTSQRFFKSDGKVRYPLSNTPKKSIN 633

Query:   374 SVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
              +  L  L+ +        A  L  LL+ +  YDP  R+TA+EAL HPFFT+
Sbjct:   634 YLQSLQTLEQIFAVSSPEVAL-LLDLLKKVFVYDPKRRITAKEALWHPFFTQ 684

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IMP;IDA

GO:0006468 "protein phosphorylation" evidence=IC

GO:0010590 "regulation of cytokinetic cell separation" evidence=IMP

GO:0032955 "regulation of barrier septum assembly" evidence=IMP

GO:0034599 "cellular response to oxidative stress" evidence=IMP

GO:0035556 "intracellular signal transduction" evidence=TAS

GO:0048026 "positive regulation of mRNA splicing, via spliceosome" evidence=IMP

GO:0051519 "activation of bipolar cell growth" evidence=IMP

GO:0060237 "regulation of fungal-type cell wall organization" evidence=IMP

GO:0060257 "negative regulation of flocculation" evidence=IMP

GO:0060258 "negative regulation of filamentous growth" evidence=IMP

UNIPROTKB|E1B9Q2 CLK2 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 858 (307.1 bits), Expect = 8.9e-86, P = 8.9e-86
 Identities = 166/351 (47%), Positives = 236/351 (67%)

Query:    77 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYRE 135
             EDD +GH ++ +G+ L  RY+I S +GEGTFG+V++C D  R    VA+KI++ ++KY+E
Sbjct:   144 EDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKE 203

Query:   136 AAMIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 194
             AA +EI VL+++ + D    N CVQ+ +WFDY  H+CI FE LG S +DFL+ NNY  +P
Sbjct:   204 AARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYP 263

Query:   195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
             I  VR +A QL + + F+HD  + HTDLKPEN+L V+S+Y    +   +L   +D    +
Sbjct:   264 IHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----E 315

Query:   255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
             R  KS+A++V+DFGS T++    + IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E  
Sbjct:   316 RSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYY 375

Query:   315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
              G  LFQTH+N EHLAMMER+LGP+P  M+++  +  +KY  RGRLDW E  ++   ++ 
Sbjct:   376 VGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRE 433

Query:   375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
               K P  + L  +  +H    L  L++ +L Y+P  RLT  EAL+HPFF R
Sbjct:   434 NCK-PLRRYLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 481

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0045721 "negative regulation of gluconeogenesis" evidence=IEA

GO:0043484 "regulation of RNA splicing" evidence=IEA

GO:0032526 "response to retinoic acid" evidence=IEA

GO:0018108 "peptidyl-tyrosine phosphorylation" evidence=IEA

GO:0010212 "response to ionizing radiation" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1P919 CLK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 858 (307.1 bits), Expect = 8.9e-86, P = 8.9e-86
 Identities = 166/351 (47%), Positives = 236/351 (67%)

Query:    77 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYRE 135
             EDD +GH ++ +G+ L  RY+I S +GEGTFG+V++C D  R    VA+KI++ ++KY+E
Sbjct:   256 EDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKE 315

Query:   136 AAMIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 194
             AA +EI VL+++ + D    N CVQ+ +WFDY  H+CI FE LG S +DFL+ NNY  +P
Sbjct:   316 AARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYP 375

Query:   195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
             I  VR +A QL + + F+HD  + HTDLKPEN+L V+S+Y    +   +L   +D    +
Sbjct:   376 IHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----E 427

Query:   255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
             R  KS+A++V+DFGS T++    + IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E  
Sbjct:   428 RSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYY 487

Query:   315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
              G  LFQTH+N EHLAMMER+LGP+P  M+++  +  +KY  RGRLDW E  ++   ++ 
Sbjct:   488 VGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRE 545

Query:   375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
               K P  + L  +  +H    L  L++ +L Y+P  RLT  EAL+HPFF R
Sbjct:   546 NCK-PLRRYLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 593

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|B1AVT0 CLK2 "Dual-specificity protein kinase CLK2" [Homo sapiens (taxid:9606)]

 Score = 858 (307.1 bits), Expect = 8.9e-86, P = 8.9e-86
 Identities = 166/351 (47%), Positives = 236/351 (67%)

Query:    77 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYRE 135
             EDD +GH ++ +G+ L  RY+I S +GEGTFG+V++C D  R    VA+KI++ ++KY+E
Sbjct:   142 EDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKE 201

Query:   136 AAMIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 194
             AA +EI VL+++ + D    N CVQ+ +WFDY  H+CI FE LG S +DFL+ NNY  +P
Sbjct:   202 AARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYP 261

Query:   195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
             I  VR +A QL + + F+HD  + HTDLKPEN+L V+S+Y    +   +L   +D    +
Sbjct:   262 IHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----E 313

Query:   255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
             R  KS+A++V+DFGS T++    + IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E  
Sbjct:   314 RSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYY 373

Query:   315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
              G  LFQTH+N EHLAMMER+LGP+P  M+++  +  +KY  RGRLDW E  ++   ++ 
Sbjct:   374 VGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRE 431

Query:   375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
               K P  + L  +  +H    L  L++ +L Y+P  RLT  EAL+HPFF R
Sbjct:   432 NCK-PLRRYLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 479

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|P49760 CLK2 "Dual specificity protein kinase CLK2" [Homo sapiens (taxid:9606)]

 Score = 858 (307.1 bits), Expect = 8.9e-86, P = 8.9e-86
 Identities = 166/351 (47%), Positives = 236/351 (67%)

Query:    77 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYRE 135
             EDD +GH ++ +G+ L  RY+I S +GEGTFG+V++C D  R    VA+KI++ ++KY+E
Sbjct:   144 EDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKE 203

Query:   136 AAMIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 194
             AA +EI VL+++ + D    N CVQ+ +WFDY  H+CI FE LG S +DFL+ NNY  +P
Sbjct:   204 AARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYP 263

Query:   195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
             I  VR +A QL + + F+HD  + HTDLKPEN+L V+S+Y    +   +L   +D    +
Sbjct:   264 IHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----E 315

Query:   255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
             R  KS+A++V+DFGS T++    + IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E  
Sbjct:   316 RSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYY 375

Query:   315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
              G  LFQTH+N EHLAMMER+LGP+P  M+++  +  +KY  RGRLDW E  ++   ++ 
Sbjct:   376 VGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRE 433

Query:   375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
               K P  + L  +  +H    L  L++ +L Y+P  RLT  EAL+HPFF R
Sbjct:   434 NCK-PLRRYLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 481

GO:0005524 "ATP binding" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0018108 "peptidyl-tyrosine phosphorylation" evidence=IEA

GO:0032526 "response to retinoic acid" evidence=IEA

GO:0016607 "nuclear speck" evidence=IEA

GO:0043484 "regulation of RNA splicing" evidence=IDA

GO:0010212 "response to ionizing radiation" evidence=IMP

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005634 "nucleus" evidence=IDA

GO:0045721 "negative regulation of gluconeogenesis" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=ISS

UNIPROTKB|F1RLJ5 CLK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 858 (307.1 bits), Expect = 8.9e-86, P = 8.9e-86
 Identities = 166/351 (47%), Positives = 236/351 (67%)

Query:    77 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYRE 135
             EDD +GH ++ +G+ L  RY+I S +GEGTFG+V++C D  R    VA+KI++ ++KY+E
Sbjct:   144 EDDAEGHLIYHVGDWLQERYEIISTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKE 203

Query:   136 AAMIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 194
             AA +EI VL+++ + D    N CVQ+ +WFDY  H+CI FE LG S +DFL+ NNY  +P
Sbjct:   204 AARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYP 263

Query:   195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
             I  VR +A QL + + F+HD  + HTDLKPEN+L V+S+Y    +   +L   +D    +
Sbjct:   264 IHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----E 315

Query:   255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
             R  KS+A++V+DFGS T++    + IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E  
Sbjct:   316 RSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYY 375

Query:   315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
              G  LFQTH+N EHLAMMER+LGP+P  M+++  +  +KY  RGRLDW E  ++   ++ 
Sbjct:   376 VGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRE 433

Query:   375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
               K P  + L  +  +H    L  L++ +L Y+P  RLT  EAL+HPFF R
Sbjct:   434 NCK-PLRRYLTSEAEEHH--QLFDLIESMLEYEPAKRLTLGEALQHPFFAR 481

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0045721 "negative regulation of gluconeogenesis" evidence=IEA

GO:0043484 "regulation of RNA splicing" evidence=IEA

GO:0032526 "response to retinoic acid" evidence=IEA

GO:0018108 "peptidyl-tyrosine phosphorylation" evidence=IEA

GO:0010212 "response to ionizing radiation" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

MGI|MGI:1098669 Clk2 "CDC-like kinase 2" [Mus musculus (taxid:10090)]

 Score = 857 (306.7 bits), Expect = 1.1e-85, P = 1.1e-85
 Identities = 166/349 (47%), Positives = 235/349 (67%)

Query:    77 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYRE 135
             EDD +GH ++ +G+ L  RY+I S +GEGTFG+V++C D  R    VA+KI++ ++KY+E
Sbjct:   143 EDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGTQVALKIIKNVEKYKE 202

Query:   136 AAMIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 194
             AA +EI VL+++ + D    N CVQ+ +WFDY  H+CI FE LG S +DFL+ NNY  +P
Sbjct:   203 AARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYP 262

Query:   195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
             I  VR +A QL + + F+HD  + HTDLKPEN+L V+S+Y    +   +L   +D    +
Sbjct:   263 IHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----E 314

Query:   255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
             R  KS+A++V+DFGS T++    + IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E  
Sbjct:   315 RSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYY 374

Query:   315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
              G  LFQTH+N EHLAMMER+LGP+P  M+++  +  +KY  RGRLDW E  ++   ++ 
Sbjct:   375 VGFTLFQTHDNREHLAMMERILGPVPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRE 432

Query:   375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
               K P  + L  +  DH    L  L++ +L Y+P  RLT  EAL+HPFF
Sbjct:   433 NCK-PLRRYLTSEAEDHH--QLFDLIENMLEYEPAKRLTLGEALQHPFF 478

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO;IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISO;IDA

GO:0010212 "response to ionizing radiation" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0018108 "peptidyl-tyrosine phosphorylation" evidence=IDA

GO:0032526 "response to retinoic acid" evidence=IDA

GO:0042221 "response to chemical stimulus" evidence=IDA

GO:0043484 "regulation of RNA splicing" evidence=ISO

GO:0045721 "negative regulation of gluconeogenesis" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P51567	AFC2_ARATH	2, ., 7, ., 1, 2, ., 1	0.8275	0.9790	0.9859	yes	no
P51566	AFC1_ARATH	2, ., 7, ., 1, 2, ., 1	0.7062	0.9883	0.9100	no	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.12.1	0.994
3rd Layer	2.7.12	0.998
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	430
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-73
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	5e-68
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-59
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-55
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-50
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-49
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-47
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-44
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-44
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-37
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-37
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-37
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-37
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-37
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-37
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-36
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-35
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-34
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-33
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-33
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-32
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-32
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-31
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-31
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-31
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-31
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-30
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-29
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-29
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-28
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-28
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-28
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-28
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-27
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-27
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-27
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-27
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-27
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-26
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-26
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-25
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-25
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-25
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-25
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-25
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-24
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-24
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-24
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-24
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-23
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-23
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-23
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-23
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-22
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-22
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-21
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-21
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-21
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-21
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-19
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-19
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-19
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-18
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-18
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-17
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-17
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-16
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-16
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-15
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-15
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-15
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-15
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-15
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-15
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-14
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-14
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-13
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-13
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-13
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-12
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-12
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-12
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	7e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-11
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-11
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-11
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-11
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-11
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	8e-11
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-11
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-10
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-10
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-10
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	7e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	8e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-08
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-08
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-08
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-07
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-07
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-07
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-07
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-06
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-06
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-06
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-06
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-05
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-05
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-05
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-05
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-05
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-05
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-05
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-05
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-04
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-04
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-04
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-04
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-04
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-04
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-04
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-04
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	0.001
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	0.001
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	0.001
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	0.001
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	0.001
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.003
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	0.003
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.003
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	0.003
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	0.003
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  230 bits (590), Expect = 1e-73
 Identities = 99/333 (29%), Positives = 148/333 (44%), Gaps = 84/333 (25%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKG 153
           Y+I  K+GEG+FG+V    D++  ++VAIK+++   IKK RE  + EI++L++L KH   
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPN- 58

Query: 154 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
               V++ + F+  + + +V E   G  L+D L+K        D  R   RQ+L  + ++
Sbjct: 59  ---IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYL 113

Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKPEN+LL    +                           +K+ DFG    
Sbjct: 114 HSKGIVHRDLKPENILLDEDGH---------------------------VKLADFGLARQ 146

Query: 273 ERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
             P +     V T  Y APEV+LG G+    DIWS+G IL EL TG+  F   + L    
Sbjct: 147 LDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLL--E 204

Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 390
           + +++  P P                      PE   S E+                   
Sbjct: 205 LFKKIGKPKPP------------------FPPPEWDISPEAK------------------ 228

Query: 391 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                   L++ LL  DP  RLTA EAL+HPFF
Sbjct: 229 -------DLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score =  223 bits (569), Expect = 5e-68
 Identities = 129/354 (36%), Positives = 197/354 (55%), Gaps = 36/354 (10%)

Query: 80  KDGHYMFALGENL---TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA 136
           ++GH+   LGE++   T R+KI S +GEGTFG+V+E WDR+RKE  A+KIVR + KY   
Sbjct: 112 EEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRD 171

Query: 137 AMIEIEVLQQLAKHDKGGN-RCVQIRNWF-DYRNHICIVFEKLGSSLYDFLRKN---NYR 191
           A IEI+ ++++ + D       ++I+ +F +   H+CIV  K G  L D++ K+   ++R
Sbjct: 172 AKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHR 231

Query: 192 SFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 250
                   +I  Q    + + H +L ++HTDLKPEN+L+ +S+   V D  ++   P   
Sbjct: 232 HLA-----QIIFQTGVALDYFHTELHLMHTDLKPENILMETSD--TVVDPVTNRALP--- 281

Query: 251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 310
                 P    +++ D G    ER  +  IVSTRHYR+PEV+LGLGW Y  D+WS+GCI+
Sbjct: 282 ------PDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII 335

Query: 311 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEK--YVRRGRLDWPEGAAS 368
            EL TG+ L+ TH+NLEHL +ME+ LG LP     R      +  Y   G+L        
Sbjct: 336 YELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQL---RPCTD 392

Query: 369 RESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
            + +  + +   ++ +I   +      L  L+ GLL YD   RL AR+   HP+
Sbjct: 393 PKHLARIARARPVREVIRDDL------LCDLIYGLLHYDRQKRLNARQMTTHPY 440

Length = 467

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  194 bits (496), Expect = 2e-59
 Identities = 89/336 (26%), Positives = 147/336 (43%), Gaps = 84/336 (25%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDK 152
           Y++  K+G G+FG V +   +   ++VA+KI++      K  + A  EI +L++L  H  
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59

Query: 153 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                V++ + F+ ++H+ +V E   G  L+D+L +        D  ++IA Q+L  + +
Sbjct: 60  I----VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEY 113

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-ST 270
           +H   +IH DLKPEN+LL  +  +K+                            DFG + 
Sbjct: 114 LHSNGIIHRDLKPENILLDENGVVKI---------------------------ADFGLAK 146

Query: 271 TYERPDQNY--IVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
              +   +    V T  Y APEV+L G G+    D+WS+G IL EL TG+  F     L+
Sbjct: 147 KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILD 206

Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L ++ R+LGP                      D P+ ++  E                 
Sbjct: 207 QLQLIRRILGPPL------------------EFDEPKWSSGSE----------------- 231

Query: 388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                  +   L++  L  DP+ R TA E L+HP+F
Sbjct: 232 -------EAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  185 bits (471), Expect = 1e-55
 Identities = 104/340 (30%), Positives = 161/340 (47%), Gaps = 69/340 (20%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR--EAAMI--EIEVLQQLAKHD 151
           YK+  ++G+GTFG V    ++E  E+VAIK  +  KK+   E  M   E++ L++L +H 
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIK--KMKKKFYSWEECMNLREVKSLRKLNEHP 58

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                 V+++  F   + +  VFE +  +LY  ++    + F   ++R I  Q+L+ +A 
Sbjct: 59  N----IVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--S 269
           +H     H DLKPEN LLVS   +                          +K+ DFG   
Sbjct: 115 IHKHGFFHRDLKPEN-LLVSGPEV--------------------------VKIADFGLAR 147

Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLE 327
               RP     VSTR YRAPE++L     Y  P DIW++GCI+ EL T   LF     ++
Sbjct: 148 EIRSRPPYTDYVSTRWYRAPEILLRSTS-YSSPVDIWALGCIMAELYTLRPLFPGSSEID 206

Query: 328 HLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGA--ASRESIKSVMKLPRL-QN 383
            L  +  VLG P  Q                   DWPEG   AS+       + P+    
Sbjct: 207 QLYKICSVLGTPTKQ-------------------DWPEGYKLASKLGF----RFPQFAPT 243

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
            + Q + +++ +   L++ +LR+DP  R TA +AL+HP+F
Sbjct: 244 SLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  171 bits (435), Expect = 3e-50
 Identities = 97/350 (27%), Positives = 157/350 (44%), Gaps = 90/350 (25%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAK 149
           Y+   K+GEGT+G V +  D++  E+VA+K +R      GI      A+ EI +L++L K
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPS---TALREISLLKEL-K 56

Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
           H    N  V++ +       + +VFE     L  +L          +L++ I  QLL  +
Sbjct: 57  HP---N-IVKLLDVIHTERKLYLVFEYCDMDLKKYL-DKRPGPLSPNLIKSIMYQLLRGL 111

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 268
           A+ H   ++H DLKP+N +L++ + +                          +K+ DFG 
Sbjct: 112 AYCHSHRILHRDLKPQN-ILINRDGV--------------------------LKLADFGL 144

Query: 269 STTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
           +  +  P + Y   V T  YRAPE++LG   ++   DIWSVGCI  E+ TG+ LF     
Sbjct: 145 ARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE 204

Query: 326 LEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           ++ L  + ++LG P  +                    WP           V KLP  +  
Sbjct: 205 IDQLFKIFQILGTPTEE-------------------SWPG----------VTKLPDYKPT 235

Query: 385 IMQH-----------VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             +            +D    D   LL  +L+Y+P  R++A+EAL+HP+F
Sbjct: 236 FPKFPPKDLEKVLPRLDPEGID---LLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  168 bits (428), Expect = 3e-49
 Identities = 100/337 (29%), Positives = 164/337 (48%), Gaps = 58/337 (17%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHD 151
           +Y++   +GEG +G VL+C ++   E+VAIK        +  ++ A+ E++VL+QL +H+
Sbjct: 2   KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHE 60

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                 V ++  F  +  + +VFE +  +L + L  +     P D VR    QLL+ IA+
Sbjct: 61  N----IVNLKEAFRRKGRLYLVFEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAY 115

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN +LVS                          +S  +K+ DFG   
Sbjct: 116 CHSHNIIHRDIKPEN-ILVS--------------------------ESGVLKLCDFGFAR 148

Query: 272 Y--ERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
               RP       V+TR YRAPE+++G   +  P D+W++GCI+ EL  GE LF    ++
Sbjct: 149 ALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI 208

Query: 327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 386
           + L ++++ LGPLP    +    +     R   + +PE  +  ES++      R    + 
Sbjct: 209 DQLYLIQKCLGPLPPSHQELFSSNP----RFAGVAFPE-PSQPESLER-----RYPGKV- 257

Query: 387 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                 +      L+  LR DP +RLT  E L+HP+F
Sbjct: 258 ------SSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  162 bits (411), Expect = 8e-47
 Identities = 100/343 (29%), Positives = 153/343 (44%), Gaps = 75/343 (21%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAK 149
           Y+   K+GEGT+G V +  D+   E+VAIK ++      GI K    A+ EI++L++L  
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPK---TALREIKLLKEL-N 56

Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
           H       +++ + F ++  + +VFE + + LY  ++    R  P  L++    QLL+ +
Sbjct: 57  HPN----IIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGL 111

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
           AF H   ++H DLKPEN+L+                                +K+ DFG 
Sbjct: 112 AFCHSHGILHRDLKPENLLI---------------------------NTEGVLKLADFGL 144

Query: 270 TTYERPDQNYI---VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
                         V TR YRAPE++LG  G++ P DIWSVGCI  EL +   LF     
Sbjct: 145 ARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE 204

Query: 326 LEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGA----ASRESIKSVMKLPR 380
           ++ L  + R LG P P+                    WP+        + S      +P 
Sbjct: 205 IDQLFKIFRTLGTPDPEV-------------------WPKFTSLARNYKFSFPKKAGMP- 244

Query: 381 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
               +  +    A D   LL  +L YDP  R+TA +AL HP+F
Sbjct: 245 -LPKLFPNASPQALD---LLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  156 bits (396), Expect = 1e-44
 Identities = 100/346 (28%), Positives = 153/346 (44%), Gaps = 76/346 (21%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHD 151
           RYKI  ++GEG  G V +  DRE  E VA+K   + R        A+ EI+ LQ   +H 
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHP 59

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                 V++ + F + +   +V E + S L + LR +  R  P   V+   R LL+ +A+
Sbjct: 60  ----YVVKLLDVFPHGSGFVLVMEYMPSDLSEVLR-DEERPLPEAQVKSYMRMLLKGVAY 114

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAIKVIDFGS 269
           MH   ++H DLKP N+L+ +   +K+ D+  +      +   Y  +              
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-------------- 160

Query: 270 TTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEH 328
                      V+TR YRAPE++ G   +    D+W+VGCI  EL  G  LF    ++E 
Sbjct: 161 -----------VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ 209

Query: 329 LAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM- 386
           LA++ R LG P  +                    WP           +  LP    +   
Sbjct: 210 LAIVFRTLGTPNEE-------------------TWPG----------LTSLPDYNKITFP 240

Query: 387 --------QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
                   +    ++ +   LL+GLL YDP+ RL+A EALRHP+FT
Sbjct: 241 ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  153 bits (389), Expect = 3e-44
 Identities = 73/218 (33%), Positives = 106/218 (48%), Gaps = 39/218 (17%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           GEG FG V    D++  + VAIKI++        E  + EIE+L++L  H       V++
Sbjct: 2   GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHP----NIVKL 56

Query: 161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
              F+  NH+ +V E   G SL D L++N  +    D +  I  Q+LE + ++H   +IH
Sbjct: 57  YGVFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIH 115

Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DLKPEN+LL S                              +K+ DFG +     D++ 
Sbjct: 116 RDLKPENILLDSDNGK--------------------------VKLADFGLSKLLTSDKSL 149

Query: 280 ---IVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVEL 313
              IV T  Y APEV+LG G ++   DIWS+G IL EL
Sbjct: 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  137 bits (348), Expect = 1e-37
 Identities = 90/343 (26%), Positives = 148/343 (43%), Gaps = 71/343 (20%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMI-EIEVLQQLA 148
           Y+  +++GEG +G V +  D      VA+K VR      GI      + + EI +L+QL 
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP----LSTLREIALLKQLE 56

Query: 149 KHDKGGNRCVQIR----NWFDYRN-HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 203
             +      V++          R   + +VFE +   L  +L K      P + ++++ R
Sbjct: 57  SFEH--PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR 114

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           QLL  + F+H   ++H DLKP+N+L+ S   +K+ D+  +                   +
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA-------------------R 155

Query: 264 VIDFGS--TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
           +  F    T+        +V T  YRAPEV+L   +  P D+WSVGCI  EL     LF+
Sbjct: 156 IYSFEMALTS--------VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFR 207

Query: 322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPR 380
                + L  +  V+G   +                   +WP   +  R S  S    PR
Sbjct: 208 GTSEADQLDKIFDVIGLPSEE------------------EWPRNVSLPRSSFPS--YTPR 247

Query: 381 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                +  +     D   LL+ +L ++P  R++A EAL+HP+F
Sbjct: 248 SFKSFVPEICEEGLD---LLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  137 bits (348), Expect = 1e-37
 Identities = 100/343 (29%), Positives = 169/343 (49%), Gaps = 72/343 (20%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK---------IVRGIKKYREAAMIEIEVLQ 145
           +Y+  SK+GEG++G V +C +RE  ++VAIK         +++ I      A+ EI +L+
Sbjct: 2   KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI------ALREIRMLK 55

Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQL 205
           QL KH       V +   F  +  + +VFE    ++ + L KN  R  P  L+++I  Q 
Sbjct: 56  QL-KH----PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQT 109

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L+ + F H    IH D+KPEN+L+                            K   IK+ 
Sbjct: 110 LQAVNFCHKHNCIHRDVKPENILIT---------------------------KQGQIKLC 142

Query: 266 DFG-STTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ 321
           DFG +     P  +Y   V+TR YRAPE+++G   +  P D+W++GC+  EL TG+ L+ 
Sbjct: 143 DFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202

Query: 322 THENLEHLAMMERVLGPL-PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              +++ L ++ + LG L P+H  +++     ++ +   +  PE   +RE ++   K P 
Sbjct: 203 GKSDVDQLYLIRKTLGDLIPRH--QQIFS-TNQFFKGLSIPEPE---TREPLE--SKFPN 254

Query: 381 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           + +  +             L+G L+ DPT+RL+  E L HP+F
Sbjct: 255 ISSPALS-----------FLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  138 bits (350), Expect = 2e-37
 Identities = 96/355 (27%), Positives = 153/355 (43%), Gaps = 81/355 (22%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMI--EIEVLQQLAKHD 151
           RY++   +G G +G V    D+     VAIK I        +A  I  EI++L+ L +H+
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHE 59

Query: 152 KGGNRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR--- 203
              N  + + +       +  N + IV E + + L+  ++       P  L  +  +   
Sbjct: 60  ---N-IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS------PQPLTDDHIQYFL 109

Query: 204 -QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
            Q+L  + ++H   +IH DLKP N+L+ S+                             +
Sbjct: 110 YQILRGLKYLHSANVIHRDLKPSNILVNSN---------------------------CDL 142

Query: 263 KVIDFG----STTYERPDQN---YIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELC 314
           K+ DFG        E        Y+V TR YRAPE++L    +T   DIWSVGCI  EL 
Sbjct: 143 KICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201

Query: 315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
           T + LF   + ++ L ++  VLG   +  LK +                    +R  +KS
Sbjct: 202 TRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI----------------TSEKARNYLKS 245

Query: 375 VMKLPRLQNL--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           + K P+ + L  +       A D   LL+ +L +DP  R+TA EAL HP+  + H
Sbjct: 246 LPKKPK-KPLSKLFPGASPEAID---LLEKMLVFDPKKRITADEALAHPYLAQLH 296

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  137 bits (346), Expect = 2e-37
 Identities = 101/336 (30%), Positives = 154/336 (45%), Gaps = 62/336 (18%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHD 151
           YKI  K+GEGTF +VL+   R+  +  AIK     K ++    +    EI+ L++L+ H 
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIK--CMKKHFKSLEQVNNLREIQALRRLSPH- 57

Query: 152 KGGNRCVQIRNWFDYR-NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
              N    I   FD +   + +VFE +  +LY+ + K   R  P   V+    QLL+ + 
Sbjct: 58  --PNILRLIEVLFDRKTGRLALVFELMDMNLYELI-KGRKRPLPEKRVKSYMYQLLKSLD 114

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS- 269
            MH   + H D+KPEN+L+                            K   +K+ DFGS 
Sbjct: 115 HMHRNGIFHRDIKPENILI----------------------------KDDILKLADFGSC 146

Query: 270 -TTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLE 327
              Y +P     +STR YRAPE +L  G +    DIW+VGC+  E+ +   LF     L+
Sbjct: 147 RGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD 206

Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            +A +  VLG     +LK+  +           ++P         K    L +L    + 
Sbjct: 207 QIAKIHDVLGTPDAEVLKKFRKSRHM-----NYNFPS--------KKGTGLRKL----LP 249

Query: 388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           +      D   LL+ LL YDP +R+TA++ALRHP+F
Sbjct: 250 NASAEGLD---LLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  136 bits (346), Expect = 3e-37
 Identities = 90/341 (26%), Positives = 153/341 (44%), Gaps = 66/341 (19%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA------AMIEIEVLQQLA 148
           RY+   K+GEGT+  V +  D+E   +VAIK ++  ++          A+ EI++LQ+L 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL- 59

Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           KH       + + + F ++++I +VFE + + L   ++  +    P D ++      L  
Sbjct: 60  KHPN----IIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD-IKSYMLMTLRG 114

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           + ++H   ++H DLKP N LL++S+ +                          +K+ DFG
Sbjct: 115 LEYLHSNWILHRDLKPNN-LLIASDGV--------------------------LKLADFG 147

Query: 269 -STTYERPDQNYI--VSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHE 324
            + ++  P++     V TR YRAPE++ G   +    D+WSVGCI  EL           
Sbjct: 148 LARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207

Query: 325 NLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
           +++ L  +   LG P  +                   +WP G  S          P    
Sbjct: 208 DIDQLGKIFEALGTPTEE-------------------NWP-GVTSLPDYVEFKPFPPTP- 246

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
            + Q    ++ D   LLQ LL  +P  R+TAR+AL HP+F+
Sbjct: 247 -LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  138 bits (349), Expect = 4e-37
 Identities = 103/357 (28%), Positives = 156/357 (43%), Gaps = 76/357 (21%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--------KKYREAAMIEI 141
           +++  +Y+I  K+G+G +G V +  DR  KE+VA+K +           + +RE     I
Sbjct: 3   KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFRE-----I 57

Query: 142 EVLQQLAKHDKGGNRCVQIRNWFDYRNH--ICIVFEKLGSSLYDFLRKNNYRSFPIDLVR 199
             LQ+L  H       V++ N     N   I +VFE + + L+  +R N          R
Sbjct: 58  MFLQELGDHPN----IVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILED---VHKR 110

Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
            I  QLL+ + ++H   +IH DLKP N+LL                   +S         
Sbjct: 111 YIMYQLLKALKYIHSGNVIHRDLKPSNILL-------------------NSDCR------ 145

Query: 260 SAIKVIDFG--------STTYERPDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCIL 310
             +K+ DFG            E P     V+TR YRAPE++LG    T   D+WSVGCIL
Sbjct: 146 --VKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCIL 203

Query: 311 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRE 370
            E+  G+ LF     L  L  +  V+GP     ++ +               P  A   +
Sbjct: 204 GEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS-------------PFAATMLD 250

Query: 371 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           S+ S  + P  +  ++      A D   LL+ LL ++P  RLTA EAL HP+  + H
Sbjct: 251 SLPSRPRKPLDE--LLPKASDDALD---LLKKLLVFNPNKRLTAEEALEHPYVAQFH 302

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  135 bits (342), Expect = 1e-36
 Identities = 94/358 (26%), Positives = 149/358 (41%), Gaps = 101/358 (28%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHD 151
           Y+  +++GEGT+GQV +  +++  E+VA+K +R ++  +E     A+ EI++LQ+L +H 
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFPITAIREIKLLQKL-RHP 58

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLY--------DF---LRKNNYRSFPIDLVRE 200
                 V++           IV  K   S+Y        D    L     + F    ++ 
Sbjct: 59  N----IVRL---------KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-FTESQIKC 104

Query: 201 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 260
             +QLLE + ++H   ++H D+K  N+L+         +    L                
Sbjct: 105 YMKQLLEGLQYLHSNGILHRDIKGSNILI---------NNDGVL---------------- 139

Query: 261 AIKVIDFG-STTYE---RPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT 315
             K+ DFG +  Y      D    V T  YR PE++LG   +    D+WSVGCIL EL  
Sbjct: 140 --KLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL 197

Query: 316 GEALFQTHENLEHLAMMERVLGP----------LPQHMLKRVDRHAEKYVRRGRLDWPEG 365
           G+ +FQ    LE L  +  + G                     +  + Y RR        
Sbjct: 198 GKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF--ENLKPKKPYKRR-------- 247

Query: 366 AASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
              RE  K ++             D SA D   LL  LL  DP  R++A +AL+H +F
Sbjct: 248 --LREFFKHLI-------------DPSALD---LLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  131 bits (330), Expect = 4e-35
 Identities = 94/335 (28%), Positives = 163/335 (48%), Gaps = 53/335 (15%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKH 150
           +++++   +GEG +G VL+C  +E KE+VAIK  +     ++ +E  + E+++L+ L + 
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
           +      V+++  F  R  + +VFE +  ++ + L +      P + VR    QL++ I 
Sbjct: 61  N-----IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP-EKVRSYIYQLIKAIH 114

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           + H   ++H D+KPEN+L+  ++ +K+ D+                          F   
Sbjct: 115 WCHKNDIVHRDIKPENLLISHNDVLKLCDF-------------------------GFARN 149

Query: 271 TYERPDQNYI--VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 328
             E  + NY   V+TR YR+PE++LG  +    D+WSVGCIL EL  G+ LF     ++ 
Sbjct: 150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ 209

Query: 329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 388
           L  +++VLGPLP   +K    +     R   L +P       ++     L R    I+  
Sbjct: 210 LFTIQKVLGPLPAEQMKLFYSNP----RFHGLRFP-------AVNHPQSLERRYLGILS- 257

Query: 389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                G L  L++ LL+ +PTDR    + L HP F
Sbjct: 258 -----GVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  129 bits (325), Expect = 4e-34
 Identities = 92/348 (26%), Positives = 139/348 (39%), Gaps = 93/348 (26%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHDKGGNR 156
           ++GEGT+G V    D    E+VA+K VR +   R+   I    EI +L  L +H      
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLREITLLLNL-RHPN---- 67

Query: 157 CVQIRNWF--DYRNHICIVFE----KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
            V+++      + + I +V E     L S L      N    F    V+ +  QLL  + 
Sbjct: 68  IVELKEVVVGKHLDSIFLVMEYCEQDLASLLD-----NMPTPFSESQVKCLMLQLLRGLQ 122

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-S 269
           ++H+  +IH DLK  N+L                           +     +K+ DFG +
Sbjct: 123 YLHENFIIHRDLKVSNLL---------------------------LTDKGCLKIADFGLA 155

Query: 270 TTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
            TY  P +     V T  YRAPE++LG   +T   D+W+VGCIL EL   + L      +
Sbjct: 156 RTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI 215

Query: 327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 386
           E L ++ ++LG   + +                  WP              LP +    +
Sbjct: 216 EQLDLIIQLLGTPNESI------------------WP----------GFSDLPLVGKFTL 247

Query: 387 QHVDHSAGDLTH-----------LLQGLLRYDPTDRLTAREALRHPFF 423
               ++  +L H           LL  LL YDP  R TA EAL   +F
Sbjct: 248 PKQPYN--NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  128 bits (322), Expect = 3e-33
 Identities = 88/345 (25%), Positives = 138/345 (40%), Gaps = 71/345 (20%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHD 151
           Y+I  K+GEG+FG+V    DR+    VA+K++        K  E  + EI++L  L    
Sbjct: 2   YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP- 57

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYR-SFPIDLVREIARQLLECI 209
                 V++ ++F     + +V E + G SL D L+K   +          I  Q+L  +
Sbjct: 58  ---PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEY-IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
            ++H   +IH D+KPEN+LL      +K+ D+                    A  + D G
Sbjct: 115 EYLHSKGIIHRDIKPENILLDRDGRVVKLIDF------------------GLAKLLPDPG 156

Query: 269 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPC---DIWSVGCILVELCTGEALFQTHEN 325
           ST+      +  V T  Y APEV+LGL   Y     DIWS+G  L EL TG   F+  +N
Sbjct: 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216

Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 385
               +   +++  LP   L                                       L 
Sbjct: 217 SSATSQTLKIILELPTPSLA------------------------------------SPLS 240

Query: 386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 430
             + +  +   + LL+ LL  DP +RL++   L H       L+ 
Sbjct: 241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE 285

Length = 384

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  125 bits (317), Expect = 4e-33
 Identities = 91/342 (26%), Positives = 151/342 (44%), Gaps = 69/342 (20%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHD 151
           Y+  +++ EGT+G V    D++  E+VA+K ++ ++K +E     ++ EI +L +L +H 
Sbjct: 7   YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK-MEKEKEGFPITSLREINILLKL-QHP 64

Query: 152 KGGNRCVQIRNWF--DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
                 V ++        + I +V E +   L   + +   + F    V+ +  QLL  +
Sbjct: 65  N----IVTVKEVVVGSNLDKIYMVMEYVEHDLKSLM-ETMKQPFLQSEVKCLMLQLLSGV 119

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 268
           A +HD  ++H DLK  N+L                           +     +K+ DFG 
Sbjct: 120 AHLHDNWILHRDLKTSNLL---------------------------LNNRGILKICDFGL 152

Query: 269 STTYERPDQNY--IVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHEN 325
           +  Y  P + Y  +V T  YRAPE++LG   ++   D+WSVGCI  EL T + LF     
Sbjct: 153 AREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE 212

Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 385
           ++ L  + ++LG  P           EK        WP G +     K         N +
Sbjct: 213 IDQLNKIFKLLG-TPT----------EK-------IWP-GFSELPGAKKKTFTKYPYNQL 253

Query: 386 MQHVDHSAGDLTH----LLQGLLRYDPTDRLTAREALRHPFF 423
            +        L+     LL  LL YDP  R++A +AL+HP+F
Sbjct: 254 RKKFPA--LSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  124 bits (313), Expect = 1e-32
 Identities = 100/335 (29%), Positives = 156/335 (46%), Gaps = 69/335 (20%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGG 154
           K+GEGT+G V +  ++   E+VA+K +R      G+      A+ EI +L++L  H    
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKEL-NHPN-- 60

Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
              V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H 
Sbjct: 61  --IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYE 273
             ++H DLKP+N LL+++E                           AIK+ DFG +  + 
Sbjct: 119 HRVLHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFG 151

Query: 274 RPDQNYI--VSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
            P + Y   V T  YRAPE++LG   ++   DIWS+GCI  E+ T  ALF     ++ L 
Sbjct: 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 211

Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQH 388
            + R LG  P  ++                 WP   +  +   S  K  R Q+   ++  
Sbjct: 212 RIFRTLGT-PDEVV-----------------WPGVTSLPDYKPSFPKWAR-QDFSKVVPP 252

Query: 389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           +D    D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 253 LDEDGRD---LLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  122 bits (307), Expect = 7e-32
 Identities = 90/333 (27%), Positives = 152/333 (45%), Gaps = 55/333 (16%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKG 153
           +K   K+GEGT+  V +  +R   E+VA+K +     +     A+ EI ++++L KH+  
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHEN- 59

Query: 154 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKN-NYRSFPIDLVREIARQLLECIAFM 212
               V++ +     N + +VFE +   L  ++  +    +   + V+    QLL+ IAF 
Sbjct: 60  ---IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116

Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H+  ++H DLKP+N+L+     +K+ D+               + ++  I V  F +   
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFG--------------LARAFGIPVNTFSNE-- 160

Query: 273 ERPDQNYIVSTRHYRAPEVILGLGWTYPC--DIWSVGCILVELCTGEALFQTHENLEHLA 330
                   V T  YRAP+V+LG   TY    DIWSVGCI+ E+ TG  LF    N + L 
Sbjct: 161 --------VVTLWYRAPDVLLG-SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL 211

Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 390
            + R++G   +     + +  E      +  +P                 LQ L      
Sbjct: 212 KIFRIMGTPTESTWPGISQLPEY-----KPTFPRYPPQ-----------DLQQLF----P 251

Query: 391 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           H+      LL  LL+ +P  R++A +AL+HP+F
Sbjct: 252 HADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  120 bits (304), Expect = 1e-31
 Identities = 82/331 (24%), Positives = 137/331 (41%), Gaps = 83/331 (25%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGG 154
           ++I  K+G+G FG+V +   +   + VAIK+++   K+ +E  + EI++L++  KH    
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KH---P 57

Query: 155 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
           N  V+    +  ++ + IV E   G SL D L K+  ++     +  + ++LL+ + ++H
Sbjct: 58  N-IVKYYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELLKGLEYLH 115

Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTY 272
              +IH D+K  N+LL S                              +K+IDFG S   
Sbjct: 116 SNGIIHRDIKAANILLTS---------------------------DGEVKLIDFGLSAQL 148

Query: 273 E-RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +N +V T ++ APEVI G  + Y  DIWS+G   +EL  G+  +   E     A+
Sbjct: 149 SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY--SELPPMKAL 206

Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
            +      P                   L  PE   S E                     
Sbjct: 207 FKIATNGPP------------------GLRNPE-KWSDE--------------------- 226

Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
                   L+  L+ +P  R TA + L+HPF
Sbjct: 227 ----FKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  120 bits (304), Expect = 2e-31
 Identities = 99/342 (28%), Positives = 164/342 (47%), Gaps = 70/342 (20%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHD 151
           +Y+    +GEG++G V++C  +E  ++VAIK        K  ++ AM EI +L+QL +H+
Sbjct: 2   KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHE 60

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDL----VREIARQLLE 207
                 V +   F  +  + +VFE +  ++ D L K     +P  L    VR+   Q+L 
Sbjct: 61  N----LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK-----YPNGLDESRVRKYLFQILR 111

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            I F H   +IH D+KPEN+L VS                          +S  +K+ DF
Sbjct: 112 GIEFCHSHNIIHRDIKPENIL-VS--------------------------QSGVVKLCDF 144

Query: 268 G-STTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 323
           G + T   P + Y   V+TR YRAPE+++G   +    DIW+VGC++ E+ TGE LF   
Sbjct: 145 GFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
            +++ L  + + LG L       + RH E +              +  + + M+LP ++ 
Sbjct: 205 SDIDQLYHIIKCLGNL-------IPRHQEIF-------------QKNPLFAGMRLPEVKE 244

Query: 384 L--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           +  + +     +G +  L +  LR DP DR ++ + L H FF
Sbjct: 245 IEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  119 bits (301), Expect = 5e-31
 Identities = 80/339 (23%), Positives = 132/339 (38%), Gaps = 72/339 (21%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHD 151
           +K    +GEG+F  V+   ++E  +  AIKI+   +  +E       IE EVL +L  H 
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH- 61

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
            G    +++   F    ++  V E      L  ++RK  Y S      R  A ++L  + 
Sbjct: 62  PG---IIKLYYTFQDEENLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALE 116

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H   +IH DLKPEN+LL    +IK+ D+ ++     +SS        S         +
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS------PESNKGDATNIDS 170

Query: 271 TYERPDQN--YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 328
             E+  +     V T  Y +PE++         D+W++GCI+ ++ TG+  F+       
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR------- 223

Query: 329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 388
                   G       +++    E         +P               P  ++LI   
Sbjct: 224 --------GSNEYLTFQKI-LKLE-------YSFPPNFP-----------PDAKDLI--- 253

Query: 389 VDHSAGDLTHLLQGLLRYDPTDRLTA----REALRHPFF 423
                       + LL  DP DRL       E   HPFF
Sbjct: 254 ------------EKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  119 bits (300), Expect = 6e-31
 Identities = 65/258 (25%), Positives = 111/258 (43%), Gaps = 54/258 (20%)

Query: 103 GEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           G G+FG V    D++  E++A+K   +    ++  EA   EI +L  L +H       V+
Sbjct: 9   GRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QH----PNIVR 63

Query: 160 IR--NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
                  + +N + I  E + G SL   L+K  +   P  ++R+  RQ+LE +A++H   
Sbjct: 64  YYGSERDEEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLHSNG 121

Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           ++H D+K  N+L+ S                              +K+ DFG       D
Sbjct: 122 IVHRDIKGANILVDSD---------------------------GVVKLADFGCAK-RLGD 153

Query: 277 QNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
                 T   R      APEVI G  +    DIWS+GC ++E+ TG+  +   E    +A
Sbjct: 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW--SELGNPMA 211

Query: 331 MMERVLG-----PLPQHM 343
            + ++        +P+H+
Sbjct: 212 ALYKIGSSGEPPEIPEHL 229

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  119 bits (301), Expect = 2e-30
 Identities = 98/345 (28%), Positives = 157/345 (45%), Gaps = 68/345 (19%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMI--EIEVLQQLAKHD 151
           RYKI   +G+G++G V    D    E VAIK +  + ++  +A  I  EI++L+ L   D
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 152 KGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE----I 201
                 V+I++        ++++ I +VFE + S L+  ++ N+      DL  E     
Sbjct: 61  -----IVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKAND------DLTPEHHQFF 108

Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             QLL  + ++H   + H DLKP+N+L  +   +K+ D+  +     D+         +A
Sbjct: 109 LYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP--------TA 160

Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEAL 319
           I   D+             V+TR YRAPE+       +T   DIWS+GCI  E+ TG+ L
Sbjct: 161 IFWTDY-------------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 207

Query: 320 FQTHENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVRRGRLDWPEGAASRESIKSVMKL 378
           F     +  L ++  +LG      + RV +  A +Y+   R   P        +    K 
Sbjct: 208 FPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQP--------VPFSQKF 259

Query: 379 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           P    L ++           LL+ LL +DP DR TA EAL  P+F
Sbjct: 260 PNADPLALR-----------LLERLLAFDPKDRPTAEEALADPYF 293

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 1e-29
 Identities = 95/336 (28%), Positives = 150/336 (44%), Gaps = 71/336 (21%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGG 154
           K+GEGT+G V +  D+   E+VA+K +R      G+      A+ EI +L++L  H    
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVP---STAIREISLLKEL-NHPN-- 59

Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
              V++ +     N + +VFE L   L  ++  +        L++    QLL+ IA+ H 
Sbjct: 60  --IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYE 273
             ++H DLKP+N+L+                            +  A+K+ DFG +  + 
Sbjct: 118 HRVLHRDLKPQNLLI---------------------------DREGALKLADFGLARAFG 150

Query: 274 RPDQNYI--VSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHL 329
            P + Y   V T  YRAPE++LG    Y  P DIWS+GCI  E+     LF     ++ L
Sbjct: 151 VPVRTYTHEVVTLWYRAPEILLG-SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL 209

Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQ 387
             + R LG   + +                  WP G  S    K        Q+L  ++ 
Sbjct: 210 FRIFRTLGTPDEDV------------------WP-GVTSLPDYKPTFPKWARQDLSKVVP 250

Query: 388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           ++D    D   LL  +L YDP  R++A+ AL+HP+F
Sbjct: 251 NLDEDGLD---LLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  115 bits (291), Expect = 4e-29
 Identities = 92/355 (25%), Positives = 155/355 (43%), Gaps = 75/355 (21%)

Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQLA 148
           + SRYK    +G G +G V    D    + VAIK I         A   + E+++L+   
Sbjct: 3   VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF- 61

Query: 149 KHDKGGNRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 203
           KHD      + IR+       D++  + +V + + S L+  +  +  +    + +R    
Sbjct: 62  KHDN----IIAIRDILRPPGADFK-DVYVVMDLMESDLHHIIHSD--QPLTEEHIRYFLY 114

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSS 260
           QLL  + ++H   +IH DLKP N+L+     +++ D+   +    +P +  YF  M    
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF--M---- 168

Query: 261 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEAL 319
                    T Y        V+TR YRAPE++L L  +T   D+WSVGCI  E+     L
Sbjct: 169 ---------TEY--------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQL 211

Query: 320 FQTHENLEHLAMMERVLGPLPQHMLK-----RVDRHAEKYVRRGRLDWPE--GAASRESI 372
           F     +  L ++  VLG   + +L      RV ++ +   R+  + W +    AS E++
Sbjct: 212 FPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEAL 271

Query: 373 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                                     LL  +L++DP +R+T  +AL+HPF  + H
Sbjct: 272 D-------------------------LLSQMLQFDPEERITVEQALQHPFLAQYH 301

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  114 bits (287), Expect = 1e-28
 Identities = 97/375 (25%), Positives = 155/375 (41%), Gaps = 105/375 (28%)

Query: 95  RYKIHSKMGEGTFGQVLECW--DRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLA 148
           +Y+I   +G GT+G+V +    + +  +  AIK  +G K+       +A  EI +L++L 
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL- 59

Query: 149 KHDKGGNRCVQIRNWF--DYRNHICIVFEKLGSSLYDFL------RKNNYRSFPIDLVRE 200
           KH+      V +   F       + ++F+    + +D        R+    S P  +V+ 
Sbjct: 60  KHEN----VVSLVEVFLEHADKSVYLLFD---YAEHDLWQIIKFHRQAKRVSIPPSMVKS 112

Query: 201 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 260
           +  Q+L  + ++H   ++H DLKP N+L++                          P+  
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEG-----------------------PERG 149

Query: 261 AIKVIDFG-STTYERP-----DQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVEL 313
            +K+ D G +  +  P     D + +V T  YRAPE++LG   +T   DIW++GCI  EL
Sbjct: 150 VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Query: 314 CTGEALFQTHE------NLEHLAMMER---VLGPLPQHMLKRVDRHAEKYVRRGRLDWPE 364
            T E +F+  E      N      +ER   VLG  P           EK       DWP+
Sbjct: 210 LTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGT-PT----------EK-------DWPD 251

Query: 365 GAASRESIKSVMKLPRLQNLIMQH------------VDHSAGDLT----HLLQGLLRYDP 408
                     + K+P    L+                             LL+ LL YDP
Sbjct: 252 ----------IKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDP 301

Query: 409 TDRLTAREALRHPFF 423
           T R+TA EAL HP+F
Sbjct: 302 TKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  113 bits (284), Expect = 1e-28
 Identities = 98/347 (28%), Positives = 152/347 (43%), Gaps = 74/347 (21%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAK 149
           Y+   K+GEGT+G+V +  D+   ++VA+K  R      GI      A+ EI +LQ L+ 
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPP---TALREISLLQMLS- 58

Query: 150 HDKGGNRCVQIRNWFDYRNHICI--VFEKLGSSLYDFL---RKNNYRSFPIDLVREIARQ 204
                 R + + +  +      +  VFE L S L  F+    +   R  P   ++    Q
Sbjct: 59  ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           LL+ +A  H   ++H DLKP+N+L+   + +                          +K+
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL--------------------------LKI 152

Query: 265 IDFG-STTYERPDQNYI--VSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEAL 319
            D G    +  P ++Y   + T  YRAPEV+LG    Y  P DIWSVGCI  E+   + L
Sbjct: 153 ADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLG-STHYSTPVDIWSVGCIFAEMSRKQPL 211

Query: 320 FQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 378
           F     L+ L  + ++LG P  Q                    WP  +  R+  +     
Sbjct: 212 FPGDSELQQLLHIFKLLGTPTEQ-------------------VWPGVSKLRDWHEFPQWK 252

Query: 379 PRLQNL--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           P  Q+L   +  +     D   LLQ +LRYDP  R++A+ AL HP+F
Sbjct: 253 P--QDLSRAVPDLSPEGLD---LLQKMLRYDPAKRISAKAALTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  112 bits (283), Expect = 2e-28
 Identities = 95/335 (28%), Positives = 159/335 (47%), Gaps = 68/335 (20%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGG 154
           K+GEGT+G V +  +++  ++VA+K +R      G+      A+ EI +L++L +H    
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVP---STAIREISLLKEL-QHPN-- 60

Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSSL---YDFLRKNNYRSFPIDLVREIARQLLECIAF 211
              V +++     + + ++FE L   L    D L K  Y     +LV+    Q+L+ I F
Sbjct: 61  --IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQY--MDAELVKSYLYQILQGILF 116

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   ++H DLKP+N+L+ +   IK+ D+               + ++  I V  +   T
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGVIKLADFG--------------LARAFGIPVRVY---T 159

Query: 272 YERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
           +E       V T  YRAPEV+LG   ++ P DIWS+G I  E+ T + LF     ++ L 
Sbjct: 160 HE-------VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF 212

Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQH 388
            + R+LG  P                     WP G  S    K+     +  +L   +++
Sbjct: 213 RIFRILGT-PTE-----------------DVWP-GVTSLPDYKNTFPKWKKGSLRSAVKN 253

Query: 389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           +D    D   LL+ +L YDP  R++A++AL HP+F
Sbjct: 254 LDEDGLD---LLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  112 bits (281), Expect = 6e-28
 Identities = 95/355 (26%), Positives = 153/355 (43%), Gaps = 76/355 (21%)

Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVL 144
           G+    ++ I  ++GEGT+GQV +  D++  E+VA+K VR +   +E     A+ EI++L
Sbjct: 2   GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVR-LDNEKEGFPITAIREIKIL 60

Query: 145 QQLAKHDKGGNRC---VQIRNWFDYRNH---ICIVFEKLGSSLYDFLRKNNYRSFPIDLV 198
           +QL  H    N        ++  D++       +VFE +   L   L ++    F  D +
Sbjct: 61  RQL-NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL-ESGLVHFSEDHI 118

Query: 199 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 258
           +   +QLLE + + H    +H D+K  N+LL +   IK+ D+  +     + S       
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES------- 171

Query: 259 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPC-DIWSVGCILVELCTGE 317
                          RP  N ++ T  YR PE++LG     P  D+WS GCIL EL T +
Sbjct: 172 ---------------RPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Query: 318 ALFQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 376
            +FQ ++ L  L ++ R+ G P P                     WP+          V+
Sbjct: 216 PIFQANQELAQLELISRLCGSPCPA-------------------VWPD----------VI 246

Query: 377 KLPRLQNL---------IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
           KLP    +         + +           LL  +L  DP+ R TA EAL  P+
Sbjct: 247 KLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 7e-28
 Identities = 81/329 (24%), Positives = 134/329 (40%), Gaps = 88/329 (26%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIE--VLQQLAKHDKGGNRCV 158
           G+G+FG+VL    ++  ++ A+K+++   I K +E      E  +L ++  H       V
Sbjct: 2   GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHP----FIV 56

Query: 159 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           ++   F     + +V E   G  L+  L K     F  +  R  A +++  + ++H L +
Sbjct: 57  KLHYAFQTEEKLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAAEIVLALEYLHSLGI 114

Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           I+ DLKPEN+LL +  +IK+ D+                    A ++   GS T      
Sbjct: 115 IYRDLKPENILLDADGHIKLTDF------------------GLAKELSSEGSRTNT---- 152

Query: 278 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 337
                T  Y APEV+LG G+    D WS+G +L E+ TG+  F   +  E   + E++L 
Sbjct: 153 --FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEKIL- 206

Query: 338 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 397
                              +  L +PE  +                           +  
Sbjct: 207 -------------------KDPLRFPEFLSP--------------------------EAR 221

Query: 398 HLLQGLLRYDPTDRLTAREA---LRHPFF 423
            L+ GLL+ DPT RL +  A     HPFF
Sbjct: 222 DLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  110 bits (277), Expect = 1e-27
 Identities = 86/337 (25%), Positives = 142/337 (42%), Gaps = 57/337 (16%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHD 151
           +Y+  +++G G +G V +  D      VA+K VR          + + E+ +L++L   D
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60

Query: 152 -----KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
                +  + C   R   D    + +VFE +   L  +L K      P + ++++ RQ L
Sbjct: 61  HPNIVRLMDVCATSRT--DRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL 118

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             + F+H  C++H DLKPEN+L+ S   +K+ D+  +        Y  +M  +       
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA------RIYSCQMALTP------ 166

Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
                        +V T  YRAPEV+L   +  P D+WSVGCI  E+   + LF  +   
Sbjct: 167 -------------VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 213

Query: 327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 386
           + L  +  ++G  P+                   DWP          S    PR    + 
Sbjct: 214 DQLGKIFDLIGLPPED------------------DWPRDVTLPRGAFS----PRGPRPVQ 251

Query: 387 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             V         LL  +L ++P  R++A  AL+HPFF
Sbjct: 252 SVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  109 bits (274), Expect = 2e-27
 Identities = 81/328 (24%), Positives = 129/328 (39%), Gaps = 78/328 (23%)

Query: 105 GTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHDKGGNRCVQI 160
           G +G+V     +   ++ AIK+++     R+      + E ++L Q           V++
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-----SPYVVKL 58

Query: 161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
              F  + ++ +V E L G  L   L   N  S   D+ R    +++  + ++H   +IH
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116

Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DLKP+N+L+ S+ ++K+ D+   L      S    + +   +   +             
Sbjct: 117 RDLKPDNILIDSNGHLKLTDF--GL------SKVGLVRRQINLNDDEKEDKR-------- 160

Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 339
           IV T  Y APEVILG G +   D WS+GCIL E   G   F  H         E +    
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPF--HGETP-----EEIF--- 210

Query: 340 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 399
            Q++L             G+++WPE          V       +LI              
Sbjct: 211 -QNILN------------GKIEWPED---------VEVSDEAIDLI-------------- 234

Query: 400 LQGLLRYDPTDRLTAR---EALRHPFFT 424
              LL  DP  RL A+   E   HPFF 
Sbjct: 235 -SKLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  108 bits (273), Expect = 3e-27
 Identities = 81/340 (23%), Positives = 143/340 (42%), Gaps = 93/340 (27%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHD 151
           +Y+I  ++G+G+FG+V     +   ++  +K +      +K RE A+ E+++L++L  H 
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFL--RKNNYRSFPIDLVREIARQLLEC 208
              N  ++    F+ +  +CIV E   G  L   +  +K   + FP + + +   QL   
Sbjct: 60  ---N-IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           + ++H   ++H D+KP+N+ L +S  +                          +K+ DFG
Sbjct: 116 LKYLHSRKILHRDIKPQNIFL-TSNGL--------------------------VKLGDFG 148

Query: 269 -STTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
            S            +V T +Y +PE+     + Y  DIWS+GC+L ELCT +  F+  EN
Sbjct: 149 ISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE-GEN 207

Query: 326 LEHLAM--MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
           L  LA+  ++    P+P             Y             S E          L+N
Sbjct: 208 LLELALKILKGQYPPIPSQ-----------Y-------------SSE----------LRN 233

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           L+                 LL+ DP +R +  + L+ PF 
Sbjct: 234 LV---------------SSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  110 bits (276), Expect = 4e-27
 Identities = 85/349 (24%), Positives = 144/349 (41%), Gaps = 62/349 (17%)

Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLA 148
              Y+I  K+GEGTFG+V +    +   +VA+K +  +   ++     A+ EI++L++L 
Sbjct: 7   LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL-MHNEKDGFPITALREIKILKKLK 65

Query: 149 -------------KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPI 195
                        + DK   +          R  + +V   +   L   L   + +    
Sbjct: 66  HPNVVPLIDMAVERPDKSKRK----------RGSVYMVTPYMDHDLSGLLENPSVKLTES 115

Query: 196 DLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 255
             ++    QLLE I ++H+  ++H D+K  N+L+ +   +K+ D+   L  P D      
Sbjct: 116 Q-IKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADF--GLARPYDGP--PP 170

Query: 256 MPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELC 314
            PK         G     R   N +V TR YR PE++LG   +T   DIW +GC+  E+ 
Sbjct: 171 NPKG--------GGGGGTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221

Query: 315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
           T   + Q   +++ L ++ ++ G   +                    WP G  S    + 
Sbjct: 222 TRRPILQGKSDIDQLHLIFKLCGTPTEE------------------TWP-GWRSLPGCEG 262

Query: 375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           V         + +       +   LL  LL  DP  RLTA +AL HP+F
Sbjct: 263 VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  109 bits (274), Expect = 8e-27
 Identities = 84/370 (22%), Positives = 155/370 (41%), Gaps = 83/370 (22%)

Query: 90  ENLTSRYK-IHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYRE------- 135
            +++ RY    + +GEGT+G+V + +D    ++VAIK V+       + K R+       
Sbjct: 4   FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63

Query: 136 --AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSF 193
               + E++++ ++   +  G   V +   F     I +V + + S L   +  +     
Sbjct: 64  HFTTLRELKIMNEIKHENIMGLVDVYVEGDF-----INLVMDIMASDLKKVV--DRKIRL 116

Query: 194 PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDS 250
               V+ I  Q+L  +  +H    +H DL P N+ + S    K+ D+   +   + P   
Sbjct: 117 TESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176

Query: 251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCI 309
           +  K        ++      T +       V T  YRAPE+++G   + +  D+WSVGCI
Sbjct: 177 TLSKDETMQRREEM------TSK-------VVTLWYRAPELLMGAEKYHFAVDMWSVGCI 223

Query: 310 LVELCTGEALFQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEG--- 365
             EL TG+ LF     ++ L  +  +LG P                      +WP+    
Sbjct: 224 FAELLTGKPLFPGENEIDQLGRIFELLGTPNED-------------------NWPQAKKL 264

Query: 366 -------AASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 418
                      + +K++               +++ D   LLQ LL+ +P +R++A+EAL
Sbjct: 265 PLYTEFTPRKPKDLKTIFP-------------NASDDAIDLLQSLLKLNPLERISAKEAL 311

Query: 419 RHPFFTRDHL 428
           +H +F  D L
Sbjct: 312 KHEYFKSDPL 321

Length = 335

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  107 bits (268), Expect = 2e-26
 Identities = 92/339 (27%), Positives = 157/339 (46%), Gaps = 64/339 (18%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKH 150
           +Y+   K+GEGT+G V +  DR   E +A+K +R +++  E     A+ EI +L+++ +H
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIR-LEQEDEGVPSTAIREISLLKEM-QH 60

Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                  V++++       + +VFE L   L   +  +   +    L++    Q+L  IA
Sbjct: 61  GN----IVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-S 269
           + H   ++H DLKP+N+L+                             ++A+K+ DFG +
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRR--------------------------TNALKLADFGLA 150

Query: 270 TTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
             +  P + +   V T  YRAPE++LG   ++ P DIWSVGCI  E+   + LF     +
Sbjct: 151 RAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210

Query: 327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL-- 384
           + L  + R+LG   +                    WP G  S    KS       ++L  
Sbjct: 211 DELFKIFRILGTPNEET------------------WP-GVTSLPDYKSAFPKWPPKDLAT 251

Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           ++  ++ +  D   LL  +LR DP+ R+TAR AL H +F
Sbjct: 252 VVPTLEPAGVD---LLSKMLRLDPSKRITARAALEHEYF 287

Length = 294

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  106 bits (266), Expect = 4e-26
 Identities = 97/349 (27%), Positives = 152/349 (43%), Gaps = 85/349 (24%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLA 148
           +Y+   K+GEGT+G V +  +RE  E+VA+K VR      G+     +A+ EI +L++L 
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKEL- 56

Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           KH       V++ +       + +VFE     L  +    N    P ++V+    QLL+ 
Sbjct: 57  KH----KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDP-EIVKSFMFQLLKG 111

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +AF H   ++H DLKP+N+L+                            K+  +K+ DFG
Sbjct: 112 LAFCHSHNVLHRDLKPQNLLI---------------------------NKNGELKLADFG 144

Query: 269 -STTYERPDQNYI--VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT-GEALFQTH 323
            +  +  P + Y   V T  YR P+V+ G   ++   D+WS GCI  EL   G  LF  +
Sbjct: 145 LARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 204

Query: 324 ENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 382
           +  + L  + R+LG P  +                    WP           V KLP  +
Sbjct: 205 DVDDQLKRIFRLLGTPTEE-------------------SWP----------GVSKLPDYK 235

Query: 383 NLIMQHVDHSAGDLT--------HLLQGLLRYDPTDRLTAREALRHPFF 423
              M     S  ++          LLQ LL  +P  R++A EAL+HP+F
Sbjct: 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  106 bits (265), Expect = 1e-25
 Identities = 87/348 (25%), Positives = 150/348 (43%), Gaps = 72/348 (20%)

Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-----EIEVLQQ 146
           +T+RY     +G G FG V    D+   + VAIK +  +K +    +      E+++L+ 
Sbjct: 8   ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI--MKPFSTPVLAKRTYRELKLLKH 65

Query: 147 LAKHDKGGNRCVQIRNWF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQL 205
           L +H+      + + + F      I  V E LG+ L+  L     R      ++    Q+
Sbjct: 66  L-RHEN----IISLSDIFISPLEDIYFVTELLGTDLHRLLTS---RPLEKQFIQYFLYQI 117

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L  + ++H   ++H DLKP N+L+                            ++  +K+ 
Sbjct: 118 LRGLKYVHSAGVVHRDLKPSNILI---------------------------NENCDLKIC 150

Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHE 324
           DFG    + P     VSTR+YRAPE++L    +    DIWS GCI  E+  G+ LF   +
Sbjct: 151 DFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210

Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR---- 380
           ++   +++  +LG  P  ++  +                    S  +++ V  LP+    
Sbjct: 211 HVNQFSIITDLLGTPPDDVINTI-------------------CSENTLRFVQSLPKREPV 251

Query: 381 -LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                  ++ D SA D   LL+ +L +DP  R++A EAL HP+    H
Sbjct: 252 PFSEKF-KNADPSAID---LLEKMLVFDPQKRISAAEALAHPYLAPYH 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 1e-25
 Identities = 66/229 (28%), Positives = 101/229 (44%), Gaps = 41/229 (17%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA---AMIEIEVLQQLAKHD 151
            Y++   +G G FG V +  + E  + VAIK +   K   EA    M EI++L+ L KH 
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KH- 58

Query: 152 KGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                 V+     +  + + I+ E     SL   ++K     FP  LV     Q+L+ +A
Sbjct: 59  ---PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLA 113

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H+  +IH D+K  N+L                             K   +K+ DFG  
Sbjct: 114 YLHEQGVIHRDIKAANIL---------------------------TTKDGVVKLADFGVA 146

Query: 271 TY---ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
           T       D   +V T ++ APEVI   G +   DIWS+GC ++EL TG
Sbjct: 147 TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  106 bits (265), Expect = 2e-25
 Identities = 93/346 (26%), Positives = 153/346 (44%), Gaps = 67/346 (19%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR--------EAAMIEIEVLQ 145
            RY+   ++G G +G V    DR     VAIK     K YR        + A  E+ +L+
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIK-----KLYRPFQSELFAKRAYRELRLLK 69

Query: 146 QLAKHDK--GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 203
            + KH+   G           D  +   +V   +G+ L   ++   +     D ++ +  
Sbjct: 70  HM-KHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK---HEKLSEDRIQFLVY 125

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L+ + ++H   +IH DLKP N L V+ +                            +K
Sbjct: 126 QMLKGLKYIHAAGIIHRDLKPGN-LAVNED--------------------------CELK 158

Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQT 322
           ++DFG       +    V TR YRAPEVIL  + +T   DIWSVGCI+ E+ TG+ LF+ 
Sbjct: 159 ILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218

Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 382
           H++L+ L  + +V G   +  ++++                    S ++   V KLPR +
Sbjct: 219 HDHLDQLMEIMKVTGTPSKEFVQKLQ-------------------SEDAKNYVKKLPRFR 259

Query: 383 NLIMQHVDHSAGDLT-HLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
               + +  +A  L  ++L+ +L  D   R+TA EAL HP+F   H
Sbjct: 260 KKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 7e-25
 Identities = 89/337 (26%), Positives = 153/337 (45%), Gaps = 47/337 (13%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQL 147
            ++  RY+  S +GEG +G V     +     VAIK +   +   + +  + EI++L++ 
Sbjct: 1   FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF 60

Query: 148 AKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +  G   +     F+  N + IV E + + LY  ++  +  +   D ++    Q+L 
Sbjct: 61  KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSN---DHIQYFLYQILR 117

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   ++H DLKP N+LL ++  +K+ D+  +     +  +   +           
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL----------- 166

Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL 326
             T Y        V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   LF   + L
Sbjct: 167 --TEY--------VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL 216

Query: 327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLI 385
             L ++  VLG   Q  L  +                    +R  IKS+   P++  N +
Sbjct: 217 HQLNLILGVLGTPSQEDLNCI----------------ISLRARNYIKSLPFKPKVPWNKL 260

Query: 386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
             + D  A D   LL  +L ++P  R+T  EAL HP+
Sbjct: 261 FPNADPKALD---LLDKMLTFNPHKRITVEEALAHPY 294

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  103 bits (259), Expect = 9e-25
 Identities = 98/348 (28%), Positives = 146/348 (41%), Gaps = 76/348 (21%)

Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKK--YREAAMIEIEVLQQLA 148
           L  RY    ++G G +G V    D+   E VAIK + R  +   + + A  E+ +L+ + 
Sbjct: 13  LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ 72

Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDF----------LRKNNYRSFPIDLV 198
             +  G   V                   G    DF          L+K        D V
Sbjct: 73  HENVIGLLDVF-------------TSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKV 119

Query: 199 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 258
           + +  Q+L  + ++H   +IH DLKP N L V+ +                         
Sbjct: 120 QYLVYQMLCGLKYIHSAGIIHRDLKPGN-LAVNED------------------------- 153

Query: 259 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGE 317
              +K++DFG   +   +    V TR YRAPEVIL  + +    DIWSVGCI+ E+ TG+
Sbjct: 154 -CELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Query: 318 ALFQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 376
            LF+  + L+ L  + +V G P P+ + K  D+ A+ Y                 IKS+ 
Sbjct: 213 TLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY-----------------IKSLP 255

Query: 377 KLPRLQ-NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           K PR   + +       A D   LL+ +L  D   RLTA EAL HP+F
Sbjct: 256 KYPRKDFSTLFPKASPQAVD---LLEKMLELDVDKRLTATEALEHPYF 300

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  103 bits (259), Expect = 1e-24
 Identities = 92/355 (25%), Positives = 151/355 (42%), Gaps = 87/355 (24%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
           RY+  S +G G +GQV   +D +    VAIK     K  R           Q A H K  
Sbjct: 16  RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK-----KLSRPF---------QSAIHAKRT 61

Query: 155 NRCVQIRNWFDYRNHIC------------------IVFEKLGSSLYDFLRKNNYRSFPID 196
            R +++    D+ N I                   +V   +G+ L + ++    +    D
Sbjct: 62  YRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC---QKLSDD 118

Query: 197 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 256
            ++ +  Q+L  + ++H   +IH DLKP N+ +     +K+ D+  + HT  +      M
Sbjct: 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE------M 172

Query: 257 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCT 315
                        T Y        V+TR YRAPE++L  + +    DIWSVGCI+ EL T
Sbjct: 173 -------------TGY--------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211

Query: 316 GEALFQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
           G+ LF   ++++ L  +  ++G P  + + K     A  Y                 I+S
Sbjct: 212 GKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNY-----------------IQS 254

Query: 375 VMKLPR--LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           + ++P+   + +     +  A D   LL+ +L  DP  R+TA EAL HP+    H
Sbjct: 255 LPQMPKKDFKEVFSGA-NPLAID---LLEKMLVLDPDKRITAAEALAHPYLAEYH 305

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  102 bits (257), Expect = 1e-24
 Identities = 84/355 (23%), Positives = 145/355 (40%), Gaps = 81/355 (22%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAK 149
           S+Y+  +K+G+GTFG+V +   ++ K++VA+K V  ++  +E     A+ EI++LQ L K
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVL-MENEKEGFPITALREIKILQLL-K 69

Query: 150 HD-------------KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPID 196
           H+                NR         Y+    +VFE     L   L  N    F + 
Sbjct: 70  HENVVNLIEICRTKATPYNR---------YKGSFYLVFEFCEHDLAGLL-SNKNVKFTLS 119

Query: 197 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 256
            ++++ + LL  + ++H   ++H D+K  N+L+                           
Sbjct: 120 EIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT-------------------------- 153

Query: 257 PKSSAIKVIDFG-------STTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGC 308
            K   +K+ DFG       S   +       V T  YR PE++LG   +  P D+W  GC
Sbjct: 154 -KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGC 212

Query: 309 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAAS 368
           I+ E+ T   + Q +     L ++ ++ G +   +   VD    K     +++ P+G   
Sbjct: 213 IMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD----KLELFKKMELPQGQKR 268

Query: 369 RESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           +   +    +     L              L+  LL  DP  R+ A  AL H FF
Sbjct: 269 KVKERLKPYVKDPHAL-------------DLIDKLLVLDPAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  102 bits (256), Expect = 3e-24
 Identities = 87/353 (24%), Positives = 153/353 (43%), Gaps = 83/353 (23%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 68

Query: 147 LAKHDKGGN-----RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N              +  N + +V   +G+ L + ++    +    D V+ +
Sbjct: 69  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 125

Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+ +                            +   
Sbjct: 126 IYQILRGLKYIHSADIIHRDLKPSNLAV---------------------------NEDCE 158

Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 159 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218

Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 219 PGTDHIDQLKLILRLVGTPGAELLKKISSE----------------SARNYIQSLTQMPK 262

Query: 381 L--QNLIM----QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +   N+ +      VD        LL+ +L  D   R+TA +AL H +F + H
Sbjct: 263 MNFANVFIGANPLAVD--------LLEKMLVLDSDKRITAAQALAHAYFAQYH 307

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  100 bits (250), Expect = 6e-24
 Identities = 86/340 (25%), Positives = 147/340 (43%), Gaps = 62/340 (18%)

Query: 95  RYKIHSKMGEGTFGQVLECWD-RERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAK 149
           +Y+  +++GEG +G+V +  D +     VA+K VR ++   E    + + E+ VL+ L  
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLET 60

Query: 150 HDKGG-----NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 204
            +        + C   R   D    + +VFE +   L  +L K      P + ++++  Q
Sbjct: 61  FEHPNVVRLFDVCTVSRT--DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           LL  + F+H   ++H DLKP+N+L+ SS  IK+ D+  +                   ++
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA-------------------RI 159

Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
             F            +V T  YRAPEV+L   +  P D+WSVGCI  E+   + LF+   
Sbjct: 160 YSFQMAL------TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213

Query: 325 NLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
           +++ L  +  V+G P  +                   DWP   A             ++ 
Sbjct: 214 DVDQLGKILDVIGLPGEE-------------------DWPRDVALPRQAFHSKSAQPIEK 254

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
            +   +D    D   LL   L ++P  R++A  AL HP+F
Sbjct: 255 FV-TDIDELGKD---LLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 99.3 bits (248), Expect = 9e-24
 Identities = 83/340 (24%), Positives = 129/340 (37%), Gaps = 101/340 (29%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHDKGGNR 156
           K+G GTFG+V    + +  E++A+K +R I+      +     E++VL+ L KH      
Sbjct: 7   KIGGGTFGKVYTAVNLDTGELMAVKEIR-IQDNDPKTIKEIADEMKVLELL-KHP----- 59

Query: 157 CVQIRNWFDY------RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
                N   Y      R  + I  E   G +L + L   + R     ++R    QLLE +
Sbjct: 60  -----NLVKYYGVEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGL 112

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
           A++H   ++H D+KP N+ L  +  IK+ D+  +                     +   +
Sbjct: 113 AYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCA-------------------VKLKNNT 153

Query: 270 TTYERPDQNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTG----EALFQT 322
           TT     Q+    T  Y APEVI G    G     DIWS+GC+++E+ TG      L   
Sbjct: 154 TTMGEEVQSL-AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212

Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 382
            + + H+    +   P+P  +                   PEG                 
Sbjct: 213 FQIMFHVGAGHK--PPIPDSLQLS----------------PEG----------------- 237

Query: 383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
                 +D             L  DP  R TA E L+HPF
Sbjct: 238 ---KDFLDRC-----------LESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  100 bits (252), Expect = 1e-23
 Identities = 72/270 (26%), Positives = 114/270 (42%), Gaps = 51/270 (18%)

Query: 165 DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP 224
           D    I +V E + S L+  +     +    D V+    Q+L  + ++H   ++H D+KP
Sbjct: 74  DPFEEIYVVTELMQSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKP 131

Query: 225 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI---- 280
            N LLV+S  +                          +K+ DFG    E PD++      
Sbjct: 132 GN-LLVNSNCV--------------------------LKICDFGLARVEEPDESKHMTQE 164

Query: 281 VSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 339
           V T++YRAPE+++G   +T   DIWSVGCI  EL     LFQ    ++ L ++  +LG  
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP 224

Query: 340 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 399
               ++     A  ++ R                   K P L  L       +  +  HL
Sbjct: 225 SLEAMRSACEGARAHILR----------------GPHKPPSLPVLYT-LSSQATHEAVHL 267

Query: 400 LQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
           L  +L +DP  R++A +AL HP+     LR
Sbjct: 268 LCRMLVFDPDKRISAADALAHPYLDEGRLR 297

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  100 bits (250), Expect = 1e-23
 Identities = 90/350 (25%), Positives = 155/350 (44%), Gaps = 77/350 (22%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  + +G G +G V   +D   ++ VA+K        ++   + YRE          +
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYREL---------R 66

Query: 147 LAKHDKGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE 200
           L KH K  N  + + + F      +  N + +V   +G+ L + ++    +    + V+ 
Sbjct: 67  LLKHMKHEN-VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK---CQKLSDEHVQF 122

Query: 201 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 260
           +  QLL  + ++H   +IH DLKP NV +                            +  
Sbjct: 123 LIYQLLRGLKYIHSAGIIHRDLKPSNVAV---------------------------NEDC 155

Query: 261 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEAL 319
            ++++DFG       +    V+TR YRAPE++L  + +    DIWSVGCI+ EL  G+AL
Sbjct: 156 ELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKAL 215

Query: 320 FQTHENLEHLA-MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 378
           F  ++ ++ L  +ME V  P P+ + K    HA KY++                     L
Sbjct: 216 FPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQ--------------------SL 255

Query: 379 PRLQNLIMQHVDHSAGDLT-HLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           P +    ++ +   A  L   LL+ +L  D   R++A EAL HP+F++ H
Sbjct: 256 PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 98.0 bits (245), Expect = 3e-23
 Identities = 78/332 (23%), Positives = 125/332 (37%), Gaps = 89/332 (26%)

Query: 100 SKMGEGTFGQVLECWDRERKEMVAIKI--VRGIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
             +G+G+ G V +   +   ++ A+K   V G +++R+  + E++ L+   +        
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS-CESPY----V 61

Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DL 215
           V+    F     I IV E + G SL D L+K      P  ++  IARQ+L+ + ++H   
Sbjct: 62  VKCYGAFYKEGEISIVLEYMDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYER 274
            +IH D+KP N+L+ S   +K+                            DFG S   E 
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIA---------------------------DFGISKVLEN 152

Query: 275 ---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                  + V T  Y +PE I G  ++Y  DIWS+G  L+E   G+  F          +
Sbjct: 153 TLDQCNTF-VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211

Query: 332 MERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 390
           M+ +  GP P                      P    S E                    
Sbjct: 212 MQAICDGPPP--------------------SLPAEEFSPE-------------------- 231

Query: 391 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
                    +   L+ DP  R +A E L+HPF
Sbjct: 232 -----FRDFISACLQKDPKKRPSAAELLQHPF 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 97.3 bits (243), Expect = 4e-23
 Identities = 64/261 (24%), Positives = 113/261 (43%), Gaps = 39/261 (14%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 158
           G G FG+V     + +    A+K V  R I +  +   I  E E+L++   H       V
Sbjct: 2   GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HP----FIV 56

Query: 159 QIRNWFDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           ++   F  + +I ++ E  LG  L+  LR      F     R     ++    ++H+  +
Sbjct: 57  KLYRTFKDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGI 114

Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           I+ DLKPEN+LL S+ Y+K+ D+  +                   K +  G  T+     
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFA-------------------KKLKSGQKTWT---- 151

Query: 278 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 337
                T  Y APE+IL  G+ +  D WS+G +L EL TG   F   ++ + + +   +L 
Sbjct: 152 --FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGE-DDEDPMEIYNDILK 208

Query: 338 PLPQHML-KRVDRHAEKYVRR 357
              +      +D+ A+  +++
Sbjct: 209 GNGKLEFPNYIDKAAKDLIKQ 229

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 96.2 bits (239), Expect = 2e-22
 Identities = 94/330 (28%), Positives = 146/330 (44%), Gaps = 60/330 (18%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA----MIEIEVLQQLAKHDKGGNR 156
           K+GEGT+  V +   +  + +VA+K +R   ++ E A    + E+ +L+ L KH      
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKNL-KH----AN 64

Query: 157 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
            V + +       + +VFE L S L  +L  N      +  V+    QLL  +++ H   
Sbjct: 65  IVTLHDIIHTERCLTLVFEYLDSDLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123

Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           ++H DLKP+N+L+     +K+ D+          +  K +P           + TY    
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADF--------GLARAKSVP-----------TKTYSNE- 163

Query: 277 QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 335
               V T  YR P+V+LG   ++ P D+W VGCIL E+ TG  +F      E L ++ R+
Sbjct: 164 ----VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRL 219

Query: 336 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP--RLQNLIMQHVDHSA 393
           LG   +                    WP G  S E  +S +  P  R Q LI  H     
Sbjct: 220 LGTPTEE------------------TWP-GITSNEEFRSYL-FPQYRAQPLI-NHAPRLD 258

Query: 394 GDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
            D   LL  LL Y+   R++A  ALRH +F
Sbjct: 259 TDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 94/351 (26%), Positives = 155/351 (44%), Gaps = 70/351 (19%)

Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQLA 148
           + ++Y     +G G +G V    + E  E VAIK I        +A   + EI++L+ L 
Sbjct: 3   VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL- 61

Query: 149 KHDKGGNRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 203
            H+      + I++       +  N + IV+E + + L+  +R +  ++   D  +    
Sbjct: 62  DHEN----VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLY 115

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           QLL  + ++H   ++H DLKP N+LL ++                             +K
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNAN---------------------------CDLK 148

Query: 264 VIDFG--STTYERPDQ--NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEA 318
           + DFG   TT E+ D    Y+V TR YRAPE++L    +T   D+WSVGCI  EL   + 
Sbjct: 149 ICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207

Query: 319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 378
           LF   + +  L ++  +LG                      L +     +R  I+S+   
Sbjct: 208 LFPGKDYVHQLKLITELLGS----------------PSEEDLGFIRNEKARRYIRSLPYT 251

Query: 379 PRLQNL--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           PR Q+   +  H +  A D   LL+ +L +DP+ R+T  EAL HP+    H
Sbjct: 252 PR-QSFARLFPHANPLAID---LLEKMLVFDPSKRITVEEALAHPYLASLH 298

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 98.6 bits (245), Expect = 2e-22
 Identities = 91/347 (26%), Positives = 155/347 (44%), Gaps = 69/347 (19%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA---KHDK 152
           YK+ + +G G+FG V E    +  E VAIK V    +Y+   ++ ++ L  +      D 
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDY 127

Query: 153 GGNRCVQI--RNWFDYRNHICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLEC 208
               C +   +N F     + +V E +  +++ +++    N  + P+ LV+  + QL   
Sbjct: 128 YYTECFKKNEKNIF-----LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +A++H   + H DLKP+N+L+                           P +  +K+ DFG
Sbjct: 183 LAYIHSKFICHRDLKPQNLLI--------------------------DPNTHTLKLCDFG 216

Query: 269 STTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE 324
           S       Q   +YI S R YRAPE++LG   +T   D+WS+GCI+ E+  G  +F    
Sbjct: 217 SAKNLLAGQRSVSYICS-RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275

Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           +++ L  + +VLG   +  LK ++              P  A         +K P ++  
Sbjct: 276 SVDQLVRIIQVLGTPTEDQLKEMN--------------PNYAD--------IKFPDVKPK 313

Query: 385 IMQHV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            ++ V    +  D  + +   L+Y+P  RL   EAL  PFF  D LR
Sbjct: 314 DLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF--DDLR 358

Length = 440

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 94.9 bits (236), Expect = 4e-22
 Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 35/221 (15%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIV------RGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           +G+G FG+V  C+D +    +A+K V         KK   A   EI++L+ L +H     
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QH----E 64

Query: 156 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
           R VQ          + I  E + G S+ D L+   Y +    + R+  RQ+LE + ++H 
Sbjct: 65  RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHS 122

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             ++H D+K  N+L  S+  +K+ D+ +S          KR+     I      S T  +
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGAS----------KRL---QTICS----SGTGMK 165

Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                +  T ++ +PEVI G G+    D+WSVGC +VE+ T
Sbjct: 166 S----VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 93.6 bits (233), Expect = 9e-22
 Identities = 79/331 (23%), Positives = 132/331 (39%), Gaps = 91/331 (27%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMI---EIEVLQQLAKHDKGGN 155
           +G G+FG V E  + +  +  A+K V      +  +EA      EI +L +L +H     
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPN--- 63

Query: 156 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ        +++ I  E + G SL   L+K  Y SFP  ++R   RQ+L  + ++HD
Sbjct: 64  -IVQYLGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
              +H D+K  N+L+ ++  +K+ D+  +              KS               
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQ-----VVEFSFAKS--------------- 160

Query: 275 PDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
                   + ++ APEVI   G +    DIWS+GC ++E+ TG+  +   E +  +  + 
Sbjct: 161 -----FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG 215

Query: 334 R--VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           R   L P+P H+                        S E           ++ I++    
Sbjct: 216 RSKELPPIPDHL------------------------SDE----------AKDFILK---- 237

Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
                       L+ DP+ R TA E L HPF
Sbjct: 238 -----------CLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 93.3 bits (232), Expect = 1e-21
 Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 37/233 (15%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHD 151
            +K+  K+G+G++G V +       +  A+K V      +K RE A+ EI +L  +   +
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 152 KGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNY--RSFPIDLVREIARQLLEC 208
                 +  +  F   N +CIV E      L   + K     +  P   +  I  QLL  
Sbjct: 61  -----IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +  +H+  ++H DLK  N+LLV+++ +K+ D   S          K + K+ A   I   
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDLVKIGDLGIS----------KVLKKNMAKTQI--- 162

Query: 269 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
                         T HY APEV  G  ++Y  DIWS+GC+L E+ T    F+
Sbjct: 163 -------------GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 94.1 bits (234), Expect = 3e-21
 Identities = 87/359 (24%), Positives = 155/359 (43%), Gaps = 79/359 (22%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMIEIEVLQQLAK 149
           +L SRY     +G G+ G V    D +  + VA+K IV    +  + A+ EI+++++L  
Sbjct: 2   DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-D 60

Query: 150 HD-----------KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLV 198
           HD            G +    + +  +  + + IV E + + L + L +        +  
Sbjct: 61  HDNIVKVYEVLGPSGSDLTEDVGSLTELNS-VYIVQEYMETDLANVLEQG---PLSEEHA 116

Query: 199 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 258
           R    QLL  + ++H   ++H DLKP NV + + + +                       
Sbjct: 117 RLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLV----------------------- 153

Query: 259 SSAIKVIDFGSTTYERPD---QNYI---VSTRHYRAPEVILG-LGWTYPCDIWSVGCILV 311
              +K+ DFG      P    + Y+   + T+ YR+P ++L    +T   D+W+ GCI  
Sbjct: 154 ---LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFA 210

Query: 312 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHA-----EKYVRRGRLDWPEGA 366
           E+ TG+ LF     LE    M+ +L  +P  +++  DR+        +VR       +G 
Sbjct: 211 EMLTGKPLFAGAHELE---QMQLILESVP--VVREEDRNELLNVIPSFVRN------DGG 259

Query: 367 ASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
             R  ++ ++            V+  A D    L+ +L ++P DRLTA EAL HP+ + 
Sbjct: 260 EPRRPLRDLLP----------GVNPEALD---FLEQILTFNPMDRLTAEEALMHPYMSC 305

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 93.0 bits (232), Expect = 3e-21
 Identities = 84/341 (24%), Positives = 140/341 (41%), Gaps = 97/341 (28%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           YK   K+GEG  G+V +  DR   + VAIK +R  K+ +E  + EI +++   KH     
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHP---- 75

Query: 156 RCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVRE----IARQLLE 207
               I +++D     + + +V E + G SL D + +N      + +       + R++L+
Sbjct: 76  ---NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEPQIAYVCREVLQ 127

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH D+K +N+LL                  KD S          +K+ DF
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILL-----------------SKDGS----------VKLADF 160

Query: 268 G---STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
           G     T E+  +N +V T ++ APEVI    +    DIWS+G + +E+  GE       
Sbjct: 161 GFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE------- 213

Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
                          P ++               R   P  A    + K    +P L+N 
Sbjct: 214 ---------------PPYL---------------REP-PLRALFLITTK---GIPPLKNP 239

Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                +  + +    L   L  DP  R +A E L+HPF  +
Sbjct: 240 -----EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 93.6 bits (233), Expect = 4e-21
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 43/225 (19%)

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S                 D +          +K
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKS-----------------DCT----------LK 158

Query: 264 VIDFG-----STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 318
           ++DFG      T++      Y+V TR+YRAPEVILG+G+    DIWSVGCI+ E+  G  
Sbjct: 159 ILDFGLARTAGTSFMMTP--YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215

Query: 319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR-RGRLDWPEGAASRESIKSVMK 377
           LF   ++++    +   LG      + R+      YV  R +     G +  E    V+ 
Sbjct: 216 LFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKY---AGYSFEELFPDVLF 272

Query: 378 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
            P  ++    H    A     LL  +L  DP  R++  +AL+HP+
Sbjct: 273 PPDSES----HNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 92.5 bits (230), Expect = 8e-21
 Identities = 92/360 (25%), Positives = 157/360 (43%), Gaps = 88/360 (24%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERK--EMVAIKIVRGI---KKYREAAMIEIEVLQQLAK 149
           RY++  ++G+G +G V    + E    E VAIK +  +   K   + A+ E+++L+    
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60

Query: 150 HDKGGNRCVQIRNWFDYR-------NHICIVFEKLGSSLYDFLRKN------NYRSFPID 196
           H         I   +D         N + +  E + + L+  +R        +++SF   
Sbjct: 61  HK-------NITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSF--- 110

Query: 197 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 256
                  Q+L  + ++H   ++H DLKP N LLV+++                       
Sbjct: 111 -----IYQILCGLKYIHSANVLHRDLKPGN-LLVNAD----------------------- 141

Query: 257 PKSSAIKVIDFG-STTY-ERPDQN--YI---VSTRHYRAPEVILGL-GWTYPCDIWSVGC 308
                +K+ DFG +  + E P +N  ++   V+TR YRAPE++L    +T   D+WSVGC
Sbjct: 142 ---CELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGC 198

Query: 309 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVRRGRLDWPEGAA 367
           IL EL   + +F+  + ++ L  + +VLG   +  L R+    A+ Y+R   L       
Sbjct: 199 ILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIR--SLPNIPK-- 254

Query: 368 SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                            I  + +  A D   LL+ LL +DPT R++  EAL HP+    H
Sbjct: 255 --------KPFES----IFPNANPLALD---LLEKLLAFDPTKRISVEEALEHPYLAIWH 299

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 81/348 (23%), Positives = 133/348 (38%), Gaps = 108/348 (31%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ----LAK 149
             + +   +G+G+FG+V +  D+   ++VAIK++       E A  EIE +QQ    L++
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-----LEEAEDEIEDIQQEIQFLSQ 55

Query: 150 HDKGGNRCVQIRNWF-----DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIAR 203
                 R   I  ++       +  + I+ E   G S  D L+           +  I R
Sbjct: 56  C-----RSPYITKYYGSFLKGSK--LWIIMEYCGGGSCLDLLK---PGKLDETYIAFILR 105

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           ++L  + ++H+   IH D+K  N+LL                            +   +K
Sbjct: 106 EVLLGLEYLHEEGKIHRDIKAANILLS---------------------------EEGDVK 138

Query: 264 VIDFG------STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 317
           + DFG      ST  +R   N  V T  + APEVI   G+    DIWS+G   +EL  GE
Sbjct: 139 LADFGVSGQLTSTMSKR---NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195

Query: 318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 377
                   L  L  M RVL  +P++    ++ +  K+ +  +                  
Sbjct: 196 P------PLSDLHPM-RVLFLIPKNNPPSLEGN--KFSKPFK------------------ 228

Query: 378 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                            D   L    L  DP +R +A+E L+H F  +
Sbjct: 229 -----------------DFVSL---CLNKDPKERPSAKELLKHKFIKK 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 87.0 bits (215), Expect = 4e-19
 Identities = 85/328 (25%), Positives = 141/328 (42%), Gaps = 56/328 (17%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA----MIEIEVLQQLAKHDKGGNR 156
           K+GEGT+  V +   +    +VA+K +R   ++ E A    + E+ +L+ L KH      
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDL-KHAN---- 65

Query: 157 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
            V + +       + +VFE L   L  +L  +   S  +  V+    QLL  + + H   
Sbjct: 66  IVTLHDIIHTEKSLTLVFEYLDKDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124

Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           ++H DLKP+N+L+     +K+ D+               + ++ +I      + TY    
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFG--------------LARAKSIP-----TKTYSNE- 164

Query: 277 QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 335
               V T  YR P+++LG   ++   D+W VGCI  E+ TG  LF      E L  + R+
Sbjct: 165 ----VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRI 220

Query: 336 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 395
           LG   +                    WP G  S E  KS        + +  H      D
Sbjct: 221 LGTPTEET------------------WP-GILSNEEFKSYNYPKYRADCLHNHAPRLDSD 261

Query: 396 LTHLLQGLLRYDPTDRLTAREALRHPFF 423
              LL  LL+++   R++A EA++HP+F
Sbjct: 262 GAELLSKLLQFEGRKRISAEEAMKHPYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 6e-19
 Identities = 89/342 (26%), Positives = 142/342 (41%), Gaps = 71/342 (20%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHD 151
           YK   K+GEG++  V +   +   ++VA+K +R   ++ E     A+ E  +L+ L KH 
Sbjct: 7   YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR--LEHEEGAPFTAIREASLLKDL-KH- 62

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                 V + +    +  + +VFE L + L  ++         +  VR    QLL  +A+
Sbjct: 63  ---ANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAY 118

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--- 268
            H   ++H DLKP+N LL+S                          +   +K+ DFG   
Sbjct: 119 CHQRRVLHRDLKPQN-LLIS--------------------------ERGELKLADFGLAR 151

Query: 269 -----STTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQT 322
                S TY     N +V T  YR P+V+LG   ++   D+W VGCI  E+ TG  LF  
Sbjct: 152 AKSVPSKTY----SNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206

Query: 323 HEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 381
             +  + L  + RVLG   +     V  + E          P    +          PRL
Sbjct: 207 STDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINH--------APRL 258

Query: 382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             +              L    L+Y+P  R++A EA++HP+F
Sbjct: 259 DRIP---------HGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 85.9 bits (212), Expect = 2e-18
 Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 32/221 (14%)

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+               + +++   
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG--------------LARTACT- 175

Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
             +F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ EL  G  +FQ  
Sbjct: 176 --NFMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
           ++++    +   LG      + R+      YV   R  +P    S E +      P    
Sbjct: 226 DHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYV-ENRPQYP--GISFEELFPDWIFPSES- 281

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
              +           LL  +L  DP  R++  EALRHP+ T
Sbjct: 282 ---ERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 75/349 (21%), Positives = 125/349 (35%), Gaps = 80/349 (22%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAA-MIEIEVLQQLAK 149
             +++   +G G FG+V    D++  ++ A+K++R    IK+ + A    E ++L     
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDIL----- 55

Query: 150 HDKGGNRCVQIRN-W-------FDYRNHICIVFEKLGSSLYDFLRK-NNYRSFPIDLVRE 200
                       + W       F    H+ +V E +     D +        FP +  R 
Sbjct: 56  --------ADADSPWIVKLYYSFQDEEHLYLVMEYMPGG--DLMNLLIRKDVFPEETARF 105

Query: 201 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFK--RM 256
              +L+  +  +H L  IH D+KP+N+L+ +  +IK+ D+     ++  KD  Y+     
Sbjct: 106 YIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSH 165

Query: 257 PKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                  V+       +R    N  V T  Y APEV+ G  +   CD WS+G IL E+  
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225

Query: 316 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV 375
           G   F                    Q    ++                            
Sbjct: 226 GFPPF---------------YSDTLQETYNKIINW------------------------- 245

Query: 376 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT-AREALRHPFF 423
                 ++L        + +   L+  LL  DP DRL    E   HPFF
Sbjct: 246 -----KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 83.4 bits (206), Expect = 5e-18
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 36/226 (15%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVR----GIK-KYREAAMI-----EIEVLQQLAKHD 151
           +G G+FG V    +    E++A+K V         K R+ +M+     EI +L++L +H+
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHE 66

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                 VQ        +H+ I  E + G S+   L  NNY +F   LVR   RQ+L+ + 
Sbjct: 67  N----IVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQILKGLN 120

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H+  +IH D+K  N+L+ +   IK+ D+  S          K++  +S         T
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGIS----------KKLEANSLS-----TKT 165

Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              RP    +  +  + APEV+    +T   DIWS+GC++VE+ TG
Sbjct: 166 NGARPS---LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 82.7 bits (205), Expect = 6e-18
 Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 38/226 (16%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           + I  K+GEG++G V +   +E  ++VAIK+V  +++  +  + EI +L+Q         
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQ-CDSP---- 58

Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             V+    +     + IV E  G  S+ D ++  N ++   + +  I  Q L+ + ++H 
Sbjct: 59  YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHS 117

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-ST--T 271
              IH D+K  N+LL                            +    K+ DFG S   T
Sbjct: 118 NKKIHRDIKAGNILL---------------------------NEEGQAKLADFGVSGQLT 150

Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 317
                +N ++ T  + APEVI  +G+    DIWS+G   +E+  G+
Sbjct: 151 DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 81.0 bits (200), Expect = 3e-17
 Identities = 68/310 (21%), Positives = 109/310 (35%), Gaps = 90/310 (29%)

Query: 118 RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 177
           + +M+A   V  +K  R   MI+ E                ++   F  ++++ +V E L
Sbjct: 31  KSDMIAKNQVTNVKAERAIMMIQGE-----------SPYVAKLYYSFQSKDYLYLVMEYL 79

Query: 178 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 236
            G      ++       P D  ++   +++  +  +H   +IH D+KPEN+L+  + ++K
Sbjct: 80  NGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLK 137

Query: 237 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG 296
           + D+  S           R                 E       V T  Y APE ILG+G
Sbjct: 138 LTDFGLS-----------RN--------------GLENKK---FVGTPDYLAPETILGVG 169

Query: 297 WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR 356
                D WS+GC++ E   G   F                   P  +   +         
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAET---------------PDAVFDNIL-------- 206

Query: 357 RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA-- 414
             R++WPE      S       P   +LI +               LL  DP  RL A  
Sbjct: 207 SRRINWPEEVKEFCS-------PEAVDLINR---------------LLCMDPAKRLGANG 244

Query: 415 -REALRHPFF 423
            +E   HPFF
Sbjct: 245 YQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 81.3 bits (200), Expect = 6e-17
 Identities = 68/225 (30%), Positives = 106/225 (47%), Gaps = 44/225 (19%)

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 172

Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ E+   + LF   
Sbjct: 173 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221

Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL- 381
           + ++    ++E++  P P+ M K++      YV     + P+ A         +  P+L 
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVE----NRPKYAG--------LTFPKLF 268

Query: 382 -QNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
             +L     +H+   A     LL  +L  DP  R++  EAL+HP+
Sbjct: 269 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 79.2 bits (195), Expect = 1e-16
 Identities = 85/335 (25%), Positives = 143/335 (42%), Gaps = 67/335 (20%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIV-----RGI--KKYREAAMIEIEVLQQLAKHDKG 153
           K+GEG++  V +   R   ++VA+K++      G+     REA+++         K  K 
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLL---------KGLKH 62

Query: 154 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
            N  V + +    +  +  VFE + + L  ++ ++     P + VR    QLL  +A++H
Sbjct: 63  AN-IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYN-VRLFMFQLLRGLAYIH 120

Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTY 272
              ++H DLKP+N+L+                     SY         +K+ DFG +   
Sbjct: 121 GQHILHRDLKPQNLLI---------------------SYL------GELKLADFGLARAK 153

Query: 273 ERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ-THENLEH 328
             P Q Y   V T  YR P+V+LG   ++   DIW  GCI +E+  G+  F    +  E 
Sbjct: 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ 213

Query: 329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 388
           L  +  VLG   +     V +    Y     L   +    R   K + + P+ ++L  Q 
Sbjct: 214 LEKIWTVLGVPTEDTWPGVSK-LPNYKPEWFL-PCKPQQLRVVWKRLSRPPKAEDLASQ- 270

Query: 389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                         +L   P DR++A++AL HP+F
Sbjct: 271 --------------MLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 36/221 (16%)

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 179

Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ E+  G  LF   
Sbjct: 180 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228

Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRL 381
           ++++    ++E++  P P+ M K++      YV     + P+ A  S E +   +  P  
Sbjct: 229 DHIDQWNKVIEQLGTPCPEFM-KKLQPTVRTYVE----NRPKYAGYSFEKLFPDVLFPAD 283

Query: 382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
                +H    A     LL  +L  D + R++  EAL+HP+
Sbjct: 284 S----EHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 70/338 (20%), Positives = 121/338 (35%), Gaps = 79/338 (23%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR---EAAMIEIEVLQQLAKH 150
             Y++   +G G    V         E VAIK +  ++K +   +    E++ + Q   H
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCN-H 58

Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLR-KNNYRSFPIDLVREIARQLLEC 208
                  V+    F   + + +V   L G SL D ++           ++  + +++L+ 
Sbjct: 59  PN----VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY--KSSLHTPKDSSYFKRMPKSSAIKVID 266
           + ++H    IH D+K  N+LL     +K+ D+   +SL    D +   R           
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR----------- 163

Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVI-LGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
                         V T  + APEV+    G+ +  DIWS G   +EL TG A +  +  
Sbjct: 164 -----------KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212

Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 385
           ++   +M  +    P           +KY            + R+ I             
Sbjct: 213 MK--VLMLTLQNDPPSL---ETGADYKKY----------SKSFRKMISLC---------- 247

Query: 386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                             L+ DP+ R TA E L+H FF
Sbjct: 248 ------------------LQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 77.2 bits (191), Expect = 7e-16
 Identities = 74/338 (21%), Positives = 129/338 (38%), Gaps = 93/338 (27%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           ++    +G G+FG+V+    +   +  A+KI+    I K ++   +  E  +LQ + +H 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHP 61

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                     ++ D  N + +V E + G  L+  LRK+    FP  + R  A Q++  + 
Sbjct: 62  ---FLVNLYGSFQDDSN-LYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALE 115

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H L +++ DLKPEN+LL S  Y                           IK+ DFG  
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGY---------------------------IKITDFGFA 148

Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
              +     +  T  Y APE+IL  G+    D W++G ++ E+  G   F        + 
Sbjct: 149 KRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD---NPIQ 205

Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 390
           + E++L                     G++ +P                           
Sbjct: 206 IYEKILE--------------------GKVRFP-----------------------SFFS 222

Query: 391 HSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
               D   L++ LL+ D T RL        +   HP+F
Sbjct: 223 ---PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 82/330 (24%), Positives = 145/330 (43%), Gaps = 60/330 (18%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA----MIEIEVLQQLAKHDKGGNR 156
           K+GEGT+  V +   +  + +VA+K +R   ++ E A    + E+ +L+ L KH      
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKDL-KHAN---- 65

Query: 157 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRK-NNYRSFPIDLVREIARQLLECIAFMHDL 215
            V + +       + +VFE L   L  ++    N  S  +  V+    Q+L  +A+ H  
Sbjct: 66  IVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMS--MHNVKIFLYQILRGLAYCHRR 123

Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
            ++H DLKP+N+L+     +K+ D+          +  K +P           + TY   
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADF--------GLARAKSVP-----------TKTYSNE 164

Query: 276 DQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 334
                V T  YR P+V+LG   ++   D+W VGCI  E+ +G  LF      + L ++ R
Sbjct: 165 -----VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR 219

Query: 335 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHSA 393
           +LG   +                    WP G +S +  K+    P+ +   ++ H     
Sbjct: 220 LLGTPTEE------------------TWP-GISSNDEFKN-YNFPKYKPQPLINHAPRLD 259

Query: 394 GDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
            +   LL   L+Y+   R++A EA++H +F
Sbjct: 260 TEGIELLTKFLQYESKKRISAEEAMKHAYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 83/333 (24%), Positives = 152/333 (45%), Gaps = 51/333 (15%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE--AAMIEIEVLQQLAKHDKG 153
           Y+   K+GEG++  V +   +   ++VA+K++R  ++      A+ E  +L+ L KH   
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHAN- 64

Query: 154 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
               V + +    +  + +VFE + + L  ++ K+     P + V+    QLL  ++++H
Sbjct: 65  ---IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP-ENVKLFLFQLLRGLSYIH 120

Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
              ++H DLKP+N+L+  +  +K+ D+               + ++ ++      S TY 
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFG--------------LARAKSVP-----SHTYS 161

Query: 274 RPDQNYIVSTRHYRAPEVILGLGWTYPC-DIWSVGCILVELCTGEALFQTHENLE-HLAM 331
                  V T  YR P+V+LG      C D+W VGCI VE+  G A F   ++++  L  
Sbjct: 162 NE-----VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLER 216

Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           +  VLG   +     V               P     R ++ S   L +  N  + +V+H
Sbjct: 217 IFLVLGTPNEDTWPGVH------------SLPHFKPERFTLYSPKNLRQAWNK-LSYVNH 263

Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
           +      L   LL+  P +RL+A+ AL H +F+
Sbjct: 264 A----EDLASKLLQCFPKNRLSAQAALSHEYFS 292

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 88/354 (24%), Positives = 152/354 (42%), Gaps = 75/354 (21%)

Query: 101 KMGEGTFGQVLECWDRERKEM--VAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 158
           K+G GT+G V +   ++ K+    A+K + G      +A  EI +L++L    K  N   
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEG-TGISMSACREIALLREL----KHPNVIA 62

Query: 159 QIRNWFDYRNH-ICIVFEKLGSSLYDFLR-----KNNYR--SFPIDLVREIARQLLECIA 210
             + +  + +  + ++F+     L+  ++     K N +    P  +V+ +  Q+L+ I 
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-S 269
           ++H   ++H DLKP N+L++                          P+   +K+ D G +
Sbjct: 123 YLHANWVLHRDLKPANILVMGEG-----------------------PERGRVKIADMGFA 159

Query: 270 TTYERP-----DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH 323
             +  P     D + +V T  YRAPE++LG   +T   DIW++GCI  EL T E +F   
Sbjct: 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ- 382
           +        E +    P H   ++DR           DW       E I+ + + P LQ 
Sbjct: 220 Q--------EDIKTSNPFHH-DQLDRIFSVMGFPADKDW-------EDIRKMPEYPTLQK 263

Query: 383 -------------NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                          + +H       +  LLQ LL  DPT R+T+ +AL+ P+F
Sbjct: 264 DFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 75.5 bits (185), Expect = 4e-15
 Identities = 88/349 (25%), Positives = 151/349 (43%), Gaps = 65/349 (18%)

Query: 101 KMGEGTFGQVLECWDRERKEM--VAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 158
           K+G GT+G V +   ++ K+    A+K + G      +A  EI +L++L KH       +
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEG-TGISMSACREIALLREL-KHPN----VI 61

Query: 159 QIRNWF--DYRNHICIVFEKLGSSLYDFLR-----KNNYR--SFPIDLVREIARQLLECI 209
            ++  F       + ++F+     L+  ++     K N +    P  +V+ +  Q+L+ I
Sbjct: 62  SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 268
            ++H   ++H DLKP N+L++                          P+   +K+ D G 
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEG-----------------------PERGRVKIADMGF 158

Query: 269 STTYERP-----DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 322
           +  +  P     D + +V T  YRAPE++LG   +T   DIW++GCI  EL T E +F  
Sbjct: 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218

Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR-- 380
            +        E +    P H   ++DR           DW +     E   ++MK  R  
Sbjct: 219 RQ--------EDIKTSNPYHH-DQLDRIFNVMGFPADKDWEDIKKMPEH-STLMKDFRRN 268

Query: 381 ------LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                 L   + +H         HLLQ LL  DP  R+T+ +A++ P+F
Sbjct: 269 TYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 74.1 bits (183), Expect = 5e-15
 Identities = 53/236 (22%), Positives = 87/236 (36%), Gaps = 55/236 (23%)

Query: 97  KIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKH 150
            +  K+GEG FG+V +         ++  VA+K ++     ++      E  ++++L  H
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DH 60

Query: 151 D-----KGGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 203
                  G   C +          + IV E    G  L D+LRKN  +   +  +   A 
Sbjct: 61  PNIVKLLGV--CTE-------EEPLMIVMEYMPGGD-LLDYLRKNRPKELSLSDLLSFAL 110

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+   + ++     IH DL   N L V    +                          +K
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCL-VGENLV--------------------------VK 143

Query: 264 VIDFGSTTYERPDQNYIVSTRH--YR--APEVILGLGWTYPCDIWSVGCILVELCT 315
           + DFG +     D  Y V       R  APE +    +T   D+WS G +L E+ T
Sbjct: 144 ISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 74.3 bits (183), Expect = 5e-15
 Identities = 74/336 (22%), Positives = 130/336 (38%), Gaps = 83/336 (24%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHD 151
             Y++  ++G GT+G V +  D    E+VAIK+++ ++   +  +I  EI +L++  +H 
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK-LEPGDDFEIIQQEISMLKE-CRH- 59

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                 V     +  R+ + IV E   G SL D  +           +  + R+ L+ +A
Sbjct: 60  ---PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLA 115

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H+   IH D+K  N+LL     +K+ D+  S      ++  KR               
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVS--AQLTATIAKR--------------- 158

Query: 271 TYERPDQNYIVSTRHYRAPEVI---LGLGWTYPCDIWSVGCILVELCTGE-ALFQTHENL 326
                     + T ++ APEV       G+   CDIW++G   +EL   +  +F  H   
Sbjct: 159 -------KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH--- 208

Query: 327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 386
               M  R L  +                                 KS    P+L++   
Sbjct: 209 ---PM--RALFLIS--------------------------------KSNFPPPKLKD--- 228

Query: 387 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
              +  +      ++  L  DP  R TA + L+HPF
Sbjct: 229 --KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 74.8 bits (184), Expect = 6e-15
 Identities = 70/268 (26%), Positives = 111/268 (41%), Gaps = 67/268 (25%)

Query: 164 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 222
           F+ + H+C+V E + G      L+  N  + P+D+ R    + +  + ++H+  ++H DL
Sbjct: 70  FETKRHLCMVMEYVEGGDCATLLK--NIGALPVDMARMYFAETVLALEYLHNYGIVHRDL 127

Query: 223 KPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
           KP+N+L+ S  +IK+ D+   K  L +   + Y   + K            T E  D+  
Sbjct: 128 KPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD-----------TREFLDKQ- 175

Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 339
           +  T  Y APEVIL  G+  P D W++G IL E   G   F                G  
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF---------------FGDT 220

Query: 340 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 399
           P+ +  +        V    ++WPEG  +         LP               D   L
Sbjct: 221 PEELFGQ--------VISDDIEWPEGDEA---------LP--------------ADAQDL 249

Query: 400 LQGLLRYDPTDRL---TAREALRHPFFT 424
           +  LLR +P +RL    A E  +H FF 
Sbjct: 250 ISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 73.9 bits (181), Expect = 7e-15
 Identities = 68/273 (24%), Positives = 124/273 (45%), Gaps = 39/273 (14%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQL 147
           + +++   +G+G FG+V  C+D +    +A+K V+         K   A   EI++L+ L
Sbjct: 2   TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61

Query: 148 AKHDKGGNRCVQIRNWF-DYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQ 204
                   R VQ      D       +F +   G S+ D L+  +Y +   ++ R+  RQ
Sbjct: 62  LHE-----RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK--SYGALTENVTRKYTRQ 114

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +LE ++++H   ++H D+K  N+L  S   +K+ D+ +S          KR+      + 
Sbjct: 115 ILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGAS----------KRL------QT 158

Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
           I    T  +      +  T ++ +PEVI G G+    DIWSVGC +VE+ T +  +   E
Sbjct: 159 ICLSGTGMKS-----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE 213

Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
            +   A+ +    P    +   V  H   +++R
Sbjct: 214 AMA--AIFKIATQPTNPVLPPHVSDHCRDFLKR 244

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 73.7 bits (182), Expect = 7e-15
 Identities = 62/301 (20%), Positives = 107/301 (35%), Gaps = 82/301 (27%)

Query: 97  KIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKH 150
           ++  K+GEG FG+V +          +  VA+K ++    ++ RE  + E  ++++L  H
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SH 60

Query: 151 DK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 203
                  G   C Q          + IV E    G  L DFLRK+      +  + ++A 
Sbjct: 61  PNIVRLLGV--CTQ-------GEPLYIVTEYMPGGD-LLDFLRKHG-EKLTLKDLLQMAL 109

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+ + + ++     +H DL   N L+             +L                 +K
Sbjct: 110 QIAKGMEYLESKNFVHRDLAARNCLV-----------TENLV----------------VK 142

Query: 264 VIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 318
           + DFG +     D  Y           + APE +    +T   D+WS G +L E+ T   
Sbjct: 143 ISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGE 202

Query: 319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMK 377
                              P P    + V     + +  G RL  PE     + +  +M 
Sbjct: 203 Q------------------PYPGMSNEEV----LELLEDGYRLPRPENCP--DELYELML 238

Query: 378 L 378
            
Sbjct: 239 Q 239

Length = 258

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 74.7 bits (184), Expect = 9e-15
 Identities = 78/347 (22%), Positives = 130/347 (37%), Gaps = 94/347 (27%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           ++I +++G+G +GQV     ++  E+VA+K +    + K  E   +  E ++L    K +
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSE 61

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                 V++   F    ++ +  E + G      L  NN      D  R    ++ E + 
Sbjct: 62  ----WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVD 115

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
            +H+L  IH DLKPEN L+ +S +IK+                            DFG +
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKL---------------------------TDFGLS 148

Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF------QTHE 324
                  N +V +  Y APEV+ G G+ +  D WS+GC+L E   G   F      +T E
Sbjct: 149 KGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE 208

Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           NL++                               L  P     R ++            
Sbjct: 209 NLKYWKET---------------------------LQRPVYDDPRFNLS----------- 230

Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR-HPFFTRDHLRR 430
                D +   +T L+      DP+ R  + E ++ HPFF       
Sbjct: 231 -----DEAWDLITKLIN-----DPSRRFGSLEDIKNHPFFKEVDWNE 267

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 57/246 (23%), Positives = 103/246 (41%), Gaps = 44/246 (17%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMI--EIEVLQQLAKHDK 152
           Y++   +G+G+FG V +   +   +++  K I  G    +E   +  E+ +L++L KH  
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPN 60

Query: 153 GGNRCVQIRNWF-DYRNH-ICIVFEKLG----SSLYDFLRKNNYRSFPIDLVREIARQLL 206
                V+  +   D  N  + IV E       + L    +K   +    + +  I  QLL
Sbjct: 61  ----IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER-KYIEEEFIWRILTQLL 115

Query: 207 ECIAFMHDLC-----MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             +   H+       ++H DLKP N+ L ++  +K+ D+  +          K +   S 
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA----------KILGHDS- 164

Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
                  + TY        V T +Y +PE +  + +    DIWS+GC++ ELC     F 
Sbjct: 165 -----SFAKTY--------VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211

Query: 322 THENLE 327
               L+
Sbjct: 212 ARNQLQ 217

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 66/252 (26%), Positives = 108/252 (42%), Gaps = 33/252 (13%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIE-VLQQLAKHDKG 153
           +Y +   +GEG+FG+ L        +  A+K +R  K          E VL    KH   
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN- 59

Query: 154 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
               V  +  F+   H+ IV E   G  L   ++    + FP D + +   Q+   +  +
Sbjct: 60  ---IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116

Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H+  ++H D+K +N+ L  +  +K+ D+ S+       +Y                + TY
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY----------------ACTY 160

Query: 273 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH--ENLEHLA 330
                   V T +Y  PE+   + +    DIWS+GCIL ELCT +  FQ +  +NL  L 
Sbjct: 161 --------VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI-LK 211

Query: 331 MMERVLGPLPQH 342
           + +    PLP H
Sbjct: 212 VCQGSYKPLPSH 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 43/236 (18%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHD 151
           +Y    K+GEG+FG+ +    +E  +   IK   I +   K RE +  E+ VL  + KH 
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHP 59

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                 VQ +  F+   ++ IV +   G  LY  +       FP D + +   Q+   + 
Sbjct: 60  N----IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-- 268
            +HD  ++H D+K +N+ L                            K   IK+ DFG  
Sbjct: 116 HVHDRKILHRDIKSQNIFLT---------------------------KDGTIKLGDFGIA 148

Query: 269 ---STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
              ++T E       + T +Y +PE+     +    DIW++GC+L E+CT +  F+
Sbjct: 149 RVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 84/335 (25%), Positives = 128/335 (38%), Gaps = 83/335 (24%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKH 150
           RY +  ++G+G+FG V    D++      +K+++ I        E      E  Q L+K 
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEA-QLLSKL 59

Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLR--KNNYRSFPIDLVREIARQLLE 207
           D      V+    F  R+  CI+ E   G  L   L   K+  ++   + V E   QLL 
Sbjct: 60  DHPA--IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL 117

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + +MH   ++H DLK +N+ L  +  +K+ D+  S           R+   S     D 
Sbjct: 118 GVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVS-----------RLLMGSC----DL 161

Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
            +T            T +Y +PE +   G+    DIWS+GCIL E+C     F+    L 
Sbjct: 162 ATT---------FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS 212

Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
              ++  V GP P                      PE               R  N IMQ
Sbjct: 213 --VVLRIVEGPTPS--------------------LPE------------TYSRQLNSIMQ 238

Query: 388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
                          +L  DP+ R +A E LR+PF
Sbjct: 239 S--------------MLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 79/343 (23%), Positives = 128/343 (37%), Gaps = 83/343 (24%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLA 148
            N    ++I  ++G+G FG+V +   +E     A KI++   ++  E  M+EI++L +  
Sbjct: 1   VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC- 59

Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           KH       V +   + Y N + I+ E       D +     R      +R + RQ+LE 
Sbjct: 60  KHPN----IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEA 115

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           + F+H   +IH DLK  N+LL     +K+ D+  S                         
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVS------------------------A 151

Query: 269 STTYERPDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTH 323
                   ++  + T ++ APEV+         + Y  DIWS+G  L+EL   E     H
Sbjct: 152 KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP---PH 208

Query: 324 ENLEHLAMMERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 382
             L  + ++ ++L    P                   LD P   +S              
Sbjct: 209 HELNPMRVLLKILKSEPPT------------------LDQPSKWSS-------------- 236

Query: 383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                            L+  L  DP DR TA E L+HPF + 
Sbjct: 237 ------------SFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 71/340 (20%), Positives = 121/340 (35%), Gaps = 98/340 (28%)

Query: 100 SKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
            ++G G  G V +   R   +++A+K +R    +  ++  + E+++L           +C
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILH----------KC 56

Query: 158 -----VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
                V     F     I I  E +     D + K      P  ++ +IA  +L+ + ++
Sbjct: 57  NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYL 116

Query: 213 H-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           H    +IH D+KP N+L+ S   IK+ D+  S           ++  S A          
Sbjct: 117 HEKHKIIHRDVKPSNILVNSRGQIKLCDFGVS----------GQLVNSLA---------- 156

Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                    V T  Y APE I G  ++   DIWS+G  L+EL T                
Sbjct: 157 ------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELAT---------------- 194

Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL------PRLQNLI 385
                                     GR  +P      + I  +++       PRL +  
Sbjct: 195 --------------------------GRFPYPPENDPPDGIFELLQYIVNEPPPRLPS-- 226

Query: 386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                  + D    +   L  DP +R + +E L HPF  +
Sbjct: 227 ----GKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 68/269 (25%), Positives = 123/269 (45%), Gaps = 47/269 (17%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGGN 155
           +G+G FG+V  C+D +    +A K V+         K   A   EI++L+ L +H+    
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHE---- 64

Query: 156 RCVQIRNWFDYRNH----ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
           R VQ       R+     + I  E + G S+ D L+   Y +    + R+  RQ+LE ++
Sbjct: 65  RIVQYYGCL--RDRAEKTLTIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMS 120

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H   ++H D+K  N+L  S+  +K+ D+ +S          KR+      + I    T
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS----------KRL------QTICMSGT 164

Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
                    +  T ++ +PEVI G G+    D+WS+GC +VE+ T +  +  +E +  + 
Sbjct: 165 GIRS-----VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF 219

Query: 331 MM--ERVLGPLPQHMLKRVDRHAEKYVRR 357
            +  +     LP H    +  HA  ++  
Sbjct: 220 KIATQPTNPQLPSH----ISEHARDFLGC 244

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 73.2 bits (180), Expect = 4e-14
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 34/237 (14%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ-------LAKHDKGGN 155
           G G FG+V     ++   + A+K +R      ++ M+E E +         LA+ D    
Sbjct: 10  GRGAFGEVRLVQKKDTGHIYAMKKLR------KSEMLEKEQVAHVRAERDILAEAD--NP 61

Query: 156 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR-EIARQLLECIAFMH 213
             V++   F   N++ ++ E L G  +   L K    +F  +  R  IA  +L  I  +H
Sbjct: 62  WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETIL-AIDSIH 118

Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYK--SSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            L  IH D+KP+N+LL +  +IK+ D+   + L     + +++ +  +     +DF S  
Sbjct: 119 KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178

Query: 272 YERPD--QNY----------IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                  + +           V T  Y APEV L  G+   CD WS+G I+ E+  G
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 33/218 (15%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 158
           +G+G FG+       E   +V  K V   R  +K R  A+ EI +L  L +H       +
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPN----II 62

Query: 159 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
              N F   N + I  E   G +LYD + +   + F  ++V     Q++  ++++H   +
Sbjct: 63  AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI 122

Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           +H D+K  N+ L  +  IK+ D+  S    K       M ++                  
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGIS----KILGSEYSMAET------------------ 160

Query: 278 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
             +V T +Y +PE+  G+ + +  DIW++GC+L EL T
Sbjct: 161 --VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 71.4 bits (175), Expect = 5e-14
 Identities = 71/248 (28%), Positives = 106/248 (42%), Gaps = 53/248 (21%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G+GT+G V    D   +  +AIK +   +  R    +  E+   L  + K  N  VQ  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIP-ERDSRYVQPLHEEIA--LHSYLKHRN-IVQYL 71

Query: 162 NWFDYRNHICIVFEKL-GSSLYDFLR------KNNYRSFPIDLVREIARQLLECIAFMHD 214
                     I  E++ G SL   LR      K+N        +    +Q+LE + ++HD
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE-----QTIIFYTKQILEGLKYLHD 126

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             ++H D+K +NVL+                    ++Y      S  +K+ DFG  T +R
Sbjct: 127 NQIVHRDIKGDNVLV--------------------NTY------SGVVKISDFG--TSKR 158

Query: 275 -----PDQNYIVSTRHYRAPEVI-LGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                P       T  Y APEVI  G  G+  P DIWS+GC +VE+ TG+  F   E  E
Sbjct: 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF--IELGE 216

Query: 328 HLAMMERV 335
             A M +V
Sbjct: 217 PQAAMFKV 224

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 71.0 bits (174), Expect = 8e-14
 Identities = 38/161 (23%), Positives = 81/161 (50%), Gaps = 26/161 (16%)

Query: 189 NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS-EYIKVPDYKSSLHTP 247
            Y +F   ++     QLL  ++++H+  +IH D+K  N+L+ S+ + +++ D+       
Sbjct: 96  KYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADF------- 148

Query: 248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVG 307
                       +A ++   G+   E   Q  ++ T  + APEV+ G  +   CD+WSVG
Sbjct: 149 -----------GAAARLAAKGTGAGEFQGQ--LLGTIAFMAPEVLRGEQYGRSCDVWSVG 195

Query: 308 CILVELCTGEALFQTHENLEHLAMMERVLG-----PLPQHM 343
           C+++E+ T +  +   ++  HLA++ ++        +P+H+
Sbjct: 196 CVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 71.0 bits (174), Expect = 8e-14
 Identities = 78/340 (22%), Positives = 128/340 (37%), Gaps = 96/340 (28%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMI-----EIEVLQQLAKH 150
           +G+GT+G+V    +    EM+A+K V       G    R+  M+     EIE L+ L   
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
           +      VQ   +     ++ I  E + G S+   LR   Y  F   LVR    Q+LE +
Sbjct: 69  N-----IVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQLVRFFTEQVLEGL 121

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
           A++H   ++H DLK +N+L+ +    K+ D+  S  +                       
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS----------------------D 159

Query: 270 TTYERPDQNYIVSTRHYRAPEVI--LGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
             Y+      +  +  + APEVI     G++   DIWS+GC+++E+  G    +   + E
Sbjct: 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR---RPWSDEE 216

Query: 328 HLAMM-----ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 382
            +A M     +R   P+P  +   +               P                   
Sbjct: 217 AIAAMFKLGNKRSAPPIPPDVSMNLS--------------PVAL---------------- 246

Query: 383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
                            L      +P +R TARE L+HPF
Sbjct: 247 ---------------DFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 35/224 (15%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-EAAMIEIEVLQQLAKHDKGG 154
           ++I  ++G+G FG+V +  ++E   + A K++    +   E  M+EIE+L          
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHP---- 69

Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
              V++   F +   + I+ E       D +     R      ++ I RQ+LE + ++H 
Sbjct: 70  -YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           + +IH DLK  NVLL     IK+ D+  S    K                      T +R
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK----------------------TLQR 166

Query: 275 PDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVEL 313
            D    + T ++ APEV++        + Y  DIWS+G  L+E+
Sbjct: 167 RDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 70/339 (20%), Positives = 132/339 (38%), Gaps = 85/339 (25%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYR--EAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G FG+V  C  +   +M A K +  + +KK +  + A+ E ++L++++         
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR-----FI 55

Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V +   F+ ++ +C+V   + G  L   +       FP       A Q++  +  +H   
Sbjct: 56  VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115

Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +++ DLKPENVLL     +++ D   ++                       G     R  
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKG-------------------GKKIKGR-- 154

Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 336
                 T  Y APEV+ G  + +  D +++GC L E+  G + F+  +            
Sbjct: 155 ----AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK------------ 198

Query: 337 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 396
                   ++V++   K               R +++  ++ P          D  + + 
Sbjct: 199 --------EKVEKEELK---------------RRTLEMAVEYP----------DKFSPEA 225

Query: 397 THLLQGLLRYDPTDRL-----TAREALRHPFFTRDHLRR 430
             L + LL+ DP  RL     +A E   HP F   + RR
Sbjct: 226 KDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRR 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 62/224 (27%), Positives = 109/224 (48%), Gaps = 39/224 (17%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIV------RGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           +G G FG+V  C+D +    +A+K V      +   K   A   EI++L+ L +HD    
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHD---- 64

Query: 156 RCVQ----IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           R VQ    +R+  + +  I + +   G S+ D L+   Y +   ++ R   RQ+L+ +++
Sbjct: 65  RIVQYYGCLRDPEEKKLSIFVEYMP-GGSIKDQLKA--YGALTENVTRRYTRQILQGVSY 121

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H   ++H D+K  N+L  S+  +K+ D+ +S          KR      I+ I    T 
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGAS----------KR------IQTICMSGTG 165

Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
            +      +  T ++ +PEVI G G+    D+WSV C +VE+ T
Sbjct: 166 IKS-----VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 59/234 (25%), Positives = 100/234 (42%), Gaps = 43/234 (18%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGI-KKYREAAMIEIEVLQQLAKHDK 152
           ++I +K+G+G+FG V +   +  K + A+K +    + ++ RE A+ E  VL +L     
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL----- 56

Query: 153 GGNRCVQIRNW--FDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
             +    IR +  F  +  + IV E      L+  L+    R  P D V     Q+L  +
Sbjct: 57  --DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL 114

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
           A +H   ++H D+K  N+ L    Y  V                         K+ D G 
Sbjct: 115 AHLHSKKILHRDIKSLNLFL--DAYDNV-------------------------KIGDLGV 147

Query: 270 TTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
                 + N+   IV T +Y +PE+     +    D+W++G +L E CTG+  F
Sbjct: 148 AKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 64/264 (24%), Positives = 109/264 (41%), Gaps = 74/264 (28%)

Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD- 151
           T  +++   +GEGT+G+V +   ++  ++VAIKI+  I+   E    E  +L++ + H  
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPN 64

Query: 152 ---------KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDF---LRKNNYRSFPIDLV 198
                    K        + W         V E   G S+ D    LRK   +    + +
Sbjct: 65  IATFYGAFIKKNPPGNDDQLWL--------VMELCGGGSVTDLVKGLRKKG-KRLKEEWI 115

Query: 199 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 258
             I R+ L  +A++H+  +IH D+K +N+LL                            K
Sbjct: 116 AYILRETLRGLAYLHENKVIHRDIKGQNILLT---------------------------K 148

Query: 259 SSAIKVIDFG------STTYERPDQNYIVSTRHYRAPEVI-----LGLGWTYPCDIWSVG 307
           ++ +K++DFG      ST   R   N  + T ++ APEVI         +    D+WS+G
Sbjct: 149 NAEVKLVDFGVSAQLDSTLGRR---NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG 205

Query: 308 CILVELCTGE----------ALFQ 321
              +EL  G+          ALF+
Sbjct: 206 ITAIELADGKPPLCDMHPMRALFK 229

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 53/224 (23%), Positives = 100/224 (44%), Gaps = 35/224 (15%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-EAAMIEIEVLQQLAKHDKGG 154
           ++I  ++G+G FG+V +  ++E   + A K++    +   E  M+EI++L      +   
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN--- 63

Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
              V++ + F Y N++ I+ E       D +     R      +R + +Q LE + ++H+
Sbjct: 64  --IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             +IH DLK  N+L      IK+ D+  S    +                      T +R
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR----------------------TIQR 159

Query: 275 PDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVEL 313
            D    + T ++ APEV++        + Y  D+WS+G  L+E+
Sbjct: 160 RDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 68.8 bits (168), Expect = 4e-13
 Identities = 66/250 (26%), Positives = 109/250 (43%), Gaps = 40/250 (16%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ---LAKHDKGGNRCV 158
           +G+G +G V  C    + +++A+K V        AA  E E LQ+   L K  K  N   
Sbjct: 8   LGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 159 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
            +    D  N I I  E + G S+   L  N +   P  +  +  +Q+L+ +A++H+ C+
Sbjct: 67  YLGTCLD-DNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123

Query: 218 IHTDLKPENVLLVSSEYIKVPDYK-------SSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           +H D+K  NV+L+ +  IK+ D+          LH    S+  K M              
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTH-SNMLKSMH------------- 169

Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
                       T ++ APEVI   G+    DIWS+GC + E+ TG+    + + L  + 
Sbjct: 170 -----------GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF 218

Query: 331 MMERVLGPLP 340
            +    G +P
Sbjct: 219 YIGAHRGLMP 228

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 68.3 bits (168), Expect = 5e-13
 Identities = 54/236 (22%), Positives = 88/236 (37%), Gaps = 56/236 (23%)

Query: 97  KIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKH 150
            +  K+GEG FG+V +        ++K  VA+K ++     ++      E  ++++L  H
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DH 60

Query: 151 D-----KGGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 203
                  G   C +          + IV E  + G  L  +LRKN  +    DL+   A 
Sbjct: 61  PNVVKLLGV--CTE-------EEPLYIVMEYMEGGD-LLSYLRKNRPKLSLSDLL-SFAL 109

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+   + ++     IH DL   N L V    +                          +K
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCL-VGENLV--------------------------VK 142

Query: 264 VIDFGSTTYERPDQNYIVSTRH--YR--APEVILGLGWTYPCDIWSVGCILVELCT 315
           + DFG +     D  Y         R  APE +    +T   D+WS G +L E+ T
Sbjct: 143 ISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 68.2 bits (167), Expect = 7e-13
 Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 40/227 (17%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHD 151
           +KI  K+G+G F  V +        +VA+K V+       K R+  + EI++L+QL  H 
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHP 62

Query: 152 KGGNRCVQIRNWFDYRNHICIVFE-----KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
                 ++    F   N + IV E      L   +  F  K   R  P   + +   QL 
Sbjct: 63  N----VIKYLASFIENNELNIVLELADAGDLSRMIKHF--KKQKRLIPERTIWKYFVQLC 116

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             +  MH   ++H D+KP NV + ++  +K+ D               R           
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLG-----------LGRF---------- 155

Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
           F S T      + +V T +Y +PE I   G+ +  DIWS+GC+L E+
Sbjct: 156 FSSKTTA---AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 68.1 bits (166), Expect = 8e-13
 Identities = 83/330 (25%), Positives = 131/330 (39%), Gaps = 87/330 (26%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           ++G+G+FG+V +  D   KE+VAIKI+       E A  EIE +QQ        +     
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 161 RNWFDY--RNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQLLECIAFMHDL 215
           R +  Y     + I+ E LG  S  D L+       P++   +  I R++L+ + ++H  
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE 120

Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
             IH D+K  NVLL     +K+ D+  +                        G  T  + 
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVA------------------------GQLTDTQI 156

Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 335
            +N  V T  + APEVI    + +  DIWS+G   +EL  GE     + +L  +    RV
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEP---PNSDLHPM----RV 209

Query: 336 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 395
           L  +P++                                    P L+    Q+    +  
Sbjct: 210 LFLIPKN----------------------------------SPPTLEG---QY----SKP 228

Query: 396 LTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
               ++  L  DP  R TA+E L+H F TR
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELLKHKFITR 258

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 75/334 (22%), Positives = 125/334 (37%), Gaps = 94/334 (28%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRC---- 157
           +G+GTFG+V+   ++   +  A+KI++     +E  + + EV   L +     N      
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILK-----KEVIIAKDEVAHTLTESRVLQNTRHPFL 57

Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++  F   + +C V E   G  L+  L +   R F  D  R    +++  + ++H   
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD 115

Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +++ DLK EN++L    +IK+ D+               + K      I  G+T      
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFG--------------LCKEG----ISDGATM----- 152

Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMMER 334
                 T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  L +ME 
Sbjct: 153 -KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 211

Query: 335 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 394
           +                                         + PR   L        + 
Sbjct: 212 I-----------------------------------------RFPR--TL--------SP 220

Query: 395 DLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
           +   LL GLL+ DP  RL      A+E + H FF
Sbjct: 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 69.0 bits (168), Expect = 2e-12
 Identities = 68/261 (26%), Positives = 123/261 (47%), Gaps = 36/261 (13%)

Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAM-IEIEVLQ 145
           GE+  + Y++  K+G G FG+V     +  +E    K +  RG+K+  ++ + IE+ V++
Sbjct: 8   GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMR 67

Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPI------DLVR 199
           +L KH        +  N  + + +I + F   G      L +N  + + +        + 
Sbjct: 68  EL-KHKNIVRYIDRFLNKANQKLYILMEFCDAGD-----LSRNIQKCYKMFGKIEEHAIV 121

Query: 200 EIARQLLECIAFMHDLC-------MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 252
           +I RQLL  +A+ H+L        ++H DLKP+N+ L  S  I+        H  K ++ 
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL--STGIR--------HIGKITAQ 171

Query: 253 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTY--PCDIWSVGC 308
              +      K+ DFG +     +   +  V T +Y +PE++L    +Y    D+W++GC
Sbjct: 172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGC 231

Query: 309 ILVELCTGEALFQTHENLEHL 329
           I+ ELC+G+  F    N   L
Sbjct: 232 IIYELCSGKTPFHKANNFSQL 252

Length = 1021

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 64/258 (24%), Positives = 116/258 (44%), Gaps = 39/258 (15%)

Query: 102 MGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           +G G+FG+V L  +  E    VAIK     K  ++  +  +   +++  +      CV +
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH-PFCVNL 96

Query: 161 RNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
              F   +++ +V E  +G   + FLR+N  + FP D+    A Q++    ++  L +++
Sbjct: 97  YGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVY 154

Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DLKPEN+LL    +IK+ D+  +                   KV+D  + TY       
Sbjct: 155 RDLKPENLLLDKDGFIKMTDFGFA-------------------KVVD--TRTYT------ 187

Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG-------EALFQTHENLEHLAMM 332
           +  T  Y APE++L +G     D W++G  + E+  G       E L    + LE +   
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF 247

Query: 333 ERVLGPLPQHMLKRVDRH 350
            + L    +H++K++  H
Sbjct: 248 PKFLDNNCKHLMKKLLSH 265

Length = 340

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 39/222 (17%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ----LAKHDKGGNR 156
           ++G+G+FG+V +  D   +++VAIKI+       E A  EIE +QQ    L++ D     
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDS--PY 63

Query: 157 CVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
             +    +     + I+ E LG  S  D LR   +  F I     + +++L+ + ++H  
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI---ATMLKEILKGLDYLHSE 120

Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
             IH D+K  NVLL     +K+ D+  +                        G  T  + 
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVA------------------------GQLTDTQI 156

Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 317
            +N  V T  + APEVI    +    DIWS+G   +EL  GE
Sbjct: 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 34/204 (16%)

Query: 189 NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHT 246
            Y +F  D+ R    + +  I  +H L  IH D+KP+N+L+    +IK+ D+  S   H 
Sbjct: 94  KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153

Query: 247 PKDSSYFKRMPKSSAIK---------VIDFGSTTYERPDQ-----------NY-IVSTRH 285
             DS+Y++++ +  + K          +D  + T    DQ            Y  V T  
Sbjct: 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPD 213

Query: 286 YRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF---QTHENL-------EHLAMMERV 335
           Y APE+ L  G+   CD WS+G I+ E   G   F    +HE         E L   + +
Sbjct: 214 YIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDI 273

Query: 336 -LGPLPQHMLKRVDRHAEKYVRRG 358
            L    + +++R+  +AE  + RG
Sbjct: 274 HLSVEAEDLIRRLITNAENRLGRG 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 65/262 (24%), Positives = 113/262 (43%), Gaps = 38/262 (14%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+GEG+ G V    ++   + VA+K +   K+ R   +    V+ +   H+      V +
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHEN----VVDM 84

Query: 161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
            N +   + + +V E L G +L D +          + +  +   +L  ++++H+  +IH
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIATVCLSVLRALSYLHNQGVIH 141

Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            D+K +++LL S   IK+ D+       K                        E P +  
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSK------------------------EVPKRKS 177

Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 339
           +V T ++ APEVI  L +    DIWS+G +++E+  GE     + N   L  M R+   L
Sbjct: 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP---PYFNEPPLQAMRRIRDNL 234

Query: 340 PQHMLKRVDRHAEKYVRRGRLD 361
           P  +    D H    V RG LD
Sbjct: 235 PPRV---KDSHKVSSVLRGFLD 253

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 65.6 bits (160), Expect = 5e-12
 Identities = 62/255 (24%), Positives = 109/255 (42%), Gaps = 38/255 (14%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHD 151
           +Y+    +G G FG V  C  +  +++V IK +   +  K  R AA  E +VL+ L+  +
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                 ++    F     + IV E   G +L ++++K        D +     Q+L  + 
Sbjct: 61  -----IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYI-KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            +H   ++H DLK +N+LL   + + K+ D+  S                   K++   S
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGIS-------------------KILSSKS 156

Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
             Y       +V T  Y +PE+  G  +    DIW++GC+L EL + +  F+   NL  L
Sbjct: 157 KAYT------VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA-ANLPAL 209

Query: 330 AM--MERVLGPLPQH 342
            +  M     P+   
Sbjct: 210 VLKIMSGTFAPISDR 224

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 67/259 (25%), Positives = 116/259 (44%), Gaps = 45/259 (17%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD---KGGNRCV 158
           +G G FG+V      + K + A+K +R     ++  ++  +V    A+ D   +  N  V
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLR-----KKDVLLRNQVAHVKAERDILAEADNEWV 63

Query: 159 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRS-------FPIDLVREIARQLLECIAF 211
            +R ++ +++   + F      + D++   +  S       FP DL R    +L   +  
Sbjct: 64  -VRLYYSFQDKDNLYF------VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVES 116

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPD---------------YKSSLHTPKDSSYFKRM 256
           +H +  IH D+KP+N+L+    +IK+ D               Y+S  H  +DS  F   
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176

Query: 257 PKSSA-------IKVIDF-GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 308
               A       +K ++   +  ++R   + +V T +Y APEV+L  G+T  CD WSVG 
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236

Query: 309 ILVELCTGEALFQTHENLE 327
           IL E+  G+  F     LE
Sbjct: 237 ILYEMLVGQPPFLAQTPLE 255

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 65.0 bits (158), Expect = 9e-12
 Identities = 57/262 (21%), Positives = 114/262 (43%), Gaps = 35/262 (13%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           ++ +  +G+G FG+V  C  R   +M A K +  + IKK +  +M   E ++L+++    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV---- 57

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                 V +   ++ ++ +C+V   + G  L   +       F        A ++   + 
Sbjct: 58  -NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
            +H   +++ DLKPEN+LL    +I++ D   ++H P+  +   R               
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR--------------- 161

Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
                     V T  Y APEV+    +T+  D W++GC+L E+  G++ FQ  +      
Sbjct: 162 ----------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 211

Query: 331 MMERVLGPLPQHMLKRVDRHAE 352
            +ER++  + +   ++    A 
Sbjct: 212 EVERLVKEVQEEYSEKFSPDAR 233

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 65/230 (28%), Positives = 99/230 (43%), Gaps = 55/230 (23%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ----LAKHDKG--- 153
           K+G+G+FG+V +  D   +++VAIKI+       E A  EIE +QQ    L++ D     
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 154 ---GNRCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQLLE 207
              G+     + W        I+ E LG  S  D L        P+D   +  I R++L+
Sbjct: 66  KYYGSYLKDTKLW--------IIMEYLGGGSALDLLEPG-----PLDETQIATILREILK 112

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H    IH D+K  NVLL     +K+ D+  +                        
Sbjct: 113 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA------------------------ 148

Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 317
           G  T  +  +N  V T  + APEVI    +    DIWS+G   +EL  GE
Sbjct: 149 GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 64.5 bits (158), Expect = 1e-11
 Identities = 54/235 (22%), Positives = 92/235 (39%), Gaps = 54/235 (22%)

Query: 101 KMGEGTFGQVLEC-WDR--ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGN 155
           K+GEG FG+V +        +   VA+K ++    ++ R+  + E  V+++L  H     
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPN--- 57

Query: 156 RCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKN-NYRSFPI-------DLVREIARQL 205
             V++         + +V E  + G  L D+LRK+      P        DL+   A Q+
Sbjct: 58  -VVRLLGVCTEEEPLYLVLEYMEGGD-LLDYLRKSRPVFPSPEKSTLSLKDLLS-FAIQI 114

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
            + + ++     +H DL   N L V  + +                          +K+ 
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCL-VGEDLV--------------------------VKIS 147

Query: 266 DFGSTTYERPDQNYIVSTR---HYR--APEVILGLGWTYPCDIWSVGCILVELCT 315
           DFG +     D  Y   T      R  APE +    +T   D+WS G +L E+ T
Sbjct: 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 38/226 (16%)

Query: 100 SKMGEGTFGQV-LECWDRER---KEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKG 153
            ++GEG FG+V L  +D       E VA+K +   G +++R     EIE+L+ L  H+  
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHEN- 67

Query: 154 GNRCVQIRNWFD--YRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
               V+ +   +      + ++ E L S SL D+L+++  +     L+   + Q+ + + 
Sbjct: 68  ---IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLL-FSSQICKGMD 123

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDFGS 269
           ++     IH DL   N+L+ S + +K+ D+  +   P+D  Y+  + P  S I       
Sbjct: 124 YLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF------ 177

Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                           + APE +    ++   D+WS G  L EL T
Sbjct: 178 ----------------WYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 74/327 (22%), Positives = 130/327 (39%), Gaps = 84/327 (25%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+GEG+ G V    D+     VA+K +   K+ R   +    V+ +  +H       V++
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN----IVEM 81

Query: 161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
            + +   + + +V E L G +L D +          + +  +   +L+ ++F+H   +IH
Sbjct: 82  YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIATVCLAVLKALSFLHAQGVIH 138

Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG---STTYERPD 276
            D+K +++LL S                              +K+ DFG     + E P 
Sbjct: 139 RDIKSDSILLTSD---------------------------GRVKLSDFGFCAQVSKEVPR 171

Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 336
           +  +V T ++ APEVI  L +    DIWS+G +++E+  GE     + N   L  M+R+ 
Sbjct: 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP---PYFNEPPLQAMKRIR 228

Query: 337 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 396
             LP  +     ++  K                         PRL++ + +         
Sbjct: 229 DNLPPKL-----KNLHKVS-----------------------PRLRSFLDR--------- 251

Query: 397 THLLQGLLRYDPTDRLTAREALRHPFF 423
                 +L  DP  R TA E L HPF 
Sbjct: 252 ------MLVRDPAQRATAAELLNHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 63/272 (23%), Positives = 103/272 (37%), Gaps = 61/272 (22%)

Query: 164 FDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 222
           F    ++C+V +   G  L+  L++   +    ++ R  A ++L  + ++H L +++ DL
Sbjct: 70  FQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDL 129

Query: 223 KPENVLLVSSEYIKVPDYKSSLHTP-------KDSSYFKRMPKSSAIKVIDFGSTTYERP 275
           KPEN+LL  S +I + D+  S  +        K      R    ++I    F      R 
Sbjct: 130 KPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFR- 188

Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 335
             N  V T  Y APEVI G G     D W++G +L E+  G   F+              
Sbjct: 189 -SNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK-------------- 233

Query: 336 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 395
                                        G+   E+  +++K              S+  
Sbjct: 234 -----------------------------GSNRDETFSNILKKEV---TFPGSPPVSS-S 260

Query: 396 LTHLLQGLLRYDPTDRL----TAREALRHPFF 423
              L++ LL  DP+ RL     A E  +HPFF
Sbjct: 261 ARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 19/147 (12%)

Query: 193 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD------------- 239
           F  DL R    +L   I  +H +  IH D+KP+N+L+    +IK+ D             
Sbjct: 98  FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157

Query: 240 --YKSSLHTPKDS-SYFKRM--PKSSAIKVID-FGSTTYERPDQNYIVSTRHYRAPEVIL 293
             Y+   H  +DS    +         +K ++      ++R   + +V T +Y APEV+L
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217

Query: 294 GLGWTYPCDIWSVGCILVELCTGEALF 320
             G+T  CD WSVG IL E+  G+  F
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 61/251 (24%), Positives = 105/251 (41%), Gaps = 52/251 (20%)

Query: 93  TSRYKIH-----SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEV 143
           TS +K+        +G G+FG+V     +   E  AIK ++  +    K  +    E  +
Sbjct: 12  TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSI 71

Query: 144 LQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIA 202
           L +L+         V +   F   N +  + E  +G  L+  LRK     FP D+ +   
Sbjct: 72  LMELSH-----PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYH 124

Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
            +L+    ++H   +I+ DLKPEN+LL +  ++KV D+           + K++      
Sbjct: 125 AELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDF----------GFAKKV------ 168

Query: 263 KVIDFGSTTYERPDQNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG----- 316
                       PD+ + +  T  Y APEVI   G     D W++G +L E   G     
Sbjct: 169 ------------PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216

Query: 317 -EALFQTHENL 326
            +  F+ +E +
Sbjct: 217 DDTPFRIYEKI 227

Length = 329

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 64.0 bits (155), Expect = 2e-11
 Identities = 63/246 (25%), Positives = 108/246 (43%), Gaps = 46/246 (18%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKG 153
           +Y  + K+G+G  G V    D    + VAIK +   K+ ++  +I EI V+++L   +  
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN-- 77

Query: 154 GNRCVQIRNWFDYR---NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
                 I N+ D     + + +V E L G SL D + +       I  V    R+ L+ +
Sbjct: 78  ------IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQAL 128

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 268
            F+H   +IH D+K +NVLL                               ++K+ DFG 
Sbjct: 129 EFLHANQVIHRDIKSDNVLL---------------------------GMDGSVKLTDFGF 161

Query: 269 --STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
               T E+  ++ +V T ++ APEV+    +    DIWS+G + +E+  GE  +     L
Sbjct: 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221

Query: 327 EHLAMM 332
             L ++
Sbjct: 222 RALYLI 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 70/337 (20%), Positives = 131/337 (38%), Gaps = 88/337 (26%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHD 151
           S Y+    +G G +G V          +VA+KI+       + + I  E+ +L QL +  
Sbjct: 1   SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQL-RQS 59

Query: 152 KGGNRCVQIRNWFDYRN--HICIVFEKL-GSSLYDFLRKNNYRSFPID--LVREIARQLL 206
           +  N     + +  Y     + I+ E   G S+   ++       PI    +  I R++L
Sbjct: 60  QPPN---ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVL 111

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             + ++H + +IH D+K  N+L+ ++  +K+ D+  +    ++SS  KR           
Sbjct: 112 VALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KR----------- 158

Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
              +T+        V T ++ APEVI  G  +    DIWS+G  + E+ TG   +   + 
Sbjct: 159 ---STF--------VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207

Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 385
                   R +  +P+                                   K PRL++  
Sbjct: 208 F-------RAMMLIPKS----------------------------------KPPRLED-- 224

Query: 386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
               +  +  L   +   L  +P +RL+A E L+  +
Sbjct: 225 ----NGYSKLLREFVAACLDEEPKERLSAEELLKSKW 257

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 73/326 (22%), Positives = 130/326 (39%), Gaps = 78/326 (23%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+GEG+ G V     +   ++VA+K +   K+ R   +    V+ +  +H+      V++
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN----VVEM 82

Query: 161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
            N +   + + +V E L G +L D +          + +  +   +L+ ++ +H   +IH
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLKALSVLHAQGVIH 139

Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            D+K +++LL     +K+ D+       K                        E P +  
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSK------------------------EVPRRKS 175

Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 339
           +V T ++ APE+I  L +    DIWS+G +++E+  GE  +     L+ + M+       
Sbjct: 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI------- 228

Query: 340 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 399
                              R + P               P+L+NL    V  S   L   
Sbjct: 229 -------------------RDNLP---------------PKLKNL--HKVSPS---LKGF 249

Query: 400 LQGLLRYDPTDRLTAREALRHPFFTR 425
           L  LL  DP  R TA E L+HPF  +
Sbjct: 250 LDRLLVRDPAQRATAAELLKHPFLAK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 76/335 (22%), Positives = 125/335 (37%), Gaps = 94/335 (28%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR----C 157
           +G+GTFG+V+   ++   +  A+KI++     +E  + + EV   L +     N      
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILK-----KEVIIAKDEVAHTLTESRVLKNTRHPFL 57

Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++  F  ++ +C V E + G  L+  L +   R F  D  R    +++  + ++H   
Sbjct: 58  TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGK 115

Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +++ DLK EN++L    +IK+ D+        D++  K                      
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF-------------------- 155

Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMMER 334
                 T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  L +ME 
Sbjct: 156 ----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED 211

Query: 335 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 394
           +                                         K PR            + 
Sbjct: 212 I-----------------------------------------KFPRTL----------SA 220

Query: 395 DLTHLLQGLLRYDPTDRL-----TAREALRHPFFT 424
           D   LL GLL  DP  RL      A+E +RH FFT
Sbjct: 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFT 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 74/338 (21%), Positives = 126/338 (37%), Gaps = 101/338 (29%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-------EAAMIEIEVLQQLAKHDKGG 154
           +G+G+FG+VL    +   E+ A+K++   KK         E  M E  VL    KH    
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVL---KKDVILQDDDVECTMTEKRVLALAGKHP--- 56

Query: 155 NRCVQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
               Q+ + F  ++ +  V E +  G  ++   R      F     R  A +++  + F+
Sbjct: 57  -FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFL 112

Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H+  +I+ DLK +NVLL S  +IK+ D+               M K      I  G TT 
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHIKIADFG--------------MCKEG----ILGGVTT- 153

Query: 273 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLA 330
                +    T  Y APE++    +    D W++G +L E+  G++ F     + L    
Sbjct: 154 -----STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208

Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 390
           + + V    P+ +                        S+E+                   
Sbjct: 209 LEDEVR--YPRWL------------------------SKEAKS----------------- 225

Query: 391 HSAGDLTHLLQGLLRYDPTDRL----TAREALR-HPFF 423
                   +L+  L  +P  RL    T  + ++ HPFF
Sbjct: 226 --------ILKSFLTKNPEKRLGCLPTGEQDIKGHPFF 255

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 62.8 bits (152), Expect = 4e-11
 Identities = 67/249 (26%), Positives = 114/249 (45%), Gaps = 35/249 (14%)

Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   K  VAIK ++      EA + E +++++L +HDK   
Sbjct: 9   RLDVKLGQGCFGEVWMGTWNGTTK--VAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVP 65

Query: 156 RCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
               +         I IV E +G  SL DFL++ + +   +  + ++A Q+ + +A++  
Sbjct: 66  LYAVVS-----EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  IH DL+  N+L+  +   K+ D+  +    +D+ Y  R      IK           
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLA-RLIEDNEYTARQGAKFPIK----------- 168

Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 169 -----------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217

Query: 334 R-VLGPLPQ 341
           R    P PQ
Sbjct: 218 RGYRMPCPQ 226

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 34/237 (14%)

Query: 101 KMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           K+G G FG+V +  W+   K  VA+K ++      E+ + E +++++L +HDK     VQ
Sbjct: 13  KLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKL-RHDK----LVQ 65

Query: 160 IRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           +         I IV E +   SL DFL+    R+  +  + ++A Q+   +A++  +  I
Sbjct: 66  LYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124

Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 278
           H DL+  N+L+      K+ D+  +    +D+ Y  R      IK               
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLA-RLIEDNEYTARQGAKFPIK--------------- 168

Query: 279 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 334
                  + APE  L   +T   D+WS G +L EL T G   +    N E L  +ER
Sbjct: 169 -------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 79/335 (23%), Positives = 131/335 (39%), Gaps = 96/335 (28%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAA--MIEIEVLQQLAKHDKGGNRC 157
           +G+G+FG+VL    +   +  A+K++  + I K +E    M E  VL +  KH       
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHP----FL 58

Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V +   F   + +  V + + G  L+  L++   RSFP    R  A ++   + ++H L 
Sbjct: 59  VGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN 116

Query: 217 MIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
           +I+ DLKPEN+LL S  ++ + D+   K  +   K +S F   P+               
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE--------------- 161

Query: 274 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
                       Y APEV+    +    D W +G +L E+  G   F + +  E   M +
Sbjct: 162 ------------YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MYD 206

Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH-VDHS 392
            +L                                             + L ++  +  S
Sbjct: 207 NILN--------------------------------------------KPLRLKPNISVS 222

Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALR----HPFF 423
           A    HLL+GLL+ D T RL A++       H FF
Sbjct: 223 A---RHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 62.3 bits (151), Expect = 8e-11
 Identities = 57/236 (24%), Positives = 102/236 (43%), Gaps = 58/236 (24%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G GT+GQV +    +  ++ AIK++   +   E   +EI +L++ + H          R
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHH----------R 73

Query: 162 NWFDY------------RNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           N   Y             + + +V E  G+ S+ D ++     +   D +  I R++L  
Sbjct: 74  NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +A +H   +IH D+K +NVLL                            +++ +K++DFG
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLT---------------------------ENAEVKLVDFG 166

Query: 269 -STTYERP--DQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTG 316
            S   +R    +N  + T ++ APEVI         + Y  DIWS+G   +E+  G
Sbjct: 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 62.6 bits (152), Expect = 8e-11
 Identities = 84/347 (24%), Positives = 134/347 (38%), Gaps = 108/347 (31%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G+FG+V++   R+ + + A+K +R      +      + E  VL Q+         C
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV--------NC 52

Query: 158 ---VQIRNWFDYRNHICIVFEKL-GSSLYDFLRK----NNYRSFPIDLVREIARQLLECI 209
              V ++  F     + +V   + G  L+  L++    +  R+      R    +LL  +
Sbjct: 53  PFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRA------RFYTAELLCAL 106

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
             +H   +I+ DLKPEN+LL         DY+                    I + DFG 
Sbjct: 107 ENLHKFNVIYRDLKPENILL---------DYQGH------------------IALCDFGL 139

Query: 270 TTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
                 D    N    T  Y APE++LG G+T   D W++G +L E+ TG          
Sbjct: 140 CKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG---------- 189

Query: 327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 386
                       LP    + V+    K ++   L +P+G                     
Sbjct: 190 ------------LPPFYDENVNEMYRKILQE-PLRFPDG--------------------- 215

Query: 387 QHVDHSAGDLTHLLQGLLRYDPTDRL---TAREALRHPFFTRDHLRR 430
              D  A D   LL GLL  DPT RL    A+E   HPFF++   ++
Sbjct: 216 --FDRDAKD---LLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKK 257

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 75/280 (26%), Positives = 109/280 (38%), Gaps = 84/280 (30%)

Query: 171 CIVFEKLGSSLYDFLRKNNYRSFPIDL--VREIARQLLECIAFMHDLCMIHTDLKPENVL 228
           C+V  K  S LY +L     R  P+ L  V  +ARQLL  I ++H   +IH D+K ENVL
Sbjct: 236 CLVLPKYRSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVL 292

Query: 229 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER-----PDQNYIVST 283
                          ++ P+D            I + DFG+  + R     P    I  T
Sbjct: 293 ---------------VNGPED------------ICLGDFGAACFARGSWSTPFHYGIAGT 325

Query: 284 RHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA-LFQTHENLEHLAMMERVLGPLPQH 342
               APEV+ G  +T   DIWS G ++ E     A LF      E      ++L      
Sbjct: 326 VDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQIL------ 379

Query: 343 MLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG-------- 394
              R+ R A+ +V     ++P+ A SR              L+ Q+   +A         
Sbjct: 380 ---RIIRQAQVHVD----EFPQHAGSR--------------LVSQYRHRAARNRRPAYTR 418

Query: 395 -----------DLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                      D+ +L+   L +D   R +A E LR P F
Sbjct: 419 PAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458

Length = 461

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 78/345 (22%), Positives = 134/345 (38%), Gaps = 85/345 (24%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           ++ +  +G+G FG+V  C  R   +M A K +  + IKK +  +M   E ++L+++    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV---- 57

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                 V +   ++ ++ +C+V   + G  L   +       F  +     A ++L  + 
Sbjct: 58  -NSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLE 116

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
            +H    ++ DLKPEN+LL    +I++ D   ++  P+  S   R               
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR--------------- 161

Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
                     V T  Y APEV+    +T   D W +GC++ E+  G++ F+         
Sbjct: 162 ----------VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR--------G 203

Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 390
             E+V     + + +RV    E Y           A   E  KS+ K+            
Sbjct: 204 RKEKV---KREEVDRRVLETEEVY----------SAKFSEEAKSICKM------------ 238

Query: 391 HSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFFTRDHLRR 430
                       LL  DP  RL      A E  RHPFF   + +R
Sbjct: 239 ------------LLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR 271

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 60/228 (26%), Positives = 94/228 (41%), Gaps = 57/228 (25%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           ++G G+FG V    D    E+VAIK      K   +     E  Q + K  +   +    
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIK------KMSYSGKQSNEKWQDIIKEVRFLQQLRH- 74

Query: 161 RNWFDY-----RNHIC-IVFEK-LGSS--LYDFLRKNNYRSFPIDLVREIA---RQLLEC 208
            N  +Y     R H   +V E  LGS+  + +  +K      P+  V EIA      L+ 
Sbjct: 75  PNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK------PLQEV-EIAAICHGALQG 127

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +A++H    IH D+K  N+LL                            +   +K+ DFG
Sbjct: 128 LAYLHSHERIHRDIKAGNILLT---------------------------EPGTVKLADFG 160

Query: 269 STTYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVEL 313
           S +   P  ++ V T ++ APEVIL +    +    D+WS+G   +EL
Sbjct: 161 SASLVSPANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 43/227 (18%)

Query: 94  SRYKIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 152
           S   +  ++G G FG V L  W  +RK  VAIK +R      E  + E +V+ +L+    
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWLEKRK--VAIKTIREGAMSEEDFIEEAQVMMKLSH--- 58

Query: 153 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
              + VQ+      R+ IC+VFE +    L D+LR      F  + +  +   + E +A+
Sbjct: 59  --PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAY 115

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +    +IH DL   N L+                            ++  +KV DFG T 
Sbjct: 116 LESSNVIHRDLAARNCLV---------------------------GENQVVKVSDFGMTR 148

Query: 272 YERPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVEL 313
           +   DQ Y  ST       + +PEV     ++   D+WS G ++ E+
Sbjct: 149 FVLDDQ-YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 61/242 (25%), Positives = 101/242 (41%), Gaps = 35/242 (14%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHD 151
           RY+I  K+GEG+FG++     +   E   IK +   K   K +EA+  E+ +L ++ KH 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHP 59

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                 V     F     + IV E   G  L   + +     F  D +     Q+   + 
Sbjct: 60  N----IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYI-KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            +HD  ++H D+K +N+ L  +  + K+ D+  +     DS                   
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIA-RQLNDSMELAYT------------- 161

Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
                      V T +Y +PE+     +    DIWS+GC+L ELCT +  F+ + NL  L
Sbjct: 162 ----------CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQL 210

Query: 330 AM 331
            +
Sbjct: 211 VL 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 79/335 (23%), Positives = 133/335 (39%), Gaps = 53/335 (15%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           Y +   +  G+ G+V       + + V +KI  G K      +IE  +LQ +  H     
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI--GQKG---TTLIEAMLLQNV-NHPS--- 118

Query: 156 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
             +++++        C+V     S LY +L K + R  PID    I +Q+LE + ++H  
Sbjct: 119 -VIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ 176

Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
            +IH D+K EN+ +   + + + D  ++           + P      V+         P
Sbjct: 177 RIIHRDVKTENIFINDVDQVCIGDLGAA-----------QFP------VVA--------P 211

Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 335
               +  T    APEV+    +    DIWS G +L E+    A   T          E V
Sbjct: 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML---AYPSTIFEDPPSTPEEYV 268

Query: 336 LGPLPQHMLKRVDR---HAEKYVRRGRLDWPEGAASRESIK--SVMKLPRLQNLIMQHVD 390
                 H+LK +     H E++ R      P     R  I+  S+ + P  +    Q V+
Sbjct: 269 KSC-HSHLLKIISTLKVHPEEFPRD-----PGSRLVRGFIEYASLERQPYTRYPCFQRVN 322

Query: 391 -HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
               G+   L+  +L +D   R +A E L +P F 
Sbjct: 323 LPIDGEF--LVHKMLTFDAAMRPSAEEILNYPMFA 355

Length = 357

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 46/225 (20%)

Query: 100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA-----KHDKGG 154
           S++GEG  G V +C  +    + A+K +           ++ ++L++L      K     
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTI----TTDPNPDLQKQILRELEINKSCKSP--- 59

Query: 155 NRCVQIRNWF--DYRNHICIVFEKLGS----SLYDFLRKNNYRSFPIDLVREIARQLLEC 208
              V+    F  +  + I I  E        S+Y  ++K   R     L + IA  +L+ 
Sbjct: 60  -YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK-IAESVLKG 117

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           ++++H   +IH D+KP N+LL     +K+ D+  S                   ++++  
Sbjct: 118 LSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG------------------ELVNSL 159

Query: 269 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
           + T+          T  Y APE I G  ++   D+WS+G  L+E+
Sbjct: 160 AGTF--------TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 59/235 (25%), Positives = 103/235 (43%), Gaps = 38/235 (16%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAK 149
           + ++I  K+G G F +V        ++ VA+K V+  +    K R+  + EI++L+QL  
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61

Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKLG----SSLYDFLRKNNYRSFPIDLVREIARQL 205
            +      ++  + F   N + IV E       S +  + +K   R  P   V +   QL
Sbjct: 62  PN-----VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQK-RLIPERTVWKYFVQL 115

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
              +  MH   ++H D+KP NV + ++  +K+ D               R          
Sbjct: 116 CSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLG-----------LGRF--------- 155

Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
            F S T      + +V T +Y +PE I   G+ +  DIWS+GC+L E+   ++ F
Sbjct: 156 -FSSKTTA---AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 60.5 bits (146), Expect = 4e-10
 Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 46/246 (18%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKG 153
           +Y    K+G+G  G V    D    + VAIK +   ++ ++  +I EI V+++       
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE------- 72

Query: 154 GNRCVQIRNWFDYR---NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
            N+   I N+ D     + + +V E L G SL D + +       I  V    R+ L+ +
Sbjct: 73  -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQAL 128

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 268
            F+H   +IH D+K +N+LL                               ++K+ DFG 
Sbjct: 129 DFLHSNQVIHRDIKSDNILL---------------------------GMDGSVKLTDFGF 161

Query: 269 --STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
               T E+  ++ +V T ++ APEV+    +    DIWS+G + +E+  GE  +     L
Sbjct: 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221

Query: 327 EHLAMM 332
             L ++
Sbjct: 222 RALYLI 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 46/151 (30%), Positives = 71/151 (47%), Gaps = 23/151 (15%)

Query: 193 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK--SSLHTPKDS 250
           FP  L R    +L   I  +H +  IH D+KP+N+L+    +IK+ D+   +      +S
Sbjct: 98  FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157

Query: 251 SYFKR--------MPKS------SAIKVIDFGSTTYERPDQNY-------IVSTRHYRAP 289
            Y+++        M  S      S  +  D   T  +R  + +       +V T +Y AP
Sbjct: 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAP 217

Query: 290 EVILGLGWTYPCDIWSVGCILVELCTGEALF 320
           EV+L  G+T  CD WSVG IL E+  G+  F
Sbjct: 218 EVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 60.1 bits (145), Expect = 5e-10
 Identities = 60/246 (24%), Positives = 107/246 (43%), Gaps = 46/246 (18%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKG 153
           +Y    K+G+G  G V    D    + VAI+ +   ++ ++  +I EI V+++       
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE------- 73

Query: 154 GNRCVQIRNWFDYR---NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
            N+   I N+ D     + + +V E L G SL D + +       I  V    R+ L+ +
Sbjct: 74  -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQAL 129

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 268
            F+H   +IH D+K +N+LL                               ++K+ DFG 
Sbjct: 130 EFLHSNQVIHRDIKSDNILL---------------------------GMDGSVKLTDFGF 162

Query: 269 --STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
               T E+  ++ +V T ++ APEV+    +    DIWS+G + +E+  GE  +     L
Sbjct: 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222

Query: 327 EHLAMM 332
             L ++
Sbjct: 223 RALYLI 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 52/227 (22%), Positives = 100/227 (44%), Gaps = 35/227 (15%)

Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGG 154
           +  S +G G  G V +        ++A K+V        R+  + E++++     H+   
Sbjct: 8   ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIM-----HECRS 62

Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
              V     F   N+IC+  E +     D + K      P++++ +IA  ++E + ++++
Sbjct: 63  PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYN 121

Query: 215 -LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
              ++H D+KP N+L+ S   IK+ D+  S                   ++I+  + T+ 
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSG------------------ELINSIADTF- 162

Query: 274 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
                  V T  Y +PE I G  +T   D+WS+G  ++EL  G+  F
Sbjct: 163 -------VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 68/257 (26%), Positives = 105/257 (40%), Gaps = 54/257 (21%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G+G+FG+V               +VR I       +  ++VL++     +   R    R
Sbjct: 4   LGQGSFGKVF--------------LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMER 49

Query: 162 NWFDYRNHICIV-----FEKLGSSLY---DFLRKNNYRS-------FPIDLVREIARQLL 206
           +     NH  IV     F+  G  LY   DFLR  +  +       F  + V+    +L 
Sbjct: 50  DILAEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELA 108

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             +  +H L +I+ DLKPEN+LL    +IK+ D+  S    K+S              ID
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS----KES--------------ID 150

Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
                Y          T  Y APEV+   G T   D WS G ++ E+ TG   FQ  +  
Sbjct: 151 HEKKAYS------FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK 204

Query: 327 EHLAMMERVLGPLPQHM 343
           E + M+ +    +PQ +
Sbjct: 205 ETMTMILKAKLGMPQFL 221

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 59.1 bits (143), Expect = 8e-10
 Identities = 62/237 (26%), Positives = 101/237 (42%), Gaps = 51/237 (21%)

Query: 95  RY-KIHSKMGEGTFGQV-LECWDRERK---EMVAIKIVRG--IKKYREAAMIEIEVLQQL 147
           RY K    +GEG FG+V L C+D       EMVA+K ++    ++       EI +L+ L
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63

Query: 148 AKHD---------KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLV 198
              +         + G + +Q+           + +  LGS L D+L K+      + L 
Sbjct: 64  YHENIVKYKGCCSEQGGKGLQL----------IMEYVPLGS-LRDYLPKHKLNLAQLLL- 111

Query: 199 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 258
              A+Q+ E +A++H    IH DL   NVLL +   +K+ D+  +   P+   Y+     
Sbjct: 112 --FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----- 164

Query: 259 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
               +V + G             S   + A E +    ++Y  D+WS G  L EL T
Sbjct: 165 ----RVREDGD------------SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 59.2 bits (143), Expect = 8e-10
 Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 35/228 (15%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREA-AMIEIEVLQQLAKHDKGGNRC 157
           +G+G FG+V     +   +M A K +   R  KK  E  A++E E+L+++          
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSP-----FI 55

Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V +   F+ + H+C+V   + G  L   +     R   ++ V   + Q+   I  +H + 
Sbjct: 56  VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115

Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +++ D+KPENVLL      ++ D   ++                       G T  +R  
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD-------------------GKTITQR-- 154

Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
                 T  Y APE++    ++YP D +++GC + E+  G   F+ H+
Sbjct: 155 ----AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 69/283 (24%), Positives = 123/283 (43%), Gaps = 40/283 (14%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 158
           +G+G++G+V     R   +   IK   +    ++ R+AA  E ++L QL KH    N   
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHP---NIVA 63

Query: 159 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
              +W      + IV     G  LY  L++   +  P + V E   Q+   + ++H+  +
Sbjct: 64  YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI 123

Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           +H DLK +NV L  +  IKV D               R+ ++      D  ST       
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLG-----------IARVLENQC----DMAST------- 161

Query: 278 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL- 336
             ++ T +Y +PE+     + Y  D+W++GC + E+ T +  F      +  +++ R++ 
Sbjct: 162 --LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK---DMNSLVYRIIE 216

Query: 337 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 379
           G LP  M K       + +       PE    R S+KS+++ P
Sbjct: 217 GKLPP-MPKDYSPELGELIATMLSKRPE---KRPSVKSILRQP 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 41/228 (17%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G+FG+VL    + + E  A+K ++     I    E  M+E  VL    ++       
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENP----FL 58

Query: 158 VQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREI--ARQLLECIAFMH 213
             +   F  + H+  V E L  G  ++    K  +     DL R    A +++  + F+H
Sbjct: 59  THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF-----DLYRATFYAAEIVCGLQFLH 113

Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
              +I+ DLK +NV+L    +IK+ D+               M K +     D  ++T+ 
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFG--------------MCKENVFG--DNRASTF- 156

Query: 274 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
                    T  Y APE++ GL +T+  D WS G +L E+  G++ F 
Sbjct: 157 -------CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 63/261 (24%), Positives = 108/261 (41%), Gaps = 54/261 (20%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ-- 159
           +G+GTFG+V+   ++      A+KI++     +E  + + EV   L +     NR +Q  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILK-----KEVIVAKDEVAHTLTE-----NRVLQNS 52

Query: 160 -------IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                  ++  F   + +C V E   G  L+  L +   R F  D  R    +++  + +
Sbjct: 53  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDY 110

Query: 212 MH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           +H +  +++ DLK EN++L    +IK+ D+       KD +  K                
Sbjct: 111 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-------------- 156

Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEH 328
                       T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  
Sbjct: 157 ----------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 206

Query: 329 LAMME-----RVLGPLPQHML 344
           L +ME     R L P  + +L
Sbjct: 207 LILMEEIRFPRTLSPEAKSLL 227

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 58/242 (23%), Positives = 102/242 (42%), Gaps = 52/242 (21%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           + + S +G G FG+V    ++   ++ A+K+   +KK   + ++  E +    +      
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKATGDIYAMKV---MKK---SVLLAQETVSFFEEE----R 52

Query: 156 RCVQIRN--W-------FDYRNHICIVFEKL-GSSLYDFLRKNNYRS-FPIDLVREIARQ 204
             + I N  W       F  ++++ +V E   G  L   L  N Y   F  D+ +    +
Sbjct: 53  DILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAE 110

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           L+  I  +H +  +H D+KPENVL+  + +IK+ D+ S+     +     ++P       
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP------- 163

Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILGL----GWTY--PCDIWSVGCILVELCTGEA 318
                           V T  Y APEV+  +      TY   CD WS+G I  E+  G +
Sbjct: 164 ----------------VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207

Query: 319 LF 320
            F
Sbjct: 208 PF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 46/231 (19%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKG 153
           +Y    K+G+G  G V    D    + VAIK +   ++ ++  +I EI V+++       
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE------- 72

Query: 154 GNRCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
            N+   I N+ D     + + +V E L G SL D + +       I  V    R+ L+ +
Sbjct: 73  -NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQAL 128

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            F+H   +IH D+K +N+LL                               ++K+ DFG 
Sbjct: 129 EFLHSNQVIHRDIKSDNILL---------------------------GMDGSVKLTDFGF 161

Query: 270 TTYERPDQN---YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 317
                P+Q+    +V T ++ APEV+    +    DIWS+G + +E+  GE
Sbjct: 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 63/248 (25%), Positives = 106/248 (42%), Gaps = 49/248 (19%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL-AKHD----KGGNR 156
           +G G FG+V     ++   + A+KI+R      +A M+E E +  + A+ D      G  
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILR------KADMLEKEQVAHIRAERDILVEADGAW 62

Query: 157 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL-----LECIA 210
            V++   F  + ++ ++ E L G  +   L K        D + E A Q      +  I 
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK-------DTLSEEATQFYIAETVLAID 115

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPD---------------YKSSLHTPKDSSYFKR 255
            +H L  IH D+KP+N+LL +  ++K+ D               Y++  H P     F+ 
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175

Query: 256 MPKSSAIKVIDFGSTTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 312
           M            + T+++  +      V T  Y APEV +  G+   CD WS+G I+ E
Sbjct: 176 MNSKRK-------AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Query: 313 LCTGEALF 320
           +  G   F
Sbjct: 229 MLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 76/339 (22%), Positives = 131/339 (38%), Gaps = 85/339 (25%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 157
           +G+G FG+V  C  R   +M A K +  + IKK +  AM   E ++L+++          
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-----NSRFV 62

Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V +   ++ ++ +C+V   + G  L   +       F  +     A ++   +  +H   
Sbjct: 63  VSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER 122

Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +++ DLKPEN+LL    +I++ D   ++  P+                   G T   R  
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPE-------------------GETIRGR-- 161

Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 336
               V T  Y APEV+    +T+  D W +GC++ E+  G++ F+  +       +ER  
Sbjct: 162 ----VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER-- 215

Query: 337 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 396
                    RV    E+Y  +    + E A S                            
Sbjct: 216 ---------RVKEDQEEYSEK----FSEAARS---------------------------- 234

Query: 397 THLLQGLLRYDPTDRL-----TAREALRHPFFTRDHLRR 430
             + + LL  DP  RL      A E   HPFF   + +R
Sbjct: 235 --ICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR 271

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 57.4 bits (138), Expect = 2e-09
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 34/241 (14%)

Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V+++L +H+K   
Sbjct: 9   RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 62

Query: 156 RCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +   SL DFL+    +   +  + ++A Q+   +A++  
Sbjct: 63  -LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL+  N+L+  +   KV D+  +    +D+ Y  R      IK           
Sbjct: 121 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIK----------- 168

Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 169 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 217

Query: 334 R 334
           R
Sbjct: 218 R 218

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 52/238 (21%), Positives = 95/238 (39%), Gaps = 59/238 (24%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKI--VRGIKKYREAAMI--EIEVLQQL-- 147
              +    +G GTFG+V    DR  +   A+K+  +  + + ++   +  E  VL+++  
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 148 --------AKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLV 198
                    +HD+                 + ++ E + G  L+ +LR  N   F     
Sbjct: 61  PFIIRLFWTEHDQ---------------RFLYMLMEYVPGGELFSYLR--NSGRFSNSTG 103

Query: 199 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 258
              A +++  + ++H   +++ DLKPEN+LL    +IK+ D+                  
Sbjct: 104 LFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDF------------------ 145

Query: 259 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
             A K+ D   T         +  T  Y APEVI   G     D W++G ++ E+  G
Sbjct: 146 GFAKKLRDRTWT---------LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 75/332 (22%), Positives = 129/332 (38%), Gaps = 86/332 (25%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 157
           +G+GTFGQV +   ++ + + A+K++  + I   +E A    E  +L +    +      
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDE--SPFI 58

Query: 158 VQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V ++  F   + + +V +   G  L+  L+K     F  D  +    +L+  +  +H   
Sbjct: 59  VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD 116

Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +++ DLKPEN+LL ++ +I + D+  S     D+                   TT     
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKANLTDN------------------KTT----- 153

Query: 277 QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 335
            N    T  Y APEV+L   G+T   D WS+G ++ E+C G + F               
Sbjct: 154 -NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF--------------- 197

Query: 336 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 395
                Q M +         +  G++ +P+   S E                         
Sbjct: 198 YAEDTQQMYRN--------IAFGKVRFPKNVLSDEG------------------------ 225

Query: 396 LTHLLQGLLRYDPTDRL----TAREALRHPFF 423
               ++GLL  +P  RL     A E   HPFF
Sbjct: 226 -RQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 60/289 (20%), Positives = 123/289 (42%), Gaps = 43/289 (14%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI- 160
           +G GT+GQV +    +  ++ AIK++       E    EI +L++ + H           
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 161 -RNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
            +N     + + +V E  G+ S+ D ++     +   + +  I R++L  ++ +H   +I
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVI 133

Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERP-- 275
           H D+K +NVLL                            +++ +K++DFG S   +R   
Sbjct: 134 HRDIKGQNVLLT---------------------------ENAEVKLVDFGVSAQLDRTVG 166

Query: 276 DQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
            +N  + T ++ APEVI         + +  D+WS+G   +E+  G         +  L 
Sbjct: 167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF 226

Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 379
           ++ R   P P+   K+  +  + ++    +   +  + R + + +MK P
Sbjct: 227 LIPR--NPAPRLKSKKWSKKFQSFIESCLV---KNHSQRPTTEQLMKHP 270

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 68/324 (20%), Positives = 124/324 (38%), Gaps = 78/324 (24%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+GEG+ G V    ++     VA+K++   K+ R   +    V+ +  +H       V++
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH----QNVVEM 83

Query: 161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
              +     + ++ E L G +L D + +       I  V E    +L+ + ++H   +IH
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCE---SVLQALCYLHSQGVIH 140

Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            D+K +++LL     +K+ D+       KD                         P +  
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDV------------------------PKRKS 176

Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 339
           +V T ++ APEVI    +    DIWS+G +++E+  GE  + +                 
Sbjct: 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS--------------- 221

Query: 340 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 399
           P   +KR+           R   P    +   I  V++                      
Sbjct: 222 PVQAMKRL-----------RDSPPPKLKNAHKISPVLR--------------------DF 250

Query: 400 LQGLLRYDPTDRLTAREALRHPFF 423
           L+ +L  +P +R TA+E L HPF 
Sbjct: 251 LERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 64/259 (24%), Positives = 103/259 (39%), Gaps = 70/259 (27%)

Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 152
           T  ++I   +G+GT+G+V +  +++   + A+KI+  I    E    E  +LQ L  H  
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN 80

Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC---- 208
                V+    F Y+    +     G  L+  L   N  S     V E+ + LL C    
Sbjct: 81  ----VVKFYGMF-YKADKLV-----GGQLWLVLELCNGGS-----VTELVKGLLICGQRL 125

Query: 209 ----IAF-----------MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 253
               I++           +H+  +IH D+K  N+LL +                      
Sbjct: 126 DEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT---------------------- 163

Query: 254 KRMPKSSAIKVIDFGST---TYERPDQNYIVSTRHYRAPEVI-----LGLGWTYPCDIWS 305
                   +K++DFG +   T  R  +N  V T  + APEVI         +   CD+WS
Sbjct: 164 -----EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWS 218

Query: 306 VGCILVELCTGE-ALFQTH 323
           +G   +EL  G+  LF  H
Sbjct: 219 LGITAIELGDGDPPLFDMH 237

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 56.6 bits (136), Expect = 8e-09
 Identities = 76/335 (22%), Positives = 121/335 (36%), Gaps = 94/335 (28%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMI-EIEVLQQLAKHDKGGNRC 157
           +G+GTFG+V+   ++      A+KI+R    I K   A  + E  VLQ   +H       
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHP----FL 57

Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++  F   + +C V E   G  L+  L +   R F  +  R    +++  + ++H   
Sbjct: 58  TALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD 115

Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +++ D+K EN++L    +IK+ D+        D +  K                      
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-------------------- 155

Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMMER 334
                 T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  L +ME 
Sbjct: 156 ----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211

Query: 335 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 394
           +  P                    R   PE  +                           
Sbjct: 212 IRFP--------------------RTLSPEAKS--------------------------- 224

Query: 395 DLTHLLQGLLRYDPTDRL-----TAREALRHPFFT 424
               LL GLL+ DP  RL      A+E + H FF 
Sbjct: 225 ----LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 56.6 bits (136), Expect = 9e-09
 Identities = 59/245 (24%), Positives = 102/245 (41%), Gaps = 38/245 (15%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G+FG+VL    +   +  A+K+++      +K ++  M E  VL +  KH       
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHP----FL 58

Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V +   F     +  V + + G  L+  L++   RSFP    R  A ++   + ++H + 
Sbjct: 59  VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN 116

Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +++ DLKPEN+LL S  ++ + D+                     I   D  +T      
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLC---------------KEGIAQSDTTTT------ 155

Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF---QTHENLEHLAMME 333
                 T  Y APEVI    +    D W +G +L E+  G   F      E  +++    
Sbjct: 156 ---FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212

Query: 334 RVLGP 338
            VL P
Sbjct: 213 LVLRP 217

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 55.8 bits (135), Expect = 9e-09
 Identities = 52/236 (22%), Positives = 101/236 (42%), Gaps = 39/236 (16%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMI-EIEVLQQLAKHD 151
           +++   +G+G FG+V     R+ K+M A+K +     ++K     ++ E  +LQ+L  H 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NH- 59

Query: 152 KGGNRCVQIRNWFDYRNHICIVFE-KLGSSL-YDFLRKNNYRSFPIDLVREIARQLLECI 209
                 V +   F    ++ +V +  LG  L Y   +K     F  + V+    +++  +
Sbjct: 60  ---PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLAL 113

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            ++H   +IH D+KP+N+LL    ++ + D+  +     D+                  +
Sbjct: 114 EYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-----------------T 156

Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
           T+           T  Y APEV+   G++   D WS+G    E   G+  ++ H  
Sbjct: 157 TST--------SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 36/234 (15%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAK 149
           + ++I  K+G G F +V           VA+K V+       K R   + EI++L+QL  
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61

Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLR--KNNYRSFPIDLVREIARQLL 206
            +      ++    F   N + IV E      L   ++  K   R  P   V +   QL 
Sbjct: 62  PN-----VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC 116

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             +  MH   ++H D+KP NV + ++  +K+ D            +F    K++A     
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL-------GRFFSS--KTTA----- 162

Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
                      + +V T +Y +PE I   G+ +  DIWS+GC+L E+   ++ F
Sbjct: 163 ----------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 52/226 (23%), Positives = 90/226 (39%), Gaps = 52/226 (23%)

Query: 105 GTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 164
           G  G    C D +  E V IK  +     R     E  +L+ +  H       +Q++  F
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAI-NHPS----IIQLKGTF 152

Query: 165 DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP 224
            Y    C++  +  + LY +L     R+  I  +  I R +L  I ++H+  +IH D+K 
Sbjct: 153 TYNKFTCLILPRYKTDLYCYL--AAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKA 210

Query: 225 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR 284
           EN+ +               + P D            + + DFG+  +       I + +
Sbjct: 211 ENIFI---------------NHPGD------------VCLGDFGAACFPVD----INANK 239

Query: 285 HY--------RAPEVILGLGWTYPCDIWSVGCILVELCTGE-ALFQ 321
           +Y         APE++    +    DIWS G +L E+ T   +LF+
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285

Length = 391

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 60/240 (25%), Positives = 101/240 (42%), Gaps = 51/240 (21%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++I   +G+GT+G+V +  +++     A+KI+  I    E    E  +L+ L+ H     
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPN--- 76

Query: 156 RCVQIRNWF---DYRN--HICIVFEKL-GSSLYD----FLRKNNYRSFPIDLVREIARQL 205
             V+    +   D +N   + +V E   G S+ D    FL++      PI  +  I  + 
Sbjct: 77  -VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI--IAYILHEA 133

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L  +  +H    IH D+K  N+LL +                              +K++
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTT---------------------------EGGVKLV 166

Query: 266 DFGST---TYERPDQNYIVSTRHYRAPEVI-----LGLGWTYPCDIWSVGCILVELCTGE 317
           DFG +   T  R  +N  V T  + APEVI     L   +   CD+WS+G   +EL  G+
Sbjct: 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGD 226

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 37/229 (16%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 157
           +G+G FG+V  C  R   +M A K +  + IKK +  AM   E  +L+++          
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-----NSRFV 62

Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI--ARQLLECIAFMHDL 215
           V +   ++ ++ +C+V   +      F    N  +   D  R I  A +L   +  +   
Sbjct: 63  VSLAYAYETKDALCLVLTIMNGGDLKF-HIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121

Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
            +++ DLKPEN+LL    +I++ D   ++  P+                   G T   R 
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE-------------------GETVRGR- 161

Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
                V T  Y APEVI    +T+  D W +GC++ E+  G++ F+  +
Sbjct: 162 -----VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 41/220 (18%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIV----RGIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           ++G G+FG V    +    E+VA+K +    +   +  +  + E++ LQQL KH      
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPN---- 82

Query: 157 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
            ++ +  +   +   +V E    S  D L  +      +++   I    L+ +A++H   
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHSHN 141

Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           MIH D+K  N+LL                            +   +K+ DFGS +   P 
Sbjct: 142 MIHRDIKAGNILLT---------------------------EPGQVKLADFGSASKSSP- 173

Query: 277 QNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVEL 313
            N  V T ++ APEVIL +    +    D+WS+G   +EL
Sbjct: 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.8 bits (132), Expect = 4e-08
 Identities = 74/348 (21%), Positives = 141/348 (40%), Gaps = 77/348 (22%)

Query: 95  RYKIHSKMGEGTFGQVLEC--WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 152
           +Y I S +  G+ G+V  C     E+++ V +K V G K        EI++L+ +     
Sbjct: 93  QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGR----EIDILKTI----- 143

Query: 153 GGNRCVQIR--NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
             +    I   + + +++ +C+V  K    L+ ++ ++     P++    I R+LLE +A
Sbjct: 144 --SHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG--PLPLEQAITIQRRLLEALA 199

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS------SLHTPKDSSYFKRMPKSSAIKV 264
           ++H   +IH D+K EN+ L   E   + D+ +         TP+   +            
Sbjct: 200 YLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW------------ 247

Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE-ALF--Q 321
                             T    +PE++    +    DIWS G +L E+      LF  Q
Sbjct: 248 ----------------SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291

Query: 322 THENLEHLAMMERVLG--PL--PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 377
              +   L  + R +   PL  PQ+    + +H ++Y    R  +           ++  
Sbjct: 292 VKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPY-----------TIPP 340

Query: 378 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           + R   + M        D+ +L+  +L +D   R +A++ L  P FT+
Sbjct: 341 VIRKYGMHM--------DVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380

Length = 392

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 57/248 (22%), Positives = 97/248 (39%), Gaps = 57/248 (22%)

Query: 102 MGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIE------IEVLQQLAKHDKGG 154
           +G G FG V L  W  +    VAIK++R      E AM E       +V+ +L+ H    
Sbjct: 12  LGSGQFGVVHLGKWRGKID--VAIKMIR------EGAMSEDDFIEEAKVMMKLS-HPN-- 60

Query: 155 NRCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
              VQ+      +  I IV E + +  L ++LR+   +    + + ++   + E + ++ 
Sbjct: 61  --LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLE 117

Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
               IH DL   N  LV  + +                          +KV DFG   Y 
Sbjct: 118 SNGFIHRDLAARNC-LVGEDNV--------------------------VKVSDFGLARYV 150

Query: 274 RPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 328
             DQ Y  S        +  PEV     ++   D+WS G ++ E+ +   +   +E   +
Sbjct: 151 LDDQ-YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM--PYERFSN 207

Query: 329 LAMMERVL 336
             ++E V 
Sbjct: 208 SEVVESVS 215

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 65/319 (20%), Positives = 129/319 (40%), Gaps = 77/319 (24%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G++ +VL    ++  ++ A+K+V+    + +  +  ++  + + +        V + 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 162 NWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
           + F   + + +V E +  G  ++   R+   R  P +  R  A ++   + F+H+  +I+
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERGIIY 119

Query: 220 TDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
            DLK +NVLL +  +IK+ DY   K  L     +S F   P                   
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP------------------- 160

Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 336
            NYI       APE++ G  + +  D W++G ++ E+  G + F                
Sbjct: 161 -NYI-------APEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI-------------- 198

Query: 337 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 396
                 +    D + E Y+ +  L+ P            +++PR  ++   HV       
Sbjct: 199 ------ITDNPDMNTEDYLFQVILEKP------------IRIPRFLSVKASHV------- 233

Query: 397 THLLQGLLRYDPTDRLTAR 415
              L+G L  DP +RL  +
Sbjct: 234 ---LKGFLNKDPKERLGCQ 249

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 64/241 (26%), Positives = 111/241 (46%), Gaps = 34/241 (14%)

Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           K+  K+G G FG+V +  +++  K  VA+K ++      EA + E  V++ L +HDK   
Sbjct: 9   KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTL-QHDK--- 62

Query: 156 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             V++ +    +  I I+ E +   SL DFL+ +     P+  + + + Q+ E +AF+  
Sbjct: 63  -LVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
              IH DL+  N+L+ +S   K+ D+  +    +D+ Y  R      IK           
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLA-RVIEDNEYTAREGAKFPIK----------- 168

Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE I    +T   D+WS G +L+E+ T G   +    N E +  +E
Sbjct: 169 -----------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 217

Query: 334 R 334
           R
Sbjct: 218 R 218

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 55/232 (23%), Positives = 100/232 (43%), Gaps = 37/232 (15%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G+FG+V     +   +  AIK ++     +    E  M+E  VL    +H       
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP----FL 58

Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI--ARQLLECIAFMHDL 215
             +   F  + ++  V E L      F  ++ ++    DL R    A +++  + F+H  
Sbjct: 59  THLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSK 115

Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
            +++ DLK +N+LL +  +IK+ D+               M K + +   D  + T+   
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFG--------------MCKENMLG--DAKTCTF--- 156

Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                  T  Y APE++LG  +    D WS G +L E+  G++ F  H+  E
Sbjct: 157 -----CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 34/153 (22%)

Query: 168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPE 225
             I I  E + G SL   L+K      P +++ +I+  +L  + ++ +   ++H D+KP 
Sbjct: 72  GEISICMEHMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPS 129

Query: 226 NVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVST 283
           N+L+ S   IK+ D+  S  L    DS                           N  V T
Sbjct: 130 NILVNSRGEIKLCDFGVSGQLI---DSM-------------------------ANSFVGT 161

Query: 284 RHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
           R Y +PE + G  +T   DIWS+G  LVE+  G
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 53.3 bits (128), Expect = 5e-08
 Identities = 64/241 (26%), Positives = 107/241 (44%), Gaps = 34/241 (14%)

Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           K+  K+G G FG+V +  ++   K  VAIK ++      EA + E  +++QL +H     
Sbjct: 9   KLVKKLGAGQFGEVWMGYYNGHTK--VAIKSLKQGSMSPEAFLAEANLMKQL-QH----P 61

Query: 156 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
           R V++      +  I I+ E +   SL DFL+        I+ + ++A Q+ E +AF+  
Sbjct: 62  RLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER 120

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
              IH DL+  N+L+  +   K+ D+  +    +D+ Y  R      IK           
Sbjct: 121 KNYIHRDLRAANILVSETLCCKIADFGLA-RLIEDNEYTAREGAKFPIK----------- 168

Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE I    +T   D+WS G +L E+ T G   +    N E +  +E
Sbjct: 169 -----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE 217

Query: 334 R 334
           R
Sbjct: 218 R 218

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 62/241 (25%), Positives = 107/241 (44%), Gaps = 35/241 (14%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL-AKHD----KGGNR 156
           +G G FG+V     ++   + A+KI+R      +A M+E E +  + A+ D         
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILR------KADMLEKEQVGHIRAERDILVEADSLW 62

Query: 157 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL-----LECIA 210
            V++   F  + ++ ++ E L G  +   L K        D + E   Q      +  I 
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-------DTLTEEETQFYIAETVLAID 115

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYK--SSLHTPKDSSYFKRMPKS--SAIKVID 266
            +H L  IH D+KP+N+LL S  ++K+ D+   + L     + +++ +  S  S     +
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 267 FGST----TYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
             S     T++R  +      V T  Y APEV +  G+   CD WS+G I+ E+  G   
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 320 F 320
           F
Sbjct: 236 F 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 53.3 bits (128), Expect = 5e-08
 Identities = 56/268 (20%), Positives = 115/268 (42%), Gaps = 52/268 (19%)

Query: 96  YKIHSKMGEGTFGQVLECWDRER-KEMVAIKIV-------RGIKKYREAA---MI-EIEV 143
           Y +   +G G FG V +   +   + ++A+K +          K+ R+ +   ++ E+ +
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 144 LQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLR--KNNYRSFPIDLVRE 200
           +++  +H       V+    F   + + IV + + G+ L +     K   + F  + +  
Sbjct: 62  IKEQLRHPN----IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117

Query: 201 IARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           I  Q++  + ++H +  ++H DL P N++L   +                          
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-------------------------- 151

Query: 260 SAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 317
             + + DFG    ++P+     +V T  Y  PE++    +    D+W+ GCIL ++CT +
Sbjct: 152 -KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQ 210

Query: 318 ALFQTHENLEHLAM--MERVLGPLPQHM 343
             F +  N+  LA   +E V  PLP+ M
Sbjct: 211 PPFYS-TNMLSLATKIVEAVYEPLPEGM 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 53.3 bits (129), Expect = 6e-08
 Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 47/186 (25%)

Query: 181 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 240
           L+D L+K          V++I RQL+E +  +H   +IH D+K ENVL            
Sbjct: 96  LFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL------------ 141

Query: 241 KSSLHTPKDSSYFKRMPKSSAIKVIDFG-------STTYERPDQNYIVSTRHYRAPEVIL 293
                      Y +   +   I + D+G        + Y+         T  Y +PE I 
Sbjct: 142 -----------YDRAKDR---IYLCDYGLCKIIGTPSCYDG--------TLDYFSPEKIK 179

Query: 294 GLGWTYPCDIWSVGCILVELCTGEALFQTH--ENLEHLAMMERVLGPLPQHMLKRVDRHA 351
           G  +    D W+VG +  EL TG+  F+    E L+  ++++R    LP   +K V ++A
Sbjct: 180 GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLP--FIKNVSKNA 237

Query: 352 EKYVRR 357
             +V+ 
Sbjct: 238 NDFVQS 243

Length = 267

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 53.6 bits (128), Expect = 7e-08
 Identities = 59/222 (26%), Positives = 90/222 (40%), Gaps = 45/222 (20%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           ++G G+FG V    D    E+VAIK      K   +     E  Q + K  K   R ++ 
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIK------KMSYSGKQSNEKWQDIIKEVKFLQR-IKH 84

Query: 161 RNWFDY-----RNHIC-IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
            N  +Y     R H   +V E    S  D L  +      +++   I    L+ +A++H 
Sbjct: 85  PNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHS 143

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             MIH D+K  N+LL                            +   +K+ DFGS +   
Sbjct: 144 HNMIHRDIKAGNILLT---------------------------EPGQVKLADFGSASIAS 176

Query: 275 PDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVEL 313
           P  N  V T ++ APEVIL +    +    D+WS+G   +EL
Sbjct: 177 P-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 57/234 (24%), Positives = 100/234 (42%), Gaps = 41/234 (17%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAA--MIEIEVLQQLAKHDKGGNRC 157
           +G+G+FG+VL    +  ++  A+K++  + I K +E    M E  VL +  KH       
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP----FL 58

Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V +   F   + +  V + + G  L+  L++   R F     R  A ++   + ++H L 
Sbjct: 59  VGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN 116

Query: 217 MIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
           +++ DLKPEN+LL S  +I + D+   K ++     +S F   P+               
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPE--------------- 161

Query: 274 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                       Y APEV+    +    D W +G +L E+  G   F +    E
Sbjct: 162 ------------YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 53.1 bits (128), Expect = 9e-08
 Identities = 58/262 (22%), Positives = 102/262 (38%), Gaps = 65/262 (24%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD--KGGNRCVQ 159
           +G G FG V +   +    ++A+K +R         + E E  + L   D     + C  
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRST-------VDEKEQKRLLMDLDVVMRSSDCPY 64

Query: 160 IRNWFDYRNH-----IC-----IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
           I  ++          IC     I  +K    +Y+ L+       P +++ +IA   ++ +
Sbjct: 65  IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSV----IPEEILGKIAVATVKAL 120

Query: 210 AFM-HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
            ++  +L +IH D+KP N+LL                            ++  IK+ DFG
Sbjct: 121 NYLKEELKIIHRDVKPSNILL---------------------------DRNGNIKLCDFG 153

Query: 269 STTYERPDQNYIVSTRH-----YRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALF 320
            +       + I  TR      Y APE I      G+    D+WS+G  L E+ TG+  +
Sbjct: 154 ISGQL---VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210

Query: 321 QTHENL-EHLAMMERVLGPLPQ 341
               ++ + L  +  V G  P 
Sbjct: 211 PKWNSVFDQLTQV--VKGDPPI 230

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 61/241 (25%), Positives = 103/241 (42%), Gaps = 37/241 (15%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++I   +G G FG+V     +  + + A+KI   + K+      E    ++       G+
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKI---LNKWEMLKRAETACFREERNVLVNGD 59

Query: 156 RCVQIRNW---FDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            C  I      F   N++ +V +  +G  L   L K   R  P D+ R    +++  I  
Sbjct: 60  -CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHS 117

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L  +H D+KP+NVLL  + +I++ D+ S L   +D +      +SS           
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-----QSSV---------- 162

Query: 272 YERPDQNYIVSTRHYRAPEVIL----GLGWTYP-CDIWSVGCILVELCTGEALFQTHENL 326
                    V T  Y +PE++     G+G   P CD WS+G  + E+  GE  F     +
Sbjct: 163 --------AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214

Query: 327 E 327
           E
Sbjct: 215 E 215

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 57/242 (23%), Positives = 99/242 (40%), Gaps = 41/242 (16%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G+FG+V+    +   E  AIK ++          E  M+E  VL    +H       
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHP----FL 58

Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
             +   F  + H+  V E L      F  +++ R F     R  A +++  + F+H   +
Sbjct: 59  THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLHKKGI 117

Query: 218 IHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           I+ DLK +NVLL    +IK+ D+   K +++    +S F                     
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF--------------------- 156

Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMM 332
                   T  Y APE++ G  +    D WS G +L E+  G++ F  +  + L    + 
Sbjct: 157 ------CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210

Query: 333 ER 334
           +R
Sbjct: 211 DR 212

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.8 bits (126), Expect = 1e-07
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 41/243 (16%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHD 151
           ++I   +G G FG+V     +   ++ A+KI+   +  + A       E +VL       
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN----- 57

Query: 152 KGGNRCVQIRNW-FDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
            G N+ +   ++ F   N++ +V +  +G  L   L K   R  P D+ R    +++  I
Sbjct: 58  -GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAI 115

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
             +H L  +H D+KP+N+L+  + +I++ D+ S L   +D +                  
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV----------------- 158

Query: 270 TTYERPDQNYIVSTRHYRAPEVIL----GLGWTYP-CDIWSVGCILVELCTGEALFQTHE 324
                   +  V T  Y +PE++     G G   P CD WS+G  + E+  GE  F    
Sbjct: 159 ------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212

Query: 325 NLE 327
            +E
Sbjct: 213 LVE 215

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 62/243 (25%), Positives = 105/243 (43%), Gaps = 45/243 (18%)

Query: 101 KMGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           K+G G FG+V    W+   K  VA+K ++      EA + E +++++L +HDK     VQ
Sbjct: 13  KLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKL-RHDK----LVQ 65

Query: 160 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           +         I IV E +   SL DFL+    +   +  + ++A Q+ E +A++     I
Sbjct: 66  LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYI 125

Query: 219 HTDLKPENVLLVSSEYIKVPDY------KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H DL   N+L+  +   K+ D+      +   +T ++ +   + P    IK         
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA---KFP----IK--------- 169

Query: 273 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAM 331
                        + APE      +T   D+WS G +L E+ T G   +    N E L  
Sbjct: 170 -------------WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ 216

Query: 332 MER 334
           +ER
Sbjct: 217 VER 219

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 50/218 (22%), Positives = 94/218 (43%), Gaps = 40/218 (18%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           +G G  G V + +    + ++A+K++      + ++  M E+E+L +           + 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS-----PYIIG 63

Query: 160 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
               F   N I I  E + G SL      + YR  P  ++  IA  +++ + ++  L ++
Sbjct: 64  FYGAFFVENRISICTEFMDGGSL------DVYRKIPEHVLGRIAVAVVKGLTYLWSLKIL 117

Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 278
           H D+KP N+L+ +   +K+ D+  S                   ++++  + TY      
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVS------------------TQLVNSIAKTY------ 153

Query: 279 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
             V T  Y APE I G  +    D+WS+G   +EL  G
Sbjct: 154 --VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALG 189

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 59/242 (24%), Positives = 104/242 (42%), Gaps = 35/242 (14%)

Query: 97  KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G G FG+V E  W+      VA+K ++      +  + E +++++L +H K   
Sbjct: 9   QLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKL-RHPK--- 62

Query: 156 RCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
             +Q+         I IV E  K GS L ++L+    R+  +  + ++A Q+   +A++ 
Sbjct: 63  -LIQLYAVCTLEEPIYIVTELMKYGS-LLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120

Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
               IH DL   NVL+  +   KV D+  +    K+  Y  R      IK          
Sbjct: 121 AQNYIHRDLAARNVLVGENNICKVADFGLA-RVIKEDIYEAREGAKFPIK---------- 169

Query: 274 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMM 332
                       + APE  L   ++   D+WS G +L E+ T G   +    N E L  +
Sbjct: 170 ------------WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217

Query: 333 ER 334
           ++
Sbjct: 218 DQ 219

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 53/228 (23%), Positives = 100/228 (43%), Gaps = 43/228 (18%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIE--VLQQLAKHD--KGGN 155
           +G G++ +VL    ++ + + A+K+V+   +    +   ++ E  V +Q + H    G +
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 156 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
            C Q  +    R    I +   G  ++   R+   R  P +  R  + ++   + ++H+ 
Sbjct: 63  SCFQTES----RLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER 115

Query: 216 CMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
            +I+ DLK +NVLL S  +IK+ DY   K  L     +S F   P               
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP--------------- 160

Query: 273 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
                NYI       APE++ G  + +  D W++G ++ E+  G + F
Sbjct: 161 -----NYI-------APEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 56/228 (24%), Positives = 92/228 (40%), Gaps = 50/228 (21%)

Query: 102 MGEGTFGQVLEC----WDRERKEM-VAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGG 154
           +G G FG+V+E       +    M VA+K+++       REA M E++++  L  H+   
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHE--- 99

Query: 155 NRCVQIRNWFDYRNH---ICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                I N          I ++ E      L +FLR+       ++ +   + Q+ + +A
Sbjct: 100 ----NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           F+     IH DL   NVLL   +                            +K+ DFG  
Sbjct: 156 FLASKNCIHRDLAARNVLLTHGK---------------------------IVKICDFGLA 188

Query: 271 TYERPDQNYIV--STR---HYRAPEVILGLGWTYPCDIWSVGCILVEL 313
                D NY+V  + R    + APE I    +T+  D+WS G +L E+
Sbjct: 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 41/220 (18%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIV----RGIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           ++G G+FG V    D    E+VAIK +    +   +  +  + E+  LQ+L +H      
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPN---- 76

Query: 157 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
            +Q R  +   +   +V E    S  D L  +      +++   +    L+ +A++H   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLHSHN 135

Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           MIH D+K  N+LL                            +   +K+ DFGS +   P 
Sbjct: 136 MIHRDVKAGNILLS---------------------------EPGLVKLGDFGSASIMAP- 167

Query: 277 QNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVEL 313
            N  V T ++ APEVIL +    +    D+WS+G   +EL
Sbjct: 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 38/233 (16%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDK 152
           Y++   +G G FG+V     +  +++ A+K++     IK+   A   E   +   A    
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--- 101

Query: 153 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                VQ+   F    ++ +V E + G  L + +  +NY   P    R    +++  +  
Sbjct: 102 -SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY-DVPEKWARFYTAEVVLALDA 157

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H +  IH D+KP+N+LL  S ++K+ D+ + +          +M K   ++        
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM----------KMNKEGMVRC------- 200

Query: 272 YERPDQNYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEALF 320
                 +  V T  Y +PEV+   G    +   CD WSVG  L E+  G+  F
Sbjct: 201 ------DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 53/240 (22%), Positives = 107/240 (44%), Gaps = 39/240 (16%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH 150
           N    +++  ++G GT+G V +  +    E+ AIK+++ ++   + A+++ E++  + K 
Sbjct: 6   NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK-LEPGEDFAVVQQEII--MMKD 62

Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQLLE 207
            K  N      ++   R+ + I  E  G  SL D      + + P+    +  ++R+ L+
Sbjct: 63  CKHSNIVAYFGSYLR-RDKLWICMEFCGGGSLQDIY----HVTGPLSESQIAYVSRETLQ 117

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H    +H D+K  N+LL  + ++K+ D+  S                        
Sbjct: 118 GLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQ---------------------I 156

Query: 268 GSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGE-ALFQTH 323
            +T  +R      + T ++ APEV       G+   CDIW+VG   +EL   +  +F  H
Sbjct: 157 TATIAKRKS---FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 50.2 bits (120), Expect = 5e-07
 Identities = 62/242 (25%), Positives = 101/242 (41%), Gaps = 44/242 (18%)

Query: 101 KMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           ++G G FG V L  W  + K  VAIK +       E  + E +V+ +L+ H K     VQ
Sbjct: 11  ELGSGQFGVVHLGKWRAQIK--VAIKAINEGAMSEEDFIEEAKVMMKLS-HPK----LVQ 63

Query: 160 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           +      +  + IV E +    L ++LR+        D++  + + + E + ++     I
Sbjct: 64  LYGVCTQQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNSFI 122

Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 278
           H DL   N  LVSS  +                          +KV DFG T Y   D+ 
Sbjct: 123 HRDLAARNC-LVSSTGV--------------------------VKVSDFGMTRYVLDDE- 154

Query: 279 YIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMM 332
           Y  S+       +  PEV     ++   D+WS G ++ E+ T G+  F+   N E + M+
Sbjct: 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214

Query: 333 ER 334
            R
Sbjct: 215 SR 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 59/241 (24%), Positives = 100/241 (41%), Gaps = 47/241 (19%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G+FG+VL    +      A+K+++      KK +   M E  VL +  KH       
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHP----FL 58

Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V +   F     +  V + + G  L+  L++   R F     R  A ++   I ++H L 
Sbjct: 59  VGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN 116

Query: 217 MIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
           +I+ DLKPEN+LL S  ++ + D+   K  +   + +S F   P+               
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPE--------------- 161

Query: 274 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF------QTHENLE 327
                       Y APEV+    +    D W +G +L E+  G   F      Q ++N+ 
Sbjct: 162 ------------YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL 209

Query: 328 H 328
           H
Sbjct: 210 H 210

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 59/241 (24%), Positives = 107/241 (44%), Gaps = 33/241 (13%)

Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           K+  K+G G FG+V +  ++   K  VA+K ++      +A + E  +++ L +HDK   
Sbjct: 9   KLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTL-QHDK--- 62

Query: 156 RCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             V++         I I+ E +   SL DFL+ +      +  + + + Q+ E +A++  
Sbjct: 63  -LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 121

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
              IH DL+  NVL+  S   K+ D+  +    +D+ Y  R      IK           
Sbjct: 122 KNYIHRDLRAANVLVSESLMCKIADFGLA-RVIEDNEYTAREGAKFPIK----------- 169

Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE I    +T   D+WS G +L E+ T G+  +    N + ++ ++
Sbjct: 170 -----------WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ 218

Query: 334 R 334
           R
Sbjct: 219 R 219

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 49.8 bits (119), Expect = 6e-07
 Identities = 64/304 (21%), Positives = 110/304 (36%), Gaps = 94/304 (30%)

Query: 126 IVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDF 184
           I++G++K  E +   + ++     +       V +  +    + + +V +   G  L+  
Sbjct: 22  ILKGLRKSSEYSRERLTIIPHCVPN------MVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75

Query: 185 LRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 244
           + K  + + P + V+  A +++  +  +H   ++  DL P N+LL    +I++       
Sbjct: 76  ISK--FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL------- 126

Query: 245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIW 304
                 +YF R             S   +  D   +     Y APEV      T  CD W
Sbjct: 127 ------TYFSRW------------SEVEDSCDGEAV--ENMYCAPEVGGISEETEACDWW 166

Query: 305 SVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPE 364
           S+G IL EL TG+ L + H                                       P 
Sbjct: 167 SLGAILFELLTGKTLVECH---------------------------------------PS 187

Query: 365 GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA-----LR 419
           G  +  ++            I + V   A     LLQ LL+++PT+RL A  A       
Sbjct: 188 GINTHTTLN-----------IPEWVSEEARS---LLQQLLQFNPTERLGAGVAGVEDIKS 233

Query: 420 HPFF 423
           HPFF
Sbjct: 234 HPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 50.6 bits (121), Expect = 7e-07
 Identities = 73/334 (21%), Positives = 135/334 (40%), Gaps = 83/334 (24%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIE--VLQQLAKHD--KGGN 155
           +G G++ +VL    ++ + + A+K+++   +    +   ++ E  V +  + H    G +
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 156 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
            C Q  +    R    I F   G  ++   R+   R  P +  R  + ++   + F+H+ 
Sbjct: 63  SCFQTES----RLFFVIEFVSGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER 115

Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
            +I+ DLK +NVLL +  +IK+ DY               M K   I+  D  ST    P
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYG--------------MCK-EGIRPGDTTSTFCGTP 160

Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 335
             NYI       APE++ G  + +  D W++G ++ E+  G + F      ++       
Sbjct: 161 --NYI-------APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN------- 204

Query: 336 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 395
                       D++ E Y+ +  L+              +++PR  ++    V      
Sbjct: 205 -----------PDQNTEDYLFQVILEKQ------------IRIPRSLSVKASSV------ 235

Query: 396 LTHLLQGLLRYDPTDRLTA------REALRHPFF 423
               L+G L  DP +RL        R+   HPFF
Sbjct: 236 ----LKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 52/233 (22%), Positives = 100/233 (42%), Gaps = 38/233 (16%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDK 152
           Y +   +G G FG+V     +  +++ A+K++     IK+   A   E   +   A    
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--- 101

Query: 153 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                VQ+   F    ++ +V E + G  L + +  +NY   P    +    +++  +  
Sbjct: 102 -SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY-DVPEKWAKFYTAEVVLALDA 157

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H + +IH D+KP+N+LL    ++K+ D+ + +          +M ++  ++        
Sbjct: 158 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM----------KMDETGMVRC------- 200

Query: 272 YERPDQNYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEALF 320
                 +  V T  Y +PEV+   G    +   CD WSVG  L E+  G+  F
Sbjct: 201 ------DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 31/121 (25%), Positives = 55/121 (45%), Gaps = 27/121 (22%)

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           +++  +  +H +  IH D+KP+N+LL  S ++K+ D+ + +          +M  +  ++
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM----------KMDANGMVR 199

Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEAL 319
                 T    PD         Y +PEV+   G    +   CD WSVG  L E+  G+  
Sbjct: 200 C----DTAVGTPD---------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Query: 320 F 320
           F
Sbjct: 247 F 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 56/259 (21%), Positives = 95/259 (36%), Gaps = 83/259 (32%)

Query: 197 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 256
           +++ I RQ+L  +  +H   ++H D+KP+N++                            
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF--------------------------S 289

Query: 257 PKSSAIKVIDFGSTT------------------YERPDQNYIVSTRHYRAPEVILGLG-- 296
             S + K+ID G+                    Y  P+Q YI+ST+   AP   +     
Sbjct: 290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQ-YIMSTQTPSAPSAPVATALS 348

Query: 297 ---WTYPC----DIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDR 349
              W        DI+S G I +++      F    +  +L    R         LKR D 
Sbjct: 349 PVLWQLNLPDRFDIYSAGLIFLQMA-----FPNLRSDSNLIQFNR--------QLKRNDY 395

Query: 350 HAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 409
               +  R  ++       R   + V+ L           D  AG    LL+ ++R+   
Sbjct: 396 DLVAW--RKLVEPRASPDLRRGFE-VLDL-----------DGGAG--WELLKSMMRFKGR 439

Query: 410 DRLTAREALRHPFFTRDHL 428
            R++A+ AL HP+F R+ L
Sbjct: 440 QRISAKAALAHPYFDREGL 458

Length = 566

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 37/221 (16%)

Query: 100 SKMGEGTFGQVLECWDRERKEMVAIKIVR-GIK-KYREAAMIEIEVLQQLAKHDKGGNRC 157
           S++G G  G V +   +    ++A K++   IK   R   + E++VL     H+      
Sbjct: 11  SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL-----HECNSPYI 65

Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V     F     I I  E + G SL   L++   +  P +++ +++  +L  +A++ +  
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH 123

Query: 217 MI-HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
            I H D+KP N+L+ S   IK+ D+  S                   ++ID  + ++   
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSG------------------QLIDSMANSF--- 162

Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                V TR Y +PE + G  ++   DIWS+G  LVEL  G
Sbjct: 163 -----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 55/232 (23%), Positives = 103/232 (44%), Gaps = 38/232 (16%)

Query: 88  LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL 147
           L  N    Y++  ++G GT+G V +  +    E+ A+KI++ ++   + ++I+ E+   +
Sbjct: 3   LRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK-LEPGDDFSLIQQEIF--M 59

Query: 148 AKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQ 204
            K  K  N      ++   R  + I  E  G  SL D      + + P+    +  + R+
Sbjct: 60  VKECKHCNIVAYFGSYLS-REKLWICMEYCGGGSLQDIY----HVTGPLSELQIAYVCRE 114

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
            L+ +A++H    +H D+K  N+LL  +  +K+ D+                    A K+
Sbjct: 115 TLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADF------------------GVAAKI 156

Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVEL 313
               +T  +R      + T ++ APEV       G+   CDIW+VG   +EL
Sbjct: 157 T---ATIAKRKS---FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 57/251 (22%), Positives = 100/251 (39%), Gaps = 56/251 (22%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDR------ERKEMVAI------KIVRGIKKY-----REA 136
           + +++   +  G FG++  C  R      E +  V        K  R I K      R A
Sbjct: 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAA 207

Query: 137 AMIEIEVLQ-QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKN--NYRSF 193
             +E E+L      H+      ++I        +  ++ +K    LY F+     +++  
Sbjct: 208 IQLENEILALGRLNHEN----ILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDR 263

Query: 194 P-IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 252
           P +   R I +QLL  + ++HD  +IH D+K EN+ L         D K  L        
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC-------DGKIVLG------- 309

Query: 253 FKRMPKSSAIKVIDFGS-TTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGC 308
                        DFG+   +E+  + +    V T    +PE++ G G+    DIWS G 
Sbjct: 310 -------------DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGL 356

Query: 309 ILVELCTGEAL 319
           IL+++ + +  
Sbjct: 357 ILLDMLSHDFC 367

Length = 501

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 32/152 (21%)

Query: 172 IVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVL 228
           I  E + +SL  F +K  +   + P D++ +IA  +++ + ++H  L +IH D+KP NVL
Sbjct: 77  ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVL 136

Query: 229 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRA 288
           +  +  +K+ D+  S +              S  K ID G               + Y A
Sbjct: 137 INRNGQVKLCDFGISGYL-----------VDSVAKTIDAGC--------------KPYMA 171

Query: 289 PEVILG----LGWTYPCDIWSVGCILVELCTG 316
           PE I       G+    D+WS+G  ++EL TG
Sbjct: 172 PERINPELNQKGYDVKSDVWSLGITMIELATG 203

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 61/255 (23%), Positives = 99/255 (38%), Gaps = 68/255 (26%)

Query: 102 MGEGTFGQVLECWDRERKEM---VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNR 156
           +G G FG V++     +      VA+K ++   I   ++  + E  V+ QL         
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL--------- 53

Query: 157 CVQIRNWFDYRNHICIV----------------FEKLGSSLYDFLRKNNYRSFPIDLVRE 200
                      +H CIV                   LG  L  +L+K   R  P+  ++E
Sbjct: 54  -----------DHPCIVRLIGVCKGEPLMLVMELAPLGP-LLKYLKKR--REIPVSDLKE 99

Query: 201 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 260
           +A Q+   +A++     +H DL   NVLLV+    K+ D+  S      S Y++      
Sbjct: 100 LAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR------ 153

Query: 261 AIKVIDFGSTTYER-PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA 318
                   +TT  R P + Y        APE I    ++   D+WS G  L E  + G  
Sbjct: 154 --------ATTAGRWPLKWY--------APECINYGKFSSKSDVWSYGVTLWEAFSYGAK 197

Query: 319 LFQTHENLEHLAMME 333
            +   +  E +AM+E
Sbjct: 198 PYGEMKGAEVIAMLE 212

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 36/229 (15%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G FG+V  C   +  +M A+K +      +K+    A+ E  +L  ++  D     C
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           +     F   + +C + + + G  L+  L ++    F    +R  A +++  +  MH+  
Sbjct: 62  MTYA--FHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNRF 117

Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +++ DLKP N+LL    ++++ D   +        + K+ P +S                
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHAS---------------- 155

Query: 277 QNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
               V T  Y APEV+  G  +    D +S+GC+L +L  G + F+ H+
Sbjct: 156 ----VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 46/246 (18%)

Query: 101 KMGEGTFGQVLECWDRERK--EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 158
           ++G G FG V +   + +K  + VA+KI   +K       ++ E+L       +  N   
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKI---LKNDNNDPALKDELL-------REANVMQ 51

Query: 159 QIRNWFDYRN-HIC------IVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
           Q+ N +  R   IC      +V E  +LG  L  FL+KN  +      + E+  Q+   +
Sbjct: 52  QLDNPYIVRMIGICEAESWMLVMELAELGP-LNKFLQKN--KHVTEKNITELVHQVSMGM 108

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            ++ +   +H DL   NVLLV+  Y K+ D+  S     D +Y+K               
Sbjct: 109 KYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK-------------AK 155

Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE-LCTGEALFQTHENLEH 328
           T  + P + Y        APE +    ++   D+WS G ++ E    G+  ++  +  E 
Sbjct: 156 THGKWPVKWY--------APECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV 207

Query: 329 LAMMER 334
             M+E 
Sbjct: 208 TQMIES 213

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 37/225 (16%)

Query: 100 SKMGEGTFGQV-LECWD---RERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGG 154
            ++G+G FG V L  +D       E+VA+K ++    ++      EIE+L+ L +HD   
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDN-- 66

Query: 155 NRCVQIRN--WFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
              V+ +   +   R ++ +V E L   SL D+L+K+  R     L+   A Q+ + + +
Sbjct: 67  --IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLL-LYASQICKGMEY 123

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDFGST 270
           +     +H DL   N+L+ S   +K+ D+  +   P+D  Y+K R P  S I        
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI-------- 175

Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                          + APE +    ++   D+WS G +L EL T
Sbjct: 176 --------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 57/236 (24%), Positives = 99/236 (41%), Gaps = 42/236 (17%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G+FG+V+    +E   + A+K+++     +    E  M E  +L     H       
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP----FL 58

Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
            Q+   F   + +  V E + G  L   ++K+  R F     R  A ++   + F+HD  
Sbjct: 59  TQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG 116

Query: 217 MIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
           +I+ DLK +NVLL    + K+ D+   K  +   K +S F                    
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF-------------------- 156

Query: 274 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
                    T  Y APE++  + +    D W++G +L E+  G A F+  EN + L
Sbjct: 157 -------CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 57/245 (23%), Positives = 108/245 (44%), Gaps = 41/245 (16%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYR--EAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G FG+V  C  R   ++ A K +  + +KK +  E AM+E  +L ++  H +     
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV--HSR---FI 55

Query: 158 VQIRNWFDYRNHICIVFEKLGSS-----LYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
           V +   F  +  +C+V   +        +Y+   +N    FP         Q++  +  +
Sbjct: 56  VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP--GFPEPRACFYTAQIISGLEHL 113

Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   +I+ DLKPENVLL +   +++ D                     A+++ D  S T 
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVRISDL------------------GLAVELKDGQSKT- 154

Query: 273 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAM 331
               + Y   T  + APE++ G  + +  D +++G  L E+      F+   E +E+  +
Sbjct: 155 ----KGY-AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 209

Query: 332 MERVL 336
            +R+L
Sbjct: 210 KQRIL 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 49/205 (23%), Positives = 81/205 (39%), Gaps = 57/205 (27%)

Query: 180 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 239
           SL D LRK+    F I  + + A Q+   + ++     IH DL   N+LL S + +K+ D
Sbjct: 81  SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGD 140

Query: 240 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR------APEVIL 293
           +             + +P++                + +Y V   H +      APE + 
Sbjct: 141 FGLM----------RALPQN----------------EDHY-VMEEHLKVPFAWCAPESLR 173

Query: 294 GLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAE 352
              +++  D+W  G  L E+ T GE               E   G     +LK++D+  E
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGE---------------EPWAGLSGSQILKKIDKEGE 218

Query: 353 KYVRRGRLDWPEGAASRESIKSVMK 377
                 RL+ PE  A  + I +VM 
Sbjct: 219 ------RLERPE--ACPQDIYNVML 235

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 39/226 (17%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G+FG+V+    +   E+ AIKI++     +    E  M+E  VL    K        
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP----FL 63

Query: 158 VQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMHD 214
            Q+ + F   + +  V E +  G  +Y   +   ++    +    EI+  L     F+H 
Sbjct: 64  TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF----FLHR 119

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             +I+ DLK +NV+L S  +IK+ D+               M K   +     G TT   
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFG--------------MCKEHMVD----GVTT--- 158

Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
                   T  Y APE+I    +    D W+ G +L E+  G+  F
Sbjct: 159 ---RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 41/230 (17%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMI--EIEVLQQLAKHDKGGNRC 157
           +G G FG+V     +   ++ A+KI+    + K  E A    E +VL        G  R 
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLV------NGDRRW 62

Query: 158 V-QIRNWFDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
           +  +   F   N++ +V +  +G  L   L K   R  P D+ R    +++  I  +H L
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVLAIDSVHQL 121

Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
             +H D+KP+NVLL  + +I++ D+ S L    D +                        
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV----------------------- 158

Query: 276 DQNYIVSTRHYRAPEVIL----GLGWTYP-CDIWSVGCILVELCTGEALF 320
             N  V T  Y +PE++     G G   P CD WS+G  + E+  GE  F
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 56/239 (23%), Positives = 99/239 (41%), Gaps = 32/239 (13%)

Query: 101 KMGEGTFGQVLECWDRERKEM--VAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           ++G G FG V +   + RK+   VAIK+++    K  R+  M E E++ QL         
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDN-----PY 56

Query: 157 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
            V++    +    + ++    G  L  FL         +  V E+  Q+   + ++    
Sbjct: 57  IVRMIGVCEAEALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN 115

Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
            +H DL   NVLLV+  Y K+ D+  S     D SY+K               +  + P 
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK-------------ARSAGKWPL 162

Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE-LCTGEALFQTHENLEHLAMMER 334
           + Y        APE I    ++   D+WS G  + E    G+  ++  +  E ++ +E+
Sbjct: 163 KWY--------APECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ 213

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 61/251 (24%), Positives = 106/251 (42%), Gaps = 39/251 (15%)

Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           +   ++G GT GQV +   ++   ++A+K +R      E   I +++   L  HD     
Sbjct: 18  ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHD----- 72

Query: 157 C---VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
           C   V+   +F   + + I  E + + L D L K      P D++ ++   +++ + ++ 
Sbjct: 73  CPYIVKCYGYFITDSDVFICMELMSTCL-DKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131

Query: 214 DL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           +   +IH D+KP N+LL +S  +K+ D+  S           R+  S A K    G   Y
Sbjct: 132 EKHGVIHRDVKPSNILLDASGNVKLCDFGIS----------GRLVDSKA-KTRSAGCAAY 180

Query: 273 ---ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
              ER D          RA             D+WS+G  LVEL TG+  F         
Sbjct: 181 MAPERIDPPDPNPKYDIRA-------------DVWSLGISLVELATGQ--FPYKNCKTEF 225

Query: 330 AMMERVLGPLP 340
            ++ ++L   P
Sbjct: 226 EVLTKILQEEP 236

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 56/245 (22%), Positives = 106/245 (43%), Gaps = 37/245 (15%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G+FG+V+    +   E+ AIK+++     +    +  M E  +L   AKH       
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHP----FL 58

Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             +   F  ++ +  V E + G  L   ++++  R F     R  A ++   + F+H   
Sbjct: 59  TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHG 116

Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLK +N+LL +  + K+ D+               M K   +     G TT     
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFG--------------MCKEGILN----GVTT----- 153

Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ--THENLEHLAMMER 334
                 T  Y APE++  L +    D W++G ++ E+  G+  F+    ++L    + + 
Sbjct: 154 -TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD 212

Query: 335 VLGPL 339
           VL P+
Sbjct: 213 VLYPV 217

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 36/229 (15%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G FG+V  C   +  +M A+K +      +K+    A+ E  +L  ++  D     C
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           +     F   + +  + + + G  L+  L ++    F    +R  A +++  +  MH+  
Sbjct: 62  MSYA--FHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEAEMRFYAAEIILGLEHMHNRF 117

Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +++ DLKP N+LL    ++++ D   +        + K+ P +S                
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHAS---------------- 155

Query: 277 QNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
               V T  Y APEV+  G+ +    D +S+GC+L +L  G + F+ H+
Sbjct: 156 ----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 37/221 (16%)

Query: 100 SKMGEGTFGQVLECWDRERKEMVAIKIVR-GIK-KYREAAMIEIEVLQQLAKHDKGGNRC 157
           S++G G  G V +   +    ++A K++   IK   R   + E++VL     H+      
Sbjct: 11  SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL-----HECNSPYI 65

Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V     F     I I  E + G SL   L+K      P  ++ +++  +++ + ++ +  
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH 123

Query: 217 MI-HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
            I H D+KP N+L+ S   IK+ D+  S                   ++ID  + ++   
Sbjct: 124 KIMHRDVKPSNILVNSRGEIKLCDFGVSG------------------QLIDSMANSF--- 162

Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                V TR Y +PE + G  ++   DIWS+G  LVE+  G
Sbjct: 163 -----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 57/232 (24%), Positives = 95/232 (40%), Gaps = 51/232 (21%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-------REAAMIEIEVLQQLAKHDKGG 154
           +G+G+FG+V+    +   E+ AIKI   +KK         E  M+E  VL    K     
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKI---LKKDVIIQDDDVECTMVEKRVLALPGK----P 60

Query: 155 NRCVQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAF 211
               Q+ + F   + +  V E +  G  +Y   +   ++    +    EIA  L     F
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLF----F 116

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +H   +I+ DLK +NV+L +  +IK+ D+   K ++   K +  F   P           
Sbjct: 117 LHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTP----------- 165

Query: 269 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
                    +YI       APE+I    +    D W+ G +L E+  G+  F
Sbjct: 166 ---------DYI-------APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 52/246 (21%), Positives = 92/246 (37%), Gaps = 61/246 (24%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA--------MIEIEVLQQLAKHD-- 151
           +GEG FG+V++      K       V  +K  +E A        + E  +L+Q+      
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTV-AVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKN----------------------N 189
           K    C Q     D    + + + K GS L  FLR++                      +
Sbjct: 67  KLYGACSQ-----DGPLLLIVEYAKYGS-LRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 190 YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 249
            R+  +  +   A Q+   + ++ ++ ++H DL   NVL+     +K+ D+  S    ++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 250 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI 309
            SY KR      +K                      + A E +    +T   D+WS G +
Sbjct: 181 DSYVKRSKGRIPVK----------------------WMAIESLFDHIYTTQSDVWSFGVL 218

Query: 310 LVELCT 315
           L E+ T
Sbjct: 219 LWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 41/230 (17%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRG--IKKYREAAMIEIEVLQQ 146
           S  KI   +G G FG+V  C  R     +R+  VAIK ++    +K R   + E  ++ Q
Sbjct: 4   SCIKIEKVIGAGEFGEV--CSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQ 61

Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
               +      + +         + IV E +   SL  FLRK++ +   I LV  + R +
Sbjct: 62  FDHPN-----IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLV-GMLRGI 115

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAIK 263
              + ++ D+  +H DL   N+L+ S+   KV D+  S  L    +++Y  R  K     
Sbjct: 116 ASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK----- 170

Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
                            +  R + APE I    +T   D+WS G ++ E+
Sbjct: 171 -----------------IPIR-WTAPEAIAYRKFTSASDVWSYGIVMWEV 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 64/252 (25%), Positives = 106/252 (42%), Gaps = 41/252 (16%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G+FG+V+    +   E+ AIKI++     +    E  M+E  VL    K        
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP----FL 63

Query: 158 VQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMHD 214
            Q+ + F   + +  V E +  G  +Y   +   ++    +    EIA  L     F+H 
Sbjct: 64  TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF----FLHS 119

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             +I+ DLK +NV+L S  +IK+ D+               M K +       G TT   
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFG--------------MCKENMWD----GVTT--- 158

Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL-AMME 333
                   T  Y APE+I    +    D W+ G +L E+  G+A F+  +  E   ++ME
Sbjct: 159 ---KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215

Query: 334 RVLGPLPQHMLK 345
             +   P+ M K
Sbjct: 216 HNVA-YPKSMSK 226

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 44.7 bits (106), Expect = 5e-05
 Identities = 51/226 (22%), Positives = 93/226 (41%), Gaps = 34/226 (15%)

Query: 100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ-----LAKHDKGG 154
           + +G G FG+VL    ++  E+ AIK    +KK    A  E+E L          + +  
Sbjct: 5   AVLGRGHFGKVLLAEYKKTGELYAIKA---LKKGDIIARDEVESLMCEKRIFETANSERH 61

Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
              V +   F   +H+C V E       D +   +   F        A  ++  + ++H+
Sbjct: 62  PFLVNLFACFQTEDHVCFVMEYAAGG--DLMMHIHTDVFSEPRAVFYAACVVLGLQYLHE 119

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             +++ DLK +N+LL +  ++K+ D+               + K      + FG  T   
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFG--------------LCKEG----MGFGDRT--- 158

Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
              +    T  + APEV+    +T   D W +G ++ E+  GE+ F
Sbjct: 159 ---STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 44.4 bits (105), Expect = 6e-05
 Identities = 33/117 (28%), Positives = 53/117 (45%), Gaps = 31/117 (26%)

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +H   +I+ DLKPEN+LL +  ++K+ D+   K S+H                      G
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE---------------------G 154

Query: 269 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
           + T+          T  Y APE+++  G     D WS+G ++ ++ TG   F T EN
Sbjct: 155 TVTHT------FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF-TAEN 204

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 37/138 (26%), Positives = 57/138 (41%), Gaps = 29/138 (21%)

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ D+K EN+LL S+ ++ + D+  S                      +F    
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK---------------------EFHEDE 159

Query: 272 YERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEH 328
            ER        T  Y AP+++ G   G     D WS+G ++ EL TG + F    E    
Sbjct: 160 VERAYS--FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217

Query: 329 LAMMERVLG---PLPQHM 343
             +  R+L    P PQ M
Sbjct: 218 AEISRRILKSEPPYPQEM 235

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 43/185 (23%), Positives = 75/185 (40%), Gaps = 43/185 (23%)

Query: 178 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 237
           G  ++  L + +   F  D VR  + +++  +  +H L +++ D+K EN+LL S  ++ +
Sbjct: 89  GGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVL 146

Query: 238 PDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG 294
            D+   K  L   K+ +Y              F  T               Y APE+I G
Sbjct: 147 TDFGLSKEFLSEEKERTY-------------SFCGTI-------------EYMAPEIIRG 180

Query: 295 -LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER-----------VLGPLPQH 342
             G     D WS+G ++ EL TG + F         + + R            +GP  Q 
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240

Query: 343 MLKRV 347
           +L ++
Sbjct: 241 LLHKL 245

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 43.9 bits (104), Expect = 8e-05
 Identities = 33/140 (23%), Positives = 59/140 (42%), Gaps = 26/140 (18%)

Query: 180 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 239
           SL  FLR+N+ +     LV  + R +   + ++ ++  +H DL   N+L+ S+   KV D
Sbjct: 91  SLDKFLRENDGKFTVGQLVG-MLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSD 149

Query: 240 YKSSLHT-PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWT 298
           +  S      +++Y  +  K                           + APE I    +T
Sbjct: 150 FGLSRRLEDSEATYTTKGGKIPI-----------------------RWTAPEAIAYRKFT 186

Query: 299 YPCDIWSVGCILVELCT-GE 317
              D+WS G ++ E+ + GE
Sbjct: 187 SASDVWSFGIVMWEVMSYGE 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 61/254 (24%), Positives = 108/254 (42%), Gaps = 57/254 (22%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK------HDKGG 154
           ++G G FG V++      +  VAIK+++      E +M E E +++ AK      H+K  
Sbjct: 11  ELGTGQFG-VVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEE-AKVMMKLSHEK-- 60

Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSS-LYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
              VQ+      +  I IV E + +  L ++LR++  R  P  L+ E+ + + E +A++ 
Sbjct: 61  --LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL-EMCKDVCEGMAYLE 117

Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
               IH DL   N L+                                +KV DFG + Y 
Sbjct: 118 SKQFIHRDLAARNCLVDD---------------------------QGCVKVSDFGLSRYV 150

Query: 274 RPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA---LFQTHE 324
             D+ Y  S        +  PEV+L   ++   D+W+ G ++ E+ + G+     F   E
Sbjct: 151 LDDE-YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE 209

Query: 325 NLEHLAMMERVLGP 338
            +E ++   R+  P
Sbjct: 210 TVEKVSQGLRLYRP 223

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 34/125 (27%), Positives = 53/125 (42%), Gaps = 25/125 (20%)

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H   M+H DLK  N+ L+ +  IK+ D+  S       S             +D  S+ 
Sbjct: 185 VHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS-------------LDVASS- 230

Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                      T +Y APE+     ++   D+WS+G IL EL T    F+     E   +
Sbjct: 231 --------FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---I 279

Query: 332 MERVL 336
           M++VL
Sbjct: 280 MQQVL 284

Length = 478

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 36/132 (27%), Positives = 54/132 (40%), Gaps = 25/132 (18%)

Query: 193 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 252
           F    VR    +++  +  +H L +I+ D+K EN+LL S  ++ + D+  S         
Sbjct: 102 FTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK-------- 153

Query: 253 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCIL 310
                        +F +   ER        T  Y APEVI G   G     D WS+G + 
Sbjct: 154 -------------EFLAEEEER--AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198

Query: 311 VELCTGEALFQT 322
            EL TG + F  
Sbjct: 199 FELLTGASPFTV 210

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 40/225 (17%)

Query: 102 MGEGTFGQVLEC-WDRE---RKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHD--KG 153
           +GEG FG+V  C +D E     E VA+K ++        A +  EIE+L+ L   +  K 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 154 GNRCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREI--ARQLLECIA 210
              C +     D  N I ++ E L S SL ++L +N  +   I+L +++  A Q+ + + 
Sbjct: 72  KGICTE-----DGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMD 123

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++     +H DL   NVL+ S   +K+ D+  +     D  Y+                T
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY----------------T 167

Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
             +  D     S   + APE ++   +    D+WS G  L EL T
Sbjct: 168 VKDDLD-----SPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 61/254 (24%), Positives = 101/254 (39%), Gaps = 40/254 (15%)

Query: 98  IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA--KHDKGGN 155
           +  K+G G +G+V E   ++    VA+K ++      E  M   E L++ A  K  K  N
Sbjct: 10  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPN 63

Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+           I+ E +   +L D+LR+ N +     ++  +A Q+   + ++  
Sbjct: 64  -LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 122

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
              IH DL   N L+  +  +KV D+  S       +Y         IK           
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIK----------- 170

Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLE 327
                      + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE
Sbjct: 171 -----------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 219

Query: 328 HLAMMERVLGPLPQ 341
               MER  G  P+
Sbjct: 220 KGYRMERPEGCPPK 233

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 42.5 bits (100), Expect = 4e-04
 Identities = 41/141 (29%), Positives = 64/141 (45%), Gaps = 29/141 (20%)

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  +  +H   MIH D+K  N+LL S+  +K+ D+            F +M   +A  
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG-----------FSKM--YAATV 197

Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
             D G T            T +Y APE+     ++   D++S+G +L EL T +  F   
Sbjct: 198 SDDVGRT---------FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG- 247

Query: 324 ENLEHLAMMERVLG----PLP 340
           EN+E +  M + L     PLP
Sbjct: 248 ENMEEV--MHKTLAGRYDPLP 266

Length = 496

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 40/227 (17%)

Query: 17  RPRKRARLGWDVPQAQVGLFCGQEVGNVTSFAPPRAPSDHVTSSSLFVKGVARNGSPPWR 76
           RPR+R  L   +PQ    L             PP + S   +SSS    G A + +    
Sbjct: 23  RPRRRPDLTLPLPQRDPSL------AVPLPLPPPSSSSSSSSSSS--ASGSAPSAAKSLS 74

Query: 77  EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YR 134
           E ++                   +++G G  G V +   R    + A+K++ G  +   R
Sbjct: 75  ELERV------------------NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR 116

Query: 135 EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSF 193
                EIE+L+    H       V+  + FD+   I ++ E + G SL           F
Sbjct: 117 RQICREIEILRD-VNHPN----VVKCHDMFDHNGEIQVLLEFMDGGSLEG--THIADEQF 169

Query: 194 PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 240
             D+    ARQ+L  IA++H   ++H D+KP N+L+ S++ +K+ D+
Sbjct: 170 LADV----ARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADF 212

Length = 353

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 41.6 bits (97), Expect = 5e-04
 Identities = 58/239 (24%), Positives = 103/239 (43%), Gaps = 51/239 (21%)

Query: 98  IHSKMGEGTFGQVL--ECWD---RERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHD 151
           +  ++GEG FG+V   EC++    + K +VA+K ++      R+    E E+L  L +H+
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHE 67

Query: 152 ---KGGNRCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSF-------PIDLVR- 199
              K    CV+        + + +VFE +    L  FLR +   +        P +L + 
Sbjct: 68  HIVKFYGVCVE-------GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120

Query: 200 ---EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 256
               IA+Q+   + ++     +H DL   N L+  +  +K+ D+  S             
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR------------ 168

Query: 257 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                    D  ST Y R   + ++  R +  PE I+   +T   D+WS+G +L E+ T
Sbjct: 169 ---------DVYSTDYYRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 41.0 bits (96), Expect = 6e-04
 Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 35/225 (15%)

Query: 97  KIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAK 149
           KI   +G G FG+V  C  R     +R+  VAIK ++    +K R   + E  ++ Q   
Sbjct: 7   KIEEVIGAGEFGEV--CRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 64

Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
            +      + +         + I+ E +   +L  FLR+N+ +   I LV  + R +   
Sbjct: 65  PN-----IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLV-GMLRGIAAG 118

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           + ++ ++  +H DL   N+L+ S+   KV D+  S     D+S                 
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS----------------- 161

Query: 269 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
             TY       I     + APE I    +T   D+WS G ++ E+
Sbjct: 162 DPTYTSSLGGKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 55/233 (23%), Positives = 92/233 (39%), Gaps = 50/233 (21%)

Query: 94  SRYKIHSKMGEGTFGQVLE-CWDRERKEMVAIKIV-RGIKKYREAAMIEIEVLQQLAKHD 151
             + +  K+G G FG+V E  W    +  VAIKI+       ++    E++ L++L +H 
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVR--VAIKILKSDDLLKQQDFQKEVQALKRL-RHK 62

Query: 152 K--------GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 203
                         V I         I  + EK   SL  FLR    +  P+  + ++A 
Sbjct: 63  HLISLFAVCSVGEPVYI---------ITELMEK--GSLLAFLRSPEGQVLPVASLIDMAC 111

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYI-KVPDYKSSLHTPKDSSYFKRMPKSSAI 262
           Q+ E +A++ +   IH DL   N+ LV  + + KV D+  +    K+  Y   +     I
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNI-LVGEDLVCKVADFGLA-RLIKEDVY---LSSDKKI 166

Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                                  + APE      ++   D+WS G +L E+ T
Sbjct: 167 PY--------------------KWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 50/230 (21%), Positives = 94/230 (40%), Gaps = 48/230 (20%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           ++G+G +G V +   R     +A+K +R      K+ +  M E+++L     H       
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM-ELDIL-----HKAVSPYI 61

Query: 158 VQIRNWFDYRN--HICIVFEKLGS--SLYDFLRKNNYRSFPIDLVREIARQLLECIAFM- 212
           V     F      ++C+ +   GS   LY           P D++R I   +++ + F+ 
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYA--GGVATEGIPEDVLRRITYAVVKGLKFLK 119

Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
            +  +IH D+KP NVL+  +  +K+ D+  S       +    + K++            
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTN------------ 161

Query: 273 ERPDQNYIVSTRHYRAPEVILGLG------WTYPCDIWSVGCILVELCTG 316
                   +  + Y APE I   G      +T   D+WS+G  ++E+  G
Sbjct: 162 --------IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 54/234 (23%), Positives = 98/234 (41%), Gaps = 36/234 (15%)

Query: 102 MGEGTFGQVLECWDRE--RKEM-VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNR 156
           +G G FG+V     +   RKE+ VAIK ++    +K R+  + E  ++ Q + H+     
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN----- 67

Query: 157 CVQIRNWFDYRNHICIVFEKLGSSLYD-FLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
            +++           I+ E + +   D +LR ++       LV  + R +   + ++ D+
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLV-GMLRGIAAGMKYLSDM 126

Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI-DFGSTTYER 274
             +H DL   N+L+ S+   KV D+  S                   +V+ D    TY  
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLS-------------------RVLEDDPEGTYTT 167

Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 327
                 +    + APE I    +T   D+WS G ++ E+ + GE  +    N E
Sbjct: 168 SGGKIPI---RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 42/176 (23%), Positives = 69/176 (39%), Gaps = 46/176 (26%)

Query: 194 PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 253
             +  R +  Q+L+ +A  H+  ++H DLKP+N+++  +                     
Sbjct: 78  AGETGRLML-QVLDALACAHNQGIVHRDLKPQNIMVSQTG-------------------- 116

Query: 254 KRMPKSSAIKVIDFGSTT----YERPDQNYI------VSTRHYRAPEVILGLGWTYPCDI 303
                    KV+DFG  T        D   +      + T  Y APE + G   T   D+
Sbjct: 117 ----VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172

Query: 304 WSVGCILVELCTGEALFQTHENLEHLAMMERVLGP----LPQ----HMLKRVDRHA 351
           ++ G I +E  TG+ + Q     E   ++ + L P    LP     H L +V R A
Sbjct: 173 YAWGLIFLECLTGQRVVQGASVAE---ILYQQLSPVDVSLPPWIAGHPLGQVLRKA 225

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 30/109 (27%), Positives = 54/109 (49%), Gaps = 10/109 (9%)

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS--SAIKVID 266
           I ++H   ++H DLKP+N+LL     + + D+ +++        FK++ +     I V +
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI--------FKKLEEEDLLDIDVDE 177

Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                        IV T  Y APE +LG+  +   DI+++G IL ++ T
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 66/268 (24%), Positives = 103/268 (38%), Gaps = 58/268 (21%)

Query: 100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           + +G+G FG V+    R +K  VA+K ++      +A + E  V+  L +H       VQ
Sbjct: 12  ATIGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAAQAFLAEASVMTTL-RHPN----LVQ 64

Query: 160 IRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           +       N + IV E +   SL D+LR        +      A  + E + ++ +   +
Sbjct: 65  LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFV 124

Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 278
           H DL   NV LVS + +                           KV DFG        Q+
Sbjct: 125 HRDLAARNV-LVSEDLVA--------------------------KVSDFGLAKEASQGQD 157

Query: 279 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 338
                  + APE +    ++   D+WS G +L E+ +                  RV  P
Sbjct: 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS----------------FGRV--P 199

Query: 339 LPQHMLKRVDRHAEK-YVRRGRLDWPEG 365
            P+  LK V  H EK Y    R++ PEG
Sbjct: 200 YPRIPLKDVVPHVEKGY----RMEAPEG 223

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 39.7 bits (92), Expect = 0.003
 Identities = 14/50 (28%), Positives = 34/50 (68%)

Query: 195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 244
           I++++ + RQ+L  +  +H + ++H D+KPEN+L+     +K+ D+ +++
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAV 357

Length = 507

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 32/137 (23%), Positives = 58/137 (42%), Gaps = 25/137 (18%)

Query: 180 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 239
           SL D +R++     P   +     Q+ + + ++ +  M+H +L   N+LL S   +++ D
Sbjct: 94  SLLDHVRQHRDSLDP-QRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIAD 152

Query: 240 YK-SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWT 298
           +  + L  P D  YF    K+  IK                      + A E IL   +T
Sbjct: 153 FGVADLLYPDDKKYFYSEHKTP-IK----------------------WMALESILFGRYT 189

Query: 299 YPCDIWSVGCILVELCT 315
           +  D+WS G  + E+ +
Sbjct: 190 HQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.5 bits (92), Expect = 0.003
 Identities = 34/142 (23%), Positives = 67/142 (47%), Gaps = 14/142 (9%)

Query: 105 GTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL-AKHD----KGGNRCVQ 159
           G FG+V     +   ++ A+K+V+      +A MI   ++ Q+ A+ D          V 
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVK------KADMINKNMVHQVQAERDALALSKSPFIVH 68

Query: 160 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           +       N++ +V E L G  +   L    Y  F  ++  +   ++   + ++H   +I
Sbjct: 69  LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRHGII 126

Query: 219 HTDLKPENVLLVSSEYIKVPDY 240
           H DLKP+N+L+ +  +IK+ D+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDF 148

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 54/248 (21%), Positives = 97/248 (39%), Gaps = 54/248 (21%)

Query: 95  RYKIHSKMGEGTFGQVLECWDR--------------ERKEMVAIKIVRG--IKKYREAAM 138
           + ++  K+GEG FG+V  C                  +  +VA+K++R    K  R   +
Sbjct: 6   QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL 65

Query: 139 IEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRK---------- 187
            EI+++ +L   +      V + +     + +C++ E +    L  FL +          
Sbjct: 66  KEIKIMSRLKNPNIIRLLGVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHA 120

Query: 188 NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 247
           NN  S  I  +  +A Q+   + ++  L  +H DL   N L+ +   IK+ D+  S    
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR--- 177

Query: 248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVG 307
                             +  S  Y R     ++  R + A E IL   +T   D+W+ G
Sbjct: 178 ------------------NLYSGDYYRIQGRAVLPIR-WMAWESILLGKFTTASDVWAFG 218

Query: 308 CILVELCT 315
             L E+ T
Sbjct: 219 VTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 38.7 bits (90), Expect = 0.003
 Identities = 36/161 (22%), Positives = 69/161 (42%), Gaps = 19/161 (11%)

Query: 196 DLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 255
           D+++ +A ++   + ++H    IH+DL   N  L +   +K+ DY  +L    +  Y  +
Sbjct: 100 DVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159

Query: 256 MPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
              +  ++ +         P+   +V  R       +L    T   +IWS+G  + EL T
Sbjct: 160 DCHAVPLRWLA--------PE---LVEIRGQD----LLPKDQTKKSNIWSLGVTMWELFT 204

Query: 316 -GEALFQTHENLEHLA--MMERVLG-PLPQHMLKRVDRHAE 352
             +  +    + + L   + E+ +  P PQ  LK  DR  E
Sbjct: 205 AADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE 245

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 53/219 (24%), Positives = 88/219 (40%), Gaps = 37/219 (16%)

Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           K+   +G+G FG V+    R  K  VA+K ++      +A + E  V+ QL +H      
Sbjct: 9   KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHSN---- 60

Query: 157 CVQIRNWF-DYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
            VQ+     + +  + IV E +   SL D+LR         D + + +  + E + ++  
Sbjct: 61  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
              +H DL   NV LVS + +                           KV DFG T    
Sbjct: 121 NNFVHRDLAARNV-LVSEDNVA--------------------------KVSDFGLTKEAS 153

Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
             Q+       + APE +    ++   D+WS G +L E+
Sbjct: 154 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	430
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.84
smart00090	237	RIO RIO-like kinase.	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.7
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.66
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.65
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.5
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.46
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.45
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.36
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.32
KOG3087	229	consensus Serine/threonine protein kinase [General	99.25
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.21
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.15
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.1
KOG1243	690	consensus Protein kinase [General function predict	99.03
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.02
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.02
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.94
COG4248	637	Uncharacterized protein with protein kinase and he	98.92
PRK09902	216	hypothetical protein; Provisional	98.83
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.75
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.67
PF01636	239	APH: Phosphotransferase enzyme family This family	98.59
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.59
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.56
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.52
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.5
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.49
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.49
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.33
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.19
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.18
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.14
PLN02876	822	acyl-CoA dehydrogenase	98.08
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.02
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.95
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.9
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.9
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.66
PRK05231	319	homoserine kinase; Provisional	97.65
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.64
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.63
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.57
KOG2270	520	consensus Serine/threonine protein kinase involved	97.57
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.43
PRK12396	409	5-methylribose kinase; Reviewed	97.25
PLN02236	344	choline kinase	97.16
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.15
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.13
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.12
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.92
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.89
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.86
PLN02756	418	S-methyl-5-thioribose kinase	96.84
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.82
PRK11768	325	serine/threonine protein kinase; Provisional	96.77
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.76
PRK10593	297	hypothetical protein; Provisional	96.55
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.28
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.93
COG2334	331	Putative homoserine kinase type II (protein kinase	95.87
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.85
PRK06148	1013	hypothetical protein; Provisional	95.72
PTZ00384	383	choline kinase; Provisional	95.62
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.39
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.23
KOG2269	531	consensus Serine/threonine protein kinase [Signal	95.13
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.9

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-63  Score=454.05  Aligned_cols=350  Identities=60%  Similarity=1.025  Sum_probs=314.1

Q ss_pred             cCCCCCCCCCCCCCCCceeecCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHH
Q 014117           68 ARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL  147 (430)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l  147 (430)
                      ++..++++..++.+|++.+..++.+.++|.+++++|+|.||.|..|.+..++..||||+++...+.++..+.|+++|+++
T Consensus        63 ~~~~~~~~~~dD~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki  142 (415)
T KOG0671|consen   63 ARLESRPGRPDDKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKI  142 (415)
T ss_pred             ccccCCCCCCCCCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHH
Confidence            56667788889999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HhcC-CCCCceEEecceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCc
Q 014117          148 AKHD-KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPEN  226 (430)
Q Consensus       148 ~~~~-~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~N  226 (430)
                      ..+. .+...|+++.+||+..++.|||+|.+|.|+.++|..++..+++...++.++.|++.+++|||+.+++|-||||+|
T Consensus       143 ~~~DP~g~~rcv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPEN  222 (415)
T KOG0671|consen  143 NESDPNGKFRCVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPEN  222 (415)
T ss_pred             HhcCCCCceEEEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChhe
Confidence            7776 445669999999999999999999999999999999888999999999999999999999999999999999999


Q ss_pred             eEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHH
Q 014117          227 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSV  306 (430)
Q Consensus       227 ILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  306 (430)
                      ||+.++.+.++-+.+..       .++.+..+...|+++|||.|+........++.|..|.|||++++-+++.++||||+
T Consensus       223 ILfvss~~~~~~~~k~~-------~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSi  295 (415)
T KOG0671|consen  223 ILFVSSEYFKTYNPKKK-------VCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSI  295 (415)
T ss_pred             EEEeccceEEEeccCCc-------cceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceee
Confidence            99999888877766543       12223356778999999999999888899999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHh
Q 014117          307 GCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM  386 (430)
Q Consensus       307 Gv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (430)
                      ||||+||.+|...|...++.|.++++..++|++|..+..+..  .++|...|.++|++...... .+.+.+.........
T Consensus       296 GCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~--~~Kyf~~~rldw~e~~~~~~-~k~v~~~ckpl~~~~  372 (415)
T KOG0671|consen  296 GCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTR--KEKYFRRGRLDWPEVSSKGK-SKYVFEPCKPLKKYM  372 (415)
T ss_pred             eeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhh--hHhhhhcccccCcccccccc-chhhhcCCccHHHHh
Confidence            999999999999999999999999999999999999988765  77888888999999887664 444444455555566


Q ss_pred             hhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          387 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       387 ~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      ...+....++.|||++||.+||.+|+|+.|+|.||||+...
T Consensus       373 ~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  373 LQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             ccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence            66677777899999999999999999999999999998753

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=7.3e-59  Score=455.74  Aligned_cols=327  Identities=39%  Similarity=0.691  Sum_probs=274.2

Q ss_pred             CCCCCCCceeecCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhc-CCCCC
Q 014117           77 EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH-DKGGN  155 (430)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~-~~~~~  155 (430)
                      -++..+.|.+...+.+..+|.|.+.||+|+||.|.+|.+..|++.||||+++..+....+...|+.+|..+..+ ..+..
T Consensus       169 ~~~~~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~  248 (586)
T KOG0667|consen  169 FDDEDGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKY  248 (586)
T ss_pred             CCCCCCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCe
Confidence            34456678888999999999999999999999999999999999999999998888889999999999999843 34457


Q ss_pred             ceEEecceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCcc
Q 014117          156 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI  235 (430)
Q Consensus       156 ~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~  235 (430)
                      |+|+++++|...+++|||+|.++.+|.++|..+....|+...++.++.||+.||.+||+.||||+||||+||||.+    
T Consensus       249 n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~----  324 (586)
T KOG0667|consen  249 NIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKD----  324 (586)
T ss_pred             eEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeecc----
Confidence            8999999999999999999999999999999998889999999999999999999999999999999999999965    


Q ss_pred             ccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh
Q 014117          236 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT  315 (430)
Q Consensus       236 ~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t  315 (430)
                                           .....+||||||++++......+.+.+..|+|||+++|.+|+.+.||||||||++||++
T Consensus       325 ---------------------~~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~t  383 (586)
T KOG0667|consen  325 ---------------------PKRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFT  383 (586)
T ss_pred             ---------------------CCcCceeEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhc
Confidence                                 33458999999999988877778889999999999999999999999999999999999


Q ss_pred             CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhc-cCcccCCCCCC-Chhh---HH--------hhcCch-hH
Q 014117          316 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR-RGRLDWPEGAA-SRES---IK--------SVMKLP-RL  381 (430)
Q Consensus       316 G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~---~~--------~~~~~~-~~  381 (430)
                      |.+.|.+.++.++++.|.+++|.+|..+++.....-..+.. .+......... .+..   ..        .....+ ..
T Consensus       384 G~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~  463 (586)
T KOG0667|consen  384 GEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGS  463 (586)
T ss_pred             CccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCC
Confidence            99999999999999999999999999999988766444433 22222111111 0000   00        001112 22


Q ss_pred             HHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCCC
Q 014117          382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       382 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      +.+...........+.|||.+||.+||.+|+|+.++|+||||+...+
T Consensus       464 ~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~~  510 (586)
T KOG0667|consen  464 RSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTSL  510 (586)
T ss_pred             cccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccccc
Confidence            22333333355667899999999999999999999999999996543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.5e-60  Score=437.19  Aligned_cols=261  Identities=30%  Similarity=0.516  Sum_probs=217.9

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhh--------HHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--------REAAMIEIEVLQQLAKHDKGGNRCVQIRN  162 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~--------~~~~~~E~~~l~~l~~~~~~~~~i~~~~~  162 (430)
                      .+.+.|.+.+.||+|+||.|-+|..+.|++.||||++++.+..        .....+|+++|++|     +||+||++++
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-----~HP~IV~~~d  243 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-----SHPNIVRIKD  243 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-----CCCCEEEEee
Confidence            3566799999999999999999999999999999999743321        12246899999999     4589999999


Q ss_pred             eeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          163 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       163 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      +|+..+..||||||+ ||+|.+.+-.++  .+.+...+.+++|++.||.|||++||+||||||+|||+..+         
T Consensus       244 ~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~---------  312 (475)
T KOG0615|consen  244 FFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSND---------  312 (475)
T ss_pred             eeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccC---------
Confidence            999999999999999 999999998775  78899999999999999999999999999999999999643         


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCC---CCCcchHHHHHHHHHHHHhC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTG  316 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGv~l~el~tG  316 (430)
                                     ..+..+||+|||+|+..+...  .++|||+.|.|||++.+..   +..++||||+||+||.+++|
T Consensus       313 ---------------~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG  377 (475)
T KOG0615|consen  313 ---------------AEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSG  377 (475)
T ss_pred             ---------------CcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEecc
Confidence                           356789999999999876443  6689999999999998765   34588999999999999999


Q ss_pred             CCCCCCCchHH-HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhH
Q 014117          317 EALFQTHENLE-HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD  395 (430)
Q Consensus       317 ~~Pf~~~~~~~-~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (430)
                      .+||.+..... ...+|.+                       |.+.+-                      ...|...+.+
T Consensus       378 ~pPFS~~~~~~sl~eQI~~-----------------------G~y~f~----------------------p~~w~~Isee  412 (475)
T KOG0615|consen  378 YPPFSEEYTDPSLKEQILK-----------------------GRYAFG----------------------PLQWDRISEE  412 (475)
T ss_pred             CCCcccccCCccHHHHHhc-----------------------Cccccc----------------------ChhhhhhhHH
Confidence            99998654332 3333333                       222211                      1123456778


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          396 LTHLLQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       396 ~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      +.+||.+||++||++|||++|+|+||||+..+
T Consensus       413 a~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  413 ALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             HHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            99999999999999999999999999999665

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-57  Score=436.97  Aligned_cols=250  Identities=32%  Similarity=0.537  Sum_probs=225.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecC----chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      .+|+..+.||+|||+.||++++..+|+.||+|++.+    ....++....|+++.+.+.     |+|||+++++|++.++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-----HpnIV~f~~~FEDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-----HPNIVQFYHFFEDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-----CCcEEeeeeEeecCCc
Confidence            479999999999999999999999999999999975    3455677888999999994     4899999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|||+|+| .++|..++..+  +.++|.+++.+++||+.||.|||+++|||||||..|+|+                   
T Consensus        93 VYivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL-------------------  151 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL-------------------  151 (592)
T ss_pred             eEEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee-------------------
Confidence            99999999 89999998854  489999999999999999999999999999999999999                   


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                              +.+.++||+|||+|+....   ...++||||.|+|||++....++..+||||+||+||.|+.|++||+..+-
T Consensus       152 --------~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v  223 (592)
T KOG0575|consen  152 --------NENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV  223 (592)
T ss_pred             --------cCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH
Confidence                    6677899999999987663   34668999999999999999999999999999999999999999999888


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+.+..|...-...|                                                 ...+.++++||.+||+
T Consensus       224 kety~~Ik~~~Y~~P-------------------------------------------------~~ls~~A~dLI~~lL~  254 (592)
T KOG0575|consen  224 KETYNKIKLNEYSMP-------------------------------------------------SHLSAEAKDLIRKLLR  254 (592)
T ss_pred             HHHHHHHHhcCcccc-------------------------------------------------cccCHHHHHHHHHHhc
Confidence            888887766544443                                                 4567789999999999


Q ss_pred             cCCCCCCCHHHHhcCCCCCCC
Q 014117          406 YDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f~~~  426 (430)
                      .||.+|||+++||.|+||++.
T Consensus       255 ~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  255 PNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             CCcccCCCHHHHhcCHhhhCC
Confidence            999999999999999999654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-55  Score=406.83  Aligned_cols=253  Identities=28%  Similarity=0.497  Sum_probs=217.8

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .+.|++++.||+|+||+||+++.+.+++.||+|++++..    +.......|..+|..+     +||+||.++..|++.+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-----~hPFiv~l~ysFQt~~   98 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-----KHPFIVKLIYSFQTEE   98 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-----CCCcEeeeEEecccCC
Confidence            356999999999999999999999999999999997543    2345567799999987     4589999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+|||+||+ ||.|+..|++.+  .|++..++.|+.+|+.||.|||++|||||||||+|||+                  
T Consensus        99 kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL------------------  158 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL------------------  158 (357)
T ss_pred             eEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee------------------
Confidence            999999999 999999999876  89999999999999999999999999999999999999                  


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccC---CCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                               +.++.++|+|||+++...   ....++|||+.|||||++.+..|+.++|+||||+++|||++|.+||.+.+
T Consensus       159 ---------d~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~  229 (357)
T KOG0598|consen  159 ---------DEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED  229 (357)
T ss_pred             ---------cCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence                     556667777777776322   23355799999999999999999999999999999999999999999988


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      .......|.+.-...+                                                +.-.+.++++||+++|
T Consensus       230 ~~~~~~~I~~~k~~~~------------------------------------------------p~~ls~~ardll~~LL  261 (357)
T KOG0598|consen  230 VKKMYDKILKGKLPLP------------------------------------------------PGYLSEEARDLLKKLL  261 (357)
T ss_pred             HHHHHHHHhcCcCCCC------------------------------------------------CccCCHHHHHHHHHHh
Confidence            7777766654332211                                                1235778999999999


Q ss_pred             hcCCCCCC----CHHHHhcCCCCCCCC
Q 014117          405 RYDPTDRL----TAREALRHPFFTRDH  427 (430)
Q Consensus       405 ~~dP~~R~----ta~elL~hp~f~~~~  427 (430)
                      ++||++|+    +++++-+||||..-+
T Consensus       262 ~rdp~~RLg~~~d~~~ik~HpfF~~in  288 (357)
T KOG0598|consen  262 KRDPRQRLGGPGDAEEIKRHPFFKGIN  288 (357)
T ss_pred             ccCHHHhcCCCCChHHhhcCcccccCC
Confidence            99999996    689999999998654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-55  Score=406.57  Aligned_cols=255  Identities=26%  Similarity=0.446  Sum_probs=216.9

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEec--CchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC-eE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-HI  170 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~--~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~-~~  170 (430)
                      ++.+.++.||+|+.|+||+|+++.|++.+|+|++.  ......++..+|+++++.+     .+++||.+|+.|...+ .+
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-----~spyIV~~ygaF~~~~~~i  153 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-----QSPYIVGFYGAFYSNGEEI  153 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-----CCCCeeeEeEEEEeCCceE
Confidence            46788899999999999999999999999999994  3345667888999999988     4488999999999988 59


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|+|||| +|+|.+++...+  ++++.....++.+|++||.|||+ ++||||||||+||||++                 
T Consensus       154 sI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs-----------------  214 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS-----------------  214 (364)
T ss_pred             EeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc-----------------
Confidence            9999999 999999998764  79999999999999999999995 99999999999999954                 


Q ss_pred             CCcccccCCCCCCeEEEeCCCcccc-CCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC--ch
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYE-RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH--EN  325 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~--~~  325 (430)
                                .+.+||||||.+... +....+++||..|||||.+.+..|+.++||||||+.++|+++|+.||...  ..
T Consensus       215 ----------kGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~  284 (364)
T KOG0581|consen  215 ----------KGEVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY  284 (364)
T ss_pred             ----------CCCEEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC
Confidence                      456777777766543 33446789999999999999999999999999999999999999999763  23


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCC-chhHHHHHHHHhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGLL  404 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~L  404 (430)
                      ...+..+..++..+|+.                                             .|.. +++++++||..||
T Consensus       285 ~~~~~Ll~~Iv~~ppP~---------------------------------------------lP~~~fS~ef~~FV~~CL  319 (364)
T KOG0581|consen  285 LDIFELLCAIVDEPPPR---------------------------------------------LPEGEFSPEFRSFVSCCL  319 (364)
T ss_pred             CCHHHHHHHHhcCCCCC---------------------------------------------CCcccCCHHHHHHHHHHh
Confidence            44455555555544432                                             2333 7889999999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      ++||.+|||+.|+|+|||+++..
T Consensus       320 ~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  320 RKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             cCCcccCCCHHHHhcCHHHhhcc
Confidence            99999999999999999998653

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.9e-56  Score=396.19  Aligned_cols=277  Identities=31%  Similarity=0.575  Sum_probs=232.6

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ++|+.+.++|+|+||+||+|+++.||+.||||.+..+.   ...+..++|++.|+++.|     +|+|.+++.|.-...+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH-----~NLVnLiEVFrrkrkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKH-----ENLVNLIEVFRRKRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhccc-----chHHHHHHHHHhccee
Confidence            46888999999999999999999999999999986432   345678899999999955     8899999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||+|||..++.+-|+... ..++.+.++.|+.|++.|+.|||+++||||||||+||||                     
T Consensus        77 hLVFE~~dhTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---------------------  134 (396)
T KOG0593|consen   77 HLVFEYCDHTVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---------------------  134 (396)
T ss_pred             EEEeeecchHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---------------------
Confidence            9999999888888888765 479999999999999999999999999999999999999                     


Q ss_pred             cccccCCCCCCeEEEeCCCccccC-CCC--CeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYER-PDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~-~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                            ..++.+||||||+|+... +..  +-++.|.+|+|||++.+ .+|+.++||||+||++.||++|.+.|.+.++.
T Consensus       135 ------t~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi  208 (396)
T KOG0593|consen  135 ------TQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI  208 (396)
T ss_pred             ------ecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH
Confidence                  566788889999888665 333  23688999999999998 58999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCc---ccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGR---LDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +++..|...+|.++++...-.       ..+..   ...|+..             ..+.+.. ..+..+.-+.||+.+|
T Consensus       209 DQLy~I~ktLG~L~prhq~iF-------~~N~~F~Gv~lP~~~-------------~~epLe~-k~p~~s~~~ld~~k~c  267 (396)
T KOG0593|consen  209 DQLYLIRKTLGNLIPRHQSIF-------SSNPFFHGVRLPEPE-------------HPEPLER-KYPKISNVLLDLLKKC  267 (396)
T ss_pred             HHHHHHHHHHcccCHHHHHHh-------ccCCceeeeecCCCC-------------Cccchhh-hcccchHHHHHHHHHH
Confidence            999999999999998653322       11211   1222211             1112222 2345566899999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~  424 (430)
                      |+.||.+|++.+|+|.||||.
T Consensus       268 L~~dP~~R~sc~qll~H~yFd  288 (396)
T KOG0593|consen  268 LKMDPDDRLSCEQLLHHPYFD  288 (396)
T ss_pred             hcCCccccccHHHHhcChHHH
Confidence            999999999999999999994

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-55  Score=414.86  Aligned_cols=287  Identities=28%  Similarity=0.474  Sum_probs=237.8

Q ss_pred             CceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           89 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        89 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      +..-.+.|+.+++||+|.||.||+|++..+|+.||+|.++...   .......+|+.||++|     +|+||+++.+...
T Consensus       112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-----~HpNIikL~eivt  186 (560)
T KOG0600|consen  112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-----DHPNIIKLEEIVT  186 (560)
T ss_pred             cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-----CCCcccceeeEEE
Confidence            3344567999999999999999999999999999999997433   3455677899999999     5589999999887


Q ss_pred             cC--CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCC
Q 014117          166 YR--NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       166 ~~--~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                      ..  ..+|||+|||..+|..++...+ -.|++.++..|+.||+.||+|||++||+|||||.+||||              
T Consensus       187 ~~~~~siYlVFeYMdhDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi--------------  251 (560)
T KOG0600|consen  187 SKLSGSIYLVFEYMDHDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI--------------  251 (560)
T ss_pred             ecCCceEEEEEecccchhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE--------------
Confidence            65  7999999999999999987654 579999999999999999999999999999999999999              


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                   +.++.+||+|||+|++.....    +..+-|++|+|||+++|. .|+.++|+||+||||.||++|++
T Consensus       252 -------------dn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkP  318 (560)
T KOG0600|consen  252 -------------DNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKP  318 (560)
T ss_pred             -------------cCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCC
Confidence                         556677777888887554433    234679999999999987 59999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      .|.+.++.+++..|.+.+|.+.+..|+. .          .+.+-....+         .......+.+....++....+
T Consensus       319 I~~G~tEveQl~kIfklcGSP~e~~W~~-~----------kLP~~~~~kp---------~~~y~r~l~E~~~~~~~~~l~  378 (560)
T KOG0600|consen  319 ILQGRTEVEQLHKIFKLCGSPTEDYWPV-S----------KLPHATIFKP---------QQPYKRRLRETFKDFPASALD  378 (560)
T ss_pred             CcCCccHHHHHHHHHHHhCCCChhcccc-c----------cCCcccccCC---------CCcccchHHHHhccCCHHHHH
Confidence            9999999999999999999999876551 1          1111111111         112233334446778889999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCCCCCCCCC
Q 014117          399 LLQGLLRYDPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      |+..||.+||.+|.||+++|+|+||+.+++
T Consensus       379 Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~  408 (560)
T KOG0600|consen  379 LLEKLLSLDPDKRGTASSALQSEYFTTEPL  408 (560)
T ss_pred             HHHHHhccCccccccHHHHhcCcccccCCC
Confidence            999999999999999999999999976654

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-54  Score=415.38  Aligned_cols=269  Identities=26%  Similarity=0.409  Sum_probs=226.9

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhh----HHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY----REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      ..+|.+.+.||.|+|++|++|+++.+++.||||++.+.--.    ......|..+|.+|.    +||.|++++..|++..
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~----~hPgivkLy~TFQD~~  147 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS----GHPGIVKLYFTFQDEE  147 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh----CCCCeEEEEEEeeccc
Confidence            46799999999999999999999999999999998643211    234557888888886    5588999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+|+|+||+ +|+|.++|.+.+  .|++..++.|+.||+.||+|||++|||||||||+|||++.+++++|+|||.|...+
T Consensus       148 sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  148 SLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             ceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            999999999 999999999886  89999999999999999999999999999999999999888888888888776554


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                      .......           .+-...........++||..|.+||++.+...++.+|+|+|||+||+|+.|.+||.+.++.-
T Consensus       226 ~~~~~~~-----------~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl  294 (604)
T KOG0592|consen  226 PSQKSQE-----------NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL  294 (604)
T ss_pred             hhhcccc-----------CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH
Confidence            3322100           00001111112355899999999999999999999999999999999999999999999988


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      .+..|.+....+|                                                 +.+++.+.|||.++|.+|
T Consensus       295 iFqkI~~l~y~fp-------------------------------------------------~~fp~~a~dLv~KLLv~d  325 (604)
T KOG0592|consen  295 IFQKIQALDYEFP-------------------------------------------------EGFPEDARDLIKKLLVRD  325 (604)
T ss_pred             HHHHHHHhcccCC-------------------------------------------------CCCCHHHHHHHHHHHccC
Confidence            8888877655544                                                 566788999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~~  427 (430)
                      |.+|+|+.||.+||||..-+
T Consensus       326 p~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  326 PSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             ccccccHHHHhhCcccccCC
Confidence            99999999999999998654

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-55  Score=415.43  Aligned_cols=284  Identities=30%  Similarity=0.521  Sum_probs=235.4

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC-
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-  168 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~-  168 (430)
                      +-++|.++++||.|+||.||+|..+.++..||||.+++.-.  ..-.-.+|+..|+++.    .|+||+++.+.+.+.+ 
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln----~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN----PHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcC----CCCcchhhHHHhhccCc
Confidence            45689999999999999999999999999999999974322  2223457898888883    2589999999998877 


Q ss_pred             eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          169 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       169 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .+|+|||||..+|++++..+ ++.|++..++.|+.||++||+|+|.+|+.||||||+||||.                  
T Consensus        84 ~L~fVfE~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~------------------  144 (538)
T KOG0661|consen   84 ILYFVFEFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS------------------  144 (538)
T ss_pred             eEeeeHHhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec------------------
Confidence            99999999999999999887 58999999999999999999999999999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                               ....+||+|||+|+-.....  +.++.|.+|+|||+++.. -|+.++||||+|||++|+.+-++.|.+.++
T Consensus       145 ---------~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE  215 (538)
T KOG0661|consen  145 ---------GNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE  215 (538)
T ss_pred             ---------ccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence                     35678888888888655444  447899999999998755 599999999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+++.+|.+++|.+....+...    ..+...-.+.+|.....  .             +....+..+.++.+||..||.
T Consensus       216 ~Dqi~KIc~VLGtP~~~~~~eg----~~La~~mnf~~P~~~~~--~-------------l~~L~p~~s~~~~~li~~ll~  276 (538)
T KOG0661|consen  216 IDQIYKICEVLGTPDKDSWPEG----YNLASAMNFRFPQVKPS--P-------------LKDLLPNASSEAASLIERLLA  276 (538)
T ss_pred             HHHHHHHHHHhCCCccccchhH----HHHHHHhccCCCcCCCC--C-------------hHHhCcccCHHHHHHHHHHhc
Confidence            9999999999999887665543    22222223333332111  1             112234578899999999999


Q ss_pred             cCCCCCCCHHHHhcCCCCCCC
Q 014117          406 YDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +||.+||||+|+|+||||+..
T Consensus       277 WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  277 WDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             CCCccCccHHHHhcCcccccc
Confidence            999999999999999999754

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-54  Score=386.63  Aligned_cols=251  Identities=26%  Similarity=0.422  Sum_probs=223.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++++.||.|+||.|.+++.+.++..||+|++++.+    +..+...+|..+|+.+.     +|+++.+++.+.+..
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-----~PFlv~l~~t~~d~~  117 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-----HPFLVKLYGTFKDNS  117 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-----CceeEEEEEeeccCC
Confidence            356999999999999999999999999999999997543    22344567899999985     488999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      ++||||||+ ||.|+.+|++.+  +|++..++.|+.||+.||+|||+++|++|||||+||||                  
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl------------------  177 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL------------------  177 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee------------------
Confidence            999999999 999999999876  89999999999999999999999999999999999999                  


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                               |.++.+||+|||+|+......-++||||.|+|||++...+|+.++|+|||||++|||+.|.+||...+...
T Consensus       178 ---------D~~G~iKitDFGFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~  248 (355)
T KOG0616|consen  178 ---------DQNGHIKITDFGFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ  248 (355)
T ss_pred             ---------ccCCcEEEEeccceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH
Confidence                     66677888899999887777777899999999999999999999999999999999999999999988888


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ...+|.+.--                                                 .+|.-++.++++||.++|++|
T Consensus       249 iY~KI~~~~v-------------------------------------------------~fP~~fs~~~kdLl~~LL~vD  279 (355)
T KOG0616|consen  249 IYEKILEGKV-------------------------------------------------KFPSYFSSDAKDLLKKLLQVD  279 (355)
T ss_pred             HHHHHHhCcc-------------------------------------------------cCCcccCHHHHHHHHHHHhhh
Confidence            7777654322                                                 244567889999999999999


Q ss_pred             CCCCC-----CHHHHhcCCCCCCC
Q 014117          408 PTDRL-----TAREALRHPFFTRD  426 (430)
Q Consensus       408 P~~R~-----ta~elL~hp~f~~~  426 (430)
                      -.+|.     ...+|..||||+.-
T Consensus       280 ~t~R~gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  280 LTKRFGNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             hHhhhcCcCCCccccccCcccccc
Confidence            99994     57899999999864

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.2e-54  Score=378.60  Aligned_cols=281  Identities=29%  Similarity=0.505  Sum_probs=233.1

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .+|...++||+|.||.||+|++.+||+.||||.++..+   .......+|++.|+.+.     |+||+.+++.|.+.+.+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~-----h~nIi~LiD~F~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK-----HPNIIELIDVFPHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc-----CcchhhhhhhccCCCce
Confidence            46888999999999999999999999999999997432   23567889999999994     48899999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      .||+||+..+|+..++... ..++...++.|+.++++||+|||++.|+||||||.|+||++                   
T Consensus        77 ~lVfEfm~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~-------------------  136 (318)
T KOG0659|consen   77 SLVFEFMPTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS-------------------  136 (318)
T ss_pred             EEEEEeccccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC-------------------
Confidence            9999999999999998764 57999999999999999999999999999999999999954                   


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                              ++.+||+|||+|+...+..   ...+-|.+|+|||++.|. .|+..+||||.||++.||+.|.+-|.+.++.
T Consensus       137 --------~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi  208 (318)
T KOG0659|consen  137 --------DGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI  208 (318)
T ss_pred             --------CCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH
Confidence                    4566777777776555433   223679999999999986 5999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +++..|...+|.+.++.|+.+........-+ .                .+.+....    ..+..+.++.||+.+||.+
T Consensus       209 dQL~~If~~LGTP~~~~WP~~~~lpdY~~~~-~----------------~P~~~~~~----lf~aas~d~ldLl~~m~~y  267 (318)
T KOG0659|consen  209 DQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ-Q----------------FPKPPLNN----LFPAASSDALDLLSKMLTY  267 (318)
T ss_pred             HHHHHHHHHcCCCCcccCccccccccHHHHh-c----------------CCCCcccc----ccccccHHHHHHHHhhhcc
Confidence            9999999999999887655443322211111 1                11111111    3456677889999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      ||.+|+|+.|+|+|+||++.+.
T Consensus       268 nP~~Rita~qaL~~~yf~~~P~  289 (318)
T KOG0659|consen  268 NPKKRITASQALKHPYFKSLPL  289 (318)
T ss_pred             CchhcccHHHHhcchhhhcCCC
Confidence            9999999999999999997654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-53  Score=394.94  Aligned_cols=262  Identities=28%  Similarity=0.506  Sum_probs=224.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      .++|.+.++||+|+||+||+|+++.++..||||.+.+.   ++..+....|+.+|+.+.     |+|||.++++++..++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~-----H~nIV~l~d~~~~~~~   83 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK-----HPNIVRLLDCIEDDDF   83 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC-----CcceeeEEEEEecCCe
Confidence            45799999999999999999999999999999998643   455666788999999995     5899999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +||||||| ||+|.+|++..+  ++++..++.++.||+.||++||+++||||||||+||||+....              
T Consensus        84 i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~--------------  147 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTAR--------------  147 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCC--------------
Confidence            99999999 899999999876  8999999999999999999999999999999999999965310              


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                             .+....+||+|||+|+...+..  .+.|||+.|||||++..+.|+.|+|+||+|+++|++++|++||+..+..
T Consensus       148 -------~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~  220 (429)
T KOG0595|consen  148 -------NDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK  220 (429)
T ss_pred             -------CCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence                   0222689999999999877654  5689999999999999999999999999999999999999999998887


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +.+..+.+.-.-.|                                              ..+...+..+.+|+...|+.
T Consensus       221 eL~~~~~k~~~~~~----------------------------------------------~~~~~~s~~~~~Ll~~ll~~  254 (429)
T KOG0595|consen  221 ELLLYIKKGNEIVP----------------------------------------------VLPAELSNPLRELLISLLQR  254 (429)
T ss_pred             HHHHHHhccccccC----------------------------------------------chhhhccCchhhhhhHHHhc
Confidence            77765443222111                                              12234455677899999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      ||.+|.+..+-+.|+++.....
T Consensus       255 ~~~~~~~~~~~~~~~~l~~~p~  276 (429)
T KOG0595|consen  255 NPKDRISFEDFFDHPFLAANPQ  276 (429)
T ss_pred             CccccCchHHhhhhhhcccCcc
Confidence            9999999999999999876643

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-53  Score=385.44  Aligned_cols=285  Identities=28%  Similarity=0.461  Sum_probs=230.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--C
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--R  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--~  167 (430)
                      .+.|+.+++|++|+||.||+|+++.|++.||+|.++-.+   .+.-...+|+.+|.+++     |+|||.+.+....  -
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~-----H~NIV~vkEVVvG~~~  149 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR-----HPNIVEVKEVVVGSNM  149 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcC-----CCCeeeeEEEEecccc
Confidence            457999999999999999999999999999999997432   24455778999999984     4889999887754  4


Q ss_pred             CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          168 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       168 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      +.+|||||||..+|..+++... .+|...+++.++.|++.||+|||.+.|+||||||+|+|++.                
T Consensus       150 d~iy~VMe~~EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~----------------  212 (419)
T KOG0663|consen  150 DKIYIVMEYVEHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSH----------------  212 (419)
T ss_pred             ceeeeeHHHHHhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeecc----------------
Confidence            6799999999999999999876 68999999999999999999999999999999999999954                


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                 .+.+||+|||+|+..+.+.   +..+-|.+|+|||++++. .|+.++||||+|||+.||+++++.|.+.
T Consensus       213 -----------~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~  281 (419)
T KOG0663|consen  213 -----------KGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK  281 (419)
T ss_pred             -----------CCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence                       4567777777777665542   445779999999999987 4999999999999999999999999999


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCC-chhHHHHHHHH
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQG  402 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~  402 (430)
                      ++.+++..|.+.+|.+.+..|+-.......    ..+..+.              .....+...|... .+....+|+++
T Consensus       282 sE~dQl~~If~llGtPte~iwpg~~~lp~~----k~~~f~~--------------~pyn~lr~kF~~~~lse~g~~Lln~  343 (419)
T KOG0663|consen  282 SEIDQLDKIFKLLGTPSEAIWPGYSELPAV----KKMTFSE--------------HPYNNLRKKFGALSLSEQGFDLLNK  343 (419)
T ss_pred             chHHHHHHHHHHhCCCccccCCCccccchh----hccccCC--------------CCchhhhhhccccccchhHHHHHHH
Confidence            999999999999999987654422111100    0000000              0011222233333 56789999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      +|.+||.+|.||+|+|+|+||...++
T Consensus       344 llt~dP~kR~tA~~~L~h~~F~e~P~  369 (419)
T KOG0663|consen  344 LLTYDPGKRITAEDGLKHEYFRETPL  369 (419)
T ss_pred             HhccCccccccHHHhhcccccccCCC
Confidence            99999999999999999999998543

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.9e-53  Score=407.37  Aligned_cols=282  Identities=27%  Similarity=0.444  Sum_probs=224.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHH----HHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~----~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++++.||+|+||.||+|+.+.||..||+|++++......    -...|..+|...     ..+.+|+++..|++..
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-----ds~~vVKLyYsFQD~~  214 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-----DSPWVVKLYYSFQDKE  214 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-----CCCcEEEEEEEecCCC
Confidence            4679999999999999999999999999999999987654332    233466666553     5588999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      ++||||||+ ||++..+|...+  .|++..++.|+.+++.|++-||+.|+|||||||+|+||+..||+|++|||++...-
T Consensus       215 ~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             eeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999 999999998876  89999999999999999999999999999999999999999999999999995443


Q ss_pred             CCCcccc-cCC-----CCCCeEEEeCCCc--cccC--C-------------CCCeeeecCcccchhhhhCCCCCCcchHH
Q 014117          248 KDSSYFK-RMP-----KSSAIKVIDFGST--TYER--P-------------DQNYIVSTRHYRAPEVILGLGWTYPCDIW  304 (430)
Q Consensus       248 ~~~~~~~-~~~-----~~~~~kl~Dfg~a--~~~~--~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw  304 (430)
                      .....-. ..+     .....+-.||...  ....  .             -....+|||.|||||++.+..|+..+|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            3211100 000     1112233444421  1000  0             01236899999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHH
Q 014117          305 SVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL  384 (430)
Q Consensus       305 slGv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (430)
                      ||||||||||.|.+||.+.+..+++..|....-.+                     .+|.                    
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l---------------------~fP~--------------------  411 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL---------------------KFPE--------------------  411 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc---------------------cCCC--------------------
Confidence            99999999999999999999999888876543211                     1121                    


Q ss_pred             HhhhcCCchhHHHHHHHHhhhcCCCCCCC---HHHHhcCCCCCCCC
Q 014117          385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLT---AREALRHPFFTRDH  427 (430)
Q Consensus       385 ~~~~~~~~~~~~~~ll~~~L~~dP~~R~t---a~elL~hp~f~~~~  427 (430)
                          ....+.++.|||.+||. ||.+|+.   ++||..||||+.-+
T Consensus       412 ----~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~  452 (550)
T KOG0605|consen  412 ----EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD  452 (550)
T ss_pred             ----cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence                12445789999999999 9999984   99999999998753

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.1e-53  Score=392.58  Aligned_cols=282  Identities=27%  Similarity=0.382  Sum_probs=231.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .+.|++++.||.|.-|+||+|+.+.++..+|+|++.+..    +...+...|.+||..+     .||.++.+|..|+...
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-----DHPFlPTLYa~fet~~  150 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-----DHPFLPTLYASFETDK  150 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-----CCCccchhhheeeccc
Confidence            457999999999999999999999999999999997532    2234567789999998     5589999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      +.|+||||| ||+|..+++++..+.|++..++.|+.+|+.||+|||-+|||+|||||+||||.++|++.++||-++...+
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            999999999 9999999999999999999999999999999999999999999999999999999999999999887664


Q ss_pred             CCCcccccCC-----CCCC---eEEEeCCCc------------------------cccCCCCCeeeecCcccchhhhhCC
Q 014117          248 KDSSYFKRMP-----KSSA---IKVIDFGST------------------------TYERPDQNYIVSTRHYRAPEVILGL  295 (430)
Q Consensus       248 ~~~~~~~~~~-----~~~~---~kl~Dfg~a------------------------~~~~~~~~~~~gt~~y~aPE~~~~~  295 (430)
                      ..+.......     ....   +.+.-|...                        .........++||-.|+|||++.|+
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~  310 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE  310 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence            4333221100     0000   001112110                        0111122457999999999999999


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhh
Q 014117          296 GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV  375 (430)
Q Consensus       296 ~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (430)
                      ..+.++|+|+|||++|||+.|..||.+.+..+++..|...--.+|..                                 
T Consensus       311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~---------------------------------  357 (459)
T KOG0610|consen  311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE---------------------------------  357 (459)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC---------------------------------
Confidence            99999999999999999999999999999999888776543333321                                 


Q ss_pred             cCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCC----HHHHhcCCCCCCC
Q 014117          376 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT----AREALRHPFFTRD  426 (430)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t----a~elL~hp~f~~~  426 (430)
                                    +..+..++|||+++|.+||++|+.    |+||.+||||+.-
T Consensus       358 --------------~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gV  398 (459)
T KOG0610|consen  358 --------------PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGV  398 (459)
T ss_pred             --------------CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCC
Confidence                          245678999999999999999998    9999999999864

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-52  Score=381.79  Aligned_cols=282  Identities=29%  Similarity=0.514  Sum_probs=233.6

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecC---chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-  166 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-  166 (430)
                      .+..+|..++.||.|+||.|..|.++.+|+.||||.+..   .....++..+|+++|+.++|     +||+.+.+.+.. 
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~H-----eNIi~l~di~~p~   93 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRH-----ENIIGLLDIFRPP   93 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcC-----CCcceEEeecccc
Confidence            445677778999999999999999999999999998862   33455778899999999964     778888887755 


Q ss_pred             ----CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          167 ----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       167 ----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                          -+.+|+|+|+|+.+|...++.+.  .|++..++.+++||+.||+|+|+.+|+||||||+|+|++            
T Consensus        94 ~~~~f~DvYiV~elMetDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n------------  159 (359)
T KOG0660|consen   94 SRDKFNDVYLVFELMETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN------------  159 (359)
T ss_pred             cccccceeEEehhHHhhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheeec------------
Confidence                46899999999999999998764  699999999999999999999999999999999999995            


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCC-----CCCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhC
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-----DQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTG  316 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG  316 (430)
                                     .+..+||+|||+|+...+     .-+..+.|.+|.|||++.. ..|+.++||||+|||+.||++|
T Consensus       160 ---------------~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~g  224 (359)
T KOG0660|consen  160 ---------------ADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTG  224 (359)
T ss_pred             ---------------cCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcC
Confidence                           455567777777765532     1134678999999999875 4699999999999999999999


Q ss_pred             CCCCCCCchHHHHHHHHHHhCCCCHHHHHHHH-hhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhH
Q 014117          317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD  395 (430)
Q Consensus       317 ~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (430)
                      ++.|.+.+..+++..|...+|.++++.+..+. +.+..|+.+-.. .|.     .             -.....+..++.
T Consensus       225 kplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~-~p~-----~-------------~f~~~fp~a~p~  285 (359)
T KOG0660|consen  225 KPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQ-IPK-----Q-------------PFSSIFPNANPL  285 (359)
T ss_pred             CCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCC-CCC-----C-------------CHHHHcCCCCHH
Confidence            99999999999999999999999999888875 334445443211 010     0             112234577889


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          396 LTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       396 ~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      +.||+.+||+.||.+|+|++|+|+||||..
T Consensus       286 AidLlekmL~fdP~kRita~eAL~hPYl~~  315 (359)
T KOG0660|consen  286 AIDLLEKMLVFDPKKRITAEEALAHPYLAP  315 (359)
T ss_pred             HHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence            999999999999999999999999999975

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-52  Score=406.59  Aligned_cols=252  Identities=25%  Similarity=0.396  Sum_probs=216.8

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|.+++.||+|+||+|++|..+.+++.||||++++.    +...+..+.|.+|+....    .||.++.++.+|++.+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~----~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN----RHPFLVNLFSCFQTKE  442 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc----cCCeEeecccccccCC
Confidence            46799999999999999999999999999999999864    345577888999988875    5699999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      ++|+||||+ ||++..+.+.   ..|++..++.|+.+|+.||+|||++||||||||.+|||++                 
T Consensus       443 ~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD-----------------  502 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD-----------------  502 (694)
T ss_pred             eEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc-----------------
Confidence            999999999 8884443322   4799999999999999999999999999999999999995                 


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccc---cCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTY---ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                .++.+||+|||+++-   .+....++|||+.|||||++.+..|+.++|+|||||+||||+.|.+||.+++
T Consensus       503 ----------~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd  572 (694)
T KOG0694|consen  503 ----------TEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD  572 (694)
T ss_pred             ----------ccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence                      555566666666652   2334567899999999999999999999999999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      +.+.+..|......                                                 +|-.++.++.++++++|
T Consensus       573 Eee~FdsI~~d~~~-------------------------------------------------yP~~ls~ea~~il~~ll  603 (694)
T KOG0694|consen  573 EEEVFDSIVNDEVR-------------------------------------------------YPRFLSKEAIAIMRRLL  603 (694)
T ss_pred             HHHHHHHHhcCCCC-------------------------------------------------CCCcccHHHHHHHHHHh
Confidence            99998877654333                                                 33456788999999999


Q ss_pred             hcCCCCCCC-----HHHHhcCCCCCCCC
Q 014117          405 RYDPTDRLT-----AREALRHPFFTRDH  427 (430)
Q Consensus       405 ~~dP~~R~t-----a~elL~hp~f~~~~  427 (430)
                      .+||++|+.     +++|..||||+..+
T Consensus       604 ~k~p~kRLG~~e~d~~~i~~hpFFr~i~  631 (694)
T KOG0694|consen  604 RKNPEKRLGSGERDAEDIKKHPFFRSID  631 (694)
T ss_pred             ccCcccccCCCCCCchhhhhCCccccCC
Confidence            999999995     68999999998754

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.6e-50  Score=407.48  Aligned_cols=321  Identities=39%  Similarity=0.727  Sum_probs=240.3

Q ss_pred             ceeecCcee---cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCC-CCCceEE
Q 014117           84 YMFALGENL---TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK-GGNRCVQ  159 (430)
Q Consensus        84 ~~~~~~~~~---~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~-~~~~i~~  159 (430)
                      +....++.+   .++|++.++||+|+||+||+|.+..+++.||||+++...........|+.+++.+.+... ++.+++.
T Consensus       116 ~~~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~  195 (467)
T PTZ00284        116 FYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK  195 (467)
T ss_pred             eeEecCCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceee
Confidence            344444433   578999999999999999999999999999999997554445556778899988876542 3456888


Q ss_pred             ecceeecC-CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEEeecCcccc
Q 014117          160 IRNWFDYR-NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKV  237 (430)
Q Consensus       160 ~~~~~~~~-~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl~~~~~~~i  237 (430)
                      ++.++... .++|+|||+++++|.+++.+.+  .+++..+..++.||+.||.|||+ .|||||||||+|||++.++..  
T Consensus       196 i~~~~~~~~~~~~iv~~~~g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~--  271 (467)
T PTZ00284        196 IQRYFQNETGHMCIVMPKYGPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTV--  271 (467)
T ss_pred             eEEEEEcCCceEEEEEeccCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcc--
Confidence            88888654 6899999999999999987764  79999999999999999999997 599999999999999766532  


Q ss_pred             CCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCC
Q 014117          238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       238 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~  317 (430)
                      .++......+         .....+||+|||.+..........+||+.|+|||++.+..|+.++|||||||++|||++|+
T Consensus       272 ~~~~~~~~~~---------~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~  342 (467)
T PTZ00284        272 VDPVTNRALP---------PDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK  342 (467)
T ss_pred             cccccccccC---------CCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCC
Confidence            1221111110         2335799999998876555556678999999999999999999999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhh-hhhhhcc-CcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRH-AEKYVRR-GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD  395 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (430)
                      +||.+.+..+.+..+.+.+|.+|..+....... ...+... +.+. +  ......+...........      ......
T Consensus       343 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~------~~~~~~  413 (467)
T PTZ00284        343 LLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLR-P--CTDPKHLARIARARPVRE------VIRDDL  413 (467)
T ss_pred             CCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhccccc-c--cCCHHHHHhhhcccchhh------hhchHH
Confidence            999999999999999999999998876543211 1111111 1110 0  000011111000000000      012456


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          396 LTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       396 ~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +.|||.+||++||.+|||++|+|+||||.+.
T Consensus       414 ~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~  444 (467)
T PTZ00284        414 LCDLIYGLLHYDRQKRLNARQMTTHPYVLKY  444 (467)
T ss_pred             HHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence            8899999999999999999999999999863

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-51  Score=397.77  Aligned_cols=253  Identities=30%  Similarity=0.502  Sum_probs=216.3

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc----h--hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----K--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      ...++|.+.+.||+|+||+|++|.+..++..||+|++.+.    .  ...+...+|+.+++.+.+    |+||+++++++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~----HpnI~~l~ev~   89 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRS----HPNIIRLLEVF   89 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhcc----CCCEeEEEEEE
Confidence            3456899999999999999999999999999999987643    1  234455579999999963    36899999999


Q ss_pred             ecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCC
Q 014117          165 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       165 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                      .....+|+||||+ ||+|++++...+  ++.+..++.++.||++||+|||++||+||||||+|||+              
T Consensus        90 ~t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill--------------  153 (370)
T KOG0583|consen   90 ATPTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL--------------  153 (370)
T ss_pred             ecCCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe--------------
Confidence            9999999999999 889999999854  89999999999999999999999999999999999999              


Q ss_pred             CCCCCCCcccccCCCC-CCeEEEeCCCccccC-C--CCCeeeecCcccchhhhhCCC-CC-CcchHHHHHHHHHHHHhCC
Q 014117          244 LHTPKDSSYFKRMPKS-SAIKVIDFGSTTYER-P--DQNYIVSTRHYRAPEVILGLG-WT-YPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~-~~~kl~Dfg~a~~~~-~--~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslGv~l~el~tG~  317 (430)
                                   +.+ +++||+|||++.... .  ...+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|.
T Consensus       154 -------------d~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~  220 (370)
T KOG0583|consen  154 -------------DGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGR  220 (370)
T ss_pred             -------------cCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCC
Confidence                         444 788999999888662 2  335679999999999999987 86 8899999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCc-hhHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS-AGDL  396 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  396 (430)
                      .||+..+.......|.+                       +.+..                          +..+ +.++
T Consensus       221 ~PF~d~~~~~l~~ki~~-----------------------~~~~~--------------------------p~~~~S~~~  251 (370)
T KOG0583|consen  221 LPFDDSNVPNLYRKIRK-----------------------GEFKI--------------------------PSYLLSPEA  251 (370)
T ss_pred             CCCCCccHHHHHHHHhc-----------------------CCccC--------------------------CCCcCCHHH
Confidence            99998666655554433                       22222                          2334 7789


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          397 THLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       397 ~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      ++|+.+||+.||.+|+|+.+++.||||+.
T Consensus       252 ~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  252 RSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            99999999999999999999999999997

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-53  Score=366.52  Aligned_cols=260  Identities=25%  Similarity=0.428  Sum_probs=221.7

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .+.+.|++.+.||+|.|+.|++|.+..+|+.+|+|+++..   ....+...+|+.|.+.|+|     |||+++.+.+...
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqH-----P~IvrL~~ti~~~   82 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-----PNIVRLHDSIQEE   82 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCC-----CcEeehhhhhccc
Confidence            3567799999999999999999999999999999998632   2234556678888777744     8999999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +..|||+|++ |++|..-+.++.  -+++..+..+++||+.||.|||.+||||||+||+|+|+.+.              
T Consensus        83 ~~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK--------------  146 (355)
T KOG0033|consen   83 SFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASK--------------  146 (355)
T ss_pred             ceeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeec--------------
Confidence            9999999999 889977665543  68899999999999999999999999999999999999653              


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                ++...+||+|||+|...+.+.  ...+|||.|||||++...+|+..+|||+.||+||-|+.|.+||.+.+
T Consensus       147 ----------~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~  216 (355)
T KOG0033|consen  147 ----------AKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED  216 (355)
T ss_pred             ----------cCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc
Confidence                      456679999999998666333  33689999999999999999999999999999999999999999887


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ....+..|.+.....|                       .                      ..+++.++++++|+++||
T Consensus       217 ~~rlye~I~~g~yd~~-----------------------~----------------------~~w~~is~~Ak~LvrrML  251 (355)
T KOG0033|consen  217 QHRLYEQIKAGAYDYP-----------------------S----------------------PEWDTVTPEAKSLIRRML  251 (355)
T ss_pred             HHHHHHHHhccccCCC-----------------------C----------------------cccCcCCHHHHHHHHHHh
Confidence            7777776655433332                       2                      135678899999999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ..||.+|+|+.|+|+|||+.+.
T Consensus       252 ~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  252 TVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             ccChhhhccHHHHhCCchhcch
Confidence            9999999999999999999865

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-51  Score=399.13  Aligned_cols=250  Identities=29%  Similarity=0.542  Sum_probs=218.8

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      +-|++.+.||.|+.|.|.+|.+..||+.+|||++.+..    ........|+.+|+.+.|     +|++.+|+.+++..+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~H-----pnVl~LydVwe~~~~   86 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEH-----PNVLRLYDVWENKQH   86 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcC-----CCeeeeeeeeccCce
Confidence            45899999999999999999999999999999997542    234557789999999955     889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|+|.||+ ||.|++++...+  +|++.++.+++.||+.|+.|||..+|+||||||+|+|+                   
T Consensus        87 lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL-------------------  145 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL-------------------  145 (786)
T ss_pred             EEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh-------------------
Confidence            99999999 999999999887  89999999999999999999999999999999999999                   


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                              +...+|||+|||+|....++.  .+.||++.|+|||++.|.+|+ .++||||+|||||.|++|++||++++-
T Consensus       146 --------d~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi  217 (786)
T KOG0588|consen  146 --------DVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI  217 (786)
T ss_pred             --------hcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH
Confidence                    555668999999988766654  557999999999999999986 889999999999999999999997665


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      ...+.++.                       +|.|.                          .|..++.++.+||++||.
T Consensus       218 r~LLlKV~-----------------------~G~f~--------------------------MPs~Is~eaQdLLr~ml~  248 (786)
T KOG0588|consen  218 RVLLLKVQ-----------------------RGVFE--------------------------MPSNISSEAQDLLRRMLD  248 (786)
T ss_pred             HHHHHHHH-----------------------cCccc--------------------------CCCcCCHHHHHHHHHHhc
Confidence            55554443                       33333                          235678899999999999


Q ss_pred             cCCCCCCCHHHHhcCCCCCCC
Q 014117          406 YDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +||++|+|.+||+.|||+..-
T Consensus       249 VDp~~RiT~~eI~kHP~l~g~  269 (786)
T KOG0588|consen  249 VDPSTRITTEEILKHPFLSGY  269 (786)
T ss_pred             cCccccccHHHHhhCchhhcC
Confidence            999999999999999999753

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.5e-50  Score=372.59  Aligned_cols=285  Identities=31%  Similarity=0.521  Sum_probs=229.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC--
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--  168 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~--  168 (430)
                      ..|+.+++||+|+||+||+|+.+.+|+.||+|.++....   ......+|+.+|+.+.|.+    +|+.+++++...+  
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~----~iv~L~dv~~~~~~~   86 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHAN----HIVRLHDVIHTSNNH   86 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCc----ceEEEEeeeeecccc
Confidence            457788899999999999999999999999999975433   4566789999999997632    2999999988776  


Q ss_pred             ----eEEEEEecCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          169 ----HICIVFEKLGSSLYDFLRKNNY--RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       169 ----~~~lv~e~~~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                          .+++||||+..+|..++.....  ..++...++.++.||+.||+|||++||+||||||+||||+            
T Consensus        87 ~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~------------  154 (323)
T KOG0594|consen   87 RGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS------------  154 (323)
T ss_pred             cccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC------------
Confidence                8999999999999999988653  3688899999999999999999999999999999999994            


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCC
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                     ..+.+||+|||+|+...-+.   ..-++|.+|.|||++.+. .|+..+||||+||+++||+++++
T Consensus       155 ---------------~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~  219 (323)
T KOG0594|consen  155 ---------------SSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRP  219 (323)
T ss_pred             ---------------CCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCC
Confidence                           45667777777776544222   234789999999999987 69999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      .|.+.++.+++..|-+.+|.+.+..|+.+........     .++..             ...+.+ ....+..+.+..+
T Consensus       220 LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~-----~f~~~-------------~~~~~l-~~~~~~~~~~~~d  280 (323)
T KOG0594|consen  220 LFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKA-----PFPKW-------------PGPKDL-SSILPKLDPDGIE  280 (323)
T ss_pred             CCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccc-----cCcCC-------------CCccch-HHhccccCccHHH
Confidence            9999999999999999999988765443322211110     11111             101111 1222333468899


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCCCCCCCCC
Q 014117          399 LLQGLLRYDPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      ++.+||+++|.+|.||+.+|+||||.....
T Consensus       281 ll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  281 LLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             HHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            999999999999999999999999987643

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.1e-51  Score=393.62  Aligned_cols=250  Identities=29%  Similarity=0.498  Sum_probs=218.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..   +......+|+++++.+.|     +||+.++++|+...++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkH-----pniv~m~esfEt~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKH-----PNIVEMLESFETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCC-----cchhhHHHhhcccceE
Confidence            46889999999999999999999999999999986443   344557789999999954     8899999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      ++|.||+-|+|..+|...+  .++++.++.++.|++.||.|||+.+|+|||+||.|||+                     
T Consensus        77 ~vVte~a~g~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---------------------  133 (808)
T KOG0597|consen   77 WVVTEYAVGDLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---------------------  133 (808)
T ss_pred             EEEehhhhhhHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---------------------
Confidence            9999999779999999876  89999999999999999999999999999999999999                     


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                            ++.+.+|+||||+|+......   ..+.|||.|||||++.+..|+..+|+||+||++||+++|++||...+-.+
T Consensus       134 ------~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~  207 (808)
T KOG0597|consen  134 ------EKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ  207 (808)
T ss_pred             ------cCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH
Confidence                  667778888888887665554   34689999999999999999999999999999999999999998877666


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....|......+                                                 ++..+.++.+|+..+|.+|
T Consensus       208 Lv~~I~~d~v~~-------------------------------------------------p~~~S~~f~nfl~gLL~kd  238 (808)
T KOG0597|consen  208 LVKSILKDPVKP-------------------------------------------------PSTASSSFVNFLQGLLIKD  238 (808)
T ss_pred             HHHHHhcCCCCC-------------------------------------------------cccccHHHHHHHHHHhhcC
Confidence            666655432222                                                 2355778999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~  426 (430)
                      |.+|+|..+++.|||.+..
T Consensus       239 P~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  239 PAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             hhhcccHHHHhcChHHhhh
Confidence            9999999999999998753

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-52  Score=366.82  Aligned_cols=242  Identities=29%  Similarity=0.459  Sum_probs=206.5

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecC---chhhHHHHHHHHHHHHHHHhcCCCCCceEEecc-eeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN-WFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~-~~~~~~  168 (430)
                      ...|+|+++||+|.||+||++.+..+|..||+|.+.-   +.+.++....|+.+|++|     +||||++.++ .|...+
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-----~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-----NHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-----CCchHHHHHHHhhhccc
Confidence            4569999999999999999999999999999998862   345567788899999999     4589999988 455544


Q ss_pred             e-EEEEEecC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh--cC--eeeccCCCCceEEeecCccccCCC
Q 014117          169 H-ICIVFEKL-GSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHD--LC--MIHTDLKPENVLLVSSEYIKVPDY  240 (430)
Q Consensus       169 ~-~~lv~e~~-~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~--ivHrDlKp~NILl~~~~~~~i~df  240 (430)
                      . ++||||+| +|+|.+.++.  ...+.+++..+++++.|++.||.+||+  .+  |+||||||.||+|           
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl-----------  161 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL-----------  161 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE-----------
Confidence            4 99999999 8999999863  445689999999999999999999998  44  9999999999999           


Q ss_pred             cCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCC
Q 014117          241 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       241 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~  317 (430)
                                      +.++.+||+|||++++.....   .+.+|||.||+||++.+.+|+.+|||||+||++|||..-+
T Consensus       162 ----------------~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~  225 (375)
T KOG0591|consen  162 ----------------TANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQ  225 (375)
T ss_pred             ----------------cCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcC
Confidence                            566788999999988776654   4579999999999999999999999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHHhCC-CCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHH
Q 014117          318 ALFQTHENLEHLAMMERVLGP-LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL  396 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (430)
                      +||.+.+-.+...+|.+..-+ +|.                                                +.+|.++
T Consensus       226 ~PF~g~n~~~L~~KI~qgd~~~~p~------------------------------------------------~~YS~~l  257 (375)
T KOG0591|consen  226 SPFYGDNLLSLCKKIEQGDYPPLPD------------------------------------------------EHYSTDL  257 (375)
T ss_pred             CCcccccHHHHHHHHHcCCCCCCcH------------------------------------------------HHhhhHH
Confidence            999998777777766553221 121                                                3457789


Q ss_pred             HHHHHHhhhcCCCCCCCH
Q 014117          397 THLLQGLLRYDPTDRLTA  414 (430)
Q Consensus       397 ~~ll~~~L~~dP~~R~ta  414 (430)
                      ..||..|+..||+.||+.
T Consensus       258 ~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  258 RELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHHHHHHccCCcccCCCc
Confidence            999999999999999984

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.4e-48  Score=371.51  Aligned_cols=278  Identities=29%  Similarity=0.497  Sum_probs=220.1

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ++|++.++||.|+||.||+|+++.+++.||+|+++...  ........|+.+++++.     |+||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK-----HANIVTLHDIIHTERCLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCC-----CCCEeeEEEEEcCCCeEE
Confidence            46999999999999999999999999999999986432  22345668999998884     488999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          172 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       172 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      +||||+.++|.+++...+ ..+++..+..++.||+.||+|||++||+||||||+|||++.+                   
T Consensus        80 lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-------------------  139 (288)
T cd07871          80 LVFEYLDSDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK-------------------  139 (288)
T ss_pred             EEEeCCCcCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-------------------
Confidence            999999889999987654 368999999999999999999999999999999999999544                   


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                              +.+||+|||++......   .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+
T Consensus       140 --------~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~  211 (288)
T cd07871         140 --------GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE  211 (288)
T ss_pred             --------CCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                    45666666665432211   122468999999999876 468999999999999999999999999988888


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      .+..+....+.++...++.+....+..    .+..+..              .... .....+..+.++.+||.+||++|
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~--------------~~~~-~~~~~~~~~~~~~dll~~mL~~d  272 (288)
T cd07871         212 ELHLIFRLLGTPTEETWPGITSNEEFR----SYLFPQY--------------RAQP-LINHAPRLDTDGIDLLSSLLLYE  272 (288)
T ss_pred             HHHHHHHHhCCCChHHhhccccchhhh----ccccCcc--------------CCCc-hHHhCCCCCHHHHHHHHHhcCcC
Confidence            888999999988887665432211100    0000000              0000 01123456778999999999999


Q ss_pred             CCCCCCHHHHhcCCCC
Q 014117          408 PTDRLTAREALRHPFF  423 (430)
Q Consensus       408 P~~R~ta~elL~hp~f  423 (430)
                      |.+|||++|+|+||||
T Consensus       273 p~~R~t~~~~l~hp~f  288 (288)
T cd07871         273 TKSRISAEAALRHSYF  288 (288)
T ss_pred             cccCCCHHHHhcCCCC
Confidence            9999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-49  Score=369.07  Aligned_cols=270  Identities=25%  Similarity=0.372  Sum_probs=217.0

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +.|++...||.|..++||+|+.+.++..||||++.-.+  ........|+..+..+     +||||+..+..|..+..++
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-----~HPNIv~~~~sFvv~~~LW  100 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-----DHPNIVTYHCSFVVDSELW  100 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-----CCCCcceEEEEEEecceeE
Confidence            46999999999999999999999999999999997433  2245677888888888     5599999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||+|| +|++.+++.......+.+..+..|.++++.||.|||++|.||||||+.||||+++|.+|++|||.+.+.    
T Consensus       101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l----  176 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL----  176 (516)
T ss_pred             EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee----
Confidence            999999 999999999877778999999999999999999999999999999999999998888888888765433    


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                                    .|-|...... - ++++||++|||||++..  ..|+.|+||||||++..||.+|..||.....+..
T Consensus       177 --------------~~~G~R~~~r-f-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv  240 (516)
T KOG0582|consen  177 --------------FDSGDRQVTR-F-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV  240 (516)
T ss_pred             --------------cccCceeeEe-e-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH
Confidence                          2222110010 1 45689999999999654  3699999999999999999999999988776655


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      +.  .+.-+.+|.....                       .              +..+....++..++.+|..||++||
T Consensus       241 Ll--~tLqn~pp~~~t~-----------------------~--------------~~~d~~k~~~ksf~e~i~~CL~kDP  281 (516)
T KOG0582|consen  241 LL--LTLQNDPPTLLTS-----------------------G--------------LDKDEDKKFSKSFREMIALCLVKDP  281 (516)
T ss_pred             HH--HHhcCCCCCcccc-----------------------c--------------CChHHhhhhcHHHHHHHHHHhhcCc
Confidence            43  3334444421100                       0              0000112334479999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCCC
Q 014117          409 TDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       409 ~~R~ta~elL~hp~f~~~~  427 (430)
                      ++||||+++|.|+||+...
T Consensus       282 ~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  282 SKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             ccCCCHHHHhccHHHhhcc
Confidence            9999999999999998764

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.4e-50  Score=367.55  Aligned_cols=280  Identities=31%  Similarity=0.539  Sum_probs=227.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-----
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-----  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~-----  167 (430)
                      .-.|.-.+.+|+|+||.||.|....+++.||||.+-..+..   ...|+++|+.+     .|+||+++..+|...     
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l-----~HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKL-----DHPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhc-----CCcCeeeEEEEEEecCCCch
Confidence            33688899999999999999999999999999987654443   34589999976     458999998877532     


Q ss_pred             CeEEEEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          168 NHICIVFEKLGSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       168 ~~~~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      -++.+||||+..+|.++++..  .+..++...++-++.||++||.|||+.||+||||||+|||++               
T Consensus        95 ~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD---------------  159 (364)
T KOG0658|consen   95 VYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD---------------  159 (364)
T ss_pred             hHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc---------------
Confidence            266799999999999999842  235799999999999999999999999999999999999996               


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                 ...+.+||||||.|+...++.  .+..-|..|+|||.+.|. .|+.+.||||.|||+.||+-|++.|.+
T Consensus       160 -----------~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG  228 (364)
T KOG0658|consen  160 -----------PDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG  228 (364)
T ss_pred             -----------CCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence                       456889999999998665443  345569999999999987 599999999999999999999999999


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      .+..+++..|.+.+|.+..+-...+......      +..|...          ...    +..-+....++++.+|+.+
T Consensus       229 ~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~------~~~p~ik----------~~~----~~~~~~~~~~~d~~dll~~  288 (364)
T KOG0658|consen  229 DSSVDQLVEIIKVLGTPTREDIKSMNPNYTE------FKFPQIK----------AHP----WHKVFFKRLPPDALDLLSK  288 (364)
T ss_pred             CCHHHHHHHHHHHhCCCCHHHHhhcCccccc------ccCcccc----------ccc----ceeecccCCCHHHHHHHHH
Confidence            9999999999999999998766654432211      1111100          000    0001345678899999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +|+++|.+|.++.|+|.||||...
T Consensus       289 ~L~Y~P~~R~~~~~~l~h~fFdel  312 (364)
T KOG0658|consen  289 LLQYSPSKRLSALEALAHPFFDEL  312 (364)
T ss_pred             HhccChhhcCCHHHHhcchhhHHh
Confidence            999999999999999999999753

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6e-49  Score=381.76  Aligned_cols=263  Identities=33%  Similarity=0.543  Sum_probs=227.2

Q ss_pred             CceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           89 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        89 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      .+.+...|++.+.||+|.||.||+|..+.+|+.+|+|++.+...    .......|+.+|+++..    |+||+.+++.|
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~----hpniv~l~~~~  105 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSG----HPNIVQLKDAF  105 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccC----CCCEEEEEEEE
Confidence            34566789999999999999999999999999999999975432    33577889999999963    58899999999


Q ss_pred             ecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCC
Q 014117          165 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       165 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                      ++...+++|||+| ||.|++.+...   .+++..+..++.||+.|+.|||+.|||||||||+|+|+....          
T Consensus       106 e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~----------  172 (382)
T KOG0032|consen  106 EDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKD----------  172 (382)
T ss_pred             EcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeecccc----------
Confidence            9999999999999 99999999876   299999999999999999999999999999999999996432          


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                                   ...+.+|++|||++......  ....+||+.|+|||++....|+..+||||+||++|.|++|.+||.
T Consensus       173 -------------~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~  239 (382)
T KOG0032|consen  173 -------------EGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFW  239 (382)
T ss_pred             -------------CCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCc
Confidence                         23468999999999987763  355799999999999999999999999999999999999999999


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      +.++......|...-..++                                             ...++..+..+++||+
T Consensus       240 ~~~~~~~~~~i~~~~~~f~---------------------------------------------~~~w~~is~~akd~i~  274 (382)
T KOG0032|consen  240 GETEFEIFLAILRGDFDFT---------------------------------------------SEPWDDISESAKDFIR  274 (382)
T ss_pred             CCChhHHHHHHHcCCCCCC---------------------------------------------CCCccccCHHHHHHHH
Confidence            9887776665443222111                                             1235677889999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          402 GLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +||..||.+|+||+++|+|||++..
T Consensus       275 ~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  275 KLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HhcccCcccCCCHHHHhcCccccCC
Confidence            9999999999999999999999864

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-50  Score=386.28  Aligned_cols=253  Identities=28%  Similarity=0.447  Sum_probs=218.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh-hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ...|....+||+|+.|.||.|....+++.||||.+..... .++-...|+.+|+...     |+|||.+++.|-..+.++
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~-----H~NiVnfl~Sylv~deLW  346 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLH-----HPNIVNFLDSYLVGDELW  346 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhcc-----chHHHHHHHHhcccceeE
Confidence            4578899999999999999999999999999999975544 3455678999999884     488999999998889999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ ||+|.+.+...   .+++.++..++++++.||+|||.+||||||||.+|||+                     
T Consensus       347 VVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---------------------  402 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---------------------  402 (550)
T ss_pred             EEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---------------------
Confidence            999999 99999998765   59999999999999999999999999999999999999                     


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                            ..++.+||+|||++......   ..+.+||++|||||++....|++++||||||++++||+.|++||-..+...
T Consensus       403 ------~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr  476 (550)
T KOG0578|consen  403 ------TMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR  476 (550)
T ss_pred             ------ccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH
Confidence                  55667899999988765443   356799999999999999999999999999999999999999998766655


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      .+..|... |.+                                             ..+.++..+..+++||.+||+.|
T Consensus       477 AlyLIa~n-g~P---------------------------------------------~lk~~~klS~~~kdFL~~cL~~d  510 (550)
T KOG0578|consen  477 ALYLIATN-GTP---------------------------------------------KLKNPEKLSPELKDFLDRCLVVD  510 (550)
T ss_pred             HHHHHhhc-CCC---------------------------------------------CcCCccccCHHHHHHHHHHhhcc
Confidence            55544332 111                                             12245677889999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~  426 (430)
                      +++|++|.|||+||||+..
T Consensus       511 v~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  511 VEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             hhcCCCHHHHhcChhhhhc
Confidence            9999999999999999754

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-49  Score=372.70  Aligned_cols=255  Identities=31%  Similarity=0.481  Sum_probs=203.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh-hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC--eE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--HI  170 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~--~~  170 (430)
                      .+|...+.||+|+||.||++.+..+|...|||.+..... ..+....|+.+|.++.     +++||++++......  .+
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~-----~p~IV~~~G~~~~~~~~~~   91 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN-----HPNIVQYYGSSSSRENDEY   91 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC-----CCCEEeeCCccccccCeee
Confidence            457888999999999999999999999999999864321 1455788999999995     488999999755444  79


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      +|+|||+ +|+|.+++...++ +|++..++.+++||+.||.|||++|||||||||+|||++..                 
T Consensus        92 ~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~-----------------  153 (313)
T KOG0198|consen   92 NIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS-----------------  153 (313)
T ss_pred             EeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC-----------------
Confidence            9999999 9999999998876 89999999999999999999999999999999999999541                 


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCC------CCCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERP------DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                               ++.+||+|||++.....      ......||+.|||||++.+. ..+.++|||||||++.||+||.+||..
T Consensus       154 ---------~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  154 ---------NGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             ---------CCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence                     34566666665553331      12346899999999999953 344699999999999999999999986


Q ss_pred             C-chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          323 H-ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       323 ~-~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      . ...+....+... +..                                              ...++..+.++++||.
T Consensus       225 ~~~~~~~~~~ig~~-~~~----------------------------------------------P~ip~~ls~~a~~Fl~  257 (313)
T KOG0198|consen  225 FFEEAEALLLIGRE-DSL----------------------------------------------PEIPDSLSDEAKDFLR  257 (313)
T ss_pred             hcchHHHHHHHhcc-CCC----------------------------------------------CCCCcccCHHHHHHHH
Confidence            3 222211111100 000                                              1245677889999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          402 GLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      +||++||++||||+++|+|||.++..
T Consensus       258 ~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  258 KCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             HHhhcCcccCcCHHHHhhChhhhccc
Confidence            99999999999999999999997753

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6e-48  Score=366.56  Aligned_cols=280  Identities=32%  Similarity=0.597  Sum_probs=220.5

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ++|++.+.||+|+||.||+|+++.+++.||+|+++...   ........|+.+++.+.     ++||+++++.+...+.+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK-----QENIVELKEAFRRRGKL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCC-----CccccchhhhEecCCEE
Confidence            46999999999999999999999999999999986432   23455677898888884     47899999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      |+||||+.+++.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.                   
T Consensus        76 ~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~-------------------  135 (287)
T cd07848          76 YLVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH-------------------  135 (287)
T ss_pred             EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC-------------------
Confidence            9999999555555554432 46999999999999999999999999999999999999944                   


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC----CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                              ++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..
T Consensus       136 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~  207 (287)
T cd07848         136 --------NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI  207 (287)
T ss_pred             --------CCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH
Confidence                    455677777766543221    12347899999999999989999999999999999999999999998888


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +....+....+++|...+.........    ....++...             .............+.++.+||.+||++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-------------~~~~~~~~~~~~~s~~~~dll~~~L~~  270 (287)
T cd07848         208 DQLFTIQKVLGPLPAEQMKLFYSNPRF----HGLRFPAVN-------------HPQSLERRYLGILSGVLLDLMKNLLKL  270 (287)
T ss_pred             HHHHHHHHhhCCCCHHHHHhhhccchh----cccccCccc-------------CcccHHHhhhcccCHHHHHHHHHHccC
Confidence            888889999999987765543221110    001111100             001112233445778899999999999


Q ss_pred             CCCCCCCHHHHhcCCCC
Q 014117          407 DPTDRLTAREALRHPFF  423 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f  423 (430)
                      ||++|||++|+|+||||
T Consensus       271 ~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         271 NPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             CcccCCCHHHHhcCCCC
Confidence            99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-48  Score=363.17  Aligned_cols=340  Identities=33%  Similarity=0.585  Sum_probs=260.3

Q ss_pred             CCCCCceeecCceec-CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCC---
Q 014117           79 DKDGHYMFALGENLT-SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG---  154 (430)
Q Consensus        79 ~~~~~~~~~~~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~---  154 (430)
                      -..|.+++.+|+.+. ++|.+.++||-|.|++||+|.|.++++.||+|+.+......+..+.|+++|++++.++..+   
T Consensus        62 ~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~  141 (590)
T KOG1290|consen   62 RKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGK  141 (590)
T ss_pred             hcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCC
Confidence            345788999999998 8999999999999999999999999999999999988888889999999999999877333   


Q ss_pred             CceEEecceeec----CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEE
Q 014117          155 NRCVQIRNWFDY----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLL  229 (430)
Q Consensus       155 ~~i~~~~~~~~~----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl  229 (430)
                      ..||++++.|..    +.++|||+|++|.+|..+|.....+.++...++.|++||+.||.|||. .||||-||||+|||+
T Consensus       142 ~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  142 KCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             ceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            458999999875    569999999999999999999998999999999999999999999995 679999999999999


Q ss_pred             eecCc-----------------------ccc--------------CC--------------------CcC--C-------
Q 014117          230 VSSEY-----------------------IKV--------------PD--------------------YKS--S-------  243 (430)
Q Consensus       230 ~~~~~-----------------------~~i--------------~d--------------------fg~--~-------  243 (430)
                      .....                       .+-              .+                    +|.  .       
T Consensus       222 ~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~  301 (590)
T KOG1290|consen  222 CSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQE  301 (590)
T ss_pred             eccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccc
Confidence            54310                       000              00                    000  0       


Q ss_pred             -----CC-CCC------------------------CC-------------------------cccc--------------
Q 014117          244 -----LH-TPK------------------------DS-------------------------SYFK--------------  254 (430)
Q Consensus       244 -----~~-~~~------------------------~~-------------------------~~~~--------------  254 (430)
                           .. ...                        ..                         +..+              
T Consensus       302 s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~  381 (590)
T KOG1290|consen  302 SYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVN  381 (590)
T ss_pred             ccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccC
Confidence                 00 000                        00                         0000              


Q ss_pred             ----cCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC------c
Q 014117          255 ----RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH------E  324 (430)
Q Consensus       255 ----~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~------~  324 (430)
                          .......+||+|||.|+.....-+.-+.|..|+|||++.+..|+..+||||++|++|||+||...|+.+      .
T Consensus       382 p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~r  461 (590)
T KOG1290|consen  382 PDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSR  461 (590)
T ss_pred             CCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCc
Confidence                012234689999999987655444457799999999999999999999999999999999999999643      4


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      +.+.++.|.+++|..|..+.....-.-+-|-..|.+.--.....+       .....-.....++...+.++.+||.-||
T Consensus       462 DEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~W-------pL~~VL~eKY~~s~e~A~~fsdFL~PmL  534 (590)
T KOG1290|consen  462 DEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPW-------PLYEVLIEKYEWSEEDAQQFSDFLSPML  534 (590)
T ss_pred             cHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCC-------cHHHHHHHHhCCCHHHHHHHHHHHHHHH
Confidence            688999999999999987755443322222233333211111100       0111111223355666778999999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~  425 (430)
                      +.+|++||||.++|+|||+..
T Consensus       535 ef~PeKR~tA~~cl~hPwLn~  555 (590)
T KOG1290|consen  535 EFDPEKRPTAAQCLKHPWLNP  555 (590)
T ss_pred             hcCccccccHHHHhcCccccC
Confidence            999999999999999999974

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.7e-50  Score=353.95  Aligned_cols=255  Identities=30%  Similarity=0.510  Sum_probs=219.4

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecC---------chhhHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---------IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN  162 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~---------~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~  162 (430)
                      +.+.|.-.+.||.|..+.|.+|..+.+++.+|+|++.-         .....+....|+.||+++.    +||+|+.+.+
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~----GHP~II~l~D   90 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVM----GHPYIIDLQD   90 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhc----CCCcEEEeee
Confidence            34567888899999999999999999999999999841         1234466778999999996    5588999999


Q ss_pred             eeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          163 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       163 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      +++.+..+++|+|.| .|.|+|+|...  ..+++...+.|++|++.|++|||.++||||||||+|||+            
T Consensus        91 ~yes~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl------------  156 (411)
T KOG0599|consen   91 VYESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL------------  156 (411)
T ss_pred             eccCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee------------
Confidence            999999999999999 89999999875  389999999999999999999999999999999999999            


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhC------CCCCCcchHHHHHHHHHHH
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG------LGWTYPCDIWSVGCILVEL  313 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGv~l~el  313 (430)
                                     +.+.++||+|||+++...++.  ...||||+|.|||.+..      ..|+..+|+||+||+||.|
T Consensus       157 ---------------ddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTL  221 (411)
T KOG0599|consen  157 ---------------DDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTL  221 (411)
T ss_pred             ---------------ccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHH
Confidence                           677889999999998777665  34799999999999863      3599999999999999999


Q ss_pred             HhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCch
Q 014117          314 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA  393 (430)
Q Consensus       314 ~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (430)
                      +.|.+||-....+-++.+|.+.-..+.                       .                      ..|++.+
T Consensus       222 LaGcpPFwHRkQmlMLR~ImeGkyqF~-----------------------s----------------------peWadis  256 (411)
T KOG0599|consen  222 LAGCPPFWHRKQMLMLRMIMEGKYQFR-----------------------S----------------------PEWADIS  256 (411)
T ss_pred             HcCCCchhHHHHHHHHHHHHhcccccC-----------------------C----------------------cchhhcc
Confidence            999999988777777766654332221                       1                      1245677


Q ss_pred             hHHHHHHHHhhhcCCCCCCCHHHHhcCCCCC
Q 014117          394 GDLTHLLQGLLRYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       394 ~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~  424 (430)
                      .+.+|||.+||++||.+|.|++|+|.||||.
T Consensus       257 ~~~KdLIsrlLqVdp~~Ritake~LaHpff~  287 (411)
T KOG0599|consen  257 ATVKDLISRLLQVDPTKRITAKEALAHPFFI  287 (411)
T ss_pred             ccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence            8899999999999999999999999999994

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-48  Score=369.69  Aligned_cols=250  Identities=25%  Similarity=0.353  Sum_probs=210.1

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++....    .....+..|+.+++.+.     |+||+++++.+.+.+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~~~~~~~~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-----HPFIIRLFWTEHDQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-----CCcHhhhHhhhccCCe
Confidence            36899999999999999999999999999999986432    22345667888888884     4889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|+||||+ +++|.+++...+  .+++..+..++.||+.||+|||++||+||||||+|||+                   
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli-------------------  134 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL-------------------  134 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE-------------------
Confidence            99999999 889999998764  79999999999999999999999999999999999999                   


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                              +.++.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus       135 --------~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~  206 (291)
T cd05612         135 --------DKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI  206 (291)
T ss_pred             --------CCCCCEEEEecCcchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                    445578888888877655444456799999999999999999999999999999999999999987665554


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      ...+....                       .                          .++...+..+++||.+||+.||
T Consensus       207 ~~~i~~~~-----------------------~--------------------------~~~~~~~~~~~~li~~~l~~dp  237 (291)
T cd05612         207 YEKILAGK-----------------------L--------------------------EFPRHLDLYAKDLIKKLLVVDR  237 (291)
T ss_pred             HHHHHhCC-----------------------c--------------------------CCCccCCHHHHHHHHHHcCCCH
Confidence            44332211                       1                          1223446679999999999999


Q ss_pred             CCCCC-----HHHHhcCCCCCCC
Q 014117          409 TDRLT-----AREALRHPFFTRD  426 (430)
Q Consensus       409 ~~R~t-----a~elL~hp~f~~~  426 (430)
                      .+|++     ++++++||||+.-
T Consensus       238 ~~R~~~~~~~~~~~l~h~~~~~~  260 (291)
T cd05612         238 TRRLGNMKNGADDVKNHRWFKSV  260 (291)
T ss_pred             HHccCCccCCHHHHhcCccccCC
Confidence            99995     9999999999753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.7e-48  Score=375.50  Aligned_cols=250  Identities=28%  Similarity=0.442  Sum_probs=210.7

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||+|+||.||+|.++.+++.||+|+++...    .....+..|+.++.++.     |+||+++++.+...+.
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~~~~~~~~~~~   92 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-----HPFIVNMMCSFQDENR   92 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-----CCCCCcEEEEEEcCCE
Confidence            56999999999999999999999999999999986432    22345677888888884     4889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|+||||+ +++|.+++...+  .+++..+..++.||+.||+|||++||+||||||+|||+                   
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll-------------------  151 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL-------------------  151 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE-------------------
Confidence            99999999 889999998764  78999999999999999999999999999999999999                   


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                              +.++.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus       152 --------~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  223 (329)
T PTZ00263        152 --------DNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI  223 (329)
T ss_pred             --------CCCCCEEEeeccCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH
Confidence                    455678888888877655555556899999999999999999999999999999999999999987665444


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      ...+...                       ...                          ++...+.++.+||.+||+.||
T Consensus       224 ~~~i~~~-----------------------~~~--------------------------~p~~~~~~~~~li~~~L~~dP  254 (329)
T PTZ00263        224 YEKILAG-----------------------RLK--------------------------FPNWFDGRARDLVKGLLQTDH  254 (329)
T ss_pred             HHHHhcC-----------------------CcC--------------------------CCCCCCHHHHHHHHHHhhcCH
Confidence            4333211                       111                          123356678999999999999


Q ss_pred             CCCCC-----HHHHhcCCCCCCC
Q 014117          409 TDRLT-----AREALRHPFFTRD  426 (430)
Q Consensus       409 ~~R~t-----a~elL~hp~f~~~  426 (430)
                      .+|++     +++++.||||+..
T Consensus       255 ~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        255 TKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             HHcCCCCCCCHHHHhcCCccCCC
Confidence            99997     7999999999864

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-47  Score=385.02  Aligned_cols=280  Identities=28%  Similarity=0.519  Sum_probs=219.7

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-----
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-----  166 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-----  166 (430)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++.....   ....|+.+++.+.     |+||+++++++..     
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~-----h~niv~l~~~~~~~~~~~  135 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLN-----HINIIFLKDYYYTECFKK  135 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcC-----CCCCcceeeeEeeccccc
Confidence            34679999999999999999999999999999998864332   2346888998884     4788888776532     


Q ss_pred             ---CCeEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          167 ---RNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       167 ---~~~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                         ...+++||||++++|.+++..  .....+++..++.++.||+.||.|||++|||||||||+|||++.          
T Consensus       136 ~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~----------  205 (440)
T PTZ00036        136 NEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP----------  205 (440)
T ss_pred             CCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC----------
Confidence               236789999998898887753  22357999999999999999999999999999999999999952          


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                      ....+||+|||+++......  ...+||+.|+|||++.+. .|+.++|||||||++|||++|.+
T Consensus       206 ----------------~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~  269 (440)
T PTZ00036        206 ----------------NTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP  269 (440)
T ss_pred             ----------------CCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence                            23357888888876443222  235789999999998765 69999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||.+.+..+.+..+.+.+|.++.+.+.........      ..++.              .....+...++...+.++.+
T Consensus       270 pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~------~~~~~--------------~~~~~l~~~~p~~~~~~~~~  329 (440)
T PTZ00036        270 IFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD------IKFPD--------------VKPKDLKKVFPKGTPDDAIN  329 (440)
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhc------ccCCc--------------cCchhHHHHhccCCCHHHHH
Confidence            99999888899999999988876655433211110      01111              01122233355667889999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          399 LLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      ||.+||++||.+|||+.|+|+||||..
T Consensus       330 li~~~L~~dP~~R~ta~e~l~hp~f~~  356 (440)
T PTZ00036        330 FISQFLKYEPLKRLNPIEALADPFFDD  356 (440)
T ss_pred             HHHHHCCCChhHCcCHHHHhCChhHHh
Confidence            999999999999999999999999964

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.6e-47  Score=370.65  Aligned_cols=279  Identities=32%  Similarity=0.499  Sum_probs=217.4

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC----
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR----  167 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~----  167 (430)
                      +|++.+.||+|+||.||+|.++.+++.||||+++..   ......+..|+.+++.+.     |+||+++++++...    
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~~~~~~~~~~~~~   75 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR-----HPDIVEIKHIMLPPSRRE   75 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCC-----CCCEeeecceEeccCCCC
Confidence            589999999999999999999999999999998632   122345678999998884     47899998877432    


Q ss_pred             -CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 -NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 -~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                       ..+|+||||++++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++             
T Consensus        76 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-------------  140 (338)
T cd07859          76 FKDIYVVFELMESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC-------------  140 (338)
T ss_pred             CceEEEEEecCCCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-------------
Confidence             3689999999889999987654  699999999999999999999999999999999999995544             


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCC------CCeeeecCcccchhhhhC--CCCCCcchHHHHHHHHHHHHhCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                    .+||+|||+++.....      ....+||+.|+|||++.+  ..++.++|||||||++|+|++|++
T Consensus       141 --------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~  206 (338)
T cd07859         141 --------------KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP  206 (338)
T ss_pred             --------------cEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCC
Confidence                          4555555555422111      122478999999999876  578999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhh-hhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      ||.+.+.......+....|.++......+..... .+...-....+                   .......+..+.++.
T Consensus       207 pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~  267 (338)
T cd07859         207 LFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQP-------------------VPFSQKFPNADPLAL  267 (338)
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCC-------------------CchHHhcCCCChHHH
Confidence            9999888888888888899888877665532211 11100000000                   001112234567899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          398 HLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +||.+||+.||++|||++|+|+||||++.
T Consensus       268 ~li~~~l~~~P~~Rpt~~e~l~hp~f~~~  296 (338)
T cd07859         268 RLLERLLAFDPKDRPTAEEALADPYFKGL  296 (338)
T ss_pred             HHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence            99999999999999999999999999753

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.7e-47  Score=365.17  Aligned_cols=284  Identities=26%  Similarity=0.435  Sum_probs=211.3

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ++|++.+.||+|+||.||+|.++.+++.||+|+++...  .......+|+.+++.+.     |+||+++++++......|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~   79 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK-----HANIVLLHDIIHTKETLT   79 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCC-----CCCcCeEEEEEecCCeEE
Confidence            57999999999999999999999999999999986432  22335667899988884     478999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          172 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       172 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      +||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+                   
T Consensus        80 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-------------------  139 (303)
T cd07869          80 LVFEYVHTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT-------------------  139 (303)
T ss_pred             EEEECCCcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-------------------
Confidence            999999889999887653 468999999999999999999999999999999999999544                   


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCch-H
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN-L  326 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~-~  326 (430)
                              +.+||+|||++......   .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..+ .
T Consensus       140 --------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  211 (303)
T cd07869         140 --------GELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ  211 (303)
T ss_pred             --------CCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH
Confidence                    45566666655432211   1224679999999998764 588999999999999999999999987544 3


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +.+..+....+.+....+..+..... +.       ++      .+.. .....+....  .....+.++.+||.+||+.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-------~~------~~~~-~~~~~~~~~~--~~~~~~~~~~dli~~mL~~  274 (303)
T cd07869         212 DQLERIFLVLGTPNEDTWPGVHSLPH-FK-------PE------RFTL-YSPKNLRQAW--NKLSYVNHAEDLASKLLQC  274 (303)
T ss_pred             HHHHHHHHHhCCCChhhccchhhccc-cc-------cc------cccc-cCCccHHHHh--hccCCChHHHHHHHHHhcc
Confidence            45556666666555443322211000 00       00      0000 0000000000  0112456789999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~~  427 (430)
                      ||++|||+.|+|+||||+.-+
T Consensus       275 dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         275 FPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             CchhccCHHHHhcCcccccCC
Confidence            999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-48  Score=363.91  Aligned_cols=262  Identities=26%  Similarity=0.382  Sum_probs=208.8

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh---------------hHHHHHHHHHHHHHHHhcCCCCC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---------------YREAAMIEIEVLQQLAKHDKGGN  155 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---------------~~~~~~~E~~~l~~l~~~~~~~~  155 (430)
                      ...++|++.+.||+|.||.|.+|++..+++.||||++.+...               ..+...+|+.+|+++.     |+
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-----H~  168 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-----HP  168 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-----Cc
Confidence            446789999999999999999999999999999999853221               1246778999999994     48


Q ss_pred             ceEEecceeecC--CeEEEEEecC-CCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEee
Q 014117          156 RCVQIRNWFDYR--NHICIVFEKL-GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS  231 (430)
Q Consensus       156 ~i~~~~~~~~~~--~~~~lv~e~~-~~~L~~~l~~~~~~~-l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~  231 (430)
                      |||++++..++.  +.+|||+||| .|.+..   ....+. +++.+++.|+++++.||+|||.+|||||||||+|+||++
T Consensus       169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w---~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKW---CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSS  245 (576)
T ss_pred             CeeEEEEeecCcccCceEEEEEeccCCcccc---CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcC
Confidence            899999999864  6899999999 665432   222234 899999999999999999999999999999999999988


Q ss_pred             cCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCC----CCCcchHHHHH
Q 014117          232 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG----WTYPCDIWSVG  307 (430)
Q Consensus       232 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG  307 (430)
                      +|++||+|||.+...+.....               |.-    ..-...+|||.|+|||...++.    -+.+.||||+|
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~---------------~~d----~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalG  306 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDE---------------GSD----DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALG  306 (576)
T ss_pred             CCcEEeeccceeeecccCCcc---------------ccH----HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhh
Confidence            777777777766544332110               000    0002258999999999998732    35788999999


Q ss_pred             HHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhh
Q 014117          308 CILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ  387 (430)
Q Consensus       308 v~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (430)
                      |+||.|+.|+.||-+....+.+.+|...--.+|.                                              
T Consensus       307 VTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~----------------------------------------------  340 (576)
T KOG0585|consen  307 VTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPE----------------------------------------------  340 (576)
T ss_pred             hhHHHhhhccCCcccchHHHHHHHHhcCcccCCC----------------------------------------------
Confidence            9999999999999998888888777654322221                                              


Q ss_pred             hcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       388 ~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                       .+...++++|||.+||++||++|+|+.+|..|||.++.
T Consensus       341 -~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  341 -NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             -cccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence             12346689999999999999999999999999999876

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.4e-47  Score=364.06  Aligned_cols=256  Identities=23%  Similarity=0.367  Sum_probs=206.2

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .|++.+.||+|+||.||+|.+..+++.||+|++....    .....+..|+.++..+.     +++++.+++.+...+.+
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-----~~~iv~~~~~~~~~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-----SRFVVSLAYAYETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-----CCcEEEEEEEEccCCeE
Confidence            3889999999999999999999999999999986432    12234567888888884     47899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++                   
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~-------------------  136 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD-------------------  136 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC-------------------
Confidence            9999999 88999888765545799999999999999999999999999999999999994                   


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                              .++.++|+|||++.......  ....||..|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus       137 --------~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~  208 (285)
T cd05631         137 --------DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV  208 (285)
T ss_pred             --------CCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch
Confidence                    44567777777776432221  23478999999999999999999999999999999999999998755432


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+......                                             ....++...+.++.+||++||+.|
T Consensus       209 ~~~~~~~~~~~---------------------------------------------~~~~~~~~~s~~~~~li~~~l~~~  243 (285)
T cd05631         209 KREEVDRRVKE---------------------------------------------DQEEYSEKFSEDAKSICRMLLTKN  243 (285)
T ss_pred             hHHHHHHHhhc---------------------------------------------ccccCCccCCHHHHHHHHHHhhcC
Confidence            22222111100                                             011123456778999999999999


Q ss_pred             CCCCCC-----HHHHhcCCCCCCCC
Q 014117          408 PTDRLT-----AREALRHPFFTRDH  427 (430)
Q Consensus       408 P~~R~t-----a~elL~hp~f~~~~  427 (430)
                      |.+|||     ++++++||||....
T Consensus       244 P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         244 PKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             HHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            999997     89999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.5e-47  Score=361.81  Aligned_cols=279  Identities=29%  Similarity=0.486  Sum_probs=214.1

Q ss_pred             CcEEEEeeeccccceEEEEEEECC-CCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee----
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRE-RKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD----  165 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~----  165 (430)
                      .+|++.+.||+|+||.||+|.+.. +++.||+|+++...   ........|+.+++.+...  .|+||+++++++.    
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~hpniv~~~~~~~~~~~   78 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF--EHPNVVRLFDVCTVSRT   78 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhccc--CCCCcceEEEEEecccC
Confidence            369999999999999999999864 46889999886322   2233456688887777432  3588999988764    


Q ss_pred             -cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          166 -YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       166 -~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                       ....+++||||++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.             
T Consensus        79 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~-------------  145 (290)
T cd07862          79 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS-------------  145 (290)
T ss_pred             CCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcC-------------
Confidence             356799999999889999998766567999999999999999999999999999999999999954             


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                    ++.+||+|||++......  .....||+.|+|||++.+..++.++|||||||++|||++|.+||.+
T Consensus       146 --------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  211 (290)
T cd07862         146 --------------SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG  211 (290)
T ss_pred             --------------CCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCC
Confidence                          445666666666533222  2335789999999999998999999999999999999999999999


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      .++.+.+..+....+.+++..++.........       +..           ..    ........+..+..+.+||.+
T Consensus       212 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~-----------~~----~~~~~~~~~~~~~~~~~li~~  269 (290)
T cd07862         212 SSDVDQLGKILDVIGLPGEEDWPRDVALPRQA-------FHS-----------KS----AQPIEKFVTDIDELGKDLLLK  269 (290)
T ss_pred             CCHHHHHHHHHHHhCCCChhhchhhhcccchh-------ccC-----------CC----CCCHHHHccCCCHHHHHHHHH
Confidence            88888888888877765543222110000000       000           00    001112234567789999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f  423 (430)
                      ||+.||++|||+.|+|+||||
T Consensus       270 ~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         270 CLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             HhccCchhcCCHHHHhcCCCC
Confidence            999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-47  Score=376.39  Aligned_cols=278  Identities=21%  Similarity=0.356  Sum_probs=213.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      ..+|++++.||+|+||.||+|.+..+++.||+|....     .....|+++++++.     |+||+++++++......|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~-----HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAIN-----HPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCC-----CCCCCCEeEEEEECCeeEE
Confidence            4579999999999999999999999999999997542     34567999999984     4889999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          173 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       173 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      |||+++++|..++....  .+++..++.++.||+.||.|||++|||||||||+|||++                      
T Consensus       161 v~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~----------------------  216 (391)
T PHA03212        161 ILPRYKTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN----------------------  216 (391)
T ss_pred             EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc----------------------
Confidence            99999889999987654  689999999999999999999999999999999999994                      


Q ss_pred             cccCCCCCCeEEEeCCCccccCC----CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERP----DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH-----  323 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~-----  323 (430)
                           ..+.+||+|||++.....    .....+||+.|+|||++.+..++.++|||||||++|||++|..||...     
T Consensus       217 -----~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~  291 (391)
T PHA03212        217 -----HPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDG  291 (391)
T ss_pred             -----CCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccc
Confidence                 445677777777753221    112357999999999999999999999999999999999999877532     


Q ss_pred             --chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhh---ccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          324 --ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV---RRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       324 --~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                        .....+..+....|..|.++............   .......+..   +..+              ......+.++.+
T Consensus       292 ~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--------------~~~~~~~~~l~~  354 (391)
T PHA03212        292 DCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGS---RPLW--------------TNLYELPIDLEY  354 (391)
T ss_pred             cCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCC---CCCH--------------HHHhhhhhhHHH
Confidence              23456677777777766543211111111000   0000000000   0000              000124567899


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          399 LLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||.+||++||++||||+|+|+||||+..
T Consensus       355 Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        355 LICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             HHHHHhcCChhhCCCHHHHhcChhhccC
Confidence            9999999999999999999999999874

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-48  Score=339.12  Aligned_cols=253  Identities=25%  Similarity=0.425  Sum_probs=216.3

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++.+.||.|.||.||+|+.++++-.||+|++.+..-    ...+..+|++|-..|     .||||.++|++|.+..
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-----~hpnilrlY~~fhd~~   95 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-----RHPNILRLYGYFHDSK   95 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-----CCccHHhhhhheeccc
Confidence            3569999999999999999999999999999999865432    234455666665555     4589999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+||++||. .|+|...|+......+++..+..|+.|++.||.|||..+||||||||+|+|++..|              
T Consensus        96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~--------------  161 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG--------------  161 (281)
T ss_pred             eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC--------------
Confidence            999999999 89999999977777899999999999999999999999999999999999995544              


Q ss_pred             CCCcccccCCCCCCeEEEeCCCcccc-CCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYE-RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                                   .+||+|||-+... .....+.|||..|.+||.+.+..++..+|+|++|++.||++.|.+||...+..
T Consensus       162 -------------~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~  228 (281)
T KOG0580|consen  162 -------------ELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS  228 (281)
T ss_pred             -------------CeeccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH
Confidence                         5566666655443 23345679999999999999999999999999999999999999999988877


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +..+.|.+..-.                                                 +|+..+.+++|||..||.+
T Consensus       229 etYkrI~k~~~~-------------------------------------------------~p~~is~~a~dlI~~ll~~  259 (281)
T KOG0580|consen  229 ETYKRIRKVDLK-------------------------------------------------FPSTISGGAADLISRLLVK  259 (281)
T ss_pred             HHHHHHHHcccc-------------------------------------------------CCcccChhHHHHHHHHhcc
Confidence            777776654333                                                 3456788899999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~  426 (430)
                      +|.+|.+..|++.|||....
T Consensus       260 ~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  260 NPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             CccccccHHHHhhhHHHHhc
Confidence            99999999999999998653

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.2e-47  Score=369.25  Aligned_cols=244  Identities=25%  Similarity=0.432  Sum_probs=200.7

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      +.||+|+||.||+|.++.+++.||+|+++...    ........|+.+++.+.     |++|+.+++.+...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----hp~i~~~~~~~~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-----HPFLTALKYSFQTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-----CCCCCCEEEEEEcCCEEEEEEe
Confidence            36899999999999999999999999987432    22344567888888773     4789999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccc
Q 014117          176 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK  254 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~  254 (430)
                      |+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++                        
T Consensus        76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~------------------------  129 (323)
T cd05571          76 YANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD------------------------  129 (323)
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC------------------------
Confidence            99 889999987654  799999999999999999999999999999999999994                        


Q ss_pred             cCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Q 014117          255 RMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM  331 (430)
Q Consensus       255 ~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~  331 (430)
                         .++.+||+|||+++....   .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+.......
T Consensus       130 ---~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~  206 (323)
T cd05571         130 ---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL  206 (323)
T ss_pred             ---CCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH
Confidence               455677777777653211   12345799999999999999999999999999999999999999987655443333


Q ss_pred             HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCC
Q 014117          332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR  411 (430)
Q Consensus       332 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R  411 (430)
                      +....                                                 ..++...+.++.+||.+||+.||++|
T Consensus       207 ~~~~~-------------------------------------------------~~~p~~~~~~~~~li~~~L~~dP~~R  237 (323)
T cd05571         207 ILMEE-------------------------------------------------IRFPRTLSPEAKSLLAGLLKKDPKQR  237 (323)
T ss_pred             HHcCC-------------------------------------------------CCCCCCCCHHHHHHHHHHccCCHHHc
Confidence            22110                                                 01234567789999999999999999


Q ss_pred             C-----CHHHHhcCCCCCCC
Q 014117          412 L-----TAREALRHPFFTRD  426 (430)
Q Consensus       412 ~-----ta~elL~hp~f~~~  426 (430)
                      |     ++.++++||||+..
T Consensus       238 ~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         238 LGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             CCCCCCCHHHHHcCCCcCCC
Confidence            9     89999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.7e-46  Score=368.22  Aligned_cols=299  Identities=27%  Similarity=0.462  Sum_probs=227.7

Q ss_pred             CceeecCc---eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCc
Q 014117           83 HYMFALGE---NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNR  156 (430)
Q Consensus        83 ~~~~~~~~---~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~  156 (430)
                      .|.+..++   .+.++|++.+.||+|+||.||+|.+..+++.||+|++...   .........|+.+++.+     .|+|
T Consensus         7 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~n   81 (359)
T cd07876           7 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-----NHKN   81 (359)
T ss_pred             cceecccchhhhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-----CCCC
Confidence            34444444   3567899999999999999999999999999999998642   22344566788888887     4488


Q ss_pred             eEEecceeecC------CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEe
Q 014117          157 CVQIRNWFDYR------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV  230 (430)
Q Consensus       157 i~~~~~~~~~~------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~  230 (430)
                      |+++++++...      ..+|+||||++++|.+.+..    .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        82 iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~  157 (359)
T cd07876          82 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  157 (359)
T ss_pred             EeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC
Confidence            99999987643      35899999998888887743    588999999999999999999999999999999999995


Q ss_pred             ecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHH
Q 014117          231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC  308 (430)
Q Consensus       231 ~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv  308 (430)
                      .                           ++.+||+|||++......  .....||+.|+|||++.+..++.++|||||||
T Consensus       158 ~---------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~  210 (359)
T cd07876         158 S---------------------------DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC  210 (359)
T ss_pred             C---------------------------CCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHH
Confidence            4                           455677777766533221  12347899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhh
Q 014117          309 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH  388 (430)
Q Consensus       309 ~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (430)
                      ++|+|++|..||.+.+..+.+..+...++.++..+..........+..... .++...     +....... ........
T Consensus       211 il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~-~~~~~~~~  283 (359)
T cd07876         211 IMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRP-QYPGIS-----FEELFPDW-IFPSESER  283 (359)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCC-CCCCcc-----hhhhcccc-cccccccc
Confidence            999999999999998888888889999999888877776655555543311 111100     00000000 00000011


Q ss_pred             cCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCC
Q 014117          389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       389 ~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~  424 (430)
                      ....+.++++||.+||+.||++|||++|+|+||||+
T Consensus       284 ~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  319 (359)
T cd07876         284 DKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT  319 (359)
T ss_pred             ccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence            223466789999999999999999999999999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.3e-47  Score=370.12  Aligned_cols=251  Identities=27%  Similarity=0.436  Sum_probs=208.8

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCC-eEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .++|++.+.||+|+||.||+|.++.++ ..||+|++....    .....+..|+.++..+.     |+||+++++++...
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~Iv~~~~~~~~~  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-----HPFCVNLYGSFKDE  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-----CCCCcceEEEEEeC
Confidence            457999999999999999999876654 689999986432    23345667888888873     48899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +.+|+||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||+                 
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl-----------------  164 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL-----------------  164 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE-----------------
Confidence            9999999999 899999998764  79999999999999999999999999999999999999                 


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                                +.++.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..
T Consensus       165 ----------~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~  234 (340)
T PTZ00426        165 ----------DKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL  234 (340)
T ss_pred             ----------CCCCCEEEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH
Confidence                      4455678888887766554445568999999999999989999999999999999999999999876655


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      .....+.....                                                 .++...+.++.++|++||+.
T Consensus       235 ~~~~~i~~~~~-------------------------------------------------~~p~~~~~~~~~li~~~l~~  265 (340)
T PTZ00426        235 LIYQKILEGII-------------------------------------------------YFPKFLDNNCKHLMKKLLSH  265 (340)
T ss_pred             HHHHHHhcCCC-------------------------------------------------CCCCCCCHHHHHHHHHHccc
Confidence            44443322111                                                 12234566789999999999


Q ss_pred             CCCCCC-----CHHHHhcCCCCCCC
Q 014117          407 DPTDRL-----TAREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~-----ta~elL~hp~f~~~  426 (430)
                      ||.+|+     |++++++||||+..
T Consensus       266 dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        266 DLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             CHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999996     89999999999864

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-48  Score=360.21  Aligned_cols=251  Identities=27%  Similarity=0.463  Sum_probs=218.5

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .++..+|++.++||.|.||.|-+|++...|+.||||.+++.+.    ..-...+|++|+..|     +||||+++|+.|+
T Consensus        49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-----NHPhII~IyEVFE  123 (668)
T KOG0611|consen   49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-----NHPHIIQIYEVFE  123 (668)
T ss_pred             cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-----CCCceeehhhhhc
Confidence            4566789999999999999999999999999999999976542    223456799999988     5699999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                      ..+.+.|||||. +|.|++|+...+  .|++.+++.+++||.+|+.|||.+++||||||.+|||+               
T Consensus       124 NkdKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---------------  186 (668)
T KOG0611|consen  124 NKDKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---------------  186 (668)
T ss_pred             CCceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---------------
Confidence            999999999999 999999999876  89999999999999999999999999999999999999               


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCC-CcchHHHHHHHHHHHHhCCCCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                                  |.+.++||+|||++.......  .++||++.|.+||++.|.+|. +.+|.|||||+||.|+.|..||+
T Consensus       187 ------------D~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD  254 (668)
T KOG0611|consen  187 ------------DQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD  254 (668)
T ss_pred             ------------cCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC
Confidence                        677788999999887655444  568999999999999999985 88999999999999999999999


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      +.+....+.+|...                       .+.-                           +.-+.++..||+
T Consensus       255 G~Dhk~lvrQIs~G-----------------------aYrE---------------------------P~~PSdA~gLIR  284 (668)
T KOG0611|consen  255 GRDHKRLVRQISRG-----------------------AYRE---------------------------PETPSDASGLIR  284 (668)
T ss_pred             CchHHHHHHHhhcc-----------------------cccC---------------------------CCCCchHHHHHH
Confidence            98776666655432                       2222                           223456889999


Q ss_pred             HhhhcCCCCCCCHHHHhcCCCCC
Q 014117          402 GLLRYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~hp~f~  424 (430)
                      .||.+||++|.|++++-.|=|+.
T Consensus       285 wmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  285 WMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             HHHhcCcccchhHHHHhhhheee
Confidence            99999999999999999998875

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.2e-46  Score=371.02  Aligned_cols=281  Identities=27%  Similarity=0.470  Sum_probs=222.0

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC---
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN---  168 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~---  168 (430)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....   ........|+++++.+.     |+||+.+++++...+   
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~   75 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK-----HDNVLSALDILQPPHIDP   75 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCC-----CCCcCCHhheecCCCccc
Confidence            3788999999999999999999999999999986421   23345677888888884     478999999988776   


Q ss_pred             --eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          169 --HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       169 --~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                        .+|+||||++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.+              
T Consensus        76 ~~~~~lv~e~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~--------------  139 (372)
T cd07853          76 FEEIYVVTELMQSDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN--------------  139 (372)
T ss_pred             cceEEEEeeccccCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC--------------
Confidence              899999999889998886643  79999999999999999999999999999999999999544              


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                                   +.+||+|||+++......    ....+|+.|+|||++.+. .++.++|||||||++|||++|++||.
T Consensus       140 -------------~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  206 (372)
T cd07853         140 -------------CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ  206 (372)
T ss_pred             -------------CCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence                         456666666554332211    223678999999999875 48999999999999999999999999


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      +.+..+.+..+...+|..+...+.........++.......+.                 ...........+.++.+||.
T Consensus       207 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~li~  269 (372)
T cd07853         207 AQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPS-----------------LPVLYTLSSQATHEAVHLLC  269 (372)
T ss_pred             CCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCc-----------------hHHhcccCCCCCHHHHHHHH
Confidence            9999999999999999888766555444333333222111110                 00111223455778999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          402 GLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +||+.||++|||+.|+|+||||...
T Consensus       270 ~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         270 RMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HhCCCChhhCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=4.5e-48  Score=367.28  Aligned_cols=324  Identities=33%  Similarity=0.596  Sum_probs=266.3

Q ss_pred             CCCCCCCCceeecCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCC-C
Q 014117           76 REDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG-G  154 (430)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~-~  154 (430)
                      ..++..|.|.+.+|+.+.++|.+....|+|-|++|..|.+...+..||||+|+.+....+.-+.|+++|++|...... -
T Consensus       414 NWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk  493 (752)
T KOG0670|consen  414 NWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDK  493 (752)
T ss_pred             CcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhh
Confidence            456778899999999999999999999999999999999999999999999998888888889999999999876532 3


Q ss_pred             CceEEecceeecCCeEEEEEecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecC
Q 014117          155 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE  233 (430)
Q Consensus       155 ~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~  233 (430)
                      .||+.++..|...+++|||||.+..+|.++|.+-+. ..|....++.|+.|++.||..|-..||+|.||||+|||+++  
T Consensus       494 ~Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE--  571 (752)
T KOG0670|consen  494 FHCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE--  571 (752)
T ss_pred             hHHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc--
Confidence            579999999999999999999999999999987653 46889999999999999999999999999999999999974  


Q ss_pred             ccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCC-eeeecCcccchhhhhCCCCCCcchHHHHHHHHHH
Q 014117          234 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN-YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE  312 (430)
Q Consensus       234 ~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~e  312 (430)
                                              ....+||||||.|.......- -+.-+..|.|||+++|.+|+...|+||+||+|||
T Consensus       572 ------------------------~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYE  627 (752)
T KOG0670|consen  572 ------------------------SKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYE  627 (752)
T ss_pred             ------------------------CcceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEE
Confidence                                    345789999999987655442 2344678999999999999999999999999999


Q ss_pred             HHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCC-ChhhHHhhcC-c---hhHHHHHhh
Q 014117          313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMK-L---PRLQNLIMQ  387 (430)
Q Consensus       313 l~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~---~~~~~~~~~  387 (430)
                      |.||+..|.+.++.+++..++.+-|.+|..++.+.+-.-..|..+..|-+-+.-. .......++. .   ..+...+..
T Consensus       628 lYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~  707 (752)
T KOG0670|consen  628 LYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIA  707 (752)
T ss_pred             eeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhc
Confidence            9999999999999999999999999999999998766666666655554433211 1111111111 1   111111111


Q ss_pred             ---hcC---CchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          388 ---HVD---HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       388 ---~~~---~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                         +++   ..-.++.+||.+||.+||++|.|..++|.||||+.
T Consensus       708 ~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  708 VQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             cCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence               111   22345899999999999999999999999999985

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.9e-46  Score=359.07  Aligned_cols=282  Identities=26%  Similarity=0.459  Sum_probs=222.8

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ++|.+.++||+|+||.||+|.++.+++.||+|.++...  ........|+.+++++.     |+|++++++++...+..|
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK-----HANIVTLHDIVHTDKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCC-----CCCcceEEEEEeeCCeEE
Confidence            56999999999999999999999999999999986332  22345667898888884     478999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          172 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       172 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      +||||+.++|.+++...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.                    
T Consensus        81 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~--------------------  139 (309)
T cd07872          81 LVFEYLDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINE--------------------  139 (309)
T ss_pred             EEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--------------------
Confidence            999999889999887654 45899999999999999999999999999999999999954                    


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                             ++.+||+|||++.......   ....+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+
T Consensus       140 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~  212 (309)
T cd07872         140 -------RGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED  212 (309)
T ss_pred             -------CCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                   4456666666664322211   22467899999999876 458999999999999999999999999988888


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+...++.++...++.+.........    ..+...               ...........+.++.+||.+||+.|
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------------~~~~~~~~~~~~~~~~~li~~~L~~d  273 (309)
T cd07872         213 ELHLIFRLLGTPTEETWPGISSNDEFKNY----NFPKYK---------------PQPLINHAPRLDTEGIELLTKFLQYE  273 (309)
T ss_pred             HHHHHHHHhCCCCHHHHhhhcchhhhhhh----hcCccC---------------CCchhhhccCCCHHHHHHHHHhccCC
Confidence            88889999998888776654332211100    000000               00001122456778999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~~  427 (430)
                      |.+|||++|+|+||||+..+
T Consensus       274 p~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         274 SKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhCCCHHHHhcChhhhhcc
Confidence            99999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.2e-46  Score=369.91  Aligned_cols=279  Identities=23%  Similarity=0.317  Sum_probs=208.8

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++++.||+|+||+||+|.++.+++.||+|+++...    ........|+.++.++     .+++|+++++.+.+...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-----~~~~iv~~~~~~~~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-----DSLWVVKMFYSFQDKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-----CCCCcceEEEEEecCCe
Confidence            36899999999999999999999999999999997432    2223456688888777     44789999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +||||||+ +++|.+++...+  .+++..++.++.||+.||+|||++|||||||||+|||++.++.++|+|||++.....
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            99999999 889999998754  799999999999999999999999999999999999998888888888888764322


Q ss_pred             CCcc-cccCCCCCCeEEEeCCCcccc------------CCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh
Q 014117          249 DSSY-FKRMPKSSAIKVIDFGSTTYE------------RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT  315 (430)
Q Consensus       249 ~~~~-~~~~~~~~~~kl~Dfg~a~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t  315 (430)
                      .... +.+  ........|+......            .......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       154 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~  231 (363)
T cd05628         154 AHRTEFYR--NLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI  231 (363)
T ss_pred             cccccccc--cccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence            1100 000  0000001111111000            000123579999999999999999999999999999999999


Q ss_pred             CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhH
Q 014117          316 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD  395 (430)
Q Consensus       316 G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (430)
                      |..||.+.+..+....+......+                     ..|.                        ....+.+
T Consensus       232 G~~Pf~~~~~~~~~~~i~~~~~~~---------------------~~p~------------------------~~~~s~~  266 (363)
T cd05628         232 GYPPFCSETPQETYKKVMNWKETL---------------------IFPP------------------------EVPISEK  266 (363)
T ss_pred             CCCCCCCCCHHHHHHHHHcCcCcc---------------------cCCC------------------------cCCCCHH
Confidence            999998876666555443211110                     0010                        1134668


Q ss_pred             HHHHHHHhhhcCCC---CCCCHHHHhcCCCCCCCC
Q 014117          396 LTHLLQGLLRYDPT---DRLTAREALRHPFFTRDH  427 (430)
Q Consensus       396 ~~~ll~~~L~~dP~---~R~ta~elL~hp~f~~~~  427 (430)
                      +++||.+|+. +|.   .||+++|+++||||+..+
T Consensus       267 ~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~  300 (363)
T cd05628         267 AKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD  300 (363)
T ss_pred             HHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence            8999999775 444   468999999999998653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-47  Score=366.52  Aligned_cols=258  Identities=25%  Similarity=0.391  Sum_probs=211.6

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++...    .....+..|++++..+.     +++|+++++.+...+.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----h~~iv~~~~~~~~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-----SEWLVKLLYAFQDDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-----CCCCccEEEEEEcCCE
Confidence            36999999999999999999999999999999987432    22344667888888773     4889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .||||||+ +++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||+                   
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~-------------------  134 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI-------------------  134 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE-------------------
Confidence            99999999 899999997654  78999999999999999999999999999999999999                   


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                              +.++.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+.
T Consensus       135 --------~~~~~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~  206 (333)
T cd05600         135 --------DASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET  206 (333)
T ss_pred             --------CCCCCEEEEeCcCCcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH
Confidence                    445678888888877655444556899999999999999999999999999999999999999988766555


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      ...+......+                     ..+....                    .....+.++.+||.+||+.+|
T Consensus       207 ~~~i~~~~~~~---------------------~~~~~~~--------------------~~~~~s~~~~~li~~~l~~~~  245 (333)
T cd05600         207 WENLKYWKETL---------------------QRPVYDD--------------------PRFNLSDEAWDLITKLINDPS  245 (333)
T ss_pred             HHHHHhccccc---------------------cCCCCCc--------------------cccccCHHHHHHHHHHhhChh
Confidence            54433211100                     0000000                    002346789999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCC
Q 014117          409 TDRLTAREALRHPFFTRD  426 (430)
Q Consensus       409 ~~R~ta~elL~hp~f~~~  426 (430)
                      ++|||+.++++||||+..
T Consensus       246 ~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         246 RRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             hhcCCHHHHHhCcccCCC
Confidence            999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.5e-46  Score=355.54  Aligned_cols=278  Identities=30%  Similarity=0.537  Sum_probs=213.6

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-----
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-----  166 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-----  166 (430)
                      +|++.+.||+|+||+||+|.++.+++.||+|.++...   ........|+.+++.+.+.  .|+||+++++++..     
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~h~ni~~~~~~~~~~~~~~   78 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAF--DHPNIVRLMDVCATSRTDR   78 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhc--CCCCeeeeeeeeccccCCC
Confidence            5899999999999999999999999999999986422   1223456788888877542  35889999987753     


Q ss_pred             CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          167 RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       167 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      ...+++|||++.++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.               
T Consensus        79 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~---------------  143 (288)
T cd07863          79 ETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS---------------  143 (288)
T ss_pred             CceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC---------------
Confidence            35689999999889999998765556999999999999999999999999999999999999954               


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                  ++.+||+|||++.......  ....||..|+|||++.+..++.++|||||||++|+|++|.+||.+..
T Consensus       144 ------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~  211 (288)
T cd07863         144 ------------GGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS  211 (288)
T ss_pred             ------------CCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence                        4456666666665432221  23468999999999999899999999999999999999999999888


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+.+..+....+.+....+....            ..+.....          ...........+..+.++.+||.+||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~~L  269 (288)
T cd07863         212 EADQLGKIFDLIGLPPEDDWPRDV------------TLPRGAFS----------PRGPRPVQSVVPEIEESGAQLLLEML  269 (288)
T ss_pred             HHHHHHHHHHHhCCCChhhCcccc------------cccccccC----------CCCCCchHHhCcCcCHHHHHHHHHHh
Confidence            777777777776665443221100            00000000          00000112233456778999999999


Q ss_pred             hcCCCCCCCHHHHhcCCCC
Q 014117          405 RYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f  423 (430)
                      ++||++|||+.|++.||||
T Consensus       270 ~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         270 TFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccCcccCCCHHHHhcCCCC
Confidence            9999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.9e-46  Score=362.81  Aligned_cols=250  Identities=25%  Similarity=0.368  Sum_probs=204.1

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      +|++++.||+|+||.||+|.++.+++.||+|+++...    ........|.+++..+.+    +++++.+++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~----~~~i~~~~~~~~~~~~~   76 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK----PPFLTQLHSCFQTMDRL   76 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCC----CCceeeeEEEEEcCCEE
Confidence            4889999999999999999999999999999987432    223445667777766643    35688899999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++                   
T Consensus        77 ~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~-------------------  135 (324)
T cd05587          77 YFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD-------------------  135 (324)
T ss_pred             EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc-------------------
Confidence            9999999 899999997654  689999999999999999999999999999999999994                   


Q ss_pred             CcccccCCCCCCeEEEeCCCccccC---CCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                              .++.+||+|||++....   ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus       136 --------~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~  207 (324)
T cd05587         136 --------AEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED  207 (324)
T ss_pred             --------CCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence                    44567777777665321   1123357999999999999999999999999999999999999999877665


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +....+......                                                 ++...+.++.+||.+||+.
T Consensus       208 ~~~~~i~~~~~~-------------------------------------------------~~~~~~~~~~~li~~~l~~  238 (324)
T cd05587         208 ELFQSIMEHNVS-------------------------------------------------YPKSLSKEAVSICKGLLTK  238 (324)
T ss_pred             HHHHHHHcCCCC-------------------------------------------------CCCCCCHHHHHHHHHHhhc
Confidence            555444321111                                                 2234567899999999999


Q ss_pred             CCCCCCCH-----HHHhcCCCCCCC
Q 014117          407 DPTDRLTA-----REALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~ta-----~elL~hp~f~~~  426 (430)
                      ||.+|+++     +++++||||...
T Consensus       239 ~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         239 HPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999976     899999999864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.6e-46  Score=365.40  Aligned_cols=299  Identities=26%  Similarity=0.447  Sum_probs=227.7

Q ss_pred             ceeecCc---eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCce
Q 014117           84 YMFALGE---NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRC  157 (430)
Q Consensus        84 ~~~~~~~---~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i  157 (430)
                      |.+..++   .+.++|++.+.||+|+||.||+|.+..+++.||+|++...   .........|+.+++.+.     |+||
T Consensus         4 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~ni   78 (355)
T cd07874           4 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-----HKNI   78 (355)
T ss_pred             eeeccCchhhhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhC-----CCch
Confidence            3444444   3467899999999999999999999999999999998643   223355667888888884     4789


Q ss_pred             EEecceeecC------CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEee
Q 014117          158 VQIRNWFDYR------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS  231 (430)
Q Consensus       158 ~~~~~~~~~~------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~  231 (430)
                      +++++.+...      ...|+||||+.++|.+.+..    .+++..+..++.||+.||.|||++||+||||||+|||++ 
T Consensus        79 v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~-  153 (355)
T cd07874          79 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-  153 (355)
T ss_pred             hceeeeeeccccccccceeEEEhhhhcccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC-
Confidence            9998877543      46899999998888887753    588999999999999999999999999999999999994 


Q ss_pred             cCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHH
Q 014117          232 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI  309 (430)
Q Consensus       232 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~  309 (430)
                                                .++.+||+|||+++......  ....||..|+|||++.+..++.++|||||||+
T Consensus       154 --------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~i  207 (355)
T cd07874         154 --------------------------SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI  207 (355)
T ss_pred             --------------------------CCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHH
Confidence                                      44567777777776433221  23578999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhc
Q 014117          310 LVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV  389 (430)
Q Consensus       310 l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (430)
                      +|+|++|+.||.+.+..+....+...++.+..+....+......+..+.. .+........     .. ...........
T Consensus       208 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~-~~~~~~~~~~~  280 (355)
T cd07874         208 MGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP-KYAGLTFPKL-----FP-DSLFPADSEHN  280 (355)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCC-ccccccchhh-----cc-ccccccccccc
Confidence            99999999999998888888888888888887777776655555543321 1110000000     00 00000011122


Q ss_pred             CCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       390 ~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      ...+.++++||.+||+.||++|||+.|+|+||||..
T Consensus       281 ~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~  316 (355)
T cd07874         281 KLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV  316 (355)
T ss_pred             cccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence            334567899999999999999999999999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-48  Score=362.00  Aligned_cols=261  Identities=26%  Similarity=0.410  Sum_probs=217.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecC----chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .+.|..-+.||+||||.|+-|..+.||+.||.|.+.+    ........+.|..+|.++..     +.||.+...|++.+
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s-----~FiVslaYAfeTkd  258 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSS-----PFIVSLAYAFETKD  258 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhcc-----CcEEEEeeeecCCC
Confidence            3568999999999999999999999999999998742    12233456789999999844     68999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+||||..| ||+|.-+|-+.++..|++..++.|+.+|+.||++||+.+||+|||||+|||+++                
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd----------------  322 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDD----------------  322 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeecc----------------
Confidence            999999999 999988888888889999999999999999999999999999999999999954                


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                                 .++++|+|+|+|.......  ...+||.+|||||++.++.|+...|+|||||+||||+.|+.||....+
T Consensus       323 -----------~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke  391 (591)
T KOG0986|consen  323 -----------HGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE  391 (591)
T ss_pred             -----------CCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence                       5556666666665433322  334899999999999999999999999999999999999999987665


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      ......+.+..-.                                             ...++++.+++++++|++.+|+
T Consensus       392 Kvk~eEvdrr~~~---------------------------------------------~~~ey~~kFS~eakslc~~LL~  426 (591)
T KOG0986|consen  392 KVKREEVDRRTLE---------------------------------------------DPEEYSDKFSEEAKSLCEGLLT  426 (591)
T ss_pred             hhhHHHHHHHHhc---------------------------------------------chhhcccccCHHHHHHHHHHHc
Confidence            5444333332211                                             1233567889999999999999


Q ss_pred             cCCCCCC-----CHHHHhcCCCCCCCCCCC
Q 014117          406 YDPTDRL-----TAREALRHPFFTRDHLRR  430 (430)
Q Consensus       406 ~dP~~R~-----ta~elL~hp~f~~~~~~~  430 (430)
                      +||.+|+     +++++.+||||++-+.+|
T Consensus       427 Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r  456 (591)
T KOG0986|consen  427 KDPEKRLGCRGEGAQEVKEHPFFKDLNWRR  456 (591)
T ss_pred             cCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence            9999998     588999999999887664

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.5e-46  Score=365.38  Aligned_cols=291  Identities=27%  Similarity=0.429  Sum_probs=224.5

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--  166 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--  166 (430)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++...   .........|+.+++.+.     |+||+.+++.+..  
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~ii~~~~~~~~~~   96 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-----HKNIIGLLNVFTPQK   96 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcC-----CCCccccceeecccc
Confidence            457899999999999999999999999999999998642   223345667888888874     4778888877643  


Q ss_pred             ----CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          167 ----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       167 ----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                          ...+|+||||++++|.+++..    .+++..+..++.|++.||.|||++||+||||||+|||++            
T Consensus        97 ~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~------------  160 (364)
T cd07875          97 SLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK------------  160 (364)
T ss_pred             cccccCeEEEEEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC------------
Confidence                346899999998899888753    488999999999999999999999999999999999994            


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                     .++.+||+|||+++......  ....||..|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       161 ---------------~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf  225 (364)
T cd07875         161 ---------------SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF  225 (364)
T ss_pred             ---------------CCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCC
Confidence                           45567777777776443321  2347899999999999999999999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .+.+..+.+..+....+.+++.+...+......+..+.... ..  .   ......... ............+.++++||
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~---~~~~~~~~~-~~~~~~~~~~~~~~~~~dll  298 (364)
T cd07875         226 PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKY-AG--Y---SFEKLFPDV-LFPADSEHNKLKASQARDLL  298 (364)
T ss_pred             CCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCc-CC--C---ChHhhCccc-cccccccccccccHHHHHHH
Confidence            99998888999989899888887777665555544331100 00  0   000000000 00001111223456789999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          401 QGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      .+||+.||.+|||++|+|+||||..
T Consensus       299 ~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         299 SKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             HHhcCcCcccCCCHHHHhcCccccc
Confidence            9999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.1e-46  Score=370.43  Aligned_cols=280  Identities=24%  Similarity=0.369  Sum_probs=208.2

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .|++++.||+|+||+||+|+++.+++.||+|+++...    .....+..|+.+++.+     .+++|+++++.+.+.+.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-----~h~~iv~l~~~~~~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-----DNEWVVKLYYSFQDKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-----CCCCeeeeEEEEecCCEE
Confidence            5899999999999999999999999999999996432    2234566788888887     348899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||+ +++|.+++....  .+++..++.++.||+.||+|||+.|||||||||+||||+.++.++++|||++......
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            9999999 889999997754  7999999999999999999999999999999999999999999999999987533211


Q ss_pred             Cc--cccc------CCCC-----CCeEEEeCCCc-------cc---cCCCCCeeeecCcccchhhhhCCCCCCcchHHHH
Q 014117          250 SS--YFKR------MPKS-----SAIKVIDFGST-------TY---ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSV  306 (430)
Q Consensus       250 ~~--~~~~------~~~~-----~~~kl~Dfg~a-------~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  306 (430)
                      ..  ....      ....     .....+.++..       ..   ........+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00  0000      0000     00000111100       00   0001123579999999999999899999999999


Q ss_pred             HHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHh
Q 014117          307 GCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM  386 (430)
Q Consensus       307 Gv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (430)
                      ||++|||++|..||...+..+....+......                     ...+                       
T Consensus       235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------~~~~-----------------------  270 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTETQLKVINWENT---------------------LHIP-----------------------  270 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------------cCCC-----------------------
Confidence            99999999999999876654443333211100                     0000                       


Q ss_pred             hhcCCchhHHHHHHHHhhhc--CCCCCCCHHHHhcCCCCCCC
Q 014117          387 QHVDHSAGDLTHLLQGLLRY--DPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       387 ~~~~~~~~~~~~ll~~~L~~--dP~~R~ta~elL~hp~f~~~  426 (430)
                       .....+.++.+||.+||..  +|..|+|+++++.||||+.-
T Consensus       271 -~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         271 -PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             -CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence             0124567899999996654  55559999999999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-46  Score=364.82  Aligned_cols=282  Identities=26%  Similarity=0.485  Sum_probs=220.8

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-  167 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~-  167 (430)
                      +.++|++++.||.|+||.||+|.+..+++.||+|++....   ........|+.+++.+.     |+||+++++++... 
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~   87 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK-----HENVIGLLDVFTPAT   87 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcC-----CCchhhhhhhhcccc
Confidence            4578999999999999999999999999999999986432   22345667899998884     47889988877532 


Q ss_pred             -----CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          168 -----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       168 -----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                           ...|++|++++++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+|||++            
T Consensus        88 ~~~~~~~~~~~~~~~~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~------------  152 (343)
T cd07878          88 SIENFNEVYLVTNLMGADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN------------  152 (343)
T ss_pred             cccccCcEEEEeecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC------------
Confidence                 46899999999999988764   3699999999999999999999999999999999999994            


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCC
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                                     .++.+||+|||++..........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus       153 ---------------~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  217 (343)
T cd07878         153 ---------------EDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP  217 (343)
T ss_pred             ---------------CCCCEEEcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence                           4456777777776655444445678999999999987 468999999999999999999999999


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      +.+..+.+..+....+..+......+............-..+              ..    .........++.+.+||.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~----~~~~~~~~~~~~~~~li~  279 (343)
T cd07878         218 GNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMP--------------QQ----DLKKIFRGANPLAIDLLE  279 (343)
T ss_pred             CCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhcccccc--------------ch----hHHHhccCCCHHHHHHHH
Confidence            888888888888888888777665543222111100000000              00    011122345567899999


Q ss_pred             HhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          402 GLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +||+.||.+|||+.|+|+||||...
T Consensus       280 ~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         280 KMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             HHcCCChhhCCCHHHHhcCcchhcc
Confidence            9999999999999999999999753

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-46  Score=370.08  Aligned_cols=280  Identities=24%  Similarity=0.392  Sum_probs=210.7

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...    .....+..|+.++..+.     |++|+++++.+...+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-----h~~iv~~~~~~~~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-----NPWVVKLYYSFQDENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-----CCCCcceEEEEEcCCe
Confidence            36999999999999999999999999999999997432    22234567888888873     5889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +||||||+ +++|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||++.....
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            99999999 889999998754  699999999999999999999999999999999999999888888899887754322


Q ss_pred             CCc--ccccCCCCCCeEEEeCCCccccCC------------CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHH
Q 014117          249 DSS--YFKRMPKSSAIKVIDFGSTTYERP------------DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC  314 (430)
Q Consensus       249 ~~~--~~~~~~~~~~~kl~Dfg~a~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~  314 (430)
                      ...  ...........-..++........            .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            110  000000000000011111000000            011247999999999999999999999999999999999


Q ss_pred             hCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchh
Q 014117          315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG  394 (430)
Q Consensus       315 tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (430)
                      +|.+||...+..+....+......                     +..+.                        ....+.
T Consensus       234 ~G~~Pf~~~~~~~~~~~i~~~~~~---------------------~~~~~------------------------~~~~s~  268 (364)
T cd05599         234 VGYPPFCSDNPQETYRKIINWKET---------------------LQFPD------------------------EVPLSP  268 (364)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCc---------------------cCCCC------------------------CCCCCH
Confidence            999999877665544333211000                     00000                        113467


Q ss_pred             HHHHHHHHhhhcCCCCCCC---HHHHhcCCCCCCC
Q 014117          395 DLTHLLQGLLRYDPTDRLT---AREALRHPFFTRD  426 (430)
Q Consensus       395 ~~~~ll~~~L~~dP~~R~t---a~elL~hp~f~~~  426 (430)
                      ++.+||.+||. +|.+|++   ++|+|.||||+..
T Consensus       269 ~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         269 EAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             HHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            89999999997 9999998   9999999999764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-46  Score=360.96  Aligned_cols=242  Identities=31%  Similarity=0.498  Sum_probs=199.6

Q ss_pred             eccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 014117          102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL  177 (430)
Q Consensus       102 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~  177 (430)
                      ||+|+||.||+|.+..+++.||+|+++...    ........|+.++.++     +|+||+++++.+...+.+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-----NCPFIVPLKFSFQSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCcEeceeeEEecCCeEEEEEcCC
Confidence            799999999999999999999999986422    2234556788888887     4488999999999999999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccC
Q 014117          178 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM  256 (430)
Q Consensus       178 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~  256 (430)
                       +++|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||++                          
T Consensus        76 ~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~--------------------------  127 (312)
T cd05585          76 NGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD--------------------------  127 (312)
T ss_pred             CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC--------------------------
Confidence             899999997754  799999999999999999999999999999999999994                          


Q ss_pred             CCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Q 014117          257 PKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME  333 (430)
Q Consensus       257 ~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~  333 (430)
                       .++.+||+|||++.....   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus       128 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~  206 (312)
T cd05585         128 -YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL  206 (312)
T ss_pred             -CCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence             455677777777764322   1233579999999999999999999999999999999999999998765544433322


Q ss_pred             HHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCC-
Q 014117          334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL-  412 (430)
Q Consensus       334 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-  412 (430)
                      ..                       .                          ..++...+.++.+||.+||+.||.+|| 
T Consensus       207 ~~-----------------------~--------------------------~~~~~~~~~~~~~li~~~L~~dp~~R~~  237 (312)
T cd05585         207 QE-----------------------P--------------------------LRFPDGFDRDAKDLLIGLLSRDPTRRLG  237 (312)
T ss_pred             cC-----------------------C--------------------------CCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence            11                       0                          012345667899999999999999997 


Q ss_pred             --CHHHHhcCCCCCCC
Q 014117          413 --TAREALRHPFFTRD  426 (430)
Q Consensus       413 --ta~elL~hp~f~~~  426 (430)
                        ++.|+|.||||++.
T Consensus       238 ~~~~~e~l~hp~~~~~  253 (312)
T cd05585         238 YNGAQEIKNHPFFSQL  253 (312)
T ss_pred             CCCHHHHHcCCCcCCC
Confidence              58999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.4e-46  Score=360.89  Aligned_cols=250  Identities=25%  Similarity=0.346  Sum_probs=202.3

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      +|.+.+.||+|+||.||+|.++.+++.||+|++++...    .......|..++..+.    ++++++.+++++...+.+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~----~~~~i~~~~~~~~~~~~~   76 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG----KPPFLTQLHSCFQTMDRL   76 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc----CCCeEeeEEEEEecCCEE
Confidence            48899999999999999999999999999999874321    1223445666655543    347889999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.                  
T Consensus        77 ~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~------------------  136 (323)
T cd05616          77 YFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS------------------  136 (323)
T ss_pred             EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC------------------
Confidence            9999999 889999987654  6999999999999999999999999999999999999954                  


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                               ++.+||+|||++.....   .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..
T Consensus       137 ---------~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~  207 (323)
T cd05616         137 ---------EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED  207 (323)
T ss_pred             ---------CCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH
Confidence                     44566666666653211   123357899999999999999999999999999999999999999887665


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +....+......                                                 ++...+.++.+|+.+||++
T Consensus       208 ~~~~~i~~~~~~-------------------------------------------------~p~~~s~~~~~li~~~l~~  238 (323)
T cd05616         208 ELFQSIMEHNVA-------------------------------------------------YPKSMSKEAVAICKGLMTK  238 (323)
T ss_pred             HHHHHHHhCCCC-------------------------------------------------CCCcCCHHHHHHHHHHccc
Confidence            555444322111                                                 2234567899999999999


Q ss_pred             CCCCCCC-----HHHHhcCCCCCCC
Q 014117          407 DPTDRLT-----AREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~t-----a~elL~hp~f~~~  426 (430)
                      ||++|++     ..++++||||+..
T Consensus       239 ~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         239 HPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             CHHhcCCCCCCCHHHHhcCCCcCCC
Confidence            9999997     4899999999754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.9e-46  Score=371.04  Aligned_cols=278  Identities=27%  Similarity=0.423  Sum_probs=209.5

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      +|++++.||+|+||.||+|++..+++.||+|++....    ........|+.+++++     .+++|+++++.+.+.+.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-----~h~~iv~~~~~~~~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-----DNEWVVRLYYSFQDKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-----CCCcCCeEEEEEEeCCEE
Confidence            5899999999999999999999999999999987432    2234566788888887     347899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||+ +++|.+++...+  .+++..++.++.||+.||+|||++|||||||||+|||++.+|.++|+|||++......
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            9999999 889999997654  7899999999999999999999999999999999999999999999999987532211


Q ss_pred             Cc--ccccCCCCCCeEEEeCCC---------------------ccc-cCCCCCeeeecCcccchhhhhCCCCCCcchHHH
Q 014117          250 SS--YFKRMPKSSAIKVIDFGS---------------------TTY-ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWS  305 (430)
Q Consensus       250 ~~--~~~~~~~~~~~kl~Dfg~---------------------a~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws  305 (430)
                      ..  .... .........+|..                     ... ........+||+.|+|||++.+..|+.++||||
T Consensus       155 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (382)
T cd05625         155 HDSKYYQS-GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  233 (382)
T ss_pred             cccccccc-ccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence            00  0000 0000000000000                     000 000112357999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHH
Q 014117          306 VGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI  385 (430)
Q Consensus       306 lGv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (430)
                      |||++|||++|++||.+.+..+....+......+                     ..|                      
T Consensus       234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------~~p----------------------  270 (382)
T cd05625         234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL---------------------HIP----------------------  270 (382)
T ss_pred             chHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc---------------------CCC----------------------
Confidence            9999999999999998776655443332211100                     000                      


Q ss_pred             hhhcCCchhHHHHHHHHhhhcCCCCCCC---HHHHhcCCCCCCC
Q 014117          386 MQHVDHSAGDLTHLLQGLLRYDPTDRLT---AREALRHPFFTRD  426 (430)
Q Consensus       386 ~~~~~~~~~~~~~ll~~~L~~dP~~R~t---a~elL~hp~f~~~  426 (430)
                        .....++++.+||.+|+ .||.+|++   ++++++||||+..
T Consensus       271 --~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         271 --PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             --CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence              01245678999999976 59999997   9999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-47  Score=359.83  Aligned_cols=256  Identities=26%  Similarity=0.474  Sum_probs=228.1

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .+.+-|.+.+.||+|.|+.|-+|++.-+|..||||++.+.+.   .......|++.|+.++|     +|||++|+.++..
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQH-----pNiVRLYEViDTQ   89 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQH-----PNIVRLYEVIDTQ   89 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcC-----cCeeeeeehhccc
Confidence            455679999999999999999999999999999999976543   23456789999998865     8899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      ..+|||+|+- +|+|++|+-+.. ..+.++.+++|+.||+.|+.|||+.-+|||||||+||.+-                
T Consensus        90 TKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF----------------  152 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF----------------  152 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe----------------
Confidence            9999999999 889999998765 5799999999999999999999999999999999999984                


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCC-CcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                .+.+.+||+|||++....++.  .+.||+..|-|||+++|..|+ +++||||||||||-|++|++||...
T Consensus       153 ----------EKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA  222 (864)
T KOG4717|consen  153 ----------EKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA  222 (864)
T ss_pred             ----------eecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc
Confidence                      567889999999987666654  568999999999999999998 7789999999999999999999999


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      ++.+.+.+|...-...|                                                 +..+.+++|||..|
T Consensus       223 NDSETLTmImDCKYtvP-------------------------------------------------shvS~eCrdLI~sM  253 (864)
T KOG4717|consen  223 NDSETLTMIMDCKYTVP-------------------------------------------------SHVSKECRDLIQSM  253 (864)
T ss_pred             cchhhhhhhhcccccCc-------------------------------------------------hhhhHHHHHHHHHH
Confidence            99999988876555444                                                 45577899999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      |+.||++|.|.+++..|+|++.-+
T Consensus       254 LvRdPkkRAslEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  254 LVRDPKKRASLEEIVSTSWLQAGD  277 (864)
T ss_pred             HhcCchhhccHHHHhccccccCCC
Confidence            999999999999999999998643

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.8e-46  Score=364.93  Aligned_cols=251  Identities=27%  Similarity=0.427  Sum_probs=194.8

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ++|+++++||+|+||.||+|.+..+++.||||++...  ......+..|+++++.+.     |+||+++++++...+.+|
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~  148 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN-----HPNVVKCHDMFDHNGEIQ  148 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCC-----CCCcceeeeEeccCCeEE
Confidence            4588899999999999999999999999999998643  233456778999998884     488999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|.+.      ...++..+..++.||+.||.|||++||+||||||+|||++.                   
T Consensus       149 lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-------------------  203 (353)
T PLN00034        149 VLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINS-------------------  203 (353)
T ss_pred             EEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC-------------------
Confidence            999999 7787542      24677888899999999999999999999999999999954                   


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhC-----CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                              ++.+||+|||++......   ....+||..|+|||++..     ...+.++|||||||++|||++|+.||..
T Consensus       204 --------~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  275 (353)
T PLN00034        204 --------AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV  275 (353)
T ss_pred             --------CCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence                    445666666666543221   123578999999998743     2345789999999999999999999974


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      ....+....+.......                                             ....+...+.++.+||.+
T Consensus       276 ~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~l~~li~~  310 (353)
T PLN00034        276 GRQGDWASLMCAICMSQ---------------------------------------------PPEAPATASREFRHFISC  310 (353)
T ss_pred             CCCccHHHHHHHHhccC---------------------------------------------CCCCCCccCHHHHHHHHH
Confidence            33222111111110000                                             001223556789999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      ||+.||++|||+.|+|+||||....
T Consensus       311 ~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        311 CLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HccCChhhCcCHHHHhcCcccccCC
Confidence            9999999999999999999998774

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-46  Score=369.68  Aligned_cols=278  Identities=24%  Similarity=0.380  Sum_probs=208.6

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|.+++.||+|+||.||+|.++.+++.||||++....    .....+..|++++..+     .+++|+++++++.+.++
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~iv~~~~~~~~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-----DSPWVVSLYYSFQDAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-----CCCCcceEEEEEEcCCe
Confidence            36899999999999999999999999999999986432    2234456688888776     45889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +||||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||++.....
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            99999999 899999997654  799999999999999999999999999999999999999999999999998853211


Q ss_pred             CC--cccccC----------CCCC-------------CeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchH
Q 014117          249 DS--SYFKRM----------PKSS-------------AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDI  303 (430)
Q Consensus       249 ~~--~~~~~~----------~~~~-------------~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  303 (430)
                      ..  ..+...          +...             ..++.+++.....  .....+||+.|+|||++.+..++.++||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di  231 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRL--MAYSTVGTPDYIAPEIFLQQGYGQECDW  231 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc--cccccCCCccccCHHHHccCCCCCceee
Confidence            10  000000          0000             0001111111100  0112479999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHH
Q 014117          304 WSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN  383 (430)
Q Consensus       304 wslGv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (430)
                      |||||++|||++|.+||...+..+.+..+......                     +.+|.                   
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------~~~p~-------------------  271 (377)
T cd05629         232 WSLGAIMFECLIGWPPFCSENSHETYRKIINWRET---------------------LYFPD-------------------  271 (377)
T ss_pred             EecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc---------------------cCCCC-------------------
Confidence            99999999999999999876665544433321100                     01111                   


Q ss_pred             HHhhhcCCchhHHHHHHHHhhhcCCCCC---CCHHHHhcCCCCCCC
Q 014117          384 LIMQHVDHSAGDLTHLLQGLLRYDPTDR---LTAREALRHPFFTRD  426 (430)
Q Consensus       384 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R---~ta~elL~hp~f~~~  426 (430)
                           ....+.++.+||.+||+ +|.+|   +|+.|++.||||+..
T Consensus       272 -----~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         272 -----DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             -----CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence                 11346789999999998 77776   599999999999853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-46  Score=366.61  Aligned_cols=280  Identities=26%  Similarity=0.397  Sum_probs=210.5

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|.+.+.||+|+||+||+|.+..+++.||+|+++...    .....+..|+.++..+.     +++++++++.+.+.++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~i~~~~~~~~~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-----SPWIVKLYYSFQDEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-----CCCccchhhheecCCe
Confidence            36999999999999999999999999999999987432    23345667888888774     5889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|+||||+ +++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||++.....
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            99999999 88999999876  3799999999999999999999999999999999999998877777777777654433


Q ss_pred             CCcccccCCCCCCe-EEEe----CCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          249 DSSYFKRMPKSSAI-KVID----FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       249 ~~~~~~~~~~~~~~-kl~D----fg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                      .............. ....    ...............||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            22100000000000 0000    000000001112357899999999999999999999999999999999999999887


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +..+....+......                     ...|                        .....+.++.+||.+|
T Consensus       234 ~~~~~~~~i~~~~~~---------------------~~~p------------------------~~~~~~~~~~~li~~l  268 (350)
T cd05573         234 TLQETYNKIINWKES---------------------LRFP------------------------PDPPVSPEAIDLICRL  268 (350)
T ss_pred             CHHHHHHHHhccCCc---------------------ccCC------------------------CCCCCCHHHHHHHHHH
Confidence            655544433321100                     0000                        0112467899999999


Q ss_pred             hhcCCCCCCC-HHHHhcCCCCCCC
Q 014117          404 LRYDPTDRLT-AREALRHPFFTRD  426 (430)
Q Consensus       404 L~~dP~~R~t-a~elL~hp~f~~~  426 (430)
                      |+ ||.+|++ ++++|+||||+.-
T Consensus       269 l~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         269 LC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             cc-ChhhcCCCHHHHhcCCCcCCC
Confidence            98 9999999 9999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.9e-46  Score=362.09  Aligned_cols=244  Identities=26%  Similarity=0.442  Sum_probs=199.3

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      +.||+|+||.||+|.++.+++.||+|++....    ........|+.+++.+     .|++|+.+++.+...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-----RHPFLTSLKYSFQTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCCcceEEEEEcCCEEEEEEe
Confidence            36899999999999999999999999987432    2234556788888777     34789999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccc
Q 014117          176 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK  254 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~  254 (430)
                      |+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++                        
T Consensus        76 y~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~------------------------  129 (328)
T cd05593          76 YVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD------------------------  129 (328)
T ss_pred             CCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC------------------------
Confidence            99 889999887654  799999999999999999999999999999999999994                        


Q ss_pred             cCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Q 014117          255 RMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM  331 (430)
Q Consensus       255 ~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~  331 (430)
                         .++.+||+|||++.....   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....
T Consensus       130 ---~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~  206 (328)
T cd05593         130 ---KDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL  206 (328)
T ss_pred             ---CCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH
Confidence               445677777776653221   11235799999999999999999999999999999999999999987655443332


Q ss_pred             HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCC
Q 014117          332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR  411 (430)
Q Consensus       332 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R  411 (430)
                      +....                                                 ..++...+.++.+||++||+.||++|
T Consensus       207 ~~~~~-------------------------------------------------~~~p~~~~~~~~~li~~~L~~dP~~R  237 (328)
T cd05593         207 ILMED-------------------------------------------------IKFPRTLSADAKSLLSGLLIKDPNKR  237 (328)
T ss_pred             hccCC-------------------------------------------------ccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence            21100                                                 01234567789999999999999999


Q ss_pred             C-----CHHHHhcCCCCCCC
Q 014117          412 L-----TAREALRHPFFTRD  426 (430)
Q Consensus       412 ~-----ta~elL~hp~f~~~  426 (430)
                      +     ++.|+++||||+..
T Consensus       238 ~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         238 LGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             CCCCCCCHHHHhcCCCcCCC
Confidence            7     89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.5e-46  Score=360.30  Aligned_cols=245  Identities=25%  Similarity=0.377  Sum_probs=199.5

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      +.||+|+||.||+|.++.+++.||+|+++...    ........|..++..+.    .|++|+++++++...+.+|+|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~----~h~~iv~~~~~~~~~~~~~iv~E   76 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR----NHPFLTQLYCCFQTPDRLFFVME   76 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcc----CCCchhceeeEEEcCCEEEEEEc
Confidence            36899999999999999999999999987432    22334556777666553    35889999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccc
Q 014117          176 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK  254 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~  254 (430)
                      |+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.                       
T Consensus        77 y~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~-----------------------  131 (320)
T cd05590          77 FVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDH-----------------------  131 (320)
T ss_pred             CCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC-----------------------
Confidence            99 889999987754  7999999999999999999999999999999999999954                       


Q ss_pred             cCCCCCCeEEEeCCCccccC---CCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Q 014117          255 RMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM  331 (430)
Q Consensus       255 ~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~  331 (430)
                          ++.+||+|||++....   ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....
T Consensus       132 ----~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~  207 (320)
T cd05590         132 ----EGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA  207 (320)
T ss_pred             ----CCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence                4566777777665321   112335799999999999999999999999999999999999999988766555444


Q ss_pred             HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCC
Q 014117          332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR  411 (430)
Q Consensus       332 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R  411 (430)
                      +......                                                 .+...+.++.+||.+||+.||++|
T Consensus       208 i~~~~~~-------------------------------------------------~~~~~~~~~~~li~~~L~~dP~~R  238 (320)
T cd05590         208 ILNDEVV-------------------------------------------------YPTWLSQDAVDILKAFMTKNPTMR  238 (320)
T ss_pred             HhcCCCC-------------------------------------------------CCCCCCHHHHHHHHHHcccCHHHC
Confidence            3321111                                                 123456689999999999999999


Q ss_pred             CCH------HHHhcCCCCCCC
Q 014117          412 LTA------REALRHPFFTRD  426 (430)
Q Consensus       412 ~ta------~elL~hp~f~~~  426 (430)
                      +++      +++++||||+..
T Consensus       239 ~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         239 LGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             CCCCCCCCHHHHHcCCCcCCC
Confidence            998      999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-47  Score=338.15  Aligned_cols=264  Identities=27%  Similarity=0.493  Sum_probs=216.4

Q ss_pred             eecCcEEEE-eeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 014117           91 NLTSRYKIH-SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---  166 (430)
Q Consensus        91 ~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~---  166 (430)
                      .++++|.+. ..||-|-.|.|..|+++.|++.+|+|++....    ...+|++..-...    .++|||.+++.|+.   
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s----~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMAS----GHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhc----CCCceEEeehhhhhhcc
Confidence            356678775 46899999999999999999999999987443    3455676655543    55889999988764   


Q ss_pred             -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          167 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       167 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                       ...+.+|||.| ||.|+..++.++...|++.++..|++||..|+.|||+++|.||||||+|+|....            
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t------------  197 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTT------------  197 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecC------------
Confidence             57899999999 9999999999998899999999999999999999999999999999999999643            


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                  ..+..+||+|||+|+.....  -.+.|-|++|.|||++-.+.|+...|+||+||+||-|++|.+||..
T Consensus       198 ------------~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS  265 (400)
T KOG0604|consen  198 ------------SPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS  265 (400)
T ss_pred             ------------CCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc
Confidence                        45678999999999865532  2445779999999999999999999999999999999999999976


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      ....           .+++.+        +..+..|.+.+|+.                      .|+..|.+++|+|++
T Consensus       266 ~hg~-----------aispgM--------k~rI~~gqy~FP~p----------------------EWs~VSe~aKdlIR~  304 (400)
T KOG0604|consen  266 NHGL-----------AISPGM--------KRRIRTGQYEFPEP----------------------EWSCVSEAAKDLIRK  304 (400)
T ss_pred             cCCc-----------cCChhH--------HhHhhccCccCCCh----------------------hHhHHHHHHHHHHHH
Confidence            4321           122222        22344555555542                      245678889999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      +|..+|.+|+|+++++.|||+.+..
T Consensus       305 LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  305 LLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             HhcCCchhheeHHHhhcCchhcccc
Confidence            9999999999999999999998653

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-45  Score=364.41  Aligned_cols=281  Identities=23%  Similarity=0.408  Sum_probs=210.2

Q ss_pred             eecCcEEEEeeeccccceEEEEEEEC--CCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDR--ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .+..+|++++.||.|+||.||+|...  .+++.||+|.+....    ....|+++++.+.     |+||+++++.+....
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l~-----h~~iv~~~~~~~~~~  159 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTIS-----HRAIINLIHAYRWKS  159 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhcC-----CCCccceeeeEeeCC
Confidence            34568999999999999999999764  356789999886432    2456899999884     478999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          169 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       169 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .+|+|||+++++|.+++...  ..+++..++.++.||+.||.|||++|||||||||+|||++.+                
T Consensus       160 ~~~lv~e~~~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~----------------  221 (392)
T PHA03207        160 TVCMVMPKYKCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP----------------  221 (392)
T ss_pred             EEEEEehhcCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC----------------
Confidence            99999999988999999544  379999999999999999999999999999999999999544                


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                 +.++|+|||++......     .....||+.|+|||++.+..|+.++|||||||++|||++|..||.+.
T Consensus       222 -----------~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        222 -----------ENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             -----------CCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence                       45566666655432211     12357899999999999999999999999999999999999999764


Q ss_pred             c---hHHHHHHHHHHhCCCCHHHHHHH----HhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHH
Q 014117          324 E---NLEHLAMMERVLGPLPQHMLKRV----DRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL  396 (430)
Q Consensus       324 ~---~~~~~~~i~~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (430)
                      .   ....+..+.+.++..|..+....    ......+.......++                 ....+  .....+.++
T Consensus       291 ~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~--~~~~~~~~~  351 (392)
T PHA03207        291 QVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYT-----------------IPPVI--RKYGMHMDV  351 (392)
T ss_pred             CCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCcc-----------------ccchh--hccCcchhH
Confidence            3   34556666666665543321110    0000111000000000                 00000  012345678


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCCCCCCCCC
Q 014117          397 THLLQGLLRYDPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       397 ~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      .+||.+||+.||++|||+.|+|.||||+..+.
T Consensus       352 ~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~  383 (392)
T PHA03207        352 EYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI  383 (392)
T ss_pred             HHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence            99999999999999999999999999987653

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.2e-45  Score=356.04  Aligned_cols=285  Identities=26%  Similarity=0.479  Sum_probs=207.8

Q ss_pred             EeeeccccceEEEEEEEC--CCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--CCeEEEEE
Q 014117           99 HSKMGEGTFGQVLECWDR--ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIVF  174 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--~~~~~lv~  174 (430)
                      .++||+|+||.||+|.++  .+++.||+|.+.... .......|+.+++++.     |+||+++++.+..  ...+|+||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELK-----HPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcC-----CCCCcceeeeEecCCCcEEEEEE
Confidence            468999999999999965  467889999987433 2345678999999984     4889999888743  56799999


Q ss_pred             ecCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          175 EKLGSSLYDFLRKNN-------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       175 e~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      ||++++|.+++....       ...+++..++.++.||+.||.|||++||+||||||+|||+...+              
T Consensus        80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~--------------  145 (317)
T cd07868          80 DYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG--------------  145 (317)
T ss_pred             eccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCC--------------
Confidence            999889999876421       12589999999999999999999999999999999999995432              


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCC------CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                               +..+.+||+|||++......      .....||+.|+|||++.+. .++.++||||+||++|+|++|.+||
T Consensus       146 ---------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f  216 (317)
T cd07868         146 ---------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF  216 (317)
T ss_pred             ---------CCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCc
Confidence                     34567888888888654322      1235789999999999874 5899999999999999999999999


Q ss_pred             CCCch---------HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCC
Q 014117          321 QTHEN---------LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH  391 (430)
Q Consensus       321 ~~~~~---------~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (430)
                      ....+         .+++..+...+|.++...+.......+.......+.  ...         .....+..........
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~---------~~~~~~~~~~~~~~~~  285 (317)
T cd07868         217 HCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFR--RNT---------YTNCSLIKYMEKHKVK  285 (317)
T ss_pred             cCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhh--ccc---------cCcccccchHHhcCCC
Confidence            75432         355667777777777665554322111100000000  000         0000001111111223


Q ss_pred             chhHHHHHHHHhhhcCCCCCCCHHHHhcCCCC
Q 014117          392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       392 ~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      .+.++.+||.+||++||.+|||++|+|+||||
T Consensus       286 ~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         286 PDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            45678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.6e-46  Score=369.25  Aligned_cols=279  Identities=25%  Similarity=0.383  Sum_probs=208.0

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++++.||+|+||.||+|++..+++.||+|++....    ........|++++..+.     +++|+++++.+...+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-----h~~iv~~~~~~~~~~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-----NEWVVKLYYSFQDKDN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-----CCCcceEEEEEEcCCE
Confidence            36999999999999999999999999999999986432    22344667888888884     4789999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|+||||+ +++|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            99999999 899999998754  789999999999999999999999999999999999999888888888887642211


Q ss_pred             C--CcccccCCCCCCeEEEeCCC-----c----------c---ccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHH
Q 014117          249 D--SSYFKRMPKSSAIKVIDFGS-----T----------T---YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC  308 (430)
Q Consensus       249 ~--~~~~~~~~~~~~~kl~Dfg~-----a----------~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv  308 (430)
                      .  ...+.. .........+...     .          .   .........+||+.|+|||++.+..++.++|||||||
T Consensus       154 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  232 (376)
T cd05598         154 THDSKYYQK-GDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  232 (376)
T ss_pred             ccccccccc-ccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence            0  000000 0000000000000     0          0   0000112357999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhh
Q 014117          309 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH  388 (430)
Q Consensus       309 ~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (430)
                      ++|||++|+.||.+.+..+....+.......                     .                        ...
T Consensus       233 ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---------------------~------------------------~~~  267 (376)
T cd05598         233 ILYEMLVGQPPFLADTPAETQLKVINWETTL---------------------H------------------------IPS  267 (376)
T ss_pred             eeeehhhCCCCCCCCCHHHHHHHHhccCccc---------------------c------------------------CCC
Confidence            9999999999998766544433222110000                     0                        001


Q ss_pred             cCCchhHHHHHHHHhhhcCCCCCC---CHHHHhcCCCCCCC
Q 014117          389 VDHSAGDLTHLLQGLLRYDPTDRL---TAREALRHPFFTRD  426 (430)
Q Consensus       389 ~~~~~~~~~~ll~~~L~~dP~~R~---ta~elL~hp~f~~~  426 (430)
                      ....+.++.+||.+|+ .+|.+|+   |+.++++||||+..
T Consensus       268 ~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         268 QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            1245678899999976 5999999   99999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.3e-46  Score=360.13  Aligned_cols=244  Identities=25%  Similarity=0.416  Sum_probs=198.5

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      +.||+|+||.||+|.++.+++.||+|+++...    ........|+.+++.+.     |+|++++++.+...+.+|||||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~i~~~~~~~~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-----HPFLTALKYAFQTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-----CCCCcceeeEEecCCEEEEEEe
Confidence            46899999999999999999999999987432    22334556888888773     4789999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccc
Q 014117          176 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK  254 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~  254 (430)
                      |+ +++|..++....  .+++..++.++.||+.||.|||++||+||||||+|||++++                      
T Consensus        76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~----------------------  131 (323)
T cd05595          76 YANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD----------------------  131 (323)
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC----------------------
Confidence            99 889999887654  79999999999999999999999999999999999999544                      


Q ss_pred             cCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Q 014117          255 RMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM  331 (430)
Q Consensus       255 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~  331 (430)
                           +.+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....
T Consensus       132 -----~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~  206 (323)
T cd05595         132 -----GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL  206 (323)
T ss_pred             -----CCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence                 45666666655432111   1235789999999999999999999999999999999999999987665544433


Q ss_pred             HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCC
Q 014117          332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR  411 (430)
Q Consensus       332 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R  411 (430)
                      +.....                                                 .++...+.++.+||.+||+.||++|
T Consensus       207 ~~~~~~-------------------------------------------------~~p~~~~~~~~~li~~~L~~dP~~R  237 (323)
T cd05595         207 ILMEEI-------------------------------------------------RFPRTLSPEAKSLLAGLLKKDPKQR  237 (323)
T ss_pred             HhcCCC-------------------------------------------------CCCCCCCHHHHHHHHHHccCCHHHh
Confidence            321110                                                 1234557789999999999999999


Q ss_pred             C-----CHHHHhcCCCCCCC
Q 014117          412 L-----TAREALRHPFFTRD  426 (430)
Q Consensus       412 ~-----ta~elL~hp~f~~~  426 (430)
                      +     ++.++++||||...
T Consensus       238 ~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         238 LGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             CCCCCCCHHHHHcCCCcCCC
Confidence            8     89999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-48  Score=364.65  Aligned_cols=252  Identities=28%  Similarity=0.414  Sum_probs=209.1

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ..|..++.||+|+||.||+|.+..+++.||+|++.-.  ....+....|+.+|.++.+     ++|.+.|+.+-.+..++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~-----~~it~yygsyl~g~~Lw   87 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDS-----PNITEYYGSYLKGTKLW   87 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCc-----chHHhhhhheeecccHH
Confidence            3577789999999999999999999999999999733  3344567789999999854     78999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      ++|||| ||++.+.|+..+  .+.+..+..++++++.||.|||.++.+|||||+.|||+..                   
T Consensus        88 iiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~-------------------  146 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSE-------------------  146 (467)
T ss_pred             HHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcceecccccccceeEec-------------------
Confidence            999999 899999998764  5688899999999999999999999999999999999954                   


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                              ++.+||+|||.+......   ..+++||+.|||||++.+..|+.++||||||++.+||++|.+||.....+.
T Consensus       147 --------~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr  218 (467)
T KOG0201|consen  147 --------SGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR  218 (467)
T ss_pred             --------cCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce
Confidence                    356777777766544332   256799999999999999899999999999999999999999998755533


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      .+..|-+..   |                                             ......+++.+++||..||++|
T Consensus       219 vlflIpk~~---P---------------------------------------------P~L~~~~S~~~kEFV~~CL~k~  250 (467)
T KOG0201|consen  219 VLFLIPKSA---P---------------------------------------------PRLDGDFSPPFKEFVEACLDKN  250 (467)
T ss_pred             EEEeccCCC---C---------------------------------------------CccccccCHHHHHHHHHHhhcC
Confidence            222221110   1                                             1122356778999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~~  427 (430)
                      |+.||+|.++|.|+|+++..
T Consensus       251 P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  251 PEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             cccCcCHHHHhhhHHHHhcC
Confidence            99999999999999998753

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=9.2e-46  Score=358.01  Aligned_cols=250  Identities=23%  Similarity=0.374  Sum_probs=202.3

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      |++++.||+|+||.||+|.++.+++.||||+++...    ...+....|+.++..+..  ..|+||+++++++...+.+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~--l~hp~i~~~~~~~~~~~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANS--ERHPFLVNLFACFQTEDHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccc--cCCCChhceeeEEEcCCEEE
Confidence            678999999999999999999999999999997432    223345566666655432  24689999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|..++..   ..+++..+..++.||+.||.|||++||+||||||+|||++.                   
T Consensus        79 lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~-------------------  136 (324)
T cd05589          79 FVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDT-------------------  136 (324)
T ss_pred             EEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC-------------------
Confidence            999999 8899888764   36999999999999999999999999999999999999954                   


Q ss_pred             cccccCCCCCCeEEEeCCCccccC---CCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                              ++.+||+|||++....   ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+
T Consensus       137 --------~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~  208 (324)
T cd05589         137 --------EGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE  208 (324)
T ss_pred             --------CCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH
Confidence                    4456666666654321   11234579999999999999999999999999999999999999998766655


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+.....                                                 ..+...+.++.+||.+||+.|
T Consensus       209 ~~~~i~~~~~-------------------------------------------------~~p~~~~~~~~~li~~~L~~d  239 (324)
T cd05589         209 VFDSIVNDEV-------------------------------------------------RYPRFLSREAISIMRRLLRRN  239 (324)
T ss_pred             HHHHHHhCCC-------------------------------------------------CCCCCCCHHHHHHHHHHhhcC
Confidence            4443322111                                                 122345678999999999999


Q ss_pred             CCCCC-----CHHHHhcCCCCCCC
Q 014117          408 PTDRL-----TAREALRHPFFTRD  426 (430)
Q Consensus       408 P~~R~-----ta~elL~hp~f~~~  426 (430)
                      |.+||     ++.++++||||+..
T Consensus       240 P~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         240 PERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             HhHcCCCCCCCHHHHhhCCCcCCC
Confidence            99999     79999999999864

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.3e-46  Score=357.05  Aligned_cols=245  Identities=27%  Similarity=0.383  Sum_probs=197.2

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      +.||+|+||.||+|.+..+++.||+|+++...    ........|..++..+    ..|++|+++++.+...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~hp~i~~~~~~~~~~~~~~lv~e   76 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA----WEHPFLTHLFCTFQTKEHLFFVME   76 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhc----cCCCCccceeeEEEcCCEEEEEEc
Confidence            36899999999999999999999999987432    1223334455555443    245889999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccc
Q 014117          176 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK  254 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~  254 (430)
                      |+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++                        
T Consensus        77 ~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~------------------------  130 (316)
T cd05592          77 YLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD------------------------  130 (316)
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC------------------------
Confidence            99 899999987654  799999999999999999999999999999999999994                        


Q ss_pred             cCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Q 014117          255 RMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM  331 (430)
Q Consensus       255 ~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~  331 (430)
                         .++.+||+|||++.....   .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....
T Consensus       131 ---~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~  207 (316)
T cd05592         131 ---KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS  207 (316)
T ss_pred             ---CCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence               445677777777653221   22345799999999999999999999999999999999999999988766554443


Q ss_pred             HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCC
Q 014117          332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR  411 (430)
Q Consensus       332 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R  411 (430)
                      +......                                                 .+...+.++.+||.+||+.||++|
T Consensus       208 i~~~~~~-------------------------------------------------~~~~~~~~~~~ll~~~l~~~P~~R  238 (316)
T cd05592         208 ILNDRPH-------------------------------------------------FPRWISKEAKDCLSKLFERDPTKR  238 (316)
T ss_pred             HHcCCCC-------------------------------------------------CCCCCCHHHHHHHHHHccCCHHHc
Confidence            3221111                                                 123456678999999999999999


Q ss_pred             CCH-HHHhcCCCCCCC
Q 014117          412 LTA-REALRHPFFTRD  426 (430)
Q Consensus       412 ~ta-~elL~hp~f~~~  426 (430)
                      +++ .++++||||...
T Consensus       239 ~~~~~~l~~h~~~~~~  254 (316)
T cd05592         239 LGVDGDIRQHPFFRGI  254 (316)
T ss_pred             CCChHHHHcCcccCCC
Confidence            986 589999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.3e-46  Score=357.43  Aligned_cols=245  Identities=27%  Similarity=0.402  Sum_probs=196.1

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      +.||+|+||.||+|.++.+++.||+|+++...    ........|..++....    .+++++++++.+...+++|+|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~----~~~~i~~~~~~~~~~~~~~lv~E   76 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAW----ENPFLTHLYCTFQTKEHLFFVME   76 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhcc----CCCCccCeeEEEEeCCEEEEEEC
Confidence            46999999999999999999999999987432    22334455666655442    34789999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccc
Q 014117          176 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK  254 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~  254 (430)
                      |+ +++|.+++....  .+++..+..++.||+.||+|||++||+||||||+|||++.+                      
T Consensus        77 ~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~----------------------  132 (316)
T cd05620          77 FLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD----------------------  132 (316)
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC----------------------
Confidence            99 889999987654  78999999999999999999999999999999999999544                      


Q ss_pred             cCCCCCCeEEEeCCCcccc---CCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Q 014117          255 RMPKSSAIKVIDFGSTTYE---RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM  331 (430)
Q Consensus       255 ~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~  331 (430)
                           +.++|+|||++...   .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....
T Consensus       133 -----~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~  207 (316)
T cd05620         133 -----GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES  207 (316)
T ss_pred             -----CCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence                 45666666655421   1112345789999999999999999999999999999999999999987665544443


Q ss_pred             HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCC
Q 014117          332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR  411 (430)
Q Consensus       332 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R  411 (430)
                      +.....                                                 ..+...+.++.+||.+||+.||++|
T Consensus       208 ~~~~~~-------------------------------------------------~~~~~~~~~~~~li~~~l~~dP~~R  238 (316)
T cd05620         208 IRVDTP-------------------------------------------------HYPRWITKESKDILEKLFERDPTRR  238 (316)
T ss_pred             HHhCCC-------------------------------------------------CCCCCCCHHHHHHHHHHccCCHHHc
Confidence            322111                                                 1123356679999999999999999


Q ss_pred             CCH-HHHhcCCCCCCC
Q 014117          412 LTA-REALRHPFFTRD  426 (430)
Q Consensus       412 ~ta-~elL~hp~f~~~  426 (430)
                      +++ +++++||||...
T Consensus       239 ~~~~~~~~~h~~f~~~  254 (316)
T cd05620         239 LGVVGNIRGHPFFKTI  254 (316)
T ss_pred             CCChHHHHcCCCcCCC
Confidence            997 589999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.1e-45  Score=355.40  Aligned_cols=294  Identities=23%  Similarity=0.356  Sum_probs=208.8

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .++|++.+.||+|+||.||+|.+..++..||+|++...  ......+..|+++++++.     |+|++++++++...+.+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN-----SPYIVGFYGAFYSDGEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC-----CCCCCeEEEEEEECCEE
Confidence            46799999999999999999999999999999998643  234456788999998884     48899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      ++||||+ +++|.+++....  .+++..+..++.|++.||.|||+. +|+||||||+|||++.+                
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~----------------  140 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR----------------  140 (331)
T ss_pred             EEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC----------------
Confidence            9999999 889999997754  689999999999999999999986 69999999999999544                


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCC-CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                                 +.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+
T Consensus       141 -----------~~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~  209 (331)
T cd06649         141 -----------GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE  209 (331)
T ss_pred             -----------CcEEEccCcccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                       4566666666543221 2233578999999999999999999999999999999999999998655443


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccC-cccCCCCCCChhhHHhhcCchhHHH-HHhhh-----cCCchhHHHHHH
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMKLPRLQN-LIMQH-----VDHSAGDLTHLL  400 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~ll  400 (430)
                      ....    .+.......   ........... ....+.......... ......+.. .....     ...++.++.+||
T Consensus       210 ~~~~----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  281 (331)
T cd06649         210 LEAI----FGRPVVDGE---EGEPHSISPRPRPPGRPVSGHGMDSRP-AMAIFELLDYIVNEPPPKLPNGVFTPDFQEFV  281 (331)
T ss_pred             HHHH----hcccccccc---cCCccccCccccccccccccccccccc-chhHHHHHHHHHhCCCcCCCCccccHHHHHHH
Confidence            3221    221110000   00000000000 000000000000000 000000001 11000     124677899999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCCCCCCCCC
Q 014117          401 QGLLRYDPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      .+||++||++|||+.|||+||||+....
T Consensus       282 ~~~L~~~P~~Rpt~~ell~h~~~~~~~~  309 (331)
T cd06649         282 NKCLIKNPAERADLKMLMNHTFIKRSEV  309 (331)
T ss_pred             HHHccCCcccCCCHHHHhcChHHhhccc
Confidence            9999999999999999999999986543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1e-45  Score=363.98  Aligned_cols=254  Identities=24%  Similarity=0.409  Sum_probs=204.8

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++++..    .....+..|+.+++.+     ++++|+.+++++.+.+
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-----~h~~iv~~~~~~~~~~  116 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-----NSEWIVQLHYAFQDDK  116 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-----CCCCcceEEEEEecCC
Confidence            467999999999999999999999999999999986432    1223355688888777     4588999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+|+||||+ +++|.+++...   .+++..+..++.||+.||+|||++||+||||||+|||++                 
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~-----------------  176 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-----------------  176 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc-----------------
Confidence            999999999 89999998653   589999999999999999999999999999999999994                 


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCC----CCeeeecCcccchhhhhCC----CCCCcchHHHHHHHHHHHHhCCCC
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGL----GWTYPCDIWSVGCILVELCTGEAL  319 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGv~l~el~tG~~P  319 (430)
                                .++.+||+|||++......    ....+||+.|+|||++.+.    .++.++|||||||++|||++|.+|
T Consensus       177 ----------~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~P  246 (370)
T cd05596         177 ----------KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP  246 (370)
T ss_pred             ----------CCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCC
Confidence                      4556777777776543322    1235799999999999764    378999999999999999999999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |.+.+....+..+.....                     ...+|.                        ....+.++.+|
T Consensus       247 f~~~~~~~~~~~i~~~~~---------------------~~~~~~------------------------~~~~s~~~~~l  281 (370)
T cd05596         247 FYADSLVGTYSKIMDHKN---------------------SLTFPD------------------------DIEISKQAKDL  281 (370)
T ss_pred             cCCCCHHHHHHHHHcCCC---------------------cCCCCC------------------------cCCCCHHHHHH
Confidence            988766554444332110                     011111                        12356789999


Q ss_pred             HHHhhhcCCCC--CCCHHHHhcCCCCCCC
Q 014117          400 LQGLLRYDPTD--RLTAREALRHPFFTRD  426 (430)
Q Consensus       400 l~~~L~~dP~~--R~ta~elL~hp~f~~~  426 (430)
                      |++||+.+|++  |+|++|+++||||++.
T Consensus       282 i~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         282 ICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             HHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            99999999998  9999999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-45  Score=349.70  Aligned_cols=257  Identities=24%  Similarity=0.378  Sum_probs=206.5

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      +|++.+.||+|+||.||++.+..+++.||+|++....    .....+..|+.+++.+.     +++++.+++.+...+.+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-----SRFVVSLAYAYETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-----CCCEeeeeeeecCCCeE
Confidence            4889999999999999999999999999999986432    12234567888888884     47899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||+ +++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++                   
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~-------------------  136 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD-------------------  136 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC-------------------
Confidence            9999999 88999888765545799999999999999999999999999999999999994                   


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                              ..+.++|+|||++.......  ...+||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+...
T Consensus       137 --------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~  208 (285)
T cd05605         137 --------DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV  208 (285)
T ss_pred             --------CCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh
Confidence                    44567777777665432221  23478999999999999899999999999999999999999998755433


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+.......                                             ....+..++..+.+||.+||+.|
T Consensus       209 ~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~~li~~~l~~~  243 (285)
T cd05605         209 KREEVERRVKED---------------------------------------------QEEYSEKFSEAARSICRQLLTKD  243 (285)
T ss_pred             HHHHHHHHhhhc---------------------------------------------ccccCcccCHHHHHHHHHHccCC
Confidence            322222111000                                             01122345678999999999999


Q ss_pred             CCCCC-----CHHHHhcCCCCCCCCC
Q 014117          408 PTDRL-----TAREALRHPFFTRDHL  428 (430)
Q Consensus       408 P~~R~-----ta~elL~hp~f~~~~~  428 (430)
                      |.+||     +++++++||||.....
T Consensus       244 P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05605         244 PGFRLGCRGEGAEEVKAHPFFRTANF  269 (285)
T ss_pred             HHHhcCCCCCCHHHHhcCcCccCCCH
Confidence            99999     9999999999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-45  Score=357.05  Aligned_cols=245  Identities=22%  Similarity=0.341  Sum_probs=200.1

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      +.||+|+||.||+|.++.+++.||+|+++...    ........|.+++..+.    +|++|+.+++++...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~----~hp~i~~~~~~~~~~~~~~lv~E   76 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA----KHPFLTALHCCFQTKDRLFFVME   76 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhcc----CCCCccceeeEEEcCCeEEEEEe
Confidence            36899999999999999999999999987432    22334556777766553    45789999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccc
Q 014117          176 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK  254 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~  254 (430)
                      |+ +++|..++....  .+++..+..++.||+.||.|||++||+||||||+|||++                        
T Consensus        77 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~------------------------  130 (321)
T cd05591          77 YVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD------------------------  130 (321)
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC------------------------
Confidence            99 889999887654  799999999999999999999999999999999999994                        


Q ss_pred             cCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Q 014117          255 RMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM  331 (430)
Q Consensus       255 ~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~  331 (430)
                         .++.+||+|||++.....   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....
T Consensus       131 ---~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~  207 (321)
T cd05591         131 ---AEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES  207 (321)
T ss_pred             ---CCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH
Confidence               455677777776653221   12335789999999999999999999999999999999999999998776655544


Q ss_pred             HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCC
Q 014117          332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR  411 (430)
Q Consensus       332 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R  411 (430)
                      +......                                                 .+...+.++.+||.+||+.||++|
T Consensus       208 i~~~~~~-------------------------------------------------~p~~~~~~~~~ll~~~L~~dp~~R  238 (321)
T cd05591         208 ILHDDVL-------------------------------------------------YPVWLSKEAVSILKAFMTKNPNKR  238 (321)
T ss_pred             HHcCCCC-------------------------------------------------CCCCCCHHHHHHHHHHhccCHHHc
Confidence            3321110                                                 123356789999999999999999


Q ss_pred             C-------CHHHHhcCCCCCCC
Q 014117          412 L-------TAREALRHPFFTRD  426 (430)
Q Consensus       412 ~-------ta~elL~hp~f~~~  426 (430)
                      +       ++.++++||||..-
T Consensus       239 ~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         239 LGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             CCCCCCCCCHHHHhcCCccCCC
Confidence            9       99999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.5e-46  Score=337.17  Aligned_cols=294  Identities=29%  Similarity=0.504  Sum_probs=229.7

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCC----eEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERK----EMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      ..|+++..||+|.||.||+|..+.++    +.+|||.++..+   .......+|+.+++.+.|     +|++.+...|-.
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h-----~nvi~Lv~Vfl~   98 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKH-----PNVISLVKVFLS   98 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcC-----CcchhHHHHHhc
Confidence            46999999999999999999665553    379999997553   345667889999999955     788998887766


Q ss_pred             -CCeEEEEEecCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          167 -RNHICIVFEKLGSSLYDFLRKNN---YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       167 -~~~~~lv~e~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                       +..+++++||...+|.+.++...   .+.++...++.|+.||+.|+.|||++-|+||||||.|||+..+|         
T Consensus        99 ~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdg---------  169 (438)
T KOG0666|consen   99 HDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDG---------  169 (438)
T ss_pred             cCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccC---------
Confidence             88999999999999999987432   25689999999999999999999999999999999999997665         


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC------CeeeecCcccchhhhhCCC-CCCcchHHHHHHHHHHHHh
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCT  315 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~t  315 (430)
                                    ...+.+||+|||+++.....-      ..++-|.+|+|||+++|.. |+++.||||+|||+.||+|
T Consensus       170 --------------perG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt  235 (438)
T KOG0666|consen  170 --------------PERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT  235 (438)
T ss_pred             --------------CccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc
Confidence                          667999999999998655432      3357799999999999875 9999999999999999999


Q ss_pred             CCCCCCCCc---------hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHH-hhcCchhHHHHH
Q 014117          316 GEALFQTHE---------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIK-SVMKLPRLQNLI  385 (430)
Q Consensus       316 G~~Pf~~~~---------~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  385 (430)
                      -++.|.+..         ..+++..|.+++|.+....|+.+....+....-            ..+. ......++..+.
T Consensus       236 l~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~l------------s~f~~~~~~n~sL~~~~  303 (438)
T KOG0666|consen  236 LEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLL------------SDFRRHYYDNVSLHKYY  303 (438)
T ss_pred             cCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHH------------HHhHHhhcCcchHHHHH
Confidence            999997643         256788899999998877665443222220000            0000 011111233333


Q ss_pred             hhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCCC
Q 014117          386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       386 ~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      ... ..-++...+|+.+||++||-+|.|++++|+|+||+.+++
T Consensus       304 ~~~-k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~l  345 (438)
T KOG0666|consen  304 HKH-KVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPL  345 (438)
T ss_pred             HHh-cCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCC
Confidence            322 233445899999999999999999999999999998854

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-47  Score=343.33  Aligned_cols=250  Identities=28%  Similarity=0.478  Sum_probs=213.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|..++.||+|.||.|-+|+.+.+++.||+|++++..    ....-...|-++|+..+|     |.+..+...|+..++
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~H-----PFLt~LKYsFQt~dr  242 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRH-----PFLTSLKYSFQTQDR  242 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccC-----cHHHHhhhhhccCce
Confidence            57999999999999999999999999999999997542    233445568888888744     778888899999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|+||||+ ||.|+-.|...  +.|++..++.+..+|+.||.|||+++||+||||.+|.|+                   
T Consensus       243 lCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL-------------------  301 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL-------------------  301 (516)
T ss_pred             EEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee-------------------
Confidence            99999999 99998888765  489999999999999999999999999999999999999                   


Q ss_pred             CCcccccCCCCCCeEEEeCCCcccc---CCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYE---RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                              |+++.+||+|||+++-.   +....++||||.|+|||++....|+.++|+|.+||+||||++|++||...+.
T Consensus       302 --------DkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh  373 (516)
T KOG0690|consen  302 --------DKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH  373 (516)
T ss_pred             --------ccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch
Confidence                    55566677777766532   2334668999999999999999999999999999999999999999998777


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      ...+..|...                                                 ...+|...+++++.|+..+|.
T Consensus       374 ~kLFeLIl~e-------------------------------------------------d~kFPr~ls~eAktLLsGLL~  404 (516)
T KOG0690|consen  374 EKLFELILME-------------------------------------------------DLKFPRTLSPEAKTLLSGLLK  404 (516)
T ss_pred             hHHHHHHHhh-------------------------------------------------hccCCccCCHHHHHHHHHHhh
Confidence            6666555332                                                 123566788999999999999


Q ss_pred             cCCCCCCC-----HHHHhcCCCCCCC
Q 014117          406 YDPTDRLT-----AREALRHPFFTRD  426 (430)
Q Consensus       406 ~dP~~R~t-----a~elL~hp~f~~~  426 (430)
                      +||.+|+.     |.|+.+|+||..-
T Consensus       405 kdP~kRLGgGpdDakEi~~h~FF~~v  430 (516)
T KOG0690|consen  405 KDPKKRLGGGPDDAKEIMRHRFFASV  430 (516)
T ss_pred             cChHhhcCCCchhHHHHHhhhhhccC
Confidence            99999994     8999999999864

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.1e-45  Score=349.71  Aligned_cols=282  Identities=27%  Similarity=0.463  Sum_probs=219.8

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ++|++.++||.|+||.||+|.++.+++.||+|.++...  ........|+.+++.+.     |+||+++++++...+..|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~nI~~~~~~~~~~~~~~   80 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-----HANIVTLHDIIHTEKSLT   80 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcC-----CCCcceEEEEEecCCeEE
Confidence            56999999999999999999999999999999986332  23345667899998884     478999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          172 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       172 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      +||||+.++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+|||+++++                  
T Consensus        81 lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~------------------  141 (301)
T cd07873          81 LVFEYLDKDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG------------------  141 (301)
T ss_pred             EEEeccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC------------------
Confidence            999999889999987654 4689999999999999999999999999999999999995544                  


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                               .++|+|||++.......   ....+++.|+|||++.+. .++.++|||||||++|+|++|++||...+..+
T Consensus       142 ---------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~  212 (301)
T cd07873         142 ---------ELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE  212 (301)
T ss_pred             ---------cEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                     55666666554322111   223568899999998764 58899999999999999999999999888888


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+...++.++...++.+....+. .   ...++..               ............+.++++||.+||+.|
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~---------------~~~~~~~~~~~~~~~~~~li~~ml~~d  273 (301)
T cd07873         213 QLHFIFRILGTPTEETWPGILSNEEF-K---SYNYPKY---------------RADCLHNHAPRLDSDGAELLSKLLQFE  273 (301)
T ss_pred             HHHHHHHHcCCCChhhchhhhccccc-c---ccccCcc---------------ccccHHhhcCCCCHHHHHHHHHHhcCC
Confidence            88888888887776555433211100 0   0001100               001111233456778999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~~  427 (430)
                      |.+|||++|+|+||||+...
T Consensus       274 p~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         274 GRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccCcCHHHHhcCccccccc
Confidence            99999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.1e-45  Score=354.12  Aligned_cols=250  Identities=25%  Similarity=0.366  Sum_probs=202.0

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      +|++.+.||+|+||.||+|.++.+++.||+|+++...    ........|..++..+.    ++++++.++.++...+.+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~----~~~~i~~~~~~~~~~~~~   76 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD----KPPFLTQLHSCFQTVDRL   76 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc----CCCchhheeeEEecCCEE
Confidence            3788999999999999999999999999999987432    12234556777766553    346688899999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.                  
T Consensus        77 ~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~------------------  136 (323)
T cd05615          77 YFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS------------------  136 (323)
T ss_pred             EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC------------------
Confidence            9999999 899999987654  7999999999999999999999999999999999999954                  


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                               ++.+||+|||++......   ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..
T Consensus       137 ---------~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~  207 (323)
T cd05615         137 ---------EGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED  207 (323)
T ss_pred             ---------CCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence                     455677777766532211   23357899999999999989999999999999999999999999876655


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      .....+.....                                                 ..+...+.++.+|+.+||+.
T Consensus       208 ~~~~~i~~~~~-------------------------------------------------~~p~~~~~~~~~li~~~l~~  238 (323)
T cd05615         208 ELFQSIMEHNV-------------------------------------------------SYPKSLSKEAVSICKGLMTK  238 (323)
T ss_pred             HHHHHHHhCCC-------------------------------------------------CCCccCCHHHHHHHHHHccc
Confidence            54443332111                                                 11234566789999999999


Q ss_pred             CCCCCCC-----HHHHhcCCCCCCC
Q 014117          407 DPTDRLT-----AREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~t-----a~elL~hp~f~~~  426 (430)
                      ||.+|++     .+++++||||+..
T Consensus       239 ~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         239 HPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             CHhhCCCCCCCCHHHHhcCcccCCC
Confidence            9999997     5799999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.3e-46  Score=359.32  Aligned_cols=244  Identities=25%  Similarity=0.426  Sum_probs=197.6

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      +.||+|+||.||+|.+..+++.||+|+++...    ........|++++..+     .|++|+.+++.+...+.+|||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-----~hp~i~~~~~~~~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-----RHPFLTALKYSFQTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCCCceEEEEEcCCEEEEEEe
Confidence            36899999999999999999999999987432    1223445677777766     44789999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          176 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      |+ +++|.+++....  .+++..+..++.||+.||.|||+ .||+||||||+|||++                       
T Consensus        76 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~-----------------------  130 (325)
T cd05594          76 YANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD-----------------------  130 (325)
T ss_pred             CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC-----------------------
Confidence            99 889999887654  79999999999999999999997 7999999999999994                       


Q ss_pred             ccCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Q 014117          254 KRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA  330 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~  330 (430)
                          .++.+||+|||++.....   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...
T Consensus       131 ----~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~  206 (325)
T cd05594         131 ----KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE  206 (325)
T ss_pred             ----CCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH
Confidence                445677777776653221   1123579999999999999999999999999999999999999998765544433


Q ss_pred             HHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCC
Q 014117          331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD  410 (430)
Q Consensus       331 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~  410 (430)
                      .+....                                                 ..++...+.++.+||.+||+.||++
T Consensus       207 ~i~~~~-------------------------------------------------~~~p~~~~~~~~~li~~~L~~dP~~  237 (325)
T cd05594         207 LILMEE-------------------------------------------------IRFPRTLSPEAKSLLSGLLKKDPKQ  237 (325)
T ss_pred             HHhcCC-------------------------------------------------CCCCCCCCHHHHHHHHHHhhcCHHH
Confidence            322110                                                 0123345778999999999999999


Q ss_pred             CC-----CHHHHhcCCCCCCC
Q 014117          411 RL-----TAREALRHPFFTRD  426 (430)
Q Consensus       411 R~-----ta~elL~hp~f~~~  426 (430)
                      |+     ++.++++||||...
T Consensus       238 R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         238 RLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             hCCCCCCCHHHHhcCCCcCCC
Confidence            97     89999999999863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.7e-45  Score=362.05  Aligned_cols=255  Identities=24%  Similarity=0.412  Sum_probs=204.1

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      ..++|++.+.||+|+||.||+|.++.+++.||+|++.+..    .....+..|+.+++.+     +|++|+++++.+...
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-----~hp~iv~~~~~~~~~  115 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-----NSPWVVQLFCAFQDD  115 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-----CCCCEeeEEEEEEcC
Confidence            3568999999999999999999999999999999986422    1233455678877776     458899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      ..+|+||||+ +++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++                
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~----------------  176 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD----------------  176 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC----------------
Confidence            9999999999 89999998654   589999999999999999999999999999999999994                


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCC----CCCcchHHHHHHHHHHHHhCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGv~l~el~tG~~  318 (430)
                                 .++.+||+|||++.......    ...+||+.|+|||++.+..    ++.++|||||||++|+|++|.+
T Consensus       177 -----------~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~  245 (370)
T cd05621         177 -----------KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDT  245 (370)
T ss_pred             -----------CCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCC
Confidence                       45567777777776443221    2457999999999997653    7899999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||.+.+.......+......                     +.+|.                        ....+..+++
T Consensus       246 Pf~~~~~~~~~~~i~~~~~~---------------------~~~p~------------------------~~~~s~~~~~  280 (370)
T cd05621         246 PFYADSLVGTYSKIMDHKNS---------------------LNFPE------------------------DVEISKHAKN  280 (370)
T ss_pred             CCCCCCHHHHHHHHHhCCcc---------------------cCCCC------------------------cccCCHHHHH
Confidence            99887665555444321111                     11111                        1134667899


Q ss_pred             HHHHhhhcCCCC--CCCHHHHhcCCCCCCC
Q 014117          399 LLQGLLRYDPTD--RLTAREALRHPFFTRD  426 (430)
Q Consensus       399 ll~~~L~~dP~~--R~ta~elL~hp~f~~~  426 (430)
                      ++.+||+.++.+  |+|++|+++||||+..
T Consensus       281 li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         281 LICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            999999866544  8899999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-45  Score=358.54  Aligned_cols=254  Identities=25%  Similarity=0.417  Sum_probs=198.2

Q ss_pred             cEEEEeeeccccceEEEEEEEC---CCCeEEEEEEecCch-----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           95 RYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      +|++++.||+|+||.||+|++.   .+++.||+|++....     ...+....|+.++..+.+    +++|+.+++++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~----~~~i~~~~~~~~~   76 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQ----SPFLVTLHYAFQT   76 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccC----CCCcccEEEEEec
Confidence            4899999999999999999874   478899999986432     122345668888877743    4789999999999


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      .+.+|+||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++               
T Consensus        77 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~---------------  139 (332)
T cd05614          77 EAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD---------------  139 (332)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC---------------
Confidence            99999999999 889999987654  799999999999999999999999999999999999994               


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCC----CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                  .++.+||+|||+++.....    ....+||+.|+|||++.+. .++.++|||||||++|||++|..||
T Consensus       140 ------------~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf  207 (332)
T cd05614         140 ------------SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF  207 (332)
T ss_pred             ------------CCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCC
Confidence                        4456777777776542211    1235799999999999875 4889999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      ...........+....                   ..                          .....+...+..+.+||
T Consensus       208 ~~~~~~~~~~~~~~~~-------------------~~--------------------------~~~~~~~~~~~~~~~li  242 (332)
T cd05614         208 TLEGERNTQSEVSRRI-------------------LK--------------------------CDPPFPSFIGPEAQDLL  242 (332)
T ss_pred             CCCCCCCCHHHHHHHH-------------------hc--------------------------CCCCCCCCCCHHHHHHH
Confidence            7432211111110000                   00                          00112345567899999


Q ss_pred             HHhhhcCCCCCC-----CHHHHhcCCCCCCC
Q 014117          401 QGLLRYDPTDRL-----TAREALRHPFFTRD  426 (430)
Q Consensus       401 ~~~L~~dP~~R~-----ta~elL~hp~f~~~  426 (430)
                      .+||+.||++||     +++++++||||+..
T Consensus       243 ~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         243 HKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999999999     88999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.2e-45  Score=362.45  Aligned_cols=278  Identities=24%  Similarity=0.373  Sum_probs=208.6

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++++.||+|+||.||+|.++.+++.||+|+++...    .....+..|+.++..+     .+++++++++.+...+.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~iv~~~~~~~~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-----DGAWVVKMFYSFQDKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-----CCCCEeeEEEEEEcCCE
Confidence            35899999999999999999999999999999986432    2234456678877776     34789999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +||||||+ +++|.+++.+.+  .+++..++.++.||+.||+|||++||+||||||+|||++.+|.++++|||++.....
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            99999999 889999997654  799999999999999999999999999999999999999889899999988764432


Q ss_pred             CCcc-cccCCCCCCeEEEeCCCccc------------cCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh
Q 014117          249 DSSY-FKRMPKSSAIKVIDFGSTTY------------ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT  315 (430)
Q Consensus       249 ~~~~-~~~~~~~~~~kl~Dfg~a~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t  315 (430)
                      .... +.......  .-.++.+...            ........+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       154 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t  231 (360)
T cd05627         154 AHRTEFYRNLTHN--PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI  231 (360)
T ss_pred             ccccccccccccC--CcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence            1100 00000000  0001110000            0000123579999999999999999999999999999999999


Q ss_pred             CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhH
Q 014117          316 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD  395 (430)
Q Consensus       316 G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (430)
                      |.+||...+..+....+......                     ..+|.                        ....+.+
T Consensus       232 G~~Pf~~~~~~~~~~~i~~~~~~---------------------~~~p~------------------------~~~~s~~  266 (360)
T cd05627         232 GYPPFCSETPQETYRKVMNWKET---------------------LVFPP------------------------EVPISEK  266 (360)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCc---------------------eecCC------------------------CCCCCHH
Confidence            99999876665544433221000                     00010                        1135678


Q ss_pred             HHHHHHHhhhcCCCCCC---CHHHHhcCCCCCCC
Q 014117          396 LTHLLQGLLRYDPTDRL---TAREALRHPFFTRD  426 (430)
Q Consensus       396 ~~~ll~~~L~~dP~~R~---ta~elL~hp~f~~~  426 (430)
                      +++||.+|+. ||.+|+   +++++++||||+..
T Consensus       267 ~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         267 AKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             HHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence            9999999874 999998   48999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.1e-46  Score=358.96  Aligned_cols=254  Identities=26%  Similarity=0.420  Sum_probs=202.8

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||+|+||.||+|.++.+++.||+|+++....    ....+..|+.+++.+     ++++|+.+++.+...+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-----~~~~i~~~~~~~~~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-----NSPWIPQLQYAFQDKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCCcceeeEEecCCe
Confidence            369999999999999999999999999999999974322    334456677777665     45889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.                 
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~-----------------  137 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR-----------------  137 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC-----------------
Confidence            99999999 899999998753 37999999999999999999999999999999999999954                 


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhh------CCCCCCcchHHHHHHHHHHHHhCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVIL------GLGWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                .+.+||+|||++.......    ....||+.|+|||++.      +..++.++|||||||++|+|++|..
T Consensus       138 ----------~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~  207 (330)
T cd05601         138 ----------TGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS  207 (330)
T ss_pred             ----------CCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCC
Confidence                      4556677777665433221    1236899999999987      4568899999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||...+....+..+.....                     ...+|                        .....+.++.+
T Consensus       208 Pf~~~~~~~~~~~i~~~~~---------------------~~~~~------------------------~~~~~~~~~~~  242 (330)
T cd05601         208 PFHEGTSAKTYNNIMNFQR---------------------FLKFP------------------------EDPKVSSDFLD  242 (330)
T ss_pred             CCCCCCHHHHHHHHHcCCC---------------------ccCCC------------------------CCCCCCHHHHH
Confidence            9987665554443322100                     00011                        01245678999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          399 LLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||.+||+ ||.+|||++++++||||+..
T Consensus       243 li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         243 LIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             HHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            9999998 99999999999999999863

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3e-45  Score=353.12  Aligned_cols=245  Identities=24%  Similarity=0.382  Sum_probs=197.0

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      +.||+|+||.||+|.+..+++.||+|+++...    ........|..++..+    ..|++|+++++.+.+.+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~hp~iv~~~~~~~~~~~~~lv~e   76 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA----WEHPFLTHLYCTFQTKENLFFVME   76 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc----cCCCcCcceEEEEEeCCEEEEEEe
Confidence            46899999999999999999999999987432    2223445566666544    245889999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccc
Q 014117          176 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK  254 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~  254 (430)
                      |+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.                       
T Consensus        77 y~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~-----------------------  131 (316)
T cd05619          77 YLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT-----------------------  131 (316)
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC-----------------------
Confidence            99 899999997653  7899999999999999999999999999999999999954                       


Q ss_pred             cCCCCCCeEEEeCCCccccC---CCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Q 014117          255 RMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM  331 (430)
Q Consensus       255 ~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~  331 (430)
                          ++.+||+|||++....   ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....
T Consensus       132 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~  207 (316)
T cd05619         132 ----DGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS  207 (316)
T ss_pred             ----CCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence                4456677777665321   122345789999999999999999999999999999999999999987665544433


Q ss_pred             HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCC
Q 014117          332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR  411 (430)
Q Consensus       332 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R  411 (430)
                      +.....                                                 ..+...+.++.+||.+||+.||++|
T Consensus       208 i~~~~~-------------------------------------------------~~~~~~~~~~~~li~~~l~~~P~~R  238 (316)
T cd05619         208 IRMDNP-------------------------------------------------CYPRWLTREAKDILVKLFVREPERR  238 (316)
T ss_pred             HHhCCC-------------------------------------------------CCCccCCHHHHHHHHHHhccCHhhc
Confidence            321110                                                 0122345678999999999999999


Q ss_pred             CCHH-HHhcCCCCCCC
Q 014117          412 LTAR-EALRHPFFTRD  426 (430)
Q Consensus       412 ~ta~-elL~hp~f~~~  426 (430)
                      +++. ++++||||+..
T Consensus       239 ~~~~~~l~~h~~~~~~  254 (316)
T cd05619         239 LGVKGDIRQHPFFREI  254 (316)
T ss_pred             CCChHHHHcCcccCCC
Confidence            9996 99999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-45  Score=354.10  Aligned_cols=244  Identities=28%  Similarity=0.381  Sum_probs=197.6

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeE-EEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC-e
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEM-VAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-H  169 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~-vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~-~  169 (430)
                      ...+.+.||+|+||+||++..+.  +. ||+|++....   ...+.+..|+.+|.+++     ||||+++++.+.... .
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~-----HpNIV~f~G~~~~~~~~  114 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDESRKAFRREASLLSRLR-----HPNIVQFYGACTSPPGS  114 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHHHHHHHHHHHHHHhCC-----CCCeeeEEEEEcCCCCc
Confidence            35566679999999999998754  44 9999997432   22557899999999984     489999999998887 8


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-eeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC-MIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      ++|||||+ +|+|.+++.......+++..+..++.||+.||.|||+++ ||||||||+|||++                 
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~-----------------  177 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD-----------------  177 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc-----------------
Confidence            99999999 999999998854468999999999999999999999999 99999999999994                 


Q ss_pred             CCCcccccCCCCC-CeEEEeCCCccccCC---CCCeeeecCcccchhhhh--CCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 014117          248 KDSSYFKRMPKSS-AIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVIL--GLGWTYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       248 ~~~~~~~~~~~~~-~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                                ... .+||+|||+++....   ......||+.|||||++.  ...|+.++||||||++||||+||..||.
T Consensus       178 ----------~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~  247 (362)
T KOG0192|consen  178 ----------LKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFE  247 (362)
T ss_pred             ----------CCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCC
Confidence                      443 677777777764442   223368999999999999  5589999999999999999999999999


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      .....+... .....+..|                                              ..+..++..+..|+.
T Consensus       248 ~~~~~~~~~-~v~~~~~Rp----------------------------------------------~~p~~~~~~l~~l~~  280 (362)
T KOG0192|consen  248 DLAPVQVAS-AVVVGGLRP----------------------------------------------PIPKECPPHLSSLME  280 (362)
T ss_pred             CCCHHHHHH-HHHhcCCCC----------------------------------------------CCCccCCHHHHHHHH
Confidence            877733332 222222222                                              123446778999999


Q ss_pred             HhhhcCCCCCCCHHHHhc
Q 014117          402 GLLRYDPTDRLTAREALR  419 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~  419 (430)
                      .||..||.+||+..+++.
T Consensus       281 ~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  281 RCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HhCCCCCCcCCCHHHHHH
Confidence            999999999999887753

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-46  Score=337.08  Aligned_cols=271  Identities=27%  Similarity=0.472  Sum_probs=218.1

Q ss_pred             EEEE-eeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           96 YKIH-SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        96 y~~~-~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      |++. +.||+|+|+.|--|....++..||||++.+.. ..+.+..+|++++.++.    +|+||++++++|+++..+|||
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cq----gh~nilqLiefFEdd~~FYLV  154 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQ----GHKNILQLIEFFEDDTRFYLV  154 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhc----CCccHHHHHHHhcccceEEEE
Confidence            4443 57899999999999999999999999997654 35667888999998885    457899999999999999999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      ||-| ||+|...++++.  .|++.++..++++|+.||.|||.+||.||||||+|||....                    
T Consensus       155 fEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~p--------------------  212 (463)
T KOG0607|consen  155 FEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESP--------------------  212 (463)
T ss_pred             EecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCC--------------------
Confidence            9999 999999998764  79999999999999999999999999999999999999654                    


Q ss_pred             cccCCCCCCeEEEeCCCccccC----------CCCCeeeecCcccchhhhh---C--CCCCCcchHHHHHHHHHHHHhCC
Q 014117          253 FKRMPKSSAIKVIDFGSTTYER----------PDQNYIVSTRHYRAPEVIL---G--LGWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~----------~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DvwslGv~l~el~tG~  317 (430)
                          +.-..+|||||.++.-..          +.-.+.+|+..|||||++.   +  .-|+++.|.||||||+|-|++|.
T Consensus       213 ----n~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGY  288 (463)
T KOG0607|consen  213 ----NKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGY  288 (463)
T ss_pred             ----CCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCC
Confidence                334457777776653211          1123458999999999975   2  25999999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      +||.+.-..+        +|=-..+.-+..+..+..-++.|++.+|+.                      -|..++.+++
T Consensus       289 pPFvG~Cg~d--------CGWdrGe~Cr~CQ~~LFesIQEGkYeFPdk----------------------dWahIS~eak  338 (463)
T KOG0607|consen  289 PPFVGHCGAD--------CGWDRGEVCRVCQNKLFESIQEGKYEFPDK----------------------DWAHISSEAK  338 (463)
T ss_pred             CCccCccCCc--------CCccCCCccHHHHHHHHHHHhccCCcCChh----------------------hhHHhhHHHH
Confidence            9998743311        122222223334455555566777777763                      2456788999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          398 HLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||++++|.+|+.+|++|.++|+|||+++.
T Consensus       339 dlisnLlvrda~~rlsa~~vlnhPw~~~~  367 (463)
T KOG0607|consen  339 DLISNLLVRDAKQRLSAAQVLNHPWVQRC  367 (463)
T ss_pred             HHHHHHHhccHHhhhhhhhccCCcccccc
Confidence            99999999999999999999999999865

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4e-45  Score=352.59  Aligned_cols=245  Identities=25%  Similarity=0.379  Sum_probs=198.8

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      +.||+|+||+||+|.++.+++.||+|++++..    ........|.+++..+.    .|++++++++++...+.+|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~----~h~~i~~~~~~~~~~~~~~lv~e   76 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG----KHPFLTQLHSCFQTKDRLFFVME   76 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhcc----CCCCccceeeEEEcCCEEEEEEc
Confidence            46999999999999999999999999987432    22334556777776663    45889999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccc
Q 014117          176 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK  254 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~  254 (430)
                      |+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.                       
T Consensus        77 ~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~-----------------------  131 (318)
T cd05570          77 YVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDS-----------------------  131 (318)
T ss_pred             CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECC-----------------------
Confidence            99 889999887764  7999999999999999999999999999999999999954                       


Q ss_pred             cCCCCCCeEEEeCCCccccC---CCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Q 014117          255 RMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM  331 (430)
Q Consensus       255 ~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~  331 (430)
                          ++.+||+|||++....   ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....
T Consensus       132 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~  207 (318)
T cd05570         132 ----EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS  207 (318)
T ss_pred             ----CCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence                4456666666654321   112335789999999999999999999999999999999999999987665544433


Q ss_pred             HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCC
Q 014117          332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR  411 (430)
Q Consensus       332 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R  411 (430)
                      +.....                                                 .++...+.++.+||.+||+.||.+|
T Consensus       208 i~~~~~-------------------------------------------------~~~~~~~~~~~~li~~~l~~dP~~R  238 (318)
T cd05570         208 ILEDEV-------------------------------------------------RYPRWLSKEAKSILKSFLTKNPEKR  238 (318)
T ss_pred             HHcCCC-------------------------------------------------CCCCcCCHHHHHHHHHHccCCHHHc
Confidence            221100                                                 1123456789999999999999999


Q ss_pred             CCH-----HHHhcCCCCCCC
Q 014117          412 LTA-----REALRHPFFTRD  426 (430)
Q Consensus       412 ~ta-----~elL~hp~f~~~  426 (430)
                      ||+     .+++.||||+..
T Consensus       239 ~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         239 LGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             CCCCCCCHHHHhcCCCcCCC
Confidence            999     999999999764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.4e-45  Score=353.99  Aligned_cols=253  Identities=21%  Similarity=0.381  Sum_probs=194.7

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      +.||+|+||.||+|.+..+++.||+|+++...    ........|..++..+.    +|++|+.+++++...+.+|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~----~hp~Iv~~~~~~~~~~~~~lv~e   76 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS----NHPFLVGLHSCFQTESRLFFVIE   76 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc----CCCCCCceEEEEEcCCEEEEEEe
Confidence            36899999999999999999999999997432    22234556777777764    34789999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccc
Q 014117          176 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK  254 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~  254 (430)
                      |+ +++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.                       
T Consensus        77 ~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~-----------------------  131 (329)
T cd05588          77 FVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA-----------------------  131 (329)
T ss_pred             CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC-----------------------
Confidence            99 889999887654  7999999999999999999999999999999999999954                       


Q ss_pred             cCCCCCCeEEEeCCCcccc---CCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Q 014117          255 RMPKSSAIKVIDFGSTTYE---RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM  331 (430)
Q Consensus       255 ~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~  331 (430)
                          ++.+||+|||++...   .......+||+.|+|||++.+..++.++|+|||||++|+|++|..||......+..  
T Consensus       132 ----~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~--  205 (329)
T cd05588         132 ----EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP--  205 (329)
T ss_pred             ----CCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccc--
Confidence                445666666665431   11123357999999999999999999999999999999999999999642110000  


Q ss_pred             HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCC
Q 014117          332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR  411 (430)
Q Consensus       332 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R  411 (430)
                           .......       ..+.+..+                          ....+...+.++.+||.+||+.||.+|
T Consensus       206 -----~~~~~~~-------~~~~~~~~--------------------------~~~~p~~~~~~~~~li~~~L~~dP~~R  247 (329)
T cd05588         206 -----DQNTEDY-------LFQVILEK--------------------------QIRIPRSLSVKASSVLKGFLNKDPKER  247 (329)
T ss_pred             -----cccchHH-------HHHHHHcC--------------------------CCCCCCCCCHHHHHHHHHHhccCHHHc
Confidence                 0000000       00000000                          112344567789999999999999999


Q ss_pred             CC------HHHHhcCCCCCC
Q 014117          412 LT------AREALRHPFFTR  425 (430)
Q Consensus       412 ~t------a~elL~hp~f~~  425 (430)
                      +|      ++++++||||..
T Consensus       248 ~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         248 LGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             CCCCCCCCHHHHhcCCCCCC
Confidence            87      789999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.5e-44  Score=353.78  Aligned_cols=299  Identities=26%  Similarity=0.446  Sum_probs=227.5

Q ss_pred             ceeecCc---eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCce
Q 014117           84 YMFALGE---NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRC  157 (430)
Q Consensus        84 ~~~~~~~---~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i  157 (430)
                      +.+..++   .+.++|++.+.||+|+||.||+|.+..+++.||+|++...   .........|+.+++++.     ++|+
T Consensus         3 ~~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i   77 (353)
T cd07850           3 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVN-----HKNI   77 (353)
T ss_pred             eeecccchhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcC-----CCCC
Confidence            4455555   4567899999999999999999999999999999998632   223345667888888884     4788


Q ss_pred             EEecceeecC------CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEee
Q 014117          158 VQIRNWFDYR------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS  231 (430)
Q Consensus       158 ~~~~~~~~~~------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~  231 (430)
                      +++++++...      ...|+||||+.++|.+.+..    .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus        78 v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~  153 (353)
T cd07850          78 IGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS  153 (353)
T ss_pred             cceeeeeccCCCccccCcEEEEEeccCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC
Confidence            9888877533      46899999998899988864    3889999999999999999999999999999999999954


Q ss_pred             cCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHH
Q 014117          232 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI  309 (430)
Q Consensus       232 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~  309 (430)
                                                 ++.+||+|||++.......  ....||..|+|||++.+..++.++|||||||+
T Consensus       154 ---------------------------~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~  206 (353)
T cd07850         154 ---------------------------DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI  206 (353)
T ss_pred             ---------------------------CCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHH
Confidence                                       4456666666665433221  22467899999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhc
Q 014117          310 LVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV  389 (430)
Q Consensus       310 l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (430)
                      +|+|++|+.||...+.......+...++.++.++...+......+..+......      ..+................+
T Consensus       207 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~  280 (353)
T cd07850         207 MGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAG------YSFEELFPDVLFPPDSESHN  280 (353)
T ss_pred             HHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCC------cchhhhCcccccCccccccc
Confidence            999999999999888888889999999999988877776655555433211100      00000000000000000012


Q ss_pred             CCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCC
Q 014117          390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       390 ~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~  424 (430)
                      ...+.++.+||.+||+.||++|||+.|+|.||||+
T Consensus       281 ~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~  315 (353)
T cd07850         281 KLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN  315 (353)
T ss_pred             ccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence            34566789999999999999999999999999886

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.2e-45  Score=353.26  Aligned_cols=244  Identities=24%  Similarity=0.407  Sum_probs=198.3

Q ss_pred             eeeccccceEEEEEEEC---CCCeEEEEEEecCch-----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117          100 SKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +.||+|+||.||+|.+.   .+++.||+|+++...     ........|+.+++.+.     |+||+++++.+...+.+|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-----hp~iv~~~~~~~~~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-----HPFIVDLIYAFQTGGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-----CCchhceeeEEecCCeEE
Confidence            67999999999999864   468899999987432     22234567888888884     488999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||++                    
T Consensus        77 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~--------------------  134 (323)
T cd05584          77 LILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD--------------------  134 (323)
T ss_pred             EEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC--------------------
Confidence            999999 889999997764  789999999999999999999999999999999999994                    


Q ss_pred             cccccCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                             .++.+||+|||++.....   .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+...
T Consensus       135 -------~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~  207 (323)
T cd05584         135 -------AQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK  207 (323)
T ss_pred             -------CCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH
Confidence                   445677777776653211   1233579999999999999899999999999999999999999998766544


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+....                       .                          ..++..+.++.+||.+||+.|
T Consensus       208 ~~~~~~~~~-----------------------~--------------------------~~~~~~~~~~~~li~~~l~~~  238 (323)
T cd05584         208 TIDKILKGK-----------------------L--------------------------NLPPYLTPEARDLLKKLLKRN  238 (323)
T ss_pred             HHHHHHcCC-----------------------C--------------------------CCCCCCCHHHHHHHHHHcccC
Confidence            433332111                       0                          123345678999999999999


Q ss_pred             CCCCC-----CHHHHhcCCCCCCC
Q 014117          408 PTDRL-----TAREALRHPFFTRD  426 (430)
Q Consensus       408 P~~R~-----ta~elL~hp~f~~~  426 (430)
                      |++||     +++++++||||+..
T Consensus       239 p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         239 PSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HhHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999     89999999999754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.6e-45  Score=353.75  Aligned_cols=244  Identities=27%  Similarity=0.420  Sum_probs=194.0

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHHH-HHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEV-LQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~-l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      +.||+|+||+||+|.++.+++.||+|++.....    .......|... ++.+     .|++|+++++.+...+.+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-----~hp~iv~~~~~~~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-----KHPFLVGLHYSFQTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-----CCCCCCCeeEEEEeCCEEEEEE
Confidence            468999999999999999999999999864321    11223334333 2333     4588999999999999999999


Q ss_pred             ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          175 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       175 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      ||+ +++|..++....  .+++..+..++.||+.||.|||++||+||||||+|||++                       
T Consensus        76 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~-----------------------  130 (323)
T cd05575          76 DYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD-----------------------  130 (323)
T ss_pred             cCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC-----------------------
Confidence            999 889999987654  799999999999999999999999999999999999994                       


Q ss_pred             ccCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Q 014117          254 KRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA  330 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~  330 (430)
                          .++.+||+|||++.....   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+...
T Consensus       131 ----~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~  206 (323)
T cd05575         131 ----SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD  206 (323)
T ss_pred             ----CCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence                445667777776653211   1233579999999999999999999999999999999999999998766544443


Q ss_pred             HHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCC
Q 014117          331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD  410 (430)
Q Consensus       331 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~  410 (430)
                      .+....                                                 ...+...+.++.+||.+||+.||.+
T Consensus       207 ~i~~~~-------------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~  237 (323)
T cd05575         207 NILNKP-------------------------------------------------LRLKPNISVSARHLLEGLLQKDRTK  237 (323)
T ss_pred             HHHcCC-------------------------------------------------CCCCCCCCHHHHHHHHHHhhcCHHh
Confidence            332110                                                 0112345678999999999999999


Q ss_pred             CCCH----HHHhcCCCCCCC
Q 014117          411 RLTA----REALRHPFFTRD  426 (430)
Q Consensus       411 R~ta----~elL~hp~f~~~  426 (430)
                      ||++    .++++||||...
T Consensus       238 R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         238 RLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             CCCCCCCHHHHHcCCCcCCC
Confidence            9987    699999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.3e-44  Score=346.82  Aligned_cols=285  Identities=26%  Similarity=0.483  Sum_probs=206.6

Q ss_pred             EeeeccccceEEEEEEECC--CCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee--cCCeEEEEE
Q 014117           99 HSKMGEGTFGQVLECWDRE--RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--YRNHICIVF  174 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~--~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~--~~~~~~lv~  174 (430)
                      ..+||+|+||.||+|.++.  ++..||+|.+.... .......|+++++.+.     |+|++++++++.  ....+++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELK-----HPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCC-----CCCeeeEEEEEeccCCCeEEEEE
Confidence            3689999999999999654  56789999987543 2345677999999884     478999998874  457899999


Q ss_pred             ecCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          175 EKLGSSLYDFLRKNN-------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       175 e~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      ||++++|.+++....       ...+++..++.++.||+.||.|||++||+||||||+|||+...+              
T Consensus        80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~--------------  145 (317)
T cd07867          80 DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG--------------  145 (317)
T ss_pred             eeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCC--------------
Confidence            999889988875321       13588999999999999999999999999999999999995432              


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCC------CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                               +..+.+||+|||+++.....      .....||+.|+|||++.+. .++.++|||||||++|||+||.+||
T Consensus       146 ---------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f  216 (317)
T cd07867         146 ---------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF  216 (317)
T ss_pred             ---------CCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence                     34567888888888654322      1235789999999999874 5899999999999999999999999


Q ss_pred             CCCch---------HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCC
Q 014117          321 QTHEN---------LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH  391 (430)
Q Consensus       321 ~~~~~---------~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (430)
                      ....+         ......+...+|.+....+..+............+..           .......+..........
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~  285 (317)
T cd07867         217 HCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRR-----------TTYANSSLIKYMEKHKVK  285 (317)
T ss_pred             ccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcc-----------cccCCchhhhhhhcccCC
Confidence            75332         3445566667776665554443221110000000000           000011111112222334


Q ss_pred             chhHHHHHHHHhhhcCCCCCCCHHHHhcCCCC
Q 014117          392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       392 ~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      .+..+.+||.+||+.||.+|||++|+|+||||
T Consensus       286 ~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         286 PDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            45678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=9.2e-45  Score=343.77  Aligned_cols=248  Identities=23%  Similarity=0.367  Sum_probs=195.7

Q ss_pred             eccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 014117          102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL  177 (430)
Q Consensus       102 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~  177 (430)
                      ||+|+||+||+|.++.+++.||+|.+.....    ....+..|+.+++.+     ++++++.+.+.+.....+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-----HSRFIVSLAYAFQTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-----CCCcEeeeeEEEcCCCeEEEEEeCC
Confidence            7999999999999999999999999864321    223456788888888     3478999999999999999999999


Q ss_pred             -CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccc
Q 014117          178 -GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK  254 (430)
Q Consensus       178 -~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~  254 (430)
                       +++|.+++...  ....+++..+..++.||+.||.|||++||+||||||+|||++                        
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~------------------------  131 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD------------------------  131 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC------------------------
Confidence             88998887532  224689999999999999999999999999999999999994                        


Q ss_pred             cCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Q 014117          255 RMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM  331 (430)
Q Consensus       255 ~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~  331 (430)
                         .++.++|+|||++.......   ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus       132 ---~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~  208 (280)
T cd05608         132 ---NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE  208 (280)
T ss_pred             ---CCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH
Confidence               44567777777765432221   234789999999999999999999999999999999999999976433211111


Q ss_pred             HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCC
Q 014117          332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR  411 (430)
Q Consensus       332 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R  411 (430)
                      +.....                   .+                          ....+...+.++.+|+.+||+.||++|
T Consensus       209 ~~~~~~-------------------~~--------------------------~~~~~~~~~~~~~~li~~~l~~~P~~R  243 (280)
T cd05608         209 LKQRIL-------------------ND--------------------------SVTYPDKFSPASKSFCEALLAKDPEKR  243 (280)
T ss_pred             HHHhhc-------------------cc--------------------------CCCCcccCCHHHHHHHHHHhcCCHHHh
Confidence            111000                   00                          001234567789999999999999999


Q ss_pred             C-----CHHHHhcCCCCCCC
Q 014117          412 L-----TAREALRHPFFTRD  426 (430)
Q Consensus       412 ~-----ta~elL~hp~f~~~  426 (430)
                      |     |++++++||||+.-
T Consensus       244 ~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         244 LGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             cCCCCCCHHHHhcChhhhcC
Confidence            9     89999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-44  Score=354.76  Aligned_cols=278  Identities=23%  Similarity=0.368  Sum_probs=201.8

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      .+|++++.||+|+||.||+|.+..+++.||+|+....     ....|+.+++++.     |+||+++++++......|+|
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVN-----HPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCC-----CCCCcChhheEEeCCeeEEE
Confidence            4799999999999999999999999999999986432     2345888888874     47899999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          174 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       174 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      ||++.++|.+++.... ..+++..+..++.||+.||.|||++|||||||||+|||++                       
T Consensus       136 ~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~-----------------------  191 (357)
T PHA03209        136 LPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN-----------------------  191 (357)
T ss_pred             EEccCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC-----------------------
Confidence            9999889999987654 4799999999999999999999999999999999999994                       


Q ss_pred             ccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCch-----
Q 014117          254 KRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE-ALFQTHEN-----  325 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~-~Pf~~~~~-----  325 (430)
                          ..+.+||+|||+++.....  .....||..|+|||++.+..++.++|||||||++|||+++. ++|.....     
T Consensus       192 ----~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~  267 (357)
T PHA03209        192 ----DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEY  267 (357)
T ss_pred             ----CCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHH
Confidence                4456777777777543221  23357899999999999999999999999999999999854 44443211     


Q ss_pred             ----HHHHHHHHHHhCCCCHHHHHH-HHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          326 ----LEHLAMMERVLGPLPQHMLKR-VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       326 ----~~~~~~i~~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                          ...+..+...++..|..+... .......++..     ...          ...+... ...-.....+.++.+||
T Consensus       268 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~----------~~~~~~~-~~~~~~~~~~~~~~~li  331 (357)
T PHA03209        268 VKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEY-----ASL----------ERQPYTR-YPCFQRVNLPIDGEFLV  331 (357)
T ss_pred             HHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhh-----ccc----------CCCcccc-cHHHhccCCCchHHHHH
Confidence                122233333344333321100 00000000000     000          0000000 00001124566788999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          401 QGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      .+||+.||.+||||.|||+||||++
T Consensus       332 ~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        332 HKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHHHcCCcccCcCHHHHhcCchhcc
Confidence            9999999999999999999999985

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.2e-45  Score=352.45  Aligned_cols=254  Identities=21%  Similarity=0.361  Sum_probs=194.8

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      +.||+|+||.||+|.++.+++.||+|++++..    ........|+.++.++.    +|++|+++++++...+.+|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~----~hp~iv~~~~~~~~~~~~~lv~E   76 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS----NHPFLVGLHSCFQTESRLFFVIE   76 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcC----CCCcCCceeeEEEeCCEEEEEEe
Confidence            46899999999999999999999999987432    22234556776666553    45889999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccc
Q 014117          176 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK  254 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~  254 (430)
                      |+ +++|..++....  .+++..++.++.||+.||.|||++||+||||||+|||++                        
T Consensus        77 ~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~------------------------  130 (329)
T cd05618          77 YVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD------------------------  130 (329)
T ss_pred             CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC------------------------
Confidence            99 889998887654  799999999999999999999999999999999999994                        


Q ss_pred             cCCCCCCeEEEeCCCccccC---CCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Q 014117          255 RMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM  331 (430)
Q Consensus       255 ~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~  331 (430)
                         .++.+||+|||++....   ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... 
T Consensus       131 ---~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~-  206 (329)
T cd05618         131 ---SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-  206 (329)
T ss_pred             ---CCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc-
Confidence               44567777777765321   11234579999999999999999999999999999999999999996321100000 


Q ss_pred             HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCC
Q 014117          332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR  411 (430)
Q Consensus       332 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R  411 (430)
                            .....       .....+...                          ....+...+.++.+||.+||+.||++|
T Consensus       207 ------~~~~~-------~~~~~i~~~--------------------------~~~~p~~~~~~~~~ll~~~L~~dP~~R  247 (329)
T cd05618         207 ------QNTED-------YLFQVILEK--------------------------QIRIPRSLSVKAASVLKSFLNKDPKER  247 (329)
T ss_pred             ------cccHH-------HHHHHHhcC--------------------------CCCCCCCCCHHHHHHHHHHhcCCHHHc
Confidence                  00000       000000000                          012344567789999999999999999


Q ss_pred             CC------HHHHhcCCCCCCC
Q 014117          412 LT------AREALRHPFFTRD  426 (430)
Q Consensus       412 ~t------a~elL~hp~f~~~  426 (430)
                      +|      ++++++||||+..
T Consensus       248 ~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         248 LGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             CCCCCCCCHHHHhcCCCCCCC
Confidence            98      5899999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1e-44  Score=344.34  Aligned_cols=256  Identities=26%  Similarity=0.410  Sum_probs=203.9

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....    ........|+.+++++.     +++++.+++.+...+.+
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-----~~~i~~~~~~~~~~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-----SRFVVSLAYAYETKDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-----CCCeeeeeEEEecCCEE
Confidence            3788899999999999999999999999999886432    12234567888888884     37799999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||+ +++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++                   
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~-------------------  136 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD-------------------  136 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC-------------------
Confidence            9999999 88999998766555799999999999999999999999999999999999994                   


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                              ..+.++|+|||++.......  ....||..|+|||++.+..++.++|+|||||++|+|++|..||.......
T Consensus       137 --------~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~  208 (285)
T cd05630         137 --------DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI  208 (285)
T ss_pred             --------CCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc
Confidence                    44567777777765432222  22478999999999999999999999999999999999999997643321


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ..........                                             ......+...+.++.+|+.+||+.|
T Consensus       209 ~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~~~~li~~~l~~~  243 (285)
T cd05630         209 KREEVERLVK---------------------------------------------EVQEEYSEKFSPDARSLCKMLLCKD  243 (285)
T ss_pred             hHHHHHhhhh---------------------------------------------hhhhhcCccCCHHHHHHHHHHhhcC
Confidence            1111111000                                             0001123456778999999999999


Q ss_pred             CCCCCC-----HHHHhcCCCCCCCC
Q 014117          408 PTDRLT-----AREALRHPFFTRDH  427 (430)
Q Consensus       408 P~~R~t-----a~elL~hp~f~~~~  427 (430)
                      |++|||     ++|+++||||++..
T Consensus       244 p~~R~s~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05630         244 PKERLGCQGGGAREVKEHPLFKQIN  268 (285)
T ss_pred             HHHccCCCCCchHHHHcChhhhccC
Confidence            999999     99999999998653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-44  Score=350.03  Aligned_cols=256  Identities=26%  Similarity=0.403  Sum_probs=200.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++.+..    .....+..|+.++..+     .+++|+.+++.+...++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-----DRRWITNLHYAFQDENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-----CCCCCCceEEEEecCCe
Confidence            36999999999999999999999999999999986422    1223455677777665     44789999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|+||||+ +++|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++                  
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~------------------  136 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD------------------  136 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC------------------
Confidence            99999999 899999997643 4699999999999999999999999999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhC-----CCCCCcchHHHHHHHHHHHHhCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEAL  319 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~tG~~P  319 (430)
                               .++.+||+|||++.......    ...+||+.|+|||++.+     ..++.++|||||||++|+|++|..|
T Consensus       137 ---------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~P  207 (331)
T cd05597         137 ---------KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP  207 (331)
T ss_pred             ---------CCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCC
Confidence                     45567788888765432221    22469999999999973     3578899999999999999999999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |...+..+....+......                     +..+                       ......+.++++|
T Consensus       208 f~~~~~~~~~~~i~~~~~~---------------------~~~~-----------------------~~~~~~~~~~~~l  243 (331)
T cd05597         208 FYAESLVETYGKIMNHKEH---------------------FQFP-----------------------PDVTDVSEEAKDL  243 (331)
T ss_pred             CCCCCHHHHHHHHHcCCCc---------------------ccCC-----------------------CccCCCCHHHHHH
Confidence            9876655544433221100                     0000                       0112357789999


Q ss_pred             HHHhhhcCCCC--CCCHHHHhcCCCCCCC
Q 014117          400 LQGLLRYDPTD--RLTAREALRHPFFTRD  426 (430)
Q Consensus       400 l~~~L~~dP~~--R~ta~elL~hp~f~~~  426 (430)
                      |++||..++++  |+++.++++||||...
T Consensus       244 i~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         244 IRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             HHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            99999764444  7899999999999764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-45  Score=354.32  Aligned_cols=251  Identities=27%  Similarity=0.498  Sum_probs=220.2

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe-
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH-  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~-  169 (430)
                      ++|.+++.+|+|+||.+++++++..++.|++|.+...   ...+...+.|+.++.++.|     |+|+.+.+.|..++. 
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~h-----P~iv~y~ds~~~~~~~   78 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLH-----PNIVEYKDSFEEDGQL   78 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccC-----CCeeeeccchhcCCce
Confidence            4699999999999999999999999999999998633   3445567889999999844     889999999988887 


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +||||+|| ||+|.+.+....+.-|+++.+..|+.|++.||.|||++.|+|||||+.||++                   
T Consensus        79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl-------------------  139 (426)
T KOG0589|consen   79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL-------------------  139 (426)
T ss_pred             EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc-------------------
Confidence            99999999 9999999987776789999999999999999999999999999999999999                   


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                              .++..|||+|||+|+...+..   .+.+||+.||+||++.+.+|+.++|||||||++|||++-+++|++.+-
T Consensus       140 --------tk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m  211 (426)
T KOG0589|consen  140 --------TKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM  211 (426)
T ss_pred             --------cccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch
Confidence                    455667888888888776654   457999999999999999999999999999999999999999999887


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      ......|......                                                ..+..++.+++.||..||.
T Consensus       212 ~~Li~ki~~~~~~------------------------------------------------Plp~~ys~el~~lv~~~l~  243 (426)
T KOG0589|consen  212 SELILKINRGLYS------------------------------------------------PLPSMYSSELRSLVKSMLR  243 (426)
T ss_pred             HHHHHHHhhccCC------------------------------------------------CCCccccHHHHHHHHHHhh
Confidence            7777766655411                                                1234567789999999999


Q ss_pred             cCCCCCCCHHHHhcCCCCC
Q 014117          406 YDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f~  424 (430)
                      .+|+.||+|.++|.+|.+.
T Consensus       244 ~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  244 KNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             cCCccCCCHHHHhhChhhh
Confidence            9999999999999998775

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.5e-44  Score=355.66  Aligned_cols=257  Identities=24%  Similarity=0.412  Sum_probs=203.8

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      ...++|++.+.||+|+||.||+|.++.+++.||+|++....    .....+..|+.+++.+     ++++|+++++.+..
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-----~hp~iv~~~~~~~~  114 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-----NSPWVVQLFYAFQD  114 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEc
Confidence            33578999999999999999999999999999999986422    1223455677777776     45889999999999


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      .+.+|+||||+ +++|.+++...   .+++..++.++.||+.||+|||++||+||||||+|||++               
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~---------------  176 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---------------  176 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC---------------
Confidence            99999999999 88999998754   589999999999999999999999999999999999994               


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCC----CCeeeecCcccchhhhhCCC----CCCcchHHHHHHHHHHHHhCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGv~l~el~tG~  317 (430)
                                  .++.+||+|||++......    ....+||+.|+|||++.+..    ++.++|||||||++|||++|.
T Consensus       177 ------------~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~  244 (371)
T cd05622         177 ------------KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD  244 (371)
T ss_pred             ------------CCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCC
Confidence                        4556777777777543321    12457999999999997643    789999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      +||...+.......+......+                     .+|.                        ....+.+++
T Consensus       245 ~Pf~~~~~~~~~~~i~~~~~~~---------------------~~~~------------------------~~~~s~~~~  279 (371)
T cd05622         245 TPFYADSLVGTYSKIMNHKNSL---------------------TFPD------------------------DNDISKEAK  279 (371)
T ss_pred             CCCCCCCHHHHHHHHHcCCCcc---------------------cCCC------------------------cCCCCHHHH
Confidence            9998876655554443221110                     1111                        124577899


Q ss_pred             HHHHHhhhcCCCC--CCCHHHHhcCCCCCCCC
Q 014117          398 HLLQGLLRYDPTD--RLTAREALRHPFFTRDH  427 (430)
Q Consensus       398 ~ll~~~L~~dP~~--R~ta~elL~hp~f~~~~  427 (430)
                      +||.+||+.++.+  |++++|+++||||++..
T Consensus       280 ~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         280 NLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             HHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence            9999999844433  78999999999998753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.3e-44  Score=338.34  Aligned_cols=277  Identities=31%  Similarity=0.511  Sum_probs=211.9

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +|++.+.||+|++|.||+|.++.+++.||+|.++...   ........|+.+++.+.     |+|++++++++..++.+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ-----HPNIVCLQDVLMQESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC-----CCCEeeeEEEEeeCCeEE
Confidence            4889999999999999999999999999999986432   22345677898888884     488999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKLGSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+.++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.                
T Consensus        76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~----------------  139 (285)
T cd07861          76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV----------------  139 (285)
T ss_pred             EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc----------------
Confidence            9999998899998875432 56899999999999999999999999999999999999965554                


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                                 ++|+|||++.......   ....+++.|+|||++.+. .++.++|||||||++|+|++|++||.+....
T Consensus       140 -----------~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~  208 (285)
T cd07861         140 -----------IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI  208 (285)
T ss_pred             -----------EEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence                       5555555443222111   123568899999998764 4789999999999999999999999988777


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +....+....+......++....... +...    .+.               .............+.++.+||.+||+.
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~---------------~~~~~~~~~~~~~~~~~~~li~~~l~~  268 (285)
T cd07861         209 DQLFRIFRILGTPTEDVWPGVTSLPD-YKNT----FPK---------------WKKGSLRSAVKNLDEDGLDLLEKMLIY  268 (285)
T ss_pred             HHHHHHHHHhCCCChhhhhcchhhHH-HHhh----ccc---------------cCcchhHHhcCCCCHHHHHHHHHHhcC
Confidence            76666666666665544432221111 0000    000               000111222345788899999999999


Q ss_pred             CCCCCCCHHHHhcCCCC
Q 014117          407 DPTDRLTAREALRHPFF  423 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f  423 (430)
                      ||++|||+.+|+.||||
T Consensus       269 dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         269 DPAKRISAKKALNHPYF  285 (285)
T ss_pred             ChhhCCCHHHHhcCCCC
Confidence            99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1e-44  Score=352.03  Aligned_cols=291  Identities=22%  Similarity=0.350  Sum_probs=208.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .++|++.++||.|+||.||+|.+..++..+|+|++...  ......+..|+++++.+.     |+||+++++++...+++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN-----SPYIVGFYGAFYSDGEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC-----CCcccceeEEEEECCEE
Confidence            46799999999999999999999999999999998643  233456778999999884     47899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      |+||||+ +++|.+++...+  .+++..+..++.||+.||.|||+. +|+||||||+|||++.                 
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~-----------------  139 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-----------------  139 (333)
T ss_pred             EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC-----------------
Confidence            9999999 889999998754  689999999999999999999975 7999999999999954                 


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCC-CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                                ++.+||+|||++..... ......||..|+|||++.+..++.++|||||||++|+|++|+.||......+
T Consensus       140 ----------~~~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~  209 (333)
T cd06650         140 ----------RGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE  209 (333)
T ss_pred             ----------CCCEEEeeCCcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH
Confidence                      44577777776653322 2233578999999999999899999999999999999999999998654433


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhh-hccCcccCCCCCCChhhHHhhcCchhHHHHH-h----hh-cCCchhHHHHHH
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKY-VRRGRLDWPEGAASRESIKSVMKLPRLQNLI-M----QH-VDHSAGDLTHLL  400 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~----~~-~~~~~~~~~~ll  400 (430)
                      ....+.......+...    ....... .......+.....+.      +......... .    .. ....+.++.+||
T Consensus       210 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  279 (333)
T cd06650         210 LELMFGCPVEGDPAES----ETSPRPRPPGRPLSSYGPDSRPP------MAIFELLDYIVNEPPPKLPSGVFGAEFQDFV  279 (333)
T ss_pred             HHHHhcCcccCCcccc----ccCcccCCccchhhhhccccccc------ccHHHHHHHHhcCCCccCCCCCcCHHHHHHH
Confidence            2211110000000000    0000000 000000000000000      0000000000 0    00 123567899999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          401 QGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      .+||++||++|||++|++.||||+...
T Consensus       280 ~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         280 NKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             HHhccCCcccCcCHHHHhhCHHHhcCc
Confidence            999999999999999999999998763

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=9e-45  Score=351.26  Aligned_cols=244  Identities=25%  Similarity=0.374  Sum_probs=193.7

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHHH-HHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEV-LQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~-l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      +.||+|+||+||+|.++.+++.||+|++.....    .......|..+ ++.+     .|+||+++++.+...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-----~hp~iv~~~~~~~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-----KHPFLVGLHYSFQTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-----CCCCCccEEEEEecCCEEEEEE
Confidence            468999999999999999999999999864321    22233334333 2323     4588999999999999999999


Q ss_pred             ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          175 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       175 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      ||+ +++|..++....  .+++..+..++.||+.||+|||++||+||||||+|||++                       
T Consensus        76 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~-----------------------  130 (325)
T cd05604          76 DFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD-----------------------  130 (325)
T ss_pred             cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC-----------------------
Confidence            999 889999887654  799999999999999999999999999999999999994                       


Q ss_pred             ccCCCCCCeEEEeCCCccccC---CCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Q 014117          254 KRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA  330 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~  330 (430)
                          .++.+||+|||++....   ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+...
T Consensus       131 ----~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~  206 (325)
T cd05604         131 ----SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD  206 (325)
T ss_pred             ----CCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH
Confidence                44567777777665321   11234579999999999999999999999999999999999999998766554443


Q ss_pred             HHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCC
Q 014117          331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD  410 (430)
Q Consensus       331 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~  410 (430)
                      .+....                                                 ....+..+..+.++|++||+.||.+
T Consensus       207 ~~~~~~-------------------------------------------------~~~~~~~~~~~~~ll~~ll~~~p~~  237 (325)
T cd05604         207 NILHKP-------------------------------------------------LVLRPGASLTAWSILEELLEKDRQR  237 (325)
T ss_pred             HHHcCC-------------------------------------------------ccCCCCCCHHHHHHHHHHhccCHHh
Confidence            322110                                                 0112345667899999999999999


Q ss_pred             CCCH----HHHhcCCCCCCC
Q 014117          411 RLTA----REALRHPFFTRD  426 (430)
Q Consensus       411 R~ta----~elL~hp~f~~~  426 (430)
                      ||++    .+++.||||...
T Consensus       238 R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         238 RLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             cCCCCCCHHHHhcCCCcCCC
Confidence            9976    599999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.4e-44  Score=349.93  Aligned_cols=244  Identities=27%  Similarity=0.422  Sum_probs=193.3

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHHH-HHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEV-LQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~-l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      +.||+|+||+||+|++..+++.||+|++.....    .......|... ++.+     .|+||+++++.+...+.+|+||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-----~h~~Iv~~~~~~~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-----KHPFLVGLHFSFQTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-----CCCCCCceeEEEEcCCeEEEEE
Confidence            368999999999999999999999999874321    11122233322 2333     4588999999999999999999


Q ss_pred             ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          175 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       175 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      ||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.                      
T Consensus        76 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~----------------------  131 (325)
T cd05602          76 DYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS----------------------  131 (325)
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC----------------------
Confidence            999 889999997654  7889999999999999999999999999999999999954                      


Q ss_pred             ccCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Q 014117          254 KRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA  330 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~  330 (430)
                           ++.+||+|||++.....   .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+...
T Consensus       132 -----~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  206 (325)
T cd05602         132 -----QGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD  206 (325)
T ss_pred             -----CCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH
Confidence                 44566677776653211   1234579999999999999999999999999999999999999998766655444


Q ss_pred             HHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCC
Q 014117          331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD  410 (430)
Q Consensus       331 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~  410 (430)
                      .+....                                                 ....+..+.++.++|.+||+.||.+
T Consensus       207 ~i~~~~-------------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~  237 (325)
T cd05602         207 NILNKP-------------------------------------------------LQLKPNITNSARHLLEGLLQKDRTK  237 (325)
T ss_pred             HHHhCC-------------------------------------------------cCCCCCCCHHHHHHHHHHcccCHHH
Confidence            332210                                                 0122355678999999999999999


Q ss_pred             CCCHH----HHhcCCCCCCC
Q 014117          411 RLTAR----EALRHPFFTRD  426 (430)
Q Consensus       411 R~ta~----elL~hp~f~~~  426 (430)
                      |+++.    ++++|+||...
T Consensus       238 R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         238 RLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             CCCCCCCHHHHhcCcccCCC
Confidence            99876    89999999653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.7e-44  Score=339.17  Aligned_cols=276  Identities=30%  Similarity=0.492  Sum_probs=211.6

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +|++.+.||.|+||.||+|++..+|+.||+|.++...   ........|+.+++++.     |+|++++++++.+...++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~-----h~~i~~~~~~~~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-----HKNIVRLYDVLHSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcC-----CCCeeeHHHHhccCCceE
Confidence            5899999999999999999999999999999986422   22244567899888884     478999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          172 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       172 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      +|+||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++                  
T Consensus        76 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~------------------  136 (284)
T cd07839          76 LVFEYCDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG------------------  136 (284)
T ss_pred             EEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC------------------
Confidence            999999889998887643 4699999999999999999999999999999999999996554                  


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCC-CCCcchHHHHHHHHHHHHhCCCCC-CCCchH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALF-QTHENL  326 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~tG~~Pf-~~~~~~  326 (430)
                               .++|+|||++.......   ....++..|+|||++.+.. ++.++|||||||++|+|++|..|| .+.+..
T Consensus       137 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~  207 (284)
T cd07839         137 ---------ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD  207 (284)
T ss_pred             ---------cEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH
Confidence                     45555555544322111   1235688999999987754 789999999999999999988775 555666


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +.+..+.+.++..+...+..+.......      .++..             .. .....+..+..+.++.+||.+||+.
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~-------------~~-~~~~~~~~~~~~~~~~~li~~~l~~  267 (284)
T cd07839         208 DQLKRIFRLLGTPTEESWPGVSKLPDYK------PYPMY-------------PA-TTSLVNVVPKLNSTGRDLLQNLLVC  267 (284)
T ss_pred             HHHHHHHHHhCCCChHHhHHhhhccccc------ccCCC-------------CC-cchhhhhcccCCHHHHHHHHHHhcC
Confidence            7777777777777765554333211110      00000             00 0001122345678899999999999


Q ss_pred             CCCCCCCHHHHhcCCCC
Q 014117          407 DPTDRLTAREALRHPFF  423 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f  423 (430)
                      ||.+|||+++++.||||
T Consensus       268 ~P~~R~t~~~il~h~~f  284 (284)
T cd07839         268 NPVQRISAEEALQHPYF  284 (284)
T ss_pred             ChhhcCCHHHHhcCCCC
Confidence            99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-45  Score=353.39  Aligned_cols=246  Identities=26%  Similarity=0.460  Sum_probs=193.2

Q ss_pred             eccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 014117          102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL  177 (430)
Q Consensus       102 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~  177 (430)
                      ||+|+||+||+|+++.+++.||+|++.....    .......|..++.+..  ...+++|+.++..+.....+|+||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~~p~i~~~~~~~~~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL--LDESPFIVGLKFSFQTDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhc--cCCCCcCcceEEEEecCCeEEEEEcCC
Confidence            7999999999999999999999999864321    1122334555555443  124588999999999999999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccC
Q 014117          178 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM  256 (430)
Q Consensus       178 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~  256 (430)
                       +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++                          
T Consensus        79 ~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~--------------------------  130 (330)
T cd05586          79 SGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD--------------------------  130 (330)
T ss_pred             CCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC--------------------------
Confidence             889999987654  799999999999999999999999999999999999994                          


Q ss_pred             CCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Q 014117          257 PKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM  332 (430)
Q Consensus       257 ~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i  332 (430)
                       .++.+||+|||++.....   .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+
T Consensus       131 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i  209 (330)
T cd05586         131 -ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI  209 (330)
T ss_pred             -CCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH
Confidence             445667777776653221   12345799999999999765 4899999999999999999999999876654444333


Q ss_pred             HHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCC
Q 014117          333 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL  412 (430)
Q Consensus       333 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~  412 (430)
                      ...                       ....+.                         ...+.++.+||.+||+.||++||
T Consensus       210 ~~~-----------------------~~~~~~-------------------------~~~~~~~~~li~~~L~~~P~~R~  241 (330)
T cd05586         210 AFG-----------------------KVRFPK-------------------------NVLSDEGRQFVKGLLNRNPQHRL  241 (330)
T ss_pred             HcC-----------------------CCCCCC-------------------------ccCCHHHHHHHHHHcCCCHHHCC
Confidence            211                       111110                         13466789999999999999998


Q ss_pred             ----CHHHHhcCCCCCCC
Q 014117          413 ----TAREALRHPFFTRD  426 (430)
Q Consensus       413 ----ta~elL~hp~f~~~  426 (430)
                          ++.++++||||...
T Consensus       242 ~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         242 GAHRDAVELKEHPFFADI  259 (330)
T ss_pred             CCCCCHHHHhcCccccCC
Confidence                79999999999753

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.4e-45  Score=351.22  Aligned_cols=244  Identities=27%  Similarity=0.457  Sum_probs=199.5

Q ss_pred             eeeccccceEEEEEEE---CCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117          100 SKMGEGTFGQVLECWD---RERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~---~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      +.||+|+||.||++.+   ..+++.||+|+++...   ........|++++.++     .|+||+++++.+...+.+|+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-----NHPFIVKLHYAFQTEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-----CCCCcccEEEEEEcCCEEEEE
Confidence            5799999999999986   3578999999987432   2234456788888887     348899999999999999999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      |||+ +++|.+++.+..  .+++..+..++.||+.||.|||++||+||||||+|||++                      
T Consensus        77 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----------------------  132 (318)
T cd05582          77 LDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD----------------------  132 (318)
T ss_pred             EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC----------------------
Confidence            9999 899999997654  799999999999999999999999999999999999994                      


Q ss_pred             cccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL  329 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~  329 (430)
                           .++.+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..
T Consensus       133 -----~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~  207 (318)
T cd05582         133 -----EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM  207 (318)
T ss_pred             -----CCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH
Confidence                 4456777777776543322   12357899999999999989999999999999999999999999876665544


Q ss_pred             HHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCC
Q 014117          330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT  409 (430)
Q Consensus       330 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~  409 (430)
                      ..+......                                                 .+...+.++.+||++||+.||+
T Consensus       208 ~~i~~~~~~-------------------------------------------------~p~~~~~~~~~li~~~l~~~P~  238 (318)
T cd05582         208 TMILKAKLG-------------------------------------------------MPQFLSPEAQSLLRALFKRNPA  238 (318)
T ss_pred             HHHHcCCCC-------------------------------------------------CCCCCCHHHHHHHHHHhhcCHh
Confidence            433221111                                                 2234567899999999999999


Q ss_pred             CCCC-----HHHHhcCCCCCCC
Q 014117          410 DRLT-----AREALRHPFFTRD  426 (430)
Q Consensus       410 ~R~t-----a~elL~hp~f~~~  426 (430)
                      +|||     +++++.||||...
T Consensus       239 ~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         239 NRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             HcCCCCCCCHHHHhCCCCcCCC
Confidence            9999     7889999999753

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.5e-44  Score=347.37  Aligned_cols=249  Identities=23%  Similarity=0.396  Sum_probs=195.6

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      +.||+|+||.||+|.+..+++.||+|+++...    ........|+.++.++.+    +++|+.+++++...+.+|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~----~~~i~~~~~~~~~~~~~~lv~e   76 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASS----NPFLVGLHSCFQTTSRLFLVIE   76 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcC----CCCEeeEEEEEEeCCEEEEEEe
Confidence            46999999999999999999999999997432    223345567777777643    4789999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccc
Q 014117          176 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK  254 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~  254 (430)
                      |+ +++|..++....  .+++..++.++.||+.||+|||++||+||||||+|||++.                       
T Consensus        77 ~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~-----------------------  131 (327)
T cd05617          77 YVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDA-----------------------  131 (327)
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeC-----------------------
Confidence            99 899999887654  7999999999999999999999999999999999999954                       


Q ss_pred             cCCCCCCeEEEeCCCccccC---CCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH---
Q 014117          255 RMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH---  328 (430)
Q Consensus       255 ~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~---  328 (430)
                          ++.+||+|||++....   ......+||+.|+|||++.+..++.++|||||||++|+|++|..||........   
T Consensus       132 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~  207 (327)
T cd05617         132 ----DGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT  207 (327)
T ss_pred             ----CCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc
Confidence                4556777777665321   112335799999999999999999999999999999999999999964321110   


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      ...+.+.                   +...                          ....+...+..+.++|.+||+.||
T Consensus       208 ~~~~~~~-------------------~~~~--------------------------~~~~p~~~~~~~~~li~~~L~~dP  242 (327)
T cd05617         208 EDYLFQV-------------------ILEK--------------------------PIRIPRFLSVKASHVLKGFLNKDP  242 (327)
T ss_pred             HHHHHHH-------------------HHhC--------------------------CCCCCCCCCHHHHHHHHHHhccCH
Confidence            0000000                   0000                          011234566789999999999999


Q ss_pred             CCCCC------HHHHhcCCCCCCC
Q 014117          409 TDRLT------AREALRHPFFTRD  426 (430)
Q Consensus       409 ~~R~t------a~elL~hp~f~~~  426 (430)
                      ++|++      +++++.||||+..
T Consensus       243 ~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         243 KERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             HHcCCCCCCCCHHHHHcCCCCCCC
Confidence            99998      5799999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4e-44  Score=347.76  Aligned_cols=256  Identities=24%  Similarity=0.394  Sum_probs=199.9

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||+|+||.||++.++.+++.||+|++.+...    ....+..|+.++..+     .+++++.+++.+...+.
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-----DNQWITTLHYAFQDENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-----CCCCEeeEEEEEecCCE
Confidence            369999999999999999999999999999999864221    122345566666555     44789999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|+||||+ +++|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++                  
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~------------------  136 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD------------------  136 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC------------------
Confidence            99999999 899999998643 3689999999999999999999999999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhC-----CCCCCcchHHHHHHHHHHHHhCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEAL  319 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~tG~~P  319 (430)
                               .++.+||+|||++.......    ...+||+.|+|||++.+     ..++.++|||||||++|||++|+.|
T Consensus       137 ---------~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~P  207 (332)
T cd05623         137 ---------MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP  207 (332)
T ss_pred             ---------CCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCC
Confidence                     44567777777665322211    23479999999999873     4588999999999999999999999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |...+..+....+......                     ..+|.                       .....+.++.+|
T Consensus       208 f~~~~~~~~~~~i~~~~~~---------------------~~~p~-----------------------~~~~~s~~~~~l  243 (332)
T cd05623         208 FYAESLVETYGKIMNHKER---------------------FQFPA-----------------------QVTDVSEDAKDL  243 (332)
T ss_pred             CCCCCHHHHHHHHhCCCcc---------------------ccCCC-----------------------ccccCCHHHHHH
Confidence            9877665555443221100                     00110                       113457789999


Q ss_pred             HHHhhhcCCCC--CCCHHHHhcCCCCCCC
Q 014117          400 LQGLLRYDPTD--RLTAREALRHPFFTRD  426 (430)
Q Consensus       400 l~~~L~~dP~~--R~ta~elL~hp~f~~~  426 (430)
                      |++||+.++++  |+|++|+++||||+..
T Consensus       244 i~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         244 IRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             HHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence            99999765554  6899999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.5e-44  Score=338.81  Aligned_cols=257  Identities=25%  Similarity=0.381  Sum_probs=206.2

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .|+..+.||.|+||+||+|.+..+++.||+|++....    ........|+++++++.+     ++++.+.+.+...+..
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~-----~~i~~~~~~~~~~~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS-----QFVVNLAYAYETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC-----cCceeEEEEEecCCEE
Confidence            3788899999999999999999999999999986432    122345678999888843     6789999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||+ +++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++                   
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~-------------------  136 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD-------------------  136 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC-------------------
Confidence            9999999 88999888765555799999999999999999999999999999999999994                   


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                              .+..++|+|||++.......  ....||..|+|||++.+..++.++|+|||||++|+|++|..||.......
T Consensus       137 --------~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~  208 (285)
T cd05632         137 --------DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV  208 (285)
T ss_pred             --------CCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                    44567777777665432211  23478999999999999899999999999999999999999998765543


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+.......+                                             ...+...+.++.+|+.+||+.|
T Consensus       209 ~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~li~~~l~~~  243 (285)
T cd05632         209 KREEVDRRVLETE---------------------------------------------EVYSAKFSEEAKSICKMLLTKD  243 (285)
T ss_pred             HHHHHHHhhhccc---------------------------------------------cccCccCCHHHHHHHHHHccCC
Confidence            3332222111000                                             0122345677899999999999


Q ss_pred             CCCCCC-----HHHHhcCCCCCCCCC
Q 014117          408 PTDRLT-----AREALRHPFFTRDHL  428 (430)
Q Consensus       408 P~~R~t-----a~elL~hp~f~~~~~  428 (430)
                      |++|||     +.+++.|+||+...+
T Consensus       244 P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05632         244 PKQRLGCQEEGAGEVKRHPFFRNMNF  269 (285)
T ss_pred             HhHcCCCcccChHHHHcChhhhcCCH
Confidence            999999     899999999987644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.1e-44  Score=346.88  Aligned_cols=244  Identities=26%  Similarity=0.374  Sum_probs=192.5

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHH-HHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIE-VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~-~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      +.||+|+||.||+|.+..+++.||+|++.+...    .......|.. +++.+     .|+||+++++.+...+.+|+||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-----~h~~iv~~~~~~~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-----KHPFLVGLHYSFQTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-----CCCCccceeeEEEcCCEEEEEE
Confidence            368999999999999999999999999864321    1222333433 23333     4588999999999999999999


Q ss_pred             ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          175 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       175 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      ||+ +++|...+....  .+++..+..++.||+.||.|||++||+||||||+|||++                       
T Consensus        76 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~-----------------------  130 (321)
T cd05603          76 DYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD-----------------------  130 (321)
T ss_pred             cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC-----------------------
Confidence            999 889998887653  789999999999999999999999999999999999994                       


Q ss_pred             ccCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Q 014117          254 KRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA  330 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~  330 (430)
                          .++.+||+|||++.....   .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+...
T Consensus       131 ----~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  206 (321)
T cd05603         131 ----SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD  206 (321)
T ss_pred             ----CCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence                445667777776653211   1233578999999999999899999999999999999999999998765544333


Q ss_pred             HHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCC
Q 014117          331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD  410 (430)
Q Consensus       331 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~  410 (430)
                      .+....                                                 ...+...+.++.++|.+||+.||.+
T Consensus       207 ~i~~~~-------------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~  237 (321)
T cd05603         207 NILHKP-------------------------------------------------LQLPGGKTVAACDLLVGLLHKDQRR  237 (321)
T ss_pred             HHhcCC-------------------------------------------------CCCCCCCCHHHHHHHHHHccCCHhh
Confidence            222110                                                 1123445667999999999999999


Q ss_pred             CCCH----HHHhcCCCCCCC
Q 014117          411 RLTA----REALRHPFFTRD  426 (430)
Q Consensus       411 R~ta----~elL~hp~f~~~  426 (430)
                      |+++    .++++|+||...
T Consensus       238 R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         238 RLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             cCCCCCCHHHHhCCCCcCCC
Confidence            9975    599999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4e-44  Score=347.56  Aligned_cols=256  Identities=24%  Similarity=0.386  Sum_probs=201.0

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||+|+||.||++.++.+++.||+|++.+..    .....+..|..++..+     .+++|+.+++.+...+.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~l~~~~~~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-----DCQWITTLHYAFQDENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEcCCE
Confidence            46999999999999999999999999999999986422    1223345566666655     45789999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .|+||||+ |++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++                  
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~------------------  136 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD------------------  136 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc------------------
Confidence            99999999 999999998643 3689999999999999999999999999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhC-----CCCCCcchHHHHHHHHHHHHhCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEAL  319 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~tG~~P  319 (430)
                               .++.+||+|||++.......    ...+||+.|+|||++.+     ..++.++|||||||++|+|++|+.|
T Consensus       137 ---------~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~P  207 (331)
T cd05624         137 ---------MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP  207 (331)
T ss_pred             ---------CCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCC
Confidence                     45567777777765433221    22479999999999876     4688999999999999999999999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |...+..+....+......                     +.+|.                       .....+.++.+|
T Consensus       208 f~~~~~~~~~~~i~~~~~~---------------------~~~p~-----------------------~~~~~~~~~~~l  243 (331)
T cd05624         208 FYAESLVETYGKIMNHEER---------------------FQFPS-----------------------HITDVSEEAKDL  243 (331)
T ss_pred             ccCCCHHHHHHHHHcCCCc---------------------ccCCC-----------------------ccccCCHHHHHH
Confidence            9876655544433221100                     00110                       112356789999


Q ss_pred             HHHhhhcCCCC--CCCHHHHhcCCCCCCC
Q 014117          400 LQGLLRYDPTD--RLTAREALRHPFFTRD  426 (430)
Q Consensus       400 l~~~L~~dP~~--R~ta~elL~hp~f~~~  426 (430)
                      |.+||+.++++  |++++++++||||+..
T Consensus       244 i~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         244 IQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             HHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            99999976655  5699999999999764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.7e-44  Score=358.22  Aligned_cols=276  Identities=26%  Similarity=0.355  Sum_probs=198.6

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      ..|.+.+.||+|+||.||+|.+..+++.||||....     .....|+++++++.     |+||+++++++...+..|+|
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~-----HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLS-----HPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCC-----CCCCCcEEEEEEECCEEEEE
Confidence            479999999999999999999999999999996432     23467999999984     48899999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          174 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       174 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      ||++.++|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+||||+.+                     
T Consensus       239 ~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~---------------------  296 (461)
T PHA03211        239 LPKYRSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP---------------------  296 (461)
T ss_pred             EEccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCC---------------------
Confidence            9999889999987653 369999999999999999999999999999999999999544                     


Q ss_pred             ccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc----
Q 014117          254 KRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE----  324 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~----  324 (430)
                            +.+||+|||+++.....     ....+||..|+|||++.+..++.++|||||||+||||++|..|+....    
T Consensus       297 ------~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~  370 (461)
T PHA03211        297 ------EDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE  370 (461)
T ss_pred             ------CCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccc
Confidence                  45666666665432211     123479999999999999999999999999999999999876543211    


Q ss_pred             ---hHHHHHHHHHHhCCC----CHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          325 ---NLEHLAMMERVLGPL----PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       325 ---~~~~~~~i~~~~g~~----p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                         ....+..+....+..    +......+..........  ...+.                ............+.++.
T Consensus       371 ~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~----------------~~~~~~~~~~~~~~~~~  432 (461)
T PHA03211        371 RRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAAR--NRRPA----------------YTRPAWTRYYKLDLDVE  432 (461)
T ss_pred             cCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhc--ccCCc----------------cCCcchhhhccccchHH
Confidence               112222222222211    110000000000000000  00000                00000000113455789


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          398 HLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      +||.+||+.||.+|||++|||+||||+.
T Consensus       433 dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        433 YLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            9999999999999999999999999975

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=9.2e-44  Score=336.40  Aligned_cols=250  Identities=23%  Similarity=0.404  Sum_probs=195.1

Q ss_pred             eccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 014117          102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL  177 (430)
Q Consensus       102 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~  177 (430)
                      ||+|+||.||++.++.+++.||+|.+....    ........|+++++++     +++|++++++.++...++|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~i~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-----NSPFIVNLAYAFESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-----CCCcEEEEEEEEecCCeEEEEEecC
Confidence            799999999999999999999999986321    1223345688888887     3488999999999999999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccC
Q 014117          178 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM  256 (430)
Q Consensus       178 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~  256 (430)
                       +++|.+++.......+++..+..++.||+.||.|||+.||+||||||+|||+++                         
T Consensus        76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~-------------------------  130 (277)
T cd05607          76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDD-------------------------  130 (277)
T ss_pred             CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcC-------------------------
Confidence             889998887666567899999999999999999999999999999999999954                         


Q ss_pred             CCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHH
Q 014117          257 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER  334 (430)
Q Consensus       257 ~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~  334 (430)
                        ++.++|+|||++.......  ....||..|+|||++.+..++.++|||||||++|||++|..||...........+..
T Consensus       131 --~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~  208 (277)
T cd05607         131 --QGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR  208 (277)
T ss_pred             --CCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH
Confidence              4556777777665433221  224689999999999998999999999999999999999999976432211111110


Q ss_pred             HhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCH
Q 014117          335 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA  414 (430)
Q Consensus       335 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta  414 (430)
                      ..                   ..+...                         .....++.++.+||.+||+.||++|||+
T Consensus       209 ~~-------------------~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~~P~~R~~~  244 (277)
T cd05607         209 RT-------------------LEDEVK-------------------------FEHQNFTEESKDICRLFLAKKPEDRLGS  244 (277)
T ss_pred             Hh-------------------hccccc-------------------------cccccCCHHHHHHHHHHhccCHhhCCCC
Confidence            00                   000000                         0012456789999999999999999999


Q ss_pred             ----HHHhcCCCCCCCC
Q 014117          415 ----REALRHPFFTRDH  427 (430)
Q Consensus       415 ----~elL~hp~f~~~~  427 (430)
                          ++++.||||+.-.
T Consensus       245 ~~~~~~~~~h~~f~~~~  261 (277)
T cd05607         245 REKNDDPRKHEFFKTIN  261 (277)
T ss_pred             ccchhhhhcChhhcCCC
Confidence                7788999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-47  Score=339.95  Aligned_cols=256  Identities=25%  Similarity=0.424  Sum_probs=210.1

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      -|.++.+||+|+||.||+|.++.+|+.+|||.+.- ....++...|+.+++++.     .+++|+.|+.+-....++|||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~-----S~yVVKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCK-----SKYVVKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcC-----CchhhhhhhhhccCCceEeeh
Confidence            48899999999999999999999999999999873 445567888999999984     478999999998889999999


Q ss_pred             ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          175 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       175 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      ||| .|++.+.++.+. ++|++.++..+++..+.||+|||...-||||||..|||++-+|++|++|||.+-.+.      
T Consensus       108 EYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT------  180 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT------  180 (502)
T ss_pred             hhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh------
Confidence            999 789999998765 689999999999999999999999999999999999999766666666665543221      


Q ss_pred             ccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Q 014117          254 KRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME  333 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~  333 (430)
                                        ..-...+++.||+.|||||++..-.|+.++||||||++..||..|++||...-.+...-+|-
T Consensus       181 ------------------DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP  242 (502)
T KOG0574|consen  181 ------------------DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP  242 (502)
T ss_pred             ------------------hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc
Confidence                              11123356789999999999999999999999999999999999999998654433222221


Q ss_pred             HHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCC
Q 014117          334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT  413 (430)
Q Consensus       334 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t  413 (430)
                        ..++|.+                                            ..|...+.++.||+++||.++|++|.|
T Consensus       243 --T~PPPTF--------------------------------------------~KPE~WS~~F~DFi~~CLiK~PE~R~T  276 (502)
T KOG0574|consen  243 --TKPPPTF--------------------------------------------KKPEEWSSEFNDFIRSCLIKKPEERKT  276 (502)
T ss_pred             --CCCCCCC--------------------------------------------CChHhhhhHHHHHHHHHhcCCHHHHHH
Confidence              0111110                                            113345778999999999999999999


Q ss_pred             HHHHhcCCCCCCCC
Q 014117          414 AREALRHPFFTRDH  427 (430)
Q Consensus       414 a~elL~hp~f~~~~  427 (430)
                      |.++++|||+++.+
T Consensus       277 A~~L~~H~FiknA~  290 (502)
T KOG0574|consen  277 ALRLCEHTFIKNAP  290 (502)
T ss_pred             HHHHhhhhhhcCCC
Confidence            99999999998764

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=378.02  Aligned_cols=255  Identities=26%  Similarity=0.425  Sum_probs=209.3

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|.|++.||+|+||.|.+++.+.+++.||+|++++..    .....|..|..+|...     +..-|++++..|+++.
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-----ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-----NSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-----CcHHHHHHHHHhcCcc
Confidence            467999999999999999999999999999999997632    2345566777776654     3467899999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      ++|+||||+ ||+|..++.+.+  ++|++.+++|+.+|+.||.-||++|+|||||||+||||+..||             
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH-------------  213 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH-------------  213 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc-------------
Confidence            999999999 999999998876  8999999999999999999999999999999999999965555             


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhC-----CCCCCcchHHHHHHHHHHHHhCCC
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                    +||+|||.+.....+.    ...+|||.|++||++..     ..|+..+|+||+||++|||+.|..
T Consensus       214 --------------ikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~T  279 (1317)
T KOG0612|consen  214 --------------IKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGET  279 (1317)
T ss_pred             --------------EeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCC
Confidence                          5555555443333222    33589999999999973     459999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||...+-.+++..|...-                     ..+.+|.                        ....|.++++
T Consensus       280 PFYadslveTY~KIm~hk---------------------~~l~FP~------------------------~~~VSeeakd  314 (1317)
T KOG0612|consen  280 PFYADSLVETYGKIMNHK---------------------ESLSFPD------------------------ETDVSEEAKD  314 (1317)
T ss_pred             cchHHHHHHHHHHHhchh---------------------hhcCCCc------------------------ccccCHHHHH
Confidence            999998888888776531                     1112221                        0346889999


Q ss_pred             HHHHhhhcCCCCCCC---HHHHhcCCCCCCCC
Q 014117          399 LLQGLLRYDPTDRLT---AREALRHPFFTRDH  427 (430)
Q Consensus       399 ll~~~L~~dP~~R~t---a~elL~hp~f~~~~  427 (430)
                      ||+++|. +|+.|+.   ++++..||||...+
T Consensus       315 LI~~ll~-~~e~RLgrngiedik~HpFF~g~~  345 (1317)
T KOG0612|consen  315 LIEALLC-DREVRLGRNGIEDIKNHPFFEGID  345 (1317)
T ss_pred             HHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence            9999876 7788887   99999999998764

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.8e-43  Score=333.84  Aligned_cols=277  Identities=32%  Similarity=0.523  Sum_probs=217.0

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +|++++.||.|++|.||+|++..+++.||||.++...   .....+..|+++++++.     |+|++++++++...+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-----HPNIVKLLDVIHTENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcC-----CCCCcchhhhcccCCcEE
Confidence            4889999999999999999999999999999886332   12345778999999884     478999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          172 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       172 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      +||||+.++|.+++.......+++..+..++.||+.||+|||+.||+|+||||+||+++.                    
T Consensus        76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~--------------------  135 (284)
T cd07860          76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--------------------  135 (284)
T ss_pred             EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--------------------
Confidence            999999879999987765567999999999999999999999999999999999999954                    


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                             ++.+||+|||++.......   ....++..|+|||++.+.. ++.++|||||||++|+|+||..||...++.+
T Consensus       136 -------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~  208 (284)
T cd07860         136 -------EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID  208 (284)
T ss_pred             -------CCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence                   4456666666654332211   2235688999999887654 6889999999999999999999999888888


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+.+..+..+...++.+.........     ++...               ...........+.++.++|.+||+.|
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~---------------~~~~~~~~~~~~~~~~~li~~~l~~~  268 (284)
T cd07860         209 QLFRIFRTLGTPDEVVWPGVTSLPDYKPS-----FPKWA---------------RQDFSKVVPPLDEDGRDLLSQMLHYD  268 (284)
T ss_pred             HHHHHHHHhCCCChhhhhhhhHHHHHHhh-----ccccc---------------ccCHHHHcccCCHHHHHHHHHhcCCC
Confidence            78788888887776655433221111000     00000               00011122456778999999999999


Q ss_pred             CCCCCCHHHHhcCCCC
Q 014117          408 PTDRLTAREALRHPFF  423 (430)
Q Consensus       408 P~~R~ta~elL~hp~f  423 (430)
                      |++|||++++|.||||
T Consensus       269 P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         269 PNKRISAKAALAHPFF  284 (284)
T ss_pred             cccCCCHHHHhcCCCC
Confidence            9999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-43  Score=358.72  Aligned_cols=251  Identities=22%  Similarity=0.253  Sum_probs=203.8

Q ss_pred             CcEEEEeeeccccceEEEEEEECCC-CeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRER-KEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ..|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... .....+..|+.+++.+     .|+||+++++.+...+.+|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-----~Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-----DHFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCCCEeEEEEEEEECCEEE
Confidence            3499999999999999999998877 7889999765332 3334566788888887     4488999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      |||||+ +++|.+++...  ....+++..+..++.||+.||.|||++|||||||||+|||++                  
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~------------------  203 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM------------------  203 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC------------------
Confidence            999999 89999988642  224689999999999999999999999999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                               ..+.+||+|||++......     ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus       204 ---------~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~  274 (478)
T PTZ00267        204 ---------PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP  274 (478)
T ss_pred             ---------CCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence                     4556777777777643222     23357999999999999999999999999999999999999999876


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +..+.+..+...  ..+                                              ..+...+.++.+||.+|
T Consensus       275 ~~~~~~~~~~~~--~~~----------------------------------------------~~~~~~s~~~~~li~~~  306 (478)
T PTZ00267        275 SQREIMQQVLYG--KYD----------------------------------------------PFPCPVSSGMKALLDPL  306 (478)
T ss_pred             CHHHHHHHHHhC--CCC----------------------------------------------CCCccCCHHHHHHHHHH
Confidence            655444333211  000                                              01234566899999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~  424 (430)
                      |+.||++|||++++|.|+|++
T Consensus       307 L~~dP~~Rps~~~~l~~~~~~  327 (478)
T PTZ00267        307 LSKNPALRPTTQQLLHTEFLK  327 (478)
T ss_pred             hccChhhCcCHHHHHhCHHHH
Confidence            999999999999999999985

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7.1e-44  Score=332.97  Aligned_cols=252  Identities=36%  Similarity=0.595  Sum_probs=202.0

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHH---HHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA---AMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~---~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      |++++.||+|+||+||+|.+..+++.||+|++.........   ...|+.+++.+.     +++|+++++++......++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~-----~~~i~~~~~~~~~~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLR-----HPNIVQILDVFQDDNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHT-----BTTBCHEEEEEEESSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccc-----ccccccccccccccccccc
Confidence            78999999999999999999999999999999765433332   244888888884     3779999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      |||++ +++|.+++....  .+++..+..++.||+.||.+||+.||+|+||||+|||+                      
T Consensus        76 v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~----------------------  131 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL----------------------  131 (260)
T ss_dssp             EEEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE----------------------
T ss_pred             cccccccccccccccccc--cccccccccccccccccccccccccccccccccccccc----------------------
Confidence            99999 559999998443  78999999999999999999999999999999999999                      


Q ss_pred             ccccCCCCCCeEEEeCCCcccc---CCCCCeeeecCcccchhhhh-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYE---RPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                           +.++.++|+|||.+...   ........+|..|+|||++. +..++.++|+||||+++|+|++|..||......+
T Consensus       132 -----~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~  206 (260)
T PF00069_consen  132 -----DENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD  206 (260)
T ss_dssp             -----STTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH
T ss_pred             -----ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchh
Confidence                 45556777777776532   11223357899999999998 7889999999999999999999999998764444


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+.+........                                          ..........++.++|.+||+.|
T Consensus       207 ~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~l~~li~~~l~~~  244 (260)
T PF00069_consen  207 QLEIIEKILKRPLPS------------------------------------------SSQQSREKSEELRDLIKKMLSKD  244 (260)
T ss_dssp             HHHHHHHHHHTHHHH------------------------------------------HTTSHTTSHHHHHHHHHHHSSSS
T ss_pred             hhhhhhhcccccccc------------------------------------------cccccchhHHHHHHHHHHHccCC
Confidence            443333322111100                                          00001122368999999999999


Q ss_pred             CCCCCCHHHHhcCCCC
Q 014117          408 PTDRLTAREALRHPFF  423 (430)
Q Consensus       408 P~~R~ta~elL~hp~f  423 (430)
                      |++|||+.++++||||
T Consensus       245 p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  245 PEQRPSAEELLKHPWF  260 (260)
T ss_dssp             GGGSTTHHHHHTSGGG
T ss_pred             hhHCcCHHHHhcCCCC
Confidence            9999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.4e-43  Score=360.39  Aligned_cols=253  Identities=23%  Similarity=0.264  Sum_probs=200.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~--  167 (430)
                      .++|.+.+.||+|+||+||+|.+..+++.||||++...   .........|+.++..+     .+++++.++..+...  
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-----~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-----DFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-----CCCcEEEeecceecccc
Confidence            46899999999999999999999999999999998643   22334456677776665     347788877765432  


Q ss_pred             ------CeEEEEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccC
Q 014117          168 ------NHICIVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP  238 (430)
Q Consensus       168 ------~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~  238 (430)
                            ..+++||||+ +++|.+++....  ...+++..+..++.||+.||.|||++||+||||||+|||++        
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~--------  177 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC--------  177 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe--------
Confidence                  2478999999 899999987532  34689999999999999999999999999999999999995        


Q ss_pred             CCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCC-----CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHH
Q 014117          239 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-----DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL  313 (430)
Q Consensus       239 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el  313 (430)
                                         .++.+||+|||+++....     .....+||+.|+|||++.+..++.++|||||||++|||
T Consensus       178 -------------------~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeL  238 (496)
T PTZ00283        178 -------------------SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYEL  238 (496)
T ss_pred             -------------------CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence                               445677777777654322     12345799999999999999999999999999999999


Q ss_pred             HhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCch
Q 014117          314 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA  393 (430)
Q Consensus       314 ~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (430)
                      ++|..||.+.+..+.+..+...  .                                              ....+...+
T Consensus       239 ltG~~Pf~~~~~~~~~~~~~~~--~----------------------------------------------~~~~~~~~~  270 (496)
T PTZ00283        239 LTLKRPFDGENMEEVMHKTLAG--R----------------------------------------------YDPLPPSIS  270 (496)
T ss_pred             HHCCCCCCCCCHHHHHHHHhcC--C----------------------------------------------CCCCCCCCC
Confidence            9999999876554433322110  0                                              001234567


Q ss_pred             hHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          394 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       394 ~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      .++.+|+.+||+.||.+|||+.++++|||++.
T Consensus       271 ~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        271 PEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            78999999999999999999999999999753

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=319.08  Aligned_cols=254  Identities=23%  Similarity=0.381  Sum_probs=205.0

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +..+++..||.|+.|+||+++.+.+|...|||.++++  +...++.+..+.++...    +..+.||+++++|..+..+.
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s----~dcpyIV~c~GyFi~n~dV~  167 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKS----HDCPYIVQCFGYFITNTDVF  167 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhc----cCCCeeeeeeeEEeeCchHH
Confidence            3467788899999999999999999999999999754  33444555555554443    13588999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      |.||.|+..+..+|.... +++|+..+-++...++.||.||- .+||||||+||+|||+                     
T Consensus       168 IcMelMs~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---------------------  225 (391)
T KOG0983|consen  168 ICMELMSTCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---------------------  225 (391)
T ss_pred             HHHHHHHHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---------------------
Confidence            999999888877776544 57999999999999999999999 5789999999999999                     


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCC---CCCCcchHHHHHHHHHHHHhCCCCCCCC-c
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALFQTH-E  324 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGv~l~el~tG~~Pf~~~-~  324 (430)
                            |..+++||||||++...-...  +...|.+.|||||.+.-.   .|+.++||||||+.++||.||..||.+. .
T Consensus       226 ------De~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t  299 (391)
T KOG0983|consen  226 ------DERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT  299 (391)
T ss_pred             ------ccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc
Confidence                  566778888888876543322  345899999999998643   6999999999999999999999999874 5


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      +.+.+..+..   ..|+.+                                           ..-..+++++.+|+..||
T Consensus       300 dFe~ltkvln---~ePP~L-------------------------------------------~~~~gFSp~F~~fv~~CL  333 (391)
T KOG0983|consen  300 DFEVLTKVLN---EEPPLL-------------------------------------------PGHMGFSPDFQSFVKDCL  333 (391)
T ss_pred             cHHHHHHHHh---cCCCCC-------------------------------------------CcccCcCHHHHHHHHHHh
Confidence            5666655544   333211                                           011347889999999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~  425 (430)
                      ++|+.+||...++|+|||+..
T Consensus       334 ~kd~r~RP~Y~~Ll~h~Fi~~  354 (391)
T KOG0983|consen  334 TKDHRKRPKYNKLLEHPFIKR  354 (391)
T ss_pred             hcCcccCcchHHHhcCcceee
Confidence            999999999999999999864

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=301.57  Aligned_cols=279  Identities=30%  Similarity=0.501  Sum_probs=222.8

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +|.-.++||+|.||+||+|+++.+++.||+|.++-..   .......+|+-+|+.+.|     .||+++++.....+.+-
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkh-----knivrl~dvlhsdkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-----KNIVRLHDVLHSDKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhh-----cceeehhhhhccCceeE
Confidence            4666789999999999999999999999999987432   345678899999999966     67999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          172 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       172 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      +|+|||..+|..+..+.+ ..++.+.++.++.|++.||.|+|++++.||||||.|.||+.                    
T Consensus        78 lvfe~cdqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~--------------------  136 (292)
T KOG0662|consen   78 LVFEFCDQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINR--------------------  136 (292)
T ss_pred             EeHHHhhHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEecc--------------------
Confidence            999999999999988765 46899999999999999999999999999999999999955                    


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCCC---eeeecCcccchhhhhCCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCchH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQN---YIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCT-GEALFQTHENL  326 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~  326 (430)
                             ++.+|++|||+++..+-+..   .-+-|.+|.+|.++.+.. |+...|+||.||++.|+.. |++.|.+.+..
T Consensus       137 -------ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd  209 (292)
T KOG0662|consen  137 -------NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD  209 (292)
T ss_pred             -------CCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH
Confidence                   45566666666654433321   125699999999999876 8899999999999999986 89999999999


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      ++++.|...+|.+.++.|+.+.......      .+|.-. ...+             -.+..+.....-+||++++|.-
T Consensus       210 dqlkrif~~lg~p~ed~wps~t~lpdyk------~yp~yp-atts-------------wsqivp~lns~grdllqkll~c  269 (292)
T KOG0662|consen  210 DQLKRIFRLLGTPTEDQWPSMTKLPDYK------PYPIYP-ATTS-------------WSQIVPKLNSTGRDLLQKLLKC  269 (292)
T ss_pred             HHHHHHHHHhCCCccccCCccccCCCCc------ccCCcc-ccch-------------HHHHhhhhcchhHHHHHHHhcc
Confidence            9999999999998876554432211110      000000 0001             1112234455678999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~  426 (430)
                      +|.+|++|+.+|+||||++-
T Consensus       270 np~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  270 NPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CcccccCHHHHhcCcccccc
Confidence            99999999999999999863

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-43  Score=332.66  Aligned_cols=278  Identities=28%  Similarity=0.466  Sum_probs=211.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ++|++.+.||+|++|.||+|.++.+++.||+|.+....  ........|+++++++.     |++|+++++++...+..|
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK-----HANIVTLHDIIHTKKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCC-----CcceeeEEEEEecCCeEE
Confidence            57999999999999999999999999999999986432  12234567999999884     478999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          172 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       172 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      +||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++                  
T Consensus        80 lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~------------------  140 (291)
T cd07844          80 LVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG------------------  140 (291)
T ss_pred             EEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC------------------
Confidence            999999779999987654 3689999999999999999999999999999999999995544                  


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCc-hH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE-NL  326 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~~~~-~~  326 (430)
                               .+||+|||++......   .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..
T Consensus       141 ---------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~  211 (291)
T cd07844         141 ---------ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE  211 (291)
T ss_pred             ---------CEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH
Confidence                     4555566555432111   112246888999999876 458899999999999999999999997655 55


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCch--hHHHHHHHHhh
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA--GDLTHLLQGLL  404 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ll~~~L  404 (430)
                      +.+..+...++.+.+..+..+..............      ..            ... .......+  .++.++|.+||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~------------~~~-~~~~~~~~~~~~~~~li~~~L  272 (291)
T cd07844         212 DQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFY------PP------------RPL-INHAPRLDRIPHGEELALKFL  272 (291)
T ss_pred             HHHHHHHHhcCCCChhhhhhhhhcccccccccccc------CC------------hhH-HHhCcCCCCchhHHHHHHHHh
Confidence            66667777777776665554432211111110000      00            000 11111222  67899999999


Q ss_pred             hcCCCCCCCHHHHhcCCCC
Q 014117          405 RYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f  423 (430)
                      +.||++|||+.++|+||||
T Consensus       273 ~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         273 QYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccCcccccCHHHHhcCCCC
Confidence            9999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.5e-43  Score=333.54  Aligned_cols=254  Identities=22%  Similarity=0.392  Sum_probs=199.9

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-----
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-----  166 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-----  166 (430)
                      ..+.|++.+.||+|+||.||+|.+..+++.||+|++............|+.++.++.+    |+|++++++.+..     
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~----h~~i~~~~~~~~~~~~~~   79 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH----HRNIATYYGAFIKKNPPG   79 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcC----CCCeeeEeeEEeecCCCC
Confidence            3467899999999999999999999999999999987655555667788888888743    4789999888764     


Q ss_pred             -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          167 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       167 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                       ...+|+||||+ +++|.+++.......+++..+..++.|++.||.|||+++|+||||||+||+++.             
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~-------------  146 (272)
T cd06637          80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE-------------  146 (272)
T ss_pred             CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECC-------------
Confidence             35789999999 789999998765567999999999999999999999999999999999999954             


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhh-----CCCCCCcchHHHHHHHHHHHHhC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTG  316 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tG  316 (430)
                                    ++.++|+|||++.....   ......|+..|+|||++.     +..++.++|||||||++|||++|
T Consensus       147 --------------~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g  212 (272)
T cd06637         147 --------------NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG  212 (272)
T ss_pred             --------------CCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhC
Confidence                          44566666666653221   123357899999999986     34588999999999999999999


Q ss_pred             CCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHH
Q 014117          317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL  396 (430)
Q Consensus       317 ~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (430)
                      ..||...........+...                      ....                         ......+.++
T Consensus       213 ~~p~~~~~~~~~~~~~~~~----------------------~~~~-------------------------~~~~~~~~~~  245 (272)
T cd06637         213 APPLCDMHPMRALFLIPRN----------------------PAPR-------------------------LKSKKWSKKF  245 (272)
T ss_pred             CCCccccCHHHHHHHHhcC----------------------CCCC-------------------------CCCCCcCHHH
Confidence            9999754433222111100                      0000                         0012345679


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCCCC
Q 014117          397 THLLQGLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       397 ~~ll~~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      .+||.+||+.||.+|||+.+++.||||
T Consensus       246 ~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         246 QSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             HHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-45  Score=356.16  Aligned_cols=256  Identities=25%  Similarity=0.461  Sum_probs=211.8

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEec-CchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~-~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      .+-|.|+..||.|+||.||+|.++.++-..|.|+|. +.....+.++-|++||..+.     ||+|+.+++.|-..+.++
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~Cd-----HP~ivkLl~ayy~enkLw  105 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECD-----HPVIVKLLSAYYFENKLW  105 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCC-----ChHHHHHHHHHhccCceE
Confidence            345889999999999999999999999889999886 34456677888999999883     589999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      |+.||| ||-+...+-.-+ +.|++.+++.+++|++.||.|||+++|||||||..|||++-+|                 
T Consensus       106 iliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG-----------------  167 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG-----------------  167 (1187)
T ss_pred             EEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC-----------------
Confidence            999999 555555554443 6899999999999999999999999999999999999996555                 


Q ss_pred             cccccCCCCCCeEEEeCCCccccC---CCCCeeeecCcccchhhhh-----CCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                .++|+|||.+....   .....+.|||+|||||++.     ..+|++++||||||++|.||.-+.+|-..
T Consensus       168 ----------dirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe  237 (1187)
T KOG0579|consen  168 ----------DIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE  237 (1187)
T ss_pred             ----------cEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence                      55666666543222   1235579999999999986     45799999999999999999999999998


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      .+.+..+..|.+...+.-                                              -.|..++..+.||+.+
T Consensus       238 lnpMRVllKiaKSePPTL----------------------------------------------lqPS~Ws~~F~DfLk~  271 (1187)
T KOG0579|consen  238 LNPMRVLLKIAKSEPPTL----------------------------------------------LQPSHWSRSFSDFLKR  271 (1187)
T ss_pred             cchHHHHHHHhhcCCCcc----------------------------------------------cCcchhhhHHHHHHHH
Confidence            888887777665433211                                              1234556789999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      ||.+||..||+++++|+||||++.+
T Consensus       272 cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  272 CLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             HHhcCCccCCCHHHHhhCcccccCC
Confidence            9999999999999999999999654

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-43  Score=360.59  Aligned_cols=292  Identities=22%  Similarity=0.311  Sum_probs=202.2

Q ss_pred             ecCceecCcEEEEeeeccccceEEEEEEECCCCe-EEEEE------------------EecCchhhHHHHHHHHHHHHHH
Q 014117           87 ALGENLTSRYKIHSKMGEGTFGQVLECWDRERKE-MVAIK------------------IVRGIKKYREAAMIEIEVLQQL  147 (430)
Q Consensus        87 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-~vAiK------------------~~~~~~~~~~~~~~E~~~l~~l  147 (430)
                      ..++.+.++|+++++||+|+||+||+|..+.... .+++|                  .+.........+..|+.++..+
T Consensus       141 ~~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l  220 (501)
T PHA03210        141 KHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL  220 (501)
T ss_pred             ccchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC
Confidence            3445567889999999999999999997654322 12222                  1122222344567899999888


Q ss_pred             HhcCCCCCceEEecceeecCCeEEEEEecCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCC
Q 014117          148 AKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNN---YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP  224 (430)
Q Consensus       148 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp  224 (430)
                      .     |+||+++++++...+..|+|+++++++|.+++....   ........++.++.||+.||.|||++|||||||||
T Consensus       221 ~-----HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP  295 (501)
T PHA03210        221 N-----HENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKL  295 (501)
T ss_pred             C-----CCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence            4     488999999999999999999999889988876432   12334667888999999999999999999999999


Q ss_pred             CceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCc
Q 014117          225 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYP  300 (430)
Q Consensus       225 ~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~  300 (430)
                      +|||++                           .++.+||+|||++.......    ...+||..|+|||++.+..++.+
T Consensus       296 ~NILl~---------------------------~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  348 (501)
T PHA03210        296 ENIFLN---------------------------CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI  348 (501)
T ss_pred             HHEEEC---------------------------CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH
Confidence            999994                           44567777777776443221    23579999999999999999999


Q ss_pred             chHHHHHHHHHHHHhCCCC-CCCC--chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcC
Q 014117          301 CDIWSVGCILVELCTGEAL-FQTH--ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK  377 (430)
Q Consensus       301 ~DvwslGv~l~el~tG~~P-f~~~--~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (430)
                      +|||||||++|||++|..+ |...  .....+..+...++..+.++.. .......++....+....             
T Consensus       349 ~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~i~~~~~~~~~-------------  414 (501)
T PHA03210        349 TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPD-PPCKLFDYIDSAEIDHAG-------------  414 (501)
T ss_pred             HHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCC-cHHHHHHHhhhhhcccCc-------------
Confidence            9999999999999998754 4322  2334444444444433222110 001111111111100000             


Q ss_pred             chhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          378 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                       ..+..+..  ....+.++.++|.+||++||.+|||+.|+|.||||....
T Consensus       415 -~~~~~~~~--~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        415 -HSVPPLIR--NLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE  461 (501)
T ss_pred             -cchhhHHH--hcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence             00111111  123566789999999999999999999999999998754

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-45  Score=336.25  Aligned_cols=252  Identities=26%  Similarity=0.384  Sum_probs=213.1

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      ..+|..+..||.|+||.|.+|..+.+.++||||++++..    ...+..+.|.++|...    ...|.+++++.+|+.-+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~----~kppFL~qlHScFQTmD  423 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP----GKPPFLVQLHSCFQTMD  423 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecC----CCCchHHHHHHHhhhhh
Confidence            456999999999999999999999999999999997542    2334556677766554    24578999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+|+||||+ ||+|--.+++-+  +|.+..+..|+.+|+.||-|||++|||+||||.+|||++.+|              
T Consensus       424 RLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG--------------  487 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG--------------  487 (683)
T ss_pred             heeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC--------------
Confidence            999999999 999988888876  899999999999999999999999999999999999995555              


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccc---cCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTY---ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                   .+||+|||+++-   ......++|||+.|+|||++..++|+.++|+||+||+||||+.|.+||++.+
T Consensus       488 -------------HiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD  554 (683)
T KOG0696|consen  488 -------------HIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED  554 (683)
T ss_pred             -------------ceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence                         555566665542   2223456899999999999999999999999999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      +.+.+..|..---.                                                 +|..+|.++.+++..+|
T Consensus       555 E~elF~aI~ehnvs-------------------------------------------------yPKslSkEAv~ickg~l  585 (683)
T KOG0696|consen  555 EDELFQAIMEHNVS-------------------------------------------------YPKSLSKEAVAICKGLL  585 (683)
T ss_pred             HHHHHHHHHHccCc-------------------------------------------------CcccccHHHHHHHHHHh
Confidence            99988877654332                                                 23456778999999999


Q ss_pred             hcCCCCCCCH-----HHHhcCCCCCCC
Q 014117          405 RYDPTDRLTA-----REALRHPFFTRD  426 (430)
Q Consensus       405 ~~dP~~R~ta-----~elL~hp~f~~~  426 (430)
                      .++|.+|+..     .++-.||||+..
T Consensus       586 tK~P~kRLGcg~~ge~di~~H~FFR~i  612 (683)
T KOG0696|consen  586 TKHPGKRLGCGPEGERDIREHPFFRRI  612 (683)
T ss_pred             hcCCccccCCCCccccchhhCcchhhc
Confidence            9999999964     689999999864

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.9e-43  Score=334.07  Aligned_cols=279  Identities=29%  Similarity=0.474  Sum_probs=213.8

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh------hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      +|++.+.||.|+||.||+|.+..+++.||+|.++....      .......|+++++++.     |++++++++++.+.+
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-----h~~i~~~~~~~~~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-----HPNIIGLLDVFGHKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-----CCCChhhhheeecCC
Confidence            48899999999999999999999999999999864322      2344567888888874     478999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          169 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       169 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .+++||||++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++               
T Consensus        76 ~~~lv~e~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~---------------  139 (298)
T cd07841          76 NINLVFEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG---------------  139 (298)
T ss_pred             EEEEEEcccCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC---------------
Confidence            999999999889999997654 4699999999999999999999999999999999999996544               


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                  .++|+|||++.......   ....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+
T Consensus       140 ------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~  207 (298)
T cd07841         140 ------------VLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS  207 (298)
T ss_pred             ------------CEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence                        45566666554332211   12346788999999865 457899999999999999999999998888


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      +.+.+..+....+.+....+..............        ...             .-........+.++.+||.+||
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~-------------~~~~~~~~~~~~~~~~li~~~l  266 (298)
T cd07841         208 DIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKP--------FPP-------------TPLKQIFPAASDDALDLLQRLL  266 (298)
T ss_pred             cHHHHHHHHHHcCCCchhhhhhcccccccccccc--------cCC-------------cchhhhcccccHHHHHHHHHHh
Confidence            7777777776666655544332211100000000        000             0011123455778999999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      +.||++|||++|+|+||||++.+
T Consensus       267 ~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         267 TLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             cCCcccCcCHHHHhhCccccCCC
Confidence            99999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-44  Score=346.39  Aligned_cols=243  Identities=25%  Similarity=0.354  Sum_probs=204.2

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      .+++++.||+|-||.||+|..+.+ ..||+|.++......+.+.+|+++|++|+|     ++||++++++..++.+||||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H-----~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRH-----EKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcc-----cCeEEEEEEEecCCceEEEE
Confidence            456778999999999999988654 359999998655566788899999999965     78999999999988999999


Q ss_pred             ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          175 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       175 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      ||| .|+|.++|+...+..+.......++.|||+|++||+++++|||||-+.||||++                      
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~----------------------  338 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDE----------------------  338 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeecc----------------------
Confidence            999 999999999866678999999999999999999999999999999999999954                      


Q ss_pred             ccCCCCCCeEEEeCCCccccCCCCCe-e---eecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHH
Q 014117          254 KRMPKSSAIKVIDFGSTTYERPDQNY-I---VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH  328 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~~~~~-~---~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~  328 (430)
                           +..+||+|||+|+....+... .   --+..|.|||.+....++.+||||||||+||||+| |+.||.+.++.+.
T Consensus       339 -----~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev  413 (468)
T KOG0197|consen  339 -----DLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV  413 (468)
T ss_pred             -----CceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH
Confidence                 455666666666632222211 1   12567999999999999999999999999999999 9999999998887


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      +..+.+.                                                ..+..|+.+|+++.+++..||..+|
T Consensus       414 ~~~le~G------------------------------------------------yRlp~P~~CP~~vY~lM~~CW~~~P  445 (468)
T KOG0197|consen  414 LELLERG------------------------------------------------YRLPRPEGCPDEVYELMKSCWHEDP  445 (468)
T ss_pred             HHHHhcc------------------------------------------------CcCCCCCCCCHHHHHHHHHHhhCCc
Confidence            7766432                                                1233467889999999999999999


Q ss_pred             CCCCCHHHHh
Q 014117          409 TDRLTAREAL  418 (430)
Q Consensus       409 ~~R~ta~elL  418 (430)
                      ++|||.+.+.
T Consensus       446 ~~RPtF~~L~  455 (468)
T KOG0197|consen  446 EDRPTFETLR  455 (468)
T ss_pred             ccCCCHHHHH
Confidence            9999988654

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-44  Score=343.31  Aligned_cols=253  Identities=27%  Similarity=0.457  Sum_probs=201.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEec---CchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~---~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ..|+++++||+||.+.||++.... .+.||+|.+.   ........+..|+..|.+|..+    ..|++++++-..++++
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~----~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGH----DKIIQLYDYEVTDGYL  435 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCC----ceEEEEeeeeccCceE
Confidence            469999999999999999997643 4567777654   3344556788999999999764    5699999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      ||||||-..+|..+|.+... .++.-.++.|..|++.|+.++|..||||.||||.|+|+.                    
T Consensus       436 YmvmE~Gd~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV--------------------  494 (677)
T KOG0596|consen  436 YMVMECGDIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV--------------------  494 (677)
T ss_pred             EEEeecccccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE--------------------
Confidence            99999999999999998763 344348899999999999999999999999999999995                    


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCCCe-----eeecCcccchhhhhCCC-----------CCCcchHHHHHHHHHHHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQNY-----IVSTRHYRAPEVILGLG-----------WTYPCDIWSVGCILVELC  314 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~gt~~y~aPE~~~~~~-----------~~~~~DvwslGv~l~el~  314 (430)
                              .+.+||||||+|....++...     .+||+.||+||.+....           .+.++||||||||||+|+
T Consensus       495 --------kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMv  566 (677)
T KOG0596|consen  495 --------KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMV  566 (677)
T ss_pred             --------eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHH
Confidence                    367999999999877766543     48999999999996432           568999999999999999


Q ss_pred             hCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchh
Q 014117          315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG  394 (430)
Q Consensus       315 tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (430)
                      .|++||....+  +...+..+..+--                                            ..+|++.-+.
T Consensus       567 YgktPf~~~~n--~~aKl~aI~~P~~--------------------------------------------~Iefp~~~~~  600 (677)
T KOG0596|consen  567 YGKTPFGQIIN--QIAKLHAITDPNH--------------------------------------------EIEFPDIPEN  600 (677)
T ss_pred             hcCCchHHHHH--HHHHHHhhcCCCc--------------------------------------------cccccCCCCc
Confidence            99999974322  2233332222100                                            1122222233


Q ss_pred             H-HHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          395 D-LTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       395 ~-~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      + +.++++.||++||.+|||+.+||+|||++-.
T Consensus       601 ~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  601 DELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             hHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            3 8999999999999999999999999999753

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.2e-43  Score=332.86  Aligned_cols=250  Identities=27%  Similarity=0.451  Sum_probs=209.0

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....    ........|+++++++.     |+||+++++.+...+.
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-----HPFLVNLYGSFQDDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-----CCCccceeeEEEcCCe
Confidence            36999999999999999999999999999999986432    23345677888888884     4889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|+||||+ +++|.+++....  .+++..+..++.||+.||.|||+.||+|+||||+|||++                  
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~------------------  135 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD------------------  135 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC------------------
Confidence            99999999 999999998764  799999999999999999999999999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                               .++.+||+|||++...........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+.
T Consensus       136 ---------~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  206 (290)
T cd05580         136 ---------SDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI  206 (290)
T ss_pred             ---------CCCCEEEeeCCCccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                     45567888888776655444556789999999999888899999999999999999999999987664433


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      ...+.....                                                 ..+...+..+.++|.+||+.||
T Consensus       207 ~~~~~~~~~-------------------------------------------------~~~~~~~~~l~~li~~~l~~~p  237 (290)
T cd05580         207 YEKILEGKV-------------------------------------------------RFPSFFSPDAKDLIRNLLQVDL  237 (290)
T ss_pred             HHHHhcCCc-------------------------------------------------cCCccCCHHHHHHHHHHccCCH
Confidence            333221110                                                 1123446679999999999999


Q ss_pred             CCCC-----CHHHHhcCCCCCCC
Q 014117          409 TDRL-----TAREALRHPFFTRD  426 (430)
Q Consensus       409 ~~R~-----ta~elL~hp~f~~~  426 (430)
                      .+|+     +++|+++||||...
T Consensus       238 ~~R~~~~~~~~~~l~~~~~~~~~  260 (290)
T cd05580         238 TKRLGNLKNGVNDIKNHPWFAGI  260 (290)
T ss_pred             HHccCcccCCHHHHHcCcccccC
Confidence            9999     99999999999764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.7e-43  Score=342.69  Aligned_cols=302  Identities=18%  Similarity=0.245  Sum_probs=204.1

Q ss_pred             EEeeeccc--cceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           98 IHSKMGEG--TFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        98 ~~~~lG~G--~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      ++++||+|  +|++||++.++.+++.||+|+++..   .........|+.+++.+     .|+||+++++++...+..|+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~hpniv~~~~~~~~~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-----NHPNIVPYRATFIADNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEEECCEEEE
Confidence            56789999  7899999999999999999998743   22334566688888877     34889999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++++||+.....     
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~-----  151 (327)
T cd08227          77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM-----  151 (327)
T ss_pred             EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcc-----
Confidence            99999 889999997654456999999999999999999999999999999999999988777777777543221     


Q ss_pred             ccccCCCCCCeEEEeCCCccc-cCCCCCeeeecCcccchhhhhC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTY-ERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                                   .++|.... .........++..|+|||++.+  ..++.++|||||||++|||++|..||........
T Consensus       152 -------------~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  218 (327)
T cd08227         152 -------------INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM  218 (327)
T ss_pred             -------------ccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence                         11221110 0001122356788999999976  4689999999999999999999999986554333


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccC-cccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....  ..+..|... .......+...... ...+........... ..................++++.+||.+||+.|
T Consensus       219 ~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  294 (327)
T cd08227         219 LLEK--LNGTVPCLL-DTTTIPAEELTMKPSRSGANSGLGESTTVS-TPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRN  294 (327)
T ss_pred             HHHH--hcCCccccc-cccchhhhhcccCCcccCCcCCCCcccccC-CcCccccCCcccccccccCHHHHHHHHHHHhhC
Confidence            2221  222222110 00000000000000 000000000000000 000000000111123345678999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~  426 (430)
                      |++|||++|||+||||++.
T Consensus       295 P~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         295 PDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             chhcCCHHHHhcChhhhhc
Confidence            9999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.8e-43  Score=331.31  Aligned_cols=278  Identities=35%  Similarity=0.602  Sum_probs=217.0

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +|++.+.||.|+||.||+|.+..+++.||+|++....   .....+..|+.+++++.     +++++++++++......|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~i~~~~~~~~~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ-----HPYVVKLLDVFPHGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC-----CCCCcceeeEEecCCeeE
Confidence            4899999999999999999999999999999986432   23456778888888884     488999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          172 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       172 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      +||||++++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.                    
T Consensus        76 ~v~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~--------------------  134 (286)
T cd07832          76 LVMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA--------------------  134 (286)
T ss_pred             EEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcC--------------------
Confidence            999999999999987654 57999999999999999999999999999999999999954                    


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                             .+.++|+|||.+.......    ....|+..|+|||.+.+. .++.++|||||||++|+|++|.+||.+.++.
T Consensus       135 -------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~  207 (286)
T cd07832         135 -------DGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI  207 (286)
T ss_pred             -------CCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH
Confidence                   4456666666665433221    234689999999998765 4689999999999999999999999988888


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +.+..+....+.+....+........ +   +...++...               ........+..+.++.+||.+||+.
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~---------------~~~~~~~~~~~~~~~~~li~~~l~~  268 (286)
T cd07832         208 EQLAIVFRTLGTPNEETWPGLTSLPD-Y---NKITFPESK---------------PIPLEEIFPDASPEALDLLKGLLVY  268 (286)
T ss_pred             HHHHHHHHHcCCCChHHHhhccCcch-h---hcccCCCCC---------------cchHHHhCCCccHHHHHHHHHHhcc
Confidence            88888777777766544332211100 0   001111000               0001122345567899999999999


Q ss_pred             CCCCCCCHHHHhcCCCCC
Q 014117          407 DPTDRLTAREALRHPFFT  424 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~  424 (430)
                      ||++|||++++|+||||.
T Consensus       269 ~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         269 DPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             ChhhCCCHHHHhhCcCcC
Confidence            999999999999999995

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7.1e-43  Score=335.47  Aligned_cols=283  Identities=29%  Similarity=0.454  Sum_probs=216.6

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~--  167 (430)
                      .++|++.+.||.|+||.||+|.+..+++.||+|+++....   .......|+.+++++.     +++++++++++...  
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~   80 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR-----HPNIVELKEVVVGKHL   80 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCC-----CCCCcceEEEEecCCC
Confidence            3579999999999999999999999999999999863321   1234557899998884     37789998888654  


Q ss_pred             CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          168 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       168 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      +.+++||||++++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||++++++              
T Consensus        81 ~~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--------------  145 (309)
T cd07845          81 DSIFLVMEYCEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG--------------  145 (309)
T ss_pred             CeEEEEEecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--------------
Confidence            5789999999889999887643 4799999999999999999999999999999999999995544              


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                   .+||+|||.+......   .....++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus       146 -------------~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~  212 (309)
T cd07845         146 -------------CLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK  212 (309)
T ss_pred             -------------CEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence                         5566666655433221   112245788999999876 45899999999999999999999999999


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +..+.+..+...++..+...++.+.....    .+.+..+....              .. ........+.++.+||.+|
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~--------------~~-~~~~~~~~~~~~~~li~~m  273 (309)
T cd07845         213 SEIEQLDLIIQLLGTPNESIWPGFSDLPL----VGKFTLPKQPY--------------NN-LKHKFPWLSEAGLRLLNFL  273 (309)
T ss_pred             CHHHHHHHHHHhcCCCChhhchhhhcccc----cccccccCCCC--------------Cc-hHHhccccCHHHHHHHHHH
Confidence            99999999988888777665543322111    11111110000              00 0111233577899999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      |+.||++|||+.|+|+||||++..
T Consensus       274 l~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         274 LMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             hcCChhhCcCHHHHhcChhhccCC
Confidence            999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-43  Score=327.71  Aligned_cols=249  Identities=28%  Similarity=0.432  Sum_probs=201.1

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch------hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+....      .....+..|+.+++++     .+++++++++++...
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-----QHERIVQYYGCLRDD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-----CCCCeeeeEEEEccC
Confidence            46899999999999999999999999999999886321      1223566788888877     348899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      ..+++||||+ +++|.+++....  .+++..+..++.|++.||.|||+.||+||||||+||+++.               
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~---------------  139 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS---------------  139 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---------------
Confidence            9999999999 889999987754  6899999999999999999999999999999999999944               


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                  ++.++|+|||++.......      ....|+..|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       140 ------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~  207 (263)
T cd06625         140 ------------AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPW  207 (263)
T ss_pred             ------------CCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence                        4556777777665332211      2245788999999999989999999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      ...+.......+.....                                               ....+...+.++.++|
T Consensus       208 ~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~~li  240 (263)
T cd06625         208 AEFEAMAAIFKIATQPT-----------------------------------------------NPQLPSHVSPDARNFL  240 (263)
T ss_pred             cccchHHHHHHHhccCC-----------------------------------------------CCCCCccCCHHHHHHH
Confidence            76544433222111000                                               0112345567899999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCCCC
Q 014117          401 QGLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      .+||..||++|||+.++|+||||
T Consensus       241 ~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         241 RRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHhhcCcccCCCHHHHhhCCCC
Confidence            99999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-45  Score=345.61  Aligned_cols=257  Identities=26%  Similarity=0.459  Sum_probs=216.8

Q ss_pred             CcEEEE--eeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           94 SRYKIH--SKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        94 ~~y~~~--~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .-|+|.  +.||+|-||+||-|.++++|+.||||+|.+.   .+...+...|+.||+.+.     ||.|+.+...|++.+
T Consensus       562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~-----HPGiV~le~M~ET~e  636 (888)
T KOG4236|consen  562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH-----HPGIVNLECMFETPE  636 (888)
T ss_pred             HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC-----CCCeeEEEEeecCCc
Confidence            345553  6899999999999999999999999998642   234467788999999994     488999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          169 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       169 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .+++|||-+.|++.+.+-.....+|++.....++.||+.||.|||-++|||+||||+|||+.+.                
T Consensus       637 rvFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~----------------  700 (888)
T KOG4236|consen  637 RVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA----------------  700 (888)
T ss_pred             eEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC----------------
Confidence            9999999998888777766666789999999999999999999999999999999999999542                


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                              +.-.++||||||+|++.+...  ..++||+.|+|||++.+..|...-||||+||++|.-++|..||..+.+.
T Consensus       701 --------~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI  772 (888)
T KOG4236|consen  701 --------SPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI  772 (888)
T ss_pred             --------CCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch
Confidence                    455689999999999887654  5579999999999999999999999999999999999999999765442


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      .                         +.+++..|-+|...                      |...+.++.|||.++|++
T Consensus       773 n-------------------------dQIQNAaFMyPp~P----------------------W~eis~~AidlIn~LLqV  805 (888)
T KOG4236|consen  773 N-------------------------DQIQNAAFMYPPNP----------------------WSEISPEAIDLINNLLQV  805 (888)
T ss_pred             h-------------------------HHhhccccccCCCc----------------------hhhcCHHHHHHHHHHHHH
Confidence            2                         12223333333221                      235577899999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~  426 (430)
                      .=.+|.|++..|.|||+++.
T Consensus       806 km~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  806 KMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHhcchHhhccchhhhcc
Confidence            99999999999999999864

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.3e-42  Score=331.19  Aligned_cols=280  Identities=31%  Similarity=0.518  Sum_probs=210.7

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe-
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH-  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~-  169 (430)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++....   ....+..|+.++..+.+    +++++++++.+..... 
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~----~~~i~~~~~~~~~~~~~   76 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSE----SIYIVRLLDVEHVEEKN   76 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccC----CCCccceeeeEeecCCC
Confidence            369999999999999999999999999999998764321   23456779999888854    3678888888776554 


Q ss_pred             ----EEEEEecCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          170 ----ICIVFEKLGSSLYDFLRKNN---YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       170 ----~~lv~e~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                          .|+||||+.++|.+++....   ...+++..++.++.||+.||.|||++||+||||||+||+++.           
T Consensus        77 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~-----------  145 (295)
T cd07837          77 GKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK-----------  145 (295)
T ss_pred             CCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec-----------
Confidence                89999999779999887543   246899999999999999999999999999999999999954           


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCC
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                     .++.+||+|||.+.......   ....+++.|+|||++.+ ..++.++|+|||||++|+|++|.+
T Consensus       146 ---------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~  210 (295)
T cd07837         146 ---------------QKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP  210 (295)
T ss_pred             ---------------CCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCC
Confidence                           14567777777665332211   12356889999999875 457899999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||.+.++.+....+....+..+...+..+........      .+.              . .........+..+.++.+
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~--------------~-~~~~~~~~~~~~~~~~~~  269 (295)
T cd07837         211 LFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHE------FPQ--------------W-KPQDLSRAVPDLSPEGLD  269 (295)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhh------cCc--------------c-cchhHHHhccccCHHHHH
Confidence            9998888777777766665544433221111000000      000              0 000111223456788999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCCCCC
Q 014117          399 LLQGLLRYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~hp~f~  424 (430)
                      ||.+||+.||.+|||++|+|.||||.
T Consensus       270 ~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         270 LLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             HHHHHccCChhhcCCHHHHhcCCCcC
Confidence            99999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.7e-42  Score=330.42  Aligned_cols=282  Identities=30%  Similarity=0.487  Sum_probs=217.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ++|++.+.||.|++|.||+|.++.+++.||+|.+....   .....+..|+++++++.     |++++++++++......
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-----HGNIVRLQDVVHSEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhcc-----CCCEeeEEEEEecCCeE
Confidence            46999999999999999999999999999999986432   22345677899988884     47899999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      |+||||++++|.+++.......+++..+..++.||+.||+|||++||+||||||+||+++.                   
T Consensus        77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~-------------------  137 (294)
T PLN00009         77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR-------------------  137 (294)
T ss_pred             EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC-------------------
Confidence            9999999889998887665455788999999999999999999999999999999999963                   


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                             .+..+||+|||++.......   ....+++.|+|||++.+. .++.++|||||||++|+|++|.+||...+..
T Consensus       138 -------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~  210 (294)
T PLN00009        138 -------RTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI  210 (294)
T ss_pred             -------CCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence                   23456777777775432211   223678899999998764 5789999999999999999999999988777


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +....+....+.++...+...........  ....|+                  ........+..+.++.++|.+||+.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~------------------~~~~~~~~~~~~~~~~~~i~~~l~~  270 (294)
T PLN00009        211 DELFKIFRILGTPNEETWPGVTSLPDYKS--AFPKWP------------------PKDLATVVPTLEPAGVDLLSKMLRL  270 (294)
T ss_pred             HHHHHHHHHhCCCChhhccccccchhhhh--hcccCC------------------CCCHHHhCcCCChHHHHHHHHHccC
Confidence            77777777666666554332111100000  000000                  0001112345677899999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||++||++.++++||||..-
T Consensus       271 ~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        271 DPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             ChhhCcCHHHHhcCchHhHH
Confidence            99999999999999999753

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.1e-43  Score=368.40  Aligned_cols=276  Identities=24%  Similarity=0.433  Sum_probs=211.9

Q ss_pred             ecCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 014117           87 ALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW  163 (430)
Q Consensus        87 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~  163 (430)
                      ..++...++|+++++||.|+||+||+|.+..++..||+|++...   ......+..|+.++.++.     |++|++++++
T Consensus         6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~-----HPNIVrl~d~   80 (1021)
T PTZ00266          6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK-----HKNIVRYIDR   80 (1021)
T ss_pred             cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC-----CCCcCeEEEE
Confidence            34566678899999999999999999999999999999998632   234456778999999984     4789999998


Q ss_pred             eec--CCeEEEEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhc-------CeeeccCCCCceEEee
Q 014117          164 FDY--RNHICIVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDL-------CMIHTDLKPENVLLVS  231 (430)
Q Consensus       164 ~~~--~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~-------~ivHrDlKp~NILl~~  231 (430)
                      |..  ...+||||||+ +++|.++|....  ...+++..++.|+.||+.||.|||+.       +||||||||+||||+.
T Consensus        81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s  160 (1021)
T PTZ00266         81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST  160 (1021)
T ss_pred             EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence            743  46799999999 889999987531  24699999999999999999999985       4999999999999965


Q ss_pred             cCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCC--CCCCcchHHHHH
Q 014117          232 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGL--GWTYPCDIWSVG  307 (430)
Q Consensus       232 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG  307 (430)
                      ... .+.+...         .....+....+||+|||++......  ....+||+.|+|||++.+.  .++.++||||||
T Consensus       161 ~~~-~lg~i~~---------~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG  230 (1021)
T PTZ00266        161 GIR-HIGKITA---------QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG  230 (1021)
T ss_pred             Ccc-ccccccc---------cccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHH
Confidence            321 1111100         0011144567999999998754332  2345799999999999753  588999999999


Q ss_pred             HHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhh
Q 014117          308 CILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ  387 (430)
Q Consensus       308 v~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (430)
                      |+||+|++|..||........+.........+|                                               
T Consensus       231 ~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp-----------------------------------------------  263 (1021)
T PTZ00266        231 CIIYELCSGKTPFHKANNFSQLISELKRGPDLP-----------------------------------------------  263 (1021)
T ss_pred             HHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC-----------------------------------------------
Confidence            999999999999986655443322211110000                                               


Q ss_pred             hcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       388 ~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                       ....+.++.+||..||+.+|.+|||+.|+|.||||+.
T Consensus       264 -i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~  300 (1021)
T PTZ00266        264 -IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN  300 (1021)
T ss_pred             -cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence             1234567999999999999999999999999999964

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-43  Score=335.87  Aligned_cols=279  Identities=24%  Similarity=0.374  Sum_probs=212.5

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....    .....+..|++++..+.     +++|+++++.+......
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-----HPFLPTLYASFQTETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-----CCCchhheeeeecCCEE
Confidence            6999999999999999999999999999999986432    13345667888888874     47899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||+ +++|.+++.......+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++++|||++......
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            9999999 889999998765567999999999999999999999999999999999999988888888888877654332


Q ss_pred             CcccccCCCCCC-----eE-EEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          250 SSYFKRMPKSSA-----IK-VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       250 ~~~~~~~~~~~~-----~k-l~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                      ............     .+ ...+. ............||..|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETF-SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             ccccccccccccccccccccchhhh-cccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            111000000000     00 00000 000011122357899999999999989999999999999999999999999876


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +....+..+......                       ++.                        ....+.++.++|.+|
T Consensus       236 ~~~~~~~~~~~~~~~-----------------------~~~------------------------~~~~~~~~~~li~~~  268 (316)
T cd05574         236 NRDETFSNILKKEVT-----------------------FPG------------------------SPPVSSSARDLIRKL  268 (316)
T ss_pred             chHHHHHHHhcCCcc-----------------------CCC------------------------ccccCHHHHHHHHHH
Confidence            655444332211100                       110                        112467899999999


Q ss_pred             hhcCCCCCCC----HHHHhcCCCCCCC
Q 014117          404 LRYDPTDRLT----AREALRHPFFTRD  426 (430)
Q Consensus       404 L~~dP~~R~t----a~elL~hp~f~~~  426 (430)
                      |+.||++|||    ++|+|.||||++.
T Consensus       269 l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         269 LVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             ccCCHhHCCCchhhHHHHHcCchhhcC
Confidence            9999999999    9999999999875

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-42  Score=337.41  Aligned_cols=287  Identities=27%  Similarity=0.463  Sum_probs=212.1

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--  167 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~--  167 (430)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++...  .........|+.+++++.     ++|++++++++...  
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~   77 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK-----HENIIGILDIIRPPSF   77 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCC-----CCCcCchhheeecccc
Confidence            356899999999999999999999999999999998632  223455677888888885     37788888765543  


Q ss_pred             ---CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          168 ---NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       168 ---~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                         ...|+|+||++++|.+++...   .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++++|||++.
T Consensus        78 ~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          78 ESFNDVYIVQELMETDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             cccceEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECccccee
Confidence               468999999988998888643   69999999999999999999999999999999999999665555555554433


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                      .......                     .........||..|+|||.+.+ ..++.++|||||||++|+|++|++||.+.
T Consensus       155 ~~~~~~~---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~  213 (336)
T cd07849         155 IADPEHD---------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK  213 (336)
T ss_pred             ecccccc---------------------ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            2111000                     0000122468999999998765 46899999999999999999999999988


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhh-hhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      +.......+...++..+.+.+....... ..+......                  ..... .....+..+.++.+||.+
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~-~~~~~~~~~~~~~~li~~  274 (336)
T cd07849         214 DYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPF------------------KPKVP-WNKLFPNADPKALDLLDK  274 (336)
T ss_pred             CHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCc------------------CCccc-HHHHhcccCcHHHHHHHH
Confidence            8777888888888876655443322111 111100000                  00000 011123457789999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||+.||++|||+.|+++||||..-
T Consensus       275 ~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         275 MLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HcCCChhhCcCHHHHhcCcccccc
Confidence            999999999999999999999753

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2e-42  Score=328.08  Aligned_cols=278  Identities=31%  Similarity=0.576  Sum_probs=208.5

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++....   ...+.+..|+.+++++.     |+|++.+++.+.....+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-----h~~i~~~~~~~~~~~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK-----HPNLVNLIEVFRRKRKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC-----CCCEeeeeeEEeeCCEE
Confidence            46999999999999999999999999999999886332   22345677899988884     47899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      ++||||+ ++.|..++...  ..+++..++.++.||+.||.|||++||+||||||+||++++++                
T Consensus        76 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~----------------  137 (286)
T cd07847          76 HLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG----------------  137 (286)
T ss_pred             EEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC----------------
Confidence            9999999 55555555443  3689999999999999999999999999999999999995544                


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                                 .++|+|||++.......   ....++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.
T Consensus       138 -----------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~  206 (286)
T cd07847         138 -----------QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD  206 (286)
T ss_pred             -----------cEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                       45666666554332221   12357889999999876 4588999999999999999999999998877


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+....+....+...+.........  .+...-....+..                ........+..+..+.+||.+||+
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~li~~~l~  268 (286)
T cd07847         207 VDQLYLIRKTLGDLIPRHQQIFSTN--QFFKGLSIPEPET----------------REPLESKFPNISSPALSFLKGCLQ  268 (286)
T ss_pred             HHHHHHHHHHhCCCChHHhhhcccc--cccccccCCCccc----------------ccCHHHHhccCCHHHHHHHHHHhc
Confidence            7777777777766554321111000  0000000000000                000111234557889999999999


Q ss_pred             cCCCCCCCHHHHhcCCCC
Q 014117          406 YDPTDRLTAREALRHPFF  423 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f  423 (430)
                      .||++|||+.|++.||||
T Consensus       269 ~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         269 MDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCccccCCHHHHhcCCCC
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6e-43  Score=340.27  Aligned_cols=249  Identities=21%  Similarity=0.332  Sum_probs=190.1

Q ss_pred             cCcEEEEeeeccccceEEEEEEEC-----CCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .++|++.+.||+|+||.||+|.+.     .+++.||+|+++...  .....+..|+.++..+.+    |+||+++++.+.
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~----h~niv~~~~~~~   81 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGN----HLNVVNLLGACT   81 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhcc----CcceeeEEeEec
Confidence            357999999999999999999752     345689999987432  234567789999988843    378999998776


Q ss_pred             c-CCeEEEEEecC-CCCHHHHHHhcC------------------------------------------------------
Q 014117          166 Y-RNHICIVFEKL-GSSLYDFLRKNN------------------------------------------------------  189 (430)
Q Consensus       166 ~-~~~~~lv~e~~-~~~L~~~l~~~~------------------------------------------------------  189 (430)
                      . .+.+++||||+ +|+|.+++....                                                      
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            5 45689999999 899999997532                                                      


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeE
Q 014117          190 ------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK  263 (430)
Q Consensus       190 ------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~k  263 (430)
                            ...+++..+..++.||+.||+|||++||+||||||+|||++.                           ++.+|
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~---------------------------~~~~k  214 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSE---------------------------NNVVK  214 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcC---------------------------CCcEE
Confidence                  124788889999999999999999999999999999999954                           44566


Q ss_pred             EEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhC
Q 014117          264 VIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLG  337 (430)
Q Consensus       264 l~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g  337 (430)
                      |+|||+++......     ....+|..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+.....   
T Consensus       215 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~---  291 (338)
T cd05102         215 ICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK---  291 (338)
T ss_pred             EeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh---
Confidence            66666665332111     12245678999999999999999999999999999997 9999986443222211110   


Q ss_pred             CCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHH
Q 014117          338 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA  417 (430)
Q Consensus       338 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~el  417 (430)
                                         .+..                         ...+...+.++.+|+.+||+.||++|||+.|+
T Consensus       292 -------------------~~~~-------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el  327 (338)
T cd05102         292 -------------------DGTR-------------------------MRAPENATPEIYRIMLACWQGDPKERPTFSAL  327 (338)
T ss_pred             -------------------cCCC-------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                               0000                         01123456779999999999999999999999


Q ss_pred             hc
Q 014117          418 LR  419 (430)
Q Consensus       418 L~  419 (430)
                      ++
T Consensus       328 ~~  329 (338)
T cd05102         328 VE  329 (338)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=9.3e-43  Score=330.06  Aligned_cols=253  Identities=24%  Similarity=0.430  Sum_probs=200.6

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee------c
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD------Y  166 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~------~  166 (430)
                      .+.|++.+.||.|+||.||+|.+..+++.||+|++............|+.++.++.+    |+|++++++++.      .
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~----h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSH----HRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcC----CCcEEEEeeehhcccccCC
Confidence            467999999999999999999999999999999987655455567778888888743    478999988874      3


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      ...+|+||||+ +++|.+++.......+++..+..++.||+.||.|||+.||+|+||||+||+++               
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~---------------  155 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---------------  155 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---------------
Confidence            56899999999 77999999876555789999999999999999999999999999999999994               


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhh-----CCCCCCcchHHHHHHHHHHHHhCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tG~  317 (430)
                                  .++.++|+|||++.....   ......|+..|+|||++.     +..++.++|+|||||++|+|++|.
T Consensus       156 ------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~  223 (282)
T cd06636         156 ------------ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA  223 (282)
T ss_pred             ------------CCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCC
Confidence                        445677777777653321   123357899999999986     346888999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      .||...........+..   ..+.                   .                         .....++.++.
T Consensus       224 ~p~~~~~~~~~~~~~~~---~~~~-------------------~-------------------------~~~~~~~~~~~  256 (282)
T cd06636         224 PPLCDMHPMRALFLIPR---NPPP-------------------K-------------------------LKSKKWSKKFI  256 (282)
T ss_pred             CCccccCHHhhhhhHhh---CCCC-------------------C-------------------------CcccccCHHHH
Confidence            99976443322211110   0000                   0                         00123566899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCCCC
Q 014117          398 HLLQGLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      +||.+||+.||.+|||+.|+|+||||
T Consensus       257 ~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         257 DFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             HHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.3e-42  Score=331.87  Aligned_cols=281  Identities=25%  Similarity=0.392  Sum_probs=203.4

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      +|++.+.||+|+||.||++.+..++..+|+|.+...  ......+..|++++.++.     |+||+++++.+...+.+|+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~l   76 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECN-----SPYIVGFYGAFYSDGEISI   76 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCC-----CCCCCeEEEEEeeCCEEEE
Confidence            599999999999999999999999999999998643  223455778999988884     4789999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      ||||+ +++|.+++.+..  .+++..+..++.||+.||.|||+ .+|+||||||+|||+++++                 
T Consensus        77 v~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-----------------  137 (308)
T cd06615          77 CMEHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-----------------  137 (308)
T ss_pred             EeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-----------------
Confidence            99999 889999998764  78999999999999999999997 6899999999999996544                 


Q ss_pred             cccccCCCCCCeEEEeCCCccccCC-CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL  329 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~  329 (430)
                                .++|+|||++..... .....+|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.....
T Consensus       138 ----------~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~  207 (308)
T cd06615         138 ----------EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE  207 (308)
T ss_pred             ----------cEEEccCCCcccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH
Confidence                      455555555442211 123357899999999998888999999999999999999999999765433222


Q ss_pred             HHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHH-HHhh----h-cCCchhHHHHHHHHh
Q 014117          330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN-LIMQ----H-VDHSAGDLTHLLQGL  403 (430)
Q Consensus       330 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----~-~~~~~~~~~~ll~~~  403 (430)
                      ..    .+..+.........       ......+........      ...... ....    . ...++.++.+|+.+|
T Consensus       208 ~~----~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  270 (308)
T cd06615         208 AM----FGRPVSEGEAKESH-------RPVSGHPPDSPRPMA------IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKC  270 (308)
T ss_pred             Hh----hcCccccccccCCc-------ccccCCCCCccchhh------HHHHHHHHhcCCCccCcCcccCHHHHHHHHHH
Confidence            11    11111100000000       000000000000000      000000 0000    0 113567899999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      |..||++|||+.++++||||.+.
T Consensus       271 l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         271 LKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             ccCChhhCcCHHHHhcChhhhhc
Confidence            99999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-42  Score=336.44  Aligned_cols=282  Identities=28%  Similarity=0.524  Sum_probs=221.9

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .+.++|++++.||+|+||.||+|.+..+++.||+|++...   ......+..|+.+++++.     |+||+++++.+...
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~   86 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK-----HENVIGLLDVFTPD   86 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcC-----CCCccceeeeecCC
Confidence            3567899999999999999999999999999999998532   223345678999998884     37789998887654


Q ss_pred             C------eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          168 N------HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       168 ~------~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      .      .+++||||++++|.+++..   ..+++..++.++.||+.||.|||+.||+||||||+|||++           
T Consensus        87 ~~~~~~~~~~lv~e~~~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~-----------  152 (343)
T cd07880          87 LSLDRFHDFYLVMPFMGTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN-----------  152 (343)
T ss_pred             ccccccceEEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc-----------
Confidence            3      5699999999999988864   3699999999999999999999999999999999999994           


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                      .++.++|+|||++...........+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||
T Consensus       153 ----------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  216 (343)
T cd07880         153 ----------------EDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF  216 (343)
T ss_pred             ----------------CCCCEEEeecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence                            4456777888877655444444577999999999876 45889999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhh-hhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEK-YVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      ...+.......+....+..+..+...+...... +...                  +.... ...........+.++.++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~-~~~~~~~~~~~~~~~~~l  277 (343)
T cd07880         217 KGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKK------------------LPRFR-KKDFRSLLPNANPLAVNV  277 (343)
T ss_pred             CCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHh------------------ccccC-cchHHHhccCCChHHHHH
Confidence            988877778888887777777665554322111 1100                  00000 001122345677789999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          400 LQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      |.+||+.||++|||+.+++.||||+..
T Consensus       278 i~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         278 LEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             HHHHcCCChhhCCCHHHHhcCccHhhh
Confidence            999999999999999999999999753

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.6e-42  Score=326.67  Aligned_cols=275  Identities=32%  Similarity=0.556  Sum_probs=213.6

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--CeEE
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHIC  171 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~--~~~~  171 (430)
                      |+++++||+|+||.||+|.+..+++.||+|+++....  .......|+.++.++.    .|+|++++++++.+.  +.++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~~~~~~~~~~~~~~   76 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS----PHPNILRLIEVLFDRKTGRLA   76 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcC----CCCCccceEEEEecCCCCcEE
Confidence            6788999999999999999999999999999864321  2223345777777664    247899999998877  8999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          172 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       172 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      +||||+.++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||+++                     
T Consensus        77 lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---------------------  134 (282)
T cd07831          77 LVFELMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---------------------  134 (282)
T ss_pred             EEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---------------------
Confidence            999999889998887643 4689999999999999999999999999999999999994                     


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                            . +.+||+|||++.......  ....++..|+|||++.. ..++.++|||||||++|||++|.+||.+.+..+.
T Consensus       135 ------~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~  207 (282)
T cd07831         135 ------D-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ  207 (282)
T ss_pred             ------C-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH
Confidence                  3 567777777775432221  23467899999998754 4578999999999999999999999999888888


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      ...+....+..++.+.......     ....+.++....               ..........+.++.+||.+||++||
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~li~~~l~~~P  267 (282)
T cd07831         208 IAKIHDVLGTPDAEVLKKFRKS-----RHMNYNFPSKKG---------------TGLRKLLPNASAEGLDLLKKLLAYDP  267 (282)
T ss_pred             HHHHHHHcCCCCHHHHHhhccc-----ccccccCccccc---------------ccHHHHcccccHHHHHHHHHHhccCc
Confidence            8888888888887663322111     011111111110               01111223557889999999999999


Q ss_pred             CCCCCHHHHhcCCCC
Q 014117          409 TDRLTAREALRHPFF  423 (430)
Q Consensus       409 ~~R~ta~elL~hp~f  423 (430)
                      ++|||++++++||||
T Consensus       268 ~~R~~~~~~l~~~~~  282 (282)
T cd07831         268 DERITAKQALRHPYF  282 (282)
T ss_pred             ccccCHHHHhhCCCC
Confidence            999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.4e-42  Score=321.34  Aligned_cols=249  Identities=25%  Similarity=0.408  Sum_probs=198.5

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-CCeE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-RNHI  170 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-~~~~  170 (430)
                      .|++.+.||.|++|.||++.++.+++.||+|.+....   ........|+++++++.     +++++.+++.+.. ...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~   75 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK-----HPNIVAYRESWEGEDGLL   75 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCC-----CCCeeeeeeeecCCCCEE
Confidence            4899999999999999999999999999999986322   23345667888888774     3778988887764 4578


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||+ +++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.                  
T Consensus        76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~------------------  137 (257)
T cd08223          76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTR------------------  137 (257)
T ss_pred             EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEec------------------
Confidence            9999999 889999998755557999999999999999999999999999999999999954                  


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                               ++.++|+|||++......   .....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..
T Consensus       138 ---------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~  208 (257)
T cd08223         138 ---------TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN  208 (257)
T ss_pred             ---------CCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH
Confidence                     445666666665433211   12346889999999999999999999999999999999999999865543


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      .....+...  .++                                              ..+...+.++.+|+.+||+.
T Consensus       209 ~~~~~~~~~--~~~----------------------------------------------~~~~~~~~~~~~li~~~l~~  240 (257)
T cd08223         209 SLVYRIIEG--KLP----------------------------------------------PMPKDYSPELGELIATMLSK  240 (257)
T ss_pred             HHHHHHHhc--CCC----------------------------------------------CCccccCHHHHHHHHHHhcc
Confidence            332222111  110                                              01234566799999999999


Q ss_pred             CCCCCCCHHHHhcCCCC
Q 014117          407 DPTDRLTAREALRHPFF  423 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f  423 (430)
                      ||++|||+.++++||||
T Consensus       241 ~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         241 RPEKRPSVKSILRQPYI  257 (257)
T ss_pred             CcccCCCHHHHhcCCCC
Confidence            99999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-42  Score=331.96  Aligned_cols=289  Identities=28%  Similarity=0.494  Sum_probs=210.8

Q ss_pred             cEEEEeeeccccceEEEEEEECC--CCeEEEEEEecCc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRE--RKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-  167 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~-  167 (430)
                      +|++.+.||+|+||.||+|.+..  +++.||+|++...    .........|+.++..+.     +++++++++++... 
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~   75 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-----HENVVSLVEVFLEHA   75 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-----CCCccceEEEEeCCC
Confidence            48899999999999999999988  8899999998752    223355677888888884     48899999999887 


Q ss_pred             -CeEEEEEecCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCC
Q 014117          168 -NHICIVFEKLGSSLYDFLRKNN---YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       168 -~~~~lv~e~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                       ..+|+||||++++|.+++....   ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++          
T Consensus        76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~----------  145 (316)
T cd07842          76 DKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEG----------  145 (316)
T ss_pred             CceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCC----------
Confidence             8999999999888888775432   13689999999999999999999999999999999999997622          


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccCCC------CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTG  316 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG  316 (430)
                                   +..+.+||+|||++......      .....+|..|+|||++.+. .++.++|||||||++|+|++|
T Consensus       146 -------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~  212 (316)
T cd07842         146 -------------PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTL  212 (316)
T ss_pred             -------------CccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhc
Confidence                         23556666777666533221      1234678999999998764 589999999999999999999


Q ss_pred             CCCCCCCchH---------HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhh
Q 014117          317 EALFQTHENL---------EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ  387 (430)
Q Consensus       317 ~~Pf~~~~~~---------~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (430)
                      ++||......         ..+..+...++.++...+.......+...........           ......+.... .
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~-~  280 (316)
T cd07842         213 EPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTK-----------TYPSNSLAKWM-E  280 (316)
T ss_pred             CCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCC-----------CCCCccHHHHH-H
Confidence            9999764432         2445556666666554443322221110000000000           00000111111 1


Q ss_pred             hcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCC
Q 014117          388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       388 ~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      .....+.++.++|.+||+.||++|||+.|+++||||
T Consensus       281 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         281 KHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             hccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            113667789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-42  Score=337.76  Aligned_cols=282  Identities=26%  Similarity=0.497  Sum_probs=221.4

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .+.++|++.+.||+|+||.||+|++..+++.||+|++...   .........|+.+++++.     +++++.+.+++...
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~   86 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD-----HENVIGLLDVFTPA   86 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhcc-----CCCHHHHHHHhhcc
Confidence            3467899999999999999999999999999999998642   223345667888888884     37788888877655


Q ss_pred             Ce------EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          168 NH------ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       168 ~~------~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      +.      .|+|+||++++|.+++..   ..+++..+..++.||+.||.|||++||+||||||+||+++           
T Consensus        87 ~~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~-----------  152 (343)
T cd07851          87 SSLEDFQDVYLVTHLMGADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-----------  152 (343)
T ss_pred             ccccccccEEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC-----------
Confidence            44      999999999999999875   3699999999999999999999999999999999999994           


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                      .++.++|+|||.+...........+|..|+|||.+.+. .++.++|||||||++|+|++|+.||
T Consensus       153 ----------------~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf  216 (343)
T cd07851         153 ----------------EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF  216 (343)
T ss_pred             ----------------CCCCEEEccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence                            44567777777776544444445788999999998763 6889999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhh-hhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEK-YVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      .+.+..+.+..+....+.+++.++.++...... +....                  .... ...........+.++.+|
T Consensus       217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~-~~~~~~~~~~~s~~l~dl  277 (343)
T cd07851         217 PGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSL------------------PQMP-KKDFKEVFSGANPLAIDL  277 (343)
T ss_pred             CCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhc------------------cccC-CCCHHHHhccCCHHHHHH
Confidence            988888888888888888887665544322111 10000                  0000 001112233457889999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          400 LQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      |.+||+.||++|||+.+|++||||.+-
T Consensus       278 i~~~l~~~P~~Rpt~~ell~h~~~~~~  304 (343)
T cd07851         278 LEKMLVLDPDKRITAAEALAHPYLAEY  304 (343)
T ss_pred             HHHhCCCChhhCCCHHHHhcCCCcccc
Confidence            999999999999999999999999764

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.2e-42  Score=337.78  Aligned_cols=281  Identities=27%  Similarity=0.497  Sum_probs=218.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee----
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD----  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~----  165 (430)
                      .++|++.+.||.|+||.||+|.++.+++.||+|++....   ........|+.+++++.     |++|+++++++.    
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~   78 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK-----HDNIIAIRDILRPPGA   78 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC-----CCCccCHHHhccccCC
Confidence            367999999999999999999999999999999986432   23345667888888884     478899888775    


Q ss_pred             cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          166 YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       166 ~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      ....+|+||||++++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.           
T Consensus        79 ~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~-----------  145 (334)
T cd07855          79 DFKDVYVVMDLMESDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE-----------  145 (334)
T ss_pred             CCceEEEEEehhhhhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc-----------
Confidence            345799999999889999987654  6999999999999999999999999999999999999965554           


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCC-------CCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~  317 (430)
                                      +||+|||++......       .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+
T Consensus       146 ----------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~  209 (334)
T cd07855         146 ----------------LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR  209 (334)
T ss_pred             ----------------EEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCC
Confidence                            555555544322111       122468899999999876 45899999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhh-hhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL  396 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (430)
                      +||.+.+.......+....|.+|...+..+..... .+...    ++....               ..........+.++
T Consensus       210 ~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------------~~~~~~~~~~~~~~  270 (334)
T cd07855         210 QLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQN----LPRKQP---------------VPWSKIFPKASPEA  270 (334)
T ss_pred             CccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhh----cccCCC---------------CCHHHHcccCCHHH
Confidence            99999888888888999999988877665432211 11110    000000               00011234567889


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          397 THLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       397 ~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      .++|.+||+.||++|||+++++.||||.+.
T Consensus       271 ~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~  300 (334)
T cd07855         271 LDLLSQMLQFDPEERITVEQALQHPFLAQY  300 (334)
T ss_pred             HHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence            999999999999999999999999999754

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.3e-42  Score=336.13  Aligned_cols=282  Identities=29%  Similarity=0.516  Sum_probs=215.7

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-  167 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~-  167 (430)
                      +..+|.+.+.||.|+||+||+|.+..+++.||||.+...   .........|+.+++.+.     |+|++++++++... 
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~ni~~~~~~~~~~~   77 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD-----HENVIAIKDIMPPPH   77 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcC-----CCCccchHHheeccc
Confidence            346799999999999999999999999999999998642   222345567888888873     47899998877543 


Q ss_pred             ----CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCC
Q 014117          168 ----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       168 ----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                          ..+|+||||++++|.+++...+  .+++..+..++.||+.||.|||+++|+||||||+|||++.++          
T Consensus        78 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~----------  145 (337)
T cd07858          78 REAFNDVYIVYELMDTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC----------  145 (337)
T ss_pred             ccccCcEEEEEeCCCCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC----------
Confidence                4589999999889999987654  799999999999999999999999999999999999995544          


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEAL  319 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~P  319 (430)
                                       .+||+|||++......   .....+|..|+|||.+.+ ..++.++|+|||||++|+|++|++|
T Consensus       146 -----------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  208 (337)
T cd07858         146 -----------------DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPL  208 (337)
T ss_pred             -----------------CEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCC
Confidence                             5566666655433221   122467889999999875 4689999999999999999999999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHh-hhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDR-HAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      |.+.+..+....+....+.++...+..... ....+...                 ......  .......+..+.++.+
T Consensus       209 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~--~~~~~~~~~~~~~~~~  269 (337)
T cd07858         209 FPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRS-----------------LPYTPR--QSFARLFPHANPLAID  269 (337)
T ss_pred             CCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHh-----------------cCcccc--cCHHHHcccCCHHHHH
Confidence            998887788888888888877654322111 11111100                 000000  0011223457788999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          399 LLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||++||+.||++|||++++|+||||..-
T Consensus       270 li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         270 LLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             HHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            9999999999999999999999999753

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.6e-42  Score=331.14  Aligned_cols=287  Identities=25%  Similarity=0.477  Sum_probs=211.1

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~--  167 (430)
                      .++|++.++||+|+||.||+|.+..+++.||+|.+....   ........|+.+++++.|     ++++++++++...  
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h-----~~iv~~~~~~~~~~~   85 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKH-----ENVVNLIEICRTKAT   85 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCC-----CCccceEEEEecccc
Confidence            356999999999999999999999999999999885321   223345678888888844     7788888876543  


Q ss_pred             ------CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          168 ------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       168 ------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                            ...++||||++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++++|||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          86 PYNRYKGSFYLVFEFCEHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             cccCCCceEEEEEcCCCcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCC
Confidence                  3569999999889998887653 468999999999999999999999999999999999999665555555555


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCC-CCCcchHHHHHHHHHHHHhCCCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                      ++.........                    .........++..|+|||++.+.. ++.++|+|||||++|+|++|.+||
T Consensus       165 ~~~~~~~~~~~--------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~  224 (310)
T cd07865         165 LARAFSLSKNS--------------------KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM  224 (310)
T ss_pred             CcccccCCccc--------------------CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC
Confidence            44322111000                    000011235788999999987654 789999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhh-hcCCchhHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ-HVDHSAGDLTHL  399 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l  399 (430)
                      .+.+.......+....|..|..+++....... +   .....+....              ...... .....+..+.+|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~--------------~~~~~~l~~~~~~~~~~dl  286 (310)
T cd07865         225 QGNTEQHQLTLISQLCGSITPEVWPGVDKLEL-F---KKMELPQGQK--------------RKVKERLKPYVKDPHALDL  286 (310)
T ss_pred             CCCCHHHHHHHHHHHhCCCChhhcccccchhh-h---hhccCCCccc--------------hhhHHhcccccCCHHHHHH
Confidence            98888888888899888888766543321110 0   0001111000              000000 011235578999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCCCC
Q 014117          400 LQGLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      |.+||+.||.+|||++|+|+||||
T Consensus       287 i~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         287 IDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             HHHHhcCChhhccCHHHHhcCCCC
Confidence            999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.2e-42  Score=335.31  Aligned_cols=283  Identities=26%  Similarity=0.469  Sum_probs=219.4

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-  166 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-  166 (430)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||+|++....   ........|+.++.++.     |+||+++++.+.. 
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-----h~~iv~~~~~~~~~   88 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-----HENVIGLLDVFTPA   88 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC-----CCcccceeeeeeec
Confidence            45678999999999999999999999999999999986432   22345667888888884     4788888887653 


Q ss_pred             -----CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          167 -----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       167 -----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                           ....|+++++++++|.+++...   .+++..+..++.||+.||.|||++||+||||||+||+++           
T Consensus        89 ~~~~~~~~~~lv~~~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~-----------  154 (345)
T cd07877          89 RSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-----------  154 (345)
T ss_pred             ccccccccEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc-----------
Confidence                 2458999999999999888643   589999999999999999999999999999999999994           


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                      .++.+||+|||++...........||..|+|||++.+ ..++.++|||||||++|+|++|++||
T Consensus       155 ----------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  218 (345)
T cd07877         155 ----------------EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF  218 (345)
T ss_pred             ----------------CCCCEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence                            4456777777776654433344578999999999876 46889999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      ...+.......+....+..+..+...+...............+                  ...........+.++.+||
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~li  280 (345)
T cd07877         219 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMP------------------KMNFANVFIGANPLAVDLL  280 (345)
T ss_pred             CCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccC------------------CcchhhhcCCCCHHHHHHH
Confidence            8887778888888888888777665443222111100000000                  0001112234577899999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          401 QGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      .+||+.||.+|+|+.++|+||||++-
T Consensus       281 ~~~L~~dp~~R~t~~e~l~h~~f~~~  306 (345)
T cd07877         281 EKMLVLDSDKRITAAQALAHAYFAQY  306 (345)
T ss_pred             HHHcCCChhhcCCHHHHhcChhhhhc
Confidence            99999999999999999999999854

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-42  Score=326.69  Aligned_cols=280  Identities=33%  Similarity=0.631  Sum_probs=218.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ++|++.+.||+|+||.||+|.++.+++.||+|.++..   ......+..|+++++.+.     +++++++++.+...+..
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~   75 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR-----HENIVNLKEAFRRKGRL   75 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC-----CCCeeehhheEEECCEE
Confidence            3699999999999999999999999999999988642   233456788999999885     47899999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      ++||||+++++.+.+.... ..+++..+..++.||+.||.|||+.||+|+||||+||+++                    
T Consensus        76 ~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~--------------------  134 (288)
T cd07833          76 YLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS--------------------  134 (288)
T ss_pred             EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC--------------------
Confidence            9999999555554444332 3689999999999999999999999999999999999994                    


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                             .++.+||+|||.+.......    ....++..|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+.
T Consensus       135 -------~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~  207 (288)
T cd07833         135 -------ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD  207 (288)
T ss_pred             -------CCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence                   45567777777765433322    234678999999999888 789999999999999999999999998888


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+....+...++.+++.............    ....+.             ..........++..++.++.+||++||.
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~li~~~l~  270 (288)
T cd07833         208 IDQLYLIQKCLGPLPPSHQELFSSNPRFA----GVAFPE-------------PSQPESLERRYPGKVSSPALDFLKACLR  270 (288)
T ss_pred             HHHHHHHHHHhCCCCHHHhhhcccCcccc----ccccCC-------------CCCcHHHHHhcCCccchHHHHHHHHHhc
Confidence            88888888888888775443322110000    000000             0111112223344558899999999999


Q ss_pred             cCCCCCCCHHHHhcCCCC
Q 014117          406 YDPTDRLTAREALRHPFF  423 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f  423 (430)
                      .||++|||+++++.||||
T Consensus       271 ~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         271 MDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cCchhcccHHHHhcCCCC
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.9e-42  Score=326.66  Aligned_cols=281  Identities=26%  Similarity=0.406  Sum_probs=209.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .++|.+.+.||+|+||.||+|.++.+++.||+|++....  ........|+.+++.+.     |+|++++++++...+..
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~ni~~~~~~~~~~~~~   78 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK-----HANIVLLHDIIHTKETL   78 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcC-----CCCEeEEEEEEecCCeE
Confidence            357999999999999999999999999999999986432  22234567888888884     37899999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      |+||||++++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.                   
T Consensus        79 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~-------------------  138 (291)
T cd07870          79 TFVFEYMHTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISY-------------------  138 (291)
T ss_pred             EEEEecccCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcC-------------------
Confidence            9999999888888776543 36888899999999999999999999999999999999954                   


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCc-h
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHE-N  325 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~-~  325 (430)
                              ++.++|+|||++......   .....+++.|+|||.+.+. .++.++|||||||++|+|++|..||...+ .
T Consensus       139 --------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~  210 (291)
T cd07870         139 --------LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV  210 (291)
T ss_pred             --------CCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH
Confidence                    445677777766532211   1223578999999998764 58899999999999999999999997644 3


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+.+..+....+.++...+..+...... ... .+....             ...+......  -..+.++.+++.+||+
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~-------------~~~~~~~~~~--~~~~~~~~~ll~~~l~  273 (291)
T cd07870         211 FEQLEKIWTVLGVPTEDTWPGVSKLPNY-KPE-WFLPCK-------------PQQLRVVWKR--LSRPPKAEDLASQMLM  273 (291)
T ss_pred             HHHHHHHHHHcCCCChhhhhhhhhcccc-cch-hccccC-------------Ccchhhhccc--cCCChHHHHHHHHHhC
Confidence            4566666677776665554433221111 000 000000             0000000000  0125678999999999


Q ss_pred             cCCCCCCCHHHHhcCCCC
Q 014117          406 YDPTDRLTAREALRHPFF  423 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f  423 (430)
                      .||.+|||+.|++.||||
T Consensus       274 ~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         274 MFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cCcccCcCHHHHhcCCCC
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8e-42  Score=323.75  Aligned_cols=277  Identities=30%  Similarity=0.502  Sum_probs=215.1

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      +|++.++||.|++|.||+|.+..+++.||+|.++...  ........|+.+++++.     |+|++++++.+...+..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK-----HENIVRLHDVIHTENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhc-----CCCEeeeeeeEeeCCcEEE
Confidence            4899999999999999999999999999999986432  22345667899999884     4789999999999999999


Q ss_pred             EEecCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKLGSSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+.++|.+++.... ...+++..+..++.||+.||.|||+.||+||||||+||++++                    
T Consensus        76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~--------------------  135 (284)
T cd07836          76 VFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINK--------------------  135 (284)
T ss_pred             EEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC--------------------
Confidence            99999879999887643 246899999999999999999999999999999999999954                    


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                             ++.++|+|||.+.......   ....+|..|++||++.+. .++.++|+|||||++|+|++|.+||.+.+..+
T Consensus       136 -------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~  208 (284)
T cd07836         136 -------RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED  208 (284)
T ss_pred             -------CCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence                   4456666666654322211   223578899999998764 57899999999999999999999999888888


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+....+.+....++.+... ..+.    ...+..  .             ........+..+.++.++|.+||+.|
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~--~-------------~~~~~~~~~~~~~~~~~~i~~~l~~~  268 (284)
T cd07836         209 QLLKIFRIMGTPTESTWPGISQL-PEYK----PTFPRY--P-------------PQDLQQLFPHADPLGIDLLHRLLQLN  268 (284)
T ss_pred             HHHHHHHHhCCCChhhHHHHhcC-chhc----ccccCC--C-------------hHHHHHHhhhcCcHHHHHHHHHhcCC
Confidence            88877777776666554433211 0000    000000  0             00112223345778999999999999


Q ss_pred             CCCCCCHHHHhcCCCC
Q 014117          408 PTDRLTAREALRHPFF  423 (430)
Q Consensus       408 P~~R~ta~elL~hp~f  423 (430)
                      |.+|||++++++||||
T Consensus       269 p~~R~~~~~~l~~~~f  284 (284)
T cd07836         269 PELRISAHDALQHPWF  284 (284)
T ss_pred             cccCCCHHHHhcCCCC
Confidence            9999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.2e-42  Score=320.39  Aligned_cols=249  Identities=26%  Similarity=0.400  Sum_probs=202.4

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +|.+.+.||+|++|.||+|.+..+++.||+|.+...   ......+..|+++++.+.     |++++++++.+...+..|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD-----SSYIIRYYESFLDKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcC-----CCCeehheeeeccCCEEE
Confidence            378899999999999999999999999999998632   334556777888888874     488999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|.+++.......+++..+..++.||+.||.|||+.||+|+||||+||+++.+                  
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~------------------  137 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY------------------  137 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC------------------
Confidence            999999 8899999987645679999999999999999999999999999999999999554                  


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                               +.++|+|||++.......   ....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+
T Consensus       138 ---------~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  208 (256)
T cd08529         138 ---------DNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA  208 (256)
T ss_pred             ---------CCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                     455666666554332221   22467899999999999889999999999999999999999998766544


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+...  ..+                                              ..+...+.++.++|.+||+.+
T Consensus       209 ~~~~~~~~--~~~----------------------------------------------~~~~~~~~~~~~~i~~~l~~~  240 (256)
T cd08529         209 LILKIIRG--VFP----------------------------------------------PVSQMYSQQLAQLIDQCLTKD  240 (256)
T ss_pred             HHHHHHcC--CCC----------------------------------------------CCccccCHHHHHHHHHHccCC
Confidence            33322211  000                                              011234567999999999999


Q ss_pred             CCCCCCHHHHhcCCCC
Q 014117          408 PTDRLTAREALRHPFF  423 (430)
Q Consensus       408 P~~R~ta~elL~hp~f  423 (430)
                      |++||++.++++|||+
T Consensus       241 p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         241 YRQRPDTFQLLRNPSL  256 (256)
T ss_pred             cccCcCHHHHhhCCCC
Confidence            9999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.9e-42  Score=328.06  Aligned_cols=254  Identities=25%  Similarity=0.451  Sum_probs=200.9

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      |++.+.||.|+||.||+|.+..++..+|+|.+... ......+..|+++++.+     .|+|++.+++.+...+..++||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~ii~~~~~~~~~~~~~~v~   81 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-----DHPNIVKLLDAFYYENNLWILI   81 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-----CCCCeeeEEEEEeeCCEEEEEE
Confidence            68889999999999999999999999999998643 23345567788888887     3478999999999999999999


Q ss_pred             ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          175 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       175 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      ||+ +++|..++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++                    
T Consensus        82 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~--------------------  140 (282)
T cd06643          82 EFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG--------------------  140 (282)
T ss_pred             EecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC--------------------
Confidence            999 788888876533 4799999999999999999999999999999999999995544                    


Q ss_pred             ccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhh-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          254 KRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                             .+||+|||++......   .....||..|+|||++.     +..++.++|+|||||++|+|++|.+||...+.
T Consensus       141 -------~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~  213 (282)
T cd06643         141 -------DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP  213 (282)
T ss_pred             -------CEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH
Confidence                   4556666655432111   12346899999999984     34578899999999999999999999987665


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+....+.....+..                                              ..+..++.++.+||.+||+
T Consensus       214 ~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~li~~~l~  247 (282)
T cd06643         214 MRVLLKIAKSEPPTL----------------------------------------------AQPSRWSSEFKDFLKKCLE  247 (282)
T ss_pred             HHHHHHHhhcCCCCC----------------------------------------------CCccccCHHHHHHHHHHcc
Confidence            554433322111100                                              0122346679999999999


Q ss_pred             cCCCCCCCHHHHhcCCCCCCCCC
Q 014117          406 YDPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      .||++|||++++++||||+....
T Consensus       248 ~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         248 KNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             CChhhCcCHHHHhcCCCEeccCC
Confidence            99999999999999999986543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.6e-42  Score=328.93  Aligned_cols=279  Identities=28%  Similarity=0.484  Sum_probs=216.0

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--C
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--N  168 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~--~  168 (430)
                      ++|++.+.||.|+||.||+|.++.+++.+|+|.++....   .......|+.++.++.     |+|++++++++...  +
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~ni~~~~~~~~~~~~~   79 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ-----HPNIVTVKEVVVGSNLD   79 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC-----CCCEEEEEEEEEecCCC
Confidence            468999999999999999999999999999999864322   2234567888888884     48899999988776  8


Q ss_pred             eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          169 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       169 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      ..|+||||+.++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.                 
T Consensus        80 ~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~-----------------  141 (293)
T cd07843          80 KIYMVMEYVEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN-----------------  141 (293)
T ss_pred             cEEEEehhcCcCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC-----------------
Confidence            999999999889999987654 36999999999999999999999999999999999999954                 


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                ++.++|+|||.+......   .....+++.|+|||.+.+.. ++.++|+|||||++|+|++|.+||...+
T Consensus       142 ----------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~  211 (293)
T cd07843         142 ----------RGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS  211 (293)
T ss_pred             ----------CCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                      455667777666533222   12235788999999987654 6899999999999999999999999988


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCC-chhHHHHHHHHh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGL  403 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~  403 (430)
                      ..+....+...++.++...+........    .....+..              .....+...++.. .+..+.+||++|
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~li~~~  273 (293)
T cd07843         212 EIDQLNKIFKLLGTPTEKIWPGFSELPG----AKKKTFTK--------------YPYNQLRKKFPALSLSDNGFDLLNRL  273 (293)
T ss_pred             hHHHHHHHHHHhCCCchHHHHHhhccch----hccccccc--------------ccchhhhccccccCCChHHHHHHHHH
Confidence            8888888888888777665543321110    00001100              0011112222333 577899999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f  423 (430)
                      |+.||++|||++|+|.||||
T Consensus       274 l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         274 LTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hccCccccCCHHHHhcCCCC
Confidence            99999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-44  Score=346.62  Aligned_cols=252  Identities=26%  Similarity=0.388  Sum_probs=215.3

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ..|.-++.||.|+||.||-|++..+.+.||||.+..+.+    --+....|+..|+++.|     ||++...++|--+..
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~H-----PntieYkgCyLre~T  100 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRH-----PNTIEYKGCYLREHT  100 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccC-----CCcccccceeeccch
Confidence            347778899999999999999999999999999864322    22456789999999954     889999999998899


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          170 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       170 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      .+||||||-|+-.|+|.-.. +++.+..+..|+.+.+.||.|||+.+.||||||..|||+                    
T Consensus       101 aWLVMEYClGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL--------------------  159 (948)
T KOG0577|consen  101 AWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL--------------------  159 (948)
T ss_pred             HHHHHHHHhccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe--------------------
Confidence            99999999888888887554 579999999999999999999999999999999999999                    


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                             ...+.|||+|||.|....+ .+.++|||+|||||+++.   +.|+.++||||||++..||...++|+-..+.+
T Consensus       160 -------se~g~VKLaDFGSAsi~~P-AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM  231 (948)
T KOG0577|consen  160 -------SEPGLVKLADFGSASIMAP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM  231 (948)
T ss_pred             -------cCCCeeeeccccchhhcCc-hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH
Confidence                   4556788888888876544 456799999999999974   46999999999999999999999999988888


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      ..+..|.+...|.-.                                               ...++..+++|+..||++
T Consensus       232 SALYHIAQNesPtLq-----------------------------------------------s~eWS~~F~~Fvd~CLqK  264 (948)
T KOG0577|consen  232 SALYHIAQNESPTLQ-----------------------------------------------SNEWSDYFRNFVDSCLQK  264 (948)
T ss_pred             HHHHHHHhcCCCCCC-----------------------------------------------CchhHHHHHHHHHHHHhh
Confidence            888888775544221                                               123466799999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~  426 (430)
                      =|++|||.+++|.|+|+.+.
T Consensus       265 ipqeRptse~ll~H~fv~R~  284 (948)
T KOG0577|consen  265 IPQERPTSEELLKHRFVLRE  284 (948)
T ss_pred             CcccCCcHHHHhhcchhccC
Confidence            99999999999999999765

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.9e-42  Score=329.29  Aligned_cols=253  Identities=26%  Similarity=0.426  Sum_probs=202.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+.+++.+.     |+|++++++.+....+.|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~-----h~~v~~~~~~~~~~~~~~   93 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-----NPNIVNYLDSYLVGDELW   93 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCC-----CCCEeeEEEEEEeCCEEE
Confidence            357999999999999999999999999999999886432 23455677888888773     478999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|.+++...   .+++..+..++.|++.||.|||+.||+||||||+|||++.+                  
T Consensus        94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~------------------  152 (296)
T cd06654          94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD------------------  152 (296)
T ss_pred             EeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC------------------
Confidence            999999 88999998653   58999999999999999999999999999999999999544                  


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                               +.++|+|||++.......   ....|++.|+|||.+.+..++.++|||||||++|+|++|.+||...+...
T Consensus       153 ---------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~  223 (296)
T cd06654         153 ---------GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR  223 (296)
T ss_pred             ---------CCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                     456666666554322211   22468899999999998889999999999999999999999997655433


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+... +..+                                             ...+...+..+.+||.+||+.|
T Consensus       224 ~~~~~~~~-~~~~---------------------------------------------~~~~~~~~~~l~~li~~~l~~~  257 (296)
T cd06654         224 ALYLIATN-GTPE---------------------------------------------LQNPEKLSAIFRDFLNRCLDMD  257 (296)
T ss_pred             hHHHHhcC-CCCC---------------------------------------------CCCccccCHHHHHHHHHHCcCC
Confidence            22211110 0000                                             0012234567899999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~  426 (430)
                      |++|||+.++++||||...
T Consensus       258 p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         258 VEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             cccCcCHHHHhhChhhhcc
Confidence            9999999999999999765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-42  Score=325.21  Aligned_cols=276  Identities=31%  Similarity=0.521  Sum_probs=214.8

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      |++.++||.|++|.||+|.++.+++.||+|++....   .....+..|+++++.+.     +++++++++++...+..|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-----~~~iv~~~~~~~~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN-----HPNIVRLLDVVHSENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcC-----CCCccCHhheeccCCeEEE
Confidence            577899999999999999999999999999986432   22345677999888884     4789999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          173 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       173 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      ||||++++|.+++.......+++..+..++.||+.||.|||+++++||||+|+||+++.                     
T Consensus        76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~---------------------  134 (283)
T cd07835          76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDR---------------------  134 (283)
T ss_pred             EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC---------------------
Confidence            99999889999998765457999999999999999999999999999999999999954                     


Q ss_pred             cccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                            ++.++|+|||++.......   ....++..|+|||++.+. .++.++|+|||||++|+|++|.+||...+....
T Consensus       135 ------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  208 (283)
T cd07835         135 ------EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ  208 (283)
T ss_pred             ------CCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                  4566777777665332211   223568899999988764 578999999999999999999999998887777


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      ...+.+..+.+....+...............  ++                  ...........+.++.++|.+||+.||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~------------------~~~~~~~~~~~~~~~~~li~~~l~~~P  268 (283)
T cd07835         209 LFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK--WA------------------RQDLSKVVPNLDEDGLDLLSKMLVYDP  268 (283)
T ss_pred             HHHHHHHhCCCChHHhhhhhhchhhhhhccc--cc------------------ccchhhhcCCCCHHHHHHHHHHhcCCh
Confidence            7777777777666554433221111000000  00                  000112234567789999999999999


Q ss_pred             CCCCCHHHHhcCCCC
Q 014117          409 TDRLTAREALRHPFF  423 (430)
Q Consensus       409 ~~R~ta~elL~hp~f  423 (430)
                      ++|||++|++.||||
T Consensus       269 ~~Rpt~~~il~~~~~  283 (283)
T cd07835         269 AKRISAKAALQHPYF  283 (283)
T ss_pred             hhCcCHHHHhcCCCC
Confidence            999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.6e-42  Score=326.73  Aligned_cols=256  Identities=23%  Similarity=0.387  Sum_probs=197.8

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      +|++++.||+|+||.||+|.+..+++.||+|++...  ......+..|+++++++.     |++++++++.+...+..++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCD-----SPYIIGFYGAFFVENRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCC-----CCCeeeEEEEEEECCEEEE
Confidence            588899999999999999999999999999998643  233456778999888873     4889999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+ +++|..+.      .+++..+..++.|++.||.|||+.||+|+||||+|||++.                    
T Consensus        77 v~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~--------------------  130 (279)
T cd06619          77 CTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT--------------------  130 (279)
T ss_pred             EEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC--------------------
Confidence            99999 77875542      5789999999999999999999999999999999999954                    


Q ss_pred             ccccCCCCCCeEEEeCCCccccCC-CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA  330 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~  330 (430)
                             ++.++|+|||++..... .....+||..|+|||++.+..++.++|+|||||++|+|++|..||......+...
T Consensus       131 -------~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~  203 (279)
T cd06619         131 -------RGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL  203 (279)
T ss_pred             -------CCCEEEeeCCcceecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc
Confidence                   45677777776653322 2234578999999999999899999999999999999999999996522111000


Q ss_pred             HHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCC
Q 014117          331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD  410 (430)
Q Consensus       331 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~  410 (430)
                              .+......+       ........                         .....+.++.+|+.+||+.||++
T Consensus       204 --------~~~~~~~~~-------~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~P~~  243 (279)
T cd06619         204 --------MPLQLLQCI-------VDEDPPVL-------------------------PVGQFSEKFVHFITQCMRKQPKE  243 (279)
T ss_pred             --------chHHHHHHH-------hccCCCCC-------------------------CCCcCCHHHHHHHHHHhhCChhh
Confidence                    000000000       00000000                         01234567999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCC
Q 014117          411 RLTAREALRHPFFTRDHL  428 (430)
Q Consensus       411 R~ta~elL~hp~f~~~~~  428 (430)
                      ||+++|++.||||.....
T Consensus       244 Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         244 RPAPENLMDHPFIVQYND  261 (279)
T ss_pred             CCCHHHHhcCcccccccC
Confidence            999999999999987644

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=328.92  Aligned_cols=256  Identities=28%  Similarity=0.480  Sum_probs=203.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      .++|++.+.||.|+||.||+|.+..+++.||+|++.... ...+.+..|+++++.+.     |++++++++.+.....+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK-----HPNIVGLYEAYFYENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCC-----CCceeEEEEEEecCCeEE
Confidence            357999999999999999999999899999999986432 33456778898888884     478999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.+                  
T Consensus        79 lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~------------------  139 (280)
T cd06611          79 ILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD------------------  139 (280)
T ss_pred             EEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC------------------
Confidence            999999 889999987654 469999999999999999999999999999999999999544                  


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhC-----CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                               +.++|+|||++......   .....||+.|+|||++..     ..++.++|+|||||++|+|++|.+||..
T Consensus       140 ---------~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~  210 (280)
T cd06611         140 ---------GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE  210 (280)
T ss_pred             ---------CCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence                     45666666655432211   123468999999999853     3577899999999999999999999987


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      .+.......+..  +..|.                                            ...+...+.++.++|.+
T Consensus       211 ~~~~~~~~~~~~--~~~~~--------------------------------------------~~~~~~~~~~~~~li~~  244 (280)
T cd06611         211 LNPMRVLLKILK--SEPPT--------------------------------------------LDQPSKWSSSFNDFLKS  244 (280)
T ss_pred             CCHHHHHHHHhc--CCCCC--------------------------------------------cCCcccCCHHHHHHHHH
Confidence            554433322211  00000                                            00123456689999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      ||+.||++|||+.++|+||||++..
T Consensus       245 ~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         245 CLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             HhccChhhCcCHHHHhcChhhcccc
Confidence            9999999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=347.01  Aligned_cols=250  Identities=25%  Similarity=0.399  Sum_probs=206.9

Q ss_pred             eeccccceEEEEEEECCCCeEEEEEEec-CchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-C
Q 014117          101 KMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G  178 (430)
Q Consensus       101 ~lG~G~~g~V~~~~~~~~~~~vAiK~~~-~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~  178 (430)
                      .||+|.||+||-|+|..+...+|||-+. +.....+-.+.|+...++++|     .|||+..+.+..++++-|.||-+ |
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrH-----kNIVrYLGs~senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRH-----KNIVRYLGSVSENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhh-----HhHHHHhhccCCCCeEEEEeecCCC
Confidence            5999999999999999999999999986 334455667889999999977     67999999999999999999999 9


Q ss_pred             CCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccC
Q 014117          179 SSLYDFLRKNNYRSF--PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM  256 (430)
Q Consensus       179 ~~L~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~  256 (430)
                      |+|.++|+..- .++  .+..+-.|.+||++||.|||++.|||||||-+||||+                          
T Consensus       657 GSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--------------------------  709 (1226)
T KOG4279|consen  657 GSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--------------------------  709 (1226)
T ss_pred             CcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--------------------------
Confidence            99999998653 245  7888999999999999999999999999999999996                          


Q ss_pred             CCCCCeEEEeCCCcccc---CCCCCeeeecCcccchhhhhCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Q 014117          257 PKSSAIKVIDFGSTTYE---RPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM  331 (430)
Q Consensus       257 ~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~  331 (430)
                      ...+.+||+|||.++..   .+-..++.||..|||||++..+  .|+.++|||||||++.||.||++||....+.+..+.
T Consensus       710 TySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF  789 (1226)
T KOG4279|consen  710 TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF  789 (1226)
T ss_pred             eccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh
Confidence            56778888888877542   3344568999999999999865  599999999999999999999999976554433222


Q ss_pred             HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCC
Q 014117          332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR  411 (430)
Q Consensus       332 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R  411 (430)
                      -+......                                              ...|...+.++++||.+|+..||.+|
T Consensus       790 kVGmyKvH----------------------------------------------P~iPeelsaeak~FilrcFepd~~~R  823 (1226)
T KOG4279|consen  790 KVGMYKVH----------------------------------------------PPIPEELSAEAKNFILRCFEPDPCDR  823 (1226)
T ss_pred             hhcceecC----------------------------------------------CCCcHHHHHHHHHHHHHHcCCCcccC
Confidence            11111111                                              11234567789999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCC
Q 014117          412 LTAREALRHPFFTRDHL  428 (430)
Q Consensus       412 ~ta~elL~hp~f~~~~~  428 (430)
                      |+|.++|++||++..+.
T Consensus       824 ~sA~~LL~DpFlq~~~k  840 (1226)
T KOG4279|consen  824 PSAKDLLQDPFLQHNNK  840 (1226)
T ss_pred             ccHHHhccCcccccCCC
Confidence            99999999999987643

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-42  Score=334.58  Aligned_cols=281  Identities=28%  Similarity=0.491  Sum_probs=218.2

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-  167 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~-  167 (430)
                      +.++|.+.+.||+|+||.||+|.+..+++.||+|++...   ......+..|+.+++.+.     |+|++++++++... 
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~~~~~~~~   87 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ-----HENVIGLLDVFTSAV   87 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcC-----CCCccchhheecccc
Confidence            356899999999999999999999999999999998642   222345677888888884     47899998887643 


Q ss_pred             -----CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          168 -----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       168 -----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                           ..+|+|+||+..+|..++.    ..+++..+..++.|++.||.|||+.||+||||||+|||+             
T Consensus        88 ~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll-------------  150 (342)
T cd07879          88 SGDEFQDFYLVMPYMQTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV-------------  150 (342)
T ss_pred             cCCCCceEEEEecccccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE-------------
Confidence                 3579999999878877652    368999999999999999999999999999999999999             


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCC
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                                    +.++.++|+|||++...........+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus       151 --------------~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~  216 (342)
T cd07879         151 --------------NEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK  216 (342)
T ss_pred             --------------CCCCCEEEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC
Confidence                          44567788888877655444444578999999999876 468999999999999999999999999


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      +.+....+..+....+..++.+.+.+...........                 .... .........+..+.++.+||.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~-~~~~~~~~~~~~~~~~~~li~  278 (342)
T cd07879         217 GKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKS-----------------LPKY-PRKDFSTLFPKASPQAVDLLE  278 (342)
T ss_pred             CCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhh-----------------cCCc-ccchHHHHhcCCCHHHHHHHH
Confidence            8887788888888888777766554432211100000                 0000 000111122356778999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          402 GLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +||+.||++|||++++|.||||..-
T Consensus       279 ~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         279 KMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHcCCChhhCcCHHHHhcCcchhhc
Confidence            9999999999999999999999754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.2e-42  Score=325.38  Aligned_cols=250  Identities=26%  Similarity=0.429  Sum_probs=190.1

Q ss_pred             eeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEec
Q 014117          101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK  176 (430)
Q Consensus       101 ~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~  176 (430)
                      .||+|+||.||++.+..+++.||+|.+....    ........|..++..+..  .++++++.+++.+...+..|+||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMTYAFHTPDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhh--CCCCcEeEEEEEEecCCeEEEEEec
Confidence            4899999999999999999999999886432    112223344444444432  2457899999999999999999999


Q ss_pred             C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccccc
Q 014117          177 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR  255 (430)
Q Consensus       177 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~  255 (430)
                      + +++|.+++...+  .+++..+..++.|++.||.|||+.||+||||||+|||++++                       
T Consensus        79 ~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~-----------------------  133 (279)
T cd05633          79 MNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH-----------------------  133 (279)
T ss_pred             CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC-----------------------
Confidence            9 889999987654  69999999999999999999999999999999999999544                       


Q ss_pred             CCCCCCeEEEeCCCccccCCC-CCeeeecCcccchhhhh-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Q 014117          256 MPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME  333 (430)
Q Consensus       256 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~  333 (430)
                          +.++|+|||++...... .....||..|+|||.+. +..++.++|+|||||++|+|++|..||......... .+.
T Consensus       134 ----~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~  208 (279)
T cd05633         134 ----GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EID  208 (279)
T ss_pred             ----CCEEEccCCcceeccccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHH
Confidence                45666666655432211 12246899999999987 456899999999999999999999999754321110 010


Q ss_pred             HHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCC-
Q 014117          334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL-  412 (430)
Q Consensus       334 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-  412 (430)
                      ......                                             ....++..+.++.++|.+||+.||++|+ 
T Consensus       209 ~~~~~~---------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~  243 (279)
T cd05633         209 RMTLTV---------------------------------------------NVELPDSFSPELKSLLEGLLQRDVSKRLG  243 (279)
T ss_pred             HHhhcC---------------------------------------------CcCCccccCHHHHHHHHHHhcCCHHHhcC
Confidence            000000                                             0112345677899999999999999999 


Q ss_pred             ----CHHHHhcCCCCCCCC
Q 014117          413 ----TAREALRHPFFTRDH  427 (430)
Q Consensus       413 ----ta~elL~hp~f~~~~  427 (430)
                          |++++++||||+...
T Consensus       244 ~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         244 CLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             CCCCCHHHHHhCccccCCC
Confidence                699999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.5e-42  Score=327.18  Aligned_cols=255  Identities=26%  Similarity=0.461  Sum_probs=200.6

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      .+.|+++++||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+.     |+|++++++.+...+.+|
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~   85 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCN-----HPYIVKLLGAFYWDGKLW   85 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCC-----CCcEeeeEEEEEeCCeEE
Confidence            356999999999999999999999999999999986433 33455677888888874     478999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|..++.+.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.+                  
T Consensus        86 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~------------------  146 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD------------------  146 (292)
T ss_pred             EEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC------------------
Confidence            999999 788888776543 468999999999999999999999999999999999999544                  


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhh-----CCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                               +.++|+|||++......   .....++..|+|||++.     ...++.++|+|||||++|+|++|.+||..
T Consensus       147 ---------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  217 (292)
T cd06644         147 ---------GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE  217 (292)
T ss_pred             ---------CCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence                     45666666655432211   12346789999999985     33478899999999999999999999976


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      .+.......+...  ..|.                                            ...+...+.++.+||.+
T Consensus       218 ~~~~~~~~~~~~~--~~~~--------------------------------------------~~~~~~~~~~~~~li~~  251 (292)
T cd06644         218 LNPMRVLLKIAKS--EPPT--------------------------------------------LSQPSKWSMEFRDFLKT  251 (292)
T ss_pred             ccHHHHHHHHhcC--CCcc--------------------------------------------CCCCcccCHHHHHHHHH
Confidence            5543333222111  0000                                            00123455678999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||+.||++||+++++++||||..-
T Consensus       252 ~l~~~p~~Rp~~~~il~~~~~~~~  275 (292)
T cd06644         252 ALDKHPETRPSAAQLLEHPFVSSV  275 (292)
T ss_pred             HhcCCcccCcCHHHHhcCcccccc
Confidence            999999999999999999999854

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=9.7e-42  Score=324.65  Aligned_cols=257  Identities=25%  Similarity=0.427  Sum_probs=200.4

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC---
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---  167 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~---  167 (430)
                      ...++|.+.+.||+|+||.||+|.+..+++.+|+|++............|+.+++++..    |+|++++++.+...   
T Consensus        19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~----h~ni~~~~~~~~~~~~~   94 (291)
T cd06639          19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPN----HPNVVKFYGMFYKADKL   94 (291)
T ss_pred             CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcC----CCCeEEEEEEEEecccc
Confidence            34678999999999999999999999999999999987554445566778888887743    47899999887643   


Q ss_pred             --CeEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          168 --NHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       168 --~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                        +..++||||+ +++|.+++...  ....+++..++.++.|++.||+|||+.||+||||||+||+++            
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~------------  162 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT------------  162 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc------------
Confidence              4689999999 88999988642  234689999999999999999999999999999999999994            


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCC-----CCCCcchHHHHHHHHHHHH
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGCILVELC  314 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGv~l~el~  314 (430)
                                     .++.+||+|||++......   .....|+..|+|||++...     .++.++|||||||++|+|+
T Consensus       163 ---------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~  227 (291)
T cd06639         163 ---------------TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG  227 (291)
T ss_pred             ---------------CCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHh
Confidence                           4455777777766543221   1234688999999998643     3689999999999999999


Q ss_pred             hCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchh
Q 014117          315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG  394 (430)
Q Consensus       315 tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (430)
                      +|++||......+....+...  ..+.                                            ...+...+.
T Consensus       228 ~g~~p~~~~~~~~~~~~~~~~--~~~~--------------------------------------------~~~~~~~~~  261 (291)
T cd06639         228 DGDPPLFDMHPVKTLFKIPRN--PPPT--------------------------------------------LLHPEKWCR  261 (291)
T ss_pred             hCCCCCCCCcHHHHHHHHhcC--CCCC--------------------------------------------CCcccccCH
Confidence            999999865543333222110  0000                                            001123445


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCCCCC
Q 014117          395 DLTHLLQGLLRYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       395 ~~~~ll~~~L~~dP~~R~ta~elL~hp~f~  424 (430)
                      ++.+||.+||+.||++||++.|+++||||+
T Consensus       262 ~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         262 SFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             HHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            799999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-42  Score=327.61  Aligned_cols=255  Identities=21%  Similarity=0.362  Sum_probs=202.7

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      +|++++.||+|+||.||+|.+..+++.||+|.++..  ......+..|+.++.++.     ++|++++++.+...+.+|+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~i~~~~~~~~~~~~~~l   76 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAV-----SPYIVDFYGAFFIEGAVYM   76 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcC-----CCcHHhhhhheecCCeEEE
Confidence            588999999999999999999999999999988642  223456778888888873     4789999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          173 VFEKL-GSSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      ||||+ +++|..++.... ...+++..+..++.||+.||.|||+ .||+||||||+||+++                   
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~-------------------  137 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN-------------------  137 (286)
T ss_pred             EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC-------------------
Confidence            99999 889998887631 2368999999999999999999996 5999999999999994                   


Q ss_pred             CcccccCCCCCCeEEEeCCCccccC-CCCCeeeecCcccchhhhhCC------CCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYER-PDQNYIVSTRHYRAPEVILGL------GWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                              .++.++|+|||.+.... .......|+..|+|||++.+.      .++.++|+|||||++|+|++|..||..
T Consensus       138 --------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  209 (286)
T cd06622         138 --------GNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP  209 (286)
T ss_pred             --------CCCCEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence                    44567777777765432 222334678899999998654      358899999999999999999999976


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      .........+.......+.                                             ..++.++.++.+||.+
T Consensus       210 ~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~li~~  244 (286)
T cd06622         210 ETYANIFAQLSAIVDGDPP---------------------------------------------TLPSGYSDDAQDFVAK  244 (286)
T ss_pred             cchhhHHHHHHHHhhcCCC---------------------------------------------CCCcccCHHHHHHHHH
Confidence            5443333332222211110                                             1233467789999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||+.||++||+++++++||||...
T Consensus       245 ~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         245 CLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             HcccCcccCCCHHHHhcChhhhhc
Confidence            999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.8e-42  Score=321.51  Aligned_cols=257  Identities=25%  Similarity=0.392  Sum_probs=197.1

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-------hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      +|++.+.||.|+||.||+|.+ .+++.+|+|+++...       .....+..|+++++.+.     ++|++++.+++...
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-----HVNIVQYLGTCLDD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-----CCCEeeEeeEeecC
Confidence            478889999999999999986 478889999886321       12244667888888874     47899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +.+++||||+ +++|.+++.+..  .+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++++|||++...
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            9999999999 889999997654  6899999999999999999999999999999999999966555555555544322


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                      ......                  ...........|+..|+|||++.+..++.++|+|||||++|+|++|..||...+..
T Consensus       153 ~~~~~~------------------~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~  214 (265)
T cd06631         153 AWVGLH------------------GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL  214 (265)
T ss_pred             hhcccc------------------ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH
Confidence            110000                  00000112246899999999999988999999999999999999999999865443


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      .....+....+..|                                              ..+...+.++.++|++||+.
T Consensus       215 ~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~i~~~l~~  248 (265)
T cd06631         215 AAMFYIGAHRGLMP----------------------------------------------RLPDSFSAAAIDFVTSCLTR  248 (265)
T ss_pred             HHHHHhhhccCCCC----------------------------------------------CCCCCCCHHHHHHHHHHhcC
Confidence            33322221111111                                              12345677899999999999


Q ss_pred             CCCCCCCHHHHhcCCCC
Q 014117          407 DPTDRLTAREALRHPFF  423 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f  423 (430)
                      ||++|||+.++|+||||
T Consensus       249 ~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         249 DQHERPSALQLLRHDFL  265 (265)
T ss_pred             CcccCCCHHHHhcCCCC
Confidence            99999999999999998

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.6e-42  Score=324.67  Aligned_cols=278  Identities=31%  Similarity=0.525  Sum_probs=211.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ++|++.++||+|+||.||+|.++.+++.||+|++....   ...+.+..|+++++.+.     |++++++++++...+..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR-----HENLVNLIEVFRRKKRL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcC-----CcchhhHHHhcccCCeE
Confidence            36999999999999999999999999999999875322   23345667888888874     47899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||+ +++|..+.....  .+++..+..++.||+.||.|||+.||+|+||+|+||+++                   
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~-------------------  134 (286)
T cd07846          76 YLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS-------------------  134 (286)
T ss_pred             EEEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC-------------------
Confidence            9999999 666766655433  589999999999999999999999999999999999994                   


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                              .++.++|+|||++.......   ....++..|+|||++.+. .++.++|||||||++|||++|.+||...+.
T Consensus       135 --------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~  206 (286)
T cd07846         135 --------QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD  206 (286)
T ss_pred             --------CCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch
Confidence                    44567777777665432221   224678899999998764 478899999999999999999999998887


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+....+....+.+++...........   ..+ ...+..             ... .......+..+..+.+|+.+||+
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~-------------~~~-~~~~~~~~~~~~~~~~li~~~l~  268 (286)
T cd07846         207 IDQLYHIIKCLGNLIPRHQEIFQKNPL---FAG-MRLPEV-------------KEI-EPLEKRFPKLSGLVLDLAKQCLR  268 (286)
T ss_pred             HHHHHHHHHHhCCCchhhHHHhccchH---hhc-cccccc-------------cCc-chHHHhCCCcCHHHHHHHHHHhc
Confidence            777777777777665432221110000   000 000000             000 01112245677889999999999


Q ss_pred             cCCCCCCCHHHHhcCCCC
Q 014117          406 YDPTDRLTAREALRHPFF  423 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f  423 (430)
                      .||++|||+.++++||||
T Consensus       269 ~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         269 IDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             CCcccchhHHHHhcCCCC
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-42  Score=324.15  Aligned_cols=252  Identities=26%  Similarity=0.419  Sum_probs=204.1

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ++|++.+.||.|+||.||+|.+..+++.||+|++....  .....+..|+.+++.+.     |+|++.+.+.+.....+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~   75 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR-----SPYITKYYGSFLKGSKLW   75 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcC-----CCCeeeeeEEEEECCeEE
Confidence            36889999999999999999999999999999986432  23345667888888884     478999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +|+||+ +++|.+++...   .+++..+..++.|++.||.|||+++|+|+||+|+||++++                   
T Consensus        76 ~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~-------------------  133 (274)
T cd06609          76 IIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE-------------------  133 (274)
T ss_pred             EEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC-------------------
Confidence            999999 88999998764   6899999999999999999999999999999999999954                   


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                              ++.++|+|||+++.....   .....|+..|+|||++.+..++.++|||||||++|+|++|..||...+...
T Consensus       134 --------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~  205 (274)
T cd06609         134 --------EGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR  205 (274)
T ss_pred             --------CCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH
Confidence                    455666777766543322   233568889999999999889999999999999999999999997655433


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCC-chhHHHHHHHHhhhc
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGLLRY  406 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~L~~  406 (430)
                      ....+.....+                                                ..... ++.++.+++.+||..
T Consensus       206 ~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~l~~~l~~  237 (274)
T cd06609         206 VLFLIPKNNPP------------------------------------------------SLEGNKFSKPFKDFVSLCLNK  237 (274)
T ss_pred             HHHHhhhcCCC------------------------------------------------CCcccccCHHHHHHHHHHhhC
Confidence            32222211000                                                00111 466799999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      ||++|||++++++||||++...
T Consensus       238 ~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         238 DPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             ChhhCcCHHHHhhChhhcCCCc
Confidence            9999999999999999987643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.1e-42  Score=326.63  Aligned_cols=252  Identities=29%  Similarity=0.458  Sum_probs=203.2

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      .+|++.+.||.|+||.||+|.+..+++.||+|.+.... .....+..|+.+++.+.     |+|++.+++++...+.+|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK-----NPNIVNFLDSFLVGDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcC-----CCceeeeeeeEecCceEEE
Confidence            56999999999999999999999999999999886432 23455677888888874     4789999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      |+||+ +++|.+++...   .+++..+..++.|++.||.|||++||+||||||+||+++.+                   
T Consensus        94 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~-------------------  151 (296)
T cd06655          94 VMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD-------------------  151 (296)
T ss_pred             EEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-------------------
Confidence            99999 88999988653   58999999999999999999999999999999999999544                   


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                              +.++|+|||++.......   ....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+....
T Consensus       152 --------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~  223 (296)
T cd06655         152 --------GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA  223 (296)
T ss_pred             --------CCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                    456666666554322221   224678899999999988899999999999999999999999987665443


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      ...+...  ..+.                                            ...+...+..+.+||.+||+.||
T Consensus       224 ~~~~~~~--~~~~--------------------------------------------~~~~~~~~~~~~~li~~~l~~dp  257 (296)
T cd06655         224 LYLIATN--GTPE--------------------------------------------LQNPEKLSPIFRDFLNRCLEMDV  257 (296)
T ss_pred             HHHHHhc--CCcc--------------------------------------------cCCcccCCHHHHHHHHHHhhcCh
Confidence            3322111  0000                                            01123456679999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCC
Q 014117          409 TDRLTAREALRHPFFTRD  426 (430)
Q Consensus       409 ~~R~ta~elL~hp~f~~~  426 (430)
                      ++|||+.+++.||||+..
T Consensus       258 ~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         258 EKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             hhCCCHHHHhhChHhhhc
Confidence            999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=9.5e-42  Score=323.68  Aligned_cols=257  Identities=24%  Similarity=0.424  Sum_probs=199.6

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee-----
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-----  164 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-----  164 (430)
                      ....++|++.+.||+|+||.||+|.+..+++.+|+|+++........+..|+.++..+..    |+|++++++++     
T Consensus        14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~----h~~i~~~~~~~~~~~~   89 (286)
T cd06638          14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSD----HPNVVKFYGMYYKKDV   89 (286)
T ss_pred             CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhc----CCCeeeeeeeeeeccc
Confidence            345678999999999999999999999999999999987544444567778888888853    37899998876     


Q ss_pred             ecCCeEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          165 DYRNHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       165 ~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      ...+.+++||||+ +++|.+++...  ....+++..+..++.|++.||.|||+.+|+||||||+||+++.          
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~----------  159 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTT----------  159 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECC----------
Confidence            3456899999999 88999987632  2246889999999999999999999999999999999999954          


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhC-----CCCCCcchHHHHHHHHHHH
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVEL  313 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~el  313 (430)
                                       .+.++|+|||++......   .....||+.|+|||++..     ..++.++|||||||++|+|
T Consensus       160 -----------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el  222 (286)
T cd06638         160 -----------------EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL  222 (286)
T ss_pred             -----------------CCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHH
Confidence                             445677777766543221   123468999999999853     4588999999999999999


Q ss_pred             HhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCch
Q 014117          314 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA  393 (430)
Q Consensus       314 ~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (430)
                      ++|..||...........+...   .+                      +.                     ...+...+
T Consensus       223 ~~g~~p~~~~~~~~~~~~~~~~---~~----------------------~~---------------------~~~~~~~~  256 (286)
T cd06638         223 GDGDPPLADLHPMRALFKIPRN---PP----------------------PT---------------------LHQPELWS  256 (286)
T ss_pred             hcCCCCCCCCchhHHHhhcccc---CC----------------------Cc---------------------ccCCCCcC
Confidence            9999999765433322111100   00                      00                     00122345


Q ss_pred             hHHHHHHHHhhhcCCCCCCCHHHHhcCCCC
Q 014117          394 GDLTHLLQGLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       394 ~~~~~ll~~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      .++.+||.+||+.||++|||+.|+|+|+||
T Consensus       257 ~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         257 NEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            679999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.5e-42  Score=328.89  Aligned_cols=253  Identities=27%  Similarity=0.436  Sum_probs=201.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ..+|.+++.||.|+||.||+|.+..+++.||+|.+.... ...+.+..|+.+++.+     .|+|++.+++.+...+..|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-----KNPNIVNYLDSYLVGDELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-----CCCCEeeEEEEEecCCEEE
Confidence            468999999999999999999999999999999986432 2334566788888776     4478999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|.+++...   .+++..+..++.|++.||.|||+.||+||||||+|||++.+                  
T Consensus        93 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~------------------  151 (297)
T cd06656          93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD------------------  151 (297)
T ss_pred             EeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC------------------
Confidence            999999 88999998653   58999999999999999999999999999999999999544                  


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                               +.++|+|||++.......   ....|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+...
T Consensus       152 ---------~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~  222 (297)
T cd06656         152 ---------GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR  222 (297)
T ss_pred             ---------CCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch
Confidence                     456666666554322221   23467899999999999889999999999999999999999997644322


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+.. .+..+                                             ...+...+..+.+|+.+||+.|
T Consensus       223 ~~~~~~~-~~~~~---------------------------------------------~~~~~~~~~~~~~li~~~l~~~  256 (297)
T cd06656         223 ALYLIAT-NGTPE---------------------------------------------LQNPERLSAVFRDFLNRCLEMD  256 (297)
T ss_pred             heeeecc-CCCCC---------------------------------------------CCCccccCHHHHHHHHHHccCC
Confidence            2111100 00000                                             0012344567899999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~  426 (430)
                      |++|||++++++||||...
T Consensus       257 p~~Rps~~~il~~~~~~~~  275 (297)
T cd06656         257 VDRRGSAKELLQHPFLKLA  275 (297)
T ss_pred             hhhCcCHHHHhcCchhccc
Confidence            9999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.3e-41  Score=326.17  Aligned_cols=270  Identities=25%  Similarity=0.402  Sum_probs=203.7

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+....    .....+..|+++++.+.     ++||+++++.+...++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~i~~~~~~~~~~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-----NPFVVSMFCSFETKRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-----CCCeeeeEEEEecCCE
Confidence            36899999999999999999999999999999986432    22345567788777763     4789999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|+||||+ |++|.+++...+  .+++..+..++.|++.||.|||++||+||||||+||+++..+.++++|||++.....
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            99999999 889999997764  789999999999999999999999999999999999997777666666665532111


Q ss_pred             CCcccccCCCCCCeEEEeCCCccc-cCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTY-ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                      ...          ..+.+...... .........|+..|+|||.+.+..++.++|+|||||++|||++|..||.+.+..+
T Consensus       154 ~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~  223 (305)
T cd05609         154 SLT----------TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE  223 (305)
T ss_pred             Ccc----------ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            000          00000000000 0000112357889999999998889999999999999999999999998765544


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+......                       ++.                       .....+.++.++|.+||+.|
T Consensus       224 ~~~~~~~~~~~-----------------------~~~-----------------------~~~~~~~~~~~li~~~l~~~  257 (305)
T cd05609         224 LFGQVISDDIE-----------------------WPE-----------------------GDEALPADAQDLISRLLRQN  257 (305)
T ss_pred             HHHHHHhcccC-----------------------CCC-----------------------ccccCCHHHHHHHHHHhccC
Confidence            33332221111                       110                       01235677999999999999


Q ss_pred             CCCCCC---HHHHhcCCCCCCC
Q 014117          408 PTDRLT---AREALRHPFFTRD  426 (430)
Q Consensus       408 P~~R~t---a~elL~hp~f~~~  426 (430)
                      |++|||   +.++|+||||...
T Consensus       258 P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         258 PLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             hhhccCccCHHHHHhCccccCC
Confidence            999997   7999999999654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.1e-41  Score=317.78  Aligned_cols=249  Identities=27%  Similarity=0.449  Sum_probs=203.7

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +|++.+.||+|+||.||++.+..+++.||+|.+...   ......+..|+.+++.+.     +++++++++++...++.|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK-----HPNIVQYQESFEENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCC-----CCCeeeeEeeecCCCeEE
Confidence            589999999999999999999999999999998632   233456778888888884     478999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+|||++.                   
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~-------------------  136 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK-------------------  136 (256)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC-------------------
Confidence            999999 889999998755456899999999999999999999999999999999999944                   


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                              +..++|+|||.+.......   ....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+
T Consensus       137 --------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~  208 (256)
T cd08218         137 --------DGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN  208 (256)
T ss_pred             --------CCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH
Confidence                    4456777777665432221   22457889999999998889999999999999999999999998655544


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+..  +..+                                              ..+...+.++.++|.+||+.+
T Consensus       209 ~~~~~~~--~~~~----------------------------------------------~~~~~~~~~~~~li~~~l~~~  240 (256)
T cd08218         209 LVLKIIR--GSYP----------------------------------------------PVSSHYSYDLRNLVSQLFKRN  240 (256)
T ss_pred             HHHHHhc--CCCC----------------------------------------------CCcccCCHHHHHHHHHHhhCC
Confidence            3332211  1110                                              112345677999999999999


Q ss_pred             CCCCCCHHHHhcCCCC
Q 014117          408 PTDRLTAREALRHPFF  423 (430)
Q Consensus       408 P~~R~ta~elL~hp~f  423 (430)
                      |++||++.++|+||||
T Consensus       241 p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         241 PRDRPSVNSILEKNFI  256 (256)
T ss_pred             hhhCcCHHHHhhCcCC
Confidence            9999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7e-42  Score=323.98  Aligned_cols=257  Identities=23%  Similarity=0.428  Sum_probs=197.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ++|++.+.||+|+||.||+|.++.+++.||+|.++...  ........|+.++.+.    .+++|++++++++...+.+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~----~~~~~iv~~~~~~~~~~~~~   76 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS----VDCPYTVTFYGALFREGDVW   76 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHH----cCCCCeeeeeEEEecCCcEE
Confidence            36899999999999999999999999999999987432  2233444555554433    24588999999999999999


Q ss_pred             EEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          172 IVFEKLGSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       172 lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +||||+.++|.+++...  ....+++..+..++.||+.||.|||++ +|+||||||+|||++.                 
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~-----------------  139 (283)
T cd06617          77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR-----------------  139 (283)
T ss_pred             EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC-----------------
Confidence            99999988998888653  224689999999999999999999997 9999999999999944                 


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhC----CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILG----LGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                ++.+||+|||.+......  .....|+..|+|||++.+    ..++.++|+|||||++|+|++|..||..
T Consensus       140 ----------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  209 (283)
T cd06617         140 ----------NGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS  209 (283)
T ss_pred             ----------CCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence                      456677777766543221  122468899999998865    4578999999999999999999999964


Q ss_pred             Cc-hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          323 HE-NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       323 ~~-~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      .. ..+....+..  +..+                    ..+                         ...++.++.+||.
T Consensus       210 ~~~~~~~~~~~~~--~~~~--------------------~~~-------------------------~~~~~~~l~~li~  242 (283)
T cd06617         210 WKTPFQQLKQVVE--EPSP--------------------QLP-------------------------AEKFSPEFQDFVN  242 (283)
T ss_pred             cccCHHHHHHHHh--cCCC--------------------CCC-------------------------ccccCHHHHHHHH
Confidence            22 2222221111  0000                    000                         1234678999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCCCCCCCCC
Q 014117          402 GLLRYDPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      +||..+|++|||+.++++||||.....
T Consensus       243 ~~l~~~p~~Rp~~~~il~~~~~~~~~~  269 (283)
T cd06617         243 KCLKKNYKERPNYPELLQHPFFELHLS  269 (283)
T ss_pred             HHccCChhhCcCHHHHhcCchhhhccc
Confidence            999999999999999999999987754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.3e-42  Score=319.23  Aligned_cols=250  Identities=26%  Similarity=0.457  Sum_probs=202.1

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      ++|++.+.||.|+||.||+|....+++.||+|.++.... .+.+..|+++++++     .+++++++++.+......|++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQC-----DSPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhC-----CCCcEeeeeeeeecCCcEEEE
Confidence            569999999999999999999998899999999875433 56788899988888     448899999999999999999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      +||+ +++|.+++.... ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++++                    
T Consensus        77 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~--------------------  135 (256)
T cd06612          77 MEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE--------------------  135 (256)
T ss_pred             EecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC--------------------
Confidence            9999 789999987644 478999999999999999999999999999999999999544                    


Q ss_pred             cccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL  329 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~  329 (430)
                             +.++|+|||++......   .....|+..|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus       136 -------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~  208 (256)
T cd06612         136 -------GQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI  208 (256)
T ss_pred             -------CcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh
Confidence                   45666666665533221   12345788999999999989999999999999999999999999865443222


Q ss_pred             HHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCC
Q 014117          330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT  409 (430)
Q Consensus       330 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~  409 (430)
                      ..+..   ..+.                                           ....+...+.++.++|.+||+.||+
T Consensus       209 ~~~~~---~~~~-------------------------------------------~~~~~~~~~~~~~~~i~~~l~~~P~  242 (256)
T cd06612         209 FMIPN---KPPP-------------------------------------------TLSDPEKWSPEFNDFVKKCLVKDPE  242 (256)
T ss_pred             hhhcc---CCCC-------------------------------------------CCCchhhcCHHHHHHHHHHHhcChh
Confidence            11100   0000                                           0001223456799999999999999


Q ss_pred             CCCCHHHHhcCCCC
Q 014117          410 DRLTAREALRHPFF  423 (430)
Q Consensus       410 ~R~ta~elL~hp~f  423 (430)
                      +|||+.|+|.||||
T Consensus       243 ~Rps~~~il~~~~~  256 (256)
T cd06612         243 ERPSAIQLLQHPFI  256 (256)
T ss_pred             hCcCHHHHhcCCCC
Confidence            99999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.5e-42  Score=333.11  Aligned_cols=299  Identities=25%  Similarity=0.425  Sum_probs=219.4

Q ss_pred             ecCcEEE-EeeeccccceEEEEEEECCCCeEEEEEEecCchhhH---------------HHHHHHHHHHHHHHhcCCCCC
Q 014117           92 LTSRYKI-HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR---------------EAAMIEIEVLQQLAKHDKGGN  155 (430)
Q Consensus        92 ~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~---------------~~~~~E~~~l~~l~~~~~~~~  155 (430)
                      +.++|.. .+.||.|+||+||+|.+..+++.||+|+++......               .....|++++..+.     |+
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~   80 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-----HE   80 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-----Cc
Confidence            3456765 467999999999999999999999999986432111               13567888888884     47


Q ss_pred             ceEEecceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCcc
Q 014117          156 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI  235 (430)
Q Consensus       156 ~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~  235 (430)
                      |++.+++++...+..|+||||+.++|.+++....  .+++..+..++.||+.||+|||+.||+|+||||+||+++.++.+
T Consensus        81 ~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         81 NIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             ceeeeeEEEecCCcEEEEEeccccCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence            8999999999999999999999889999987654  68999999999999999999999999999999999999888777


Q ss_pred             ccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHH
Q 014117          236 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELC  314 (430)
Q Consensus       236 ~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~  314 (430)
                      +++|||++............        -.+.+..  .........++..|+|||.+.+. .++.++|+|||||++|+|+
T Consensus       159 kl~dfg~~~~~~~~~~~~~~--------~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~  228 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTL--------SKDETMQ--RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL  228 (335)
T ss_pred             EECCccceeecccccccccc--------ccccccc--ccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHH
Confidence            77777766543221100000        0000000  00111123568899999998764 4789999999999999999


Q ss_pred             hCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchh
Q 014117          315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG  394 (430)
Q Consensus       315 tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (430)
                      +|.+||.+.++.+.+..+...++.++...++........        .+....             ............+.
T Consensus       229 tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--------~~~~~~-------------~~~~~~~~~~~~~~  287 (335)
T PTZ00024        229 TGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLY--------TEFTPR-------------KPKDLKTIFPNASD  287 (335)
T ss_pred             hCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccc--------cccCcC-------------CcccHHHhCcCCCh
Confidence            999999998888888888887777665432211100000        000000             00011122345577


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCCC
Q 014117          395 DLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       395 ~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      ++.++|.+||+.||++|||++|+|.||||+....
T Consensus       288 ~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~  321 (335)
T PTZ00024        288 DAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL  321 (335)
T ss_pred             HHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence            8999999999999999999999999999997754

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-42  Score=319.79  Aligned_cols=248  Identities=25%  Similarity=0.453  Sum_probs=193.2

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCchhhH----HHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      +.||.|+||.||+|.+..+++.||+|+++......    .....|..++..    ...++|++++++.+...+.+|+|||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~----~~~~~~i~~~~~~~~~~~~~~lv~e   77 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMI----QGESPYVAKLYYSFQSKDYLYLVME   77 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhh----cCCCCCeeeeeeeEEcCCeEEEEEe
Confidence            56899999999999999999999999986432211    112223332222    2255889999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccc
Q 014117          176 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK  254 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~  254 (430)
                      |+ +++|.+++....  .+++..+..++.||+.||.|||+.+|+|+||+|+||+++                        
T Consensus        78 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~------------------------  131 (260)
T cd05611          78 YLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID------------------------  131 (260)
T ss_pred             ccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC------------------------
Confidence            99 889999997654  689999999999999999999999999999999999994                        


Q ss_pred             cCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHH
Q 014117          255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER  334 (430)
Q Consensus       255 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~  334 (430)
                         ..+.++|+|||++..... .....|+..|+|||.+.+..++.++||||||+++|+|++|.+||...+..+....+..
T Consensus       132 ---~~~~~~l~dfg~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  207 (260)
T cd05611         132 ---QTGHLKLTDFGLSRNGLE-NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS  207 (260)
T ss_pred             ---CCCcEEEeecccceeccc-cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence               445677777776654332 2334688999999999988899999999999999999999999987655443332221


Q ss_pred             HhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCC-
Q 014117          335 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT-  413 (430)
Q Consensus       335 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-  413 (430)
                      .                       ...++.                      ......+.++.++|.+||+.||++||| 
T Consensus       208 ~-----------------------~~~~~~----------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~  242 (260)
T cd05611         208 R-----------------------RINWPE----------------------EVKEFCSPEAVDLINRLLCMDPAKRLGA  242 (260)
T ss_pred             c-----------------------ccCCCC----------------------cccccCCHHHHHHHHHHccCCHHHccCC
Confidence            1                       111111                      011245678999999999999999995 


Q ss_pred             --HHHHhcCCCCCCC
Q 014117          414 --AREALRHPFFTRD  426 (430)
Q Consensus       414 --a~elL~hp~f~~~  426 (430)
                        ++|+|.||||++.
T Consensus       243 ~~~~~~l~~~~~~~~  257 (260)
T cd05611         243 NGYQEIKSHPFFKSI  257 (260)
T ss_pred             CcHHHHHcChHhhcC
Confidence              5799999999865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.4e-41  Score=327.67  Aligned_cols=281  Identities=27%  Similarity=0.500  Sum_probs=221.2

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-C
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-R  167 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-~  167 (430)
                      +.++|++.+.||.|+||.||+|.+..+++.||+|.+...   .........|++++..+.     |+|++++.+++.. .
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~~~~~~~~~~   82 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR-----HENIISLSDIFISPL   82 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcC-----CCCeeeEeeeEecCC
Confidence            567899999999999999999999999999999987532   223355667899988884     4889999998865 5


Q ss_pred             CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          168 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       168 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      ...|+||||++++|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||++                 
T Consensus        83 ~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~-----------------  142 (328)
T cd07856          83 EDIYFVTELLGTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN-----------------  142 (328)
T ss_pred             CcEEEEeehhccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC-----------------
Confidence            689999999988999888643   588999999999999999999999999999999999994                 


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                                ..+.++|+|||.+...........++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||......
T Consensus       143 ----------~~~~~~l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~  212 (328)
T cd07856         143 ----------ENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV  212 (328)
T ss_pred             ----------CCCCEEeCccccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence                      4456677777766544333344567889999998766 56899999999999999999999999988888


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhh-hhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRH-AEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .....+.+.+|.+|+++...+... ...+........+                   .......+..+.++.++|.+||+
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~li~~~l~  273 (328)
T cd07856         213 NQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREP-------------------VPFSEKFKNADPSAIDLLEKMLV  273 (328)
T ss_pred             HHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCC-------------------CcHHHHcCCCCHHHHHHHHHHcC
Confidence            888888899999988776543211 1111111000000                   00011224567789999999999


Q ss_pred             cCCCCCCCHHHHhcCCCCCCC
Q 014117          406 YDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f~~~  426 (430)
                      .||++|||+++++.||||...
T Consensus       274 ~~P~~R~t~~ell~~~~~~~~  294 (328)
T cd07856         274 FDPQKRISAAEALAHPYLAPY  294 (328)
T ss_pred             CChhhCCCHHHHhcCCccccc
Confidence            999999999999999999754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.8e-41  Score=329.07  Aligned_cols=288  Identities=26%  Similarity=0.424  Sum_probs=215.2

Q ss_pred             cEEEEeeeccccceEEEEEEECCC--CeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee----
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRER--KEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD----  165 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~--~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~----  165 (430)
                      +|.+.+.||+|+||.||+|.+..+  +..||+|.+...   .........|+.+++++.+    |+||+++++...    
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~----h~~iv~~~~~~~~~~~   76 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG----HKNITCLYDMDIVFPG   76 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcC----CCChheeeeeeeeccc
Confidence            488999999999999999999888  889999998632   1223456778888888743    467888877532    


Q ss_pred             cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          166 YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       166 ~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      ....+|+++++++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus        77 ~~~~~~~~~e~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          77 NFNELYLYEELMEADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             cCCcEEEEEecccCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            23568999999988999998754  3799999999999999999999999999999999999996655555555554432


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                      ......                    ..........||..|+|||++.+ ..++.++|+|||||++|+|++|.+||...+
T Consensus       155 ~~~~~~--------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~  214 (332)
T cd07857         155 FSENPG--------------------ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD  214 (332)
T ss_pred             cccccc--------------------cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence            211000                    00001123478999999998876 468999999999999999999999999988


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+.+..+...+|.++...+..+...............+.              .    ......+..+.++.+|+.+||
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~----~~~~~~~~~~~~~~~li~~~l  276 (332)
T cd07857         215 YVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPK--------------K----PFESIFPNANPLALDLLEKLL  276 (332)
T ss_pred             HHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCC--------------c----chHhhCCCCCHHHHHHHHHHc
Confidence            8889999999999888776655433222111110000000              0    011122345678999999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +.||++|||+.|++.||||+.-
T Consensus       277 ~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         277 AFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             cCCcccCCCHHHHhcChhhhhh
Confidence            9999999999999999999744

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.3e-41  Score=317.04  Aligned_cols=250  Identities=26%  Similarity=0.397  Sum_probs=204.6

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+...   ......+..|+++++++.     +++++++++.+...+..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~i~~~~~~~~~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS-----HPNIIEYYENFLEDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCC-----CCchhheeeeEecCCEEE
Confidence            589999999999999999999999999999998643   223456778899888884     478999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++.+                  
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~------------------  137 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH------------------  137 (256)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC------------------
Confidence            999999 8899999987655578999999999999999999999999999999999999532                  


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                              +..++|+|||.+.......  ....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+....
T Consensus       138 --------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~  209 (256)
T cd08220         138 --------KMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL  209 (256)
T ss_pred             --------CCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH
Confidence                    3346777777766443222  234688999999999988899999999999999999999999987654443


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      ...+....                                                ....++..+.++.+++.+||+.||
T Consensus       210 ~~~~~~~~------------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p  241 (256)
T cd08220         210 VLKIMSGT------------------------------------------------FAPISDRYSPDLRQLILSMLNLDP  241 (256)
T ss_pred             HHHHHhcC------------------------------------------------CCCCCCCcCHHHHHHHHHHccCCh
Confidence            33221100                                                001123456789999999999999


Q ss_pred             CCCCCHHHHhcCCCC
Q 014117          409 TDRLTAREALRHPFF  423 (430)
Q Consensus       409 ~~R~ta~elL~hp~f  423 (430)
                      ++|||+.|+++||||
T Consensus       242 ~~Rpt~~~ll~~p~~  256 (256)
T cd08220         242 SKRPQLSQIMAQPIC  256 (256)
T ss_pred             hhCCCHHHHhhCCCC
Confidence            999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-42  Score=332.84  Aligned_cols=279  Identities=29%  Similarity=0.507  Sum_probs=218.9

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC---
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN---  168 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~---  168 (430)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+...   ....+.+..|+.+++.+.     +++++.+.+++....   
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~   75 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR-----HENIIGLLDILRPPSPED   75 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC-----CcchhhhhhhhcccCccc
Confidence            589999999999999999999999999999998643   223456778899988884     478999999887765   


Q ss_pred             --eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          169 --HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       169 --~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                        .+|+||||++++|.+++....  .+++..+..++.||+.||.|||+.||+||||||+|||++.+              
T Consensus        76 ~~~~~lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~--------------  139 (330)
T cd07834          76 FNDVYIVTELMETDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN--------------  139 (330)
T ss_pred             ccceEEEecchhhhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC--------------
Confidence              899999999889999987654  79999999999999999999999999999999999999554              


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCC------CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEAL  319 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~P  319 (430)
                                   +.++|+|||.+......      .....+|..|+|||++.+. .++.++|+|||||++|+|++|.+|
T Consensus       140 -------------~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~p  206 (330)
T cd07834         140 -------------CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPL  206 (330)
T ss_pred             -------------CCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCC
Confidence                         45555566555433222      1224678999999999887 799999999999999999999999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHH-hhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      |.+.+..+....+....+.++...+.... .....++...                  .... ........+..+.++.+
T Consensus       207 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~-~~~~~~~~~~~~~~~~~  267 (330)
T cd07834         207 FPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSL------------------PKKP-KKPLSKLFPGASPEAID  267 (330)
T ss_pred             cCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhc------------------ccCC-cchhHHhcccCCHHHHH
Confidence            99988888888888888888766544211 1111111100                  0000 00112233457888999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          399 LLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||..||++||++|||+++++.||||++-
T Consensus       268 li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         268 LLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             HHHHHccCChhhCCCHHHHHhCccHHhh
Confidence            9999999999999999999999999753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-42  Score=338.07  Aligned_cols=253  Identities=25%  Similarity=0.391  Sum_probs=213.8

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .-.+.|.+.++||+|.|+.|.+|++..++..||||++.+..   .......+|+++++.+     +||||++++.+++..
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-----~HPnIvkl~~v~~t~  127 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-----NHPNIVKLFSVIETE  127 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-----CCcceeeeeeeeeec
Confidence            34567999999999999999999999999999999997543   2334477899999998     559999999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      ..+|+||||+ +|.++++|.+.+  ++.+..++.++.|+.+|++|||+++|||||||++||||                 
T Consensus       128 ~~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL-----------------  188 (596)
T KOG0586|consen  128 ATLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL-----------------  188 (596)
T ss_pred             ceeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc-----------------
Confidence            9999999999 999999999987  67779999999999999999999999999999999999                 


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCC-CcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                +.+.++||+|||++.......  .+.||++.|+|||+..+..|+ +.+|+||+|+++|-|++|.+||++.
T Consensus       189 ----------~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~  258 (596)
T KOG0586|consen  189 ----------DENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ  258 (596)
T ss_pred             ----------ccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence                      667778999999887655433  567999999999999999875 8899999999999999999999975


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +-.+.-...                       ..|++.                          .+--.+.++.+||+++
T Consensus       259 ~lk~Lr~rv-----------------------l~gk~r--------------------------Ip~~ms~dce~lLrk~  289 (596)
T KOG0586|consen  259 NLKELRPRV-----------------------LRGKYR--------------------------IPFYMSCDCEDLLRKF  289 (596)
T ss_pred             ccccccchh-----------------------eeeeec--------------------------ccceeechhHHHHHHh
Confidence            543321111                       111111                          1223456799999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      |.++|.+|++.+++..|.|....
T Consensus       290 lvl~Pskr~~~dqim~~~W~n~~  312 (596)
T KOG0586|consen  290 LVLNPSKRGPCDQIMKDRWRNDL  312 (596)
T ss_pred             hccCccccCCHHHhhhhcccchh
Confidence            99999999999999999998754

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-42  Score=321.63  Aligned_cols=255  Identities=24%  Similarity=0.415  Sum_probs=200.0

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC----
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR----  167 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~----  167 (430)
                      ..++|++.+.||.|+||.||+|.++.+++.+|+|++.........+..|+.+++++..    |+|++++++++...    
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~----h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSN----HPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcC----CCChheEEEEEEecCCCC
Confidence            3578999999999999999999999999999999987655555677889999888843    47899999988653    


Q ss_pred             --CeEEEEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          168 --NHICIVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       168 --~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                        ..+|+||||+ +++|.+++....  ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.           
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~-----------  148 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTK-----------  148 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEcc-----------
Confidence              4599999999 789999887533  357899999999999999999999999999999999999954           


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCC-----CCCCcchHHHHHHHHHHHH
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGCILVELC  314 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGv~l~el~  314 (430)
                                      ++.++|+|||.+......   .....|+..|+|||++...     .++.++|||||||++|+|+
T Consensus       149 ----------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~  212 (275)
T cd06608         149 ----------------NAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA  212 (275)
T ss_pred             ----------------CCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHH
Confidence                            445666666665432211   1234689999999998642     4778999999999999999


Q ss_pred             hCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchh
Q 014117          315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG  394 (430)
Q Consensus       315 tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (430)
                      +|.+||...........+...   .+..                                           ...+...+.
T Consensus       213 ~g~~p~~~~~~~~~~~~~~~~---~~~~-------------------------------------------~~~~~~~~~  246 (275)
T cd06608         213 DGKPPLCDMHPMRALFKIPRN---PPPT-------------------------------------------LKSPENWSK  246 (275)
T ss_pred             hCCCCccccchHHHHHHhhcc---CCCC-------------------------------------------CCchhhcCH
Confidence            999999765443333222110   0000                                           001123456


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCCCC
Q 014117          395 DLTHLLQGLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       395 ~~~~ll~~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      ++.+||.+||..||++|||+.|+++|||+
T Consensus       247 ~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         247 KFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             HHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            79999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.5e-42  Score=323.40  Aligned_cols=251  Identities=24%  Similarity=0.405  Sum_probs=195.8

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++... ........|+.+++.+     .|++++++++.+...+.+|+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-----~h~~ii~~~~~~~~~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-----KHSNIVAYFGSYLRRDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-----CCCCeeeEEEEEEeCCEEEE
Confidence            47889999999999999999999999999999987432 2234456788887777     34889999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+ +++|.+++...+  .+++..+..++.|++.||.|||+.||+|+||||+||+++.+                   
T Consensus        84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-------------------  142 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDN-------------------  142 (267)
T ss_pred             EEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-------------------
Confidence            99999 789999987664  79999999999999999999999999999999999999544                   


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhh---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                              +.++|+|||++......   .....||..|+|||++.   ...++.++|+|||||++|+|++|.+||.....
T Consensus       143 --------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~  214 (267)
T cd06645         143 --------GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP  214 (267)
T ss_pred             --------CCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence                    45666666655432211   12347899999999985   44688999999999999999999999965443


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      ......+... ...+.                      .                     ......++..+.++|.+||+
T Consensus       215 ~~~~~~~~~~-~~~~~----------------------~---------------------~~~~~~~~~~~~~li~~~l~  250 (267)
T cd06645         215 MRALFLMTKS-NFQPP----------------------K---------------------LKDKMKWSNSFHHFVKMALT  250 (267)
T ss_pred             hhhHHhhhcc-CCCCC----------------------c---------------------ccccCCCCHHHHHHHHHHcc
Confidence            2222111100 00000                      0                     00011345678999999999


Q ss_pred             cCCCCCCCHHHHhcCCC
Q 014117          406 YDPTDRLTAREALRHPF  422 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~  422 (430)
                      .||++|||++++++|||
T Consensus       251 ~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         251 KNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CCchhCcCHHHHhcCCC
Confidence            99999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.6e-42  Score=322.01  Aligned_cols=252  Identities=23%  Similarity=0.380  Sum_probs=195.6

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.... ........|+.++.++     .|++++++++.+...+.++
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-----~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-----KHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-----CCCCeeeeeEEEEeCCEEE
Confidence            357999999999999999999999999999999986432 2334566788888877     4478999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|.+++....  .+++..+..++.|++.||.|||+.||+||||||+||+++.+                  
T Consensus        83 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~------------------  142 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN------------------  142 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC------------------
Confidence            999999 789999987654  78999999999999999999999999999999999999544                  


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhh---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                               +.++|+|||++......   .....|+..|+|||.+.   ...++.++|+|||||++|||++|..||....
T Consensus       143 ---------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~  213 (267)
T cd06646         143 ---------GDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH  213 (267)
T ss_pred             ---------CCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence                     44666666655433211   12346889999999985   3457889999999999999999999996543


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+....+..                       ..+..+.                     .......+..+.+||++||
T Consensus       214 ~~~~~~~~~~-----------------------~~~~~~~---------------------~~~~~~~~~~~~~li~~~l  249 (267)
T cd06646         214 PMRALFLMSK-----------------------SNFQPPK---------------------LKDKTKWSSTFHNFVKISL  249 (267)
T ss_pred             hhhhheeeec-----------------------CCCCCCC---------------------CccccccCHHHHHHHHHHh
Confidence            3221111100                       0000000                     0001234668999999999


Q ss_pred             hcCCCCCCCHHHHhcCCC
Q 014117          405 RYDPTDRLTAREALRHPF  422 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~  422 (430)
                      +.||++|||++++|+|+|
T Consensus       250 ~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         250 TKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             hCChhhCcCHHHHhcCCC
Confidence            999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-41  Score=320.10  Aligned_cols=256  Identities=27%  Similarity=0.413  Sum_probs=198.4

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----------hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      +|.+...||.|+||.||+|.+..+++.||+|.+....          ...+.+..|+.++.++.     |++++++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~   75 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-----HENIVQYLGSS   75 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-----CCCeeeEEEEE
Confidence            4778899999999999999999899999999885321          11234667888888884     47899999999


Q ss_pred             ecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCC
Q 014117          165 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       165 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                      ...+..++||||+ +++|.+++...+  .+++..+..++.|++.||+|||+.||+||||||+||+++.++.++++|||.+
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          76 LDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             EeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCC
Confidence            9999999999999 889999997754  6899999999999999999999999999999999999966665555555544


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                      .........                  ...........|+..|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus       154 ~~~~~~~~~------------------~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  215 (267)
T cd06628         154 KKLEANSLS------------------TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC  215 (267)
T ss_pred             ccccccccc------------------CCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence            322111000                  00000112245788999999999888999999999999999999999999875


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +.......+...  .                                              ....+...+.++.++|++|
T Consensus       216 ~~~~~~~~~~~~--~----------------------------------------------~~~~~~~~~~~~~~li~~~  247 (267)
T cd06628         216 TQLQAIFKIGEN--A----------------------------------------------SPEIPSNISSEAIDFLEKT  247 (267)
T ss_pred             cHHHHHHHHhcc--C----------------------------------------------CCcCCcccCHHHHHHHHHH
Confidence            443322221110  0                                              0012234567899999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f  423 (430)
                      |+.||.+||++.|+++||||
T Consensus       248 l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         248 FEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ccCCchhCcCHHHHhhCCCC
Confidence            99999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.6e-41  Score=329.33  Aligned_cols=279  Identities=26%  Similarity=0.440  Sum_probs=205.5

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC----
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR----  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~----  167 (430)
                      .++|.+.+.||.|+||.||+|.++.+++.||+|.+.... ........|+++++.+.     +++++++++.+...    
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~-----h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD-----HDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcC-----CCcchhhHhhhccccccc
Confidence            468999999999999999999999999999999986433 33355677899998884     37788888765543    


Q ss_pred             ----------CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCcccc
Q 014117          168 ----------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV  237 (430)
Q Consensus       168 ----------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i  237 (430)
                                ...|+||||++++|.+++...   .+++..++.++.||+.||.|||+.||+||||||+||+++.+     
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~-----  150 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYMETDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTE-----  150 (342)
T ss_pred             ccccccccccceEEEEeecccccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC-----
Confidence                      468999999988998888643   68999999999999999999999999999999999999532     


Q ss_pred             CCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC------CCeeeecCcccchhhhhC-CCCCCcchHHHHHHHH
Q 014117          238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCIL  310 (430)
Q Consensus       238 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l  310 (430)
                                           +..++|+|||.+......      .....|+..|+|||.+.+ ..++.++|||||||++
T Consensus       151 ---------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil  209 (342)
T cd07854         151 ---------------------DLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF  209 (342)
T ss_pred             ---------------------CceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHH
Confidence                                 234566666655432111      112357889999998765 4688999999999999


Q ss_pred             HHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcC
Q 014117          311 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD  390 (430)
Q Consensus       311 ~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  390 (430)
                      |+|++|..||...+..+....+..........................  .+.                 ..........
T Consensus       210 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-----------------~~~~~~~~~~  270 (342)
T cd07854         210 AEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRND--GGE-----------------PRRPLRDLLP  270 (342)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhc--ccc-----------------cCCCHHHHcc
Confidence            999999999988777666665555444333322221111111111000  000                 0000111234


Q ss_pred             CchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCC
Q 014117          391 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       391 ~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~  424 (430)
                      ..+.++.+||.+||+.||++|||+.++|.||||+
T Consensus       271 ~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~  304 (342)
T cd07854         271 GVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS  304 (342)
T ss_pred             CCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence            5677899999999999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.5e-41  Score=318.61  Aligned_cols=255  Identities=25%  Similarity=0.393  Sum_probs=200.9

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ++|++.+.||.|+||+||+|....++..+|+|++....  ........|+++++.+.     +++++++++.+...+..+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN-----HPNVVKYYTSFVVGDELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcC-----CCCEEEEEEEEeeCCEEE
Confidence            36999999999999999999998899999999986432  23456677888888773     478999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      +|||++ +++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+||++++++                
T Consensus        76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~----------------  139 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG----------------  139 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC----------------
Confidence            999999 8899999976432 4689999999999999999999999999999999999995544                


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCC-------CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCC
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                                 .++|+|||++......       .....|+..|+|||++... .++.++|+|||||++|+|++|..||.
T Consensus       140 -----------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~  208 (267)
T cd06610         140 -----------SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS  208 (267)
T ss_pred             -----------CEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcc
Confidence                       4566666655322221       1234689999999999877 78999999999999999999999998


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      ..+.......+..   ..+..                   ++.                     ......++.++.+|+.
T Consensus       209 ~~~~~~~~~~~~~---~~~~~-------------------~~~---------------------~~~~~~~~~~~~~li~  245 (267)
T cd06610         209 KYPPMKVLMLTLQ---NDPPS-------------------LET---------------------GADYKKYSKSFRKMIS  245 (267)
T ss_pred             ccChhhhHHHHhc---CCCCC-------------------cCC---------------------ccccccccHHHHHHHH
Confidence            6554433322211   11100                   000                     0002345678999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCCCC
Q 014117          402 GLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      +||+.||++|||++++++||||
T Consensus       246 ~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         246 LCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             HHcCCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.4e-43  Score=340.19  Aligned_cols=249  Identities=22%  Similarity=0.394  Sum_probs=208.1

Q ss_pred             EEEeeeccccceEEEEEEECCCCeEEEEEEec-----CchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC--e
Q 014117           97 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-----GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--H  169 (430)
Q Consensus        97 ~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~-----~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~--~  169 (430)
                      +....||+|+|-+||+|.|..+|..||.-.++     +.....+++..|+.+|+.|.     |+||+++|.++.+..  .
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-----H~NIirfy~SW~d~~n~~  117 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-----HPNIIRFYDSWVDTDNKT  117 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-----CCceeeeeeheecCCCce
Confidence            45678999999999999999999999875543     23344578889999999984     488999999887654  5


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +.+|+|++ .|+|..|+.+.+  ++....++.|++||+.||.|||++.  |||||||.+||+|+                
T Consensus       118 in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin----------------  179 (632)
T KOG0584|consen  118 INFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN----------------  179 (632)
T ss_pred             eeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc----------------
Confidence            88999999 999999998875  7899999999999999999999887  99999999999996                


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC-CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                                ...+.+||+|+|+|+...... ..++|||.|||||+.. +.|+..+||||||.+|+||+|+.+||..+.+
T Consensus       180 ----------G~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n  248 (632)
T KOG0584|consen  180 ----------GNLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN  248 (632)
T ss_pred             ----------CCcCceeecchhHHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC
Confidence                      567899999999998765544 4579999999999887 7899999999999999999999999998876


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      ..+...  ++.....+..+.                                            ..-.+++++||.+||.
T Consensus       249 ~AQIYK--KV~SGiKP~sl~--------------------------------------------kV~dPevr~fIekCl~  282 (632)
T KOG0584|consen  249 PAQIYK--KVTSGIKPAALS--------------------------------------------KVKDPEVREFIEKCLA  282 (632)
T ss_pred             HHHHHH--HHHcCCCHHHhh--------------------------------------------ccCCHHHHHHHHHHhc
Confidence            554432  222222222222                                            1224679999999999


Q ss_pred             cCCCCCCCHHHHhcCCCCCCC
Q 014117          406 YDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f~~~  426 (430)
                      . .++|+||.|||.||||..+
T Consensus       283 ~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  283 T-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             C-chhccCHHHHhhChhhccc
Confidence            9 9999999999999999976

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.8e-41  Score=324.15  Aligned_cols=293  Identities=25%  Similarity=0.404  Sum_probs=215.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---  166 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~---  166 (430)
                      .++|.+.+.||.|+||.||+|.++.+++.||+|++....   ........|+++++.+.     |++|+++++.+..   
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~   81 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK-----HPNVVPLIDMAVERPD   81 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcC-----CCCccchhhheecccc
Confidence            568999999999999999999999999999999885321   12234567889888884     3778888887643   


Q ss_pred             -----CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          167 -----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       167 -----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                           ...+++||||++++|...+.... ..+++..+..++.||+.||.|||++||+|+||||+|||+++++.++++|||
T Consensus        82 ~~~~~~~~~~lv~~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          82 KSKRKRGSVYMVTPYMDHDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             cccccCceEEEEEecCCcCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence                 34679999999888888876543 479999999999999999999999999999999999999887777777777


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                      ++............            +.. ..........|++.|+|||.+.+. .++.++|||||||++|+|++|.+||
T Consensus       161 ~~~~~~~~~~~~~~------------~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~  227 (311)
T cd07866         161 LARPYDGPPPNPKG------------GGG-GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL  227 (311)
T ss_pred             cchhccCCCccccc------------CCc-ccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence            66543222110000            000 000111234678999999988764 5899999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .+.+.......+....+.+++..+..+..............                   ............+.++.+||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~i  288 (311)
T cd07866         228 QGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTN-------------------YPRTLEERFGKLGPEGLDLL  288 (311)
T ss_pred             CCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCC-------------------CCccHHHHcccCChhHHHHH
Confidence            99888888888888887776654332211111000000000                   00001112234557799999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCCCC
Q 014117          401 QGLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      .+||+.||++|||+.|++.||||
T Consensus       289 ~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         289 SKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHcccCcccCcCHHHHhcCCCC
Confidence            99999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.1e-42  Score=320.47  Aligned_cols=253  Identities=25%  Similarity=0.472  Sum_probs=200.4

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-------hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      +|+..+.||+|+||.||+|.+..+++.||+|+++...       .....+..|+.+++++.|     ++++++++.+.+.
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-----~~iv~~~~~~~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH-----PHIIRMLGATCED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCC-----CceehhhceeccC
Confidence            4788899999999999999999999999999986322       134567789999988843     7899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +.+++||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+|+||||+||+++.++             
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~-------------  140 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG-------------  140 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-------------
Confidence            9999999999 889999997654  789999999999999999999999999999999999995432             


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCC-------CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL  319 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~P  319 (430)
                                   ..++|+|||.+......       .....||..|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus       141 -------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p  207 (268)
T cd06630         141 -------------QRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP  207 (268)
T ss_pred             -------------CEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCC
Confidence                         24666666665433221       1234688999999999988899999999999999999999999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |...........+......                  .+                          ....++..+.++.++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~------------------~~--------------------------~~~~~~~~~~~~~~~  243 (268)
T cd06630         208 WNAEKHSNHLALIFKIASA------------------TT--------------------------APSIPEHLSPGLRDV  243 (268)
T ss_pred             CCCCCCcchHHHHHHHhcc------------------CC--------------------------CCCCchhhCHHHHHH
Confidence            9754332222211111000                  00                          001223456789999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCCCCC
Q 014117          400 LQGLLRYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~hp~f~  424 (430)
                      +.+||+.||++|||+.++++||||+
T Consensus       244 i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         244 TLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHcCCCcccCcCHHHHhcCcccC
Confidence            9999999999999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.8e-41  Score=323.03  Aligned_cols=282  Identities=29%  Similarity=0.479  Sum_probs=213.0

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      +...++|++.+.||.|+||.||+|.++.+++.||+|+++...   ........|+++++++.     |+|++++++++..
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-----h~~i~~~~~~~~~   77 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN-----HRNIVNLKEIVTD   77 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC-----CCCeeeeeheecC
Confidence            344578999999999999999999999999999999986322   22345567888888884     4789999888765


Q ss_pred             CC----------eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccc
Q 014117          167 RN----------HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK  236 (430)
Q Consensus       167 ~~----------~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~  236 (430)
                      ..          .+|+||||++++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||||+||++++++   
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~---  153 (302)
T cd07864          78 KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG---  153 (302)
T ss_pred             cchhhhccccCCcEEEEEcccCccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC---
Confidence            44          899999999778888887653 4799999999999999999999999999999999999995544   


Q ss_pred             cCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHH
Q 014117          237 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILV  311 (430)
Q Consensus       237 i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~  311 (430)
                                              .+||+|||.+.......    ....++..|+|||.+.+. .++.++|||||||++|
T Consensus       154 ------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~  209 (302)
T cd07864         154 ------------------------QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG  209 (302)
T ss_pred             ------------------------cEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHH
Confidence                                    55555665554322211    112467889999988754 5789999999999999


Q ss_pred             HHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCC
Q 014117          312 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH  391 (430)
Q Consensus       312 el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (430)
                      +|++|++||...+..+.+..+.+..+..+...++.+..........    .               ..............
T Consensus       210 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~---------------~~~~~~~~~~~~~~  270 (302)
T cd07864         210 ELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMK----P---------------KKQYRRRLREEFSF  270 (302)
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccc----c---------------ccccccchhhhcCC
Confidence            9999999999888888888888887776655433221111000000    0               00000111122334


Q ss_pred             chhHHHHHHHHhhhcCCCCCCCHHHHhcCCCC
Q 014117          392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       392 ~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      .+..+.++|..||+.||++|||+.+++.||||
T Consensus       271 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         271 IPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            57789999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1e-41  Score=318.61  Aligned_cols=249  Identities=24%  Similarity=0.403  Sum_probs=201.7

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      +|++.+.||.|+||.||+|.+..+++.||+|++....    .....+..|+++++++     +|+|++.+++.+.....+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-----NHPFLVNLWYSFQDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-----CCCChHHHHHhhcCCCeE
Confidence            4899999999999999999999999999999986432    2345677788888887     347899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+|+||+ +++|.+++...  ..+++..+..++.||+.||.|||++||+|+||||+||++++                  
T Consensus        76 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~------------------  135 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDE------------------  135 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcC------------------
Confidence            9999999 88999999876  37999999999999999999999999999999999999954                  


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                               ++.++|+|||.+......  .....|+..|+|||++.+..++.++|+||||+++|+|++|..||...+...
T Consensus       136 ---------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  206 (258)
T cd05578         136 ---------QGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI  206 (258)
T ss_pred             ---------CCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH
Confidence                     455677777766543332  123467889999999998889999999999999999999999998765321


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ..........                                              .....+...+.++.++|.+||+.|
T Consensus       207 ~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~~~~i~~~l~~~  240 (258)
T cd05578         207 RDQIRAKQET----------------------------------------------ADVLYPATWSTEAIDAINKLLERD  240 (258)
T ss_pred             HHHHHHHhcc----------------------------------------------ccccCcccCcHHHHHHHHHHccCC
Confidence            1110000000                                              001123345678999999999999


Q ss_pred             CCCCCCH--HHHhcCCCC
Q 014117          408 PTDRLTA--REALRHPFF  423 (430)
Q Consensus       408 P~~R~ta--~elL~hp~f  423 (430)
                      |.+||++  .|+++||||
T Consensus       241 p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         241 PQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             hhHcCCccHHHHhcCCCC
Confidence            9999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.5e-41  Score=319.90  Aligned_cols=250  Identities=26%  Similarity=0.400  Sum_probs=190.7

Q ss_pred             eeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEec
Q 014117          101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK  176 (430)
Q Consensus       101 ~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~  176 (430)
                      .||+|+||.||+|.+..+++.||+|++....    ........|..+++.+..  ..+++++.+++.+...+.+|+||||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~v~e~   78 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMSYAFHTPDKLSFILDL   78 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHh--CCCCcEeeeeeeeecCCEEEEEEec
Confidence            4899999999999999999999999986421    112223445555554433  2458899999999999999999999


Q ss_pred             C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccccc
Q 014117          177 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR  255 (430)
Q Consensus       177 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~  255 (430)
                      + |++|.+++...+  .+++..++.++.|++.||.|||+.+|+||||||+||+++.+                       
T Consensus        79 ~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~-----------------------  133 (278)
T cd05606          79 MNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-----------------------  133 (278)
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC-----------------------
Confidence            9 899999887654  79999999999999999999999999999999999999544                       


Q ss_pred             CCCCCCeEEEeCCCccccCC-CCCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Q 014117          256 MPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME  333 (430)
Q Consensus       256 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~  333 (430)
                          +.++|+|||++..... ......||..|+|||++.+. .++.++|+||+||++|+|++|..||.............
T Consensus       134 ----~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~  209 (278)
T cd05606         134 ----GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR  209 (278)
T ss_pred             ----CCEEEccCcCccccCccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH
Confidence                4556666665543221 12234789999999999754 68999999999999999999999997643211111000


Q ss_pred             HHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCC-
Q 014117          334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL-  412 (430)
Q Consensus       334 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-  412 (430)
                      ....                    .                          ....+...+.++.+++.+||+.||.+|+ 
T Consensus       210 ~~~~--------------------~--------------------------~~~~~~~~s~~~~~li~~~l~~~p~~R~~  243 (278)
T cd05606         210 MTLT--------------------M--------------------------AVELPDSFSPELRSLLEGLLQRDVNRRLG  243 (278)
T ss_pred             Hhhc--------------------c--------------------------CCCCCCcCCHHHHHHHHHHhhcCHHhccC
Confidence            0000                    0                          0112334567899999999999999999 


Q ss_pred             ----CHHHHhcCCCCCCCC
Q 014117          413 ----TAREALRHPFFTRDH  427 (430)
Q Consensus       413 ----ta~elL~hp~f~~~~  427 (430)
                          ++.++++||||+...
T Consensus       244 ~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         244 CLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             CCCCCHHHHHhCccccCCC
Confidence                999999999998653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4e-41  Score=314.07  Aligned_cols=249  Identities=28%  Similarity=0.453  Sum_probs=203.5

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +|++.+.||.|+||.||.+.+..+++.+++|.+...   ......+..|+.+++++.     |+|++++++++...+.++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~-----h~~i~~~~~~~~~~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ-----HPNIIAYYNHFMDDNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCC-----CCCeeEEEeEEecCCeEE
Confidence            589999999999999999999999999999987532   333456778999998883     478999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|.+++.......+++..+..++.|++.||.|||+.||+|+||||+||+++.++                 
T Consensus        76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~-----------------  138 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-----------------  138 (256)
T ss_pred             EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC-----------------
Confidence            999999 88999999876445789999999999999999999999999999999999996544                 


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                                .+||+|||++.......   ....|++.|+|||.+.+..++.++|+|||||++|+|++|..||......+
T Consensus       139 ----------~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~  208 (256)
T cd08221         139 ----------LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN  208 (256)
T ss_pred             ----------CEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence                      45566666554332211   23468999999999998889999999999999999999999998765554


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+..  +.++.                                              .+...+.++.++|.+||..|
T Consensus       209 ~~~~~~~--~~~~~----------------------------------------------~~~~~~~~~~~~i~~~l~~~  240 (256)
T cd08221         209 LVVKIVQ--GNYTP----------------------------------------------VVSVYSSELISLVHSLLQQD  240 (256)
T ss_pred             HHHHHHc--CCCCC----------------------------------------------CccccCHHHHHHHHHHcccC
Confidence            4443321  11110                                              11345667999999999999


Q ss_pred             CCCCCCHHHHhcCCCC
Q 014117          408 PTDRLTAREALRHPFF  423 (430)
Q Consensus       408 P~~R~ta~elL~hp~f  423 (430)
                      |.+|||+.++|+|||+
T Consensus       241 p~~R~s~~~ll~~~~l  256 (256)
T cd08221         241 PEKRPTADEVLDQPLL  256 (256)
T ss_pred             cccCCCHHHHhhCcCC
Confidence            9999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.2e-41  Score=321.75  Aligned_cols=250  Identities=25%  Similarity=0.415  Sum_probs=197.1

Q ss_pred             eccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 014117          102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL  177 (430)
Q Consensus       102 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~  177 (430)
                      ||+|+||+||+|.+..+++.||+|++....    .....+..|+++++++.     +++++.+++.+...+..|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-----SRFIVSLAYAFETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-----CCCEeeeeeEEecCCeEEEEEecC
Confidence            699999999999999999999999986422    22334567888888884     488999999999999999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccC
Q 014117          178 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM  256 (430)
Q Consensus       178 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~  256 (430)
                       +++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||++++                         
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~-------------------------  130 (277)
T cd05577          76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDD-------------------------  130 (277)
T ss_pred             CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC-------------------------
Confidence             889999998765557999999999999999999999999999999999999954                         


Q ss_pred             CCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHH
Q 014117          257 PKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER  334 (430)
Q Consensus       257 ~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~  334 (430)
                        ++.++|+|||.+......  .....++..|+|||++.+..++.++|+|||||++|+|++|+.||...........+..
T Consensus       131 --~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  208 (277)
T cd05577         131 --HGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR  208 (277)
T ss_pred             --CCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh
Confidence              445666666665433211  1223578899999999888899999999999999999999999976443111111111


Q ss_pred             HhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCC--
Q 014117          335 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL--  412 (430)
Q Consensus       335 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~--  412 (430)
                      ..-                                             ......+...+.++.++|.+||+.||++||  
T Consensus       209 ~~~---------------------------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~  243 (277)
T cd05577         209 RTL---------------------------------------------EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGC  243 (277)
T ss_pred             ccc---------------------------------------------cccccCCccCCHHHHHHHHHHccCChhHccCC
Confidence            000                                             001112345677899999999999999999  


Q ss_pred             ---CHHHHhcCCCCCCCCC
Q 014117          413 ---TAREALRHPFFTRDHL  428 (430)
Q Consensus       413 ---ta~elL~hp~f~~~~~  428 (430)
                         ++.+++.||||++...
T Consensus       244 ~~~~~~~ll~h~~~~~~~~  262 (277)
T cd05577         244 RGGSADEVREHPLFKDLNW  262 (277)
T ss_pred             CcccHHHHHhChhhhcCCh
Confidence               9999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.7e-41  Score=321.91  Aligned_cols=237  Identities=16%  Similarity=0.160  Sum_probs=191.1

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCchhh----HHHHHHHHHHHHHHHhcCCCCCceEEecceeec----CCeEE
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY----REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNHIC  171 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~----~~~~~  171 (430)
                      ..||+|+++.||+|..  +++.||+|.++.....    .+.+.+|+.++.++.|     +||+++++++.+    ...++
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-----~nIv~~~g~~~~~~~~~~~~~   98 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDS-----NNILKIYGFIIDIVDDLPRLS   98 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCC-----CCEEEEeeeEEecccCCCceE
Confidence            5689999999999987  6889999998754322    3556689999999844     789999998865    45789


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      +||||+ +|+|.+++.+..  .+++.....++.|++.||.|||+ .+++||||||+|||++                   
T Consensus        99 lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~-------------------  157 (283)
T PHA02988         99 LILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT-------------------  157 (283)
T ss_pred             EEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC-------------------
Confidence            999999 889999998754  78999999999999999999998 5899999999999994                   


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                              .++.+||+|||++...........||..|+|||++.+  ..++.++|||||||++|||++|..||.+.+..+
T Consensus       158 --------~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~  229 (283)
T PHA02988        158 --------ENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE  229 (283)
T ss_pred             --------CCCcEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH
Confidence                    4556777777776644333334578999999999976  679999999999999999999999998766555


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+......++                                               .+...+.++.+|+.+||+.|
T Consensus       230 ~~~~i~~~~~~~~-----------------------------------------------~~~~~~~~l~~li~~cl~~d  262 (283)
T PHA02988        230 IYDLIINKNNSLK-----------------------------------------------LPLDCPLEIKCIVEACTSHD  262 (283)
T ss_pred             HHHHHHhcCCCCC-----------------------------------------------CCCcCcHHHHHHHHHHhcCC
Confidence            4443322111110                                               12245678999999999999


Q ss_pred             CCCCCCHHHHhc
Q 014117          408 PTDRLTAREALR  419 (430)
Q Consensus       408 P~~R~ta~elL~  419 (430)
                      |++|||++|+++
T Consensus       263 p~~Rps~~ell~  274 (283)
T PHA02988        263 SIKRPNIKEILY  274 (283)
T ss_pred             cccCcCHHHHHH
Confidence            999999999985

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-41  Score=319.04  Aligned_cols=276  Identities=29%  Similarity=0.493  Sum_probs=212.2

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--CeE
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHI  170 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~--~~~  170 (430)
                      |++.+.||.|+||.||+|.+..+++.+|+|.+...   ......+..|+.+++++.     +++++++++.+...  +..
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~~   75 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR-----HPNIVRLKEIVTSKGKGSI   75 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc-----CCCeeeheeeEecCCCCcE
Confidence            67899999999999999999999999999999754   233455677899998884     47899999998887  899


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      ++||||++++|.+++.... ..+++..+..++.||+.||+|||+.|++|+||||+|||++++                  
T Consensus        76 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~------------------  136 (287)
T cd07840          76 YMVFEYMDHDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND------------------  136 (287)
T ss_pred             EEEeccccccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC------------------
Confidence            9999999889999887653 479999999999999999999999999999999999999544                  


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                               +.++|+|||.+.......    ....++..|+|||.+.+. .++.++|||||||++|+|++|..||...+.
T Consensus       137 ---------~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~  207 (287)
T cd07840         137 ---------GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE  207 (287)
T ss_pred             ---------CCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                     455666666554332221    223568889999987654 588999999999999999999999998888


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCC-chhHHHHHHHHhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGLL  404 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~L  404 (430)
                      ......+....+.++...+..+.....  ...                 ................. .+.++.+++++||
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  268 (287)
T cd07840         208 LEQLEKIFELCGSPTDENWPGVSKLPW--FEN-----------------LKPKKPYKRRLREFFKHLIDPSALDLLDKLL  268 (287)
T ss_pred             HHHHHHHHHHhCCCchhhccccccchh--hhh-----------------ccccccchhHHHHHhcccCCHHHHHHHHHHc
Confidence            888888877777766544332211100  000                 00000001111112222 4788999999999


Q ss_pred             hcCCCCCCCHHHHhcCCCC
Q 014117          405 RYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f  423 (430)
                      +.||++|||+.++++||||
T Consensus       269 ~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         269 TLDPKKRISADQALQHEYF  287 (287)
T ss_pred             CCChhhCcCHHHHhhCcCC
Confidence            9999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-41  Score=319.56  Aligned_cols=276  Identities=33%  Similarity=0.601  Sum_probs=217.8

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      |++.+.||.|++|.||+|.+..+++.+|+|.++....   .......|+.+++.+.     +++++++++.+......++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN-----HPNIIKLLDVFRHKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc-----CCCcchHHHhhccCCCEEE
Confidence            5678899999999999999999999999999864322   3456677888888884     4789999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          173 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       173 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      ||||+.++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+||+++                      
T Consensus        76 v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~----------------------  132 (283)
T cd05118          76 VFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN----------------------  132 (283)
T ss_pred             EEeccCCCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC----------------------
Confidence            99999889999887754 4799999999999999999999999999999999999994                      


Q ss_pred             cccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                           .++.++|+|||.+.......   ....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..+.
T Consensus       133 -----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~  207 (283)
T cd05118         133 -----TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ  207 (283)
T ss_pred             -----CCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                 44567777777665443322   123578899999999877 789999999999999999999999998888888


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      ...+...++......+...........    ...+.....               ......+..+.++.+||.+||+.||
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~---------------~~~~~~~~~~~~~~~~i~~~l~~~P  268 (283)
T cd05118         208 LFKIFRTLGTPDPEVWPKFTSLARNYK----FSFPKKAGM---------------PLPKLFPNASPQALDLLSQMLHYDP  268 (283)
T ss_pred             HHHHHHHcCCCchHhcccchhhhhhhh----hhhcccccc---------------CHHHhhhhhCHHHHHHHHHHhccCc
Confidence            887777777766555444332211111    111110000               0011234567889999999999999


Q ss_pred             CCCCCHHHHhcCCCC
Q 014117          409 TDRLTAREALRHPFF  423 (430)
Q Consensus       409 ~~R~ta~elL~hp~f  423 (430)
                      .+||++.+++.||||
T Consensus       269 ~~Rp~~~~ll~~~~~  283 (283)
T cd05118         269 HKRITAEQALAHPYF  283 (283)
T ss_pred             ccCcCHHHHhhCCCC
Confidence            999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-41  Score=318.41  Aligned_cols=276  Identities=30%  Similarity=0.538  Sum_probs=209.6

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe---
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH---  169 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~---  169 (430)
                      |++.+.||.|+||.||+|.++.+++.||+|+++....   .......|+.+++++..  ..+++++++++.+...+.   
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~h~~i~~~~~~~~~~~~~~~   78 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLES--FEHPNIVRLLDVCHGPRTDRE   78 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhc--cCCCCcceEEEEEeeccCCCC
Confidence            6789999999999999999998899999999863221   22345568888877753  235889999999887766   


Q ss_pred             --EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          170 --ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       170 --~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                        ++++|||+.++|.+++.......+++..++.++.||+.||.|||+.+|+|+||||+||+++                 
T Consensus        79 ~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~-----------------  141 (287)
T cd07838          79 LKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT-----------------  141 (287)
T ss_pred             ceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc-----------------
Confidence              9999999988999998876545699999999999999999999999999999999999995                 


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                                .++.++|+|||.+.......  ....++..|+|||++.+..++.++|+|||||++|+|++|.+||...+.
T Consensus       142 ----------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~  211 (287)
T cd07838         142 ----------SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE  211 (287)
T ss_pred             ----------cCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh
Confidence                      44567777777665432221  234578899999999998999999999999999999999999998888


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCC-ChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      .+....+....+......                  |+.... ....+...     .........+..+.++.++|.+||
T Consensus       212 ~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l  268 (287)
T cd07838         212 ADQLDKIFDVIGLPSEEE------------------WPRNVSLPRSSFPSY-----TPRSFKSFVPEICEEGLDLLKKML  268 (287)
T ss_pred             HHHHHHHHHHcCCCChHh------------------cCCCcccchhhcccc-----cccchhhhhhhhhHHHHHHHHHHh
Confidence            777776665554332211                  110000 00000000     000011122345678899999999


Q ss_pred             hcCCCCCCCHHHHhcCCCC
Q 014117          405 RYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f  423 (430)
                      +.||++||++.|++.||||
T Consensus       269 ~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         269 TFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccCCccCCCHHHHhcCcCC
Confidence            9999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.9e-41  Score=323.57  Aligned_cols=254  Identities=21%  Similarity=0.308  Sum_probs=192.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEECC----------------CCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRE----------------RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGG  154 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~  154 (430)
                      .++|++.++||+|+||.||+|.+..                ++..||+|+++..  ......+..|+.++.++.     |
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----h   78 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLK-----D   78 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcC-----C
Confidence            3579999999999999999998542                3457999998743  233456778999998884     4


Q ss_pred             CceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcC
Q 014117          155 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY-----------------RSFPIDLVREIARQLLECIAFMHDLC  216 (430)
Q Consensus       155 ~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-----------------~~l~~~~~~~i~~qi~~aL~~lH~~~  216 (430)
                      +||+++++++...+..|+||||+ +++|.+++.....                 ..+++..+..++.||+.||.|||+.|
T Consensus        79 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~  158 (304)
T cd05096          79 PNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN  158 (304)
T ss_pred             CCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence            88999999999999999999999 8899999865321                 24677889999999999999999999


Q ss_pred             eeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhh
Q 014117          217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEV  291 (430)
Q Consensus       217 ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~  291 (430)
                      |+||||||+|||++.++                           .+||+|||+++......     ....++..|+|||+
T Consensus       159 ivH~dlkp~Nill~~~~---------------------------~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~  211 (304)
T cd05096         159 FVHRDLATRNCLVGENL---------------------------TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWEC  211 (304)
T ss_pred             ccccCcchhheEEcCCc---------------------------cEEECCCccceecccCceeEecCcCCCCccccCHHH
Confidence            99999999999996544                           45555555554322111     12345788999999


Q ss_pred             hhCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCCh
Q 014117          292 ILGLGWTYPCDIWSVGCILVELCT--GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASR  369 (430)
Q Consensus       292 ~~~~~~~~~~DvwslGv~l~el~t--G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (430)
                      +.+..++.++|||||||++|||++  +..||...+..+....+.........                            
T Consensus       212 ~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----------------------------  263 (304)
T cd05096         212 ILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGR----------------------------  263 (304)
T ss_pred             HhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccc----------------------------
Confidence            998899999999999999999986  66888876655444332221100000                            


Q ss_pred             hhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          370 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                                   ......++..+..+.+|+.+||+.||++|||+.+|..
T Consensus       264 -------------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         264 -------------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             -------------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence                         0001123455678999999999999999999999943

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-44  Score=312.43  Aligned_cols=295  Identities=26%  Similarity=0.463  Sum_probs=220.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecC---chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee----
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD----  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~----  165 (430)
                      .+.|+-..+||+|.||.||+|+.+.+++.||+|++--   ...+.....+|+++|..+.|     +|++.+++.+.    
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkH-----env~nliEic~tk~T   90 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKH-----ENVVNLIEICRTKAT   90 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcc-----hhHHHHHHHHhhccC
Confidence            4568888999999999999999999999999987531   22355667889999999965     55666666553    


Q ss_pred             ----cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          166 ----YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       166 ----~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                          +...+|+||.+|..+|..+|.... .+|+...+..++.+++.||.|+|++.|+|||+||+|+||+.+|.++++|||
T Consensus        91 p~~r~r~t~ylVf~~cehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   91 PTNRDRATFYLVFDFCEHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             CcccccceeeeeHHHhhhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccc
Confidence                234699999999999999997653 579999999999999999999999999999999999999655555555554


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                      +++.......                    ...+.-+..+-|.+|.+||.++|. .|+++.|||..||++.||.+|.+.|
T Consensus       170 lar~fs~~~n--------------------~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspim  229 (376)
T KOG0669|consen  170 LARAFSTSKN--------------------VVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIM  229 (376)
T ss_pred             cccceecccc--------------------cCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccc
Confidence            4432211100                    000111223569999999999986 5999999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .+.++..++..|...+|....+.|+.++...-...-. ..+.++...+           .+++..-  +-.-..++.+|+
T Consensus       230 qgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie-~ePl~~~~~r-----------kv~n~~k--p~~kd~~a~dLl  295 (376)
T KOG0669|consen  230 QGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIE-LEPLPKGQKR-----------KVKNRLK--PYVKDDEALDLL  295 (376)
T ss_pred             cCChHHHHHHHHHHHhccCCcccCCCcccchHHHhcc-CCCCCcchhh-----------hhhhhcc--cccCChhHHHHH
Confidence            9999999999999999999988777654322211100 0001111100           0111111  112245789999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          401 QGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      .+||.+||.+|++++++|+|.||..++
T Consensus       296 e~ll~~DP~kR~~ad~alnh~~F~kdp  322 (376)
T KOG0669|consen  296 EKLLKLDPTKRIDADQALNHDFFWKDP  322 (376)
T ss_pred             HHHhccCcccCcchHhhhchhhhhcCC
Confidence            999999999999999999999998765

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.9e-41  Score=316.28  Aligned_cols=249  Identities=28%  Similarity=0.442  Sum_probs=192.9

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch------hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-  166 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-  166 (430)
                      .+|++.+.||+|+||.||+|.+..++..||+|++....      .....+..|+.+++++.     |+|++++++++.. 
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~   76 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-----HERIVQYYGCLRDR   76 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-----CCCeeeEEEEEEcC
Confidence            36889999999999999999999999999999885321      22345667888888884     3789999988765 


Q ss_pred             -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          167 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       167 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                       ...++++|||+ +++|.+++....  .+++..+..++.||+.||.|||+++|+||||||+||+++.++           
T Consensus        77 ~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~-----------  143 (266)
T cd06651          77 AEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG-----------  143 (266)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-----------
Confidence             46889999999 789999997654  689999999999999999999999999999999999995544           


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCC------CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERP------DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                      .++|+|||++.....      ......++..|+|||++.+..++.++|+|||||++|+|++|+.
T Consensus       144 ----------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~  207 (266)
T cd06651         144 ----------------NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKP  207 (266)
T ss_pred             ----------------CEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCC
Confidence                            455555555442211      1122457889999999999889999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||...........+.. .+..                                              ...+...+..+.+
T Consensus       208 pf~~~~~~~~~~~~~~-~~~~----------------------------------------------~~~~~~~~~~~~~  240 (266)
T cd06651         208 PWAEYEAMAAIFKIAT-QPTN----------------------------------------------PQLPSHISEHARD  240 (266)
T ss_pred             CccccchHHHHHHHhc-CCCC----------------------------------------------CCCchhcCHHHHH
Confidence            9976543332221110 0000                                              0112234556788


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCCCCC
Q 014117          399 LLQGLLRYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~hp~f~  424 (430)
                      ++ +||..||++|||++|+++||||+
T Consensus       241 li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         241 FL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HH-HHhcCChhhCcCHHHHhcCcccc
Confidence            88 57778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.5e-41  Score=315.00  Aligned_cols=255  Identities=26%  Similarity=0.433  Sum_probs=193.9

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc------hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-  166 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-  166 (430)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+...      ......+..|+.+++++.     |++++++++++.+ 
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~   76 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-----HERIVQYYGCLRDP   76 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-----CCCeeeEEeEeccC
Confidence            4689999999999999999999999999999987532      122345667888888884     4789999998765 


Q ss_pred             -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          167 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       167 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                       ...+++||||+ +++|.+++....  .+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++++|||++.
T Consensus        77 ~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          77 MERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             CCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence             35789999999 889999987654  68899999999999999999999999999999999999665555555554433


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                      ......                     ..........|+..|+|||++.+..++.++|+|||||++|+|++|+.||....
T Consensus       155 ~~~~~~---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  213 (265)
T cd06652         155 RLQTIC---------------------LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE  213 (265)
T ss_pred             cccccc---------------------ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc
Confidence            211000                     00001122468899999999998889999999999999999999999997654


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      .......+   ......                                            ...+...+..+.++|++||
T Consensus       214 ~~~~~~~~---~~~~~~--------------------------------------------~~~~~~~~~~~~~~i~~~l  246 (265)
T cd06652         214 AMAAIFKI---ATQPTN--------------------------------------------PVLPPHVSDHCRDFLKRIF  246 (265)
T ss_pred             hHHHHHHH---hcCCCC--------------------------------------------CCCchhhCHHHHHHHHHHh
Confidence            33322211   111000                                            0012234557889999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~  424 (430)
                      . +|++|||++|+++|||+.
T Consensus       247 ~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         247 V-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             c-ChhhCCCHHHHhcCcccC
Confidence            5 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.9e-41  Score=317.58  Aligned_cols=249  Identities=25%  Similarity=0.396  Sum_probs=193.5

Q ss_pred             CcEEEEeee--ccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           94 SRYKIHSKM--GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        94 ~~y~~~~~l--G~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ++|.+.+.+  |+|+||.||++.++.++..+|+|++......    ..|+.....+.    .+++++++++.+...+.+|
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~----~~e~~~~~~~~----~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN----AIEPMVHQLMK----DNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc----hhhHHHHHHhh----cCCCEEEEEEEEecCCeeE
Confidence            456776666  9999999999999999999999998643211    11333222222    3588999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|.+++....  .+++..+..++.||+.||.|||+.||+||||||+||+++.++                 
T Consensus        86 iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-----------------  146 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK-----------------  146 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC-----------------
Confidence            999999 899999998764  799999999999999999999999999999999999995432                 


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-H
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH-L  329 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~-~  329 (430)
                               ..++|+|||++...... ....|+..|+|||++.+..++.++|||||||++|+|++|..||......+. .
T Consensus       147 ---------~~~~l~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~  216 (267)
T PHA03390        147 ---------DRIYLCDYGLCKIIGTP-SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL  216 (267)
T ss_pred             ---------CeEEEecCccceecCCC-ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH
Confidence                     26778888876544322 234688999999999998999999999999999999999999985433221 0


Q ss_pred             HHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCC
Q 014117          330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT  409 (430)
Q Consensus       330 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~  409 (430)
                      ..+......                                              ....+...+..+.+||.+||+.||.
T Consensus       217 ~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~  250 (267)
T PHA03390        217 ESLLKRQQK----------------------------------------------KLPFIKNVSKNANDFVQSMLKYNIN  250 (267)
T ss_pred             HHHHHhhcc----------------------------------------------cCCcccccCHHHHHHHHHHhccChh
Confidence            111000000                                              0011234677899999999999999


Q ss_pred             CCCC-HHHHhcCCCCCC
Q 014117          410 DRLT-AREALRHPFFTR  425 (430)
Q Consensus       410 ~R~t-a~elL~hp~f~~  425 (430)
                      +|++ ++++|+||||..
T Consensus       251 ~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        251 YRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             hCCchHHHHhcCCcccC
Confidence            9996 599999999974

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=344.74  Aligned_cols=245  Identities=29%  Similarity=0.410  Sum_probs=199.0

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecC-chhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee-ec-----
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG-IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-DY-----  166 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-~~-----  166 (430)
                      .+++|.+.|.+|||+.||+|.+...+..||+|++-. +....+...+|+++|+.|.    +|+|||.+++.. ..     
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~----gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLS----GHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhc----CCCceeeEeccccccccCCC
Confidence            468999999999999999999998888999998753 3445567788999999996    457899999832 21     


Q ss_pred             -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeccCCCCceEEeecCccccCCCcC
Q 014117          167 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       167 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                       .-.++|+|||| ||+|.|++.++...+|++.++++|+.|+++|+.+||...  |||||||-+||||+.           
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~-----------  181 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA-----------  181 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC-----------
Confidence             23788999999 789999999777778999999999999999999999988  999999999999954           


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-C-----------eeeecCcccchhhhh---CCCCCCcchHHHHH
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-N-----------YIVSTRHYRAPEVIL---GLGWTYPCDIWSVG  307 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~-----------~~~gt~~y~aPE~~~---~~~~~~~~DvwslG  307 (430)
                                      ++..||||||.|+-.-... .           ...-|+.|+|||.+.   +...+.|+||||||
T Consensus       182 ----------------~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALG  245 (738)
T KOG1989|consen  182 ----------------DGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALG  245 (738)
T ss_pred             ----------------CCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHH
Confidence                            4566777777665221111 0           024599999999884   66899999999999


Q ss_pred             HHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhh
Q 014117          308 CILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ  387 (430)
Q Consensus       308 v~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (430)
                      |+||-|+....||+.....                           .|.+|.+.+|.                       
T Consensus       246 clLYkLCy~t~PFe~sg~l---------------------------aIlng~Y~~P~-----------------------  275 (738)
T KOG1989|consen  246 CLLYKLCYFTTPFEESGKL---------------------------AILNGNYSFPP-----------------------  275 (738)
T ss_pred             HHHHHHHHhCCCcCcCcce---------------------------eEEeccccCCC-----------------------
Confidence            9999999999999864332                           13455566554                       


Q ss_pred             hcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       388 ~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                       ++.++..+++||+.||+.||.+||++.|++.+
T Consensus       276 -~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  276 -FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             -CccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence             24667789999999999999999999999875

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.3e-41  Score=315.44  Aligned_cols=246  Identities=21%  Similarity=0.326  Sum_probs=197.9

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      ..|.+.+.||+|+||.||+|.++.+++.||+|++.........+..|+++++.+.     |++++++++++...+.+++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-----HPNLVQLLGVCTREPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCC-----CCChhheEEEEcCCCCcEEE
Confidence            4589999999999999999999999999999998765545566788999998884     47899999999999999999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      |||+ +++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||+++++.                  
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~------------------  142 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL------------------  142 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc------------------
Confidence            9999 889999998765567899999999999999999999999999999999999965554                  


Q ss_pred             cccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHH
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE  327 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~  327 (430)
                               +||+|||.+.......    ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus       143 ---------~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~  213 (263)
T cd05052         143 ---------VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ  213 (263)
T ss_pred             ---------EEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence                     5555555444322211    11123567999999999899999999999999999998 999998765544


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+....                                                ....+...+.++.++|.+||+.|
T Consensus       214 ~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~li~~cl~~~  245 (263)
T cd05052         214 VYELLEKGY------------------------------------------------RMERPEGCPPKVYELMRACWQWN  245 (263)
T ss_pred             HHHHHHCCC------------------------------------------------CCCCCCCCCHHHHHHHHHHccCC
Confidence            333322110                                                00122345678999999999999


Q ss_pred             CCCCCCHHHHhc
Q 014117          408 PTDRLTAREALR  419 (430)
Q Consensus       408 P~~R~ta~elL~  419 (430)
                      |++|||+.++++
T Consensus       246 p~~Rp~~~~l~~  257 (263)
T cd05052         246 PSDRPSFAEIHQ  257 (263)
T ss_pred             cccCCCHHHHHH
Confidence            999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-41  Score=314.04  Aligned_cols=252  Identities=26%  Similarity=0.427  Sum_probs=200.6

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|++.... ........|+++++++     +|++++++++.+...+.+|+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-----RHPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-----CCCChhceEEEEEeCCEEEE
Confidence            57999999999999999999999999999999987432 2345677888888888     44889999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      +|||+ +++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+                   
T Consensus        78 ~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-------------------  137 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED-------------------  137 (262)
T ss_pred             EEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC-------------------
Confidence            99999 789999887652 379999999999999999999999999999999999999544                   


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                              +.++|+|||.+......   .....++..|+|||.+.+.   .++.++|+|||||++|+|++|.+||...+.
T Consensus       138 --------~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~  209 (262)
T cd06613         138 --------GDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP  209 (262)
T ss_pred             --------CCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence                    45666666665433221   1234688899999999877   789999999999999999999999987654


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      ......+....-. +.                      .                     .......+.++.+||.+||+
T Consensus       210 ~~~~~~~~~~~~~-~~----------------------~---------------------~~~~~~~~~~~~~li~~~l~  245 (262)
T cd06613         210 MRALFLISKSNFP-PP----------------------K---------------------LKDKEKWSPVFHDFIKKCLT  245 (262)
T ss_pred             HHHHHHHHhccCC-Cc----------------------c---------------------ccchhhhhHHHHHHHHHHcC
Confidence            4433222111000 00                      0                     00112335678999999999


Q ss_pred             cCCCCCCCHHHHhcCCC
Q 014117          406 YDPTDRLTAREALRHPF  422 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~  422 (430)
                      .||.+|||+.+++.|+|
T Consensus       246 ~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         246 KDPKKRPTATKLLQHPF  262 (262)
T ss_pred             CChhhCCCHHHHhcCCC
Confidence            99999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.7e-41  Score=334.24  Aligned_cols=248  Identities=23%  Similarity=0.330  Sum_probs=190.1

Q ss_pred             CcEEEEeeeccccceEEEEEEECCC-----CeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRER-----KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      ++|++.+.||+|+||.||+|.+..+     ++.||+|+++...  .....+..|+.+++.+.    .|+||+++++.+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~----~h~nIv~~~~~~~~  113 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLG----QHKNIVNLLGACTH  113 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhc----cCCceeeEeeEecC
Confidence            4699999999999999999986543     3579999987432  23455778999998883    24789999999999


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcC--------------------------------------------------------
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNN--------------------------------------------------------  189 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~--------------------------------------------------------  189 (430)
                      .+.+|+||||+ +++|.+++....                                                        
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            99999999999 899999986431                                                        


Q ss_pred             ------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCC
Q 014117          190 ------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP  257 (430)
Q Consensus       190 ------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~  257 (430)
                                  ..++++..++.++.||+.||.|||++||+||||||+|||++.++                        
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~------------------------  249 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR------------------------  249 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC------------------------
Confidence                        12478889999999999999999999999999999999995544                        


Q ss_pred             CCCCeEEEeCCCccccCCCCC-----eeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHHHH
Q 014117          258 KSSAIKVIDFGSTTYERPDQN-----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAM  331 (430)
Q Consensus       258 ~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~~  331 (430)
                         .+||+|||+++.......     ...++..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus       250 ---~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~  326 (374)
T cd05106         250 ---VAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK  326 (374)
T ss_pred             ---eEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHH
Confidence               456666665543221111     1234567999999998899999999999999999997 9999976443222221


Q ss_pred             HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCC
Q 014117          332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR  411 (430)
Q Consensus       332 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R  411 (430)
                      +......                                               ...+...+.++.+++.+||+.||++|
T Consensus       327 ~~~~~~~-----------------------------------------------~~~~~~~~~~l~~li~~cl~~dp~~R  359 (374)
T cd05106         327 MVKRGYQ-----------------------------------------------MSRPDFAPPEIYSIMKMCWNLEPTER  359 (374)
T ss_pred             HHHcccC-----------------------------------------------ccCCCCCCHHHHHHHHHHcCCChhhC
Confidence            1110000                                               00122346789999999999999999


Q ss_pred             CCHHHHhc
Q 014117          412 LTAREALR  419 (430)
Q Consensus       412 ~ta~elL~  419 (430)
                      ||+.++++
T Consensus       360 Ps~~~l~~  367 (374)
T cd05106         360 PTFSQISQ  367 (374)
T ss_pred             cCHHHHHH
Confidence            99999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6e-41  Score=317.58  Aligned_cols=278  Identities=32%  Similarity=0.557  Sum_probs=214.6

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      |++.+.||.|++|.||+|.+..+++.||||.+.....  .......|+..+.++.    .+++++.+++.+...+..|+|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~----~h~~i~~~~~~~~~~~~~~lv   76 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN----EHPNIVKLKEVFRENDELYFV   76 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhcc----CCCCchhHHHHhhcCCcEEEE
Confidence            6788999999999999999999999999999864322  2223345777777663    247899999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          174 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       174 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      |||++++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++                       
T Consensus        77 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~-----------------------  133 (283)
T cd07830          77 FEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS-----------------------  133 (283)
T ss_pred             EecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc-----------------------
Confidence            999988999998876545789999999999999999999999999999999999994                       


Q ss_pred             ccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Q 014117          254 KRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA  330 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~  330 (430)
                          ..+.++|+|||++.......  ....|+..|+|||++.+ ..++.++|+||||+++|+|++|.+||...+..+...
T Consensus       134 ----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~  209 (283)
T cd07830         134 ----GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY  209 (283)
T ss_pred             ----CCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH
Confidence                45567777777665433221  23467889999998754 458899999999999999999999999888888888


Q ss_pred             HHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCC
Q 014117          331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD  410 (430)
Q Consensus       331 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~  410 (430)
                      .+...++.++...+.........    ....++...               ...........+.++.+||++||+.||++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~---------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~  270 (283)
T cd07830         210 KICSVLGTPTKQDWPEGYKLASK----LGFRFPQFA---------------PTSLHQLIPNASPEAIDLIKDMLRWDPKK  270 (283)
T ss_pred             HHHHhcCCCChhhhhhHhhhhcc----ccccccccc---------------cccHHHHcccCCHHHHHHHHHhcccCccc
Confidence            88888888776544332111110    001111000               00011222334678999999999999999


Q ss_pred             CCCHHHHhcCCCC
Q 014117          411 RLTAREALRHPFF  423 (430)
Q Consensus       411 R~ta~elL~hp~f  423 (430)
                      |||+.|++.||||
T Consensus       271 Rpt~~ei~~~~~~  283 (283)
T cd07830         271 RPTASQALQHPYF  283 (283)
T ss_pred             CCCHHHHhhCCCC
Confidence            9999999999998

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-42  Score=332.11  Aligned_cols=252  Identities=23%  Similarity=0.321  Sum_probs=197.4

Q ss_pred             ecCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecC---chhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 014117           87 ALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW  163 (430)
Q Consensus        87 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~  163 (430)
                      ...+...+.+.+...||+|.||+||+|++..+   ||||+++-   .....+.|..|+.++++-+|     .||+-+.++
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH-----~NIlLFMG~  456 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRH-----ENILLFMGA  456 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcch-----hhheeeehh
Confidence            44455566788999999999999999987644   99999863   23455778899999999866     679999999


Q ss_pred             eecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          164 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       164 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                      +..+.. .||..+| |.+|+.+|+... .+|.....+.|++||++|+.|||.++|||||||..||++.            
T Consensus       457 ~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~------------  522 (678)
T KOG0193|consen  457 CMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH------------  522 (678)
T ss_pred             hcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc------------
Confidence            988777 9999999 779999998765 6799999999999999999999999999999999999994            


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCC-----CCCeeeecCcccchhhhhCC---CCCCcchHHHHHHHHHHHH
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-----DQNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELC  314 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGv~l~el~  314 (430)
                                     .++.|||+|||+++....     +.....|...|||||++..+   +|++.+||||||||+|||+
T Consensus       523 ---------------~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELl  587 (678)
T KOG0193|consen  523 ---------------EDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELL  587 (678)
T ss_pred             ---------------cCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHH
Confidence                           446677777777653221     11234678899999999744   6999999999999999999


Q ss_pred             hCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchh
Q 014117          315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG  394 (430)
Q Consensus       315 tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (430)
                      ||..||.. +..++...++ .-|.+-+                                          .........+.
T Consensus       588 tg~lPysi-~~~dqIifmV-GrG~l~p------------------------------------------d~s~~~s~~pk  623 (678)
T KOG0193|consen  588 TGELPYSI-QNRDQIIFMV-GRGYLMP------------------------------------------DLSKIRSNCPK  623 (678)
T ss_pred             hCcCCcCC-CChhheEEEe-cccccCc------------------------------------------cchhhhccCHH
Confidence            99999994 3333221111 0111111                                          11112345667


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          395 DLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       395 ~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      ++++|+..||.+++++||...+||.
T Consensus       624 ~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  624 AMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHHhcCcccCccHHHHHH
Confidence            8999999999999999999988876

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.6e-41  Score=316.62  Aligned_cols=252  Identities=27%  Similarity=0.420  Sum_probs=195.7

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh-----------hHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-----------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNW  163 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-----------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~  163 (430)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.++....           ..+.+..|+.+++.+.     ++++++++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~   76 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-----HLNIVQYLGF   76 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-----CCCcceEEEE
Confidence            58889999999999999999999999999998753111           1234566888888773     4789999999


Q ss_pred             eecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          164 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       164 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                      +...+.+++||||+ +++|.+++...+  .+++..+..++.||+.||.|||++|++||||||+||+++.+          
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~----------  144 (272)
T cd06629          77 ETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD----------  144 (272)
T ss_pred             eccCCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC----------
Confidence            99999999999999 899999998764  78999999999999999999999999999999999999544          


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCC--CCCcchHHHHHHHHHHHHh
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLG--WTYPCDIWSVGCILVELCT  315 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGv~l~el~t  315 (430)
                                       +.++|+|||++......     .....|+..|+|||.+.+..  ++.++|+||||+++|+|++
T Consensus       145 -----------------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~  207 (272)
T cd06629         145 -----------------GICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA  207 (272)
T ss_pred             -----------------CeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHh
Confidence                             45666666655432211     12246788999999988754  8899999999999999999


Q ss_pred             CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhH
Q 014117          316 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD  395 (430)
Q Consensus       316 G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (430)
                      |..||......+....+.....                     ....+                      ......++.+
T Consensus       208 g~~p~~~~~~~~~~~~~~~~~~---------------------~~~~~----------------------~~~~~~~~~~  244 (272)
T cd06629         208 GRRPWSDEEAIAAMFKLGNKRS---------------------APPIP----------------------PDVSMNLSPV  244 (272)
T ss_pred             CCCCCcCcchHHHHHHhhcccc---------------------CCcCC----------------------ccccccCCHH
Confidence            9999975444332221110000                     00000                      0011235678


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCCCC
Q 014117          396 LTHLLQGLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       396 ~~~ll~~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      +.++|.+||+.||++|||++++|+||||
T Consensus       245 ~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         245 ALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             HHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.3e-41  Score=324.21  Aligned_cols=252  Identities=26%  Similarity=0.433  Sum_probs=199.9

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      +.|.....||.|+||.||++.+..++..||||.+.... ...+.+..|+.+++.+.     |+|++++++.+...+..|+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~ii~~~~~~~~~~~~~l   96 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH-----HENVVDMYNSYLVGDELWV   96 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCC-----CCcHHHHHHheecCCeEEE
Confidence            44666678999999999999999999999999986432 33455677888888773     4789999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+ +++|.+++...   .+++..+..++.||+.||.|||++||+||||||+||+++++                   
T Consensus        97 v~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-------------------  154 (292)
T cd06658          97 VMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD-------------------  154 (292)
T ss_pred             EEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-------------------
Confidence            99999 78999888543   58999999999999999999999999999999999999544                   


Q ss_pred             ccccCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                              +.++|+|||++.....   ......|+..|+|||.+.+..++.++|+|||||++|||++|..||...+..+.
T Consensus       155 --------~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~  226 (292)
T cd06658         155 --------GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA  226 (292)
T ss_pred             --------CCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                    4566666665543211   11234689999999999988899999999999999999999999987655444


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      +..+.........                                              .....+..+.+++.+||+.||
T Consensus       227 ~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~li~~~l~~~P  260 (292)
T cd06658         227 MRRIRDNLPPRVK----------------------------------------------DSHKVSSVLRGFLDLMLVREP  260 (292)
T ss_pred             HHHHHhcCCCccc----------------------------------------------cccccCHHHHHHHHHHccCCh
Confidence            3332221111000                                              011345678999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCC
Q 014117          409 TDRLTAREALRHPFFTRD  426 (430)
Q Consensus       409 ~~R~ta~elL~hp~f~~~  426 (430)
                      ++|||++++++||||...
T Consensus       261 ~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         261 SQRATAQELLQHPFLKLA  278 (292)
T ss_pred             hHCcCHHHHhhChhhhcc
Confidence            999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.9e-41  Score=312.40  Aligned_cols=248  Identities=29%  Similarity=0.457  Sum_probs=198.3

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch------hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      +|+..+.||+|+||.||+|.+..+++.||+|.+....      .....+..|+.+++.+.     +++++++++++....
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-----h~~i~~~~~~~~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-----HPNIVQYLGTEREED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-----CCCchheeeeEecCC
Confidence            4777899999999999999999899999999886322      23355677888888773     478999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+|+||||+ +++|.+++....  .+++..+..++.||+.||.|||+.||+|+||||+||+++.                
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~----------------  137 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT----------------  137 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC----------------
Confidence            999999999 889999998754  6899999999999999999999999999999999999954                


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                 ++.+||+|||.+......  .....|+..|+|||.+.... ++.++|+|||||++|+|++|..||....
T Consensus       138 -----------~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~  206 (258)
T cd06632         138 -----------NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE  206 (258)
T ss_pred             -----------CCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence                       445666666655433222  13346889999999998776 8999999999999999999999997655


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+....+... ...                                              ...+...+.++.+++.+||
T Consensus       207 ~~~~~~~~~~~-~~~----------------------------------------------~~~~~~~~~~~~~li~~~l  239 (258)
T cd06632         207 GVAAVFKIGRS-KEL----------------------------------------------PPIPDHLSDEAKDFILKCL  239 (258)
T ss_pred             HHHHHHHHHhc-ccC----------------------------------------------CCcCCCcCHHHHHHHHHHh
Confidence            33322211110 000                                              0123345678999999999


Q ss_pred             hcCCCCCCCHHHHhcCCCC
Q 014117          405 RYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f  423 (430)
                      +.||++|||+.+++.|||+
T Consensus       240 ~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         240 QRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             hcCcccCcCHHHHhcCCCC
Confidence            9999999999999999997

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.7e-41  Score=315.86  Aligned_cols=245  Identities=20%  Similarity=0.280  Sum_probs=191.9

Q ss_pred             CcEEEEeeeccccceEEEEEEEC---CCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      ++|++.+.||+|+||.||+|.++   ..+..||+|+++...  .....+..|+..+.++     .|+|++++++++...+
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~   79 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-----DHSNIVRLEGVITRGN   79 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-----CCCCcCeEEEEEecCC
Confidence            46999999999999999999765   456789999987432  3334567788888877     3488999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      ..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.     
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~-----  153 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRR-----  153 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcc-----
Confidence            999999999 789999987653 4689999999999999999999999999999999999996655555555543     


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT  322 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~  322 (430)
                                            +.......    ....++..|+|||++.+..++.++|||||||++||+++ |..||..
T Consensus       154 ----------------------~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~  211 (266)
T cd05064         154 ----------------------LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD  211 (266)
T ss_pred             ----------------------cccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence                                  32211110    11234678999999999999999999999999999775 9999987


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      .+..+....+......                                                ..+..++..+.+++.+
T Consensus       212 ~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~li~~  243 (266)
T cd05064         212 MSGQDVIKAVEDGFRL------------------------------------------------PAPRNCPNLLHQLMLD  243 (266)
T ss_pred             CCHHHHHHHHHCCCCC------------------------------------------------CCCCCCCHHHHHHHHH
Confidence            6655444333211000                                                0123456679999999


Q ss_pred             hhhcCCCCCCCHHHHhc
Q 014117          403 LLRYDPTDRLTAREALR  419 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~  419 (430)
                      ||+.+|++|||++++++
T Consensus       244 c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         244 CWQKERGERPRFSQIHS  260 (266)
T ss_pred             HcCCCchhCCCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.9e-41  Score=314.68  Aligned_cols=244  Identities=27%  Similarity=0.425  Sum_probs=197.2

Q ss_pred             eccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 014117          102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL  177 (430)
Q Consensus       102 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~  177 (430)
                      ||.|+||.||+|.+..+++.||+|++....    ...+.+..|+.+++.+.     |++++++++.+..+..+|+||||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-----HPFIVKLYRTFKDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-----CCCEeeeeeeEEcCCccEEEEecC
Confidence            699999999999999999999999986432    23455777888888873     478999999999999999999998


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccC
Q 014117          178 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM  256 (430)
Q Consensus       178 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~  256 (430)
                       +++|.+++.+..  .+++..+..++.||+.||.|||++|++|+||||+||+++                          
T Consensus        76 ~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~--------------------------  127 (262)
T cd05572          76 LGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD--------------------------  127 (262)
T ss_pred             CCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc--------------------------
Confidence             899999998754  689999999999999999999999999999999999994                          


Q ss_pred             CCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc--hHHHHHHH
Q 014117          257 PKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE--NLEHLAMM  332 (430)
Q Consensus       257 ~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~--~~~~~~~i  332 (430)
                       .++.++|+|||.+......  .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||....  ..+....+
T Consensus       128 -~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  206 (262)
T cd05572         128 -SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI  206 (262)
T ss_pred             -CCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH
Confidence             4456777777776644332  223468899999999988889999999999999999999999997655  22222221


Q ss_pred             HHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCC
Q 014117          333 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL  412 (430)
Q Consensus       333 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~  412 (430)
                      .....                                               ...++...+.++.++|.+||+.||++|+
T Consensus       207 ~~~~~-----------------------------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~  239 (262)
T cd05572         207 LKGNG-----------------------------------------------KLEFPNYIDKAAKDLIKQLLRRNPEERL  239 (262)
T ss_pred             hccCC-----------------------------------------------CCCCCcccCHHHHHHHHHHccCChhhCc
Confidence            10000                                               0012233466899999999999999999


Q ss_pred             C-----HHHHhcCCCCCCC
Q 014117          413 T-----AREALRHPFFTRD  426 (430)
Q Consensus       413 t-----a~elL~hp~f~~~  426 (430)
                      |     ++|+++||||+.-
T Consensus       240 ~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         240 GNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             CCcccCHHHHhcChhhhCC
Confidence            9     9999999999853

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.9e-41  Score=327.41  Aligned_cols=284  Identities=32%  Similarity=0.499  Sum_probs=215.9

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-  166 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-  166 (430)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|.+...   .........|+.++.++.    +|+||+++++++.. 
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~ni~~~~~~~~~~   79 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG----DHPNIVKLLNVIKAE   79 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhc----CCCCccceeeeeccC
Confidence            4567899999999999999999999999999999987532   222344567888888882    23789999998754 


Q ss_pred             -CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          167 -RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       167 -~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                       ...+|+||||++++|.+++...   .+++..+..++.||+.||.|||+.||+||||||+|||++.++.           
T Consensus        80 ~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~-----------  145 (337)
T cd07852          80 NDKDIYLVFEYMETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR-----------  145 (337)
T ss_pred             CCceEEEEecccccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc-----------
Confidence             4478999999988999988754   6889999999999999999999999999999999999965554           


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCC--------CCCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERP--------DQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTG  316 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG  316 (430)
                                      +||+|||++.....        ......||..|+|||++.+ ..++.++|+|||||++|+|++|
T Consensus       146 ----------------~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg  209 (337)
T cd07852         146 ----------------VKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG  209 (337)
T ss_pred             ----------------EEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhC
Confidence                            55555554432211        1123468999999998765 4588999999999999999999


Q ss_pred             CCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHH
Q 014117          317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL  396 (430)
Q Consensus       317 ~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (430)
                      ++||.+....+....+....+..+...+..+........... .                ...... .........+.++
T Consensus       210 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~----------------~~~~~~-~~~~~~~~~~~~l  271 (337)
T cd07852         210 KPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDS-L----------------PSRPRK-PLDELLPKASDDA  271 (337)
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhh-c----------------cccccc-chhhhccCCCHHH
Confidence            999998888888888888888777665554433222211110 0                000000 0112223467889


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          397 THLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       397 ~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      .+||.+||+.||++|||+.++++||||++-
T Consensus       272 ~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         272 LDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence            999999999999999999999999999653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8e-41  Score=312.00  Aligned_cols=246  Identities=25%  Similarity=0.400  Sum_probs=197.4

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      +|++.+.||.|+||.||++.+..+++.||+|.++..  ....+....|+.+++.+.     |+|++++.+.+...+.+|+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK-----HPNIVAFKESFEADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCC-----CCCcceEEEEEEECCEEEE
Confidence            488999999999999999999999999999998632  233455667888888773     4789999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+ +++|.+++.......+++..+..++.||+.||.|||++||+|+||||+|||++.+                   
T Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~-------------------  136 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN-------------------  136 (255)
T ss_pred             EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC-------------------
Confidence            99999 8899999876555678999999999999999999999999999999999999544                   


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                              +.++|+|||.+......   .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+....
T Consensus       137 --------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~  208 (255)
T cd08219         137 --------GKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL  208 (255)
T ss_pred             --------CcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH
Confidence                    45666666655433221   1234688999999999998899999999999999999999999987554333


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      ...+...  ..+                                              ..+...+..+.+||.+||+.||
T Consensus       209 ~~~~~~~--~~~----------------------------------------------~~~~~~~~~~~~li~~~l~~~P  240 (255)
T cd08219         209 ILKVCQG--SYK----------------------------------------------PLPSHYSYELRSLIKQMFKRNP  240 (255)
T ss_pred             HHHHhcC--CCC----------------------------------------------CCCcccCHHHHHHHHHHHhCCc
Confidence            3222110  000                                              0122345678999999999999


Q ss_pred             CCCCCHHHHhcC
Q 014117          409 TDRLTAREALRH  420 (430)
Q Consensus       409 ~~R~ta~elL~h  420 (430)
                      ++|||+.+++.-
T Consensus       241 ~~Rp~~~~il~~  252 (255)
T cd08219         241 RSRPSATTILSR  252 (255)
T ss_pred             ccCCCHHHHhhc
Confidence            999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-41  Score=315.71  Aligned_cols=275  Identities=31%  Similarity=0.533  Sum_probs=217.6

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      |++.+.||+|+||.||+|.+..+++.||+|++...   .........|+.+++.+.     +++++++++++...+..++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~i~~~~~~~~~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK-----HPNIVKLLDVIHTERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcC-----CCCHHHHHhhhhcCCceEE
Confidence            56788999999999999999999999999998753   233455677888888874     4889999999999999999


Q ss_pred             EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          173 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       173 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      ||||++++|.+++.... ..+++..+..++.|++.||.|||++||+||||+|+||++++                     
T Consensus        76 v~e~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~---------------------  133 (282)
T cd07829          76 VFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINR---------------------  133 (282)
T ss_pred             EecCcCcCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcC---------------------
Confidence            99999889999998753 36999999999999999999999999999999999999954                     


Q ss_pred             cccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                            ++.++|+|||.+.......   ....++..|+|||.+.+. .++.++|||||||++|||++|.+||...+..+.
T Consensus       134 ------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~  207 (282)
T cd07829         134 ------DGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ  207 (282)
T ss_pred             ------CCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence                  4556677777665433221   123457789999998876 789999999999999999999999999888888


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      +..+...++...+..+..+.... . ...   .++..              . ........+..+.++.++|++||+.||
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~-~-~~~---~~~~~--------------~-~~~~~~~~~~~~~~~~~~i~~~l~~~P  267 (282)
T cd07829         208 LFKIFQILGTPTEESWPGVTKLP-D-YKP---TFPKF--------------P-PKDLEKVLPRLDPEGIDLLSKMLQYNP  267 (282)
T ss_pred             HHHHHHHhCCCcHHHHHhhcccc-c-ccc---ccccc--------------C-ccchHHhcccccHHHHHHHHHhhccCc
Confidence            88888888887776655443322 0 000   00000              0 000111223447789999999999999


Q ss_pred             CCCCCHHHHhcCCCC
Q 014117          409 TDRLTAREALRHPFF  423 (430)
Q Consensus       409 ~~R~ta~elL~hp~f  423 (430)
                      ++||++.+++.||||
T Consensus       268 ~~Rp~~~~~l~~p~~  282 (282)
T cd07829         268 AKRISAKEALKHPYF  282 (282)
T ss_pred             ccCCCHHHHhhCcCC
Confidence            999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.2e-41  Score=312.25  Aligned_cols=250  Identities=26%  Similarity=0.403  Sum_probs=201.6

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +|.+.+.||.|+||.||+|.++.++..||+|.+...   ......+..|+.+++.+.     ++|++++++.+......+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~-----h~~i~~~~~~~~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK-----HPNIVTFFASFQENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC-----CCChhhhhheeccCCeEE
Confidence            588999999999999999999999999999998643   123445677888888884     478999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +|+||+ +++|.+++.......+++..+..++.|++.||.|||+.+|+|+||||+||++++++                 
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~-----------------  138 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNG-----------------  138 (257)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCC-----------------
Confidence            999999 88999999876555689999999999999999999999999999999999995432                 


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                               ..++|+|||.+.......   ....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+
T Consensus       139 ---------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  209 (257)
T cd08225         139 ---------MVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ  209 (257)
T ss_pred             ---------CeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence                     235667776665433221   12357889999999988889999999999999999999999998655433


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+..  +..                                              ....+..+.++.++|.+||+.+
T Consensus       210 ~~~~~~~--~~~----------------------------------------------~~~~~~~~~~~~~~i~~~l~~~  241 (257)
T cd08225         210 LVLKICQ--GYF----------------------------------------------APISPNFSRDLRSLISQLFKVS  241 (257)
T ss_pred             HHHHHhc--ccC----------------------------------------------CCCCCCCCHHHHHHHHHHhccC
Confidence            3222111  000                                              0012345667999999999999


Q ss_pred             CCCCCCHHHHhcCCCC
Q 014117          408 PTDRLTAREALRHPFF  423 (430)
Q Consensus       408 P~~R~ta~elL~hp~f  423 (430)
                      |++|||+.|++.||||
T Consensus       242 p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         242 PRDRPSITSILKRPFL  257 (257)
T ss_pred             hhhCcCHHHHhhCCCC
Confidence            9999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.4e-41  Score=317.89  Aligned_cols=252  Identities=27%  Similarity=0.422  Sum_probs=200.6

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ..|+.+++||.|+||.||+|.+..++..||+|++....  .....+..|+.++..+     .|++++++++.+......|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~   78 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYVTKYYGSYLKGTKLW   78 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEECCEEE
Confidence            35888899999999999999999999999999986432  3345566788888777     3478999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|.+++...   .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++                 
T Consensus        79 lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~-----------------  138 (277)
T cd06640          79 IIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-----------------  138 (277)
T ss_pred             EEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC-----------------
Confidence            999999 88999998753   589999999999999999999999999999999999996544                 


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                                .++|+|||++......   .....++..|+|||++.+..++.++|+|||||++|||++|.+||.......
T Consensus       139 ----------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~  208 (277)
T cd06640         139 ----------DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR  208 (277)
T ss_pred             ----------CEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh
Confidence                      4555566555332211   122467889999999998889999999999999999999999997654433


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+...  . +                                             ...+...+.++.+++.+||+.|
T Consensus       209 ~~~~~~~~--~-~---------------------------------------------~~~~~~~~~~~~~li~~~l~~~  240 (277)
T cd06640         209 VLFLIPKN--N-P---------------------------------------------PTLTGEFSKPFKEFIDACLNKD  240 (277)
T ss_pred             HhhhhhcC--C-C---------------------------------------------CCCchhhhHHHHHHHHHHcccC
Confidence            22211100  0 0                                             0112234567899999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~~~  428 (430)
                      |++|||+.++++||||.+...
T Consensus       241 p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         241 PSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             cccCcCHHHHHhChHhhhcch
Confidence            999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.9e-41  Score=319.45  Aligned_cols=262  Identities=24%  Similarity=0.368  Sum_probs=201.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ++|++++.||+|+||+||++.+..+++.||+|++...  ......+..|++++..+.     +++++++++.+...+.++
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR-----SPYIVSFYGAFLNENNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcC-----CCCcceEeeeEecCCEEE
Confidence            5689999999999999999999999999999987633  234456778999888873     488999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      +||||+ +++|.+++...+  .+++..+..++.|++.||.|||+ .+|+||||||+||++++                  
T Consensus        80 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~------------------  139 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS------------------  139 (284)
T ss_pred             EEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC------------------
Confidence            999999 889999887654  68999999999999999999997 68999999999999954                  


Q ss_pred             CcccccCCCCCCeEEEeCCCccccC-CCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYER-PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                               ++.++|+|||++.... ......+||..|+|||++.+..++.++|+|||||++|+|++|..||......+.
T Consensus       140 ---------~~~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~  210 (284)
T cd06620         140 ---------RGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD  210 (284)
T ss_pred             ---------CCcEEEccCCcccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh
Confidence                     4456677777654321 122335789999999999888999999999999999999999999986443211


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhc-CCchhHHHHHHHHhhhcC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV-DHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~~L~~d  407 (430)
                      ..       ..+..+..    .....+....                          ...+ ..++.++.+|+.+||+.|
T Consensus       211 ~~-------~~~~~~~~----~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~d  253 (284)
T cd06620         211 GQ-------DDPMGILD----LLQQIVQEPP--------------------------PRLPSSDFPEDLRDFVDACLLKD  253 (284)
T ss_pred             hh-------hhhhHHHH----HHHHHhhccC--------------------------CCCCchhcCHHHHHHHHHHhcCC
Confidence            00       00000000    0000000000                          0000 124567999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~  426 (430)
                      |++|||+.|+++|+||.+.
T Consensus       254 p~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         254 PTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             cccCcCHHHHhcCcccccc
Confidence            9999999999999999654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.2e-41  Score=322.24  Aligned_cols=251  Identities=24%  Similarity=0.443  Sum_probs=200.2

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      |....+||+|+||.||+|.+..+++.||+|++... ......+..|+.++..+     .|+|++++++.+...+..|+||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-----QHQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-----CCCchhhhhhheeeCCeEEEEE
Confidence            44556899999999999999999999999998632 23345566788887777     3478999999999999999999


Q ss_pred             ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          175 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       175 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      ||+ +++|.+++...   .+++..+..++.|++.||.|||++||+||||||+||+++                       
T Consensus        98 e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~-----------------------  151 (297)
T cd06659          98 EFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT-----------------------  151 (297)
T ss_pred             ecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc-----------------------
Confidence            999 88999887553   689999999999999999999999999999999999994                       


Q ss_pred             ccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Q 014117          254 KRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA  330 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~  330 (430)
                          .++.++|+|||++......   .....|+..|+|||++.+..++.++|||||||++|||++|..||...+..+...
T Consensus       152 ----~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~  227 (297)
T cd06659         152 ----LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK  227 (297)
T ss_pred             ----cCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                4456677777766432221   223578999999999998889999999999999999999999998765544433


Q ss_pred             HHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCC
Q 014117          331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD  410 (430)
Q Consensus       331 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~  410 (430)
                      .+..   ..+..                                           .......+.++.++|.+||+.||++
T Consensus       228 ~~~~---~~~~~-------------------------------------------~~~~~~~~~~l~~~i~~~l~~~P~~  261 (297)
T cd06659         228 RLRD---SPPPK-------------------------------------------LKNAHKISPVLRDFLERMLTREPQE  261 (297)
T ss_pred             HHhc---cCCCC-------------------------------------------ccccCCCCHHHHHHHHHHhcCCccc
Confidence            2221   00000                                           0011234567899999999999999


Q ss_pred             CCCHHHHhcCCCCCCCC
Q 014117          411 RLTAREALRHPFFTRDH  427 (430)
Q Consensus       411 R~ta~elL~hp~f~~~~  427 (430)
                      |||++++++||||.+..
T Consensus       262 Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         262 RATAQELLDHPFLLQTG  278 (297)
T ss_pred             CcCHHHHhhChhhccCC
Confidence            99999999999998774

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8e-41  Score=315.80  Aligned_cols=271  Identities=27%  Similarity=0.392  Sum_probs=209.7

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++....    ........|.+++.++.    .++|++++++++...+.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~----~~~~i~~~~~~~~~~~~   76 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN----GHPGIIKLYYTFQDEEN   76 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcc----cCCCchhHHHHhcCCce
Confidence            36999999999999999999999999999999986422    22345566777777774    35889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .++|||++ +++|.+++.+.+  .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++++|||++.....
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999 999999998764  799999999999999999999999999999999999998888888888887755433


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                      ........    .....++..............|+..|+|||++.+..++.++|+|||||+++++++|..||...+....
T Consensus       155 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  230 (280)
T cd05581         155 NSSPESNK----GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT  230 (280)
T ss_pred             ccccccCC----CCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence            22110000    00001111111111122334678999999999888899999999999999999999999987664443


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      +..+.....                                                 ..+...+..+.+||.+||+.||
T Consensus       231 ~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~li~~~l~~~p  261 (280)
T cd05581         231 FQKILKLEY-------------------------------------------------SFPPNFPPDAKDLIEKLLVLDP  261 (280)
T ss_pred             HHHHHhcCC-------------------------------------------------CCCCccCHHHHHHHHHHhcCCH
Confidence            333221111                                                 1223446679999999999999


Q ss_pred             CCCCCH----HHHhcCCCC
Q 014117          409 TDRLTA----REALRHPFF  423 (430)
Q Consensus       409 ~~R~ta----~elL~hp~f  423 (430)
                      ++|||+    +++|+||||
T Consensus       262 ~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         262 QDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             hhCCCcccCHHHHhcCCCC
Confidence            999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.5e-40  Score=311.34  Aligned_cols=250  Identities=30%  Similarity=0.463  Sum_probs=196.6

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +|++.+.||+|+||.||+|.+..+++.||+|.++....   ....+..|+.+++.+.     +++|+++++.+...+.++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~-----~~~i~~~~~~~~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-----HPNLVKYYGVEVHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCC-----CCChhheeeeEecCCEEE
Confidence            58999999999999999999999999999999874433   4566778888888884     378999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +|+||+ +++|.+++....  .+++..+..++.|++.||.|||+.||+|+||||+||++++++.                
T Consensus        76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~----------------  137 (264)
T cd06626          76 IFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV----------------  137 (264)
T ss_pred             EEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC----------------
Confidence            999999 889999997653  6899999999999999999999999999999999999965554                


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC-------CeeeecCcccchhhhhCCC---CCCcchHHHHHHHHHHHHhCCCCC
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                 +||+|||.+.......       ....++..|+|||++.+..   ++.++|||||||++|+|++|..||
T Consensus       138 -----------~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf  206 (264)
T cd06626         138 -----------IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW  206 (264)
T ss_pred             -----------EEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCc
Confidence                       5555555443322111       1235788999999998766   889999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      ............... +..+.                    .|                        .....+..+.+||
T Consensus       207 ~~~~~~~~~~~~~~~-~~~~~--------------------~~------------------------~~~~~~~~~~~li  241 (264)
T cd06626         207 SELDNEFQIMFHVGA-GHKPP--------------------IP------------------------DSLQLSPEGKDFL  241 (264)
T ss_pred             cCCcchHHHHHHHhc-CCCCC--------------------CC------------------------cccccCHHHHHHH
Confidence            764322221111110 11110                    00                        0112356789999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCCCC
Q 014117          401 QGLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      .+||+.||++|||+.|++.|||+
T Consensus       242 ~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         242 DRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHccCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.3e-40  Score=313.00  Aligned_cols=250  Identities=26%  Similarity=0.384  Sum_probs=194.8

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      +.....||+|+||.||+|.+..++..||+|.+.... ...+.+..|+.+++.+.     |+|++++++++...+..++||
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLK-----HRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcC-----CCCeeeeeeeeccCCEEEEEE
Confidence            344568999999999999999999999999886432 33456778888888874     478999999999999999999


Q ss_pred             ecC-CCCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          175 EKL-GSSLYDFLRKNNYRSF--PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       175 e~~-~~~L~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||+ +++|.+++.... ..+  ++..+..++.||+.||.|||++||+||||||+||+++.                    
T Consensus        85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~--------------------  143 (268)
T cd06624          85 EQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT--------------------  143 (268)
T ss_pred             ecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--------------------
Confidence            999 889999997643 234  88889999999999999999999999999999999953                    


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLG--WTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                            ....++|+|||.+......   .....|+..|+|||++.+..  ++.++|+|||||++|+|++|..||......
T Consensus       144 ------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~  217 (268)
T cd06624         144 ------YSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP  217 (268)
T ss_pred             ------CCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh
Confidence                  2346778888876543221   12245789999999987643  889999999999999999999999753321


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      ...........                                              .....+...+.++.+|+.+||+.
T Consensus       218 ~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~~~li~~~l~~  251 (268)
T cd06624         218 QAAMFKVGMFK----------------------------------------------IHPEIPESLSAEAKNFILRCFEP  251 (268)
T ss_pred             hhhHhhhhhhc----------------------------------------------cCCCCCcccCHHHHHHHHHHcCC
Confidence            11100000000                                              00112345567899999999999


Q ss_pred             CCCCCCCHHHHhcCCCC
Q 014117          407 DPTDRLTAREALRHPFF  423 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f  423 (430)
                      +|++|||+.|++.||||
T Consensus       252 ~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         252 DPDKRASAHDLLQDPFL  268 (268)
T ss_pred             CchhCCCHHHHHhCCCC
Confidence            99999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.6e-41  Score=316.86  Aligned_cols=254  Identities=26%  Similarity=0.437  Sum_probs=202.1

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      +|++.+.||.|+||.||+|.++.+++.||+|.+...  ......+..|+++++++.     ++|++++++.+...+..++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~i~~~~~~~~~~~~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN-----SPYIVGFYGAFYNNGDISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC-----CCchhhhheeeecCCEEEE
Confidence            578889999999999999999999999999998643  233455677888888874     4789999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      |+||+ +++|.+++.... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++                    
T Consensus        77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~--------------------  135 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN--------------------  135 (265)
T ss_pred             EEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC--------------------
Confidence            99999 689999998653 479999999999999999999999 9999999999999994                    


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC-CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch--HH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN--LE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~--~~  327 (430)
                             .++.++|+|||.+...... .....++..|+|||.+.+..++.++|||||||++|+|++|..||.....  ..
T Consensus       136 -------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  208 (265)
T cd06605         136 -------SRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG  208 (265)
T ss_pred             -------CCCCEEEeecccchhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc
Confidence                   4556788888876543221 1225788999999999999999999999999999999999999965421  11


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcC-CchhHHHHHHHHhhhc
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD-HSAGDLTHLLQGLLRY  406 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ll~~~L~~  406 (430)
                      ....+.......+.                                             ..+. ..+.++.++|.+||..
T Consensus       209 ~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~li~~~l~~  243 (265)
T cd06605         209 IFELLQYIVNEPPP---------------------------------------------RLPSGKFSPDFQDFVNLCLIK  243 (265)
T ss_pred             HHHHHHHHhcCCCC---------------------------------------------CCChhhcCHHHHHHHHHHcCC
Confidence            11111111111000                                             0011 1566799999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||++|||+.+++.||||++-
T Consensus       244 ~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         244 DPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             CchhCcCHHHHhhCchhhcc
Confidence            99999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.6e-41  Score=330.82  Aligned_cols=250  Identities=23%  Similarity=0.354  Sum_probs=191.5

Q ss_pred             cCcEEEEeeeccccceEEEEEEE-----CCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .++|++.+.||+|+||.||+|..     ..++..||+|+++...  ...+.+..|+.++..+.+    |+||+++++.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~----HpnIv~l~~~~~  109 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN----HINIVNLLGACT  109 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcC----Ccceeeeeeeec
Confidence            34799999999999999999964     3456789999986432  234567789999998842    478999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcC-------------------------------------------------------
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNN-------------------------------------------------------  189 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~-------------------------------------------------------  189 (430)
                      ..+..++||||+ +|+|.+++....                                                       
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            999999999999 999999986532                                                       


Q ss_pred             ------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          190 ------------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       190 ------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                                        ...+++..+..++.||+.||.|||+.||+||||||+|||++.++                  
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~------------------  251 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR------------------  251 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC------------------
Confidence                              12478888999999999999999999999999999999996544                  


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCch
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN  325 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~  325 (430)
                               .+||+|||++.......     ....++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus       252 ---------~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~  322 (375)
T cd05104         252 ---------ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV  322 (375)
T ss_pred             ---------cEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc
Confidence                     45566666554322211     11234667999999999999999999999999999998 8999976543


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      ......+..                      .+.                         ....+...+.++.+||.+||+
T Consensus       323 ~~~~~~~~~----------------------~~~-------------------------~~~~~~~~~~~l~~li~~cl~  355 (375)
T cd05104         323 DSKFYKMIK----------------------EGY-------------------------RMLSPECAPSEMYDIMKSCWD  355 (375)
T ss_pred             hHHHHHHHH----------------------hCc-------------------------cCCCCCCCCHHHHHHHHHHcc
Confidence            322211110                      000                         000122345679999999999


Q ss_pred             cCCCCCCCHHHHhcC
Q 014117          406 YDPTDRLTAREALRH  420 (430)
Q Consensus       406 ~dP~~R~ta~elL~h  420 (430)
                      .||++|||+.|+++.
T Consensus       356 ~dP~~RPs~~eil~~  370 (375)
T cd05104         356 ADPLKRPTFKQIVQL  370 (375)
T ss_pred             CChhHCcCHHHHHHH
Confidence            999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=7.8e-41  Score=351.31  Aligned_cols=144  Identities=22%  Similarity=0.367  Sum_probs=128.2

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|.++++||.|+||.||+|.+..+++.||||+++...    .....+..|+.++..+.     +++|+.++..+....+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~Iv~~~~~~~~~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-----SPFIVHLYYSLQSANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-----CCCcCeEEEEEEECCE
Confidence            57999999999999999999999999999999986432    22355667888887763     4789999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                      +||||||+ +++|.+++...+  .+++..++.|+.||+.||.|||++|||||||||+||||+.++.++|+|||++.
T Consensus        79 ~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999 899999997654  68999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.3e-41  Score=320.45  Aligned_cols=258  Identities=23%  Similarity=0.360  Sum_probs=197.5

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      +|+..+.||+|+||.||++.+..+++.||+|.+....  .....+..|+.++.++.    .+++++++++++..++..++
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~----~~~~iv~~~~~~~~~~~~~~   80 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS----DCPYIVKFYGALFREGDCWI   80 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhc----CCCCEeeeeeEEecCCcEEE
Confidence            4667789999999999999999999999999986432  23445667888877774    24789999999988999999


Q ss_pred             EEecCCCCHHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          173 VFEKLGSSLYDFLR---KNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       173 v~e~~~~~L~~~l~---~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|||++.+|.++..   ......+++..+..++.|++.||+|||+ .+|+||||||+|||+++                 
T Consensus        81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~-----------------  143 (288)
T cd06616          81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR-----------------  143 (288)
T ss_pred             EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc-----------------
Confidence            99999777665432   2233579999999999999999999997 49999999999999954                 


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCC---CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                .+.++|+|||++......  .....||..|+|||++.+.   .++.++|||||||++|+|++|++||...
T Consensus       144 ----------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  213 (288)
T cd06616         144 ----------NGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW  213 (288)
T ss_pred             ----------CCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence                      445777777776533221  1234688999999999876   6899999999999999999999999764


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      .  .....+.+.....+...                                         ....+...+.++.+||.+|
T Consensus       214 ~--~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~l~~li~~~  250 (288)
T cd06616         214 N--SVFDQLTQVVKGDPPIL-----------------------------------------SNSEEREFSPSFVNFINLC  250 (288)
T ss_pred             c--hHHHHHhhhcCCCCCcC-----------------------------------------CCcCCCccCHHHHHHHHHH
Confidence            3  12222222211111000                                         0001124567899999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      |+.||++|||+++++.||||...
T Consensus       251 l~~~p~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         251 LIKDESKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             ccCChhhCcCHHHHhcChhhhch
Confidence            99999999999999999999764

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.3e-41  Score=327.78  Aligned_cols=302  Identities=16%  Similarity=0.199  Sum_probs=198.0

Q ss_pred             eeeccc--cceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117          100 SKMGEG--TFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus       100 ~~lG~G--~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      ..||.|  +||+||+|.+..+++.||+|++....   ...+.+..|+.+++.+     .|+||+++++++..++..|+||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-----~h~niv~~~~~~~~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-----RHPNIMTSWTVFTTGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCcceEeeeEecCCceEEEE
Confidence            456666  99999999999999999999986432   2234556677776666     4488999999999999999999


Q ss_pred             ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          175 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       175 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      ||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+.......   
T Consensus        79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~---  155 (328)
T cd08226          79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG---  155 (328)
T ss_pred             ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC---
Confidence            999 7899999987655579999999999999999999999999999999999999877766666665332111000   


Q ss_pred             ccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Q 014117          254 KRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM  331 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~  331 (430)
                                    +.............++..|+|||++.+.  .++.++|||||||++|+|++|.+||......+....
T Consensus       156 --------------~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~  221 (328)
T cd08226         156 --------------QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ  221 (328)
T ss_pred             --------------ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHH
Confidence                          0000000001112356779999999764  478999999999999999999999987655443333


Q ss_pred             HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhc-CchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCC
Q 014117          332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM-KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD  410 (430)
Q Consensus       332 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~  410 (430)
                      ........|.....  ..............+... .......... .......+....+..++.++.+||++||+.||++
T Consensus       222 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  298 (328)
T cd08226         222 KLKGPPYSPLDITT--FPCEESRMKNSQSGVDSG-IGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEK  298 (328)
T ss_pred             HhcCCCCCCccccc--cchhhhhhccchhhhhcc-cccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCccc
Confidence            22211111110000  000000000000000000 0000000000 0000000111123456778999999999999999


Q ss_pred             CCCHHHHhcCCCCCCC
Q 014117          411 RLTAREALRHPFFTRD  426 (430)
Q Consensus       411 R~ta~elL~hp~f~~~  426 (430)
                      |||++|+|+||||+..
T Consensus       299 Rpta~e~l~~~~~~~~  314 (328)
T cd08226         299 RPSASSLLSHAFFKQV  314 (328)
T ss_pred             CCCHHHHhhCHHHHHH
Confidence            9999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=4.3e-42  Score=296.52  Aligned_cols=283  Identities=26%  Similarity=0.526  Sum_probs=221.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--CeE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHI  170 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~--~~~  170 (430)
                      .++|++++++|+|.|+.||.|.+..+++.++||+++..+  .+...+|+.+|+.|+    +++||+.+++...++  ...
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~----gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLR----GGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhcc----CCCCeeehhhhhcCccccCc
Confidence            568999999999999999999999999999999998544  356778999999996    458899999988764  567


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      .|++||+ ..+...+.     ..|+.-.++.++.|++.||.|||++||+|||+||.|++|+                   
T Consensus       111 aLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId-------------------  166 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID-------------------  166 (338)
T ss_pred             hhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec-------------------
Confidence            8999999 44544433     3688899999999999999999999999999999999996                   


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCCCe--eeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCC-CCCch
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF-QTHEN  325 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf-~~~~~  325 (430)
                             .+...++|+|||+|-+..+....  .+.+..|-.||++..- .|+..-|+|||||++..|+..+.|| .+.++
T Consensus       167 -------h~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN  239 (338)
T KOG0668|consen  167 -------HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN  239 (338)
T ss_pred             -------hhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC
Confidence                   34567999999999888777643  5778999999998765 5899999999999999999987776 78899


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHH-hhhcCCchhHHHHHHHHhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI-MQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~~L  404 (430)
                      .+++..|.+++|.          ++...|+.+.....+....   .+...-.......++ .+...-.++++.|||.++|
T Consensus       240 ~DQLVkIakVLGt----------~el~~Yl~KY~i~Ldp~~~---~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklL  306 (338)
T KOG0668|consen  240 YDQLVKIAKVLGT----------DELYAYLNKYQIDLDPQFE---DILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLL  306 (338)
T ss_pred             HHHHHHHHHHhCh----------HHHHHHHHHHccCCChhHh---hHhhccccccHHHhCCccccccCChHHHHHHHHHH
Confidence            9999999999996          3444555544433322110   000000000001111 1111234688999999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~  425 (430)
                      .+|.++|+||.|++.||||..
T Consensus       307 rYDHqeRlTakEam~HpyF~~  327 (338)
T KOG0668|consen  307 RYDHQERLTAKEAMAHPYFAP  327 (338)
T ss_pred             hhccccccchHHHhcCchHHH
Confidence            999999999999999999963

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-43  Score=332.67  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=214.6

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      ..+++++..||-||||.|=++..+.....+|+|++++..    +..+-...|..+|..++     .+.|+++|..|.+..
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-----s~fIvrLYrTfrd~k  493 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-----SDFIVRLYRTFRDSK  493 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-----chHHHHHHHHhccch
Confidence            456888999999999999998877666679999987532    22334556888888874     388999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      ++|++||.| ||.|+..|+.++  .|....++.|+..++.|++|||++|||+|||||+|.|++                 
T Consensus       494 yvYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd-----------------  554 (732)
T KOG0614|consen  494 YVYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD-----------------  554 (732)
T ss_pred             hhhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec-----------------
Confidence            999999999 999999999887  899999999999999999999999999999999999995                 


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                                ..+-+||.|||+|+......  .++|||+.|.|||++++...+.++|.||||+++|||++|.+||++.+.
T Consensus       555 ----------~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp  624 (732)
T KOG0614|consen  555 ----------NRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP  624 (732)
T ss_pred             ----------cCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence                      45556777777777655443  458999999999999999999999999999999999999999999998


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      +..+..|.+...                                               ...+|...+..+.+||+++..
T Consensus       625 mktYn~ILkGid-----------------------------------------------~i~~Pr~I~k~a~~Lik~LCr  657 (732)
T KOG0614|consen  625 MKTYNLILKGID-----------------------------------------------KIEFPRRITKTATDLIKKLCR  657 (732)
T ss_pred             HHHHHHHHhhhh-----------------------------------------------hhhcccccchhHHHHHHHHHh
Confidence            888877765431                                               123445566778999999999


Q ss_pred             cCCCCCCC-----HHHHhcCCCCCCC
Q 014117          406 YDPTDRLT-----AREALRHPFFTRD  426 (430)
Q Consensus       406 ~dP~~R~t-----a~elL~hp~f~~~  426 (430)
                      .+|.+|+.     +.++-.|.||..-
T Consensus       658 ~~P~ERLG~~~~gI~DIkkH~Wf~gf  683 (732)
T KOG0614|consen  658 DNPTERLGYQKGGINDIKKHRWFEGF  683 (732)
T ss_pred             cCcHhhhccccCChHHHHhhhhhhcC
Confidence            99999996     8999999999753

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.8e-40  Score=315.12  Aligned_cols=251  Identities=27%  Similarity=0.446  Sum_probs=199.7

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      .|...+.||.|++|.||++.+..+++.+|+|.+.... ...+.+..|+.+++.+     .+++++++++++...+..|+|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-----~h~~vv~~~~~~~~~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-----QHPNIVEMYSSYLVGDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-----CCCChheEEEEEEcCCeEEEE
Confidence            4666789999999999999999999999999886332 2334567788888887     347899999999999999999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      +||+ +++|.+++..   .++++..+..++.||+.||.|||++||+||||||+||+++.+                    
T Consensus        95 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~--------------------  151 (285)
T cd06648          95 MEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD--------------------  151 (285)
T ss_pred             EeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC--------------------
Confidence            9999 8899999876   268999999999999999999999999999999999999544                    


Q ss_pred             cccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL  329 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~  329 (430)
                             +.++|+|||.+......   .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+..+..
T Consensus       152 -------~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~  224 (285)
T cd06648         152 -------GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM  224 (285)
T ss_pred             -------CcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH
Confidence                   45566666654422211   12246889999999999888999999999999999999999999875544443


Q ss_pred             HHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCC
Q 014117          330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT  409 (430)
Q Consensus       330 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~  409 (430)
                      ..+.....+..                                              ..+...+..+.+|+++||+.||+
T Consensus       225 ~~~~~~~~~~~----------------------------------------------~~~~~~~~~l~~li~~~l~~~p~  258 (285)
T cd06648         225 KRIRDNLPPKL----------------------------------------------KNLHKVSPRLRSFLDRMLVRDPA  258 (285)
T ss_pred             HHHHhcCCCCC----------------------------------------------cccccCCHHHHHHHHHHcccChh
Confidence            33222100000                                              01123456799999999999999


Q ss_pred             CCCCHHHHhcCCCCCCC
Q 014117          410 DRLTAREALRHPFFTRD  426 (430)
Q Consensus       410 ~R~ta~elL~hp~f~~~  426 (430)
                      +|||+.++++||||+..
T Consensus       259 ~Rpt~~~il~~~~~~~~  275 (285)
T cd06648         259 QRATAAELLNHPFLAKA  275 (285)
T ss_pred             hCcCHHHHccCcccccC
Confidence            99999999999999765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-41  Score=315.48  Aligned_cols=254  Identities=22%  Similarity=0.381  Sum_probs=200.4

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      .|++.+.||.|+||.||+|.+..+++.||+|.++..  ......+..|+.+++.+.+  ..+++++++++.+......|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~--~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ--SQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhcc--CCCCCeeeEeeeeeeCCEEEE
Confidence            478889999999999999999999999999998642  2334557788999998864  235889999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+ +++|.+++...   .+++..+..++.|++.||.|||+.||+|+||+|+||+++.                    
T Consensus        80 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~--------------------  136 (277)
T cd06917          80 IMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN--------------------  136 (277)
T ss_pred             EEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcC--------------------
Confidence            99999 88999998653   6899999999999999999999999999999999999954                    


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                             .+.++|+|||.+......   .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+...
T Consensus       137 -------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~  209 (277)
T cd06917         137 -------TGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR  209 (277)
T ss_pred             -------CCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence                   445666666665543222   123468899999999875 457899999999999999999999997654332


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+...   .++                   ..                         .....+.++.+++.+||+.|
T Consensus       210 ~~~~~~~~---~~~-------------------~~-------------------------~~~~~~~~~~~~i~~~l~~~  242 (277)
T cd06917         210 AMMLIPKS---KPP-------------------RL-------------------------EDNGYSKLLREFVAACLDEE  242 (277)
T ss_pred             hhhccccC---CCC-------------------CC-------------------------CcccCCHHHHHHHHHHcCCC
Confidence            22111000   000                   00                         00124567999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~~  427 (430)
                      |++|||+.+++.||||++..
T Consensus       243 p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         243 PKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             cccCcCHHHHhhChHhhccc
Confidence            99999999999999997653

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.4e-40  Score=309.68  Aligned_cols=249  Identities=24%  Similarity=0.441  Sum_probs=198.3

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee--cCCe
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--YRNH  169 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~--~~~~  169 (430)
                      +|++.+.||.|+||.||+|.+..+++.||+|++...   ....+.+..|+++++.+.     +++++++++.+.  ....
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~   75 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK-----HPNIVRYYDRIIDRSNQT   75 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcC-----CCccceeeeeeecCCCCE
Confidence            488999999999999999999999999999998632   233455677888888884     478999888664  4567


Q ss_pred             EEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH-----hcCeeeccCCCCceEEeecCccccCCCc
Q 014117          170 ICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMH-----DLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH-----~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      +|++|||+ +++|.+++...  ....+++..++.++.||+.||.|||     +.+|+|+||||+||+++.          
T Consensus        76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~----------  145 (265)
T cd08217          76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA----------  145 (265)
T ss_pred             EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEec----------
Confidence            89999999 88999998753  2347899999999999999999999     899999999999999954          


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                       ++.+||+|||++.......   ....|++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus       146 -----------------~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~  208 (265)
T cd08217         146 -----------------NNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP  208 (265)
T ss_pred             -----------------CCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCC
Confidence                             4456666666665433222   23468999999999998889999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||...+..+....+..                       +..                         ...+...+.++.+
T Consensus       209 p~~~~~~~~~~~~~~~-----------------------~~~-------------------------~~~~~~~~~~~~~  240 (265)
T cd08217         209 PFTARNQLQLASKIKE-----------------------GKF-------------------------RRIPYRYSSELNE  240 (265)
T ss_pred             cccCcCHHHHHHHHhc-----------------------CCC-------------------------CCCccccCHHHHH
Confidence            9987654333222211                       000                         0122345668999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCCCC
Q 014117          399 LLQGLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      ++.+||+.+|++|||+.+||+|||+
T Consensus       241 l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         241 VIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHccCCcccCCCHHHHhhCCCC
Confidence            9999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=331.55  Aligned_cols=247  Identities=27%  Similarity=0.414  Sum_probs=201.9

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +...|.+...+|.|+|+.|-.|.+..+++.+++|++.+..   .....|+.++....    .++|++++.+.+.+..+.|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~----~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVR----DHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhc----CCCcceeecceecCCceee
Confidence            4567888899999999999999999999999999997552   22344666666664    4478999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +|||++ |+.|.+.+....   .....+..|+.||+.|+.|||++|||||||||+|||+.                    
T Consensus       393 ~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--------------------  449 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--------------------  449 (612)
T ss_pred             eeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--------------------
Confidence            999999 777777766553   33377888999999999999999999999999999993                    


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA  330 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~  330 (430)
                            +..++++|+|||.+......-.+.+-|..|.|||++....|+.++||||||++||+|++|+.||......   .
T Consensus       450 ------~~~g~lrltyFG~a~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~  520 (612)
T KOG0603|consen  450 ------GSAGHLRLTYFGFWSELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---I  520 (612)
T ss_pred             ------CCCCcEEEEEechhhhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---H
Confidence                  2445688888888876665533446689999999999999999999999999999999999999876554   1


Q ss_pred             HHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCC
Q 014117          331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD  410 (430)
Q Consensus       331 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~  410 (430)
                      .|...++..+                                               +....|.++++||++||+.||.+
T Consensus       521 ei~~~i~~~~-----------------------------------------------~s~~vS~~AKdLl~~LL~~dP~~  553 (612)
T KOG0603|consen  521 EIHTRIQMPK-----------------------------------------------FSECVSDEAKDLLQQLLQVDPAL  553 (612)
T ss_pred             HHHHhhcCCc-----------------------------------------------cccccCHHHHHHHHHhccCChhh
Confidence            2222222211                                               12467889999999999999999


Q ss_pred             CCCHHHHhcCCCCC
Q 014117          411 RLTAREALRHPFFT  424 (430)
Q Consensus       411 R~ta~elL~hp~f~  424 (430)
                      |+|+.+++.||||.
T Consensus       554 Rl~~~~i~~h~w~~  567 (612)
T KOG0603|consen  554 RLGADEIGAHPWFL  567 (612)
T ss_pred             CcChhhhccCcchh
Confidence            99999999999993

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8.7e-41  Score=316.59  Aligned_cols=247  Identities=23%  Similarity=0.318  Sum_probs=195.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCC-----eEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERK-----EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      ++|++.+.||+|+||.||+|.+...+     ..||+|.++...  .....+..|+.++..+.     +++++++++++..
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~-----h~~i~~~~~~~~~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ-----HPNIVCLLGVCTK   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcC-----CcccceEEEEEcC
Confidence            46899999999999999999876655     689999986432  23455778898888874     4789999999998


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEee
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNY--------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS  231 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~  231 (430)
                      ....|++|||+ +++|.+++.....              ..+++..+..++.||+.||.|||++||+||||||+|||+++
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence            99999999999 8899999976421              45888999999999999999999999999999999999965


Q ss_pred             cCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchHHHH
Q 014117          232 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSV  306 (430)
Q Consensus       232 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  306 (430)
                      ++                           .++|+|||++......     .....+|+.|+|||.+.+..++.++|||||
T Consensus       160 ~~---------------------------~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~sl  212 (283)
T cd05048         160 GL---------------------------TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF  212 (283)
T ss_pred             CC---------------------------cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHH
Confidence            44                           4555555555432111     122356788999999998899999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHH
Q 014117          307 GCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI  385 (430)
Q Consensus       307 Gv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (430)
                      ||++|||++ |..||.+.+..+....+....  .                                              
T Consensus       213 G~il~el~~~g~~p~~~~~~~~~~~~i~~~~--~----------------------------------------------  244 (283)
T cd05048         213 GVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ--L----------------------------------------------  244 (283)
T ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--c----------------------------------------------
Confidence            999999998 999998766554443332110  0                                              


Q ss_pred             hhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       386 ~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      ...+...+.++.+|+.+||+.||.+|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         245 LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            01134567789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.4e-40  Score=313.54  Aligned_cols=263  Identities=23%  Similarity=0.360  Sum_probs=198.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--CCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--~~~  169 (430)
                      ++|+..+.||.|++|.||+|.+..+++.||+|.+....  .....+..|+++++++.     |+||+.+++++..  .+.
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~   75 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCK-----SPYIVKYYGAFLDESSSS   75 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCC-----CCCeeeeeeEEEccCCCe
Confidence            36899999999999999999999999999999987432  24456778998888873     4889999988754  457


Q ss_pred             EEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +|+||||+ +++|.+++...  ....+++..+..++.||+.||.|||+.|++|+||+|+||+++++              
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~--------------  141 (287)
T cd06621          76 IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK--------------  141 (287)
T ss_pred             EEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC--------------
Confidence            99999999 88999887542  22468999999999999999999999999999999999999544              


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCC-CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                                   +.++|+|||++...... .....++..|+|||.+.+..++.++|||||||++|+|++|..||.....
T Consensus       142 -------------~~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  208 (287)
T cd06621         142 -------------GQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE  208 (287)
T ss_pred             -------------CeEEEeeccccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccC
Confidence                         45667777765432221 1234578899999999998999999999999999999999999976422


Q ss_pred             --HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          326 --LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       326 --~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                        ..............+..                   .+..                    .......+..+.+||.+|
T Consensus       209 ~~~~~~~~~~~~~~~~~~~-------------------~~~~--------------------~~~~~~~~~~~~~li~~~  249 (287)
T cd06621         209 PPLGPIELLSYIVNMPNPE-------------------LKDE--------------------PGNGIKWSEEFKDFIKQC  249 (287)
T ss_pred             CCCChHHHHHHHhcCCchh-------------------hccC--------------------CCCCCchHHHHHHHHHHH
Confidence              00011111000000000                   0000                    000012356789999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      |+.||++|||+.|+++||||++..
T Consensus       250 l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         250 LEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             cCCCcccCCCHHHHHhCccccccc
Confidence            999999999999999999997653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.6e-40  Score=310.99  Aligned_cols=245  Identities=22%  Similarity=0.337  Sum_probs=194.8

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      ++|+++++||+|+||.||+|.+. ++..||+|.+.......+.+..|+.+++.+.     |++++++++.+...+..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQ-----HDKLVRLYAVVTKEEPIYII   79 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCC-----CCCeeeEEEEEcCCCCcEEE
Confidence            57999999999999999999865 4567999988754444567788999999884     47899999999999999999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      |||+ +++|.+++.......+++..+..++.|++.||+|||+.+++||||||+||+++.++.                  
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~------------------  141 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM------------------  141 (261)
T ss_pred             EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc------------------
Confidence            9999 889999998765567899999999999999999999999999999999999965554                  


Q ss_pred             cccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHH
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE  327 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~  327 (430)
                               ++|+|||++.......    ....++..|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus       142 ---------~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~  212 (261)
T cd05072         142 ---------CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD  212 (261)
T ss_pred             ---------EEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH
Confidence                     5555555554322111    11235678999999998889999999999999999998 999998765544


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+....                        .+                        ......+.++.+++.+||..|
T Consensus       213 ~~~~~~~~~------------------------~~------------------------~~~~~~~~~~~~li~~~l~~~  244 (261)
T cd05072         213 VMSALQRGY------------------------RM------------------------PRMENCPDELYDIMKTCWKEK  244 (261)
T ss_pred             HHHHHHcCC------------------------CC------------------------CCCCCCCHHHHHHHHHHccCC
Confidence            433322110                        00                        011345667999999999999


Q ss_pred             CCCCCCHHHHhc
Q 014117          408 PTDRLTAREALR  419 (430)
Q Consensus       408 P~~R~ta~elL~  419 (430)
                      |++|||++++++
T Consensus       245 p~~Rp~~~~i~~  256 (261)
T cd05072         245 AEERPTFDYLQS  256 (261)
T ss_pred             cccCcCHHHHHH
Confidence            999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.6e-40  Score=318.81  Aligned_cols=254  Identities=25%  Similarity=0.377  Sum_probs=202.3

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|.+....    .....+..|+++++.+.     |+|++++.+++...
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----h~niv~~~~~~~~~   87 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-----HPNTIEYKGCYLRE   87 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-----CCCEEEEEEEEEeC
Confidence            3456999999999999999999999999999999886322    22345667888888874     48899999999999


Q ss_pred             CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          168 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       168 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      +..|+||||+.++|.+++.... ..+++..+..++.||+.||.|||+.||+||||+|+||+++                 
T Consensus        88 ~~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~-----------------  149 (307)
T cd06607          88 HTAWLVMEYCLGSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT-----------------  149 (307)
T ss_pred             CeEEEEHHhhCCCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC-----------------
Confidence            9999999999888888876543 3689999999999999999999999999999999999994                 


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhh---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                .++.++|+|||++...... ....|+..|+|||++.   ...++.++||||||+++|||++|.+||...+
T Consensus       150 ----------~~~~~kL~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~  218 (307)
T cd06607         150 ----------EPGTVKLADFGSASLVSPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  218 (307)
T ss_pred             ----------CCCCEEEeecCcceecCCC-CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc
Confidence                      4556788888877644332 2346788999999885   3468899999999999999999999998655


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      .......+...  ..+.                    .                         .....+.++.++|.+||
T Consensus       219 ~~~~~~~~~~~--~~~~--------------------~-------------------------~~~~~~~~~~~li~~~l  251 (307)
T cd06607         219 AMSALYHIAQN--DSPT--------------------L-------------------------SSNDWSDYFRNFVDSCL  251 (307)
T ss_pred             HHHHHHHHhcC--CCCC--------------------C-------------------------CchhhCHHHHHHHHHHh
Confidence            44433222110  0000                    0                         00123457899999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +.||++|||+.+++.||||...
T Consensus       252 ~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         252 QKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             cCChhhCcCHHHHhcChhhccc
Confidence            9999999999999999999765

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.7e-40  Score=310.83  Aligned_cols=253  Identities=28%  Similarity=0.462  Sum_probs=203.2

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      +|++.+.||.|++|.||+|.+..+++.||+|++....  .....+..|+..+..+.     +++++++++.+...+.+++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE-----SPYVVKCYGAFYKEGEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcC-----CCCeeeEEEEEccCCeEEE
Confidence            5899999999999999999999999999999987543  23456778888888874     4789999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      ||||+ +++|.+++...  ..+++..+..++.||+.||.|||+ .|++|+||+|+||+++.                   
T Consensus        77 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~-------------------  135 (264)
T cd06623          77 VLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS-------------------  135 (264)
T ss_pred             EEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECC-------------------
Confidence            99999 79999999875  379999999999999999999999 99999999999999954                   


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                              ++.++|+|||.+.......   ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......
T Consensus       136 --------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~  207 (264)
T cd06623         136 --------KGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS  207 (264)
T ss_pred             --------CCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC
Confidence                    4456666666655332221   23468899999999998889999999999999999999999997654211


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCC-chhHHHHHHHHhhhc
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGLLRY  406 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~L~~  406 (430)
                      ....+........                                             ...+.. .+..+.++|.+||..
T Consensus       208 ~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~l~~li~~~l~~  242 (264)
T cd06623         208 FFELMQAICDGPP---------------------------------------------PSLPAEEFSPEFRDFISACLQK  242 (264)
T ss_pred             HHHHHHHHhcCCC---------------------------------------------CCCCcccCCHHHHHHHHHHccC
Confidence            1111111111000                                             001122 567899999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~  426 (430)
                      +|++|||+.++++||||++.
T Consensus       243 ~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         243 DPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             ChhhCCCHHHHHhCHHHHhc
Confidence            99999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8.2e-41  Score=318.82  Aligned_cols=254  Identities=27%  Similarity=0.442  Sum_probs=201.3

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      .++|.+.+.||+|+||.||++.+..+++.||+|.+... ....+.+..|+.+++.+.     |++++++++.+...+..|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-----hp~i~~~~~~~~~~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK-----HPNIVNYLDSYLVGDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcC-----CCCeeehhheeeeCCcEE
Confidence            36899999999999999999999889999999998632 233455677888877763     478999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +|+||+ +++|.+++.+.   .+++..+..++.|++.||.|||++|++|+||||+||+++.+                  
T Consensus        93 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~------------------  151 (293)
T cd06647          93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD------------------  151 (293)
T ss_pred             EEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC------------------
Confidence            999999 88999998754   58899999999999999999999999999999999999544                  


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                               +.++|+|||++.......   ....|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+
T Consensus       152 ---------~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~  222 (293)
T cd06647         152 ---------GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR  222 (293)
T ss_pred             ---------CCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence                     456666666554322211   22468889999999988889999999999999999999999998655433


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+..  +..|.                                            ...+...+..+.++|++||+.+
T Consensus       223 ~~~~~~~--~~~~~--------------------------------------------~~~~~~~~~~l~~li~~~l~~~  256 (293)
T cd06647         223 ALYLIAT--NGTPE--------------------------------------------LQNPEKLSAIFRDFLNRCLEMD  256 (293)
T ss_pred             heeehhc--CCCCC--------------------------------------------CCCccccCHHHHHHHHHHccCC
Confidence            2221110  00000                                            0012234567899999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~~  427 (430)
                      |++||++.+++.||||+...
T Consensus       257 p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         257 VEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             hhhCcCHHHHhcCHHHhcCc
Confidence            99999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-42  Score=333.50  Aligned_cols=281  Identities=25%  Similarity=0.378  Sum_probs=213.4

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhh-H---HHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-R---EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~-~---~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      -|..++.||-|+||.|.+++...|..+||+|.+++.+-. +   .-...|..||...     .++-||++|..|++.+.+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-----Dn~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-----DNEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-----CCcceEEEEEEeccCCce
Confidence            488999999999999999999999999999998754321 1   1233466776665     447799999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC--CCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL--HTP  247 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~--~~~  247 (430)
                      |+||+|+ ||++-.+|-+.+  .|+++.++.|+.++.+|+++.|.+|+|||||||+||||+.+|++|++|||++.  +|.
T Consensus       705 YFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             EEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999 999999988876  89999999999999999999999999999999999999999999999999874  444


Q ss_pred             CCCcccccCCCC------CCeEEEeCCCcc---------cc-CCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHH
Q 014117          248 KDSSYFKRMPKS------SAIKVIDFGSTT---------YE-RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILV  311 (430)
Q Consensus       248 ~~~~~~~~~~~~------~~~kl~Dfg~a~---------~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~  311 (430)
                      .++.++..-+..      ..--..|-+.+-         .. .-..+..+||+.|+|||++....|+..+|+||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence            444444321110      001112222110         00 00124468999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCC
Q 014117          312 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH  391 (430)
Q Consensus       312 el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (430)
                      ||+.|++||...+..+....+.....                                             .+....-.+
T Consensus       863 em~~g~~pf~~~tp~~tq~kv~nw~~---------------------------------------------~l~~~~~~~  897 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGETQYKVINWRN---------------------------------------------FLHIPYQGN  897 (1034)
T ss_pred             HHhhCCCCccCCCCCcceeeeeehhh---------------------------------------------ccccccccc
Confidence            99999999987665443322221100                                             001112246


Q ss_pred             chhHHHHHHHHhhhcCCCCCC---CHHHHhcCCCCCCCCC
Q 014117          392 SAGDLTHLLQGLLRYDPTDRL---TAREALRHPFFTRDHL  428 (430)
Q Consensus       392 ~~~~~~~ll~~~L~~dP~~R~---ta~elL~hp~f~~~~~  428 (430)
                      ++.++.+||.++ ..+++.|+   .++||..||||+..++
T Consensus       898 ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkgIDf  936 (1034)
T KOG0608|consen  898 LSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKGIDF  936 (1034)
T ss_pred             cCHHHHHHHHHH-hcChhhhhcccchhhhhcCccccccch
Confidence            678899999984 55788998   4788999999998754

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.4e-40  Score=309.08  Aligned_cols=244  Identities=25%  Similarity=0.353  Sum_probs=193.6

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      ++|++.+.||+|+||.||++..+. +..+|+|.+.........+..|+.+++.+.     +++++++++++...+..++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLS-----HPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCC-----CCCceeEEEEEccCCCEEEE
Confidence            458999999999999999998754 457999988754444566788999999984     48899999999999999999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      |||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.                  
T Consensus        78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~------------------  138 (256)
T cd05114          78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV------------------  138 (256)
T ss_pred             EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe------------------
Confidence            9999 899999987643 35899999999999999999999999999999999999965544                  


Q ss_pred             cccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHH
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE  327 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~  327 (430)
                               +||+|||.++......    ....++..|+|||++.+..++.++|+|||||++|+|++ |+.||...+..+
T Consensus       139 ---------~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~  209 (256)
T cd05114         139 ---------VKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE  209 (256)
T ss_pred             ---------EEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence                     5555555544321111    11234568999999998889999999999999999999 999998776655


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+......                                                ..+...+.++.+|+.+||+.|
T Consensus       210 ~~~~i~~~~~~------------------------------------------------~~~~~~~~~~~~li~~c~~~~  241 (256)
T cd05114         210 VVEMISRGFRL------------------------------------------------YRPKLASMTVYEVMYSCWHEK  241 (256)
T ss_pred             HHHHHHCCCCC------------------------------------------------CCCCCCCHHHHHHHHHHccCC
Confidence            55443321100                                                011233557899999999999


Q ss_pred             CCCCCCHHHHhc
Q 014117          408 PTDRLTAREALR  419 (430)
Q Consensus       408 P~~R~ta~elL~  419 (430)
                      |++|||++++++
T Consensus       242 p~~Rps~~~l~~  253 (256)
T cd05114         242 PEGRPTFAELLR  253 (256)
T ss_pred             cccCcCHHHHHH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-40  Score=315.40  Aligned_cols=246  Identities=22%  Similarity=0.337  Sum_probs=194.1

Q ss_pred             CcEEEEeeeccccceEEEEEEECC-----CCeEEEEEEecCchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      .+|.+.+.||+|+||.||+|.+..     +++.||+|+++....  ....+..|+++++.+.     +++++.+++++..
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~   79 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ-----HENIVKFYGVCTE   79 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcC-----CCCchheeeEEec
Confidence            468899999999999999998753     367899999874332  3467788999999884     3789999999999


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNN------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE  233 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~  233 (430)
                      ....++||||+ +++|.+++...+            ...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence            99999999999 899999997643            23578899999999999999999999999999999999996555


Q ss_pred             ccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchHHHHHH
Q 014117          234 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC  308 (430)
Q Consensus       234 ~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv  308 (430)
                      .                           ++|+|||++......     .....++..|+|||++.+..++.++|||||||
T Consensus       160 ~---------------------------~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  212 (280)
T cd05049         160 V---------------------------VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV  212 (280)
T ss_pred             e---------------------------EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHH
Confidence            4                           455555544322111     11234578899999999999999999999999


Q ss_pred             HHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhh
Q 014117          309 ILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ  387 (430)
Q Consensus       309 ~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (430)
                      ++|||++ |..||...+..+....+.....                                                ..
T Consensus       213 il~e~~~~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------------~~  244 (280)
T cd05049         213 VLWEIFTYGKQPWYGLSNEEVIECITQGRL------------------------------------------------LQ  244 (280)
T ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHHHcCCc------------------------------------------------CC
Confidence            9999998 9999987665544433321100                                                00


Q ss_pred             hcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       388 ~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      .+...+..+.+++.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         245 RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            12345678999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.5e-40  Score=311.73  Aligned_cols=251  Identities=21%  Similarity=0.289  Sum_probs=198.1

Q ss_pred             cCcEEEEeeeccccceEEEEEEECC-----CCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .++|.+.+.||+|+||.||+|.+..     ++..||+|.++...  .....+..|+.+++.+.     +++++++++++.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~   79 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN-----HQNIVRLIGVSF   79 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-----CCCEeeEEEEEc
Confidence            3579999999999999999999987     77889999886332  23345677888888874     478999999988


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNNY-----RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD  239 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~d  239 (430)
                      ..+..++||||+ +++|.+++.....     ..+++..+..++.||+.||+|||+++++||||||+|||++..+      
T Consensus        80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~------  153 (277)
T cd05036          80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG------  153 (277)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC------
Confidence            888999999999 8999999976532     2589999999999999999999999999999999999996532      


Q ss_pred             CcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHH
Q 014117          240 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC  314 (430)
Q Consensus       240 fg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~  314 (430)
                                        ....+||+|||+++......     .....+..|+|||++.+..++.++|||||||++|||+
T Consensus       154 ------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~  215 (277)
T cd05036         154 ------------------PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIF  215 (277)
T ss_pred             ------------------CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHH
Confidence                              23357778887776442211     1123356799999999889999999999999999999


Q ss_pred             h-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCch
Q 014117          315 T-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA  393 (430)
Q Consensus       315 t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (430)
                      + |..||.+.+..+....+.....                                                ...+...+
T Consensus       216 ~~g~~pf~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~  247 (277)
T cd05036         216 SLGYMPYPGRTNQEVMEFVTGGGR------------------------------------------------LDPPKGCP  247 (277)
T ss_pred             cCCCCCCCCCCHHHHHHHHHcCCc------------------------------------------------CCCCCCCC
Confidence            7 9999987665544332221100                                                01123456


Q ss_pred             hHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          394 GDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       394 ~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      ..+.+++.+||+.||++|||+.+|++|
T Consensus       248 ~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         248 GPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            679999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-41  Score=324.87  Aligned_cols=208  Identities=25%  Similarity=0.364  Sum_probs=175.5

Q ss_pred             CceeecCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhh-HHHHHHHHHHHHHHHhcCCCCCceEEec
Q 014117           83 HYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLAKHDKGGNRCVQIR  161 (430)
Q Consensus        83 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~E~~~l~~l~~~~~~~~~i~~~~  161 (430)
                      .|.+......+++|.-...||+|+||.||+|....+ ..||||.+...... ..++..|++++.+++     |+|+++++
T Consensus        64 ~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~-----H~Nlv~Ll  137 (361)
T KOG1187|consen   64 SFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLR-----HPNLVKLL  137 (361)
T ss_pred             eeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCC-----CcCcccEE
Confidence            355556667788999999999999999999987654 88999988754443 456999999999995     48899999


Q ss_pred             ceeecCC-eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeeccCCCCceEEeecCccc
Q 014117          162 NWFDYRN-HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC---MIHTDLKPENVLLVSSEYIK  236 (430)
Q Consensus       162 ~~~~~~~-~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlKp~NILl~~~~~~~  236 (430)
                      ++|.+.+ +.+||+||+ .|+|.++|.......++|....+|+.+++.||+|||+..   ||||||||+|||+       
T Consensus       138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL-------  210 (361)
T KOG1187|consen  138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL-------  210 (361)
T ss_pred             EEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE-------
Confidence            9999888 599999999 889999998765337899999999999999999999855   9999999999999       


Q ss_pred             cCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCC-CCCe--e-eecCcccchhhhhCCCCCCcchHHHHHHHHHH
Q 014117          237 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-DQNY--I-VSTRHYRAPEVILGLGWTYPCDIWSVGCILVE  312 (430)
Q Consensus       237 i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~--~-~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~e  312 (430)
                                          |.+.++||+|||+|..... ....  . .||.+|+|||++.....+.++|||||||+|+|
T Consensus       211 --------------------D~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllE  270 (361)
T KOG1187|consen  211 --------------------DEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLE  270 (361)
T ss_pred             --------------------CCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHH
Confidence                                5566677777777754443 2222  1 79999999999999899999999999999999


Q ss_pred             HHhCCCCCCCC
Q 014117          313 LCTGEALFQTH  323 (430)
Q Consensus       313 l~tG~~Pf~~~  323 (430)
                      |+||+.|.+..
T Consensus       271 litgr~~~d~~  281 (361)
T KOG1187|consen  271 LITGRKAVDQS  281 (361)
T ss_pred             HHhCCcccCCC
Confidence            99999888753

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=295.28  Aligned_cols=251  Identities=24%  Similarity=0.310  Sum_probs=197.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee-----c
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-----Y  166 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~-----~  166 (430)
                      .++|.|.+.||+|||+-||++....+++.||+|.+.... +..+..++|++..+++.     ++|+++++++..     .
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~-----s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFN-----SPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhC-----CcchHHHHHHHHHhhccC
Confidence            468999999999999999999999999999999997654 56677889999999884     478888777553     3


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeccCCCCceEEeecCccccCCCc
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      ....||+++|. .|+|.+.++..  .+..+++.++..|+.+|++||++||+..  +.||||||.|||+.+          
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~----------  164 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD----------  164 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC----------
Confidence            45699999998 89999998753  3346899999999999999999999998  999999999999954          


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCC------------eeeecCcccchhhhh---CCCCCCcchHHHH
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN------------YIVSTRHYRAPEVIL---GLGWTYPCDIWSV  306 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------------~~~gt~~y~aPE~~~---~~~~~~~~Dvwsl  306 (430)
                                       .+.++|.|||.++...-...            .-.-|..|+|||++.   +...+.++|||||
T Consensus       165 -----------------~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSL  227 (302)
T KOG2345|consen  165 -----------------SGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSL  227 (302)
T ss_pred             -----------------CCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhh
Confidence                             45677777777654322110            012488999999986   4457899999999


Q ss_pred             HHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHh
Q 014117          307 GCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM  386 (430)
Q Consensus       307 Gv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (430)
                      ||+||+|+.|..||+..-.         .-|            ...--+.++++.||..                     
T Consensus       228 GCtLYa~mf~~sPfe~~~~---------~Gg------------SlaLAv~n~q~s~P~~---------------------  265 (302)
T KOG2345|consen  228 GCTLYAMMFGESPFERIYQ---------QGG------------SLALAVQNAQISIPNS---------------------  265 (302)
T ss_pred             hHHHHHHHHcCCcchHHhh---------cCC------------eEEEeeeccccccCCC---------------------
Confidence            9999999999999963110         000            1111234556666653                     


Q ss_pred             hhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          387 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       387 ~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                         ..+++.+.+||..||+.||.+||++.+++.+
T Consensus       266 ---~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  266 ---SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             ---CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence               2367789999999999999999999999864

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.9e-41  Score=318.17  Aligned_cols=248  Identities=30%  Similarity=0.449  Sum_probs=196.6

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      .|++.+.||.|+||.||+|.+..+++.||+|+++...  .....+..|+++++.+     .|+|++++++.+...+..|+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYITRYYGSYLKGTKLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-----CCCccHhhhcccccCCceEE
Confidence            4677888999999999999999999999999986332  3334567788888877     34889999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+ +++|.+++...   .+++..+..++.||+.||.|||++||+|+||||+||++++++                  
T Consensus        80 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~------------------  138 (277)
T cd06642          80 IMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG------------------  138 (277)
T ss_pred             EEEccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC------------------
Confidence            99999 78999988643   689999999999999999999999999999999999996544                  


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                               .++|+|||++.......   ....|+..|+|||++.+..++.++|+|||||++|||++|..||........
T Consensus       139 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~  209 (277)
T cd06642         139 ---------DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV  209 (277)
T ss_pred             ---------CEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH
Confidence                     45556666554322211   223578899999999998899999999999999999999999975443322


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      ...+...  . +                                             .......+.++.++|.+||+.+|
T Consensus       210 ~~~~~~~--~-~---------------------------------------------~~~~~~~~~~~~~li~~~l~~~p  241 (277)
T cd06642         210 LFLIPKN--S-P---------------------------------------------PTLEGQYSKPFKEFVEACLNKDP  241 (277)
T ss_pred             HhhhhcC--C-C---------------------------------------------CCCCcccCHHHHHHHHHHccCCc
Confidence            2111000  0 0                                             00112345678999999999999


Q ss_pred             CCCCCHHHHhcCCCCCC
Q 014117          409 TDRLTAREALRHPFFTR  425 (430)
Q Consensus       409 ~~R~ta~elL~hp~f~~  425 (430)
                      ++|||+.++++||||..
T Consensus       242 ~~Rp~~~~il~~~~~~~  258 (277)
T cd06642         242 RFRPTAKELLKHKFITR  258 (277)
T ss_pred             ccCcCHHHHHHhHHHHH
Confidence            99999999999999964

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-40  Score=308.54  Aligned_cols=246  Identities=24%  Similarity=0.337  Sum_probs=196.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      .++|++.+.||+|+||.||+|.+.. ++.||+|.++......+.+..|+.+++++.     |+|++++++++...+..|+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLR-----HPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCC-----CCCccceeEEEecCCCeee
Confidence            4579999999999999999998754 567999998755444566788999999884     4789999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+ +++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++                  
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~------------------  140 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN------------------  140 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC------------------
Confidence            99999 89999999876556799999999999999999999999999999999999995544                  


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCC-Ce---eeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQ-NY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL  326 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~---~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~  326 (430)
                               .++|+|||++....... ..   ...+..|+|||++.+..++.++|+|||||++|+|++ |+.||.+.+..
T Consensus       141 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  211 (261)
T cd05068         141 ---------ICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA  211 (261)
T ss_pred             ---------CEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence                     45666666554332111 11   122457999999998899999999999999999999 99999876655


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      .....+..... +                                               ..+...+..+.+++.+||+.
T Consensus       212 ~~~~~~~~~~~-~-----------------------------------------------~~~~~~~~~~~~li~~~l~~  243 (261)
T cd05068         212 EVLQQVDQGYR-M-----------------------------------------------PCPPGCPKELYDIMLDCWKE  243 (261)
T ss_pred             HHHHHHHcCCC-C-----------------------------------------------CCCCcCCHHHHHHHHHHhhc
Confidence            44443322110 0                                               01223456799999999999


Q ss_pred             CCCCCCCHHHHhc
Q 014117          407 DPTDRLTAREALR  419 (430)
Q Consensus       407 dP~~R~ta~elL~  419 (430)
                      ||++||++.++++
T Consensus       244 ~P~~Rp~~~~l~~  256 (261)
T cd05068         244 DPDDRPTFETLQW  256 (261)
T ss_pred             CcccCCCHHHHHH
Confidence            9999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.1e-39  Score=302.42  Aligned_cols=249  Identities=29%  Similarity=0.505  Sum_probs=204.0

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh-hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      .|.+.+.||+|++|.||++.+..+++.+++|++..... ....+..|++.++++.     +++++++++.+......+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK-----HPNIVKYYGSYLKKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCC-----CCCEeEEEEEEecCCeEEEE
Confidence            37889999999999999999998999999999875432 4566778888888874     47899999999999999999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      +||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++                      
T Consensus        76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~----------------------  132 (253)
T cd05122          76 MEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT----------------------  132 (253)
T ss_pred             EecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc----------------------
Confidence            9999 689999987753 4799999999999999999999999999999999999994                      


Q ss_pred             cccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA  330 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~  330 (430)
                           .++.++|+|||.+.......  ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+...
T Consensus       133 -----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  207 (253)
T cd05122         133 -----SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF  207 (253)
T ss_pred             -----cCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH
Confidence                 45567888888776554443  44678999999999998889999999999999999999999998765433332


Q ss_pred             HHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCC
Q 014117          331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD  410 (430)
Q Consensus       331 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~  410 (430)
                      .+..  ...+.                    .+                        .....+.++.++|.+||+.||++
T Consensus       208 ~~~~--~~~~~--------------------~~------------------------~~~~~~~~~~~~i~~~l~~~p~~  241 (253)
T cd05122         208 KIAT--NGPPG--------------------LR------------------------NPEKWSDEFKDFLKKCLQKNPEK  241 (253)
T ss_pred             HHHh--cCCCC--------------------cC------------------------cccccCHHHHHHHHHHccCChhh
Confidence            2221  00000                    00                        01112567999999999999999


Q ss_pred             CCCHHHHhcCCC
Q 014117          411 RLTAREALRHPF  422 (430)
Q Consensus       411 R~ta~elL~hp~  422 (430)
                      |||+.|+|+|||
T Consensus       242 R~t~~~~l~~~~  253 (253)
T cd05122         242 RPTAEQLLKHPF  253 (253)
T ss_pred             CCCHHHHhcCCC
Confidence            999999999999

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=7.2e-40  Score=315.28  Aligned_cols=255  Identities=25%  Similarity=0.376  Sum_probs=202.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .+.|...++||+|+||+||+|.+..+++.||+|++....    .....+..|+++++.+.     |++++.+++++.+..
T Consensus        20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~   94 (313)
T cd06633          20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-----HPNTIEYKGCYLKEH   94 (313)
T ss_pred             HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-----CCCCccEEEEEEeCC
Confidence            344777889999999999999999999999999986321    22234667888888874     478999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          169 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       169 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      ..|+||||+.++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++                  
T Consensus        95 ~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~------------------  155 (313)
T cd06633          95 TAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT------------------  155 (313)
T ss_pred             EEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC------------------
Confidence            999999999888988887643 4689999999999999999999999999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhh---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                               .++.+||+|||++..... .....|+..|+|||++.   ...++.++|||||||++|+|++|..||...+.
T Consensus       156 ---------~~~~~kL~dfg~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~  225 (313)
T cd06633         156 ---------EPGQVKLADFGSASKSSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  225 (313)
T ss_pred             ---------CCCCEEEeecCCCcccCC-CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence                     445677777777654322 23457899999999985   35688999999999999999999999987655


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      ......+...  ..|.                                             ......+..+.+|+.+||+
T Consensus       226 ~~~~~~~~~~--~~~~---------------------------------------------~~~~~~~~~l~~li~~~l~  258 (313)
T cd06633         226 MSALYHIAQN--DSPT---------------------------------------------LQSNEWTDSFRGFVDYCLQ  258 (313)
T ss_pred             HHHHHHHHhc--CCCC---------------------------------------------CCccccCHHHHHHHHHHcc
Confidence            4444332211  1110                                             0012334568999999999


Q ss_pred             cCCCCCCCHHHHhcCCCCCCCCC
Q 014117          406 YDPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      .+|.+|||+.+++.||||+..+.
T Consensus       259 ~~P~~Rp~~~~~l~~~~~~~~~~  281 (313)
T cd06633         259 KIPQERPASAELLRHDFVRRDRP  281 (313)
T ss_pred             CChhhCcCHHHHhcCcccCCCch
Confidence            99999999999999999987643

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.9e-40  Score=311.40  Aligned_cols=249  Identities=29%  Similarity=0.431  Sum_probs=199.0

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      -|++.+.||.|+||.||+|.+..+++.||+|++....  .....+..|+.++.++     .|++++++++.+......|+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYVTKYYGSYLKDTKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-----CCCCEeEEEEEEEeCCeEEE
Confidence            4788899999999999999999999999999976332  2334566788888877     34789999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+ +++|.+++...   .+++..+..++.|++.||.|||+.||+|+||||+||++++                    
T Consensus        80 v~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~--------------------  136 (277)
T cd06641          80 IMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE--------------------  136 (277)
T ss_pred             EEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECC--------------------
Confidence            99999 78999988643   6899999999999999999999999999999999999954                    


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                             ++.++|+|||++......   .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||........
T Consensus       137 -------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  209 (277)
T cd06641         137 -------HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV  209 (277)
T ss_pred             -------CCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH
Confidence                   445666666665432221   1224678899999999888899999999999999999999999976443332


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      ...+..  +..+                                              ......+.++.+++.+||+.+|
T Consensus       210 ~~~~~~--~~~~----------------------------------------------~~~~~~~~~~~~~i~~~l~~~p  241 (277)
T cd06641         210 LFLIPK--NNPP----------------------------------------------TLEGNYSKPLKEFVEACLNKEP  241 (277)
T ss_pred             HHHHhc--CCCC----------------------------------------------CCCcccCHHHHHHHHHHccCCh
Confidence            222110  0000                                              0123456679999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCC
Q 014117          409 TDRLTAREALRHPFFTRD  426 (430)
Q Consensus       409 ~~R~ta~elL~hp~f~~~  426 (430)
                      ++||++.++++||||.+.
T Consensus       242 ~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         242 SFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             hhCcCHHHHHhCHHHhhh
Confidence            999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.9e-40  Score=309.13  Aligned_cols=244  Identities=30%  Similarity=0.536  Sum_probs=195.6

Q ss_pred             eccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 014117          102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL  177 (430)
Q Consensus       102 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~  177 (430)
                      ||.|+||.||+|.+..+++.||+|++....    ........|++++.++.     |+|++++++.+......|+||||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-----h~~i~~~~~~~~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-----SPYVVKLYYSFQGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-----CcchhHHHHheecCcEEEEEEecC
Confidence            689999999999999999999999986432    23445667788887774     478999999999999999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccC
Q 014117          178 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM  256 (430)
Q Consensus       178 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~  256 (430)
                       +++|.+++...+  .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++                       
T Consensus        76 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-----------------------  130 (265)
T cd05579          76 PGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-----------------------  130 (265)
T ss_pred             CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-----------------------
Confidence             789999998765  799999999999999999999999999999999999995544                       


Q ss_pred             CCCCCeEEEeCCCccccCCC-----------CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          257 PKSSAIKVIDFGSTTYERPD-----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       257 ~~~~~~kl~Dfg~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                          .++|+|||++......           .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.....
T Consensus       131 ----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~  206 (265)
T cd05579         131 ----HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP  206 (265)
T ss_pred             ----CEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence                5556666655432211           1234678899999999988899999999999999999999999987665


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+....+..                       +...++..                        ...+..+.+++.+||+
T Consensus       207 ~~~~~~~~~-----------------------~~~~~~~~------------------------~~~~~~~~~~i~~~l~  239 (265)
T cd05579         207 EEIFQNILN-----------------------GKIEWPED------------------------VEVSDEAIDLISKLLV  239 (265)
T ss_pred             HHHHHHHhc-----------------------CCcCCCcc------------------------ccCCHHHHHHHHHHhc
Confidence            444433222                       11111110                        0135678999999999


Q ss_pred             cCCCCCCCH---HHHhcCCCCCCC
Q 014117          406 YDPTDRLTA---REALRHPFFTRD  426 (430)
Q Consensus       406 ~dP~~R~ta---~elL~hp~f~~~  426 (430)
                      .+|.+|||+   .++|+||||+.-
T Consensus       240 ~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         240 PDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             CCHhhcCCCccHHHHhcCccccCC
Confidence            999999999   999999999854

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.6e-40  Score=308.44  Aligned_cols=245  Identities=27%  Similarity=0.357  Sum_probs=191.3

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      .++|.+.++||+|+||.||+|.+..++ .||+|+++........+..|+++++.+.     +++++++++.+. ....++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~-----~~~i~~~~~~~~-~~~~~l   77 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLR-----HEKLVQLYAVVS-EEPIYI   77 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCC-----CCCcceEEEEEC-CCCcEE
Confidence            357999999999999999999887664 5999999754444566788999998874     377899888764 456899


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+ +++|.+++.......+++..+..++.|++.||.|||+.+|+||||||+||++++++                  
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~------------------  139 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL------------------  139 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC------------------
Confidence            99999 78999999865445689999999999999999999999999999999999995544                  


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL  326 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~  326 (430)
                               .++|+|||.+.......    ....++..|+|||++.+..++.++|+|||||++|+|++ |..||.+....
T Consensus       140 ---------~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~  210 (262)
T cd05071         140 ---------VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR  210 (262)
T ss_pred             ---------cEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH
Confidence                     45566666554322211    11245678999999998899999999999999999999 89999876554


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +....+.... ..+                                               .....+.++.+|+.+||+.
T Consensus       211 ~~~~~~~~~~-~~~-----------------------------------------------~~~~~~~~l~~li~~~l~~  242 (262)
T cd05071         211 EVLDQVERGY-RMP-----------------------------------------------CPPECPESLHDLMCQCWRK  242 (262)
T ss_pred             HHHHHHhcCC-CCC-----------------------------------------------CccccCHHHHHHHHHHccC
Confidence            4433221100 000                                               1123456789999999999


Q ss_pred             CCCCCCCHHHHhc
Q 014117          407 DPTDRLTAREALR  419 (430)
Q Consensus       407 dP~~R~ta~elL~  419 (430)
                      ||++|||++++++
T Consensus       243 ~p~~Rp~~~~~~~  255 (262)
T cd05071         243 EPEERPTFEYLQA  255 (262)
T ss_pred             CcccCCCHHHHHH
Confidence            9999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=304.86  Aligned_cols=289  Identities=27%  Similarity=0.476  Sum_probs=229.7

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-  167 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~-  167 (430)
                      +..+|.-+..+|.|.- .|.-|.|..+++.||+|.+...   .....+..+|..++..+.     +.|++.++..|... 
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~-----~~nii~l~n~ftP~~   88 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN-----HKNIISLLNVFTPQK   88 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhc-----ccceeeeeeccCccc
Confidence            4568999999999999 8999999999999999987422   233456778999888884     47899999988653 


Q ss_pred             -----CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          168 -----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       168 -----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                           ...|+|||+|..+|.+.+..    .++-+.+..++.|++.|++|||+.||+||||||+||++..+          
T Consensus        89 ~l~~~~e~y~v~e~m~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~----------  154 (369)
T KOG0665|consen   89 TLEEFQEVYLVMELMDANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD----------  154 (369)
T ss_pred             cHHHHHhHHHHHHhhhhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecch----------
Confidence                 47899999999999998873    47788899999999999999999999999999999999554          


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                       ..+||.|||+|+..+..  .+-++.|..|.|||++.+..|...+||||+||++.||++|+..|
T Consensus       155 -----------------~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf  217 (369)
T KOG0665|consen  155 -----------------CTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLF  217 (369)
T ss_pred             -----------------hheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEe
Confidence                             45666666666554443  12357899999999999999999999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .+.+..+++.++.+.+|.+.+.+..++.+....|..+-. .+..     .++....+..-.. -..+.+...+..+++|+
T Consensus       218 ~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~-~y~~-----~~f~~~fpD~~f~-~~~e~~~~~~~~ardll  290 (369)
T KOG0665|consen  218 PGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRP-QYQA-----ISFSELFPDSLFP-VVLEGSKLDCSLARDLL  290 (369)
T ss_pred             cCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcCh-Hhhc-----cchhhhCCccccc-ccccCCccchHHHHHHH
Confidence            999999999999999999999999999999988886311 0000     0011111100000 01112233455689999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCCCCC
Q 014117          401 QGLLRYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~hp~f~  424 (430)
                      .+||..||++|.+++++|+||||+
T Consensus       291 ~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  291 SKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHhhccChhhcccHHHHhcCCeee
Confidence            999999999999999999999996

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4e-40  Score=312.70  Aligned_cols=257  Identities=28%  Similarity=0.454  Sum_probs=205.9

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ...+.|++.+.||+|+||.||+|.+..+++.||+|++.........+..|++.++.+.     ++|++++++.+......
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~   90 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCK-----HPNIVDYYDSYLVGDEL   90 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCC-----CCCeeEEEEEEEECCEE
Confidence            4556799999999999999999999988999999999754444556778888888874     47899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+|+||+ +++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++                
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~----------------  153 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG----------------  153 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC----------------
Confidence            9999999 789999998764 4799999999999999999999999999999999999996544                


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                                 .++|+|||.+......   .....++..|+|||++.+..++.++|+|||||++|+|++|..||...+..
T Consensus       154 -----------~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~  222 (286)
T cd06614         154 -----------SVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL  222 (286)
T ss_pred             -----------CEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH
Confidence                       4555555544322211   12235788999999999888999999999999999999999999865554


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      .....+...  ..+.                    .                        ..+..++.++.+||.+||+.
T Consensus       223 ~~~~~~~~~--~~~~--------------------~------------------------~~~~~~~~~l~~li~~~l~~  256 (286)
T cd06614         223 RALFLITTK--GIPP--------------------L------------------------KNPEKWSPEFKDFLNKCLVK  256 (286)
T ss_pred             HHHHHHHhc--CCCC--------------------C------------------------cchhhCCHHHHHHHHHHhcc
Confidence            433322110  0000                    0                        00122456799999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~  426 (430)
                      +|.+|||+.++++|+||++.
T Consensus       257 ~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         257 DPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             ChhhCcCHHHHhhChHhhcc
Confidence            99999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.6e-40  Score=306.80  Aligned_cols=245  Identities=22%  Similarity=0.337  Sum_probs=193.0

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      ++|.+.+.||+|+||.||+|.... +..+|+|.++........+..|+.++.++.     +++++++++++.....+++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLS-----HEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCC-----CCCeeeEEEEEccCCCcEEE
Confidence            458999999999999999997654 446999998754444566788998888873     48899999999988999999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      |||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++                   
T Consensus        78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~-------------------  137 (256)
T cd05113          78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG-------------------  137 (256)
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-------------------
Confidence            9999 889999997654 3689999999999999999999999999999999999995544                   


Q ss_pred             cccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHH
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE  327 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~  327 (430)
                              .+||+|||.+.......    ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+
T Consensus       138 --------~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~  209 (256)
T cd05113         138 --------CVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE  209 (256)
T ss_pred             --------CEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence                    45555555544322111    01234678999999998889999999999999999998 999998766544


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+......                                                ..+...+..+.+++.+||+.|
T Consensus       210 ~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~li~~cl~~~  241 (256)
T cd05113         210 TVEKVSQGLRL------------------------------------------------YRPHLASEKVYAIMYSCWHEK  241 (256)
T ss_pred             HHHHHhcCCCC------------------------------------------------CCCCCCCHHHHHHHHHHcCCC
Confidence            43333221110                                                011234567999999999999


Q ss_pred             CCCCCCHHHHhcC
Q 014117          408 PTDRLTAREALRH  420 (430)
Q Consensus       408 P~~R~ta~elL~h  420 (430)
                      |.+|||+.+++.+
T Consensus       242 p~~Rp~~~~ll~~  254 (256)
T cd05113         242 AEERPTFQQLLSS  254 (256)
T ss_pred             cccCCCHHHHHHh
Confidence            9999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.8e-40  Score=322.63  Aligned_cols=250  Identities=21%  Similarity=0.322  Sum_probs=189.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECC-----CCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .++|++.+.||.|+||.||+|.+..     +++.||+|+++...  ........|+.++.++.+    ++||+++++++.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~----h~niv~~~~~~~   81 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGH----HLNVVNLLGACT   81 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhcc----CcchhheeeeEe
Confidence            3579999999999999999997543     45789999987432  233456678888888743    378999988765


Q ss_pred             -cCCeEEEEEecC-CCCHHHHHHhcCC-----------------------------------------------------
Q 014117          166 -YRNHICIVFEKL-GSSLYDFLRKNNY-----------------------------------------------------  190 (430)
Q Consensus       166 -~~~~~~lv~e~~-~~~L~~~l~~~~~-----------------------------------------------------  190 (430)
                       ....+++||||+ +++|.+++.....                                                     
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence             456899999999 8899999864321                                                     


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEE
Q 014117          191 ------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV  264 (430)
Q Consensus       191 ------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl  264 (430)
                            ..+++..+..++.||+.||.|||++||+||||||+|||++.+                           +.++|
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~---------------------------~~vkL  214 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN---------------------------NVVKI  214 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC---------------------------CcEEE
Confidence                  268899999999999999999999999999999999999544                           45666


Q ss_pred             EeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCC
Q 014117          265 IDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGP  338 (430)
Q Consensus       265 ~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~  338 (430)
                      +|||++.......     ....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+.....    
T Consensus       215 ~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~----  290 (337)
T cd05054         215 CDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK----  290 (337)
T ss_pred             eccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHh----
Confidence            6666665332111     12345678999999999999999999999999999998 9999976433222211110    


Q ss_pred             CCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHh
Q 014117          339 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL  418 (430)
Q Consensus       339 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL  418 (430)
                                        .+.                         ....+...+.++.+++.+||+.+|++|||+.|++
T Consensus       291 ------------------~~~-------------------------~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell  327 (337)
T cd05054         291 ------------------EGT-------------------------RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELV  327 (337)
T ss_pred             ------------------ccC-------------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence                              000                         0001234456799999999999999999999998


Q ss_pred             cC
Q 014117          419 RH  420 (430)
Q Consensus       419 ~h  420 (430)
                      +|
T Consensus       328 ~~  329 (337)
T cd05054         328 EI  329 (337)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7.5e-40  Score=311.32  Aligned_cols=255  Identities=22%  Similarity=0.332  Sum_probs=195.0

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECC-----CCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      ..++|++.+.||+|+||.||+|..+.     .+..||+|.++...  .....+..|+.+++.+.     +++++++++.+
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~   78 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT-----CHHVVRLLGVV   78 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCC-----CCCeeeEEEEE
Confidence            35689999999999999999997652     35579999886433  22334567888888773     47899999999


Q ss_pred             ecCCeEEEEEecC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCcc
Q 014117          165 DYRNHICIVFEKL-GSSLYDFLRKNN--------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI  235 (430)
Q Consensus       165 ~~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~  235 (430)
                      ...+..|+||||+ +++|.+++....        ...++...+..++.||+.||.|||+++|+||||||+|||++.++  
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~--  156 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF--  156 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC--
Confidence            9999999999999 899999997532        12456778899999999999999999999999999999996544  


Q ss_pred             ccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHH
Q 014117          236 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL  310 (430)
Q Consensus       236 ~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l  310 (430)
                                               .++|+|||+++......     ....++..|+|||.+.+..++.++|+|||||++
T Consensus       157 -------------------------~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l  211 (288)
T cd05061         157 -------------------------TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL  211 (288)
T ss_pred             -------------------------cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHH
Confidence                                     45555555544221111     112456789999999988999999999999999


Q ss_pred             HHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhc
Q 014117          311 VELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV  389 (430)
Q Consensus       311 ~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (430)
                      |||++ |..||.+....+....+..  +..+                                              ..+
T Consensus       212 ~el~~~~~~p~~~~~~~~~~~~~~~--~~~~----------------------------------------------~~~  243 (288)
T cd05061         212 WEITSLAEQPYQGLSNEQVLKFVMD--GGYL----------------------------------------------DQP  243 (288)
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHc--CCCC----------------------------------------------CCC
Confidence            99998 7899987554443332211  0000                                              012


Q ss_pred             CCchhHHHHHHHHhhhcCCCCCCCHHHHhc------CCCCCCC
Q 014117          390 DHSAGDLTHLLQGLLRYDPTDRLTAREALR------HPFFTRD  426 (430)
Q Consensus       390 ~~~~~~~~~ll~~~L~~dP~~R~ta~elL~------hp~f~~~  426 (430)
                      ...+..+.+++.+||+.||++|||+.++++      ||||...
T Consensus       244 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         244 DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            234567999999999999999999999987      9999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.7e-40  Score=307.23  Aligned_cols=246  Identities=26%  Similarity=0.359  Sum_probs=194.8

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ..++|+++++||+|+||.||+|... +++.||+|.+.........+..|+.+++++.     +++++++++.+. .+..+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQ-----HPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcC-----CcCeeeEEEEEc-cCCcE
Confidence            3567999999999999999999865 4677999998765555567888999998884     377899888764 56789


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|.+++.......+++..+..++.|++.||+|||+.||+||||||+||++++++                 
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-----------------  139 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL-----------------  139 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC-----------------
Confidence            999999 88999999876656799999999999999999999999999999999999995544                 


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCch
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN  325 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~  325 (430)
                                .++|+|||++.......    ....++..|+|||++.+..++.++|||||||++|||++ |++||.+.+.
T Consensus       140 ----------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  209 (260)
T cd05067         140 ----------CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN  209 (260)
T ss_pred             ----------CEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence                      45555555554322111    11245678999999998889999999999999999999 9999987665


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+....+......                                                ..+...+.++.+++.+||+
T Consensus       210 ~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~li~~~l~  241 (260)
T cd05067         210 PEVIQNLERGYRM------------------------------------------------PRPDNCPEELYELMRLCWK  241 (260)
T ss_pred             HHHHHHHHcCCCC------------------------------------------------CCCCCCCHHHHHHHHHHcc
Confidence            5444333211100                                                0123446679999999999


Q ss_pred             cCCCCCCCHHHHhc
Q 014117          406 YDPTDRLTAREALR  419 (430)
Q Consensus       406 ~dP~~R~ta~elL~  419 (430)
                      .||++|||+++++.
T Consensus       242 ~~p~~Rp~~~~l~~  255 (260)
T cd05067         242 EKPEERPTFEYLRS  255 (260)
T ss_pred             CChhhCCCHHHHHH
Confidence            99999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8.6e-40  Score=304.46  Aligned_cols=249  Identities=28%  Similarity=0.509  Sum_probs=202.0

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +|++.+.||.|+||.||++.+..+++.||+|++....   ........|+++++.+.     +++++++.+.+......+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~~~~~~~~~~~~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-----HPNIIKYYESFEEKGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC-----CCChhheEEEEecCCEEE
Confidence            5889999999999999999999999999999986432   34456777888888884     478999999888889999


Q ss_pred             EEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|+|++ +++|.+++....  ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.+                
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~----------------  139 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN----------------  139 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC----------------
Confidence            999999 789999998642  3579999999999999999999999999999999999999544                


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                                 +.++|+|||.+......   .....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.
T Consensus       140 -----------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~  208 (258)
T cd08215         140 -----------GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL  208 (258)
T ss_pred             -----------CcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH
Confidence                       45666666655433222   1234688999999999988899999999999999999999999987654


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+....+....  .                                              ...+...+.++.+++.+||.
T Consensus       209 ~~~~~~~~~~~--~----------------------------------------------~~~~~~~~~~~~~~i~~~l~  240 (258)
T cd08215         209 LELALKILKGQ--Y----------------------------------------------PPIPSQYSSELRNLVSSLLQ  240 (258)
T ss_pred             HHHHHHHhcCC--C----------------------------------------------CCCCCCCCHHHHHHHHHHcC
Confidence            33332221110  0                                              01123456779999999999


Q ss_pred             cCCCCCCCHHHHhcCCCC
Q 014117          406 YDPTDRLTAREALRHPFF  423 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f  423 (430)
                      .||++|||+.++|+||||
T Consensus       241 ~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         241 KDPEERPSIAQILQSPFI  258 (258)
T ss_pred             CChhhCcCHHHHhcCCCC
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7.5e-40  Score=309.40  Aligned_cols=249  Identities=21%  Similarity=0.308  Sum_probs=191.6

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECC-----CCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      ..++|++.+.||+|+||.||+|.++.     ++..||+|.+....  .....+..|+.+++.+     .++|++++++++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~iv~~~~~~   78 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-----NCHHVVRLLGVV   78 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEE
Confidence            45789999999999999999998652     35679999986432  2344567788888877     347899999999


Q ss_pred             ecCCeEEEEEecC-CCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCcc
Q 014117          165 DYRNHICIVFEKL-GSSLYDFLRKNNY--------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI  235 (430)
Q Consensus       165 ~~~~~~~lv~e~~-~~~L~~~l~~~~~--------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~  235 (430)
                      ......++||||+ +++|.+++.....        ..+++..+..++.|++.||.|||+.|++||||||+|||++.++  
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~--  156 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--  156 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC--
Confidence            9999999999999 8899999875321        2357788999999999999999999999999999999996554  


Q ss_pred             ccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHH
Q 014117          236 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL  310 (430)
Q Consensus       236 ~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l  310 (430)
                                               .++|+|||+++......     ....++..|+|||++.+..++.++|||||||++
T Consensus       157 -------------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l  211 (277)
T cd05062         157 -------------------------TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL  211 (277)
T ss_pred             -------------------------CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHH
Confidence                                     45555555544221111     112457789999999998999999999999999


Q ss_pred             HHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhc
Q 014117          311 VELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV  389 (430)
Q Consensus       311 ~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (430)
                      |||++ |..||.+.+..+....+...  ..+                                              ..+
T Consensus       212 ~el~~~~~~p~~~~~~~~~~~~~~~~--~~~----------------------------------------------~~~  243 (277)
T cd05062         212 WEIATLAEQPYQGMSNEQVLRFVMEG--GLL----------------------------------------------DKP  243 (277)
T ss_pred             HHHHcCCCCCCCCCCHHHHHHHHHcC--CcC----------------------------------------------CCC
Confidence            99999 78999876554433322211  000                                              012


Q ss_pred             CCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       390 ~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      ...+.++.+++.+||+.||++|||+.|++++
T Consensus       244 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         244 DNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3445679999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-42  Score=327.66  Aligned_cols=234  Identities=24%  Similarity=0.369  Sum_probs=192.2

Q ss_pred             EeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-
Q 014117           99 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-  177 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-  177 (430)
                      ++-||+|+.|.||+|+.  .++.||||.++.      ....+++-|++|.|     +||+.+.+.|.....+||||||| 
T Consensus       129 LeWlGSGaQGAVF~Grl--~netVAVKKV~e------lkETdIKHLRkLkH-----~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRE------LKETDIKHLRKLKH-----PNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhccCcccceeeeec--cCceehhHHHhh------hhhhhHHHHHhccC-----cceeeEeeeecCCceeEEeeeccc
Confidence            45699999999999976  467899998752      23456778888854     88999999999999999999999 


Q ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCC
Q 014117          178 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP  257 (430)
Q Consensus       178 ~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~  257 (430)
                      .|-|...|+...  .++......|..+|+.|+.|||.+.|||||||.-||||.                           
T Consensus       196 ~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---------------------------  246 (904)
T KOG4721|consen  196 QGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---------------------------  246 (904)
T ss_pred             cccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---------------------------
Confidence            899999998764  899999999999999999999999999999999999994                           


Q ss_pred             CCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHH
Q 014117          258 KSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV  335 (430)
Q Consensus       258 ~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~~  335 (430)
                      .+..|||+|||.++......  -.++||..|||||++.+++.+.|+||||||||||||+||..||...+....   | -.
T Consensus       247 ~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---I-wG  322 (904)
T KOG4721|consen  247 YDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---I-WG  322 (904)
T ss_pred             ccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---E-Ee
Confidence            45567777777666443332  237999999999999999999999999999999999999999976433211   1 00


Q ss_pred             hCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHH
Q 014117          336 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR  415 (430)
Q Consensus       336 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~  415 (430)
                      .|.                                           -.+....|..++.-++-||+.||+-.|..||++.
T Consensus       323 VGs-------------------------------------------NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFr  359 (904)
T KOG4721|consen  323 VGS-------------------------------------------NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFR  359 (904)
T ss_pred             ccC-------------------------------------------CcccccCcccCchHHHHHHHHHHhcCCCCCccHH
Confidence            111                                           0122335677888899999999999999999999


Q ss_pred             HHhcCC
Q 014117          416 EALRHP  421 (430)
Q Consensus       416 elL~hp  421 (430)
                      ++|.|=
T Consensus       360 qil~Hl  365 (904)
T KOG4721|consen  360 QILLHL  365 (904)
T ss_pred             HHHHHH
Confidence            999983

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-40  Score=307.38  Aligned_cols=244  Identities=22%  Similarity=0.327  Sum_probs=193.4

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      +|++.+.||+|+||.||+|.++ ++..+|+|++.........+..|+++++++.     +++++++++++...+..|+||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLS-----HPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCC-----CCCEEEEEEEEcCCCceEEEE
Confidence            5889999999999999999876 4667999998754444456778999988874     478999999999999999999


Q ss_pred             ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          175 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       175 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      ||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||++++++                    
T Consensus        79 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~--------------------  137 (256)
T cd05059          79 EYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN--------------------  137 (256)
T ss_pred             ecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC--------------------
Confidence            999 889999997654 3689999999999999999999999999999999999996554                    


Q ss_pred             ccCCCCCCeEEEeCCCccccCCCCC----eeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHH
Q 014117          254 KRMPKSSAIKVIDFGSTTYERPDQN----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH  328 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~  328 (430)
                             .+||+|||.++.......    ...++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+.
T Consensus       138 -------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~  210 (256)
T cd05059         138 -------VVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV  210 (256)
T ss_pred             -------cEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH
Confidence                   455555555543221111    1123457999999999899999999999999999999 8999987665544


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      ...+.....                                                ...+...+.++.+++.+||+.+|
T Consensus       211 ~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~li~~cl~~~p  242 (256)
T cd05059         211 VESVSAGYR------------------------------------------------LYRPKLAPTEVYTIMYSCWHEKP  242 (256)
T ss_pred             HHHHHcCCc------------------------------------------------CCCCCCCCHHHHHHHHHHhcCCh
Confidence            433221110                                                01123456789999999999999


Q ss_pred             CCCCCHHHHhcC
Q 014117          409 TDRLTAREALRH  420 (430)
Q Consensus       409 ~~R~ta~elL~h  420 (430)
                      ++|||+.|+++.
T Consensus       243 ~~Rpt~~~~l~~  254 (256)
T cd05059         243 EDRPAFKKLLSQ  254 (256)
T ss_pred             hhCcCHHHHHHH
Confidence            999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=304.99  Aligned_cols=248  Identities=27%  Similarity=0.441  Sum_probs=194.9

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc------hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-  166 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-  166 (430)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++...      ......+..|+++++++.     +++++++++++.. 
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-----h~~i~~~~~~~~~~   76 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-----HDRIVQYYGCLRDP   76 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-----CCCcceEEEEEEcC
Confidence            4699999999999999999999999999999987421      123345677889888884     3778999988765 


Q ss_pred             -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          167 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       167 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                       ...+++||||+ +++|.+++...+  .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+++       
T Consensus        77 ~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l-------  147 (264)
T cd06653          77 EEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKL-------  147 (264)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEE-------
Confidence             35789999999 889999997654  5899999999999999999999999999999999999965555444       


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCC------CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERP------DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                          +|||++.....      ......|+..|+|||++.+..++.++|+|||||++|+|++|+.
T Consensus       148 --------------------~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~  207 (264)
T cd06653         148 --------------------GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKP  207 (264)
T ss_pred             --------------------CccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence                                45544432211      1122468899999999999889999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||...........   .....+.                                            ...++..+..+.+
T Consensus       208 p~~~~~~~~~~~~---~~~~~~~--------------------------------------------~~~p~~~~~~~~~  240 (264)
T cd06653         208 PWAEYEAMAAIFK---IATQPTK--------------------------------------------PMLPDGVSDACRD  240 (264)
T ss_pred             CCCccCHHHHHHH---HHcCCCC--------------------------------------------CCCCcccCHHHHH
Confidence            9976544332221   1111100                                            1124456778999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCCCC
Q 014117          399 LLQGLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      +|.+||+ +|.+|||+.+++.|||.
T Consensus       241 ~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         241 FLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHhc-CcccCccHHHHhcCCCC
Confidence            9999999 57999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5e-40  Score=344.52  Aligned_cols=268  Identities=21%  Similarity=0.271  Sum_probs=196.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.++||+|+||.||+|.+..+++.||+|+++..    ......+..|++++..+.     |+|++++++.+...+.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-----HPNIVkl~~v~~d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-----HPGIVPVYSICSDGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-----CcCcCeEEEEEeeCCE
Confidence            5799999999999999999999999999999998642    233456778999998884     4889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNN---------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD  239 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~d  239 (430)
                      .|+||||+ |++|.+++....         ...++...+..++.||+.||+|||++||+||||||+|||++.++.++++|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD  156 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD  156 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence            99999999 899999986421         12356677889999999999999999999999999999998777777777


Q ss_pred             CcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCC
Q 014117          240 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL  319 (430)
Q Consensus       240 fg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~P  319 (430)
                      ||++.........      ........-+............+||+.|+|||++.+..++.++|||||||++|||+||..|
T Consensus       157 FGLAk~i~~~~~~------~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P  230 (932)
T PRK13184        157 WGAAIFKKLEEED------LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP  230 (932)
T ss_pred             cCcceeccccccc------ccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence            7766544221110      0000000000000001112235799999999999999999999999999999999999999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |...........  .... .|..                                           ..-....+..+.++
T Consensus       231 F~~~~~~ki~~~--~~i~-~P~~-------------------------------------------~~p~~~iP~~L~~L  264 (932)
T PRK13184        231 YRRKKGRKISYR--DVIL-SPIE-------------------------------------------VAPYREIPPFLSQI  264 (932)
T ss_pred             CCCcchhhhhhh--hhcc-Chhh-------------------------------------------ccccccCCHHHHHH
Confidence            976433221110  0000 0000                                           00012456678999


Q ss_pred             HHHhhhcCCCCCCCHHHHh
Q 014117          400 LQGLLRYDPTDRLTAREAL  418 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL  418 (430)
                      +.+||+.||++|++..+.+
T Consensus       265 I~rcL~~DP~kR~ss~eeL  283 (932)
T PRK13184        265 AMKALAVDPAERYSSVQEL  283 (932)
T ss_pred             HHHHccCChhhCcCHHHHH
Confidence            9999999999998765554

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2e-40  Score=310.32  Aligned_cols=246  Identities=23%  Similarity=0.344  Sum_probs=197.1

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh-hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ..+|++.++||.|+||.||+|.+.. ++.+|+|++..... ....+..|+.+++.+.     +++++++++++......+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~   78 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLR-----HKHLISLFAVCSVGEPVY   78 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCC-----CcchhheeeeEecCCCeE
Confidence            3468999999999999999999987 88899999875443 4556777888888873     478999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|.+++.......+++..+..++.||+.||.|||++||+|+||||+|||+++++.                
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~----------------  142 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV----------------  142 (261)
T ss_pred             EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce----------------
Confidence            999999 889999998765567999999999999999999999999999999999999965554                


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL  326 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~  326 (430)
                                 +||+|||.+.......   ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..
T Consensus       143 -----------~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~  211 (261)
T cd05148         143 -----------CKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH  211 (261)
T ss_pred             -----------EEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence                       4555555443322111   11234678999999998899999999999999999998 89999876655


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +.+..+.....                                                ...+...+..+.+++.+||+.
T Consensus       212 ~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~i~~~l~~  243 (261)
T cd05148         212 EVYDQITAGYR------------------------------------------------MPCPAKCPQEIYKIMLECWAA  243 (261)
T ss_pred             HHHHHHHhCCc------------------------------------------------CCCCCCCCHHHHHHHHHHcCC
Confidence            54443331100                                                011235567899999999999


Q ss_pred             CCCCCCCHHHHhc
Q 014117          407 DPTDRLTAREALR  419 (430)
Q Consensus       407 dP~~R~ta~elL~  419 (430)
                      ||++|||+.++++
T Consensus       244 ~p~~Rpt~~~l~~  256 (261)
T cd05148         244 EPEDRPSFKALRE  256 (261)
T ss_pred             CchhCcCHHHHHH
Confidence            9999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-41  Score=303.54  Aligned_cols=263  Identities=22%  Similarity=0.386  Sum_probs=199.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|.+++.||+|+|++|.+++.++|.+.||+|++++.-    ..-.-...|..+..+.    .++|.++-+..+|+.+.
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~a----sn~pflvglhscfqtes  324 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----SNNPFLVGLHSCFQTES  324 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhc----cCCCeEEehhhhhcccc
Confidence            357999999999999999999999999999999997532    2223344566666655    35688999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+++|.||+ ||+|--.++++  +++|++.++.+..+|+.||.|||++|||+||||.+|||++..|++|++|||+.....
T Consensus       325 rlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             eEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999 88986666654  489999999999999999999999999999999999999666665555555443221


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                      .                        .+...+++|||+.|+|||++.+..|+..+|+|+|||+|+||+.|+.||+--..  
T Consensus       403 ~------------------------~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm--  456 (593)
T KOG0695|consen  403 G------------------------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGM--  456 (593)
T ss_pred             C------------------------CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecC--
Confidence            1                        12233568999999999999999999999999999999999999999963110  


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                                ..|+       ...++|..+-                      +-......|...+-.+..+++..|++|
T Consensus       457 ----------~n~d-------~ntedylfqv----------------------ilekqiriprslsvkas~vlkgflnkd  497 (593)
T KOG0695|consen  457 ----------DNPD-------MNTEDYLFQV----------------------ILEKQIRIPRSLSVKASHVLKGFLNKD  497 (593)
T ss_pred             ----------CCcc-------cchhHHHHHH----------------------HhhhcccccceeehhhHHHHHHhhcCC
Confidence                      0000       0011111000                      000011123345556788999999999


Q ss_pred             CCCCCC------HHHHhcCCCCCCC
Q 014117          408 PTDRLT------AREALRHPFFTRD  426 (430)
Q Consensus       408 P~~R~t------a~elL~hp~f~~~  426 (430)
                      |.+|+.      ..++..|+||+..
T Consensus       498 p~erlgc~~~~g~~dik~h~ffr~i  522 (593)
T KOG0695|consen  498 PKERLGCRPQTGFSDIKSHAFFRSI  522 (593)
T ss_pred             cHHhcCCCcccchhhhhcchhhhhC
Confidence            999984      6899999999853

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.5e-40  Score=307.32  Aligned_cols=245  Identities=26%  Similarity=0.361  Sum_probs=192.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      .++|++.++||+|+||.||+|.+. .+..+|+|.++........+..|+.+++++.|     ++++++++.+. ....|+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~-----~~i~~~~~~~~-~~~~~l   77 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRH-----DKLVQLYAVVS-EEPIYI   77 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCC-----CceEEEEeEEC-CCCcEE
Confidence            457999999999999999999876 45669999987554445667889999998843     77899888775 456899


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+ +++|.+++.......+++..+..++.|++.||.|||++||+||||||+||++++++                  
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~------------------  139 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL------------------  139 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc------------------
Confidence            99999 88999999876556789999999999999999999999999999999999996544                  


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL  326 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~  326 (430)
                               .++|+|||.+.......    ....++..|+|||++.+..++.++|+|||||++|+|++ |.+||.+.+..
T Consensus       140 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~  210 (260)
T cd05070         140 ---------VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR  210 (260)
T ss_pred             ---------eEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence                     45555555554322111    11234567999999998889999999999999999999 99999876655


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +....+.... .                                               ...+...+..+.+|+.+||+.
T Consensus       211 ~~~~~~~~~~-~-----------------------------------------------~~~~~~~~~~~~~li~~~l~~  242 (260)
T cd05070         211 EVLEQVERGY-R-----------------------------------------------MPCPQDCPISLHELMLQCWKK  242 (260)
T ss_pred             HHHHHHHcCC-C-----------------------------------------------CCCCCcCCHHHHHHHHHHccc
Confidence            4443332110 0                                               011234566799999999999


Q ss_pred             CCCCCCCHHHHhc
Q 014117          407 DPTDRLTAREALR  419 (430)
Q Consensus       407 dP~~R~ta~elL~  419 (430)
                      ||++|||++++++
T Consensus       243 ~p~~Rpt~~~l~~  255 (260)
T cd05070         243 DPEERPTFEYLQS  255 (260)
T ss_pred             CcccCcCHHHHHH
Confidence            9999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-39  Score=301.97  Aligned_cols=247  Identities=29%  Similarity=0.452  Sum_probs=201.4

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +|++.+.||+|++|.||++.+..+++.||+|.+....   .....+..|++++.++.     +++++++++++...+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK-----HPNIVKYIGSIETSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC-----CCCccEEEEEEEeCCEEE
Confidence            4889999999999999999999999999999987543   34456778888888874     377899999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +|||++ +++|.+++....  .+++..+..++.|++.||.|||+.||+||||||+||+++.                   
T Consensus        76 ~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~-------------------  134 (254)
T cd06627          76 IILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK-------------------  134 (254)
T ss_pred             EEEecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECC-------------------
Confidence            999999 789999998763  7999999999999999999999999999999999999954                   


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                              ++.++|+|||.+.......   ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+...
T Consensus       135 --------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~  206 (254)
T cd06627         135 --------DGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA  206 (254)
T ss_pred             --------CCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence                    4456777777665443322   23467899999999988889999999999999999999999997654332


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+..  ..                                              ....+...+..+.+++.+||+.+
T Consensus       207 ~~~~~~~--~~----------------------------------------------~~~~~~~~~~~~~~~i~~~l~~~  238 (254)
T cd06627         207 ALFRIVQ--DD----------------------------------------------HPPLPEGISPELKDFLMQCFQKD  238 (254)
T ss_pred             HHHHHhc--cC----------------------------------------------CCCCCCCCCHHHHHHHHHHHhCC
Confidence            2221110  00                                              00123345678999999999999


Q ss_pred             CCCCCCHHHHhcCCCC
Q 014117          408 PTDRLTAREALRHPFF  423 (430)
Q Consensus       408 P~~R~ta~elL~hp~f  423 (430)
                      |++|||+.+++.||||
T Consensus       239 p~~R~~~~~~l~~~~~  254 (254)
T cd06627         239 PNLRPTAKQLLKHPWI  254 (254)
T ss_pred             hhhCcCHHHHhcCCCC
Confidence            9999999999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.2e-40  Score=316.65  Aligned_cols=245  Identities=20%  Similarity=0.264  Sum_probs=188.9

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeE----EEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEM----VAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .+|++.+.||+|+||.||+|.+..+++.    ||+|+++..  ......+..|+.+++.+.     |+||+++++++...
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~g~~~~~   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-----NPHVCRLLGICLTS   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCC-----CCCCCeEEEEEcCC
Confidence            4699999999999999999998666553    899998633  234456778888888873     47899999988764


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                       ..++|+||+ +|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++             
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~-------------  146 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ-------------  146 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC-------------
Confidence             567899998 899999998654 4688999999999999999999999999999999999995544             


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCCC-----eeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN-----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF  320 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf  320 (430)
                                    .+||+|||+++.......     ...++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus       147 --------------~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~  212 (316)
T cd05108         147 --------------HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY  212 (316)
T ss_pred             --------------cEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence                          455556665543322111     1123678999999999999999999999999999998 99999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .+....+....+ .....+                                               ..+...+.++.+++
T Consensus       213 ~~~~~~~~~~~~-~~~~~~-----------------------------------------------~~~~~~~~~~~~li  244 (316)
T cd05108         213 DGIPASEISSIL-EKGERL-----------------------------------------------PQPPICTIDVYMIM  244 (316)
T ss_pred             CCCCHHHHHHHH-hCCCCC-----------------------------------------------CCCCCCCHHHHHHH
Confidence            875443322211 110000                                               01233456789999


Q ss_pred             HHhhhcCCCCCCCHHHHhcC
Q 014117          401 QGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~h  420 (430)
                      .+||+.||.+|||+.+++.+
T Consensus       245 ~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         245 VKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHccCChhhCcCHHHHHHH
Confidence            99999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6.5e-40  Score=324.85  Aligned_cols=249  Identities=21%  Similarity=0.261  Sum_probs=191.5

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCC-----CeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRER-----KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .++|++.+.||+|+||.||+|.+...     +..||||+++...  ...+.+..|++++.++.    .|+||+++++++.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~----~HpnIv~l~~~~~  111 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG----PHLNIVNLLGACT  111 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC----CCCCeeeEEEEEc
Confidence            45789999999999999999987433     3579999986432  23456778999998884    2488999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcC-------------------------------------------------------
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNN-------------------------------------------------------  189 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~-------------------------------------------------------  189 (430)
                      ..+.+||||||+ +|+|.++|.++.                                                       
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            999999999999 899999886531                                                       


Q ss_pred             ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEe
Q 014117          190 ---------------------------------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV  230 (430)
Q Consensus       190 ---------------------------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~  230 (430)
                                                             ...+++..+..++.||+.||.|||+.+|+||||||+|||++
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~  271 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence                                                   12478888899999999999999999999999999999995


Q ss_pred             ecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchHHH
Q 014117          231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWS  305 (430)
Q Consensus       231 ~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dvws  305 (430)
                      .+                           ..+||+|||++......     .....++..|+|||++.+..++.++||||
T Consensus       272 ~~---------------------------~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwS  324 (400)
T cd05105         272 QG---------------------------KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWS  324 (400)
T ss_pred             CC---------------------------CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHH
Confidence            44                           45666666666532211     11235678899999999989999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHH
Q 014117          306 VGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL  384 (430)
Q Consensus       306 lGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (430)
                      |||++|||++ |..||.................                                               
T Consensus       325 lGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~-----------------------------------------------  357 (400)
T cd05105         325 YGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGY-----------------------------------------------  357 (400)
T ss_pred             HHHHHHHHHHCCCCCCcccchhHHHHHHHhcCC-----------------------------------------------
Confidence            9999999997 9999976433222211110000                                               


Q ss_pred             HhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       385 ~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      ....+...+.++.+++.+||+.||++|||+.+|.+
T Consensus       358 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         358 RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            00112345678999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.6e-39  Score=302.58  Aligned_cols=249  Identities=30%  Similarity=0.458  Sum_probs=201.5

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--Ce
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NH  169 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~--~~  169 (430)
                      +|.+.+.||+|++|.||+|.+..+++.|++|++....   .....+..|+.+++++.     +++++++++.+...  ..
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~   75 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-----HPNIVRYYGSERDEEKNT   75 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC-----CCCEeeEEEEEecCCCCe
Confidence            4788999999999999999999999999999987543   34566778888888884     48899999999888  89


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .++|+|++ +++|.+++....  .+++..+..++.|++.||.|||+.|++|+||+|+||+++.                 
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~-----------------  136 (260)
T cd06606          76 LNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDS-----------------  136 (260)
T ss_pred             EEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC-----------------
Confidence            99999999 899999998765  7999999999999999999999999999999999999954                 


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                ++.++|+|||.+......     .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus       137 ----------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (260)
T cd06606         137 ----------DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL  206 (260)
T ss_pred             ----------CCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                      455666666666543332     22346789999999999888999999999999999999999999865


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      .+...  .+.....                   .                         ......+...+.++.++|.+|
T Consensus       207 ~~~~~--~~~~~~~-------------------~-------------------------~~~~~~~~~~~~~l~~~i~~~  240 (260)
T cd06606         207 GNPMA--ALYKIGS-------------------S-------------------------GEPPEIPEHLSEEAKDFLRKC  240 (260)
T ss_pred             CchHH--HHHhccc-------------------c-------------------------CCCcCCCcccCHHHHHHHHHh
Confidence            42111  1111000                   0                         000112334467899999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f  423 (430)
                      |+.||++|||+.+++.||||
T Consensus       241 l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         241 LRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             CcCChhhCCCHHHHhhCCCC
Confidence            99999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.5e-40  Score=314.66  Aligned_cols=248  Identities=21%  Similarity=0.289  Sum_probs=191.5

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeE--EEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEM--VAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||+|+||.||+|.++.++..  +|+|.++..  ......+..|++++.++.+    |+|++++++++...+.
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~----h~~iv~~~~~~~~~~~   82 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH----HPNIINLLGACEHRGY   82 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcC----CCCcceEEEEECCCCC
Confidence            4699999999999999999998877754  577776532  2334556778988888843    4789999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCc
Q 014117          170 ICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY  234 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~  234 (430)
                      +|+||||+ +++|.+++....              ...+++..++.++.||+.||+|||++||+||||||+|||++.+  
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~--  160 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--  160 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC--
Confidence            99999999 889999997542              1358899999999999999999999999999999999999544  


Q ss_pred             cccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHH
Q 014117          235 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE  312 (430)
Q Consensus       235 ~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~e  312 (430)
                                               +.+||+|||++......  .....++..|+|||++.+..++.++|||||||++||
T Consensus       161 -------------------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  215 (303)
T cd05088         161 -------------------------YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE  215 (303)
T ss_pred             -------------------------CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHH
Confidence                                     45666666655422111  111233667999999988889999999999999999


Q ss_pred             HHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCC
Q 014117          313 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH  391 (430)
Q Consensus       313 l~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (430)
                      |+| |..||...+..+....+...   .                     .                        ...+..
T Consensus       216 llt~g~~p~~~~~~~~~~~~~~~~---~---------------------~------------------------~~~~~~  247 (303)
T cd05088         216 IVSLGGTPYCGMTCAELYEKLPQG---Y---------------------R------------------------LEKPLN  247 (303)
T ss_pred             HHhcCCCCcccCChHHHHHHHhcC---C---------------------c------------------------CCCCCC
Confidence            998 99999765554433322110   0                     0                        001223


Q ss_pred             chhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          392 SAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       392 ~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      .+.++.+|+.+||+.||++|||++++|++
T Consensus       248 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         248 CDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            45678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.4e-39  Score=304.58  Aligned_cols=244  Identities=25%  Similarity=0.365  Sum_probs=192.1

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      ++|.+...||+|+||.||+|.+..+. .+|+|.+.........+..|+.+++++.     +++++++++++. .+..++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLR-----HDKLVPLYAVVS-EEPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCC-----CCCeeeEEEEEc-CCCcEEE
Confidence            56999999999999999999887654 5999988754444566778999999884     477888888775 4668999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      |||+ +++|.+++.......+++..+..++.||+.||.|||+.||+|+||||+||+++.+                    
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~--------------------  138 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN--------------------  138 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC--------------------
Confidence            9999 7899999987654568999999999999999999999999999999999999544                    


Q ss_pred             cccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHH
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE  327 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~  327 (430)
                             +.++|+|||.+.......    ....++..|+|||.+.+..++.++|||||||++|+|++ |.+||.+....+
T Consensus       139 -------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  211 (260)
T cd05069         139 -------LVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE  211 (260)
T ss_pred             -------CeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence                   456666666654332211    11245678999999998899999999999999999999 999998766555


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+.... ..                                               ..+...+..+.+++.+||+.|
T Consensus       212 ~~~~~~~~~-~~-----------------------------------------------~~~~~~~~~~~~li~~~l~~~  243 (260)
T cd05069         212 VLEQVERGY-RM-----------------------------------------------PCPQGCPESLHELMKLCWKKD  243 (260)
T ss_pred             HHHHHHcCC-CC-----------------------------------------------CCCcccCHHHHHHHHHHccCC
Confidence            443332110 00                                               012234567999999999999


Q ss_pred             CCCCCCHHHHhc
Q 014117          408 PTDRLTAREALR  419 (430)
Q Consensus       408 P~~R~ta~elL~  419 (430)
                      |++|||++++++
T Consensus       244 p~~Rp~~~~i~~  255 (260)
T cd05069         244 PDERPTFEYIQS  255 (260)
T ss_pred             cccCcCHHHHHH
Confidence            999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.2e-39  Score=306.09  Aligned_cols=247  Identities=25%  Similarity=0.385  Sum_probs=192.9

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++..    ......+..|+++++.+.     |++++++++.+...+.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-----HPNVIKYLDSFIEDNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-----CcceeeeeeeEEECCe
Confidence            4699999999999999999999999999999987532    233345677899888884     4889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      .++||||+ +++|.+++...  ....+++..+..++.||+.||.|||++||+|+||||+|||++.++             
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~-------------  143 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG-------------  143 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-------------
Confidence            99999999 78999888642  224589999999999999999999999999999999999995544             


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                    .++|+|||.+.......   ....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus       144 --------------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~  209 (267)
T cd08228         144 --------------VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             --------------CEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence                          45666666554332211   2246788999999999888999999999999999999999999653


Q ss_pred             ch--HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          324 EN--LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       324 ~~--~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      ..  .+....+ ...+.++.                                              .....+.++.+++.
T Consensus       210 ~~~~~~~~~~~-~~~~~~~~----------------------------------------------~~~~~~~~~~~li~  242 (267)
T cd08228         210 KMNLFSLCQKI-EQCDYPPL----------------------------------------------PTEHYSEKLRELVS  242 (267)
T ss_pred             cccHHHHHHHH-hcCCCCCC----------------------------------------------ChhhcCHHHHHHHH
Confidence            32  1111111 11111000                                              01234567899999


Q ss_pred             HhhhcCCCCCCCHHHHhc
Q 014117          402 GLLRYDPTDRLTAREALR  419 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~  419 (430)
                      +||+.+|++|||+.++++
T Consensus       243 ~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         243 MCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             HHCCCCcccCcCHHHHHH
Confidence            999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1e-39  Score=304.77  Aligned_cols=243  Identities=23%  Similarity=0.318  Sum_probs=191.5

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee-ecCCeEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-DYRNHICI  172 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-~~~~~~~l  172 (430)
                      .+|++.+.||+|+||.||++...  +..||+|.++... ..+.+..|+.+++++.     +++++++++.+ ...+..++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLR-----HSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCC-----CCCeeeEEEEEEcCCCceEE
Confidence            36899999999999999999764  6779999986433 3456778999988884     37789988864 55678999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+||+++.                    
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~--------------------  137 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSE--------------------  137 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcC--------------------
Confidence            99999 789999998766556899999999999999999999999999999999999954                    


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHHH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA  330 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~  330 (430)
                             ++.+||+|||++...........++..|+|||++.+..++.++|||||||++|+|++ |..||......+...
T Consensus       138 -------~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~  210 (256)
T cd05082         138 -------DNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP  210 (256)
T ss_pred             -------CCcEEecCCccceeccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence                   445666666665543333333345678999999998899999999999999999998 999997654433332


Q ss_pred             HHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCC
Q 014117          331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD  410 (430)
Q Consensus       331 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~  410 (430)
                      .+.+..                                                ....++..+..+.+++.+||+.||++
T Consensus       211 ~~~~~~------------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~  242 (256)
T cd05082         211 RVEKGY------------------------------------------------KMDAPDGCPPVVYDVMKQCWHLDAAT  242 (256)
T ss_pred             HHhcCC------------------------------------------------CCCCCCCCCHHHHHHHHHHhcCChhh
Confidence            221100                                                00122345678999999999999999


Q ss_pred             CCCHHHHhc
Q 014117          411 RLTAREALR  419 (430)
Q Consensus       411 R~ta~elL~  419 (430)
                      |||+.++++
T Consensus       243 Rpt~~~l~~  251 (256)
T cd05082         243 RPSFLQLRE  251 (256)
T ss_pred             CcCHHHHHH
Confidence            999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1e-39  Score=309.49  Aligned_cols=247  Identities=20%  Similarity=0.313  Sum_probs=192.5

Q ss_pred             CcEEEEeeeccccceEEEEEEEC----CCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDR----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      +.|++.+.||+|+||.||+|.+.    .+++.||+|.++...  .....+..|+.+++++.     |+|++++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH-----HPNIVCLLGVVTQE   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC-----CCCeeeEEEEEecC
Confidence            46899999999999999999853    456789999986422  22345677898988884     48899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEee
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNN---------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS  231 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~---------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~  231 (430)
                      ...|+||||+ +++|.+++....               ...+++..+..++.|++.||.|||++||+||||||+|||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~  159 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence            9999999999 889999986332               134788999999999999999999999999999999999955


Q ss_pred             cCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchHHHH
Q 014117          232 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSV  306 (430)
Q Consensus       232 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  306 (430)
                      ++                           .+||+|||+++.....     .....++..|+|||++.+..++.++|||||
T Consensus       160 ~~---------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  212 (283)
T cd05090         160 QL---------------------------HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSF  212 (283)
T ss_pred             CC---------------------------cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHH
Confidence            44                           4566666655432211     122345678999999998889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHH
Q 014117          307 GCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI  385 (430)
Q Consensus       307 Gv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (430)
                      ||++|||++ |.+||.+.+..+....+.... .                                               
T Consensus       213 G~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~-----------------------------------------------  244 (283)
T cd05090         213 GVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ-L-----------------------------------------------  244 (283)
T ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-c-----------------------------------------------
Confidence            999999998 999998765544333322100 0                                               


Q ss_pred             hhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       386 ~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      ...+...+..+.+++.+||+.||.+||++.+++++
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         245 LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            01123456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8e-40  Score=304.69  Aligned_cols=239  Identities=21%  Similarity=0.345  Sum_probs=186.7

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL  177 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~  177 (430)
                      +.||+|+||.||+|.++.+++.||+|.+...  ......+..|+++++++.     |+|++++++++......|+||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS-----HPNIVRLIGVCTQKQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCC-----CCCcceEEEEEcCCCCeEEEEeec
Confidence            3689999999999999999999999987633  233456778999888873     488999999999999999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccC
Q 014117          178 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM  256 (430)
Q Consensus       178 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~  256 (430)
                       +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++++|||++             
T Consensus        76 ~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~-------------  141 (252)
T cd05084          76 QGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMS-------------  141 (252)
T ss_pred             cCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccC-------------
Confidence             889999997643 46899999999999999999999999999999999999966555555555544             


Q ss_pred             CCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHHH
Q 014117          257 PKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA  330 (430)
Q Consensus       257 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~  330 (430)
                                    .......     ....++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+......
T Consensus       142 --------------~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~  207 (252)
T cd05084         142 --------------REEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE  207 (252)
T ss_pred             --------------cccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH
Confidence                          3211110     01122457999999998889999999999999999998 999997655433322


Q ss_pred             HHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCC
Q 014117          331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD  410 (430)
Q Consensus       331 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~  410 (430)
                      .+.... .                                               ...+...+..+.+|+.+||+.||++
T Consensus       208 ~~~~~~-~-----------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~  239 (252)
T cd05084         208 AIEQGV-R-----------------------------------------------LPCPELCPDAVYRLMERCWEYDPGQ  239 (252)
T ss_pred             HHHcCC-C-----------------------------------------------CCCcccCCHHHHHHHHHHcCCChhh
Confidence            221100 0                                               0112344667999999999999999


Q ss_pred             CCCHHHHhc
Q 014117          411 RLTAREALR  419 (430)
Q Consensus       411 R~ta~elL~  419 (430)
                      |||+.++++
T Consensus       240 Rps~~~~~~  248 (252)
T cd05084         240 RPSFSTVHQ  248 (252)
T ss_pred             CcCHHHHHH
Confidence            999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=9.7e-40  Score=311.30  Aligned_cols=250  Identities=26%  Similarity=0.456  Sum_probs=197.2

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      |....+||+|+||.||++.+..+++.||+|.+.... .....+..|+.+++.+.     +++++++++.+...+..++||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-----HENVVEMYNSYLVGDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcC-----CcchhheeeEEEeCCEEEEEE
Confidence            344467999999999999999999999999885322 33455677888888773     478999999999999999999


Q ss_pred             ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          175 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       175 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      ||+ +++|.+++...   .+++..+..++.|++.||+|||+.||+|+||||+||+++.++                    
T Consensus        97 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~--------------------  153 (292)
T cd06657          97 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG--------------------  153 (292)
T ss_pred             ecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--------------------
Confidence            999 78998887543   589999999999999999999999999999999999995544                    


Q ss_pred             ccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Q 014117          254 KRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA  330 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~  330 (430)
                             .++|+|||++......   .....||+.|+|||.+.+..++.++|+|||||++|+|++|..||.+....+...
T Consensus       154 -------~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~  226 (292)
T cd06657         154 -------RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK  226 (292)
T ss_pred             -------CEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                   4555666554322211   122468899999999988889999999999999999999999998765544443


Q ss_pred             HHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCC
Q 014117          331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD  410 (430)
Q Consensus       331 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~  410 (430)
                      .+.......                                              .......+..+.+++.+||+.||.+
T Consensus       227 ~~~~~~~~~----------------------------------------------~~~~~~~~~~l~~li~~~l~~~P~~  260 (292)
T cd06657         227 MIRDNLPPK----------------------------------------------LKNLHKVSPSLKGFLDRLLVRDPAQ  260 (292)
T ss_pred             HHHhhCCcc----------------------------------------------cCCcccCCHHHHHHHHHHHhCCccc
Confidence            332211100                                              0011234567899999999999999


Q ss_pred             CCCHHHHhcCCCCCCC
Q 014117          411 RLTAREALRHPFFTRD  426 (430)
Q Consensus       411 R~ta~elL~hp~f~~~  426 (430)
                      ||++.++|.||||...
T Consensus       261 R~~~~~ll~~~~~~~~  276 (292)
T cd06657         261 RATAAELLKHPFLAKA  276 (292)
T ss_pred             CcCHHHHhcChHHhcc
Confidence            9999999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.4e-39  Score=309.49  Aligned_cols=246  Identities=23%  Similarity=0.345  Sum_probs=192.1

Q ss_pred             CcEEEEeeeccccceEEEEEEE-----CCCCeEEEEEEecCc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .+|.+.+.||+|+||.||++.+     ..++..+|+|.+... ......+..|+++++++.     +++++++++++...
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ-----HEHIVKFYGVCVEG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCC-----CCCcceEEEEEecC
Confidence            4689999999999999999985     334567999998643 234456778999988884     37899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCcc
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNN-----------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI  235 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~  235 (430)
                      +.+++||||+ +++|.+++...+           ...+++..+..++.||+.||+|||++||+||||||+|||++.++. 
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~-  158 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL-  158 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc-
Confidence            9999999999 889999997543           124899999999999999999999999999999999999965554 


Q ss_pred             ccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHH
Q 014117          236 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL  310 (430)
Q Consensus       236 ~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l  310 (430)
                                                ++|+|||++.......     ....++..|+|||++.+..++.++|+|||||++
T Consensus       159 --------------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il  212 (288)
T cd05093         159 --------------------------VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL  212 (288)
T ss_pred             --------------------------EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHH
Confidence                                      5555555544222111     112457789999999998999999999999999


Q ss_pred             HHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhc
Q 014117          311 VELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV  389 (430)
Q Consensus       311 ~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (430)
                      |+|++ |.+||......+....+...  ..+                                              ..+
T Consensus       213 ~~l~t~g~~p~~~~~~~~~~~~i~~~--~~~----------------------------------------------~~~  244 (288)
T cd05093         213 WEIFTYGKQPWYQLSNNEVIECITQG--RVL----------------------------------------------QRP  244 (288)
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHcC--CcC----------------------------------------------CCC
Confidence            99998 99999876554433332211  000                                              012


Q ss_pred             CCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          390 DHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       390 ~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      ...+.++.+|+.+||+.||.+|||+.+++.
T Consensus       245 ~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         245 RTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            345667999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2e-39  Score=312.74  Aligned_cols=253  Identities=25%  Similarity=0.389  Sum_probs=200.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      ...|...+.||+|+||.||++.+..++..||+|.+....    .....+..|+++++.+.     +++++++++++....
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~   98 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-----HPNSIEYKGCYLREH   98 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-----CCCEEEEEEEEeeCC
Confidence            345888999999999999999999999999999986332    22345667888888773     478999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          169 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       169 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      ..++||||+.++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||+++.                 
T Consensus        99 ~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~-----------------  160 (317)
T cd06635          99 TAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE-----------------  160 (317)
T ss_pred             eEEEEEeCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC-----------------
Confidence            999999999778888876543 46899999999999999999999999999999999999944                 


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhh---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                                ++.++|+|||++..... .....|+..|+|||++.   +..++.++|||||||++|+|++|..||.....
T Consensus       161 ----------~~~~kl~dfg~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~  229 (317)
T cd06635         161 ----------PGQVKLADFGSASIASP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  229 (317)
T ss_pred             ----------CCCEEEecCCCccccCC-cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence                      45677777776654332 22346889999999984   34688999999999999999999999976554


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      ......+.....+..                                               .....+..+.+||.+||+
T Consensus       230 ~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~l~~li~~~l~  262 (317)
T cd06635         230 MSALYHIAQNESPTL-----------------------------------------------QSNEWSDYFRNFVDSCLQ  262 (317)
T ss_pred             HHHHHHHHhccCCCC-----------------------------------------------CCccccHHHHHHHHHHcc
Confidence            443333222111000                                               012345678999999999


Q ss_pred             cCCCCCCCHHHHhcCCCCCCC
Q 014117          406 YDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f~~~  426 (430)
                      .+|.+|||+.++++|+|+...
T Consensus       263 ~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         263 KIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             CCcccCcCHHHHHhChhhhcc
Confidence            999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=303.43  Aligned_cols=244  Identities=23%  Similarity=0.322  Sum_probs=196.7

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      ++|++.+.||.|+||.||+|...  ++.||+|.++......+.+..|+.+++.+.     +++++++++++......|+|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLR-----HPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcC-----CcceeeeEEEEcCCCCeEEE
Confidence            46899999999999999999864  788999999865544567788999988884     47899999999889999999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      |||+ +++|.+++.......+++..+..++.|++.||.|||+.||+|+||||+||+++.                     
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~---------------------  137 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE---------------------  137 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeC---------------------
Confidence            9999 789999998766557999999999999999999999999999999999999954                     


Q ss_pred             cccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHHHH
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAM  331 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~~  331 (430)
                            ++.++|+|||.+...........++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....
T Consensus       138 ------~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~  211 (256)
T cd05039         138 ------DLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH  211 (256)
T ss_pred             ------CCCEEEcccccccccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence                  445666777766544332222344667999999988889999999999999999997 9999986654433222


Q ss_pred             HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCC
Q 014117          332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR  411 (430)
Q Consensus       332 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R  411 (430)
                      +....                                                ....+...+.++.++|.+||+.+|++|
T Consensus       212 ~~~~~------------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R  243 (256)
T cd05039         212 VEKGY------------------------------------------------RMEAPEGCPPEVYKVMKDCWELDPAKR  243 (256)
T ss_pred             HhcCC------------------------------------------------CCCCccCCCHHHHHHHHHHhccChhhC
Confidence            21100                                                001123456789999999999999999


Q ss_pred             CCHHHHhc
Q 014117          412 LTAREALR  419 (430)
Q Consensus       412 ~ta~elL~  419 (430)
                      ||+.+++.
T Consensus       244 p~~~~l~~  251 (256)
T cd05039         244 PTFKQLRE  251 (256)
T ss_pred             cCHHHHHH
Confidence            99999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-39  Score=303.43  Aligned_cols=246  Identities=26%  Similarity=0.338  Sum_probs=197.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      .++|.+.+.||+|+||.||+|.+. .++.||+|.+.........+..|+.+++.+.     +++++++++.+......++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLR-----HDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCC-----CCCEeeeeeeeecCCceEE
Confidence            467999999999999999999976 4577999998765555567888999998874     4789999999998899999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+ +++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||+++++                   
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~-------------------  139 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN-------------------  139 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC-------------------
Confidence            99999 8899999987665679999999999999999999999999999999999999554                   


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL  326 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~  326 (430)
                              +.++|+|||.+.......    ....++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.+..
T Consensus       140 --------~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  211 (261)
T cd05034         140 --------LVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR  211 (261)
T ss_pred             --------CCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence                    455666666554332111    11224568999999998889999999999999999998 99999876655


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      .....+......                                                ..+...+.++.+++.+||+.
T Consensus       212 ~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~i~~~l~~  243 (261)
T cd05034         212 EVLEQVERGYRM------------------------------------------------PRPPNCPEELYDLMLQCWDK  243 (261)
T ss_pred             HHHHHHHcCCCC------------------------------------------------CCCCCCCHHHHHHHHHHccc
Confidence            444433221100                                                01223456799999999999


Q ss_pred             CCCCCCCHHHHhc
Q 014117          407 DPTDRLTAREALR  419 (430)
Q Consensus       407 dP~~R~ta~elL~  419 (430)
                      ||++|||++++++
T Consensus       244 ~p~~Rp~~~~l~~  256 (261)
T cd05034         244 DPEERPTFEYLQS  256 (261)
T ss_pred             CcccCCCHHHHHH
Confidence            9999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-39  Score=306.96  Aligned_cols=247  Identities=22%  Similarity=0.325  Sum_probs=193.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCC-----eEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERK-----EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .++|.+.+.||+|+||.||+|.++...     ..||+|.+....  .....+..|+.++..+     .+++++++++++.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-----NCHHVVRLLGVVS   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-----CCCceeEEEEEEc
Confidence            457999999999999999999886543     789999986432  2334566788888777     3478999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccc
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNN--------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK  236 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~  236 (430)
                      .....++||||+ +++|.+++....        ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++   
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~---  156 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL---  156 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC---
Confidence            999999999999 889999987532        12478889999999999999999999999999999999995544   


Q ss_pred             cCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHH
Q 014117          237 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILV  311 (430)
Q Consensus       237 i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~  311 (430)
                                              .+||+|||+++.....     .....+|..|+|||.+.+..++.++|||||||++|
T Consensus       157 ------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  212 (277)
T cd05032         157 ------------------------TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW  212 (277)
T ss_pred             ------------------------CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHH
Confidence                                    4555555555422111     12235678899999999888999999999999999


Q ss_pred             HHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcC
Q 014117          312 ELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD  390 (430)
Q Consensus       312 el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  390 (430)
                      ||++ |..||...+..+....+..  +..                                              ...+.
T Consensus       213 el~t~g~~p~~~~~~~~~~~~~~~--~~~----------------------------------------------~~~~~  244 (277)
T cd05032         213 EMATLAEQPYQGLSNEEVLKFVID--GGH----------------------------------------------LDLPE  244 (277)
T ss_pred             HhhccCCCCCccCCHHHHHHHHhc--CCC----------------------------------------------CCCCC
Confidence            9998 9999987665544433321  100                                              01223


Q ss_pred             CchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          391 HSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       391 ~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      ..+.++.+++.+||+.+|++|||+.++++
T Consensus       245 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         245 NCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            44678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8.7e-40  Score=312.31  Aligned_cols=248  Identities=22%  Similarity=0.294  Sum_probs=191.2

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCe--EEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKE--MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~--~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||.|+||.||+|.+..++.  .+|+|.++..  ....+.+..|+.++.++.+    |++++++++++...+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~----hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH----HPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcC----CCchhheEEEEccCCc
Confidence            468999999999999999999877764  4788887632  2334567778888888743    4789999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCc
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNY--------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY  234 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~  234 (430)
                      +|+||||+ +++|.+++.....              ..+++..++.++.||+.||+|||++||+||||||+|||++.++ 
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-  156 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL-  156 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC-
Confidence            99999999 8899999975421              2588999999999999999999999999999999999995544 


Q ss_pred             cccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHH
Q 014117          235 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE  312 (430)
Q Consensus       235 ~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~e  312 (430)
                                                .+||+|||++.......  .....+..|+|||++.+..++.++|||||||++||
T Consensus       157 --------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~e  210 (297)
T cd05089         157 --------------------------ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWE  210 (297)
T ss_pred             --------------------------eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHH
Confidence                                      45555555553221111  11122557999999998899999999999999999


Q ss_pred             HHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCC
Q 014117          313 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH  391 (430)
Q Consensus       313 l~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (430)
                      |++ |..||......+....+.....                                                ...+..
T Consensus       211 l~t~g~~pf~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~  242 (297)
T cd05089         211 IVSLGGTPYCGMTCAELYEKLPQGYR------------------------------------------------MEKPRN  242 (297)
T ss_pred             HHcCCCCCCCCCCHHHHHHHHhcCCC------------------------------------------------CCCCCC
Confidence            997 9999987655443332211100                                                011234


Q ss_pred             chhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          392 SAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       392 ~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      ++.++.+|+.+||+.||.+|||++++++.
T Consensus       243 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         243 CDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            56789999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.3e-39  Score=309.86  Aligned_cols=255  Identities=24%  Similarity=0.430  Sum_probs=197.4

Q ss_pred             cEEEEeeeccccceEEEEEEEC---CCCeEEEEEEecCch-----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           95 RYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      +|++.+.||.|+||.||+|.+.   .+++.||+|+++...     ...+....|+.++.++.+    +++|+.+++.++.
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~----~~~i~~~~~~~~~   76 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ----SPFLVTLHYAFQT   76 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhccc----CCChhceeeEeec
Confidence            4889999999999999999875   478899999986422     223456678888888853    3779999999999


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      ...+|+||||+ +++|.+++....  .+++..+..++.||+.||.|||+.||+||||||+|||++.              
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~--------------  140 (290)
T cd05613          77 DTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS--------------  140 (290)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECC--------------
Confidence            99999999999 889999998754  6899999999999999999999999999999999999944              


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCC--CCCCcchHHHHHHHHHHHHhCCCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEAL  319 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~tG~~P  319 (430)
                                   ++.+||+|||++.......    ....|+..|+|||.+.+.  .++.++|||||||++|+|++|..|
T Consensus       141 -------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p  207 (290)
T cd05613         141 -------------NGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP  207 (290)
T ss_pred             -------------CCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCC
Confidence                         4566777777665432211    234689999999998753  478899999999999999999999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |...........+....                   ....                          ...+...+..+.+|
T Consensus       208 ~~~~~~~~~~~~~~~~~-------------------~~~~--------------------------~~~~~~~~~~~~~l  242 (290)
T cd05613         208 FTVDGEKNSQAEISRRI-------------------LKSE--------------------------PPYPQEMSALAKDI  242 (290)
T ss_pred             CCcCCccccHHHHHHHh-------------------hccC--------------------------CCCCccCCHHHHHH
Confidence            96432211111111100                   0000                          01123456678999


Q ss_pred             HHHhhhcCCCCCC-----CHHHHhcCCCCCCCC
Q 014117          400 LQGLLRYDPTDRL-----TAREALRHPFFTRDH  427 (430)
Q Consensus       400 l~~~L~~dP~~R~-----ta~elL~hp~f~~~~  427 (430)
                      +.+||+.||++|+     ++++++.||||....
T Consensus       243 l~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         243 IQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             HHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            9999999999997     899999999998653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.9e-39  Score=310.73  Aligned_cols=249  Identities=23%  Similarity=0.378  Sum_probs=192.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEE-----CCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .++|.+.+.||+|+||.||+|.+     ..++..||+|+++...  ...+.+..|+.+++++..    |+||+++++.+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~----h~~iv~~~~~~~  109 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN----HENIVNLLGACT  109 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccC----CCCcceEEEEEe
Confidence            45799999999999999999975     2345689999987432  233457789999988842    378999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                      ..+..++||||+ +++|.+++.......+++..+..++.||+.||.|||+++|+|+||||+|||++.++.          
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~----------  179 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI----------  179 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe----------
Confidence            999999999999 889999997655445899999999999999999999999999999999999965554          


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA  318 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~  318 (430)
                                       ++|+|||++.......     ....++..|+|||.+.+..++.++|||||||++|+|++ |..
T Consensus       180 -----------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~  242 (302)
T cd05055         180 -----------------VKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSN  242 (302)
T ss_pred             -----------------EEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCC
Confidence                             4555555444222111     11235778999999999899999999999999999998 999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||......+.+.....                      .+. .                        ...+...+.++.+
T Consensus       243 p~~~~~~~~~~~~~~~----------------------~~~-~------------------------~~~~~~~~~~~~~  275 (302)
T cd05055         243 PYPGMPVDSKFYKLIK----------------------EGY-R------------------------MAQPEHAPAEIYD  275 (302)
T ss_pred             CcCCCCchHHHHHHHH----------------------cCC-c------------------------CCCCCCCCHHHHH
Confidence            9986554332221111                      000 0                        0012234567999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhc
Q 014117          399 LLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~  419 (430)
                      |+.+||+.+|++|||+.|+++
T Consensus       276 li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         276 IMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             HHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-39  Score=304.86  Aligned_cols=251  Identities=22%  Similarity=0.312  Sum_probs=192.7

Q ss_pred             CcEEEEeeeccccceEEEEEEECCC---CeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      ++|++.+.||+|+||.||+|.++.+   ...||+|+++..  ......+..|+.++..+.     +++++++++++...+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD-----HPNIIRLEGVVTKSR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCC-----CCCcceEeEEEecCC
Confidence            4699999999999999999988654   457999998643  233455677888888884     478999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      ..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++++|||++....
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          79 PVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            999999999 889999997654 378999999999999999999999999999999999999665555555555443322


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchH
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL  326 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~  326 (430)
                      .....         .             ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus       158 ~~~~~---------~-------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~  215 (266)
T cd05033         158 DSEAT---------Y-------------TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ  215 (266)
T ss_pred             ccccc---------e-------------eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH
Confidence            10000         0             0001134678999999998899999999999999999998 99999766554


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +....+.... ..|                                               .+...+..+.+|+.+||+.
T Consensus       216 ~~~~~~~~~~-~~~-----------------------------------------------~~~~~~~~l~~li~~cl~~  247 (266)
T cd05033         216 DVIKAVEDGY-RLP-----------------------------------------------PPMDCPSALYQLMLDCWQK  247 (266)
T ss_pred             HHHHHHHcCC-CCC-----------------------------------------------CCCCCCHHHHHHHHHHcCC
Confidence            4333332110 000                                               1123466799999999999


Q ss_pred             CCCCCCCHHHHhcC
Q 014117          407 DPTDRLTAREALRH  420 (430)
Q Consensus       407 dP~~R~ta~elL~h  420 (430)
                      ||++||++++++++
T Consensus       248 ~p~~Rp~~~ei~~~  261 (266)
T cd05033         248 DRNERPTFSQIVST  261 (266)
T ss_pred             CcccCcCHHHHHHH
Confidence            99999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.3e-39  Score=312.89  Aligned_cols=253  Identities=26%  Similarity=0.381  Sum_probs=198.8

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      ...|...+.||.|+||.||+|.++.+++.+|+|.+...    ......+..|+++++.+.     +++++++.+++....
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~   88 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-----HPNTIQYRGCYLREH   88 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-----CCCcccEEEEEEcCC
Confidence            44688889999999999999999999999999988632    122345667888888874     477999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          169 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       169 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      ..++||||+.++|.+++.... ..+++..+..++.|++.||.|||+.+++||||||+|||++.                 
T Consensus        89 ~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~-----------------  150 (308)
T cd06634          89 TAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE-----------------  150 (308)
T ss_pred             eeEEEEEccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECC-----------------
Confidence            999999999888888876543 46899999999999999999999999999999999999954                 


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhh---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                                ++.++|+|||++...... ....|+..|+|||.+.   ...++.++|||||||++|+|++|..||...+.
T Consensus       151 ----------~~~~kl~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  219 (308)
T cd06634         151 ----------PGLVKLGDFGSASIMAPA-NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA  219 (308)
T ss_pred             ----------CCcEEECCcccceeecCc-ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH
Confidence                      445666666665543322 2346889999999985   34688999999999999999999999976544


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+....+....  .|.                                             ......+..+.+||.+||+
T Consensus       220 ~~~~~~~~~~~--~~~---------------------------------------------~~~~~~~~~~~~li~~cl~  252 (308)
T cd06634         220 MSALYHIAQNE--SPA---------------------------------------------LQSGHWSEYFRNFVDSCLQ  252 (308)
T ss_pred             HHHHHHHhhcC--CCC---------------------------------------------cCcccccHHHHHHHHHHhh
Confidence            33332221110  000                                             0012455678999999999


Q ss_pred             cCCCCCCCHHHHhcCCCCCCC
Q 014117          406 YDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f~~~  426 (430)
                      .+|++|||++++++|||+...
T Consensus       253 ~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         253 KIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             CCcccCCCHHHHhhCcccccc
Confidence            999999999999999999765

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.9e-39  Score=333.08  Aligned_cols=272  Identities=22%  Similarity=0.335  Sum_probs=178.5

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCC----CeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecce-----
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRER----KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW-----  163 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~-----  163 (430)
                      .++|++.+.||+|+||.||+|.+..+    +..||+|.+..... .     |.....++.+...  .++..+...     
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~-----e~~~~e~l~~~~~--~~~~~~~~~~~~~~  202 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-V-----EIWMNERVRRACP--NSCADFVYGFLEPV  202 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-h-----HHHHHHHHHhhch--hhHHHHHHhhhccc
Confidence            46899999999999999999999988    89999998763221 1     1111122211100  111111111     


Q ss_pred             -eecCCeEEEEEecC-CCCHHHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCC
Q 014117          164 -FDYRNHICIVFEKL-GSSLYDFLRKNNYR------------------SFPIDLVREIARQLLECIAFMHDLCMIHTDLK  223 (430)
Q Consensus       164 -~~~~~~~~lv~e~~-~~~L~~~l~~~~~~------------------~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlK  223 (430)
                       ......++|||||+ +++|.+++......                  ......+..++.||+.||.|||++||||||||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK  282 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK  282 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence             24567899999999 78999998754310                  11234567899999999999999999999999


Q ss_pred             CCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC----CCeeeecCcccchhhhhCC----
Q 014117          224 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGL----  295 (430)
Q Consensus       224 p~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~----  295 (430)
                      |+|||++.                          ..+.+||+|||+|+.....    ....+||+.|+|||.+...    
T Consensus       283 P~NILl~~--------------------------~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~  336 (566)
T PLN03225        283 PQNIIFSE--------------------------GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTP  336 (566)
T ss_pred             HHHEEEeC--------------------------CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCC
Confidence            99999952                          2456888888887643222    2345789999999976432    


Q ss_pred             ------------------CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhcc
Q 014117          296 ------------------GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR  357 (430)
Q Consensus       296 ------------------~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~  357 (430)
                                        .++.++|||||||+||||+++..|+.  ++...+..+....+.....+.......       
T Consensus       337 ~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~-------  407 (566)
T PLN03225        337 SAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDLVAWRKLVEPR-------  407 (566)
T ss_pred             CCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcHHHHHHhhccc-------
Confidence                              23456799999999999998766554  333333333333332222111110000       


Q ss_pred             CcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          358 GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                                ...         .... .....+.......+||.+||++||++|||++|+|+||||+...
T Consensus       408 ----------~~~---------~~~~-~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~  457 (566)
T PLN03225        408 ----------ASP---------DLRR-GFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREG  457 (566)
T ss_pred             ----------cch---------hhhh-hhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCC
Confidence                      000         0000 0111233344577999999999999999999999999998754

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.5e-39  Score=304.25  Aligned_cols=248  Identities=29%  Similarity=0.475  Sum_probs=194.7

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc------hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      +|.+.+.||+|+||.||++.+..++..+++|+++..      .........|+.+++.+     .|+|++++++++....
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-----DHPAIVKFHASFLERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-----CCCcHHHHHHHHhcCC
Confidence            589999999999999999999888777777776532      11223455677777776     3488999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      ..++||||+ +++|.+++..  .....+++..++.++.|++.||.|||+.||+|+||||+||++++              
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~--------------  141 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN--------------  141 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec--------------
Confidence            999999999 8899988864  22347999999999999999999999999999999999999942              


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                    ..++|+|||.+.......   ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus       142 --------------~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~  207 (260)
T cd08222         142 --------------NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG  207 (260)
T ss_pred             --------------CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                          236777777665332211   234578899999999888899999999999999999999999976


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      .........+..  +..|                                              ..+...+.++.++|.+
T Consensus       208 ~~~~~~~~~~~~--~~~~----------------------------------------------~~~~~~~~~~~~li~~  239 (260)
T cd08222         208 QNFLSVVLRIVE--GPTP----------------------------------------------SLPETYSRQLNSIMQS  239 (260)
T ss_pred             ccHHHHHHHHHc--CCCC----------------------------------------------CCcchhcHHHHHHHHH
Confidence            554333322211  1111                                              0123456679999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f  423 (430)
                      ||+.||++||++.|+++||||
T Consensus       240 ~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         240 MLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HhcCChhhCcCHHHHhhCCCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.9e-39  Score=309.51  Aligned_cols=253  Identities=23%  Similarity=0.347  Sum_probs=194.2

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCC----------------eEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERK----------------EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGN  155 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~----------------~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~  155 (430)
                      ++|++++.||+|+||.||+|.+..++                ..||+|++....  .....+..|++++.++.|     +
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~-----~   79 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSD-----P   79 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCC-----C
Confidence            57999999999999999999876543                568999987432  345567789999999843     7


Q ss_pred             ceEEecceeecCCeEEEEEecC-CCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCC
Q 014117          156 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNN---------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPE  225 (430)
Q Consensus       156 ~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~  225 (430)
                      |++++++++...+..++|||++ +++|.+++....         ...+++..+..++.|++.||.|||+.||+||||||+
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~  159 (296)
T cd05051          80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR  159 (296)
T ss_pred             CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence            8999999999999999999999 889999997643         126899999999999999999999999999999999


Q ss_pred             ceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCc
Q 014117          226 NVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYP  300 (430)
Q Consensus       226 NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~  300 (430)
                      ||+++.++.                           ++|+|||.+......     .....+|..|+|||++.+..++.+
T Consensus       160 Nili~~~~~---------------------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  212 (296)
T cd05051         160 NCLVGKNYT---------------------------IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK  212 (296)
T ss_pred             ceeecCCCc---------------------------eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCcc
Confidence            999965554                           555555544322111     112345778999999998889999


Q ss_pred             chHHHHHHHHHHHHh--CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCc
Q 014117          301 CDIWSVGCILVELCT--GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL  378 (430)
Q Consensus       301 ~DvwslGv~l~el~t--G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  378 (430)
                      +|||||||++|||++  |..||...+..+.+..+........                  .                   
T Consensus       213 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~------------------~-------------------  255 (296)
T cd05051         213 SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDG------------------R-------------------  255 (296)
T ss_pred             chhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccc------------------c-------------------
Confidence            999999999999998  7889977665554433322110000                  0                   


Q ss_pred             hhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          379 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                          ......+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       256 ----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         256 ----QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             ----cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence                0000112345678999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.2e-39  Score=305.42  Aligned_cols=245  Identities=23%  Similarity=0.287  Sum_probs=187.1

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCe----EEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKE----MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      ..+|++.+.||+|+||+||+|.+..+++    .||+|+++..  ......+..|+.++..+     +++|++.+++++..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-----GSPYVCRLLGICLT   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-----CCCCCceEEEEEcC
Confidence            3579999999999999999999876665    4899998643  23345566777777766     34788888887764


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                       ...+++|||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+++++            
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~------------  146 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN------------  146 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC------------
Confidence             4578999999 889999987643 3689999999999999999999999999999999999995544            


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCCC-----eeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN-----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL  319 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~P  319 (430)
                                     .+||+|||+++.......     ...++..|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus       147 ---------------~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p  211 (279)
T cd05109         147 ---------------HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP  211 (279)
T ss_pred             ---------------cEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence                           456666665543322111     1134678999999999899999999999999999998 9999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |......+....+... ..++                                               .+...+.++.++
T Consensus       212 ~~~~~~~~~~~~~~~~-~~~~-----------------------------------------------~~~~~~~~~~~l  243 (279)
T cd05109         212 YDGIPAREIPDLLEKG-ERLP-----------------------------------------------QPPICTIDVYMI  243 (279)
T ss_pred             CCCCCHHHHHHHHHCC-CcCC-----------------------------------------------CCccCCHHHHHH
Confidence            9765543332222110 0000                                               122446678999


Q ss_pred             HHHhhhcCCCCCCCHHHHhc
Q 014117          400 LQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~  419 (430)
                      +.+||+.||++|||+.+++.
T Consensus       244 i~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         244 MVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.3e-39  Score=308.56  Aligned_cols=249  Identities=22%  Similarity=0.330  Sum_probs=193.3

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCC-----CeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRER-----KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .++|++.+.||+|+||.||++.....     ...+|+|++....  .....+..|+.++.++.    .|+|++++++++.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~i~~~~~~~~   86 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG----KHKNIINLLGVCT   86 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhc----CCCCeeeEEEEEc
Confidence            45799999999999999999987644     3789999987432  23345677888888873    2478999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEe
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKN--------------NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV  230 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~  230 (430)
                      ..+.+++||||+ +++|.+++...              ....+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence            999999999999 88999999752              234689999999999999999999999999999999999996


Q ss_pred             ecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHH
Q 014117          231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWS  305 (430)
Q Consensus       231 ~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Dvws  305 (430)
                      .++                           .+||+|||.++......     ....++..|+|||++.+..++.++||||
T Consensus       167 ~~~---------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  219 (293)
T cd05053         167 EDH---------------------------VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWS  219 (293)
T ss_pred             CCC---------------------------eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceee
Confidence            544                           45555555554322211     1112456799999999889999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHH
Q 014117          306 VGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL  384 (430)
Q Consensus       306 lGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (430)
                      |||++|||++ |..||.+....+....+....                                                
T Consensus       220 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------------------------------------------------  251 (293)
T cd05053         220 FGVLLWEIFTLGGSPYPGIPVEELFKLLKEGY------------------------------------------------  251 (293)
T ss_pred             hhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCC------------------------------------------------
Confidence            9999999998 999998765544433222100                                                


Q ss_pred             HhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       385 ~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      ....+...+.++.+|+.+||+.||++|||+.|++++
T Consensus       252 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         252 RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            001123446679999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.3e-39  Score=307.38  Aligned_cols=246  Identities=23%  Similarity=0.376  Sum_probs=191.3

Q ss_pred             CcEEEEeeeccccceEEEEEEEC-----CCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .+|.+.+.||+|+||.||+|.+.     .++..+|+|.++... .....+..|++++.++.     +++++++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ-----HEHIVKFYGVCGDG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCC-----CCCcceEEEEEccC
Confidence            45899999999999999999854     345679999986433 23345778888888874     47899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeec
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNY--------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS  232 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~  232 (430)
                      +..++||||+ +++|.+++.....              ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            9999999999 8999999976431              348899999999999999999999999999999999999655


Q ss_pred             CccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchHHHHH
Q 014117          233 EYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVG  307 (430)
Q Consensus       233 ~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  307 (430)
                      +.                           ++|+|||++......     .....++..|+|||++.+..++.++||||||
T Consensus       160 ~~---------------------------~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  212 (291)
T cd05094         160 LL---------------------------VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG  212 (291)
T ss_pred             Cc---------------------------EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHH
Confidence            54                           455555544322211     1123567889999999999999999999999


Q ss_pred             HHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHh
Q 014117          308 CILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM  386 (430)
Q Consensus       308 v~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (430)
                      |++|||++ |..||......+....+..                       +..                         .
T Consensus       213 ~il~el~t~g~~p~~~~~~~~~~~~~~~-----------------------~~~-------------------------~  244 (291)
T cd05094         213 VILWEIFTYGKQPWFQLSNTEVIECITQ-----------------------GRV-------------------------L  244 (291)
T ss_pred             HHHHHHHhCCCCCCCCCCHHHHHHHHhC-----------------------CCC-------------------------C
Confidence            99999999 9999977655443322211                       000                         0


Q ss_pred             hhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          387 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       387 ~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      ..+...+.++.+++.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         245 ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            012234667999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-39  Score=301.26  Aligned_cols=241  Identities=24%  Similarity=0.374  Sum_probs=193.6

Q ss_pred             eeeccccceEEEEEEECCC---CeEEEEEEecCchhh--HHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117          100 SKMGEGTFGQVLECWDRER---KEMVAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      +.||+|+||.||+|.+...   +..||+|+++.....  ...+..|++.+..+.     +++++++++++.....+++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~i~~~~~~~~~~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-----HPNVVRLLGVCTEEEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcC-----CCChheeeeeecCCCceEEEE
Confidence            4689999999999999866   889999998754332  456778888888884     478999999999999999999


Q ss_pred             ecC-CCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          175 EKL-GSSLYDFLRKNN-------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       175 e~~-~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      ||+ +++|.+++....       ...+++..+..++.|++.||.|||++||+||||||+||+++.+              
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~--------------  141 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED--------------  141 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC--------------
Confidence            999 999999998751       2479999999999999999999999999999999999999554              


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF  320 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf  320 (430)
                                   +.++|+|||.+......     .....++..|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus       142 -------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~  208 (262)
T cd00192         142 -------------LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY  208 (262)
T ss_pred             -------------CcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCC
Confidence                         45566666655433322     122456889999999998899999999999999999999 69999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      ......+....+..  +.                                              ....+...+.++.+++
T Consensus       209 ~~~~~~~~~~~~~~--~~----------------------------------------------~~~~~~~~~~~~~~li  240 (262)
T cd00192         209 PGLSNEEVLEYLRK--GY----------------------------------------------RLPKPEYCPDELYELM  240 (262)
T ss_pred             CCCCHHHHHHHHHc--CC----------------------------------------------CCCCCccCChHHHHHH
Confidence            87655444333221  00                                              0112334567899999


Q ss_pred             HHhhhcCCCCCCCHHHHhcC
Q 014117          401 QGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~h  420 (430)
                      .+||+.||++|||+.|++++
T Consensus       241 ~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         241 LSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHccCCcccCcCHHHHHHh
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.5e-39  Score=308.89  Aligned_cols=255  Identities=24%  Similarity=0.408  Sum_probs=194.0

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ++|++.+.||+|+||.||+|.+..+++.||||+++...  ........|+.++.+..    .+++++++++++.....+|
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~----~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH----DCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhcc----CCCchHhhheeeecCCeEE
Confidence            56999999999999999999999989999999987432  22233445565554442    4588999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||++++|.+++.... ..+++..+..++.||+.||.|||+ .||+||||||+||+++++                  
T Consensus        91 ~v~e~~~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~------------------  151 (296)
T cd06618          91 ICMELMSTCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS------------------  151 (296)
T ss_pred             EEeeccCcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCC------------------
Confidence            999999888888776643 379999999999999999999997 699999999999999544                  


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                               +.+||+|||.+.......  ....++..|+|||.+.+..    ++.++|+|||||++|+|++|+.||....
T Consensus       152 ---------~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  222 (296)
T cd06618         152 ---------GNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK  222 (296)
T ss_pred             ---------CCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch
Confidence                     456666666554322111  2235788999999987654    8899999999999999999999997532


Q ss_pred             h-HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          325 N-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       325 ~-~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      . .+....+   .....                   ..++                        ....++.++.+|+.+|
T Consensus       223 ~~~~~~~~~---~~~~~-------------------~~~~------------------------~~~~~~~~l~~li~~~  256 (296)
T cd06618         223 TEFEVLTKI---LQEEP-------------------PSLP------------------------PNEGFSPDFCSFVDLC  256 (296)
T ss_pred             hHHHHHHHH---hcCCC-------------------CCCC------------------------CCCCCCHHHHHHHHHH
Confidence            2 1211111   11000                   0000                        0013456799999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      |+.||++|||++++++||||...
T Consensus       257 l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         257 LTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             ccCChhhCCCHHHHhcChhhhcc
Confidence            99999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.4e-39  Score=299.88  Aligned_cols=249  Identities=28%  Similarity=0.433  Sum_probs=200.0

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+....   ........|+.+++.+.     +++++.+.+.+......|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN-----HPNIISYKEAFLDGNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC-----CCCchhhhhhhccCCEEE
Confidence            4899999999999999999999999999999986432   23345567888888774     478999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +||||+ +++|.+++...  ....+++..+..++.|++.||.|||+.|++|+||||+||+++.                 
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~-----------------  138 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA-----------------  138 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEec-----------------
Confidence            999999 88999998662  2246899999999999999999999999999999999999954                 


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC-CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                                ...+||+|||++...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+
T Consensus       139 ----------~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~  208 (256)
T cd08530         139 ----------NDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD  208 (256)
T ss_pred             ----------CCcEEEeeccchhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                      445677777766543322 122357889999999999889999999999999999999999998765544


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+...  ..+                                              ..+...+.++.+++.+||+.+
T Consensus       209 ~~~~~~~~--~~~----------------------------------------------~~~~~~~~~~~~li~~~l~~~  240 (256)
T cd08530         209 LRYKVQRG--KYP----------------------------------------------PIPPIYSQDLQNFIRSMLQVK  240 (256)
T ss_pred             HHHHHhcC--CCC----------------------------------------------CCchhhCHHHHHHHHHHcCCC
Confidence            33322110  000                                              011234567999999999999


Q ss_pred             CCCCCCHHHHhcCCCC
Q 014117          408 PTDRLTAREALRHPFF  423 (430)
Q Consensus       408 P~~R~ta~elL~hp~f  423 (430)
                      |++|||+.++++||++
T Consensus       241 p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         241 PKLRPNCDKILASPAV  256 (256)
T ss_pred             cccCCCHHHHhcCCCC
Confidence            9999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=9.9e-39  Score=299.53  Aligned_cols=246  Identities=26%  Similarity=0.418  Sum_probs=193.2

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.++..    .........|+++++++.     +++++.+++.+...+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-----~~~i~~~~~~~~~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-----HPNVIKYLASFIENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-----CCCeeeeeeeeecCCe
Confidence            5799999999999999999999999999999988532    223456778898888884     4789999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      .++||||+ +++|.+++...  ....+++..+..++.||+.||.|||+.||+||||||+||+++.               
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~---------------  141 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA---------------  141 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECC---------------
Confidence            99999999 88999998653  2346899999999999999999999999999999999999954               


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                  ++.++|+|||++......   .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus       142 ------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  209 (267)
T cd08224         142 ------------TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             ------------CCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence                        445666666665433221   12346888999999999889999999999999999999999999653


Q ss_pred             chH--HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhc-CCchhHHHHHH
Q 014117          324 ENL--EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV-DHSAGDLTHLL  400 (430)
Q Consensus       324 ~~~--~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll  400 (430)
                      ...  +....+..  +..+                                              ..+ ...+.++.++|
T Consensus       210 ~~~~~~~~~~~~~--~~~~----------------------------------------------~~~~~~~~~~~~~~i  241 (267)
T cd08224         210 KMNLYSLCKKIEK--CDYP----------------------------------------------PLPADHYSEELRDLV  241 (267)
T ss_pred             CccHHHHHhhhhc--CCCC----------------------------------------------CCChhhcCHHHHHHH
Confidence            311  11111100  0000                                              001 13456789999


Q ss_pred             HHhhhcCCCCCCCHHHHhc
Q 014117          401 QGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~  419 (430)
                      .+||..+|++|||+.+|++
T Consensus       242 ~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         242 SRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHcCCCcccCCCHHHHHH
Confidence            9999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-40  Score=334.46  Aligned_cols=245  Identities=23%  Similarity=0.393  Sum_probs=209.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECC-----CCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      ..+.+..++||+|+||+||+|+...     ....||||.++..  .+.+++|.+|++.+..+.     |+|||++++.+.
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~-----H~nIVrLlGVC~  559 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQ-----HPNIVRLLGVCR  559 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhcc-----CCCeEEEEEEEc
Confidence            4567888999999999999997643     3468999999743  346788999999999994     489999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcCC--------C----CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeec
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNNY--------R----SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS  232 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~~--------~----~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~  232 (430)
                      .++.+|+|+||| .|+|.+||.....        .    .|+..+.+.|+.||+.|++||-++.+|||||-..|+||   
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---  636 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---  636 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---
Confidence            999999999999 8999999975321        2    27888999999999999999999999999999999999   


Q ss_pred             CccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeee-----ecCcccchhhhhCCCCCCcchHHHHH
Q 014117          233 EYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV-----STRHYRAPEVILGLGWTYPCDIWSVG  307 (430)
Q Consensus       233 ~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~-----gt~~y~aPE~~~~~~~~~~~DvwslG  307 (430)
                                              ..+..|||+|||+++.....+.+.+     -+..|||||.|+..+|+.+|||||||
T Consensus       637 ------------------------ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~G  692 (774)
T KOG1026|consen  637 ------------------------GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFG  692 (774)
T ss_pred             ------------------------ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhh
Confidence                                    5677888899998886555443332     36789999999999999999999999


Q ss_pred             HHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHh
Q 014117          308 CILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM  386 (430)
Q Consensus       308 v~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (430)
                      |+|||+++ |..||.+.++.+.+..|.+                       |.                         ..
T Consensus       693 VvLWEIFsyG~QPy~glSn~EVIe~i~~-----------------------g~-------------------------lL  724 (774)
T KOG1026|consen  693 VVLWEIFSYGKQPYYGLSNQEVIECIRA-----------------------GQ-------------------------LL  724 (774)
T ss_pred             hhhhhhhccccCcccccchHHHHHHHHc-----------------------CC-------------------------cc
Confidence            99999998 9999999999887776543                       11                         13


Q ss_pred             hhcCCchhHHHHHHHHhhhcCCCCCCCHHHH
Q 014117          387 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREA  417 (430)
Q Consensus       387 ~~~~~~~~~~~~ll~~~L~~dP~~R~ta~el  417 (430)
                      ..|++++.++.+|+..||+.+|++||+++||
T Consensus       725 ~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  725 SCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             cCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            3567889999999999999999999999887

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.2e-39  Score=304.19  Aligned_cols=247  Identities=26%  Similarity=0.400  Sum_probs=191.9

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+...    ......+..|+.+++.+.     |+|++++++.+...+.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----h~~i~~~~~~~~~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-----HPNVIKYYASFIEDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-----CCchhhhhheeEeCCe
Confidence            4688999999999999999999999999999987532    223346677888888873     4789999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      .++||||+ +++|.+++...  ....+++..+..++.||+.||.|||++||+|+||||+||+++.++             
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-------------  143 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-------------  143 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-------------
Confidence            99999999 88999988742  224689999999999999999999999999999999999995544             


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                    .++|+|||++.......   ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+.
T Consensus       144 --------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  209 (267)
T cd08229         144 --------------VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             --------------CEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence                          45666666554332211   2346889999999999888999999999999999999999999753


Q ss_pred             chH--HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          324 ENL--EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       324 ~~~--~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      ...  +....+...  .                       ++.                      ..+...+.++.++|.
T Consensus       210 ~~~~~~~~~~~~~~--~-----------------------~~~----------------------~~~~~~~~~~~~li~  242 (267)
T cd08229         210 KMNLYSLCKKIEQC--D-----------------------YPP----------------------LPSDHYSEELRQLVN  242 (267)
T ss_pred             cchHHHHhhhhhcC--C-----------------------CCC----------------------CCcccccHHHHHHHH
Confidence            321  111111100  0                       000                      001235667999999


Q ss_pred             HhhhcCCCCCCCHHHHhc
Q 014117          402 GLLRYDPTDRLTAREALR  419 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~  419 (430)
                      +||+.||++|||+++|++
T Consensus       243 ~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         243 MCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HhcCCCcccCCCHHHHHH
Confidence            999999999999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.5e-39  Score=309.56  Aligned_cols=249  Identities=20%  Similarity=0.311  Sum_probs=191.3

Q ss_pred             cCcEEEEeeeccccceEEEEEEECC-------CCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRE-------RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW  163 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~  163 (430)
                      .++|.+.+.||+|+||.||+|.+..       +...+|+|+++...  .....+..|++++..+..    |++++++++.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~----h~~i~~~~~~   92 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK----HKNIINLLGA   92 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcC----CCCEeeEEEE
Confidence            4679999999999999999998643       23569999987432  233456678888888743    3789999999


Q ss_pred             eecCCeEEEEEecC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceE
Q 014117          164 FDYRNHICIVFEKL-GSSLYDFLRKNNY--------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL  228 (430)
Q Consensus       164 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NIL  228 (430)
                      +...+..|+||||+ +++|.+++.....              ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  172 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  172 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence            99999999999999 7899999976421              25889999999999999999999999999999999999


Q ss_pred             EeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchH
Q 014117          229 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDI  303 (430)
Q Consensus       229 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Dv  303 (430)
                      ++.++                           .+||+|||.+.......     ....++..|+|||++.+..++.++|+
T Consensus       173 l~~~~---------------------------~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv  225 (307)
T cd05098         173 VTEDN---------------------------VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV  225 (307)
T ss_pred             EcCCC---------------------------cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHH
Confidence            96554                           45555555544322110     11123568999999999889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHH
Q 014117          304 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ  382 (430)
Q Consensus       304 wslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (430)
                      |||||++|+|++ |..||.+....+....+....                                              
T Consensus       226 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------------------------------------------  259 (307)
T cd05098         226 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH----------------------------------------------  259 (307)
T ss_pred             HHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCC----------------------------------------------
Confidence            999999999998 899997655443333221100                                              


Q ss_pred             HHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       383 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                        ....+...+.++.+|+.+||..+|++|||+.+++++
T Consensus       260 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         260 --RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             --CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence              001223456789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-39  Score=299.81  Aligned_cols=239  Identities=31%  Similarity=0.538  Sum_probs=196.6

Q ss_pred             eccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 014117          102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL  177 (430)
Q Consensus       102 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~  177 (430)
                      ||.|+||.||++.+..+++.||+|+++....    ....+..|+.+++++.     +++++++++.++.....|+|||++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-----HPFIVKLHYAFQTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-----CCcHHHHHHHeecCCeeEEEEecC
Confidence            6999999999999998899999999864322    3346677888888884     478999999999999999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccC
Q 014117          178 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM  256 (430)
Q Consensus       178 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~  256 (430)
                       +++|.+++....  .+++..+..++.|++.||.|||+.+++|+||||+||+++                          
T Consensus        76 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~--------------------------  127 (250)
T cd05123          76 PGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD--------------------------  127 (250)
T ss_pred             CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc--------------------------
Confidence             999999998764  689999999999999999999999999999999999994                          


Q ss_pred             CCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Q 014117          257 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME  333 (430)
Q Consensus       257 ~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~  333 (430)
                       .++.++|+|||.+......   .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.
T Consensus       128 -~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~  206 (250)
T cd05123         128 -ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL  206 (250)
T ss_pred             -CCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence             4456777777776644332   233567889999999998889999999999999999999999997765433333222


Q ss_pred             HHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCC
Q 014117          334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT  413 (430)
Q Consensus       334 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t  413 (430)
                      .                       +.+                          ..+...+.++.++|++||..||++|||
T Consensus       207 ~-----------------------~~~--------------------------~~~~~~~~~l~~~i~~~l~~~p~~R~~  237 (250)
T cd05123         207 K-----------------------DPL--------------------------RFPEFLSPEARDLISGLLQKDPTKRLG  237 (250)
T ss_pred             c-----------------------CCC--------------------------CCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence            1                       001                          122344667999999999999999999


Q ss_pred             H---HHHhcCCCC
Q 014117          414 A---REALRHPFF  423 (430)
Q Consensus       414 a---~elL~hp~f  423 (430)
                      +   +++++||||
T Consensus       238 ~~~~~~l~~~~~f  250 (250)
T cd05123         238 SGGAEEIKAHPFF  250 (250)
T ss_pred             cccHHHHHhCCCC
Confidence            9   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.2e-39  Score=315.89  Aligned_cols=250  Identities=22%  Similarity=0.332  Sum_probs=188.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEE-----CCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .++|++.+.||.|+||.||+|.+     ..+++.||||+++...  .....+..|+.++.++.+    |+|++++++++.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~----h~niv~~~~~~~   81 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH----HLNVVNLLGACT   81 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccC----CccHhhhcceee
Confidence            35799999999999999999984     3467899999997432  233457789999988854    367899988765


Q ss_pred             c-CCeEEEEEecC-CCCHHHHHHhcCC-----------------------------------------------------
Q 014117          166 Y-RNHICIVFEKL-GSSLYDFLRKNNY-----------------------------------------------------  190 (430)
Q Consensus       166 ~-~~~~~lv~e~~-~~~L~~~l~~~~~-----------------------------------------------------  190 (430)
                      . ...+++||||+ +++|.+++.....                                                     
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            4 56789999999 8999999875321                                                     


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCC
Q 014117          191 ------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK  258 (430)
Q Consensus       191 ------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~  258 (430)
                                  ..+++..+..++.||+.||.|||++||+||||||+|||++.                           
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~---------------------------  214 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE---------------------------  214 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcC---------------------------
Confidence                        23678888999999999999999999999999999999954                           


Q ss_pred             CCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHHHHH
Q 014117          259 SSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMM  332 (430)
Q Consensus       259 ~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~~i  332 (430)
                      +..+||+|||++.......     ....++..|+|||.+.+..++.++|||||||++|+|++ |..||............
T Consensus       215 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~  294 (343)
T cd05103         215 NNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  294 (343)
T ss_pred             CCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH
Confidence            4456777777665432111     11234677999999999899999999999999999997 99999764332211111


Q ss_pred             HHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCC
Q 014117          333 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL  412 (430)
Q Consensus       333 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~  412 (430)
                      ..                      ++..                         ...+...+.++.+++..||+.||++||
T Consensus       295 ~~----------------------~~~~-------------------------~~~~~~~~~~~~~~~~~cl~~~p~~Rp  327 (343)
T cd05103         295 LK----------------------EGTR-------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRP  327 (343)
T ss_pred             Hh----------------------ccCC-------------------------CCCCCCCCHHHHHHHHHHccCChhhCc
Confidence            00                      0000                         001122355789999999999999999


Q ss_pred             CHHHHhcC
Q 014117          413 TAREALRH  420 (430)
Q Consensus       413 ta~elL~h  420 (430)
                      |+.|+++|
T Consensus       328 s~~eil~~  335 (343)
T cd05103         328 TFSELVEH  335 (343)
T ss_pred             CHHHHHHH
Confidence            99999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.4e-39  Score=308.51  Aligned_cols=247  Identities=20%  Similarity=0.253  Sum_probs=191.5

Q ss_pred             CcEEEEeeeccccceEEEEEEECCC-----CeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRER-----KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      .+|++.++||.|+||.||+|.+..+     ++.||+|+++...  .....+..|+.++..+.     +++|+++++.+..
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----h~~iv~~~~~~~~   79 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ-----HPNIVCLLGVVTK   79 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCC-----CCCcCeEEEEEcC
Confidence            3578889999999999999987543     5789999987432  22345667787777763     4789999999999


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEee
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS  231 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~  231 (430)
                      ....++++||+ +++|.+++....              ...+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~  159 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD  159 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence            99999999999 889999985321              135788899999999999999999999999999999999954


Q ss_pred             cCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHH
Q 014117          232 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSV  306 (430)
Q Consensus       232 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  306 (430)
                      ++                           .+||+|||+++......     ....+++.|+|||.+.+..++.++|||||
T Consensus       160 ~~---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  212 (283)
T cd05091         160 KL---------------------------NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY  212 (283)
T ss_pred             CC---------------------------ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHH
Confidence            44                           45666666554321111     12245778999999998889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHH
Q 014117          307 GCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI  385 (430)
Q Consensus       307 Gv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (430)
                      ||++|||++ |..||.+....+....+.....                                                
T Consensus       213 G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~------------------------------------------------  244 (283)
T cd05091         213 GVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV------------------------------------------------  244 (283)
T ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc------------------------------------------------
Confidence            999999998 8899987665544433322110                                                


Q ss_pred             hhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       386 ~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      ...+..++.++.+|+.+||+.||.+||++++++..
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         245 LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            01234567789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9e-40  Score=301.95  Aligned_cols=228  Identities=25%  Similarity=0.379  Sum_probs=180.2

Q ss_pred             ccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-CCCHHH
Q 014117          105 GTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYD  183 (430)
Q Consensus       105 G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~  183 (430)
                      |.||.||+|.++.+++.||+|.++.....    ..|...+...     .++|++++++++...+..|+||||+ +++|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~----~~~~~~~~~~-----~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSEY----SRERLTIIPH-----CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhhh----hhHHHHHHhc-----CCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            89999999999999999999998754322    1222222221     3588999999999999999999999 889999


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeE
Q 014117          184 FLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK  263 (430)
Q Consensus       184 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~k  263 (430)
                      ++....  .+++..+..++.|++.||.|||++||+||||||+||+++.                           ++.++
T Consensus        75 ~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~---------------------------~~~~~  125 (237)
T cd05576          75 HISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDD---------------------------RGHIQ  125 (237)
T ss_pred             HHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC---------------------------CCCEE
Confidence            987654  6999999999999999999999999999999999999954                           45567


Q ss_pred             EEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHH
Q 014117          264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHM  343 (430)
Q Consensus       264 l~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~  343 (430)
                      ++|||.+...........++..|+|||.+.+..++.++|+||+||++|||++|..||........         .     
T Consensus       126 l~df~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------~-----  191 (237)
T cd05576         126 LTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------T-----  191 (237)
T ss_pred             EecccchhccccccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------c-----
Confidence            77777655443333334567789999999888899999999999999999999988753211000         0     


Q ss_pred             HHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCH-----HHHh
Q 014117          344 LKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA-----REAL  418 (430)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta-----~elL  418 (430)
                                   .                          .....++..+..+.+||.+||+.||++|+|+     ++++
T Consensus       192 -------------~--------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~  232 (237)
T cd05576         192 -------------H--------------------------TTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIK  232 (237)
T ss_pred             -------------c--------------------------cccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHH
Confidence                         0                          0001233456789999999999999999986     9999


Q ss_pred             cCCCC
Q 014117          419 RHPFF  423 (430)
Q Consensus       419 ~hp~f  423 (430)
                      +||||
T Consensus       233 ~h~~~  237 (237)
T cd05576         233 SHPFF  237 (237)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.5e-39  Score=300.69  Aligned_cols=236  Identities=23%  Similarity=0.346  Sum_probs=182.7

Q ss_pred             eeccccceEEEEEEE--CCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117          101 KMGEGTFGQVLECWD--RERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus       101 ~lG~G~~g~V~~~~~--~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      +||+|+||.||+|..  ..++..+|+|+++...   ...+.+..|+.+++.+     .++++++++++++ .+..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~-~~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-----DNPYIVRMIGICE-AESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEc-CCCcEEEEe
Confidence            689999999999964  4567899999986432   2345667788888887     3478999988875 456799999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccc
Q 014117          176 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK  254 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~  254 (430)
                      |+ +++|.+++....  .+++..+..++.|++.||+|||++||+||||||+|||++.++.                    
T Consensus        76 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~--------------------  133 (257)
T cd05116          76 LAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY--------------------  133 (257)
T ss_pred             cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe--------------------
Confidence            99 789999997654  6899999999999999999999999999999999999965554                    


Q ss_pred             cCCCCCCeEEEeCCCccccCCCC------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHH
Q 014117          255 RMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE  327 (430)
Q Consensus       255 ~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~  327 (430)
                             +||+|||++.......      ....++..|+|||.+.+..++.++|+|||||++|||++ |..||...+..+
T Consensus       134 -------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  206 (257)
T cd05116         134 -------AKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE  206 (257)
T ss_pred             -------EEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence                   4555555443322111      11134578999999988889999999999999999998 999998765554


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+.+...                                                ...+...+.++.+||.+||+.|
T Consensus       207 ~~~~i~~~~~------------------------------------------------~~~~~~~~~~l~~li~~~~~~~  238 (257)
T cd05116         207 VTQMIESGER------------------------------------------------MECPQRCPPEMYDLMKLCWTYG  238 (257)
T ss_pred             HHHHHHCCCC------------------------------------------------CCCCCCCCHHHHHHHHHHhccC
Confidence            4443321100                                                0123356778999999999999


Q ss_pred             CCCCCCHHHHhc
Q 014117          408 PTDRLTAREALR  419 (430)
Q Consensus       408 P~~R~ta~elL~  419 (430)
                      |++||++++|..
T Consensus       239 p~~Rp~~~~i~~  250 (257)
T cd05116         239 VDERPGFAVVEL  250 (257)
T ss_pred             chhCcCHHHHHH
Confidence            999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.4e-39  Score=299.69  Aligned_cols=245  Identities=25%  Similarity=0.377  Sum_probs=192.8

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      .+|++.+.||.|+||.||+|.+. .+..+|+|+++........+..|+++++++.     +++++++++++......|+|
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLS-----HPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCC-----CCCeeeEEEEEccCCceEEE
Confidence            46899999999999999999875 4667999998754444556788999999884     47899999999999999999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      |||+ +++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++                   
T Consensus        78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~-------------------  137 (256)
T cd05112          78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-------------------  137 (256)
T ss_pred             EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC-------------------
Confidence            9999 889999987653 3689999999999999999999999999999999999996544                   


Q ss_pred             cccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHH
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE  327 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~  327 (430)
                              .++|+|||.+.......    ....++..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus       138 --------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  209 (256)
T cd05112         138 --------VVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE  209 (256)
T ss_pred             --------eEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence                    45555555544221111    11234678999999998889999999999999999998 999998765544


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+......                                                ..+...+..+.+|+.+||+.+
T Consensus       210 ~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~l~~~~l~~~  241 (256)
T cd05112         210 VVETINAGFRL------------------------------------------------YKPRLASQSVYELMQHCWKER  241 (256)
T ss_pred             HHHHHhCCCCC------------------------------------------------CCCCCCCHHHHHHHHHHcccC
Confidence            33332211000                                                011234567999999999999


Q ss_pred             CCCCCCHHHHhcC
Q 014117          408 PTDRLTAREALRH  420 (430)
Q Consensus       408 P~~R~ta~elL~h  420 (430)
                      |++|||+.+++++
T Consensus       242 p~~Rp~~~~~l~~  254 (256)
T cd05112         242 PEDRPSFSLLLHQ  254 (256)
T ss_pred             hhhCCCHHHHHHh
Confidence            9999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.7e-39  Score=311.15  Aligned_cols=284  Identities=20%  Similarity=0.234  Sum_probs=194.0

Q ss_pred             cceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-CCCH
Q 014117          106 TFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSL  181 (430)
Q Consensus       106 ~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L  181 (430)
                      ++|.||.+....+++.||+|+++..   ......+..|+++++.+.     |+||+++++.+...+..+++|||+ +++|
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~-----h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ-----HPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcC-----CcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            5566777777779999999998643   234456778999998884     478999999999999999999999 7899


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCC
Q 014117          182 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA  261 (430)
Q Consensus       182 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~  261 (430)
                      .+++.......+++..+..++.||+.||.|||+++|+||||||+|||++.++.++++||+.+........        ..
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~--------~~  158 (314)
T cd08216          87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK--------RQ  158 (314)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccc--------cc
Confidence            9999876555799999999999999999999999999999999999998777777777765543321100        00


Q ss_pred             eEEEeCCCccccCCCCCeeeecCcccchhhhhCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCC
Q 014117          262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL  339 (430)
Q Consensus       262 ~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~  339 (430)
                      ..+.+         ......++..|+|||++.+.  .++.++|+|||||++|||++|..||.........  +....+..
T Consensus       159 ~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~  227 (314)
T cd08216         159 RVVHD---------FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTV  227 (314)
T ss_pred             ccccc---------ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccC
Confidence            00000         11223568889999998763  5889999999999999999999999865443322  22222222


Q ss_pred             CHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          340 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       340 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      +..+......     ...+......        ...................++.++.+|+.+||++||++|||++++|+
T Consensus       228 ~~~~~~~~~~-----~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         228 PCLLDKSTYP-----LYEDSMSQSR--------SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             ccccccCchh-----hhcCCcCccc--------ccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            2110000000     0000000000        00000000000111122344668999999999999999999999999


Q ss_pred             CCCCCCC
Q 014117          420 HPFFTRD  426 (430)
Q Consensus       420 hp~f~~~  426 (430)
                      ||||+..
T Consensus       295 ~p~~~~~  301 (314)
T cd08216         295 HSFFKQC  301 (314)
T ss_pred             CchHhhh
Confidence            9999854

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-39  Score=308.52  Aligned_cols=253  Identities=23%  Similarity=0.331  Sum_probs=191.5

Q ss_pred             CcEEEEeeeccccceEEEEEEECCC--------------CeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCce
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRER--------------KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRC  157 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~--------------~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i  157 (430)
                      ++|++.+.||+|+||.||+|.+..+              ...||+|.++..  ......+..|+++++++.     ++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~-----h~~i   79 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLK-----NPNI   79 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-----CCCc
Confidence            5799999999999999999987543              235999998643  233456778999999884     4789


Q ss_pred             EEecceeecCCeEEEEEecC-CCCHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCc
Q 014117          158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY----------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPEN  226 (430)
Q Consensus       158 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~----------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~N  226 (430)
                      +++++++...+..++||||+ +++|.+++.....          ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus        80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N  159 (295)
T cd05097          80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN  159 (295)
T ss_pred             CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence            99999999999999999999 8899999865321          246888999999999999999999999999999999


Q ss_pred             eEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcc
Q 014117          227 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPC  301 (430)
Q Consensus       227 ILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~  301 (430)
                      ||++.++.                           +||+|||++.......     ....++..|+|||++.+..++.++
T Consensus       160 ill~~~~~---------------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  212 (295)
T cd05097         160 CLVGNHYT---------------------------IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTAS  212 (295)
T ss_pred             EEEcCCCc---------------------------EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchh
Confidence            99965544                           5555555543221111     112446789999999988999999


Q ss_pred             hHHHHHHHHHHHHh--CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCch
Q 014117          302 DIWSVGCILVELCT--GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP  379 (430)
Q Consensus       302 DvwslGv~l~el~t--G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (430)
                      |+|||||++|+|++  |..||...+..+....+.+....                  .+...                  
T Consensus       213 DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~------------------~~~~~------------------  256 (295)
T cd05097         213 DVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRN------------------QGRQI------------------  256 (295)
T ss_pred             hHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhh------------------ccccc------------------
Confidence            99999999999988  67899876655444332221100                  00000                  


Q ss_pred             hHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          380 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                           ....++..+..+.+|+.+||+.||++|||++++++
T Consensus       257 -----~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         257 -----YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             -----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                 00112345678999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.9e-39  Score=299.24  Aligned_cols=246  Identities=25%  Similarity=0.370  Sum_probs=191.6

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ..++|++.++||+|+||.||++.+. .+..+|+|.+.........+..|+.+++.+.     +++++++++.+.. ...+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-----HDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcC-----CCCcceEEEEEcC-CCeE
Confidence            3467999999999999999999865 4456999988755545567788999998884     3778998888877 7889


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|.+++.+.....+++..+..++.||+.||.|||+.|++|+||||+||+++..+.                
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~----------------  140 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV----------------  140 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc----------------
Confidence            999999 789999998765567899999999999999999999999999999999999965554                


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCch
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN  325 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~  325 (430)
                                 +||+|||.+.......    ....++..|+|||++.+..++.++|+|||||++|++++ |..||...+.
T Consensus       141 -----------~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~  209 (260)
T cd05073         141 -----------CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN  209 (260)
T ss_pred             -----------EEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence                       5555555443221111    11235677999999998889999999999999999999 9999987655


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+....+.....                                                ...+...+.++.+++.+||+
T Consensus       210 ~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~i~~~l~  241 (260)
T cd05073         210 PEVIRALERGYR------------------------------------------------MPRPENCPEELYNIMMRCWK  241 (260)
T ss_pred             HHHHHHHhCCCC------------------------------------------------CCCcccCCHHHHHHHHHHcc
Confidence            443332211100                                                00123456679999999999


Q ss_pred             cCCCCCCCHHHHhc
Q 014117          406 YDPTDRLTAREALR  419 (430)
Q Consensus       406 ~dP~~R~ta~elL~  419 (430)
                      .||++||++.+++.
T Consensus       242 ~~p~~Rp~~~~l~~  255 (260)
T cd05073         242 NRPEERPTFEYIQS  255 (260)
T ss_pred             cCcccCcCHHHHHH
Confidence            99999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-39  Score=303.07  Aligned_cols=245  Identities=19%  Similarity=0.262  Sum_probs=186.7

Q ss_pred             EEEEeeeccccceEEEEEEECCC---CeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC-
Q 014117           96 YKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-  168 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~-  168 (430)
                      |++.+.||+|+||.||+|....+   +..||+|+++...   .....+..|+..++.+.     |++++++++.+.... 
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~   75 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD-----HPNVMKLIGVCFEASS   75 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCC-----CCCeeeEEeeeccCCc
Confidence            56789999999999999987653   4789999987432   22345677888888873     478999988765544 


Q ss_pred             -----eEEEEEecC-CCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccC
Q 014117          169 -----HICIVFEKL-GSSLYDFLRKN----NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP  238 (430)
Q Consensus       169 -----~~~lv~e~~-~~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~  238 (430)
                           ..++||||+ +++|..++...    ....+++..+..++.|++.||.|||+++|+||||||+||++++++     
T Consensus        76 ~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~-----  150 (273)
T cd05035          76 LQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM-----  150 (273)
T ss_pred             cccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC-----
Confidence                 489999999 88999988543    223689999999999999999999999999999999999995544     


Q ss_pred             CCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHH
Q 014117          239 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL  313 (430)
Q Consensus       239 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el  313 (430)
                                            .+||+|||+++......     ....++..|+|||.+.+..++.++|||||||++|||
T Consensus       151 ----------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el  208 (273)
T cd05035         151 ----------------------TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI  208 (273)
T ss_pred             ----------------------eEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHH
Confidence                                  45555555554322111     112346789999999888899999999999999999


Q ss_pred             Hh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCc
Q 014117          314 CT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS  392 (430)
Q Consensus       314 ~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (430)
                      ++ |.+||.+.+..+....+...  ..                                              ...+...
T Consensus       209 ~~~g~~p~~~~~~~~~~~~~~~~--~~----------------------------------------------~~~~~~~  240 (273)
T cd05035         209 ATRGQTPYPGVENHEIYDYLRHG--NR----------------------------------------------LKQPEDC  240 (273)
T ss_pred             HhCCCCCCCCCCHHHHHHHHHcC--CC----------------------------------------------CCCCcCC
Confidence            99 99999876654433322110  00                                              0112345


Q ss_pred             hhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          393 AGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       393 ~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      +.++.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         241 LDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-39  Score=304.63  Aligned_cols=245  Identities=24%  Similarity=0.330  Sum_probs=190.5

Q ss_pred             eeeccccceEEEEEEECCCCe-------EEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117          100 SKMGEGTFGQVLECWDRERKE-------MVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~-------~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +.||.|+||.||+|.++..+.       .||+|.+.... ...+.+..|..+++.+     .|+|++.+++++......+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-----~h~~iv~~~~~~~~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-----SHKHLVLNYGVCVCGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-----CCCChhheeeEEEeCCCcE
Confidence            368999999999998866543       38888875432 2334566777777776     4488999999999989999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++..+++++          
T Consensus        76 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~----------  144 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNP----------  144 (258)
T ss_pred             EEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCC----------
Confidence            999999 889999998654 36899999999999999999999999999999999999988766555443          


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhC-CCCCCCCchHHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTG-EALFQTHENLEH  328 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG-~~Pf~~~~~~~~  328 (430)
                               ..++++|||.+...... ....++..|+|||++.+. .++.++|||||||++|+|++| .+||...+....
T Consensus       145 ---------~~~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~  214 (258)
T cd05078         145 ---------PFIKLSDPGISITVLPK-EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK  214 (258)
T ss_pred             ---------ceEEecccccccccCCc-hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH
Confidence                     35789999988654432 335688999999999874 589999999999999999998 567665433222


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      .... ..                                                 ....+...+.++.+||.+||+.||
T Consensus       215 ~~~~-~~-------------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p  244 (258)
T cd05078         215 LQFY-ED-------------------------------------------------RHQLPAPKWTELANLINQCMDYEP  244 (258)
T ss_pred             HHHH-Hc-------------------------------------------------cccCCCCCcHHHHHHHHHHhccCh
Confidence            1110 00                                                 001223345678999999999999


Q ss_pred             CCCCCHHHHhcC
Q 014117          409 TDRLTAREALRH  420 (430)
Q Consensus       409 ~~R~ta~elL~h  420 (430)
                      ++|||++++++.
T Consensus       245 ~~Rps~~~il~~  256 (258)
T cd05078         245 DFRPSFRAIIRD  256 (258)
T ss_pred             hhCCCHHHHHHh
Confidence            999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=8.1e-39  Score=300.68  Aligned_cols=246  Identities=21%  Similarity=0.311  Sum_probs=191.6

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCe---EEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .++|...+.||+|+||.||+|.+..++.   .+|+|.++..  ......+..|++++..+.     +++++++.+++...
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~   78 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS-----HHNIIRLEGVVTKF   78 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCC-----CCCeeEEEEEEccC
Confidence            3568899999999999999999876554   7999998643  233456677888887774     47899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +..|+||||+ +++|.+++.... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++++||      
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~df------  151 (268)
T cd05063          79 KPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDF------  151 (268)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCC------
Confidence            9999999999 789999987643 46899999999999999999999999999999999999965555555555      


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCCC------eeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL  319 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~P  319 (430)
                                           |++........      ....+..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus       152 ---------------------g~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p  210 (268)
T cd05063         152 ---------------------GLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP  210 (268)
T ss_pred             ---------------------ccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCC
Confidence                                 44432211110      0122457999999998889999999999999999997 9999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |...+..+....+.... ..|                                               .+...+.++.++
T Consensus       211 ~~~~~~~~~~~~i~~~~-~~~-----------------------------------------------~~~~~~~~~~~l  242 (268)
T cd05063         211 YWDMSNHEVMKAINDGF-RLP-----------------------------------------------APMDCPSAVYQL  242 (268)
T ss_pred             CCcCCHHHHHHHHhcCC-CCC-----------------------------------------------CCCCCCHHHHHH
Confidence            98766555444443211 111                                               112345678999


Q ss_pred             HHHhhhcCCCCCCCHHHHhc
Q 014117          400 LQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~  419 (430)
                      +.+||+.||++||++.++++
T Consensus       243 i~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         243 MLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHcCCCcccCcCHHHHHH
Confidence            99999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4e-39  Score=300.44  Aligned_cols=242  Identities=21%  Similarity=0.307  Sum_probs=190.1

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      ++|++.+.||+|+||.||++.  .+++.||+|+++... ....+..|+.++.++.     +++++++++++... ..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~-----~~~i~~~~~~~~~~-~~~~v   76 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-TAQAFLEETAVMTKLH-----HKNLVRLLGVILHN-GLYIV   76 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-hHHHHHHHHHHHHhCC-----CCCcCeEEEEEcCC-CcEEE
Confidence            469999999999999999985  467789999987432 3456778888888874     47889998887654 57999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      |||+ +++|.+++.......+++..+..++.|++.||.|||+.|++||||||+|||++.                     
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~---------------------  135 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE---------------------  135 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC---------------------
Confidence            9999 889999998766557899999999999999999999999999999999999954                     


Q ss_pred             cccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHHHH
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAM  331 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~~  331 (430)
                            ++.+||+|||++............+..|+|||.+.+..++.++|+|||||++|+|++ |++||...+..+....
T Consensus       136 ------~~~~kl~Dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  209 (254)
T cd05083         136 ------DGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC  209 (254)
T ss_pred             ------CCcEEECCCccceeccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence                  445666666666543322222334667999999988889999999999999999998 9999987654433322


Q ss_pred             HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCC
Q 014117          332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR  411 (430)
Q Consensus       332 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R  411 (430)
                      +.+...                                                ...+...+.++.+++.+||+.+|++|
T Consensus       210 ~~~~~~------------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R  241 (254)
T cd05083         210 VEKGYR------------------------------------------------MEPPEGCPADVYVLMTSCWETEPKKR  241 (254)
T ss_pred             HhCCCC------------------------------------------------CCCCCcCCHHHHHHHHHHcCCChhhC
Confidence            211000                                                00123456779999999999999999


Q ss_pred             CCHHHHhc
Q 014117          412 LTAREALR  419 (430)
Q Consensus       412 ~ta~elL~  419 (430)
                      ||+++++.
T Consensus       242 p~~~~l~~  249 (254)
T cd05083         242 PSFHKLRE  249 (254)
T ss_pred             cCHHHHHH
Confidence            99999975

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.5e-39  Score=305.21  Aligned_cols=254  Identities=24%  Similarity=0.404  Sum_probs=195.1

Q ss_pred             cEEEEeeeccccceEEEEEEEC---CCCeEEEEEEecCch-----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           95 RYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      +|++.+.||+|+||.||+|.+.   .+++.||+|+++...     .....+..|+.++.++.+    +++++.+++.+..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~----~~~i~~~~~~~~~   76 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRR----CPFLVTLHYAFQT   76 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccC----Ccchhhhheeeec
Confidence            3889999999999999999864   457889999986432     123445678888888753    4779999999999


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      ...+|+||||+ +++|.+++....  .+++..++.++.|++.||.|||+.|++||||||+||+++               
T Consensus        77 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~---------------  139 (288)
T cd05583          77 DTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD---------------  139 (288)
T ss_pred             CCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---------------
Confidence            99999999999 889999987653  689999999999999999999999999999999999994               


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCC--CCCcchHHHHHHHHHHHHhCCCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLG--WTYPCDIWSVGCILVELCTGEAL  319 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGv~l~el~tG~~P  319 (430)
                                  .++.++|+|||++.......    ....|+..|+|||.+.+..  ++.++|+||||+++|+|++|..|
T Consensus       140 ------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p  207 (288)
T cd05583         140 ------------SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP  207 (288)
T ss_pred             ------------CCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCC
Confidence                        44567777777665432221    2246889999999987765  78899999999999999999999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |...........+.+..                   ...                          ....+..++.++.++
T Consensus       208 ~~~~~~~~~~~~~~~~~-------------------~~~--------------------------~~~~~~~~~~~l~~l  242 (288)
T cd05583         208 FTVDGEQNSQSEISRRI-------------------LKS--------------------------KPPFPKTMSAEARDF  242 (288)
T ss_pred             cccCcccchHHHHHHHH-------------------Hcc--------------------------CCCCCcccCHHHHHH
Confidence            96432211111111000                   000                          001123456679999


Q ss_pred             HHHhhhcCCCCCCC---HHHHhcCCCCCCC
Q 014117          400 LQGLLRYDPTDRLT---AREALRHPFFTRD  426 (430)
Q Consensus       400 l~~~L~~dP~~R~t---a~elL~hp~f~~~  426 (430)
                      |.+||+.||++|||   +.++|+||||+..
T Consensus       243 i~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         243 IQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             HHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            99999999999998   5678999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-39  Score=298.81  Aligned_cols=237  Identities=24%  Similarity=0.356  Sum_probs=184.2

Q ss_pred             eeeccccceEEEEEEECCCC---eEEEEEEecCchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117          100 SKMGEGTFGQVLECWDRERK---EMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~---~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      ++||+|+||.||+|....++   ..||+|.+.....  ....+..|+.+++.+     .|++++++++++. .+..++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~-~~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-----DHPCIVRLIGVCK-GEPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEc-CCceEEEE
Confidence            46999999999999876655   7899999874433  445677888888887     3478999998765 55789999


Q ss_pred             ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          175 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       175 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      ||+ +++|.+++....  .+++..+..++.|++.||.|||..+|+|+||||+|||++.++.++++||             
T Consensus        75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df-------------  139 (257)
T cd05060          75 ELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDF-------------  139 (257)
T ss_pred             EeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccc-------------
Confidence            999 889999998764  7899999999999999999999999999999999999966555555554             


Q ss_pred             ccCCCCCCeEEEeCCCccccCCCCCe------eeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchH
Q 014117          254 KRMPKSSAIKVIDFGSTTYERPDQNY------IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL  326 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~  326 (430)
                                    |.+.........      ..++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..
T Consensus       140 --------------~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~  205 (257)
T cd05060         140 --------------GMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA  205 (257)
T ss_pred             --------------cccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH
Confidence                          444322211111      123567999999998899999999999999999998 99999876554


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +....+.... .                                               ...+...+..+.++|.+||+.
T Consensus       206 ~~~~~~~~~~-~-----------------------------------------------~~~~~~~~~~l~~li~~cl~~  237 (257)
T cd05060         206 EVIAMLESGE-R-----------------------------------------------LPRPEECPQEIYSIMLSCWKY  237 (257)
T ss_pred             HHHHHHHcCC-c-----------------------------------------------CCCCCCCCHHHHHHHHHHhcC
Confidence            4333322110 0                                               012234566899999999999


Q ss_pred             CCCCCCCHHHHhc
Q 014117          407 DPTDRLTAREALR  419 (430)
Q Consensus       407 dP~~R~ta~elL~  419 (430)
                      ||++|||+.++++
T Consensus       238 ~p~~Rp~~~~l~~  250 (257)
T cd05060         238 RPEDRPTFSELES  250 (257)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=351.55  Aligned_cols=255  Identities=30%  Similarity=0.427  Sum_probs=205.6

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      +++-+++-..+||.|.||.||.|.+..+|...|+|-++..   .+......+|..++..+     +|+|+|+.++.-.+.
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-----nHpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-----NHPNLVRYYGVEVHR 1306 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-----cCccccccCceeecH
Confidence            3455788889999999999999999999999999988632   22334566789999998     458899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +..+|.|||| +|+|.++++..+  ..++...+.+..|++.||.|||+.|||||||||.|||++..|             
T Consensus      1307 ekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g------------- 1371 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG------------- 1371 (1509)
T ss_pred             HHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-------------
Confidence            9999999999 999999998653  678888899999999999999999999999999999995544             


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC-------CeeeecCcccchhhhhCC---CCCCcchHHHHHHHHHHHHhC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTG  316 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGv~l~el~tG  316 (430)
                                    .+|++|||.|.......       +..+||+.|||||++.+.   +...++||||||||+.||+||
T Consensus      1372 --------------~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tG 1437 (1509)
T KOG4645|consen 1372 --------------LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATG 1437 (1509)
T ss_pred             --------------cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecC
Confidence                          55666666554333222       336899999999999864   467899999999999999999


Q ss_pred             CCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHH
Q 014117          317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL  396 (430)
Q Consensus       317 ~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (430)
                      +.||...++.=+.+. .-..|..|+                                              .|...+.+-
T Consensus      1438 krPW~~~dne~aIMy-~V~~gh~Pq----------------------------------------------~P~~ls~~g 1470 (1509)
T KOG4645|consen 1438 KRPWAELDNEWAIMY-HVAAGHKPQ----------------------------------------------IPERLSSEG 1470 (1509)
T ss_pred             CCchhhccchhHHHh-HHhccCCCC----------------------------------------------CchhhhHhH
Confidence            999987544332222 222333332                                              334467788


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          397 THLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       397 ~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +|||..||+.||.+|+++.|+|+|.|-+..
T Consensus      1471 ~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             HHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence            999999999999999999999999987643

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5e-39  Score=302.63  Aligned_cols=244  Identities=18%  Similarity=0.261  Sum_probs=183.9

Q ss_pred             EEEeeeccccceEEEEEEECCCCe--EEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-----
Q 014117           97 KIHSKMGEGTFGQVLECWDRERKE--MVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-----  166 (430)
Q Consensus        97 ~~~~~lG~G~~g~V~~~~~~~~~~--~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-----  166 (430)
                      .+.+.||+|+||.||+|.+..++.  .||+|.++..   ......+..|+++++.+.     |+|++++++.+..     
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~   76 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD-----HPNVMRLIGVCLQTVESE   76 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCC-----CCCcceEEEEEccCCccc
Confidence            467889999999999999887765  5999988643   333456677888888873     4778988876532     


Q ss_pred             -CCeEEEEEecC-CCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCC
Q 014117          167 -RNHICIVFEKL-GSSLYDFLRKN----NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY  240 (430)
Q Consensus       167 -~~~~~lv~e~~-~~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~df  240 (430)
                       ....++||||+ +++|.+++...    ....+++..+..++.||+.||.|||++||+||||||+|||++.++       
T Consensus        77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-------  149 (272)
T cd05075          77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM-------  149 (272)
T ss_pred             CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC-------
Confidence             23578999999 88999887432    123589999999999999999999999999999999999996544       


Q ss_pred             cCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh
Q 014117          241 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT  315 (430)
Q Consensus       241 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t  315 (430)
                                          .+||+|||++.......     ....+++.|+|||.+.+..++.++|||||||++|||++
T Consensus       150 --------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~  209 (272)
T cd05075         150 --------------------NVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT  209 (272)
T ss_pred             --------------------CEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHc
Confidence                                45555555554322111     11245778999999999899999999999999999999


Q ss_pred             -CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchh
Q 014117          316 -GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG  394 (430)
Q Consensus       316 -G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (430)
                       |.+||.+....+....+...  ..                                              ...+...+.
T Consensus       210 ~g~~p~~~~~~~~~~~~~~~~--~~----------------------------------------------~~~~~~~~~  241 (272)
T cd05075         210 RGQTPYPGVENSEIYDYLRQG--NR----------------------------------------------LKQPPDCLD  241 (272)
T ss_pred             CCCCCCCCCCHHHHHHHHHcC--CC----------------------------------------------CCCCCCCCH
Confidence             89999875554433322110  00                                              001234556


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          395 DLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       395 ~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      .+.++|.+||+.||++|||+.+++++
T Consensus       242 ~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         242 GLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            78999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6.1e-39  Score=317.80  Aligned_cols=250  Identities=21%  Similarity=0.302  Sum_probs=192.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEEC-----CCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .++|.+.++||+|+||.||+|++.     .+++.||+|+++...  .....+..|++++.++..    |+||+.+++.+.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~----H~niv~~~~~~~  111 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGP----HLNIVNLLGACT  111 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCC----CCCeEEEEEEEc
Confidence            457899999999999999999864     355789999997432  223457789999988842    478999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcCC------------------------------------------------------
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNNY------------------------------------------------------  190 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~~------------------------------------------------------  190 (430)
                      ..+.+++||||+ +|+|.+++.....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            999999999999 8999999975421                                                      


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceE
Q 014117          191 ------------------------------------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL  228 (430)
Q Consensus       191 ------------------------------------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NIL  228 (430)
                                                                ..+++..+..++.||+.||.|||+.+|+||||||+|||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL  271 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL  271 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence                                                      23677788899999999999999999999999999999


Q ss_pred             EeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchH
Q 014117          229 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDI  303 (430)
Q Consensus       229 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dv  303 (430)
                      ++..+                           .+||+|||+++.....     .....++..|+|||.+.+..++.++||
T Consensus       272 l~~~~---------------------------~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv  324 (401)
T cd05107         272 ICEGK---------------------------LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDV  324 (401)
T ss_pred             EeCCC---------------------------EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHH
Confidence            95544                           4566666665432111     122356788999999998889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHH
Q 014117          304 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ  382 (430)
Q Consensus       304 wslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (430)
                      |||||++|||++ |..||......+........                      +.                       
T Consensus       325 wslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~----------------------~~-----------------------  359 (401)
T cd05107         325 WSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR----------------------GY-----------------------  359 (401)
T ss_pred             HHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHc----------------------CC-----------------------
Confidence            999999999998 89999765443322211110                      00                       


Q ss_pred             HHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       383 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                        ....+...+.++.+|+.+||+.+|.+||++.||++.
T Consensus       360 --~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         360 --RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence              001123456789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.3e-39  Score=303.71  Aligned_cols=246  Identities=23%  Similarity=0.354  Sum_probs=191.5

Q ss_pred             CcEEEEeeeccccceEEEEEEEC-----CCCeEEEEEEecCc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .+|++.++||+|+||.||+|...     .++..+|+|.+... ......+..|++++..+.     ++||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ-----HQHIVRFYGVCTEG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCC-----CCCCceEEEEEecC
Confidence            46889999999999999999743     35678999988643 234456778888888874     37899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNY-------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE  233 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~-------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~  233 (430)
                      ...++||||+ +++|.+++.....             ..+++..+..++.||+.||+|||+.||+||||||+|||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            9999999999 8899999876431             2588999999999999999999999999999999999996554


Q ss_pred             ccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHH
Q 014117          234 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGC  308 (430)
Q Consensus       234 ~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv  308 (430)
                      .                           +||+|||++.......     ....+++.|+|||++.+..++.++|||||||
T Consensus       160 ~---------------------------~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  212 (280)
T cd05092         160 V---------------------------VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGV  212 (280)
T ss_pred             C---------------------------EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHH
Confidence            4                           5555555543221111     1224577899999999999999999999999


Q ss_pred             HHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhh
Q 014117          309 ILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ  387 (430)
Q Consensus       309 ~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (430)
                      ++|||++ |.+||......+....+.....                                                ..
T Consensus       213 il~el~~~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------------~~  244 (280)
T cd05092         213 VLWEIFTYGKQPWYQLSNTEAIECITQGRE------------------------------------------------LE  244 (280)
T ss_pred             HHHHHHcCCCCCCccCCHHHHHHHHHcCcc------------------------------------------------CC
Confidence            9999998 9999977655444332221100                                                01


Q ss_pred             hcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       388 ~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      .+...+..+.+||.+||+.||++||++.+|+.
T Consensus       245 ~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         245 RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            12345677999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.9e-39  Score=304.16  Aligned_cols=245  Identities=19%  Similarity=0.322  Sum_probs=189.3

Q ss_pred             cEEEEeeeccccceEEEEEEECC-----CCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+....  .....+..|+.+++.+.     |+||+++++.+...
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN-----HPHVIKLYGACSQD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCC-----CCCEeeEEEEEecC
Confidence            47889999999999999998753     23579999886432  23356778999888884     48899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNN----------------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP  224 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp  224 (430)
                      +..++||||+ +++|.+++....                      ...+++..+..++.|++.||.|||+.||+||||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp  155 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA  155 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence            9999999999 899999986521                      13578899999999999999999999999999999


Q ss_pred             CceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCC
Q 014117          225 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTY  299 (430)
Q Consensus       225 ~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~  299 (430)
                      +|||+++++                           .+||+|||++.......     ....++..|+|||.+.+..++.
T Consensus       156 ~nill~~~~---------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~  208 (290)
T cd05045         156 RNVLVAEGR---------------------------KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT  208 (290)
T ss_pred             heEEEcCCC---------------------------cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcch
Confidence            999995544                           45556666554321111     1124567899999999888999


Q ss_pred             cchHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCc
Q 014117          300 PCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL  378 (430)
Q Consensus       300 ~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  378 (430)
                      ++|||||||++|||++ |..||.+....+....+....                        .                 
T Consensus       209 ~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------------------~-----------------  247 (290)
T cd05045         209 QSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGY------------------------R-----------------  247 (290)
T ss_pred             HhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC------------------------C-----------------
Confidence            9999999999999998 999998755433332211100                        0                 


Q ss_pred             hhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          379 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                             ...+...+.++.+|+..||+.||++||++++++.
T Consensus       248 -------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         248 -------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             -------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                   0112345667999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.2e-38  Score=299.60  Aligned_cols=245  Identities=24%  Similarity=0.338  Sum_probs=190.7

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCC---eEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERK---EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .+|++.+.||+|+||.||+|.++.++   ..+|+|.++..  ......+..|+.+++++.     |+|++++++++...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD-----HPNIIHLEGVVTKSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCC-----CCCcceEEEEEecCC
Confidence            47999999999999999999886544   37999988643  233456777888888873     488999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      ..|+||||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++           
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~-----------  146 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCK-----------  146 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEE-----------
Confidence            999999999 889999998654 4689999999999999999999999999999999999996555544           


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCCC------eeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF  320 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf  320 (430)
                                      |+|||.+........      ...++..|+|||.+.+..++.++|+|||||++|++++ |..||
T Consensus       147 ----------------l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~  210 (267)
T cd05066         147 ----------------VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY  210 (267)
T ss_pred             ----------------eCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCc
Confidence                            445554433221111      1123567999999998899999999999999999886 99999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      ...+..+....+.+... +|                                               .+...+..+.+++
T Consensus       211 ~~~~~~~~~~~~~~~~~-~~-----------------------------------------------~~~~~~~~~~~li  242 (267)
T cd05066         211 WEMSNQDVIKAIEEGYR-LP-----------------------------------------------APMDCPAALHQLM  242 (267)
T ss_pred             ccCCHHHHHHHHhCCCc-CC-----------------------------------------------CCCCCCHHHHHHH
Confidence            87655443333321100 00                                               1123466789999


Q ss_pred             HHhhhcCCCCCCCHHHHhc
Q 014117          401 QGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~  419 (430)
                      .+||+.+|++|||+.++++
T Consensus       243 ~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         243 LDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHcccCchhCCCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.9e-38  Score=305.55  Aligned_cols=248  Identities=21%  Similarity=0.312  Sum_probs=191.1

Q ss_pred             cCcEEEEeeeccccceEEEEEEECC-------CCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRE-------RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW  163 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~  163 (430)
                      .++|.+.+.||+|+||.||+|.+..       ....+|+|+++...  .....+..|+.+++++.    .|+||++++++
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~   86 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG----KHKNIINLLGV   86 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhcc----CCCCeeeEEEE
Confidence            3579999999999999999997632       34579999987432  23345667888887773    24789999999


Q ss_pred             eecCCeEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceE
Q 014117          164 FDYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL  228 (430)
Q Consensus       164 ~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NIL  228 (430)
                      +...+.+|+||||+ +++|.+++....              ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  166 (314)
T cd05099          87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL  166 (314)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence            99999999999999 889999997642              135889999999999999999999999999999999999


Q ss_pred             EeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchH
Q 014117          229 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDI  303 (430)
Q Consensus       229 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Dv  303 (430)
                      ++.++                           .+||+|||.++......     ....++..|+|||++.+..++.++||
T Consensus       167 l~~~~---------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  219 (314)
T cd05099         167 VTEDN---------------------------VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDV  219 (314)
T ss_pred             EcCCC---------------------------cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchh
Confidence            95544                           45666666554322111     11123467999999999899999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHH
Q 014117          304 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ  382 (430)
Q Consensus       304 wslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (430)
                      |||||++|+|++ |..||.+....+....+....                                              
T Consensus       220 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------------------------------------------  253 (314)
T cd05099         220 WSFGILMWEIFTLGGSPYPGIPVEELFKLLREGH----------------------------------------------  253 (314)
T ss_pred             hHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------------------------------------------
Confidence            999999999999 899998765544443322100                                              


Q ss_pred             HHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       383 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                        ....+...+.++.+|+.+||+.||++|||+.++++
T Consensus       254 --~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         254 --RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence              00112345667999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.3e-38  Score=299.44  Aligned_cols=251  Identities=22%  Similarity=0.314  Sum_probs=190.9

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCe---EEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      +.|++.+.||+|+||.||+|.++.+++   .||+|+++..  ......+..|+.+++++.     |+|++++++++....
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~ni~~~~~~~~~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-----HPNIIHLEGVVTKSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-----CcCcceEEEEECCCC
Confidence            458999999999999999999887654   6999998643  334456778898888874     478999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      ..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++++|||++....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            999999999 789999987654 468999999999999999999999999999999999999655555555554433221


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCCCee--eecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCc
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI--VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE  324 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~  324 (430)
                      .....                     .......  ..+..|+|||.+.+..++.++|||||||++|||++ |..||...+
T Consensus       158 ~~~~~---------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~  216 (269)
T cd05065         158 DDTSD---------------------PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS  216 (269)
T ss_pred             cCccc---------------------cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence            11000                     0000000  12457999999998899999999999999999886 999998765


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+....+.... .                       .                        ..+...+..+.+++.+||
T Consensus       217 ~~~~~~~i~~~~-~-----------------------~------------------------~~~~~~~~~~~~li~~~l  248 (269)
T cd05065         217 NQDVINAIEQDY-R-----------------------L------------------------PPPMDCPTALHQLMLDCW  248 (269)
T ss_pred             HHHHHHHHHcCC-c-----------------------C------------------------CCcccCCHHHHHHHHHHc
Confidence            544333322110 0                       0                        012344667899999999


Q ss_pred             hcCCCCCCCHHHHhc
Q 014117          405 RYDPTDRLTAREALR  419 (430)
Q Consensus       405 ~~dP~~R~ta~elL~  419 (430)
                      +.+|++||++.+++.
T Consensus       249 ~~~p~~Rp~~~~i~~  263 (269)
T cd05065         249 QKDRNARPKFGQIVS  263 (269)
T ss_pred             CCChhhCcCHHHHHH
Confidence            999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.3e-38  Score=304.05  Aligned_cols=254  Identities=22%  Similarity=0.339  Sum_probs=190.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECC----------------CCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRE----------------RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGG  154 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~  154 (430)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|+++..  ......+..|+.+++.+.     +
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~-----~   78 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLK-----D   78 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC-----C
Confidence            3579999999999999999986432                3457999998743  233456778999998884     3


Q ss_pred             CceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCC
Q 014117          155 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY---------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP  224 (430)
Q Consensus       155 ~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp  224 (430)
                      ++++++++++...+..++||||+ +++|.+++.....         ..+++..+..++.||+.||+|||+.||+||||||
T Consensus        79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp  158 (296)
T cd05095          79 PNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT  158 (296)
T ss_pred             CCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence            78999999999999999999999 8899999976431         2467888999999999999999999999999999


Q ss_pred             CceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCC
Q 014117          225 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTY  299 (430)
Q Consensus       225 ~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~  299 (430)
                      +|||++.++                           .++|+|||++.......     ....++..|+|||+..+..++.
T Consensus       159 ~Nili~~~~---------------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~  211 (296)
T cd05095         159 RNCLVGKNY---------------------------TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTT  211 (296)
T ss_pred             heEEEcCCC---------------------------CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccc
Confidence            999996544                           45555555554321111     1123467899999998889999


Q ss_pred             cchHHHHHHHHHHHHh--CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcC
Q 014117          300 PCDIWSVGCILVELCT--GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK  377 (430)
Q Consensus       300 ~~DvwslGv~l~el~t--G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (430)
                      ++|+|||||++|||++  |..||...+..+.........                  ...+...                
T Consensus       212 ~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~------------------~~~~~~~----------------  257 (296)
T cd05095         212 ASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFF------------------RDQGRQV----------------  257 (296)
T ss_pred             hhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHH------------------hhccccc----------------
Confidence            9999999999999998  789997655544332211100                  0000000                


Q ss_pred             chhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          378 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                             ....+..++..+.+|+..||+.||++|||+.++++
T Consensus       258 -------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         258 -------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             -------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                   00112345567999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.3e-38  Score=296.84  Aligned_cols=244  Identities=25%  Similarity=0.356  Sum_probs=192.9

Q ss_pred             EEEEeeeccccceEEEEEEECCCC----eEEEEEEecCchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERK----EMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~----~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      +++.+.||.|+||.||+|.+...+    ..||+|+++....  ....+..|+..+..+     ++++++++++++...+.
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-----DHPNIVKLLGVCTEEEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-----CCCchheEEEEEcCCCe
Confidence            356789999999999999998766    8899999874432  455677888888888     34789999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .+++||++ +++|.+++.......+++..+..++.||+.||+|||+.||+|+||||+||++++++               
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~---------------  140 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL---------------  140 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC---------------
Confidence            99999999 88999999875533399999999999999999999999999999999999996554               


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCCC----eeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQN----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH  323 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~  323 (430)
                                  .++|+|||.+........    ...++..|+|||.+.+..++.++|+|||||++|+|++ |.+||...
T Consensus       141 ------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~  208 (258)
T smart00219      141 ------------VVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM  208 (258)
T ss_pred             ------------eEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence                        455555555543322211    1126788999999988889999999999999999998 89999875


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +..+....+.....                                                ...+...+.++.+++.+|
T Consensus       209 ~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~i~~~  240 (258)
T smart00219      209 SNEEVLEYLKKGYR------------------------------------------------LPKPENCPPEIYKLMLQC  240 (258)
T ss_pred             CHHHHHHHHhcCCC------------------------------------------------CCCCCcCCHHHHHHHHHH
Confidence            55444433221100                                                011223567899999999


Q ss_pred             hhcCCCCCCCHHHHhc
Q 014117          404 LRYDPTDRLTAREALR  419 (430)
Q Consensus       404 L~~dP~~R~ta~elL~  419 (430)
                      |+.||++|||+.|+++
T Consensus       241 l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      241 WAEDPEDRPTFSELVE  256 (258)
T ss_pred             CcCChhhCcCHHHHHh
Confidence            9999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.7e-39  Score=300.66  Aligned_cols=243  Identities=28%  Similarity=0.416  Sum_probs=189.2

Q ss_pred             EEEeeeccccceEEEEEEEC----CCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           97 KIHSKMGEGTFGQVLECWDR----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        97 ~~~~~lG~G~~g~V~~~~~~----~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ++.+.||.|.||.||+|...    ..+..|+||+++..  ....+.+..|++.+.++.     |+||+++++++...+..
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~-----h~ni~~~~g~~~~~~~~   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLR-----HPNIVKLYGFCIENEPL   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHS-----BTTBE-EEEEEESSSSE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccc-----ccccccccccccccccc
Confidence            56789999999999999988    45678999999642  233577888999998883     37899999999988889


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      ++||||+ +++|.++|.......+++..+..++.||+.||.|||+++|+|+||+++|||++.                  
T Consensus        77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~------------------  138 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDS------------------  138 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEET------------------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------------------
Confidence            9999999 789999999874467999999999999999999999999999999999999954                  


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH  323 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~  323 (430)
                               ++.+||+|||++.......     ....+...|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       139 ---------~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~  209 (259)
T PF07714_consen  139 ---------NGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY  209 (259)
T ss_dssp             ---------TTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred             ---------ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence                     4456666666665442111     11245778999999999889999999999999999999 78999877


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +..+....+.+..                                                ....+..++.++.++|..|
T Consensus       210 ~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~li~~C  241 (259)
T PF07714_consen  210 DNEEIIEKLKQGQ------------------------------------------------RLPIPDNCPKDIYSLIQQC  241 (259)
T ss_dssp             CHHHHHHHHHTTE------------------------------------------------ETTSBTTSBHHHHHHHHHH
T ss_pred             ccccccccccccc------------------------------------------------cceeccchhHHHHHHHHHH
Confidence            6655444332110                                                0112345677899999999


Q ss_pred             hhcCCCCCCCHHHHhc
Q 014117          404 LRYDPTDRLTAREALR  419 (430)
Q Consensus       404 L~~dP~~R~ta~elL~  419 (430)
                      |..||++|||+.++++
T Consensus       242 ~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  242 WSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             T-SSGGGS--HHHHHH
T ss_pred             cCCChhhCcCHHHHHh
Confidence            9999999999999974

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-38  Score=302.05  Aligned_cols=258  Identities=24%  Similarity=0.300  Sum_probs=186.9

Q ss_pred             CcE-EEEeeeccccceEEEEEE----ECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           94 SRY-KIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        94 ~~y-~~~~~lG~G~~g~V~~~~----~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      ++| ++++.||+|+||+||++.    ...+++.||+|+++...  .....+..|+++++.+.     |+|++++++++..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~   77 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY-----HENIVKYKGCCSE   77 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCC-----CCCEeeEEEEEec
Confidence            455 999999999999998865    33567889999987432  24456778999998884     4789999987654


Q ss_pred             --CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCC
Q 014117          167 --RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       167 --~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                        ...+++||||+ +++|.+++...   .+++..+..++.|++.||.|||++||+||||||+|||+++++          
T Consensus        78 ~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~----------  144 (283)
T cd05080          78 QGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR----------  144 (283)
T ss_pred             CCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC----------
Confidence              45789999999 88999999764   599999999999999999999999999999999999995544          


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccCCCC------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~  317 (430)
                                       .++|+|||++.......      ....++..|+|||.+.+..++.++|||||||++|+|++|.
T Consensus       145 -----------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~  207 (283)
T cd05080         145 -----------------LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHC  207 (283)
T ss_pred             -----------------cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCC
Confidence                             55666666554332211      1123466799999999888999999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      .||....... ...+....+......       .......                         ......+...+.++.
T Consensus       208 ~p~~~~~~~~-~~~~~~~~~~~~~~~-------~~~~~~~-------------------------~~~~~~~~~~~~~~~  254 (283)
T cd05080         208 DSKQSPPKKF-EEMIGPKQGQMTVVR-------LIELLER-------------------------GMRLPCPKNCPQEVY  254 (283)
T ss_pred             CCCCCCcchh-hhhhcccccccchhh-------hhhhhhc-------------------------CCCCCCCCCCCHHHH
Confidence            9986533210 000000000000000       0000000                         000112345677899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhc
Q 014117          398 HLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      +++.+||+.||++|||++++++
T Consensus       255 ~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         255 ILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             HHHHHHhccChhhCCCHHHHHH
Confidence            9999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-38  Score=301.32  Aligned_cols=244  Identities=20%  Similarity=0.249  Sum_probs=182.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCe----EEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKE----MVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      ++|++.+.||.|+||+||+|.+..+++    .+|+|.+....  .....+..|+..+..+     .|+||+++++++. .
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-----~h~~iv~~~~~~~-~   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-----DHAYIVRLLGICP-G   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-----CCCCcceEEEEEC-C
Confidence            468999999999999999999877766    47777764221  1223344555555554     4588999999875 4


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      ...++++||+ +++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.+              
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~--------------  145 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD--------------  145 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC--------------
Confidence            5678899998 899999997654 468999999999999999999999999999999999999544              


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF  320 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf  320 (430)
                                   ..+||+|||.++......     ....++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus       146 -------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~  212 (279)
T cd05111         146 -------------SIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY  212 (279)
T ss_pred             -------------CcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence                         455666666554322111     12346778999999998899999999999999999998 99999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .+.........+.                       ++...                         ..+...+.++.+++
T Consensus       213 ~~~~~~~~~~~~~-----------------------~~~~~-------------------------~~~~~~~~~~~~li  244 (279)
T cd05111         213 AGMRPHEVPDLLE-----------------------KGERL-------------------------AQPQICTIDVYMVM  244 (279)
T ss_pred             CCCCHHHHHHHHH-----------------------CCCcC-------------------------CCCCCCCHHHHHHH
Confidence            8754433222111                       11000                         00122345688899


Q ss_pred             HHhhhcCCCCCCCHHHHhc
Q 014117          401 QGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~  419 (430)
                      .+||..||++|||+.|+++
T Consensus       245 ~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         245 VKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHcCCCcccCcCHHHHHH
Confidence            9999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.6e-38  Score=296.75  Aligned_cols=246  Identities=22%  Similarity=0.297  Sum_probs=188.4

Q ss_pred             eeeccccceEEEEEEECC-CC--eEEEEEEecCchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117          100 SKMGEGTFGQVLECWDRE-RK--EMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~-~~--~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      +.||+|++|.||+|.+.. ++  ..||+|.++....  ..+.+..|+.++.++.     |+|++++++.+.. ...++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~-~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-----HENLIRLYGVVLT-HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcC-----CCCccceeEEEcC-CeEEEEE
Confidence            368999999999998865 33  3699999875432  4456778899888884     4789999998887 8999999


Q ss_pred             ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          175 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       175 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      ||+ +++|.+++.......+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++++|||++..........
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999 8999999987643568999999999999999999999999999999999999766555555555443321110000


Q ss_pred             ccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHHHHH
Q 014117          254 KRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMM  332 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~~i  332 (430)
                                           .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+
T Consensus       155 ---------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~  213 (257)
T cd05040         155 ---------------------VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI  213 (257)
T ss_pred             ---------------------ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence                                 00012346788999999999899999999999999999999 99999876655544433


Q ss_pred             HHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCC
Q 014117          333 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL  412 (430)
Q Consensus       333 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~  412 (430)
                      .......                                               ..+...+.++.+++.+||+.+|++||
T Consensus       214 ~~~~~~~-----------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp  246 (257)
T cd05040         214 DKEGERL-----------------------------------------------ERPEACPQDIYNVMLQCWAHNPADRP  246 (257)
T ss_pred             HhcCCcC-----------------------------------------------CCCccCCHHHHHHHHHHCCCCcccCC
Confidence            2210000                                               01223456799999999999999999


Q ss_pred             CHHHHhc
Q 014117          413 TAREALR  419 (430)
Q Consensus       413 ta~elL~  419 (430)
                      |+.++++
T Consensus       247 s~~~~~~  253 (257)
T cd05040         247 TFAALRE  253 (257)
T ss_pred             CHHHHHH
Confidence            9999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.1e-38  Score=296.35  Aligned_cols=237  Identities=23%  Similarity=0.352  Sum_probs=182.4

Q ss_pred             eeccccceEEEEEEEC--CCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEec
Q 014117          101 KMGEGTFGQVLECWDR--ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK  176 (430)
Q Consensus       101 ~lG~G~~g~V~~~~~~--~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~  176 (430)
                      .||+|+||.||+|.++  .++..||+|++....  ...+.+..|+.+++++.     |++++++++.++ ....++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~ii~~~~~~~-~~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD-----NPYIVRMIGVCE-AEALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcC-----CCCeEEEEEEEc-CCCeEEEEEe
Confidence            4899999999999775  445679999986432  23455778999999884     478999999876 4578999999


Q ss_pred             C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccccc
Q 014117          177 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR  255 (430)
Q Consensus       177 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~  255 (430)
                      + +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.                     
T Consensus        76 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~---------------------  133 (257)
T cd05115          76 ASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY---------------------  133 (257)
T ss_pred             CCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc---------------------
Confidence            9 889999987543 47899999999999999999999999999999999999965544                     


Q ss_pred             CCCCCCeEEEeCCCccccCCCCC------eeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHH
Q 014117          256 MPKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH  328 (430)
Q Consensus       256 ~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~  328 (430)
                            +||+|||++........      ...++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.
T Consensus       134 ------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  207 (257)
T cd05115         134 ------AKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV  207 (257)
T ss_pred             ------EEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence                  55555555442221111      0123568999999998889999999999999999996 9999987655443


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      ...+.+..                                                ....+...+.++.++|.+||+.||
T Consensus       208 ~~~~~~~~------------------------------------------------~~~~~~~~~~~l~~li~~c~~~~~  239 (257)
T cd05115         208 MSFIEQGK------------------------------------------------RLDCPAECPPEMYALMKDCWIYKW  239 (257)
T ss_pred             HHHHHCCC------------------------------------------------CCCCCCCCCHHHHHHHHHHcCCCh
Confidence            33222110                                                001234556789999999999999


Q ss_pred             CCCCCHHHHhc
Q 014117          409 TDRLTAREALR  419 (430)
Q Consensus       409 ~~R~ta~elL~  419 (430)
                      ++||++.++.+
T Consensus       240 ~~Rp~~~~i~~  250 (257)
T cd05115         240 EDRPNFAKVEE  250 (257)
T ss_pred             hhCcCHHHHHH
Confidence            99999998865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-38  Score=304.53  Aligned_cols=249  Identities=19%  Similarity=0.305  Sum_probs=191.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEEC-------CCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDR-------ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW  163 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~  163 (430)
                      ..+|.+.+.||+|+||.||+|...       ..+..||+|.+...  ......+..|+.++..+..    |+||+++++.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~----h~~i~~~~~~   89 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK----HKNIINLLGA   89 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhcc----CCCchheeEE
Confidence            457999999999999999999753       23457999998643  2334567788888888732    3789999999


Q ss_pred             eecCCeEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceE
Q 014117          164 FDYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL  228 (430)
Q Consensus       164 ~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NIL  228 (430)
                      +......|+||||+ +++|.+++....              ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil  169 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL  169 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence            99999999999999 889999997642              135788889999999999999999999999999999999


Q ss_pred             EeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchH
Q 014117          229 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDI  303 (430)
Q Consensus       229 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Dv  303 (430)
                      ++.++.                           +||+|||.+.......     ....++..|+|||++.+..++.++||
T Consensus       170 i~~~~~---------------------------~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  222 (304)
T cd05101         170 VTENNV---------------------------MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV  222 (304)
T ss_pred             EcCCCc---------------------------EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhH
Confidence            965554                           5555555544322111     11235678999999999889999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHH
Q 014117          304 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ  382 (430)
Q Consensus       304 wslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (430)
                      |||||++|+|++ |..||.+.+..+....+.....                                             
T Consensus       223 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------------------------------------  257 (304)
T cd05101         223 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR---------------------------------------------  257 (304)
T ss_pred             HHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc---------------------------------------------
Confidence            999999999998 8899987655444333211000                                             


Q ss_pred             HHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       383 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                         ...+...+.++.+|+.+||+.+|++|||+.|+++.
T Consensus       258 ---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         258 ---MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence               00123456789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.8e-38  Score=301.68  Aligned_cols=247  Identities=20%  Similarity=0.321  Sum_probs=190.6

Q ss_pred             cCcEEEEeeeccccceEEEEEEECC-----CCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .++|++.+.||+|+||.||+|.+..     ++..||+|++....  .....+..|+.++..+     .|++++++++++.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~iv~~~~~~~   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-----DHPNIVKLLGVCA   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-----CCCchheEEEEEc
Confidence            3579999999999999999998753     67889999986432  3345577789888888     3478999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNN--------------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP  224 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp  224 (430)
                      .....|+||||+ +++|.+++....                    ...+++..+..++.||+.||.|||++|++||||||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p  158 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT  158 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence            999999999999 789999997432                    12478889999999999999999999999999999


Q ss_pred             CceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCC
Q 014117          225 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTY  299 (430)
Q Consensus       225 ~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~  299 (430)
                      +|||++.++.                           ++|+|||.+......     .....++..|+|||.+.+..++.
T Consensus       159 ~nil~~~~~~---------------------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  211 (288)
T cd05050         159 RNCLVGENMV---------------------------VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTT  211 (288)
T ss_pred             hheEecCCCc---------------------------eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCc
Confidence            9999965544                           555555554322111     11123466799999999989999


Q ss_pred             cchHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCc
Q 014117          300 PCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL  378 (430)
Q Consensus       300 ~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  378 (430)
                      ++|||||||++|||++ |..||.+.+..+....+..                       +..                  
T Consensus       212 ~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~-----------------------~~~------------------  250 (288)
T cd05050         212 ESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRD-----------------------GNV------------------  250 (288)
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----------------------CCC------------------
Confidence            9999999999999998 8889976554443332211                       000                  


Q ss_pred             hhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          379 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                             ...+...+.++.+||.+||+.||++|||+.|+++
T Consensus       251 -------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         251 -------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                   0012345667999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.2e-38  Score=298.83  Aligned_cols=252  Identities=20%  Similarity=0.305  Sum_probs=193.3

Q ss_pred             CcEEEEeeeccccceEEEEEEECC-----CCeEEEEEEecCchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      ++|++...||.|+||.||+|+.+.     ..+.||+|.+.....  ....+..|+++++++.     |++++++++++..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS-----HKNVVRLLGLCRE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcC-----CcceeeeEEEECC
Confidence            468999999999999999999754     346799998864332  3456788999999984     3789999999999


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNY-------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP  238 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~  238 (430)
                      ....|+||||+ +++|.+++.....       ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence            99999999999 7899999976542       158999999999999999999999999999999999999666555555


Q ss_pred             CCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CC
Q 014117          239 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE  317 (430)
Q Consensus       239 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~  317 (430)
                      |||++......                       .........++..|+|||.+.+..++.++|||||||++|+|++ |.
T Consensus       160 ~~~~~~~~~~~-----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~  216 (275)
T cd05046         160 LLSLSKDVYNS-----------------------EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE  216 (275)
T ss_pred             ccccccccCcc-----------------------cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            55443211100                       0001122356778999999988889999999999999999999 88


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      .||...........+.                       .+...|+                        .+..++..+.
T Consensus       217 ~p~~~~~~~~~~~~~~-----------------------~~~~~~~------------------------~~~~~~~~l~  249 (275)
T cd05046         217 LPFYGLSDEEVLNRLQ-----------------------AGKLELP------------------------VPEGCPSRLY  249 (275)
T ss_pred             CCccccchHHHHHHHH-----------------------cCCcCCC------------------------CCCCCCHHHH
Confidence            9997654433332211                       1111111                        1234567899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcC
Q 014117          398 HLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      +++.+||+.||++|||+.|++.+
T Consensus       250 ~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         250 KLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             HHHHHHcCCCcccCCCHHHHHHH
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-39  Score=316.00  Aligned_cols=247  Identities=23%  Similarity=0.336  Sum_probs=199.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCe---E-EEEEEecC----chhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKE---M-VAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~-vAiK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      .++-.+.++||+|+||.||+|..+..+.   . ||+|..+.    .......++.|+++++++     +|+||+++|++.
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-----~H~NVVr~yGVa  230 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-----NHPNVVRFYGVA  230 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEE
Confidence            3455666899999999999999876532   3 89999874    244567788999999998     458999999999


Q ss_pred             ecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCC
Q 014117          165 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       165 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                      .....++||||+| ||+|.++|++.+. .++..+...++.+.+.||+|||++++|||||-.+|+|++..+.+||+|||+ 
T Consensus       231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGL-  308 (474)
T KOG0194|consen  231 VLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGL-  308 (474)
T ss_pred             cCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccc-
Confidence            9999999999999 9999999998763 699999999999999999999999999999999999997665555555554 


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--C-eeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--N-YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL  319 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~-~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~P  319 (430)
                                                ++......  . ...-+..|+|||.+....|+.++|||||||++||+++ |..|
T Consensus       309 --------------------------s~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~P  362 (474)
T KOG0194|consen  309 --------------------------SRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEP  362 (474)
T ss_pred             --------------------------ccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCC
Confidence                                      43221000  0 0123578999999999999999999999999999998 8899


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |.+.+..+....|.......                                               ..+...+.++..+
T Consensus       363 y~g~~~~~v~~kI~~~~~r~-----------------------------------------------~~~~~~p~~~~~~  395 (474)
T KOG0194|consen  363 YPGMKNYEVKAKIVKNGYRM-----------------------------------------------PIPSKTPKELAKV  395 (474)
T ss_pred             CCCCCHHHHHHHHHhcCccC-----------------------------------------------CCCCCCHHHHHHH
Confidence            99988877766664322222                                               2234567788999


Q ss_pred             HHHhhhcCCCCCCCHHHHhc
Q 014117          400 LQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~  419 (430)
                      +.+|+..||++|||+.++.+
T Consensus       396 ~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  396 MKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHhccCChhhccCHHHHHH
Confidence            99999999999999987754

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.6e-38  Score=300.75  Aligned_cols=258  Identities=16%  Similarity=0.238  Sum_probs=180.8

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCC---CeEEEEEEecCchhhH--HH-------HHHHHHHHHHHHhcCCCCCce
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGIKKYR--EA-------AMIEIEVLQQLAKHDKGGNRC  157 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~~--~~-------~~~E~~~l~~l~~~~~~~~~i  157 (430)
                      +...++|++.+.||+|+||+||+|.+..+   +..+|+|+........  +.       ...++..+..+  ....++++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~--~~~~h~~i   85 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI--HNIDHLGI   85 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHh--ccCCCCCC
Confidence            34457899999999999999999998877   6778888653221110  00       01112222222  22345778


Q ss_pred             EEecceeecCC----eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecC
Q 014117          158 VQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE  233 (430)
Q Consensus       158 ~~~~~~~~~~~----~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~  233 (430)
                      +.+++......    ..+++++++..++.+.+....  .+++..+..++.||+.||.|||+.+|+||||||+|||++.  
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~--  161 (294)
T PHA02882         86 PKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDG--  161 (294)
T ss_pred             CcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--
Confidence            88877554332    557889988778888776543  4688889999999999999999999999999999999954  


Q ss_pred             ccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCC----------CCCeeeecCcccchhhhhCCCCCCcchH
Q 014117          234 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP----------DQNYIVSTRHYRAPEVILGLGWTYPCDI  303 (430)
Q Consensus       234 ~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  303 (430)
                                               ...++|+|||+++....          ......||+.|+|||++.+..++.++||
T Consensus       162 -------------------------~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~Di  216 (294)
T PHA02882        162 -------------------------NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDL  216 (294)
T ss_pred             -------------------------CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHH
Confidence                                     44566666666643211          1123469999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHH
Q 014117          304 WSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN  383 (430)
Q Consensus       304 wslGv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (430)
                      |||||++|||++|.+||.+.+...........      .+..        .+.++..                       
T Consensus       217 wSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~------~~~~--------~~~~~~~-----------------------  259 (294)
T PHA02882        217 ESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC------DFIK--------RLHEGKI-----------------------  259 (294)
T ss_pred             HHHHHHHHHHHhCCCCCCccccchHHHHHhHH------HHHH--------Hhhhhhh-----------------------
Confidence            99999999999999999876332221111110      0000        0000000                       


Q ss_pred             HHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       384 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                          .....+.++.+++..|++.+|++||+.+++++
T Consensus       260 ----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        260 ----KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             ----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                12344677999999999999999999999875

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2e-38  Score=308.05  Aligned_cols=249  Identities=20%  Similarity=0.301  Sum_probs=191.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCC-------CeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRER-------KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW  163 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~  163 (430)
                      ..+|++.+.||+|+||.||+|.+...       +..||+|+++..  ......+..|+++++++..    ++||++++++
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~----h~~iv~~~~~   86 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK----HKNIINLLGA   86 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcC----CCCeeeeeEE
Confidence            45799999999999999999986432       346999988743  2234567788998888843    3789999999


Q ss_pred             eecCCeEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceE
Q 014117          164 FDYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL  228 (430)
Q Consensus       164 ~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NIL  228 (430)
                      +...+.+++||||+ +++|.+++....              ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil  166 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL  166 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence            99999999999999 889999997532              134788889999999999999999999999999999999


Q ss_pred             EeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchH
Q 014117          229 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDI  303 (430)
Q Consensus       229 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Dv  303 (430)
                      ++.++.                           +||+|||+++......     ....++..|+|||++.+..++.++||
T Consensus       167 l~~~~~---------------------------~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  219 (334)
T cd05100         167 VTEDNV---------------------------MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV  219 (334)
T ss_pred             EcCCCc---------------------------EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhh
Confidence            965544                           5555555544322111     11233567999999999999999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHH
Q 014117          304 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ  382 (430)
Q Consensus       304 wslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (430)
                      |||||++|||++ |..||.+.+..+....+....                                              
T Consensus       220 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----------------------------------------------  253 (334)
T cd05100         220 WSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGH----------------------------------------------  253 (334)
T ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------------------------------------------
Confidence            999999999998 899998765544433322100                                              


Q ss_pred             HHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       383 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                        ....+...+.++.+|+.+||+.+|.+|||+.|++++
T Consensus       254 --~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         254 --RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence              001123446679999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-38  Score=293.61  Aligned_cols=238  Identities=24%  Similarity=0.359  Sum_probs=187.1

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL  177 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~  177 (430)
                      ++||.|+||.||+|.+.. ++.||+|+++....  ....+..|+++++++.     +++++.+++++......++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD-----HPNIVKLIGVCVQKQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCC-----CCCeEEEEEEEecCCCeEEEEEcC
Confidence            468999999999999887 89999999864322  3456778888888873     478999999999999999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccC
Q 014117          178 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM  256 (430)
Q Consensus       178 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~  256 (430)
                       +++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++                       
T Consensus        75 ~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-----------------------  130 (251)
T cd05041          75 PGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-----------------------  130 (251)
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-----------------------
Confidence             889999997654 3688999999999999999999999999999999999995544                       


Q ss_pred             CCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHHH
Q 014117          257 PKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA  330 (430)
Q Consensus       257 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~  330 (430)
                          .++|+|||.+.......     ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||..........
T Consensus       131 ----~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~  206 (251)
T cd05041         131 ----VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE  206 (251)
T ss_pred             ----cEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH
Confidence                55666666554322111     11223567999999998889999999999999999999 899997765433332


Q ss_pred             HHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCC
Q 014117          331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD  410 (430)
Q Consensus       331 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~  410 (430)
                      .+.....                                                ...+...+.++.+++.+||+.+|++
T Consensus       207 ~~~~~~~------------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~  238 (251)
T cd05041         207 RIESGYR------------------------------------------------MPAPQLCPEEIYRLMLQCWAYDPEN  238 (251)
T ss_pred             HHhcCCC------------------------------------------------CCCCccCCHHHHHHHHHHhccChhh
Confidence            2211100                                                0012345668999999999999999


Q ss_pred             CCCHHHHhc
Q 014117          411 RLTAREALR  419 (430)
Q Consensus       411 R~ta~elL~  419 (430)
                      |||+.|+++
T Consensus       239 Rp~~~ell~  247 (251)
T cd05041         239 RPSFSEIYN  247 (251)
T ss_pred             CcCHHHHHH
Confidence            999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.3e-38  Score=300.44  Aligned_cols=266  Identities=22%  Similarity=0.335  Sum_probs=190.0

Q ss_pred             cEEEEeeeccccceEEEEEEE----CCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-
Q 014117           95 RYKIHSKMGEGTFGQVLECWD----RERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-  167 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~----~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~-  167 (430)
                      .|++++.||+|+||.||+|..    ..++..||+|.++..  ......+..|+.+++++.     ++|++++++++... 
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~   79 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-----HENIVKYKGICTEDG   79 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCC-----CCCeeeeeeEEecCC
Confidence            478999999999999999974    456889999998633  233456778999998884     47899998887764 


Q ss_pred             -CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          168 -NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       168 -~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                       ...++||||+ +++|.+++.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||++..
T Consensus        80 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          80 GNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             CCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccc
Confidence             6789999999 899999997653 3689999999999999999999999999999999999997665555555554433


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                      .......                     ........|+..|+|||++.+..++.++|||||||++|+|+++..|+.....
T Consensus       159 ~~~~~~~---------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~  217 (284)
T cd05079         159 IETDKEY---------------------YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT  217 (284)
T ss_pred             cccCccc---------------------eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc
Confidence            2111000                     0000123467789999999988899999999999999999998876543211


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                           ......++.+.+....   ........+.                         ....+..++.++.+|+.+||+
T Consensus       218 -----~~~~~~~~~~~~~~~~---~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~  264 (284)
T cd05079         218 -----LFLKMIGPTHGQMTVT---RLVRVLEEGK-------------------------RLPRPPNCPEEVYQLMRKCWE  264 (284)
T ss_pred             -----hhhhhcccccccccHH---HHHHHHHcCc-------------------------cCCCCCCCCHHHHHHHHHHcc
Confidence                 1111122211110000   0000011110                         011234567789999999999


Q ss_pred             cCCCCCCCHHHHhcC
Q 014117          406 YDPTDRLTAREALRH  420 (430)
Q Consensus       406 ~dP~~R~ta~elL~h  420 (430)
                      .||++|||+.+++++
T Consensus       265 ~~p~~Rpt~~~il~~  279 (284)
T cd05079         265 FQPSKRTTFQNLIEG  279 (284)
T ss_pred             CCcccCcCHHHHHHH
Confidence            999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-38  Score=298.02  Aligned_cols=240  Identities=22%  Similarity=0.284  Sum_probs=183.8

Q ss_pred             eeccccceEEEEEEECCCCe--EEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEec
Q 014117          101 KMGEGTFGQVLECWDRERKE--MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK  176 (430)
Q Consensus       101 ~lG~G~~g~V~~~~~~~~~~--~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~  176 (430)
                      .||+|+||.||+|.+..++.  .+|+|.++..  ......+..|++++.++.+    |+|++++++++...+.+++||||
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~----h~~iv~~~~~~~~~~~~~lv~e~   77 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH----HPNIINLLGACEHRGYLYLAIEY   77 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhcc----CCCeeeEEEEEecCCCceEEEEe
Confidence            58999999999999988775  4688888632  2344567789999888853    37899999999999999999999


Q ss_pred             C-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          177 L-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       177 ~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      + +++|.+++....              ...+++..+..++.|++.||+|||+.||+||||||+|||++.++.       
T Consensus        78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~-------  150 (270)
T cd05047          78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-------  150 (270)
T ss_pred             CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe-------
Confidence            9 889999997542              124789999999999999999999999999999999999965544       


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA  318 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~  318 (430)
                                          +||+|||++......  ......+..|+|||++.+..++.++|+|||||++|||++ |..
T Consensus       151 --------------------~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~  210 (270)
T cd05047         151 --------------------AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT  210 (270)
T ss_pred             --------------------EEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence                                555555554321111  011123567999999988889999999999999999997 999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||.+.+..+....+....                                                ....+...+.++.+
T Consensus       211 pf~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~  242 (270)
T cd05047         211 PYCGMTCAELYEKLPQGY------------------------------------------------RLEKPLNCDDEVYD  242 (270)
T ss_pred             CccccCHHHHHHHHhCCC------------------------------------------------CCCCCCcCCHHHHH
Confidence            997655433332221100                                                00012234567899


Q ss_pred             HHHHhhhcCCCCCCCHHHHhc
Q 014117          399 LLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~  419 (430)
                      |+.+||+.||.+|||+++++.
T Consensus       243 li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         243 LMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             HHHHHcccChhhCCCHHHHHH
Confidence            999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=321.13  Aligned_cols=202  Identities=27%  Similarity=0.419  Sum_probs=174.6

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecC--chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC----
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR----  167 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~----  167 (430)
                      ..|...+.||+|+||.||+++++.+|+.||||.++.  .....+...+|+++|+++.     |+|||++++.-++.    
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn-----h~NIVk~f~iee~~~~~~   87 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLN-----HPNIVKLFDIEETKFLGL   87 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcC-----chhhhhhcccCCccccCc
Confidence            347778899999999999999999999999999874  3456778889999999994     58899998876543    


Q ss_pred             --CeEEEEEecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCC
Q 014117          168 --NHICIVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       168 --~~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                        ....+||||| ||||...|++..+ ..|++.+.+.+..++..||.|||++|||||||||.||++-..+          
T Consensus        88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Ge----------  157 (732)
T KOG4250|consen   88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGE----------  157 (732)
T ss_pred             ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC----------
Confidence              3678999999 9999999986433 5799999999999999999999999999999999999995433          


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                   +.....||+|||.|+-...+.  ..++||..|.+||++.. ..|+..+|.|||||++|+++||..||
T Consensus       158 -------------dgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF  224 (732)
T KOG4250|consen  158 -------------DGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPF  224 (732)
T ss_pred             -------------CCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCC
Confidence                         456678999999998665544  55799999999999994 78999999999999999999999999


Q ss_pred             CCC
Q 014117          321 QTH  323 (430)
Q Consensus       321 ~~~  323 (430)
                      ...
T Consensus       225 ~p~  227 (732)
T KOG4250|consen  225 IPF  227 (732)
T ss_pred             CcC
Confidence            643

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.5e-38  Score=298.79  Aligned_cols=243  Identities=23%  Similarity=0.318  Sum_probs=183.0

Q ss_pred             eeccccceEEEEEEECC------------------------CCeEEEEEEecCchh-hHHHHHHHHHHHHHHHhcCCCCC
Q 014117          101 KMGEGTFGQVLECWDRE------------------------RKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGN  155 (430)
Q Consensus       101 ~lG~G~~g~V~~~~~~~------------------------~~~~vAiK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~  155 (430)
                      .||+|+||.||+|....                        ....||+|++..... ....+..|+.+++.+     .|+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-----~h~   76 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-----SHI   76 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-----CCC
Confidence            68999999999997432                        124589998864322 234456677777666     458


Q ss_pred             ceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCc
Q 014117          156 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY  234 (430)
Q Consensus       156 ~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~  234 (430)
                      ||+++++++......++||||+ +++|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++..+.
T Consensus        77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCc
Confidence            8999999999999999999999 889988886543 46899999999999999999999999999999999999975432


Q ss_pred             cccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHH
Q 014117          235 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVEL  313 (430)
Q Consensus       235 ~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el  313 (430)
                      ..                    .....+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|||
T Consensus       156 ~~--------------------~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el  214 (274)
T cd05076         156 AE--------------------GTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI  214 (274)
T ss_pred             cc--------------------CccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHH
Confidence            10                    12335789999987543222 22357888999998875 5689999999999999998


Q ss_pred             H-hCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCc
Q 014117          314 C-TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS  392 (430)
Q Consensus       314 ~-tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (430)
                      + +|..||......+....+.. ..                                                 ..+...
T Consensus       215 ~~~g~~p~~~~~~~~~~~~~~~-~~-------------------------------------------------~~~~~~  244 (274)
T cd05076         215 CFDGEVPLKERTPSEKERFYEK-KH-------------------------------------------------RLPEPS  244 (274)
T ss_pred             HhCCCCCccccChHHHHHHHHh-cc-------------------------------------------------CCCCCC
Confidence            4 69999976544332111110 00                                                 011223


Q ss_pred             hhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          393 AGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       393 ~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      +.++.++|.+||+.+|++|||+.++|++
T Consensus       245 ~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         245 CKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             ChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            4568999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.6e-38  Score=295.67  Aligned_cols=244  Identities=20%  Similarity=0.256  Sum_probs=183.7

Q ss_pred             eeeccccceEEEEEEECC------------CCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117          100 SKMGEGTFGQVLECWDRE------------RKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~------------~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      +.||+|+||.||+|....            ....||+|++.... .....+..|+.++..+     .|+||+++++++..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-----~hp~iv~~~~~~~~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-----SHKHIVLLYGVCVR   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-----CCCCEeeEEEEEec
Confidence            368999999999997532            23358999876432 2333556677777777     44889999999998


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      ....++||||+ +++|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++..+         
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~---------  145 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDG---------  145 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccC---------
Confidence            89999999999 788888876543 4689999999999999999999999999999999999997544210         


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhh-CCCCCCcchHHHHHHHHHHHH-hCCCCCCCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELC-TGEALFQTH  323 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~-tG~~Pf~~~  323 (430)
                                 .....++++|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..||...
T Consensus       146 -----------~~~~~~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (262)
T cd05077         146 -----------ECGPFIKLSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK  213 (262)
T ss_pred             -----------CCCceeEeCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence                       12334888999987654322 2346788999999987 456899999999999999997 588998764


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      ...+.......                        ..                          ......+.++.+||.+|
T Consensus       214 ~~~~~~~~~~~------------------------~~--------------------------~~~~~~~~~~~~li~~c  243 (262)
T cd05077         214 TLAEKERFYEG------------------------QC--------------------------MLVTPSCKELADLMTHC  243 (262)
T ss_pred             chhHHHHHHhc------------------------Cc--------------------------cCCCCChHHHHHHHHHH
Confidence            43222111000                        00                          01122345789999999


Q ss_pred             hhcCCCCCCCHHHHhcC
Q 014117          404 LRYDPTDRLTAREALRH  420 (430)
Q Consensus       404 L~~dP~~R~ta~elL~h  420 (430)
                      |+.||.+||++.+|+++
T Consensus       244 l~~dp~~Rp~~~~il~~  260 (262)
T cd05077         244 MNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             cCCChhhCcCHHHHHHh
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-38  Score=296.10  Aligned_cols=244  Identities=21%  Similarity=0.284  Sum_probs=188.9

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCe----EEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKE----MVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .+|++.+.||+|+||.||+|.++.+++    .+|+|.+....  .....+..|+.+++.+.     |+|++++++++.. 
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~-   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD-----HPHVVRLLGICLS-   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-----CCCcceEEEEEec-
Confidence            569999999999999999999876654    68999886443  23355677888888873     4789999998876 


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      ...++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.            
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~------------  147 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH------------  147 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe------------
Confidence            7899999999 899999998654 35899999999999999999999999999999999999965554            


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCCCe-----eeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY-----IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF  320 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf  320 (430)
                                     +||+|||.+.........     ..++..|+|||.+....++.++|+|||||++||+++ |..||
T Consensus       148 ---------------~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~  212 (279)
T cd05057         148 ---------------VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY  212 (279)
T ss_pred             ---------------EEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCC
Confidence                           455555544432211110     123567999999988889999999999999999998 99999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .+....+....+... ...                                               ..+...+.++.+++
T Consensus       213 ~~~~~~~~~~~~~~~-~~~-----------------------------------------------~~~~~~~~~~~~~~  244 (279)
T cd05057         213 EGIPAVEIPDLLEKG-ERL-----------------------------------------------PQPPICTIDVYMVL  244 (279)
T ss_pred             CCCCHHHHHHHHhCC-CCC-----------------------------------------------CCCCCCCHHHHHHH
Confidence            876554433322210 000                                               01223456789999


Q ss_pred             HHhhhcCCCCCCCHHHHhc
Q 014117          401 QGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~  419 (430)
                      .+||..||.+|||+.++++
T Consensus       245 ~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         245 VKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHcCCChhhCCCHHHHHH
Confidence            9999999999999998864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.4e-38  Score=296.57  Aligned_cols=247  Identities=18%  Similarity=0.253  Sum_probs=189.9

Q ss_pred             cCcEEEEeeeccccceEEEEEEECC----CCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRE----RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      .++|++.+.||+|+||.||+|.+..    ++..||+|+++..  ......+..|+.+++.+     .|+|++++++++..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~   79 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-----SHQNILPILHVCIE   79 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEec
Confidence            3579999999999999999999876    3578999988643  23345567788888887     44789999887554


Q ss_pred             -CCeEEEEEecC-CCCHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccC
Q 014117          167 -RNHICIVFEKL-GSSLYDFLRKNNY------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP  238 (430)
Q Consensus       167 -~~~~~lv~e~~-~~~L~~~l~~~~~------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~  238 (430)
                       ....+++++|+ +++|.+++.....      ..+++..+..++.||+.||+|||+++|+||||||+|||++.++     
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~-----  154 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL-----  154 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC-----
Confidence             57889999999 7899999876432      3589999999999999999999999999999999999996554     


Q ss_pred             CCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHH
Q 014117          239 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL  313 (430)
Q Consensus       239 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el  313 (430)
                                            .+||+|||+++......     ....++..|+|||++.+..++.++|||||||++||+
T Consensus       155 ----------------------~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el  212 (280)
T cd05043         155 ----------------------QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWEL  212 (280)
T ss_pred             ----------------------cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHH
Confidence                                  45555555554322111     112356789999999998999999999999999999


Q ss_pred             Hh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCc
Q 014117          314 CT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS  392 (430)
Q Consensus       314 ~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (430)
                      ++ |++||...+..+....+....                        .+                        ..+...
T Consensus       213 ~~~g~~p~~~~~~~~~~~~~~~~~------------------------~~------------------------~~~~~~  244 (280)
T cd05043         213 MTLGQTPYVEIDPFEMAAYLKDGY------------------------RL------------------------AQPINC  244 (280)
T ss_pred             hcCCCCCcCcCCHHHHHHHHHcCC------------------------CC------------------------CCCCcC
Confidence            99 999998765444322221100                        00                        012234


Q ss_pred             hhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          393 AGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       393 ~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      +.++.+++.+||+.||++|||+.++++
T Consensus       245 ~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         245 PDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            567999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=293.62  Aligned_cols=280  Identities=28%  Similarity=0.462  Sum_probs=219.4

Q ss_pred             EEeeeccccceEEEEEEECCCCeEEEEEEecCchh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-----Ce
Q 014117           98 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-----NH  169 (430)
Q Consensus        98 ~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~-----~~  169 (430)
                      --+.||.|+||.||-+.|..+|+.||+|.+.....   ..+.+..|++.|.-++|     .|+....+..+..     ..
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkH-----dNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRH-----DNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhcc-----ccHHHHHHhcCCCCchHHHH
Confidence            34789999999999999999999999998863322   33556678888877755     5566666655543     35


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          170 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       170 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      +|+|.|+|..+|...+.+..  .++.+.+..+.+||++||+|||+.||.||||||.|.|++                   
T Consensus       132 iYV~TELmQSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN-------------------  190 (449)
T KOG0664|consen  132 LYVLTELMQSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN-------------------  190 (449)
T ss_pred             HHHHHHHHHhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec-------------------
Confidence            78899999889998887653  799999999999999999999999999999999999995                   


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCCCe----eeecCcccchhhhhCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQNY----IVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~----~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                              .+..+||||||+|+....+...    -+-|-+|.|||++.|.+ |+.++||||+||++.||+..+..|...+
T Consensus       191 --------SNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~  262 (449)
T KOG0664|consen  191 --------SNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG  262 (449)
T ss_pred             --------cCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence                    4556777777777755544322    35588999999999874 9999999999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+++..|...+|.+..+..+.-.+-.+..+..+...-|...       -+        +....++.-..+..+++.++|
T Consensus       263 PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~-------vL--------YtlsS~~~~~heav~~~~~~l  327 (449)
T KOG0664|consen  263 PIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQ-------RL--------YKIASPDDKNHEAVDLLQKLL  327 (449)
T ss_pred             hHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCcc-------ce--------eeecCCcccchHHHHHHHHHh
Confidence            999999999999999887766655555555544443333211       00        001112334456788999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ..||++|.+.++++.|+++.+-
T Consensus       328 ~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  328 HFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             CCCCcccccHhhhccccccccc
Confidence            9999999999999999998654

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.9e-38  Score=295.06  Aligned_cols=244  Identities=22%  Similarity=0.278  Sum_probs=179.1

Q ss_pred             eeeccccceEEEEEEECC--CCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117          100 SKMGEGTFGQVLECWDRE--RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~--~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      ++||+|+||.||+|....  ....+|+|.+....  .....+..|+.+++.+     .|+||+++++.+.....+|+|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-----~h~nii~~~~~~~~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-----NHPNVLQCLGQCIESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-----CCCCcceEEEEECCCCceEEEEE
Confidence            368999999999996533  44578999875332  2334566788887776     45889999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          176 KL-GSSLYDFLRKNNY---RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      |+ +++|.+++.....   ..+++..+..++.||+.||+|||++||+||||||+|||++.++                  
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~------------------  137 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL------------------  137 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC------------------
Confidence            99 8899999976432   2356788899999999999999999999999999999995544                  


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhC-------CCCCCcchHHHHHHHHHHHHh-CCC
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILG-------LGWTYPCDIWSVGCILVELCT-GEA  318 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGv~l~el~t-G~~  318 (430)
                               .+||+|||++......     .....++..|+|||++..       ..++.++|||||||++|||++ |..
T Consensus       138 ---------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~  208 (269)
T cd05042         138 ---------SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQ  208 (269)
T ss_pred             ---------cEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCC
Confidence                     5556666655432111     112245778999999753       357889999999999999999 889


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||....+.+....+....                      ...++..                     ......+..+.+
T Consensus       209 p~~~~~~~~~~~~~~~~~----------------------~~~~~~~---------------------~~~~~~~~~~~~  245 (269)
T cd05042         209 PYPDLSDEQVLKQVVREQ----------------------DIKLPKP---------------------QLDLKYSDRWYE  245 (269)
T ss_pred             CCCcCCHHHHHHHHhhcc----------------------CccCCCC---------------------cccccCCHHHHH
Confidence            998766555443332211                      1111110                     012345567788


Q ss_pred             HHHHhhhcCCCCCCCHHHHhc
Q 014117          399 LLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~  419 (430)
                      ++..|+ .||++|||+++|++
T Consensus       246 ~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         246 VMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             HHHHHh-cCcccccCHHHHHH
Confidence            898888 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.4e-38  Score=294.56  Aligned_cols=245  Identities=24%  Similarity=0.313  Sum_probs=189.7

Q ss_pred             CcEEEEeeeccccceEEEEEEECCC---CeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .+|.+.+.||.|+||.||+|.+...   ...||+|.....  ....+.+..|+.+++.+.     |+|++++++++.. .
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~-----h~~i~~~~~~~~~-~   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD-----HPHIVKLIGVITE-N   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCC-----CCchhceeEEEcC-C
Confidence            4689999999999999999987644   346999988643  234456778888888884     4789999988765 5


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      ..|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+|||++..+              
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~--------------  144 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD--------------  144 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC--------------
Confidence            678999999 889999997654 3689999999999999999999999999999999999996544              


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT  322 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~  322 (430)
                                   .++|+|||++.......    ....++..|+|||.+....++.++|||||||++|||++ |..||..
T Consensus       145 -------------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~  211 (270)
T cd05056         145 -------------CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG  211 (270)
T ss_pred             -------------CeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence                         45555555554322111    11234567999999988889999999999999999986 9999987


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      .+..+....+.....                                                ...+...+.++.+++.+
T Consensus       212 ~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~li~~  243 (270)
T cd05056         212 VKNNDVIGRIENGER------------------------------------------------LPMPPNCPPTLYSLMTK  243 (270)
T ss_pred             CCHHHHHHHHHcCCc------------------------------------------------CCCCCCCCHHHHHHHHH
Confidence            665554433221100                                                00123456789999999


Q ss_pred             hhhcCCCCCCCHHHHhcC
Q 014117          403 LLRYDPTDRLTAREALRH  420 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~h  420 (430)
                      ||..+|++|||+.+++..
T Consensus       244 ~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         244 CWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HcCCChhhCcCHHHHHHH
Confidence            999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.6e-38  Score=296.35  Aligned_cols=245  Identities=21%  Similarity=0.321  Sum_probs=189.4

Q ss_pred             eeeccccceEEEEEEECCCC------eEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117          100 SKMGEGTFGQVLECWDRERK------EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~------~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +.||+|+||.||+|.++...      +.+|+|.+....  .....+..|+.+++.+.     |++|+++++++...+..+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN-----HPNIVKLLGVCLLNEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcC-----CCCeeeEeeeecCCCCeE
Confidence            36899999999999886544      789999886432  33456778888888883     488999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNN-----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      +||||+ +++|.+++....     ...+++..+..++.||+.||.|||+.+|+|+||||+|||++..+.           
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~-----------  144 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGY-----------  144 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCC-----------
Confidence            999999 889999997532     234788999999999999999999999999999999999975441           


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL  319 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~P  319 (430)
                                 +....++|+|||++.......     ....++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       145 -----------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p  213 (269)
T cd05044         145 -----------DADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP  213 (269)
T ss_pred             -----------CCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCC
Confidence                       122356777777664322111     11245678999999999899999999999999999998 9999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |...+..+....+....                                                ....+...+.++.+|
T Consensus       214 ~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~~l  245 (269)
T cd05044         214 YPALNNQEVLQHVTAGG------------------------------------------------RLQKPENCPDKIYQL  245 (269)
T ss_pred             CcccCHHHHHHHHhcCC------------------------------------------------ccCCcccchHHHHHH
Confidence            98766554443322100                                                001123456778999


Q ss_pred             HHHhhhcCCCCCCCHHHHhc
Q 014117          400 LQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~  419 (430)
                      |.+||+.+|++|||++++++
T Consensus       246 i~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         246 MTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             HHHHcCCCcccCCCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1e-37  Score=290.07  Aligned_cols=238  Identities=23%  Similarity=0.338  Sum_probs=184.7

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL  177 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~  177 (430)
                      +.||+|+||.||+|... ++..||+|+++...  .....+..|+.+++.+     .|+|++++++++...+..++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQY-----DHPNIVKLIGVCTQRQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-----CCCCcCeEEEEEecCCccEEEEECC
Confidence            36899999999999865 67889999986432  2334567788888887     3478999999999999999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccC
Q 014117          178 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM  256 (430)
Q Consensus       178 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~  256 (430)
                       +++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.                      
T Consensus        75 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~----------------------  131 (250)
T cd05085          75 PGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV----------------------  131 (250)
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe----------------------
Confidence             899999987643 46899999999999999999999999999999999999965554                      


Q ss_pred             CCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHHHH
Q 014117          257 PKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAM  331 (430)
Q Consensus       257 ~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~~  331 (430)
                           +||+|||++.......    ....++..|+|||++.+..++.++|||||||++|++++ |..||...........
T Consensus       132 -----~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~  206 (250)
T cd05085         132 -----LKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ  206 (250)
T ss_pred             -----EEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence                 4555555443221111    11234567999999998889999999999999999998 9999987654433322


Q ss_pred             HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCC
Q 014117          332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR  411 (430)
Q Consensus       332 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R  411 (430)
                      +....                                                ....+...+.++.+++.+||+.+|++|
T Consensus       207 ~~~~~------------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R  238 (250)
T cd05085         207 VEKGY------------------------------------------------RMSCPQKCPDDVYKVMQRCWDYKPENR  238 (250)
T ss_pred             HHcCC------------------------------------------------CCCCCCCCCHHHHHHHHHHcccCcccC
Confidence            21100                                                001123456789999999999999999


Q ss_pred             CCHHHHhc
Q 014117          412 LTAREALR  419 (430)
Q Consensus       412 ~ta~elL~  419 (430)
                      ||+.++++
T Consensus       239 p~~~~l~~  246 (250)
T cd05085         239 PKFSELQK  246 (250)
T ss_pred             CCHHHHHH
Confidence            99999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5e-38  Score=293.39  Aligned_cols=242  Identities=22%  Similarity=0.290  Sum_probs=185.8

Q ss_pred             eeeccccceEEEEEEECCCC----------eEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117          100 SKMGEGTFGQVLECWDRERK----------EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~----------~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      +.||+|+||.||+|.+..++          ..+++|++.........+.+|+.+++.+.     |+|++.+++++.. ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLS-----HKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCC-----CcchhheeeEEec-CC
Confidence            46899999999999998776          45888887644433566777888888773     4789999998877 77


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .++||||+ +++|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++.++..             
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~-------------  140 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLN-------------  140 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccc-------------
Confidence            89999999 8899999987542 68999999999999999999999999999999999999654310             


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCC--CCCCcchHHHHHHHHHHHHh-CCCCCCCCch
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCT-GEALFQTHEN  325 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~  325 (430)
                             ......+||+|||++..... .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||...+.
T Consensus       141 -------~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~  212 (259)
T cd05037         141 -------EGYVPFIKLSDPGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS  212 (259)
T ss_pred             -------cCCceeEEeCCCCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence                   01223688888888775433 2234577889999999876  78999999999999999999 5888876432


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+...... ...                       .                          .+.....++.++|.+||+
T Consensus       213 ~~~~~~~~-~~~-----------------------~--------------------------~~~~~~~~~~~li~~~l~  242 (259)
T cd05037         213 SEKERFYQ-DQH-----------------------R--------------------------LPMPDCAELANLINQCWT  242 (259)
T ss_pred             hhHHHHHh-cCC-----------------------C--------------------------CCCCCchHHHHHHHHHhc
Confidence            22111100 000                       0                          011112578999999999


Q ss_pred             cCCCCCCCHHHHhc
Q 014117          406 YDPTDRLTAREALR  419 (430)
Q Consensus       406 ~dP~~R~ta~elL~  419 (430)
                      .||++|||+.++++
T Consensus       243 ~~p~~Rpt~~~il~  256 (259)
T cd05037         243 YDPTKRPSFRAILR  256 (259)
T ss_pred             cChhhCCCHHHHHH
Confidence            99999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-37  Score=294.55  Aligned_cols=265  Identities=22%  Similarity=0.320  Sum_probs=186.8

Q ss_pred             CcEEEEeeeccccceEEEEEE----ECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee--c
Q 014117           94 SRYKIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--Y  166 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~--~  166 (430)
                      .+|++++.||+|+||.||+|.    +..+++.||+|.+.... .....+..|++++.++.     |+|++++++++.  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~   78 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ-----HDNIVKYKGVCYSAG   78 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC-----CCCeeEEEEEEccCC
Confidence            468999999999999999997    44578899999986433 23456678999988884     478999988653  3


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      ...+++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++++|||++..
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence            45789999999 899999997643 3689999999999999999999999999999999999996655555555554433


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                      .+.....         ..            ......++..|+|||++.+..++.++|||||||++|||++|..|+.....
T Consensus       158 ~~~~~~~---------~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~  216 (284)
T cd05081         158 LPQDKEY---------YK------------VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA  216 (284)
T ss_pred             ccCCCcc---------ee------------ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch
Confidence            2211100         00            00001234569999999988899999999999999999999877654321


Q ss_pred             HHHHHHHHHHhCCCCH--HHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          326 LEHLAMMERVLGPLPQ--HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      . ..    ...+....  ......    ......+                         .....+...+.++.+|+.+|
T Consensus       217 ~-~~----~~~~~~~~~~~~~~~~----~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~c  262 (284)
T cd05081         217 E-FM----RMMGNDKQGQMIVYHL----IELLKNN-------------------------GRLPAPPGCPAEIYAIMKEC  262 (284)
T ss_pred             h-hh----hhcccccccccchHHH----HHHHhcC-------------------------CcCCCCCCCCHHHHHHHHHH
Confidence            1 11    11111000  000000    0000000                         00112345677899999999


Q ss_pred             hhcCCCCCCCHHHHhc
Q 014117          404 LRYDPTDRLTAREALR  419 (430)
Q Consensus       404 L~~dP~~R~ta~elL~  419 (430)
                      |+.+|++|||+.|++.
T Consensus       263 l~~~p~~Rpt~~ei~~  278 (284)
T cd05081         263 WNNDPSQRPSFSELAL  278 (284)
T ss_pred             ccCChhhCCCHHHHHH
Confidence            9999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=319.93  Aligned_cols=258  Identities=23%  Similarity=0.406  Sum_probs=213.8

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-----C
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-----R  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-----~  167 (430)
                      ++.|+|.+.||.|.+|.||++..+.+++..|+|+........++...|.++|+...+    |+|++.++++|-.     +
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~----hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSH----HPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccC----CCCcceEEEEEEEecCCCC
Confidence            456999999999999999999999999999999998777777888888888888754    4789999888753     5


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +.++|||||| ||+..|++....+.++.|+.+..|++.++.||.+||.+.++|||||-.|||+                 
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL-----------------  156 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL-----------------  156 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE-----------------
Confidence            7999999999 8999999987767889999999999999999999999999999999999999                 


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCC-----CCCCcchHHHHHHHHHHHHhCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                ..++.+||+|||.+......   ..+.+||+.|||||++...     .|+.++|+||||++..||.-|.+
T Consensus       157 ----------T~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~P  226 (953)
T KOG0587|consen  157 ----------TENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAP  226 (953)
T ss_pred             ----------eccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCC
Confidence                      55667888888877654433   3557899999999999643     48899999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      |+-..-.+   ..+..+...+|+.+                                           ..|...+.++.+
T Consensus       227 Pl~DmHPm---raLF~IpRNPPPkL-------------------------------------------krp~kWs~~Fnd  260 (953)
T KOG0587|consen  227 PLCDMHPM---RALFLIPRNPPPKL-------------------------------------------KRPKKWSKKFND  260 (953)
T ss_pred             CccCcchh---hhhccCCCCCCccc-------------------------------------------cchhhHHHHHHH
Confidence            99653332   22222222233221                                           223455678999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          399 LLQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      ||..||.+|-.+||+..++|+|||++...
T Consensus       261 FIs~cL~Kd~e~RP~~~~ll~hpFi~e~~  289 (953)
T KOG0587|consen  261 FISTCLVKDYEQRPSTEELLKHPFITEQP  289 (953)
T ss_pred             HHHHHHhhccccCcchhhhccCCcccccc
Confidence            99999999999999999999999998543

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.5e-37  Score=292.31  Aligned_cols=244  Identities=19%  Similarity=0.228  Sum_probs=178.3

Q ss_pred             eeeccccceEEEEEEEC--CCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117          100 SKMGEGTFGQVLECWDR--ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~--~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      +.||+|+||.||+|...  .++..+|+|.++...  .....+..|+.+++++.     |+|++++++.+.+...+++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ-----HSNLLQCLGQCTEVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCC-----CCCEeeEEEEEcCCCCcEEEEE
Confidence            36899999999999754  355679999886433  23345667888888884     4889999999999999999999


Q ss_pred             cC-CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          176 KL-GSSLYDFLRKNN---YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      |+ +++|.+++....   ....++..++.++.|++.||+|||+.||+||||||+||+++.++.+                
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~----------------  139 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTV----------------  139 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcE----------------
Confidence            99 889999997532   1245677888999999999999999999999999999999655544                


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCC-------CCCCcchHHHHHHHHHHHHh-CCC
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGL-------GWTYPCDIWSVGCILVELCT-GEA  318 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslGv~l~el~t-G~~  318 (430)
                                 +|+|||.+......     .....|+..|+|||++.+.       .++.++|+|||||++|||++ |..
T Consensus       140 -----------kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~  208 (269)
T cd05087         140 -----------KIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQ  208 (269)
T ss_pred             -----------EECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCC
Confidence                       45555544322111     1123567889999998642       36789999999999999996 999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||......+.........                      ....+.                     .......+..+.+
T Consensus       209 p~~~~~~~~~~~~~~~~~----------------------~~~~~~---------------------~~~~~~~~~~~~~  245 (269)
T cd05087         209 PYRHLSDEQVLTYTVREQ----------------------QLKLPK---------------------PRLKLPLSDRWYE  245 (269)
T ss_pred             CCCCCChHHHHHHHhhcc----------------------cCCCCC---------------------CccCCCCChHHHH
Confidence            998755544332211100                      000000                     0011234556889


Q ss_pred             HHHHhhhcCCCCCCCHHHHhc
Q 014117          399 LLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~  419 (430)
                      ++..|+ .+|++|||++||+.
T Consensus       246 l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         246 VMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             HHHHHh-cCcccCCCHHHHHH
Confidence            999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.7e-37  Score=291.83  Aligned_cols=248  Identities=20%  Similarity=0.378  Sum_probs=189.4

Q ss_pred             cEEEEeeeccccceEEEEEEECC-CCeEEEEEEecCch-----------hhHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRE-RKEMVAIKIVRGIK-----------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRN  162 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vAiK~~~~~~-----------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~  162 (430)
                      .|++.+.||.|+||.||+|.+.. +++.+|+|.+....           ........|+.++.+.    ..|+|++++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~----~~h~~i~~~~~   76 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ----LRHPNIVRYYK   76 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhc----CCCCCeeeEEe
Confidence            37889999999999999999988 67889999875211           1122344555555442    24588999999


Q ss_pred             eeecCCeEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEEeecCccccC
Q 014117          163 WFDYRNHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVP  238 (430)
Q Consensus       163 ~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl~~~~~~~i~  238 (430)
                      ++...+..++||||+ +++|.+++...  ....+++..+..++.|++.||.|||+ .||+|+||||+|||+++       
T Consensus        77 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~-------  149 (269)
T cd08528          77 TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE-------  149 (269)
T ss_pred             eEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC-------
Confidence            999999999999999 88999887542  22468999999999999999999996 78999999999999944       


Q ss_pred             CCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhC
Q 014117          239 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG  316 (430)
Q Consensus       239 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG  316 (430)
                                          ++.++|+|||.+.......  ....|+..|+|||.+.+..++.++|+|||||++|+|++|
T Consensus       150 --------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g  209 (269)
T cd08528         150 --------------------DDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTL  209 (269)
T ss_pred             --------------------CCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhC
Confidence                                4566777777665433221  234688999999999988899999999999999999999


Q ss_pred             CCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHH
Q 014117          317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL  396 (430)
Q Consensus       317 ~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (430)
                      .+||...........+......+.                                               .....+.++
T Consensus       210 ~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~l  242 (269)
T cd08528         210 QPPFYSTNMLSLATKIVEAVYEPL-----------------------------------------------PEGMYSEDV  242 (269)
T ss_pred             CCcccccCHHHHHHHHhhccCCcC-----------------------------------------------CcccCCHHH
Confidence            999976544433322221110000                                               011345679


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          397 THLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       397 ~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      .++|.+||+.||++|||+.|+..+
T Consensus       243 ~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         243 TDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HHHHHHHCCCCCccCCCHHHHHHH
Confidence            999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.6e-37  Score=290.80  Aligned_cols=239  Identities=18%  Similarity=0.228  Sum_probs=177.6

Q ss_pred             eeeccccceEEEEEEECC---CCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee-cCCeEEEE
Q 014117          100 SKMGEGTFGQVLECWDRE---RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-YRNHICIV  173 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~---~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~-~~~~~~lv  173 (430)
                      +.||+|+||.||+|.+..   .+..||+|.+...  ......+..|+.+++.+     .|++++++++.+. .++..++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~lv   75 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-----SHPNVLSLLGICLPSEGSPLVV   75 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-----CCCCcceEEEEeecCCCCcEEE
Confidence            368999999999998653   3467999988532  22345666788887776     3478999988654 56678999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      |||+ +++|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.                  
T Consensus        76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~------------------  136 (262)
T cd05058          76 LPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT------------------  136 (262)
T ss_pred             EecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc------------------
Confidence            9999 899999997654 34678888899999999999999999999999999999965554                  


Q ss_pred             cccCCCCCCeEEEeCCCccccCCC-------CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCc
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE  324 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~  324 (430)
                               +||+|||+++.....       .....++..|+|||.+.+..++.++|||||||++|||++ |.+||...+
T Consensus       137 ---------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~  207 (262)
T cd05058         137 ---------VKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD  207 (262)
T ss_pred             ---------EEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence                     455555544322110       112245778999999998899999999999999999999 567787654


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+....+...  ..                                              ...+...+..+.+++.+||
T Consensus       208 ~~~~~~~~~~~--~~----------------------------------------------~~~~~~~~~~~~~li~~cl  239 (262)
T cd05058         208 SFDITVYLLQG--RR----------------------------------------------LLQPEYCPDPLYEVMLSCW  239 (262)
T ss_pred             HHHHHHHHhcC--CC----------------------------------------------CCCCCcCCHHHHHHHHHHc
Confidence            43332221110  00                                              0011234567899999999


Q ss_pred             hcCCCCCCCHHHHhc
Q 014117          405 RYDPTDRLTAREALR  419 (430)
Q Consensus       405 ~~dP~~R~ta~elL~  419 (430)
                      +.+|++||++.+++.
T Consensus       240 ~~~p~~Rp~~~~il~  254 (262)
T cd05058         240 HPKPEMRPTFSELVS  254 (262)
T ss_pred             CCChhhCCCHHHHHH
Confidence            999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-40  Score=290.67  Aligned_cols=258  Identities=21%  Similarity=0.348  Sum_probs=200.1

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      +.+-+..||.|+||+|++-.++.+|+..|||.++...  +...++..|.+...+-    .+.++||++|+..-.++..+|
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks----~~cp~IVkfyGa~F~EGdcWi  140 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKS----SNCPNIVKFYGALFSEGDCWI  140 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhh----cCCcHHHHHhhhhhcCCceee
Confidence            4556778999999999999999999999999998544  4455666677665554    355889999999888899999


Q ss_pred             EEecCCCCHHHHH---HhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          173 VFEKLGSSLYDFL---RKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       173 v~e~~~~~L~~~l---~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .||+|.-||..+-   ..-....+++..+-.|....+.||.||-. ..||||||||+|||+                   
T Consensus       141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl-------------------  201 (361)
T KOG1006|consen  141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL-------------------  201 (361)
T ss_pred             eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE-------------------
Confidence            9999987775543   22223479999999999999999999984 679999999999999                   


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                              +..+.+||||||++......-  +.-+|...|||||.+..  ..|+.+||+||||++|||+.||..||.+.+
T Consensus       202 --------dr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~  273 (361)
T KOG1006|consen  202 --------DRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD  273 (361)
T ss_pred             --------ecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence                    566678888888876543321  33478899999999964  359999999999999999999999998754


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      +  .+.++..+...-|+.+..                 +                       ...-.++..+..+|.-||
T Consensus       274 s--vfeql~~Vv~gdpp~l~~-----------------~-----------------------~~~~~~s~~~~~fintCl  311 (361)
T KOG1006|consen  274 S--VFEQLCQVVIGDPPILLF-----------------D-----------------------KECVHYSFSMVRFINTCL  311 (361)
T ss_pred             H--HHHHHHHHHcCCCCeecC-----------------c-----------------------ccccccCHHHHHHHHHHh
Confidence            3  344444333333322110                 0                       001235677999999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~  425 (430)
                      .+|-++||...+++.+||++.
T Consensus       312 ~Kd~~~Rpky~~Lk~~~fyr~  332 (361)
T KOG1006|consen  312 IKDRSDRPKYDDLKKFPFYRM  332 (361)
T ss_pred             hcccccCcchhhhhcCchhhh
Confidence            999999999999999999864

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.9e-37  Score=297.01  Aligned_cols=245  Identities=22%  Similarity=0.267  Sum_probs=185.8

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCe----EEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKE----MVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      ++|++.+.||+|+||.||+|.+..++.    .||+|++....  .....+..|+.+++.+     .|+|++++++++.. 
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-----~h~niv~~~~~~~~-   80 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-----DHPHLVRLLGVCLS-   80 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCcccEEEEEcC-
Confidence            468999999999999999999877775    47889876432  2233566788888877     34889999998765 


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      ...++|+||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++             
T Consensus        81 ~~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~-------------  146 (303)
T cd05110          81 PTIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN-------------  146 (303)
T ss_pred             CCceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC-------------
Confidence            4567899999 889999987653 3689999999999999999999999999999999999995544             


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF  320 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf  320 (430)
                                    .+||+|||+++......     ....++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus       147 --------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~  212 (303)
T cd05110         147 --------------HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY  212 (303)
T ss_pred             --------------ceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence                          45556666554322111     11235678999999999899999999999999999997 99999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .+....+....+.. ...++                                               .+...+.++.+++
T Consensus       213 ~~~~~~~~~~~~~~-~~~~~-----------------------------------------------~~~~~~~~~~~li  244 (303)
T cd05110         213 DGIPTREIPDLLEK-GERLP-----------------------------------------------QPPICTIDVYMVM  244 (303)
T ss_pred             CCCCHHHHHHHHHC-CCCCC-----------------------------------------------CCCCCCHHHHHHH
Confidence            76543332221110 00000                                               1123455789999


Q ss_pred             HHhhhcCCCCCCCHHHHhcC
Q 014117          401 QGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~h  420 (430)
                      .+||..||++||+++++++.
T Consensus       245 ~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         245 VKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHcCCChhhCcCHHHHHHH
Confidence            99999999999999998764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.9e-37  Score=308.89  Aligned_cols=271  Identities=21%  Similarity=0.366  Sum_probs=184.5

Q ss_pred             cCcEEEEeeeccccceEEEEEEEC----------------CCCeEEEEEEecCchh-h--------------HHHHHHHH
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDR----------------ERKEMVAIKIVRGIKK-Y--------------REAAMIEI  141 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~----------------~~~~~vAiK~~~~~~~-~--------------~~~~~~E~  141 (430)
                      .++|++.++||+|+||.||+|.+.                ..++.||||.++.... .              .+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            468999999999999999999752                2346799999863221 1              12233466


Q ss_pred             HHHHHHHhcCCCCCceEEecceeec--------CCeEEEEEecC-CCCHHHHHHhcCC----------------------
Q 014117          142 EVLQQLAKHDKGGNRCVQIRNWFDY--------RNHICIVFEKL-GSSLYDFLRKNNY----------------------  190 (430)
Q Consensus       142 ~~l~~l~~~~~~~~~i~~~~~~~~~--------~~~~~lv~e~~-~~~L~~~l~~~~~----------------------  190 (430)
                      ..+.++.++.....+++.+++++..        .+..+|||||+ +++|.++++....                      
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            6777776655555667777776643        35789999999 8899998874211                      


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCc
Q 014117          191 RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST  270 (430)
Q Consensus       191 ~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a  270 (430)
                      ..+++..++.++.|++.||.|||+.+|+||||||+|||++                           .+..+||+|||++
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~---------------------------~~~~~kL~DFGla  356 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT---------------------------VDGQVKIIDFGAA  356 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC---------------------------CCCcEEEEeCcCc
Confidence            1345678889999999999999999999999999999994                           4456777777776


Q ss_pred             cccCCCC--C--eeeecCcccchhhhhCCC--------------------CC--CcchHHHHHHHHHHHHhCCC-CCCCC
Q 014117          271 TYERPDQ--N--YIVSTRHYRAPEVILGLG--------------------WT--YPCDIWSVGCILVELCTGEA-LFQTH  323 (430)
Q Consensus       271 ~~~~~~~--~--~~~gt~~y~aPE~~~~~~--------------------~~--~~~DvwslGv~l~el~tG~~-Pf~~~  323 (430)
                      .......  .  ...+|+.|+|||.+....                    |+  .+.||||+||++|+|++|.. ||...
T Consensus       357 ~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~  436 (507)
T PLN03224        357 VDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANI  436 (507)
T ss_pred             cccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccch
Confidence            5432211  1  123488999999986432                    22  34799999999999999875 77543


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      ......  +.. ....    ..    ..+. .....+.                        ....+..+...+||+.+|
T Consensus       437 ~~f~~~--~~~-~~~~----~~----~~r~-~~~~~~~------------------------~~~~d~~s~~~~dLi~~L  480 (507)
T PLN03224        437 RLFNTE--LRQ-YDND----LN----RWRM-YKGQKYD------------------------FSLLDRNKEAGWDLACKL  480 (507)
T ss_pred             hhhhhH--Hhh-ccch----HH----HHHh-hcccCCC------------------------cccccccChHHHHHHHHH
Confidence            221110  000 0000    00    0000 0000111                        112345677899999999


Q ss_pred             hhcCC---CCCCCHHHHhcCCCCCCC
Q 014117          404 LRYDP---TDRLTAREALRHPFFTRD  426 (430)
Q Consensus       404 L~~dP---~~R~ta~elL~hp~f~~~  426 (430)
                      |..+|   .+|+|++|+|+||||..+
T Consensus       481 L~~~~~~~~~RlSa~eaL~Hp~f~~~  506 (507)
T PLN03224        481 ITKRDQANRGRLSVGQALSHRFFLPE  506 (507)
T ss_pred             hccCCCCcccCCCHHHHhCCCCcCCC
Confidence            99876   689999999999999764

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.7e-38  Score=326.79  Aligned_cols=273  Identities=24%  Similarity=0.344  Sum_probs=192.9

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---  166 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~---  166 (430)
                      ..++|+.+..||+||||.||+|+++-+|+.||||.|.-.  ........+|+..|.++.|     +|+|+++..+.+   
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnH-----pNVVRYysAWVEs~~  551 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNH-----PNVVRYYSAWVESTA  551 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCC-----cceeeeehhhhccCC
Confidence            345688999999999999999999999999999998744  4445667789999999955     444433221100   


Q ss_pred             --------------------------------------------------------------------------------
Q 014117          167 --------------------------------------------------------------------------------  166 (430)
Q Consensus       167 --------------------------------------------------------------------------------  166 (430)
                                                                                                      
T Consensus       552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S  631 (1351)
T KOG1035|consen  552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS  631 (1351)
T ss_pred             ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------C--------CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Q 014117          167 ----------------------------R--------NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI  209 (430)
Q Consensus       167 ----------------------------~--------~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL  209 (430)
                                                  +        -.+||-|||| ...|.++++.+. ..-....++++++||+.||
T Consensus       632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~-~~~~~d~~wrLFreIlEGL  710 (1351)
T KOG1035|consen  632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH-FNSQRDEAWRLFREILEGL  710 (1351)
T ss_pred             cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc-cchhhHHHHHHHHHHHHHH
Confidence                                        0        2478899999 445556665543 1114778899999999999


Q ss_pred             HHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCC-CCCeeeecCcccc
Q 014117          210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRA  288 (430)
Q Consensus       210 ~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~a  288 (430)
                      .|+|++|||||||||.||++++++.+||.|||+|.-.....       ........+.+.-.-... ..+..+||.-|+|
T Consensus       711 aYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~-------~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA  783 (1351)
T KOG1035|consen  711 AYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENL-------ESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA  783 (1351)
T ss_pred             HHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhh-------hhHhhccCccccccCCCCcccccccceeeeec
Confidence            99999999999999999999988888888888775421100       011111222222111111 2345699999999


Q ss_pred             hhhhhCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCC
Q 014117          289 PEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEG  365 (430)
Q Consensus       289 PE~~~~~~---~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  365 (430)
                      ||++.+..   |+.|+||||||+|++||+   .||.  +.++-...+....                    +|.++.+  
T Consensus       784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~--TsMERa~iL~~LR--------------------~g~iP~~--  836 (1351)
T KOG1035|consen  784 PELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFG--TSMERASILTNLR--------------------KGSIPEP--  836 (1351)
T ss_pred             HHHhcccccccccchhhhHHHHHHHHHHh---ccCC--chHHHHHHHHhcc--------------------cCCCCCC--
Confidence            99998765   999999999999999997   5676  3444333322211                    1111111  


Q ss_pred             CCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCC
Q 014117          366 AASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~  424 (430)
                                          ..++.+.-+.-..+|+.||+.||.+||||.|+|++.||-
T Consensus       837 --------------------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  837 --------------------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             --------------------cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence                                112334445567899999999999999999999999997

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=324.47  Aligned_cols=247  Identities=22%  Similarity=0.335  Sum_probs=204.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCC-----eEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERK-----EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      ..+..+.+.||+|+||.||.|......     ..||+|.+++.  ......+..|..+|..+     +|+||+.+++.+-
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-----~HpNiv~liGv~l  765 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-----DHPNIVSLIGVCL  765 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-----CCcceeeEEEeec
Confidence            346788899999999999999876543     34999998754  45667889999999998     5589999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNN-----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD  239 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~d  239 (430)
                      .....+|++||| ||+|..||++..     ...++..+...++.||++|++||+++.+|||||..+|+|++         
T Consensus       766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~---------  836 (1025)
T KOG1095|consen  766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD---------  836 (1025)
T ss_pred             CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec---------
Confidence            999999999999 999999999761     24689999999999999999999999999999999999994         


Q ss_pred             CcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCee-----eecCcccchhhhhCCCCCCcchHHHHHHHHHHHH
Q 014117          240 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI-----VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC  314 (430)
Q Consensus       240 fg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~  314 (430)
                                        ....+||+|||+|+.......+.     .-...|||||.+....++.++|||||||+|||++
T Consensus       837 ------------------~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEif  898 (1025)
T KOG1095|consen  837 ------------------ERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIF  898 (1025)
T ss_pred             ------------------ccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHH
Confidence                              44667777777777433322221     2256899999999999999999999999999999


Q ss_pred             h-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCch
Q 014117          315 T-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA  393 (430)
Q Consensus       315 t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (430)
                      | |..||.+.++.+.+..+..                      .|.++                          .|..++
T Consensus       899 slG~~PY~~~~n~~v~~~~~~----------------------ggRL~--------------------------~P~~CP  930 (1025)
T KOG1095|consen  899 SLGATPYPSRSNFEVLLDVLE----------------------GGRLD--------------------------PPSYCP  930 (1025)
T ss_pred             hCCCCCCCCcchHHHHHHHHh----------------------CCccC--------------------------CCCCCC
Confidence            9 9999999888777654432                      12222                          345677


Q ss_pred             hHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          394 GDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       394 ~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      ..+.++|..||+-+|++||++..|++
T Consensus       931 ~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  931 EKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             hHHHHHHHHHccCChhhCccHHHHHh
Confidence            88999999999999999999999886

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.7e-37  Score=291.52  Aligned_cols=259  Identities=23%  Similarity=0.334  Sum_probs=190.0

Q ss_pred             CcEEEEeeeccccceEEEEEEEC----CCCeEEEEEEecCchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDR----ERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-  166 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-  166 (430)
                      ..|++.+.||+|+||.||+|...    .+++.||+|+++....  ....+..|+++++.+.     +++++++++++.. 
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~-----~~~i~~~~~~~~~~   78 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD-----HENIVKYKGVCEKP   78 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCC-----CCChheEEeeeecC
Confidence            35788899999999999999864    3478999999875444  3566788898888874     3789999888876 


Q ss_pred             -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          167 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       167 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                       ....++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.+            
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~------------  145 (284)
T cd05038          79 GGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE------------  145 (284)
T ss_pred             CCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC------------
Confidence             66899999999 889999997654 359999999999999999999999999999999999999544            


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCCC------eeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                     +.++|+|||.+........      ...++..|+|||.+.+..++.++|+|||||++|||++|..
T Consensus       146 ---------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~  210 (284)
T cd05038         146 ---------------DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGD  210 (284)
T ss_pred             ---------------CCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCC
Confidence                           4556666665554332111      1134567999999998899999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCH-HHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQ-HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      ||.......     ....+.... .....+.    .....+ .                        ....+...+.++.
T Consensus       211 p~~~~~~~~-----~~~~~~~~~~~~~~~~~----~~~~~~-~------------------------~~~~~~~~~~~~~  256 (284)
T cd05038         211 PSQSPPAEF-----LRMIGIAQGQMIVTRLL----ELLKEG-E------------------------RLPRPPSCPDEVY  256 (284)
T ss_pred             Ccccccchh-----ccccccccccccHHHHH----HHHHcC-C------------------------cCCCCccCCHHHH
Confidence            986532211     001111000 0000000    000000 0                        0011234456799


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhc
Q 014117          398 HLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      +|+.+||+.||++|||+.|+++
T Consensus       257 ~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         257 DLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHHhccChhhCCCHHHHHH
Confidence            9999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.1e-37  Score=287.06  Aligned_cols=243  Identities=21%  Similarity=0.224  Sum_probs=177.6

Q ss_pred             eeccccceEEEEEEECCC--CeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEec
Q 014117          101 KMGEGTFGQVLECWDRER--KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK  176 (430)
Q Consensus       101 ~lG~G~~g~V~~~~~~~~--~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~  176 (430)
                      .||+|+||.||+|.....  ...+++|.++...  .....+..|+.+++.+     .|+|++++++.+......|+||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-----~h~~iv~~~~~~~~~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-----QHPNILQCLGQCVEAIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-----CCcchhheEEEecCCCccEEEEec
Confidence            589999999999975433  3356777765332  3445677788887776     448899999999999999999999


Q ss_pred             C-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          177 L-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       177 ~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      + +++|.+++.+..  ...+++..+..++.||+.||+|||+.+|+||||||+|||++.++.                   
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~-------------------  137 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT-------------------  137 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc-------------------
Confidence            9 889999997642  234677788899999999999999999999999999999965544                   


Q ss_pred             ccCCCCCCeEEEeCCCccccCC-----CCCeeeecCcccchhhhhC-------CCCCCcchHHHHHHHHHHHHh-CCCCC
Q 014117          254 KRMPKSSAIKVIDFGSTTYERP-----DQNYIVSTRHYRAPEVILG-------LGWTYPCDIWSVGCILVELCT-GEALF  320 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGv~l~el~t-G~~Pf  320 (430)
                              ++|+|||++.....     .....+|+..|+|||++..       ..++.++|||||||++|||++ |.+||
T Consensus       138 --------~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~  209 (268)
T cd05086         138 --------VKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY  209 (268)
T ss_pred             --------EEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Confidence                    55555555432111     1123467889999999853       246789999999999999997 57899


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      ...++.+....+......                      ..+.                     .......+..+.+++
T Consensus       210 ~~~~~~~~~~~~~~~~~~----------------------~~~~---------------------~~~~~~~~~~~~~l~  246 (268)
T cd05086         210 SHLSDREVLNHVIKDQQV----------------------KLFK---------------------PQLELPYSERWYEVL  246 (268)
T ss_pred             CCCCHHHHHHHHHhhccc----------------------ccCC---------------------CccCCCCcHHHHHHH
Confidence            876665544433211100                      0000                     011223556788999


Q ss_pred             HHhhhcCCCCCCCHHHHhc
Q 014117          401 QGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~  419 (430)
                      ..|| .+|++|||++++++
T Consensus       247 ~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         247 QFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             HHHh-hCcccCCCHHHHHH
Confidence            9999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7.7e-37  Score=287.92  Aligned_cols=245  Identities=18%  Similarity=0.248  Sum_probs=183.7

Q ss_pred             EEEEeeeccccceEEEEEEECC---CCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC-
Q 014117           96 YKIHSKMGEGTFGQVLECWDRE---RKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-  168 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~---~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~-  168 (430)
                      |.+.+.||+|+||.||+|..+.   +++.||+|++...   ....+.+..|+.+++++.     |++++++++++.... 
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~   75 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD-----HPNVIKLIGVSLRSRA   75 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCC-----CCCcceEEEEEccCCC
Confidence            5678899999999999998653   5789999998643   223445677888888883     478999998775432 


Q ss_pred             -----eEEEEEecC-CCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccC
Q 014117          169 -----HICIVFEKL-GSSLYDFLRKNN----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP  238 (430)
Q Consensus       169 -----~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~  238 (430)
                           ..++++||+ +++|.+++....    ...++...+..++.||+.||+|||+.||+||||||+||++++++     
T Consensus        76 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~-----  150 (273)
T cd05074          76 KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-----  150 (273)
T ss_pred             CCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC-----
Confidence                 357889998 889988875321    12578999999999999999999999999999999999995544     


Q ss_pred             CCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHH
Q 014117          239 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL  313 (430)
Q Consensus       239 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el  313 (430)
                                            .+||+|||+++......     ....+++.|++||.+.+..++.++|||||||++|+|
T Consensus       151 ----------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el  208 (273)
T cd05074         151 ----------------------TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEI  208 (273)
T ss_pred             ----------------------CEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHH
Confidence                                  45555665554322111     122456789999999998999999999999999999


Q ss_pred             Hh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCc
Q 014117          314 CT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS  392 (430)
Q Consensus       314 ~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (430)
                      ++ |.+||.+.+..+....+... .                     ..                          ..+...
T Consensus       209 ~~~g~~p~~~~~~~~~~~~~~~~-~---------------------~~--------------------------~~~~~~  240 (273)
T cd05074         209 MTRGQTPYAGVENSEIYNYLIKG-N---------------------RL--------------------------KQPPDC  240 (273)
T ss_pred             hhCCCCCCCCCCHHHHHHHHHcC-C---------------------cC--------------------------CCCCCC
Confidence            99 89999865544333222110 0                     00                          011234


Q ss_pred             hhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          393 AGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       393 ~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      +..+.+++.+||+.+|++|||+.+++.+
T Consensus       241 ~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         241 LEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5679999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-37  Score=294.61  Aligned_cols=260  Identities=23%  Similarity=0.339  Sum_probs=210.1

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      +-..+...++++||+|-||.|.+|... .+..||+|+++..  +..+..+..|+++|.+++|     |||+.+++.|...
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkh-----PNIveLvGVC~~D  607 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKH-----PNIVELLGVCVQD  607 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCC-----CCeeEEEeeeecC
Confidence            334567899999999999999999754 4688999999743  3455789999999999944     8999999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +.+|+++||+ .|+|.+|+..+....+.......|+.||+.|++||.+.++|||||.+.|||+                 
T Consensus       608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv-----------------  670 (807)
T KOG1094|consen  608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV-----------------  670 (807)
T ss_pred             CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee-----------------
Confidence            9999999999 9999999998753344455566799999999999999999999999999999                 


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCCCe-----eeecCcccchhhhhCCCCCCcchHHHHHHHHHHHH--hCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY-----IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC--TGEAL  319 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~--tG~~P  319 (430)
                                +.+.++||+|||.++....++.+     .+-+..|||||.+...+++.++|+|+||+++||++  +...|
T Consensus       671 ----------~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~P  740 (807)
T KOG1094|consen  671 ----------DGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQP  740 (807)
T ss_pred             ----------cCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCc
Confidence                      56667777777777754444422     34578999999999999999999999999999986  58899


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |...++.+........+...+..                                         .....|..++..+.+|
T Consensus       741 y~~lt~e~vven~~~~~~~~~~~-----------------------------------------~~l~~P~~cp~~lyel  779 (807)
T KOG1094|consen  741 YSQLTDEQVVENAGEFFRDQGRQ-----------------------------------------VVLSRPPACPQGLYEL  779 (807)
T ss_pred             hhhhhHHHHHHhhhhhcCCCCcc-----------------------------------------eeccCCCcCcHHHHHH
Confidence            99887777665544443332211                                         1223467788889999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          400 LQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      +..||.+|-.+|||.+++  |-+|++
T Consensus       780 ml~Cw~~es~~RPsFe~l--h~~lq~  803 (807)
T KOG1094|consen  780 MLRCWRRESEQRPSFEQL--HLFLQE  803 (807)
T ss_pred             HHHHhchhhhcCCCHHHH--HHHHHH
Confidence            999999999999999998  445543

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=297.77  Aligned_cols=245  Identities=22%  Similarity=0.342  Sum_probs=211.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      ..+..+.++||-|-||.||.|++++-.-.||||.++......++++.|..+|+.+.     |+|+|++++.|..+..+||
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeik-----HpNLVqLLGVCT~EpPFYI  340 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-----HPNLVQLLGVCTHEPPFYI  340 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhc-----CccHHHHhhhhccCCCeEE
Confidence            34566778999999999999999998899999999988788899999999999994     4889999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      |.||| .|+|.+||+..++.-++....+.++.||.+|++||..+++|||||-..|+|+                      
T Consensus       341 iTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV----------------------  398 (1157)
T KOG4278|consen  341 ITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV----------------------  398 (1157)
T ss_pred             EEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc----------------------
Confidence            99999 9999999999887788999999999999999999999999999999999999                      


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCCCe-eee---cCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQNY-IVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL  326 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-~~g---t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~  326 (430)
                           .++..+|++|||+++....+..+ ..|   ..-|.|||-+....++.++|||+|||+|||+.| |..||.+.+-.
T Consensus       399 -----gEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS  473 (1157)
T KOG4278|consen  399 -----GENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  473 (1157)
T ss_pred             -----cccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH
Confidence                 56667888888888765544322 122   667999999999999999999999999999998 99999986654


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +.+..+.+                                                .+.++.+..+++.+.+|++.||++
T Consensus       474 qVY~LLEk------------------------------------------------gyRM~~PeGCPpkVYeLMraCW~W  505 (1157)
T KOG4278|consen  474 QVYGLLEK------------------------------------------------GYRMDGPEGCPPKVYELMRACWNW  505 (1157)
T ss_pred             HHHHHHhc------------------------------------------------cccccCCCCCCHHHHHHHHHHhcC
Confidence            44433221                                                234456778899999999999999


Q ss_pred             CCCCCCCHHHH
Q 014117          407 DPTDRLTAREA  417 (430)
Q Consensus       407 dP~~R~ta~el  417 (430)
                      +|.+||+.+|+
T Consensus       506 sPsDRPsFaei  516 (1157)
T KOG4278|consen  506 SPSDRPSFAEI  516 (1157)
T ss_pred             CcccCccHHHH
Confidence            99999998876

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=9.7e-38  Score=291.79  Aligned_cols=325  Identities=23%  Similarity=0.368  Sum_probs=222.1

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECC---CCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRE---RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .+.+.|.++++||.|.|++||+|.+..   ..+.||+|.+.... .......|++.|..+..    ..||+.+.+++..+
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG----~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGG----SDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhcc----chhhhcchhhhccC
Confidence            345679999999999999999999987   78899999986433 34568889999999854    46799999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeec-CccccCCCcCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS-EYIKVPDYKSSLH  245 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~-~~~~i~dfg~~~~  245 (430)
                      +..++||||+ .....++..     .++...++.|++.++.||.++|.+|||||||||+|+|.+.. +.-.+.|||+|-.
T Consensus       108 d~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             CeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence            9999999999 556666664     46788999999999999999999999999999999999764 6778899999862


Q ss_pred             CCCCC-ccc-------ccCC-CCCCeEEEeCC-------Ccc--ccC-C-CCCeeeecCcccchhhhhCCC-CCCcchHH
Q 014117          246 TPKDS-SYF-------KRMP-KSSAIKVIDFG-------STT--YER-P-DQNYIVSTRHYRAPEVILGLG-WTYPCDIW  304 (430)
Q Consensus       246 ~~~~~-~~~-------~~~~-~~~~~kl~Dfg-------~a~--~~~-~-~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvw  304 (430)
                      ..... ...       .... ....+--..+-       ..+  ... + ......||++|.|||++...+ .+.++|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            11100 000       0000 00000000000       000  000 0 011247999999999998764 78999999


Q ss_pred             HHHHHHHHHHhCCCCC-CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhh-cC---c-
Q 014117          305 SVGCILVELCTGEALF-QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV-MK---L-  378 (430)
Q Consensus       305 slGv~l~el~tG~~Pf-~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~-  378 (430)
                      |.|||+.-++++..|| ...++.+.+.+|...+|...-.-.+..-.. .-+++.  .+.+........+..+ +.   - 
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~-~~l~~k--sn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGR-ILLWQK--SNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCc-eeeecc--ccccccHHHHhchhccChhhcccc
Confidence            9999999999999998 456677788888888886442221111111 001110  0011111111111111 00   0 


Q ss_pred             hhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCCC
Q 014117          379 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      ....-......+..+..+.+|+.+||..||.+|.||+++|.||||+..+.
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence            00001223445677778999999999999999999999999999986543

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=295.58  Aligned_cols=261  Identities=25%  Similarity=0.454  Sum_probs=202.5

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh--------hHHHHHHHHHHHHHHHhcCCCCCceEEec
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--------YREAAMIEIEVLQQLAKHDKGGNRCVQIR  161 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~  161 (430)
                      ..+.++|-++..||+|||+.||+|+|...++.||+|+-.-++.        ..+-..+|..|.+.|     .|+.||++|
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-----DHpRIVKlY  533 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-----DHPRIVKLY  533 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-----Ccceeeeee
Confidence            4566789999999999999999999999999999998532222        223345566666666     568899999


Q ss_pred             ceee-cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeccCCCCceEEeecCcccc
Q 014117          162 NWFD-YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKV  237 (430)
Q Consensus       162 ~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlKp~NILl~~~~~~~i  237 (430)
                      ++|. +.+.+|-|+||| |.+|.-||.++.  .+++.+++.|+.||+.||.||.+..  |||-||||.|||+.+.     
T Consensus       534 DyfslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~G-----  606 (775)
T KOG1151|consen  534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNG-----  606 (775)
T ss_pred             eeeeeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecC-----
Confidence            9996 467899999999 889988888764  8999999999999999999999765  9999999999999653     


Q ss_pred             CCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC----------CeeeecCcccchhhhhCC----CCCCcchH
Q 014117          238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGL----GWTYPCDI  303 (430)
Q Consensus       238 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~----~~~~~~Dv  303 (430)
                                         ...+.+||+|||++++...+.          ....||.+|++||.+.-.    ..+.++||
T Consensus       607 -------------------tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDV  667 (775)
T KOG1151|consen  607 -------------------TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDV  667 (775)
T ss_pred             -------------------cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceee
Confidence                               456778888888887654332          235799999999987633    37899999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCch-HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHH
Q 014117          304 WSVGCILVELCTGEALFQTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ  382 (430)
Q Consensus       304 wslGv~l~el~tG~~Pf~~~~~-~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (430)
                      ||+|||+|..+.|+-||...-. .+.+.. -.++                   +.....+|.                  
T Consensus       668 WSvGVIFyQClYGrKPFGhnqsQQdILqe-NTIl-------------------kAtEVqFP~------------------  709 (775)
T KOG1151|consen  668 WSVGVIFYQCLYGRKPFGHNQSQQDILQE-NTIL-------------------KATEVQFPP------------------  709 (775)
T ss_pred             EeeehhhhhhhccCCCCCCchhHHHHHhh-hchh-------------------cceeccCCC------------------
Confidence            9999999999999999975322 221111 0000                   000111111                  


Q ss_pred             HHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       383 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                            -+..+.++++||+.||++.-++|....++-.||||.-
T Consensus       710 ------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  710 ------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             ------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence                  1456788999999999999999999999999999975

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=301.34  Aligned_cols=246  Identities=23%  Similarity=0.345  Sum_probs=212.2

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCe---EEEEEEecC--chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vAiK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      +...|.+.||.|.||.|++|+.+..++   .||||.++.  ..+.+..|+.|+.||.++.     ||||+.+.+......
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd-----HPNIIrLEGVVTks~  703 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD-----HPNIIRLEGVVTKSK  703 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC-----CCcEEEEEEEEecCc
Confidence            456888999999999999999987664   699999983  4566778999999999994     489999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+.||.||| .|+|..||+++.+ .|+..+...+++.|+.|++||-++|+|||||...|||+                  
T Consensus       704 PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV------------------  764 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV------------------  764 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee------------------
Confidence            999999999 9999999999885 49999999999999999999999999999999999999                  


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCCCe----eee--cCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY----IVS--TRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF  320 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~----~~g--t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf  320 (430)
                               +.+..+|++|||+++....+...    .-|  +..|.|||.+....++.+|||||+|++|||.++ |+-||
T Consensus       765 ---------NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY  835 (996)
T KOG0196|consen  765 ---------NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY  835 (996)
T ss_pred             ---------ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence                     55677777788877755433311    112  568999999999999999999999999999987 99999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      -..++.+.++.|.+...-+|                                                |.+++..+..|+
T Consensus       836 WdmSNQdVIkaIe~gyRLPp------------------------------------------------PmDCP~aL~qLM  867 (996)
T KOG0196|consen  836 WDMSNQDVIKAIEQGYRLPP------------------------------------------------PMDCPAALYQLM  867 (996)
T ss_pred             cccchHHHHHHHHhccCCCC------------------------------------------------CCCCcHHHHHHH
Confidence            99899888888876554443                                                357788899999


Q ss_pred             HHhhhcCCCCCCCHHHHhcC
Q 014117          401 QGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~h  420 (430)
                      ..||++|-.+||+.+||+.+
T Consensus       868 ldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  868 LDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHhhcCCCHHHHHHH
Confidence            99999999999999998753

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=304.34  Aligned_cols=253  Identities=23%  Similarity=0.292  Sum_probs=190.1

Q ss_pred             EEEEeeeccccceE-EEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117           96 YKIHSKMGEGTFGQ-VLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus        96 y~~~~~lG~G~~g~-V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      |.-.+.+|.|+-|+ ||+|..  .++.||||.+-  ......+.+|+..|+.-.    .|+||++.++.-.+..++||+.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll--~e~~~~A~rEi~lL~eSD----~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLL--EEFFDFAQREIQLLQESD----EHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHh--hHhHHHHHHHHHHHHhcc----CCCceEEEEeeccCCceEEEEe
Confidence            33446789999887 599976  57799999874  334455677888877763    4589999999999999999999


Q ss_pred             ecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          175 EKLGSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       175 e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      |+|..+|.++++..+  .........+.+..|++.||++||+.+||||||||.||||+...                   
T Consensus       583 ELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~-------------------  643 (903)
T KOG1027|consen  583 ELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS-------------------  643 (903)
T ss_pred             hHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC-------------------
Confidence            999999999998741  11122245678899999999999999999999999999997531                   


Q ss_pred             cccCCCCCCeEEEeCCCccccCCCCC------eeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCch
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG-EALFQTHEN  325 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG-~~Pf~~~~~  325 (430)
                         .+....++|+|||+++....+.+      ...||-+|+|||++....-..++|||||||++|+.++| ..||...  
T Consensus       644 ---~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--  718 (903)
T KOG1027|consen  644 ---ADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--  718 (903)
T ss_pred             ---CCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--
Confidence               03456778888888776554442      24789999999999998888999999999999999985 8999742  


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+.-..|....                       +.             +.   .       ..+....++.|||.+||.
T Consensus       719 ~~R~~NIl~~~-----------------------~~-------------L~---~-------L~~~~d~eA~dLI~~ml~  752 (903)
T KOG1027|consen  719 LERQANILTGN-----------------------YT-------------LV---H-------LEPLPDCEAKDLISRMLN  752 (903)
T ss_pred             HHhhhhhhcCc-----------------------cc-------------ee---e-------eccCchHHHHHHHHHhcC
Confidence            22112221100                       00             00   0       001111178999999999


Q ss_pred             cCCCCCCCHHHHhcCCCCCCC
Q 014117          406 YDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f~~~  426 (430)
                      .||..||+|.+||.||||=..
T Consensus       753 ~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  753 PDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             CCcccCCCHHHHhCCCccCCh
Confidence            999999999999999999543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=9.7e-35  Score=267.27  Aligned_cols=238  Identities=37%  Similarity=0.608  Sum_probs=188.6

Q ss_pred             cceEEEEEEECCCCeEEEEEEecCchhh--HHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-CCCHH
Q 014117          106 TFGQVLECWDRERKEMVAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLY  182 (430)
Q Consensus       106 ~~g~V~~~~~~~~~~~vAiK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~  182 (430)
                      +||.||+|.+..+++.+|+|++......  ...+..|++.++++     .+++++++++++......++++|++ +++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-----KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-----CCCcHHHHHhheeeCCEEEEEEeCCCCCCHH
Confidence            5899999999988999999998743321  46777888888888     4478999999999889999999999 55999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCe
Q 014117          183 DFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI  262 (430)
Q Consensus       183 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~  262 (430)
                      +++....  .+++..+..++.+++.+|.|||+.+|+|+||+|+||+++.                           ++.+
T Consensus        76 ~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~---------------------------~~~~  126 (244)
T smart00220       76 DLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDE---------------------------DGHV  126 (244)
T ss_pred             HHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECC---------------------------CCcE
Confidence            9997754  3899999999999999999999999999999999999954                           4566


Q ss_pred             EEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHHHhCCC
Q 014117          263 KVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL-AMMERVLGPL  339 (430)
Q Consensus       263 kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~-~~i~~~~g~~  339 (430)
                      +|+|||.+......  .....++..|++||.+.+..++.++|+||||+++|+|++|..||....+.+.. ..+...... 
T Consensus       127 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-  205 (244)
T smart00220      127 KLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP-  205 (244)
T ss_pred             EEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC-
Confidence            77777766544332  23346788999999999888999999999999999999999999763332222 211110000 


Q ss_pred             CHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          340 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       340 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                                            ...                       .....+.++.+++.+||..||++||++.++++
T Consensus       206 ----------------------~~~-----------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      206 ----------------------FPP-----------------------PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ----------------------Ccc-----------------------ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence                                  000                       00115567999999999999999999999999


Q ss_pred             CCCC
Q 014117          420 HPFF  423 (430)
Q Consensus       420 hp~f  423 (430)
                      ||||
T Consensus       241 ~~~~  244 (244)
T smart00220      241 HPFF  244 (244)
T ss_pred             CCCC
Confidence            9997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=283.28  Aligned_cols=198  Identities=28%  Similarity=0.484  Sum_probs=175.1

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHH---------HHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA---------MIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~---------~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      ..|..++.+|.|+||.|++|.++.+...|+||.+.+.+-....+         -.|++||..+..|  .|+||++++++|
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~--sH~NIlKlLdfF  638 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKH--SHENILKLLDFF  638 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhc--Cccchhhhhhee
Confidence            45999999999999999999999999999999987654333222         2499999999765  469999999999


Q ss_pred             ecCCeEEEEEecC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          165 DYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       165 ~~~~~~~lv~e~~--~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                      ++.+++||+||.-  |-+|+++++...  .+++.++..|++||+.|+++||++||||||||-+||.+             
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv-------------  703 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV-------------  703 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEE-------------
Confidence            9999999999988  569999998875  89999999999999999999999999999999999999             


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-CeeeecCcccchhhhhCCCC-CCcchHHHHHHHHHHHHhCCCCC
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                    +.++-+||+|||.|.....+. ..++||..|.|||++.|..| +..-|||++|++||.++....||
T Consensus       704 --------------d~~g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  704 --------------DSNGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             --------------ecCCeEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence                          566789999999988766554 56899999999999999987 57789999999999999999999


Q ss_pred             CC
Q 014117          321 QT  322 (430)
Q Consensus       321 ~~  322 (430)
                      ..
T Consensus       770 yn  771 (772)
T KOG1152|consen  770 YN  771 (772)
T ss_pred             cC
Confidence            64

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-35  Score=284.43  Aligned_cols=241  Identities=22%  Similarity=0.357  Sum_probs=192.1

Q ss_pred             EEEEeeeccccceEEEEEEECCC----CeEEEEEEecC--chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           96 YKIHSKMGEGTFGQVLECWDRER----KEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~----~~~vAiK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ..+.+.||.|-||.||+|....-    .-.||||..+.  .....+.++.|..+++.+     .||||+++++.+.+ ..
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-----dHphIikLIGv~~e-~P  464 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-----DHPHIIKLIGVCVE-QP  464 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-----CCcchhheeeeeec-cc
Confidence            34456899999999999987533    34599998874  334567899999999999     44899999998864 67


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .+||||++ -|.|..||+.+. ..|+......++.||+.||.|||+.++|||||...|||+.+...              
T Consensus       465 ~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--------------  529 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC--------------  529 (974)
T ss_pred             eeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce--------------
Confidence            89999999 899999998765 47999999999999999999999999999999999999976555              


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCCCe----eeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNY----IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH  323 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~----~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~  323 (430)
                                   +||+|||+++....+..+    ..-+.-|||||.+.-.+++.++|||-|||+|||+++ |..||.+-
T Consensus       530 -------------VKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv  596 (974)
T KOG4257|consen  530 -------------VKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV  596 (974)
T ss_pred             -------------eeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc
Confidence                         455555555544333211    122567999999999999999999999999999987 99999987


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      .+.+....|.+                       |                         .....|+.+++.+..|+.+|
T Consensus       597 kNsDVI~~iEn-----------------------G-------------------------eRlP~P~nCPp~LYslmskc  628 (974)
T KOG4257|consen  597 KNSDVIGHIEN-----------------------G-------------------------ERLPCPPNCPPALYSLMSKC  628 (974)
T ss_pred             cccceEEEecC-----------------------C-------------------------CCCCCCCCCChHHHHHHHHH
Confidence            66554433321                       1                         01224678899999999999


Q ss_pred             hhcCCCCCCCHHHHh
Q 014117          404 LRYDPTDRLTAREAL  418 (430)
Q Consensus       404 L~~dP~~R~ta~elL  418 (430)
                      |.+||.+||+..++.
T Consensus       629 WayeP~kRPrftei~  643 (974)
T KOG4257|consen  629 WAYEPSKRPRFTEIK  643 (974)
T ss_pred             hccCcccCCcHHHHH
Confidence            999999999987664

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-35  Score=286.37  Aligned_cols=245  Identities=22%  Similarity=0.311  Sum_probs=199.0

Q ss_pred             cEEEEeeeccccceEEEEEEECCC-C--eEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRER-K--EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~-~--~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ...+.++||+|.||.|++|.++.. |  -.||||.++...  .....+.+|+.+|.++.|     +|++++|+..-+ ..
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H-----~hliRLyGvVl~-qp  184 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQH-----PHLIRLYGVVLD-QP  184 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccC-----cceeEEeeeecc-ch
Confidence            456778999999999999988753 3  358999997433  245678999999999955     789999998876 77


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +.+|||++ .|+|.+.|++.....|.......|+.||+.|+.||.++++|||||-..|||+-...               
T Consensus       185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr---------------  249 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR---------------  249 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc---------------
Confidence            88999999 99999999985556788999999999999999999999999999999999995544               


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCCCeee------ecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV------STRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQ  321 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~------gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~  321 (430)
                                  .+||+|||+.+........++      -...|+|||.+....++.++|||+|||+||||+| |+.||.
T Consensus       250 ------------tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~  317 (1039)
T KOG0199|consen  250 ------------TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV  317 (1039)
T ss_pred             ------------eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC
Confidence                        455555555554433332221      2567999999999999999999999999999998 899999


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      +......+..|.+  |.                                              ....+..++.++.+++.
T Consensus       318 G~~g~qIL~~iD~--~e----------------------------------------------rLpRPk~csedIY~imk  349 (1039)
T KOG0199|consen  318 GCRGIQILKNIDA--GE----------------------------------------------RLPRPKYCSEDIYQIMK  349 (1039)
T ss_pred             CCCHHHHHHhccc--cc----------------------------------------------cCCCCCCChHHHHHHHH
Confidence            9888777766542  11                                              12235678889999999


Q ss_pred             HhhhcCCCCCCCHHHHhcC
Q 014117          402 GLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~h  420 (430)
                      .||..+|++|||+..|.+.
T Consensus       350 ~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  350 NCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             HhccCCccccccHHHHHHh
Confidence            9999999999999887544

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=245.22  Aligned_cols=209  Identities=22%  Similarity=0.411  Sum_probs=168.4

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      ....+..||+|+||.|=+-++..+|+..|+|.++..  .+...+...|+.+..+.    ...|.++.+|+.+-..+.++|
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~----~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRT----VDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccC----CCCCeEEEeehhhhccccEEE
Confidence            455677899999999999999999999999998743  33445555666665544    245789999998888899999


Q ss_pred             EEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          173 VFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       173 v~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      .||.|..||..+-.+  ..+..+++..+-+|+..|+.||.|||+ ..|||||+||+||||                    
T Consensus       123 cME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI--------------------  182 (282)
T KOG0984|consen  123 CMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI--------------------  182 (282)
T ss_pred             eHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE--------------------
Confidence            999999898776542  122479999999999999999999996 579999999999999                    


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC-Ce-eeecCcccchhhhhC----CCCCCcchHHHHHHHHHHHHhCCCCCCC-
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ-NY-IVSTRHYRAPEVILG----LGWTYPCDIWSVGCILVELCTGEALFQT-  322 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~-~~gt~~y~aPE~~~~----~~~~~~~DvwslGv~l~el~tG~~Pf~~-  322 (430)
                             +..+++|+||||++......- .+ -.|.-.|||||.+..    ..|+.++||||||+.+.||.+++.||+. 
T Consensus       183 -------n~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  183 -------NYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             -------ccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence                   566788888888876554432 22 367889999999863    3699999999999999999999999975 


Q ss_pred             CchHHHHHHHHH
Q 014117          323 HENLEHLAMMER  334 (430)
Q Consensus       323 ~~~~~~~~~i~~  334 (430)
                      .+..+++.++.+
T Consensus       256 ~tpF~qLkqvVe  267 (282)
T KOG0984|consen  256 GTPFQQLKQVVE  267 (282)
T ss_pred             CCHHHHHHHHhc
Confidence            566777766654

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5e-34  Score=314.03  Aligned_cols=187  Identities=20%  Similarity=0.275  Sum_probs=153.5

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      ..|...+.||+|+||.||+|.++.++..||+|.++.....   ...|+++++++     .|+||+++++++...+..|+|
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l-----~HpnIv~~~~~~~~~~~~~lv  761 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKL-----QHPNIVKLIGLCRSEKGAYLI  761 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhC-----CCCCcceEEEEEEcCCCCEEE
Confidence            3466678899999999999999999999999998643322   23457777777     458999999999999999999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH---DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |||+ +++|.++++     .+++..+..++.||+.||+|||   +.+|+||||||+||+++.+                 
T Consensus       762 ~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-----------------  819 (968)
T PLN00113        762 HEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-----------------  819 (968)
T ss_pred             EeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-----------------
Confidence            9999 899999995     3889999999999999999999   6799999999999999543                 


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                ...++. ||.+...... ....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       820 ----------~~~~~~-~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~  880 (968)
T PLN00113        820 ----------DEPHLR-LSLPGLLCTD-TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA  880 (968)
T ss_pred             ----------CceEEE-eccccccccC-CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence                      333332 4443322111 223678999999999999999999999999999999999999954

>PLN00181 protein SPA1-RELATED; Provisional

Probab=100.00  E-value=1.1e-34  Score=311.51  Aligned_cols=199  Identities=19%  Similarity=0.229  Sum_probs=156.2

Q ss_pred             CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          168 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       168 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      ..++++||+++++|.++|.... ..+++..++.++.||+.||.|||++|||||||||+||||+..|.+|++|||++....
T Consensus        53 ~~~~~~~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~  131 (793)
T PLN00181         53 DSIVRALECEDVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG  131 (793)
T ss_pred             chhhhhhccCCccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence            4677889999999999997543 569999999999999999999999999999999999999999999999999886543


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCC-------------------CCeeeecCcccchhhhhCCCCCCcchHHHHHH
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPD-------------------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC  308 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv  308 (430)
                      .        +....+|++|||+++.....                   ....+||+.|||||++.+..|+.++|||||||
T Consensus       132 ~--------~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGv  203 (793)
T PLN00181        132 S--------DEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGV  203 (793)
T ss_pred             c--------cccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHH
Confidence            2        34568999999998642210                   01146899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhh
Q 014117          309 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH  388 (430)
Q Consensus       309 ~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (430)
                      +||||++|.+||....  .....+...  .+|+..                                             
T Consensus       204 iL~ELl~~~~~~~~~~--~~~~~~~~~--~~~~~~---------------------------------------------  234 (793)
T PLN00181        204 LLFELFCPVSSREEKS--RTMSSLRHR--VLPPQI---------------------------------------------  234 (793)
T ss_pred             HHHHHhhCCCchhhHH--HHHHHHHHh--hcChhh---------------------------------------------
Confidence            9999999998875321  111111110  011100                                             


Q ss_pred             cCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       389 ~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                       ........+++.+||+.||.+|||+.|+|+||||..
T Consensus       235 -~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~  270 (793)
T PLN00181        235 -LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE  270 (793)
T ss_pred             -hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence             011234568899999999999999999999999975

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-34  Score=269.92  Aligned_cols=260  Identities=22%  Similarity=0.274  Sum_probs=183.0

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC----e
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----H  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~----~  169 (430)
                      ...++.+.||+|.||.||+|..  +++.||||++.  ...++.+..|.+|....   .-.|+||+++++.-+...    .
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp--~~~kqs~~~Ek~Iy~lp---~m~h~nIl~Fi~~ekr~t~~~~e  282 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFP--EQEKQSFQNEKNIYSLP---GMKHENILQFIGAEKRGTADRME  282 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc--cCceeEEEecC--HHHHHHHHhHHHHHhcc---CccchhHHHhhchhccCCccccc
Confidence            3467788999999999999965  56899999997  44567788888887765   235688999988765544    8


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------cCeeeccCCCCceEEeecCccccCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD---------LCMIHTDLKPENVLLVSSEYIKVPD  239 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---------~~ivHrDlKp~NILl~~~~~~~i~d  239 (430)
                      +.||++|. .|+|.+||..+   .++|....+++..+++||+|||+         ..|+|||||..||||.++++     
T Consensus       283 ywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT-----  354 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT-----  354 (534)
T ss_pred             eeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc-----
Confidence            99999998 99999999876   69999999999999999999995         35999999999999965554     


Q ss_pred             CcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCC-C-----CCcchHHHHHH
Q 014117          240 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLG-W-----TYPCDIWSVGC  308 (430)
Q Consensus       240 fg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~-~-----~~~~DvwslGv  308 (430)
                                            ..|+|||+|....+..     ..-+||..|||||++.+.- +     -.+.||||+|.
T Consensus       355 ----------------------ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgL  412 (534)
T KOG3653|consen  355 ----------------------CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGL  412 (534)
T ss_pred             ----------------------EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHH
Confidence                                  5555555554333221     2258999999999998752 2     25689999999


Q ss_pred             HHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhh
Q 014117          309 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH  388 (430)
Q Consensus       309 ~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (430)
                      |||||++...-+......+...-..+.+|.-|..  ..++.....  ++..-.+|+..                   .. 
T Consensus       413 VLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~--e~mq~~VV~--kK~RP~~p~~W-------------------~~-  468 (534)
T KOG3653|consen  413 VLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL--EEMQELVVR--KKQRPKIPDAW-------------------RK-  468 (534)
T ss_pred             HHHHHHhhcccccCCCCCcccCchhHHhcCCCCH--HHHHHHHHh--hccCCCChhhh-------------------hc-
Confidence            9999999765553222222223333344544421  111111100  01111111110                   00 


Q ss_pred             cCCchhHHHHHHHHhhhcCCCCCCCHH
Q 014117          389 VDHSAGDLTHLLQGLLRYDPTDRLTAR  415 (430)
Q Consensus       389 ~~~~~~~~~~ll~~~L~~dP~~R~ta~  415 (430)
                       ......+++.+..||+.||+.|+||.
T Consensus       469 -h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  469 -HAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             -CccHHHHHHHHHHHcCCchhhhhhhH
Confidence             12234589999999999999999985

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=282.70  Aligned_cols=257  Identities=24%  Similarity=0.394  Sum_probs=204.3

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      .++|+++..+|+|.||.||+|+++.+++..|+|+++-.. ........|+-+++..+|     +||+.+++.+.-...++
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h-----~nivay~gsylr~dklw   88 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRH-----PNIVAYFGSYLRRDKLW   88 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCC-----cChHHHHhhhhhhcCcE
Confidence            457999999999999999999999999999999997433 233445567777777744     88999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      ++|||| ||+|.+.-+-.+  ++++.++...+++.++||+|||++|-+|||||-.|||+++.|.                
T Consensus        89 icMEycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD----------------  150 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD----------------  150 (829)
T ss_pred             EEEEecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc----------------
Confidence            999999 889998776655  8999999999999999999999999999999999999966555                


Q ss_pred             cccccCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhh---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                 +|+.|||.+.....   ....+.||++|||||+..   ...|...+|+|++|+...|+-.-.+|.-..-
T Consensus       151 -----------vklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh  219 (829)
T KOG0576|consen  151 -----------VKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH  219 (829)
T ss_pred             -----------eeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc
Confidence                       45555554433222   224468999999999875   4469999999999999999988888765545


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      .+..+..+.+....+|. +                                           +-....++-+.+|++.+|
T Consensus       220 pmr~l~LmTkS~~qpp~-l-------------------------------------------kDk~kws~~fh~fvK~al  255 (829)
T KOG0576|consen  220 PMRALFLMTKSGFQPPT-L-------------------------------------------KDKTKWSEFFHNFVKGAL  255 (829)
T ss_pred             hHHHHHHhhccCCCCCc-c-------------------------------------------cCCccchHHHHHHHHHHh
Confidence            55555444443333331 1                                           012344556899999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      .++|.+|||++.+|+|||.+...
T Consensus       256 tknpKkRptaeklL~h~fvs~~l  278 (829)
T KOG0576|consen  256 TKNPKKRPTAEKLLQHPFVSQTL  278 (829)
T ss_pred             cCCCccCCChhhheeceeeccch
Confidence            99999999999999999998763

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-32  Score=283.10  Aligned_cols=248  Identities=25%  Similarity=0.412  Sum_probs=195.8

Q ss_pred             cCcEEEEeeeccccceEEEEEEECC-------CCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRE-------RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW  163 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~  163 (430)
                      .++.++.+.||+|.||.|++|....       ....||||..+..  ....+.+..|++++..+.+    |+|++.+.+.
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~----H~niv~llG~  370 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGK----HPNIVNLLGA  370 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcC----Ccchhhheee
Confidence            4455777799999999999997541       1457999998743  2456778889999999965    4789999999


Q ss_pred             eecCCeEEEEEecC-CCCHHHHHHhcC------------C--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceE
Q 014117          164 FDYRNHICIVFEKL-GSSLYDFLRKNN------------Y--RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL  228 (430)
Q Consensus       164 ~~~~~~~~lv~e~~-~~~L~~~l~~~~------------~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NIL  228 (430)
                      +...+.+++|+||+ .|+|.++|+...            .  ..++......++.||+.|++||++..+|||||-..|||
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVL  450 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEE
Confidence            99999999999999 899999998764            0  13888999999999999999999999999999999999


Q ss_pred             EeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCee----ee--cCcccchhhhhCCCCCCcch
Q 014117          229 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI----VS--TRHYRAPEVILGLGWTYPCD  302 (430)
Q Consensus       229 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~----~g--t~~y~aPE~~~~~~~~~~~D  302 (430)
                      +.                           .+..+||+|||+|+.......+.    .|  ...|||||.+....|+.++|
T Consensus       451 i~---------------------------~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSD  503 (609)
T KOG0200|consen  451 IT---------------------------KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSD  503 (609)
T ss_pred             ec---------------------------CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccch
Confidence            94                           45567777777776544433222    12  34599999999999999999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCc-hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchh
Q 014117          303 IWSVGCILVELCT-GEALFQTHE-NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR  380 (430)
Q Consensus       303 vwslGv~l~el~t-G~~Pf~~~~-~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (430)
                      ||||||+||||+| |..||.+.. ..+.+.                       ++..|                      
T Consensus       504 VWSfGI~L~EifsLG~~PYp~~~~~~~l~~-----------------------~l~~G----------------------  538 (609)
T KOG0200|consen  504 VWSFGILLWEIFTLGGTPYPGIPPTEELLE-----------------------FLKEG----------------------  538 (609)
T ss_pred             hhHHHHHHHHHhhCCCCCCCCCCcHHHHHH-----------------------HHhcC----------------------
Confidence            9999999999998 899998743 222222                       11222                      


Q ss_pred             HHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          381 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                         .....|..++.++.++++.||+.+|++||+..++.+
T Consensus       539 ---~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  539 ---NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence               122345667888999999999999999999988764

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-32  Score=255.75  Aligned_cols=195  Identities=24%  Similarity=0.331  Sum_probs=149.2

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC---
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---  167 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~---  167 (430)
                      .+..+..+++.||+|.||.||+|..  .|+.||||++....  ...+.+|.+|.+...-   .|.||..++..-...   
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd--E~SWfrEtEIYqTvmL---RHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD--ERSWFRETEIYQTVML---RHENILGFIAADNKDNGS  280 (513)
T ss_pred             hhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc--hhhhhhHHHHHHHHHh---ccchhhhhhhccccCCCc
Confidence            4566789999999999999999976  57789999997443  3557778888877644   347788877654322   


Q ss_pred             -CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----cC---eeeccCCCCceEEeecCcccc
Q 014117          168 -NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-----LC---MIHTDLKPENVLLVSSEYIKV  237 (430)
Q Consensus       168 -~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-----~~---ivHrDlKp~NILl~~~~~~~i  237 (430)
                       ..++||.+|- .|||+|||...   .++.+...+++..++.||+|||-     +|   |.|||||..|||+..+|..-|
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence             4899999999 99999999874   69999999999999999999994     33   999999999999976665555


Q ss_pred             CCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCC------CCCcchHHHHHHHHH
Q 014117          238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG------WTYPCDIWSVGCILV  311 (430)
Q Consensus       238 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslGv~l~  311 (430)
                      +|+|+|.....+.+            .+|.        ..+..+||-.|||||++...-      --..+||||||.|+|
T Consensus       358 ADLGLAv~h~~~t~------------~idi--------~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlW  417 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTD------------TIDI--------PPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLW  417 (513)
T ss_pred             eeceeeEEecccCC------------cccC--------CCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHH
Confidence            55555543332211            1111        224459999999999996531      125689999999999


Q ss_pred             HHHh
Q 014117          312 ELCT  315 (430)
Q Consensus       312 el~t  315 (430)
                      |++.
T Consensus       418 Eiar  421 (513)
T KOG2052|consen  418 EIAR  421 (513)
T ss_pred             HHHH
Confidence            9985

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5e-32  Score=270.04  Aligned_cols=241  Identities=21%  Similarity=0.249  Sum_probs=190.6

Q ss_pred             EEEEeeeccccceEEEEEEECCCC----eEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERK----EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~----~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      .+..+.||+|+||+||+|..--.+    ..||||++...  .+...+++.|+-+|..+     .|+|++++++++.... 
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-----dHpnl~RLLgvc~~s~-  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-----DHPNLLRLLGVCMLST-  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-----CCchHHHHhhhcccch-
Confidence            455678999999999999875444    46899988633  33456788888888888     4588999999987655 


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +-||++|+ .|+|.++++.+. ..+-....+.|..||++||.|||.+++|||||-..|||+....++||+          
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkit----------  840 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKIT----------  840 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEE----------
Confidence            88999999 999999998754 578889999999999999999999999999999999999666555555          


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCCCee-----eecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI-----VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT  322 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~  322 (430)
                                       |||+++...++...+     .-.+.|||-|.+....|+.++|||||||++||++| |..|+.+
T Consensus       841 -----------------dfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g  903 (1177)
T KOG1025|consen  841 -----------------DFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG  903 (1177)
T ss_pred             -----------------ecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC
Confidence                             555444433332111     12567999999999999999999999999999998 9999998


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      ....+.-..+...                                                .....|+..+-++.-++.+
T Consensus       904 i~~~eI~dlle~g------------------------------------------------eRLsqPpiCtiDVy~~mvk  935 (1177)
T KOG1025|consen  904 IPAEEIPDLLEKG------------------------------------------------ERLSQPPICTIDVYMVMVK  935 (1177)
T ss_pred             CCHHHhhHHHhcc------------------------------------------------ccCCCCCCccHHHHHHHHH
Confidence            7765543332211                                                1123467788899999999


Q ss_pred             hhhcCCCCCCCHHHHh
Q 014117          403 LLRYDPTDRLTAREAL  418 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL  418 (430)
                      ||..|+..||+++++-
T Consensus       936 Cwmid~~~rp~fkel~  951 (1177)
T KOG1025|consen  936 CWMIDADSRPTFKELA  951 (1177)
T ss_pred             HhccCcccCccHHHHH
Confidence            9999999999998774

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=9.7e-30  Score=228.20  Aligned_cols=208  Identities=39%  Similarity=0.622  Sum_probs=177.1

Q ss_pred             eccccceEEEEEEECCCCeEEEEEEecCchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-C
Q 014117          102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G  178 (430)
Q Consensus       102 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~  178 (430)
                      ||+|++|.||++.+..+++.+++|++.....  ....+..|+..++.+.+     ++++++++++......++|||++ +
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~-----~~i~~~~~~~~~~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH-----PNIVKLYGVFEDENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCC-----CCeeeEeeeeecCCeEEEEEecCCC
Confidence            6899999999999988899999999875433  24667889999998854     78999999999889999999999 5


Q ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCC
Q 014117          179 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK  258 (430)
Q Consensus       179 ~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~  258 (430)
                      ++|.+++.... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++.                          .
T Consensus        76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~--------------------------~  128 (215)
T cd00180          76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDS--------------------------D  128 (215)
T ss_pred             CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeC--------------------------C
Confidence            89999998653 36899999999999999999999999999999999999953                          1


Q ss_pred             CCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHH
Q 014117          259 SSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER  334 (430)
Q Consensus       259 ~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~  334 (430)
                      ...++|+|||.+......   .....+...|++||.+... .++.++|+|++|+++++|                     
T Consensus       129 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------  187 (215)
T cd00180         129 NGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------  187 (215)
T ss_pred             CCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------
Confidence            456778888877654433   2334678899999999887 788999999999999999                     


Q ss_pred             HhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCH
Q 014117          335 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA  414 (430)
Q Consensus       335 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta  414 (430)
                            .                                                     .+.+++.+||+.||++||++
T Consensus       188 ------~-----------------------------------------------------~~~~~l~~~l~~~p~~R~~~  208 (215)
T cd00180         188 ------P-----------------------------------------------------ELKDLIRKMLQKDPEKRPSA  208 (215)
T ss_pred             ------H-----------------------------------------------------HHHHHHHHHhhCCcccCcCH
Confidence                  0                                                     26789999999999999999


Q ss_pred             HHHhcCC
Q 014117          415 REALRHP  421 (430)
Q Consensus       415 ~elL~hp  421 (430)
                      +++++|+
T Consensus       209 ~~l~~~~  215 (215)
T cd00180         209 KEILEHL  215 (215)
T ss_pred             HHHhhCC
Confidence            9999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-32  Score=240.11  Aligned_cols=200  Identities=26%  Similarity=0.361  Sum_probs=163.9

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecc-eeecCCeE
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN-WFDYRNHI  170 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~-~~~~~~~~  170 (430)
                      +.+.|.|.+.||+|.||.+.+|+++.++..+++|.+.+.......+.+|..---.|.    +|.||+.-|+ .|+..+.+
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls----~H~hIi~tY~vaFqt~d~Y   97 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLS----PHQHIIDTYEVAFQTSDAY   97 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeec----cchhhhHHHHHHhhcCceE
Confidence            456799999999999999999999999999999999866555566666665433333    3345665544 57888999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      .+++||+ -|+|..-+...   .+.+.....++.|+++||.|||+.++||||||.+||||-..                 
T Consensus        98 vF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~-----------------  157 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA-----------------  157 (378)
T ss_pred             EEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC-----------------
Confidence            9999999 88998887665   48899999999999999999999999999999999999532                 


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                              ...++||||||.++..+..-...--+..|.+||+....     ...+.+|+|.||+++|.++||.+||...
T Consensus       158 --------df~rvKlcDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka  228 (378)
T KOG1345|consen  158 --------DFYRVKLCDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA  228 (378)
T ss_pred             --------CccEEEeeecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence                    23489999999998766655555567889999987632     2568899999999999999999999753

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=4.6e-29  Score=227.22  Aligned_cols=197  Identities=36%  Similarity=0.605  Sum_probs=165.8

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+.....  ....+..|++.++.+.     +++++++++++......+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~-----~~~i~~~~~~~~~~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLK-----HPNIVKLYGVFEDPEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCC-----CCChhhheeeeecCCceEEE
Confidence            5678899999999999999998899999999875432  3566777888888883     36789999998888999999


Q ss_pred             EecC-CCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          174 FEKL-GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~-l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      +|++ +++|.+++....  . +++..+..++.+++.+|.+||+.+++|+||+|+||+++                     
T Consensus        76 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~---------------------  132 (225)
T smart00221       76 MEYCEGGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG---------------------  132 (225)
T ss_pred             EeccCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---------------------
Confidence            9999 669999998754  3 89999999999999999999999999999999999994                     


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhh-hCCCCCCcchHHHHHHHHHHHHhCCCCCCC-Cch
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVI-LGLGWTYPCDIWSVGCILVELCTGEALFQT-HEN  325 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGv~l~el~tG~~Pf~~-~~~  325 (430)
                            ....++|+|||.+.......    ....++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .++
T Consensus       133 ------~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~  206 (225)
T smart00221      133 ------MDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEF  206 (225)
T ss_pred             ------CCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchh
Confidence                  44677888888776544332    445788899999998 666788899999999999999999999976 444


Q ss_pred             H
Q 014117          326 L  326 (430)
Q Consensus       326 ~  326 (430)
                      .
T Consensus       207 ~  207 (225)
T smart00221      207 T  207 (225)
T ss_pred             H
Confidence            3

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=232.71  Aligned_cols=247  Identities=17%  Similarity=0.234  Sum_probs=188.9

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCC-----eEEEEEEecCchh--hHHHHHHHHHHHHHHHhcCCCCCceEEeccee-
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERK-----EMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-  164 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-  164 (430)
                      ..+++....+-+|.||.||.|..+..+     +.|-+|.++....  ....+..|.-.+..+     +|+|+..+.+.. 
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-----sH~nll~V~~V~i  357 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-----SHPNLLSVLGVSI  357 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-----cCCCccceeEEEe
Confidence            457888889999999999999766433     2344554442211  112233333333333     467888777654 


Q ss_pred             ecCCeEEEEEecC-CCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCcccc
Q 014117          165 DYRNHICIVFEKL-GSSLYDFLRKN------NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV  237 (430)
Q Consensus       165 ~~~~~~~lv~e~~-~~~L~~~l~~~------~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i  237 (430)
                      ++....++++.++ -|+|-.+|...      +.+.++-.+...++.|++.|++|||+.||||.||...|++|        
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI--------  429 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI--------  429 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee--------
Confidence            4556777888888 68999999832      22457778888999999999999999999999999999999        


Q ss_pred             CCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeee-----cCcccchhhhhCCCCCCcchHHHHHHHHHH
Q 014117          238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVS-----TRHYRAPEVILGLGWTYPCDIWSVGCILVE  312 (430)
Q Consensus       238 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~g-----t~~y~aPE~~~~~~~~~~~DvwslGv~l~e  312 (430)
                                         +...++||+|-.+++..-+.+....|     +..||+||.+.+..|+.++|+|||||+|||
T Consensus       430 -------------------dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWE  490 (563)
T KOG1024|consen  430 -------------------DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWE  490 (563)
T ss_pred             -------------------hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHH
Confidence                               66789999999998876665544334     567999999999999999999999999999


Q ss_pred             HHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCC
Q 014117          313 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH  391 (430)
Q Consensus       313 l~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (430)
                      |+| |+.|+...+..|+...+..                       |                         .....|-+
T Consensus       491 Lmtlg~~PyaeIDPfEm~~ylkd-----------------------G-------------------------yRlaQP~N  522 (563)
T KOG1024|consen  491 LMTLGKLPYAEIDPFEMEHYLKD-----------------------G-------------------------YRLAQPFN  522 (563)
T ss_pred             HHhcCCCCccccCHHHHHHHHhc-----------------------c-------------------------ceecCCCC
Confidence            998 9999988777766554432                       1                         12334568


Q ss_pred             chhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          392 SAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       392 ~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      +++++..++.-||..+|++||+.+|+..
T Consensus       523 CPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  523 CPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             CcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            8999999999999999999999999864

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=5.7e-28  Score=233.08  Aligned_cols=208  Identities=29%  Similarity=0.374  Sum_probs=171.2

Q ss_pred             cEEEEeeeccccceEEEEEEECCCC-eEEEEEEecCchh-hHHHHHHHHHHHHHHHhcCCCCCceEEeccee-ecCCeEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-DYRNHIC  171 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~-~~vAiK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-~~~~~~~  171 (430)
                      +|.+.++||+|+||.||+|.+..++ ..+|+|+...... .......|..++..+.. ..+..++..++... ....+.+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~-~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEK-KNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhh-hcCCCCCCEEEEeccCCCceeE
Confidence            7999999999999999999998774 6899998764322 12267789999999975 33345677888877 5788999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          172 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       172 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      |||+.+|.+|.++......+.|+...+..++.|++.+|++||+.|+|||||||+|+++...+.                 
T Consensus        98 iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~-----------------  160 (322)
T KOG1164|consen   98 IVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSR-----------------  160 (322)
T ss_pred             EEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCC-----------------
Confidence            999999999999987766678999999999999999999999999999999999999953210                 


Q ss_pred             ccccCCCCCCeEEEeCCCcc--ccC--------CC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCC
Q 014117          252 YFKRMPKSSAIKVIDFGSTT--YER--------PD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~--~~~--------~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~  318 (430)
                           .....+.|+|||+++  ...        +.   ...+.||..|+++....+...+.+.|+||++.++.+++.|..
T Consensus       161 -----~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~L  235 (322)
T KOG1164|consen  161 -----SEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSL  235 (322)
T ss_pred             -----cccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCC
Confidence                 122468889999887  210        11   123469999999999999999999999999999999999999


Q ss_pred             CCCCCch
Q 014117          319 LFQTHEN  325 (430)
Q Consensus       319 Pf~~~~~  325 (430)
                      ||.+.+.
T Consensus       236 PW~~~~~  242 (322)
T KOG1164|consen  236 PWEALEM  242 (322)
T ss_pred             CCccccc
Confidence            9976554

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-28  Score=213.81  Aligned_cols=204  Identities=27%  Similarity=0.372  Sum_probs=173.7

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ...++|.++++||+|+||.+|+|....+|..||||+-+..... .+...|..+.+.+++.    ..|+.+..+..+..+-
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-pqL~yEskvY~iL~~g----~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-PQLLYESKVYRILQGG----VGIPHIRHYGTEKDYN   86 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-cchhHHHHHHHHhccC----CCCchhhhhccccccc
Confidence            3467899999999999999999999999999999987644333 4567788888888653    4577778888889999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      .+||+++|.+|.+++.-.. +.|+...++-++-|++.-++|+|.+++|||||||+|+|+.-.                  
T Consensus        87 vlVMdLLGPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlg------------------  147 (341)
T KOG1163|consen   87 VLVMDLLGPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLG------------------  147 (341)
T ss_pred             eeeeeccCccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccc------------------
Confidence            9999999999999988665 579999999999999999999999999999999999999321                  


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC----------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                            .....+.++|||+|+......          ....||..|.+-....+...+.+.|+=|+|.+|.+...|..||
T Consensus       148 ------rh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPW  221 (341)
T KOG1163|consen  148 ------RHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPW  221 (341)
T ss_pred             ------cccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcc
Confidence                  234578999999997544322          3358999999999888888899999999999999999999999


Q ss_pred             CCCc
Q 014117          321 QTHE  324 (430)
Q Consensus       321 ~~~~  324 (430)
                      .+..
T Consensus       222 Qglk  225 (341)
T KOG1163|consen  222 QGLK  225 (341)
T ss_pred             cccc
Confidence            8754

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=3.1e-29  Score=220.51  Aligned_cols=166  Identities=23%  Similarity=0.290  Sum_probs=123.3

Q ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCC
Q 014117          179 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK  258 (430)
Q Consensus       179 ~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~  258 (430)
                      |+|.+++...+ ..+++..++.++.||+.||.|||+++      ||+|||++                           .
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~---------------------------~   46 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT---------------------------W   46 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc---------------------------C
Confidence            68999998654 46999999999999999999999999      99999994                           4


Q ss_pred             CCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHHHHhC
Q 014117          259 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL-EHLAMMERVLG  337 (430)
Q Consensus       259 ~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~-~~~~~i~~~~g  337 (430)
                      ++.+|+  ||++.......  ..||+.|||||++.+..|+.++|||||||++|||++|+.||...... .....+.....
T Consensus        47 ~~~~~~--fG~~~~~~~~~--~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  122 (176)
T smart00750       47 DGLLKL--DGSVAFKTPEQ--SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP  122 (176)
T ss_pred             ccceee--ccceEeecccc--CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc
Confidence            445666  77665443322  26899999999999999999999999999999999999999754332 11222111111


Q ss_pred             CCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCch--hHHHHHHHHhhhcCCCCCCCHH
Q 014117          338 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA--GDLTHLLQGLLRYDPTDRLTAR  415 (430)
Q Consensus       338 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ll~~~L~~dP~~R~ta~  415 (430)
                      ....                      ...   .                 .+...+  .++.++|..||+.||.+|||+.
T Consensus       123 ~~~~----------------------~~~---~-----------------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~  160 (176)
T smart00750      123 ADDP----------------------RDR---S-----------------NLESVSAARSFADFMRVCASRLPQRREAAN  160 (176)
T ss_pred             cCCc----------------------ccc---c-----------------cHHHHHhhhhHHHHHHHHHhcccccccCHH
Confidence            0000                      000   0                 000111  2689999999999999999999


Q ss_pred             HHhcCCCCC
Q 014117          416 EALRHPFFT  424 (430)
Q Consensus       416 elL~hp~f~  424 (430)
                      |+++|+|+.
T Consensus       161 ~ll~~~~~~  169 (176)
T smart00750      161 HYLAHCRAL  169 (176)
T ss_pred             HHHHHHHHH
Confidence            999999875

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=4.1e-28  Score=220.57  Aligned_cols=211  Identities=25%  Similarity=0.334  Sum_probs=180.6

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      .|++.++||+|+||..++|.+..+++.||||.-.. +...-+...|.+..+.|..    .+.|.+.|.+..++.+-.|||
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g----~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGG----TEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcC----CCCCCceeeeccccchhhhhh
Confidence            59999999999999999999999999999998653 3334567788888888853    366888888888999999999


Q ss_pred             ecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccc
Q 014117          175 EKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK  254 (430)
Q Consensus       175 e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~  254 (430)
                      |++|.+|.|+++-.+ ++|+...+..++.|++.-++|+|++.+|+|||||+|+||...+.                    
T Consensus       104 dLLGPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~--------------------  162 (449)
T KOG1165|consen  104 DLLGPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGT--------------------  162 (449)
T ss_pred             hhhCcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCC--------------------
Confidence            999999999999887 68999999999999999999999999999999999999976542                    


Q ss_pred             cCCCCCCeEEEeCCCccccCCCC----------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-
Q 014117          255 RMPKSSAIKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH-  323 (430)
Q Consensus       255 ~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~-  323 (430)
                        .....|.|+|||+|+......          ....||..||+-...+|...+.+.|+=|||-++++.+-|.+||.+. 
T Consensus       163 --k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  163 --KDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             --CCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence              455679999999998655433          2357999999999999999999999999999999999999999764 


Q ss_pred             --chHHHHHHHH
Q 014117          324 --ENLEHLAMME  333 (430)
Q Consensus       324 --~~~~~~~~i~  333 (430)
                        +..+....|-
T Consensus       241 A~tnK~kYeKIG  252 (449)
T KOG1165|consen  241 ADTNKEKYEKIG  252 (449)
T ss_pred             CcchHHHHHHhc
Confidence              4455444443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1.9e-27  Score=243.90  Aligned_cols=255  Identities=21%  Similarity=0.280  Sum_probs=177.4

Q ss_pred             EEEeeeccccceEEEEEEECCCCeEEEEEEec----CchhhHHH---HHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           97 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREA---AMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        97 ~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~----~~~~~~~~---~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      .-...+|.|++|.|+.+......+.++.|..+    ........   ...|.-+     .....+++++.....+.+...
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i-----~~~l~h~~~~e~l~~~~~~~~  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCI-----GSSLSHPNIIETLDIVQEIDG  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheee-----cccccCCchhhhHHHHhhccc
Confidence            35678999999988888877766667776553    11111111   1122222     222345666665555555444


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          170 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       170 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      .+-+||||..+|+.++...+  .++...+..++.|++.||+|||++||.||||||+|+++..                  
T Consensus       396 ~~~~mE~~~~Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~------------------  455 (601)
T KOG0590|consen  396 ILQSMEYCPYDLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTE------------------  455 (601)
T ss_pred             chhhhhcccHHHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEec------------------
Confidence            44459999449999998764  6899999999999999999999999999999999999954                  


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC-------CeeeecCcccchhhhhCCCCCC-cchHHHHHHHHHHHHhCCCCCC
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLGWTY-PCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~-~~DvwslGv~l~el~tG~~Pf~  321 (430)
                               .+.+||+|||.+.......       ..++|+..|+|||++.+..|++ .+||||.|++++.|++|+.||.
T Consensus       456 ---------~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk  526 (601)
T KOG0590|consen  456 ---------NGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWK  526 (601)
T ss_pred             ---------CCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccc
Confidence                     4466667777654322211       2368999999999999999985 5699999999999999999997


Q ss_pred             CCchHHHHH-HHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          322 THENLEHLA-MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       322 ~~~~~~~~~-~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .....+... .+.   +                      ..+-.                ...-.......++.+.+.+|
T Consensus       527 ~a~~~~~~~~~~~---~----------------------~~~~~----------------~~~~~~~~~~~lp~~~~~~~  565 (601)
T KOG0590|consen  527 VAKKSDNSFKTNN---Y----------------------SDQRN----------------IFEGPNRLLSLLPRETRIII  565 (601)
T ss_pred             cccccccchhhhc---c----------------------ccccc----------------cccChHHHHHhchhhHHHHH
Confidence            543322110 000   0                      00000                00001112234566789999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          401 QGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ..||++||.+|.|+++|++.+||+..
T Consensus       566 ~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  566 YRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             HHHccCChhheecHHHHhhChHhhhc
Confidence            99999999999999999999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.94  E-value=5e-27  Score=241.07  Aligned_cols=238  Identities=26%  Similarity=0.396  Sum_probs=174.3

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      +.|..++.|..|+||.||+++++.+.+.+|+|+=+ .+.          +++.          |..+      .+..+.|
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l----------ilRn----------ilt~------a~npfvv  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL----------ILRN----------ILTF------AGNPFVV  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcccc-cch----------hhhc----------cccc------cCCccee
Confidence            45899999999999999999999999999996432 211          1111          1111      1111122


Q ss_pred             EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          174 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       174 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                           |+=...+...+  .++...        +.+++|||+-||||||+||+|.||+.-|++|++|||++.-..+.... 
T Consensus       136 -----gDc~tllk~~g--~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at-  199 (1205)
T KOG0606|consen  136 -----GDCATLLKNIG--PLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT-  199 (1205)
T ss_pred             -----chhhhhcccCC--CCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc-
Confidence                 33334444433  455443        67899999999999999999999999999999999988655443221 


Q ss_pred             ccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Q 014117          254 KRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME  333 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~  333 (430)
                       + -+.+.++-    .++.  -.....+||+.|+|||++..+.|++.+|||++|+|+||.+-|..||.+++.++.+..+.
T Consensus       200 -n-l~eg~I~k----~t~E--f~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi  271 (1205)
T KOG0606|consen  200 -N-LKEGHIEK----DTHE--FQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI  271 (1205)
T ss_pred             -h-hhhcchHH----HHHH--hhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence             0 11111110    1111  12244699999999999999999999999999999999999999999999888888776


Q ss_pred             HHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCC-
Q 014117          334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL-  412 (430)
Q Consensus       334 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~-  412 (430)
                      ......|+.                                              .+..+++++++|..+|+.+|..|. 
T Consensus       272 sd~i~wpE~----------------------------------------------dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  272 SDDIEWPEE----------------------------------------------DEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             hhhcccccc----------------------------------------------CcCCCHHHHHHHHHHHHhChHhhcc
Confidence            655544432                                              245677899999999999999997 


Q ss_pred             --CHHHHhcCCCCCCCCC
Q 014117          413 --TAREALRHPFFTRDHL  428 (430)
Q Consensus       413 --ta~elL~hp~f~~~~~  428 (430)
                        .+-++.+|+||+..+.
T Consensus       306 t~ga~evk~h~ff~~LDw  323 (1205)
T KOG0606|consen  306 TGGALEVKQHGFFQLLDW  323 (1205)
T ss_pred             cchhhhhhhccceeeccc
Confidence              5789999999987654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=3.5e-24  Score=204.80  Aligned_cols=257  Identities=32%  Similarity=0.493  Sum_probs=192.2

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      |.+...||.|+||.||++.+.   ..+|+|.+.....    ....+..|+.++..+.++    ++++.+...+......+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~----~~i~~~~~~~~~~~~~~   74 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP----PNIVKLYDFFQDEGSLY   74 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCC----cceeeEEEEEecCCEEE
Confidence            778899999999999999987   7799998864322    355677788888888553    26888888888788899


Q ss_pred             EEEecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      ++++++ ++++.+++..... ..++...+..++.|++.+|.|+|+.+++|||+||+||+++..+                
T Consensus        75 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~----------------  138 (384)
T COG0515          75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDG----------------  138 (384)
T ss_pred             EEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCC----------------
Confidence            999999 8899877765432 2689999999999999999999999999999999999995433                


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCC---------CCeeeecCcccchhhhhC---CCCCCcchHHHHHHHHHHHHhCC
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPD---------QNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---------~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~tG~  317 (430)
                                ..++++|||.+......         .....||..|+|||.+.+   ..++...|+||+|++++++++|.
T Consensus       139 ----------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~  208 (384)
T COG0515         139 ----------RVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL  208 (384)
T ss_pred             ----------CeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCC
Confidence                      15677777766533221         244689999999999988   57889999999999999999999


Q ss_pred             CCCCCCch----HHHHHHHHHHhCC-CCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCc
Q 014117          318 ALFQTHEN----LEHLAMMERVLGP-LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS  392 (430)
Q Consensus       318 ~Pf~~~~~----~~~~~~i~~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (430)
                      .||.....    ......+.....+ ....                     .  ....                  ....
T Consensus       209 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~--~~~~------------------~~~~  247 (384)
T COG0515         209 PPFEGEKNSSATSQTLKIILELPTPSLASP---------------------L--SPSN------------------PELI  247 (384)
T ss_pred             CCCCCCCccccHHHHHHHHHhcCCcccccc---------------------c--Cccc------------------cchh
Confidence            99877653    2222222221111 0000                     0  0000                  0122


Q ss_pred             hhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       393 ~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ...+.+++..++..+|..|.+..+...++|....
T Consensus       248 ~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         248 SKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             hHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            3468899999999999999999998888766543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.5e-27  Score=231.67  Aligned_cols=237  Identities=25%  Similarity=0.395  Sum_probs=185.7

Q ss_pred             eccccceEEEEEEEC---CCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117          102 MGEGTFGQVLECWDR---ERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus       102 lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      +|.|.||.|++++..   ..++.||+|+.++..   ........|..++..+.    .++.++.+...++.+..++++++
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~----~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVH----NTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhcc----CCCceeeeeeeeccccchhHhhh
Confidence            699999999987543   457789999875321   11123345666666663    35789999999999999999999


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccc
Q 014117          176 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK  254 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~  254 (430)
                      +. |+.|...+.+..  .+++.....+...++.|++++|+.+|+|||+|++||+++.+|++++.|               
T Consensus        78 ~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~td---------------  140 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTD---------------  140 (612)
T ss_pred             hcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCC---------------
Confidence            99 889988876654  788999999999999999999999999999999999996666555555               


Q ss_pred             cCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHH
Q 014117          255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER  334 (430)
Q Consensus       255 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~  334 (430)
                                  ||+++..-..... |||..|||||++.  ....++|+||||++++||++|..||..    +....|.+
T Consensus       141 ------------fglske~v~~~~~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~  201 (612)
T KOG0603|consen  141 ------------FGLSKEAVKEKIA-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK  201 (612)
T ss_pred             ------------chhhhHhHhhhhc-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh
Confidence                        4544432222222 8999999999998  588999999999999999999999986    55555555


Q ss_pred             HhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCC-
Q 014117          335 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT-  413 (430)
Q Consensus       335 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~t-  413 (430)
                      ..-..|.+                                                 .+..+.+++..++..+|..|+. 
T Consensus       202 ~~~~~p~~-------------------------------------------------l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  202 AELEMPRE-------------------------------------------------LSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hccCCchh-------------------------------------------------hhHHHHHHHHHHHhhCHHHHhcc
Confidence            44444433                                                 3556899999999999999985 


Q ss_pred             ----HHHHhcCCCCCCCC
Q 014117          414 ----AREALRHPFFTRDH  427 (430)
Q Consensus       414 ----a~elL~hp~f~~~~  427 (430)
                          +.|+++|+||....
T Consensus       233 ~~~~~~eik~h~f~~~i~  250 (612)
T KOG0603|consen  233 GPDGVDEIKQHEFFQSID  250 (612)
T ss_pred             CcchhHHHhccchheeee
Confidence                57999999998653

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=3e-25  Score=214.25  Aligned_cols=168  Identities=21%  Similarity=0.209  Sum_probs=121.9

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECC-CCeEEEEEEecCc------hhhHHHHHHHHHHHHHHHhcCCCCCceE-Eecce
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRE-RKEMVAIKIVRGI------KKYREAAMIEIEVLQQLAKHDKGGNRCV-QIRNW  163 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vAiK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~i~-~~~~~  163 (430)
                      +.++|.+.+.||+|+||+||+|.++. +++.||||++...      ......+..|+++|+++.+     ++++ .++..
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h-----~~iv~~l~~~   90 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRG-----IGVVPQLLAT   90 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccC-----CCCCcEEEEc
Confidence            45679999999999999999999876 6788899986422      2234567899999999965     3344 44432


Q ss_pred             eecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccC-CCCceEEeecCccccCCCc
Q 014117          164 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL-KPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       164 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDl-Kp~NILl~~~~~~~i~dfg  241 (430)
                          +..||||||+ |++|.. +..     ..   ...++.|++.||.|||++||+|||| ||+|||++.          
T Consensus        91 ----~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~----------  147 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGP----------  147 (365)
T ss_pred             ----CCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcC----------
Confidence                4689999999 778862 211     11   1467899999999999999999999 999999944          


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----------CeeeecCcccchhhhhCCC------CCCcchHH
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----------NYIVSTRHYRAPEVILGLG------WTYPCDIW  304 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----------~~~~gt~~y~aPE~~~~~~------~~~~~Dvw  304 (430)
                                       ++.+||+|||+|+......           ...++++.|+|||.+.-..      .+..+|-|
T Consensus       148 -----------------~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        148 -----------------DGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             -----------------CCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence                             3456667777665332211           2357888999999986432      33456665

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=6.4e-24  Score=196.77  Aligned_cols=202  Identities=20%  Similarity=0.271  Sum_probs=125.0

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHHHHHHHHh---------c--CCCCCceEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAK---------H--DKGGNRCVQ  159 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~---------~--~~~~~~i~~  159 (430)
                      .+...+.||.|+++.||.+.+..|++.+|+|+......    ..+...+|.-....+.+         +  ..-..-+++
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            46778899999999999999999999999998742211    12222222211111100         0  000011222


Q ss_pred             ecc---eeecC---C-----eEEEEEecCCCCHHHHHHh---cCCC--CCCHHHHHHHHHHHHHHHHHHHhcCeeeccCC
Q 014117          160 IRN---WFDYR---N-----HICIVFEKLGSSLYDFLRK---NNYR--SFPIDLVREIARQLLECIAFMHDLCMIHTDLK  223 (430)
Q Consensus       160 ~~~---~~~~~---~-----~~~lv~e~~~~~L~~~l~~---~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlK  223 (430)
                      +.+   ++...   .     ..+++|+-+.++|.+++..   ....  .+.......+..|+++.+++||+.||||+|||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence            221   11111   1     3478899888899887652   2211  12233345677999999999999999999999


Q ss_pred             CCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCC--------
Q 014117          224 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL--------  295 (430)
Q Consensus       224 p~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--------  295 (430)
                      |+|+|+                           +.++.++|+||+.....+........+..|.+||.....        
T Consensus       173 ~~nfll---------------------------~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~  225 (288)
T PF14531_consen  173 PENFLL---------------------------DQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNA  225 (288)
T ss_dssp             GGGEEE----------------------------TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEE
T ss_pred             eeeEEE---------------------------cCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccc
Confidence            999999                           556677788887554433222112346779999987542        


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          296 GWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       296 ~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                      .++.+.|.|+||+++|.|.||..||...
T Consensus       226 ~~t~~~DaW~LG~~ly~lWC~~lPf~~~  253 (288)
T PF14531_consen  226 PYTFATDAWQLGITLYSLWCGRLPFGLS  253 (288)
T ss_dssp             EE-HHHHHHHHHHHHHHHHHSS-STCCC
T ss_pred             eeeeccCHHHHHHHHHHHHHccCCCCCC
Confidence            4788999999999999999999999854

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=2.3e-24  Score=221.78  Aligned_cols=252  Identities=24%  Similarity=0.337  Sum_probs=176.1

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      .|...+.||++.|=+|.+|.+++. . |+||++-+...  ....+.++++-.+   .....+||++.+..+.......||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG-~-vVvKVFvk~~p~~sL~~~~qrL~~ik---~~l~~~pn~lPfqk~~~t~kAAyl   98 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREG-L-VVVKVFVKQDPTISLRPFKQRLEEIK---FALMKAPNCLPFQKVLVTDKAAYL   98 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCc-e-EEEEEEeccCCCCCchHHHHHHHHHH---HHhhcCCcccchHHHHHhhHHHHH
Confidence            588889999999999999987643 3 99999854321  1122222222222   112245889999988888899999


Q ss_pred             EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC--CCCCC
Q 014117          173 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH--TPKDS  250 (430)
Q Consensus       173 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~--~~~~~  250 (430)
                      |=+|...+|+|.|..++  -+...+-+.|+.||+.||.-+|..||+|+|||.+||||++=+=+.++||..-..  +|.++
T Consensus        99 vRqyvkhnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen   99 VRQYVKHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHHHHhhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            99999999999998765  567778889999999999999999999999999999998877777777753322  12221


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCC----------C-CCCcchHHHHHHHHHHHHh-CCC
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL----------G-WTYPCDIWSVGCILVELCT-GEA  318 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslGv~l~el~t-G~~  318 (430)
                      .             +||+.-.....      --..|+|||.+...          . .+++-||||+||+++||++ |++
T Consensus       177 P-------------adf~fFFDTSr------RRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~P  237 (1431)
T KOG1240|consen  177 P-------------ADFTFFFDTSR------RRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRP  237 (1431)
T ss_pred             c-------------ccceEEEecCC------ceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCC
Confidence            1             34443321111      12369999988542          2 5678899999999999987 899


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||.-    .++-.....-...|+..+++                                            ..+..+++
T Consensus       238 lF~L----SQL~aYr~~~~~~~e~~Le~--------------------------------------------Ied~~~Rn  269 (1431)
T KOG1240|consen  238 LFTL----SQLLAYRSGNADDPEQLLEK--------------------------------------------IEDVSLRN  269 (1431)
T ss_pred             cccH----HHHHhHhccCccCHHHHHHh--------------------------------------------CcCccHHH
Confidence            9952    11111111111111211111                                            11225899


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcC
Q 014117          399 LLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      ||..|++.||++|++|++.|+-
T Consensus       270 lil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  270 LILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHHccCchhccCHHHHHHh
Confidence            9999999999999999999974

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=2.9e-22  Score=177.97  Aligned_cols=137  Identities=19%  Similarity=0.200  Sum_probs=102.3

Q ss_pred             EeeeccccceEEEEEEECCCCeEEEEEEecCchh---h------------------------HHHHHHHHHHHHHHHhcC
Q 014117           99 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---Y------------------------REAAMIEIEVLQQLAKHD  151 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~------------------------~~~~~~E~~~l~~l~~~~  151 (430)
                      ...||+|+||.||+|.+. +|+.||||+++....   .                        ......|.+.+.++.+..
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999987 899999999864311   0                        112234889999997644


Q ss_pred             CCCCceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhcCeeeccCCCCceEE
Q 014117          152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM-HDLCMIHTDLKPENVLL  229 (430)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~l-H~~~ivHrDlKp~NILl  229 (430)
                      ...|.+..      .. ..+|||||+ |+++...+...  ..++...+..++.|++.+|.++ |+.||+||||||+|||+
T Consensus        81 v~~p~~~~------~~-~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli  151 (190)
T cd05147          81 IPCPEPIL------LK-SHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLY  151 (190)
T ss_pred             CCCCcEEE------ec-CCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence            33333321      11 237999999 55555443222  3689999999999999999999 79999999999999999


Q ss_pred             eecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCcccc
Q 014117          230 VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE  273 (430)
Q Consensus       230 ~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~  273 (430)
                      +                            ++.++|+|||+|...
T Consensus       152 ~----------------------------~~~v~LiDFG~a~~~  167 (190)
T cd05147         152 H----------------------------DGKLYIIDVSQSVEH  167 (190)
T ss_pred             E----------------------------CCcEEEEEccccccC
Confidence            4                            246899999998743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=1.8e-22  Score=181.78  Aligned_cols=170  Identities=14%  Similarity=0.152  Sum_probs=123.0

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhH----HH------HHHHHHHHHHHHhcCCCCCceEEe
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EA------AMIEIEVLQQLAKHDKGGNRCVQI  160 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~----~~------~~~E~~~l~~l~~~~~~~~~i~~~  160 (430)
                      .+.++|++++.||.|+||.||++.+  ++..+|+|+++......    ..      +.+|+..+.++.+..     +...
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~G-----I~~~  100 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEG-----LASL  100 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCC-----CCcc
Confidence            4578999999999999999999755  35579999986322111    12      467888899996643     4443


Q ss_pred             cceee--------cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEee
Q 014117          161 RNWFD--------YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS  231 (430)
Q Consensus       161 ~~~~~--------~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~  231 (430)
                      ..++.        ..+..+|||||+ |.+|.++.      .+++    ....+|+.+|..||+.||+|||+||+||+++ 
T Consensus       101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~-  169 (232)
T PRK10359        101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS-  169 (232)
T ss_pred             eEeeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe-
Confidence            33322        235689999999 67897763      2333    2456999999999999999999999999994 


Q ss_pred             cCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHH
Q 014117          232 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILV  311 (430)
Q Consensus       232 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~  311 (430)
                                                .++ ++|+|||..........         ...+++...|+.++|+||||+++.
T Consensus       170 --------------------------~~g-i~liDfg~~~~~~e~~a---------~d~~vler~y~~~~di~~lg~~~~  213 (232)
T PRK10359        170 --------------------------KNG-LRIIDLSGKRCTAQRKA---------KDRIDLERHYGIKNEIKDLGYYLL  213 (232)
T ss_pred             --------------------------CCC-EEEEECCCcccccchhh---------HHHHHHHhHhcccccccceeEeeh
Confidence                                      344 89999997764422211         112445556888999999999987


Q ss_pred             HHH
Q 014117          312 ELC  314 (430)
Q Consensus       312 el~  314 (430)
                      .+.
T Consensus       214 ~~~  216 (232)
T PRK10359        214 IYK  216 (232)
T ss_pred             HHH
Confidence            654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.4e-22  Score=187.05  Aligned_cols=195  Identities=21%  Similarity=0.306  Sum_probs=146.0

Q ss_pred             cCCCCCceEEecceeec---------------------------CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHH
Q 014117          150 HDKGGNRCVQIRNWFDY---------------------------RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIA  202 (430)
Q Consensus       150 ~~~~~~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~  202 (430)
                      |...||||+.+...|.+                           +..+|+||..-..+|.+++..+.   .+....+-++
T Consensus       271 hLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~---~s~r~~~~~l  347 (598)
T KOG4158|consen  271 HLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH---RSYRTGRVIL  347 (598)
T ss_pred             ccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC---CchHHHHHHH
Confidence            34568999999887643                           24689999988899999998764   6777788899


Q ss_pred             HHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCC-------
Q 014117          203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-------  275 (430)
Q Consensus       203 ~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------  275 (430)
                      .|+++|+.|||++||.|||+|.+||||.-+.                       |.-..+.|+|||.+-....       
T Consensus       348 aQlLEav~hL~~hgvAhRDlKSDNiL~Eldd-----------------------D~~P~LVvaDFGCcLAd~~hGlqlpy  404 (598)
T KOG4158|consen  348 AQLLEAVTHLHKHGVAHRDLKSDNILLELDD-----------------------DEIPQLVVADFGCCLADDNHGLQLPY  404 (598)
T ss_pred             HHHHHHHHHHHHccchhhcccccceEEEecC-----------------------CCCcEEEEcccceeeecccccccccc
Confidence            9999999999999999999999999995432                       5566788899996642221       


Q ss_pred             --CCCeeeecCcccchhhhhCCC-----C-CCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHHHhCCCCHHHHH
Q 014117          276 --DQNYIVSTRHYRAPEVILGLG-----W-TYPCDIWSVGCILVELCTGEALFQTHENLEH--LAMMERVLGPLPQHMLK  345 (430)
Q Consensus       276 --~~~~~~gt~~y~aPE~~~~~~-----~-~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~--~~~i~~~~g~~p~~~~~  345 (430)
                        .....-|....||||+....+     . -.++|.|+.|.+.||+++...||.+..++..  ...-             
T Consensus       405 ~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq-------------  471 (598)
T KOG4158|consen  405 ESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ-------------  471 (598)
T ss_pred             ccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh-------------
Confidence              111235788899999987542     1 2578999999999999999999987443211  0111             


Q ss_pred             HHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCH---HHHhc
Q 014117          346 RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA---REALR  419 (430)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta---~elL~  419 (430)
                                                          +......++.+++.+++|+..+|+.||++|+++   +.+|+
T Consensus       472 ------------------------------------e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  472 ------------------------------------ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             ------------------------------------hhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence                                                111223456778899999999999999999984   45553

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.5e-21  Score=172.14  Aligned_cols=182  Identities=18%  Similarity=0.169  Sum_probs=132.5

Q ss_pred             EEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHH-----HHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           97 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE-----AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        97 ~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~-----~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      .+...|++|+||+|+++..  .+..++.+.+........     .+.+|+++|+++.++    ++++.++++    +..|
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~----~~vP~ll~~----~~~~   74 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGL----PRTPRLLHW----DGRH   74 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCC----CCCCEEEEE----cCEE
Confidence            4567899999999997754  566788777664433222     467899999999653    446666654    3469


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccC-CCCceEEeecCccccCCCcCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL-KPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDl-Kp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      ++|||+ |.+|.+.+..        . ...++.|++.+|.++|++||||||| ||+|||++                   
T Consensus        75 lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~-------------------  126 (218)
T PRK12274         75 LDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ-------------------  126 (218)
T ss_pred             EEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc-------------------
Confidence            999999 7788654321        1 1357889999999999999999999 79999994                   


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCCC----------------eeeecCcccchhhhhCC-CCC-CcchHHHHHHHHH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQN----------------YIVSTRHYRAPEVILGL-GWT-YPCDIWSVGCILV  311 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~----------------~~~gt~~y~aPE~~~~~-~~~-~~~DvwslGv~l~  311 (430)
                              .++.++|+|||+|........                ....++.|++|+...-. ..+ ...++++.|+-+|
T Consensus       127 --------~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~  198 (218)
T PRK12274        127 --------EDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVY  198 (218)
T ss_pred             --------CCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHH
Confidence                    445677777777764433221                11358889999875432 344 6679999999999


Q ss_pred             HHHhCCCCCCCCc
Q 014117          312 ELCTGEALFQTHE  324 (430)
Q Consensus       312 el~tG~~Pf~~~~  324 (430)
                      .++|+..|+-+++
T Consensus       199 ~~~~~~~~~~~~~  211 (218)
T PRK12274        199 RFVTRRVLHWEDN  211 (218)
T ss_pred             HHHhccCCccccC
Confidence            9999999886544

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=2.2e-21  Score=172.79  Aligned_cols=136  Identities=17%  Similarity=0.121  Sum_probs=100.7

Q ss_pred             EeeeccccceEEEEEEECCCCeEEEEEEecCchhh---------------------------HHHHHHHHHHHHHHHhcC
Q 014117           99 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY---------------------------REAAMIEIEVLQQLAKHD  151 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~---------------------------~~~~~~E~~~l~~l~~~~  151 (430)
                      .+.||+|+||.||+|.+. +|+.||||+++.....                           ......|.+.+.++.+..
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 8999999998743110                           112346788888887644


Q ss_pred             CCCCceEEecceeecCCeEEEEEecC-CCCHHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceE
Q 014117          152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYD-FLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVL  228 (430)
Q Consensus       152 ~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~-~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NIL  228 (430)
                      ...+..   +..    ...+|||||+ |+++.. .+..   ..++...+..++.|++.+|.++|+ .||+||||||+|||
T Consensus        81 i~~p~~---~~~----~~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIl  150 (190)
T cd05145          81 VPVPEP---ILL----KKNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNIL  150 (190)
T ss_pred             CCCceE---EEe----cCCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEE
Confidence            322222   211    1248999999 444433 3433   257888999999999999999999 99999999999999


Q ss_pred             EeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCcccc
Q 014117          229 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE  273 (430)
Q Consensus       229 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~  273 (430)
                      ++                            ++.++|+|||++...
T Consensus       151 l~----------------------------~~~~~liDFG~a~~~  167 (190)
T cd05145         151 YH----------------------------DGKPYIIDVSQAVEL  167 (190)
T ss_pred             EE----------------------------CCCEEEEEcccceec
Confidence            93                            356888888888654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=7.9e-21  Score=170.51  Aligned_cols=141  Identities=18%  Similarity=0.183  Sum_probs=110.6

Q ss_pred             EeeeccccceEEEEEEECCCCeEEEEEEecCc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC---eEE-EE
Q 014117           99 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN---HIC-IV  173 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~---~~~-lv  173 (430)
                      ...||+|+||.||.  +..++.. +||++... ........+|+.+++.+.+....++||+++++++++..   .++ +|
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            46799999999995  6666555 69987643 22446688999999999877777899999999998863   544 78


Q ss_pred             EecC---CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          174 FEKL---GSSLYDFLRKNNYRSFPIDLVREIARQLLECI-AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       174 ~e~~---~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL-~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |||+   +++|.+++.+.   .+++.  ..++.|++.++ +|||+++||||||||+|||++..+                
T Consensus        84 ~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~----------------  142 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRIS----------------  142 (210)
T ss_pred             ecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccC----------------
Confidence            9995   48999999653   46666  35688888888 999999999999999999996432                


Q ss_pred             CcccccCCCCCCeEEEeCCCc
Q 014117          250 SSYFKRMPKSSAIKVIDFGST  270 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a  270 (430)
                             +....++|+||+.+
T Consensus       143 -------~~~~~~~LiDg~G~  156 (210)
T PRK10345        143 -------ESEVIPVVCDNIGE  156 (210)
T ss_pred             -------CCCCcEEEEECCCC
Confidence                   34458999995443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=7.8e-21  Score=199.28  Aligned_cols=199  Identities=24%  Similarity=0.390  Sum_probs=153.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      ...|.|.+.||.|+||+||+|.... ++.||||+-+....+  ++..-.+++.+|.  ....+-|..+...+...+.-+|
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W--EfYI~~q~~~RLk--~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW--EFYICLQVMERLK--PQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce--eeeehHHHHHhhc--hhhhcchHHHHHHHccCCccee
Confidence            3579999999999999999999877 999999987643322  1122223333333  1111334555555566778889


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      |+||. -|+|.+++..  .+.+++..+..++.|++.-|++||.++|||+||||+|+||...-.   .|            
T Consensus       772 v~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~---~~------------  834 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREIC---AD------------  834 (974)
T ss_pred             eeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccC---CC------------
Confidence            99999 8999999984  358999999999999999999999999999999999999954311   11            


Q ss_pred             ccccCCCCCCeEEEeCCCccccC--CCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCC
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYER--PDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~--~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~  318 (430)
                           .....++|||||-+....  ++.   ...++|-.+-.+|...|.+++..+|.|.|+.+++.|+.|+.
T Consensus       835 -----~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  835 -----SDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             -----CcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence                 225579999999875432  222   23578999999999999999999999999999999999863

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.84  E-value=1.7e-21  Score=173.18  Aligned_cols=241  Identities=16%  Similarity=0.183  Sum_probs=181.3

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecC---chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ...++.+|.....|..|+|+...+  .++.|+++-   .......+..|.-.|+.+.     ||||..+++.+..+.++.
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifs-----hpnilpvlgacnsppnlv  263 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFS-----HPNILPVLGACNSPPNLV  263 (448)
T ss_pred             hhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeec-----CCchhhhhhhccCCCCce
Confidence            355677889999999999987544  467777652   2233345667777777774     488999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      ++..|| -|+|+..|+.......+-.++.+++.+|+.|+.|||+..  |.---|....++|+++-+++|           
T Consensus       264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltari-----------  332 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARI-----------  332 (448)
T ss_pred             EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhe-----------
Confidence            999999 889999999877666788899999999999999999875  444568888999965433222           


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCC---CcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWT---YPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                                    ..+|--++... ..   ..=.+.||+||.+...+-+   .++|+|||++++|||.|.+.||...+.
T Consensus       333 --------------smad~kfsfqe-~g---r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp  394 (448)
T KOG0195|consen  333 --------------SMADTKFSFQE-VG---RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP  394 (448)
T ss_pred             --------------ecccceeeeec-cc---cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc
Confidence                          22222222111 00   1226889999999887644   578999999999999999999998888


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      ++.-.+|.                                               ++.+....|+..+..+..|+.-|+.
T Consensus       395 mecgmkia-----------------------------------------------leglrv~ippgis~hm~klm~icmn  427 (448)
T KOG0195|consen  395 MECGMKIA-----------------------------------------------LEGLRVHIPPGISRHMNKLMNICMN  427 (448)
T ss_pred             hhhhhhhh-----------------------------------------------hccccccCCCCccHHHHHHHHHHhc
Confidence            77554432                                               1233344567888899999999999


Q ss_pred             cCCCCCCCHHHHh
Q 014117          406 YDPTDRLTAREAL  418 (430)
Q Consensus       406 ~dP~~R~ta~elL  418 (430)
                      .||.+||..+.++
T Consensus       428 edpgkrpkfdmiv  440 (448)
T KOG0195|consen  428 EDPGKRPKFDMIV  440 (448)
T ss_pred             CCCCcCCCcceeh
Confidence            9999999987653

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=6.2e-20  Score=168.61  Aligned_cols=141  Identities=21%  Similarity=0.161  Sum_probs=106.5

Q ss_pred             EEEEeeeccccceEEEEEE-ECCCCeEEEEEEecCchh-------------------------hHHHHHHHHHHHHHHHh
Q 014117           96 YKIHSKMGEGTFGQVLECW-DRERKEMVAIKIVRGIKK-------------------------YREAAMIEIEVLQQLAK  149 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~-~~~~~~~vAiK~~~~~~~-------------------------~~~~~~~E~~~l~~l~~  149 (430)
                      |.+.+.||.|+||.||+|. +..+|+.||+|+++....                         .......|+..+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            7888999999999999999 667899999999863211                         11234579999999965


Q ss_pred             cCCCCCceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-eeeccCCCCce
Q 014117          150 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC-MIHTDLKPENV  227 (430)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-ivHrDlKp~NI  227 (430)
                      ..   ..++.++.+    ...+|||||+ |.+|...+...  ..+....+..++.||+.+|.+||+.| |+||||||+||
T Consensus       110 ~~---i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NI  180 (237)
T smart00090      110 AG---VPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNI  180 (237)
T ss_pred             cC---CCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhE
Confidence            32   223333332    2348999999 55666554332  24666677899999999999999999 99999999999


Q ss_pred             EEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCcccc
Q 014117          228 LLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE  273 (430)
Q Consensus       228 Ll~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~  273 (430)
                      |+                           + .+.++|+|||.+...
T Consensus       181 li---------------------------~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      181 LV---------------------------H-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EE---------------------------E-CCCEEEEEChhhhcc
Confidence            99                           3 457899999988743

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.82  E-value=6.4e-21  Score=184.37  Aligned_cols=184  Identities=27%  Similarity=0.404  Sum_probs=128.8

Q ss_pred             CeEEEEEecC-CCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRK-NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      .++||.|++| ..+|.++|.. ......++.....++.|++.|++|   +|.+|||+||.||++..++.+||.|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            4789999999 8899999973 333567788899999999999999   9999999999999996555555555554433


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCc
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE  324 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~  324 (430)
                      .......                  .......+.-+||..||+||.+.+..|+.++||||||++|+||+. =...|.   
T Consensus       406 ~~~~~~~------------------~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---  464 (516)
T KOG1033|consen  406 QDKDETV------------------APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---  464 (516)
T ss_pred             cccCCcc------------------cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---
Confidence            2221100                  000001233589999999999999999999999999999999987 222222   


Q ss_pred             hHHHHHHHHH-HhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          325 NLEHLAMMER-VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       325 ~~~~~~~i~~-~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                         ....+.. .-|.+|+..+                                             .+ -++-.+|+.+|
T Consensus       465 ---r~~t~~d~r~g~ip~~~~---------------------------------------------~d-~p~e~~ll~~l  495 (516)
T KOG1033|consen  465 ---RIATLTDIRDGIIPPEFL---------------------------------------------QD-YPEEYTLLQQL  495 (516)
T ss_pred             ---HHHhhhhhhcCCCChHHh---------------------------------------------hc-CcHHHHHHHHh
Confidence               1111111 1122232111                                             11 12356899999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~  424 (430)
                      |...|.+||++.+.-.|.|.+
T Consensus       496 ls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  496 LSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             cCCCcccCchHHHHhhhhhcC
Confidence            999999999999988888863

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=4.9e-18  Score=153.83  Aligned_cols=132  Identities=22%  Similarity=0.274  Sum_probs=100.7

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCch---------hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      +.||+|++|.||+|..  .+..+++|+.....         ........|++++..+.+.....|     ..++...+..
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p-----~~~~~~~~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVP-----AVYFVDPENF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCC-----eEEEEeCCCC
Confidence            5789999999999987  56679999764211         112346678889988876432222     2223345678


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      ++||||+ |++|.+++....     . ....++.+++.+|.++|+.|++|||++|+|||++                   
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-------------------  129 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-------------------  129 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-------------------
Confidence            8999999 889999986532     2 7788999999999999999999999999999993                   


Q ss_pred             CcccccCCCCCCeEEEeCCCccc
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTY  272 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~  272 (430)
                               .+.++|+|||.+..
T Consensus       130 ---------~~~~~liDf~~a~~  143 (211)
T PRK14879        130 ---------GGKIYLIDFGLAEF  143 (211)
T ss_pred             ---------CCCEEEEECCcccC
Confidence                     35688999998765

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=1.1e-17  Score=150.06  Aligned_cols=135  Identities=24%  Similarity=0.258  Sum_probs=99.8

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh-----------------------hHHHHHHHHHHHHHHHhcCC
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-----------------------YREAAMIEIEVLQQLAKHDK  152 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-----------------------~~~~~~~E~~~l~~l~~~~~  152 (430)
                      |.+.+.||.|+||.||+|... +++.||||+++....                       .......|..++..+.+...
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            778899999999999999875 789999998753210                       11224567888888865421


Q ss_pred             CCCceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEee
Q 014117          153 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS  231 (430)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~  231 (430)
                         .++..+.    ....++||||+ |++|......        .....++.+++.++.++|+.||+||||||+||++  
T Consensus        96 ---~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill--  158 (198)
T cd05144          96 ---PVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV--  158 (198)
T ss_pred             ---CCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE--
Confidence               2233332    23458999999 7787654321        3456788999999999999999999999999999  


Q ss_pred             cCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCcccc
Q 014117          232 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE  273 (430)
Q Consensus       232 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~  273 (430)
                                               +.++.++|+|||.+...
T Consensus       159 -------------------------~~~~~~~liDfg~~~~~  175 (198)
T cd05144         159 -------------------------DDDEKIYIIDWPQMVST  175 (198)
T ss_pred             -------------------------cCCCcEEEEECCccccC
Confidence                                     45667888888887543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=1.7e-17  Score=148.93  Aligned_cols=129  Identities=21%  Similarity=0.252  Sum_probs=96.9

Q ss_pred             eeccccceEEEEEEECCCCeEEEEEEecCch---------hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117          101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus       101 ~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      .||+|+||.||+|..  .+..+++|+.....         ........|++++..+.+....   ++.++.  ...+..+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~---~p~~~~--~~~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVN---TPVVYD--VDPDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCC---CCEEEE--EECCCCE
Confidence            389999999999984  56779999854211         1124456799999998764322   233332  2345678


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ |++|.+++....  .       .++.|++.+|.+||+.|++|+|+||+|||++                    
T Consensus        74 lv~e~~~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~--------------------  124 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGN--D-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR--------------------  124 (199)
T ss_pred             EEEEEECCccHHHHHhhcH--H-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE--------------------
Confidence            999999 889998875532  1       7899999999999999999999999999993                    


Q ss_pred             cccccCCCCCCeEEEeCCCcccc
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYE  273 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~  273 (430)
                              .+.++++|||.+...
T Consensus       125 --------~~~~~liDfg~a~~~  139 (199)
T TIGR03724       125 --------DDKLYLIDFGLGKYS  139 (199)
T ss_pred             --------CCcEEEEECCCCcCC
Confidence                    456889999987653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=1.8e-19  Score=185.28  Aligned_cols=256  Identities=20%  Similarity=0.296  Sum_probs=183.6

Q ss_pred             cEEEEeeeccccceEEEEEEECCC-CeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRER-KEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~-~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .|.+.+.||+|+|+.|-++..... ...+|.|.+....   ........|..+-+.+.    .|.|++.+++........
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s----~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLS----KHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCcccccccccc----ccccccccCCccCCCccc
Confidence            377778899999999998877443 4457777665332   12222223444433432    267899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCeeeccCCCCceEEeecC-ccccCCCcCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSE-YIKVPDYKSSLHTP  247 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivHrDlKp~NILl~~~~-~~~i~dfg~~~~~~  247 (430)
                      ++++++. |+++++.+........+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .++++|||      
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~------  170 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFG------  170 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCch------
Confidence            9999999 889988874333235777888899999999999999 99999999999999997666 55555554      


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCC-CC-----Ceeee-cCcccchhhhhCCC-CCCcchHHHHHHHHHHHHhCCCC
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERP-DQ-----NYIVS-TRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEAL  319 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~-----~~~~g-t~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~tG~~P  319 (430)
                                           +|..... ..     ...+| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|
T Consensus       171 ---------------------~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p  229 (601)
T KOG0590|consen  171 ---------------------LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELP  229 (601)
T ss_pred             ---------------------hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCC
Confidence                                 4443222 11     12477 99999999998854 56888999999999999999999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      +.........                             ...|.+...               ......+...+....++
T Consensus       230 ~~~~~~~~~~-----------------------------~~~~~~~~~---------------~~~~~~~~~~~~~~~~~  265 (601)
T KOG0590|consen  230 WDFPSRKDGR-----------------------------YSSWKSNKG---------------RFTQLPWNSISDQAHDL  265 (601)
T ss_pred             cccccccccc-----------------------------ceeeccccc---------------ccccCccccCChhhhhc
Confidence            9753322100                             001111000               00011234556678899


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          400 LQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      +.++|..+|..|.+..++..+||+..
T Consensus       266 l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  266 LHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccccccCCchhccccccccccccccc
Confidence            99999999999999999999999987

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=8.4e-17  Score=165.68  Aligned_cols=135  Identities=22%  Similarity=0.235  Sum_probs=100.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEe-cC---ch-----hhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV-RG---IK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW  163 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~-~~---~~-----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~  163 (430)
                      ...|...+.||+|+||+||++......  +++|+. .+   ..     ...+.+..|++++..+.++     +++....+
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~-----~i~~p~~~  404 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRA-----GVPTPVIY  404 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhccc-----CCCeeEEE
Confidence            445567889999999999999875443  444432 11   11     1224567899999998653     33333334


Q ss_pred             eecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          164 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       164 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                      .......++||||+ |++|.+++.          ....++.|++.+|.+||+.||+||||||+|||++            
T Consensus       405 ~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~------------  462 (535)
T PRK09605        405 DVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR------------  462 (535)
T ss_pred             EEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE------------
Confidence            44456778999999 889998875          3467899999999999999999999999999992            


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccc
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTY  272 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~  272 (430)
                                      +..++|+|||+++.
T Consensus       463 ----------------~~~~~liDFGla~~  476 (535)
T PRK09605        463 ----------------DDRLYLIDFGLGKY  476 (535)
T ss_pred             ----------------CCcEEEEeCccccc
Confidence                            24688999998874

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=1.1e-16  Score=142.03  Aligned_cols=134  Identities=22%  Similarity=0.250  Sum_probs=91.0

Q ss_pred             EeeeccccceEEEEEEECCCCeEEEEEEecCchhh----HH---------------------HHHHHHHHHHHHHhcCCC
Q 014117           99 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY----RE---------------------AAMIEIEVLQQLAKHDKG  153 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~----~~---------------------~~~~E~~~l~~l~~~~~~  153 (430)
                      .+.||+|+||+||+|.+. +++.||||+++.....    ..                     ....|...+..+.+... 
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~-   79 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV-   79 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC-
Confidence            467999999999999886 7889999998642211    00                     01245556666654321 


Q ss_pred             CCceEEecceeecCCeEEEEEecC-CCCHH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEEe
Q 014117          154 GNRCVQIRNWFDYRNHICIVFEKL-GSSLY-DFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLV  230 (430)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~-~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl~  230 (430)
                        .+...+..    ...++||||+ ++.+. ..+....   .. ..+..++.+++.++.++|. .||+|+||||+||+++
T Consensus        80 --~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~  149 (187)
T cd05119          80 --PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD  149 (187)
T ss_pred             --CCCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence              12222222    2358999999 43321 1222111   11 5678899999999999999 9999999999999994


Q ss_pred             ecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccc
Q 014117          231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY  272 (430)
Q Consensus       231 ~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~  272 (430)
                                                  ++.++|+|||.+..
T Consensus       150 ----------------------------~~~~~liDfg~a~~  163 (187)
T cd05119         150 ----------------------------DGKVYIIDVPQAVE  163 (187)
T ss_pred             ----------------------------CCcEEEEECccccc
Confidence                                        45678888887753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.70  E-value=7.2e-17  Score=159.11  Aligned_cols=195  Identities=21%  Similarity=0.237  Sum_probs=140.4

Q ss_pred             CCceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCe-eeccCCCCceEEee
Q 014117          154 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM-IHTDLKPENVLLVS  231 (430)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i-vHrDlKp~NILl~~  231 (430)
                      |.|+.++++.+-++...++|.+|| -|+|.|.+.... ..+++.....++++|+.||.|+|.-.| .|+.++..|++++.
T Consensus         6 h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~   84 (484)
T KOG1023|consen    6 HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDS   84 (484)
T ss_pred             hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeee
Confidence            467899999999999999999999 899999998743 578888899999999999999998776 99999999999954


Q ss_pred             cCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCC-----CCCeeeecCcccchhhhhCCC-------CCC
Q 014117          232 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-----DQNYIVSTRHYRAPEVILGLG-------WTY  299 (430)
Q Consensus       232 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~-------~~~  299 (430)
                                                 ...+||+|||+......     ......-..-|.|||.+.+..       .+.
T Consensus        85 ---------------------------~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~  137 (484)
T KOG1023|consen   85 ---------------------------RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQ  137 (484)
T ss_pred             ---------------------------eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccc
Confidence                                       45556666665544321     111112245699999998742       467


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCCch----HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhh
Q 014117          300 PCDIWSVGCILVELCTGEALFQTHEN----LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV  375 (430)
Q Consensus       300 ~~DvwslGv~l~el~tG~~Pf~~~~~----~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (430)
                      +.|+||||++++|+++...||.....    .+....+.+ .+..+                    ..|.           
T Consensus       138 ~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~-~~~~~--------------------~rP~-----------  185 (484)
T KOG1023|consen  138 KGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK-GGSNP--------------------FRPS-----------  185 (484)
T ss_pred             cCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh-cCCCC--------------------cCcc-----------
Confidence            79999999999999999999975322    122222222 01100                    0000           


Q ss_pred             cCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHh
Q 014117          376 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL  418 (430)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL  418 (430)
                               ..... ...+++..+++.||..+|.+||+++++-
T Consensus       186 ---------i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~  218 (484)
T KOG1023|consen  186 ---------IELLN-ELPPELLLLVARCWEEIPEKRPSIEQIR  218 (484)
T ss_pred             ---------hhhhh-hcchHHHHHHHHhcccChhhCccHHHHH
Confidence                     00000 2334688999999999999999998764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.69  E-value=8.1e-18  Score=173.87  Aligned_cols=282  Identities=21%  Similarity=0.264  Sum_probs=197.9

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      .+.+.+-+-+|.++.++.+.-..++...++|+.............++..-..+ .+...+|.++.....+......+||+
T Consensus       805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~-~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNI-LITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCc-cccCCCCceecccCCCCCCCCcchhh
Confidence            36777788899999999998888887778777653332222111111111111 11122355555555566788999999


Q ss_pred             ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC-Ccc
Q 014117          175 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD-SSY  252 (430)
Q Consensus       175 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~-~~~  252 (430)
                      +|. +++|...|+..+  ..+.+.++.++..+..+++|||+..++|||++|.|+|+...|+.+++||+.....+.- ...
T Consensus       884 ~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~  961 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT  961 (1205)
T ss_pred             HHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence            999 889999888776  6788888999999999999999999999999999999999999999999843322111 110


Q ss_pred             cccCCCCCCeEEEeCCCccc---cC----CCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          253 FKRMPKSSAIKVIDFGSTTY---ER----PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~---~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                      -.. ......-.-+++....   ..    .......||+.|.+||.+.+......+|+|++|++++|.++|.+||...+.
T Consensus       962 ~~s-g~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen  962 DLS-GPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred             Ccc-cccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence            000 0000001111221110   00    112346899999999999999999999999999999999999999998776


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      ...+..|.                       ++...||..                       +...+.++.+++..+|.
T Consensus      1041 q~~f~ni~-----------------------~~~~~~p~g-----------------------~~~~s~~aq~~~~~ll~ 1074 (1205)
T KOG0606|consen 1041 QQIFENIL-----------------------NRDIPWPEG-----------------------PEEGSYEAQDLINRLLT 1074 (1205)
T ss_pred             hhhhhccc-----------------------cCCCCCCCC-----------------------ccccChhhhhhhhhhhc
Confidence            65554433                       234445542                       23556778999999999


Q ss_pred             cCCCCCCCHH---HHhcCCCCCCC
Q 014117          406 YDPTDRLTAR---EALRHPFFTRD  426 (430)
Q Consensus       406 ~dP~~R~ta~---elL~hp~f~~~  426 (430)
                      .+|.+|.++.   ++-.||||+.-
T Consensus      1075 ~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1075 EEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred             cCchhccCcccccccccCCccCCC
Confidence            9999999877   99999999864

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=8.8e-16  Score=130.50  Aligned_cols=133  Identities=24%  Similarity=0.314  Sum_probs=105.7

Q ss_pred             EEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 014117           98 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL  177 (430)
Q Consensus        98 ~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~  177 (430)
                      +++.||.|.++.||++....  ..+++|....... ...+..|..++..+.++   ...+++++.+.+..+..+++|||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~---~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARK---GLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHc---CCCCCeEEEEcCCCCccEEEEEec
Confidence            45789999999999998754  6799999865433 45677899999999875   245677777777778999999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          178 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL---CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       178 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                       +..+..+         +......++.+++.+|.++|..   +++|+|+||+|||++                       
T Consensus        76 ~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~-----------------------  123 (155)
T cd05120          76 EGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-----------------------  123 (155)
T ss_pred             CCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE-----------------------
Confidence             5555432         4566677899999999999985   699999999999994                       


Q ss_pred             ccCCCCCCeEEEeCCCccc
Q 014117          254 KRMPKSSAIKVIDFGSTTY  272 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~  272 (430)
                          ....++++|||.+..
T Consensus       124 ----~~~~~~l~Df~~~~~  138 (155)
T cd05120         124 ----DGKILGIIDWEYAGY  138 (155)
T ss_pred             ----CCcEEEEEecccccC
Confidence                345688889887763

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.66  E-value=2.3e-15  Score=138.55  Aligned_cols=134  Identities=20%  Similarity=0.192  Sum_probs=96.3

Q ss_pred             eeec-cccceEEEEEEECCCCeEEEEEEecCc--------------hhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117          100 SKMG-EGTFGQVLECWDRERKEMVAIKIVRGI--------------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus       100 ~~lG-~G~~g~V~~~~~~~~~~~vAiK~~~~~--------------~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      ..|| .||.|+||.+...  +..++||.+...              .........|++++..+.+....   ++..+...
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~---vP~pl~~~  111 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLP---VPRPIAAR  111 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCC---CceeEeee
Confidence            4577 8899999988664  667999987421              01234567799999999775432   33333332


Q ss_pred             ec-CC---eEEEEEecC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccC
Q 014117          165 DY-RN---HICIVFEKL-G-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP  238 (430)
Q Consensus       165 ~~-~~---~~~lv~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~  238 (430)
                      .. ..   ..++|||++ | .+|.+++...   .+++..    +.||+.+|.+||+.||+||||||+|||+         
T Consensus       112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv---------  175 (239)
T PRK01723        112 VVRHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILL---------  175 (239)
T ss_pred             eeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEE---------
Confidence            21 22   235999999 5 5899888653   455543    5789999999999999999999999999         


Q ss_pred             CCcCCCCCCCCCcccccCCCCCCeEEEeCCCccc
Q 014117          239 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY  272 (430)
Q Consensus       239 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~  272 (430)
                                        +.++.++|+|||.+..
T Consensus       176 ------------------~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        176 ------------------DPDGKFWLIDFDRGEL  191 (239)
T ss_pred             ------------------cCCCCEEEEECCCccc
Confidence                              3445799999998764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=6.4e-16  Score=152.57  Aligned_cols=259  Identities=21%  Similarity=0.255  Sum_probs=184.6

Q ss_pred             cCcEEEEeeecc--ccceEEEEEEE--CCCCeEEEEEEecC--c-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGE--GTFGQVLECWD--RERKEMVAIKIVRG--I-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~--G~~g~V~~~~~--~~~~~~vAiK~~~~--~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      ...|.+...+|.  |.+|.||.+..  ..++..+|+|.-+.  . ......-.+|+....++    ..+.+.+..+..++
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i----~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKI----DSHENPVRDSPAWE  188 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhccccc----CccccccccCcccc
Confidence            456788899999  99999999998  88899999997321  1 12222333444443333    23466778888889


Q ss_pred             cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHhcCeeeccCCCCceEEeec-CccccCCC
Q 014117          166 YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE----CIAFMHDLCMIHTDLKPENVLLVSS-EYIKVPDY  240 (430)
Q Consensus       166 ~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~----aL~~lH~~~ivHrDlKp~NILl~~~-~~~~i~df  240 (430)
                      ..+.+|+-+|+|+.+|..+..... .-++...++.++.+...    ||.++|+.+|+|-|+||.||++..+ ...++.||
T Consensus       189 ~~~~lfiqtE~~~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  189 GSGILFIQTELCGESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             cCCcceeeeccccchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence            999999999999999999987654 34888999999999999    9999999999999999999999765 44555555


Q ss_pred             cCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          241 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       241 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                      |+.                  .+|.|.+++...... ....|..-|++||...+ -++..+|++++|-++.+..+|..++
T Consensus       268 ~~v------------------~~i~~~~~~~~~~~~-~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~  327 (524)
T KOG0601|consen  268 GLV------------------SKISDGNFSSVFKVS-KRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLP  327 (524)
T ss_pred             cee------------------EEccCCccccceeee-ecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccc
Confidence            432                  122222222211111 11145667999998766 5889999999999999999987776


Q ss_pred             CCC--chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          321 QTH--ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       321 ~~~--~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ...  +...+...+     .+                                             ..++-...+.++..
T Consensus       328 ~~g~~~~W~~~r~~-----~i---------------------------------------------p~e~~~~~s~~l~~  357 (524)
T KOG0601|consen  328 SVGKNSSWSQLRQG-----YI---------------------------------------------PLEFCEGGSSSLRS  357 (524)
T ss_pred             cCCCCCCccccccc-----cC---------------------------------------------chhhhcCcchhhhh
Confidence            543  221111100     01                                             11223344556777


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          399 LLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      .+..|++.+|..|+++..++.|++...-
T Consensus       358 ~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  358 VTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             HHHHhcCcchhhhhHHHHHhccccccch
Confidence            8999999999999999999999998743

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=1.2e-13  Score=138.14  Aligned_cols=140  Identities=19%  Similarity=0.210  Sum_probs=94.0

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCchhh-----------------------------------H------HHHH
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-----------------------------------R------EAAM  138 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~-----------------------------------~------~~~~  138 (430)
                      +.||+|++|+||+|+.+ +|+.||||+.+.....                                   .      -.+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            56999999999999875 6889999997532100                                   0      0133


Q ss_pred             HHHHHHHHHHhcCCCCCce--EEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 014117          139 IEIEVLQQLAKHDKGGNRC--VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE-CIAFMHD  214 (430)
Q Consensus       139 ~E~~~l~~l~~~~~~~~~i--~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~-aL~~lH~  214 (430)
                      .|...+.++.....+.+++  +.++.  +.....+|||||+ |.+|.++..... ..++   ...++.+++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHh
Confidence            4555566665543333433  23332  2344579999999 888888765321 1222   2345556655 4788999


Q ss_pred             cCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCcccc
Q 014117          215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE  273 (430)
Q Consensus       215 ~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~  273 (430)
                      .|++|+|+||.||++                           ..++.++++|||++...
T Consensus       276 ~g~~H~D~hPgNilv---------------------------~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       276 DGFFHADLHPGNIFV---------------------------LKDGKIIALDFGIVGRL  307 (437)
T ss_pred             CCceeCCCCcccEEE---------------------------CCCCcEEEEeCCCeeEC
Confidence            999999999999999                           45567899999987644

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.50  E-value=3.5e-14  Score=143.64  Aligned_cols=150  Identities=19%  Similarity=0.312  Sum_probs=95.1

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-----------------------------------hhHH---
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-----------------------------------KYRE---  135 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----------------------------------~~~~---  135 (430)
                      ..|.. +.||+|++|+||+|+.+.+|+.||||+.+...                                   ....   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34665 78999999999999998889999999986321                                   0011   


Q ss_pred             ---HHHHHHHHHHHHHhcCCCCCceEEeccee-ecCCeEEEEEecC-CCCHHHH--HHhcCC--CCCCHHHHHHHHHHHH
Q 014117          136 ---AAMIEIEVLQQLAKHDKGGNRCVQIRNWF-DYRNHICIVFEKL-GSSLYDF--LRKNNY--RSFPIDLVREIARQLL  206 (430)
Q Consensus       136 ---~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-~~~~~~~lv~e~~-~~~L~~~--l~~~~~--~~l~~~~~~~i~~qi~  206 (430)
                         .+..|...+.++.....+.+. +.+-..+ +.....+|||||+ |+.+.++  +...+.  ..+.+..+..++.|++
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~-v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDM-LYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCC-eecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence               123344455555443322222 2222222 2345678999999 8888774  333221  1244444555555554


Q ss_pred             HHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCC
Q 014117          207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP  275 (430)
Q Consensus       207 ~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~  275 (430)
                             ..|++|+|+||.||+++.+|                       ...+.++++|||+.....+
T Consensus       278 -------~~GffHaDpHPGNIlv~~~g-----------------------~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 -------RDGFFHADMHPGNIFVSYDP-----------------------PENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -------hCCeeeCCCChHHeEEecCC-----------------------CCCCeEEEEecceEEECCH
Confidence                   58999999999999996544                       2334788888888765543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.46  E-value=1.4e-12  Score=115.12  Aligned_cols=136  Identities=17%  Similarity=0.190  Sum_probs=96.6

Q ss_pred             eeeccccceEEEEEEECC------CCeEEEEEEecCc--------------h---------hhHH----HHHHHHHHHHH
Q 014117          100 SKMGEGTFGQVLECWDRE------RKEMVAIKIVRGI--------------K---------KYRE----AAMIEIEVLQQ  146 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~------~~~~vAiK~~~~~--------------~---------~~~~----~~~~E~~~l~~  146 (430)
                      ..||.|.-+.||.|....      .+..+|||+.+..              .         ....    ....|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            568999999999998654      3578999987410              0         0111    23379999999


Q ss_pred             HHhcCCCCCceEEecceeecCCeEEEEEecCCCC-HH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhcCeeeccCC
Q 014117          147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSS-LY-DFLRKNNYRSFPIDLVREIARQLLECIAFM-HDLCMIHTDLK  223 (430)
Q Consensus       147 l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~-L~-~~l~~~~~~~l~~~~~~~i~~qi~~aL~~l-H~~~ivHrDlK  223 (430)
                      +.......|   ..+.+    ..-+|||||++++ +. ..+..   ..++......+..|++.+|..| |+.||||+||+
T Consensus        83 l~~~Gv~vP---~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs  152 (197)
T cd05146          83 MQKAGIPCP---EVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS  152 (197)
T ss_pred             HHHcCCCCC---eEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            988654444   43332    4567999999553 32 22322   1355666778889999999999 89999999999


Q ss_pred             CCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCcccc
Q 014117          224 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE  273 (430)
Q Consensus       224 p~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~  273 (430)
                      +.|||+.                            ++.++|+|||.+...
T Consensus       153 ~~NIL~~----------------------------~~~v~iIDF~qav~~  174 (197)
T cd05146         153 EYNMLWH----------------------------DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHHEEEE----------------------------CCcEEEEECCCceeC
Confidence            9999994                            246899999977543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.45  E-value=6.6e-13  Score=115.70  Aligned_cols=127  Identities=17%  Similarity=0.086  Sum_probs=91.2

Q ss_pred             EeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-
Q 014117           99 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-  177 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-  177 (430)
                      ++.|+.|.++.||++...  +..|++|+.............|..+++.+.....    +++++....  ...++|||++ 
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~----~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGI----GPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCC----CCceEEEeC--CCCeEEEEecC
Confidence            467899999999999764  6789999976443223345678999998876432    334444332  2347999999 


Q ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCe-----eeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          178 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM-----IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       178 ~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i-----vHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      |.++.+.          ......++.+++.+|..||+.++     +|+|+||+||+++                      
T Consensus        75 G~~l~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----------------------  122 (170)
T cd05151          75 GSELLTE----------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----------------------  122 (170)
T ss_pred             CCccccc----------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----------------------
Confidence            6565432          01123457899999999999885     9999999999994                      


Q ss_pred             cccCCCCCCeEEEeCCCcc
Q 014117          253 FKRMPKSSAIKVIDFGSTT  271 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~  271 (430)
                            .+.++++||+.+.
T Consensus       123 ------~~~~~liDf~~a~  135 (170)
T cd05151         123 ------DGRLWLIDWEYAG  135 (170)
T ss_pred             ------CCeEEEEeccccc
Confidence                  3468899998775

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.36  E-value=2.1e-12  Score=118.62  Aligned_cols=191  Identities=19%  Similarity=0.278  Sum_probs=130.9

Q ss_pred             CceEEecceeecC-----CeEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeccCCC
Q 014117          155 NRCVQIRNWFDYR-----NHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKP  224 (430)
Q Consensus       155 ~~i~~~~~~~~~~-----~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlKp  224 (430)
                      .|+++++.++.+.     ....++.||+ .++|.++|++.  ....+......+|+.||+.||.|||+..  |+|+.+..
T Consensus       127 snlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc  206 (458)
T KOG1266|consen  127 SNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTC  206 (458)
T ss_pred             HHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcch
Confidence            4578888877653     4688999999 89999999753  2356888889999999999999999876  99999999


Q ss_pred             CceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccC-------CCCCeeeecCcccchhhhhCCCC
Q 014117          225 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER-------PDQNYIVSTRHYRAPEVILGLGW  297 (430)
Q Consensus       225 ~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-------~~~~~~~gt~~y~aPE~~~~~~~  297 (430)
                      +-|++..+|-+|+                           .--.......       .......|-++|.|||.=.....
T Consensus       207 ~tifiq~ngLIki---------------------------g~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~  259 (458)
T KOG1266|consen  207 DTIFIQHNGLIKI---------------------------GSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT  259 (458)
T ss_pred             hheeecCCceEEe---------------------------cccCccccchhhhhhhHhhhhccccCCccccCCcCccccc
Confidence            9999955444333                           2111111000       01112245678999997666677


Q ss_pred             CCcchHHHHHHHHHHHHhCCCC-CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhc
Q 014117          298 TYPCDIWSVGCILVELCTGEAL-FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM  376 (430)
Q Consensus       298 ~~~~DvwslGv~l~el~tG~~P-f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (430)
                      +.++|||+||....+|..|..- =.+.+..+.-..+....-.                                      
T Consensus       260 ~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~--------------------------------------  301 (458)
T KOG1266|consen  260 TGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG--------------------------------------  301 (458)
T ss_pred             ccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheee--------------------------------------
Confidence            8899999999999999887642 2222211111111111100                                      


Q ss_pred             CchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCC
Q 014117          377 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~  424 (430)
                                    -....-++++.+||+-.|..||++.++|.||-+-
T Consensus       302 --------------len~lqr~~i~kcl~~eP~~rp~ar~llfHpllf  335 (458)
T KOG1266|consen  302 --------------LENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF  335 (458)
T ss_pred             --------------ccCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence                          0011236689999999999999999999999653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.32  E-value=1e-12  Score=130.07  Aligned_cols=250  Identities=21%  Similarity=0.183  Sum_probs=165.9

Q ss_pred             ecCcEEEEeeeccccceEEEEEEEC-CCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDR-ERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      ...+|..+..||.|.|+.|+.+..+ .++..|++|.+.+.   ...+.....|+.+...+..+    .+++.....+...
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~----~~~~g~~~~W~~~  338 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSH----LPSVGKNSSWSQL  338 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcc----cccCCCCCCcccc
Confidence            3567899999999999999998766 67888999976522   22233344566666665433    3345544445555


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      ...|+-.||| ++++...+.-.  ..+.+...+.+..|++.++.++|++.++|+|+||+||++.++|             
T Consensus       339 r~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-------------  403 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-------------  403 (524)
T ss_pred             ccccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-------------
Confidence            6667899999 77665544222  2578888999999999999999999999999999999997642             


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCccc--chhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR--APEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                   ...++.|||..+...-......++..+.  +++......+..++|++|||.-+.+.++|...=....
T Consensus       404 -------------~~~~~~~~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~  470 (524)
T KOG0601|consen  404 -------------FFSKLGDFGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV  470 (524)
T ss_pred             -------------hhhhccccccccccceecccccccccccccchhhccccccccccccccccccccccccCcccCcccc
Confidence                         3345566665543211111122333444  4555556678899999999999999998864322111


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      .   ...|.                       .|...                          .......++..+...++
T Consensus       471 ~---~~~i~-----------------------~~~~p--------------------------~~~~~~~~~q~~~kv~~  498 (524)
T KOG0601|consen  471 Q---SLTIR-----------------------SGDTP--------------------------NLPGLKLQLQVLLKVMI  498 (524)
T ss_pred             c---ceeee-----------------------ccccc--------------------------CCCchHHhhhhhhhhhc
Confidence            1   00010                       01000                          01122346778888999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~  425 (430)
                      ..++..|+.+.++..|+=|.+
T Consensus       499 ~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  499 NPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             CCccccchhhhhhcccchhhh
Confidence            999999999999998876643

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.25  E-value=2.7e-10  Score=97.13  Aligned_cols=145  Identities=23%  Similarity=0.176  Sum_probs=105.2

Q ss_pred             EEeeeccccceEEEEEEECCCCeEEEEEEec-C--------chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           98 IHSKMGEGTFGQVLECWDRERKEMVAIKIVR-G--------IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        98 ~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~-~--------~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .+..|-+|+-+.|+++..  .|+.+.||.-. +        .+-.+.+...|++.|.++.......|   .++  +.+..
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P---~l~--~~D~~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAP---RLI--FIDTY   83 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCc---eEE--EEecC
Confidence            467788999999999965  57777787531 1        12234566789999999877543333   333  23344


Q ss_pred             eEEEEEecCCC--CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          169 HICIVFEKLGS--SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       169 ~~~lv~e~~~~--~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      .-+|+|||+.|  ++.+++...............++.+|=..|.-||..+|||+||..+||++.+++             
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~-------------  150 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG-------------  150 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC-------------
Confidence            55688999955  889998776544444444478889999999999999999999999999997653             


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCcccc
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYE  273 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~  273 (430)
                                 ....+.++|||++...
T Consensus       151 -----------~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  151 -----------NQITPILIDFGLSSVS  166 (229)
T ss_pred             -----------CcCceEEEeecchhcc
Confidence                       4456789999998643

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.21  E-value=1.5e-10  Score=105.22  Aligned_cols=107  Identities=17%  Similarity=0.144  Sum_probs=72.3

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC---CeEEEEE
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---NHICIVF  174 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~---~~~~lv~  174 (430)
                      +.||.|.++.||++.... |+.+++|+......  .......|.++++.+.....   .+++++.+....   +..++||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~---~vp~~~~~~~~~~~~~~~~~v~   79 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGV---PVPKVLALCEDPSVLGTPFYVM   79 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCC---CCCCEEEECCCCCccCCceEEE
Confidence            568999999999998743 57899999764332  34567889999999976432   234444444432   3678999


Q ss_pred             ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 014117          175 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH  213 (430)
Q Consensus       175 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH  213 (430)
                      |++ |.++.+.+..   ..++......++.+++.+|..||
T Consensus        80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH  116 (223)
T cd05154          80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALH  116 (223)
T ss_pred             EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHh
Confidence            999 6666554321   13566666666777777777776

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.15  E-value=6.6e-10  Score=95.21  Aligned_cols=130  Identities=20%  Similarity=0.211  Sum_probs=91.3

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEe-cCc--------hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIV-RGI--------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~-~~~--------~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ..|++|+-+.+|.+..  -+..+++|.- ++.        +-...+...|..++.++.....+   ++.+++  .+....
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~---~P~v~d--vD~~~~   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVP---VPIVYD--VDPDNG   74 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCC---CCeEEE--EcCCCC
Confidence            3578899999999854  3334667742 211        11235567799999999775433   344443  345667


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      .|+|||+ |..|.+++...     .    ..++..|=.-+.-||..||||+||.++||++..                  
T Consensus        75 ~I~me~I~G~~lkd~l~~~-----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~------------------  127 (204)
T COG3642          75 LIVMEYIEGELLKDALEEA-----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSG------------------  127 (204)
T ss_pred             EEEEEEeCChhHHHHHHhc-----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeC------------------
Confidence            7999999 55777788764     1    345566666678899999999999999999942                  


Q ss_pred             CcccccCCCCCCeEEEeCCCcccc
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYE  273 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~  273 (430)
                                ..+.++|||++...
T Consensus       128 ----------~~i~~IDfGLg~~s  141 (204)
T COG3642         128 ----------GRIYFIDFGLGEFS  141 (204)
T ss_pred             ----------CcEEEEECCccccc
Confidence                      34899999998743

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.10  E-value=5.1e-09  Score=97.64  Aligned_cols=140  Identities=18%  Similarity=0.065  Sum_probs=95.3

Q ss_pred             EEEEEECCCCeEEEEEEecCchh------------hHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--CCeEEEEEe
Q 014117          110 VLECWDRERKEMVAIKIVRGIKK------------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIVFE  175 (430)
Q Consensus       110 V~~~~~~~~~~~vAiK~~~~~~~------------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--~~~~~lv~e  175 (430)
                      |+++.  ..|+.|.||.......            ....+..|...+.++.......|..+-+...-..  ...-+||||
T Consensus        38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            55543  2566788887642221            1113678999999998766554544333211111  345789999


Q ss_pred             cCCC--CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          176 KLGS--SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       176 ~~~~--~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      ++++  +|.+++........+......++.+++..+.-||..||+|+|++++|||++.+..                   
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~-------------------  176 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFP-------------------  176 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEecccc-------------------
Confidence            9944  7999886433235667778899999999999999999999999999999963100                   


Q ss_pred             ccCCCCCCeEEEeCCCcc
Q 014117          254 KRMPKSSAIKVIDFGSTT  271 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~  271 (430)
                       .......+.+|||+.+.
T Consensus       177 -~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        177 -GREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             -CCCCCceEEEEECCccc
Confidence             00234679999999775

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.03  E-value=2.8e-09  Score=107.06  Aligned_cols=168  Identities=17%  Similarity=0.258  Sum_probs=115.5

Q ss_pred             EEEECCCCeEEEEEEecCchh-hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecCCCCHHHHHHhcCC
Q 014117          112 ECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNY  190 (430)
Q Consensus       112 ~~~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~  190 (430)
                      .|..+.++..|.|...+.... ......+-++.|+.++|     |+|++++..++..+.+|||+|.+- .|..++...  
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRH-----P~Il~yL~t~e~~~~~ylvTErV~-Pl~~~lk~l--  101 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRH-----PNILSYLDTTEEEGTLYLVTERVR-PLETVLKEL--  101 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccC-----chhhhhhhhhcccCceEEEeeccc-cHHHHHHHh--
Confidence            455566777888887764433 22334455677777755     889999999999999999999883 355566543  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHH-hcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCC
Q 014117          191 RSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS  269 (430)
Q Consensus       191 ~~l~~~~~~~i~~qi~~aL~~lH-~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~  269 (430)
                         ....+..-+.||+.||.||| ..+++|++|.-+-|+++..|.+|+.+|.+....+.                  |+-
T Consensus       102 ---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~------------------~~~  160 (690)
T KOG1243|consen  102 ---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASG------------------FNA  160 (690)
T ss_pred             ---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEecccc------------------CCc
Confidence               36677778999999999998 56799999999999997777666665543321111                  110


Q ss_pred             ccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhC
Q 014117          270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG  316 (430)
Q Consensus       270 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG  316 (430)
                            ......--..|..|+.+....  ...|.|-|||+++|++.|
T Consensus       161 ------~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  161 ------PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ------ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence                  001111122356666543222  457999999999999999

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.02  E-value=9.4e-11  Score=117.91  Aligned_cols=164  Identities=20%  Similarity=0.328  Sum_probs=111.3

Q ss_pred             HHHHHHHHHHh-cCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeee
Q 014117          204 QLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVS  282 (430)
Q Consensus       204 qi~~aL~~lH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~g  282 (430)
                      +++.||.|+|. .++||+.|.|++|.++..|.+|++-|+.+........+        ....=|+++.-.       ..-
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~--------p~~~yd~~lp~~-------~~~  171 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEY--------PFSEYDPPLPLL-------LQP  171 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCcc--------ccccCCCCCChh-------hcc
Confidence            34489999994 67999999999999988888877777655433322111        111112222211       123


Q ss_pred             cCcccchhhhhCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCccc
Q 014117          283 TRHYRAPEVILGLGWTYPCDIWSVGCILVELC-TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD  361 (430)
Q Consensus       283 t~~y~aPE~~~~~~~~~~~DvwslGv~l~el~-tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  361 (430)
                      ...|.|||++.+...+.++|++|+||++|.+. .|+..|...+..... .+....+..+                     
T Consensus       172 ~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~~~~---------------------  229 (700)
T KOG2137|consen  172 HLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLLNAG---------------------  229 (700)
T ss_pred             CcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcccccc---------------------
Confidence            56799999999988899999999999999999 466555543222111 1111111100                     


Q ss_pred             CCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          362 WPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                                             ........+.++++=|.++|..++.-||++.+++..|||++--
T Consensus       230 -----------------------~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~  272 (700)
T KOG2137|consen  230 -----------------------AFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG  272 (700)
T ss_pred             -----------------------cccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence                                   0011246778899999999999999999999999999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.02  E-value=1.8e-09  Score=95.10  Aligned_cols=126  Identities=26%  Similarity=0.311  Sum_probs=77.6

Q ss_pred             EEEEEEECCCCeEEEEEEecCc---------------------------hhhHHHHHHHHHHHHHHHhcCCCCCceEEec
Q 014117          109 QVLECWDRERKEMVAIKIVRGI---------------------------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIR  161 (430)
Q Consensus       109 ~V~~~~~~~~~~~vAiK~~~~~---------------------------~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~  161 (430)
                      .||.|... .+..+|+|+.+..                           .........|.+.|.++.....   +++..+
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv---~vP~p~   76 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGV---PVPKPY   76 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT----SS--EE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCc---cCCcEE
Confidence            38888764 5678999987310                           0012345578888888866543   344444


Q ss_pred             ceeecCCeEEEEEecCC--CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHhcCeeeccCCCCceEEeecCccccC
Q 014117          162 NWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIARQLLECIAF-MHDLCMIHTDLKPENVLLVSSEYIKVP  238 (430)
Q Consensus       162 ~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~-lH~~~ivHrDlKp~NILl~~~~~~~i~  238 (430)
                      .+.    ..+|||||++  |.....|...   .++......++.+++..+.. +|+.||||+||.+.|||++        
T Consensus        77 ~~~----~~~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~--------  141 (188)
T PF01163_consen   77 DYN----RNVIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD--------  141 (188)
T ss_dssp             EEE----TTEEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE--------
T ss_pred             EEe----CCEEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee--------
Confidence            332    2369999996  6433334332   12245566788888886665 5799999999999999994        


Q ss_pred             CCcCCCCCCCCCcccccCCCCCCeEEEeCCCcccc
Q 014117          239 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE  273 (430)
Q Consensus       239 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~  273 (430)
                                         .+ .+.|||||.+...
T Consensus       142 -------------------~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  142 -------------------DG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             -------------------TT-CEEE--GTTEEET
T ss_pred             -------------------cc-eEEEEecCcceec
Confidence                               22 7999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.94  E-value=5e-08  Score=95.44  Aligned_cols=165  Identities=17%  Similarity=0.242  Sum_probs=121.8

Q ss_pred             ceEEEEEEECCCCeEEEEEEecCchh-hHHHHHHHHHHHHHHHhcCCCCCceEEecceeec----CCeEEEEEecC--CC
Q 014117          107 FGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNHICIVFEKL--GS  179 (430)
Q Consensus       107 ~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~--~~  179 (430)
                      -.+.|+|....+|..|++|.+...+. .......-++..+++.|     .|+|++.+.|..    ...+++|++|.  .+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h-----~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCH-----TNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhcc-----CceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            45679999999999999999953321 12223344677778755     789999888873    45789999997  66


Q ss_pred             CHHHHHHhc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          180 SLYDFLRKN-------------NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       180 ~L~~~l~~~-------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +|.++.-..             .+.+.+++.++.|+.||..||.++|+.|..-+-|.|.+||+                 
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv-----------------  426 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV-----------------  426 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe-----------------
Confidence            887765321             12457899999999999999999999999889999999999                 


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~  317 (430)
                                ....+++|...|+......+.    +       |.+.+   -.+-|.=.||.+++.|.||.
T Consensus       427 ----------~G~~RIriS~C~i~Dvl~~d~----~-------~~le~---~Qq~D~~~lG~ll~aLAt~~  473 (655)
T KOG3741|consen  427 ----------TGKMRIRISGCGIMDVLQEDP----T-------EPLES---QQQNDLRDLGLLLLALATGT  473 (655)
T ss_pred             ----------eCcceEEEecccceeeecCCC----C-------cchhH---HhhhhHHHHHHHHHHHhhcc
Confidence                      444577887777655443332    0       11111   24569999999999999995

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.92  E-value=3.9e-08  Score=93.91  Aligned_cols=191  Identities=15%  Similarity=0.212  Sum_probs=119.1

Q ss_pred             EeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecce------eec-CCeEE
Q 014117           99 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW------FDY-RNHIC  171 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~------~~~-~~~~~  171 (430)
                      .+.||+|+-+.+|-.-.-   ...+.|++.+.....+..  .++.|...-.    ++-+..-+.|      ... ...+.
T Consensus        16 gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aq--k~a~la~~p~----~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQ--KVAELAATPD----APLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             CccccCCccceeeecchh---hchhheeecCCCchHHHH--HHHHhccCCC----CcchhhhhcccHHHhhCCCccceeE
Confidence            467899999999965322   224567775433222211  1222222211    1111110111      111 23488


Q ss_pred             EEEecC-CC-CHHHHHHh----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          172 IVFEKL-GS-SLYDFLRK----NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       172 lv~e~~-~~-~L~~~l~~----~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      ++|+.+ |. .+.+++.-    +...-+.|..+.+.++.|+.+..-||+.|.+-+|+.++|+|+.+++.+.+.|-     
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVds-----  161 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDS-----  161 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcc-----
Confidence            999988 33 45555432    12234678999999999999999999999999999999999977665555432     


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhh-----CCCCCCcchHHHHHHHHHHHHhC-CCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTG-EAL  319 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tG-~~P  319 (430)
                                    ....|++-|.-      ....+|...|.+||.-.     +..-+...|.|.|||++++|+.| +.|
T Consensus       162 --------------Dsfqi~~ng~~------~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHP  221 (637)
T COG4248         162 --------------DSFQINANGTL------HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHP  221 (637)
T ss_pred             --------------cceeeccCCce------EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCC
Confidence                          01112221111      11237889999999765     33456788999999999999886 999


Q ss_pred             CCCC
Q 014117          320 FQTH  323 (430)
Q Consensus       320 f~~~  323 (430)
                      |.+.
T Consensus       222 ysGI  225 (637)
T COG4248         222 YSGI  225 (637)
T ss_pred             CCcc
Confidence            9873

>PRK09902 hypothetical protein; Provisional

Probab=98.83  E-value=1.9e-07  Score=82.95  Aligned_cols=125  Identities=11%  Similarity=0.093  Sum_probs=91.9

Q ss_pred             ccccceEEEEEEECCCCeEEEEEEec----Cc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--CCeEEEE
Q 014117          103 GEGTFGQVLECWDRERKEMVAIKIVR----GI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIV  173 (430)
Q Consensus       103 G~G~~g~V~~~~~~~~~~~vAiK~~~----~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--~~~~~lv  173 (430)
                      |+||.+.|+.....  |+.|-+|.-.    .+   ......+..|...+.++.......|.++ ..+.-..  .-.-+||
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            67888889886542  3357777642    11   2245678899999999988766545444 2221111  2356899


Q ss_pred             EecCC--CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEe
Q 014117          174 FEKLG--SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV  230 (430)
Q Consensus       174 ~e~~~--~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~  230 (430)
                      +|-++  .+|.+++......+.+......++.+|+..|.-||+.|+.|+|+-+.|||++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~  162 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVK  162 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeec
Confidence            99885  5999998775544567777889999999999999999999999999999995

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.75  E-value=1e-07  Score=85.79  Aligned_cols=113  Identities=26%  Similarity=0.305  Sum_probs=83.4

Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCceEEecceeec-CCeEEEEEecC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Q 014117          134 REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-RNHICIVFEKL-G-SSLYDFLRKNNYRSFPIDLVREIARQLLECIA  210 (430)
Q Consensus       134 ~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~  210 (430)
                      ......|...+..+......-|..+-+...-.. ....+||+|++ + .+|.+++....  .++......++.+++..+.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence            346778999999998766554444333221111 13568999999 4 37999988744  2667778899999999999


Q ss_pred             HHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccc
Q 014117          211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY  272 (430)
Q Consensus       211 ~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~  272 (430)
                      -||..||+|+|+++.|||++.++                        ....+.++||+.+..
T Consensus       133 ~lH~~gi~H~Dl~~~NILv~~~~------------------------~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHDAGIYHGDLNPSNILVDPDD------------------------GQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHCcCCCCCCCcccEEEeCCC------------------------CceeEEEEcchhcee
Confidence            99999999999999999996431                        234789999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.67  E-value=2.4e-07  Score=84.31  Aligned_cols=134  Identities=28%  Similarity=0.353  Sum_probs=92.5

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEec-------Cch----------------hhHHHHHHHHHHHHHHHhcCC
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-------GIK----------------KYREAAMIEIEVLQQLAKHDK  152 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~-------~~~----------------~~~~~~~~E~~~l~~l~~~~~  152 (430)
                      ..+..+||-|.-|.||.|.+. .+..+|||.=+       +.+                -.+.....|.++|.+|.....
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            456789999999999999876 67789999632       000                112345678999999865421


Q ss_pred             CCCceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEee
Q 014117          153 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS  231 (430)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~  231 (430)
                         .++.-++    -+...+|||++ |-.|...       +++.+....++..|+.-+.-+-..||||+|+.+=|||+  
T Consensus       172 ---~VP~P~~----~nRHaVvMe~ieG~eL~~~-------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV--  235 (304)
T COG0478         172 ---KVPKPIA----WNRHAVVMEYIEGVELYRL-------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV--  235 (304)
T ss_pred             ---CCCCccc----cccceeeeehcccceeecc-------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE--
Confidence               1222222    35667999999 5454332       23455556666777777666668999999999999999  


Q ss_pred             cCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCcc
Q 014117          232 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT  271 (430)
Q Consensus       232 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~  271 (430)
                                               +.++.+.++||--+.
T Consensus       236 -------------------------~~dg~~~vIDwPQ~v  250 (304)
T COG0478         236 -------------------------TEDGDIVVIDWPQAV  250 (304)
T ss_pred             -------------------------ecCCCEEEEeCcccc
Confidence                                     455678888886544

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.59  E-value=1.2e-06  Score=79.89  Aligned_cols=82  Identities=21%  Similarity=0.214  Sum_probs=56.4

Q ss_pred             EeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-
Q 014117           99 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-  177 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-  177 (430)
                      ++.|+.|..+.||++....  ..+++|+.... ........|..+++.+..+....|.++............+++|+++ 
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4678999999999998765  47999998654 4456677899999999876542333332211223345689999999 


Q ss_pred             CCCHHH
Q 014117          178 GSSLYD  183 (430)
Q Consensus       178 ~~~L~~  183 (430)
                      |..+..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            556555

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.59  E-value=1.8e-07  Score=94.51  Aligned_cols=127  Identities=17%  Similarity=0.221  Sum_probs=78.9

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCch-----------------------------------hhH------HHHH
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-----------------------------------KYR------EAAM  138 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----------------------------------~~~------~~~~  138 (430)
                      ..|+.++-|+||+|+.+. |+.||||+.+..-                                   ...      -...
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            678999999999999764 8999999863110                                   000      0123


Q ss_pred             HHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-CCCHHHH--HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 014117          139 IEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDF--LRKNNYRSFPIDLVREIARQLLECIAFMHDL  215 (430)
Q Consensus       139 ~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~--l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~  215 (430)
                      .|...+.+++....+.+.+.-=.-+.+..+.-.|+|||+ |-.+.+.  +...   .++...+.....++  -+.-+=..
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d~k~ia~~~~~~--f~~q~~~d  284 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---GIDRKELAELLVRA--FLRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc---CCCHHHHHHHHHHH--HHHHHHhc
Confidence            466667777666555554322222234456778999999 6677776  4443   34433332222221  12333348


Q ss_pred             CeeeccCCCCceEEeec
Q 014117          216 CMIHTDLKPENVLLVSS  232 (430)
Q Consensus       216 ~ivHrDlKp~NILl~~~  232 (430)
                      |+.|.|.+|.||++..+
T Consensus       285 gffHaDpHpGNi~v~~~  301 (517)
T COG0661         285 GFFHADPHPGNILVRSD  301 (517)
T ss_pred             CccccCCCccceEEecC
Confidence            99999999999999543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.56  E-value=1.7e-06  Score=78.13  Aligned_cols=136  Identities=16%  Similarity=0.150  Sum_probs=91.0

Q ss_pred             EeeeccccceEEEEEEECCCCeEEEEEEecCchh-------------------------hHHHHHHHHHHHHHHHhcCCC
Q 014117           99 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------------------------YREAAMIEIEVLQQLAKHDKG  153 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------------------------~~~~~~~E~~~l~~l~~~~~~  153 (430)
                      ...|++|.-+.||+|.. ..+..+|+|+++....                         ...-...|..-|.++......
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            34677888889999975 4678899999852211                         011234577778887664322


Q ss_pred             CCceEEecceeecCCeEEEEEecCCCCH--HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEEe
Q 014117          154 GNRCVQIRNWFDYRNHICIVFEKLGSSL--YDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLV  230 (430)
Q Consensus       154 ~~~i~~~~~~~~~~~~~~lv~e~~~~~L--~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl~  230 (430)
                         +++-+.+    ..-.|||||+|..-  .-.|..   ..+..+.+..+..++++.+.-|-. .++||+||..=|||+.
T Consensus       132 ---vP~Pi~~----~~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~  201 (268)
T COG1718         132 ---VPEPIAF----RNNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH  201 (268)
T ss_pred             ---CCCceee----cCCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence               2222222    23359999995541  111221   123444788889999999988876 8999999999999993


Q ss_pred             ecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCcccc
Q 014117          231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE  273 (430)
Q Consensus       231 ~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~  273 (430)
                                                  .+.+.|||||-|...
T Consensus       202 ----------------------------~~~p~iID~~QaV~~  216 (268)
T COG1718         202 ----------------------------DGEPYIIDVSQAVTI  216 (268)
T ss_pred             ----------------------------CCeEEEEECcccccc
Confidence                                        467899999987643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.52  E-value=2.3e-06  Score=78.15  Aligned_cols=72  Identities=11%  Similarity=0.125  Sum_probs=51.0

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecCCC
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS  179 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~  179 (430)
                      ..||.|..+.||+.    .+..+++|+..... .......|.+++..+......   ++..+.+.+..+..++|||++.|
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glp---vP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIP---TPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCC---CCceEEEEecCCeeeeeeeecCC
Confidence            56899999999984    23457899876422 334467899999998754432   34555556667778899999944

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.50  E-value=2.5e-06  Score=76.16  Aligned_cols=127  Identities=19%  Similarity=0.204  Sum_probs=78.7

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHH----------HHHHHHHHHHHHhcCCCCC---ceE
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----------AMIEIEVLQQLAKHDKGGN---RCV  158 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~----------~~~E~~~l~~l~~~~~~~~---~i~  158 (430)
                      +.++|++.+.+-......|.+-.  ..++.+++|..+......++          ..+++..+..+....-..+   .++
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            45689999998887777777764  35677999987532211111          2233444444433211111   112


Q ss_pred             EecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEe
Q 014117          159 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV  230 (430)
Q Consensus       159 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~  230 (430)
                      .....+......+|||||+ |..|.++..      +++    .+...|..++.-||+.|+.|+|.+|+|+++.
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~  169 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS  169 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE
Confidence            1122223345667999999 767766532      333    2446677889999999999999999999994

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.49  E-value=4.9e-06  Score=73.95  Aligned_cols=123  Identities=16%  Similarity=0.255  Sum_probs=92.6

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCch-----------------hhHHHHHHHHHHHHHHH-hcCCCCCceEEec
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-----------------KYREAAMIEIEVLQQLA-KHDKGGNRCVQIR  161 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----------------~~~~~~~~E~~~l~~l~-~~~~~~~~i~~~~  161 (430)
                      ..||+|+.-.||.--   .+....||+++...                 ....+...|+.-...+. .......+|.+++
T Consensus         7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            568999999999742   33447899886433                 23466778888888888 7777778899999


Q ss_pred             ceeecCCeEEEEEecC-------CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeec
Q 014117          162 NWFDYRNHICIVFEKL-------GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS  232 (430)
Q Consensus       162 ~~~~~~~~~~lv~e~~-------~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~  232 (430)
                      ++.++.--+.+|+|.+       +.+|.+++...   .++. .....   +-.-.+||-+.+|+.+||+|.||++...
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRR  154 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEec
Confidence            9999999999999976       23688888654   3655 33333   3334567889999999999999999754

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.49  E-value=1e-08  Score=102.36  Aligned_cols=245  Identities=16%  Similarity=0.086  Sum_probs=159.1

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCc-eEEecceeecCCeEEEEE
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR-CVQIRNWFDYRNHICIVF  174 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~-i~~~~~~~~~~~~~~lv~  174 (430)
                      +...+.+++|+++.+++.+...+...+ .+.+...    ....-++++|.++.+     || .+..++.++.+.+..++|
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~-----P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNN-----PNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccC-----CCCcccccccCCcccccchhh
Confidence            445566889999999999887776655 7776543    333456788888844     44 556666677788999999


Q ss_pred             ecC-CC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          175 EKL-GS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       175 e~~-~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      +++ ++ +........ ...+..-+...+.+.-..+|+++|+.-=+|+|    ||+..+                     
T Consensus       314 ~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~---------------------  367 (829)
T KOG0576|consen  314 RICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE---------------------  367 (829)
T ss_pred             hhhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc---------------------
Confidence            999 33 221111000 01122333445666777899999988779998    888643                     


Q ss_pred             cccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA  330 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~  330 (430)
                             ...+..||+........  .....+|+.++|||+.....++...|.|++|+--.++.-|.+|-.....  .. 
T Consensus       368 -------~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~-  437 (829)
T KOG0576|consen  368 -------EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VL-  437 (829)
T ss_pred             -------cccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--cc-
Confidence                   34566666665544433  4556889999999999999999999999999877777777776643100  00 


Q ss_pred             HHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCC
Q 014117          331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD  410 (430)
Q Consensus       331 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~  410 (430)
                         ...|.-|                    +-+.  +...                ..+...  .-.++...|+..-|..
T Consensus       438 ---~~~g~~p--------------------~s~~--L~~~----------------~aw~~~--~~~~~~~~~~~g~P~~  474 (829)
T KOG0576|consen  438 ---PMIGNGP--------------------NSPM--LTDK----------------SAWSPV--FHRDFPAPCLNGLPPT  474 (829)
T ss_pred             ---CCCCCCC--------------------Cccc--cchh----------------hhcCcc--cccCCcccccCCCCCC
Confidence               0000000                    0000  0000                000000  1124678899999999


Q ss_pred             CCCHHHHhcCCCCCCCCCC
Q 014117          411 RLTAREALRHPFFTRDHLR  429 (430)
Q Consensus       411 R~ta~elL~hp~f~~~~~~  429 (430)
                      |+++..++.|.+|.++++|
T Consensus       475 pkv~mgacfsKvfngCpl~  493 (829)
T KOG0576|consen  475 PKVHMGACFSKVFNGCPLR  493 (829)
T ss_pred             CcchhhHHHHHHhccCccc
Confidence            9999999999999998875

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.33  E-value=3.4e-05  Score=68.09  Aligned_cols=119  Identities=19%  Similarity=0.276  Sum_probs=84.1

Q ss_pred             CcEEEEeeeccccc-eEEEEEEECCCCeEEEEEEecC------------ch----------hhHHHHHHHHHHHHHHHhc
Q 014117           94 SRYKIHSKMGEGTF-GQVLECWDRERKEMVAIKIVRG------------IK----------KYREAAMIEIEVLQQLAKH  150 (430)
Q Consensus        94 ~~y~~~~~lG~G~~-g~V~~~~~~~~~~~vAiK~~~~------------~~----------~~~~~~~~E~~~l~~l~~~  150 (430)
                      .+++.++.||.|.- |.||++..  .|+.||||+.+.            ..          .....+..|.+...+|...
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            67999999999999 99999965  577999999320            00          1123466799999999876


Q ss_pred             CCCCCceEEecceeecC------------------CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 014117          151 DKGGNRCVQIRNWFDYR------------------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM  212 (430)
Q Consensus       151 ~~~~~~i~~~~~~~~~~------------------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~l  212 (430)
                      ...+.--+++++|+--.                  ....||.||+...-          .++.    .-+.+|.+-|..+
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~  180 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKIL  180 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHH
Confidence            54333348888887211                  23467888763221          1222    2356677788999


Q ss_pred             HhcCeeeccCCCCceE
Q 014117          213 HDLCMIHTDLKPENVL  228 (430)
Q Consensus       213 H~~~ivHrDlKp~NIL  228 (430)
                      |..||+-+|+|+.|..
T Consensus       181 ~k~gI~~~Dv~~~ny~  196 (207)
T PF13095_consen  181 HKLGIVPRDVKPRNYR  196 (207)
T ss_pred             HHCCeeeccCcccccc
Confidence            9999999999999987

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.19  E-value=1.3e-05  Score=85.90  Aligned_cols=202  Identities=24%  Similarity=0.306  Sum_probs=124.2

Q ss_pred             HHHHHHHHHHHHHhcCCCCCceEEecceeecCC----eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Q 014117          136 AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA  210 (430)
Q Consensus       136 ~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~  210 (430)
                      ....|...+..+.|.+     +...+.+--...    .+.+..++| ..++...++..+  ..+.+.++.+..+++.||.
T Consensus       228 ~~E~e~~~l~k~~~~n-----~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~  300 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDN-----LGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLA  300 (1351)
T ss_pred             HHHHHHHHHHhhcccc-----ccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHH
Confidence            3445666677776543     444433332222    222334567 668888887765  7899999999999999999


Q ss_pred             HHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEE--eCCCccccCCCCCe--eeecCcc
Q 014117          211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI--DFGSTTYERPDQNY--IVSTRHY  286 (430)
Q Consensus       211 ~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~--Dfg~a~~~~~~~~~--~~gt~~y  286 (430)
                      |+|+..       -.|+.+..+...                 ....+......++  ||+...........  ..-+..+
T Consensus       301 ~~h~~~-------l~~v~L~~s~~~-----------------~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~  356 (1351)
T KOG1035|consen  301 YLHSLS-------LEHVVLSASSSK-----------------ESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIR  356 (1351)
T ss_pred             HHHHhc-------cceeEEeccccc-----------------ccccCccceeecchhhhcccccCCCcccchhhcCcccc
Confidence            999884       344444322100                 0001333344444  66655543332211  2335567


Q ss_pred             cchhhhhCCCCCCc--chHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCC
Q 014117          287 RAPEVILGLGWTYP--CDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPE  364 (430)
Q Consensus       287 ~aPE~~~~~~~~~~--~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  364 (430)
                      .++|......++.+  .|+|.+|.+...+..|..+-....      .+...++                           
T Consensus       357 ~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~------~~~~~l~---------------------------  403 (1351)
T KOG1035|consen  357 NADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA------VPVSLLD---------------------------  403 (1351)
T ss_pred             ccccccccccchhhhhhHHHHHHHHHhhhhhcCccccccc------chhhhhc---------------------------
Confidence            88888777666544  699999999999988764332110      0000000                           


Q ss_pred             CCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          365 GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                                               ..+..+..+++.+|+.-++++|+++.+++.|+|.+-.
T Consensus       404 -------------------------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  404 -------------------------VLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP  440 (1351)
T ss_pred             -------------------------cccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence                                     1111157788999999999999999999999998743

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.18  E-value=2.3e-05  Score=72.49  Aligned_cols=73  Identities=15%  Similarity=0.071  Sum_probs=49.5

Q ss_pred             eccccc-eEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-CC
Q 014117          102 MGEGTF-GQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS  179 (430)
Q Consensus       102 lG~G~~-g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~  179 (430)
                      |-.|.+ +.||+....  +..+.+|+.....  ......|+++++.+..+ ..   +++++.+....+..++|||++ |.
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~-~~---vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGK-LP---VPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhc-CC---CCeEEEEEecCCccEEEEEeeCCc
Confidence            444554 788998653  3568889876432  33466799999998765 22   556666666666788999999 65


Q ss_pred             CHH
Q 014117          180 SLY  182 (430)
Q Consensus       180 ~L~  182 (430)
                      +|.
T Consensus        78 ~l~   80 (244)
T cd05150          78 PAA   80 (244)
T ss_pred             cHh
Confidence            554

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.14  E-value=2.4e-05  Score=71.94  Aligned_cols=73  Identities=14%  Similarity=0.075  Sum_probs=44.1

Q ss_pred             eeeccccce-EEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhc-CCCCCceEEecceeec---CCeEEEEE
Q 014117          100 SKMGEGTFG-QVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH-DKGGNRCVQIRNWFDY---RNHICIVF  174 (430)
Q Consensus       100 ~~lG~G~~g-~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~-~~~~~~i~~~~~~~~~---~~~~~lv~  174 (430)
                      +.|+.|+.. .||+..     ..+++|+.+. .........|.+++..+... ....|   ..+...+.   ....++||
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP---~~~~~~~~~~~~~~~~~l~   73 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVP---EPLGKGEPGEGYPWPWSVY   73 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCC---ceeecCCCccCCCcceEEE
Confidence            567777766 489762     2477887654 22344678899999998753 22223   33332222   23458899


Q ss_pred             ecC-CCCH
Q 014117          175 EKL-GSSL  181 (430)
Q Consensus       175 e~~-~~~L  181 (430)
                      +++ |.++
T Consensus        74 ~~i~G~~l   81 (235)
T cd05155          74 RWLEGETA   81 (235)
T ss_pred             EeecCCCC
Confidence            998 5444

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=98.08  E-value=7.7e-05  Score=81.11  Aligned_cols=79  Identities=15%  Similarity=0.088  Sum_probs=51.9

Q ss_pred             EeeeccccceEEEEEEECCCC--eEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC---CeEE
Q 014117           99 HSKMGEGTFGQVLECWDRERK--EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---NHIC  171 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~--~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~---~~~~  171 (430)
                      +..|+.|.+..+|+......+  ..+++|+.....  ........|.++++.+..+.  ...+++++.++.+.   +..|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~--~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHT--DVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcC--CCCCCcEEEEecCCCcCCCce
Confidence            577899999999998765432  457788764322  12345678999999996421  12245556655543   5678


Q ss_pred             EEEecCCC
Q 014117          172 IVFEKLGS  179 (430)
Q Consensus       172 lv~e~~~~  179 (430)
                      +|||++.|
T Consensus       121 lVME~v~G  128 (822)
T PLN02876        121 YIMEYLEG  128 (822)
T ss_pred             EEEEecCC
Confidence            99999943

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.02  E-value=0.00016  Score=71.19  Aligned_cols=76  Identities=22%  Similarity=0.223  Sum_probs=53.4

Q ss_pred             EeeeccccceEEEEEEECCCCeEEEEEEecC------c--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           99 HSKMGEGTFGQVLECWDRERKEMVAIKIVRG------I--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~------~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .+.||.|.+..||++.+...++.|+||.-..      .  ....++...|.+.|..+.....  ..+++++.+.  .+..
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p--~~VPkV~~~D--~~~~  106 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVP--DLVPKVYHYD--EELA  106 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCC--CCCCeEEEEC--CCCC
Confidence            4679999999999999875546899998421      1  1234566778888888765422  3466666653  3557


Q ss_pred             EEEEecCC
Q 014117          171 CIVFEKLG  178 (430)
Q Consensus       171 ~lv~e~~~  178 (430)
                      ++|||++.
T Consensus       107 ~lVME~L~  114 (401)
T PRK09550        107 VTVMEDLS  114 (401)
T ss_pred             EEEEecCC
Confidence            89999983

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.95  E-value=8.9e-05  Score=63.56  Aligned_cols=131  Identities=24%  Similarity=0.263  Sum_probs=86.2

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      .++.+.||.|.+|.||+|..  .+..+|+|+-+ .+..+..+..|.++|..+.....    -.+++.+-.    .++.||
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr-~ds~r~~l~kEakiLeil~g~~~----~p~vy~yg~----~~i~me   92 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRR-RDSPRRNLEKEAKILEILAGEGV----TPEVYFYGE----DFIRME   92 (201)
T ss_pred             hhhhhhhhcccccEEEEeec--cCceEEEEEec-CCcchhhHHHHHHHHHHhhhcCC----CceEEEech----hhhhhh
Confidence            45678899999999999976  45579999765 34456678889999998865432    234444332    235699


Q ss_pred             cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCC-CC-ceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          176 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLK-PE-NVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlK-p~-NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      |+ |..|.+.-...     +.    +-...++..---|-..||-|..|. |. ||++                       
T Consensus        93 ~i~G~~L~~~~~~~-----~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv-----------------------  140 (201)
T COG2112          93 YIDGRPLGKLEIGG-----DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV-----------------------  140 (201)
T ss_pred             hhcCcchhhhhhcc-----cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEe-----------------------
Confidence            99 66877654321     22    223344555444667899998886 44 4444                       


Q ss_pred             cccCCCCCCeEEEeCCCccccC
Q 014117          253 FKRMPKSSAIKVIDFGSTTYER  274 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~  274 (430)
                           .+..+.||||-.|+...
T Consensus       141 -----~~~~~~iIDFd~At~k~  157 (201)
T COG2112         141 -----NDRDVYIIDFDSATFKK  157 (201)
T ss_pred             -----cCCcEEEEEccchhhcc
Confidence                 23378999999887443

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.90  E-value=0.00019  Score=65.79  Aligned_cols=75  Identities=15%  Similarity=0.305  Sum_probs=46.4

Q ss_pred             EeeeccccceEEEEEEECC-CCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 014117           99 HSKMGEGTFGQVLECWDRE-RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL  177 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~-~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~  177 (430)
                      ++.|..|-...||++.... .++.|++|+.............|..++..+.....    .++++...+.    .+||||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl----~P~v~~~~~~----~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGL----APKLYATFQN----GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCC----CCeEEEEeCC----cEEEEee
Confidence            4567788888999986543 34678899775332221223468888888876443    2344433332    3799998


Q ss_pred             -CCCH
Q 014117          178 -GSSL  181 (430)
Q Consensus       178 -~~~L  181 (430)
                       |.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence             5443

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.90  E-value=7.9e-05  Score=75.44  Aligned_cols=145  Identities=14%  Similarity=0.124  Sum_probs=87.6

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCc--------------------------------hhhHH------HHHHHH
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGI--------------------------------KKYRE------AAMIEI  141 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------------------------------~~~~~------~~~~E~  141 (430)
                      +.||.-+.|.||+|+.+. |+.||||+=+..                                +...+      .+..|.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            579999999999999876 899999984210                                00011      123344


Q ss_pred             HHHHHHHhcCCCCC-----ceEEecceeecCCeEEEEEecC-CCCHH--HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 014117          142 EVLQQLAKHDKGGN-----RCVQIRNWFDYRNHICIVFEKL-GSSLY--DFLRKNNYRSFPIDLVREIARQLLECIAFMH  213 (430)
Q Consensus       142 ~~l~~l~~~~~~~~-----~i~~~~~~~~~~~~~~lv~e~~-~~~L~--~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH  213 (430)
                      +-..++++...+..     .|++++..  ....-.|+|||| |..+.  +.+.+.   .++...+...+.+...  +-|=
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~--~qIf  318 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYL--EQIF  318 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHH--HHHH
Confidence            44444433221111     13444432  345678999999 65444  445554   3666544433333322  2233


Q ss_pred             hcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCC
Q 014117          214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP  275 (430)
Q Consensus       214 ~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~  275 (430)
                      ..|++|+|-+|.||++..++                       ..+..+.+-|||+......
T Consensus       319 ~~GffHaDPHPGNilv~~~~-----------------------~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  319 KTGFFHADPHPGNILVRPNP-----------------------EGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             hcCCccCCCCCCcEEEecCC-----------------------CCCccEEEEcccccccccH
Confidence            57899999999999996432                       3467889999998765433

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.66  E-value=0.00071  Score=64.38  Aligned_cols=78  Identities=12%  Similarity=0.047  Sum_probs=48.7

Q ss_pred             EeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEe-cc--eeecCCeEEEEEe
Q 014117           99 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI-RN--WFDYRNHICIVFE  175 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~-~~--~~~~~~~~~lv~e  175 (430)
                      ++.|..|....+|+....  +..+++|+...  ........|++++..+..+....+.++.. -+  +....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            567778888899998543  34689998764  23345667888888887654322222221 11  1133456789999


Q ss_pred             cC-CCC
Q 014117          176 KL-GSS  180 (430)
Q Consensus       176 ~~-~~~  180 (430)
                      ++ |..
T Consensus        95 ~i~G~~  100 (296)
T cd05153          95 FLAGEH  100 (296)
T ss_pred             eCCCCC
Confidence            99 434

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.65  E-value=0.0015  Score=62.97  Aligned_cols=75  Identities=12%  Similarity=0.011  Sum_probs=45.5

Q ss_pred             EeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEec-c--eeecCCeEEEEEe
Q 014117           99 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR-N--WFDYRNHICIVFE  175 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~-~--~~~~~~~~~lv~e  175 (430)
                      ++.|+.|....+|+.... ++ .+++|++..  ........|..++..|.......|.++... +  +....+..+++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeC-CC-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            355777888899998643 33 589998752  223344557788888866543333333211 1  1123567789999


Q ss_pred             cC
Q 014117          176 KL  177 (430)
Q Consensus       176 ~~  177 (430)
                      ++
T Consensus       103 ~l  104 (319)
T PRK05231        103 FL  104 (319)
T ss_pred             ec
Confidence            98

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.64  E-value=0.00026  Score=65.98  Aligned_cols=69  Identities=13%  Similarity=0.004  Sum_probs=42.0

Q ss_pred             eccccceEEEEEEECCCCeEEEEEEecCchhhH-HHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-CC
Q 014117          102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS  179 (430)
Q Consensus       102 lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~-~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~  179 (430)
                      +..|-...+|+..  .+++.+++|+........ .....|.++++.+..... .|.+   +....    -++||||+ |.
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~-~P~~---i~~~~----~~~v~e~i~G~   73 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGL-APKP---ILVNE----HWLLVEWLEGE   73 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCC-CCce---EEEeC----CEEEEEeccCc
Confidence            4567788899886  345678889764322111 134678999999976532 2333   32222    26899998 44


Q ss_pred             C
Q 014117          180 S  180 (430)
Q Consensus       180 ~  180 (430)
                      .
T Consensus        74 ~   74 (256)
T TIGR02721        74 V   74 (256)
T ss_pred             c
Confidence            4

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.63  E-value=0.00058  Score=65.26  Aligned_cols=74  Identities=15%  Similarity=0.128  Sum_probs=45.7

Q ss_pred             eeeccccceEEEEEEECC------CCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117          100 SKMGEGTFGQVLECWDRE------RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~------~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      +.|..|-...||++....      .++.|++|+.............|.+++..+.....    .++++..+..    .+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~----~P~~~~~~~~----~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNL----GPKLYGIFPN----GRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCC----CCceEEEeCC----Cch
Confidence            456666677888886543      25779999976433333345678889999876542    2344444432    257


Q ss_pred             EecC-CCCH
Q 014117          174 FEKL-GSSL  181 (430)
Q Consensus       174 ~e~~-~~~L  181 (430)
                      +||+ |..+
T Consensus        76 ~e~i~G~~l   84 (302)
T cd05156          76 EEFIPSRTL   84 (302)
T ss_pred             hheeCCCcC
Confidence            8887 4443

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.57  E-value=0.0018  Score=62.08  Aligned_cols=78  Identities=12%  Similarity=-0.014  Sum_probs=46.8

Q ss_pred             EEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecc---eeecCCeEEEE
Q 014117           97 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN---WFDYRNHICIV  173 (430)
Q Consensus        97 ~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~---~~~~~~~~~lv  173 (430)
                      ..+..++.|....||++.. .++ .+++|+..... .......|.+++..|.......+.++....   .....+..++|
T Consensus        25 ~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l  101 (307)
T TIGR00938        25 LSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL  101 (307)
T ss_pred             eeccccCCccccceEEEEe-CCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence            3456677887889998864 233 58899875422 123455678888888664432233322111   11234678899


Q ss_pred             EecC
Q 014117          174 FEKL  177 (430)
Q Consensus       174 ~e~~  177 (430)
                      |+++
T Consensus       102 ~e~i  105 (307)
T TIGR00938       102 VEFL  105 (307)
T ss_pred             EEeC
Confidence            9998

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.57  E-value=0.0011  Score=63.25  Aligned_cols=137  Identities=21%  Similarity=0.249  Sum_probs=93.4

Q ss_pred             EEEeeeccccceEEEEEEECCCCeEEEEEEecCc---------------------------hhhHHHHHHHHHHHHHHHh
Q 014117           97 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---------------------------KKYREAAMIEIEVLQQLAK  149 (430)
Q Consensus        97 ~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------------------------~~~~~~~~~E~~~l~~l~~  149 (430)
                      .|..-|..|.-+.||.|.. ..|..+|||+++.+                           +....-+..|++-|+++..
T Consensus       147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            3455688899999999975 46777999987421                           1112234568888888876


Q ss_pred             cCCCCCceEEecceeecCCeEEEEEecCCCC--HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCeeeccCCCCc
Q 014117          150 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSS--LYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPEN  226 (430)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~--L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivHrDlKp~N  226 (430)
                      .....|--+.+       ....|||+|+|.+  -.-.|..   ..++...+..+-.|++.-+.-|- ..++||.||.-=|
T Consensus       226 aGIP~PePIlL-------k~hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN  295 (520)
T KOG2270|consen  226 AGIPCPEPILL-------KNHVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN  295 (520)
T ss_pred             cCCCCCCceee-------ecceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence            54433322222       2345999999543  1222222   25777788888888888887765 5679999999999


Q ss_pred             eEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccc
Q 014117          227 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY  272 (430)
Q Consensus       227 ILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~  272 (430)
                      +|+.                            ++.+.|||-+-+.-
T Consensus       296 ~Lyh----------------------------dG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  296 LLYH----------------------------DGKLYIIDVSQSVE  313 (520)
T ss_pred             heEE----------------------------CCEEEEEEcccccc
Confidence            9983                            56789999886643

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.43  E-value=0.002  Score=62.26  Aligned_cols=73  Identities=21%  Similarity=0.259  Sum_probs=48.6

Q ss_pred             eeccccceEEEEEEECCCCeEEEEEEec----C----chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117          101 KMGEGTFGQVLECWDRERKEMVAIKIVR----G----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus       101 ~lG~G~~g~V~~~~~~~~~~~vAiK~~~----~----~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      .||.|....||++.+..+++.|+||.-.    .    ......+...|.+.|+......+  ..+++++.+  ++....+
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P--~~vP~vy~~--D~e~~~~   77 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVP--HLVPRIFHF--DTEMAVT   77 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCc--cccCeEEEE--cccccee
Confidence            5799999999999986544689999732    1    12233455678888877655332  345565543  3455668


Q ss_pred             EEecC
Q 014117          173 VFEKL  177 (430)
Q Consensus       173 v~e~~  177 (430)
                      |||++
T Consensus        78 vMEdL   82 (370)
T TIGR01767        78 VMEDL   82 (370)
T ss_pred             hHhhC
Confidence            99998

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.25  E-value=0.0022  Score=62.72  Aligned_cols=75  Identities=24%  Similarity=0.346  Sum_probs=51.4

Q ss_pred             EeeeccccceEEEEEEECCCCeEEEEEEe----cC---chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           99 HSKMGEGTFGQVLECWDRERKEMVAIKIV----RG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~----~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ++.||.|.-..||++.+...++.|+||.-    +.   -.....+...|.+.|+......+  ..+++++.+  ++....
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P--~~VP~vy~~--D~e~~~  109 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAP--GLVPKVYLF--DSVMNC  109 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCC--CcCCeEEEE--CcHHhh
Confidence            67889999999999998544567999963    21   12234566778888888766432  345566543  345566


Q ss_pred             EEEecC
Q 014117          172 IVFEKL  177 (430)
Q Consensus       172 lv~e~~  177 (430)
                      +|||++
T Consensus       110 ~vMEdL  115 (409)
T PRK12396        110 CVMEDL  115 (409)
T ss_pred             HHHHhC
Confidence            888888

>PLN02236 choline kinase

Probab=97.16  E-value=0.0051  Score=59.91  Aligned_cols=75  Identities=15%  Similarity=0.081  Sum_probs=44.3

Q ss_pred             EeeeccccceEEEEEEECC----CCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117           99 HSKMGEGTFGQVLECWDRE----RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~----~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      +..|-.|-.-.+|++....    .++.|++|+........-....|..+++.+...... |   ++++.+..+    .|.
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~-P---~~~~~~~~g----~v~  112 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQG-P---RLLGRFPNG----RVE  112 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCC-C---ceEEEECCc----eEE
Confidence            3455557788899886432    246789998754322222235689999998775542 2   334444332    578


Q ss_pred             ecC-CCCH
Q 014117          175 EKL-GSSL  181 (430)
Q Consensus       175 e~~-~~~L  181 (430)
                      +|+ +.+|
T Consensus       113 efi~g~~l  120 (344)
T PLN02236        113 EFIHARTL  120 (344)
T ss_pred             EeeCCCCC
Confidence            887 4343

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.15  E-value=0.0043  Score=59.12  Aligned_cols=77  Identities=12%  Similarity=0.007  Sum_probs=40.8

Q ss_pred             EEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC--eEE
Q 014117           97 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--HIC  171 (430)
Q Consensus        97 ~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~--~~~  171 (430)
                      .+++.+..|..-.+|...+.  ++.+++. ....   ........+|..+++.+.....   -+...++.+.++.  ..+
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~v---P~p~~~~~~~~~~~g~pf  101 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDV---PVPRAFGLCGEGYLGTPF  101 (321)
T ss_pred             ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCC---CCcccccccccCCCCCce
Confidence            34455544444455655443  6667777 3311   1122334456777777654322   2344455554443  778


Q ss_pred             EEEecCCC
Q 014117          172 IVFEKLGS  179 (430)
Q Consensus       172 lv~e~~~~  179 (430)
                      .||+++.|
T Consensus       102 ~v~~~veG  109 (321)
T COG3173         102 YVMEWVEG  109 (321)
T ss_pred             EEEEEecc
Confidence            99999833

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.13  E-value=0.00084  Score=63.13  Aligned_cols=130  Identities=20%  Similarity=0.259  Sum_probs=84.9

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEec-------C--chh--------------hHHHHHHHHHHHHHHHhcCC
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-------G--IKK--------------YREAAMIEIEVLQQLAKHDK  152 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~-------~--~~~--------------~~~~~~~E~~~l~~l~~~~~  152 (430)
                      +.+.+.||-|.-+.||.+-+. .|+..++|+-+       .  .+.              .+-....|...|+.|..+.-
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            577889999999999999765 56778888631       0  000              11234568888888876543


Q ss_pred             CCCceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEee
Q 014117          153 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS  231 (430)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~  231 (430)
                      ..|   .-+    +.+..|+|||++ |-.|.+.-+-        ..+..+...+..-+.-|-.+|+||+|..-=||++..
T Consensus       173 pVP---kpi----D~~RH~Vvmelv~g~Pl~~v~~v--------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  173 PVP---KPI----DHNRHCVVMELVDGYPLRQVRHV--------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCC---Ccc----cccceeeHHHhhcccceeeeeec--------CChHHHHHHHHHHHHHHHHcCceecccchheeEEec
Confidence            222   221    235678999998 6676554321        122344555555566788899999999999999965


Q ss_pred             cCccccCCCc
Q 014117          232 SEYIKVPDYK  241 (430)
Q Consensus       232 ~~~~~i~dfg  241 (430)
                      ++.+.+.||.
T Consensus       238 d~~i~vIDFP  247 (465)
T KOG2268|consen  238 DDKIVVIDFP  247 (465)
T ss_pred             CCCEEEeech
Confidence            5555444443

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.12  E-value=0.00036  Score=77.04  Aligned_cols=128  Identities=14%  Similarity=0.053  Sum_probs=95.1

Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhcC-----eeeccCCCCceEEeecCccccC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYR--SFPIDLVREIARQLLECIAFMHDLC-----MIHTDLKPENVLLVSSEYIKVP  238 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~-----ivHrDlKp~NILl~~~~~~~i~  238 (430)
                      ....+.+++++ +|.+++.+-+...+  .+...-+.....+.+.+..-+|+..     .+|++||+-|.+|         
T Consensus      1303 s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmI--------- 1373 (2724)
T KOG1826|consen 1303 STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMI--------- 1373 (2724)
T ss_pred             ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccce---------
Confidence            45678999999 99999988764322  2333334444444477777877532     7999999999999         


Q ss_pred             CCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh
Q 014117          239 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT  315 (430)
Q Consensus       239 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t  315 (430)
                                        ....++|++++|+.+...+..   ...++++.|++|++...-.++.++|+|..|+.+|++--
T Consensus      1374 ------------------Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1374 ------------------VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             ------------------ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence                              455667778888877444433   22467889999999988889999999999999999988


Q ss_pred             CCCCCC
Q 014117          316 GEALFQ  321 (430)
Q Consensus       316 G~~Pf~  321 (430)
                      |..+|-
T Consensus      1436 ~n~~fi 1441 (2724)
T KOG1826|consen 1436 GNAYFI 1441 (2724)
T ss_pred             ccHHHH
Confidence            877763

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.92  E-value=0.012  Score=57.01  Aligned_cols=70  Identities=13%  Similarity=0.219  Sum_probs=41.0

Q ss_pred             eeeccccceEEEEEEECCC---CeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEec
Q 014117          100 SKMGEGTFGQVLECWDRER---KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK  176 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~  176 (430)
                      +.|..|-...+|++.....   +..|++|+........-....|..+++.+......    ++++.++.. +   +|.+|
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~----P~~l~~~~~-G---~i~~f   91 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFG----AKLLGVFGN-G---MIQSF   91 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCC----CceeEEeCC-c---Eeehh
Confidence            4444477778888865432   23688998753322222235688899998775533    234444432 2   57787


Q ss_pred             C
Q 014117          177 L  177 (430)
Q Consensus       177 ~  177 (430)
                      +
T Consensus        92 i   92 (330)
T PLN02421         92 I   92 (330)
T ss_pred             h
Confidence            7

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.89  E-value=0.008  Score=60.00  Aligned_cols=89  Identities=25%  Similarity=0.260  Sum_probs=63.2

Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCc
Q 014117          299 YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL  378 (430)
Q Consensus       299 ~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  378 (430)
                      +++||||+|.++.++.-|...+......+....+.+.. ..+.....-..+.                            
T Consensus       110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~-~~d~~~~~~a~e~----------------------------  160 (725)
T KOG1093|consen  110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYY-TDDQELLSTAMEH----------------------------  160 (725)
T ss_pred             cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhc-cCchhHHHHHHHH----------------------------
Confidence            49999999999999999998888777777776665543 2222221111111                            


Q ss_pred             hhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCC
Q 014117          379 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~  424 (430)
                              .+.-..+..+..++.+|+-..|..||...++..|+-|+
T Consensus       161 --------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~  198 (725)
T KOG1093|consen  161 --------LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFT  198 (725)
T ss_pred             --------HHHHhhhHhHHHHhccCCccccccccchhHHhcCccHH
Confidence                    01112344578899999999999999999999988775

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.86  E-value=0.012  Score=55.43  Aligned_cols=46  Identities=26%  Similarity=0.141  Sum_probs=29.4

Q ss_pred             ccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhc
Q 014117          103 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH  150 (430)
Q Consensus       103 G~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~  150 (430)
                      ++|-...|+.+. ...|+.+++|.-+. .........|.+++..+..+
T Consensus        20 ~~g~~~~v~~i~-~~~g~~~VlR~p~~-~~~~~~l~rE~~vL~~L~~~   65 (276)
T cd05152          20 ESGLDFQVVFAK-DTDGVPWVLRIPRR-PDVSERAAAEKRVLALVRKH   65 (276)
T ss_pred             CCcceeEEEEEE-cCCCCeEEEEecCC-HHHHHHHHHHHHHHHHHHhc
Confidence            444445566553 23466788887653 22335578899999999764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.84  E-value=0.02  Score=56.43  Aligned_cols=76  Identities=14%  Similarity=0.099  Sum_probs=49.9

Q ss_pred             EEeeeccccceEEEEEEECCCCeEEEEEEec-----Cch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           98 IHSKMGEGTFGQVLECWDRERKEMVAIKIVR-----GIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        98 ~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~-----~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ..+.||.|....||+..+.  +..|+||.-.     ...   ....+...|.+.|+.+....  ...+++++.+.+  +.
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~--p~~VPkVy~~de--d~  109 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLC--PDHVPEVYHFDR--TM  109 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcC--CCCCCeEEEECC--CC
Confidence            3678899999999998863  3468899743     111   12344556777777765432  135677777665  45


Q ss_pred             EEEEEecCCC
Q 014117          170 ICIVFEKLGS  179 (430)
Q Consensus       170 ~~lv~e~~~~  179 (430)
                      -+++||++.+
T Consensus       110 ~vlvME~L~~  119 (418)
T PLN02756        110 ALIGMRYLEP  119 (418)
T ss_pred             CEEEEeecCC
Confidence            6788999933

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.82  E-value=0.0041  Score=54.93  Aligned_cols=92  Identities=25%  Similarity=0.242  Sum_probs=64.7

Q ss_pred             HHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecCC-CCHHHH---HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 014117          139 IEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG-SSLYDF---LRKNNYRSFPIDLVREIARQLLECIAFMHD  214 (430)
Q Consensus       139 ~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~---l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~  214 (430)
                      .|.-+++.+.+.    .+++++++++..    ++|.||.+ +++...   +.+.  ..-+|..+.+|+.+++..+++++.
T Consensus         8 ~E~lll~~l~~~----~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~   77 (188)
T PF12260_consen    8 NEPLLLQLLQGS----EPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDH   77 (188)
T ss_pred             cHHHHHHHcCCC----CCCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhc
Confidence            366677777542    368889988833    46888884 444321   1111  146899999999999999999997


Q ss_pred             ---cCeeeccCCCCceEEeecCccccCCC
Q 014117          215 ---LCMIHTDLKPENVLLVSSEYIKVPDY  240 (430)
Q Consensus       215 ---~~ivHrDlKp~NILl~~~~~~~i~df  240 (430)
                         ..+.-.|++|+|+-++++|.+|+.|.
T Consensus        78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDl  106 (188)
T PF12260_consen   78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDL  106 (188)
T ss_pred             CCCCcEEEeecchHHeEEeCCCcEEEEec
Confidence               44888999999999966554444444

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.77  E-value=0.063  Score=51.86  Aligned_cols=72  Identities=15%  Similarity=0.083  Sum_probs=42.8

Q ss_pred             cceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecc--eeecCCeEEEEEecCC
Q 014117          106 TFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN--WFDYRNHICIVFEKLG  178 (430)
Q Consensus       106 ~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~--~~~~~~~~~lv~e~~~  178 (430)
                      .-..||+... .++..+++|+.+...........|.+.+..|.......+-.+..-+  ....++..+.|+++++
T Consensus        37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~  110 (325)
T PRK11768         37 YENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG  110 (325)
T ss_pred             ccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence            3456888754 3455699998864333455667789999888764332111111112  1233567788999883

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.76  E-value=0.078  Score=50.67  Aligned_cols=64  Identities=11%  Similarity=0.171  Sum_probs=37.6

Q ss_pred             EEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecc---eeecCCeEEEEEecC
Q 014117          109 QVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN---WFDYRNHICIVFEKL  177 (430)
Q Consensus       109 ~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~---~~~~~~~~~lv~e~~  177 (430)
                      .||++... .| .+++|++...   ......|..++..|.......+.++...+   +...++..++|++++
T Consensus        11 ~v~~v~t~-~g-~~~LK~~~~~---~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i   77 (313)
T TIGR02906        11 NVYKVETD-SG-NKCLKKINYP---PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWI   77 (313)
T ss_pred             cEEEEEeC-CC-CeEEEEcCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhc
Confidence            48887642 33 5899987532   23345577778888665433233332211   122356789999998

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK10593 hypothetical protein; Provisional

Probab=96.55  E-value=0.026  Score=53.77  Aligned_cols=107  Identities=15%  Similarity=0.121  Sum_probs=72.3

Q ss_pred             EEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee---cCCeEEEE
Q 014117           97 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD---YRNHICIV  173 (430)
Q Consensus        97 ~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~---~~~~~~lv  173 (430)
                      .-.+.||.|..+.||+..... + .+.+|..+. ......+..|.+.|+.+....  ...++++++.+.   ..+..+||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~--~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARS-FSTPGVAQQEAWKLSMLARSG--TVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             heeeecCCccceeEEEEEcCC-C-CEEEEEecc-cccchHHHHHHHHHHHHccCC--CCCcCcEEEEeccCCcCCCeEEE
Confidence            345779999999999985432 3 377787542 223457888999999997642  123555665544   34678999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL  215 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~  215 (430)
                      ||++ |.++.+.       ..+......+..+++.+|.-||+.
T Consensus        92 mE~i~G~~~~~~-------~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         92 LERLRGVSVEAP-------ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             EeccCCEecCCC-------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            9999 6566541       123444556778888999999974

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.28  E-value=0.015  Score=55.06  Aligned_cols=75  Identities=17%  Similarity=0.191  Sum_probs=50.0

Q ss_pred             EEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEec
Q 014117           97 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK  176 (430)
Q Consensus        97 ~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~  176 (430)
                      +-.+.|+.|....+|+..  .+++.+.||+-.  ......+..|.+-|+.|...  ....+++.+.+....+.-+|||||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~--~~~~vP~vi~~G~~~~~~fLlle~   93 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEA--NPIRVPKVIAWGEYDDDAFLLLEF   93 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHT--TTSBS--EEEEEE-SSCCEEEEE-
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhc--CCCCCCeEEEEEeecCCceEEEEe
Confidence            345678989999999976  567789999865  33445678899999999553  235577788877777777999999


Q ss_pred             C
Q 014117          177 L  177 (430)
Q Consensus       177 ~  177 (430)
                      +
T Consensus        94 l   94 (288)
T PF03881_consen   94 L   94 (288)
T ss_dssp             -
T ss_pred             e
Confidence            8

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.93  E-value=0.04  Score=53.75  Aligned_cols=60  Identities=28%  Similarity=0.372  Sum_probs=42.6

Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhcCeeeccCCCCceEEee
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM-HDLCMIHTDLKPENVLLVS  231 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~l-H~~~ivHrDlKp~NILl~~  231 (430)
                      ...||-+|. |-++..++...   ..++.....++.--..||--+ --.+.+|.|++|.||++.-
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            445666688 77998888764   356666666666556665433 3567999999999999953

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.87  E-value=0.17  Score=48.84  Aligned_cols=74  Identities=19%  Similarity=0.129  Sum_probs=45.0

Q ss_pred             cceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCc-eEEecc----eeecCCeEEEEEecC-CC
Q 014117          106 TFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR-CVQIRN----WFDYRNHICIVFEKL-GS  179 (430)
Q Consensus       106 ~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~-i~~~~~----~~~~~~~~~lv~e~~-~~  179 (430)
                      .-..||+...... + +++|+.+.. ....+...|+..+..+..+....+- +..+-+    .+..+.+.+-|++|+ |.
T Consensus        37 ~eN~~f~~~~~~g-~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTEDG-R-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEecCC-C-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence            4566888765433 3 499999865 5566777889999998876532211 122211    111123788889999 44


Q ss_pred             CHH
Q 014117          180 SLY  182 (430)
Q Consensus       180 ~L~  182 (430)
                      .+.
T Consensus       114 ~~~  116 (331)
T COG2334         114 PLE  116 (331)
T ss_pred             CcC
Confidence            444

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.85  E-value=0.036  Score=49.83  Aligned_cols=51  Identities=22%  Similarity=0.125  Sum_probs=29.3

Q ss_pred             CeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 014117          119 KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL  177 (430)
Q Consensus       119 ~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~  177 (430)
                      ++.|++|+........-....|..+++.+......    +.+++.+..+    +|.+|+
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~----p~~~~~~~~g----~v~e~i   52 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLG----PKIIYFFENG----RVEEFI   52 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSS----S-EEEEETTE----EEEE--
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCC----CeEEEEcCCC----cEEEEe
Confidence            35688888765544444556788899888775432    3444444332    456776

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK06148 hypothetical protein; Provisional

Probab=95.72  E-value=0.17  Score=56.43  Aligned_cols=81  Identities=15%  Similarity=0.096  Sum_probs=44.9

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcC--CCCCceEEec-c----eeec-CC--e
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD--KGGNRCVQIR-N----WFDY-RN--H  169 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~--~~~~~i~~~~-~----~~~~-~~--~  169 (430)
                      +.|+ |..-.+|+... .+++.+++|+.+... .......|.+.+..|....  ...|.++... +    .... .+  .
T Consensus        31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEe-CCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            4564 34577888754 356679999987432 2334445667777776542  2233333321 1    1111 22  5


Q ss_pred             EEEEEecC-CCCHHH
Q 014117          170 ICIVFEKL-GSSLYD  183 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~  183 (430)
                      .+-+++|+ |..+.+
T Consensus       108 ~vrLl~~l~G~~l~~  122 (1013)
T PRK06148        108 LLRLLSWLPGTPLAE  122 (1013)
T ss_pred             EEEEEeccCCCcHHh
Confidence            67789999 555543

>PTZ00384 choline kinase; Provisional

Probab=95.62  E-value=0.22  Score=49.12  Aligned_cols=75  Identities=17%  Similarity=0.174  Sum_probs=42.3

Q ss_pred             EeeeccccceEEEEEEECCCC-e-----EEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           99 HSKMGEGTFGQVLECWDRERK-E-----MVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~-~-----~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      ++.|..|-...+|++...... .     .|.+++........-....|.++++.+..+..    -.++++.+..    ++
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~gl----gP~l~~~f~~----g~  126 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNF----GPKIIGRFGD----FT  126 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCC----CCeEEEecCC----EE
Confidence            456666888899998754321 1     24444432111111223458889999876543    2355555543    58


Q ss_pred             EEecC-CCCH
Q 014117          173 VFEKL-GSSL  181 (430)
Q Consensus       173 v~e~~-~~~L  181 (430)
                      |.||+ |..|
T Consensus       127 l~efIeGr~l  136 (383)
T PTZ00384        127 IQEWVEGNTM  136 (383)
T ss_pred             EEEEeccccC
Confidence            88888 4443

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.39  E-value=0.33  Score=46.47  Aligned_cols=66  Identities=12%  Similarity=0.192  Sum_probs=36.8

Q ss_pred             ccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecc------eeecCCeEEEEEecC
Q 014117          105 GTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN------WFDYRNHICIVFEKL  177 (430)
Q Consensus       105 G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~------~~~~~~~~~lv~e~~  177 (430)
                      |.-+.||++.. ..| .+++|.+....   +.......++..+....  .+.++.++.      +...++..+++|+++
T Consensus        17 ~~~~~v~~v~T-~~G-~~~Lk~~~~~~---~~l~~~~~~~~~L~~~G--~~~~~~~~~t~~G~~~~~~~~~~~~L~~wi   88 (309)
T TIGR02904        17 QVTGKLFKVYT-DQG-VFALKKLYADR---NTIESFVSQIQVLSEKG--FSRIVPVYPTKDGSYYLFHGHFLYYLMPWL   88 (309)
T ss_pred             cccCcEEEEEe-CCC-CEEEEEeccch---HhHHHHHHHHHHHHHcC--CCcCCceeecCCCCeeeEECCEEEEEeCCc
Confidence            34568999864 334 58999887332   22334455566665432  222333321      223356679999998

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.23  E-value=0.09  Score=47.15  Aligned_cols=83  Identities=14%  Similarity=0.240  Sum_probs=53.3

Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 014117          134 REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM  212 (430)
Q Consensus       134 ~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~l  212 (430)
                      ..-+..+..++.++.       .|+++..  +..-.+.++.|.| ....           .+    ..++.-=+.+|.-.
T Consensus       102 ~~~y~nky~v~Armh-------GilrL~N--Dn~~~yGvIlE~Cy~~~i-----------~~----~N~i~agi~~L~~f  157 (308)
T PF07387_consen  102 DALYFNKYRVFARMH-------GILRLKN--DNNYKYGVILERCYKIKI-----------NF----SNFITAGIKDLMDF  157 (308)
T ss_pred             hhhhhhhhhHHHHhh-------heeEeec--CCCceeEEEEeeccCccc-----------ch----hHHHHHhHHHHHHh
Confidence            344566788888883       3677763  2455677999998 3221           11    11222224678888


Q ss_pred             Hh--cCeeeccCCCCceEEeecCccccCCC
Q 014117          213 HD--LCMIHTDLKPENVLLVSSEYIKVPDY  240 (430)
Q Consensus       213 H~--~~ivHrDlKp~NILl~~~~~~~i~df  240 (430)
                      |+  .+.+|+|-.|+||+-+..|.+|+.|-
T Consensus       158 H~~~~~~lHGD~np~NiM~D~~G~lKlVDP  187 (308)
T PF07387_consen  158 HSENQHCLHGDCNPDNIMCDKFGYLKLVDP  187 (308)
T ss_pred             hccCCCeecCCCChhheeecCCCCEEecCh
Confidence            93  45999999999999966666655554

The function of this family is unknown.

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=95.13  E-value=0.052  Score=51.34  Aligned_cols=123  Identities=20%  Similarity=0.282  Sum_probs=83.7

Q ss_pred             EEeeeccccceEEEEEEEC------C----CCeEEEEEEecCch--------------hh-------------HHHHHHH
Q 014117           98 IHSKMGEGTFGQVLECWDR------E----RKEMVAIKIVRGIK--------------KY-------------REAAMIE  140 (430)
Q Consensus        98 ~~~~lG~G~~g~V~~~~~~------~----~~~~vAiK~~~~~~--------------~~-------------~~~~~~E  140 (430)
                      |...|..|.-+.|+.|.--      +    ....+|||+++..-              .+             .--...|
T Consensus       256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE  335 (531)
T KOG2269|consen  256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE  335 (531)
T ss_pred             hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence            4567888999999888431      1    23458999874210              00             1123357


Q ss_pred             HHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecCCCC-H-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCe
Q 014117          141 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSS-L-YDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCM  217 (430)
Q Consensus       141 ~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~-L-~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~i  217 (430)
                      ..-|.++..+..+.|.+|.+..       ..|||.|+|.+ + .--|.   ...|+..+.+....|+...+.-|- +.-+
T Consensus       336 mhNL~RMq~~GlpcP~vV~lkk-------hvLVMsFiGd~~~aAPkLK---~v~l~d~E~~~aY~q~~~~M~~lY~Ec~L  405 (531)
T KOG2269|consen  336 MHNLSRMQKHGLPCPQVVKLKK-------HVLVMSFIGDQGLAAPKLK---NVELTDDERRNAYDQVQSIMCRLYKECLL  405 (531)
T ss_pred             HHHHHHHHhcCCCCCceeeeec-------ceEEEEeecCCCCCCcccc---ccccChHHHHHHHHHHHHHHHHHHHhhhe
Confidence            7778888888777777777643       35999999542 1 22222   135888889988899998887664 5669


Q ss_pred             eeccCCCCceEEe
Q 014117          218 IHTDLKPENVLLV  230 (430)
Q Consensus       218 vHrDlKp~NILl~  230 (430)
                      ||-||.--|+|+.
T Consensus       406 VHADlSEyN~Lw~  418 (531)
T KOG2269|consen  406 VHADLSEYNLLWT  418 (531)
T ss_pred             eecchhhhhheec
Confidence            9999999999983

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.90  E-value=0.099  Score=50.36  Aligned_cols=75  Identities=13%  Similarity=0.199  Sum_probs=53.9

Q ss_pred             ecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeccCCCCceEEeecCccccCCCcCC
Q 014117          165 DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       165 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                      +...+.|++|++-|++|.-.-      ....+++..++.+.+.-|.-+... ..=|||+.-.||||              
T Consensus       296 de~~y~yl~~kdhgt~is~ik------~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI--------------  355 (488)
T COG5072         296 DETLYLYLHFKDHGTPISIIK------ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI--------------  355 (488)
T ss_pred             CCceEEEEEEecCCceeeeee------cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee--------------
Confidence            445688899999988774321      234667777877777666655543 37899999999999              


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCcccc
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYE  273 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~  273 (430)
                                   + .+++.||||-+++..
T Consensus       356 -------------d-~GnvtLIDfklsRl~  371 (488)
T COG5072         356 -------------D-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             -------------e-cCceEEEEeeeeecc
Confidence                         4 567778888777743

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	430
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-90
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-83
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-83
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-83
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-81
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-80
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		6e-66
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-49
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-49
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-49
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-48
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-48
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-48
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		8e-44
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		9e-44
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		1e-42
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		3e-37
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		3e-37
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-27
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-27
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-27
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-26
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-26
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-26
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-26
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-26
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-26
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-26
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-26
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-26
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-26
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-26
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-26
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-26
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-26
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-26
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-26
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-26
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-26
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-26
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-26
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-26
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-26
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-26
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-26
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-26
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-26
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-26
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-26
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-26
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-26
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-25
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-25
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-25
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-25
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-25
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-25
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-24
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-24
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-24
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-24
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-24
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-24
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-24
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-24
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-23
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-23
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-23
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-23
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-23
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-23
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-22
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-22
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-22
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-22
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-22
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-22
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-22
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-22
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-22
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-22
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-22
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-22
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-22
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-22
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-22
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-22
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-22
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-22
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-22
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-22
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-22
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-22
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-22
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-22
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-22
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-22
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-22
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-22
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-22
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-22
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-22
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-22
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-22
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-22
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-22
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-22
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-22
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-22
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-22
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-22
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-22
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-22
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-22
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-22
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-22
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-22
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-22
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-22
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-22
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-22
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-22
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-22
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-22
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-22
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-22
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-22
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-22
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		9e-22
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-22
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-21
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-21
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-21
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-21
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-21
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-21
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-21
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-21
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-21
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-21
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-21
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-21
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-21
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-21
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-21
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		9e-21
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-21
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-20
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-20
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-20
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-20
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-20
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-20
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-20
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-20
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-20
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-20
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-20
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-20
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-20
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-20
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-20
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-20
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-20
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-20
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-20
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-20
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-20
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-20
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-20
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-20
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-20
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-20
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-20
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-20
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-20
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-20
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-20
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-20
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-20
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-20
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-20
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-20
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-20
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-20
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-19
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-19
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-19
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-19
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-19
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-19
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-19
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		8e-19
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		9e-19
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-18
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-18
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-18
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-18
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-18
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-18
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-18
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-18
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-17
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-17
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-17
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-17
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-17
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-17
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-17
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-17
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-17
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-17
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-16
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-16
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-16
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-16
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-16
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-16
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-16
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-16
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-16
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-16
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-16
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-16
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-16
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-16
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-16
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-16
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-16
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-16
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-16
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-16
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-16
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-16
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-16
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-16
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-16
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-16
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-16
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-16
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-16
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-16
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		8e-16
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		8e-16
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		9e-16
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		9e-16
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		9e-16
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		9e-16
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		9e-16
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		9e-16
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-15
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-15
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-15
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-15
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-15
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-15
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-15
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-15
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-15
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-15
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-15
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-15
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-15
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		9e-15
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-14
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-14
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-14
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-14
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-14
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-14
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-14
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-14
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-14
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-14
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-14
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-14
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-14
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-14
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-14
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-14
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		4e-14
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		6e-14
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-14
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		9e-14
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-13
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-13
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-13
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-13
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-13
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-13
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-13
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-13
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-13
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-13
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-13
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-13
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-13
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-13
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-13
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-13
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-13
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-13
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-13
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-13
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-13
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-13
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-13
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-13
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-13
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-13
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-13
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-13
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-13
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-13
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-13
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		9e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-12
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-12
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-12
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-12
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-12
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-12
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-11
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-11
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-11
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-11
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-11
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-10
3soa_A	444	Full-Length Human Camkii Length = 444		7e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		9e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		9e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		9e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-09
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-09
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-09
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-09
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-09
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-09
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-09
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-09
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-09
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-09
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-09
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-09
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-09
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-09
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-09
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-09
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-09
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-09
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-09
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-09
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-09
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-09
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-09
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-09
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-09
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		8e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-08
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-08
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		4e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		6e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		7e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		8e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-07
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-07
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-07
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-07
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		2e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-07
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-07
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		3e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-07
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-07
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-07
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		7e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-07
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-06
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-06
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-06
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-06
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-06
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-06
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-06
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		2e-06
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		2e-06
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-06
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-06
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		2e-06
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-06
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-06
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-06
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-06
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-06
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-06
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-06
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-06
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-06
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-06
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-06
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-06
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-06
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-06
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-06
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-06
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-06
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-06
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-06
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		6e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-06
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		6e-06
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-06
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-06
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-06
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-06
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		7e-06
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		8e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-06
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-06
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		9e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-06
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-06
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		9e-06
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-05
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-05
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-05
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-05
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-05
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-05
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-05
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-05
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-05
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-05
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-05
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-05
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-05
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-05
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-05
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-05
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-05
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-05
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-05
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-05
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-05
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-05
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-05
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-05
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-05
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-05
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		6e-05
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-05
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		6e-05
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-05
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-05
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		7e-05
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-05
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-05
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-05
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-05
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-05
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-05
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		8e-05
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-05
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-05
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-05
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-05
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		9e-05
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-04
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-04
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-04
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-04
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-04
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-04
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-04
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-04
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-04
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-04
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-04
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-04
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-04
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-04
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-04
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-04
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-04
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-04
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-04
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-04
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-04
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-04
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-04
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-04
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-04
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-04
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-04
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-04
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-04
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-04
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-04
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-04
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-04
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-04
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-04
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-04
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-04
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-04
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-04

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score =  329 bits (844), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 166/351 (47%), Positives = 236/351 (67%), Gaps = 15/351 (4%)
Query: 77  EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYRE 135
           EDD +GH ++ +G+ L  RY+I S +GEGTFG+V++C D  R    VA+KI++ ++KY+E
Sbjct: 16  EDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKE 75
Query: 136 AAMIEIEVLQQLAKHD-KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 194
           AA +EI VL+++ + D    N CVQ+ +WFDY  H+CI FE LG S +DFL+ NNY  +P
Sbjct: 76  AARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYP 135
Query: 195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
           I  VR +A QL + + F+HD  + HTDLKPEN+L V+S+Y    +   +L   +D    +
Sbjct: 136 IHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDY----ELTYNLEKKRD----E 187
Query: 255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
           R  KS+A++V+DFGS T++    + IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E  
Sbjct: 188 RSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYY 247
Query: 315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
            G  LFQTH+N EHLAMMER+LGP+P  M+++  +  +KY  RGRLDW E  ++   ++ 
Sbjct: 248 VGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRE 305
Query: 375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
             K P  + L  +  +H    L  L++ +L Y+P  RLT  EAL+HPFF R
Sbjct: 306 NCK-PLRRYLTSEAEEHHQ--LFDLIESMLEYEPAKRLTLGEALQHPFFAR 353

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score =  306 bits (785), Expect = 1e-83,   Method: Compositional matrix adjust.
 Identities = 156/350 (44%), Positives = 225/350 (64%), Gaps = 15/350 (4%)
Query: 77  EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRER-KEMVAIKIVRGIKKYRE 135
           EDDK+GH +  +G+ L  RY+I   +GEGTFG+V+EC D  R K  VA+KI+R + KYRE
Sbjct: 11  EDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYRE 70
Query: 136 AAMIEIEVLQQLAKHDKGGN-RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 194
           AA +EI VL+++ + DK     CV + +WF++  H+CI FE LG + ++FL++NN++ +P
Sbjct: 71  AARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYP 130
Query: 195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
           +  VR +A QL   + F+H+  + HTDLKPEN+L V+SE+        +L+    S   K
Sbjct: 131 LPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEF-------ETLYNEHKSCEEK 183
Query: 255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
            + K+++I+V DFGS T++      IV+TRHYR PEVIL LGW  PCD+WS+GCIL E  
Sbjct: 184 SV-KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 242
Query: 315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
            G  LFQTHEN EHL MME++LGP+P HM+ R  +  +KY  +G L W E ++    +K 
Sbjct: 243 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRK--QKYFYKGGLVWDENSSDGRYVKE 300
Query: 375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             K P    ++   ++H    L  L++ +L +DP  R+T  EAL HPFF 
Sbjct: 301 NCK-PLKSYMLQDSLEHV--QLFDLMRRMLEFDPAQRITLAEALLHPFFA 347

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score =  306 bits (785), Expect = 1e-83,   Method: Compositional matrix adjust.
 Identities = 156/350 (44%), Positives = 225/350 (64%), Gaps = 15/350 (4%)
Query: 77  EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRER-KEMVAIKIVRGIKKYRE 135
           EDDK+GH +  +G+ L  RY+I   +GEGTFG+V+EC D  R K  VA+KI+R + KYRE
Sbjct: 34  EDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYRE 93
Query: 136 AAMIEIEVLQQLAKHDKGGN-RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 194
           AA +EI VL+++ + DK     CV + +WF++  H+CI FE LG + ++FL++NN++ +P
Sbjct: 94  AARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYP 153
Query: 195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
           +  VR +A QL   + F+H+  + HTDLKPEN+L V+SE+        +L+    S   K
Sbjct: 154 LPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEF-------ETLYNEHKSCEEK 206
Query: 255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
            + K+++I+V DFGS T++      IV+TRHYR PEVIL LGW  PCD+WS+GCIL E  
Sbjct: 207 SV-KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 265
Query: 315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
            G  LFQTHEN EHL MME++LGP+P HM+ R  +  +KY  +G L W E ++    +K 
Sbjct: 266 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRK--QKYFYKGGLVWDENSSDGRYVKE 323
Query: 375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             K P    ++   ++H    L  L++ +L +DP  R+T  EAL HPFF 
Sbjct: 324 NCK-PLKSYMLQDSLEHV--QLFDLMRRMLEFDPAQRITLAEALLHPFFA 370

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score =  306 bits (783), Expect = 2e-83,   Method: Compositional matrix adjust.
 Identities = 156/350 (44%), Positives = 225/350 (64%), Gaps = 15/350 (4%)
Query: 77  EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRER-KEMVAIKIVRGIKKYRE 135
           EDDK+GH +  +G+ L  RY+I   +GEGTFG+V+EC D  R K  VA+KI+R + KYRE
Sbjct: 2   EDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYRE 61
Query: 136 AAMIEIEVLQQLAKHDKGGN-RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 194
           AA +EI VL+++ + DK     CV + +WF++  H+CI FE LG + ++FL++NN++ +P
Sbjct: 62  AARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYP 121
Query: 195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
           +  VR +A QL   + F+H+  + HTDLKPEN+L V+SE+        +L+    S   K
Sbjct: 122 LPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEF-------ETLYNEHKSCEEK 174
Query: 255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
            + K+++I+V DFGS T++      IV+TRHYR PEVIL LGW  PCD+WS+GCIL E  
Sbjct: 175 SV-KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233
Query: 315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
            G  LFQTHEN EHL MME++LGP+P HM+ R  +  +KY  +G L W E ++    +K 
Sbjct: 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRK--QKYFYKGGLVWDENSSDGRYVKE 291
Query: 375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             K P    ++   ++H    L  L++ +L +DP  R+T  EAL HPFF 
Sbjct: 292 NCK-PLKSYMLQDSLEHV--QLFDLMRRMLEFDPAQRITLAEALLHPFFA 338

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score =  300 bits (767), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 155/343 (45%), Positives = 222/343 (64%), Gaps = 15/343 (4%)
Query: 83  HYMFALGENLTSRYKIHSKMGEGTFGQVLECWD-RERKEMVAIKIVRGIKKYREAAMIEI 141
           H +   G+ L++RY+I   +GEG FG+V+EC D +     VA+KIV+ + +Y EAA  EI
Sbjct: 3   HLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEI 62
Query: 142 EVLQQLAKHDKGGN-RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE 200
           +VL+ L   D     RCVQ+  WF++  HICIVFE LG S YDF+++N +  F +D +R+
Sbjct: 63  QVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRK 122
Query: 201 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 260
           +A Q+ + + F+H   + HTDLKPEN+L V S+Y +  + K      +D    +R   + 
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK----IKRD----ERTLINP 174
Query: 261 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
            IKV+DFGS TY+    + +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E   G  +F
Sbjct: 175 DIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
            TH++ EHLAMMER+LGPLP+HM+++  +   KY    RLDW E +++   +    K P 
Sbjct: 235 PTHDSKEHLAMMERILGPLPKHMIQKTRK--RKYFHHDRLDWDEHSSAGRYVSRACK-PL 291
Query: 381 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
            + ++ Q V+H    L  L+Q +L YDP  R+T REAL+HPFF
Sbjct: 292 KEFMLSQDVEHER--LFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score =  296 bits (757), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 153/343 (44%), Positives = 220/343 (64%), Gaps = 15/343 (4%)
Query: 83  HYMFALGENLTSRYKIHSKMGEGTFGQVLECWD-RERKEMVAIKIVRGIKKYREAAMIEI 141
           H +   G+ L++RY+I   +GEG FG+V+EC D +     VA+KIV+ + +Y EAA  EI
Sbjct: 3   HLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEI 62
Query: 142 EVLQQLAKHDKGGN-RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE 200
           +VL+ L   D     RCVQ+  WF++  HICIVFE LG S YDF+++N +  F +D +R+
Sbjct: 63  QVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRK 122
Query: 201 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 260
           +A Q+ + + F+H   + HTDLKPEN+L V S+Y +  + K      +D    +R   + 
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK----IKRD----ERTLINP 174
Query: 261 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
            IKV+DFGS TY+    + +V  RHYRAPEVIL LGW+ PCD+WS+GCIL+E   G  +F
Sbjct: 175 DIKVVDFGSATYDDEHHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
            TH++ EHLAMMER+LGPLP+HM+++  +   KY    RLDW E +++   +    K P 
Sbjct: 235 PTHDSKEHLAMMERILGPLPKHMIQKTRK--RKYFHHDRLDWDEHSSAGRYVSRACK-PL 291
Query: 381 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
            + ++ Q V+H    L  L+Q +L YDP  R+T REAL+HPFF
Sbjct: 292 KEFMLSQDVEHER--LFDLIQKMLEYDPAKRITLREALKHPFF 332

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score =  248 bits (632), Expect = 6e-66,   Method: Compositional matrix adjust.
 Identities = 138/356 (38%), Positives = 211/356 (59%), Gaps = 19/356 (5%)
Query: 75  WREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR 134
           ++ DD+  H+ +  G  L + + +  KMG+GTFG+VL C   + K+  A+K+VR IKKY 
Sbjct: 16  FQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT 75
Query: 135 EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 194
            +A IE ++L+++   D   N  V+    F Y +H+C++FE LG SLY+ + +NNY  F 
Sbjct: 76  RSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFH 135
Query: 195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
           I+ ++    ++L+ + ++  + + HTDLKPEN+LL        P ++ SL T +  +  K
Sbjct: 136 IEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD------PYFEKSLITVRRVTDGK 189
Query: 255 RM----PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 310
           ++     KS+ IK+IDFG  T++      I++TR YRAPEVIL LGW    D+WS GC+L
Sbjct: 190 KIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249
Query: 311 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDR-HAEKYVRRG--RLDWPEGAA 367
            EL TG  LF+THE++EHLAMME ++ P+P++ML    + +  KYV +   +L WPE A+
Sbjct: 250 AELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENAS 309
Query: 368 SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           S  SIK V K   L  +I   +          L  +L+ DPT R +  E L+H F 
Sbjct: 310 SINSIKHVKKCLPLYKIIKHEL------FCDFLYSILQIDPTLRPSPAELLKHKFL 359

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  194 bits (492), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 121/360 (33%), Positives = 188/360 (52%), Gaps = 53/360 (14%)
Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA 148
           GE    RY+I S +G+G+FGQV++ +DR  +E VAIKI++  K +   A IE+ +L+ + 
Sbjct: 30  GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMN 89
Query: 149 KHD-KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
           KHD +     V ++  F +RNH+C+VFE L  +LYD LR  N+R   ++L R+ A+Q+  
Sbjct: 90  KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 149
Query: 208 CIAFMH--DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
            + F+   +L +IH DLKPEN+LL +                         PK SAIK++
Sbjct: 150 ALLFLATPELSIIHCDLKPENILLCN-------------------------PKRSAIKIV 184
Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
           DFGS+          + +R YR+PEV+LG+ +    D+WS+GCILVE+ TGE LF     
Sbjct: 185 DFGSSCQLGQRIYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 244
Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS---VMKLP--- 379
           ++ +  +  VLG  P H+L +  + A K+  +     P+G  + +  K      K P   
Sbjct: 245 VDQMNKIVEVLGIPPAHILDQAPK-ARKFFEK----LPDGTWNLKKTKDGKREYKPPGTR 299
Query: 380 RLQNLI-----------MQHVDHSAGD---LTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +L N++                H+  D      L+  +L YDP  R+    AL+H FF +
Sbjct: 300 KLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 359

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 121/360 (33%), Positives = 188/360 (52%), Gaps = 53/360 (14%)
Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA 148
           GE    RY+I S +G+G+FGQV++ +DR  +E VAIKI++  K +   A IE+ +L+ + 
Sbjct: 49  GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMN 108
Query: 149 KHD-KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
           KHD +     V ++  F +RNH+C+VFE L  +LYD LR  N+R   ++L R+ A+Q+  
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 208 CIAFMH--DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
            + F+   +L +IH DLKPEN+LL +                         PK SAIK++
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCN-------------------------PKRSAIKIV 203
Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
           DFGS+          + +R YR+PEV+LG+ +    D+WS+GCILVE+ TGE LF     
Sbjct: 204 DFGSSCQLGQRIYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263
Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS---VMKLP--- 379
           ++ +  +  VLG  P H+L +  + A K+  +     P+G  + +  K      K P   
Sbjct: 264 VDQMNKIVEVLGIPPAHILDQAPK-ARKFFEK----LPDGTWNLKKTKDGKREYKPPGTR 318
Query: 380 RLQNLI-----------MQHVDHSAGD---LTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +L N++                H+  D      L+  +L YDP  R+    AL+H FF +
Sbjct: 319 KLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  192 bits (487), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 120/360 (33%), Positives = 187/360 (51%), Gaps = 53/360 (14%)
Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA 148
           GE    RY+I S +G+G+FGQV++ +DR  +E VAIKI++  K +   A IE+ +L+ + 
Sbjct: 49  GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMN 108
Query: 149 KHD-KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
           KHD +     V ++  F +RNH+C+VFE L  +LYD LR  N+R   ++L R+ A+Q+  
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 208 CIAFMH--DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
            + F+   +L +IH DLKPEN+LL +                         PK  AIK++
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCN-------------------------PKRXAIKIV 203
Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
           DFGS+          + +R YR+PEV+LG+ +    D+WS+GCILVE+ TGE LF     
Sbjct: 204 DFGSSCQLGQRIYQXIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263
Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS---VMKLP--- 379
           ++ +  +  VLG  P H+L +  + A K+  +     P+G  + +  K      K P   
Sbjct: 264 VDQMNKIVEVLGIPPAHILDQAPK-ARKFFEK----LPDGTWNLKKTKDGKREYKPPGTR 318
Query: 380 RLQNLI-----------MQHVDHSAGD---LTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +L N++                H+  D      L+  +L YDP  R+    AL+H FF +
Sbjct: 319 KLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 119/363 (32%), Positives = 182/363 (50%), Gaps = 44/363 (12%)
Query: 78  DDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA 137
           DD  G Y+    +++  RY++   +G+G+FGQV++ +D +  + VA+K+VR  K++   A
Sbjct: 81  DDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 138 MIEIEVLQQLAKHDKGGN-RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPID 196
             EI +L+ L K DK      + +   F +RNHIC+ FE L  +LY+ ++KN ++ F + 
Sbjct: 141 AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLP 200
Query: 197 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 256
           LVR+ A  +L+C+  +H   +IH DLKPEN+LL                         + 
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILL-------------------------KQ 235
Query: 257 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              S IKVIDFGS+ YE       + +R YRAPEVILG  +  P D+WS+GCIL EL TG
Sbjct: 236 QGRSGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295
Query: 317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR--------------GRLDW 362
             L    +  + LA M  +LG +P   L    + A+ +V                G +  
Sbjct: 296 YPLLPGEDEGDQLACMIELLG-MPSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVL 354
Query: 363 PEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
             G + R  ++   +     N +    D    D    L+  L +DP  R+T  +ALRHP+
Sbjct: 355 NGGRSRRGKLRGPPESREWGNALKGCDDPLFLD---FLKQCLEWDPAVRMTPGQALRHPW 411
Query: 423 FTR 425
             R
Sbjct: 412 LRR 414

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 119/363 (32%), Positives = 182/363 (50%), Gaps = 44/363 (12%)
Query: 78  DDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA 137
           DD  G Y+    +++  RY++   +G+G+FGQV++ +D +  + VA+K+VR  K++   A
Sbjct: 81  DDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 138 MIEIEVLQQLAKHDKGGN-RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPID 196
             EI +L+ L K DK      + +   F +RNHIC+ FE L  +LY+ ++KN ++ F + 
Sbjct: 141 AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLP 200
Query: 197 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 256
           LVR+ A  +L+C+  +H   +IH DLKPEN+LL                         + 
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILL-------------------------KQ 235
Query: 257 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              S IKVIDFGS+ YE       + +R YRAPEVILG  +  P D+WS+GCIL EL TG
Sbjct: 236 QGRSGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295
Query: 317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR--------------GRLDW 362
             L    +  + LA M  +LG +P   L    + A+ +V                G +  
Sbjct: 296 YPLLPGEDEGDQLACMIELLG-MPSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVL 354
Query: 363 PEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
             G + R  ++   +     N +    D    D    L+  L +DP  R+T  +ALRHP+
Sbjct: 355 NGGRSRRGKLRGPPESREWGNALKGCDDPLFLD---FLKQCLEWDPAVRMTPGQALRHPW 411
Query: 423 FTR 425
             R
Sbjct: 412 LRR 414

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 119/363 (32%), Positives = 181/363 (49%), Gaps = 44/363 (12%)
Query: 78  DDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA 137
           DD  G Y+    +++  RY++   +G+G FGQV++ +D +  + VA+K+VR  K++   A
Sbjct: 81  DDDQGSYVQVPHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 138 MIEIEVLQQLAKHDKGGN-RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPID 196
             EI +L+ L K DK      + +   F +RNHIC+ FE L  +LY+ ++KN ++ F + 
Sbjct: 141 AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLP 200
Query: 197 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 256
           LVR+ A  +L+C+  +H   +IH DLKPEN+LL                         + 
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILL-------------------------KQ 235
Query: 257 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              S IKVIDFGS+ YE       + +R YRAPEVILG  +  P D+WS+GCIL EL TG
Sbjct: 236 QGRSGIKVIDFGSSCYEHQRVYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295
Query: 317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR--------------GRLDW 362
             L    +  + LA M  +LG +P   L    + A+ +V                G +  
Sbjct: 296 YPLLPGEDEGDQLACMIELLG-MPXQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVL 354
Query: 363 PEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
             G + R  ++   +     N +    D    D    L+  L +DP  R+T  +ALRHP+
Sbjct: 355 NGGRSRRGKLRGPPESREWGNALKGCDDPLFLD---FLKQCLEWDPAVRMTPGQALRHPW 411
Query: 423 FTR 425
             R
Sbjct: 412 LRR 414

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score =  174 bits (441), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 114/386 (29%), Positives = 192/386 (49%), Gaps = 53/386 (13%)
Query: 80  KDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI 139
           K G+++  +G+    RY +  K+G G F  V   WD + K+ VA+K+V+  + Y E A+ 
Sbjct: 7   KGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD 66
Query: 140 EIEVLQQLAKHDKGG-NRCVQIRNWFDYR------NHICIVFEKLGSSLYDFLRKNNYRS 192
           EI +L+ +   D    NR + ++   D++       HIC+VFE LG  L  ++ K+NY+ 
Sbjct: 67  EIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG 126
Query: 193 FPIDLVREIARQLLECIAFMHDLC-MIHTDLKPENVLL-VSSEYIK-----VPDYKSSLH 245
            P+  V++I +Q+L+ + ++H  C +IHTD+KPEN+LL V+ +YI+       +++ S  
Sbjct: 127 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 186
Query: 246 TPKDSSYFKRMPKSSA----------------IKVIDFGSTTYERPDQNYIVSTRHYRAP 289
            P   S     P ++                 +K+ D G+  +        + TR YR+ 
Sbjct: 187 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSL 246
Query: 290 EVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE------HLAMMERVLGPLPQHM 343
           EV++G G+  P DIWS  C+  EL TG+ LF+ H   E      H+A++  +LG +P+ +
Sbjct: 247 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 306
Query: 344 LKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP--RLQNLIMQHVDHS---AGDLTH 398
           +       E + ++G L            K + KL    L  ++++  + S   A   T 
Sbjct: 307 IVAGKYSKEFFTKKGDL------------KHITKLKPWGLFEVLVEKYEWSQEEAAGFTD 354
Query: 399 LLQGLLRYDPTDRLTAREALRHPFFT 424
            L  +L   P  R TA E LRHP+  
Sbjct: 355 FLLPMLELIPEKRATAAECLRHPWLN 380

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score =  174 bits (441), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 114/386 (29%), Positives = 192/386 (49%), Gaps = 53/386 (13%)
Query: 80  KDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI 139
           K G+++  +G+    RY +  K+G G F  V   WD + K+ VA+K+V+  + Y E A+ 
Sbjct: 23  KGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD 82
Query: 140 EIEVLQQLAKHDKGG-NRCVQIRNWFDYR------NHICIVFEKLGSSLYDFLRKNNYRS 192
           EI +L+ +   D    NR + ++   D++       HIC+VFE LG  L  ++ K+NY+ 
Sbjct: 83  EIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG 142
Query: 193 FPIDLVREIARQLLECIAFMHDLC-MIHTDLKPENVLL-VSSEYIK-----VPDYKSSLH 245
            P+  V++I +Q+L+ + ++H  C +IHTD+KPEN+LL V+ +YI+       +++ S  
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 246 TPKDSSYFKRMPKSSA----------------IKVIDFGSTTYERPDQNYIVSTRHYRAP 289
            P   S     P ++                 +K+ D G+  +        + TR YR+ 
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSL 262
Query: 290 EVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE------HLAMMERVLGPLPQHM 343
           EV++G G+  P DIWS  C+  EL TG+ LF+ H   E      H+A++  +LG +P+ +
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 344 LKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP--RLQNLIMQHVDHS---AGDLTH 398
           +       E + ++G L            K + KL    L  ++++  + S   A   T 
Sbjct: 323 IVAGKYSKEFFTKKGDL------------KHITKLKPWGLFEVLVEKYEWSQEEAAGFTD 370
Query: 399 LLQGLLRYDPTDRLTAREALRHPFFT 424
            L  +L   P  R TA E LRHP+  
Sbjct: 371 FLLPMLELIPEKRATAAECLRHPWLN 396

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 112/382 (29%), Positives = 186/382 (48%), Gaps = 47/382 (12%)
Query: 80  KDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI 139
           K G++   +G+    RY +  K+G G F  V  CWD + K  VA+K+V+  + Y E A+ 
Sbjct: 17  KGGYHPVKIGDLFNGRYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALD 76
Query: 140 EIEVLQQLAKHDKGG---NRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRS 192
           EI++L+ + + D      +  VQ+ + F        H+C+VFE LG  L  ++ K+NY+ 
Sbjct: 77  EIKLLKCVRESDPSDPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQG 136
Query: 193 FPIDLVREIARQLLECIAFMHDLC-MIHTDLKPENVLL-VSSEYIK-----VPDYKSSLH 245
            P+  V+ I RQ+L+ + ++H  C +IHTD+KPEN+L+ V   Y++       +++ +  
Sbjct: 137 LPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGA 196
Query: 246 TPKDSSYFKRMPKSSA--------------IKVIDFGSTTYERPDQNYIVSTRHYRAPEV 291
            P   S     P +                +K+ D G+  +        + TR YR+ EV
Sbjct: 197 PPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLGNACWVHKHFTEDIQTRQYRSIEV 256
Query: 292 ILGLGWTYPCDIWSVGCILVELCTGEALFQTHE------NLEHLAMMERVLGPLPQHMLK 345
           ++G G++ P DIWS  C+  EL TG+ LF+ H       + +H+A +  +LG +P+H   
Sbjct: 257 LIGAGYSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRHFAL 316
Query: 346 RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD---HSAGDLTHLLQG 402
                 E + RRG L        R   K  +K   L +++++        A   T  L  
Sbjct: 317 SGKYSREFFNRRGEL--------RHITK--LKPWSLFDVLVEKYGWPHEDAAQFTDFLIP 366
Query: 403 LLRYDPTDRLTAREALRHPFFT 424
           +L   P  R +A E LRHP+  
Sbjct: 367 MLEMVPEKRASAGECLRHPWLN 388

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 109/352 (30%), Positives = 176/352 (50%), Gaps = 55/352 (15%)
Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK- 152
           +RY +  K+G G F  V    D      VA+KIVRG K Y EAA  EI++LQ++   D  
Sbjct: 19  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 153 -----GGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 203
                G N  +++ + F+++     H+ +VFE LG +L   ++K  +R  P+  V++I++
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 204 QLLECIAFMHDLC-MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
           QLL  + +MH  C +IHTD+KPENVL+   E +  P+                      I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLM---EIVDSPE------------------NLIQI 177
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
           K+ D G+  +        + TR YR+PEV+LG  W    DIWS  C++ EL TG+ LF+ 
Sbjct: 178 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237
Query: 323 HE------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 376
            E      + +H+A +  +LG LP ++L+       KY R           SR  ++++ 
Sbjct: 238 DEGHSYTKDDDHIAQIIELLGELPSYLLRN-----GKYTRT-------FFNSRGLLRNIS 285
Query: 377 KLP--RLQNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           KL    L++++ +    S   A +++  L  +L+ DP  R  A   + HP+ 
Sbjct: 286 KLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 109/352 (30%), Positives = 176/352 (50%), Gaps = 55/352 (15%)
Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK- 152
           +RY +  K+G G F  V    D      VA+KIVRG K Y EAA  EI++LQ++   D  
Sbjct: 19  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 153 -----GGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 203
                G N  +++ + F+++     H+ +VFE LG +L   ++K  +R  P+  V++I++
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 204 QLLECIAFMHDLC-MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
           QLL  + +MH  C +IHTD+KPENVL+   E +  P+                      I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLM---EIVDSPE------------------NLIQI 177
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
           K+ D G+  +        + TR YR+PEV+LG  W    DIWS  C++ EL TG+ LF+ 
Sbjct: 178 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237
Query: 323 HE------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 376
            E      + +H+A +  +LG LP ++L+       KY R           SR  ++++ 
Sbjct: 238 DEGHSYTKDDDHIAQIIELLGELPSYLLRN-----GKYTRT-------FFNSRGLLRNIS 285
Query: 377 KLP--RLQNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           KL    L++++ +    S   A +++  L  +L+ DP  R  A   + HP+ 
Sbjct: 286 KLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 99/331 (29%), Positives = 155/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 64
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L DF+  +     P+ L++    QLL+ +AF H   +
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKPEN LL+++E                           AIK+ DFG +  +  P 
Sbjct: 125 LHRDLKPEN-LLINTE--------------------------GAIKLADFGLARAFGVPV 157
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 158 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 218 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 258
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 259 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 98/331 (29%), Positives = 155/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 66
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L DF+  +     P+ L++    QLL+ +AF H   +
Sbjct: 67  VKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 126
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 127 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 159
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 160 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 219
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 220 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 260
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 261 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 98/331 (29%), Positives = 155/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 67
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L DF+  +     P+ L++    QLL+ +AF H   +
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 128 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 160
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 161 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 220
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 221 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 261
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 262 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 98/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 65
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 66  VKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKPEN LL+++E                           AIK+ DFG +  +  P 
Sbjct: 126 LHRDLKPEN-LLINTE--------------------------GAIKLADFGLARAFGVPV 158
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 159 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 218
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 219 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 259
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 260 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 98/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 67
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKPEN LL+++E                           AIK+ DFG +  +  P 
Sbjct: 128 LHRDLKPEN-LLINTE--------------------------GAIKLADFGLARAFGVPV 160
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 161 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 220
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 221 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 261
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 262 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 98/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 65
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKPEN LL+++E                           AIK+ DFG +  +  P 
Sbjct: 126 LHRDLKPEN-LLINTE--------------------------GAIKLADFGLARAFGVPV 158
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 159 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 218
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 219 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 259
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 260 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 98/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 66
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 126
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKPEN LL+++E                           AIK+ DFG +  +  P 
Sbjct: 127 LHRDLKPEN-LLINTE--------------------------GAIKLADFGLARAFGVPV 159
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 160 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 219
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 220 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 260
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 261 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 71
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 131
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 132 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 164
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 165 RTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 224
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 225 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 265
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 266 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 64
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 125 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 157
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 158 RTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 218 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 258
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 259 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 68
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 128
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 129 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 161
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 162 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 221
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 222 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 262
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 263 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 71
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 131
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 132 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 164
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 165 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 224
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 225 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 265
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 266 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 96/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 67
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE +   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 68  VKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 128 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 160
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 161 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 220
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 221 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 261
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 262 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 64
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 125 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 157
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 158 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 218 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 258
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 259 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 67
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 128 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 160
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 161 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 220
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 221 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 261
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 262 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 66
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 126
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 127 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 159
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 160 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 219
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 220 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 260
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 261 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 66
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 126
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 127 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 159
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 160 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 219
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 220 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 260
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 261 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 67
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 128 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 160
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 161 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 220
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 221 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 261
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 262 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 65
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 126 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 158
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 159 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 218
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 219 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 259
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 260 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 63
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 124 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 156
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 217 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 257
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 258 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 64
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 125 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 157
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 158 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 218 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 258
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 259 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 63
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 124 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 156
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 217 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 257
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 258 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 67
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 127
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 128 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 160
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 161 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 220
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 221 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 261
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 262 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 64
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 125 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 157
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 158 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 218 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 258
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 259 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 64
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 125 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 157
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 158 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 218 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 258
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 259 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 65
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 126 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 158
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 159 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 218
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 219 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 259
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 260 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 68
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 128
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 129 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 161
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 162 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 221
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 222 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 262
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 263 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 64
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 125 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 157
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 158 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 218 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 258
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 259 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 65
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 125
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 126 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 158
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 159 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 218
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 219 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 259
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 260 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 93/340 (27%), Positives = 170/340 (50%), Gaps = 20/340 (5%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQLAKHD 151
           +Y++  K+G+G +G V +  DR   E+VA+K I    +   +A     EI +L +L+ H+
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
              N    +R   D    + +VF+ + + L+  +R N     P+   + +  QL++ I +
Sbjct: 70  NIVNLLNVLR--ADNDRDVYLVFDYMETDLHAVIRANILE--PVH-KQYVVYQLIKVIKY 124
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H   ++H D+KP N+LL +  ++KV D+  S            +P S      +F    
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD-- 182
Query: 272 YERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
            ++P     V+TR YRAPE++LG   +T   D+WS+GCIL E+  G+ +F     +  L 
Sbjct: 183 -DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL- 240
Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 390
             ER++G +     + V+     + +       E    R+S K  +   + +NL+++ ++
Sbjct: 241 --ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDI-FTKWKNLLLK-IN 296
Query: 391 HSAG---DLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
             A    +   LL  LL+++P  R++A +AL+HPF +  H
Sbjct: 297 PKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH 336

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 63
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 124 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 156
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 157 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 217 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 257
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 258 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 63
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 124 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 156
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 157 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 217 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 257
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 258 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 96/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 63
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE +   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 64  VKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 124 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 156
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 217 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 257
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 258 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 97/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 64
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 125 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 157
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 158 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 218 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 258
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 259 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 96/331 (29%), Positives = 154/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +      
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----I 64
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ ++F H   +
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRV 124
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 125 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 157
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 158 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 218 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 258
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 259 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 94/343 (27%), Positives = 162/343 (47%), Gaps = 66/343 (19%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLA 148
           +  +Y+   K+GEG++G V +C +R+  ++VAIK     +     ++ A+ EI +L+QL 
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL- 59
Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           KH       V +   F  +  + +VFE    ++   L +   R  P  LV+ I  Q L+ 
Sbjct: 60  KHPN----LVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQA 114
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           + F H    IH D+KPEN+L+                            K S IK+ DFG
Sbjct: 115 VNFCHKHNCIHRDVKPENILIT---------------------------KHSVIKLCDFG 147
Query: 269 STTYERPDQNYI---VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE 324
                    +Y    V+TR YR+PE+++G   +  P D+W++GC+  EL +G  L+    
Sbjct: 148 FARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           +++ L ++ + LG L       + RH + +             S     S +K+P  ++ 
Sbjct: 208 DVDQLYLIRKTLGDL-------IPRHQQVF-------------STNQYFSGVKIPDPED- 246
Query: 385 IMQHVDHSAGDLTH----LLQGLLRYDPTDRLTAREALRHPFF 423
            M+ ++    ++++    LL+G L  DPT+RLT  + L HP+F
Sbjct: 247 -MEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 96/383 (25%), Positives = 162/383 (42%), Gaps = 97/383 (25%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVL----- 144
           E  + +Y +   +G G+FG V E +D E  +  A+K V    +Y+   +  ++VL     
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNI 62
Query: 145 ------------------QQLAKHDKGGNRCVQIRNWF-------DYRNHICIVFEKLGS 179
                             Q    H+K G +   + N             ++ ++ E +  
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 180 SLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 237
           +L+  L+    + RS P++L+     QL   + F+H L + H D+KP+N+L+ S      
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS------ 176
Query: 238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI--VSTRHYRAPEVILGL 295
                               K + +K+ DFGS     P +  +  + +R YRAPE++LG 
Sbjct: 177 --------------------KDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGA 216
Query: 296 G-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKY 354
             +T   D+WS+GC+  EL  G+ LF    +++ L  + +++G   +  + R++ H  + 
Sbjct: 217 TEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE- 275
Query: 355 VRRGRL---DW----PEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 407
           VR   L   DW    PEG  S                              LL+ +LRY+
Sbjct: 276 VRFPTLKAKDWRKILPEGTPSLA--------------------------IDLLEQILRYE 309
Query: 408 PTDRLTAREALRHPFFTRDHLRR 430
           P  R+   EA+ HPFF  DHLR 
Sbjct: 310 PDLRINPYEAMAHPFF--DHLRN 330

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 96/331 (29%), Positives = 153/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+  +R     +     A+ EI +L++L   +      
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN-----I 64
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 124
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 125 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 157
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 158 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 217
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 218 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 258
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 259 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 96/331 (29%), Positives = 153/331 (46%), Gaps = 61/331 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEGT+G V +  ++   E+VA+  +R     +     A+ EI +L++L   +      
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN-----I 63
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF H   +
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 276
           +H DLKP+N LL+++E                           AIK+ DFG +  +  P 
Sbjct: 124 LHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGVPV 156
Query: 277 QNYI--VSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
           + Y   V T  YRAPE++LG  + +   DIWS+GCI  E+ T  ALF     ++ L  + 
Sbjct: 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 216
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHS 392
           R LG  P  ++                 WP   +  +   S  K  R   + ++  +D  
Sbjct: 217 RTLG-TPDEVV-----------------WPGVTSMPDYKPSFPKWARQDFSKVVPPLDE- 257
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 258 --DGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 96/351 (27%), Positives = 162/351 (46%), Gaps = 77/351 (21%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKH 150
           +S++K   K+G GT+  V +  ++     VA+K V+    +     A+ EI ++++L KH
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KH 62
Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRK----NNYRSFPIDLVREIARQLL 206
           +      V++ +     N + +VFE + + L  ++      N  R   ++LV+    QLL
Sbjct: 63  E----NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
           + +AF H+  ++H DLKP+N+L+     +K+ D+               + ++  I V  
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFG--------------LARAFGIPVNT 164
Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
           F S           V T  YRAP+V++G   ++   DIWS GCIL E+ TG+ LF    +
Sbjct: 165 FSSE----------VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214
Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR----- 380
            E L ++  ++G  P   L                 WP          SV KLP+     
Sbjct: 215 EEQLKLIFDIMGT-PNESL-----------------WP----------SVTKLPKYNPNI 246
Query: 381 -------LQNLIMQHVDHSA-GDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                  L+ ++  H      G+L   L GLL+ +P  RL+A++AL HP+F
Sbjct: 247 QQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 93/339 (27%), Positives = 154/339 (45%), Gaps = 60/339 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWD-RERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKH 150
           +Y+  +++GEG +G+V +  D +     VA+K VR   G +    + + E+ VL+ L   
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 151 DKGG-----NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQL 205
           +        + C   R   D    + +VFE +   L  +L K      P + ++++  QL
Sbjct: 72  EHPNVVRLFDVCTVSRT--DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L  + F+H   ++H DLKP+N+L+ SS  IK+ D+  +        Y  +M  +S     
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------RIYSFQMALTS----- 178
Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
                         +V T  YRAPEV+L   +  P D+WSVGCI  E+   + LF+   +
Sbjct: 179 --------------VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224
Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRLQNL 384
           ++ L  +  V+G LP                 G  DWP   A  R++  S    P ++  
Sbjct: 225 VDQLGKILDVIG-LP-----------------GEEDWPRDVALPRQAFHSKSAQP-IEKF 265
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           +   +D    D   LL   L ++P  R++A  AL HP+F
Sbjct: 266 VTD-IDELGKD---LLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 93/339 (27%), Positives = 154/339 (45%), Gaps = 60/339 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWD-RERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKH 150
           +Y+  +++GEG +G+V +  D +     VA+K VR   G +    + + E+ VL+ L   
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 151 DKGG-----NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQL 205
           +        + C   R   D    + +VFE +   L  +L K      P + ++++  QL
Sbjct: 72  EHPNVVRLFDVCTVSRT--DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L  + F+H   ++H DLKP+N+L+ SS  IK+ D+  +        Y  +M  +S     
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------RIYSFQMALTS----- 178
Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
                         +V T  YRAPEV+L   +  P D+WSVGCI  E+   + LF+   +
Sbjct: 179 --------------VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224
Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRLQNL 384
           ++ L  +  V+G LP                 G  DWP   A  R++  S    P ++  
Sbjct: 225 VDQLGKILDVIG-LP-----------------GEEDWPRDVALPRQAFHSKSAQP-IEKF 265
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           +   +D    D   LL   L ++P  R++A  AL HP+F
Sbjct: 266 VTD-IDELGKD---LLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 93/339 (27%), Positives = 154/339 (45%), Gaps = 60/339 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWD-RERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKH 150
           +Y+  +++GEG +G+V +  D +     VA+K VR   G +    + + E+ VL+ L   
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 151 DKGG-----NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQL 205
           +        + C   R   D    + +VFE +   L  +L K      P + ++++  QL
Sbjct: 72  EHPNVVRLFDVCTVSRT--DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L  + F+H   ++H DLKP+N+L+ SS  IK+ D+  +        Y  +M  +S     
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------RIYSFQMALTS----- 178
Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
                         +V T  YRAPEV+L   +  P D+WSVGCI  E+   + LF+   +
Sbjct: 179 --------------VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224
Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRLQNL 384
           ++ L  +  V+G LP                 G  DWP   A  R++  S    P ++  
Sbjct: 225 VDQLGKILDVIG-LP-----------------GEEDWPRDVALPRQAFHSKSAQP-IEKF 265
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           +   +D    D   LL   L ++P  R++A  AL HP+F
Sbjct: 266 VTD-IDELGKD---LLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 88/351 (25%), Positives = 151/351 (43%), Gaps = 62/351 (17%)
Query: 88  LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL 147
           LG   TSRY+  +++G G +G V +  D      VA+K VR          + I  ++++
Sbjct: 3   LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREV 62
Query: 148 A--------KHD---KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPID 196
           A        +H    +  + C   R   D    + +VFE +   L  +L K      P +
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRT--DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 197 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 256
            ++++ RQ L  + F+H  C++H DLKPEN+L+ S   +K+ D+  +        Y  +M
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA------RIYSYQM 174
Query: 257 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
             +                    +V T  YRAPEV+L   +  P D+WSVGCI  E+   
Sbjct: 175 ALTP-------------------VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215
Query: 317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSV 375
           + LF  +   + L  +  ++G  P+                   DWP   +  R +    
Sbjct: 216 KPLFCGNSEADQLGKIFDLIGLPPED------------------DWPRDVSLPRGAFPP- 256
Query: 376 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
            + PR    ++  ++ S      LL  +L ++P  R++A  AL+H +  +D
Sbjct: 257 -RGPRPVQSVVPEMEESGA---QLLLEMLTFNPHKRISAFRALQHSYLHKD 303

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 86/343 (25%), Positives = 149/343 (43%), Gaps = 59/343 (17%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAK 149
           TSRY+  +++G G +G V +  D      VA+K VR   G +    + + E+ +L++L  
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 150 HDKGG-----NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 204
            +        + C   R   D    + +VFE +   L  +L K      P + ++++ RQ
Sbjct: 63  FEHPNVVRLMDVCATSRT--DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
            L  + F+H  C++H DLKPEN+L+ S   +K+ D+  +       + F           
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP---------- 170
Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
                          +V T  YRAPEV+L   +  P D+WSVGCI  E+   + LF  + 
Sbjct: 171 ---------------VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 215
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRLQN 383
             + L  +  ++G  P+                   DWP   +  R +     + PR   
Sbjct: 216 EADQLGKIFDLIGLPPED------------------DWPRDVSLPRGAFPP--RGPRPVQ 255
Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
            ++  ++ S      LL  +L ++P  R++A  AL+H +  +D
Sbjct: 256 SVVPEMEESGA---QLLLEMLTFNPHKRISAFRALQHSYLHKD 295

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 87/343 (25%), Positives = 152/343 (44%), Gaps = 59/343 (17%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAK 149
           TSRY+  +++G G +G V +  D      VA+K VR   G +    + + E+ +L++L  
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 150 HDKGG-----NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 204
            +        + C   R   D    + +VFE +   L  +L K      P + ++++ RQ
Sbjct: 63  FEHPNVVRLMDVCATSRT--DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
            L  + F+H  C++H DLKPEN+L+ S   +K+ D+  +    +  SY   +        
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA----RIYSYQMAL-------- 168
Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
                        + +V T  YRAPEV+L   +  P D+WSVGCI  E+   + LF  + 
Sbjct: 169 -------------DPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 215
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRLQN 383
             + L  +  ++G  P+                   DWP   +  R +     + PR   
Sbjct: 216 EADQLGKIFDLIGLPPED------------------DWPRDVSLPRGAFPP--RGPRPVQ 255
Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
            ++  ++ S      LL  +L ++P  R++A  AL+H +  +D
Sbjct: 256 SVVPEMEESGA---QLLLEMLTFNPHKRISAFRALQHSYLHKD 295

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 104/362 (28%), Positives = 159/362 (43%), Gaps = 88/362 (24%)
Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA 148
           GE     Y     +G G+FG V +    E  E VAIK V   K+++     E+++++ + 
Sbjct: 35  GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR---ELQIMR-IV 89
Query: 149 KHDKGGNRCVQIRNWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVR 199
           KH       V ++ +F Y N        + +V E +  ++Y   R      ++ P+ L++
Sbjct: 90  KHPN----VVDLKAFF-YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIK 144
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
               QLL  +A++H + + H D+KP+N+LL                           P S
Sbjct: 145 LYMYQLLRSLAYIHSIGICHRDIKPQNLLL--------------------------DPPS 178
Query: 260 SAIKVIDFGSTTY---ERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCT 315
             +K+IDFGS        P+ + I S R+YRAPE+I G   +T   DIWS GC++ EL  
Sbjct: 179 GVLKLIDFGSAKILIAGEPNVSXICS-RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237
Query: 316 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV 375
           G+ LF     ++ L  + +VL                            G  SRE IK++
Sbjct: 238 GQPLFPGESGIDQLVEIIKVL----------------------------GTPSREQIKTM 269
Query: 376 M------KLPRLQNLIMQHV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                  K P+++      V    +  D   L+  LL Y P+ RLTA EAL HPFF  D 
Sbjct: 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF--DE 327
Query: 428 LR 429
           LR
Sbjct: 328 LR 329

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 87/343 (25%), Positives = 151/343 (44%), Gaps = 59/343 (17%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAK 149
           TSRY+  +++G G +G V +  D      VA+K VR   G +    + + E+ +L++L  
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 150 HDKGG-----NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 204
            +        + C   R   D    + +VFE +   L  +L K      P + ++++ RQ
Sbjct: 63  FEHPNVVRLMDVCATSRT--DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
            L  + F+H  C++H DLKPEN+L+ S   +K+ D+  +        Y  +M  +     
Sbjct: 121 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA------RIYSYQMALAP---- 170
Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
                          +V T  YRAPEV+L   +  P D+WSVGCI  E+   + LF  + 
Sbjct: 171 ---------------VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 215
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRLQN 383
             + L  +  ++G  P+                   DWP   +  R +     + PR   
Sbjct: 216 EADQLGKIFDLIGLPPED------------------DWPRDVSLPRGAFPP--RGPRPVQ 255
Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
            ++  ++ S      LL  +L ++P  R++A  AL+H +  +D
Sbjct: 256 SVVPEMEESGA---QLLLEMLTFNPHKRISAFRALQHSYLHKD 295

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 89/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTD---DHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + + S 
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDSE 163
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 164 LKILDFGLCRHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/348 (25%), Positives = 155/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 79
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 80  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 136
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + + S 
Sbjct: 137 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDSE 169
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 170 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 230 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 273
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 274 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 318

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 89/348 (25%), Positives = 155/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 75
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 76  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 132
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + + S 
Sbjct: 133 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDSE 165
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 166 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 226 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 269
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 270 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 314

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTD---DHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDXE 163
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 164 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 90/349 (25%), Positives = 151/349 (43%), Gaps = 75/349 (21%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    +A+K        I+   + YRE          +
Sbjct: 52  RYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYREL---------R 102
Query: 147 LAKHDKGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE 200
           L KH K  N  + + + F      +  N + +V   +G+ L + ++         D V+ 
Sbjct: 103 LLKHMKHEN-VIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQF 158
Query: 201 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 260
           +  Q+L  + ++H   +IH DLKP N+                            + +  
Sbjct: 159 LIYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDC 191
Query: 261 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEAL 319
            +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  L
Sbjct: 192 ELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTL 251
Query: 320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 379
           F   +++  L  + R+ G  P  ++ R+  H                 +R  I S+ ++P
Sbjct: 252 FPGTDHINQLQQIMRLTGTPPASVISRMPSH----------------EARNYINSLPQMP 295
Query: 380 RLQNLIMQHVDHSAGDLT-HLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +        V   A  L   LL+ +L  D   R+TA EAL HP+F++ H
Sbjct: 296 KRN---FADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYH 341

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTD---DHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 163
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 164 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL---------R 93
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 94  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 150
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 151 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 183
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 184 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 243
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 244 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLAQMPK 287
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 288 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 332

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 28  RYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 78
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 79  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 135
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 136 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDXE 168
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 169 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 229 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 272
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 273 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 317

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL---------R 69
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 126
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 159
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 160 LKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 220 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLAQMPK 263
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 264 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 163
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 164 LKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL---------R 69
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 126
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 159
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 160 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 220 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLAQMPK 263
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 264 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL---------R 92
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 93  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 149
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 150 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 182
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 183 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 242
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 243 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLAQMPK 286
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 287 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 331

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 163
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 164 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLAQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 163
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 164 LKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLAQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 78
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 79  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 135
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 136 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDXE 168
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 169 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 229 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 272
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 273 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 317

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL---------R 69
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTD---DHVQFL 126
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 159
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 160 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 220 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLAQMPK 263
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 264 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 84
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 85  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 141
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 142 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDXE 174
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 175 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 234
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 235 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 278
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 279 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 323

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL---------R 93
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 94  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 150
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 151 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 183
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 184 LKILDFGLARHTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 243
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 244 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLAQMPK 287
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 288 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 332

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 93/341 (27%), Positives = 155/341 (45%), Gaps = 39/341 (11%)
Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLA 148
           N++S +++ S +GEG +G V     +   E+VAIK +    K  +    + EI++L+   
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
             +      +Q  + F+  N + I+ E + + L+   R  + +    D ++    Q L  
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDDHIQYFIYQTLRA 124
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +  +H   +IH DLKP N+L+ S+  +KV D+              R+   SA    D  
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFG-----------LARIIDESAA---DNS 170
Query: 269 STTYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
             T ++      V+TR YRAPEV+L    ++   D+WS GCIL EL     +F   +   
Sbjct: 171 EPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH 230
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIM 386
            L ++  ++G            H++  +R       E   +RE IKS+   P      + 
Sbjct: 231 QLLLIFGIIG----------TPHSDNDLR-----CIESPRAREYIKSLPMYPAAPLEKMF 275
Query: 387 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
             V+    DL   LQ +L +DP  R+TA+EAL HP+    H
Sbjct: 276 PRVNPKGIDL---LQRMLVFDPAKRITAKEALEHPYLQTYH 313

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL---------R 79
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 80  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 136
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 137 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 169
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 170 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 230 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLAQMPK 273
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 274 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 318

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 163
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 164 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 163
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 164 LKILDFGLARHTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 93/341 (27%), Positives = 155/341 (45%), Gaps = 39/341 (11%)
Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLA 148
           N++S +++ S +GEG +G V     +   E+VAIK +    K  +    + EI++L+   
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
             +      +Q  + F+  N + I+ E + + L+   R  + +    D ++    Q L  
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDDHIQYFIYQTLRA 124
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +  +H   +IH DLKP N+L+ S+  +KV D+              R+   SA    D  
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFG-----------LARIIDESAA---DNS 170
Query: 269 STTYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
             T ++      V+TR YRAPEV+L    ++   D+WS GCIL EL     +F   +   
Sbjct: 171 EPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH 230
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIM 386
            L ++  ++G            H++  +R       E   +RE IKS+   P      + 
Sbjct: 231 QLLLIFGIIG----------TPHSDNDLR-----CIESPRAREYIKSLPMYPAAPLEKMF 275
Query: 387 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
             V+    DL   LQ +L +DP  R+TA+EAL HP+    H
Sbjct: 276 PRVNPKGIDL---LQRMLVFDPAKRITAKEALEHPYLQTYH 313

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 78
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 79  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 135
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 136 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 168
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 169 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 229 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 272
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 273 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 317

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 80
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 137
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 170
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 171 LKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 231 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 274
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 275 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 75
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 76  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 132
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 133 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 165
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 166 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 226 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 269
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 270 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 314

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYREL---------R 85
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 86  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 142
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 143 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 175
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 176 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 236 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 279
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 280 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 324

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 78
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 79  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 135
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 136 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 168
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 169 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 229 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 272
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 273 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 317

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 85
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 86  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 142
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 143 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 175
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 176 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 236 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 279
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 280 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 324

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 22  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 72
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 73  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 129
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 130 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 162
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 163 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 222
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 223 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 266
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 267 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 311

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 85
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 86  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 142
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 143 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 175
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 176 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 236 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 279
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 280 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 324

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 21  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 71
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 72  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 128
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 129 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 161
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 162 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 221
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 222 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 265
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 266 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 310

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 80
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 137
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 170
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 171 LKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 231 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 274
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 275 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 163
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 164 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 163
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 164 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 70
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 71  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 127
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 128 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 160
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 161 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 220
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 221 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 264
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 265 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 309

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 69
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 126
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 159
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 160 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 220 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 263
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 264 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 96
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 97  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 153
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 154 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 186
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 187 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 246
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 247 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 290
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 291 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 335

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 80
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 137
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 170
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 171 LKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 231 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 274
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 275 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 163
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 164 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 70
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 71  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 127
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 128 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 160
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 161 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 220
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 221 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 264
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 265 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 309

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 84
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 85  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 141
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 142 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 174
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 175 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 234
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 235 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 278
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 279 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 323

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 93
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 94  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 150
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 151 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 183
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 184 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 243
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 244 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 287
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 288 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 332

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 80
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 137
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 170
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 171 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 231 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 274
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 275 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 75
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 76  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 132
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 133 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 165
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 166 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 226 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 269
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 270 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 314

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 75
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 76  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 132
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 133 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 165
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 166 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 226 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 269
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 270 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 314

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 163
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 164 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 96
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 97  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 153
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 154 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 186
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 187 LKILDFGLARHTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 246
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 247 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 290
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 291 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 335

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 163
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 164 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 92
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 93  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 149
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 150 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 182
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 183 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 242
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 243 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 286
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 287 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 331

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 163
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 164 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 163
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 164 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 79
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 80  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 136
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 137 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 169
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 170 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 230 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 273
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 274 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 318

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 93/341 (27%), Positives = 155/341 (45%), Gaps = 39/341 (11%)
Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLA 148
           N++S +++ S +GEG +G V     +   E+VAIK +    K  +    + EI++L+   
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
             +      +Q  + F+  N + I+ E + + L+   R  + +    D ++    Q L  
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDDHIQYFIYQTLRA 124
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +  +H   +IH DLKP N+L+ S+  +KV D+              R+   SA    D  
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFG-----------LARIIDESAA---DNS 170
Query: 269 STTYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
             T ++      V+TR YRAPEV+L    ++   D+WS GCIL EL     +F   +   
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH 230
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIM 386
            L ++  ++G            H++  +R       E   +RE IKS+   P      + 
Sbjct: 231 QLLLIFGIIG----------TPHSDNDLR-----CIESPRAREYIKSLPMYPAAPLEKMF 275
Query: 387 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
             V+    DL   LQ +L +DP  R+TA+EAL HP+    H
Sbjct: 276 PRVNPKGIDL---LQRMLVFDPAKRITAKEALEHPYLQTYH 313

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  + +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 33  RYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL---------R 83
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 84  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 140
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 141 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 173
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 174 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 233
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 234 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLAQMPK 277
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 278 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 322

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 79
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 80  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 136
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 137 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 169
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 170 LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 230 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 273
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 274 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 318

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 89/348 (25%), Positives = 154/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+ +     +K+ DY  + HT  + + +        
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGY-------- 182
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
                              V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 183 -------------------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 95/351 (27%), Positives = 158/351 (45%), Gaps = 70/351 (19%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
           R+++    G+GTFG V    ++     VAIK V    ++R     E++++Q LA      
Sbjct: 24  RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR---ELQIMQDLAVLHHPN 80
Query: 155 NRCVQIRNWF------DYRN-HICIVFEKLGSSLYDFLRKNNYR---SFPIDLVREIARQ 204
              VQ++++F      D R+ ++ +V E +  +L+   R N YR   + P  L++    Q
Sbjct: 81  --IVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCR-NYYRRQVAPPPILIKVFLFQ 137
Query: 205 LLECIAFMH--DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
           L+  I  +H   + + H D+KP NVL+  ++                            +
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEAD--------------------------GTL 171
Query: 263 KVIDFGSTTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEAL 319
           K+ DFGS     P +  +  + +R+YRAPE+I G   +T   DIWSVGCI  E+  GE +
Sbjct: 172 KLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPI 231
Query: 320 FQTHENLEHLAMMERVLGPLPQHMLKRVD---RHAEKYVRRGRLDWPEGAASRESIKSVM 376
           F+   +   L  + RVLG   + +L++++      + Y  +G + W              
Sbjct: 232 FRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKG-IPW-------------- 276
Query: 377 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                 N+   H    A +   LL  LL+Y P +R+   EAL HP+F   H
Sbjct: 277 -----SNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 89/342 (26%), Positives = 152/342 (44%), Gaps = 64/342 (18%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKK--YREAAMIEIEVLQQLA 148
           L   Y   + +G G +G V    D+   E VAIK + R  +   + + A  E+ +L+ + 
Sbjct: 40  LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 99
Query: 149 KHDKGG-----NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 203
             +  G          +RN++D+  ++ + F +        L+K     F  + ++ +  
Sbjct: 100 HENVIGLLDVFTPASSLRNFYDF--YLVMPFMQTD------LQKIMGMEFSEEKIQYLVY 151
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L+ + ++H   ++H DLKP N+                            + +   +K
Sbjct: 152 QMLKGLKYIHSAGVVHRDLKPGNL---------------------------AVNEDCELK 184
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQT 322
           ++DFG   +   +    V TR YRAPEVIL  + +    DIWSVGCI+ E+ TG+ LF+ 
Sbjct: 185 ILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244
Query: 323 HENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 381
            + L+ L  + +V G P  + + K  D+ A+ Y                 I+S+ + PR 
Sbjct: 245 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY-----------------IQSLPQTPRK 287
Query: 382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                Q    ++     LL+ +L  D   RLTA +AL HPFF
Sbjct: 288 D--FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 88/348 (25%), Positives = 155/348 (44%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+ +     +K+ D+  + HT  + + +        
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGY-------- 182
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
                              V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 183 -------------------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 89/342 (26%), Positives = 152/342 (44%), Gaps = 64/342 (18%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKK--YREAAMIEIEVLQQLA 148
           L   Y   + +G G +G V    D+   E VAIK + R  +   + + A  E+ +L+ + 
Sbjct: 22  LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 149 KHDKGG-----NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 203
             +  G          +RN++D+  ++ + F +        L+K     F  + ++ +  
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDF--YLVMPFMQTD------LQKIMGLKFSEEKIQYLVY 133
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L+ + ++H   ++H DLKP N+                            + +   +K
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNL---------------------------AVNEDCELK 166
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQT 322
           ++DFG   +   +    V TR YRAPEVIL  + +    DIWSVGCI+ E+ TG+ LF+ 
Sbjct: 167 ILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226
Query: 323 HENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 381
            + L+ L  + +V G P  + + K  D+ A+ Y                 I+S+ + PR 
Sbjct: 227 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY-----------------IQSLPQTPRK 269
Query: 382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                Q    ++     LL+ +L  D   RLTA +AL HPFF
Sbjct: 270 D--FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 87/343 (25%), Positives = 147/343 (42%), Gaps = 59/343 (17%)
Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLA 148
           ++  RY     +GEG +G V   +D  RK  VAIK +     + Y +  + EI++L +  
Sbjct: 40  DVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFR 99
Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
             +  G R +   +  +    + IV + + + LY  L+     +   D +     Q+L  
Sbjct: 100 HENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSN---DHICYFLYQILRG 156
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           + ++H   ++H DLKP N+L+ ++                             +K+ DFG
Sbjct: 157 LKYIHSANVLHRDLKPSNLLINTT---------------------------CDLKICDFG 189
Query: 269 STTYERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQ 321
                 P+ ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F 
Sbjct: 190 LARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 249
Query: 322 THENLEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
               L+ L  +  +LG   Q  L   ++  A  Y+        +   S+  +      P+
Sbjct: 250 GKHYLDQLNHILGILGSPSQEDLNCIINMKARNYL--------QSLPSKTKVAWAKLFPK 301
Query: 381 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                    D  A D   LL  +L ++P  R+T  EAL HP+ 
Sbjct: 302 --------SDSKALD---LLDRMLTFNPNKRITVEEALAHPYL 333

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 87/344 (25%), Positives = 153/344 (44%), Gaps = 77/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K+++     E++++++L       + C  +R
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------DHCNIVR 115
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 176 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 209
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ +YI S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 210 QLVRGEPNVSYICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 268
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++                      K P+++     
Sbjct: 269 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 306
Query: 388 HV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            V    +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 307 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 348

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 87/344 (25%), Positives = 153/344 (44%), Gaps = 77/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K+++     E++++++L       + C  +R
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------DHCNIVR 113
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 174 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 207
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ +YI S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 208 QLVRGEPNVSYICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 266
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++                      K P+++     
Sbjct: 267 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 304
Query: 388 HV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            V    +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 305 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 346

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 87/344 (25%), Positives = 153/344 (44%), Gaps = 77/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K+++     E++++++L       + C  +R
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------DHCNIVR 111
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 172 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 205
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ +YI S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 206 QLVRGEPNVSYICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++                      K P+++     
Sbjct: 265 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 302
Query: 388 HV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            V    +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 303 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 344

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/344 (25%), Positives = 153/344 (44%), Gaps = 77/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K+++     E++++++L       + C  +R
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------DHCNIVR 156
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 217 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 250
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ +YI S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 251 QLVRGEPNVSYICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 309
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++                      K P+++     
Sbjct: 310 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 347
Query: 388 HV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            V    +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 348 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 389

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/344 (25%), Positives = 153/344 (44%), Gaps = 77/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K+++     E++++++L       + C  +R
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------DHCNIVR 105
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 165
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 166 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 199
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ +YI S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 200 QLVRGEPNVSYICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 258
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++                      K P+++     
Sbjct: 259 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 296
Query: 388 HV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            V    +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 297 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 338

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/344 (24%), Positives = 155/344 (45%), Gaps = 72/344 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---------GIKKYREAAMIEIEVLQ 145
           RY+    +GEG F  V +  D+   ++VAIK ++         GI +    A+ EI++LQ
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINR---TALREIKLLQ 67
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQL 205
           +L+  +      + + + F ++++I +VF+ + + L   ++ N+    P   ++      
Sbjct: 68  ELSHPN-----IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP-SHIKAYMLMT 121
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L+ + ++H   ++H DLKP N+LL                            ++  +K+ 
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLL---------------------------DENGVLKLA 154
Query: 266 DFG-STTYERPDQNYI--VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQ 321
           DFG + ++  P++ Y   V TR YRAPE++ G   +    D+W+VGCIL EL        
Sbjct: 155 DFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 214
Query: 322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 381
              +L+ L  +   LG   +                    WP+      S+   +     
Sbjct: 215 GDSDLDQLTRIFETLGTPTEE------------------QWPDMC----SLPDYVTFKSF 252
Query: 382 QNLIMQHVDHSAG-DLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             + + H+  +AG DL  L+QGL  ++P  R+TA +AL+  +F+
Sbjct: 253 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/348 (25%), Positives = 152/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++         D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 163
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++ FG   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 164 LKILGFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 87/344 (25%), Positives = 153/344 (44%), Gaps = 77/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K+++     E++++++L       + C  +R
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------DHCNIVR 82
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 142
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 143 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 176
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ +YI S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 177 QLVRGEPNVSYICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 235
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++                      K P+++     
Sbjct: 236 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 273
Query: 388 HV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            V    +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 274 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 315

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 87/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 163
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++D G   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 164 LKILDAGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 87/344 (25%), Positives = 153/344 (44%), Gaps = 77/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K+++     E++++++L       + C  +R
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------DHCNIVR 90
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 150
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 151 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 184
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ +YI S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 185 QLVRGEPNVSYICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 243
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++                      K P+++     
Sbjct: 244 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 281
Query: 388 HV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            V    +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 282 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 323

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 87/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 163
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++D G   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 164 LKILDGGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 87/348 (25%), Positives = 153/348 (43%), Gaps = 73/348 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQ 146
           RY+  S +G G +G V   +D +    VA+K        I+   + YRE          +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------R 73
Query: 147 LAKHDKGGNRCVQIRNWFDYR-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           L KH K  N    +  +   R     N + +V   +G+ L + ++    +    D V+ +
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFL 130
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H   +IH DLKP N+                            + +   
Sbjct: 131 IYQILRGLKYIHSADIIHRDLKPSNL---------------------------AVNEDCE 163
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 320
           +K++D G   +   +    V+TR YRAPE++L  + +    DIWSVGCI+ EL TG  LF
Sbjct: 164 LKILDRGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
              ++++ L ++ R++G     +LK++                   ++R  I+S+ ++P+
Sbjct: 224 PGTDHIDQLKLILRLVGTPGAELLKKI----------------SSESARNYIQSLTQMPK 267
Query: 381 LQNLIMQHVDHSAGDL-THLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +      +V   A  L   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 268 MN---FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 87/344 (25%), Positives = 153/344 (44%), Gaps = 77/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K+++     E++++++L       + C  +R
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------DHCNIVR 77
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 138 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 171
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ +YI S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 172 QLVRGEPNVSYICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++                      K P+++     
Sbjct: 231 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 268
Query: 388 HV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            V    +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 269 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 310

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L      + 
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 142
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                           S +K+ DFG    
Sbjct: 143 HSANVLHRDLKPSNLLLNTT---------------------------SDLKICDFGLARV 175
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 176 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 235
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 236 LDQLNHILGILGSPSQEDLNCGINLKARNYLL--------------SLPHKNKVP--WNR 279
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 280 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLAQ 317

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + +V   +G+ LY  L+  +  +   D +     Q+L  + ++
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSN---DHICYFLYQILRGLKYI 160
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 161 HSANVLHRDLKPSNLLLNTT---------------------------XDLKICDFGLARV 193
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 194 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 253
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 254 LDQLNHILGILGSPSQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 297
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 298 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 335

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 87/344 (25%), Positives = 152/344 (44%), Gaps = 77/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K ++     E++++++L       + C  +R
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR---ELQIMRKL-------DHCNIVR 77
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 138 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 171
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ +YI S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 172 QLVRGEPNVSYICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++                      K P+++     
Sbjct: 231 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 268
Query: 388 HV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            V    +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 269 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 310

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 92/350 (26%), Positives = 160/350 (45%), Gaps = 78/350 (22%)
Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKH 150
            +Y+    +GEG++G V++C +++   +VAIK        K  ++ AM EI++L+QL +H
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RH 83
Query: 151 DKGGNR---CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR---- 203
           +   N    C + + W+       +VFE +  ++ D     +   FP  L  ++ +    
Sbjct: 84  ENLVNLLEVCKKKKRWY-------LVFEFVDHTILD-----DLELFPNGLDYQVVQKYLF 131
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q++  I F H   +IH D+KPEN+L+                            +S  +K
Sbjct: 132 QIINGIGFCHSHNIIHRDIKPENILV---------------------------SQSGVVK 164
Query: 264 VIDFG-STTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEAL 319
           + DFG + T   P + Y   V+TR YRAPE+++G + +    D+W++GC++ E+  GE L
Sbjct: 165 LCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPL 224
Query: 320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR---GRLDWPEGAASRESIKSVM 376
           F    +++ L  +   LG L       + RH E + +      +  PE    RE ++   
Sbjct: 225 FPGDSDIDQLYHIMMCLGNL-------IPRHQELFNKNPVFAGVRLPE-IKEREPLER-- 274
Query: 377 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
           + P+L  +++            L +  L  DP  R    E L H FF  D
Sbjct: 275 RYPKLSEVVID-----------LAKKCLHIDPDKRPFCAELLHHDFFQMD 313

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENI 87
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 144
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 145 HSANVLHRDLKPSNLLLNTT---------------------------XDLKICDFGLARV 177
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 281
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 282 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 85/334 (25%), Positives = 157/334 (47%), Gaps = 54/334 (16%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           Y++  K+G G + +V E  +    E V +KI++ +KK +     EI++L+ L    +GG 
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKR--EIKILENL----RGGP 92
Query: 156 RCVQIRNWFD--YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
             + + +           +VFE + ++  DF  K  Y++     +R    ++L+ + + H
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
            + ++H D+KP NV+ +  E+ K                         +++ID+G   + 
Sbjct: 149 SMGIMHRDVKPHNVM-IDHEHRK-------------------------LRLIDWGLAEFY 182
Query: 274 RPDQNYIV--STRHYRAPEVILGLG-WTYPCDIWSVGCILVELC-TGEALFQTHENLEHL 329
            P Q Y V  ++R+++ PE+++    + Y  D+WS+GC+L  +    E  F  H+N + L
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
             + +VLG   + +   +D++  +   R           R S K   +    +N   QH+
Sbjct: 243 VRIAKVLGT--EDLYDYIDKYNIELDPRF-----NDILGRHSRKRWERFVHSEN---QHL 292
Query: 390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
              + +    L  LLRYD   RLTAREA+ HP+F
Sbjct: 293 --VSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 89/342 (26%), Positives = 154/342 (45%), Gaps = 73/342 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K ++     E++++++L       + C  +R
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR---ELQIMRKL-------DHCNIVR 77
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 138 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 171
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ +YI S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 172 QLVRGEPNVSYICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++       +P+  A       V + PR       
Sbjct: 231 QLVEIIKVLGTPTREQIREMNPNYTEFA------FPQIKA--HPWTKVFR-PR------- 274
Query: 388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
               +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 275 ----TPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 310

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 87/338 (25%), Positives = 145/338 (42%), Gaps = 55/338 (16%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKK--YREAAMIEIEVLQQLAKHDK 152
           Y+    +G G +G V    D      VAIK + R  +   + + A  E+ +L+ +   + 
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 153 GGNRCVQIRN-WFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            G   V   +   D      +V   +G+ L   ++   +     D ++ +  Q+L+ + +
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRY 143
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H   +IH DLKP N+ +                            +   +K++DFG   
Sbjct: 144 IHAAGIIHRDLKPGNLAV---------------------------NEDCELKILDFGLAR 176
Query: 272 YERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
               +    V TR YRAPEVIL  + +T   DIWSVGCI+ E+ TG+ LF+  ++L+ L 
Sbjct: 177 QADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 236
Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 390
            + +V G  P   ++R+     K   +G                   LP L+      + 
Sbjct: 237 EIMKVTGTPPAEFVQRLQSDEAKNYMKG-------------------LPELEKKDFASIL 277
Query: 391 HSAGDLT-HLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
            +A  L  +LL+ +L  D   R+TA EAL HP+F   H
Sbjct: 278 TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 86/344 (25%), Positives = 152/344 (44%), Gaps = 77/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K+++     E++++++L       + C  +R
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------DHCNIVR 111
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 172 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 205
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ + I S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 206 QLVRGEPNVSXICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++                      K P+++     
Sbjct: 265 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 302
Query: 388 HV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            V    +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 303 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 344

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 140
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 141 HSANVLHRDLKPSNLLLNTT---------------------------XDLKIXDFGLARV 173
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 326 LEHLAMMERVLGPLPQHMLKR-VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 234 LDQLNHILGILGSPSQEDLNXIINLKARNYLL--------------SLPHKNKVP--WNR 277
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 278 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 140
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 141 HSANVLHRDLKPSNLLLNTT---------------------------XDLKICDFGLARV 173
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 326 LEHLAMMERVLGPLPQHMLKR-VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 234 LDQLNHILGILGSPSQEDLNXIINLKARNYLL--------------SLPHKNKVP--WNR 277
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 278 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 87/344 (25%), Positives = 149/344 (43%), Gaps = 79/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQLAKHDKG 153
           +G G +G V   +D   ++ VA+K        ++   + YRE          +L KH K 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYREL---------RLLKHLKH 86
Query: 154 GNRCVQIRNWF-------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
            N  + + + F       D+ + + +V   +G+ L + ++    ++   + V+ +  QLL
Sbjct: 87  EN-VIGLLDVFTPATSIEDF-SEVYLVTTLMGADLNNIVKS---QALSDEHVQFLVYQLL 141
Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             + ++H   +IH DLKP NV                            + + S ++++D
Sbjct: 142 RGLKYIHSAGIIHRDLKPSNV---------------------------AVNEDSELRILD 174
Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
           FG       +    V+TR YRAPE++L  + +    DIWSVGCI+ EL  G+ALF   + 
Sbjct: 175 FGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDY 234
Query: 326 LEHLA-MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           ++ L  +ME V  P P+ + K    HA  Y++                     LP +   
Sbjct: 235 IDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ--------------------SLPPMPQK 274
Query: 385 IMQHVDHSAGDLT-HLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
            +  +   A  L   LL  +L  D   R++A EAL H +F++ H
Sbjct: 275 DLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYH 318

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/344 (25%), Positives = 152/344 (44%), Gaps = 77/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K+++     E++++++L       + C  +R
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------DHCNIVR 89
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 150 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 183
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ + I S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 184 QLVRGEPNVSXICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 242
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++                      K P+++     
Sbjct: 243 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 280
Query: 388 HV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            V    +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 281 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 322

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/344 (25%), Positives = 152/344 (44%), Gaps = 77/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K+++     E++++++L       + C  +R
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------DHCNIVR 89
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 150 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 183
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ + I S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 184 QLVRGEPNVSXICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 242
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++                      K P+++     
Sbjct: 243 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 280
Query: 388 HV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            V    +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 281 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 322

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 104 IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 160
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 161 HSANVLHRDLKPSNLLLNTT---------------------------CDLKICDFGLARV 193
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 194 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 253
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 254 LDQLNHILGILGSPSQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 297
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 298 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 335

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 145/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L      + 
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 142
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 143 HSANVLHRDLKPSNLLLNTT---------------------------CDLKICDFGLARV 175
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 176 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 235
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 236 LDQLNHILGILGSPSQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 279
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 280 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLAQ 317

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 144
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 145 HSANVLHRDLKPSNLLLNTT---------------------------XDLKICDFGLARV 177
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 281
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 282 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/344 (25%), Positives = 152/344 (44%), Gaps = 77/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K+++     E++++++L       + C  +R
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------DHCNIVR 85
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 145
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 146 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 179
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ + I S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 180 QLVRGEPNVSXICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 238
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++                      K P+++     
Sbjct: 239 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 276
Query: 388 HV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            V    +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 277 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 318

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 91
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 92  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 148
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 149 HSANVLHRDLKPSNLLLNTT---------------------------CDLKICDFGLARV 181
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 182 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 241
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 242 LDQLNHILGILGSPSQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 285
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 286 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 323

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 140
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 141 HSANVLHRDLKPSNLLLNTT---------------------------CDLKICDFGLARV 173
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 234 LDQLNHILGILGSPSQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 277
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 278 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 85
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 142
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 143 HSANVLHRDLKPSNLLLNTT---------------------------CDLKICDFGLARV 175
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 176 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 235
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 236 LDQLNHILGILGSPSQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 279
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 280 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 317

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 140
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 141 HSANVLHRDLKPSNLLLNTT---------------------------XDLKICDFGLARV 173
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 234 LDQLNHILGILGSPSQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 277
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 278 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 145
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 146 HSANVLHRDLKPSNLLLNTT---------------------------CDLKICDFGLARV 178
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 179 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 238
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 239 LDQLNHILGILGSPSQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 282
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 283 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 320

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 89
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 90  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 146
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 147 HSANVLHRDLKPSNLLLNTT---------------------------CDLKICDFGLARV 179
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 180 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 239
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 240 LDQLNHILGILGSPSQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 283
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 284 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 321

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 80
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 81  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 137
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 138 HSANVLHRDLKPSNLLLNTT---------------------------CDLKICDFGLARV 170
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 171 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 230
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 231 LDQLNHILGILGSPSQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 274
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 275 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 312

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 144
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 145 HSANVLHRDLKPSNLLLNTT---------------------------CDLKICDFGLARV 177
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 281
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 282 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/344 (25%), Positives = 152/344 (44%), Gaps = 77/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K+++     E++++++L       + C  +R
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------DHCNIVR 96
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 156
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 157 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 190
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ + I S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 191 QLVRGEPNVSXICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 249
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++                      K P+++     
Sbjct: 250 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 287
Query: 388 HV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            V    +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 288 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 329

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 140
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 141 HSANVLHRDLKPSNLLLNTT---------------------------CDLKICDFGLARV 173
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 234 LDQLNHILGILGSPSQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 277
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 278 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 315

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 144
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 145 HSANVLHRDLKPSNLLLNTT---------------------------CDLKICDFGLARV 177
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 178 ADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 281
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 282 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 145
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 146 HSANVLHRDLKPSNLLLNTT---------------------------CDLKICDFGLARV 178
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 179 ADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 238
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 239 LDQLNHILGILGSPSQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 282
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 283 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 320

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 138
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 139 HSANVLHRDLKPSNLLLNTT---------------------------CDLKICDFGLARV 171
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 172 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 231
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 232 LDQLNHILGILGSPSQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 275
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 276 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 313

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/344 (25%), Positives = 152/344 (44%), Gaps = 77/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K+++     E++++++L       + C  +R
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------DHCNIVR 81
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 141
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 142 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 175
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ + I S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 176 QLVRGEPNVSXICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 234
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++                      K P+++     
Sbjct: 235 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 272
Query: 388 HV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            V    +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 273 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 314

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/344 (25%), Positives = 152/344 (44%), Gaps = 77/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K+++     E++++++L       + C  +R
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------DHCNIVR 77
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 138 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 171
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ + I S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 172 QLVRGEPNVSXICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++                      K P+++     
Sbjct: 231 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 268
Query: 388 HV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            V    +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 269 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 310

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/344 (25%), Positives = 152/344 (44%), Gaps = 77/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K+++     E++++++L       + C  +R
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------DHCNIVR 77
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 138 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 171
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ + I S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 172 QLVRGEPNVSXICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++                      K P+++     
Sbjct: 231 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 268
Query: 388 HV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            V    +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 269 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 310

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/344 (25%), Positives = 152/344 (44%), Gaps = 77/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K+++     E++++++L       + C  +R
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------DHCNIVR 77
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 138 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 171
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ + I S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 172 QLVRGEPNVSXICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++                      K P+++     
Sbjct: 231 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 268
Query: 388 HV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            V    +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 269 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 310

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 138
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 139 HSANVLHRDLKPSNLLLNTT---------------------------CDLKICDFGLARV 171
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 172 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 231
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 232 LDQLNHILGILGSPEQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 275
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 276 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 313

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/344 (25%), Positives = 152/344 (44%), Gaps = 77/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K+++     E++++++L       + C  +R
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-------DHCNIVR 78
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + +  ++Y   R      ++ P+  V+    QL   +A+
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 138
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 139 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 172
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ + I S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 173 QLVRGEPNVSXICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 231
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++                      K P+++     
Sbjct: 232 QLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWT 269
Query: 388 HV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
            V    +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 270 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 311

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 87/344 (25%), Positives = 149/344 (43%), Gaps = 79/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQLAKHDKG 153
           +G G +G V   +D   ++ VA+K        ++   + YRE          +L KH K 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYREL---------RLLKHLKH 86
Query: 154 GNRCVQIRNWF-------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
            N  + + + F       D+ + + +V   +G+ L + ++    ++   + V+ +  QLL
Sbjct: 87  EN-VIGLLDVFTPATSIEDF-SEVYLVTTLMGADLNNIVK---CQALSDEHVQFLVYQLL 141
Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             + ++H   +IH DLKP NV                            + + S ++++D
Sbjct: 142 RGLKYIHSAGIIHRDLKPSNV---------------------------AVNEDSELRILD 174
Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
           FG       +    V+TR YRAPE++L  + +    DIWSVGCI+ EL  G+ALF   + 
Sbjct: 175 FGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDY 234
Query: 326 LEHLA-MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           ++ L  +ME V  P P+ + K    HA  Y++                     LP +   
Sbjct: 235 IDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ--------------------SLPPMPQK 274
Query: 385 IMQHVDHSAGDLT-HLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
            +  +   A  L   LL  +L  D   R++A EAL H +F++ H
Sbjct: 275 DLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYH 318

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 93/372 (25%), Positives = 161/372 (43%), Gaps = 62/372 (16%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAI-KIVRGIKKYREAAMI--EIEVLQQLA 148
           +  RY+I   +G G++G V E +D+  K +VAI KI+R  +   +   I  EI +L +L 
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN 110
Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDL-VREIARQLLE 207
                    + I    +  + + +V E   S      R   Y +   +L ++ +   LL 
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLT---ELHIKTLLYNLLV 167
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY--KSSLHTPKD-SSYFKRMPKSSAIKV 264
            + ++H   ++H DLKP N L+     +KV D+    ++  P++ +S     P+   + +
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVI-LGLGWTYPCDIWSVGCILVELCT-------- 315
           + F  T   +      V TR YRAPE+I L   +T   D+WS+GCI  EL          
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287
Query: 316 -----------------------GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRH-A 351
                                   +  F T  N + L ++  +LG   +  ++ +++  A
Sbjct: 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDA 347
Query: 352 EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 411
           ++Y+R     +P+    RE      + P            S+ D  HLL+ +L ++P  R
Sbjct: 348 KRYIRI----FPK----REGTDLAERFPA-----------SSADAIHLLKRMLVFNPNKR 388
Query: 412 LTAREALRHPFF 423
           +T  E L HPFF
Sbjct: 389 ITINECLAHPFF 400

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAIK +     + Y +  + EI++L +    + 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSN---DHICYFLYQILRGLKYI 144
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 145 HSANVLHRDLKPSNLLLNTT---------------------------CDLKICDFGLARV 177
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 281
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 282 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 88/342 (25%), Positives = 154/342 (45%), Gaps = 73/342 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG V +    +  E+VAIK V   K ++     E++++++L       + C  +R
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR---ELQIMRKL-------DHCNIVR 77
Query: 162 -NWFDYRN-------HICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAF 211
             +F Y +       ++ +V + + +++Y   R      ++ P+  V+    QL   +A+
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 270
           +H   + H D+KP+N+LL                           P ++ +K+ DFGS  
Sbjct: 138 IHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAK 171
Query: 271 --TYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                 P+ + I S R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F     ++
Sbjct: 172 QLVRGEPNVSXICS-RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230
Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG   +  ++ ++ +  ++       +P+  A       V + PR       
Sbjct: 231 QLVEIIKVLGTPTREQIREMNPNYTEFA------FPQIKA--HPWTKVFR-PR------- 274
Query: 388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
               +  +   L   LL Y PT RLT  EA  H FF  D LR
Sbjct: 275 ----TPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 310

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 87/341 (25%), Positives = 146/341 (42%), Gaps = 59/341 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK 152
           RY   S +GEG +G V   +D   K  VAI+ +     + Y +  + EI++L +    + 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            G   +      +    + IV + + + LY  L+  +  +   D +     Q+L  + ++
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN---DHICYFLYQILRGLKYI 144
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKP N+LL ++                             +K+ DFG    
Sbjct: 145 HSANVLHRDLKPSNLLLNTT---------------------------CDLKICDFGLARV 177
Query: 273 ERPDQNYI------VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 325
             PD ++       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 326 LEHLAMMERVLGPLPQHMLK-RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           L+ L  +  +LG   Q  L   ++  A  Y+               S+    K+P   N 
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLL--------------SLPHKNKVP--WNR 281
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           +  + D  A D   LL  +L ++P  R+   +AL HP+  +
Sbjct: 282 LFPNADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQ 319

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 90/339 (26%), Positives = 154/339 (45%), Gaps = 84/339 (24%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKY--REAAMIEIEVLQQL 147
            + RYK    +G+G+FG+V+ C D+   +  A+K++  R +K+   +E+ + E+++L+QL
Sbjct: 48  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 148 AKHDKGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
              +      +++  +F+ + +  +V E   G  L+D +     R   +D  R I RQ+L
Sbjct: 108 DHPN-----IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAAR-IIRQVL 160
Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             I +MH   ++H DLKPEN+LL S                          K + I++ID
Sbjct: 161 SGITYMHKNKIVHRDLKPENLLLESK------------------------SKDANIRIID 196
Query: 267 FGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
           FG +T+    +     + T +Y APEV+ G  +   CD+WS G IL  L +G   F    
Sbjct: 197 FGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFN--- 252
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
                       G     +LK+V++                       K   +LP+ +  
Sbjct: 253 ------------GANEYDILKKVEKG----------------------KYTFELPQWKK- 277
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
               V  SA D   L++ +L Y P+ R++AR+AL H + 
Sbjct: 278 ----VSESAKD---LIRKMLTYVPSMRISARDALDHEWI 309

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 90/339 (26%), Positives = 154/339 (45%), Gaps = 84/339 (24%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKY--REAAMIEIEVLQQL 147
            + RYK    +G+G+FG+V+ C D+   +  A+K++  R +K+   +E+ + E+++L+QL
Sbjct: 47  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 148 AKHDKGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
              +      +++  +F+ + +  +V E   G  L+D +     R   +D  R I RQ+L
Sbjct: 107 DHPN-----IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAAR-IIRQVL 159
Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             I +MH   ++H DLKPEN+LL S                          K + I++ID
Sbjct: 160 SGITYMHKNKIVHRDLKPENLLLESK------------------------SKDANIRIID 195
Query: 267 FGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
           FG +T+    +     + T +Y APEV+ G  +   CD+WS G IL  L +G   F    
Sbjct: 196 FGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFN--- 251
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
                       G     +LK+V++                       K   +LP+ +  
Sbjct: 252 ------------GANEYDILKKVEKG----------------------KYTFELPQWKK- 276
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
               V  SA D   L++ +L Y P+ R++AR+AL H + 
Sbjct: 277 ----VSESAKD---LIRKMLTYVPSMRISARDALDHEWI 308

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 86/342 (25%), Positives = 155/342 (45%), Gaps = 61/342 (17%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKH 150
           RY+  +K+GEGT+G+V +  D    E VAIK +R ++   E     A+ E+ +L++L   
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR-LEHEEEGVPGTAIREVSLLKELQHR 93
Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
           +      +++++   + + + ++FE   + L  ++ KN   S  + +++    QL+  + 
Sbjct: 94  N-----IIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVS--MRVIKSFLYQLINGVN 146
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-S 269
           F H    +H DLKP+N+LL  S+  + P                       +K+ DFG +
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETP----------------------VLKIGDFGLA 184
Query: 270 TTYERPDQNYI--VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL 326
             +  P + +   + T  YR PE++LG   ++   DIWS+ CI  E+     LF     +
Sbjct: 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI 244
Query: 327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 386
           + L  +  VLG LP                     WP   A  +  +S    P+ +   +
Sbjct: 245 DQLFKIFEVLG-LPDDT-----------------TWPGVTALPDWKQS---FPKFRGKTL 283
Query: 387 QHV--DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
           + V       +   LL  +L  DP  R++A+ AL HP+F+ +
Sbjct: 284 KRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 90/339 (26%), Positives = 154/339 (45%), Gaps = 84/339 (24%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKY--REAAMIEIEVLQQL 147
            + RYK    +G+G+FG+V+ C D+   +  A+K++  R +K+   +E+ + E+++L+QL
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 148 AKHDKGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
              +      +++  +F+ + +  +V E   G  L+D +     R   +D  R I RQ+L
Sbjct: 84  DHPN-----IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAAR-IIRQVL 136
Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             I +MH   ++H DLKPEN+LL S                          K + I++ID
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESK------------------------SKDANIRIID 172
Query: 267 FGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
           FG +T+    +     + T +Y APEV+ G  +   CD+WS G IL  L +G   F    
Sbjct: 173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFN--- 228
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
                       G     +LK+V++                       K   +LP+ +  
Sbjct: 229 ------------GANEYDILKKVEKG----------------------KYTFELPQWKK- 253
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
               V  SA D   L++ +L Y P+ R++AR+AL H + 
Sbjct: 254 ----VSESAKD---LIRKMLTYVPSMRISARDALDHEWI 285

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 90/336 (26%), Positives = 153/336 (45%), Gaps = 84/336 (25%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKY--REAAMIEIEVLQQL 147
            + RYK    +G+G+FG+V+ C D+   +  A+K++  R +K+   +E+ + E+++L+QL
Sbjct: 30  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 148 AKHDKGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
              +      +++  +F+ + +  +V E   G  L+D +     R   +D  R I RQ+L
Sbjct: 90  DHPN-----IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAAR-IIRQVL 142
Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             I +MH   ++H DLKPEN+LL S                          K + I++ID
Sbjct: 143 SGITYMHKNKIVHRDLKPENLLLESK------------------------SKDANIRIID 178
Query: 267 FGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
           FG +T+    +     + T +Y APEV+ G  +   CD+WS G IL  L +G   F    
Sbjct: 179 FGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFN--- 234
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
                       G     +LK+V++                       K   +LP+ +  
Sbjct: 235 ------------GANEYDILKKVEKG----------------------KYTFELPQWKK- 259
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
               V  SA D   L++ +L Y P+ R++AR+AL H
Sbjct: 260 ----VSESAKD---LIRKMLTYVPSMRISARDALDH 288

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 90/343 (26%), Positives = 152/343 (44%), Gaps = 71/343 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHD 151
           +Y+   K+GEGT+G V +  +RE  E+VA+K VR     +    +A+ EI +L++L KH 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KH- 60
Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                 V++ +       + +VFE     L  +    N    P ++V+    QLL+ + F
Sbjct: 61  ---KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP-EIVKSFLFQLLKGLGF 116
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   ++H DLKP+N+L+  +  +K+ ++               + ++  I V  + +  
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFG--------------LARAFGIPVRCYSAE- 161
Query: 272 YERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCT-GEALFQTHENLEHL 329
                    V T  YR P+V+ G   ++   D+WS GCI  EL   G  LF  ++  + L
Sbjct: 162 ---------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
             + R+LG   +                    WP          S+ KLP  +   M   
Sbjct: 213 KRIFRLLGTPTEEQ------------------WP----------SMTKLPDYKPYPMYPA 244
Query: 390 DHSAGDLT--------HLLQGLLRYDPTDRLTAREALRHPFFT 424
             S  ++          LLQ LL+ +P  R++A EAL+HP+F+
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/344 (25%), Positives = 148/344 (43%), Gaps = 79/344 (22%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQLAKHDKG 153
           +G G +G V   +D   ++ VA+K        ++   + YRE          +L KH K 
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYREL---------RLLKHLKH 78
Query: 154 GNRCVQIRNWF-------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
            N  + + + F       D+ + + +V   +G+ L + ++    ++   + V+ +  QLL
Sbjct: 79  EN-VIGLLDVFTPATSIEDF-SEVYLVTTLMGADLNNIVK---CQALSDEHVQFLVYQLL 133
Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             + ++H   +IH DLKP NV                            + +   ++++D
Sbjct: 134 RGLKYIHSAGIIHRDLKPSNV---------------------------AVNEDCELRILD 166
Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
           FG       +    V+TR YRAPE++L  + +    DIWSVGCI+ EL  G+ALF   + 
Sbjct: 167 FGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDY 226
Query: 326 LEHLA-MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           ++ L  +ME V  P P+ + K    HA  Y++                     LP +   
Sbjct: 227 IDQLKRIMEVVGTPSPEVLAKISSEHARTYIQ--------------------SLPPMPQK 266
Query: 385 IMQHVDHSAGDLT-HLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
            +  +   A  L   LL  +L  D   R++A EAL H +F++ H
Sbjct: 267 DLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYH 310

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 90/343 (26%), Positives = 151/343 (44%), Gaps = 71/343 (20%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHD 151
           +Y+   K+GEGT+G V +  +RE  E+VA+K VR     +    +A+ EI +L++L KH 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KH- 60
Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                 V++ +       + +VFE     L  +    N    P ++V+    QLL+ + F
Sbjct: 61  ---KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP-EIVKSFLFQLLKGLGF 116
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   ++H DLKP+N+L+  +  +K+ D+               + ++  I V  + +  
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLADFG--------------LARAFGIPVRCYSAE- 161
Query: 272 YERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGE-ALFQTHENLEHL 329
                    V T  YR P+V+ G   ++   D+WS GCI  EL      LF  ++  + L
Sbjct: 162 ---------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQL 212
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
             + R+LG   +                    WP          S+ KLP  +   M   
Sbjct: 213 KRIFRLLGTPTEEQ------------------WP----------SMTKLPDYKPYPMYPA 244
Query: 390 DHSAGDLT--------HLLQGLLRYDPTDRLTAREALRHPFFT 424
             S  ++          LLQ LL+ +P  R++A EAL+HP+F+
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 94/352 (26%), Positives = 155/352 (44%), Gaps = 55/352 (15%)
Query: 86  FALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIE 142
           F +  ++   Y+I   +G G +G V     R   + VAIK +     +    +  + E++
Sbjct: 47  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK 106
Query: 143 VLQQLAKHDKGGNRCVQIRNWFDYR--NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE 200
           +L+   KHD        +R    Y     + +V + + S L+  +  +  +   ++ VR 
Sbjct: 107 ILKHF-KHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSS--QPLTLEHVRY 163
Query: 201 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMP 257
              QLL  + +MH   +IH DLKP N+L+  +  +K+ D+   +    +P +  YF    
Sbjct: 164 FLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM--- 220
Query: 258 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTG 316
                       T Y        V+TR YRAPE++L L  +T   D+WSVGCI  E+   
Sbjct: 221 ------------TEY--------VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLAR 260
Query: 317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 376
             LF     +  L ++  VLG     +++ V   AE+               R  I+S  
Sbjct: 261 RQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG--AERV--------------RAYIQS-- 302
Query: 377 KLPRLQNLIMQHVDHSAG-DLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
            LP  Q +  + V   A      LL  +LR++P+ R++A  ALRHPF  + H
Sbjct: 303 -LPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 353

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 94/352 (26%), Positives = 155/352 (44%), Gaps = 55/352 (15%)
Query: 86  FALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIE 142
           F +  ++   Y+I   +G G +G V     R   + VAIK +     +    +  + E++
Sbjct: 46  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK 105
Query: 143 VLQQLAKHDKGGNRCVQIRNWFDYR--NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE 200
           +L+   KHD        +R    Y     + +V + + S L+  +  +  +   ++ VR 
Sbjct: 106 ILKHF-KHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSS--QPLTLEHVRY 162
Query: 201 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMP 257
              QLL  + +MH   +IH DLKP N+L+  +  +K+ D+   +    +P +  YF    
Sbjct: 163 FLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM--- 219
Query: 258 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTG 316
                       T Y        V+TR YRAPE++L L  +T   D+WSVGCI  E+   
Sbjct: 220 ------------TEY--------VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLAR 259
Query: 317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 376
             LF     +  L ++  VLG     +++ V   AE+               R  I+S  
Sbjct: 260 RQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG--AERV--------------RAYIQS-- 301
Query: 377 KLPRLQNLIMQHVDHSAG-DLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
            LP  Q +  + V   A      LL  +LR++P+ R++A  ALRHPF  + H
Sbjct: 302 -LPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 148/341 (43%), Gaps = 83/341 (24%)
Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV-RGIKKYREAAMI--EIEVLQQL 147
               RY I   +G+G+FG+VL+C DR  ++  A+K++ +   K ++ + I  E+E+L++L
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 148 AKHDKGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
              +      +++    +  +   IV E   G  L+D + K   + F       I +Q+ 
Sbjct: 79  DHPN-----IMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVF 131
Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             I +MH   ++H DLKPEN+LL S E                        K   IK+ID
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKE------------------------KDCDIKIID 167
Query: 267 FG-STTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
           FG ST +++  +    + T +Y APEV+ G  +   CD+WS G IL  L +G   F    
Sbjct: 168 FGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF---- 222
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
                       G     +LKRV                      E+ K    LP+ + +
Sbjct: 223 -----------YGKNEYDILKRV----------------------ETGKYAFDLPQWRTI 249
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                   + D   L++ +L + P+ R+TA + L HP+  +
Sbjct: 250 --------SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 36/227 (15%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +GEG+F    +C  ++  +  A+KI+   K+       EI  L+    H       V++ 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIIS--KRMEANTQKEITALKLCEGHP----NIVKLH 72
Query: 162 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 220
             F  + H  +V E L G  L++ ++K  +  F       I R+L+  ++ MHD+ ++H 
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 221 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI 280
           DLKPEN+L          D   +L                 IK+IDFG    + PD   +
Sbjct: 131 DLKPENLLFT--------DENDNLE----------------IKIIDFGFARLKPPDNQPL 166
Query: 281 VS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
            +   T HY APE++   G+   CD+WS+G IL  + +G+  FQ+H+
Sbjct: 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 83/341 (24%)
Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV-RGIKKYREAAMI--EIEVLQQL 147
               RY I   +G+G+FG+VL+C DR  ++  A+K++ +   K ++ + I  E+E+L++L
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 148 AKHDKGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
              +      +++    +  +   IV E   G  L+D + K   + F       I +Q+ 
Sbjct: 79  DHPN-----IMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVF 131
Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             I +MH   ++H DLKPEN+LL S E                        K   IK+ID
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKE------------------------KDCDIKIID 167
Query: 267 FGSTTYERPDQNYI--VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
           FG +T  + +      + T +Y APEV+ G  +   CD+WS G IL  L +G   F    
Sbjct: 168 FGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPF---- 222
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
                       G     +LKRV                      E+ K    LP+ + +
Sbjct: 223 -----------YGKNEYDILKRV----------------------ETGKYAFDLPQWRTI 249
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                   + D   L++ +L + P+ R+TA + L HP+  +
Sbjct: 250 --------SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 89/339 (26%), Positives = 151/339 (44%), Gaps = 84/339 (24%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKY--REAAMIEIEVLQQL 147
            + RYK    +G+G+FG+V+ C D+   +  A+K++  R +K+   +E+ + E+++L+QL
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 148 AKHDKGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
              +       ++  +F+ + +  +V E   G  L+D +     R   +D  R I RQ+L
Sbjct: 84  DHPN-----IXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAAR-IIRQVL 136
Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             I + H   ++H DLKPEN+LL S                          K + I++ID
Sbjct: 137 SGITYXHKNKIVHRDLKPENLLLESK------------------------SKDANIRIID 172
Query: 267 FGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
           FG +T+    +     + T +Y APEV+ G  +   CD+WS G IL  L +G   F    
Sbjct: 173 FGLSTHFEASKKXKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFN--- 228
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
                       G     +LK+V++                       K   +LP+    
Sbjct: 229 ------------GANEYDILKKVEKG----------------------KYTFELPQ---- 250
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
             + V  SA D   L++  L Y P+ R++AR+AL H + 
Sbjct: 251 -WKKVSESAKD---LIRKXLTYVPSXRISARDALDHEWI 285

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 146/341 (42%), Gaps = 83/341 (24%)
Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV-RGIKKYREAAMI--EIEVLQQL 147
               RY I   +G+G+FG+VL+C DR  ++  A+K++ +   K ++ + I  E+E+L++L
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 148 AKHDKGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
              +      +++    +  +   IV E   G  L+D + K   + F       I +Q+ 
Sbjct: 79  DHPN-----IMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVF 131
Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             I +MH   ++H DLKPEN+LL S E                        K   IK+ID
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKE------------------------KDCDIKIID 167
Query: 267 FGSTTYERPDQNYI--VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
           FG +T  + +      + T +Y APEV+ G  +   CD+WS G IL  L +G   F    
Sbjct: 168 FGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPF---- 222
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
                       G     +LKRV                      E+ K    LP+ + +
Sbjct: 223 -----------YGKNEYDILKRV----------------------ETGKYAFDLPQWRTI 249
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                   + D   L++ +L + P+ R+TA + L HP+  +
Sbjct: 250 --------SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 93/354 (26%), Positives = 151/354 (42%), Gaps = 89/354 (25%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKH 150
           +Y    K+GEGT+G V +  +    E  A+K +R ++K  E      + EI +L++L KH
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR-LEKEDEGIPSTTIREISILKEL-KH 59
Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLEC 208
               +  V++ +    +  + +VFE L   L   L   +    S      +    QLL  
Sbjct: 60  ----SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVT---AKSFLLQLLNG 112
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           IA+ HD  ++H DLKP+N+L+                            +   +K+ DFG
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLI---------------------------NREGELKIADFG 145
Query: 269 -STTYERPDQNYI--VSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHE 324
            +  +  P + Y   V T  YRAP+V++G   ++   DIWSVGCI  E+  G  LF    
Sbjct: 146 LARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVS 205
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-- 382
             + L  + R+LG  P                    +WP          +V +LP+    
Sbjct: 206 EADQLMRIFRILGT-PNSK-----------------NWP----------NVTELPKYDPN 237
Query: 383 ---------NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                       ++ +D S  D   LL  +L+ DP  R+TA++AL H +F  ++
Sbjct: 238 FTVYEPLPWESFLKGLDESGID---LLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 93/354 (26%), Positives = 151/354 (42%), Gaps = 89/354 (25%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKH 150
           +Y    K+GEGT+G V +  +    E  A+K +R ++K  E      + EI +L++L KH
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR-LEKEDEGIPSTTIREISILKEL-KH 59
Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLEC 208
               +  V++ +    +  + +VFE L   L   L   +    S      +    QLL  
Sbjct: 60  ----SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVT---AKSFLLQLLNG 112
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           IA+ HD  ++H DLKP+N+L+                            +   +K+ DFG
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLI---------------------------NREGELKIADFG 145
Query: 269 -STTYERPDQNYI--VSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHE 324
            +  +  P + Y   V T  YRAP+V++G   ++   DIWSVGCI  E+  G  LF    
Sbjct: 146 LARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-- 382
             + L  + R+LG  P                    +WP          +V +LP+    
Sbjct: 206 EADQLMRIFRILGT-PNSK-----------------NWP----------NVTELPKYDPN 237
Query: 383 ---------NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                       ++ +D S  D   LL  +L+ DP  R+TA++AL H +F  ++
Sbjct: 238 FTVYEPLPWESFLKGLDESGID---LLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 84/328 (25%), Positives = 142/328 (43%), Gaps = 56/328 (17%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA----MIEIEVLQQLAKHDKGGNR 156
           K+GEGT+  V +   +    +VA+K +R   ++ E A    + E+ +L+ L KH      
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDL-KH----AN 61
Query: 157 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
            V + +       + +VFE L   L  +L         +  V+    QLL  +A+ H   
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           ++H DLKP+N+L+     +K+ D+               + ++ +I      + TY+   
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFG--------------LARAKSIP-----TKTYDNE- 160
Query: 277 QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 335
               V T  YR P+++LG   ++   D+W VGCI  E+ TG  LF      E L  + R+
Sbjct: 161 ----VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI 216
Query: 336 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 395
           LG   +                    WP G  S E  K+          ++ H      D
Sbjct: 217 LGTPTEET------------------WP-GILSNEEFKTYNYPKYRAEALLSHAPRLDSD 257
Query: 396 LTHLLQGLLRYDPTDRLTAREALRHPFF 423
              LL  LL+++  +R++A +A++HPFF
Sbjct: 258 GADLLTKLLQFEGRNRISAEDAMKHPFF 285

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 92/354 (25%), Positives = 151/354 (42%), Gaps = 89/354 (25%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKH 150
           +Y    K+GEGT+G V +  +    E  A+K +R ++K  E      + EI +L++L KH
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR-LEKEDEGIPSTTIREISILKEL-KH 59
Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLEC 208
               +  V++ +    +  + +VFE L   L   L   +    S      +    QLL  
Sbjct: 60  ----SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVT---AKSFLLQLLNG 112
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           IA+ HD  ++H DLKP+N+L+                            +   +K+ DFG
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLI---------------------------NREGELKIADFG 145
Query: 269 -STTYERPDQNYI--VSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHE 324
            +  +  P + Y   + T  YRAP+V++G   ++   DIWSVGCI  E+  G  LF    
Sbjct: 146 LARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-- 382
             + L  + R+LG  P                    +WP          +V +LP+    
Sbjct: 206 EADQLMRIFRILGT-PNSK-----------------NWP----------NVTELPKYDPN 237
Query: 383 ---------NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                       ++ +D S  D   LL  +L+ DP  R+TA++AL H +F  ++
Sbjct: 238 FTVYEPLPWESFLKGLDESGID---LLSKMLKLDPNQRITAKQALEHAYFKENN 288

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 121/261 (46%), Gaps = 37/261 (14%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           +G G FGQV +C +      +A KI+  RG+K  +E    EI V+ QL   +      +Q
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD-KEEVKNEISVMNQLDHAN-----LIQ 150
Query: 160 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           + + F+ +N I +V E + G  L+D +   +Y    +D +    +Q+ E I  MH + ++
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL-FMKQICEGIRHMHQMYIL 209
Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 278
           H DLKPEN+L V+ +                         +  IK+IDFG     +P + 
Sbjct: 210 HLDLKPENILCVNRD-------------------------AKQIKIIDFGLARRYKPREK 244
Query: 279 YIVS--TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 336
             V+  T  + APEV+     ++P D+WSVG I   L +G + F    + E L  +    
Sbjct: 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACR 304
Query: 337 GPLPQHMLKRVDRHAEKYVRR 357
             L     + +   A++++ +
Sbjct: 305 WDLEDEEFQDISEEAKEFISK 325

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 91/354 (25%), Positives = 153/354 (43%), Gaps = 86/354 (24%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEV 143
           + L  +Y+   K+GEGT+G V +  D + + +VA+K +R      GI      A+ EI +
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIP---STAIREISL 72
Query: 144 LQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 203
           L++L   +      V + +       + +VFE +   L   L +N         ++    
Sbjct: 73  LKELHHPN-----IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLY 126
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           QLL  +A  H   ++H DLKP+N+L+ S                             A+K
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSD---------------------------GALK 159
Query: 264 VIDFG-STTYERPDQNYI--VSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEAL 319
           + DFG +  +  P ++Y   V T  YRAP+V++G   ++   DIWS+GCI  E+ TG+ L
Sbjct: 160 LADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPL 219
Query: 320 FQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 378
           F    + + L  +  +LG P P+                   +WP+          V +L
Sbjct: 220 FPGVTDDDQLPKIFSILGTPNPR-------------------EWPQ----------VQEL 250
Query: 379 PRLQNLIMQHVDHS---------AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           P  +    Q  +             +   LL  +L +DP  R++AR+A+ HP+F
Sbjct: 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 91/354 (25%), Positives = 153/354 (43%), Gaps = 86/354 (24%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEV 143
           + L  +Y+   K+GEGT+G V +  D + + +VA+K +R      GI      A+ EI +
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIP---STAIREISL 72
Query: 144 LQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 203
           L++L   +      V + +       + +VFE +   L   L +N         ++    
Sbjct: 73  LKELHHPN-----IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLY 126
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           QLL  +A  H   ++H DLKP+N+L+ S                             A+K
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSD---------------------------GALK 159
Query: 264 VIDFG-STTYERPDQNYI--VSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEAL 319
           + DFG +  +  P ++Y   V T  YRAP+V++G   ++   DIWS+GCI  E+ TG+ L
Sbjct: 160 LADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPL 219
Query: 320 FQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 378
           F    + + L  +  +LG P P+                   +WP+          V +L
Sbjct: 220 FPGVTDDDQLPKIFSILGTPNPR-------------------EWPQ----------VQEL 250
Query: 379 PRLQNLIMQHVDHS---------AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           P  +    Q  +             +   LL  +L +DP  R++AR+A+ HP+F
Sbjct: 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 93/364 (25%), Positives = 154/364 (42%), Gaps = 59/364 (16%)
Query: 76  REDDKDGHYMFALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---- 128
           R    +  Y   +G++   +  RY+    +G G  G V   +D   +  VAIK +     
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 129 ----GIKKYREAAMIEIEVLQQLAKHDK--GGNRCVQIRNWFDYRNHICIVFEKLGSSLY 182
                 + YRE       VL ++  H    G       +   +    + IV E + ++L 
Sbjct: 63  NQTHAKRAYREL------VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLS 116
Query: 183 DFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 242
             ++         + +  +  Q+L  I  +H   +IH DLKP N+++ S   +K+ D+  
Sbjct: 117 QVIQ----MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG- 171
Query: 243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCD 302
                       R   +S      F  T Y        V TR+YRAPEVILG+G+    D
Sbjct: 172 ----------LARTAGTS------FMMTPY--------VVTRYYRAPEVILGMGYKENVD 207
Query: 303 IWSVGCILVELCTGEALFQTHENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD 361
           IWSVGCI+ E+  G  LF   ++++    ++E++  P P+ M K++      YV     +
Sbjct: 208 IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM-KKLQPTVRTYVE----N 262
Query: 362 WPEGAA-SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
            P+ A  S E +   +  P       +H    A     LL  +L  D + R++  EAL+H
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADS----EHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 421 PFFT 424
           P+  
Sbjct: 319 PYIN 322

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 93/364 (25%), Positives = 154/364 (42%), Gaps = 59/364 (16%)
Query: 76  REDDKDGHYMFALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---- 128
           R    +  Y   +G++   +  RY+    +G G  G V   +D   +  VAIK +     
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 129 ----GIKKYREAAMIEIEVLQQLAKHDK--GGNRCVQIRNWFDYRNHICIVFEKLGSSLY 182
                 + YRE       VL ++  H    G       +   +    + IV E + ++L 
Sbjct: 63  NQTHAKRAYREL------VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLS 116
Query: 183 DFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 242
             ++         + +  +  Q+L  I  +H   +IH DLKP N+++ S   +K+ D+  
Sbjct: 117 QVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG- 171
Query: 243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCD 302
                       R   +S      F  T Y        V TR+YRAPEVILG+G+    D
Sbjct: 172 ----------LARTAGTS------FMMTPY--------VVTRYYRAPEVILGMGYKENVD 207
Query: 303 IWSVGCILVELCTGEALFQTHENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD 361
           IWSVGCI+ E+  G  LF   ++++    ++E++  P P+ M K++      YV     +
Sbjct: 208 IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM-KKLQPTVRTYVE----N 262
Query: 362 WPEGAA-SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
            P+ A  S E +   +  P       +H    A     LL  +L  D + R++  EAL+H
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADS----EHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 421 PFFT 424
           P+  
Sbjct: 319 PYIN 322

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 83/344 (24%), Positives = 148/344 (43%), Gaps = 51/344 (14%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAK 149
            S+Y+  +K+G+GTFG+V +   R+  + VA+K V      + +   A+ EI++LQ L K
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ-LLK 75
Query: 150 HDKGGNRCVQIRN----WFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQL 205
           H+   N     R     +   +  I +VF+     L   L  N    F +  ++ + + L
Sbjct: 76  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQML 134
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L  + ++H   ++H D+K  NVL+     +K+ D+                      +  
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF-------------------GLARAF 175
Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE 324
                +      N +V T  YR PE++LG   +  P D+W  GCI+ E+ T   + Q + 
Sbjct: 176 SLAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 234
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAAS--RESIKSVMKLPRLQ 382
               LA++ ++ G +   +   VD     Y    +L+  +G     ++ +K+ ++ P   
Sbjct: 235 EQHQLALISQLCGSITPEVWPNVD----NYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 290
Query: 383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
           +LI                 LL  DP  R+ + +AL H FF  D
Sbjct: 291 DLI---------------DKLLVLDPAQRIDSDDALNHDFFWSD 319

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 87/348 (25%), Positives = 152/348 (43%), Gaps = 83/348 (23%)
Query: 82  GHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMI 139
           G ++ +   +L+  Y+   K+G G +G+VL C D+      AIKI+R   +     + ++
Sbjct: 25  GMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLL 84
Query: 140 EIEVLQQLAKHDKGGNRCVQIRNWF-DYRNHICIVFEKLGSSLYD-FLRKNNYRSFPIDL 197
           E   + +L  H       +++ ++F D RN+  ++    G  L+D  + +  +      +
Sbjct: 85  EEVAVLKLLDHP----NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV 140
Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
              I +Q+L  + ++H   ++H DLKPEN+LL S E                        
Sbjct: 141 ---IIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE------------------------ 173
Query: 258 KSSAIKVIDFG-STTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
           K + IK++DFG S  +E   +    + T +Y APEV L   +   CD+WS+G IL  L  
Sbjct: 174 KDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLA 232
Query: 316 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV 375
           G   F                G   Q +L++V++   KY      D PE           
Sbjct: 233 GYPPFG---------------GQTDQEILRKVEKG--KYT----FDSPE----------- 260
Query: 376 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                      ++V   A D   L++ +L++D   R++A++AL HP+ 
Sbjct: 261 ----------WKNVSEGAKD---LIKQMLQFDSQRRISAQQALEHPWI 295

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 91/365 (24%), Positives = 145/365 (39%), Gaps = 93/365 (25%)
Query: 82  GHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREA- 136
           G +M    + L   Y +   +G G  G+V   ++R+  + VAIKI+      I   REA 
Sbjct: 4   GSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREAD 63
Query: 137 ----AMIEIEVLQQLAKHDKGGNRCV-QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYR 191
                  EIE+L++L       + C+ +I+N+FD  ++  ++    G  L+D +  N  +
Sbjct: 64  PALNVETEIEILKKL------NHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGN--K 115
Query: 192 SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 251
                  +    Q+L  + ++H+  +IH DLKPENVLL S E                  
Sbjct: 116 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------------------ 157
Query: 252 YFKRMPKSSAIKVIDFGSTTY--ERPDQNYIVSTRHYRAPEVILGL---GWTYPCDIWSV 306
                 +   IK+ DFG +    E      +  T  Y APEV++ +   G+    D WS+
Sbjct: 158 ------EDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 211
Query: 307 GCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW-PEG 365
           G IL    +G   F  H                      R     +  +  G+ ++ PE 
Sbjct: 212 GVILFICLSGYPPFSEH----------------------RTQVSLKDQITSGKYNFIPE- 248
Query: 366 AASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                              +   V   A D   L++ LL  DP  R T  EALRHP+   
Sbjct: 249 -------------------VWAEVSEKALD---LVKKLLVVDPKARFTTEEALRHPWLQD 286
Query: 426 DHLRR 430
           + ++R
Sbjct: 287 EDMKR 291

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 91/346 (26%), Positives = 142/346 (41%), Gaps = 90/346 (26%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQ 145
           + L+ RY+   K+G G +G+VL C D+      AIKI++           A + E+ VL+
Sbjct: 17  QGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 146 QLAKHDKGGNRCVQIRNWF-DYRNHICIVFEKLGSSLYD--FLRKNNYRSFPIDLVREIA 202
           QL   +      +++  +F D RN+  ++    G  L+D   LR+     F       I 
Sbjct: 77  QLDHPN-----IMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK----FSEVDAAVIM 127
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSE---YIKVPDYKSSLHTPKDSSYFKRMPKS 259
           +Q+L    ++H   ++H DLKPEN+LL S      IK+ D+  S H              
Sbjct: 128 KQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAH-------------- 173
Query: 260 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
                 + G    ER      + T +Y APEV L   +   CD+WS G IL  L  G   
Sbjct: 174 -----FEVGGKMKER------LGTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPP 221
Query: 320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 379
           F                G   Q +LKRV++       +   D P+     +  K ++KL 
Sbjct: 222 FG---------------GQTDQEILKRVEKG------KFSFDPPDWTQVSDEAKQLVKL- 259
Query: 380 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                                  +L Y+P+ R++A EAL HP+  +
Sbjct: 260 -----------------------MLTYEPSKRISAEEALNHPWIVK 282

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 93/364 (25%), Positives = 153/364 (42%), Gaps = 59/364 (16%)
Query: 76  REDDKDGHYMFALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---- 128
           R    +  Y   +G++   +  RY+    +G G  G V   +D   +  VAIK +     
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 129 ----GIKKYREAAMIEIEVLQQLAKHDK--GGNRCVQIRNWFDYRNHICIVFEKLGSSLY 182
                 + YRE       VL +   H    G       +   +    + IV E + ++L 
Sbjct: 63  NQTHAKRAYREL------VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLS 116
Query: 183 DFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 242
             ++         + +  +  Q+L  I  +H   +IH DLKP N+++ S   +K+ D+  
Sbjct: 117 QVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG- 171
Query: 243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCD 302
                       R   +S      F  T Y        V TR+YRAPEVILG+G+    D
Sbjct: 172 ----------LARTAGTS------FMMTPY--------VVTRYYRAPEVILGMGYKENVD 207
Query: 303 IWSVGCILVELCTGEALFQTHENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD 361
           IWSVGCI+ E+  G  LF   ++++    ++E++  P P+ M K++      YV     +
Sbjct: 208 IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM-KKLQPTVRTYVE----N 262
Query: 362 WPEGAA-SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
            P+ A  S E +   +  P       +H    A     LL  +L  D + R++  EAL+H
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADS----EHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 421 PFFT 424
           P+  
Sbjct: 319 PYIN 322

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 84/345 (24%), Positives = 151/345 (43%), Gaps = 53/345 (15%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLA 148
            S+Y+  +K+G+GTFG+V +   R+  + VA+K V  ++  +E     A+ EI++LQ L 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQ-LL 74
Query: 149 KHDKGGNRCVQIRN----WFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 204
           KH+   N     R     +   +  I +VF+     L   L  N    F +  ++ + + 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQM 133
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           LL  + ++H   ++H D+K  NVL+     +K+ D+  +                   + 
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA-------------------RA 174
Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 323
                 +      N +V T  YR PE++LG   +  P D+W  GCI+ E+ T   + Q +
Sbjct: 175 FSLAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 233
Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAAS--RESIKSVMKLPRL 381
                LA++ ++ G +   +   VD     Y    +L+  +G     ++ +K+ ++ P  
Sbjct: 234 TEQHQLALISQLCGSITPEVWPNVD----NYELYEKLELVKGQKRKVKDRLKAYVRDPYA 289
Query: 382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
            +LI                 LL  DP  R+ + +AL H FF  D
Sbjct: 290 LDLI---------------DKLLVLDPAQRIDSDDALNHDFFWSD 319

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 83/344 (24%), Positives = 149/344 (43%), Gaps = 51/344 (14%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAK 149
            S+Y+  +K+G+GTFG+V +   R+  + VA+K V      + +   A+ EI++LQ L K
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ-LLK 74
Query: 150 HDKGGNRCVQIRN----WFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQL 205
           H+   N     R     +   +  I +VF+     L   L  N    F +  ++ + + L
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQML 133
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L  + ++H   ++H D+K  NVL+     +K+ D+  +                   +  
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA-------------------RAF 174
Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE 324
                +      N +V T  YR PE++LG   +  P D+W  GCI+ E+ T   + Q + 
Sbjct: 175 SLAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAAS--RESIKSVMKLPRLQ 382
               LA++ ++ G +   +   VD     Y    +L+  +G     ++ +K+ ++ P   
Sbjct: 234 EQHQLALISQLCGSITPEVWPNVD----NYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 289
Query: 383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
           +LI                 LL  DP  R+ + +AL H FF  D
Sbjct: 290 DLI---------------DKLLVLDPAQRIDSDDALNHDFFWSD 318

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 92/364 (25%), Positives = 154/364 (42%), Gaps = 59/364 (16%)
Query: 76  REDDKDGHYMFALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---- 128
           R    +  Y   +G++   +  RY+    +G G  G V+  +D   +  VAIK +     
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQ 62
Query: 129 ----GIKKYREAAMIEIEVLQQLAKHDK--GGNRCVQIRNWFDYRNHICIVFEKLGSSLY 182
                 + YRE       VL ++  H    G       +   +    + IV E + ++L 
Sbjct: 63  NQTHAKRAYREL------VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLS 116
Query: 183 DFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 242
             ++         + +  +  Q+L  I  +H   +IH DLKP N+++ S   +K+ D+  
Sbjct: 117 QVIQ----MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG- 171
Query: 243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCD 302
                       R   +S      F  T Y        V TR+YRAPEVILG+G+    D
Sbjct: 172 ----------LARTAGTS------FMMTPY--------VVTRYYRAPEVILGMGYKENVD 207
Query: 303 IWSVGCILVELCTGEALFQTHENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD 361
           IWSVG I+ E+  G  LF   ++++    ++E++  P P+ M K++      YV     +
Sbjct: 208 IWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM-KKLQPTVRTYVE----N 262
Query: 362 WPEGAA-SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
            P+ A  S E +   +  P       +H    A     LL  +L  D + R++  EAL+H
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADS----EHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 421 PFFT 424
           P+  
Sbjct: 319 PYIN 322

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 91/345 (26%), Positives = 141/345 (40%), Gaps = 90/345 (26%)
Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQ 146
            L+ RY+   K+G G +G+VL C D+      AIKI++           A + E+ VL+Q
Sbjct: 1   GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 60
Query: 147 LAKHDKGGNRCVQIRNWF-DYRNHICIVFEKLGSSLYD--FLRKNNYRSFPIDLVREIAR 203
           L   +      +++  +F D RN+  ++    G  L+D   LR    + F       I +
Sbjct: 61  LDHPN-----IMKLYEFFEDKRNYYLVMEVYRGGELFDEIILR----QKFSEVDAAVIMK 111
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSE---YIKVPDYKSSLHTPKDSSYFKRMPKSS 260
           Q+L    ++H   ++H DLKPEN+LL S      IK+ D+  S H               
Sbjct: 112 QVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAH--------------- 156
Query: 261 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
                + G    ER      + T +Y APEV L   +   CD+WS G IL  L  G   F
Sbjct: 157 ----FEVGGKMKER------LGTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPPF 205
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
                           G   Q +LKRV++       +   D P+     +  K ++KL  
Sbjct: 206 G---------------GQTDQEILKRVEKG------KFSFDPPDWTQVSDEAKQLVKL-- 242
Query: 381 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                                 +L Y+P+ R++A EAL HP+  +
Sbjct: 243 ----------------------MLTYEPSKRISAEEALNHPWIVK 265

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/344 (24%), Positives = 149/344 (43%), Gaps = 51/344 (14%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAK 149
            S+Y+  +K+G+GTFG+V +   R+  + VA+K V      + +   A+ EI++LQ L K
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ-LLK 75
Query: 150 HDKGGNRCVQIRN----WFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQL 205
           H+   N     R     +   +  I +VF+     L   L  N    F +  ++ + + L
Sbjct: 76  HENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQML 134
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L  + ++H   ++H D+K  NVL+     +K+ D+  +                   +  
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA-------------------RAF 175
Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE 324
                +      N +V T  YR PE++LG   +  P D+W  GCI+ E+ T   + Q + 
Sbjct: 176 SLAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 234
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAAS--RESIKSVMKLPRLQ 382
               LA++ ++ G +   +   VD     Y    +L+  +G     ++ +K+ ++ P   
Sbjct: 235 EQHQLALISQLCGSITPEVWPNVD----NYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 290
Query: 383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
           +LI                 LL  DP  R+ + +AL H FF  D
Sbjct: 291 DLI---------------DKLLVLDPAQRIDSDDALNHDFFWSD 319

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+               + ++++  
Sbjct: 132 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG--------------LARTAST- 176
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
             +F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ EL  G  +FQ  
Sbjct: 177 --NFMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 226
Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
           ++++    +   LG      +  +      YV   R  +P G A  E     +     + 
Sbjct: 227 DHIDQWNKVIEQLGTPSAEFMAALQPTVRNYV-ENRPAYP-GIAFEELFPDWIFPSESER 284
Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             ++           LL  +L  DP  R++  EALRHP+ T
Sbjct: 285 DKIK-----TSQARDLLSKMLVIDPDKRISVDEALRHPYIT 320

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 44/227 (19%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 134 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFG-----------LARTAGTS--- 179
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ E+   + LF   
Sbjct: 180 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL- 381
           + ++    ++E++  P P+ M K++      YV     + P+ A         +  P+L 
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVE----NRPKYAG--------LTFPKLF 275
Query: 382 -QNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             +L     +H+   A     LL  +L  DP  R++  +AL+HP+  
Sbjct: 276 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 44/227 (19%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 134 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFG-----------LARTAGTS--- 179
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ E+   + LF   
Sbjct: 180 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL- 381
           + ++    ++E++  P P+ M K++      YV     + P+ A         +  P+L 
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVE----NRPKYAG--------LTFPKLF 275
Query: 382 -QNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             +L     +H+   A     LL  +L  DP  R++  +AL+HP+  
Sbjct: 276 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 105/223 (47%), Gaps = 36/223 (16%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 180
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ E+  G  LF   
Sbjct: 181 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRL 381
           ++++    ++E++  P P+ M K++      YV     + P+ A  S E +   +  P  
Sbjct: 230 DHIDQWNKVIEQLGTPCPEFM-KKLQPTVRTYVE----NRPKYAGYSFEKLFPDVLFPAD 284
Query: 382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
                +H    A     LL  +L  D + R++  EAL+HP+  
Sbjct: 285 S----EHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 99/229 (43%), Gaps = 48/229 (20%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+  +                    
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-----------------RTA 176
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
             +F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ EL  G  +FQ  
Sbjct: 177 CTNFMMTPY--------VVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGT 228
Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR--------RGRLDWPEGAASRESIKSV 375
           ++++    +   LG      +  +      YV         +    +P+     ES +  
Sbjct: 229 DHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDK 288
Query: 376 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
           +K  + ++               LL  +L  DP  R++  EALRHP+ T
Sbjct: 289 IKTSQARD---------------LLSKMLVIDPDKRISVDEALRHPYIT 322

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 44/227 (19%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 127 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFG-----------LARTAGTS--- 172
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ E+   + LF   
Sbjct: 173 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL- 381
           + ++    ++E++  P P+ M K++      YV     + P+ A         +  P+L 
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVE----NRPKYAG--------LTFPKLF 268
Query: 382 -QNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             +L     +H+   A     LL  +L  DP  R++  +AL+HP+  
Sbjct: 269 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 93/364 (25%), Positives = 153/364 (42%), Gaps = 59/364 (16%)
Query: 76  REDDKDGHYMFALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---- 128
           R    +  Y   +G++   +  RY+    +G G  G V   +D   +  VAIK +     
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 129 ----GIKKYREAAMIEIEVLQQLAKHDK--GGNRCVQIRNWFDYRNHICIVFEKLGSSLY 182
                 + YRE       VL +   H    G       +   +    + IV E + ++L 
Sbjct: 63  NQTHAKRAYREL------VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLS 116
Query: 183 DFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 242
             ++         + +  +  Q+L  I  +H   +IH DLKP N+++ S   +K+ D+  
Sbjct: 117 QVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG- 171
Query: 243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCD 302
                       R   +S      F  T Y        V TR+YRAPEVILG+G+    D
Sbjct: 172 ----------LARTAGTS------FMMTPY--------VVTRYYRAPEVILGMGYKENVD 207
Query: 303 IWSVGCILVELCTGEALFQTHENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD 361
           IWSVGCI+ E+  G  LF   ++++    ++E++  P P+ M K++      YV     +
Sbjct: 208 IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM-KKLQPTVRTYVE----N 262
Query: 362 WPEGAA-SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
            P+ A  S E +   +  P       +H    A     LL  +L  D + R++  EAL+H
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADS----EHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 421 PFFT 424
           P+  
Sbjct: 319 PYIN 322

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 105/223 (47%), Gaps = 36/223 (16%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 179
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ E+  G  LF   
Sbjct: 180 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRL 381
           ++++    ++E++  P P+ M K++      YV     + P+ A  S E +   +  P  
Sbjct: 229 DHIDQWNKVIEQLGTPCPEFM-KKLQPTVRTYVE----NRPKYAGYSFEKLFPDVLFPAD 283
Query: 382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
                +H    A     LL  +L  D + R++  EAL+HP+  
Sbjct: 284 S----EHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 93/364 (25%), Positives = 153/364 (42%), Gaps = 59/364 (16%)
Query: 76  REDDKDGHYMFALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---- 128
           R    +  Y   +G++   +  RY+    +G G  G V   +D   +  VAIK +     
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 129 ----GIKKYREAAMIEIEVLQQLAKHDK--GGNRCVQIRNWFDYRNHICIVFEKLGSSLY 182
                 + YRE       VL +   H    G       +   +    + IV E + ++L 
Sbjct: 63  NQTHAKRAYREL------VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC 116
Query: 183 DFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 242
             ++         + +  +  Q+L  I  +H   +IH DLKP N+++ S   +K+ D+  
Sbjct: 117 QVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG- 171
Query: 243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCD 302
                       R   +S      F  T Y        V TR+YRAPEVILG+G+    D
Sbjct: 172 ----------LARTAGTS------FMMTPY--------VVTRYYRAPEVILGMGYKENVD 207
Query: 303 IWSVGCILVELCTGEALFQTHENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD 361
           IWSVGCI+ E+  G  LF   ++++    ++E++  P P+ M K++      YV     +
Sbjct: 208 IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM-KKLQPTVRTYVE----N 262
Query: 362 WPEGAA-SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
            P+ A  S E +   +  P       +H    A     LL  +L  D + R++  EAL+H
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADS----EHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 421 PFFT 424
           P+  
Sbjct: 319 PYIN 322

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/338 (23%), Positives = 140/338 (41%), Gaps = 84/338 (24%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDK 152
           Y I  ++G G FG V  C ++    +   K +     + KY      EI ++ QL  H K
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY--TVKNEISIMNQL-HHPK 109
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                + + + F+ +  + ++ E L G  L+D +   +Y+    +++  + RQ  E +  
Sbjct: 110 ----LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM-RQACEGLKH 164
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           MH+  ++H D+KPEN++  +                          K+S++K+IDFG  T
Sbjct: 165 MHEHSIVHLDIKPENIMCETK-------------------------KASSVKIIDFGLAT 199
Query: 272 YERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
              PD+      +T  + APE++      +  D+W++G +   L +G + F   ++LE L
Sbjct: 200 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 259
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
                                  + V+R   ++ E A S  S       P  ++ I    
Sbjct: 260 -----------------------QNVKRCDWEFDEDAFSSVS-------PEAKDFI---- 285
Query: 390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                      + LL+ +P  RLT  +AL HP+   DH
Sbjct: 286 -----------KNLLQKEPRKRLTVHDALEHPWLKGDH 312

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 92/364 (25%), Positives = 153/364 (42%), Gaps = 59/364 (16%)
Query: 76  REDDKDGHYMFALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---- 128
           R    +  Y   +G++   +  RY+    +G G  G V   +D   +  VAIK +     
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 129 ----GIKKYREAAMIEIEVLQQLAKHDK--GGNRCVQIRNWFDYRNHICIVFEKLGSSLY 182
                 + YRE       VL ++  H    G       +   +    + IV E + ++L 
Sbjct: 63  NQTHAKRAYREL------VLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLS 116
Query: 183 DFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 242
             ++         + +  +  Q+L  I  +H   +IH DLKP N+++ S   +K+ D+  
Sbjct: 117 QVIQ----MELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG- 171
Query: 243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCD 302
                       R   +S      F  T Y        V TR+YRAPEVILG+G+    D
Sbjct: 172 ----------LARTAGTS------FMMTPY--------VVTRYYRAPEVILGMGYKENVD 207
Query: 303 IWSVGCILVELCTGEALFQTHENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD 361
           IWSVG I+ E+  G  LF   ++++    ++E++  P P+ M K++      YV     +
Sbjct: 208 IWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFM-KKLQPTVRTYVE----N 262
Query: 362 WPEGAA-SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
            P+ A  S E +   +  P       +H    A     LL  +L  D + R++  EAL+H
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADS----EHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 421 PFFT 424
           P+  
Sbjct: 319 PYIN 322

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 44/227 (19%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFG-----------LARTAGTS--- 179
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ E+   + LF   
Sbjct: 180 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL- 381
           + ++    ++E++  P P+ M K++      YV     + P+ A         +  P+L 
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVE----NRPKYAG--------LTFPKLF 275
Query: 382 -QNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             +L     +H+   A     LL  +L  DP  R++  +AL+HP+  
Sbjct: 276 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 44/227 (19%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFG-----------LARTAGTS--- 179
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ E+   + LF   
Sbjct: 180 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL- 381
           + ++    ++E++  P P+ M K++      YV     + P+ A         +  P+L 
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVE----NRPKYAG--------LTFPKLF 275
Query: 382 -QNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             +L     +H+   A     LL  +L  DP  R++  +AL+HP+  
Sbjct: 276 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 89/355 (25%), Positives = 141/355 (39%), Gaps = 93/355 (26%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREA-----AMIEIE 142
           L   Y +   +G G  G+V   ++R+  + VAIKI+      I   REA        EIE
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 143 VLQQLAKHDKGGNRCV-QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           +L++L       + C+ +I+N+FD  ++  ++    G  L+D +  N  +       +  
Sbjct: 68  ILKKL------NHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLY 119
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H+  +IH DLKPENVLL S E                        +   
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------------------------EDCL 155
Query: 262 IKVIDFGSTTY--ERPDQNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTG 316
           IK+ DFG +    E      +  T  Y APEV++ +   G+    D WS+G IL    +G
Sbjct: 156 IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
Query: 317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW-PEGAASRESIKSV 375
              F  H                      R     +  +  G+ ++ PE           
Sbjct: 216 YPPFSEH----------------------RTQVSLKDQITSGKYNFIPE----------- 242
Query: 376 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 430
                    +   V   A D   L++ LL  DP  R T  EALRHP+   + ++R
Sbjct: 243 ---------VWAEVSEKALD---LVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 285

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 36/223 (16%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+  +       + F  +P      
Sbjct: 136 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMVP------ 186
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
                            V TR+YRAPEVILG+G+    DIWSVGCI+ E+  G  LF   
Sbjct: 187 ----------------FVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 230
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRL 381
           ++++    ++E++  P P+ M K++      YV     + P+ A  S E +   +  P  
Sbjct: 231 DHIDQWNKVIEQLGTPCPEFM-KKLQPTVRTYVE----NRPKYAGYSFEKLFPDVLFPAD 285
Query: 382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
                +H    A     LL  +L  D + R++  EAL+HP+  
Sbjct: 286 S----EHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 324

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 89/355 (25%), Positives = 141/355 (39%), Gaps = 93/355 (26%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREA-----AMIEIE 142
           L   Y +   +G G  G+V   ++R+  + VAIKI+      I   REA        EIE
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 143 VLQQLAKHDKGGNRCV-QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           +L++L       + C+ +I+N+FD  ++  ++    G  L+D +  N  +       +  
Sbjct: 68  ILKKL------NHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLY 119
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H+  +IH DLKPENVLL S E                        +   
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------------------------EDCL 155
Query: 262 IKVIDFGSTTY--ERPDQNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTG 316
           IK+ DFG +    E      +  T  Y APEV++ +   G+    D WS+G IL    +G
Sbjct: 156 IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
Query: 317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW-PEGAASRESIKSV 375
              F  H                      R     +  +  G+ ++ PE           
Sbjct: 216 YPPFSEH----------------------RTQVSLKDQITSGKYNFIPE----------- 242
Query: 376 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 430
                    +   V   A D   L++ LL  DP  R T  EALRHP+   + ++R
Sbjct: 243 ---------VWAEVSEKALD---LVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 285

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 90/364 (24%), Positives = 153/364 (42%), Gaps = 59/364 (16%)
Query: 76  REDDKDGHYMFALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---- 128
           R    +  Y   +G++   +  RY+    +G G  G V   +D   +  VAIK +     
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 129 ----GIKKYREAAMIEIEVLQQLAKHDK--GGNRCVQIRNWFDYRNHICIVFEKLGSSLY 182
                 + YRE       VL +   H    G       +   +    + IV E + ++L 
Sbjct: 63  NQTHAKRAYREL------VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC 116
Query: 183 DFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 242
             ++         + +  +  Q+L  I  +H   +IH DLKP N+++ S   +K+ D+  
Sbjct: 117 QVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 172
Query: 243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCD 302
           +                        G++    P+    V TR+YRAPEVILG+G+    D
Sbjct: 173 ARTA---------------------GTSFMMTPE----VVTRYYRAPEVILGMGYKENVD 207
Query: 303 IWSVGCILVELCTGEALFQTHENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD 361
           IWSVGCI+ E+  G  LF   ++++    ++E++  P P+ M K++      YV     +
Sbjct: 208 IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM-KKLQPTVRTYVE----N 262
Query: 362 WPEGAA-SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
            P+ A  S E +   +  P       +H    A     LL  +L  D + R++  EAL+H
Sbjct: 263 RPKYAGYSFEKLFPDVLFPADS----EHNALKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 421 PFFT 424
           P+  
Sbjct: 319 PYIN 322

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 89/355 (25%), Positives = 141/355 (39%), Gaps = 93/355 (26%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREA-----AMIEIE 142
           L   Y +   +G G  G+V   ++R+  + VAIKI+      I   REA        EIE
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 143 VLQQLAKHDKGGNRCV-QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           +L++L       + C+ +I+N+FD  ++  ++    G  L+D +  N  +       +  
Sbjct: 68  ILKKL------NHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLY 119
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H+  +IH DLKPENVLL S E                        +   
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------------------------EDCL 155
Query: 262 IKVIDFGSTTY--ERPDQNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTG 316
           IK+ DFG +    E      +  T  Y APEV++ +   G+    D WS+G IL    +G
Sbjct: 156 IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
Query: 317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW-PEGAASRESIKSV 375
              F  H                      R     +  +  G+ ++ PE           
Sbjct: 216 YPPFSEH----------------------RTQVSLKDQITSGKYNFIPE----------- 242
Query: 376 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 430
                    +   V   A D   L++ LL  DP  R T  EALRHP+   + ++R
Sbjct: 243 ---------VWAEVSEKALD---LVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 285

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 89/355 (25%), Positives = 141/355 (39%), Gaps = 93/355 (26%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREA-----AMIEIE 142
           L   Y +   +G G  G+V   ++R+  + VAIKI+      I   REA        EIE
Sbjct: 7   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 66
Query: 143 VLQQLAKHDKGGNRCV-QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           +L++L       + C+ +I+N+FD  ++  ++    G  L+D +  N  +       +  
Sbjct: 67  ILKKL------NHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLY 118
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H+  +IH DLKPENVLL S E                        +   
Sbjct: 119 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------------------------EDCL 154
Query: 262 IKVIDFGSTTY--ERPDQNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTG 316
           IK+ DFG +    E      +  T  Y APEV++ +   G+    D WS+G IL    +G
Sbjct: 155 IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214
Query: 317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW-PEGAASRESIKSV 375
              F  H                      R     +  +  G+ ++ PE           
Sbjct: 215 YPPFSEH----------------------RTQVSLKDQITSGKYNFIPE----------- 241
Query: 376 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 430
                    +   V   A D   L++ LL  DP  R T  EALRHP+   + ++R
Sbjct: 242 ---------VWAEVSEKALD---LVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 284

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 87/334 (26%), Positives = 158/334 (47%), Gaps = 54/334 (16%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           Y++  K+G G + +V E  +    E VA+KI++ +KK  +    EI++L+ L    +GG 
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKK--KKIKREIKILENL----RGGP 92
Query: 156 RCVQIRNWFD--YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
             + + +           +VFE + ++  DF  K  Y++     +R    ++L+ + + H
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
            + ++H D+KP NVL +  E+ K                         +++ID+G   + 
Sbjct: 149 SMGIMHRDVKPHNVL-IDHEHRK-------------------------LRLIDWGLAEFY 182
Query: 274 RPDQNYIV--STRHYRAPEVILGLG-WTYPCDIWSVGCILVELC-TGEALFQTHENLEHL 329
            P Q Y V  ++R+++ PE+++    + Y  D+WS+GC+L  +    E  F  H+N + L
Sbjct: 183 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
             + +VLG   + +   +D++  +   R           R S K   +    +N   QH+
Sbjct: 243 VRIAKVLGT--EDLYDYIDKYNIELDPRF-----NDILGRHSRKRWERFVHSEN---QHL 292
Query: 390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
              + +    L  LLRYD   RLTAREA+ HP+F
Sbjct: 293 --VSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 44/227 (19%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 217
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ E+   + LF   
Sbjct: 218 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL- 381
           + ++    ++E++  P P+ M K++      YV     + P+ A         +  P+L 
Sbjct: 267 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVE----NRPKYAG--------LTFPKLF 313
Query: 382 -QNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             +L     +H+   A     LL  +L  DP  R++  +AL+HP+  
Sbjct: 314 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 44/227 (19%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 217
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ E+   + LF   
Sbjct: 218 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL- 381
           + ++    ++E++  P P+ M K++      YV     + P+ A         +  P+L 
Sbjct: 267 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVE----NRPKYAG--------LTFPKLF 313
Query: 382 -QNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             +L     +H+   A     LL  +L  DP  R++  +AL+HP+  
Sbjct: 314 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 44/227 (19%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 180
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ E+   + LF   
Sbjct: 181 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 229
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL- 381
           + ++    ++E++  P P+ M K++      YV     + P+ A         +  P+L 
Sbjct: 230 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVE----NRPKYAG--------LTFPKLF 276
Query: 382 -QNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             +L     +H+   A     LL  +L  DP  R++  +AL+HP+  
Sbjct: 277 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 323

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 44/227 (19%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 179
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ E+   + LF   
Sbjct: 180 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL- 381
           + ++    ++E++  P P+ M K++      YV     + P+ A         +  P+L 
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVE----NRPKYAG--------LTFPKLF 275
Query: 382 -QNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             +L     +H+   A     LL  +L  DP  R++  +AL+HP+  
Sbjct: 276 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 44/227 (19%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 133 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 178
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ E+   + LF   
Sbjct: 179 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 227
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL- 381
           + ++    ++E++  P P+ M K++      YV     + P+ A         +  P+L 
Sbjct: 228 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVE----NRPKYAG--------LTFPKLF 274
Query: 382 -QNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             +L     +H+   A     LL  +L  DP  R++  +AL+HP+  
Sbjct: 275 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 321

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 44/227 (19%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 179
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ E+   + LF   
Sbjct: 180 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL- 381
           + ++    ++E++  P P+ M K++      YV     + P+ A         +  P+L 
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVE----NRPKYAG--------LTFPKLF 275
Query: 382 -QNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             +L     +H+   A     LL  +L  DP  R++  +AL+HP+  
Sbjct: 276 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 44/227 (19%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 180
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ E+   + LF   
Sbjct: 181 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 229
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL- 381
           + ++    ++E++  P P+ M K++      YV     + P+ A         +  P+L 
Sbjct: 230 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVE----NRPKYAG--------LTFPKLF 276
Query: 382 -QNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             +L     +H+   A     LL  +L  DP  R++  +AL+HP+  
Sbjct: 277 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 323

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 121/257 (47%), Gaps = 46/257 (17%)
Query: 171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 230
            +VFE + ++  DF  K  Y++     +R    ++L+ + + H + ++H D+KP NV+ +
Sbjct: 109 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 163
Query: 231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV--STRHYRA 288
             E+ K                         +++ID+G   +  P Q Y V  ++R+++ 
Sbjct: 164 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 198
Query: 289 PEVILGLG-WTYPCDIWSVGCILVELC-TGEALFQTHENLEHLAMMERVLGPLPQHMLKR 346
           PE+++    + Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG   + +   
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EDLYDY 256
Query: 347 VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 406
           +D++  +   R           R S K   +    +N   QH+   + +    L  LLRY
Sbjct: 257 IDKYNIELDPRF-----NDILGRHSRKRWERFVHSEN---QHL--VSPEALDFLDKLLRY 306
Query: 407 DPTDRLTAREALRHPFF 423
           D   RLTAREA+ HP+F
Sbjct: 307 DHQSRLTAREAMEHPYF 323

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 121/257 (47%), Gaps = 46/257 (17%)
Query: 171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 230
            +VFE + ++  DF  K  Y++     +R    ++L+ + + H + ++H D+KP NV+ +
Sbjct: 110 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 164
Query: 231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV--STRHYRA 288
             E+ K                         +++ID+G   +  P Q Y V  ++R+++ 
Sbjct: 165 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 289 PEVILGLG-WTYPCDIWSVGCILVELC-TGEALFQTHENLEHLAMMERVLGPLPQHMLKR 346
           PE+++    + Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG   + +   
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EDLYDY 257
Query: 347 VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 406
           +D++  +   R           R S K   +    +N   QH+   + +    L  LLRY
Sbjct: 258 IDKYNIELDPRF-----NDILGRHSRKRWERFVHSEN---QHL--VSPEALDFLDKLLRY 307
Query: 407 DPTDRLTAREALRHPFF 423
           D   RLTAREA+ HP+F
Sbjct: 308 DHQSRLTAREAMEHPYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 121/257 (47%), Gaps = 46/257 (17%)
Query: 171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 230
            +VFE + ++  DF  K  Y++     +R    ++L+ + + H + ++H D+KP NV+ +
Sbjct: 110 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 164
Query: 231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV--STRHYRA 288
             E+ K                         +++ID+G   +  P Q Y V  ++R+++ 
Sbjct: 165 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 289 PEVILGLG-WTYPCDIWSVGCILVELC-TGEALFQTHENLEHLAMMERVLGPLPQHMLKR 346
           PE+++    + Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG   + +   
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EDLYDY 257
Query: 347 VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 406
           +D++  +   R           R S K   +    +N   QH+   + +    L  LLRY
Sbjct: 258 IDKYNIELDPRF-----NDILGRHSRKRWERFVHSEN---QHL--VSPEALDFLDKLLRY 307
Query: 407 DPTDRLTAREALRHPFF 423
           D   RLTAREA+ HP+F
Sbjct: 308 DHQSRLTAREAMEHPYF 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 121/257 (47%), Gaps = 46/257 (17%)
Query: 171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 230
            +VFE + ++  DF  K  Y++     +R    ++L+ + + H + ++H D+KP NV+ +
Sbjct: 109 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 163
Query: 231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV--STRHYRA 288
             E+ K                         +++ID+G   +  P Q Y V  ++R+++ 
Sbjct: 164 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 198
Query: 289 PEVILGLG-WTYPCDIWSVGCILVELC-TGEALFQTHENLEHLAMMERVLGPLPQHMLKR 346
           PE+++    + Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG   + +   
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EDLYDY 256
Query: 347 VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 406
           +D++  +   R           R S K   +    +N   QH+   + +    L  LLRY
Sbjct: 257 IDKYNIELDPRF-----NDILGRHSRKRWERFVHSEN---QHL--VSPEALDFLDKLLRY 306
Query: 407 DPTDRLTAREALRHPFF 423
           D   RLTAREA+ HP+F
Sbjct: 307 DHQSRLTAREAMEHPYF 323

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 121/257 (47%), Gaps = 46/257 (17%)
Query: 171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 230
            +VFE + ++  DF  K  Y++     +R    ++L+ + + H + ++H D+KP NV+ +
Sbjct: 110 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 164
Query: 231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV--STRHYRA 288
             E+ K                         +++ID+G   +  P Q Y V  ++R+++ 
Sbjct: 165 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 289 PEVILGLG-WTYPCDIWSVGCILVELC-TGEALFQTHENLEHLAMMERVLGPLPQHMLKR 346
           PE+++    + Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG   + +   
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EDLYDY 257
Query: 347 VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 406
           +D++  +   R           R S K   +    +N   QH+   + +    L  LLRY
Sbjct: 258 IDKYNIELDPRF-----NDILGRHSRKRWERFVHSEN---QHL--VSPEALDFLDKLLRY 307
Query: 407 DPTDRLTAREALRHPFF 423
           D   RLTAREA+ HP+F
Sbjct: 308 DHQSRLTAREAMEHPYF 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 121/257 (47%), Gaps = 46/257 (17%)
Query: 171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 230
            +VFE + ++  DF  K  Y++     +R    ++L+ + + H + ++H D+KP NV+ +
Sbjct: 110 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 164
Query: 231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV--STRHYRA 288
             E+ K                         +++ID+G   +  P Q Y V  ++R+++ 
Sbjct: 165 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 289 PEVILGLG-WTYPCDIWSVGCILVELC-TGEALFQTHENLEHLAMMERVLGPLPQHMLKR 346
           PE+++    + Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG   + +   
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EDLYDY 257
Query: 347 VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 406
           +D++  +   R           R S K   +    +N   QH+   + +    L  LLRY
Sbjct: 258 IDKYNIELDPRF-----NDILGRHSRKRWERFVHSEN---QHL--VSPEALDFLDKLLRY 307
Query: 407 DPTDRLTAREALRHPFF 423
           D   RLTAREA+ HP+F
Sbjct: 308 DHQSRLTAREAMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 121/257 (47%), Gaps = 46/257 (17%)
Query: 171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 230
            +VFE + ++  DF  K  Y++     +R    ++L+ + + H + ++H D+KP NV+ +
Sbjct: 110 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 164
Query: 231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV--STRHYRA 288
             E+ K                         +++ID+G   +  P Q Y V  ++R+++ 
Sbjct: 165 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 289 PEVILGLG-WTYPCDIWSVGCILVELC-TGEALFQTHENLEHLAMMERVLGPLPQHMLKR 346
           PE+++    + Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG   + +   
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EDLYDY 257
Query: 347 VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 406
           +D++  +   R           R S K   +    +N   QH+   + +    L  LLRY
Sbjct: 258 IDKYNIELDPRF-----NDILGRHSRKRWERFVHSEN---QHL--VSPEALDFLDKLLRY 307
Query: 407 DPTDRLTAREALRHPFF 423
           D   RLTAREA+ HP+F
Sbjct: 308 DHQSRLTAREAMEHPYF 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 121/257 (47%), Gaps = 46/257 (17%)
Query: 171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 230
            +VFE + ++  DF  K  Y++     +R    ++L+ + + H + ++H D+KP NV+ +
Sbjct: 110 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 164
Query: 231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV--STRHYRA 288
             E+ K                         +++ID+G   +  P Q Y V  ++R+++ 
Sbjct: 165 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 289 PEVILGLG-WTYPCDIWSVGCILVELC-TGEALFQTHENLEHLAMMERVLGPLPQHMLKR 346
           PE+++    + Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG   + +   
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EDLYDY 257
Query: 347 VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 406
           +D++  +   R           R S K   +    +N   QH+   + +    L  LLRY
Sbjct: 258 IDKYNIELDPRF-----NDILGRHSRKRWERFVHSEN---QHL--VSPEALDFLDKLLRY 307
Query: 407 DPTDRLTAREALRHPFF 423
           D   RLTAREA+ HP+F
Sbjct: 308 DHQSRLTAREAMEHPYF 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 121/257 (47%), Gaps = 46/257 (17%)
Query: 171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 230
            +VFE + ++  DF  K  Y++     +R    ++L+ + + H + ++H D+KP NV+ +
Sbjct: 110 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 164
Query: 231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV--STRHYRA 288
             E+ K                         +++ID+G   +  P Q Y V  ++R+++ 
Sbjct: 165 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 289 PEVILGLG-WTYPCDIWSVGCILVELC-TGEALFQTHENLEHLAMMERVLGPLPQHMLKR 346
           PE+++    + Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG   + +   
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EDLYDY 257
Query: 347 VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 406
           +D++  +   R           R S K   +    +N   QH+   + +    L  LLRY
Sbjct: 258 IDKYNIELDPRF-----NDILGRHSRKRWERFVHSEN---QHL--VSPEALDFLDKLLRY 307
Query: 407 DPTDRLTAREALRHPFF 423
           D   RLTAREA+ HP+F
Sbjct: 308 DHQSRLTAREAMEHPYF 324

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 44/227 (19%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 173
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ E+   + LF   
Sbjct: 174 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 222
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL- 381
           + ++    ++E++  P P+ M K++      YV     + P+ A         +  P+L 
Sbjct: 223 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVE----NRPKYAG--------LTFPKLF 269
Query: 382 -QNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             +L     +H+   A     LL  +L  DP  R++  +AL+HP+  
Sbjct: 270 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 316

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 121/257 (47%), Gaps = 46/257 (17%)
Query: 171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 230
            +VFE + ++  DF  K  Y++     +R    ++L+ + + H + ++H D+KP NV+ +
Sbjct: 115 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 169
Query: 231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV--STRHYRA 288
             E+ K                         +++ID+G   +  P Q Y V  ++R+++ 
Sbjct: 170 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 204
Query: 289 PEVILGLG-WTYPCDIWSVGCILVELC-TGEALFQTHENLEHLAMMERVLGPLPQHMLKR 346
           PE+++    + Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG   + +   
Sbjct: 205 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EDLYDY 262
Query: 347 VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 406
           +D++  +   R           R S K   +    +N   QH+   + +    L  LLRY
Sbjct: 263 IDKYNIELDPRF-----NDILGRHSRKRWERFVHSEN---QHL--VSPEALDFLDKLLRY 312
Query: 407 DPTDRLTAREALRHPFF 423
           D   RLTAREA+ HP+F
Sbjct: 313 DHQSRLTAREAMEHPYF 329

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 44/227 (19%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 173
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ E+   + LF   
Sbjct: 174 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 222
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL- 381
           + ++    ++E++  P P+ M K++      YV     + P+ A         +  P+L 
Sbjct: 223 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVE----NRPKYAG--------LTFPKLF 269
Query: 382 -QNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             +L     +H+   A     LL  +L  DP  R++  +AL+HP+  
Sbjct: 270 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 316

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 121/257 (47%), Gaps = 46/257 (17%)
Query: 171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 230
            +VFE + ++  DF  K  Y++     +R    ++L+ + + H + ++H D+KP NV+ +
Sbjct: 108 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 162
Query: 231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV--STRHYRA 288
             E+ K                         +++ID+G   +  P Q Y V  ++R+++ 
Sbjct: 163 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 197
Query: 289 PEVILGLG-WTYPCDIWSVGCILVELC-TGEALFQTHENLEHLAMMERVLGPLPQHMLKR 346
           PE+++    + Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG   + +   
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EDLYDY 255
Query: 347 VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 406
           +D++  +   R           R S K   +    +N   QH+   + +    L  LLRY
Sbjct: 256 IDKYNIELDPRF-----NDILGRHSRKRWERFVHSEN---QHL--VSPEALDFLDKLLRY 305
Query: 407 DPTDRLTAREALRHPFF 423
           D   RLTAREA+ HP+F
Sbjct: 306 DHQSRLTAREAMEHPYF 322

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 44/227 (19%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 172
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    DIWSVGCI+ E+   + LF   
Sbjct: 173 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL- 381
           + ++    ++E++  P P+ M K++      YV     + P+ A         +  P+L 
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVE----NRPKYAG--------LTFPKLF 268
Query: 382 -QNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             +L     +H+   A     LL  +L  DP  R++  +AL+HP+  
Sbjct: 269 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 121/257 (47%), Gaps = 46/257 (17%)
Query: 171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 230
            +VFE + ++  DF  K  Y++     +R    ++L+ + + H + ++H D+KP NV+ +
Sbjct: 110 ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 164
Query: 231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV--STRHYRA 288
             E+ K                         +++ID+G   +  P Q Y V  ++R+++ 
Sbjct: 165 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 289 PEVILGLG-WTYPCDIWSVGCILVELC-TGEALFQTHENLEHLAMMERVLGPLPQHMLKR 346
           PE+++    + Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG   + +   
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EDLYDY 257
Query: 347 VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 406
           +D++  +   R           R S K   +    +N   QH+   + +    L  LLRY
Sbjct: 258 IDKYNIELDPRF-----NDILGRHSRKRWERFVHSEN---QHL--VSPEALDFLDKLLRY 307
Query: 407 DPTDRLTAREALRHPFF 423
           D   RLTAREA+ HP+F
Sbjct: 308 DHQSRLTAREAMEHPYF 324

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 88/355 (24%), Positives = 141/355 (39%), Gaps = 93/355 (26%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREA-----AMIEIE 142
           L   Y +   +G G  G+V   ++R+  + VAI+I+      I   REA        EIE
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 143 VLQQLAKHDKGGNRCV-QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           +L++L       + C+ +I+N+FD  ++  ++    G  L+D +  N  +       +  
Sbjct: 193 ILKKL------NHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLY 244
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H+  +IH DLKPENVLL S E                        +   
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------------------------EDCL 280
Query: 262 IKVIDFGSTTY--ERPDQNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTG 316
           IK+ DFG +    E      +  T  Y APEV++ +   G+    D WS+G IL    +G
Sbjct: 281 IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
Query: 317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW-PEGAASRESIKSV 375
              F  H                      R     +  +  G+ ++ PE           
Sbjct: 341 YPPFSEH----------------------RTQVSLKDQITSGKYNFIPE----------- 367
Query: 376 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 430
                    +   V   A D   L++ LL  DP  R T  EALRHP+   + ++R
Sbjct: 368 ---------VWAEVSEKALD---LVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 88/355 (24%), Positives = 141/355 (39%), Gaps = 93/355 (26%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREA-----AMIEIE 142
           L   Y +   +G G  G+V   ++R+  + VAI+I+      I   REA        EIE
Sbjct: 147 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 206
Query: 143 VLQQLAKHDKGGNRCV-QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
           +L++L       + C+ +I+N+FD  ++  ++    G  L+D +  N  +       +  
Sbjct: 207 ILKKL------NHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLY 258
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  + ++H+  +IH DLKPENVLL S E                        +   
Sbjct: 259 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------------------------EDCL 294
Query: 262 IKVIDFGSTTY--ERPDQNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTG 316
           IK+ DFG +    E      +  T  Y APEV++ +   G+    D WS+G IL    +G
Sbjct: 295 IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354
Query: 317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW-PEGAASRESIKSV 375
              F  H                      R     +  +  G+ ++ PE           
Sbjct: 355 YPPFSEH----------------------RTQVSLKDQITSGKYNFIPE----------- 381
Query: 376 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 430
                    +   V   A D   L++ LL  DP  R T  EALRHP+   + ++R
Sbjct: 382 ---------VWAEVSEKALD---LVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 424

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 120/257 (46%), Gaps = 46/257 (17%)
Query: 171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 230
            +VFE + ++ +  LR+    +     +R    ++L+ + + H + ++H D+KP NV+ +
Sbjct: 110 ALVFEHVNNTDFKQLRQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM-I 164
Query: 231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV--STRHYRA 288
             E+ K                         +++ID+G   +  P Q Y V  ++R+++ 
Sbjct: 165 DHEHRK-------------------------LRLIDWGLAEFYHPGQEYNVRVASRYFKG 199
Query: 289 PEVILGLG-WTYPCDIWSVGCILVELC-TGEALFQTHENLEHLAMMERVLGPLPQHMLKR 346
           PE+++    + Y  D+WS+GC+L  +    E  F  H+N + L  + +VLG   + +   
Sbjct: 200 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT--EDLYDY 257
Query: 347 VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 406
           +D++  +   R           R S K   +    +N   QH+   + +    L  LLRY
Sbjct: 258 IDKYNIELDPRF-----NDILGRHSRKRWERFVHSEN---QHL--VSPEALDFLDKLLRY 307
Query: 407 DPTDRLTAREALRHPFF 423
           D   RLTAREA+ HP+F
Sbjct: 308 DHQSRLTAREAMEHPYF 324

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 91/358 (25%), Positives = 152/358 (42%), Gaps = 47/358 (13%)
Query: 76  REDDKDGHYMFALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIK 131
           R    +  Y   +G++   +  RY+    +G G  G V   +D   +  VAIK + R  +
Sbjct: 8   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 67
Query: 132 KYREAAMIEIE-VLQQLAKHDK--GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKN 188
               A     E VL +   H    G       +   +    + IV E + ++L   ++  
Sbjct: 68  NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-- 125
Query: 189 NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 248
                  + +  +  Q+L  I  +H   +IH DLKP N+++ S   +K+ D+        
Sbjct: 126 --MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG------- 176
Query: 249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 308
                 R   +S      F  T Y        V TR+YRAPEVILG+G+    D+WSVGC
Sbjct: 177 ----LARTAGTS------FMMTPY--------VVTRYYRAPEVILGMGYKENVDLWSVGC 218
Query: 309 ILVELCTGEALFQTHENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA 367
           I+ E+   + LF   + ++    ++E++  P P+ M K++      YV     + P+ A 
Sbjct: 219 IMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFM-KKLQPTVRTYVE----NRPKYAG 273
Query: 368 -SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
            S E +   +  P       +H    A     LL  +L  D + R++  EAL+HP+  
Sbjct: 274 YSFEKLFPDVLFPADS----EHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 327

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 36/223 (16%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+              R   +S   
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 173
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
              F  T Y        V TR+YRAPEVILG+G+    D+WSVGCI+ E+   + LF   
Sbjct: 174 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGR 222
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRL 381
           + ++    ++E++  P P+ M K++      YV     + P+ A  S E +   +  P  
Sbjct: 223 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRTYVE----NRPKYAGYSFEKLFPDVLFPAD 277
Query: 382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
                +H    A     LL  +L  D + R++  EAL+HP+  
Sbjct: 278 S----EHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 316

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 36/223 (16%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+  +                    
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----------------- 176
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
               G++    P+    V TR+YRAPEVILG+G+    DIWSVGCI+ E+   + LF   
Sbjct: 177 ----GTSFMMEPE----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGR 228
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRL 381
           + ++    ++E++  P P  M K++      YV     + P+ A  S E +   +  P  
Sbjct: 229 DYIDQWNKVIEQLGTPCPAFM-KKLQPTVRNYVE----NRPKYAGYSFEKLFPDVLFPAD 283
Query: 382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
                +H    A     LL  +L  D + R++  EAL+HP+  
Sbjct: 284 S----EHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 36/223 (16%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  I  +H   +IH DLKP N+++ S   +K+ D+  +                    
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----------------- 176
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
               G++    P+    V TR+YRAPEVILG+G+    D+WSVGCI+ E+   + LF   
Sbjct: 177 ----GTSFMMEPE----VVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGR 228
Query: 324 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRL 381
           + ++    ++E++  P P+ M K++      YV     + P+ A  S E +   +  P  
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRTYVE----NRPKYAGYSFEKLFPDVLFPAD 283
Query: 382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
                +H    A     LL  +L  D + R++  EAL+HP+  
Sbjct: 284 S----EHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 107/251 (42%), Gaps = 48/251 (19%)
Query: 193 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 252
            P  +V+ +  Q+L+ I ++H   ++H DLKP N+L++                      
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG------------------- 165
Query: 253 FKRMPKSSAIKVIDFG-STTYERP-----DQNYIVSTRHYRAPEVILGL-GWTYPCDIWS 305
               P+   +K+ D G +  +  P     D + +V T  YRAPE++LG   +T   DIW+
Sbjct: 166 ----PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 221
Query: 306 VGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEG 365
           +GCI  EL T E +F   +        E +    P H   ++DR           DW E 
Sbjct: 222 IGCIFAELLTSEPIFHCRQ--------EDIKTSNPYHH-DQLDRIFNVMGFPADKDW-ED 271
Query: 366 AASRESIKSVMKLPR--------LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 417
                   ++MK  R        L   + +H         HLLQ LL  DP  R+T+ +A
Sbjct: 272 IKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331
Query: 418 LRHPFFTRDHL 428
           ++ P+F  D L
Sbjct: 332 MQDPYFLEDPL 342

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 119/260 (45%), Gaps = 48/260 (18%)
Query: 171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 230
            ++FE + ++ +  L    Y +     +R    +LL+ + + H   ++H D+KP NV+ +
Sbjct: 125 SLIFEYVNNTDFKVL----YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-I 179
Query: 231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV--STRHYRA 288
             E  K                         +++ID+G   +  P + Y V  ++R+++ 
Sbjct: 180 DHELRK-------------------------LRLIDWGLAEFYHPGKEYNVRVASRYFKG 214
Query: 289 PEVILGL-GWTYPCDIWSVGCILVELC-TGEALFQTHENLEHLAMMERVLGPLPQHMLKR 346
           PE+++ L  + Y  D+WS+GC+   +    E  F  H+N + L  + +VLG         
Sbjct: 215 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DG 268
Query: 347 VDRHAEKYVRRGRLD-WPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 405
           ++ +  KY  R  LD   E    R S K  +K     N   QH+   + +    L  LLR
Sbjct: 269 LNAYLNKY--RIELDPQLEALVGRHSRKPWLKFMNADN---QHL--VSPEAIDFLDKLLR 321
Query: 406 YDPTDRLTAREALRHPFFTR 425
           YD  +RLTA EA+ HP+F +
Sbjct: 322 YDHQERLTALEAMTHPYFQQ 341

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/339 (23%), Positives = 132/339 (38%), Gaps = 80/339 (23%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLA 148
           +++   Y IH ++G G FG V    +R      A K V    +  +E    EI+ +  L 
Sbjct: 47  DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL- 105
Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
           +H       V + + F+  N + +++E + G  L++ +  + +     D   E  RQ+ +
Sbjct: 106 RHPT----LVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCK 160
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            +  MH+   +H DLKPEN++  +                          +S+ +K+IDF
Sbjct: 161 GLCHMHENNYVHLDLKPENIMFTTK-------------------------RSNELKLIDF 195
Query: 268 GSTTYERPDQNYIVS--TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
           G T +  P Q+  V+  T  + APEV  G    Y  D+WSVG +   L +G + F    +
Sbjct: 196 GLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 255
Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 385
            E L  ++                           DW    ++   I             
Sbjct: 256 DETLRNVKSC-------------------------DWNMDDSAFSGISE----------- 279
Query: 386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
                    D    ++ LL  DP  R+T  +AL HP+ T
Sbjct: 280 ---------DGKDFIRKLLLADPNTRMTIHQALEHPWLT 309

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 44/233 (18%)
Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
           +R    +LL+ + + H   ++H D+KP NV+ +  E  K                     
Sbjct: 128 IRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRK--------------------- 165
Query: 258 KSSAIKVIDFGSTTYERPDQNYIV--STRHYRAPEVILGL-GWTYPCDIWSVGCILVELC 314
               +++ID+G   +  P + Y V  ++R+++ PE+++ L  + Y  D+WS+GC+   + 
Sbjct: 166 ----LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 221
Query: 315 -TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-WPEGAASRESI 372
              E  F  H+N + L  + +VLG         ++ +  KY  R  LD   E    R S 
Sbjct: 222 FRKEPFFYGHDNHDQLVKIAKVLGT------DGLNVYLNKY--RIELDPQLEALVGRHSR 273
Query: 373 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           K  +K     N   QH+   + +    L  LLRYD  +RLTA EA+ HP+F +
Sbjct: 274 KPWLKFMNADN---QHL--VSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 321

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 44/233 (18%)
Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
           +R    +LL+ + + H   ++H D+KP NV+ +  E  K                     
Sbjct: 127 IRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRK--------------------- 164
Query: 258 KSSAIKVIDFGSTTYERPDQNYIV--STRHYRAPEVILGL-GWTYPCDIWSVGCILVELC 314
               +++ID+G   +  P + Y V  ++R+++ PE+++ L  + Y  D+WS+GC+   + 
Sbjct: 165 ----LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 220
Query: 315 -TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-WPEGAASRESI 372
              E  F  H+N + L  + +VLG         ++ +  KY  R  LD   E    R S 
Sbjct: 221 FRKEPFFYGHDNHDQLVKIAKVLGT------DGLNVYLNKY--RIELDPQLEALVGRHSR 272
Query: 373 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           K  +K     N   QH+   + +    L  LLRYD  +RLTA EA+ HP+F +
Sbjct: 273 KPWLKFMNADN---QHL--VSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 44/233 (18%)
Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
           +R    +LL+ + + H   ++H D+KP NV+ +  E  K                     
Sbjct: 127 IRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRK--------------------- 164
Query: 258 KSSAIKVIDFGSTTYERPDQNYIV--STRHYRAPEVILGL-GWTYPCDIWSVGCILVELC 314
               +++ID+G   +  P + Y V  ++R+++ PE+++ L  + Y  D+WS+GC+   + 
Sbjct: 165 ----LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 220
Query: 315 -TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-WPEGAASRESI 372
              E  F  H+N + L  + +VLG         ++ +  KY  R  LD   E    R S 
Sbjct: 221 FRKEPFFYGHDNHDQLVKIAKVLGT------DGLNVYLNKY--RIELDPQLEALVGRHSR 272
Query: 373 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           K  +K     N   QH+   + +    L  LLRYD  +RLTA EA+ HP+F +
Sbjct: 273 KPWLKFMNADN---QHL--VSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 44/233 (18%)
Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
           +R    +LL+ + + H   ++H D+KP NV+ +  E  K                     
Sbjct: 127 IRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRK--------------------- 164
Query: 258 KSSAIKVIDFGSTTYERPDQNYIV--STRHYRAPEVILGL-GWTYPCDIWSVGCILVELC 314
               +++ID+G   +  P + Y V  ++R+++ PE+++ L  + Y  D+WS+GC+   + 
Sbjct: 165 ----LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 220
Query: 315 -TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-WPEGAASRESI 372
              E  F  H+N + L  + +VLG         ++ +  KY  R  LD   E    R S 
Sbjct: 221 FRKEPFFYGHDNHDQLVKIAKVLGT------DGLNVYLNKY--RIELDPQLEALVGRHSR 272
Query: 373 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           K  +K     N   QH+   + +    L  LLRYD  +RLTA EA+ HP+F +
Sbjct: 273 KPWLKFMNADN---QHL--VSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 44/233 (18%)
Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
           +R    +LL+ + + H   ++H D+KP NV+ +  E  K                     
Sbjct: 129 IRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRK--------------------- 166
Query: 258 KSSAIKVIDFGSTTYERPDQNYIV--STRHYRAPEVILGL-GWTYPCDIWSVGCILVELC 314
               +++ID+G   +  P + Y V  ++R+++ PE+++ L  + Y  D+WS+GC+   + 
Sbjct: 167 ----LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 222
Query: 315 -TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-WPEGAASRESI 372
              E  F  H+N + L  + +VLG         ++ +  KY  R  LD   E    R S 
Sbjct: 223 FRKEPFFYGHDNHDQLVKIAKVLGT------DGLNVYLNKY--RIELDPQLEALVGRHSR 274
Query: 373 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           K  +K     N   QH+   + +    L  LLRYD  +RLTA EA+ HP+F +
Sbjct: 275 KPWLKFMNADN---QHL--VSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 322

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 44/233 (18%)
Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
           +R    +LL+ + + H   ++H D+KP NV+ +  E  K                     
Sbjct: 127 IRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRK--------------------- 164
Query: 258 KSSAIKVIDFGSTTYERPDQNYIV--STRHYRAPEVILGL-GWTYPCDIWSVGCILVELC 314
               +++ID+G   +  P + Y V  ++R+++ PE+++ L  + Y  D+WS+GC+   + 
Sbjct: 165 ----LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 220
Query: 315 -TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-WPEGAASRESI 372
              E  F  H+N + L  + +VLG         ++ +  KY  R  LD   E    R S 
Sbjct: 221 FRKEPFFYGHDNHDQLVKIAKVLGT------DGLNVYLNKY--RIELDPQLEALVGRHSR 272
Query: 373 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           K  +K     N   QH+   + +    L  LLRYD  +RLTA EA+ HP+F +
Sbjct: 273 KPWLKFMNADN---QHL--VSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 44/233 (18%)
Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
           +R    +LL+ + + H   ++H D+KP NV+ +  E  K                     
Sbjct: 127 IRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRK--------------------- 164
Query: 258 KSSAIKVIDFGSTTYERPDQNYIV--STRHYRAPEVILGL-GWTYPCDIWSVGCILVELC 314
               +++ID+G   +  P + Y V  ++R+++ PE+++ L  + Y  D+WS+GC+   + 
Sbjct: 165 ----LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 220
Query: 315 -TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-WPEGAASRESI 372
              E  F  H+N + L  + +VLG         ++ +  KY  R  LD   E    R S 
Sbjct: 221 FRKEPFFYGHDNHDQLVKIAKVLGT------DGLNVYLNKY--RIELDPQLEALVGRHSR 272
Query: 373 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           K  +K     N   QH+   + +    L  LLRYD  +RLTA EA+ HP+F +
Sbjct: 273 KPWLKFMNADN---QHL--VSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 44/233 (18%)
Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
           +R    +LL+ + + H   ++H D+KP NV+ +  E  K                     
Sbjct: 128 IRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRK--------------------- 165
Query: 258 KSSAIKVIDFGSTTYERPDQNYIV--STRHYRAPEVILGL-GWTYPCDIWSVGCILVELC 314
               +++ID+G   +  P + Y V  ++R+++ PE+++ L  + Y  D+WS+GC+   + 
Sbjct: 166 ----LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 221
Query: 315 -TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-WPEGAASRESI 372
              E  F  H+N + L  + +VLG         ++ +  KY  R  LD   E    R S 
Sbjct: 222 FRKEPFFYGHDNHDQLVKIAKVLGT------DGLNVYLNKY--RIELDPQLEALVGRHSR 273
Query: 373 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           K  +K     N   QH+   + +    L  LLRYD  +RLTA EA+ HP+F +
Sbjct: 274 KPWLKFMNADN---QHL--VSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 321

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/339 (22%), Positives = 131/339 (38%), Gaps = 80/339 (23%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLA 148
           +++   Y IH ++G G FG V    +R      A K V    +  +E    EI+ +  L 
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL- 211
Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
           +H       V + + F+  N + +++E + G  L++ +  + +     D   E  RQ+ +
Sbjct: 212 RHPT----LVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCK 266
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            +  MH+   +H DLKPEN++  +                          +S+ +K+IDF
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTK-------------------------RSNELKLIDF 301
Query: 268 GSTTYERPDQNYIVS--TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
           G T +  P Q+  V+  T  + APEV  G    Y  D+WSVG +   L +G + F    +
Sbjct: 302 GLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361
Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 385
            E L  ++     +       +    + ++R+                            
Sbjct: 362 DETLRNVKSCDWNMDDSAFSGISEDGKDFIRK---------------------------- 393
Query: 386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
                            LL  DP  R+T  +AL HP+ T
Sbjct: 394 -----------------LLLADPNTRMTIHQALEHPWLT 415

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 44/233 (18%)
Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
           +R    +LL+ + + H   ++H D+KP NV+ +  E  K                     
Sbjct: 127 IRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRK--------------------- 164
Query: 258 KSSAIKVIDFGSTTYERPDQNYIV--STRHYRAPEVILGL-GWTYPCDIWSVGCILVELC 314
               +++ID+G   +  P + Y V  ++R+++ PE+++ L  + Y  D+WS+GC+   + 
Sbjct: 165 ----LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 220
Query: 315 -TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-WPEGAASRESI 372
              E  F  H+N + L  + +VLG         ++ +  KY  R  LD   E    R S 
Sbjct: 221 FRKEPFFYGHDNHDQLVKIAKVLGT------DGLNVYLNKY--RIELDPQLEALVGRHSR 272
Query: 373 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           K  +K     N   QH+   + +    L  LLRYD  +RLTA EA+ HP+F +
Sbjct: 273 KPWLKFMNADN---QHL--VSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 92/363 (25%), Positives = 151/363 (41%), Gaps = 85/363 (23%)
Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMIEIEVLQQL 147
           G +L SRY     +G G  G V    D +  + VAIK IV    +  + A+ EI+++++L
Sbjct: 6   GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL 65
Query: 148 AKHDK----------GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDL 197
             HD            G++           N + IV E + + L + L +         L
Sbjct: 66  -DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG-------PL 117
Query: 198 VREIAR----QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 253
           + E AR    QLL  + ++H   ++H DLKP N+ + + + +                  
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV------------------ 159
Query: 254 KRMPKSSAIKVIDFGSTTYERPDQNYI------VSTRHYRAPEVILGLG-WTYPCDIWSV 306
                   +K+ DFG      P  ++       + T+ YR+P ++L    +T   D+W+ 
Sbjct: 160 --------LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 211
Query: 307 GCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRH-----AEKYVRRGRLD 361
           GCI  E+ TG+ LF     LE    M+ +L  +P  ++   DR         Y+R     
Sbjct: 212 GCIFAEMLTGKTLFAGAHELEQ---MQLILESIP--VVHEEDRQELLSVIPVYIRNDM-- 264
Query: 362 WPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHP 421
                   E  K + +L  L  +  + VD         L+ +L + P DRLTA EAL HP
Sbjct: 265 -------TEPHKPLTQL--LPGISREAVD--------FLEQILTFSPMDRLTAEEALSHP 307
Query: 422 FFT 424
           + +
Sbjct: 308 YMS 310

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/356 (23%), Positives = 137/356 (38%), Gaps = 92/356 (25%)
Query: 86  FALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---------GIKKYREA 136
           +A  +    +Y     +G G    V  C  R      A+KI+           +++ REA
Sbjct: 86  WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145
Query: 137 AMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPI 195
              E  +L+Q+A H       + + + ++  + + +VF+ +    L+D+L +    +   
Sbjct: 146 TRRETHILRQVAGHP----HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSE 199
Query: 196 DLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 255
              R I R LLE ++F+H   ++H DLKPEN+LL  +  I++ D+  S H          
Sbjct: 200 KETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH---------- 249
Query: 256 MPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVI-LGLGWTYP-----CDIWSVGCI 309
                    ++ G    E      +  T  Y APE++   +  T+P      D+W+ G I
Sbjct: 250 ---------LEPGEKLRE------LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
Query: 310 LVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASR 369
           L  L  G   F     +  L M+                   E   +    +W       
Sbjct: 295 LFTLLAGSPPFWHRRQILMLRMI------------------MEGQYQFSSPEW------- 329
Query: 370 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                               D  +  +  L+  LL+ DP  RLTA +AL+HPFF R
Sbjct: 330 --------------------DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/343 (23%), Positives = 141/343 (41%), Gaps = 84/343 (24%)
Query: 92  LTSRYKIHSK-MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH 150
           +T  Y++  + +G G  G+VLEC+ R   +  A+K++    K R+    E++   Q +  
Sbjct: 26  VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ----EVDHHWQAS-- 79
Query: 151 DKGGNRCVQIRNWFDYRNH----ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
             GG   V I + ++  +H    + I+ E + G  L+  +++   ++F      EI R +
Sbjct: 80  --GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
              I F+H   + H D+KPEN+L  S E                        K + +K+ 
Sbjct: 138 GTAIQFLHSHNIAHRDVKPENLLYTSKE------------------------KDAVLKLT 173
Query: 266 DFGSTTYERPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
           DFG    +   QN + +   T +Y APEV+    +   CD+WS+G I+  L  G      
Sbjct: 174 DFGFA--KETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG------ 225
Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 382
                          P   +  + +    ++ +R G+  +P    S  S           
Sbjct: 226 -------------FPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS----------- 261
Query: 383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                       D   L++ LL+ DPT+RLT  + + HP+  +
Sbjct: 262 -----------EDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/343 (23%), Positives = 141/343 (41%), Gaps = 84/343 (24%)
Query: 92  LTSRYKIHSK-MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH 150
           +T  Y++  + +G G  G+VLEC+ R   +  A+K++    K R+    E++   Q +  
Sbjct: 7   VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ----EVDHHWQAS-- 60
Query: 151 DKGGNRCVQIRNWFDYRNH----ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
             GG   V I + ++  +H    + I+ E + G  L+  +++   ++F      EI R +
Sbjct: 61  --GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 118
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
              I F+H   + H D+KPEN+L  S E                        K + +K+ 
Sbjct: 119 GTAIQFLHSHNIAHRDVKPENLLYTSKE------------------------KDAVLKLT 154
Query: 266 DFGSTTYERPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
           DFG    +   QN + +   T +Y APEV+    +   CD+WS+G I+  L  G      
Sbjct: 155 DFGFA--KETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG------ 206
Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 382
                          P   +  + +    ++ +R G+  +P    S  S           
Sbjct: 207 -------------FPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS----------- 242
Query: 383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                       D   L++ LL+ DPT+RLT  + + HP+  +
Sbjct: 243 -----------EDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 274

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 111/258 (43%), Gaps = 48/258 (18%)
Query: 171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 230
            +VFE + ++  DF  K  Y+      +R    +LL+ + + H   ++H D+KP NV++ 
Sbjct: 116 ALVFEYINNT--DF--KQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMID 171
Query: 231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV--STRHYRA 288
             +                            +++ID+G   +  P Q Y V  ++R+++ 
Sbjct: 172 HQQ--------------------------KKLRLIDWGLAEFYHPAQEYNVRVASRYFKG 205
Query: 289 PEVILGLG-WTYPCDIWSVGCILVELC-TGEALFQTHENLEHLAMMERVLGPLPQHMLKR 346
           PE+++    + Y  D+WS+GC+L  +    E  F   +N + L  + +VLG         
Sbjct: 206 PELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT-------- 257
Query: 347 VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG-DLTHLLQGLLR 405
                  Y+++  +D          I       R +N I     H    +   LL  LLR
Sbjct: 258 --EELYGYLKKYHIDLD---PHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLR 312
Query: 406 YDPTDRLTAREALRHPFF 423
           YD   RLTA+EA+ HP+F
Sbjct: 313 YDHQQRLTAKEAMEHPYF 330

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 111/258 (43%), Gaps = 48/258 (18%)
Query: 171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 230
            +VFE + ++  DF  K  Y+      +R    +LL+ + + H   ++H D+KP NV++ 
Sbjct: 111 ALVFEYINNT--DF--KQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMID 166
Query: 231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV--STRHYRA 288
             +                            +++ID+G   +  P Q Y V  ++R+++ 
Sbjct: 167 HQQ--------------------------KKLRLIDWGLAEFYHPAQEYNVRVASRYFKG 200
Query: 289 PEVILGLG-WTYPCDIWSVGCILVELC-TGEALFQTHENLEHLAMMERVLGPLPQHMLKR 346
           PE+++    + Y  D+WS+GC+L  +    E  F   +N + L  + +VLG         
Sbjct: 201 PELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT-------- 252
Query: 347 VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG-DLTHLLQGLLR 405
                  Y+++  +D          I       R +N I     H    +   LL  LLR
Sbjct: 253 --EELYGYLKKYHIDLD---PHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLR 307
Query: 406 YDPTDRLTAREALRHPFF 423
           YD   RLTA+EA+ HP+F
Sbjct: 308 YDHQQRLTAKEAMEHPYF 325

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 87/337 (25%), Positives = 134/337 (39%), Gaps = 81/337 (24%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK--HDKG 153
           Y++   +G+G F  V  C +RE  +  A+KIV  + K+  +  +  E L++ A   H   
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIV-DVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 154 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPID--LVREIARQLLECIA 210
               V++   +     + +VFE + G+ L   + K     F     +     RQ+LE + 
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           + HD  +IH D+KPENVLL S E                         S+ +K+ DFG  
Sbjct: 145 YCHDNNIIHRDVKPENVLLASKE------------------------NSAPVKLGDFG-V 179
Query: 271 TYERPDQNYI----VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
             +  +   +    V T H+ APEV+    +  P D+W  G IL  L +G         L
Sbjct: 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG--------CL 231
Query: 327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 386
                 ER+                            EG      IK   K+   Q    
Sbjct: 232 PFYGTKERLF---------------------------EGI-----IKGKYKMNPRQ---W 256
Query: 387 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
            H+  SA D   L++ +L  DP +R+T  EAL HP+ 
Sbjct: 257 SHISESAKD---LVRRMLMLDPAERITVYEALNHPWL 290

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 82/363 (22%), Positives = 139/363 (38%), Gaps = 85/363 (23%)
Query: 71  GSPPWREDDKDGHYMFALGENLT-------SRYKIHSKMGEGTFGQVLECWDRERKEMVA 123
           GS P RE  +  H  F     L        S      K+GEG+ G V     R   ++VA
Sbjct: 1   GSSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVA 60
Query: 124 IKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLY 182
           +K +   K+ R   +    V+ +  +H+      V++ N +   + + +V E L G +L 
Sbjct: 61  VKKMDLRKQQRRELLFNEVVIMRDYQHEN----VVEMYNSYLVGDELWVVMEFLEGGALT 116
Query: 183 DFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 242
           D +          + +  +   +L+ ++ +H   +IH D+K +++LL     +K+ D+  
Sbjct: 117 DIVTHTRMNE---EQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF 173
Query: 243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCD 302
                K                        E P +  +V T ++ APE+I  L +    D
Sbjct: 174 CAQVSK------------------------EVPRRKXLVGTPYWMAPELISRLPYGPEVD 209
Query: 303 IWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW 362
           IWS+G +++E+  GE  +     L+ + M+                          R + 
Sbjct: 210 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMI--------------------------RDNL 243
Query: 363 PEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
           P               PRL+NL        +  L   L  LL  DP  R TA E L+HPF
Sbjct: 244 P---------------PRLKNL-----HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF 283
Query: 423 FTR 425
             +
Sbjct: 284 LAK 286

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 94/368 (25%), Positives = 158/368 (42%), Gaps = 68/368 (18%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV-RGIKKYREAAMI--EIEVLQQLAKHD 151
            Y I   +G G++G V   +D+  ++ VAIK V R  +   +   I  EI +L +L    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE----IARQLLE 207
                 + I +     + + IV E   S L    +       PI L  E    I   LL 
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT------PIFLTEEHIKTILYNLLL 140
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY--KSSLHTPKDSSYFKRMPKSSAIKVI 265
              F+H+  +IH DLKP N LL     +KV D+    ++++ KD++    + ++      
Sbjct: 141 GENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP- 199
Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCT--------- 315
              +   ++   +++V TR YRAPE+IL    +T   DIWS GCI  EL           
Sbjct: 200 --HNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 316 --------GEALF---------QTHE--NLEHLAMMERVLGPLPQHMLKRVDR-HAEKYV 355
                   G + F         + HE  N + L ++  ++G   +  LK +++    KY+
Sbjct: 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYI 316
Query: 356 RRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 415
           +     +P     R+ I    K P +           + D  +LL+ +L+++P  R+T  
Sbjct: 317 KL----FPH----RKPINLKQKYPSI-----------SDDGINLLESMLKFNPNKRITID 357
Query: 416 EALRHPFF 423
           +AL HP+ 
Sbjct: 358 QALDHPYL 365

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 54/285 (18%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIE 140
           EN+   Y    ++G G F  V +C ++      A K +         RG+   RE    E
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS--REDIERE 64
Query: 141 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR 199
           + +L+++   +      + +   ++ +  + ++ E + G  L+DFL +    S   +   
Sbjct: 65  VSILKEIQHPN-----VITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E  +Q+L  + ++H L + H DLKPEN++L+                       + +PK 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKP 155
Query: 260 SAIKVIDFG---STTYERPDQNYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVE 312
             IK+IDFG      +    +N I  T  + APE++    LGL      D+WS+G I   
Sbjct: 156 R-IKIIDFGLAHKIDFGNEFKN-IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYI 209
Query: 313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           L +G + F      E LA +  V               A+ ++RR
Sbjct: 210 LLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 254

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 54/285 (18%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIE 140
           EN+   Y    ++G G F  V +C ++      A K +         RG+   RE    E
Sbjct: 7   ENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS--REDIERE 64
Query: 141 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR 199
           + +L+++   +      + +   ++ +  + ++ E + G  L+DFL +    S   +   
Sbjct: 65  VSILKEIQHPN-----VITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E  +Q+L  + ++H L + H DLKPEN++L+                       + +PK 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKP 155
Query: 260 SAIKVIDFG---STTYERPDQNYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVE 312
             IK+IDFG      +    +N I  T  + APE++    LGL      D+WS+G I   
Sbjct: 156 R-IKIIDFGLAHKIDFGNEFKN-IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYI 209
Query: 313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           L +G + F      E LA +  V               A+ ++RR
Sbjct: 210 LLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 254

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/337 (24%), Positives = 140/337 (41%), Gaps = 77/337 (22%)
Query: 96  YKIHSK-MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
           YK+ S+ +G G  G+VL+ +++  +E  A+K+++   K R     E+E L   A      
Sbjct: 33  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVE-LHWRASQCPHI 87
Query: 155 NRCVQI-RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            R V +  N +  R  + IV E L G  L+  ++    ++F      EI + + E I ++
Sbjct: 88  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 147
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H + + H D+KPEN+L  S    K P+                    + +K+ DFG    
Sbjct: 148 HSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFAK- 182
Query: 273 ERPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
           E    N + +   T +Y APEV+    +   CD+WS+G I+  L  G   F ++  L   
Sbjct: 183 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-- 240
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
                            +    +  +R G+ ++P    S  S +  M             
Sbjct: 241 -----------------ISPGMKTRIRMGQYEFPNPEWSEVSEEVKM------------- 270
Query: 390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                    L++ LL+ +PT R+T  E + HP+  + 
Sbjct: 271 ---------LIRNLLKTEPTQRMTITEFMNHPWIMQS 298

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 54/285 (18%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIE 140
           EN+   Y    ++G G F  V +C ++      A K +         RG+   RE    E
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS--REDIERE 63
Query: 141 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR 199
           + +L+++   +      + +   ++ +  + ++ E + G  L+DFL +    S   +   
Sbjct: 64  VSILKEIQHPN-----VITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 116
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E  +Q+L  + ++H L + H DLKPEN++L+                       + +PK 
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKP 154
Query: 260 SAIKVIDFG---STTYERPDQNYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVE 312
             IK+IDFG      +    +N I  T  + APE++    LGL      D+WS+G I   
Sbjct: 155 R-IKIIDFGLAHKIDFGNEFKN-IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYI 208
Query: 313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           L +G + F      E LA +  V               A+ ++RR
Sbjct: 209 LLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 253

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 54/285 (18%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIE 140
           EN+   Y    ++G G F  V +C ++      A K +         RG+   RE    E
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS--REDIERE 64
Query: 141 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR 199
           + +L+++   +      + +   ++ +  + ++ E + G  L+DFL +    S   +   
Sbjct: 65  VSILKEIQHPN-----VITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E  +Q+L  + ++H L + H DLKPEN++L+                       + +PK 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKP 155
Query: 260 SAIKVIDFG---STTYERPDQNYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVE 312
             IK+IDFG      +    +N I  T  + APE++    LGL      D+WS+G I   
Sbjct: 156 R-IKIIDFGLAHKIDFGNEFKN-IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYI 209
Query: 313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           L +G + F      E LA +  V               A+ ++RR
Sbjct: 210 LLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 254

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 54/285 (18%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIE 140
           EN+   Y    ++G G F  V +C ++      A K +         RG+   RE    E
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS--REDIERE 63
Query: 141 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR 199
           + +L+++   +      + +   ++ +  + ++ E + G  L+DFL +    S   +   
Sbjct: 64  VSILKEIQHPN-----VITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 116
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E  +Q+L  + ++H L + H DLKPEN++L+                       + +PK 
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKP 154
Query: 260 SAIKVIDFG---STTYERPDQNYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVE 312
             IK+IDFG      +    +N I  T  + APE++    LGL      D+WS+G I   
Sbjct: 155 R-IKIIDFGLAHKIDFGNEFKN-IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYI 208
Query: 313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           L +G + F      E LA +  V               A+ ++RR
Sbjct: 209 LLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 253

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 54/285 (18%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIE 140
           EN+   Y    ++G G F  V +C ++      A K +         RG+   RE    E
Sbjct: 7   ENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS--REDIERE 64
Query: 141 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR 199
           + +L+++   +      + +   ++ +  + ++ E + G  L+DFL +    S   +   
Sbjct: 65  VSILKEIQHPN-----VITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E  +Q+L  + ++H L + H DLKPEN++L+                       + +PK 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKP 155
Query: 260 SAIKVIDFG---STTYERPDQNYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVE 312
             IK+IDFG      +    +N I  T  + APE++    LGL      D+WS+G I   
Sbjct: 156 R-IKIIDFGLAHKIDFGNEFKN-IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYI 209
Query: 313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           L +G + F      E LA +  V               A+ ++RR
Sbjct: 210 LLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 254

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/337 (24%), Positives = 140/337 (41%), Gaps = 77/337 (22%)
Query: 96  YKIHSK-MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
           YK+ S+ +G G  G+VL+ +++  +E  A+K+++   K R     E+E L   A      
Sbjct: 25  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVE-LHWRASQCPHI 79
Query: 155 NRCVQI-RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            R V +  N +  R  + IV E L G  L+  ++    ++F      EI + + E I ++
Sbjct: 80  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 139
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H + + H D+KPEN+L  S    K P+                    + +K+ DFG    
Sbjct: 140 HSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFAK- 174
Query: 273 ERPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
           E    N + +   T +Y APEV+    +   CD+WS+G I+  L  G   F ++  L   
Sbjct: 175 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-- 232
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
                            +    +  +R G+ ++P    S  S +  M             
Sbjct: 233 -----------------ISPGMKTRIRMGQYEFPNPEWSEVSEEVKM------------- 262
Query: 390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                    L++ LL+ +PT R+T  E + HP+  + 
Sbjct: 263 ---------LIRNLLKTEPTQRMTITEFMNHPWIMQS 290

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 54/285 (18%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIE 140
           EN+   Y    ++G G F  V +C ++      A K +         RG+   RE    E
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS--REDIERE 64
Query: 141 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR 199
           + +L+++   +      + +   ++ +  + ++ E + G  L+DFL +    S   +   
Sbjct: 65  VSILKEIQHPN-----VITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E  +Q+L  + ++H L + H DLKPEN++L+                       + +PK 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKP 155
Query: 260 SAIKVIDFG---STTYERPDQNYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVE 312
             IK+IDFG      +    +N I  T  + APE++    LGL      D+WS+G I   
Sbjct: 156 R-IKIIDFGLAHKIDFGNEFKN-IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYI 209
Query: 313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           L +G + F      E LA +  V               A+ ++RR
Sbjct: 210 LLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 254

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/337 (24%), Positives = 140/337 (41%), Gaps = 77/337 (22%)
Query: 96  YKIHSK-MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
           YK+ S+ +G G  G+VL+ +++  +E  A+K+++   K R     E+E L   A      
Sbjct: 18  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVE-LHWRASQCPHI 72
Query: 155 NRCVQI-RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            R V +  N +  R  + IV E L G  L+  ++    ++F      EI + + E I ++
Sbjct: 73  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 132
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H + + H D+KPEN+L  S    K P+                    + +K+ DFG    
Sbjct: 133 HSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFAK- 167
Query: 273 ERPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
           E    N + +   T +Y APEV+    +   CD+WS+G I+  L  G   F ++  L   
Sbjct: 168 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-- 225
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
                            +    +  +R G+ ++P    S  S +  M             
Sbjct: 226 -----------------ISPGMKTRIRMGQYEFPNPEWSEVSEEVKM------------- 255
Query: 390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                    L++ LL+ +PT R+T  E + HP+  + 
Sbjct: 256 ---------LIRNLLKTEPTQRMTITEFMNHPWIMQS 283

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/337 (24%), Positives = 140/337 (41%), Gaps = 77/337 (22%)
Query: 96  YKIHSK-MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
           YK+ S+ +G G  G+VL+ +++  +E  A+K+++   K R     E+E L   A      
Sbjct: 24  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVE-LHWRASQCPHI 78
Query: 155 NRCVQI-RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            R V +  N +  R  + IV E L G  L+  ++    ++F      EI + + E I ++
Sbjct: 79  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 138
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H + + H D+KPEN+L  S    K P+                    + +K+ DFG    
Sbjct: 139 HSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFAK- 173
Query: 273 ERPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
           E    N + +   T +Y APEV+    +   CD+WS+G I+  L  G   F ++  L   
Sbjct: 174 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-- 231
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
                            +    +  +R G+ ++P    S  S +  M             
Sbjct: 232 -----------------ISPGMKTRIRMGQYEFPNPEWSEVSEEVKM------------- 261
Query: 390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                    L++ LL+ +PT R+T  E + HP+  + 
Sbjct: 262 ---------LIRNLLKTEPTQRMTITEFMNHPWIMQS 289

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/336 (24%), Positives = 140/336 (41%), Gaps = 77/336 (22%)
Query: 96  YKIHSK-MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
           YK+ S+ +G G  G+VL+ +++  +E  A+K+++   K R     E+E L   A      
Sbjct: 17  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVE-LHWRASQCPHI 71
Query: 155 NRCVQI-RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            R V +  N +  R  + IV E L G  L+  ++    ++F      EI + + E I ++
Sbjct: 72  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 131
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H + + H D+KPEN+L  S    K P+                    + +K+ DFG    
Sbjct: 132 HSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFAK- 166
Query: 273 ERPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
           E    N + +   T +Y APEV+    +   CD+WS+G I+  L  G   F ++  L   
Sbjct: 167 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-- 224
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
                            +    +  +R G+ ++P    S  S +  M             
Sbjct: 225 -----------------ISPGMKTRIRMGQYEFPNPEWSEVSEEVKM------------- 254
Query: 390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                    L++ LL+ +PT R+T  E + HP+  +
Sbjct: 255 ---------LIRNLLKTEPTQRMTITEFMNHPWIMQ 281

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/337 (24%), Positives = 140/337 (41%), Gaps = 77/337 (22%)
Query: 96  YKIHSK-MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
           YK+ S+ +G G  G+VL+ +++  +E  A+K+++   K R     E+E L   A      
Sbjct: 23  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVE-LHWRASQCPHI 77
Query: 155 NRCVQI-RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            R V +  N +  R  + IV E L G  L+  ++    ++F      EI + + E I ++
Sbjct: 78  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 137
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H + + H D+KPEN+L  S    K P+                    + +K+ DFG    
Sbjct: 138 HSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFAK- 172
Query: 273 ERPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
           E    N + +   T +Y APEV+    +   CD+WS+G I+  L  G   F ++  L   
Sbjct: 173 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-- 230
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
                            +    +  +R G+ ++P    S  S +  M             
Sbjct: 231 -----------------ISPGMKTRIRMGQYEFPNPEWSEVSEEVKM------------- 260
Query: 390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                    L++ LL+ +PT R+T  E + HP+  + 
Sbjct: 261 ---------LIRNLLKTEPTQRMTITEFMNHPWIMQS 288

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 54/285 (18%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIE 140
           EN+   Y    ++G G F  V +C ++      A K +         RG+   RE    E
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS--REDIERE 64
Query: 141 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR 199
           + +L+++   +      + +   ++ +  + ++ E + G  L+DFL +    S   +   
Sbjct: 65  VSILKEIQHPN-----VITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E  +Q+L  + ++H L + H DLKPEN++L+                       + +PK 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKP 155
Query: 260 SAIKVIDFG---STTYERPDQNYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVE 312
             IK+IDFG      +    +N I  T  + APE++    LGL      D+WS+G I   
Sbjct: 156 R-IKIIDFGLAHKIDFGNEFKN-IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYI 209
Query: 313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           L +G + F      E LA +  V               A+ ++RR
Sbjct: 210 LLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 254

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/336 (24%), Positives = 140/336 (41%), Gaps = 77/336 (22%)
Query: 96  YKIHSK-MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
           YK+ S+ +G G  G+VL+ +++  +E  A+K+++   K R     E+E L   A      
Sbjct: 19  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVE-LHWRASQCPHI 73
Query: 155 NRCVQI-RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            R V +  N +  R  + IV E L G  L+  ++    ++F      EI + + E I ++
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H + + H D+KPEN+L  S    K P+                    + +K+ DFG    
Sbjct: 134 HSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFAK- 168
Query: 273 ERPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
           E    N + +   T +Y APEV+    +   CD+WS+G I+  L  G   F ++  L   
Sbjct: 169 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-- 226
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
                            +    +  +R G+ ++P    S  S +  M             
Sbjct: 227 -----------------ISPGMKTRIRMGQYEFPNPEWSEVSEEVKM------------- 256
Query: 390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                    L++ LL+ +PT R+T  E + HP+  +
Sbjct: 257 ---------LIRNLLKTEPTQRMTITEFMNHPWIMQ 283

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 54/285 (18%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIE 140
           EN+   Y    ++G G F  V +C ++      A K +         RG+   RE    E
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS--REDIERE 64
Query: 141 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR 199
           + +L+++   +      + +   ++ +  + ++ E + G  L+DFL +    S   +   
Sbjct: 65  VSILKEIQHPN-----VITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E  +Q+L  + ++H L + H DLKPEN++L+                       + +PK 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKP 155
Query: 260 SAIKVIDFG---STTYERPDQNYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVE 312
             IK+IDFG      +    +N I  T  + APE++    LGL      D+WS+G I   
Sbjct: 156 R-IKIIDFGLAHKIDFGNEFKN-IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYI 209
Query: 313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           L +G + F      E LA +  V               A+ ++RR
Sbjct: 210 LLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 254

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 54/285 (18%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIE 140
           EN+   Y    ++G G F  V +C ++      A K +         RG+   RE    E
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS--REDIERE 64
Query: 141 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR 199
           + +L+++   +      + +   ++ +  + ++ E + G  L+DFL +    S   +   
Sbjct: 65  VSILKEIQHPN-----VITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E  +Q+L  + ++H L + H DLKPEN++L+                       + +PK 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKP 155
Query: 260 SAIKVIDFG---STTYERPDQNYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVE 312
             IK+IDFG      +    +N I  T  + APE++    LGL      D+WS+G I   
Sbjct: 156 R-IKIIDFGLAHKIDFGNEFKN-IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYI 209
Query: 313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           L +G + F      E LA +  V               A+ ++RR
Sbjct: 210 LLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 254

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 80/336 (23%), Positives = 140/336 (41%), Gaps = 77/336 (22%)
Query: 96  YKIHSK-MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
           YK+ S+ +G G  G+VL+ +++  +E  A+K+++   K R     E+E L   A      
Sbjct: 69  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVE-LHWRASQCPHI 123
Query: 155 NRCVQI-RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            R V +  N +  R  + IV E L G  L+  ++    ++F      EI + + E I ++
Sbjct: 124 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 183
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H + + H D+KPEN+L  S    K P+                    + +K+ DFG    
Sbjct: 184 HSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFAK- 218
Query: 273 ERPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
           E    N + +   T +Y APEV+    +   CD+WS+G I+  L  G   F ++  L   
Sbjct: 219 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-- 276
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
                            +    +  +R G+ ++P    S  S                  
Sbjct: 277 -----------------ISPGMKTRIRMGQYEFPNPEWSEVS------------------ 301
Query: 390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                ++  L++ LL+ +PT R+T  E + HP+  +
Sbjct: 302 ----EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 333

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 54/285 (18%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIE 140
           EN+   Y    ++G G F  V +C ++      A K +         RG+   RE    E
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS--REDIERE 64
Query: 141 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR 199
           + +L+++   +      + +   ++ +  + ++ E + G  L+DFL +    S   +   
Sbjct: 65  VSILKEIQHPN-----VITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E  +Q+L  + ++H L + H DLKPEN++L+                       + +PK 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKP 155
Query: 260 SAIKVIDFG---STTYERPDQNYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVE 312
             IK+IDFG      +    +N I  T  + APE++    LGL      D+WS+G I   
Sbjct: 156 R-IKIIDFGLAHKIDFGNEFKN-IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYI 209
Query: 313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           L +G + F      E LA +  V               A+ ++RR
Sbjct: 210 LLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 254

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 80/336 (23%), Positives = 140/336 (41%), Gaps = 77/336 (22%)
Query: 96  YKIHSK-MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
           YK+ S+ +G G  G+VL+ +++  +E  A+K+++   K R     E+E L   A      
Sbjct: 63  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVE-LHWRASQCPHI 117
Query: 155 NRCVQI-RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            R V +  N +  R  + IV E L G  L+  ++    ++F      EI + + E I ++
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H + + H D+KPEN+L  S    K P+                    + +K+ DFG    
Sbjct: 178 HSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFAK- 212
Query: 273 ERPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
           E    N + +   T +Y APEV+    +   CD+WS+G I+  L  G   F ++  L   
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-- 270
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
                            +    +  +R G+ ++P    S  S                  
Sbjct: 271 -----------------ISPGMKTRIRMGQYEFPNPEWSEVS------------------ 295
Query: 390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                ++  L++ LL+ +PT R+T  E + HP+  +
Sbjct: 296 ----EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/336 (24%), Positives = 140/336 (41%), Gaps = 77/336 (22%)
Query: 96  YKIHSK-MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
           YK+ S+ +G G  G+VL+ +++  +E  A+K+++   K R     E+E L   A      
Sbjct: 19  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVE-LHWRASQCPHI 73
Query: 155 NRCVQI-RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            R V +  N +  R  + IV E L G  L+  ++    ++F      EI + + E I ++
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H + + H D+KPEN+L  S    K P+                    + +K+ DFG    
Sbjct: 134 HSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFAK- 168
Query: 273 ERPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
           E    N + +   T +Y APEV+    +   CD+WS+G I+  L  G   F ++  L   
Sbjct: 169 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-- 226
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
                            +    +  +R G+ ++P    S  S +  M             
Sbjct: 227 -----------------ISPGMKTRIRMGQYEFPNPEWSEVSEEVKM------------- 256
Query: 390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                    L++ LL+ +PT R+T  E + HP+  +
Sbjct: 257 ---------LIRNLLKTEPTQRMTITEFMNHPWIMQ 283

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 116/275 (42%), Gaps = 46/275 (16%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIEIEVLQQ 146
           Y I  ++G G F  V +C ++      A K +         RG+   RE    E+ +L+Q
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVS--REEIEREVSILRQ 71
Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
           +  H+      + + + ++ R  + ++ E + G  L+DFL +    S   +      +Q+
Sbjct: 72  VLHHN-----VITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQI 124
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L+ + ++H   + H DLKPEN++L+    I +P                       IK+I
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKN-IPIPH----------------------IKLI 161
Query: 266 DFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
           DFG   +E  D      I  T  + APE++         D+WS+G I   L +G + F  
Sbjct: 162 DFG-LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
               E LA +  V     +    +    A+ ++R+
Sbjct: 221 DTKQETLANITAVSYDFDEEFFSQTSELAKDFIRK 255

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 115/275 (41%), Gaps = 46/275 (16%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIEIEVLQQ 146
           Y I  ++G G F  V +C ++      A K +         RG+   RE    E+ +L+Q
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVS--REEIEREVSILRQ 71
Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
           +  H+      + + + ++ R  + ++ E + G  L+DFL +    S   +      +Q+
Sbjct: 72  VLHHN-----VITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQI 124
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L+ + ++H   + H DLKPEN++L+    I +P                       IK+I
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKN-IPIPH----------------------IKLI 161
Query: 266 DFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
           DFG   +E  D      I  T  + APE++         D+WS+G I   L +G + F  
Sbjct: 162 DFG-LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
               E LA +  V     +         A+ ++R+
Sbjct: 221 DTKQETLANITSVSYDFDEEFFSHTSELAKDFIRK 255

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 119/279 (42%), Gaps = 54/279 (19%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIEIEVLQQ 146
           Y I  ++G G F  V +C ++      A K +         RG+   RE    E+ +L+Q
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVS--REEIEREVSILRQ 71
Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
           +  H+      + + + ++ R  + ++ E + G  L+DFL +    S   +      +Q+
Sbjct: 72  VLHHN-----VITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQI 124
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L+ + ++H   + H DLKPEN++L+    I +P                       IK+I
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKN-IPIPH----------------------IKLI 161
Query: 266 DFGSTTYERPDQ---NYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVELCTGEA 318
           DFG   +E  D      I  T  + APE++    LGL      D+WS+G I   L +G +
Sbjct: 162 DFG-LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLSGAS 216
Query: 319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
            F      E LA +  V     +    +    A+ ++R+
Sbjct: 217 PFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRK 255

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/337 (22%), Positives = 132/337 (39%), Gaps = 84/337 (24%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           Y +   +G G++ +   C  +      A+K+   I K +     EIE+L +  +H     
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKV---IDKSKRDPSEEIEILLRYGQHPN--- 82
Query: 156 RCVQIRNWFDYRNHICIVFEKL-GSSLYD-FLRKNNYRSFPIDLVREIARQLLECIAFMH 213
             + +++ +D   H+ +V E + G  L D  LR+  +       V     + +E   ++H
Sbjct: 83  -IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVE---YLH 138
Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
              ++H DLKP N+L                       Y         +++ DFG     
Sbjct: 139 SQGVVHRDLKPSNIL-----------------------YVDESGNPECLRICDFGFAKQL 175
Query: 274 RPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
           R +   +++   T ++ APEV+   G+   CDIWS+G +L  +  G   F          
Sbjct: 176 RAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFAN-------- 227
Query: 331 MMERVLGP--LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 388
                 GP   P+ +L R+   + K+   G  +W                          
Sbjct: 228 ------GPSDTPEEILTRIG--SGKFTLSGG-NW------------------------NT 254
Query: 389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           V  +A D   L+  +L  DP  RLTA++ L+HP+ T+
Sbjct: 255 VSETAKD---LVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 54/285 (18%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIE 140
           EN+   Y    ++G G F  V +C ++      A K +         RG+   RE    E
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS--REDIERE 64
Query: 141 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR 199
           + +L+++   +      + +   ++ +  + ++ E + G  L+DFL +    S   +   
Sbjct: 65  VSILKEIQHPN-----VITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E  +Q+L  + ++H L + H DLKPEN++L+                       + +PK 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKP 155
Query: 260 SAIKVIDFG---STTYERPDQNYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVE 312
             IK+IDFG      +    +N I  T  + APE++    LGL      D+WS+G I   
Sbjct: 156 R-IKIIDFGLAHKIDFGNEFKN-IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYI 209
Query: 313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           L +G + F      E LA +  V               A+ ++RR
Sbjct: 210 LLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 254

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 109/236 (46%), Gaps = 42/236 (17%)
Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAM-IEIEVLQQ 146
            E++   Y     +G G F +V+   D+  +++VAIK I +   + +E +M  EI VL +
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK 72
Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIAR-- 203
           + KH       V + + ++   H+ ++ + + G  L+D + +  + +      R+ +R  
Sbjct: 73  I-KH----PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYT-----ERDASRLI 122
Query: 204 -QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
            Q+L+ + ++HDL ++H DLKPEN+L  S                        + + S I
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLLYYS------------------------LDEDSKI 158
Query: 263 KVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            + DFG +  E P    +    T  Y APEV+    ++   D WS+G I   L  G
Sbjct: 159 MISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 102/223 (45%), Gaps = 32/223 (14%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           + +  K+GEG++G V +   +E  ++VAIK V  ++   +  + EI ++QQ         
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQC-----DSP 84
Query: 156 RCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             V+    +     + IV E  G+ S+ D +R  N ++   D +  I +  L+ + ++H 
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHF 143
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  IH D+K  N+LL +  + K+ D+  +                        G  T   
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVA------------------------GQLTDXM 179
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 317
             +N ++ T  + APEVI  +G+    DIWS+G   +E+  G+
Sbjct: 180 AKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/337 (22%), Positives = 132/337 (39%), Gaps = 84/337 (24%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           Y +   +G G++ +   C  +      A+K+   I K +     EIE+L +  +H     
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKV---IDKSKRDPSEEIEILLRYGQHP---- 81
Query: 156 RCVQIRNWFDYRNHICIVFEKL-GSSLYD-FLRKNNYRSFPIDLVREIARQLLECIAFMH 213
             + +++ +D   H+ +V E + G  L D  LR+  +       V     + +E   ++H
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVE---YLH 138
Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
              ++H DLKP N+L                       Y         +++ DFG     
Sbjct: 139 SQGVVHRDLKPSNIL-----------------------YVDESGNPECLRICDFGFAKQL 175
Query: 274 RPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
           R +   +++   T ++ APEV+   G+   CDIWS+G +L  +  G   F          
Sbjct: 176 RAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFAN-------- 227
Query: 331 MMERVLGP--LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 388
                 GP   P+ +L R+   + K+   G  +W                          
Sbjct: 228 ------GPSDTPEEILTRIG--SGKFTLSGG-NW------------------------NT 254
Query: 389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           V  +A D   L+  +L  DP  RLTA++ L+HP+ T+
Sbjct: 255 VSETAKD---LVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/326 (22%), Positives = 129/326 (39%), Gaps = 78/326 (23%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+GEG+ G V     R   ++VA+K +   K+ R   +    V+ +  +H+      V++
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN----VVEM 213
Query: 161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
            N +   + + +V E L G +L D +          + +  +   +L+ ++ +H   +IH
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLQALSVLHAQGVIH 270
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            D+K +++LL     +K+ D+       K                        E P +  
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFCAQVSK------------------------EVPRRKX 306
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 339
           +V T ++ APE+I  L +    DIWS+G +++E+  GE  +     L+ + M+       
Sbjct: 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI------- 359
Query: 340 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 399
                              R + P               PRL+NL        +  L   
Sbjct: 360 -------------------RDNLP---------------PRLKNL-----HKVSPSLKGF 380
Query: 400 LQGLLRYDPTDRLTAREALRHPFFTR 425
           L  LL  DP  R TA E L+HPF  +
Sbjct: 381 LDRLLVRDPAQRATAAELLKHPFLAK 406

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 54/285 (18%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIE 140
           EN+   Y    ++G G F  V +C ++      A K +         RG+   RE    E
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS--REDIERE 64
Query: 141 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR 199
           + +L+++   +      + +   ++ +  + ++ E + G  L+DFL +    S   +   
Sbjct: 65  VSILKEIQHPN-----VITLHEVYENKTDVILIGELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E  +Q+L  + ++H L + H DLKPEN++L+                       + +PK 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKP 155
Query: 260 SAIKVIDFG---STTYERPDQNYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVE 312
             IK+IDFG      +    +N I  T  + APE++    LGL      D+WS+G I   
Sbjct: 156 R-IKIIDFGLAHKIDFGNEFKN-IFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYI 209
Query: 313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           L +G + F      E LA +  V               A+ ++RR
Sbjct: 210 LLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 254

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 115/275 (41%), Gaps = 46/275 (16%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIEIEVLQQ 146
           Y I  ++G G F  V +C ++      A K +         RG+   RE    E+ +L+Q
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVS--REEIEREVSILRQ 71
Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
           +  H+      + + + ++ R  + ++ E + G  L+DFL +    S   +      +Q+
Sbjct: 72  VLHHN-----VITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQI 124
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L+ + ++H   + H DLKPEN++L+    I +P                       IK+I
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKN-IPIPH----------------------IKLI 161
Query: 266 DFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
           DFG   +E  D      I  T  + APE++         D+WS+G I   L +G + F  
Sbjct: 162 DFG-LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
               E LA +  V     +         A+ ++R+
Sbjct: 221 DTKQETLANITSVSYDFDEEFFSHTSELAKDFIRK 255

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 81/336 (24%), Positives = 139/336 (41%), Gaps = 77/336 (22%)
Query: 96  YKIHSK-MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
           YK+ S+ +G G  G+VL+ +++  +E  A+K+++   K R     E+E L   A      
Sbjct: 17  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVE-LHWRASQCPHI 71
Query: 155 NRCVQI-RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            R V +  N +  R  + IV E L G  L+  ++    ++F      EI + + E I ++
Sbjct: 72  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 131
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H + + H D+KPEN+L  S    K P+                    + +K+ DFG    
Sbjct: 132 HSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFAK- 166
Query: 273 ERPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
           E    N +     T +Y APEV+    +   CD+WS+G I+  L  G   F ++  L   
Sbjct: 167 ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-- 224
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
                            +    +  +R G+ ++P    S  S +  M             
Sbjct: 225 -----------------ISPGMKTRIRMGQYEFPNPEWSEVSEEVKM------------- 254
Query: 390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                    L++ LL+ +PT R+T  E + HP+  +
Sbjct: 255 ---------LIRNLLKTEPTQRMTITEFMNHPWIMQ 281

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 118/279 (42%), Gaps = 54/279 (19%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIEIEVLQQ 146
           Y I  ++G G F  V +C ++      A K +         RG+   RE    E+ +L+Q
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVS--REEIEREVSILRQ 71
Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
           +  H+      + + + ++ R  + ++ E + G  L+DFL +    S   +      +Q+
Sbjct: 72  VLHHN-----VITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQI 124
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L+ + ++H   + H DLKPEN++L+    I +P                       IK+I
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKN-IPIPH----------------------IKLI 161
Query: 266 DFGSTTYERPDQ---NYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVELCTGEA 318
           DFG   +E  D      I  T  + APE++    LGL      D+WS+G I   L +G +
Sbjct: 162 DFG-LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLSGAS 216
Query: 319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
            F      E LA +  V     +         A+ ++R+
Sbjct: 217 PFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRK 255

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 74/339 (21%), Positives = 128/339 (37%), Gaps = 82/339 (24%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD 151
            T  Y++   +G G++     C  +      A+KI   I K +     EIE+L +  +H 
Sbjct: 20  FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI---IDKSKRDPTEEIEILLRYGQHP 76
Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                 + +++ +D   ++ +V E + G  L D + +  +  F       +   + + + 
Sbjct: 77  N----IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVE 130
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H   ++H DLKP N+L                       Y        +I++ DFG  
Sbjct: 131 YLHAQGVVHRDLKPSNIL-----------------------YVDESGNPESIRICDFGFA 167
Query: 271 TYERPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
              R +   +++   T ++ APEV+   G+   CDIWS+G +L  + TG   F       
Sbjct: 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN----- 222
Query: 328 HLAMMERVLGP--LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 385
                    GP   P+ +L R+          G+     G                    
Sbjct: 223 ---------GPDDTPEEILARIG--------SGKFSLSGG-------------------Y 246
Query: 386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
              V  +A D   L+  +L  DP  RLTA   LRHP+  
Sbjct: 247 WNSVSDTAKD---LVSKMLHVDPHQRLTAALVLRHPWIV 282

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 73/326 (22%), Positives = 129/326 (39%), Gaps = 78/326 (23%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+GEG+ G V     R   ++VA+K +   K+ R   +    V+ +  +H+      V++
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN----VVEM 136
Query: 161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
            N +   + + +V E L G +L D +          + +  +   +L+ ++ +H   +IH
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLQALSVLHAQGVIH 193
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            D+K +++LL     +K+ D+       K                        E P +  
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFCAQVSK------------------------EVPRRKX 229
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 339
           +V T ++ APE+I  L +    DIWS+G +++E+  GE  +     L+ + M+       
Sbjct: 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI------- 282
Query: 340 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 399
                              R + P               PRL+NL        +  L   
Sbjct: 283 -------------------RDNLP---------------PRLKNL-----HKVSPSLKGF 303
Query: 400 LQGLLRYDPTDRLTAREALRHPFFTR 425
           L  LL  DP  R TA E L+HPF  +
Sbjct: 304 LDRLLVRDPAQRATAAELLKHPFLAK 329

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 54/285 (18%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIE 140
           EN+   Y    ++G G F  V +C ++      A K +         RG+   RE    E
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVS--REDIERE 64
Query: 141 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR 199
           + +L+++   +      + +   ++ +  + ++ E + G  L+DFL +    S   +   
Sbjct: 65  VSILKEIQHPN-----VITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E  +Q+L  + ++H L + H DLKPEN++L+                       + +PK 
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIMLLD----------------------RNVPKP 155
Query: 260 SAIKVIDFG---STTYERPDQNYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVE 312
             IK+IDFG      +    +N I  T  + APE++    LGL      D+WS+G I   
Sbjct: 156 R-IKIIDFGLAHKIDFGNEFKN-IFGTPAFVAPEIVNYEPLGL----EADMWSIGVITYI 209
Query: 313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           L +G + F      E LA +  V               A+ ++RR
Sbjct: 210 LLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 254

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 109/236 (46%), Gaps = 42/236 (17%)
Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAM-IEIEVLQQ 146
            E++   Y     +G G F +V+   D+  +++VAIK I +   + +E +M  EI VL +
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHK 72
Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIAR-- 203
           + KH       V + + ++   H+ ++ + + G  L+D + +  + +      R+ +R  
Sbjct: 73  I-KH----PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYT-----ERDASRLI 122
Query: 204 -QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
            Q+L+ + ++HDL ++H DLKPEN+L  S                        + + S I
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLLYYS------------------------LDEDSKI 158
Query: 263 KVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            + DFG +  E P    +    T  Y APEV+    ++   D WS+G I   L  G
Sbjct: 159 MISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 80/346 (23%), Positives = 139/346 (40%), Gaps = 87/346 (25%)
Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAM-IEIEVLQQ 146
            E++   Y     +G G F +V+   D+  +++VAIK I +   + +E +M  EI VL +
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHK 72
Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIAR-- 203
           + KH       V + + ++   H+ ++ + + G  L+D + +  + +      R+ +R  
Sbjct: 73  I-KH----PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYT-----ERDASRLI 122
Query: 204 -QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
            Q+L+ + ++HDL ++H DLKPEN+L  S                        + + S I
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLLYYS------------------------LDEDSKI 158
Query: 263 KVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
            + DFG +  E P    +    T  Y APEV+    ++   D WS+G I   L  G   F
Sbjct: 159 MISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
               +             L + +LK        Y       W +                
Sbjct: 219 YDEND-----------AKLFEQILKAEYEFDSPY-------WDD---------------- 244
Query: 381 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                   +  SA D    ++ L+  DP  R T  +AL+HP+   D
Sbjct: 245 --------ISDSAKD---FIRHLMEKDPEKRFTCEQALQHPWIAGD 279

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 80/346 (23%), Positives = 139/346 (40%), Gaps = 87/346 (25%)
Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAM-IEIEVLQQ 146
            E++   Y     +G G F +V+   D+  +++VAIK I +   + +E +M  EI VL +
Sbjct: 13  AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHK 72
Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIAR-- 203
           + KH       V + + ++   H+ ++ + + G  L+D + +  + +      R+ +R  
Sbjct: 73  I-KH----PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYT-----ERDASRLI 122
Query: 204 -QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
            Q+L+ + ++HDL ++H DLKPEN+L  S                        + + S I
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLLYYS------------------------LDEDSKI 158
Query: 263 KVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
            + DFG +  E P    +    T  Y APEV+    ++   D WS+G I   L  G   F
Sbjct: 159 MISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
               +             L + +LK        Y       W +                
Sbjct: 219 YDEND-----------AKLFEQILKAEYEFDSPY-------WDD---------------- 244
Query: 381 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                   +  SA D    ++ L+  DP  R T  +AL+HP+   D
Sbjct: 245 --------ISDSAKD---FIRHLMEKDPEKRFTCEQALQHPWIAGD 279

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 73/326 (22%), Positives = 129/326 (39%), Gaps = 78/326 (23%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+GEG+ G V     R   ++VA+K +   K+ R   +    V+ +  +H+      V++
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN----VVEM 86
Query: 161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
            N +   + + +V E L G +L D +          + +  +   +L+ ++ +H   +IH
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLQALSVLHAQGVIH 143
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            D+K +++LL     +K+ D+       K                        E P +  
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQVSK------------------------EVPRRKX 179
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 339
           +V T ++ APE+I  L +    DIWS+G +++E+  GE  +     L+ + M+       
Sbjct: 180 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI------- 232
Query: 340 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 399
                              R + P               PRL+NL        +  L   
Sbjct: 233 -------------------RDNLP---------------PRLKNL-----HKVSPSLKGF 253
Query: 400 LQGLLRYDPTDRLTAREALRHPFFTR 425
           L  LL  DP  R TA E L+HPF  +
Sbjct: 254 LDRLLVRDPAQRATAAELLKHPFLAK 279

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 80/360 (22%), Positives = 137/360 (38%), Gaps = 85/360 (23%)
Query: 74  PWREDDKDGHYMFALGENLT-------SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKI 126
           P RE  +  H  F     L        S      K+GEG+ G V     R   ++VA+K 
Sbjct: 2   PQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKK 61
Query: 127 VRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFL 185
           +   K+ R   +    V+ +  +H+      V++ N +   + + +V E L G +L D +
Sbjct: 62  MDLRKQQRRELLFNEVVIMRDYQHEN----VVEMYNSYLVGDELWVVMEFLEGGALTDIV 117
Query: 186 RKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 245
                     + +  +   +L+ ++ +H   +IH D+K +++LL     +K+ D+     
Sbjct: 118 THTRMNE---EQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 174
Query: 246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWS 305
             K                        E P +  +V T ++ APE+I  L +    DIWS
Sbjct: 175 VSK------------------------EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWS 210
Query: 306 VGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEG 365
           +G +++E+  GE  +     L+ + M+                          R + P  
Sbjct: 211 LGIMVIEMVDGEPPYFNEPPLKAMKMI--------------------------RDNLP-- 242
Query: 366 AASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                        PRL+NL        +  L   L  LL  DP  R TA E L+HPF  +
Sbjct: 243 -------------PRLKNL-----HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 284

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 124/299 (41%), Gaps = 56/299 (18%)
Query: 71  GSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--- 127
           G   +R++D + HY   +GE L          G G F  V +C  +   +  A K +   
Sbjct: 1   GMSTFRQEDVEDHY--EMGEEL----------GSGQFAIVRKCRQKGTGKEYAAKFIKKR 48
Query: 128 ------RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 180
                 RG+   RE    E+ +L+++ +H       + + + F+ +  + ++ E + G  
Sbjct: 49  RLSSSRRGVS--REEIEREVNILREI-RHPN----IITLHDIFENKTDVVLILELVSGGE 101
Query: 181 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 240
           L+DFL +    S   D   +  +Q+L+ + ++H   + H DLKPEN++L+      VP+ 
Sbjct: 102 LFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDK---NVPN- 155
Query: 241 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWT 298
                 P+             IK+IDFG          +  I  T  + APE++      
Sbjct: 156 ------PR-------------IKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLG 196
Query: 299 YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
              D+WS+G I   L +G + F      E L  +  V     +         A+ ++RR
Sbjct: 197 LEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRR 255

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/326 (22%), Positives = 129/326 (39%), Gaps = 78/326 (23%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+GEG+ G V     R   ++VA+K +   K+ R   +    V+ +  +H+      V++
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN----VVEM 82
Query: 161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
            N +   + + +V E L G +L D +          + +  +   +L+ ++ +H   +IH
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLQALSVLHAQGVIH 139
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            D+K +++LL     +K+ D+       K                        E P +  
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSK------------------------EVPRRKX 175
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 339
           +V T ++ APE+I  L +    DIWS+G +++E+  GE  +     L+ + M+       
Sbjct: 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI------- 228
Query: 340 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 399
                              R + P               PRL+NL        +  L   
Sbjct: 229 -------------------RDNLP---------------PRLKNL-----HKVSPSLKGF 249
Query: 400 LQGLLRYDPTDRLTAREALRHPFFTR 425
           L  LL  DP  R TA E L+HPF  +
Sbjct: 250 LDRLLVRDPAQRATAAELLKHPFLAK 275

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/324 (23%), Positives = 127/324 (39%), Gaps = 78/324 (24%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+GEG+ G V    ++   + VA+K +   K+ R   +    V+ +   HD      V +
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDN----VVDM 107
Query: 161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
            + +   + + +V E L G +L D +          + +  +   +L  ++++H+  +IH
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIATVCLSVLRALSYLHNQGVIH 164
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            D+K +++LL S   IK+ D+       K                        E P +  
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFCAQVSK------------------------EVPKRKX 200
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 339
           +V T ++ APEVI  L +    DIWS+G +++E+  GE     + N   L  M R+   L
Sbjct: 201 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP---PYFNEPPLQAMRRIRDSL 257
Query: 340 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 399
           P  +    D H    V RG LD                                      
Sbjct: 258 PPRV---KDLHKVSSVLRGFLDL------------------------------------- 277
Query: 400 LQGLLRYDPTDRLTAREALRHPFF 423
              +L  +P+ R TA+E L HPF 
Sbjct: 278 ---MLVREPSQRATAQELLGHPFL 298

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 85/341 (24%), Positives = 135/341 (39%), Gaps = 81/341 (23%)
Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEV-LQQLA 148
           ++T  Y+++  +G+G F  V  C         A KI+   K   R+   +E E  + +L 
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
           KH    +  V++ +         +VF+ + G  L++ +    Y S   D    I +Q+LE
Sbjct: 61  KH----SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS-EADASHCI-QQILE 114
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            +   H + ++H DLKPEN+LL S                          K +A+K+ DF
Sbjct: 115 AVLHCHQMGVVHRDLKPENLLLASK------------------------CKGAAVKLADF 150
Query: 268 GSTTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
           G     + DQ        T  Y +PEV+    +  P DIW+ G IL  L  G   F   +
Sbjct: 151 GLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDED 210
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
                           QH L        + ++ G  D+P       S +     P  +NL
Sbjct: 211 ----------------QHKLY-------QQIKAGAYDFP-------SPEWDTVTPEAKNL 240
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           I Q               +L  +P  R+TA EAL+HP+  +
Sbjct: 241 INQ---------------MLTINPAKRITAHEALKHPWVCQ 266

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/347 (22%), Positives = 130/347 (37%), Gaps = 93/347 (26%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV----------RGIKKYREAAMIEIEVLQ 145
           Y+    +G G    V  C  +   +  A+KI+            +++ REA + E+++L+
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQ 204
           +++ H       +Q+++ ++      +VF+ +    L+D+L +    +      R+I R 
Sbjct: 79  KVSGHPN----IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRA 132
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           LLE I  +H L ++H DLKPEN+LL     IK+ D+  S                     
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ------------------- 173
Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILGL------GWTYPCDIWSVGCILVELCTGEA 318
           +D G    E      +  T  Y APE+I         G+    D+WS G I+  L  G  
Sbjct: 174 LDPGEKLRE------VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227
Query: 319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 378
            F   + +  L M+                       + G  +W                
Sbjct: 228 PFWHRKQMLMLRMI------------------MSGNYQFGSPEW---------------- 253
Query: 379 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                      D  +  +  L+   L   P  R TA EAL HPFF +
Sbjct: 254 -----------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/342 (22%), Positives = 141/342 (41%), Gaps = 87/342 (25%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK 149
           + L+  +++ S++G G    V  C  +  ++  A+K+++     ++    EI VL +L+ 
Sbjct: 49  DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-KKIVRTEIGVLLRLSH 107
Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIA---RQL 205
            +      ++++  F+    I +V E + G  L+D + +  Y S      R+ A   +Q+
Sbjct: 108 PN-----IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYS-----ERDAADAVKQI 157
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           LE +A++H+  ++H DLKPEN+L  +      PD                    + +K+ 
Sbjct: 158 LEAVAYLHENGIVHRDLKPENLLYATP----APD--------------------APLKIA 193
Query: 266 DFGSTTY--ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELCTGEALFQT 322
           DFG +     +     +  T  Y APE++ G  +    D+WSVG I  + LC  E  +  
Sbjct: 194 DFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253
Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 382
             +               Q M +R+  + E Y                            
Sbjct: 254 RGD---------------QFMFRRI-LNCEYY---------------------------- 269
Query: 383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             I    D  + +   L++ L+  DP  RLT  +AL+HP+ T
Sbjct: 270 -FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/347 (22%), Positives = 130/347 (37%), Gaps = 93/347 (26%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV----------RGIKKYREAAMIEIEVLQ 145
           Y+    +G G    V  C  +   +  A+KI+            +++ REA + E+++L+
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQ 204
           +++ H       +Q+++ ++      +VF+ +    L+D+L +    +      R+I R 
Sbjct: 66  KVSGHP----NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRA 119
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           LLE I  +H L ++H DLKPEN+LL     IK+ D+  S                     
Sbjct: 120 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ------------------- 160
Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILGL------GWTYPCDIWSVGCILVELCTGEA 318
           +D G    E      +  T  Y APE+I         G+    D+WS G I+  L  G  
Sbjct: 161 LDPGEKLRE------VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 214
Query: 319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 378
            F   + +  L M+                       + G  +W                
Sbjct: 215 PFWHRKQMLMLRMI------------------MSGNYQFGSPEW---------------- 240
Query: 379 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                      D  +  +  L+   L   P  R TA EAL HPFF +
Sbjct: 241 -----------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 99/226 (43%), Gaps = 43/226 (19%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-----EAAMIEIEVLQQLAKHDKGGN 155
           K+G G FG V    +R        ++++ I K R     E    EIEVL+ L   +    
Sbjct: 29  KLGSGAFGDVHLVEERSSG---LERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN---- 81
Query: 156 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPID--LVREIARQLLECIAFM 212
             ++I   F+  +++ IV E   G  L + +     R   +    V E+ +Q++  +A+ 
Sbjct: 82  -IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKPEN+L             +S H+P              IK+IDFG    
Sbjct: 141 HSQHVVHKDLKPENILF----------QDTSPHSP--------------IKIIDFGLAEL 176
Query: 273 ERPDQNYI--VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            + D++      T  Y APEV      T+ CDIWS G ++  L TG
Sbjct: 177 FKSDEHSTNAAGTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEV-LQQLAKH 150
             Y+I   +GEG+FG+V   +     + VA+KI+  + + K      IE E+   +L +H
Sbjct: 8   GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 67
Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                  +++ +    ++ I +V E  G+ L+D++ + +  S      R   +Q++  + 
Sbjct: 68  P----HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE--QEARRFFQQIISAVE 121
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           + H   ++H DLKPEN+LL     +K+ D+  S +   D ++ K             GS 
Sbjct: 122 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKT----------SCGSP 170
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELC 314
            Y  P+   ++S + Y  PEV          D+WS G IL V LC
Sbjct: 171 NYAAPE---VISGKLYAGPEV----------DVWSCGVILYVMLC 202

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/349 (22%), Positives = 129/349 (36%), Gaps = 97/349 (27%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV----------RGIKKYREAAMIEIEVLQ 145
           Y+    +G G    V  C  +   +  A+KI+            +++ REA + E+++L+
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQ 204
           +++ H       +Q+++ ++      +VF+ +    L+D+L +    +      R+I R 
Sbjct: 79  KVSGHPN----IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRA 132
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           LLE I  +H L ++H DLKPEN+LL                                IK+
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILL---------------------------DDDMNIKL 165
Query: 265 IDFGSTTYERPDQNY--IVSTRHYRAPEVILGL------GWTYPCDIWSVGCILVELCTG 316
            DFG +    P +    +  T  Y APE+I         G+    D+WS G I+  L  G
Sbjct: 166 TDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
Query: 317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 376
              F   + +  L M+                       + G  +W              
Sbjct: 226 SPPFWHRKQMLMLRMI------------------MSGNYQFGSPEW-------------- 253
Query: 377 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                        D  +  +  L+   L   P  R TA EAL HPFF +
Sbjct: 254 -------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEV-LQQLAKH 150
             Y+I   +GEG+FG+V   +     + VA+KI+  + + K      IE E+   +L +H
Sbjct: 13  GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 72
Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                  +++ +    ++ I +V E  G+ L+D++ + +  S      R   +Q++  + 
Sbjct: 73  P----HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE--QEARRFFQQIISAVE 126
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           + H   ++H DLKPEN+LL     +K+ D+  S +   D ++ K             GS 
Sbjct: 127 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKT----------SCGSP 175
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELC 314
            Y  P+   ++S + Y  PEV          D+WS G IL V LC
Sbjct: 176 NYAAPE---VISGKLYAGPEV----------DVWSCGVILYVMLC 207

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEV-LQQLAKH 150
             Y+I   +GEG+FG+V   +     + VA+KI+  + + K      IE E+   +L +H
Sbjct: 14  GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 73
Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                  +++ +    ++ I +V E  G+ L+D++ + +  S      R   +Q++  + 
Sbjct: 74  P----HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE--QEARRFFQQIISAVE 127
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           + H   ++H DLKPEN+LL     +K+ D+  S +   D ++ K             GS 
Sbjct: 128 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKT----------SCGSP 176
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELC 314
            Y  P+   ++S + Y  PEV          D+WS G IL V LC
Sbjct: 177 NYAAPE---VISGKLYAGPEV----------DVWSCGVILYVMLC 208

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 52/278 (18%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIEIEVLQQ 146
           Y++  ++G G F  V +C  +   +  A K +         RG+   RE    E+ +L++
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVS--REEIEREVNILRE 85
Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
           + +H       + + + F+ +  + ++ E + G  L+DFL +    S   D   +  +Q+
Sbjct: 86  I-RHPN----IITLHDIFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQI 138
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L+ + ++H   + H DLKPEN++L+      VP+       P+             IK+I
Sbjct: 139 LDGVHYLHSKRIAHFDLKPENIMLLDK---NVPN-------PR-------------IKLI 175
Query: 266 DFGSTTYERPDQNY--IVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVELCTGEAL 319
           DFG          +  I  T  + APE++    LGL      D+WS+G I   L +G + 
Sbjct: 176 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGL----EADMWSIGVITYILLSGASP 231
Query: 320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           F      E L  +  V     +         A+ ++RR
Sbjct: 232 FLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRR 269

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEV-LQQLAKH 150
             Y+I   +GEG+FG+V   +     + VA+KI+  + + K      IE E+   +L +H
Sbjct: 4   GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 63
Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                  +++ +    ++ I +V E  G+ L+D++ + +  S      R   +Q++  + 
Sbjct: 64  P----HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE--QEARRFFQQIISAVE 117
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           + H   ++H DLKPEN+LL     +K+ D+  S +   D ++ K             GS 
Sbjct: 118 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKT----------SCGSP 166
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELC 314
            Y  P+   ++S + Y  PEV          D+WS G IL V LC
Sbjct: 167 NYAAPE---VISGKLYAGPEV----------DVWSCGVILYVMLC 198

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 35/220 (15%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 158
           ++G+G+FG+V +  D   +++VAIKI+     +   E    EI VL Q        +   
Sbjct: 30  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSSYVT 84
Query: 159 QIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           +    +   + + I+ E LG  S  D LR   +  F I     + +++L+ + ++H    
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQI---ATMLKEILKGLDYLHSEKK 141
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           IH D+K  NVLL     +K+ D+  +                        G  T  +  +
Sbjct: 142 IHRDIKAANVLLSEQGDVKLADFGVA------------------------GQLTDTQIKR 177
Query: 278 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 317
           N  V T  + APEVI    +    DIWS+G   +EL  GE
Sbjct: 178 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 217

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 116/274 (42%), Gaps = 44/274 (16%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIEIEVLQQ 146
           Y++  ++G G F  V +C  +   +  A K +         RG+   RE    E+ +L++
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVS--REEIEREVNILRE 64
Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
           + +H       + + + F+ +  + ++ E + G  L+DFL +    S   D   +  +Q+
Sbjct: 65  I-RHPN----IITLHDIFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQI 117
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L+ + ++H   + H DLKPEN++L+      VP+       P+             IK+I
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDK---NVPN-------PR-------------IKLI 154
Query: 266 DFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
           DFG          +  I  T  + APE++         D+WS+G I   L +G + F   
Sbjct: 155 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 214
Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
              E L  +  V     +         A+ ++RR
Sbjct: 215 TKQETLTNISAVNYDFDEEYFSNTSELAKDFIRR 248

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 92/376 (24%), Positives = 155/376 (41%), Gaps = 104/376 (27%)
Query: 61  SLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKE 120
           +L+ +G+A N  P      K+G     +GE   S +K+  K+G G +G+VL C ++    
Sbjct: 13  NLYFQGIAIN--PGMYVRKKEG----KIGE---SYFKVR-KLGSGAYGEVLLCKEKNGHS 62
Query: 121 MVAIKIVR--------------GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 166
             AIK+++               I+K+ E    EI +L+ L   +      +++ + F+ 
Sbjct: 63  EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN-----IIKLFDVFED 117
Query: 167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPE 225
           + +  +V E   G  L++ +   N   F       I +Q+L  I ++H   ++H D+KPE
Sbjct: 118 KKYFYLVTEFYEGGELFEQII--NRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPE 175
Query: 226 NVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY--IVST 283
           N+LL +         K+SL                 IK++DFG +++   D      + T
Sbjct: 176 NILLEN---------KNSLLN---------------IKIVDFGLSSFFSKDYKLRDRLGT 211
Query: 284 RHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHM 343
            +Y APEV L   +   CD+WS G I+  L  G   F                G   Q +
Sbjct: 212 AYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPPFG---------------GQNDQDI 255
Query: 344 LKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 403
           +K+V++   KY      D+ +     +  K ++KL                        +
Sbjct: 256 IKKVEKG--KYY----FDFNDWKNISDEAKELIKL------------------------M 285
Query: 404 LRYDPTDRLTAREALR 419
           L YD   R TA EAL 
Sbjct: 286 LTYDYNKRCTAEEALN 301

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 101/228 (44%), Gaps = 35/228 (15%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-EAAMIEIEVLQQLAKHDKGG 154
           ++I  ++G+G FG+V +  ++E   + A K++    +   E  M+EI++L      +   
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN--- 95
Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
              V++ + F Y N++ I+ E       D +     R      ++ + +Q L+ + ++HD
Sbjct: 96  --IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             +IH DLK  N+L      IK+ D+  S    +                      T +R
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR----------------------TIQR 191
Query: 275 PDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGE 317
            D    + T ++ APEV++        + Y  D+WS+G  L+E+   E
Sbjct: 192 RDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 237

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/228 (22%), Positives = 103/228 (45%), Gaps = 35/228 (15%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-EAAMIEIEVLQQLAKHDKGG 154
           ++I  ++G+G FG+V +  ++E   + A K++    +   E  M+EI++L      +   
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN--- 95
Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
              V++ + F Y N++ I+ E       D +     R      ++ + +Q L+ + ++HD
Sbjct: 96  --IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             +IH DLK  N+L      IK+ D+  S    K++   +R                   
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVS---AKNTRXIQR------------------- 191
Query: 275 PDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGE 317
             ++  + T ++ APEV++        + Y  D+WS+G  L+E+   E
Sbjct: 192 --RDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 237

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 94/373 (25%), Positives = 153/373 (41%), Gaps = 77/373 (20%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV-RGIKKYREAAMI--EIEVLQQLAKHDK 152
           Y+I   +G G++G V   +D+   + VAIK V R  +   +   I  EI +L +L     
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 89
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDL----VREIARQLLEC 208
                + I       + + IV E   S L    +       PI L    V+ I   LL  
Sbjct: 90  IRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKT------PIFLTEQHVKTILYNLLLG 143
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY--KSSLHTPKDSSYFKRMPKSSAIKVID 266
             F+H+  +IH DLKP N LL     +K+ D+    ++++ KD      + +    +   
Sbjct: 144 EKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPG 203
Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVI-LGLGWTYPCDIWSVGCILVELCT---------- 315
             +   ++   +++V TR YRAPE+I L   +T   DIWS GCI  EL            
Sbjct: 204 PHNKNLKKQLTSHVV-TRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPT 262
Query: 316 -------GEALF---------QTHE--NLEHLAMMERVLGPLPQHMLKRVDRH-AEKYVR 356
                  G + F         + HE  N + L ++  V+G  P+  LK + +    KY++
Sbjct: 263 NRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIK 322
Query: 357 ----RGRLDWPE--GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 410
               R  +D  +   + S+E I                          LL+ +LR++   
Sbjct: 323 LFPTRDGIDLSKKYSSISKEGID-------------------------LLESMLRFNAQK 357
Query: 411 RLTAREALRHPFF 423
           R+T  +AL HP+ 
Sbjct: 358 RITIDKALSHPYL 370

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/228 (22%), Positives = 103/228 (45%), Gaps = 35/228 (15%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-EAAMIEIEVLQQLAKHDKGG 154
           ++I  ++G+G FG+V +  ++E   + A K++    +   E  M+EI++L      +   
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN--- 95
Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
              V++ + F Y N++ I+ E       D +     R      ++ + +Q L+ + ++HD
Sbjct: 96  --IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             +IH DLK  N+L      IK+ D+  S    K++   +R                   
Sbjct: 154 NKIIHRDLKAGNILFTLDGDIKLADFGVS---AKNTRXIQR------------------- 191
Query: 275 PDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGE 317
             ++  + T ++ APEV++        + Y  D+WS+G  L+E+   E
Sbjct: 192 --RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 237

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 86/333 (25%), Positives = 132/333 (39%), Gaps = 73/333 (21%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK--HDKG 153
           Y++   +G+G F  V  C +RE  +  A+KIV  + K+  +  +  E L++ A   H   
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIV-DVAKFTSSPGLSTEDLKREASICHMLK 86
Query: 154 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPID--LVREIARQLLECIA 210
               V++   +     + +VFE + G+ L   + K     F     +     RQ+LE + 
Sbjct: 87  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 146
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           + HD  +IH D+KP  VLL S E               +S+  K      AI++ + G  
Sbjct: 147 YCHDNNIIHRDVKPHCVLLASKE---------------NSAPVKLGGFGVAIQLGESGLV 191
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
              R      V T H+ APEV+    +  P D+W  G IL  L +G         L    
Sbjct: 192 AGGR------VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG--------CLPFYG 237
Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 390
             ER+                            EG      IK   K+   Q     H+ 
Sbjct: 238 TKERLF---------------------------EGI-----IKGKYKMNPRQ---WSHIS 262
Query: 391 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
            SA D   L++ +L  DP +R+T  EAL HP+ 
Sbjct: 263 ESAKD---LVRRMLMLDPAERITVYEALNHPWL 292

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 76/339 (22%), Positives = 125/339 (36%), Gaps = 84/339 (24%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD 151
            T  Y++   +G G++     C  +      A+KI   I K +     EIE+L +  +H 
Sbjct: 20  FTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKI---IDKSKRDPTEEIEILLRYGQHP 76
Query: 152 KGGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
                 + +++ +D   ++ +V E  K G  L   LR+   + F       +   + + +
Sbjct: 77  N----IITLKDVYDDGKYVYVVTELXKGGELLDKILRQ---KFFSEREASAVLFTITKTV 129
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            ++H   ++H DLKP N+L                       Y        +I++ DFG 
Sbjct: 130 EYLHAQGVVHRDLKPSNIL-----------------------YVDESGNPESIRICDFGF 166
Query: 270 TTYERPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
               R +   + +   T ++ APEV+   G+   CDIWS+G +L    TG   F      
Sbjct: 167 AKQLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFAN---- 222
Query: 327 EHLAMMERVLGP--LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
                     GP   P+ +L R+          G+     G                   
Sbjct: 223 ----------GPDDTPEEILARIG--------SGKFSLSGG------------------- 245
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
               V  +A D   L+   L  DP  RLTA   LRHP+ 
Sbjct: 246 YWNSVSDTAKD---LVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 86/333 (25%), Positives = 132/333 (39%), Gaps = 73/333 (21%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK--HDKG 153
           Y++   +G+G F  V  C +RE  +  A+KIV  + K+  +  +  E L++ A   H   
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIV-DVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 154 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPID--LVREIARQLLECIA 210
               V++   +     + +VFE + G+ L   + K     F     +     RQ+LE + 
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           + HD  +IH D+KP  VLL S E               +S+  K      AI++ + G  
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKE---------------NSAPVKLGGFGVAIQLGESGLV 189
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
              R      V T H+ APEV+    +  P D+W  G IL  L +G         L    
Sbjct: 190 AGGR------VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG--------CLPFYG 235
Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 390
             ER+                            EG      IK   K+   Q     H+ 
Sbjct: 236 TKERLF---------------------------EGI-----IKGKYKMNPRQ---WSHIS 260
Query: 391 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
            SA D   L++ +L  DP +R+T  EAL HP+ 
Sbjct: 261 ESAKD---LVRRMLMLDPAERITVYEALNHPWL 290

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 39/222 (17%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 158
           ++G+G+FG+V +  D   KE+VAIKI+     +   E    EI VL Q        +   
Sbjct: 26  RIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-------DSPY 78
Query: 159 QIRNWFDY--RNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
             R +  Y     + I+ E LG  S  D L+           +  I R++L+ + ++H  
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEE---TYIATILREILKGLDYLHSE 135
Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
             IH D+K  NVLL     +K+ D+  +                        G  T  + 
Sbjct: 136 RKIHRDIKAANVLLSEQGDVKLADFGVA------------------------GQLTDTQI 171
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 317
            +N  V T  + APEVI    + +  DIWS+G   +EL  GE
Sbjct: 172 KRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 213

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 45/222 (20%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
            +L  +  +H+  ++H DL P N+LL  +  I + D+  +     D+             
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA------------- 188
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 322
                       ++ + V+ R YRAPE+++   G+T   D+WS GC++ E+   +ALF+ 
Sbjct: 189 ------------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236
Query: 323 HENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 381
                 L  +  V+G P  + ++      A  Y+R    + P                R 
Sbjct: 237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP---------------ARA 281
Query: 382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
              ++   D  A D   L+  +L ++P  R++  +ALRHP+F
Sbjct: 282 WTAVVPTADPVALD---LIAKMLEFNPQRRISTEQALRHPYF 320

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 45/222 (20%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
            +L  +  +H+  ++H DL P N+LL  +  I + D+  +     D+             
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA------------- 188
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 322
                       ++ + V+ R YRAPE+++   G+T   D+WS GC++ E+   +ALF+ 
Sbjct: 189 ------------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236
Query: 323 HENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 381
                 L  +  V+G P  + ++      A  Y+R    + P                R 
Sbjct: 237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP---------------ARA 281
Query: 382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
              ++   D  A D   L+  +L ++P  R++  +ALRHP+F
Sbjct: 282 WTAVVPTADPVALD---LIAKMLEFNPQRRISTEQALRHPYF 320

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/291 (23%), Positives = 121/291 (41%), Gaps = 33/291 (11%)
Query: 86  FALGENLTSRYKIHSK-MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVL 144
           F   EN  + Y + SK +G G F  V +C  +   +  A K    +KK R       E+L
Sbjct: 20  FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKF---LKKRRRGQDCRAEIL 76
Query: 145 QQLAKHD--KGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREI 201
            ++A  +  K   R + +   ++  + I ++ E   G  ++             + V  +
Sbjct: 77  HEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL 136
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            +Q+LE + ++H   ++H DLKP+N+LL            SS++   D            
Sbjct: 137 IKQILEGVYYLHQNNIVHLDLKPQNILL------------SSIYPLGD------------ 172
Query: 262 IKVIDFGST--TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
           IK++DFG +       +   I+ T  Y APE++     T   D+W++G I   L T  + 
Sbjct: 173 IKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
Query: 320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRE 370
           F   +N E    + +V     +     V + A  +++   +  PE   + E
Sbjct: 233 FVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAE 283

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 115/275 (41%), Gaps = 46/275 (16%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIEIEVLQQ 146
           Y I  ++G G F  V +C ++      A K +         RG+   RE    E+ +L+Q
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV--CREEIEREVSILRQ 71
Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
           +   +      + + + ++ R  + ++ E + G  L+DFL +    S   +      +Q+
Sbjct: 72  VLHPN-----IITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQI 124
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L+ + ++H   + H DLKPEN++L+    I +P                       IK+I
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKN-IPIPH----------------------IKLI 161
Query: 266 DFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
           DFG   +E  D      I  T  + APE++         D+WS+G I   L +G + F  
Sbjct: 162 DFG-LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
               E LA +  V     +    +    A+ ++R+
Sbjct: 221 DTKQETLANITAVSYDFDEEFFSQTSELAKDFIRK 255

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 116/267 (43%), Gaps = 38/267 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY----REAAMIEIEVLQ 145
           +N   +Y++   +G+G FG+V  C  R   +M A K +   +         A+ E ++L+
Sbjct: 183 KNTFRQYRV---LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
           ++          V +   ++ ++ +C+V   + G  L   +       FP       A +
Sbjct: 240 KV-----NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +   +  +H   +++ DLKPEN+LL    +I++ D   ++H P+                
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---------------- 338
Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
              G T   R      V T  Y APEV+    +T+  D W++GC+L E+  G++ FQ  +
Sbjct: 339 ---GQTIKGR------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHA 351
                  +ER++  +P+   +R    A
Sbjct: 390 KKIKREEVERLVKEVPEEYSERFSPQA 416

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 42/233 (18%)
Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAM-IEIEVLQQLAK 149
           N+   +     +G G F +V     R   ++ A+K ++    +R++++  EI VL+++ K
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-K 64
Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYD-FLRKNNYRSFPIDLVREIARQLLE 207
           H+      V + + ++   H  +V + + G  L+D  L +  Y      LV    +Q+L 
Sbjct: 65  HE----NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV---IQQVLS 117
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H+  ++H DLKPEN+L ++ E                        ++S I + DF
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPE------------------------ENSKIMITDF 153
Query: 268 GSTTYERPDQNYIVSTR----HYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
           G +  E   QN I+ST      Y APEV+    ++   D WS+G I   L  G
Sbjct: 154 GLSKME---QNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 80/336 (23%), Positives = 135/336 (40%), Gaps = 77/336 (22%)
Query: 96  YKIHSK-MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
           YK+ S+ +G G  G+VL+ +++  +E  A+K ++   K R     E+E L   A      
Sbjct: 63  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQDCPKARR----EVE-LHWRASQCPHI 117
Query: 155 NRCVQI-RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            R V +  N +  R  + IV E L G  L+  ++    ++F      EI + + E I ++
Sbjct: 118 VRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYL 177
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H + + H D+KPEN+L  S    K P+                    + +K+ DFG    
Sbjct: 178 HSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFAK- 212
Query: 273 ERPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
           E    N + +   T +Y APEV+    +   CD WS+G I   L  G   F ++  L   
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLA-- 270
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
                            +    +  +R G+ ++P    S  S                  
Sbjct: 271 -----------------ISPGXKTRIRXGQYEFPNPEWSEVS------------------ 295
Query: 390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                ++  L++ LL+ +PT R T  E   HP+  +
Sbjct: 296 ----EEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQ 327

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/321 (23%), Positives = 131/321 (40%), Gaps = 64/321 (19%)
Query: 88  LGENLT-SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ 146
           LG  +T + ++    +G+GTFG+V+   ++      A+KI++     +E  + + EV   
Sbjct: 1   LGSRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK-----KEVIVAKDEVAHT 55
Query: 147 LAKHDKGGNRCVQ---------IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPID 196
           L +     NR +Q         ++  F   + +C V E   G  L+  L +   R F  D
Sbjct: 56  LTE-----NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSED 108
Query: 197 LVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 255
             R    +++  + ++H +  +++ DLK EN++L    +IK+ D+       KD +  K 
Sbjct: 109 RARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX 168
Query: 256 MPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                                      T  Y APEV+    +    D W +G ++ E+  
Sbjct: 169 ------------------------FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 204
Query: 316 GEALF--QTHENLEHLAMME-----RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAAS 368
           G   F  Q HE L  L +ME     R LGP  + +L  + +   K     RL        
Sbjct: 205 GRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPK----QRL-----GGG 255
Query: 369 RESIKSVMKLPRLQNLIMQHV 389
            E  K +M+      ++ QHV
Sbjct: 256 SEDAKEIMQHRFFAGIVWQHV 276

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 116/267 (43%), Gaps = 38/267 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY----REAAMIEIEVLQ 145
           +N   +Y++   +G+G FG+V  C  R   +M A K +   +         A+ E ++L+
Sbjct: 183 KNTFRQYRV---LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
           ++          V +   ++ ++ +C+V   + G  L   +       FP       A +
Sbjct: 240 KV-----NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +   +  +H   +++ DLKPEN+LL    +I++ D   ++H P+                
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---------------- 338
Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
              G T   R      V T  Y APEV+    +T+  D W++GC+L E+  G++ FQ  +
Sbjct: 339 ---GQTIKGR------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHA 351
                  +ER++  +P+   +R    A
Sbjct: 390 KKIKREEVERLVKEVPEEYSERFSPQA 416

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 113/261 (43%), Gaps = 46/261 (17%)
Query: 94  SRYKIHSKMGEGTFGQVL---ECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAK 149
           S++++   +G+G+FG+V    +    + +++ A+K+++    K R+    ++E       
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME------- 76
Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRS-------FPIDLVREIA 202
                +  V++ + F  + H     E     + DFLR  +  +       F  + V+   
Sbjct: 77  ----RDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
            +L   +  +H L +I+ DLKPEN+LL    +IK+ D+  S    K+S            
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS----KES------------ 176
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
             ID     Y          T  Y APEV+   G T   D WS G ++ E+ TG   FQ 
Sbjct: 177 --IDHEKKAYS------FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228
Query: 323 HENLEHLAMMERVLGPLPQHM 343
            +  E + M+ +    +PQ +
Sbjct: 229 KDRKETMTMILKAKLGMPQFL 249

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 110/241 (45%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           K+  K+G G FG+V +  +++  K  VA+K ++      EA + E  V++ L +HDK   
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTL-QHDK--- 244
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             V++      +  I I+ E +   SL DFL+ +     P+  + + + Q+ E +AF+  
Sbjct: 245 -LVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
              IH DL+  N+L+ +S   K+ D+  +    +D+ Y  R      IK           
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLA-RVIEDNEYTAREGAKFPIK----------- 350
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE I    +T   D+WS G +L+E+ T G   +    N E +  +E
Sbjct: 351 -----------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
Query: 334 R 334
           R
Sbjct: 400 R 400

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/360 (21%), Positives = 138/360 (38%), Gaps = 91/360 (25%)
Query: 72  SPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RG 129
           S  W++  +D   +F   E L          G G F +V+   ++   ++ A+K +  + 
Sbjct: 10  SSSWKKQAEDIKKIFEFKETL----------GTGAFSEVVLAEEKATGKLFAVKCIPKKA 59
Query: 130 IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKN 188
           +K    +   EI VL+++ KH+      V + + ++  NH+ +V + + G  L+D + + 
Sbjct: 60  LKGKESSIENEIAVLRKI-KHE----NIVALEDIYESPNHLYLVMQLVSGGELFDRIVEK 114
Query: 189 NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 248
            +  +       + RQ+L+ + ++H + ++H DLKPEN+L  S +               
Sbjct: 115 GF--YTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQD--------------- 157
Query: 249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSV 306
                    + S I + DFG +  E      +    T  Y APEV+    ++   D WS+
Sbjct: 158 ---------EESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSI 208
Query: 307 GCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGA 366
           G I   L  G   F    +             L + +LK        Y       W +  
Sbjct: 209 GVIAYILLCGYPPFYDEND-----------SKLFEQILKAEYEFDSPY-------WDD-- 248
Query: 367 ASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                                 +  SA D    ++ L+  DP  R T  +A RHP+   D
Sbjct: 249 ----------------------ISDSAKD---FIRNLMEKDPNKRYTCEQAARHPWIAGD 283

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 63/306 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ-- 159
           +G+GTFG+V+   ++      A+KI++     +E  + + EV   L +     NR +Q  
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILK-----KEVIVAKDEVAHTLTE-----NRVLQNS 67
Query: 160 -------IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                  ++  F   + +C V E   G  L+  L +   R F  D  R    +++  + +
Sbjct: 68  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDY 125
Query: 212 MH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           +H +  +++ DLK EN++L    +IK+ D+       KD +  K                
Sbjct: 126 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX--------------- 170
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEH 328
                       T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  
Sbjct: 171 ---------FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 221
Query: 329 LAMME-----RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
           L +ME     R LGP  + +L  + +   K     RL         E  K +M+      
Sbjct: 222 LILMEEIRFPRTLGPEAKSLLSGLLKKDPK----QRL-----GGGSEDAKEIMQHRFFAG 272
Query: 384 LIMQHV 389
           ++ QHV
Sbjct: 273 IVWQHV 278

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/306 (24%), Positives = 126/306 (41%), Gaps = 63/306 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ-- 159
           +G+GTFG+V+   ++      A+KI++     +E  + + EV   L +     NR +Q  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILK-----KEVIVAKDEVAHTLTE-----NRVLQNS 205
Query: 160 -------IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                  ++  F   + +C V E   G  L+  L +   R F  D  R    +++  + +
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDY 263
Query: 212 MH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           +H +  +++ DLK EN++L    +IK+ D+       KD +  K                
Sbjct: 264 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--------------- 308
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEH 328
                       T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  
Sbjct: 309 ---------FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359
Query: 329 LAMME-----RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
           L +ME     R LGP  + +L  + +   K     RL    G  S E  K +M+      
Sbjct: 360 LILMEEIRFPRTLGPEAKSLLSGLLKKDPKQ----RL----GGGS-EDAKEIMQHRFFAG 410
Query: 384 LIMQHV 389
           ++ QHV
Sbjct: 411 IVWQHV 416

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 63/306 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ-- 159
           +G+GTFG+V+   ++      A+KI++     +E  + + EV   L +     NR +Q  
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILK-----KEVIVAKDEVAHTLTE-----NRVLQNS 66
Query: 160 -------IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                  ++  F   + +C V E   G  L+  L +   R F  D  R    +++  + +
Sbjct: 67  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDY 124
Query: 212 MH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           +H +  +++ DLK EN++L    +IK+ D+       KD +  K                
Sbjct: 125 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX--------------- 169
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEH 328
                       T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  
Sbjct: 170 ---------FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 220
Query: 329 LAMME-----RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
           L +ME     R LGP  + +L  + +   K     RL         E  K +M+      
Sbjct: 221 LILMEEIRFPRTLGPEAKSLLSGLLKKDPK----QRL-----GGGSEDAKEIMQHRFFAG 271
Query: 384 LIMQHV 389
           ++ QHV
Sbjct: 272 IVWQHV 277

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 115/274 (41%), Gaps = 57/274 (20%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA---------AMIEIEV 143
           + +Y   S +G G FG V    D+E+ + V +K ++  K   +            +EI +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 144 LQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 203
           L ++   +      +++ + F+ +    +V EK GS L  F   + +      L   I R
Sbjct: 83  LSRVEHAN-----IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           QL+  + ++    +IH D+K EN+++                            +   IK
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIA---------------------------EDFTIK 170
Query: 264 VIDFGSTTY-ERPDQNY-IVSTRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALF 320
           +IDFGS  Y ER    Y    T  Y APEV++G  +  P  ++WS+G  L  L   E  F
Sbjct: 171 LIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230
Query: 321 -QTHENLEH------------LAMMERVLGPLPQ 341
            +  E +E             ++++  +L P+P+
Sbjct: 231 CELEETVEAAIHPPYLVSKELMSLVSGLLQPVPE 264

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/306 (24%), Positives = 126/306 (41%), Gaps = 63/306 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ-- 159
           +G+GTFG+V+   ++      A+KI++     +E  + + EV   L +     NR +Q  
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILK-----KEVIVAKDEVAHTLTE-----NRVLQNS 208
Query: 160 -------IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                  ++  F   + +C V E   G  L+  L +   R F  D  R    +++  + +
Sbjct: 209 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDY 266
Query: 212 MH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           +H +  +++ DLK EN++L    +IK+ D+       KD +  K                
Sbjct: 267 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--------------- 311
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEH 328
                       T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  
Sbjct: 312 ---------FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 362
Query: 329 LAMME-----RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
           L +ME     R LGP  + +L  + +   K     RL    G  S E  K +M+      
Sbjct: 363 LILMEEIRFPRTLGPEAKSLLSGLLKKDPKQ----RL----GGGS-EDAKEIMQHRFFAG 413
Query: 384 LIMQHV 389
           ++ QHV
Sbjct: 414 IVWQHV 419

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 113/261 (43%), Gaps = 46/261 (17%)
Query: 94  SRYKIHSKMGEGTFGQVL---ECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAK 149
           S++++   +G+G+FG+V    +    + +++ A+K+++    K R+    ++E       
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME------- 77
Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRS-------FPIDLVREIA 202
                +  V++ + F  + H     E     + DFLR  +  +       F  + V+   
Sbjct: 78  ----RDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 133
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
            +L   +  +H L +I+ DLKPEN+LL    +IK+ D+  S    K+S            
Sbjct: 134 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS----KES------------ 177
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
             ID     Y          T  Y APEV+   G T   D WS G ++ E+ TG   FQ 
Sbjct: 178 --IDHEKKAYS------FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 229
Query: 323 HENLEHLAMMERVLGPLPQHM 343
            +  E + M+ +    +PQ +
Sbjct: 230 KDRKETMTMILKAKLGMPQFL 250

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 108/247 (43%), Gaps = 51/247 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           +G+GT+G V    D   +  +AIK I     +Y +    EI     L KH K  N  VQ 
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEI----ALHKHLKHKN-IVQY 84
Query: 161 RNWFDYRNHICIVFEKL-GSSLYDFLR------KNNYRSFPIDLVREIARQLLECIAFMH 213
              F     I I  E++ G SL   LR      K+N ++          +Q+LE + ++H
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-----YTKQILEGLKYLH 139
Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST--- 270
           D  ++H D+K +NVL+                    ++Y      S  +K+ DFG++   
Sbjct: 140 DNQIVHRDIKGDNVLI--------------------NTY------SGVLKISDFGTSKRL 173
Query: 271 TYERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 328
               P       T  Y APE+I     G+    DIWS+GC ++E+ TG+  F  +E  E 
Sbjct: 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF--YELGEP 231
Query: 329 LAMMERV 335
            A M +V
Sbjct: 232 QAAMFKV 238

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 113/261 (43%), Gaps = 46/261 (17%)
Query: 94  SRYKIHSKMGEGTFGQVL---ECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAK 149
           S++++   +G+G+FG+V    +    + +++ A+K+++    K R+    ++E       
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME------- 76
Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRS-------FPIDLVREIA 202
                +  V++ + F  + H     E     + DFLR  +  +       F  + V+   
Sbjct: 77  ----RDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
            +L   +  +H L +I+ DLKPEN+LL    +IK+ D+  S    K+S            
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS----KES------------ 176
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
             ID     Y          T  Y APEV+   G T   D WS G ++ E+ TG   FQ 
Sbjct: 177 --IDHEKKAYS------FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228
Query: 323 HENLEHLAMMERVLGPLPQHM 343
            +  E + M+ +    +PQ +
Sbjct: 229 KDRKETMTMILKAKLGMPQFL 249

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 83/343 (24%), Positives = 135/343 (39%), Gaps = 83/343 (24%)
Query: 90  ENL--TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEV-LQ 145
           ENL   S Y++  ++G+G F  V  C      +  A KI+   K   R+   +E E  + 
Sbjct: 16  ENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARIC 75
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
           +L KH       V++ +      H  ++F+ + G  L++ +    Y S   D    I +Q
Sbjct: 76  RLLKHPN----IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS-EADASHCI-QQ 129
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +LE +   H + ++H DLKPEN+LL S                          K +A+K+
Sbjct: 130 ILEAVLHCHQMGVVHRDLKPENLLLASK------------------------LKGAAVKL 165
Query: 265 IDFGSTTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
            DFG       +Q        T  Y +PEV+    +  P D+W+ G IL  L  G   F 
Sbjct: 166 ADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW 225
Query: 322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 381
             +                QH L        + ++ G  D+P               P  
Sbjct: 226 DED----------------QHRLY-------QQIKAGAYDFPS--------------PEW 248
Query: 382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
             +  +  D        L+  +L  +P+ R+TA EAL+HP+ +
Sbjct: 249 DTVTPEAKD--------LINKMLTINPSKRITAAEALKHPWIS 283

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/347 (21%), Positives = 132/347 (38%), Gaps = 91/347 (26%)
Query: 88  LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-----EIE 142
           +GE +   +K+ + +G+G+F  V           VAIK++     Y+ A M+     E++
Sbjct: 6   IGEKIED-FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK-AGMVQRVQNEVK 63
Query: 143 VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIA 202
           +  QL KH       +++ N+F+  N++ +V E   +   +   KN  + F  +  R   
Sbjct: 64  IHCQL-KHPS----ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM 118
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY--KSSLHTPKDSSYFKRMPKSS 260
            Q++  + ++H   ++H DL   N+LL  +  IK+ D+   + L  P +  Y        
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY-------- 170
Query: 261 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
                              +  T +Y +PE+          D+WS+GC+   L  G   F
Sbjct: 171 ------------------TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF 212
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
            T                                               +++K+ +    
Sbjct: 213 DT-----------------------------------------------DTVKNTLNKVV 225
Query: 381 LQNLIM-QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
           L +  M   +   A DL H    LLR +P DRL+    L HPF +R+
Sbjct: 226 LADYEMPSFLSIEAKDLIH---QLLRRNPADRLSLSSVLDHPFMSRN 269

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 108/241 (44%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           K+  K+G G FG+V +  +++  K  VA+K ++      EA + E  V++ L +HDK   
Sbjct: 18  KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVK 74
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
               +      +  I I+ E +   SL DFL+ +     P+  + + + Q+ E +AF+  
Sbjct: 75  LHAVVT-----KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 129
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
              IH DL+  N+L+ +S   K+ D+  +    +D+ Y  R      IK           
Sbjct: 130 RNYIHRDLRAANILVSASLVCKIADFGLA-RVIEDNEYTAREGAKFPIK----------- 177
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE I    +T   D+WS G +L+E+ T G   +    N E +  +E
Sbjct: 178 -----------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 226
Query: 334 R 334
           R
Sbjct: 227 R 227

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 108/247 (43%), Gaps = 51/247 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           +G+GT+G V    D   +  +AIK I     +Y +    EI     L KH K  N  VQ 
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEI----ALHKHLKHKN-IVQY 70
Query: 161 RNWFDYRNHICIVFEKL-GSSLYDFLR------KNNYRSFPIDLVREIARQLLECIAFMH 213
              F     I I  E++ G SL   LR      K+N ++          +Q+LE + ++H
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-----YTKQILEGLKYLH 125
Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST--- 270
           D  ++H D+K +NVL+                    ++Y      S  +K+ DFG++   
Sbjct: 126 DNQIVHRDIKGDNVLI--------------------NTY------SGVLKISDFGTSKRL 159
Query: 271 TYERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 328
               P       T  Y APE+I     G+    DIWS+GC ++E+ TG+  F  +E  E 
Sbjct: 160 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF--YELGEP 217
Query: 329 LAMMERV 335
            A M +V
Sbjct: 218 QAAMFKV 224

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 80/332 (24%), Positives = 132/332 (39%), Gaps = 85/332 (25%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKY-REAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G F +  E  D + KE+ A KIV     +K + RE   +EI + + LA         
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-----HV 103
Query: 158 VQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V    +F+  + + +V E     SL +  ++    + P    R   RQ++    ++H   
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP--EARYYLRQIVLGCQYLHRNR 161
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +IH DLK  N+ L     +K+ D+                    A KV       Y+   
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDF------------------GLATKV------EYDGER 197
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 336
           +  +  T +Y APEV+   G ++  D+WS+GCI+  L  G+  F+T              
Sbjct: 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-------------- 243
Query: 337 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 396
                  LK      E Y+R  + ++                      I +H++  A   
Sbjct: 244 -----SCLK------ETYLRIKKNEYS---------------------IPKHINPVAAS- 270
Query: 397 THLLQGLLRYDPTDRLTAREALRHPFFTRDHL 428
             L+Q +L+ DPT R T  E L   FFT  ++
Sbjct: 271 --LIQKMLQTDPTARPTINELLNDEFFTSGYI 300

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 80/332 (24%), Positives = 132/332 (39%), Gaps = 85/332 (25%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKY-REAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G F +  E  D + KE+ A KIV     +K + RE   +EI + + LA         
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-----HV 101
Query: 158 VQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V    +F+  + + +V E     SL +  ++    + P    R   RQ++    ++H   
Sbjct: 102 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP--EARYYLRQIVLGCQYLHRNR 159
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +IH DLK  N+ L     +K+ D+                    A KV       Y+   
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDF------------------GLATKV------EYDGER 195
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 336
           +  +  T +Y APEV+   G ++  D+WS+GCI+  L  G+  F+T              
Sbjct: 196 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-------------- 241
Query: 337 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 396
                  LK      E Y+R  + ++                      I +H++  A   
Sbjct: 242 -----SCLK------ETYLRIKKNEYS---------------------IPKHINPVAAS- 268
Query: 397 THLLQGLLRYDPTDRLTAREALRHPFFTRDHL 428
             L+Q +L+ DPT R T  E L   FFT  ++
Sbjct: 269 --LIQKMLQTDPTARPTINELLNDEFFTSGYI 298

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 39/222 (17%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 158
           K+G+G+FG+V +  D   +++VAIKI+     +   E    EI VL Q            
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYVT 83
Query: 159 QIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQLLECIAFMHDL 215
           +    +     + I+ E LG  S  D L        P+D   +  I R++L+ + ++H  
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 138
Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
             IH D+K  NVLL     +K+ D+  +                        G  T  + 
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVA------------------------GQLTDTQI 174
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 317
            +N  V T  + APEVI    +    DIWS+G   +EL  GE
Sbjct: 175 KRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 82/335 (24%), Positives = 135/335 (40%), Gaps = 91/335 (27%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKY-REAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G F +  E  D + KE+ A KIV     +K + RE   +EI + + LA         
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-----HV 83
Query: 158 VQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V    +F+  + + +V E     SL +  ++    + P    R   RQ++    ++H   
Sbjct: 84  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP--EARYYLRQIVLGCQYLHRNR 141
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT---YE 273
           +IH DLK  N+ L  +E ++V                         K+ DFG  T   Y+
Sbjct: 142 VIHRDLKLGNLFL--NEDLEV-------------------------KIGDFGLATKVEYD 174
Query: 274 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
              +  +  T +Y APEV+   G ++  D+WS+GCI+  L  G+  F+T           
Sbjct: 175 GERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET----------- 223
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 393
                     LK      E Y+R  + ++                      I +H++  A
Sbjct: 224 --------SCLK------ETYLRIKKNEYS---------------------IPKHINPVA 248
Query: 394 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 428
                L+Q +L+ DPT R T  E L   FFT  ++
Sbjct: 249 AS---LIQKMLQTDPTARPTINELLNDEFFTSGYI 280

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 116/275 (42%), Gaps = 44/275 (16%)
Query: 91  NLTSRYKIHSKMGEGTFGQV-LECWDRERKEMVAIKI----VRGIKKYREAAMIEIEVLQ 145
           ++   Y + + +G G++G+V +      R    A KI    V  + ++++    EIE+++
Sbjct: 23  DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ----EIEIMK 78
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQ 204
            L   +      +++   F+    I +V E   G  L++  R  + R F       I + 
Sbjct: 79  SLDHPN-----IIRLYETFEDNTDIYLVMELCTGGELFE--RVVHKRVFRESDAARIMKD 131
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +L  +A+ H L + H DLKPEN L ++      PD                    S +K+
Sbjct: 132 VLSAVAYCHKLNVAHRDLKPENFLFLTDS----PD--------------------SPLKL 167
Query: 265 IDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
           IDFG     +P +     V T +Y +P+V+ GL +   CD WS G ++  L  G   F  
Sbjct: 168 IDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSA 226
Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
             + E +  +       P+     V   AE  +RR
Sbjct: 227 PTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 261

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 116/275 (42%), Gaps = 44/275 (16%)
Query: 91  NLTSRYKIHSKMGEGTFGQV-LECWDRERKEMVAIKI----VRGIKKYREAAMIEIEVLQ 145
           ++   Y + + +G G++G+V +      R    A KI    V  + ++++    EIE+++
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ----EIEIMK 61
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQ 204
            L   +      +++   F+    I +V E   G  L++  R  + R F       I + 
Sbjct: 62  SLDHPN-----IIRLYETFEDNTDIYLVMELCTGGELFE--RVVHKRVFRESDAARIMKD 114
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +L  +A+ H L + H DLKPEN L ++      PD                    S +K+
Sbjct: 115 VLSAVAYCHKLNVAHRDLKPENFLFLTDS----PD--------------------SPLKL 150
Query: 265 IDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
           IDFG     +P +     V T +Y +P+V+ GL +   CD WS G ++  L  G   F  
Sbjct: 151 IDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSA 209
Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
             + E +  +       P+     V   AE  +RR
Sbjct: 210 PTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 39/222 (17%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 158
           K+G+G+FG+V +  D   +++VAIKI+     +   E    EI VL Q            
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYVT 68
Query: 159 QIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQLLECIAFMHDL 215
           +    +     + I+ E LG  S  D L        P+D   +  I R++L+ + ++H  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 123
Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
             IH D+K  NVLL     +K+ D+  +                        G  T  + 
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVA------------------------GQLTDTQI 159
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 317
            +N  V T  + APEVI    +    DIWS+G   +EL  GE
Sbjct: 160 KRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 39/222 (17%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 158
           K+G+G+FG+V +  D   +++VAIKI+     +   E    EI VL Q            
Sbjct: 14  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYVT 68
Query: 159 QIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQLLECIAFMHDL 215
           +    +     + I+ E LG  S  D L        P+D   +  I R++L+ + ++H  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 123
Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
             IH D+K  NVLL     +K+ D+  +                        G  T  + 
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVA------------------------GQLTDTQI 159
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 317
            +N  V T  + APEVI    +    DIWS+G   +EL  GE
Sbjct: 160 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 80/332 (24%), Positives = 132/332 (39%), Gaps = 85/332 (25%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKY-REAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G F +  E  D + KE+ A KIV     +K + RE   +EI + + LA         
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-----HV 79
Query: 158 VQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V    +F+  + + +V E     SL +  ++    + P    R   RQ++    ++H   
Sbjct: 80  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP--EARYYLRQIVLGCQYLHRNR 137
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +IH DLK  N+ L     +K+ D+                    A KV       Y+   
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDF------------------GLATKV------EYDGER 173
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 336
           +  +  T +Y APEV+   G ++  D+WS+GCI+  L  G+  F+T              
Sbjct: 174 KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-------------- 219
Query: 337 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 396
                  LK      E Y+R  + ++                      I +H++  A   
Sbjct: 220 -----SCLK------ETYLRIKKNEYS---------------------IPKHINPVAAS- 246
Query: 397 THLLQGLLRYDPTDRLTAREALRHPFFTRDHL 428
             L+Q +L+ DPT R T  E L   FFT  ++
Sbjct: 247 --LIQKMLQTDPTARPTINELLNDEFFTSGYI 276

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 80/332 (24%), Positives = 132/332 (39%), Gaps = 85/332 (25%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKY-REAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G F +  E  D + KE+ A KIV     +K + RE   +EI + + LA         
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-----HV 79
Query: 158 VQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V    +F+  + + +V E     SL +  ++    + P    R   RQ++    ++H   
Sbjct: 80  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP--EARYYLRQIVLGCQYLHRNR 137
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +IH DLK  N+ L     +K+ D+                    A KV       Y+   
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDF------------------GLATKV------EYDGER 173
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 336
           +  +  T +Y APEV+   G ++  D+WS+GCI+  L  G+  F+T              
Sbjct: 174 KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-------------- 219
Query: 337 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 396
                  LK      E Y+R  + ++                      I +H++  A   
Sbjct: 220 -----SCLK------ETYLRIKKNEYS---------------------IPKHINPVAAS- 246
Query: 397 THLLQGLLRYDPTDRLTAREALRHPFFTRDHL 428
             L+Q +L+ DPT R T  E L   FFT  ++
Sbjct: 247 --LIQKMLQTDPTARPTINELLNDEFFTSGYI 276

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 81/341 (23%), Positives = 132/341 (38%), Gaps = 81/341 (23%)
Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEV-LQQLA 148
           ++T  Y++  ++G+G F  V  C      +  A KI+   K   R+   +E E  + +L 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
           KH       V++ +         +VF+ + G  L++ +    Y S   D    I +Q+LE
Sbjct: 61  KHP----NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS-EADASHCI-QQILE 114
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            +   H   ++H DLKPEN+LL S                          K +A+K+ DF
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKS------------------------KGAAVKLADF 150
Query: 268 GSTTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
           G     + DQ        T  Y +PEV+    +  P D+W+ G IL  L  G   F   +
Sbjct: 151 GLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDED 210
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
                           QH L        + ++ G  D+P               P    +
Sbjct: 211 ----------------QHRLY-------QQIKAGAYDFPS--------------PEWDTV 233
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
             +  D        L+  +L  +P  R+TA EAL+HP+  +
Sbjct: 234 TPEAKD--------LINKMLTINPAKRITASEALKHPWICQ 266

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 39/222 (17%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 158
           K+G+G+FG+V +  D   +++VAIKI+     +   E    EI VL Q            
Sbjct: 34  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYVT 88
Query: 159 QIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQLLECIAFMHDL 215
           +    +     + I+ E LG  S  D L        P+D   +  I R++L+ + ++H  
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 143
Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
             IH D+K  NVLL     +K+ D+  +                        G  T  + 
Sbjct: 144 KKIHRDIKAANVLLSEHGEVKLADFGVA------------------------GQLTDTQI 179
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 317
            +N  V T  + APEVI    +    DIWS+G   +EL  GE
Sbjct: 180 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 221

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 80/332 (24%), Positives = 132/332 (39%), Gaps = 85/332 (25%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKY-REAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G F +  E  D + KE+ A KIV     +K + RE   +EI + + LA         
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-----HV 77
Query: 158 VQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V    +F+  + + +V E     SL +  ++    + P    R   RQ++    ++H   
Sbjct: 78  VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP--EARYYLRQIVLGCQYLHRNR 135
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +IH DLK  N+ L     +K+ D+                    A KV       Y+   
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDF------------------GLATKV------EYDGER 171
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 336
           +  +  T +Y APEV+   G ++  D+WS+GCI+  L  G+  F+T              
Sbjct: 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-------------- 217
Query: 337 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 396
                  LK      E Y+R  + ++                      I +H++  A   
Sbjct: 218 -----SCLK------ETYLRIKKNEYS---------------------IPKHINPVAAS- 244
Query: 397 THLLQGLLRYDPTDRLTAREALRHPFFTRDHL 428
             L+Q +L+ DPT R T  E L   FFT  ++
Sbjct: 245 --LIQKMLQTDPTARPTINELLNDEFFTSGYI 274

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 81/341 (23%), Positives = 132/341 (38%), Gaps = 81/341 (23%)
Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEV-LQQLA 148
           ++T  Y++  ++G+G F  V  C      +  A KI+   K   R+   +E E  + +L 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
           KH       V++ +         +VF+ + G  L++ +    Y S   D    I +Q+LE
Sbjct: 61  KHPN----IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS-EADASHCI-QQILE 114
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            +   H   ++H DLKPEN+LL S                          K +A+K+ DF
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKS------------------------KGAAVKLADF 150
Query: 268 GSTTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
           G     + DQ        T  Y +PEV+    +  P D+W+ G IL  L  G   F   +
Sbjct: 151 GLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDED 210
Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
                           QH L        + ++ G  D+P               P    +
Sbjct: 211 ----------------QHRLY-------QQIKAGAYDFPS--------------PEWDTV 233
Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
             +  D        L+  +L  +P  R+TA EAL+HP+  +
Sbjct: 234 TPEAKD--------LINKMLTINPAKRITASEALKHPWICQ 266

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 83/340 (24%), Positives = 133/340 (39%), Gaps = 81/340 (23%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEV-LQQLAK 149
            T  Y++  ++G+G F  V  C  +   +  A KI+   K   R+   +E E  + +L K
Sbjct: 29  FTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLK 88
Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           H       V++ +         +VF+ + G  L++ +    Y S   D    I  Q+LE 
Sbjct: 89  HPN----IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS-EADASHCI-HQILES 142
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +  +H   ++H DLKPEN+LL S                          K +A+K+ DFG
Sbjct: 143 VNHIHQHDIVHRDLKPENLLLASK------------------------CKGAAVKLADFG 178
Query: 269 STTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
                + +Q        T  Y +PEV+    +  P DIW+ G IL  L  G   F   + 
Sbjct: 179 LAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDED- 237
Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 385
                          QH L        + ++ G  D+P       S +     P  +NLI
Sbjct: 238 ---------------QHKLY-------QQIKAGAYDFP-------SPEWDTVTPEAKNLI 268
Query: 386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
            Q               +L  +P  R+TA +AL+HP+  +
Sbjct: 269 NQ---------------MLTINPAKRITADQALKHPWVCQ 293

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 119
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+    S P    R  A Q++    +
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 177
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+  ++           
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVKGATWT--------- 218
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 219 --------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 35/218 (16%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE      +  +  N    ++
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKI---LDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVK 106
Query: 162 NWFDYRNH--ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
             F ++++  + +V E   G  ++  LR+    S P    R  A Q++    ++H L +I
Sbjct: 107 LEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLDLI 164
Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 278
           + DLKPEN+L+    YIKV D+           + KR+           G T        
Sbjct: 165 YRDLKPENLLIDQQGYIKVADF----------GFAKRVK----------GRTWX------ 198
Query: 279 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 98
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+    S P    R  A Q++    +
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 156
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 196
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 197 X-------LAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V+++L +H+K   
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 323
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +   SL DFL+    +   +  + ++A Q+   +A++  
Sbjct: 324 -LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL+  N+L+  +   KV D+  +    +D+ Y  R      IK           
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIK----------- 429
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 430 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
Query: 334 R 334
           R
Sbjct: 479 R 479

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+    +E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 103
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E + G  ++  LR+    S P    R  A Q++    ++H L 
Sbjct: 104 VKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLD 161
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+L+    YI+V D+           + KR+           G T      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTWX---- 197
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 198 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+    +E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 103
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E + G  ++  LR+    S P    R  A Q++    ++H L 
Sbjct: 104 VKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLD 161
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+L+    YI+V D+           + KR+           G T      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTWX---- 197
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 198 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+    +E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 103
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E + G  ++  LR+    S P    R  A Q++    ++H L 
Sbjct: 104 VKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLD 161
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+L+    YI+V D+           + KR+           G T      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTWX---- 197
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 198 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/335 (21%), Positives = 132/335 (39%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++RK ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 64
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K +   F          +L   +++
Sbjct: 65  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQKLS--KFDEQRTATYITELANALSY 120
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 121 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 159
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 160 -----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 214
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 215 ISRVEFTFPD------------FVTEGARD------------------------------ 232
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 233 -------LISRLLKHNPSQRPMLREVLEHPWITAN 260

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 98
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+    S P    R  A Q++    +
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 156
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 196
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 197 X-------LXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 103/228 (45%), Gaps = 33/228 (14%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEV-LQQLAKHDK 152
           Y I   +GEG+FG+V      + ++ VA+K +  + +KK      +E E+   +L +H  
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP- 69
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
                +++ +       I +V E  G  L+D++ +   +    D  R   +Q++  I + 
Sbjct: 70  ---HIIKLYDVITTPTDIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYC 124
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   ++H DLKPEN+LL  +  +K+ D+  S +   D ++ K             GS  Y
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLK----------TSCGSPNY 173
Query: 273 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
             P+   +++ + Y  PEV          D+WS G +L  +  G   F
Sbjct: 174 AAPE---VINGKLYAGPEV----------DVWSCGIVLYVMLVGRLPF 208

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 119
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+    S P    R  A Q++    +
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 177
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 217
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 218 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 49/236 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 98
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+    S P    R  A Q++    +
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 156
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 196
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                   +  T  Y APE+IL  G+    D W++G ++ E+  G   F   E ++
Sbjct: 197 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQ 245

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+     E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 103
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E + G  ++  LR+    S P    R  A Q++    ++H L 
Sbjct: 104 VKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLD 161
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+L+    YIKV D+           + KR+           G T      
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADF----------GFAKRVK----------GRTWX---- 197
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 198 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 99
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+    S P    R  A Q++    +
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 157
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 197
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 198 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 98
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+    S P    R  A Q++    +
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 156
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 196
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 197 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+     E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 103
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E + G  ++  LR+    S P    R  A Q++    ++H L 
Sbjct: 104 VKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLD 161
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+L+    YIKV D+           + KR+           G T      
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADF----------GFAKRVK----------GRTWX---- 197
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 198 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 112/271 (41%), Gaps = 38/271 (14%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD 151
           L  +Y I   +G G FG V  C +   K+    K V+     +     EI +L  +A+H 
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILN-IARH- 60
Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIA---RQLLEC 208
                 + +   F+    + ++FE +  S  D   + N  +F ++  REI     Q+ E 
Sbjct: 61  ---RNILHLHESFESMEELVMIFEFI--SGLDIFERINTSAFELN-EREIVSYVHQVCEA 114
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           + F+H   + H D++PEN++           Y++               +SS IK+I+FG
Sbjct: 115 LQFLHSHNIGHFDIRPENII-----------YQTR--------------RSSTIKIIEFG 149
Query: 269 STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
                +P  N+  + +   Y APEV      +   D+WS+G ++  L +G   F    N 
Sbjct: 150 QARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209
Query: 327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
           + +  +        +   K +   A  +V R
Sbjct: 210 QIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 98
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+    S P    R  A Q++    +
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 156
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 196
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 197 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 108/249 (43%), Gaps = 36/249 (14%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           + I   +G+G FG V    +R+ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVL--FKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K +   F          +L   +++
Sbjct: 72  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQKLS--RFDEQRTATYITELANALSY 127
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 128 CHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR--------------------- 166
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                ++ +  T  Y  PE+I G       D+WS+G +  E   G   F+ H   E    
Sbjct: 167 -----RDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRR 221
Query: 332 MERVLGPLP 340
           + RV    P
Sbjct: 222 ISRVEFTFP 230

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+    +E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 104
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E + G  ++  LR+    S P    R  A Q++    ++H L 
Sbjct: 105 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLD 162
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+L+    YI+V D+           + KR+           G T      
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTWX---- 198
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 199 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 98
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+    S P    R  A Q++    +
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 156
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 196
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 197 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+    +E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 104
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E + G  ++  LR+    S P    R  A Q++    ++H L 
Sbjct: 105 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLD 162
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+L+    YI+V D+           + KR+           G T      
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTWX---- 198
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 199 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 99
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+    S P    R  A Q++    +
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 157
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 197
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 198 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 98
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+    S P    R  A Q++    +
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 156
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 196
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 197 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 78/345 (22%), Positives = 134/345 (38%), Gaps = 78/345 (22%)
Query: 96  YKIHSKM-GEGTFGQVLECWDRERKEMVAIKIV-RGIKKYREAAMIEIEVLQQLAKHDKG 153
           YK+ S++ GEG + +V      +  +  A+KI+ +     R     E+E L Q     +G
Sbjct: 14  YKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQC----QG 69
Query: 154 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
               +++  +F+      +VFEKL G S+   ++K  +  F       + R +   + F+
Sbjct: 70  NKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH--FNEREASRVVRDVAAALDFL 127
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF--GS- 269
           H   + H DLKPEN+L  S E                        K S +K+ DF  GS 
Sbjct: 128 HTKGIAHRDLKPENILCESPE------------------------KVSPVKICDFDLGSG 163
Query: 270 -------TTYERPDQNYIVSTRHYRAPEVI-----LGLGWTYPCDIWSVGCILVELCTGE 317
                  T    P+      +  Y APEV+         +   CD+WS+G +L  + +G 
Sbjct: 164 MKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGY 223
Query: 318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 377
             F  H   +         G     + +       + ++ G+ ++P+   +         
Sbjct: 224 PPFVGHCGAD--------CGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWA--------- 266
Query: 378 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
                     H+   A D   L+  LL  D   RL+A + L+HP+
Sbjct: 267 ----------HISSEAKD---LISKLLVRDAKQRLSAAQVLQHPW 298

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 98/228 (42%), Gaps = 35/228 (15%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-EAAMIEIEVLQQLAKHDKGG 154
           ++I  ++G+G FG+V +  ++E   + A K++    +   E  ++EIE+L          
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-----DH 75
Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
              V++   + +   + I+ E       D +     R      ++ + RQ+LE + F+H 
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             +IH DLK  NVL+     I++ D+  S    K                      T ++
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK----------------------TLQK 173
Query: 275 PDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGE 317
            D    + T ++ APEV++        + Y  DIWS+G  L+E+   E
Sbjct: 174 RDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 35/228 (15%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-EAAMIEIEVLQQLAKHDKGG 154
           ++I  ++G+G FG+V +  ++E   + A K++    +   E  ++EIE+L     H    
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT-CDHP--- 68
Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
              V++   + +   + I+ E       D +     R      ++ + RQ+LE + F+H 
Sbjct: 69  -YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 127
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             +IH DLK  NVL+     I++ D+  S    K                      T ++
Sbjct: 128 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK----------------------TLQK 165
Query: 275 PDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGE 317
            D    + T ++ APEV++        + Y  DIWS+G  L+E+   E
Sbjct: 166 RDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 211

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 46/246 (18%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKG 153
           +Y    K+G+G  G V    D    + VAI+ +   ++ ++  +I EI V+++       
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE------- 73
Query: 154 GNRCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
            N+   I N+ D     + + +V E L G SL D + +       I  V    R+ L+ +
Sbjct: 74  -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQAL 129
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            F+H   +IH D+K +N+LL                               ++K+ DFG 
Sbjct: 130 EFLHSNQVIHRDIKSDNILL---------------------------GMDGSVKLTDFGF 162
Query: 270 TTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
                P+Q   + +V T ++ APEV+    +    DIWS+G + +E+  GE  +     L
Sbjct: 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222
Query: 327 EHLAMM 332
             L ++
Sbjct: 223 RALYLI 228

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+    +E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 96
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E + G  ++  LR+    S P    R  A Q++    ++H L 
Sbjct: 97  VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLD 154
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+L+    YI+V D+           + KR+           G T      
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTWX---- 190
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 191 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 108/241 (44%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  ++G G FG+V +  W+   K  VAIK ++      E+ + E +++++L KHDK   
Sbjct: 12  QLIKRLGNGQFGEVWMGTWNGNTK--VAIKTLKPGTMSPESFLEEAQIMKKL-KHDK--- 65
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +   SL DFL+    R+  +  + ++A Q+   +A++  
Sbjct: 66  -LVQLYAVVS-EEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 123
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  IH DL+  N+L+ +    K+ D+  +    +D+    R      IK           
Sbjct: 124 MNYIHRDLRSANILVGNGLICKIADFGLA-RLIEDNEXTARQGAKFPIK----------- 171
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 172 -----------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE 220
Query: 334 R 334
           R
Sbjct: 221 R 221

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 46/246 (18%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKG 153
           +Y    K+G+G  G V    D    + VAI+ +   ++ ++  +I EI V+++       
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE------- 73
Query: 154 GNRCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
            N+   I N+ D     + + +V E L G SL D + +       I  V    R+ L+ +
Sbjct: 74  -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQAL 129
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            F+H   +IH D+K +N+LL                               ++K+ DFG 
Sbjct: 130 EFLHSNQVIHRDIKSDNILL---------------------------GMDGSVKLTDFGF 162
Query: 270 TTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
                P+Q   + +V T ++ APEV+    +    DIWS+G + +E+  GE  +     L
Sbjct: 163 CAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222
Query: 327 EHLAMM 332
             L ++
Sbjct: 223 RALYLI 228

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+    +E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 104
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E   G  ++  LR+    S P    R  A Q++    ++H L 
Sbjct: 105 VKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLD 162
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+++    YIKV D+           + KR+           G T      
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDF----------GFAKRVK----------GRTWX---- 198
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 199 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 107/249 (42%), Gaps = 36/249 (14%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           + I   +G+G FG V    +R+ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVL--FKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K +   F          +L   +++
Sbjct: 72  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQKLS--RFDEQRTATYITELANALSY 127
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 128 CHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR--------------------- 166
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G   F+ H   E    
Sbjct: 167 -----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRR 221
Query: 332 MERVLGPLP 340
           + RV    P
Sbjct: 222 ISRVEFTFP 230

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 46/246 (18%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKG 153
           +Y    K+G+G  G V    D    + VAI+ +   ++ ++  +I EI V+++       
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE------- 73
Query: 154 GNRCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
            N+   I N+ D     + + +V E L G SL D + +       I  V    R+ L+ +
Sbjct: 74  -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQAL 129
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            F+H   +IH D+K +N+LL                               ++K+ DFG 
Sbjct: 130 EFLHSNQVIHRDIKSDNILL---------------------------GMDGSVKLTDFGF 162
Query: 270 TTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
                P+Q+    +V T ++ APEV+    +    DIWS+G + +E+  GE  +     L
Sbjct: 163 CAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222
Query: 327 EHLAMM 332
             L ++
Sbjct: 223 RALYLI 228

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 46/246 (18%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKG 153
           +Y    K+G+G  G V    D    + VAI+ +   ++ ++  +I EI V+++       
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE------- 74
Query: 154 GNRCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
            N+   I N+ D     + + +V E L G SL D + +       I  V    R+ L+ +
Sbjct: 75  -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQAL 130
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            F+H   +IH D+K +N+LL                               ++K+ DFG 
Sbjct: 131 EFLHSNQVIHRDIKSDNILL---------------------------GMDGSVKLTDFGF 163
Query: 270 TTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
                P+Q   + +V T ++ APEV+    +    DIWS+G + +E+  GE  +     L
Sbjct: 164 CAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 223
Query: 327 EHLAMM 332
             L ++
Sbjct: 224 RALYLI 229

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/264 (23%), Positives = 108/264 (40%), Gaps = 52/264 (19%)
Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG 153
           S +++   +G+G+FG+V               +VR + +     +  ++VL++     + 
Sbjct: 28  SHFELLKVLGQGSFGKVF--------------LVRKVTRPDSGHLYAMKVLKKATLKVRD 73
Query: 154 GNRCVQIRNWFDYRNHICIV-----FEKLGSS--LYDFLRKNNYRS-------FPIDLVR 199
             R    R+     NH  +V     F+  G    + DFLR  +  +       F  + V+
Sbjct: 74  RVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 133
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
               +L   +  +H L +I+ DLKPEN+LL    +IK+ D+  S                
Sbjct: 134 FYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS---------------- 177
Query: 260 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
              + ID     Y          T  Y APEV+   G ++  D WS G ++ E+ TG   
Sbjct: 178 --KEAIDHEKKAYS------FCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229
Query: 320 FQTHENLEHLAMMERVLGPLPQHM 343
           FQ  +  E + ++ +    +PQ +
Sbjct: 230 FQGKDRKETMTLILKAKLGMPQFL 253

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+     E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 103
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E + G  ++  LR+    S P    R  A Q++    ++H L 
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLD 161
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+L+    YIKV D+           + KR+           G T      
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADF----------GFAKRVK----------GRTWX---- 197
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 198 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 85
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+    S P    R  A Q++    +
Sbjct: 86  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 143
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 144 LHSLDLIYRDLKPENLLIDEQGYIQVTDF----------GFAKRVK----------GRTW 183
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 184 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 130/335 (38%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 93
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K     F          +L   +++
Sbjct: 94  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQK--LSKFDEQRTATYITELANALSY 149
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 150 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 188
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 189 -----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 243
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 244 ISRVEFTFPD------------FVTEGARD------------------------------ 261
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 262 -------LISRLLKHNPSQRPMLREVLEHPWITAN 289

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 73/335 (21%), Positives = 132/335 (39%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 93
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K     F          +L   +++
Sbjct: 94  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQK--LSKFDEQRTATYITELANALSY 149
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                       +
Sbjct: 150 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-----------------------S 186
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
             R D   +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 187 SRRDD---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 243
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 244 ISRVEFTFPD------------FVTEGARD------------------------------ 261
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 262 -------LISRLLKHNPSQRPMLREVLEHPWITAN 289

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 105/251 (41%), Gaps = 39/251 (15%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHD 151
           +++H  +G+G+FG+V     ++  +  AIK ++     +    E  M+E  VL    +H 
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
                   +   F  + ++  V E L  G  +Y      +   F +      A +++  +
Sbjct: 80  ----FLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGL 132
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            F+H   +++ DLK +N+LL    +IK+ D+               M K + +     G 
Sbjct: 133 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFG--------------MCKENML-----GD 173
Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLE 327
                   N    T  Y APE++LG  + +  D WS G +L E+  G++ F  Q  E L 
Sbjct: 174 AK-----TNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 228
Query: 328 HLAMMERVLGP 338
           H   M+    P
Sbjct: 229 HSIRMDNPFYP 239

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 102/233 (43%), Gaps = 36/233 (15%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHD 151
           RY     +G+G F +  E  D + KE+ A K+V     +K +++  M       ++A H 
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS-----TEIAIHK 97
Query: 152 KGGN-RCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECI 209
              N   V    +F+  + + +V E     SL +  ++    + P    R   RQ ++ +
Sbjct: 98  SLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEP--EARYFMRQTIQGV 155
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            ++H+  +IH DLK  N+ L     +K+ D+                    A K+     
Sbjct: 156 QYLHNNRVIHRDLKLGNLFLNDDMDVKIGDF------------------GLATKI----- 192
Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
             ++   +  +  T +Y APEV+   G ++  DIWS+GCIL  L  G+  F+T
Sbjct: 193 -EFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 102/233 (43%), Gaps = 36/233 (15%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHD 151
           RY     +G+G F +  E  D + KE+ A K+V     +K +++  M       ++A H 
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS-----TEIAIHK 97
Query: 152 KGGN-RCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECI 209
              N   V    +F+  + + +V E     SL +  ++    + P    R   RQ ++ +
Sbjct: 98  SLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEP--EARYFMRQTIQGV 155
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            ++H+  +IH DLK  N+ L     +K+ D+                    A K+     
Sbjct: 156 QYLHNNRVIHRDLKLGNLFLNDDMDVKIGDF------------------GLATKI----- 192
Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
             ++   +  +  T +Y APEV+   G ++  DIWS+GCIL  L  G+  F+T
Sbjct: 193 -EFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V+++L +H+K   
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 240
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +   SL DFL+    +   +  + ++A Q+   +A++  
Sbjct: 241 -LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL+  N+L+  +   KV D+  +    +D+ Y  R      IK           
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIK----------- 346
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 347 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
Query: 334 R 334
           R
Sbjct: 396 R 396

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V+++L +H+K   
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 240
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +   SL DFL+    +   +  + ++A Q+   +A++  
Sbjct: 241 -LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL+  N+L+  +   KV D+  +    +D+ Y  R      IK           
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIK----------- 346
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 347 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
Query: 334 R 334
           R
Sbjct: 396 R 396

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 78/339 (23%), Positives = 131/339 (38%), Gaps = 81/339 (23%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEV-LQQLAK 149
            T  Y++  ++G+G F  V  C      +  A  I+   K   R+   +E E  + +L K
Sbjct: 9   FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK 68
Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           H       V++ +      H  ++F+ + G  L++ +    Y S   D    I +Q+LE 
Sbjct: 69  HPN----IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS-EADASHCI-QQILEA 122
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +   H + ++H +LKPEN+LL S                          K +A+K+ DFG
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASK------------------------LKGAAVKLADFG 158
Query: 269 STTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
                  +Q        T  Y +PEV+    +  P D+W+ G IL  L  G   F   + 
Sbjct: 159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED- 217
Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 385
                          QH L        + ++ G  D+P               P    + 
Sbjct: 218 ---------------QHRLY-------QQIKAGAYDFPS--------------PEWDTVT 241
Query: 386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
            +  D        L+  +L  +P+ R+TA EAL+HP+ +
Sbjct: 242 PEAKD--------LINKMLTINPSKRITAAEALKHPWIS 272

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+     E     A+KI   + K +   + EIE       H     R +Q  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKI---LDKQKVVKLKEIE-------HTLNEKRILQAV 98
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E   G  ++  LR+    S P    R  A Q++    +
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 156
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+++    YIKV                            DFG   
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIKV---------------------------TDFGLAK 189
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
             +     +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 73/335 (21%), Positives = 132/335 (39%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K     F          +L   +++
Sbjct: 73  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQK--LSKFDEQRTATYITELANALSY 128
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                       +
Sbjct: 129 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-----------------------S 165
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
             R D   +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 166 SRRTD---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 222
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 223 ISRVEFTFPD------------FVTEGARD------------------------------ 240
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 241 -------LISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V+++L +H+K   
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 240
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +   SL DFL+    +   +  + ++A Q+   +A++  
Sbjct: 241 -LVQLYAVVS-EEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL+  N+L+  +   KV D+  +    +D+ Y  R      IK           
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIK----------- 346
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 347 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
Query: 334 R 334
           R
Sbjct: 396 R 396

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V+++L +H+K   
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 74
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +   SL DFL+    +   +  + ++A Q+   +A++  
Sbjct: 75  -LVQLYAVVS-EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL+  N+L+  +   KV D+  +    +D+ Y  R      IK           
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIK----------- 180
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 181 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 334 R 334
           R
Sbjct: 230 R 230

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 131/335 (39%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K     F          +L   +++
Sbjct: 69  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQK--LSKFDEQRTATYITELANALSY 124
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 125 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 163
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                ++ +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 164 -----RDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 218
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 219 ISRVEFTFPD------------FVTEGARD------------------------------ 236
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 237 -------LISRLLKHNPSQRPMLREVLEHPWITAN 264

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 98
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+    S P    R  A Q++    +
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 156
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 196
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ ++  G
Sbjct: 197 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 74/332 (22%), Positives = 130/332 (39%), Gaps = 80/332 (24%)
Query: 99  HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 158
           + K+GEG+ G V    ++     VA+K++   K+ R   +    V+ +  +H       V
Sbjct: 50  YVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH----FNVV 105
Query: 159 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           ++   +     + ++ E L G +L D + +       I  V E    +L+ +A++H   +
Sbjct: 106 EMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCE---AVLQALAYLHAQGV 162
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           IH D+K +++LL     +K+ D+       KD                         P +
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV------------------------PKR 198
Query: 278 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 337
             +V T ++ APEVI    +    DIWS+G +++E+  GE  + +               
Sbjct: 199 KXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS------------- 245
Query: 338 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD-L 396
             P   +KR+             D P               P+L+N       H     L
Sbjct: 246 --PVQAMKRLR------------DSPP--------------PKLKN------SHKVSPVL 271
Query: 397 THLLQGLLRYDPTDRLTAREALRHPFFTRDHL 428
              L+ +L  DP +R TA+E L HPF  +  L
Sbjct: 272 RDFLERMLVRDPQERATAQELLDHPFLLQTGL 303

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V+++L +H+K   
Sbjct: 14  RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 67
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +   SL DFL+    +   +  + ++A Q+   +A++  
Sbjct: 68  -LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 125
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL+  N+L+  +   KV D+  +    +D+ Y  R      IK           
Sbjct: 126 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIK----------- 173
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 174 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 222
Query: 334 R 334
           R
Sbjct: 223 R 223

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 130/335 (38%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 84
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K     F          +L   +++
Sbjct: 85  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQK--LSKFDEQRTATYITELANALSY 140
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 141 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 179
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 180 -----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 234
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 235 ISRVEFTFPD------------FVTEGARD------------------------------ 252
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 253 -------LISRLLKHNPSQRPMLREVLEHPWITAN 280

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+     E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 104
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E + G  ++  LR+    S P    R  A Q++    ++H L 
Sbjct: 105 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLD 162
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+L+    YI+V D+           + KR+   +                
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVKGRTWT-------------- 198
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 199 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 98
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+    + P    R  A Q++    +
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEP--HARFYAAQIVLTFEY 156
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 196
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 197 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 130/335 (38%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K     F          +L   +++
Sbjct: 68  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQK--LSKFDEQRTATYITELANALSY 123
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 162
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 163 -----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 217
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 218 ISRVEFTFPD------------FVTEGARD------------------------------ 235
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 236 -------LISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 131/335 (39%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K +   F          +L   +++
Sbjct: 68  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQKLS--KFDEQRTATYITELANALSY 123
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 162
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 163 -----RTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 217
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 218 ISRVEFTFPD------------FVTEGARD------------------------------ 235
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 236 -------LISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 102/233 (43%), Gaps = 36/233 (15%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHD 151
           RY     +G+G F +  E  D + KE+ A K+V     +K +++  M       ++A H 
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS-----TEIAIHK 97
Query: 152 KGGN-RCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECI 209
              N   V    +F+  + + +V E     SL +  ++    + P    R   RQ ++ +
Sbjct: 98  SLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEP--EARYFMRQTIQGV 155
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            ++H+  +IH DLK  N+ L     +K+ D+                    A K+     
Sbjct: 156 QYLHNNRVIHRDLKLGNLFLNDDMDVKIGDF------------------GLATKI----- 192
Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
             ++   +  +  T +Y APEV+   G ++  DIWS+GCIL  L  G+  F+T
Sbjct: 193 -EFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 131/335 (39%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 71
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K +   F          +L   +++
Sbjct: 72  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQKLS--KFDEQRTATYITELANALSY 127
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 128 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 166
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 167 -----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 221
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 222 ISRVEFTFPD------------FVTEGARD------------------------------ 239
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 240 -------LISRLLKHNPSQRPMLREVLEHPWITAN 267

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 129/335 (38%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K     F          +L   +++
Sbjct: 73  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQK--LSKFDEQRTATYITELANALSY 128
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 129 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 167
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 168 -----RTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 222
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 223 ISRVEFTFPD------------FVTEGARD------------------------------ 240
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 241 -------LISRLLKHNPSQRPXLREVLEHPWITAN 268

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 130/335 (38%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K     F          +L   +++
Sbjct: 71  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQK--LSKFDEQRTATYITELANALSY 126
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 127 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 165
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 166 -----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 220
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 221 ISRVEFTFPD------------FVTEGARD------------------------------ 238
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 239 -------LISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+     E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 103
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E + G  ++  LR+    S P    R  A Q++    ++H L 
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLD 161
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+L+    YI+V D+           + KR+           G T      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTWX---- 197
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 198 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 130/335 (38%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K     F          +L   +++
Sbjct: 73  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQK--LSKFDEQRTATYITELANALSY 128
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 129 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 167
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 168 -----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 222
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 223 ISRVEFTFPD------------FVTEGARD------------------------------ 240
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 241 -------LISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/335 (21%), Positives = 132/335 (39%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K     F          +L   +++
Sbjct: 69  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQK--LSKFDEQRTATYITELANALSY 124
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                       +
Sbjct: 125 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-----------------------S 161
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
             R D   +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 162 SRRTD---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 218
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 219 ISRVEFTFPD------------FVTEGARD------------------------------ 236
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 237 -------LISRLLKHNPSQRPMLREVLEHPWITAN 264

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 106/241 (43%), Gaps = 44/241 (18%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           K+  K+G G FG+V +  +++  K  VA+K ++      EA + E  V++ L +HDK   
Sbjct: 185 KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTL-QHDK--- 238
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             V++      +  I I+ E +   SL DFL+ +     P+  + + + Q+ E +AF+  
Sbjct: 239 -LVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 296
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
              IH DL+  N+L+ +S   K+ D+              R+     IK           
Sbjct: 297 RNYIHRDLRAANILVSASLVCKIADFG-----------LARVGAKFPIK----------- 334
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE I    +T   D+WS G +L+E+ T G   +    N E +  +E
Sbjct: 335 -----------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 383
Query: 334 R 334
           R
Sbjct: 384 R 384

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 111/254 (43%), Gaps = 36/254 (14%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHD 151
           RY     +G+G F +  E  D + KE+ A K+V     +K +++  M       ++A H 
Sbjct: 27  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS-----TEIAIHK 81
Query: 152 KGGN-RCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECI 209
              N   V    +F+  + + +V E     SL +  ++    + P    R   RQ ++ +
Sbjct: 82  SLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEP--EARYFMRQTIQGV 139
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            ++H+  +IH DLK  N+ L     +K+ D+                    A K+     
Sbjct: 140 QYLHNNRVIHRDLKLGNLFLNDDMDVKIGDF------------------GLATKI----- 176
Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
             ++   +  +  T +Y APEV+   G ++  DIWS+GCIL  L  G+  F+T    E  
Sbjct: 177 -EFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETY 235
Query: 330 AMMERVLGPLPQHM 343
             +++    +P+H+
Sbjct: 236 IRIKKNEYSVPRHI 249

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 104/251 (41%), Gaps = 39/251 (15%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHD 151
           + +H  +G+G+FG+V     ++  +  AIK ++     +    E  M+E  VL    +H 
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
                   +   F  + ++  V E L  G  +Y      +   F +      A +++  +
Sbjct: 79  ----FLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGL 131
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            F+H   +++ DLK +N+LL    +IK+ D+               M K + +     G 
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFG--------------MCKENML-----GD 172
Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLE 327
                   N    T  Y APE++LG  + +  D WS G +L E+  G++ F  Q  E L 
Sbjct: 173 AK-----TNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227
Query: 328 HLAMMERVLGP 338
           H   M+    P
Sbjct: 228 HSIRMDNPFYP 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 119
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+     F     R  A Q++    +
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEY 177
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 178 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 217
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 218 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+     E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 104
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E + G  ++  LR+    S P    R  A Q++    ++H L 
Sbjct: 105 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLD 162
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+L+    YI+V D+           + KR+           G T      
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTWX---- 198
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 199 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 131/335 (39%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 66
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K +   F          +L   +++
Sbjct: 67  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQKLS--KFDEQRTATYITELANALSY 122
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 123 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 161
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 162 -----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 216
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 217 ISRVEFTFPD------------FVTEGARD------------------------------ 234
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 235 -------LISRLLKHNPSQRPMLREVLEHPWITAN 262

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+     E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 103
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E + G  ++  LR+    S P    R  A Q++    ++H L 
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLD 161
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+L+    YI+V D+           + KR+           G T      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTWX---- 197
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 198 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 100/230 (43%), Gaps = 35/230 (15%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G+G FGQV++  +       AIK +R  ++     + E+ +L  L       N    +R
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-------NHQYVVR 66
Query: 162 ---NWFDYRNHI---------CIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQL 205
               W + RN +           +F ++      +LYD +   N      +  R + RQ+
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR-LFRQI 125
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           LE ++++H   +IH DLKP N+ +  S  +K+ D+  +          K + +S  I  +
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA----------KNVHRSLDILKL 175
Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELC 314
           D  +      +    + T  Y A EV+ G G +    D++S+G I  E+ 
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 132/335 (39%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K +   F          +L   +++
Sbjct: 71  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQKLS--KFDEQRTATYITELANALSY 126
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 127 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 165
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                ++ +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 166 -----RDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 220
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 221 ISRVEFTFPD------------FVTEGARD------------------------------ 238
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 239 -------LISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 130/335 (38%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K     F          +L   +++
Sbjct: 68  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQK--LSKFDEQRTATYITELANALSY 123
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 162
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 163 -----RTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 217
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 218 ISRVEFTFPD------------FVTEGARD------------------------------ 235
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 236 -------LISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+     E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 103
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E + G  ++  LR+    S P    R  A Q++    ++H L 
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLD 161
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+L+    YI+V D+           + KR+           G T      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTWX---- 197
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 198 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/335 (21%), Positives = 131/335 (39%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K     F          +L   +++
Sbjct: 68  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQK--LSKFDEQRTATYITELANALSY 123
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---------------------- 161
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
             R D   +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 162 -RRTD---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 217
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 218 ISRVEFTFPD------------FVTEGARD------------------------------ 235
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 236 -------LISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+     E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 89
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E + G  ++  LR+    S P    R  A Q++    ++H L 
Sbjct: 90  VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLD 147
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+L+    YI+V D+           + KR+   +                
Sbjct: 148 LIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVKGRTWT-------------- 183
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 184 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 130/335 (38%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 69
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K     F          +L   +++
Sbjct: 70  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQK--LSKFDEQRTATYITELANALSY 125
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 126 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 164
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 165 -----RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 219
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 220 ISRVEFTFPD------------FVTEGARD------------------------------ 237
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 238 -------LISRLLKHNPSQRPMLREVLEHPWITAN 265

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 43/231 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           K+GEG+FG+ +     E      IK   I R   K RE +  E+ VL  + KH       
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHP----NI 85
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           VQ R  F+    + IV +   G  L+  +       F  D + +   Q+   +  +HD  
Sbjct: 86  VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-----STT 271
           ++H D+K +N+ L                            K   +++ DFG     ++T
Sbjct: 146 ILHRDIKSQNIFLT---------------------------KDGTVQLGDFGIARVLNST 178
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
            E       + T +Y +PE+     +    DIW++GC+L ELCT +  F+ 
Sbjct: 179 VELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA 227

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+     E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 98
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+    S P    R  A Q++    +
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 156
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 196
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 197 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 130/335 (38%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K     F          +L   +++
Sbjct: 71  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQK--LSKFDEQRTATYITELANALSY 126
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 127 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 165
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 166 -----RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 220
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 221 ISRVEFTFPD------------FVTEGARD------------------------------ 238
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 239 -------LISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 51/236 (21%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++I   +G G+FG+V     R      A+K+++           EI V  +  +H     
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK----------EIVVRLKQVEHTNDER 57
Query: 156 RCVQI-------RNWFDYRN--HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
             + I       R W  +++   I ++ + + G  L+  LRK+  + FP  + +  A ++
Sbjct: 58  LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEV 115
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
              + ++H   +I+ DLKPEN+LL                            K+  IK+ 
Sbjct: 116 CLALEYLHSKDIIYRDLKPENILL---------------------------DKNGHIKIT 148
Query: 266 DFGSTTYERPDQNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
           DFG   Y  PD  Y +  T  Y APEV+    +    D WS G ++ E+  G   F
Sbjct: 149 DFGFAKY-VPDVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/335 (21%), Positives = 131/335 (39%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K     F          +L   +++
Sbjct: 68  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQK--LSKFDEQRTATYITELANALSY 123
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---------------------- 161
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
             R D   +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 162 -RRTD---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 217
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 218 ISRVEFTFPD------------FVTEGARD------------------------------ 235
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 236 -------LISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 77/336 (22%), Positives = 134/336 (39%), Gaps = 98/336 (29%)
Query: 96  YKIHSK-MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
           YK+ S+ +G G  G+VL+ +++  +E  A+K+++   K R     E+E L   A      
Sbjct: 19  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVE-LHWRASQCPHI 73
Query: 155 NRCVQI-RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            R V +  N +  R  + IV E L G  L+  ++    ++F      EI + + E I ++
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG---S 269
           H + + H D+KPEN+L  S    K P+                    + +K+ DFG    
Sbjct: 134 HSINIAHRDVKPENLLYTS----KRPN--------------------AILKLTDFGFAKE 169
Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
           TT E+ D++                      CD+WS+G I+  L  G   F ++  L   
Sbjct: 170 TTGEKYDKS----------------------CDMWSLGVIMYILLCGYPPFYSNHGLA-- 205
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
                            +    +  +R G+ ++P    S  S +  M             
Sbjct: 206 -----------------ISPGMKTRIRMGQYEFPNPEWSEVSEEVKM------------- 235
Query: 390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                    L++ LL+ +PT R+T  E + HP+  +
Sbjct: 236 ---------LIRNLLKTEPTQRMTITEFMNHPWIMQ 262

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 108/241 (44%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V+++L +H+K   
Sbjct: 188 RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGNMSPEAFLQEAQVMKKL-RHEK--- 241
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +   SL DFL+    +   +  + ++A Q+   +A++  
Sbjct: 242 -LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 299
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL+  N+L+  +   KV D+       +D+ Y  R      IK           
Sbjct: 300 MNYVHRDLRAANILVGENLVCKVADFGLG-RLIEDNEYTARQGAKFPIK----------- 347
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 348 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 396
Query: 334 R 334
           R
Sbjct: 397 R 397

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 98
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+     F     R  A Q++    +
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEY 156
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 196
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 197 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V+++L +H+K   
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 74
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +   SL DFL+    +   +  + ++A Q+   +A++  
Sbjct: 75  -LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL+  N+L+  +   KV D+  +    +D+ Y  R      IK           
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIK----------- 180
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 181 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 334 R 334
           R
Sbjct: 230 R 230

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+     E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 99
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E   G  ++  LR+    S P    R  A Q++    +
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 157
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+++    YIKV D+           + KR+           G T 
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDF----------GFAKRVK----------GRTW 197
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 198 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 131/335 (39%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K +   F          +L   +++
Sbjct: 71  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQKLS--KFDEQRTATYITELANALSY 126
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 127 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 165
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 166 -----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 220
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 221 ISRVEFTFPD------------FVTEGARD------------------------------ 238
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 239 -------LISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 98
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+     F     R  A Q++    +
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEY 156
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 196
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 197 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+     E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 103
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E   G  ++  LR+    S P    R  A Q++    ++H L 
Sbjct: 104 VKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLD 161
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+++    YIKV D+           + KR+           G T      
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDF----------GFAKRVK----------GRTWX---- 197
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 198 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+     E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 99
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E   G  ++  LR+    S P    R  A Q++    +
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 157
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+++    YIKV D+           + KR+           G T 
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDF----------GFAKRVK----------GRTW 197
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 198 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 98
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+    S P    R  A Q++    +
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 156
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+++    YI+V D+           + KR+           G T 
Sbjct: 157 LHSLDLIYRDLKPENLIIDQQGYIQVTDF----------GFAKRVK----------GRTW 196
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+I+  G+    D W++G ++ E+  G
Sbjct: 197 X-------LCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 131/335 (39%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K +   F          +L   +++
Sbjct: 68  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQKLS--KFDEQRTATYITELANALSY 123
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 162
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 163 -----RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 217
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 218 ISRVEFTFPD------------FVTEGARD------------------------------ 235
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 236 -------LISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 93
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+     F     R  A Q++    +
Sbjct: 94  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEY 151
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 152 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 191
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 192 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+    +E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 96
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E + G  ++  LR+     F     R  A Q++    ++H L 
Sbjct: 97  VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSLD 154
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+L+    YI+V D+           + KR+           G T      
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTWX---- 190
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 191 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/239 (23%), Positives = 106/239 (44%), Gaps = 35/239 (14%)
Query: 88  LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEV 143
           +G+ +  RYKI  K+G G    V    D      VAIK +    + +E  +     E+  
Sbjct: 5   IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN 64
Query: 144 LQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIA 202
             QL+  +      V + +  +  +   +V E + G +L +++   ++    +D      
Sbjct: 65  SSQLSHQN-----IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAINFT 117
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
            Q+L+ I   HD+ ++H D+KP+N+L+ S++ +K+ D+  +          K + ++S  
Sbjct: 118 NQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIA----------KALSETSLT 167
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
           +              N+++ T  Y +PE   G       DI+S+G +L E+  GE  F 
Sbjct: 168 QT-------------NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 131/335 (39%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K +   F          +L   +++
Sbjct: 71  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQKLS--KFDEQRTATYITELANALSY 126
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 127 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 165
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 166 -----RXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 220
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 221 ISRVEFTFPD------------FVTEGARD------------------------------ 238
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 239 -------LISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 100/230 (43%), Gaps = 35/230 (15%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G+G FGQV++  +       AIK +R  ++     + E+ +L  L       N    +R
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-------NHQYVVR 66
Query: 162 ---NWFDYRNHI---------CIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQL 205
               W + RN +           +F ++      +LYD +   N      +  R + RQ+
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR-LFRQI 125
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           LE ++++H   +IH DLKP N+ +  S  +K+ D+  +          K + +S  I  +
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA----------KNVHRSLDILKL 175
Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELC 314
           D  +      +    + T  Y A EV+ G G +    D++S+G I  E+ 
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V+++L +H+K   
Sbjct: 10  RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 63
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +   SL DFL+    +   +  + ++A Q+   +A++  
Sbjct: 64  -LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 121
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL+  N+L+  +   KV D+  +    +D+ Y  R      IK           
Sbjct: 122 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIK----------- 169
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 170 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 218
Query: 334 R 334
           R
Sbjct: 219 R 219

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/334 (20%), Positives = 127/334 (38%), Gaps = 83/334 (24%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 154 GNRCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            N  +++  +F     + ++ E      +Y  L+K     F          +L   +++ 
Sbjct: 73  PN-ILRLYGYFHDATRVYLILEYAPRGEVYKELQK--LSKFDEQRTATYITELANALSYC 129
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   +IH D+KPEN+LL S+  +K+ D+  S+H P                         
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---------------------- 167
Query: 273 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 332
               +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    +
Sbjct: 168 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 223
Query: 333 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 392
            RV    P             +V  G  D                               
Sbjct: 224 SRVEFTFPD------------FVTEGARD------------------------------- 240
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                 L+  LL+++P+ R   RE L HP+ T +
Sbjct: 241 ------LISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 98
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+    S P    R  A Q++    +
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 156
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 196
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y AP +IL  G+    D W++G ++ E+  G
Sbjct: 197 X-------LCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 109/241 (45%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V+++L +H+K   
Sbjct: 18  RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 71
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +   SL DFL+    +   +  + +++ Q+   +A++  
Sbjct: 72  -LVQLYAVVS-EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER 129
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL+  N+L+  +   KV D+  +    +D+ Y  R      IK           
Sbjct: 130 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIK----------- 177
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 178 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 226
Query: 334 R 334
           R
Sbjct: 227 R 227

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V+++L +H+K   
Sbjct: 12  RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 65
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +   SL DFL+    +   +  + ++A Q+   +A++  
Sbjct: 66  -LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 123
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL+  N+L+  +   KV D+  +    +D+ Y  R      IK           
Sbjct: 124 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIK----------- 171
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 172 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 220
Query: 334 R 334
           R
Sbjct: 221 R 221

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 76/343 (22%), Positives = 135/343 (39%), Gaps = 79/343 (23%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           Y++   +G G    V   +   +KE VAIK +  ++K + +       + +L K  +  +
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN-LEKCQTS-------MDELLKEIQAMS 63
Query: 156 RC-----VQIRNWFDYRNHICIVFEKL-GSSLYDFLR----KNNYRSFPID--LVREIAR 203
           +C     V     F  ++ + +V + L G S+ D ++    K  ++S  +D   +  I R
Sbjct: 64  QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 123
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           ++LE + ++H    IH D+K  N+LL     +++ D+  S                    
Sbjct: 124 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG-------------- 169
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 322
               G  T  +  + + V T  + APEV+  + G+ +  DIWS G   +EL TG A +  
Sbjct: 170 ----GDITRNKVRKTF-VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 224
Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 382
           +  ++ L +  +   P                          G   +E +K   K  R  
Sbjct: 225 YPPMKVLMLTLQNDPP----------------------SLETGVQDKEMLKKYGKSFR-- 260
Query: 383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                           ++   L+ DP  R TA E LRH FF +
Sbjct: 261 ---------------KMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 98
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+     F     R  A Q++    +
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEY 156
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 196
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 197 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/334 (20%), Positives = 127/334 (38%), Gaps = 83/334 (24%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 154 GNRCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            N  +++  +F     + ++ E      +Y  L+K     F          +L   +++ 
Sbjct: 73  PN-ILRLYGYFHDATRVYLILEYAPRGEVYKELQK--LSKFDEQRTATYITELANALSYC 129
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   +IH D+KPEN+LL S+  +K+ D+  S+H P                         
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---------------------- 167
Query: 273 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 332
               +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    +
Sbjct: 168 ----RXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 223
Query: 333 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 392
            RV    P             +V  G  D                               
Sbjct: 224 SRVEFTFPD------------FVTEGARD------------------------------- 240
Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                 L+  LL+++P+ R   RE L HP+ T +
Sbjct: 241 ------LISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+     E     A+KI   + K +   + EIE       H     R +Q  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKI---LDKQKVVKLKEIE-------HTLNEKRILQAV 98
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E   G  ++  LR+    S P    R  A Q++    +
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 156
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+++    YI+V                            DFG   
Sbjct: 157 LHSLDLIYRDLKPENLMIDQQGYIQV---------------------------TDFGLAK 189
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
             +     +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 129/335 (38%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K     F          +L   +++
Sbjct: 69  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQK--LSKFDEQRTATYITELANALSY 124
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S H P                        
Sbjct: 125 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR--------------------- 163
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 164 -----RTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 218
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 219 ISRVEFTFPD------------FVTEGARD------------------------------ 236
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 237 -------LISRLLKHNPSQRPMLREVLEHPWITAN 264

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 76/343 (22%), Positives = 135/343 (39%), Gaps = 79/343 (23%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           Y++   +G G    V   +   +KE VAIK +  ++K + +       + +L K  +  +
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN-LEKCQTS-------MDELLKEIQAMS 68
Query: 156 RC-----VQIRNWFDYRNHICIVFEKL-GSSLYDFLR----KNNYRSFPID--LVREIAR 203
           +C     V     F  ++ + +V + L G S+ D ++    K  ++S  +D   +  I R
Sbjct: 69  QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           ++LE + ++H    IH D+K  N+LL     +++ D+  S                    
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG-------------- 174
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 322
               G  T  +  + + V T  + APEV+  + G+ +  DIWS G   +EL TG A +  
Sbjct: 175 ----GDITRNKVRKTF-VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229
Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 382
           +  ++ L +  +   P                          G   +E +K   K  R  
Sbjct: 230 YPPMKVLMLTLQNDPP----------------------SLETGVQDKEMLKKYGKSFR-- 265
Query: 383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                           ++   L+ DP  R TA E LRH FF +
Sbjct: 266 ---------------KMISLCLQKDPEKRPTAAELLRHKFFQK 293

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 98/236 (41%), Gaps = 36/236 (15%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 152
           + RY++   +G G FG      D++  E+VA+K +   +K  E    EI +  +  +H  
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREI-INHRSLRHPN 76
Query: 153 GGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                V+ +       H+ IV E   G  L++  R  N   F  D  R   +QL+  +++
Sbjct: 77  ----IVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 130
Query: 212 MHDLCMIHTDLKPENVLLVSSEY--IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            H + + H DLK EN LL  S    +K+ D+  S      +S     PKS+         
Sbjct: 131 AHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYS-----KASVLHSQPKSA--------- 176
Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHE 324
                      V T  Y APEV+L   +     D+WS G  L  +  G   F+  E
Sbjct: 177 -----------VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 221

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/327 (22%), Positives = 136/327 (41%), Gaps = 75/327 (22%)
Query: 72  SPPWREDDKDGHYMFALGENLTSRYKIHS---KMGEGTFGQVLECWDRERKEMVAIKIV- 127
           SP    DD D     A  E ++ + +I+S   ++G G   +V +  + E+K++ AIK V 
Sbjct: 32  SPDLGTDDDDKASSSA-NECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN 89
Query: 128 ------RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSL 181
                 + +  YR     EI  L +L +H    ++ +++ ++     +I +V E     L
Sbjct: 90  LEEADNQTLDSYRN----EIAYLNKLQQH---SDKIIRLYDYEITDQYIYMVMECGNIDL 142
Query: 182 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 241
             +L+K   +S      +   + +LE +  +H   ++H+DLKP N L+V           
Sbjct: 143 NSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----------- 189
Query: 242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI-----VSTRHYRAPEVILGLG 296
                               +K+IDFG     +PD   +     V T +Y  PE I  + 
Sbjct: 190 -----------------DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 297 WT-----------YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP------- 338
            +              D+WS+GCIL  +  G+  FQ  + +  ++ +  ++ P       
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHEIEFP 290
Query: 339 -LPQHMLKRVDRHAEKYVRRGRLDWPE 364
            +P+  L+ V +   K   + R+  PE
Sbjct: 291 DIPEKDLQDVLKCCLKRDPKQRISIPE 317

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/335 (21%), Positives = 131/335 (39%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K +   F          +L   +++
Sbjct: 68  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQKLS--KFDEQRTATYITELANALSY 123
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 124 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 162
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 163 -----RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 217
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 218 ISRVEFTFPD------------FVTEGARD------------------------------ 235
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 236 -------LISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V+++L +H+K   
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 74
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +   SL DFL+    +   +  + ++A Q+   +A++  
Sbjct: 75  -LVQLYAVVS-EEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL+  N+L+  +   KV D+  +    +D+ Y  R      IK           
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIK----------- 180
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 181 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 334 R 334
           R
Sbjct: 230 R 230

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 120/289 (41%), Gaps = 49/289 (16%)
Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           ++   +G G FG V  C  + R + VAIK +   +  R+A ++E+  L ++       N 
Sbjct: 12  EVEEVVGRGAFGVV--CKAKWRAKDVAIKQIES-ESERKAFIVELRQLSRV-------NH 61
Query: 157 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC---IAFM 212
              ++ +    N +C+V E   G SLY+ L  +     P           L+C   +A++
Sbjct: 62  PNIVKLYGACLNPVCLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 213 HDL---CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
           H +    +IH DLKP N+LLV+                            + +K+ DFG+
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAG--------------------------GTVLKICDFGT 153
Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
               +        +  + APEV  G  ++  CD++S G IL E+ T    F         
Sbjct: 154 ACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR 213
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 378
            M     G  P  ++K + +  E  + R    W +  + R S++ ++K+
Sbjct: 214 IMWAVHNGTRPP-LIKNLPKPIESLMTRC---WSKDPSQRPSMEEIVKI 258

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/244 (22%), Positives = 99/244 (40%), Gaps = 38/244 (15%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR----C 157
           +G+GTFG+V+   ++      A+KI+R     +E  + + EV   + +     N      
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILR-----KEVIIAKDEVAHTVTESRVLQNTRHPFL 70
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++  F   + +C V E   G  L+  L +   R F  +  R    +++  + ++H   
Sbjct: 71  TALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD 128
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +++ D+K EN++L    +IK+ D+        D +  K                      
Sbjct: 129 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--------------------- 167
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMMER 334
                 T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  L +ME 
Sbjct: 168 ---FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 224
Query: 335 VLGP 338
           +  P
Sbjct: 225 IRFP 228

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/244 (22%), Positives = 99/244 (40%), Gaps = 38/244 (15%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR----C 157
           +G+GTFG+V+   ++      A+KI+R     +E  + + EV   + +     N      
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILR-----KEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++  F   + +C V E   G  L+  L +   R F  +  R    +++  + ++H   
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD 125
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +++ D+K EN++L    +IK+ D+        D +  K                      
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--------------------- 164
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMMER 334
                 T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  L +ME 
Sbjct: 165 ---FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221
Query: 335 VLGP 338
           +  P
Sbjct: 222 IRFP 225

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/244 (22%), Positives = 99/244 (40%), Gaps = 38/244 (15%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR----C 157
           +G+GTFG+V+   ++      A+KI+R     +E  + + EV   + +     N      
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILR-----KEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++  F   + +C V E   G  L+  L +   R F  +  R    +++  + ++H   
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD 125
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +++ D+K EN++L    +IK+ D+        D +  K                      
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX--------------------- 164
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMMER 334
                 T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  L +ME 
Sbjct: 165 ---FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221
Query: 335 VLGP 338
           +  P
Sbjct: 222 IRFP 225

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/244 (22%), Positives = 99/244 (40%), Gaps = 38/244 (15%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR----C 157
           +G+GTFG+V+   ++      A+KI+R     +E  + + EV   + +     N      
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILR-----KEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++  F   + +C V E   G  L+  L +   R F  +  R    +++  + ++H   
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD 125
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +++ D+K EN++L    +IK+ D+        D +  K                      
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--------------------- 164
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMMER 334
                 T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  L +ME 
Sbjct: 165 ---FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221
Query: 335 VLGP 338
           +  P
Sbjct: 222 IRFP 225

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/290 (20%), Positives = 123/290 (42%), Gaps = 37/290 (12%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI- 160
           +G GT+GQV +    +  ++ AIK++       E    EI +L++ + H           
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 161 -RNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
            +N     + + +V E  G+ S+ D ++     +   + +  I R++L  ++ +H   +I
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVI 151
Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 278
           H D+K +NVLL  +  +K+ D+  S     D +  +R                      N
Sbjct: 152 HRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRR----------------------N 187
Query: 279 YIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
             + T ++ APEVI         + +  D+WS+G   +E+  G         +  L ++ 
Sbjct: 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 247
Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
           R   P P+   K+  +  + ++    +   +  + R + + +MK P +++
Sbjct: 248 R--NPAPRLKSKKWSKKFQSFIESCLV---KNHSQRPATEQLMKHPFIRD 292

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 106/246 (43%), Gaps = 46/246 (18%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKG 153
           +Y    K+G+G  G V    D    + VAI+ +   ++ ++  +I EI V+++       
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE------- 74
Query: 154 GNRCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
            N+   I N+ D     + + +V E L G SL D + +       I  V    R+ L+ +
Sbjct: 75  -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQAL 130
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            F+H   +IH ++K +N+LL                               ++K+ DFG 
Sbjct: 131 EFLHSNQVIHRNIKSDNILL---------------------------GMDGSVKLTDFGF 163
Query: 270 TTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
                P+Q   + +V T ++ APEV+    +    DIWS+G + +E+  GE  +     L
Sbjct: 164 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 223
Query: 327 EHLAMM 332
             L ++
Sbjct: 224 RALYLI 229

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/244 (22%), Positives = 99/244 (40%), Gaps = 38/244 (15%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR----C 157
           +G+GTFG+V+   ++      A+KI+R     +E  + + EV   + +     N      
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILR-----KEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++  F   + +C V E   G  L+  L +   R F  +  R    +++  + ++H   
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD 125
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +++ D+K EN++L    +IK+ D+        D +  K                      
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX--------------------- 164
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMMER 334
                 T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  L +ME 
Sbjct: 165 ---FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221
Query: 335 VLGP 338
           +  P
Sbjct: 222 IRFP 225

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/327 (22%), Positives = 136/327 (41%), Gaps = 75/327 (22%)
Query: 72  SPPWREDDKDGHYMFALGENLTSRYKIHS---KMGEGTFGQVLECWDRERKEMVAIKIV- 127
           SP    DD D     A  E ++ + +I+S   ++G G   +V +  + E+K++ AIK V 
Sbjct: 32  SPDLGTDDDDKASSSA-NECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN 89
Query: 128 ------RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSL 181
                 + +  YR     EI  L +L +H    ++ +++ ++     +I +V E     L
Sbjct: 90  LEEADNQTLDSYRN----EIAYLNKLQQH---SDKIIRLYDYEITDQYIYMVMECGNIDL 142
Query: 182 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 241
             +L+K   +S      +   + +LE +  +H   ++H+DLKP N L+V           
Sbjct: 143 NSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----------- 189
Query: 242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI-----VSTRHYRAPEVILGLG 296
                               +K+IDFG     +PD   +     V T +Y  PE I  + 
Sbjct: 190 -----------------DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 297 WT-----------YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP------- 338
            +              D+WS+GCIL  +  G+  FQ  + +  ++ +  ++ P       
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHEIEFP 290
Query: 339 -LPQHMLKRVDRHAEKYVRRGRLDWPE 364
            +P+  L+ V +   K   + R+  PE
Sbjct: 291 DIPEKDLQDVLKCCLKRDPKQRISIPE 317

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 120/289 (41%), Gaps = 49/289 (16%)
Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           ++   +G G FG V  C  + R + VAIK +   +  R+A ++E+  L ++       N 
Sbjct: 11  EVEEVVGRGAFGVV--CKAKWRAKDVAIKQIES-ESERKAFIVELRQLSRV-------NH 60
Query: 157 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC---IAFM 212
              ++ +    N +C+V E   G SLY+ L  +     P           L+C   +A++
Sbjct: 61  PNIVKLYGACLNPVCLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 213 HDL---CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
           H +    +IH DLKP N+LLV+                            + +K+ DFG+
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAG--------------------------GTVLKICDFGT 152
Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
               +        +  + APEV  G  ++  CD++S G IL E+ T    F         
Sbjct: 153 ACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR 212
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 378
            M     G  P  ++K + +  E  + R    W +  + R S++ ++K+
Sbjct: 213 IMWAVHNGTRPP-LIKNLPKPIESLMTRC---WSKDPSQRPSMEEIVKI 257

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 109/241 (45%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V++++ +H+K   
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKI-RHEK--- 74
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +   SL DFL+    +   +  + ++A Q+   +A++  
Sbjct: 75  -LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL+  N+L+  +   KV D+  +    +D+ Y  R      IK           
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIK----------- 180
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 181 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 334 R 334
           R
Sbjct: 230 R 230

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 108/241 (44%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V+++L +H+K   
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 74
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +   SL DFL+    +   +  + ++A Q+   +A++  
Sbjct: 75  -LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL   N+L+  +   KV D+  +    +D+ Y  R      IK           
Sbjct: 133 MNYVHRDLAAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIK----------- 180
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 181 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 334 R 334
           R
Sbjct: 230 R 230

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/244 (22%), Positives = 99/244 (40%), Gaps = 38/244 (15%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR----C 157
           +G+GTFG+V+   ++      A+KI+R     +E  + + EV   + +     N      
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILR-----KEVIIAKDEVAHTVTESRVLQNTRHPFL 72
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++  F   + +C V E   G  L+  L +   R F  +  R    +++  + ++H   
Sbjct: 73  TALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD 130
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +++ D+K EN++L    +IK+ D+        D +  K                      
Sbjct: 131 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX--------------------- 169
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMMER 334
                 T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  L +ME 
Sbjct: 170 ---FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 226
Query: 335 VLGP 338
           +  P
Sbjct: 227 IRFP 230

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 89
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 90  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 143
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 182
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 183 -SPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 74/309 (23%), Positives = 131/309 (42%), Gaps = 50/309 (16%)
Query: 74  PWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY 133
           PW ED+          E      K+  ++G G FG+V   +     + VA+K ++     
Sbjct: 12  PWWEDE---------WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMS 61
Query: 134 REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS 192
            +A + E  +++QL        R V++      +  I I+ E +   SL DFL+  +   
Sbjct: 62  PDAFLAEANLMKQLQHQ-----RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIK 115
Query: 193 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 252
             I+ + ++A Q+ E +AF+ +   IH DL+  N+L+  +   K+ D+  +    +D+ Y
Sbjct: 116 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEY 174
Query: 253 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 312
             R      IK                      + APE I    +T   D+WS G +L E
Sbjct: 175 TAREGAKFPIK----------------------WTAPEAINYGTFTIKSDVWSFGILLTE 212
Query: 313 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW---PEGAAS 368
           + T G   +    N E +  +ER       + + R D   E+  +  RL W   PE   +
Sbjct: 213 IVTHGRIPYPGMTNPEVIQNLER------GYRMVRPDNCPEELYQLMRLCWKERPEDRPT 266
Query: 369 RESIKSVMK 377
            + ++SV++
Sbjct: 267 FDYLRSVLE 275

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 103/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 89
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 90  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGC-LLKYIRKIG--SFDETCTRFYTAEIVS 143
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 182
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++     +   D+W++GCI+ +L  G
Sbjct: 183 -SPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 96/237 (40%), Gaps = 38/237 (16%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 152
           + RY     +G G FG      D+  KE+VA+K +         A I+  V +++  H  
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE------RGAAIDENVQREIINHRS 72
Query: 153 GGN-RCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
             +   V+ +       H+ I+ E   G  LY+  R  N   F  D  R   +QLL  ++
Sbjct: 73  LRHPNIVRFKEVILTPTHLAIIMEYASGGELYE--RICNAGRFSEDEARFFFQQLLSGVS 130
Query: 211 FMHDLCMIHTDLKPENVLLVSSEY--IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           + H + + H DLK EN LL  S    +K+ D+  S      SS     PKS+        
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS-----KSSVLHSQPKST-------- 177
Query: 269 STTYERPDQNYIVSTRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHE 324
                       V T  Y APEV+L   +     D+WS G  L  +  G   F+  E
Sbjct: 178 ------------VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/244 (22%), Positives = 99/244 (40%), Gaps = 38/244 (15%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR----C 157
           +G+GTFG+V+   ++      A+KI+R     +E  + + EV   + +     N      
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILR-----KEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++  F   + +C V E   G  L+  L +   R F  +  R    +++  + ++H   
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD 125
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +++ D+K EN++L    +IK+ D+        D +  K                      
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX--------------------- 164
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMMER 334
                 T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  L +ME 
Sbjct: 165 ---FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221
Query: 335 VLGP 338
           +  P
Sbjct: 222 IRFP 225

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 101/237 (42%), Gaps = 38/237 (16%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA-KHD 151
           + RY++   +G G FG      D++  E+VA+K +   +K   AA ++ E++   + +H 
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI--AANVKREIINHRSLRHP 75
Query: 152 KGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                 V+ +       H+ IV E   G  L++  R  N   F  D  R   +QL+  ++
Sbjct: 76  N----IVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVS 129
Query: 211 FMHDLCMIHTDLKPENVLLVSSEY--IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           + H + + H DLK EN LL  S    +K+ D+  S      SS     PKS+        
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-----KSSVLHSQPKST-------- 176
Query: 269 STTYERPDQNYIVSTRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHE 324
                       V T  Y APEV+L   +     D+WS G  L  +  G   F+  E
Sbjct: 177 ------------VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 221

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 99/242 (40%), Gaps = 40/242 (16%)
Query: 88  LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEV 143
           +G N  + ++I  K+G G F +V           VA+K V+       K R   + EI++
Sbjct: 26  MGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDL 85
Query: 144 LQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLR-----KNNYRSFPIDLV 198
           L+QL   +      ++    F   N + IV E   +   D  R     K   R  P   V
Sbjct: 86  LKQLNHPN-----VIKYYASFIEDNELNIVLELADAG--DLSRMIKHFKKQKRLIPERTV 138
Query: 199 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 258
            +   QL   +  MH   ++H D+KP NV + ++  +K+ D                   
Sbjct: 139 WKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF------------- 185
Query: 259 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 318
                   F S T      + +V T +Y +PE I   G+ +  DIWS+GC+L E+   ++
Sbjct: 186 --------FSSKTTA---AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
Query: 319 LF 320
            F
Sbjct: 235 PF 236

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/335 (20%), Positives = 130/335 (38%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 69
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K     F          +L   +++
Sbjct: 70  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQK--LSKFDEQRTATYITELANALSY 125
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ ++  S+H P                        
Sbjct: 126 CHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR--------------------- 164
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 165 -----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 219
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 220 ISRVEFTFPD------------FVTEGARD------------------------------ 237
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 238 -------LISRLLKHNPSQRPMLREVLEHPWITAN 265

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 94/234 (40%), Gaps = 32/234 (13%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 152
           + RY++   +G G FG      D++  E+VA+K +   +K  E    EI +  +  +H  
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREI-INHRSLRHPN 76
Query: 153 GGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                V+ +       H+ IV E   G  L++  R  N   F  D  R   +QL+  +++
Sbjct: 77  ----IVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 130
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H + + H DLK EN LL  S     P  K        SS     PKS+           
Sbjct: 131 CHAMQVCHRDLKLENTLLDGS---PAPRLKICAFGYSKSSVLHSQPKST----------- 176
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHE 324
                    V T  Y APEV+L   +     D+WS G  L  +  G   F+  E
Sbjct: 177 ---------VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 221

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+     E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 103
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E   G  ++  LR+    S P    R  A Q++    ++H L 
Sbjct: 104 VKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEYLHSLD 161
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+++    YI+V D+           + KR+           G T      
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDF----------GFAKRVK----------GRTWX---- 197
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 198 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+     E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 103
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E + G  ++  LR+     F     R  A Q++    ++H L 
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSLD 161
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+L+    YI+V D+           + KR+           G T      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTWX---- 197
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 198 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 98/236 (41%), Gaps = 36/236 (15%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 152
           + RY++   +G G FG      D++  E+VA+K +   +K  E    EI +  +  +H  
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREI-INHRSLRHPN 75
Query: 153 GGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                V+ +       H+ IV E   G  L++  R  N   F  D  R   +QL+  +++
Sbjct: 76  ----IVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 129
Query: 212 MHDLCMIHTDLKPENVLLVSSEY--IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            H + + H DLK EN LL  S    +K+ D+  S      SS     PKS+         
Sbjct: 130 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-----KSSVLHSQPKST--------- 175
Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHE 324
                      V T  Y APEV+L   +     D+WS G  L  +  G   F+  E
Sbjct: 176 -----------VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 220

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/300 (22%), Positives = 124/300 (41%), Gaps = 71/300 (23%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV-------RGIKKYREAAMIEIEVLQQLA 148
           Y I  ++G G   +V +  + E+K++ AIK V       + +  YR     EI  L +L 
Sbjct: 11  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN----EIAYLNKLQ 65
Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           +H    ++ +++ ++     +I +V E     L  +L+K   +S      +   + +LE 
Sbjct: 66  QH---SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEA 120
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +  +H   ++H+DLKP N L+V                               +K+IDFG
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIV----------------------------DGMLKLIDFG 152
Query: 269 STTYERPDQNYI-----VSTRHYRAPEVILGLGWT-----------YPCDIWSVGCILVE 312
                +PD   +     V T +Y  PE I  +  +              D+WS+GCIL  
Sbjct: 153 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 212
Query: 313 LCTGEALFQTHENLEHLAMMERVLGP--------LPQHMLKRVDRHAEKYVRRGRLDWPE 364
           +  G+  FQ  + +  ++ +  ++ P        +P+  L+ V +   K   + R+  PE
Sbjct: 213 MTYGKTPFQ--QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 270

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 41/286 (14%)
Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           K+  ++G G FG+V   +     + VA+K ++      +A + E  +++QL        R
Sbjct: 11  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQ-----R 64
Query: 157 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
            V++      +  I I+ E +   SL DFL+  +     I+ + ++A Q+ E +AF+ + 
Sbjct: 65  LVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 123
Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
             IH DL+  N+L+  +   K+ D+  +    +D+ Y  R      IK            
Sbjct: 124 NYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPIK------------ 170
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 334
                     + APE I    +T   D+WS G +L E+ T G   +    N E +  +ER
Sbjct: 171 ----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 220
Query: 335 VLGPLPQHMLKRVDRHAEKYVRRGRLDW---PEGAASRESIKSVMK 377
                  + + R D   E+  +  RL W   PE   + + ++SV++
Sbjct: 221 ------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 260

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/335 (20%), Positives = 131/335 (39%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    +++ K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 154 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F     + ++ E   LG+ +Y  L+K +   F          +L   +++
Sbjct: 71  PN-ILRLYGYFHDATRVYLILEYAPLGT-VYRELQKLS--KFDEQRTATYITELANALSY 126
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ ++  S+H P                        
Sbjct: 127 CHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR--------------------- 165
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    
Sbjct: 166 -----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 220
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 221 ISRVEFTFPD------------FVTEGARD------------------------------ 238
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 239 -------LISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/303 (22%), Positives = 125/303 (41%), Gaps = 71/303 (23%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV-------RGIKKYREAAMIEIEVLQQLA 148
           Y I  ++G G   +V +  + E+K++ AIK V       + +  YR     EI  L +L 
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN----EIAYLNKLQ 84
Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           +H    ++ +++ ++     +I +V E     L  +L+K   +S      +   + +LE 
Sbjct: 85  QH---SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEA 139
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +  +H   ++H+DLKP N L+V                               +K+IDFG
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIV----------------------------DGMLKLIDFG 171
Query: 269 STTYERPDQNYI-----VSTRHYRAPEVILGLGWT-----------YPCDIWSVGCILVE 312
                +PD   +     V T +Y  PE I  +  +              D+WS+GCIL  
Sbjct: 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231
Query: 313 LCTGEALFQTHENLEHLAMMERVLGP--------LPQHMLKRVDRHAEKYVRRGRLDWPE 364
           +  G+  FQ  + +  ++ +  ++ P        +P+  L+ V +   K   + R+  PE
Sbjct: 232 MTYGKTPFQ--QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 289
Query: 365 GAA 367
             A
Sbjct: 290 LLA 292

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+     E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 103
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E + G  ++  LR+     F     R  A Q++    ++H L 
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSLD 161
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+L+    YI+V D+           + KR+           G T      
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTWX---- 197
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 198 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+     E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 104
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E + G  ++  LR+     F     R  A Q++    ++H L 
Sbjct: 105 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSLD 162
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+L+    YI+V D+           + KR+           G T      
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTWX---- 198
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 199 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 108/241 (44%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V+++L +H+K   
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 74
Query: 156 RCVQIRNWFDYRNHICIVFEKLGSS-LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +    L DFL+    +   +  + ++A Q+   +A++  
Sbjct: 75  -LVQLYAVVS-EEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL+  N+L+  +   KV D+  +    +D+ Y  R      IK           
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIK----------- 180
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 181 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 334 R 334
           R
Sbjct: 230 R 230

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 74/309 (23%), Positives = 131/309 (42%), Gaps = 50/309 (16%)
Query: 74  PWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY 133
           PW ED+          E      K+  ++G G FG+V   +     + VA+K ++     
Sbjct: 2   PWWEDE---------WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMS 51
Query: 134 REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS 192
            +A + E  +++QL        R V++      +  I I+ E +   SL DFL+  +   
Sbjct: 52  PDAFLAEANLMKQLQHQ-----RLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIK 105
Query: 193 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 252
             I+ + ++A Q+ E +AF+ +   IH DL+  N+L+  +   K+ D+  +    +D+ Y
Sbjct: 106 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEY 164
Query: 253 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 312
             R      IK                      + APE I    +T   D+WS G +L E
Sbjct: 165 TAREGAKFPIK----------------------WTAPEAINYGTFTIKSDVWSFGILLTE 202
Query: 313 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW---PEGAAS 368
           + T G   +    N E +  +ER       + + R D   E+  +  RL W   PE   +
Sbjct: 203 IVTHGRIPYPGMTNPEVIQNLER------GYRMVRPDNCPEELYQLMRLCWKERPEDRPT 256
Query: 369 RESIKSVMK 377
            + ++SV++
Sbjct: 257 FDYLRSVLE 265

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+    +E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 98
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E + G  ++  LR+    S P    R  A Q++    +
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLTFEY 156
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+L+    YI+V D+           + KR+           G T 
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDF----------GFAKRVK----------GRTW 196
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T    APE+IL  G+    D W++G ++ E+  G
Sbjct: 197 X-------LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 92
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 93  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 146
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 147 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 185
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 186 -SPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 89
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 90  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 143
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 182
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 183 -SPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 90
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 91  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 144
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 145 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 183
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 184 -SPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/303 (22%), Positives = 125/303 (41%), Gaps = 71/303 (23%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV-------RGIKKYREAAMIEIEVLQQLA 148
           Y I  ++G G   +V +  + E+K++ AIK V       + +  YR     EI  L +L 
Sbjct: 14  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN----EIAYLNKLQ 68
Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           +H    ++ +++ ++     +I +V E     L  +L+K   +S      +   + +LE 
Sbjct: 69  QH---SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEA 123
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +  +H   ++H+DLKP N L+V                               +K+IDFG
Sbjct: 124 VHTIHQHGIVHSDLKPANFLIV----------------------------DGMLKLIDFG 155
Query: 269 STTYERPDQNYI-----VSTRHYRAPEVILGLGWT-----------YPCDIWSVGCILVE 312
                +PD   +     V T +Y  PE I  +  +              D+WS+GCIL  
Sbjct: 156 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 215
Query: 313 LCTGEALFQTHENLEHLAMMERVLGP--------LPQHMLKRVDRHAEKYVRRGRLDWPE 364
           +  G+  FQ  + +  ++ +  ++ P        +P+  L+ V +   K   + R+  PE
Sbjct: 216 MTYGKTPFQ--QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 273
Query: 365 GAA 367
             A
Sbjct: 274 LLA 276

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/335 (20%), Positives = 131/335 (39%), Gaps = 85/335 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ--LAKHDKG 153
           ++I   +G+G FG V    ++  K ++A+K++   K   E A +E ++ ++  +  H + 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVL--FKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 154 GNRCVQIRNWF--DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            N  +++  +F    R ++ + +  LG+ +Y  L+K +   F          +L   +++
Sbjct: 68  PN-ILRLYGYFHDSTRVYLILEYAPLGT-VYRELQKLS--KFDEQRTATYITELANALSY 123
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   +IH D+KPEN+LL S+  +K+ D+  S+H P                        
Sbjct: 124 CHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--------------------- 162
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   +    
Sbjct: 163 -----RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKR 217
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           + RV    P             +V  G  D                              
Sbjct: 218 ISRVEFTFPD------------FVTEGARD------------------------------ 235
Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  L+  LL+++P+ R   RE L HP+ T +
Sbjct: 236 -------LISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 74/309 (23%), Positives = 131/309 (42%), Gaps = 50/309 (16%)
Query: 74  PWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY 133
           PW ED+          E      K+  ++G G FG+V   +     + VA+K ++     
Sbjct: 8   PWWEDE---------WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMS 57
Query: 134 REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS 192
            +A + E  +++QL        R V++      +  I I+ E +   SL DFL+  +   
Sbjct: 58  PDAFLAEANLMKQLQHQ-----RLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIK 111
Query: 193 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 252
             I+ + ++A Q+ E +AF+ +   IH DL+  N+L+  +   K+ D+  +    +D+ Y
Sbjct: 112 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEY 170
Query: 253 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 312
             R      IK                      + APE I    +T   D+WS G +L E
Sbjct: 171 TAREGAKFPIK----------------------WTAPEAINYGTFTIKSDVWSFGILLTE 208
Query: 313 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW---PEGAAS 368
           + T G   +    N E +  +ER       + + R D   E+  +  RL W   PE   +
Sbjct: 209 IVTHGRIPYPGMTNPEVIQNLER------GYRMVRPDNCPEELYQLMRLCWKERPEDRPT 262
Query: 369 RESIKSVMK 377
            + ++SV++
Sbjct: 263 FDYLRSVLE 271

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G G+FG+V+     E     A+KI+   K    K  E  + E  +LQ +          
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFL 103
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V++   F   +++ +V E   G  ++  LR+     F     R  A Q++    ++H L 
Sbjct: 104 VKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSLD 161
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLKPEN+++    YIKV D+           + KR+           G T      
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDF----------GFAKRVK----------GRTWX---- 197
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 198 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/303 (22%), Positives = 125/303 (41%), Gaps = 71/303 (23%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV-------RGIKKYREAAMIEIEVLQQLA 148
           Y I  ++G G   +V +  + E+K++ AIK V       + +  YR     EI  L +L 
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN----EIAYLNKLQ 84
Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           +H    ++ +++ ++     +I +V E     L  +L+K   +S      +   + +LE 
Sbjct: 85  QH---SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEA 139
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +  +H   ++H+DLKP N L+V                               +K+IDFG
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIV----------------------------DGMLKLIDFG 171
Query: 269 STTYERPDQNYI-----VSTRHYRAPEVILGLGWT-----------YPCDIWSVGCILVE 312
                +PD   +     V T +Y  PE I  +  +              D+WS+GCIL  
Sbjct: 172 IANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231
Query: 313 LCTGEALFQTHENLEHLAMMERVLGP--------LPQHMLKRVDRHAEKYVRRGRLDWPE 364
           +  G+  FQ  + +  ++ +  ++ P        +P+  L+ V +   K   + R+  PE
Sbjct: 232 MTYGKTPFQ--QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 289
Query: 365 GAA 367
             A
Sbjct: 290 LLA 292

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 99/236 (41%), Gaps = 31/236 (13%)
Query: 84  YMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV 143
           +M       +  Y +  ++G+G F  V  C  +      A KI+   KK       ++E 
Sbjct: 19  FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLER 77
Query: 144 LQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIA 202
             ++ +  +  N  V++ +     +   +VF+ + G  L++ +    + S   D    I 
Sbjct: 78  EARICRKLQHPN-IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS-EADASHCI- 134
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
           +Q+LE IA+ H   ++H +LKPEN+LL S                          K +A+
Sbjct: 135 QQILESIAYCHSNGIVHRNLKPENLLLASK------------------------AKGAAV 170
Query: 263 KVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
           K+ DFG        + +     T  Y +PEV+    ++ P DIW+ G IL  L  G
Sbjct: 171 KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 90
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 91  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 144
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 145 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 183
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 184 -SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 89
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 90  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 143
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 182
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 183 -SPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 74/309 (23%), Positives = 131/309 (42%), Gaps = 50/309 (16%)
Query: 74  PWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY 133
           PW ED+          E      K+  ++G G FG+V   +     + VA+K ++     
Sbjct: 7   PWWEDE---------WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMS 56
Query: 134 REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS 192
            +A + E  +++QL        R V++      +  I I+ E +   SL DFL+  +   
Sbjct: 57  PDAFLAEANLMKQLQHQ-----RLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIK 110
Query: 193 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 252
             I+ + ++A Q+ E +AF+ +   IH DL+  N+L+  +   K+ D+  +    +D+ Y
Sbjct: 111 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEY 169
Query: 253 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 312
             R      IK                      + APE I    +T   D+WS G +L E
Sbjct: 170 TAREGAKFPIK----------------------WTAPEAINYGTFTIKSDVWSFGILLTE 207
Query: 313 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW---PEGAAS 368
           + T G   +    N E +  +ER       + + R D   E+  +  RL W   PE   +
Sbjct: 208 IVTHGRIPYPGMTNPEVIQNLER------GYRMVRPDNCPEELYQLMRLCWKERPEDRPT 261
Query: 369 RESIKSVMK 377
            + ++SV++
Sbjct: 262 FDYLRSVLE 270

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 87
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 88  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 141
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 180
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 181 -SPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 89
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 90  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 143
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 182
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 183 -SPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 49/225 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G G+FG+V+     E     A+KI   + K +   + +IE       H     R +Q  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKI---LDKQKVVKLKQIE-------HTLNEKRILQAV 99
Query: 162 NW---------FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           N+         F   +++ +V E   G  ++  LR+     F     R  A Q++    +
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEY 157
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H L +I+ DLKPEN+++    YIKV D+           + KR+           G T 
Sbjct: 158 LHSLDLIYRDLKPENLMIDQQGYIKVTDF----------GFAKRVK----------GRTW 197
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                   +  T  Y APE+IL  G+    D W++G ++ E+  G
Sbjct: 198 X-------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 89
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 90  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 143
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 182
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 183 -SPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 87
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 88  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 141
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 180
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 181 -SPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 87
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 88  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 141
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 180
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 181 -SPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/303 (22%), Positives = 125/303 (41%), Gaps = 71/303 (23%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV-------RGIKKYREAAMIEIEVLQQLA 148
           Y I  ++G G   +V +  + E+K++ AIK V       + +  YR     EI  L +L 
Sbjct: 10  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN----EIAYLNKLQ 64
Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           +H    ++ +++ ++     +I +V E     L  +L+K   +S      +   + +LE 
Sbjct: 65  QH---SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEA 119
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +  +H   ++H+DLKP N L+V                               +K+IDFG
Sbjct: 120 VHTIHQHGIVHSDLKPANFLIV----------------------------DGMLKLIDFG 151
Query: 269 STTYERPDQNYI-----VSTRHYRAPEVILGLGWT-----------YPCDIWSVGCILVE 312
                +PD   +     V T +Y  PE I  +  +              D+WS+GCIL  
Sbjct: 152 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 211
Query: 313 LCTGEALFQTHENLEHLAMMERVLGP--------LPQHMLKRVDRHAEKYVRRGRLDWPE 364
           +  G+  FQ  + +  ++ +  ++ P        +P+  L+ V +   K   + R+  PE
Sbjct: 212 MTYGKTPFQ--QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 269
Query: 365 GAA 367
             A
Sbjct: 270 LLA 272

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 108/241 (44%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V+++L +H+K   
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 74
Query: 156 RCVQIRNWFDYRNHICIVFEKLGSS-LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +    L DFL+    +   +  + ++A Q+   +A++  
Sbjct: 75  -LVQLYAVVS-EEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL+  N+L+  +   KV D+  +    +D+ Y  R      IK           
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIK----------- 180
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 181 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 334 R 334
           R
Sbjct: 230 R 230

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 109/241 (45%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V+++L +H+K   
Sbjct: 18  RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 71
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +   SL DFL+    +   +  + +++ Q+   +A++  
Sbjct: 72  -LVQLYAVVS-EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER 129
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL+  N+L+  +   KV D+  +    +D+ +  R      IK           
Sbjct: 130 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEWTARQGAKFPIK----------- 177
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 178 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 226
Query: 334 R 334
           R
Sbjct: 227 R 227

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 108/241 (44%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V+++L +H+K   
Sbjct: 11  RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 64
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +   SL DFL+    +   +  + ++A Q+   +A++  
Sbjct: 65  -LVQLYAVVS-EEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 122
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL+  N+L+  +   KV D+  +    +D+    R      IK           
Sbjct: 123 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEXTARQGAKFPIK----------- 170
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 171 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 219
Query: 334 R 334
           R
Sbjct: 220 R 220

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/300 (22%), Positives = 123/300 (41%), Gaps = 71/300 (23%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV-------RGIKKYREAAMIEIEVLQQLA 148
           Y I  ++G G   +V +  + E+K++ AIK V       + +  YR     EI  L +L 
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN----EIAYLNKLQ 112
Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           +H    ++ +++ ++     +I +V E     L  +L+K   +S      +   + +LE 
Sbjct: 113 QH---SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEA 167
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +  +H   ++H+DLKP N L+V                               +K+IDFG
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIV----------------------------DGMLKLIDFG 199
Query: 269 STTYERPDQNYIVSTR-----HYRAPEVILGLGWT-----------YPCDIWSVGCILVE 312
                +PD   +V        +Y  PE I  +  +              D+WS+GCIL  
Sbjct: 200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 259
Query: 313 LCTGEALFQTHENLEHLAMMERVLGP--------LPQHMLKRVDRHAEKYVRRGRLDWPE 364
           +  G+  FQ  + +  ++ +  ++ P        +P+  L+ V +   K   + R+  PE
Sbjct: 260 MTYGKTPFQ--QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 317

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 67
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 68  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 121
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 122 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 160
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 161 -SPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 108/241 (44%), Gaps = 34/241 (14%)
Query: 97  KIHSKMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++  K+G+G FG+V +  W+   +  VAIK ++      EA + E +V+++L +H+K   
Sbjct: 21  RLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK--- 74
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             VQ+         I IV E +   SL DFL+    +   +  + ++A Q+   +A++  
Sbjct: 75  -LVQLYAVVS-EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 132
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL+  N+L+  +   KV D+  +    +D+    R      IK           
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEXTARQGAKFPIK----------- 180
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
                      + APE  L   +T   D+WS G +L EL T G   +    N E L  +E
Sbjct: 181 -----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 334 R 334
           R
Sbjct: 230 R 230

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 64
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 65  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 118
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 119 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 157
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 158 -SPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 66
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 67  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 120
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 121 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 159
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 160 -SPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 65
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 66  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 119
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 158
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 159 -SPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 103/245 (42%), Gaps = 46/245 (18%)
Query: 80  KDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAA 137
           K GHY+  LG+ L          G GTFG+V           VA+KI+  + I+      
Sbjct: 14  KIGHYI--LGDTL----------GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVG 61
Query: 138 MIEIEVLQ-QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPI 195
            I  E+   +L +H       +++       + I +V E + G  L+D++ KN       
Sbjct: 62  KIRREIQNLKLFRHP----HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG--RLDE 115
Query: 196 DLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 255
              R + +Q+L  + + H   ++H DLKPENVLL +    K+ D+  S +   D  + + 
Sbjct: 116 KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRX 174
Query: 256 MPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                       GS  Y  P+   ++S R Y  PEV          DIWS G IL  L  
Sbjct: 175 ----------SCGSPNYAAPE---VISGRLYAGPEV----------DIWSSGVILYALLC 211
Query: 316 GEALF 320
           G   F
Sbjct: 212 GTLPF 216

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 93/234 (39%), Gaps = 32/234 (13%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 152
           + RY++   +G G FG      D++  E+VA+K +   +K  E    EI +  +  +H  
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREI-INHRSLRHPN 76
Query: 153 GGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                V+ +       H+ IV E   G  L++  R  N   F  D  R   +QL+  +++
Sbjct: 77  ----IVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 130
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H + + H DLK EN LL  S     P  K        SS     PK +           
Sbjct: 131 CHAMQVCHRDLKLENTLLDGS---PAPRLKICAFGYSKSSVLHSQPKDT----------- 176
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHE 324
                    V T  Y APEV+L   +     D+WS G  L  +  G   F+  E
Sbjct: 177 ---------VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 221

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 86
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 87  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 140
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 141 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 179
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 180 -SPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 125/286 (43%), Gaps = 41/286 (14%)
Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           K+  ++G G FG+V   +     + VA+K ++      +A + E  +++QL        R
Sbjct: 12  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQ-----R 65
Query: 157 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
            V++      +  I I+ E +   SL DFL+  +     I+ + ++A Q+ E +AF+ + 
Sbjct: 66  LVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 124
Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
             IH +L+  N+L+  +   K+ D+  +    +D+ Y  R      IK            
Sbjct: 125 NYIHRNLRAANILVSDTLSCKIADFGLA-RLIEDNEYTAREGAKFPIK------------ 171
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 334
                     + APE I    +T   D+WS G +L E+ T G   +    N E +  +ER
Sbjct: 172 ----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 221
Query: 335 VLGPLPQHMLKRVDRHAEKYVRRGRLDW---PEGAASRESIKSVMK 377
                  + + R D   E+  +  RL W   PE   + + ++SV++
Sbjct: 222 ------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 261

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 71
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 72  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 125
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 126 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 164
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 165 -SPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 101/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 94
Query: 152 KGGNRCVQIRNWF----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F    D + +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 95  ---DHPFFVKLYFCFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 148
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 149 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 187
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 188 -SPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQ-QLAKHDK 152
           Y +   +G GTFG+V     +     VA+KI+  + I+       I+ E+   +L +H  
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP- 71
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                +++           +V E + G  L+D++ K+  R   ++  R + +Q+L  + +
Sbjct: 72  ---HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEME-ARRLFQQILSAVDY 126
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   ++H DLKPENVLL +    K+ D+  S +   D  + +             GS  
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLR----------TSCGSPN 175
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
           Y  P+   ++S R Y  PEV          DIWS G IL  L  G   F
Sbjct: 176 YAAPE---VISGRLYAGPEV----------DIWSCGVILYALLCGTLPF 211

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAA--MIEIEVLQQLAKHDKGGNRC 157
           +G+G+FG+VL    +  +   A+K++  + I K +E    M E  VL +  KH       
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP----FL 101
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V +   F   + +  V + + G  L+  L++   R F     R  A ++   + ++H L 
Sbjct: 102 VGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN 159
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +++ DLKPEN+LL S  +I + D+                      + I+  STT     
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDF------------------GLCKENIEHNSTT----- 196
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
            +    T  Y APEV+    +    D W +G +L E+  G   F +    E
Sbjct: 197 -STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 246

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 98/233 (42%), Gaps = 30/233 (12%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           + I   +G+G FG V    +++ K ++A+K++   +  +E    ++    ++  H +  N
Sbjct: 17  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 76
Query: 156 RCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             +++ N+F  R  I ++ E      LY  L+K+    F          +L + + + H+
Sbjct: 77  -ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHE 133
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             +IH D+KPEN+L+     +K+ D+  S+H P   S  +R                   
Sbjct: 134 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP---SLRRRX------------------ 172
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                +  T  Y  PE+I G       D+W  G +  E   G   F +  + E
Sbjct: 173 -----MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 220

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F  V+   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 86
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 87  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 140
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 141 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 179
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 180 -SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 101/236 (42%), Gaps = 34/236 (14%)
Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQ- 145
           G      Y +   +G GTFG+V     +     VA+KI+  + I+       I+ E+   
Sbjct: 6   GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
           +L +H       +++           +V E + G  L+D++ K+  R   ++  R + +Q
Sbjct: 66  KLFRHP----HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEME-ARRLFQQ 119
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +L  + + H   ++H DLKPENVLL +    K+ D+  S +   D  + +          
Sbjct: 120 ILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRD--------- 169
Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
              GS  Y  P+   ++S R Y  PEV          DIWS G IL  L  G   F
Sbjct: 170 -SCGSPNYAAPE---VISGRLYAGPEV----------DIWSCGVILYALLCGTLPF 211

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 94/378 (24%), Positives = 151/378 (39%), Gaps = 62/378 (16%)
Query: 80  KDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRER---KEMVAIK-IVRGIKKYRE 135
           KD   ++     L++ +KI  K+GEGTF  V     + +   +E +A+K ++      R 
Sbjct: 7   KDIEKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRI 66
Query: 136 AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFP 194
           AA  E++ L        G +  + ++  F   +H+ I    L   S  D L   +++   
Sbjct: 67  AA--ELQCLTVAG----GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQE-- 118
Query: 195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS--SEYIKVPDYKSSLHTPKDSSY 252
              VRE    L + +  +H   ++H D+KP N L      +Y  V D+  +  T      
Sbjct: 119 ---VREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALV-DFGLAQGTHDTKIE 174
Query: 253 FKRMPKSSAIKVIDFGSTTYERPDQNYI-------------VSTRHYRAPEVILGL-GWT 298
             +  +S A +         ER  QN                 T  +RAPEV+      T
Sbjct: 175 LLKFVQSEAQQ---------ERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQT 225
Query: 299 YPCDIWSVGCILVELCTGE-ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
              D+WS G I + L +G    ++  ++L  LA +  + G        R    A K   +
Sbjct: 226 TAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRG-------SRETIQAAKTFGK 278
Query: 358 GRLDWPEGAASR-----ESIKSV-MKLPRLQNLIMQHVDHSAG------DLTHLLQGLLR 405
             L   E  A       E ++ +    P+L + I  H  +  G      +   LL  LL 
Sbjct: 279 SILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLD 338
Query: 406 YDPTDRLTAREALRHPFF 423
            +P  R+TA EAL HPFF
Sbjct: 339 LNPASRITAEEALLHPFF 356

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 40/229 (17%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHD 151
           +K    +GEG+F   +   +       AIKI+  R I K  +   +  E +V+ +L    
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL---- 87
Query: 152 KGGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              +    ++ +F +++    +  + + K G  L  ++RK    SF     R    +++ 
Sbjct: 88  ---DHPFFVKLYFTFQDDEKLYFGLSYAKNGE-LLKYIRKIG--SFDETCTRFYTAEIVS 141
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLKPEN+LL    +I++ D+ ++                   KV+  
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA-------------------KVL-- 180
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
            S   ++   N  V T  Y +PE++         D+W++GCI+ +L  G
Sbjct: 181 -SPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 97/228 (42%), Gaps = 35/228 (15%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           +G+G FGQV++  +       AIK +R  ++     + E+ +L  L       N    +R
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASL-------NHQYVVR 66
Query: 162 ---NWFDYRNHI---------CIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQL 205
               W + RN +           +F +       +LYD +   N      +  R + RQ+
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR-LFRQI 125
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           LE ++++H   +IH +LKP N+ +  S  +K+ D+  +          K + +S  I  +
Sbjct: 126 LEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLA----------KNVHRSLDILKL 175
Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVE 312
           D  +      +    + T  Y A EV+ G G +    D +S+G I  E
Sbjct: 176 DSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 98/233 (42%), Gaps = 30/233 (12%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           + I   +G+G FG V    +++ K ++A+K++   +  +E    ++    ++  H +  N
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 156 RCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             +++ N+F  R  I ++ E      LY  L+K+    F          +L + + + H+
Sbjct: 76  -ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHE 132
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             +IH D+KPEN+L+     +K+ D+  S+H P   S  +R                   
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP---SLRRRX------------------ 171
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                +  T  Y  PE+I G       D+W  G +  E   G   F +  + E
Sbjct: 172 -----MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 106/245 (43%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 4   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 63
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E++     L+DF+ +    +   +L R   
Sbjct: 64  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERG--ALQEELARSFF 120
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 121 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 170
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 171 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 215
Query: 322 THENL 326
             E +
Sbjct: 216 HDEEI 220

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 34/221 (15%)
Query: 102 MGEGTFGQV-LECWDRERK---EMVAIKIVRGI--KKYREAAMIEIEVLQQLA-KHDKGG 154
           +GEG FG+V L C+D       EMVA+K ++     ++R     EI++L+ L  +H    
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             C + +   +    + + +  LGS L D+L ++   S  +  +   A+Q+ E +A++H 
Sbjct: 82  KGCCEDQG--EKSLQLVMEYVPLGS-LRDYLPRH---SIGLAQLLLFAQQICEGMAYLHS 135
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
              IH +L   NVLL +   +K+ D+  +   P+   Y++                   R
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV------------------R 177
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
            D +   S   + APE +    + Y  D+WS G  L EL T
Sbjct: 178 EDGD---SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/309 (23%), Positives = 130/309 (42%), Gaps = 50/309 (16%)
Query: 74  PWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY 133
           PW ED+          E      K+  ++G G FG+V   +     + VA+K ++     
Sbjct: 11  PWWEDE---------WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMS 60
Query: 134 REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS 192
            +A + E  +++QL        R V++      +  I I+ E +   SL DFL+  +   
Sbjct: 61  PDAFLAEANLMKQLQHQ-----RLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIK 114
Query: 193 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 252
             I+ + ++A Q+ E +AF+ +   IH DL+  N+L+  +   K+ D+  +    +D+  
Sbjct: 115 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEX 173
Query: 253 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 312
             R      IK                      + APE I    +T   D+WS G +L E
Sbjct: 174 TAREGAKFPIK----------------------WTAPEAINYGTFTIKSDVWSFGILLTE 211
Query: 313 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW---PEGAAS 368
           + T G   +    N E +  +ER       + + R D   E+  +  RL W   PE   +
Sbjct: 212 IVTHGRIPYPGMTNPEVIQNLER------GYRMVRPDNCPEELYQLMRLCWKERPEDRPT 265
Query: 369 RESIKSVMK 377
            + ++SV++
Sbjct: 266 FDYLRSVLE 274

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 41/243 (16%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHD 151
           ++I   +G G FG+V     +  + + A+KI+   +  + A       E +VL       
Sbjct: 76  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVN----- 130
Query: 152 KGGNRCVQIRNW-FDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
            G  + +   ++ F   NH+ +V +  +G  L   L K   +  P D+ R    +++  I
Sbjct: 131 -GDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDK-LPEDMARFYIGEMVLAI 188
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
             +H L  +H D+KP+NVLL  + +I++ D+ S L    D +      +SS         
Sbjct: 189 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTV-----QSSV-------- 235
Query: 270 TTYERPDQNYIVSTRHYRAPEVIL----GLGWTYP-CDIWSVGCILVELCTGEALFQTHE 324
                      V T  Y +PE++     G+G   P CD WS+G  + E+  GE  F    
Sbjct: 236 ----------AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 285
Query: 325 NLE 327
            +E
Sbjct: 286 LVE 288

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 41/221 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNR 156
           ++G G+FG V    D    E+VAIK +    K      +  + E+  LQ+L +H      
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPN---- 115
Query: 157 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
            +Q R  +   +   +V E    S  D L  +      +++   +    L+ +A++H   
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLHSHN 174
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           MIH D+K  N+LL                            +   +K+ DFGS +   P 
Sbjct: 175 MIHRDVKAGNILL---------------------------SEPGLVKLGDFGSASIMAP- 206
Query: 277 QNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELC 314
            N  V T ++ APEVIL +    +    D+WS+G   +EL 
Sbjct: 207 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 74/335 (22%), Positives = 129/335 (38%), Gaps = 76/335 (22%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD 151
            +  Y +  ++G+G F  V  C  +      A KI+   KK       ++E   ++ +  
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICRKL 62
Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
           +  N  V++ +     +   +VF+ + G  L++ +    + S   D    I +Q+LE IA
Sbjct: 63  QHPN-IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS-EADASHCI-QQILESIA 119
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           + H   ++H +LKPEN+LL S                          K +A+K+ DFG  
Sbjct: 120 YCHSNGIVHRNLKPENLLLASK------------------------AKGAAVKLADFGLA 155
Query: 271 TYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 328
                 + +     T  Y +PEV+    ++ P DIW+ G IL  L  G   F   +    
Sbjct: 156 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---- 211
Query: 329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 388
                       QH L     +A+  ++ G  D+P                         
Sbjct: 212 ------------QHRL-----YAQ--IKAGAYDYPS----------------------PE 230
Query: 389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
            D    +   L+  +L  +P  R+TA +AL+ P+ 
Sbjct: 231 WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 41/243 (16%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHD 151
           ++I   +G G FG+V     +  + + A+KI+   +  + A       E +VL       
Sbjct: 92  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVN----- 146
Query: 152 KGGNRCVQIRNW-FDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
            G  + +   ++ F   NH+ +V +  +G  L   L K   +  P D+ R    +++  I
Sbjct: 147 -GDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDK-LPEDMARFYIGEMVLAI 204
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
             +H L  +H D+KP+NVLL  + +I++ D+ S L    D +      +SS         
Sbjct: 205 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTV-----QSSV-------- 251
Query: 270 TTYERPDQNYIVSTRHYRAPEVIL----GLGWTYP-CDIWSVGCILVELCTGEALFQTHE 324
                      V T  Y +PE++     G+G   P CD WS+G  + E+  GE  F    
Sbjct: 252 ----------AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 301
Query: 325 NLE 327
            +E
Sbjct: 302 LVE 304

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/309 (23%), Positives = 130/309 (42%), Gaps = 50/309 (16%)
Query: 74  PWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY 133
           PW ED+          E      K+  ++G G FG+V   +     + VA+K ++     
Sbjct: 2   PWWEDE---------WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMS 51
Query: 134 REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS 192
            +A + E  +++QL        R V++      +  I I+ E +   SL DFL+  +   
Sbjct: 52  PDAFLAEANLMKQLQHQ-----RLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIK 105
Query: 193 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 252
             I+ + ++A Q+ E +AF+ +   IH DL+  N+L+  +   K+ D+  +    +D+  
Sbjct: 106 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEX 164
Query: 253 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 312
             R      IK                      + APE I    +T   D+WS G +L E
Sbjct: 165 TAREGAKFPIK----------------------WTAPEAINYGTFTIKSDVWSFGILLTE 202
Query: 313 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW---PEGAAS 368
           + T G   +    N E +  +ER       + + R D   E+  +  RL W   PE   +
Sbjct: 203 IVTHGRIPYPGMTNPEVIQNLER------GYRMVRPDNCPEELYQLMRLCWKERPEDRPT 256
Query: 369 RESIKSVMK 377
            + ++SV++
Sbjct: 257 FDYLRSVLE 265

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/309 (23%), Positives = 130/309 (42%), Gaps = 50/309 (16%)
Query: 74  PWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY 133
           PW ED+          E      K+  ++G G FG+V   +     + VA+K ++     
Sbjct: 4   PWWEDE---------WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMS 53
Query: 134 REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS 192
            +A + E  +++QL        R V++      +  I I+ E +   SL DFL+  +   
Sbjct: 54  PDAFLAEANLMKQLQHQ-----RLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIK 107
Query: 193 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 252
             I+ + ++A Q+ E +AF+ +   IH DL+  N+L+  +   K+ D+  +    +D+  
Sbjct: 108 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEX 166
Query: 253 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 312
             R      IK                      + APE I    +T   D+WS G +L E
Sbjct: 167 TAREGAKFPIK----------------------WTAPEAINYGTFTIKSDVWSFGILLTE 204
Query: 313 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW---PEGAAS 368
           + T G   +    N E +  +ER       + + R D   E+  +  RL W   PE   +
Sbjct: 205 IVTHGRIPYPGMTNPEVIQNLER------GYRMVRPDNCPEELYQLMRLCWKERPEDRPT 258
Query: 369 RESIKSVMK 377
            + ++SV++
Sbjct: 259 FDYLRSVLE 267

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 31/228 (13%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD 151
            +  Y +  ++G+G F  V  C  +      A KI+   KK       ++E   ++ +  
Sbjct: 3   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICRKL 61
Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
           +  N  V++ +     +   +VF+ + G  L++ +    + S   D    I +Q+LE IA
Sbjct: 62  QHPN-IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS-EADASHCI-QQILESIA 118
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           + H   ++H +LKPEN+LL S                          K +A+K+ DFG  
Sbjct: 119 YCHSNGIVHRNLKPENLLLASK------------------------AKGAAVKLADFGLA 154
Query: 271 TYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                 + +     T  Y +PEV+    ++ P DIW+ G IL  L  G
Sbjct: 155 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/309 (23%), Positives = 130/309 (42%), Gaps = 50/309 (16%)
Query: 74  PWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY 133
           PW ED+          E      K+  ++G G FG+V   +     + VA+K ++     
Sbjct: 10  PWWEDE---------WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMS 59
Query: 134 REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS 192
            +A + E  +++QL        R V++      +  I I+ E +   SL DFL+  +   
Sbjct: 60  PDAFLAEANLMKQLQHQ-----RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIK 113
Query: 193 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 252
             I+ + ++A Q+ E +AF+ +   IH DL+  N+L+  +   K+ D+  +    +D+  
Sbjct: 114 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEX 172
Query: 253 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 312
             R      IK                      + APE I    +T   D+WS G +L E
Sbjct: 173 TAREGAKFPIK----------------------WTAPEAINYGTFTIKSDVWSFGILLTE 210
Query: 313 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW---PEGAAS 368
           + T G   +    N E +  +ER       + + R D   E+  +  RL W   PE   +
Sbjct: 211 IVTHGRIPYPGMTNPEVIQNLER------GYRMVRPDNCPEELYQLMRLCWKERPEDRPT 264
Query: 369 RESIKSVMK 377
            + ++SV++
Sbjct: 265 FDYLRSVLE 273

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/309 (23%), Positives = 130/309 (42%), Gaps = 50/309 (16%)
Query: 74  PWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY 133
           PW ED+          E      K+  ++G G FG+V   +     + VA+K ++     
Sbjct: 8   PWWEDE---------WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMS 57
Query: 134 REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS 192
            +A + E  +++QL        R V++      +  I I+ E +   SL DFL+  +   
Sbjct: 58  PDAFLAEANLMKQLQHQ-----RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIK 111
Query: 193 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 252
             I+ + ++A Q+ E +AF+ +   IH DL+  N+L+  +   K+ D+  +    +D+  
Sbjct: 112 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEX 170
Query: 253 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 312
             R      IK                      + APE I    +T   D+WS G +L E
Sbjct: 171 TAREGAKFPIK----------------------WTAPEAINYGTFTIKSDVWSFGILLTE 208
Query: 313 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW---PEGAAS 368
           + T G   +    N E +  +ER       + + R D   E+  +  RL W   PE   +
Sbjct: 209 IVTHGRIPYPGMTNPEVIQNLER------GYRMVRPDNCPEELYQLMRLCWKERPEDRPT 262
Query: 369 RESIKSVMK 377
            + ++SV++
Sbjct: 263 FDYLRSVLE 271

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 31/228 (13%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD 151
            +  Y +  ++G+G F  V  C  +      A KI+   KK       ++E   ++ +  
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICRKL 62
Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
           +  N  V++ +     +   +VF+ + G  L++ +    + S   D    I +Q+LE IA
Sbjct: 63  QHPN-IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS-EADASHCI-QQILESIA 119
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           + H   ++H +LKPEN+LL S                          K +A+K+ DFG  
Sbjct: 120 YCHSNGIVHRNLKPENLLLASK------------------------AKGAAVKLADFGLA 155
Query: 271 TYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                 + +     T  Y +PEV+    ++ P DIW+ G IL  L  G
Sbjct: 156 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 34/221 (15%)
Query: 102 MGEGTFGQV-LECWDRERK---EMVAIKIVRGI--KKYREAAMIEIEVLQQLA-KHDKGG 154
           +GEG FG+V L C+D       EMVA+K ++     ++R     EI++L+ L  +H    
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             C + +   +    + + +  LGS L D+L ++   S  +  +   A+Q+ E +A++H 
Sbjct: 82  KGCCEDQG--EKSLQLVMEYVPLGS-LRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA 135
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
              IH +L   NVLL +   +K+ D+  +   P+   Y++                   R
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV------------------R 177
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
            D +   S   + APE +    + Y  D+WS G  L EL T
Sbjct: 178 EDGD---SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           ++G G+FG+V    D++     A+K VR ++ +R   ++    L           R V +
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVR-LEVFRAEELMACAGLTS--------PRIVPL 150
Query: 161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                    + I  E L G SL   +++      P D       Q LE + ++H   ++H
Sbjct: 151 YGAVREGPWVNIFMELLEGGSLGQLVKEQG--CLPEDRALYYLGQALEGLEYLHSRRILH 208
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-- 277
            D+K +NVLL S                 D S+           + DFG     +PD   
Sbjct: 209 GDVKADNVLLSS-----------------DGSH---------AALCDFGHAVCLQPDGLG 242
Query: 278 ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                 +YI  T  + APEV+LG       D+WS  C+++ +  G
Sbjct: 243 KSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/309 (23%), Positives = 130/309 (42%), Gaps = 50/309 (16%)
Query: 74  PWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY 133
           PW ED+          E      K+  ++G G FG+V   +     + VA+K ++     
Sbjct: 3   PWWEDE---------WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMS 52
Query: 134 REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS 192
            +A + E  +++QL        R V++      +  I I+ E +   SL DFL+  +   
Sbjct: 53  PDAFLAEANLMKQLQHQ-----RLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIK 106
Query: 193 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 252
             I+ + ++A Q+ E +AF+ +   IH DL+  N+L+  +   K+ D+  +    +D+  
Sbjct: 107 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEX 165
Query: 253 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 312
             R      IK                      + APE I    +T   D+WS G +L E
Sbjct: 166 TAREGAKFPIK----------------------WTAPEAINYGTFTIKSDVWSFGILLTE 203
Query: 313 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW---PEGAAS 368
           + T G   +    N E +  +ER       + + R D   E+  +  RL W   PE   +
Sbjct: 204 IVTHGRIPYPGMTNPEVIQNLER------GYRMVRPDNCPEELYQLMRLCWKERPEDRPT 257
Query: 369 RESIKSVMK 377
            + ++SV++
Sbjct: 258 FDYLRSVLE 266

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/309 (23%), Positives = 130/309 (42%), Gaps = 50/309 (16%)
Query: 74  PWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY 133
           PW ED+          E      K+  ++G G FG+V   +     + VA+K ++     
Sbjct: 2   PWWEDE---------WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMS 51
Query: 134 REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS 192
            +A + E  +++QL        R V++      +  I I+ E +   SL DFL+  +   
Sbjct: 52  PDAFLAEANLMKQLQHQ-----RLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIK 105
Query: 193 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 252
             I+ + ++A Q+ E +AF+ +   IH DL+  N+L+  +   K+ D+  +    +D+  
Sbjct: 106 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDNEX 164
Query: 253 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 312
             R      IK                      + APE I    +T   D+WS G +L E
Sbjct: 165 TAREGAKFPIK----------------------WTAPEAINYGTFTIKSDVWSFGILLTE 202
Query: 313 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW---PEGAAS 368
           + T G   +    N E +  +ER       + + R D   E+  +  RL W   PE   +
Sbjct: 203 IVTHGRIPYPGMTNPEVIQNLER------GYRMVRPDNCPEELYQLMRLCWKERPEDRPT 256
Query: 369 RESIKSVMK 377
            + ++SV++
Sbjct: 257 FDYLRSVLE 265

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 38/233 (16%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDK 152
           Y++   +G G FG+V     +  +++ A+K++     IK+   A   E   +   A    
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--- 132
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                VQ+   F    ++ +V E + G  L + +  +NY   P    R    +++  +  
Sbjct: 133 -SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY-DVPEKWARFYTAEVVLALDA 188
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H +  IH D+KP+N+LL  S ++K+ D+ + +          +M K   ++        
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM----------KMNKEGMVRC------- 231
Query: 272 YERPDQNYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEALF 320
                 +  V T  Y +PEV+   G    +   CD WSVG  L E+  G+  F
Sbjct: 232 ------DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/244 (22%), Positives = 109/244 (44%), Gaps = 48/244 (19%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD 151
           + +++++  K+G G+FG++    + +  E VAIK+   +K      + E ++ + L    
Sbjct: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRIL---- 59
Query: 152 KGGNRCVQIRNWFDYR-NHICIVFEKLGSSLYDFLRKNNY--RSFPIDLVREIARQLLEC 208
           +GG     +R WF    ++  +V + LG SL D     N+  R   +  V  +A Q++  
Sbjct: 60  QGGTGIPNVR-WFGVEGDYNVLVMDLLGPSLEDLF---NFCSRKLSLKTVLMLADQMINR 115
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           + F+H    +H D+KP+N L+                            +++ + +IDFG
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGR------------------------RANQVYIIDFG 151
Query: 269 -------STTYE----RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 317
                  ++T++    R ++N +  T  Y +    LG+  +   D+ S+G +L+    G 
Sbjct: 152 LAKKYRDTSTHQHIPYRENKN-LTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
Query: 318 ALFQ 321
             +Q
Sbjct: 211 LPWQ 214

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 38/233 (16%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDK 152
           Y++   +G G FG+V     +  +++ A+K++     IK+   A   E   +   A    
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA---- 126
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                VQ+   F    ++ +V E + G  L + +  +NY   P    R    +++  +  
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY-DVPEKWARFYTAEVVLALDA 183
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H +  IH D+KP+N+LL  S ++K+ D+ + +          +M K   ++        
Sbjct: 184 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM----------KMNKEGMVRC------- 226
Query: 272 YERPDQNYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEALF 320
                 +  V T  Y +PEV+   G    +   CD WSVG  L E+  G+  F
Sbjct: 227 ------DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 39  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 99  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 155
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 205
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 206 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 250
Query: 322 THENL 326
             E +
Sbjct: 251 HDEEI 255

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 88/225 (39%), Gaps = 46/225 (20%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           ++G G+FG+V    D++     A+K VR ++ +R   ++    L           R V +
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVR-LEVFRAEELMACAGLTS--------PRIVPL 131
Query: 161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                    + I  E L G SL   +++      P D       Q LE + ++H   ++H
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLVKEQG--CLPEDRALYYLGQALEGLEYLHSRRILH 189
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-- 277
            D+K +NVLL S                            S   + DFG     +PD   
Sbjct: 190 GDVKADNVLLSSD--------------------------GSHAALCDFGHAVCLQPDGLG 223
Query: 278 ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                 +YI  T  + APEV+LG       D+WS  C+++ +  G
Sbjct: 224 KDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 104/233 (44%), Gaps = 37/233 (15%)
Query: 88  LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIK-KYREAAMIEIEVLQ 145
           +GE     ++  S++G G  G V +   R    ++A K++   IK   R   + E++VL 
Sbjct: 10  VGELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVL- 68
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
               H+      V     F     I I  E + G SL   L++   +  P +++ +++  
Sbjct: 69  ----HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIA 122
Query: 205 LLECIAFMHDLCMI-HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           +L  +A++ +   I H D+KP N+L+ S   IK+ D+  S                   +
Sbjct: 123 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG------------------Q 164
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
           +ID  + ++        V TR Y APE + G  ++   DIWS+G  LVEL  G
Sbjct: 165 LIDSMANSF--------VGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVG 209

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 52  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 111
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 112 L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 168
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 169 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 218
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 219 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 263
Query: 322 THENL 326
             E +
Sbjct: 264 HDEEI 268

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 27  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 86
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 87  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 143
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 144 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 193
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 194 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 238
Query: 322 THENL 326
             E +
Sbjct: 239 HDEEI 243

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 38/233 (16%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDK 152
           Y++   +G G FG+V     +  +++ A+K++     IK+   A   E   +   A    
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--- 132
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                VQ+   F    ++ +V E + G  L + +  +NY   P    R    +++  +  
Sbjct: 133 -SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY-DVPEKWARFYTAEVVLALDA 188
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H +  IH D+KP+N+LL  S ++K+ D+ + +          +M K   ++        
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM----------KMNKEGMVRC------- 231
Query: 272 YERPDQNYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEALF 320
                 +  V T  Y +PEV+   G    +   CD WSVG  L E+  G+  F
Sbjct: 232 ------DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 20  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 80  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 136
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 137 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 186
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 187 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 231
Query: 322 THENL 326
             E +
Sbjct: 232 HDEEI 236

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 41/221 (18%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNR 156
           ++G G+FG V    D    E+VAIK +    K      +  + E+  LQ+L +H      
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPN---- 76
Query: 157 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
            +Q R  +   +   +V E    S  D L  +      +++   +    L+ +A++H   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLHSHN 135
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           MIH D+K  N+LL                            +   +K+ DFGS +   P 
Sbjct: 136 MIHRDVKAGNILL---------------------------SEPGLVKLGDFGSASIMAP- 167
Query: 277 QNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELC 314
            N  V T ++ APEVIL +    +    D+WS+G   +EL 
Sbjct: 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 112/250 (44%), Gaps = 45/250 (18%)
Query: 93  TSRYKIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYRE---AAMIEIEVLQQLA 148
            S   + +++G G+FG V +  W  +    VA+KI++ +    E   A   E+ VL++  
Sbjct: 35  ASEVMLSTRIGSGSFGTVYKGKWHGD----VAVKILKVVDPTPEQFQAFRNEVAVLRK-- 88
Query: 149 KHDKGGNRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
                  R V I  +  Y  ++++ IV +   GSSLY  L     + F +  + +IARQ 
Sbjct: 89  ------TRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETK-FQMFQLIDIARQT 141
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
            + + ++H   +IH D+K  N+ L     +K+ D+  +    + S               
Sbjct: 142 AQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS--------------- 186
Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQT 322
             GS   E+P  + +     + APEVI       +++  D++S G +L EL TGE  +  
Sbjct: 187 --GSQQVEQPTGSVL-----WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH 239
Query: 323 HENLEHLAMM 332
             N + +  M
Sbjct: 240 INNRDQIIFM 249

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 19  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 78
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 79  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 135
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 136 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 185
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 186 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 230
Query: 322 THENL 326
             E +
Sbjct: 231 HDEEI 235

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 20  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 80  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 136
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 137 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 186
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 187 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 231
Query: 322 THENL 326
             E +
Sbjct: 232 HDEEI 236

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 102 MGEGTFGQV-LECWDRERK---EMVAIKIVRGIK--KYREAAMIEIEVLQQLA-KHDKGG 154
           +GEG FG+V L C+D       EMVA+K ++     ++R     EI++L+ L  +H    
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             C +       +  + + +  LGS L D+L ++   S  +  +   A+Q+ E +A++H 
Sbjct: 99  KGCCEDAGAASLQ--LVMEYVPLGS-LRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA 152
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
              IH DL   NVLL +   +K+ D+  +   P+    ++                   R
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRV------------------R 194
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
            D +   S   + APE +    + Y  D+WS G  L EL T
Sbjct: 195 EDGD---SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 47  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 106
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 107 L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 163
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 164 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 213
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 214 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 258
Query: 322 THENL 326
             E +
Sbjct: 259 HDEEI 263

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 20  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 80  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 136
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 137 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 186
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 187 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 231
Query: 322 THENL 326
             E +
Sbjct: 232 HDEEI 236

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 5   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 65  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 121
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 122 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 171
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 172 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 216
Query: 322 THENL 326
             E +
Sbjct: 217 HDEEI 221

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 19  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 78
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 79  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 135
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 136 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 185
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 186 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 230
Query: 322 THENL 326
             E +
Sbjct: 231 HDEEI 235

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 4   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 63
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 64  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 120
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 121 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 170
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 171 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 215
Query: 322 THENL 326
             E +
Sbjct: 216 HDEEI 220

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 47  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 106
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 107 L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 163
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 164 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 213
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 214 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 258
Query: 322 THENL 326
             E +
Sbjct: 259 HDEEI 263

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 92  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 148
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 149 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 198
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 199 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 243
Query: 322 THENL 326
             E +
Sbjct: 244 HDEEI 248

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 93  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 149
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 150 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 199
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 200 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 244
Query: 322 THENL 326
             E +
Sbjct: 245 HDEEI 249

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 5   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 65  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 121
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 122 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 171
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 172 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 216
Query: 322 THENL 326
             E +
Sbjct: 217 HDEEI 221

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 93  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 149
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 150 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 199
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 200 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 244
Query: 322 THENL 326
             E +
Sbjct: 245 HDEEI 249

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 92  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 148
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 149 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 198
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 199 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 243
Query: 322 THENL 326
             E +
Sbjct: 244 HDEEI 248

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 93  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 149
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 150 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 199
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 200 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 244
Query: 322 THENL 326
             E +
Sbjct: 245 HDEEI 249

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 5   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 65  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 121
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 122 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 171
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 172 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 216
Query: 322 THENL 326
             E +
Sbjct: 217 HDEEI 221

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 33  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 93  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 149
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 150 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 199
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 200 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 244
Query: 322 THENL 326
             E +
Sbjct: 245 HDEEI 249

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 92  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 148
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 149 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 198
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 199 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 243
Query: 322 THENL 326
             E +
Sbjct: 244 HDEEI 248

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 32  EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 92  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 148
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 149 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 198
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 199 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 243
Query: 322 THENL 326
             E +
Sbjct: 244 HDEEI 248

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/254 (21%), Positives = 112/254 (44%), Gaps = 53/254 (20%)
Query: 73  PPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK- 131
           PP  ++++D ++           ++I   +G+G+FG+V      + K+M A+K +   K 
Sbjct: 3   PPVFDENEDVNF---------DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC 53
Query: 132 -KYREAAMI--EIEVLQQLAKHDKGGNRCVQIRNWFDYRNH---ICIVFEKLGSSLYDFL 185
            +  E   +  E++++Q       G      +  W+ +++      +V   LG  L   L
Sbjct: 54  VERNEVRNVFKELQIMQ-------GLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL 106
Query: 186 RKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 245
           ++N +  F  + V+    +L+  + ++ +  +IH D+KP+N+LL    ++ + D+  +  
Sbjct: 107 QQNVH--FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAM 164
Query: 246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCD 302
            P+++                   TT        +  T+ Y APE+     G G+++  D
Sbjct: 165 LPRETQI-----------------TT--------MAGTKPYMAPEMFSSRKGAGYSFAVD 199
Query: 303 IWSVGCILVELCTG 316
            WS+G    EL  G
Sbjct: 200 WWSLGVTAYELLRG 213

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 114/264 (43%), Gaps = 44/264 (16%)
Query: 76  REDDKDGHYMFALGENLTSRYKIHS-----KMGEGTFGQVLECWDRERKEMVAIKIVRGI 130
           +E  K+G+    +G N ++R  I +      +G+G+FG+V+    +E  ++ A+K+++  
Sbjct: 3   KESSKEGN---GIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKD 59
Query: 131 KKYR----EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFL 185
              +    E  M E  +L     H        Q+   F   + +  V E + G  L   +
Sbjct: 60  VILQDDDVECTMTEKRILSLARNHP----FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI 115
Query: 186 RKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 245
           +K+  R F     R  A +++  + F+HD  +I+ DLK +NVLL    + K+ D+     
Sbjct: 116 QKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG---- 169
Query: 246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWS 305
                     M K         G TT           T  Y APE++  + +    D W+
Sbjct: 170 ----------MCKEGICN----GVTTAT------FCGTPDYIAPEILQEMLYGPAVDWWA 209
Query: 306 VGCILVELCTGEALFQTHENLEHL 329
           +G +L E+  G A F+  EN + L
Sbjct: 210 MGVLLYEMLCGHAPFEA-ENEDDL 232

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 105/245 (42%), Gaps = 36/245 (14%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVL 144
           E L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+
Sbjct: 3   EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 62
Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIA 202
             L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R   
Sbjct: 63  L-LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFF 119
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            Q+LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y         
Sbjct: 120 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY--------- 169
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
               DF  T    P +       H R+  V            WS+G +L ++  G+  F+
Sbjct: 170 ---TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFE 214
Query: 322 THENL 326
             E +
Sbjct: 215 HDEEI 219

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 98/228 (42%), Gaps = 30/228 (13%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++I   +G+G FG V    +++   +VA+K++   +  +E    ++    ++  H    N
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 156 RCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             +++ N+F  R  I ++ E      LY  L+K+   +F       I  +L + + + H 
Sbjct: 85  -ILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC--TFDEQRTATIMEELADALMYCHG 141
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             +IH D+KPEN+LL     +K+ D+  S+H P      +R                   
Sbjct: 142 KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPS----LRR------------------- 178
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
                +  T  Y  PE+I G       D+W +G +  EL  G   F++
Sbjct: 179 ---KTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFES 223

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 99/228 (43%), Gaps = 43/228 (18%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIE--VLQQLAKHD--KGGN 155
           +G G++ +VL    ++   + A+K+V+   +    +   ++ E  V +Q + H    G +
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 156 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
            C Q  +    R    I +   G  ++   R+   R  P +  R  + ++   + ++H+ 
Sbjct: 77  SCFQTES----RLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER 129
Query: 216 CMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
            +I+ DLK +NVLL S  +IK+ DY   K  L     +S F   P               
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTP--------------- 174
Query: 273 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
                NYI       APE++ G  + +  D W++G ++ E+  G + F
Sbjct: 175 -----NYI-------APEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 27/226 (11%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKG 153
           +++  ++G G FG VL    ++  E VAIK  R     K RE   +EI+++++L   +  
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 154 GNRCVQIRNWFDYRNHICIVFEKL--GSSLYDFLRK-NNYRSFPIDLVREIARQLLECIA 210
             R V         N + ++  +   G  L  +L +  N        +R +   +   + 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H+  +IH DLKPEN++L        P  +  +H   D  Y K +         D G  
Sbjct: 136 YLHENRIIHRDLKPENIVL-------QPGPQRLIHKIIDLGYAKEL---------DQGEL 179
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
             E       V T  Y APE++    +T   D WS G +  E  TG
Sbjct: 180 CTE------FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 99/228 (43%), Gaps = 43/228 (18%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIE--VLQQLAKHD--KGGN 155
           +G G++ +VL    ++   + A+K+V+   +    +   ++ E  V +Q + H    G +
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 156 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
            C Q  +    R    I +   G  ++   R+   R  P +  R  + ++   + ++H+ 
Sbjct: 73  SCFQTES----RLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER 125
Query: 216 CMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
            +I+ DLK +NVLL S  +IK+ DY   K  L     +S F   P               
Sbjct: 126 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTP--------------- 170
Query: 273 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
                NYI       APE++ G  + +  D W++G ++ E+  G + F
Sbjct: 171 -----NYI-------APEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 36/243 (14%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVLQQ 146
           L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+  
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL- 60
Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIARQ 204
           L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R    Q
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQ 118
Query: 205 LLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           +LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y           
Sbjct: 119 VLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY----------- 166
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
             DF  T    P +       H R+  V            WS+G +L ++  G+  F+  
Sbjct: 167 -TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFEHD 213
Query: 324 ENL 326
           E +
Sbjct: 214 EEI 216

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 102/235 (43%), Gaps = 44/235 (18%)
Query: 101 KMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           ++G G FG V L  W    K+ VAIK +R      E  + E EV+ +L+ H K     VQ
Sbjct: 17  EIGSGQFGLVHLGYW--LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPK----LVQ 69
Query: 160 IRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           +      +  IC+VFE +    L D+LR      F  + +  +   + E +A++ + C+I
Sbjct: 70  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVI 128
Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 278
           H DL   N L+                            ++  IKV DFG T +   DQ 
Sbjct: 129 HRDLAARNCLV---------------------------GENQVIKVSDFGMTRFVLDDQ- 160
Query: 279 YIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 327
           Y  ST       + +PEV     ++   D+WS G ++ E+ + G+  ++   N E
Sbjct: 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 215

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 27/226 (11%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKG 153
           +++  ++G G FG VL    ++  E VAIK  R     K RE   +EI+++++L   +  
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 154 GNRCVQIRNWFDYRNHICIVFEKL--GSSLYDFLRK-NNYRSFPIDLVREIARQLLECIA 210
             R V         N + ++  +   G  L  +L +  N        +R +   +   + 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H+  +IH DLKPEN++L        P  +  +H   D  Y K +         D G  
Sbjct: 137 YLHENRIIHRDLKPENIVL-------QPGPQRLIHKIIDLGYAKEL---------DQGEL 180
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
             E       V T  Y APE++    +T   D WS G +  E  TG
Sbjct: 181 CTE------FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 47/227 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGGNRCVQI 160
           +GEG +G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+        +
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE-------NV 67
Query: 161 RNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++ +R    I +  L    G  L+D +  +     P    +    QL+  + ++H + 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           + H D+KPEN+LL         D + +L                  K+ DFG  T  R +
Sbjct: 126 ITHRDIKPENLLL---------DERDNL------------------KISDFGLATVFRYN 158
Query: 277 Q-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
                 N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 47/227 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGGNRCVQI 160
           +GEG +G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+        +
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE-------NV 66
Query: 161 RNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++ +R    I +  L    G  L+D +  +     P    +    QL+  + ++H + 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           + H D+KPEN+LL         D + +L                  K+ DFG  T  R +
Sbjct: 125 ITHRDIKPENLLL---------DERDNL------------------KISDFGLATVFRYN 157
Query: 277 Q-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
                 N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 102/235 (43%), Gaps = 44/235 (18%)
Query: 101 KMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           ++G G FG V L  W    K+ VAIK +R      E  + E EV+ +L+ H K     VQ
Sbjct: 14  EIGSGQFGLVHLGYW--LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPK----LVQ 66
Query: 160 IRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           +      +  IC+VFE +    L D+LR      F  + +  +   + E +A++ + C+I
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVI 125
Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 278
           H DL   N L+                            ++  IKV DFG T +   DQ 
Sbjct: 126 HRDLAARNCLV---------------------------GENQVIKVSDFGMTRFVLDDQ- 157
Query: 279 YIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 327
           Y  ST       + +PEV     ++   D+WS G ++ E+ + G+  ++   N E
Sbjct: 158 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 212

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 102/235 (43%), Gaps = 44/235 (18%)
Query: 101 KMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           ++G G FG V L  W    K+ VAIK +R      E  + E EV+ +L+ H K     VQ
Sbjct: 12  EIGSGQFGLVHLGYW--LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPK----LVQ 64
Query: 160 IRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           +      +  IC+VFE +    L D+LR      F  + +  +   + E +A++ + C+I
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 278
           H DL   N L+                            ++  IKV DFG T +   DQ 
Sbjct: 124 HRDLAARNCLV---------------------------GENQVIKVSDFGMTRFVLDDQ- 155
Query: 279 YIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 327
           Y  ST       + +PEV     ++   D+WS G ++ E+ + G+  ++   N E
Sbjct: 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 99/228 (43%), Gaps = 43/228 (18%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIE--VLQQLAKHD--KGGN 155
           +G G++ +VL    ++   + A+K+V+   +    +   ++ E  V +Q + H    G +
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 156 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
            C Q  +    R    I +   G  ++   R+   R  P +  R  + ++   + ++H+ 
Sbjct: 88  SCFQTES----RLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER 140
Query: 216 CMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
            +I+ DLK +NVLL S  +IK+ DY   K  L     +S F   P               
Sbjct: 141 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTP--------------- 185
Query: 273 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
                NYI       APE++ G  + +  D W++G ++ E+  G + F
Sbjct: 186 -----NYI-------APEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 36/243 (14%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVLQQ 146
           L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+  
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL- 60
Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIARQ 204
           L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R    Q
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQ 118
Query: 205 LLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           +LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y           
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY----------- 166
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
             DF  T    P +       H R+  V            WS+G +L ++  G+  F+  
Sbjct: 167 -TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFEHD 213
Query: 324 ENL 326
           E +
Sbjct: 214 EEI 216

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 109/278 (39%), Gaps = 57/278 (20%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKI-----VRGIKKYREAAMIEIEVL 144
           E   + Y++   +G+G FG V        +  VAIK+     V G     ++    +EV 
Sbjct: 27  EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV- 85
Query: 145 QQLAKHDKGGNR--CVQIRNWFDYRNHICIVFEKL--GSSLYDFL-RKNNYRSFPIDLVR 199
             L K   GG     +++ +WF+ +    +V E+      L+D++  K      P    R
Sbjct: 86  ALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP---SR 142
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
               Q++  I   H   ++H D+K EN+L+                            + 
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--------------------------RR 176
Query: 260 SAIKVIDFGSTT--YERPDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTG 316
              K+IDFGS    ++ P  ++   TR Y  PE I    +   P  +WS+G +L ++  G
Sbjct: 177 GCAKLIDFGSGALLHDEPYTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235
Query: 317 EALFQ-------------THENLEHLAMMERVLGPLPQ 341
           +  F+              H + +  A++ R L P P 
Sbjct: 236 DIPFERDQEILEAELHFPAHVSPDCCALIRRCLAPKPS 273

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 36/243 (14%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYRE---AAMIEIEVLQQ 146
           L S+Y++   +G G FG V           VAIK V    I  + E      + +EV+  
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL- 60
Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIARQ 204
           L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R    Q
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQ 118
Query: 205 LLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           +LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y           
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY----------- 166
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
             DF  T    P +       H R+  V            WS+G +L ++  G+  F+  
Sbjct: 167 -TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFEHD 213
Query: 324 ENL 326
           E +
Sbjct: 214 EEI 216

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 47/227 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGGNRCVQI 160
           +GEG +G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+        +
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE-------NV 67
Query: 161 RNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++ +R    I +  L    G  L+D +  +     P    +    QL+  + ++H + 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           + H D+KPEN+LL         D + +L                  K+ DFG  T  R +
Sbjct: 126 ITHRDIKPENLLL---------DERDNL------------------KISDFGLATVFRYN 158
Query: 277 Q-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
                 N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 159 NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 47/227 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGGNRCVQI 160
           +GEG +G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+        +
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE-------NV 66
Query: 161 RNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++ +R    I +  L    G  L+D +  +     P    +    QL+  + ++H + 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           + H D+KPEN+LL         D + +L                  K+ DFG  T  R +
Sbjct: 125 ITHRDIKPENLLL---------DERDNL------------------KISDFGLATVFRYN 157
Query: 277 Q-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
                 N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 47/227 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGGNRCVQI 160
           +GEG +G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+        +
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE-------NV 66
Query: 161 RNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++ +R    I +  L    G  L+D +  +     P    +    QL+  + ++H + 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           + H D+KPEN+LL         D + +L                  K+ DFG  T  R +
Sbjct: 125 ITHRDIKPENLLL---------DERDNL------------------KISDFGLATVFRYN 157
Query: 277 Q-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
                 N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 80/343 (23%), Positives = 136/343 (39%), Gaps = 70/343 (20%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK 149
           +NL    KI   +G G+ G V+     + +  VA+K  R +  + + A++EI++L +   
Sbjct: 32  KNLVVSEKI---LGYGSSGTVVFQGSFQGRP-VAVK--RMLIDFCDIALMEIKLLTESDD 85
Query: 150 H-DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE-----IAR 203
           H +     C +  + F Y     I  E    +L D +   N     + L +E     + R
Sbjct: 86  HPNVIRYYCSETTDRFLY-----IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR 140
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+   +A +H L +IH DLKP+N+L+ +S          + +     S F         K
Sbjct: 141 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF------GLCK 194
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVI---LGLGWTYPCDIWSVGCILVELCTGEALF 320
            +D G   + R + N    T  +RAPE++        T   DI+S+GC+   + +     
Sbjct: 195 KLDSGQXXF-RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSK---- 249
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
                           G  P           +KY R   +           I+ +  L  
Sbjct: 250 ----------------GKHP---------FGDKYSRESNI-----------IRGIFSLDE 273
Query: 381 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           ++ L   H      + T L+  ++ +DP  R TA + LRHP F
Sbjct: 274 MKCL---HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 80/343 (23%), Positives = 136/343 (39%), Gaps = 70/343 (20%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK 149
           +NL    KI   +G G+ G V+     + +  VA+K  R +  + + A++EI++L +   
Sbjct: 32  KNLVVSEKI---LGYGSSGTVVFQGSFQGRP-VAVK--RMLIDFCDIALMEIKLLTESDD 85
Query: 150 H-DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE-----IAR 203
           H +     C +  + F Y     I  E    +L D +   N     + L +E     + R
Sbjct: 86  HPNVIRYYCSETTDRFLY-----IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR 140
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+   +A +H L +IH DLKP+N+L+ +S          + +     S F         K
Sbjct: 141 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF------GLCK 194
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVI---LGLGWTYPCDIWSVGCILVELCTGEALF 320
            +D G   + R + N    T  +RAPE++        T   DI+S+GC+   + +     
Sbjct: 195 KLDSGQXXF-RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSK---- 249
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
                           G  P           +KY R   +           I+ +  L  
Sbjct: 250 ----------------GKHP---------FGDKYSRESNI-----------IRGIFSLDE 273
Query: 381 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           ++ L   H      + T L+  ++ +DP  R TA + LRHP F
Sbjct: 274 MKCL---HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 80/347 (23%), Positives = 138/347 (39%), Gaps = 74/347 (21%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK 149
           +NL    KI   +G G+ G V+     + +  VA+K  R +  + + A++EI++L +   
Sbjct: 14  KNLVVSEKI---LGYGSSGTVVFQGSFQGRP-VAVK--RMLIDFCDIALMEIKLLTESDD 67
Query: 150 H-DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE-----IAR 203
           H +     C +  + F Y     I  E    +L D +   N     + L +E     + R
Sbjct: 68  HPNVIRYYCSETTDRFLY-----IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+   +A +H L +IH DLKP+N+L+ +S          + +     S F         K
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF------GLCK 176
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG-------WTYPCDIWSVGCILVELCTG 316
            +D G +++ R + N    T  +RAPE++            T   DI+S+GC+   + + 
Sbjct: 177 KLDSGQSSF-RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 376
                               G  P           +KY R   +           I+ + 
Sbjct: 236 --------------------GKHP---------FGDKYSRESNI-----------IRGIF 255
Query: 377 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
            L  ++ L   H      + T L+  ++ +DP  R TA + LRHP F
Sbjct: 256 SLDEMKCL---HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 47/227 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGGNRCVQI 160
           +GEG +G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+        +
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE-------NV 67
Query: 161 RNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++ +R    I +  L    G  L+D +  +     P    +    QL+  + ++H + 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           + H D+KPEN+LL         D + +L                  K+ DFG  T  R +
Sbjct: 126 ITHRDIKPENLLL---------DERDNL------------------KISDFGLATVFRYN 158
Query: 277 Q-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
                 N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 47/227 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGGNRCVQI 160
           +GEG +G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+        +
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE-------NV 67
Query: 161 RNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++ +R    I +  L    G  L+D +  +     P    +    QL+  + ++H + 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           + H D+KPEN+LL         D + +L                  K+ DFG  T  R +
Sbjct: 126 ITHRDIKPENLLL---------DERDNL------------------KISDFGLATVFRYN 158
Query: 277 Q-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
                 N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 47/227 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGGNRCVQI 160
           +GEG +G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+        +
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE-------NV 67
Query: 161 RNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++ +R    I +  L    G  L+D +  +     P    +    QL+  + ++H + 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           + H D+KPEN+LL         D + +L                  K+ DFG  T  R +
Sbjct: 126 ITHRDIKPENLLL---------DERDNL------------------KISDFGLATVFRYN 158
Query: 277 Q-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
                 N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 47/227 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGGNRCVQI 160
           +GEG +G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+        +
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE-------NV 66
Query: 161 RNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++ +R    I +  L    G  L+D +  +     P    +    QL+  + ++H + 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           + H D+KPEN+LL         D + +L                  K+ DFG  T  R +
Sbjct: 125 ITHRDIKPENLLL---------DERDNL------------------KISDFGLATVFRYN 157
Query: 277 Q-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
                 N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 103/228 (45%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 151
           K   ++G+G FG V  C          E+VA+K ++   +++      EIE+L+ L +HD
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 71
Query: 152 KGGNRCVQIRN--WFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
                 V+ +   +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + 
Sbjct: 72  N----IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKG 126
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDF 267
           + ++     IH DL   N+L+ +   +K+ D+  +   P+D  +FK + P  S I     
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI----- 181
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             + APE +    ++   D+WS G +L EL T
Sbjct: 182 -----------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 42/239 (17%)
Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG 153
           +RY++  K+G G+FG +    D    E VAIK+   +K       IE ++ + +    +G
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMM----QG 61
Query: 154 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
           G     IR      ++  +V E LG SL D     + R F +  V  +A Q++  I ++H
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH 120
Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG----- 268
               IH D+KP+N L+   +                        K + + +IDFG     
Sbjct: 121 SKNFIHRDVKPDNFLMGLGK------------------------KGNLVYIIDFGLAKKY 156
Query: 269 --STTYE----RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
             + T++    R ++N +  T  Y +    LG+  +   D+ S+G +L+    G   +Q
Sbjct: 157 RDARTHQHIPYRENKN-LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 47/227 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGGNRCVQI 160
           +GEG +G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+        +
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE-------NV 66
Query: 161 RNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++ +R    I +  L    G  L+D +  +     P    +    QL+  + ++H + 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           + H D+KPEN+LL         D + +L                  K+ DFG  T  R +
Sbjct: 125 ITHRDIKPENLLL---------DERDNL------------------KISDFGLATVFRYN 157
Query: 277 Q-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
                 N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 47/227 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGGNRCVQI 160
           +GEG +G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+        +
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE-------NV 65
Query: 161 RNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++ +R    I +  L    G  L+D +  +     P    +    QL+  + ++H + 
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           + H D+KPEN+LL         D + +L                  K+ DFG  T  R +
Sbjct: 124 ITHRDIKPENLLL---------DERDNL------------------KISDFGLATVFRYN 156
Query: 277 Q-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
                 N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 67/286 (23%), Positives = 123/286 (43%), Gaps = 41/286 (14%)
Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           K+  ++G G  G+V   +     + VA+K ++      +A + E  +++QL        R
Sbjct: 16  KLVERLGAGQAGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQ-----R 69
Query: 157 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
            V++      +  I I+ E +   SL DFL+  +     I+ + ++A Q+ E +AF+ + 
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
             IH DL+  N+L+  +   K+ D+  +    +D+    R      IK            
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLA-RLIEDAEXTAREGAKFPIK------------ 175
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 334
                     + APE I    +T   D+WS G +L E+ T G   +    N E +  +ER
Sbjct: 176 ----------WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
Query: 335 VLGPLPQHMLKRVDRHAEKYVRRGRLDW---PEGAASRESIKSVMK 377
                  + + R D   E+  +  RL W   PE   + + ++SV++
Sbjct: 226 ------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 88/225 (39%), Gaps = 46/225 (20%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           ++G G+FG+V    D++     A+K VR ++ +R   ++    L           R V +
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVR-LEVFRVEELVACAGLSS--------PRIVPL 129
Query: 161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                    + I  E L G SL   +++      P D       Q LE + ++H   ++H
Sbjct: 130 YGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILH 187
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-- 277
            D+K +NVLL S                            S   + DFG     +PD   
Sbjct: 188 GDVKADNVLLSSD--------------------------GSRAALCDFGHALCLQPDGLG 221
Query: 278 ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                 +YI  T  + APEV++G       DIWS  C+++ +  G
Sbjct: 222 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 42/239 (17%)
Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG 153
           +RY++  K+G G+FG +    D    E VAIK+   +K       IE ++ + +    +G
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMM----QG 63
Query: 154 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
           G     IR      ++  +V E LG SL D     + R F +  V  +A Q++  I ++H
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH 122
Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG----- 268
               IH D+KP+N L+   +                        K + + +IDFG     
Sbjct: 123 SKNFIHRDVKPDNFLMGLGK------------------------KGNLVYIIDFGLAKKY 158
Query: 269 --STTYE----RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
             + T++    R ++N +  T  Y +    LG+  +   D+ S+G +L+    G   +Q
Sbjct: 159 RDARTHQHIPYRENKN-LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 216

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 47/227 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGGNRCVQI 160
           +GEG +G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+        +
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE-------NV 67
Query: 161 RNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++ +R    I +  L    G  L+D +  +     P    +    QL+  + ++H + 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           + H D+KPEN+LL         D + +L                  K+ DFG  T  R +
Sbjct: 126 ITHRDIKPENLLL---------DERDNL------------------KISDFGLATVFRYN 158
Query: 277 Q-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
                 N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 47/227 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGGNRCVQI 160
           +GEG +G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+        +
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE-------NV 66
Query: 161 RNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++ +R    I +  L    G  L+D +  +     P    +    QL+  + ++H + 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           + H D+KPEN+LL         D + +L                  K+ DFG  T  R +
Sbjct: 125 ITHRDIKPENLLL---------DERDNL------------------KISDFGLATVFRYN 157
Query: 277 Q-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
                 N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/276 (21%), Positives = 119/276 (43%), Gaps = 51/276 (18%)
Query: 58  TSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTS----RYKIHSKMGEGTFGQVLEC 113
           T+ +L+ +G   +G     E++K+       G+  +S     + +   +G G++ +VL  
Sbjct: 16  TTENLYFQGAMGSGI----EEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLV 71
Query: 114 WDRERKEMVAIKIVRG--IKKYREAAMIEIE--VLQQLAKHD--KGGNRCVQIRNWFDYR 167
             ++   + A+++V+   +    +   ++ E  V +Q + H    G + C Q  +    R
Sbjct: 72  RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----R 127
Query: 168 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENV 227
               I +   G  ++   R+   R  P +  R  + ++   + ++H+  +I+ DLK +NV
Sbjct: 128 LFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184
Query: 228 LLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR 284
           LL S  +IK+ DY   K  L     +S F   P                    NYI    
Sbjct: 185 LLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP--------------------NYI---- 220
Query: 285 HYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
              APE++ G  + +  D W++G ++ E+  G + F
Sbjct: 221 ---APEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 25/232 (10%)
Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKG 153
           R ++   + EG F  V E  D       A+K +   ++ +  A+I E+  +++L+ H   
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 154 GNRC----VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRS-FPIDLVREIARQLLEC 208
              C    +        +    ++ E     L +FL+K   R     D V +I  Q    
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 209 IAFMH--DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
           +  MH     +IH DLK EN+LL +   IK+ D+ S+        Y     + + ++   
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE--- 205
Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPC----DIWSVGCILVELC 314
                 E   +N   +T  YR PE+I  L   +P     DIW++GCIL  LC
Sbjct: 206 ------EEITRN---TTPMYRTPEII-DLYSNFPIGEKQDIWALGCILYLLC 247

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 54/121 (44%), Gaps = 21/121 (17%)
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E+     + + F H   +IH D+KP N+L+ ++  +KV D+                   
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDF------------------G 161
Query: 260 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
            A  + D G++  +      ++ T  Y +PE   G       D++S+GC+L E+ TGE  
Sbjct: 162 IARAIADSGNSVXQ---TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
Query: 320 F 320
           F
Sbjct: 219 F 219

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 74/339 (21%), Positives = 134/339 (39%), Gaps = 87/339 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHD 151
           + +H  +G G FG+V  C   +  +M A+K +      +K+    A+ E  +L  ++  D
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 249
Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                C+     F   + +  + + + G  L+  L ++    F    +R  A +++  + 
Sbjct: 250 CPFIVCMSYA--FHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLE 305
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
            MH+  +++ DLKP N+LL    ++++ D   +        + K+ P +S          
Sbjct: 306 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHAS---------- 349
Query: 271 TYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
                     V T  Y APEV+  G+ +    D +S+GC+L +L  G + F+ H      
Sbjct: 350 ----------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH------ 393
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
                          K  D+H                  R ++   ++LP          
Sbjct: 394 ---------------KTKDKH---------------EIDRMTLTMAVELP---------- 413
Query: 390 DHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
           D  + +L  LL+GLL+ D   RL      A+E    PFF
Sbjct: 414 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 452

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 74/339 (21%), Positives = 134/339 (39%), Gaps = 87/339 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHD 151
           + +H  +G G FG+V  C   +  +M A+K +      +K+    A+ E  +L  ++  D
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                C+     F   + +  + + + G  L+  L ++    F    +R  A +++  + 
Sbjct: 251 CPFIVCMSYA--FHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLE 306
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
            MH+  +++ DLKP N+LL    ++++ D   +        + K+ P +S          
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHAS---------- 350
Query: 271 TYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
                     V T  Y APEV+  G+ +    D +S+GC+L +L  G + F+ H      
Sbjct: 351 ----------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH------ 394
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
                          K  D+H                  R ++   ++LP          
Sbjct: 395 ---------------KTKDKH---------------EIDRMTLTMAVELP---------- 414
Query: 390 DHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
           D  + +L  LL+GLL+ D   RL      A+E    PFF
Sbjct: 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 47/227 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGGNRCVQI 160
           +GEG +G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+        +
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE-------NV 66
Query: 161 RNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             ++ +R    I +  L    G  L+D +  +     P    +    QL+  + ++H + 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           + H D+KPEN+LL         D + +L                  K+ DFG  T  R +
Sbjct: 125 ITHRDIKPENLLL---------DERDNL------------------KISDFGLATVFRYN 157
Query: 277 Q-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
                 N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 74/339 (21%), Positives = 134/339 (39%), Gaps = 87/339 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHD 151
           + +H  +G G FG+V  C   +  +M A+K +      +K+    A+ E  +L  ++  D
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                C+     F   + +  + + + G  L+  L ++    F    +R  A +++  + 
Sbjct: 251 CPFIVCMSYA--FHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLE 306
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
            MH+  +++ DLKP N+LL    ++++ D   +        + K+ P +S          
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHAS---------- 350
Query: 271 TYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
                     V T  Y APEV+  G+ +    D +S+GC+L +L  G + F+ H      
Sbjct: 351 ----------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH------ 394
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
                          K  D+H                  R ++   ++LP          
Sbjct: 395 ---------------KTKDKH---------------EIDRMTLTMAVELP---------- 414
Query: 390 DHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
           D  + +L  LL+GLL+ D   RL      A+E    PFF
Sbjct: 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 74/339 (21%), Positives = 134/339 (39%), Gaps = 87/339 (25%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHD 151
           + +H  +G G FG+V  C   +  +M A+K +      +K+    A+ E  +L  ++  D
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                C+     F   + +  + + + G  L+  L ++    F    +R  A +++  + 
Sbjct: 251 CPFIVCMSYA--FHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLE 306
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
            MH+  +++ DLKP N+LL    ++++ D   +        + K+ P +S          
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHAS---------- 350
Query: 271 TYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
                     V T  Y APEV+  G+ +    D +S+GC+L +L  G + F+ H      
Sbjct: 351 ----------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH------ 394
Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
                          K  D+H                  R ++   ++LP          
Sbjct: 395 ---------------KTKDKH---------------EIDRMTLTMAVELP---------- 414
Query: 390 DHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
           D  + +L  LL+GLL+ D   RL      A+E    PFF
Sbjct: 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 34/221 (15%)
Query: 102 MGEGTFGQV-LECWDRERK---EMVAIKIVR--GIKKYREAAMIEIEVLQQLA-KHDKGG 154
           +GEG FG+V L C+D       EMVA+K ++     + R     EIE+L+ L  +H    
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             C + +   +    + + +  LGS L D+L ++      +  +   A+Q+ E +A++H 
Sbjct: 76  KGCCEDQG--EKSVQLVMEYVPLGS-LRDYLPRH---CVGLAQLLLFAQQICEGMAYLHA 129
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
              IH  L   NVLL +   +K+ D+  +   P+   Y++                   R
Sbjct: 130 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV------------------R 171
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
            D +   S   + APE +    + Y  D+WS G  L EL T
Sbjct: 172 EDGD---SPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 34/221 (15%)
Query: 102 MGEGTFGQV-LECWDRERK---EMVAIKIVR--GIKKYREAAMIEIEVLQQLA-KHDKGG 154
           +GEG FG+V L C+D       EMVA+K ++     + R     EIE+L+ L  +H    
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             C + +   +    + + +  LGS L D+L ++      +  +   A+Q+ E +A++H 
Sbjct: 77  KGCCEDQG--EKSVQLVMEYVPLGS-LRDYLPRH---CVGLAQLLLFAQQICEGMAYLHA 130
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
              IH  L   NVLL +   +K+ D+  +   P+   Y++                   R
Sbjct: 131 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV------------------R 172
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
            D +   S   + APE +    + Y  D+WS G  L EL T
Sbjct: 173 EDGD---SPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 47/233 (20%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGG 154
           + +   +GEG +G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 64
Query: 155 NRCVQIRNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  + 
Sbjct: 65  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVV 118
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H + + H D+KPEN+LL         D + +L                  K+ DFG  
Sbjct: 119 YLHGIGITHRDIKPENLLL---------DERDNL------------------KISDFGLA 151
Query: 271 TYERPDQ-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
           T  R +      N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 152 TVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 88/225 (39%), Gaps = 46/225 (20%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           ++G G+FG+V    D++     A+K VR ++ +R   ++    L           R V +
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVR-LEVFRVEELVACAGLSS--------PRIVPL 115
Query: 161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                    + I  E L G SL   +++      P D       Q LE + ++H   ++H
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILH 173
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-- 277
            D+K +NVLL S                            S   + DFG     +PD   
Sbjct: 174 GDVKADNVLLSSD--------------------------GSRAALCDFGHALCLQPDGLG 207
Query: 278 ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                 +YI  T  + APEV++G       DIWS  C+++ +  G
Sbjct: 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 47/233 (20%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGG 154
           + +   +GEG +G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 64
Query: 155 NRCVQIRNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  + 
Sbjct: 65  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVV 118
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H + + H D+KPEN+LL         D + +L                  K+ DFG  
Sbjct: 119 YLHGIGITHRDIKPENLLL---------DERDNL------------------KISDFGLA 151
Query: 271 TYERPDQ-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
           T  R +      N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 152 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 47/233 (20%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGG 154
           + +   +GEG +G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+   
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 65
Query: 155 NRCVQIRNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  + 
Sbjct: 66  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVV 119
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H + + H D+KPEN+LL         D + +L                  K+ DFG  
Sbjct: 120 YLHGIGITHRDIKPENLLL---------DERDNL------------------KISDFGLA 152
Query: 271 TYERPDQ-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
           T  R +      N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 47/233 (20%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGG 154
           + +   +GEG +G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 64
Query: 155 NRCVQIRNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  + 
Sbjct: 65  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVV 118
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H + + H D+KPEN+LL         D + +L                  K+ DFG  
Sbjct: 119 YLHGIGITHRDIKPENLLL---------DERDNL------------------KISDFGLA 151
Query: 271 TYERPDQ-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
           T  R +      N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 152 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 73/342 (21%), Positives = 139/342 (40%), Gaps = 60/342 (17%)
Query: 17  RPRKRA--RLGWDVPQAQVGLFCGQEVGNVTSFAPPRAPSDHVTSSSLFVKGVARNGSPP 74
           RP+K    R  +  PQAQ  LFC     +  + A  RA +       L    +A  G  P
Sbjct: 103 RPQKAQALRAAYLEPQAQ--LFC--SFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAP 158
Query: 75  WREDDKDGHYMFAL----------GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAI 124
           ++E     +++  L          GE+    +++   +G G FG+V  C  +   ++ A 
Sbjct: 159 FQEFLDSKYFLRFLQWKWLEAQPMGEDWFLDFRV---LGRGGFGEVFACQMKATGKLYAC 215
Query: 125 KIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSS 180
           K +   +  +    + AM+E ++L ++  H +     V +   F+ +  +C+V   +   
Sbjct: 216 KKLNKKRLKKRKGYQGAMVEKKILAKV--HSR---FIVSLAYAFETKTDLCLVMTIMNGG 270
Query: 181 -----LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 235
                +Y+    N     P  +      Q++  +  +H   +I+ DLKPENVLL     +
Sbjct: 271 DIRYHIYNVDEDNPGFQEPRAIF--YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNV 328
Query: 236 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL 295
           ++ D   ++             K+   K   +  T               + APE++LG 
Sbjct: 329 RISDLGLAVEL-----------KAGQTKTKGYAGTP-------------GFMAPELLLGE 364
Query: 296 GWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAMMERVL 336
            + +  D +++G  L E+      F+   E +E+  + +RVL
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL 406

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 88/225 (39%), Gaps = 46/225 (20%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           ++G G+FG+V    D++     A+K VR ++ +R   ++    L           R V +
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVR-LEVFRVEELVACAGLSS--------PRIVPL 131
Query: 161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                    + I  E L G SL   +++      P D       Q LE + ++H   ++H
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILH 189
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-- 277
            D+K +NVLL S                            S   + DFG     +PD   
Sbjct: 190 GDVKADNVLLSSD--------------------------GSRAALCDFGHALCLQPDGLG 223
Query: 278 ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                 +YI  T  + APEV++G       DIWS  C+++ +  G
Sbjct: 224 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 47/233 (20%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGG 154
           + +   +GEG +G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+   
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 64
Query: 155 NRCVQIRNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  + 
Sbjct: 65  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVV 118
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H + + H D+KPEN+LL         D + +L                  K+ DFG  
Sbjct: 119 YLHGIGITHRDIKPENLLL---------DERDNL------------------KISDFGLA 151
Query: 271 TYERPDQ-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
           T  R +      N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 152 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/238 (22%), Positives = 96/238 (40%), Gaps = 29/238 (12%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++I   +G G F +V     ++  ++ A+KI   + K+      E+   ++       G+
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKI---MNKWDMLKRGEVSCFREERDVLVNGD 119
Query: 156 R--CVQIRNWFDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
           R    Q+   F   N++ +V E  +G  L   L K   R  P ++ R    +++  I  +
Sbjct: 120 RRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAIDSV 178
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H L  +H D+KP+N+LL    +I++ D+ S L    D          +   ++  G+  Y
Sbjct: 179 HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD---------GTVRSLVAVGTPDY 229
Query: 273 ERPDQNYIV---STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
             P+    V          PE          CD W++G    E+  G+  F      E
Sbjct: 230 LSPEILQAVGGGPGTGSYGPE----------CDWWALGVFAYEMFYGQTPFYADSTAE 277

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 97/233 (41%), Gaps = 47/233 (20%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGG 154
           + +   +GEG +G+V    +R  +E VA+KIV   +       I+ E+ +  +  H+   
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE--- 65
Query: 155 NRCVQIRNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  + 
Sbjct: 66  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVV 119
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H + + H D+KPEN+LL         D + +L                  K+ DFG  
Sbjct: 120 YLHGIGITHRDIKPENLLL---------DERDNL------------------KISDFGLA 152
Query: 271 TYERPDQ-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
           T  R +      N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 63/141 (44%), Gaps = 22/141 (15%)
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E+     + + F H   +IH D+KP N+++ ++  +KV D+                   
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDF------------------G 161
Query: 260 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
            A  + D G++  +      ++ T  Y +PE   G       D++S+GC+L E+ TGE  
Sbjct: 162 IARAIADSGNSVTQ---TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
Query: 320 FQTHENLEHLAMMERVLGPLP 340
           F T ++ + +A       P+P
Sbjct: 219 F-TGDSPDSVAYQHVREDPIP 238

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 102/235 (43%), Gaps = 44/235 (18%)
Query: 101 KMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           ++G G FG V L  W    K+ VAIK ++      +  + E EV+ +L+ H K     VQ
Sbjct: 34  EIGSGQFGLVHLGYW--LNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLS-HPK----LVQ 86
Query: 160 IRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           +      +  IC+VFE +    L D+LR      F  + +  +   + E +A++ + C+I
Sbjct: 87  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVI 145
Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 278
           H DL   N L+                            ++  IKV DFG T +   DQ 
Sbjct: 146 HRDLAARNCLV---------------------------GENQVIKVSDFGMTRFVLDDQ- 177
Query: 279 YIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 327
           Y  ST       + +PEV     ++   D+WS G ++ E+ + G+  ++   N E
Sbjct: 178 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 232

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/121 (24%), Positives = 54/121 (44%), Gaps = 21/121 (17%)
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E+     + + F H   +IH D+KP N+++ ++  +KV D+                   
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDF------------------G 161
Query: 260 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
            A  + D G++  +      ++ T  Y +PE   G       D++S+GC+L E+ TGE  
Sbjct: 162 IARAIADSGNSVTQ---TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
Query: 320 F 320
           F
Sbjct: 219 F 219

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 100/235 (42%), Gaps = 37/235 (15%)
Query: 86  FALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIK-KYREAAMIEIEV 143
            ALGE     ++  S++G G  G V +   +    ++A K++   IK   R   + E++V
Sbjct: 1   MALGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 60
Query: 144 LQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIA 202
           L     H+      V     F     I I  E + G SL   L+K      P  ++ +++
Sbjct: 61  L-----HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVS 113
Query: 203 RQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             +++ + ++ +   ++H D+KP N+L+ S   IK+ D+  S                  
Sbjct: 114 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS------------------ 155
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                 G    E    N  V TR Y +PE + G  ++   DIWS+G  LVE+  G
Sbjct: 156 ------GQLIDEM--ANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 202

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/121 (24%), Positives = 54/121 (44%), Gaps = 21/121 (17%)
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E+     + + F H   +IH D+KP N+++ ++  +KV D+                   
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDF------------------G 161
Query: 260 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
            A  + D G++  +      ++ T  Y +PE   G       D++S+GC+L E+ TGE  
Sbjct: 162 IARAIADSGNSVTQ---TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
Query: 320 F 320
           F
Sbjct: 219 F 219

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 111/257 (43%), Gaps = 46/257 (17%)
Query: 100 SKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
            +MG GT GQV +   R+   ++A+K +R  G K+  +  +++++V+  L  HD     C
Sbjct: 31  GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV--LKSHD-----C 83
Query: 158 ---VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
              VQ    F     + I  E +G+   + L+K      P  ++ ++   +++ + ++ +
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELMGTCA-EKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 215 L-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
              +IH D+KP N+LL     IK+ D+  S     D +                      
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---------------------- 180
Query: 274 RPDQNYIVSTRHYRAPEVILGLGWTYP-----CDIWSVGCILVELCTGEALFQT-HENLE 327
              ++       Y APE I     T P      D+WS+G  LVEL TG+  ++    + E
Sbjct: 181 ---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE 237
Query: 328 HLAMMERVLGP-LPQHM 343
            L  + +   P LP HM
Sbjct: 238 VLTKVLQEEPPLLPGHM 254

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/121 (24%), Positives = 54/121 (44%), Gaps = 21/121 (17%)
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E+     + + F H   +IH D+KP N+++ ++  +KV D+                   
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDF------------------G 161
Query: 260 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
            A  + D G++  +      ++ T  Y +PE   G       D++S+GC+L E+ TGE  
Sbjct: 162 IARAIADSGNSVTQ---TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
Query: 320 F 320
           F
Sbjct: 219 F 219

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 151
           K   ++G+G FG V  C          E+VA+K ++   +++      EIE+L+ L +HD
Sbjct: 14  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 72
Query: 152 KGGNRCVQIRN--WFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
                 V+ +   +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + 
Sbjct: 73  N----IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKG 127
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDF 267
           + ++     IH +L   N+L+ +   +K+ D+  +   P+D  Y+K + P  S I     
Sbjct: 128 MEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI----- 182
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             + APE +    ++   D+WS G +L EL T
Sbjct: 183 -----------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 73/342 (21%), Positives = 139/342 (40%), Gaps = 60/342 (17%)
Query: 17  RPRKRA--RLGWDVPQAQVGLFCGQEVGNVTSFAPPRAPSDHVTSSSLFVKGVARNGSPP 74
           RP+K    R  +  PQAQ  LFC     +  + A  RA +       L    +A  G  P
Sbjct: 103 RPQKAQALRAAYLEPQAQ--LFC--SFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAP 158
Query: 75  WREDDKDGHYMFAL----------GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAI 124
           ++E     +++  L          GE+    +++   +G G FG+V  C  +   ++ A 
Sbjct: 159 FQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRV---LGRGGFGEVFACQMKATGKLYAC 215
Query: 125 KIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSS 180
           K +   +  +    + AM+E ++L ++  H +     V +   F+ +  +C+V   +   
Sbjct: 216 KKLNKKRLKKRKGYQGAMVEKKILAKV--HSR---FIVSLAYAFETKTDLCLVMTIMNGG 270
Query: 181 -----LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 235
                +Y+    N     P  +      Q++  +  +H   +I+ DLKPENVLL     +
Sbjct: 271 DIRYHIYNVDEDNPGFQEPRAIF--YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNV 328
Query: 236 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL 295
           ++ D   ++             K+   K   +  T               + APE++LG 
Sbjct: 329 RISDLGLAVEL-----------KAGQTKTKGYAGTP-------------GFMAPELLLGE 364
Query: 296 GWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAMMERVL 336
            + +  D +++G  L E+      F+   E +E+  + +RVL
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL 406

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 73/342 (21%), Positives = 139/342 (40%), Gaps = 60/342 (17%)
Query: 17  RPRKRA--RLGWDVPQAQVGLFCGQEVGNVTSFAPPRAPSDHVTSSSLFVKGVARNGSPP 74
           RP+K    R  +  PQAQ  LFC     +  + A  RA +       L    +A  G  P
Sbjct: 103 RPQKAQALRAAYLEPQAQ--LFC--SFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAP 158
Query: 75  WREDDKDGHYMFAL----------GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAI 124
           ++E     +++  L          GE+    +++   +G G FG+V  C  +   ++ A 
Sbjct: 159 FQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRV---LGRGGFGEVFACQMKATGKLYAC 215
Query: 125 KIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSS 180
           K +   +  +    + AM+E ++L ++  H +     V +   F+ +  +C+V   +   
Sbjct: 216 KKLNKKRLKKRKGYQGAMVEKKILAKV--HSR---FIVSLAYAFETKTDLCLVMTIMNGG 270
Query: 181 -----LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 235
                +Y+    N     P  +      Q++  +  +H   +I+ DLKPENVLL     +
Sbjct: 271 DIRYHIYNVDEDNPGFQEPRAIF--YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNV 328
Query: 236 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL 295
           ++ D   ++             K+   K   +  T               + APE++LG 
Sbjct: 329 RISDLGLAVEL-----------KAGQTKTKGYAGTP-------------GFMAPELLLGE 364
Query: 296 GWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAMMERVL 336
            + +  D +++G  L E+      F+   E +E+  + +RVL
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL 406

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 80/347 (23%), Positives = 136/347 (39%), Gaps = 74/347 (21%)
Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK 149
           +NL    KI   +G G+ G V+     + +  VA+K  R +  + + A++EI++L +   
Sbjct: 14  KNLVVSEKI---LGYGSSGTVVFQGSFQGRP-VAVK--RMLIDFCDIALMEIKLLTESDD 67
Query: 150 H-DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE-----IAR 203
           H +     C +  + F Y     I  E    +L D +   N     + L +E     + R
Sbjct: 68  HPNVIRYYCSETTDRFLY-----IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+   +A +H L +IH DLKP+N+L+ +S          + +     S F         K
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF------GLCK 176
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG-------WTYPCDIWSVGCILVELCTG 316
            +D G   + R + N    T  +RAPE++            T   DI+S+GC+   + + 
Sbjct: 177 KLDSGQXXF-RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 376
                               G  P           +KY R   +           I+ + 
Sbjct: 236 --------------------GKHP---------FGDKYSRESNI-----------IRGIF 255
Query: 377 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
            L  ++ L   H      + T L+  ++ +DP  R TA + LRHP F
Sbjct: 256 SLDEMKCL---HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 43/227 (18%)
Query: 100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEI---EVLQQLAKHDKGGNR 156
           +KMGEG FG V + +       VA+K        + AAM++I   E+ QQ  +  K   +
Sbjct: 37  NKMGEGGFGVVYKGY--VNNTTVAVK--------KLAAMVDITTEELKQQFDQEIKVMAK 86
Query: 157 C-----VQIRNWFDYRNHICIVFEKL-GSSLYDFLR-KNNYRSFPIDLVREIARQLLECI 209
           C     V++  +    + +C+V+  +   SL D L   +        +  +IA+     I
Sbjct: 87  CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI 146
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            F+H+   IH D+K  N+LL  +   K+ D+  +  + K                  F  
Sbjct: 147 NFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK------------------FAQ 188
Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
           T       + IV T  Y APE + G   T   DI+S G +L+E+ TG
Sbjct: 189 TVM----XSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG 230

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/278 (22%), Positives = 117/278 (42%), Gaps = 37/278 (13%)
Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           K+  ++G G FG+V   +     + VA+K ++      +A + E  +++ L +HDK    
Sbjct: 16  KLVKRLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTL-QHDK---- 69
Query: 157 CVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
            V++         I I+ E +   SL DFL+ +      +  + + + Q+ E +A++   
Sbjct: 70  LVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 129
Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
             IH DL+  NVL+  S   K+ D+  +    +D+ Y  R      IK            
Sbjct: 130 NYIHRDLRAANVLVSESLMCKIADFGLA-RVIEDNEYTAREGAKFPIK------------ 176
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 334
                     + APE I    +T   D+WS G +L E+ T G+  +    N + +  + +
Sbjct: 177 ----------WTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQ 226
Query: 335 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESI 372
                  + + RV+   ++     ++ W E A  R + 
Sbjct: 227 ------GYRMPRVENCPDELYDIMKMCWKEKAEERPTF 258

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/121 (24%), Positives = 54/121 (44%), Gaps = 21/121 (17%)
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           E+     + + F H   +IH D+KP N+++ ++  +KV D+                   
Sbjct: 137 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDF------------------G 178
Query: 260 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
            A  + D G++  +      ++ T  Y +PE   G       D++S+GC+L E+ TGE  
Sbjct: 179 IARAIADSGNSVTQ---TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235
Query: 320 F 320
           F
Sbjct: 236 F 236

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 106/243 (43%), Gaps = 41/243 (16%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHD 151
           ++I   +G G FG+V     +   ++ A+KI+   +  + A       E +VL       
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN----- 130
Query: 152 KGGNRCVQIRNW-FDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
            G ++ +   ++ F   N++ +V +  +G  L   L K   R  P ++ R    +++  I
Sbjct: 131 -GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIAI 188
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
             +H L  +H D+KP+N+L+  + +I++ D+ S L   +D +      +SS         
Sbjct: 189 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-----QSSV-------- 235
Query: 270 TTYERPDQNYIVSTRHYRAPEVIL----GLGWTYP-CDIWSVGCILVELCTGEALFQTHE 324
                      V T  Y +PE++     G G   P CD WS+G  + E+  GE  F    
Sbjct: 236 ----------AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285
Query: 325 NLE 327
            +E
Sbjct: 286 LVE 288

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 43/227 (18%)
Query: 100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEI---EVLQQLAKHDKGGNR 156
           +KMGEG FG V + +       VA+K        + AAM++I   E+ QQ  +  K   +
Sbjct: 37  NKMGEGGFGVVYKGY--VNNTTVAVK--------KLAAMVDITTEELKQQFDQEIKVMAK 86
Query: 157 C-----VQIRNWFDYRNHICIVFEKL-GSSLYDFLR-KNNYRSFPIDLVREIARQLLECI 209
           C     V++  +    + +C+V+  +   SL D L   +        +  +IA+     I
Sbjct: 87  CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI 146
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            F+H+   IH D+K  N+LL  +   K+ D+  +  + K                  F  
Sbjct: 147 NFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK------------------FAQ 188
Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
           T         IV T  Y APE + G   T   DI+S G +L+E+ TG
Sbjct: 189 TVMXX----RIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG 230

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 97/233 (41%), Gaps = 47/233 (20%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV-LQQLAKHDKGG 154
           + +   +GEG  G+V    +R  +E VA+KIV   +       I+ E+ + ++  H+   
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE--- 64
Query: 155 NRCVQIRNWFDYRNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                +  ++ +R    I +  L    G  L+D +  +     P    +    QL+  + 
Sbjct: 65  ----NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVV 118
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H + + H D+KPEN+LL         D + +L                  K+ DFG  
Sbjct: 119 YLHGIGITHRDIKPENLLL---------DERDNL------------------KISDFGLA 151
Query: 271 TYERPDQ-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGE 317
           T  R +      N +  T  Y APE++    +   P D+WS G +L  +  GE
Sbjct: 152 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 73/342 (21%), Positives = 139/342 (40%), Gaps = 60/342 (17%)
Query: 17  RPRKRA--RLGWDVPQAQVGLFCGQEVGNVTSFAPPRAPSDHVTSSSLFVKGVARNGSPP 74
           RP+K    R  +  PQAQ  LFC     +  + A  RA +       L    +A  G  P
Sbjct: 103 RPQKAQALRAAYLEPQAQ--LFC--SFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAP 158
Query: 75  WREDDKDGHYMFAL----------GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAI 124
           ++E     +++  L          GE+    +++   +G G FG+V  C  +   ++ A 
Sbjct: 159 FQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRV---LGRGGFGEVFACQMKATGKLYAC 215
Query: 125 KIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSS 180
           K +   +  +    + AM+E ++L ++  H +     V +   F+ +  +C+V   +   
Sbjct: 216 KKLNKKRLKKRKGYQGAMVEKKILAKV--HSR---FIVSLAYAFETKTDLCLVMTIMNGG 270
Query: 181 -----LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 235
                +Y+    N     P  +      Q++  +  +H   +I+ DLKPENVLL     +
Sbjct: 271 DIRYHIYNVDEDNPGFQEPRAIF--YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNV 328
Query: 236 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL 295
           ++ D   ++             K+   K   +  T               + APE++LG 
Sbjct: 329 RISDLGLAVEL-----------KAGQTKTKGYAGTP-------------GFMAPELLLGE 364
Query: 296 GWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAMMERVL 336
            + +  D +++G  L E+      F+   E +E+  + +RVL
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL 406

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 103/233 (44%), Gaps = 37/233 (15%)
Query: 88  LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIK-KYREAAMIEIEVLQ 145
           +GE     ++  S++G G  G V +   +    ++A K++   IK   R   + E++VL 
Sbjct: 62  VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL- 120
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
               H+      V     F     I I  E + G SL   L+K      P  ++ +++  
Sbjct: 121 ----HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIA 174
Query: 205 LLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           +++ + ++ +   ++H D+KP N+L+ S   IK+ D+  S                   +
Sbjct: 175 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG------------------Q 216
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
           +ID  + ++        V TR Y +PE + G  ++   DIWS+G  LVE+  G
Sbjct: 217 LIDSMANSF--------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 261

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 99/233 (42%), Gaps = 38/233 (16%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDK 152
           Y +   +G G FG+V     +  +++ A+K++     IK+   A   E   +   A    
Sbjct: 77  YDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--- 133
Query: 153 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                VQ+   F    ++ +V E + G  L + +  +NY   P    +    +++  +  
Sbjct: 134 -SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY-DVPEKWAKFYTAEVVLALDA 189
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H + +IH D+KP+N+LL    ++K+ D+ + +          +M ++  +         
Sbjct: 190 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM----------KMDETGMVHC------- 232
Query: 272 YERPDQNYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEALF 320
                 +  V T  Y +PEV+   G    +   CD WSVG  L E+  G+  F
Sbjct: 233 ------DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 96/233 (41%), Gaps = 39/233 (16%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G+FG+V+    +  +E+ AIKI++     +    E  M+E  VL  L K        
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKP----PFL 82
Query: 158 VQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMHD 214
            Q+ + F   + +  V E +  G  +Y   +   ++    +    EI+  L     F+H 
Sbjct: 83  TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLF----FLHK 138
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             +I+ DLK +NV+L S  +IK+ D+        D                  G TT E 
Sbjct: 139 RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMD------------------GVTTRE- 179
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                   T  Y APE+I    +    D W+ G +L E+  G+  F   +  E
Sbjct: 180 -----FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 227

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/228 (22%), Positives = 94/228 (41%), Gaps = 42/228 (18%)
Query: 102 MGEGTFGQVLEC----WDRERKEM-VAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGG 154
           +G G FG+V+E       +E   + VA+K+++       +EA M E++++  L +H+   
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE--- 110
Query: 155 NRCVQIRNWFDYRNHICIVFEKLG-SSLYDFLR--------KNNYRSFPIDLVREIARQL 205
              V +     +   + ++ E      L +FLR        K + R   +  +   + Q+
Sbjct: 111 -NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 169
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
            + +AF+     IH D+   NVLL +    K+ D+  +     DS+Y  +      +K  
Sbjct: 170 AQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK-- 227
Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
                               + APE I    +T   D+WS G +L E+
Sbjct: 228 --------------------WMAPESIFDCVYTVQSDVWSYGILLWEI 255

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 30/220 (13%)
Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           K+  K+G G FG+V   +     + VA+K ++      +A + E  +++ L +HDK    
Sbjct: 15  KLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTL-QHDK---- 68
Query: 157 CVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
            V++         I I+ E +   SL DFL+ +      +  + + + Q+ E +A++   
Sbjct: 69  LVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 128
Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
             IH DL+  NVL+  S   K+ D+  +    +D+ Y  R      IK            
Sbjct: 129 NYIHRDLRAANVLVSESLMCKIADFGLA-RVIEDNEYTAREGAKFPIK------------ 175
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                     + APE I    +T   ++WS G +L E+ T
Sbjct: 176 ----------WTAPEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 44/235 (18%)
Query: 101 KMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           ++G G FG V L  W    K+ VAIK +R      E  + E EV+ +L+ H K     VQ
Sbjct: 14  EIGSGQFGLVHLGYW--LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPK----LVQ 66
Query: 160 IRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           +      +  IC+VFE +    L D+LR      F  + +  +   + E +A++ +  +I
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEASVI 125
Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 278
           H DL   N L+                            ++  IKV DFG T +   DQ 
Sbjct: 126 HRDLAARNCLV---------------------------GENQVIKVSDFGMTRFVLDDQ- 157
Query: 279 YIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 327
           Y  ST       + +PEV     ++   D+WS G ++ E+ + G+  ++   N E
Sbjct: 158 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 212

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 44/235 (18%)
Query: 101 KMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           ++G G FG V L  W    K+ VAIK +R      E  + E EV+ +L+ H K     VQ
Sbjct: 15  EIGSGQFGLVHLGYW--LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPK----LVQ 67
Query: 160 IRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           +      +  IC+V E +    L D+LR      F  + +  +   + E +A++ + C+I
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVI 126
Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 278
           H DL   N L+                            ++  IKV DFG T +   DQ 
Sbjct: 127 HRDLAARNCLV---------------------------GENQVIKVSDFGMTRFVLDDQ- 158
Query: 279 YIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 327
           Y  ST       + +PEV     ++   D+WS G ++ E+ + G+  ++   N E
Sbjct: 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/228 (22%), Positives = 94/228 (41%), Gaps = 42/228 (18%)
Query: 102 MGEGTFGQVLEC----WDRERKEM-VAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGG 154
           +G G FG+V+E       +E   + VA+K+++       +EA M E++++  L +H+   
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE--- 102
Query: 155 NRCVQIRNWFDYRNHICIVFEKLG-SSLYDFLR--------KNNYRSFPIDLVREIARQL 205
              V +     +   + ++ E      L +FLR        K + R   +  +   + Q+
Sbjct: 103 -NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 161
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
            + +AF+     IH D+   NVLL +    K+ D+  +     DS+Y  +      +K  
Sbjct: 162 AQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK-- 219
Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
                               + APE I    +T   D+WS G +L E+
Sbjct: 220 --------------------WMAPESIFDCVYTVQSDVWSYGILLWEI 247

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 107/245 (43%), Gaps = 45/245 (18%)
Query: 98  IHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKG 153
           +  ++G G+FG V +  W  +    VA+K++       +  +A   E+ VL++       
Sbjct: 28  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRK------- 76
Query: 154 GNRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
             R V I  +  Y  +  + IV +   GSSLY  L  +  + F +  + +IARQ    + 
Sbjct: 77  -TRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMD 134
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H   +IH DLK  N+ L     +K+ D+  +    + S                 GS 
Sbjct: 135 YLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS-----------------GSH 177
Query: 271 TYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
            +E+   + +     + APEVI       +++  D+++ G +L EL TG+  +    N +
Sbjct: 178 QFEQLSGSIL-----WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 232
Query: 328 HLAMM 332
            +  M
Sbjct: 233 QIIEM 237

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 96/235 (40%), Gaps = 47/235 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           +G G FG V E  ++      AIK +R   +   RE  M E++ L   AK +  G   V+
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKAL---AKLEHPG--IVR 67
Query: 160 IRNWFDYRNHICIVFEKLGSS-----LY---DFLRKNNYRSF----------PIDLVREI 201
             N +  +N      EKL  S     LY      RK N + +             +   I
Sbjct: 68  YFNAWLEKNTT----EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD---SSYFKRMPK 258
             Q+ E + F+H   ++H DLKP N+     + +KV D+       +D    +    MP 
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP- 182
Query: 259 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
                        Y R      V T+ Y +PE I G  +++  DI+S+G IL EL
Sbjct: 183 ------------AYARHTGQ--VGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 103/233 (44%), Gaps = 37/233 (15%)
Query: 88  LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIK-KYREAAMIEIEVLQ 145
           +GE     ++  S++G G  G V +   +    ++A K++   IK   R   + E++VL 
Sbjct: 27  VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL- 85
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
               H+      V     F     I I  E + G SL   L+K      P  ++ +++  
Sbjct: 86  ----HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIA 139
Query: 205 LLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           +++ + ++ +   ++H D+KP N+L+ S   IK+ D+  S                   +
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG------------------Q 181
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
           +ID  + ++        V TR Y +PE + G  ++   DIWS+G  LVE+  G
Sbjct: 182 LIDSMANSF--------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 74/339 (21%), Positives = 130/339 (38%), Gaps = 79/339 (23%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLAKHDKGGNRCVQI 160
           +GEG   +V  C +    +  A+KI+     + R     E+E+L Q   H       +++
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH----RNVLEL 76
Query: 161 RNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
             +F+  +   +VFEK+  GS L    ++ ++      +V +     L+   F+H+  + 
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALD---FLHNKGIA 133
Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG---------- 268
           H DLKPEN+L      +                        S +K+ DFG          
Sbjct: 134 HRDLKPENILCEHPNQV------------------------SPVKICDFGLGSGIKLNGD 169
Query: 269 STTYERPDQNYIVSTRHYRAPEVILGLG-----WTYPCDIWSVGCILVELCTGEALFQTH 323
            +    P+      +  Y APEV+         +   CD+WS+G IL  L +G   F   
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229
Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
              +          P  Q+ML        + ++ G+ ++P+   +               
Sbjct: 230 CGSD-CGWDRGEACPACQNMLF-------ESIQEGKYEFPDKDWA--------------- 266
Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
               H+  +A D   L+  LL  D   RL+A + L+HP+
Sbjct: 267 ----HISCAAKD---LISKLLVRDAKQRLSAAQVLQHPW 298

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 78/182 (42%), Gaps = 34/182 (18%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           YK+  ++GEG+FG + E  +    + VAIK         E    +   L+   +  K   
Sbjct: 11  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF--------EPRRSDAPQLRDEYRTYKLLA 62
Query: 156 RCVQIRNWFDYRN---HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            C  I N + +     H  +V + LG SL D L     R F +  V   A+Q+L  +  +
Sbjct: 63  GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSI 121
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H+  +++ D+KP+N L      I  P+ K+                ++ I V+DFG   +
Sbjct: 122 HEKSLVYRDIKPDNFL------IGRPNSKN----------------ANMIYVVDFGMVKF 159
Query: 273 ER 274
            R
Sbjct: 160 YR 161

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 78/182 (42%), Gaps = 34/182 (18%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           YK+  ++GEG+FG + E  +    + VAIK         E    +   L+   +  K   
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF--------EPRRSDAPQLRDEYRTYKLLA 63
Query: 156 RCVQIRNWFDYRN---HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            C  I N + +     H  +V + LG SL D L     R F +  V   A+Q+L  +  +
Sbjct: 64  GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSI 122
Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H+  +++ D+KP+N L      I  P+ K+                ++ I V+DFG   +
Sbjct: 123 HEKSLVYRDIKPDNFL------IGRPNSKN----------------ANMIYVVDFGMVKF 160
Query: 273 ER 274
            R
Sbjct: 161 YR 162

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 43/227 (18%)
Query: 100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEI---EVLQQLAKHDKGGNR 156
           +KMGEG FG V + +       VA+K        + AAM++I   E+ QQ  +  K   +
Sbjct: 31  NKMGEGGFGVVYKGY--VNNTTVAVK--------KLAAMVDITTEELKQQFDQEIKVMAK 80
Query: 157 C-----VQIRNWFDYRNHICIVFEKL-GSSLYDFLR-KNNYRSFPIDLVREIARQLLECI 209
           C     V++  +    + +C+V+  +   SL D L   +        +  +IA+     I
Sbjct: 81  CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI 140
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            F+H+   IH D+K  N+LL  +   K+ D+              R  +  A  V+    
Sbjct: 141 NFLHENHHIHRDIKSANILLDEAFTAKISDFG-----------LARASEKFAQXVM---- 185
Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                     IV T  Y APE + G   T   DI+S G +L+E+ TG
Sbjct: 186 -------XXRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG 224

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 106/245 (43%), Gaps = 45/245 (18%)
Query: 98  IHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKG 153
           +  ++G G+FG V +  W  +    VA+K++       +  +A   E+ VL++       
Sbjct: 28  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRK------- 76
Query: 154 GNRCVQIRNWFDYRN--HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
             R V I  +  Y     + IV +   GSSLY  L  +  + F +  + +IARQ    + 
Sbjct: 77  -TRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMD 134
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H   +IH DLK  N+ L     +K+ D+  +    + S                 GS 
Sbjct: 135 YLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS-----------------GSH 177
Query: 271 TYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
            +E+   + +     + APEVI       +++  D+++ G +L EL TG+  +    N +
Sbjct: 178 QFEQLSGSIL-----WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 232
Query: 328 HLAMM 332
            +  M
Sbjct: 233 QIIEM 237

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 64/133 (48%), Gaps = 5/133 (3%)
Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           ++  K+G G FG++    +    E VAIK+   IK       +E    +QL    +G   
Sbjct: 3   RVGKKIGCGNFGELRLGKNLYTNEYVAIKL-EPIKSRAPQLHLEYRFYKQLGSAGEG--- 58
Query: 157 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             Q+  +     +  +V E LG SL D     + R+F +  V  IA QLL  + ++H   
Sbjct: 59  LPQVYYFGPXGKYNAMVLELLGPSLEDLFDLCD-RTFTLKTVLMIAIQLLSRMEYVHSKN 117
Query: 217 MIHTDLKPENVLL 229
           +I+ D+KPEN L+
Sbjct: 118 LIYRDVKPENFLI 130

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 37/221 (16%)
Query: 100 SKMGEGTFGQVLECWDRERKEMVAIKIVR-GIK-KYREAAMIEIEVLQQLAKHDKGGNRC 157
           S++G G  G V +   +    ++A K++   IK   R   + E++VL     H+      
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-----HECNSPYI 66
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL- 215
           V     F     I I  E + G SL   L+K      P  ++ +++  +++ + ++ +  
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH 124
Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
            ++H D+KP N+L+ S   IK+ D+  S                   ++ID  + ++   
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSG------------------QLIDSMANSF--- 163
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                V TR Y +PE + G  ++   DIWS+G  LVE+  G
Sbjct: 164 -----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 29/180 (16%)
Query: 169 HICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD---LCMIHTDLKP 224
           ++C+V E   G  L   L     +  P D++   A Q+   + ++HD   + +IH DLK 
Sbjct: 80  NLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKS 136
Query: 225 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQNYIVST 283
            N+L++     KV +   S               +  +K+ DFG +  + R  +      
Sbjct: 137 SNILILQ----KVENGDLS---------------NKILKITDFGLAREWHRTTKMSAAGA 177
Query: 284 RHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL--EHLAMMERVLGPLPQ 341
             + APEVI    ++   D+WS G +L EL TGE  F+  + L   +   M ++  P+P 
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 58/255 (22%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           Y++   +G+G F +V              K+ R I   +E A+  I+  Q  +   +   
Sbjct: 9   YRLLKTIGKGNFAKV--------------KLARHILTGKEVAVKIIDKTQLNSSSLQKLF 54
Query: 156 RCVQIRNWFDYRNHICIVFEKL--------------GSSLYDFLRKNNYRSFPIDLVREI 201
           R V+I    ++ N I  +FE +              G  ++D+L  + +        R  
Sbjct: 55  REVRIMKVLNHPN-IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGW--MKEKEARAK 111
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            RQ++  + + H   ++H DLK EN+LL +   IK+ D+  S     + ++  ++     
Sbjct: 112 FRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDTFC- 166
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
                 GS  Y  P+   +   + Y  PEV          D+WS+G IL  L +G   F 
Sbjct: 167 ------GSPPYAAPE---LFQGKKYDGPEV----------DVWSLGVILYTLVSGSLPFD 207
Query: 322 THENLEHLAMMERVL 336
             +NL+ L   ERVL
Sbjct: 208 G-QNLKELR--ERVL 219

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 103/254 (40%), Gaps = 41/254 (16%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G+FG+V+    +   E+ A+KI++     +    E  M+E  VL    K        
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP----FL 404
Query: 158 VQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMHD 214
            Q+ + F   + +  V E +  G  +Y   +   ++    +    EIA  L     F+  
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF----FLQS 460
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             +I+ DLK +NV+L S  +IK+ D+        D                  G TT   
Sbjct: 461 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD------------------GVTT--- 499
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL-AMME 333
                   T  Y APE+I    +    D W+ G +L E+  G+A F+  +  E   ++ME
Sbjct: 500 ---KXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556
Query: 334 RVLGPLPQHMLKRV 347
             +   P+ M K  
Sbjct: 557 HNVA-YPKSMSKEA 569

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/227 (20%), Positives = 101/227 (44%), Gaps = 35/227 (15%)
Query: 98  IHSK-MGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           IH + +G+G FGQ ++   RE  E++ +K ++R  ++ +   + E++V+           
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVM----------- 61
Query: 156 RCVQIRNWFDY------RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
           RC++  N   +         +  + E +       + K+    +P       A+ +   +
Sbjct: 62  RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGM 121
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
           A++H + +IH DL   N L+  ++ + V D+  +     +    K  P+         G 
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE----KTQPE---------GL 168
Query: 270 TTYERPDQN---YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
            + ++PD+     +V   ++ APE+I G  +    D++S G +L E+
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 37/221 (16%)
Query: 100 SKMGEGTFGQVLECWDRERKEMVAIKIVR-GIK-KYREAAMIEIEVLQQLAKHDKGGNRC 157
           S++G G  G V +   +    ++A K++   IK   R   + E++VL     H+      
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-----HECNSPYI 66
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL- 215
           V     F     I I  E + G SL   L+K      P  ++ +++  +++ + ++ +  
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH 124
Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
            ++H D+KP N+L+ S   IK+ D+  S                   ++ID  + ++   
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSG------------------QLIDSMANSF--- 163
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                V TR Y +PE + G  ++   DIWS+G  LVE+  G
Sbjct: 164 -----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 37/221 (16%)
Query: 100 SKMGEGTFGQVLECWDRERKEMVAIKIVR-GIK-KYREAAMIEIEVLQQLAKHDKGGNRC 157
           S++G G  G V +   +    ++A K++   IK   R   + E++VL     H+      
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-----HECNSPYI 66
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL- 215
           V     F     I I  E + G SL   L+K      P  ++ +++  +++ + ++ +  
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH 124
Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
            ++H D+KP N+L+ S   IK+ D+  S                   ++ID  + ++   
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSG------------------QLIDSMANSF--- 163
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                V TR Y +PE + G  ++   DIWS+G  LVE+  G
Sbjct: 164 -----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRG--IKKYREAAMIEIEVLQ 145
            S  KI   +G G FG+V  C  R     +R+  VAIK ++     K R   + E  ++ 
Sbjct: 28  ASCIKIEKVIGVGEFGEV--CSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMG 85
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
           Q    +      + +         + I+ E +   SL  FLRKN+ R   I LV  + R 
Sbjct: 86  QFDHPN-----IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLV-GMLRG 139
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAI 262
           +   + ++ D+  +H DL   N+L+ S+   KV D+  S  L    +++Y  R  K    
Sbjct: 140 IGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK---- 195
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQ 321
                             +  R + APE I    +T   D+WS G ++ E+ + GE  + 
Sbjct: 196 ------------------IPIR-WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 236
Query: 322 THENLEHLAMME 333
              N + +  +E
Sbjct: 237 DMSNQDVIKAIE 248

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 103/233 (44%), Gaps = 37/233 (15%)
Query: 88  LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIK-KYREAAMIEIEVLQ 145
           +GE     ++  S++G G  G V +   +    ++A K++   IK   R   + E++VL 
Sbjct: 19  VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL- 77
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
               H+      V     F     I I  E + G SL   L+K      P  ++ +++  
Sbjct: 78  ----HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIA 131
Query: 205 LLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           +++ + ++ +   ++H D+KP N+L+ S   IK+ D+  S                   +
Sbjct: 132 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG------------------Q 173
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
           +ID  + ++        V TR Y +PE + G  ++   DIWS+G  LVE+  G
Sbjct: 174 LIDSMANSF--------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 218

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 79/334 (23%), Positives = 132/334 (39%), Gaps = 69/334 (20%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLAKHDKGGNRCVQI 160
           +GEG   +V  C +    +  A+KI+     + R     E+E+L Q   H       +++
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH----RNVLEL 76
Query: 161 RNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
             +F+  +   +VFEK+  GS L    ++ ++      +V +     L+   F+H+  + 
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALD---FLHNKGIA 133
Query: 219 HTDLKPENVLL-----VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
           H DLKPEN+L      VS   I   D  S +    D S     P S+   +   GS    
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS-----PISTPELLTPCGSA--- 185
Query: 274 RPDQNYIVSTRHYRAPEVILGLG-----WTYPCDIWSVGCILVELCTGEALFQTHENLEH 328
                       Y APEV+         +   CD+WS+G IL  L +G   F      + 
Sbjct: 186 -----------EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD- 233
Query: 329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 388
                    P  Q+ML        + ++ G+ ++P+   +                   H
Sbjct: 234 CGWDRGEACPACQNMLF-------ESIQEGKYEFPDKDWA-------------------H 267
Query: 389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
           +  +A D   L+  LL  D   RL+A + L+HP+
Sbjct: 268 ISCAAKD---LISKLLVRDAKQRLSAAQVLQHPW 298

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 103/254 (40%), Gaps = 41/254 (16%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G+FG+V+    +   E+ A+KI++     +    E  M+E  VL    K        
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP----FL 83
Query: 158 VQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMHD 214
            Q+ + F   + +  V E +  G  +Y   +   ++    +    EIA  L     F+  
Sbjct: 84  TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF----FLQS 139
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             +I+ DLK +NV+L S  +IK+ D+        D                  G TT   
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD------------------GVTT--- 178
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL-AMME 333
                   T  Y APE+I    +    D W+ G +L E+  G+A F+  +  E   ++ME
Sbjct: 179 ---KXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235
Query: 334 RVLGPLPQHMLKRV 347
             +   P+ M K  
Sbjct: 236 HNVA-YPKSMSKEA 248

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 27/134 (20%)
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
           RQ++  + + H   ++H DLK EN+LL +   IK+ D+  S     + ++  ++ +    
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDEFC-- 173
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
                GS  Y  P+   +   + Y  PEV          D+WS+G IL  L +G   F  
Sbjct: 174 -----GSPPYAAPE---LFQGKKYDGPEV----------DVWSLGVILYTLVSGSLPFDG 215
Query: 323 HENLEHLAMMERVL 336
            +NL+ L   ERVL
Sbjct: 216 -QNLKELR--ERVL 226

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/237 (22%), Positives = 97/237 (40%), Gaps = 47/237 (19%)
Query: 102 MGEGTFGQVLEC----WDRERKEM-VAIKIVRGIKKY--REAAMIEIEVLQQLAKHDK-- 152
           +G G FG+V+E       +E   + VA+K+++       +EA M E++++  L +H+   
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 153 -------GGNRCVQIRNWFDYRNHICIVFEK----LGSSLY-----DFLRKNNYRSFPID 196
                   G   + I  +  Y + +  +  K    LG SL      + L K + R   + 
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 197 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 256
            +   + Q+ + +AF+     IH D+   NVLL +    K+ D+  +     DS+Y  + 
Sbjct: 159 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 218
Query: 257 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
                +K                      + APE I    +T   D+WS G +L E+
Sbjct: 219 NARLPVK----------------------WMAPESIFDCVYTVQSDVWSYGILLWEI 253

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/233 (22%), Positives = 94/233 (40%), Gaps = 48/233 (20%)
Query: 102 MGEGTFGQVLEC----WDRERKEM-VAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGG 154
           +G G FG+V+E       +E   + VA+K+++       +EA M E++++  L +H+   
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE--- 110
Query: 155 NRCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIAR---------- 203
              V +     +   + ++ E      L +FLR+ + R    D    IA           
Sbjct: 111 -NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKS-RVLETDPAFAIANSTASTRDLLH 168
Query: 204 ---QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 260
              Q+ + +AF+     IH D+   NVLL +    K+ D+  +     DS+Y  +     
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 261 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
            +K                      + APE I    +T   D+WS G +L E+
Sbjct: 229 PVK----------------------WMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/115 (30%), Positives = 51/115 (44%), Gaps = 22/115 (19%)
Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+ E + F+H   ++H DLKP N+     + +KV D+   L T  D              
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF--GLVTAMDQ------------- 216
Query: 264 VIDFGSTTYERPDQNYI-----VSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
             D    T   P   Y      V T+ Y +PE I G  +++  DI+S+G IL EL
Sbjct: 217 --DEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/233 (22%), Positives = 94/233 (40%), Gaps = 48/233 (20%)
Query: 102 MGEGTFGQVLEC----WDRERKEM-VAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGG 154
           +G G FG+V+E       +E   + VA+K+++       +EA M E++++  L +H+   
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE--- 110
Query: 155 NRCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIAR---------- 203
              V +     +   + ++ E      L +FLR+ + R    D    IA           
Sbjct: 111 -NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKS-RVLETDPAFAIANSTLSTRDLLH 168
Query: 204 ---QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 260
              Q+ + +AF+     IH D+   NVLL +    K+ D+  +     DS+Y  +     
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 261 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
            +K                      + APE I    +T   D+WS G +L E+
Sbjct: 229 PVK----------------------WMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 107/245 (43%), Gaps = 45/245 (18%)
Query: 98  IHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKG 153
           +  ++G G+FG V +  W  +    VA+K++       +  +A   E+ VL++       
Sbjct: 40  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRK------- 88
Query: 154 GNRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
             R V I  +  Y  +  + IV +   GSSLY  L     +   I L+ +IARQ  + + 
Sbjct: 89  -TRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMD 146
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H   +IH DLK  N+ L     +K+ D+  +    + S                 GS 
Sbjct: 147 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWS-----------------GSH 189
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLE 327
            +E+   + +     + APEVI       +++  D+++ G +L EL TG+  +    N +
Sbjct: 190 QFEQLSGSIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 244
Query: 328 HLAMM 332
            +  M
Sbjct: 245 QIIFM 249

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 107/245 (43%), Gaps = 45/245 (18%)
Query: 98  IHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKG 153
           +  ++G G+FG V +  W  +    VA+K++       +  +A   E+ VL++       
Sbjct: 16  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRK------- 64
Query: 154 GNRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
             R V I  +  Y  +  + IV +   GSSLY  L  +  + F +  + +IARQ    + 
Sbjct: 65  -TRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMD 122
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H   +IH DLK  N+ L     +K+ D+                   + +K    GS 
Sbjct: 123 YLHAKSIIHRDLKSNNIFLHEDNTVKIGDF-----------------GLATVKSRWSGSH 165
Query: 271 TYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
            +E+   + +     + APEVI       +++  D+++ G +L EL TG+  +    N +
Sbjct: 166 QFEQLSGSIL-----WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 220
Query: 328 HLAMM 332
            +  M
Sbjct: 221 QIIEM 225

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 151
           K   ++G+G FG V  C          E+VA+K ++   +++      EIE+L+ L +HD
Sbjct: 20  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 78
Query: 152 KGGNRCVQIRN--WFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
                 V+ +   +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + 
Sbjct: 79  N----IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKG 133
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDF 267
           + ++     IH DL   N+L+ +   +K+ D+  +   P+D    K + P  S I     
Sbjct: 134 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----- 188
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             + APE +    ++   D+WS G +L EL T
Sbjct: 189 -----------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 61/134 (45%), Gaps = 27/134 (20%)
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
           RQ++  + + H   ++H DLK EN+LL +   IK+ D+         S+ F    K  A 
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGF-------SNEFTFGNKLDAF 172
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
                G+  Y  P+   +   + Y  PEV          D+WS+G IL  L +G   F  
Sbjct: 173 ----CGAPPYAAPE---LFQGKKYDGPEV----------DVWSLGVILYTLVSGSLPFDG 215
Query: 323 HENLEHLAMMERVL 336
            +NL+ L   ERVL
Sbjct: 216 -QNLKEL--RERVL 226

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 102/239 (42%), Gaps = 32/239 (13%)
Query: 101 KMGEGTFGQVLECWDRERKEM--VAIKIVR-GIKKY-REAAMIEIEVLQQLAKHDKGGNR 156
           ++G G FG V +   R RK+   VAIK+++ G +K   E  M E +++ QL         
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-----DNPY 71
Query: 157 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
            V++         + ++    G  L+ FL        P+  V E+  Q+   + ++ +  
Sbjct: 72  IVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
            +H DL   NVLLV+  Y K+ D+  S     D SY+                +  + P 
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT-------------ARSAGKWPL 177
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE-LCTGEALFQTHENLEHLAMMER 334
           + Y        APE I    ++   D+WS G  + E L  G+  ++  +  E +A +E+
Sbjct: 178 KWY--------APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 94/217 (43%), Gaps = 26/217 (11%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           ++G G +G V +       +++A+K +R     +E   + +++   ++         V  
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL--DISMRTVDCPFTVTF 115
Query: 161 RNWFDYRNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHD-LCM 217
                    + I  E + +SL  F ++  +  ++ P D++ +IA  +++ +  +H  L +
Sbjct: 116 YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 175
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           IH D+KP NVL+ +   +K+ D+  S +              S  K ID G   Y  P+ 
Sbjct: 176 IHRDVKPSNVLINALGQVKMCDFGISGYL-----------VDSVAKTIDAGCKPYMAPE- 223
Query: 278 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
                    R    +   G++   DIWS+G  ++EL 
Sbjct: 224 ---------RINPELNQKGYSVKSDIWSLGITMIELA 251

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 37/221 (16%)
Query: 100 SKMGEGTFGQVLECWDRERKEMVAIKIVR-GIK-KYREAAMIEIEVLQQLAKHDKGGNRC 157
           S++G G  G V +   +    ++A K++   IK   R   + E++VL     H+      
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-----HECNSPYI 66
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL- 215
           V     F     I I  E + G SL   L+K      P  ++ +++  +++ + ++ +  
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH 124
Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
            ++H D+KP N+L+ S   IK+ D+  S                   ++ID  + ++   
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSG------------------QLIDSMANSF--- 163
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                V TR Y +PE + G  ++   DIWS+G  LVE+  G
Sbjct: 164 -----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 37/221 (16%)
Query: 100 SKMGEGTFGQVLECWDRERKEMVAIKIVR-GIK-KYREAAMIEIEVLQQLAKHDKGGNRC 157
           S++G G  G V +   +    ++A K++   IK   R   + E++VL     H+      
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-----HECNSPYI 66
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL- 215
           V     F     I I  E + G SL   L+K      P  ++ +++  +++ + ++ +  
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH 124
Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
            ++H D+KP N+L+ S   IK+ D+  S                   ++ID  + ++   
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSG------------------QLIDSMANSF--- 163
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                V TR Y +PE + G  ++   DIWS+G  LVE+  G
Sbjct: 164 -----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 151
           K   ++G+G FG V  C          E+VA+K ++   +++      EIE+L+ L +HD
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 102
Query: 152 KGGNRCVQIRN--WFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
                 V+ +   +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + 
Sbjct: 103 N----IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKG 157
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDF 267
           + ++     IH DL   N+L+ +   +K+ D+  +   P+D    K + P  S I     
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----- 212
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             + APE +    ++   D+WS G +L EL T
Sbjct: 213 -----------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 151
           K   ++G+G FG V  C          E+VA+K ++   +++      EIE+L+ L +HD
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 89
Query: 152 KGGNRCVQIRN--WFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
                 V+ +   +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + 
Sbjct: 90  N----IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKG 144
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDF 267
           + ++     IH DL   N+L+ +   +K+ D+  +   P+D    K + P  S I     
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----- 199
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             + APE +    ++   D+WS G +L EL T
Sbjct: 200 -----------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 151
           K   ++G+G FG V  C          E+VA+K ++   +++      EIE+L+ L +HD
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 74
Query: 152 KGGNRCVQIRN--WFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
                 V+ +   +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + 
Sbjct: 75  N----IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKG 129
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDF 267
           + ++     IH DL   N+L+ +   +K+ D+  +   P+D    K + P  S I     
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----- 184
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             + APE +    ++   D+WS G +L EL T
Sbjct: 185 -----------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRG--IKKYREAAMIEIEVLQ 145
            S  KI   +G G FG+V  C  R     +R+  VAIK ++     K R   + E  ++ 
Sbjct: 13  ASCIKIEKVIGVGEFGEV--CSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMG 70
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
           Q    +      + +         + I+ E +   SL  FLRKN+ R   I LV  + R 
Sbjct: 71  QFDHPN-----IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLV-GMLRG 124
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAI 262
           +   + ++ D+  +H DL   N+L+ S+   KV D+  S  L    +++Y  R  K    
Sbjct: 125 IGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK---- 180
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQ 321
                             +  R + APE I    +T   D+WS G ++ E+ + GE  + 
Sbjct: 181 ------------------IPIR-WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 221
Query: 322 THENLEHLAMME 333
              N + +  +E
Sbjct: 222 DMSNQDVIKAIE 233

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 62/134 (46%), Gaps = 27/134 (20%)
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
           RQ++  + + H   ++H DLK EN+LL +   IK+ D+  S     + ++  ++      
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDTFC-- 173
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
                GS  Y  P+   +   + Y  PEV          D+WS+G IL  L +G   F  
Sbjct: 174 -----GSPPYAAPE---LFQGKKYDGPEV----------DVWSLGVILYTLVSGSLPFDG 215
Query: 323 HENLEHLAMMERVL 336
            +NL+ L   ERVL
Sbjct: 216 -QNLKELR--ERVL 226

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 151
           K   ++G+G FG V  C          E+VA+K ++   +++      EIE+L+ L +HD
Sbjct: 18  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 76
Query: 152 KGGNRCVQIRN--WFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
                 V+ +   +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + 
Sbjct: 77  N----IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKG 131
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDF 267
           + ++     IH DL   N+L+ +   +K+ D+  +   P+D    K + P  S I     
Sbjct: 132 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----- 186
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             + APE +    ++   D+WS G +L EL T
Sbjct: 187 -----------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 151
           K   ++G+G FG V  C          E+VA+K ++   +++      EIE+L+ L +HD
Sbjct: 19  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 77
Query: 152 KGGNRCVQIRN--WFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
                 V+ +   +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + 
Sbjct: 78  N----IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKG 132
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDF 267
           + ++     IH DL   N+L+ +   +K+ D+  +   P+D    K + P  S I     
Sbjct: 133 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----- 187
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             + APE +    ++   D+WS G +L EL T
Sbjct: 188 -----------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 151
           K   ++G+G FG V  C          E+VA+K ++   +++      EIE+L+ L +HD
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 71
Query: 152 KGGNRCVQIRN--WFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
                 V+ +   +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + 
Sbjct: 72  N----IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKG 126
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDF 267
           + ++     IH DL   N+L+ +   +K+ D+  +   P+D    K + P  S I     
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----- 181
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             + APE +    ++   D+WS G +L EL T
Sbjct: 182 -----------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 107/245 (43%), Gaps = 45/245 (18%)
Query: 98  IHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKG 153
           +  ++G G+FG V +  W  +    VA+K++       +  +A   E+ VL++       
Sbjct: 32  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRK------- 80
Query: 154 GNRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
             R V I  +  Y  +  + IV +   GSSLY  L     +   I L+ +IARQ  + + 
Sbjct: 81  -TRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMD 138
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H   +IH DLK  N+ L     +K+ D+  +    + S                 GS 
Sbjct: 139 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWS-----------------GSH 181
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLE 327
            +E+   + +     + APEVI       +++  D+++ G +L EL TG+  +    N +
Sbjct: 182 QFEQLSGSIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 236
Query: 328 HLAMM 332
            +  M
Sbjct: 237 QIIFM 241

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 105/255 (41%), Gaps = 58/255 (22%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           Y++   +G+G F +V              K+ R I   +E A+  I+  Q  +   +   
Sbjct: 16  YRLLKTIGKGNFAKV--------------KLARHILTGKEVAVKIIDKTQLNSSSLQKLF 61
Query: 156 RCVQIRNWFDYRNHICIVFEKL--------------GSSLYDFLRKNNYRSFPIDLVREI 201
           R V+I    ++ N I  +FE +              G  ++D+L  +          R  
Sbjct: 62  REVRIMKVLNHPN-IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG--RMKEKEARAK 118
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            RQ++  + + H   ++H DLK EN+LL +   IK+ D+  S     + ++  ++     
Sbjct: 119 FRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDTFC- 173
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
                 GS  Y  P+   +   + Y  PEV          D+WS+G IL  L +G   F 
Sbjct: 174 ------GSPPYAAPE---LFQGKKYDGPEV----------DVWSLGVILYTLVSGSLPFD 214
Query: 322 THENLEHLAMMERVL 336
             +NL+ L   ERVL
Sbjct: 215 G-QNLKELR--ERVL 226

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 151
           K   ++G+G FG V  C          E+VA+K ++   +++      EIE+L+ L +HD
Sbjct: 12  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 70
Query: 152 KGGNRCVQIRN--WFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
                 V+ +   +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + 
Sbjct: 71  N----IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKG 125
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDF 267
           + ++     IH DL   N+L+ +   +K+ D+  +   P+D    K + P  S I     
Sbjct: 126 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----- 180
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             + APE +    ++   D+WS G +L EL T
Sbjct: 181 -----------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 151
           K   ++G+G FG V  C          E+VA+K ++   +++      EIE+L+ L +HD
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 71
Query: 152 KGGNRCVQIRN--WFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
                 V+ +   +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + 
Sbjct: 72  N----IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKG 126
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDF 267
           + ++     IH DL   N+L+ +   +K+ D+  +   P+D    K + P  S I     
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----- 181
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             + APE +    ++   D+WS G +L EL T
Sbjct: 182 -----------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/232 (21%), Positives = 93/232 (40%), Gaps = 32/232 (13%)
Query: 100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR--C 157
           S++G G++G+V +   +E   + A+K  R +  +R         L ++  H+K G    C
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVK--RSMSPFR-GPKDRARKLAEVGSHEKVGQHPCC 119
Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           V++   ++    + +  E  G SL          S P   V    R  L  +A +H   +
Sbjct: 120 VRLEQAWEEGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGL 178
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           +H D+KP N+ L      K+ D+                     +++   G+   +  D 
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDF------------------GLLVELGTAGAGEVQEGDP 220
Query: 278 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
            Y+       APE++ G  +    D++S+G  ++E+     L    E  + L
Sbjct: 221 RYM-------APELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 62/134 (46%), Gaps = 27/134 (20%)
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
           RQ++  + + H   ++H DLK EN+LL +   IK+ D+  S     + ++  ++      
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDTFC-- 173
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
                GS  Y  P+   +   + Y  PEV          D+WS+G IL  L +G   F  
Sbjct: 174 -----GSPPYAAPE---LFQGKKYDGPEV----------DVWSLGVILYTLVSGSLPFDG 215
Query: 323 HENLEHLAMMERVL 336
            +NL+ L   ERVL
Sbjct: 216 -QNLKELR--ERVL 226

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 67/139 (48%), Gaps = 6/139 (4%)
Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH 150
           ++   +++  K+G G FG++    +    E VAIK+   IK       +E    +QL+  
Sbjct: 1   SMGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL-EPIKSRAPQLHLEYRFYKQLSAT 59
Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
           +       Q+  +     +  +V E LG SL D     + R+F +  V  IA QL+  + 
Sbjct: 60  EG----VPQVYYFGPXGKYNAMVLELLGPSLEDLFDLCD-RTFTLKTVLMIAIQLITRME 114
Query: 211 FMHDLCMIHTDLKPENVLL 229
           ++H   +I+ D+KPEN L+
Sbjct: 115 YVHTKSLIYRDVKPENFLV 133

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 102/239 (42%), Gaps = 32/239 (13%)
Query: 101 KMGEGTFGQVLECWDRERKEM--VAIKIVR-GIKKY-REAAMIEIEVLQQLAKHDKGGNR 156
           ++G G FG V +   R RK+   VAIK+++ G +K   E  M E +++ QL         
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-----DNPY 397
Query: 157 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
            V++         + ++    G  L+ FL        P+  V E+  Q+   + ++ +  
Sbjct: 398 IVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
            +H +L   NVLLV+  Y K+ D+  S     D SY+                +  + P 
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT-------------ARSAGKWPL 503
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE-LCTGEALFQTHENLEHLAMMER 334
           + Y        APE I    ++   D+WS G  + E L  G+  ++  +  E +A +E+
Sbjct: 504 KWY--------APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 103/241 (42%), Gaps = 42/241 (17%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD 151
           + ++Y++  K+G G+FG +    +    E VAIK+     +  +    ++ +  +  K  
Sbjct: 7   VGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKL-----ECVKTKHPQLHIESKFYKMM 61
Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
           +GG     I+      ++  +V E LG SL D     + R F +  V  +A Q++  I +
Sbjct: 62  QGGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEY 120
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--- 268
           +H    IH D+KP+N L+   +                        K + + +IDFG   
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGK------------------------KGNLVYIIDFGLAK 156
Query: 269 ----STTYE----RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
               + T++    R ++N +  T  Y +    LG+  +   D+ S+G +L+    G   +
Sbjct: 157 KYRDARTHQHIPYRENKN-LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215
Query: 321 Q 321
           Q
Sbjct: 216 Q 216

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 151
           K   ++G+G FG V  C          E+VA+K ++   +++      EIE+L+ L +HD
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 89
Query: 152 KGGNRCVQIRN--WFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
                 V+ +   +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + 
Sbjct: 90  N----IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKG 144
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDF 267
           + ++     IH DL   N+L+ +   +K+ D+  +   P+D    K + P  S I     
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----- 199
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             + APE +    ++   D+WS G +L EL T
Sbjct: 200 -----------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 151
           K   ++G+G FG V  C          E+VA+K ++   +++      EIE+L+ L +HD
Sbjct: 11  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 69
Query: 152 KGGNRCVQIRN--WFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
                 V+ +   +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + 
Sbjct: 70  N----IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKG 124
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDF 267
           + ++     IH DL   N+L+ +   +K+ D+  +   P+D    K + P  S I     
Sbjct: 125 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----- 179
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             + APE +    ++   D+WS G +L EL T
Sbjct: 180 -----------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 151
           K   ++G+G FG V  C          E+VA+K ++   +++      EIE+L+ L +HD
Sbjct: 17  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 75
Query: 152 KGGNRCVQIRN--WFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
                 V+ +   +   R ++ ++ E L   SL D+L+K+  R   I L+ +   Q+ + 
Sbjct: 76  N----IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKG 130
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDF 267
           + ++     IH DL   N+L+ +   +K+ D+  +   P+D    K + P  S I     
Sbjct: 131 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----- 185
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             + APE +    ++   D+WS G +L EL T
Sbjct: 186 -----------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 105/252 (41%), Gaps = 42/252 (16%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRG--IKKYREAAMIEIEVLQ 145
            S  KI   +G G FG+V  C  R     +R+  VAIK ++     K R   + E  ++ 
Sbjct: 7   ASCIKIEKVIGVGEFGEV--CSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMG 64
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
           Q    +      + +         + I+ E +   SL  FLRKN+ R   I LV  + R 
Sbjct: 65  QFDHPN-----IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLV-GMLRG 118
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAI 262
           +   + ++ D+  +H DL   N+L+ S+   KV D+  S  L    +++Y  R  K    
Sbjct: 119 IGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK---- 174
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQ 321
                             +  R + APE I    +T   D+WS G ++ E+ + GE  + 
Sbjct: 175 ------------------IPIR-WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 215
Query: 322 THENLEHLAMME 333
              N + +  +E
Sbjct: 216 DMSNQDVIKAIE 227

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 65/134 (48%), Gaps = 6/134 (4%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           +++  K+G G FG++    +    E VAIK+   +K       +E    +QL      G+
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKL-EPMKSRAPQLHLEYRFYKQLGS----GD 65
Query: 156 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
              Q+  +     +  +V E LG SL D     + R+F +  V  IA QL+  + ++H  
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 216 CMIHTDLKPENVLL 229
            +I+ D+KPEN L+
Sbjct: 125 NLIYRDVKPENFLI 138

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 65/134 (48%), Gaps = 6/134 (4%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           +++  K+G G FG++    +    E VAIK+   +K       +E    +QL      G+
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKL-EPMKSRAPQLHLEYRFYKQLG----SGD 65
Query: 156 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
              Q+  +     +  +V E LG SL D     + R+F +  V  IA QL+  + ++H  
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 216 CMIHTDLKPENVLL 229
            +I+ D+KPEN L+
Sbjct: 125 NLIYRDVKPENFLI 138

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 61/134 (45%), Gaps = 27/134 (20%)
Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
           RQ++  + + H   ++H DLK EN+LL +   IK+ D+         S+ F    K  A 
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGF-------SNEFTFGNKLDAF 172
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
                G+  Y  P+   +   + Y  PEV          D+WS+G IL  L +G   F  
Sbjct: 173 ----CGAPPYAAPE---LFQGKKYDGPEV----------DVWSLGVILYTLVSGSLPFDG 215
Query: 323 HENLEHLAMMERVL 336
            +NL+ L   ERVL
Sbjct: 216 -QNLKELR--ERVL 226

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 102/258 (39%), Gaps = 60/258 (23%)
Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG 153
             Y++   +G+G F +V              K+ R +   RE A+  I+  Q      + 
Sbjct: 15  GNYRLQKTIGKGNFAKV--------------KLARHVLTGREVAVKIIDKTQLNPTSLQK 60
Query: 154 GNRCVQIRNWFDYRNHICIVFEKL--------------GSSLYDFLRKNNYRSFPIDLVR 199
             R V+I    ++ N I  +FE +              G  ++D+L  +          R
Sbjct: 61  LFREVRIMKILNHPN-IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG--RMKEKEAR 117
Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
              RQ++  + + H   ++H DLK EN+LL     IK+ D+  S               +
Sbjct: 118 AKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEF------------T 165
Query: 260 SAIKVIDF-GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 318
              K+  F GS  Y  P+   +   + Y  PEV          D+WS+G IL  L +G  
Sbjct: 166 VGNKLDTFCGSPPYAAPE---LFQGKKYDGPEV----------DVWSLGVILYTLVSGSL 212
Query: 319 LFQTHENLEHLAMMERVL 336
            F   +NL+ L   ERVL
Sbjct: 213 PFDG-QNLKELR--ERVL 227

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 65/134 (48%), Gaps = 6/134 (4%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           +++  K+G G FG++    +    E VAIK+   +K       +E    +QL      G+
Sbjct: 32  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKL-EPMKSRAPQLHLEYRFYKQLGS----GD 86
Query: 156 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
              Q+  +     +  +V E LG SL D     + R+F +  V  IA QL+  + ++H  
Sbjct: 87  GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSK 145
Query: 216 CMIHTDLKPENVLL 229
            +I+ D+KPEN L+
Sbjct: 146 NLIYRDVKPENFLI 159

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 105/243 (43%), Gaps = 44/243 (18%)
Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRE---RKEMVAIKIVRGIKKYREAAMI--EIEVLQQ 146
           L  +Y +   +GEG++G+V E  D E   R+ +  +K  +  +     A +  EI++L++
Sbjct: 3   LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 147 LAKHDKGGNRCVQIRN--WFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 204
           L +H       +Q+ +  + + +  + +V E     + + L     + FP+        Q
Sbjct: 63  L-RH----KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQ 117
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           L++ + ++H   ++H D+KP N+LL +   +K+                      SA+ V
Sbjct: 118 LIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKI----------------------SALGV 155
Query: 265 ID----FGSTTYERPDQNYIVSTRHYRAPEVILGLGW--TYPCDIWSVGCILVELCTGEA 318
            +    F +    R  Q     +  ++ PE+  GL     +  DIWS G  L  + TG  
Sbjct: 156 AEALHPFAADDTCRTSQG----SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLY 211
Query: 319 LFQ 321
            F+
Sbjct: 212 PFE 214

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 56/133 (42%), Gaps = 34/133 (25%)
Query: 197 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 256
           L+  I RQ+   + ++H+  + H D+KPEN L  ++                        
Sbjct: 169 LISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN------------------------ 204
Query: 257 PKSSAIKVIDFGSTT--YERPDQNYI-----VSTRHYRAPEVILGLGWTY--PCDIWSVG 307
            KS  IK++DFG +   Y+  +  Y        T ++ APEV+     +Y   CD WS G
Sbjct: 205 -KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 308 CILVELCTGEALF 320
            +L  L  G   F
Sbjct: 264 VLLHLLLMGAVPF 276

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 107/245 (43%), Gaps = 45/245 (18%)
Query: 98  IHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKG 153
           +  ++G G+FG V +  W  +    VA+K++       +  +A   E+ VL++       
Sbjct: 40  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRK------- 88
Query: 154 GNRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
             R V I  +  Y  +  + IV +   GSSLY  L     +   I L+ +IARQ  + + 
Sbjct: 89  -TRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMD 146
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H   +IH DLK  N+ L     +K+ D+                   + +K    GS 
Sbjct: 147 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDF-----------------GLATVKSRWSGSH 189
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLE 327
            +E+   + +     + APEVI       +++  D+++ G +L EL TG+  +    N +
Sbjct: 190 QFEQLSGSIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 244
Query: 328 HLAMM 332
            +  M
Sbjct: 245 QIIFM 249

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 107/245 (43%), Gaps = 45/245 (18%)
Query: 98  IHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKG 153
           +  ++G G+FG V +  W  +    VA+K++       +  +A   E+ VL++       
Sbjct: 39  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRK------- 87
Query: 154 GNRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
             R V I  +  Y  +  + IV +   GSSLY  L     +   I L+ +IARQ  + + 
Sbjct: 88  -TRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMD 145
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H   +IH DLK  N+ L     +K+ D+                   + +K    GS 
Sbjct: 146 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDF-----------------GLATVKSRWSGSH 188
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLE 327
            +E+   + +     + APEVI       +++  D+++ G +L EL TG+  +    N +
Sbjct: 189 QFEQLSGSIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 243
Query: 328 HLAMM 332
            +  M
Sbjct: 244 QIIFM 248

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 96/243 (39%), Gaps = 51/243 (20%)
Query: 95  RYKIHSKMGEGTFGQVLEC----WDRERK-EMVAIKIVRGIKKYRE--AAMIEIEVLQQL 147
           R K+   +G G FGQV+E      D+      VA+K+++    + E  A M E+++L  +
Sbjct: 30  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 89
Query: 148 AKHDKGGN---RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNN-----YRSFPIDLVR 199
             H    N    C +          + + F K G+ L  +LR        Y+  P DL +
Sbjct: 90  GHHLNVVNLLGACTKPGGPL----MVIVEFCKFGN-LSTYLRSKRNEFVPYKEAPEDLYK 144
Query: 200 EI---------ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 250
           +          + Q+ + + F+     IH DL   N+LL     +K+ D+  +    KD 
Sbjct: 145 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 204
Query: 251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 310
            Y ++      +K                      + APE I    +T   D+WS G +L
Sbjct: 205 DYVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGVLL 242
Query: 311 VEL 313
            E+
Sbjct: 243 WEI 245

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 107/245 (43%), Gaps = 45/245 (18%)
Query: 98  IHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKG 153
           +  ++G G+FG V +  W  +    VA+K++       +  +A   E+ VL++       
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRK------- 60
Query: 154 GNRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
             R V I  +  Y  +  + IV +   GSSLY  L     +   I L+ +IARQ  + + 
Sbjct: 61  -TRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMD 118
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H   +IH DLK  N+ L     +K+ D+  +    + S                 GS 
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWS-----------------GSH 161
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLE 327
            +E+   + +     + APEVI       +++  D+++ G +L EL TG+  +    N +
Sbjct: 162 QFEQLSGSIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216
Query: 328 HLAMM 332
            +  M
Sbjct: 217 QIIFM 221

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           ++G G +G V +       +++A+K +R     +E   + +++   ++         V  
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL--DISMRTVDCPFTVTF 71
Query: 161 RNWFDYRNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHD-LCM 217
                    + I  E + +SL  F ++  +  ++ P D++ +IA  +++ +  +H  L +
Sbjct: 72  YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           IH D+KP NVL+ +   +K+ D+  S +   D +           K ID G   Y  P+ 
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA-----------KDIDAGCKPYMAPE- 179
Query: 278 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
                    R    +   G++   DIWS+G  ++EL 
Sbjct: 180 ---------RINPELNQKGYSVKSDIWSLGITMIELA 207

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 44/99 (44%), Gaps = 24/99 (24%)
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           ++H DLKP NV L   + +K+ D+  +     D+S+ K                      
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--------------------- 175
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
               V T +Y +PE +  + +    DIWS+GC+L ELC 
Sbjct: 176 ---FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 44/99 (44%), Gaps = 24/99 (24%)
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           ++H DLKP NV L   + +K+ D+  +     D+S+ K                      
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--------------------- 175
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
               V T +Y +PE +  + +    DIWS+GC+L ELC 
Sbjct: 176 ---FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 100/225 (44%), Gaps = 37/225 (16%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCV 158
           ++G G +G V +   +   +++A+K +R    +K ++  +++++V+ +        + C 
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMR-------SSDCP 81
Query: 159 QIRNWFD--YRNHICIVFEKLGSSLYDFLRKNNYRSF----PIDLVREIARQLLECIAFM 212
            I  ++   +R   C +  +L S+ +D   K  Y       P +++ +I    ++ +  +
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 213 -HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
             +L +IH D+KP N+LL  S  IK+ D+  S                S  K  D G   
Sbjct: 142 KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL-----------VDSIAKTRDAGCRP 190
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
           Y  P++    ++R           G+    D+WS+G  L EL TG
Sbjct: 191 YMAPERIDPSASRQ----------GYDVRSDVWSLGITLYELATG 225

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 96/243 (39%), Gaps = 51/243 (20%)
Query: 95  RYKIHSKMGEGTFGQVLEC----WDRERK-EMVAIKIVRGIKKYRE--AAMIEIEVLQQL 147
           R K+   +G G FGQV+E      D+      VA+K+++    + E  A M E+++L  +
Sbjct: 65  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 124
Query: 148 AKHDKGGN---RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNN-----YRSFPIDLVR 199
             H    N    C +          + + F K G+ L  +LR        Y+  P DL +
Sbjct: 125 GHHLNVVNLLGACTKPGGPL----MVIVEFCKFGN-LSTYLRSKRNEFVPYKVAPEDLYK 179
Query: 200 EI---------ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 250
           +          + Q+ + + F+     IH DL   N+LL     +K+ D+  +    KD 
Sbjct: 180 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 239
Query: 251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 310
            Y ++      +K                      + APE I    +T   D+WS G +L
Sbjct: 240 DYVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGVLL 277
Query: 311 VEL 313
            E+
Sbjct: 278 WEI 280

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 103/255 (40%), Gaps = 58/255 (22%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           Y++   +G+G F +V              K+ R I   RE A+  I+  Q      +   
Sbjct: 17  YRLLKTIGKGNFAKV--------------KLARHILTGREVAIKIIDKTQLNPTSLQKLF 62
Query: 156 RCVQIRNWFDYRNHICIVFEKL--------------GSSLYDFLRKNNYRSFPIDLVREI 201
           R V+I    ++ N I  +FE +              G  ++D+L  +          R  
Sbjct: 63  REVRIMKILNHPN-IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSK 119
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            RQ++  + + H   ++H DLK EN+LL +   IK+ D+         S+ F    K  A
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF-------SNEFTVGGKLDA 172
Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
                 G+  Y  P+   +   + Y  PEV          D+WS+G IL  L +G   F 
Sbjct: 173 F----CGAPPYAAPE---LFQGKKYDGPEV----------DVWSLGVILYTLVSGSLPFD 215
Query: 322 THENLEHLAMMERVL 336
             +NL+ L   ERVL
Sbjct: 216 G-QNLKELR--ERVL 227

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 96/243 (39%), Gaps = 51/243 (20%)
Query: 95  RYKIHSKMGEGTFGQVLEC----WDRERK-EMVAIKIVRGIKKYRE--AAMIEIEVLQQL 147
           R K+   +G G FGQV+E      D+      VA+K+++    + E  A M E+++L  +
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 87
Query: 148 AKHDKGGN---RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNN-----YRSFPIDLVR 199
             H    N    C +          + + F K G+ L  +LR        Y+  P DL +
Sbjct: 88  GHHLNVVNLLGACTKPGGPL----MVIVEFCKFGN-LSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 200 EI---------ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 250
           +          + Q+ + + F+     IH DL   N+LL     +K+ D+  +    KD 
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 310
            Y ++      +K                      + APE I    +T   D+WS G +L
Sbjct: 203 DYVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 311 VEL 313
            E+
Sbjct: 241 WEI 243

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 103/248 (41%), Gaps = 32/248 (12%)
Query: 94  SRYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLA 148
           S  KI   +G G FG+V     +   +R+  VAIK ++    +K R   + E  ++ Q  
Sbjct: 33  SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 92
Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
             +      + +         + I+ E +   SL  FLR+N+ +   I LV  + R +  
Sbjct: 93  HPN-----VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVG-MLRGIAA 146
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++ D+  +H DL   N+L+ S+   KV D+  S     D+S                
Sbjct: 147 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS---------------- 190
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 326
              TY       I     + APE I    +T   D+WS G ++ E+ + GE  +    N 
Sbjct: 191 -DPTYTSALGGKI--PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 247
Query: 327 EHLAMMER 334
           + +  +E+
Sbjct: 248 DVINAIEQ 255

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 103/256 (40%), Gaps = 60/256 (23%)
Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           Y++   +G+G F +V              K+ R I   RE A+  I+  Q      +   
Sbjct: 14  YRLLKTIGKGNFAKV--------------KLARHILTGREVAIKIIDKTQLNPTSLQKLF 59
Query: 156 RCVQIRNWFDYRNHICIVFEKL--------------GSSLYDFLRKNNYRSFPIDLVREI 201
           R V+I    ++ N I  +FE +              G  ++D+L  +          R  
Sbjct: 60  REVRIMKILNHPN-IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSK 116
Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            RQ++  + + H   ++H DLK EN+LL +   IK+ D+  S               +  
Sbjct: 117 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF------------TVG 164
Query: 262 IKVIDF-GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
            K+  F GS  Y  P+   +   + Y  PEV          D+WS+G IL  L +G   F
Sbjct: 165 GKLDTFCGSPPYAAPE---LFQGKKYDGPEV----------DVWSLGVILYTLVSGSLPF 211
Query: 321 QTHENLEHLAMMERVL 336
              +NL+ L   ERVL
Sbjct: 212 DG-QNLKELR--ERVL 224

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 94/243 (38%), Gaps = 51/243 (20%)
Query: 95  RYKIHSKMGEGTFGQVLEC----WDRERK-EMVAIKIVRGIKKYRE--AAMIEIEVLQQL 147
           R K+   +G G FGQV+E      D+      VA+K+++    + E  A M E+++L  +
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 78
Query: 148 AKHDKGGN---RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNN-----YRSFPIDLVR 199
             H    N    C +           C    K G+ L  +LR        Y+  P DL +
Sbjct: 79  GHHLNVVNLLGACTKPGGPLMVITEFC----KFGN-LSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 200 EI---------ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 250
           +          + Q+ + + F+     IH DL   N+LL     +K+ D+  +    KD 
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 193
Query: 251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 310
            Y ++      +K                      + APE I    +T   D+WS G +L
Sbjct: 194 DYVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 311 VEL 313
            E+
Sbjct: 232 WEI 234

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/253 (21%), Positives = 104/253 (41%), Gaps = 36/253 (14%)
Query: 102 MGEGTFGQVL---ECWDRERKEMVAIKIVRGIKKYREAAMIE-IEVLQQLAKHDKGGNRC 157
           +G G +G+V    +    +  ++ A+K+++     ++A   E     +Q+ +H +     
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           V +   F     + ++ + + G  L+  L +     F    V+    +++  +  +H L 
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG 179
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ D+K EN+LL S+ ++ + D+  S          K        +  DF  T      
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLS----------KEFVADETERAYDFCGTI----- 224
Query: 277 QNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAMME 333
                    Y AP+++ G   G     D WS+G ++ EL TG + F    E      +  
Sbjct: 225 --------EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 276
Query: 334 RVLG---PLPQHM 343
           R+L    P PQ M
Sbjct: 277 RILKSEPPYPQEM 289

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 94/243 (38%), Gaps = 51/243 (20%)
Query: 95  RYKIHSKMGEGTFGQVLEC----WDRERK-EMVAIKIVRGIKKYRE--AAMIEIEVLQQL 147
           R K+   +G G FGQV+E      D+      VA+K+++    + E  A M E+++L  +
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 78
Query: 148 AKHDKGGN---RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNN-----YRSFPIDLVR 199
             H    N    C +           C    K G+ L  +LR        Y+  P DL +
Sbjct: 79  GHHLNVVNLLGACTKPGGPLMVITEFC----KFGN-LSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 200 EI---------ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 250
           +          + Q+ + + F+     IH DL   N+LL     +K+ D+  +    KD 
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 193
Query: 251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 310
            Y ++      +K                      + APE I    +T   D+WS G +L
Sbjct: 194 DYVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 311 VEL 313
            E+
Sbjct: 232 WEI 234

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/241 (22%), Positives = 102/241 (42%), Gaps = 37/241 (15%)
Query: 98  IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           +  ++G G+FG V +        +  + +     +  +A   E+ VL++         R 
Sbjct: 17  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--------TRH 68
Query: 158 VQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
           V I  +  Y  +  + IV +   GSSLY  L     +   I L+ +IARQ  + + ++H 
Sbjct: 69  VNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHA 127
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             +IH DLK  N+ L     +K+ D+  +    + S                 GS  +E+
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-----------------GSHQFEQ 170
Query: 275 PDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
              + +     + APEVI       +++  D+++ G +L EL TG+  +    N + +  
Sbjct: 171 LSGSIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 225
Query: 332 M 332
           M
Sbjct: 226 M 226

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 107/245 (43%), Gaps = 45/245 (18%)
Query: 98  IHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKG 153
           +  ++G G+FG V +  W  +    VA+K++       +  +A   E+ VL++       
Sbjct: 14  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRK------- 62
Query: 154 GNRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
             R V I  +  Y  +  + IV +   GSSLY  L     +   I L+ +IARQ  + + 
Sbjct: 63  -TRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMD 120
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H   +IH DLK  N+ L     +K+ D+  +    + S                 GS 
Sbjct: 121 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-----------------GSH 163
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLE 327
            +E+   + +     + APEVI       +++  D+++ G +L EL TG+  +    N +
Sbjct: 164 QFEQLSGSIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 218
Query: 328 HLAMM 332
            +  M
Sbjct: 219 QIIFM 223

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 107/245 (43%), Gaps = 45/245 (18%)
Query: 98  IHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKG 153
           +  ++G G+FG V +  W  +    VA+K++       +  +A   E+ VL++       
Sbjct: 17  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRK------- 65
Query: 154 GNRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
             R V I  +  Y  +  + IV +   GSSLY  L     +   I L+ +IARQ  + + 
Sbjct: 66  -TRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMD 123
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H   +IH DLK  N+ L     +K+ D+  +    + S                 GS 
Sbjct: 124 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-----------------GSH 166
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLE 327
            +E+   + +     + APEVI       +++  D+++ G +L EL TG+  +    N +
Sbjct: 167 QFEQLSGSIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 221
Query: 328 HLAMM 332
            +  M
Sbjct: 222 QIIFM 226

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 107/245 (43%), Gaps = 45/245 (18%)
Query: 98  IHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKG 153
           +  ++G G+FG V +  W  +    VA+K++       +  +A   E+ VL++       
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRK------- 60
Query: 154 GNRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
             R V I  +  Y  +  + IV +   GSSLY  L     +   I L+ +IARQ  + + 
Sbjct: 61  -TRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMD 118
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H   +IH DLK  N+ L     +K+ D+  +    + S                 GS 
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-----------------GSH 161
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLE 327
            +E+   + +     + APEVI       +++  D+++ G +L EL TG+  +    N +
Sbjct: 162 QFEQLSGSIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216
Query: 328 HLAMM 332
            +  M
Sbjct: 217 QIIFM 221

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 106/245 (43%), Gaps = 45/245 (18%)
Query: 98  IHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKG 153
           +  ++G G+FG V +  W  +    VA+K++       +  +A   E+ VL++       
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRK------- 60
Query: 154 GNRCVQIRNWFDYRN--HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
             R V I  +  Y     + IV +   GSSLY  L     +   I L+ +IARQ  + + 
Sbjct: 61  -TRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMD 118
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H   +IH DLK  N+ L     +K+ D+  +    + S                 GS 
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS-----------------GSH 161
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLE 327
            +E+   + +     + APEVI       +++  D+++ G +L EL TG+  +    N +
Sbjct: 162 QFEQLSGSIL-----WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216
Query: 328 HLAMM 332
            +  M
Sbjct: 217 QIIFM 221

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/246 (22%), Positives = 89/246 (36%), Gaps = 54/246 (21%)
Query: 94  SRYKIHSKMGEGTFGQVLECW-----DRERKEMVAIKIVRGIKKY--REAAMIEIEVLQQ 146
           +R      +G G FG+V+E         +    VA+K+++       REA M E++VL  
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 147 LAKHDKGGN---RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNN-----YRSFPIDLV 198
           L  H    N    C           + C         L +FLR+        ++ P  + 
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCY------GDLLNFLRRKRDSFICSKTSPAIME 159
Query: 199 R-----------EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 247
                         + Q+ + +AF+     IH DL   N+LL      K+ D+  + H  
Sbjct: 160 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIK 219
Query: 248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVG 307
            DS+Y  +      +K                      + APE I    +T+  D+WS G
Sbjct: 220 NDSNYVVKGNARLPVK----------------------WMAPESIFNCVYTFESDVWSYG 257
Query: 308 CILVEL 313
             L EL
Sbjct: 258 IFLWEL 263

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKH 150
           K  S++G+G FG V  C           +VA+K ++  G  + R+    EI++L+ L   
Sbjct: 13  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR-EIQILKALHSD 71
Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSS-LYDFLRKNNYRSFPIDLVREI--ARQLLE 207
                R V   ++   R  + +V E L S  L DFL+++  R   +D  R +  + Q+ +
Sbjct: 72  FIVKYRGV---SYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICK 125
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++     +H DL   N+L+ S  ++K+ D+  +   P D  Y+              
Sbjct: 126 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY-------------- 171
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                  P Q+ I     + APE +    ++   D+WS G +L EL T
Sbjct: 172 ---VVREPGQSPIF----WYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKH 150
           K  S++G+G FG V  C           +VA+K ++  G  + R+    EI++L+ L   
Sbjct: 14  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR-EIQILKALHSD 72
Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSS-LYDFLRKNNYRSFPIDLVREI--ARQLLE 207
                R V   ++   R  + +V E L S  L DFL+++  R   +D  R +  + Q+ +
Sbjct: 73  FIVKYRGV---SYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICK 126
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++     +H DL   N+L+ S  ++K+ D+  +   P D  Y+              
Sbjct: 127 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY-------------- 172
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                  P Q+ I     + APE +    ++   D+WS G +L EL T
Sbjct: 173 ---VVREPGQSPIF----WYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/241 (22%), Positives = 97/241 (40%), Gaps = 47/241 (19%)
Query: 95  RYKIHSKMGEGTFGQVLEC----WDR-ERKEMVAIKIVRGIKKYRE--AAMIEIEVLQQL 147
           R  +   +G G FGQV+E      D+      VA+K+++    + E  A M E+++L  +
Sbjct: 28  RLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHI 87
Query: 148 AKHDKGGN---RCVQIRNWFDYRNHICIVFEKLGSSLYDFLR---------KNNYRSF-P 194
             H    N    C +          + + F K G+ L  +LR         K+ Y+ F  
Sbjct: 88  GHHLNVVNLLGACTKPGGPL----MVIVEFCKFGN-LSTYLRSKRNEFVPYKDLYKDFLT 142
Query: 195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
           ++ +   + Q+ + + F+     IH DL   N+LL     +K+ D+  +    KD  Y +
Sbjct: 143 LEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVR 202
Query: 255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
           +      +K                      + APE I    +T   D+WS G +L E+ 
Sbjct: 203 KGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGVLLWEIF 240
Query: 315 T 315
           +
Sbjct: 241 S 241

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 95/235 (40%), Gaps = 50/235 (21%)
Query: 102 MGEGTFGQVLEC----WDRERKEM-VAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGG 154
           +G G FG+V+E       +E   + VA+K+++       +EA M E++++  L +H+   
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE--- 110
Query: 155 NRCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKN-----NYRSFPI----------DLV 198
              V +     +   + ++ E      L +FLR+       Y   P           DL+
Sbjct: 111 -NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLL 169
Query: 199 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 258
              + Q+ + +AF+     IH D+   NVLL +    K+ D+  +     DS+Y  +   
Sbjct: 170 H-FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 228
Query: 259 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
              +K                      + APE I    +T   D+WS G +L E+
Sbjct: 229 RLPVK----------------------WMAPESIFDCVYTVQSDVWSYGILLWEI 261

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 43/227 (18%)
Query: 100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEI---EVLQQLAKHDKGGNR 156
           +K GEG FG V + +       VA+K        + AAM++I   E+ QQ  +  K   +
Sbjct: 28  NKXGEGGFGVVYKGY--VNNTTVAVK--------KLAAMVDITTEELKQQFDQEIKVXAK 77
Query: 157 C-----VQIRNWFDYRNHICIVFEKL-GSSLYDFLR-KNNYRSFPIDLVREIARQLLECI 209
           C     V++  +    + +C+V+      SL D L   +           +IA+     I
Sbjct: 78  CQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGI 137
Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            F+H+   IH D+K  N+LL  +   K+ D+       + S  F +    S         
Sbjct: 138 NFLHENHHIHRDIKSANILLDEAFTAKISDFG----LARASEKFAQXVXXS--------- 184
Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
                     IV T  Y APE + G   T   DI+S G +L+E+ TG
Sbjct: 185 ---------RIVGTTAYXAPEALRG-EITPKSDIYSFGVVLLEIITG 221

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 151
           K   ++G+G FG V  C          E+VA+K ++   +++      EIE+L+ L +HD
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 74
Query: 152 KGGNRCVQIRN--WFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
                 V+ +   +   R ++ ++ E L   SL D+L+ +  R   I L+ +   Q+ + 
Sbjct: 75  N----IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLL-QYTSQICKG 129
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDF 267
           + ++     IH DL   N+L+ +   +K+ D+  +   P+D    K + P  S I     
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----- 184
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             + APE +    ++   D+WS G +L EL T
Sbjct: 185 -----------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKH 150
           K  S++G+G FG V  C           +VA+K ++  G  + R+    EI++L+ L   
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR-EIQILKALHSD 84
Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSS-LYDFLRKNNYRSFPIDLVREI--ARQLLE 207
                R V   ++   R  + +V E L S  L DFL+++  R   +D  R +  + Q+ +
Sbjct: 85  FIVKYRGV---SYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICK 138
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++     +H DL   N+L+ S  ++K+ D+  +   P D  Y+              
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY-------------- 184
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                  P Q+ I     + APE +    ++   D+WS G +L EL T
Sbjct: 185 ---VVREPGQSPIF----WYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 96/240 (40%), Gaps = 47/240 (19%)
Query: 95  RYKIHSKMGEGTFGQVLEC----WDR-ERKEMVAIKIVRGIKKYRE--AAMIEIEVLQQL 147
           R K+   +G G FGQV+E      D+      VA+K+++    + E  A M E+++L  +
Sbjct: 30  RLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHI 89
Query: 148 AKHDKGGN---RCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSF-PIDLVREI- 201
             H    N    C +          + + F K G+ S Y   ++N +  + P DL ++  
Sbjct: 90  GHHLNVVNLLGACTKPGGPL----MVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFL 145
Query: 202 --------ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 253
                   + Q+ + + F+     IH DL   N+LL     +K+ D+  +    KD    
Sbjct: 146 TLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 254 KRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
           ++      +K                      + APE I    +T   D+WS G +L E+
Sbjct: 206 RKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 151
           K   ++G+G FG V  C          E+VA+K ++   +++      EIE+L+ L +HD
Sbjct: 16  KFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 74
Query: 152 KGGNRCVQIRN--WFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
                 V+ +   +   R ++ ++ E L   SL ++L+K+  R   I L+ +   Q+ + 
Sbjct: 75  N----IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLL-QYTSQICKG 129
Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDF 267
           + ++     IH DL   N+L+ +   +K+ D+  +   P+D    K + P  S I     
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----- 184
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             + APE +    ++   D+WS G +L EL T
Sbjct: 185 -----------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 42/99 (42%), Gaps = 24/99 (24%)
Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           ++H DLKP NV L   + +K+ D+  +     D  + K                      
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKE--------------------- 175
Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
               V T +Y +PE +  + +    DIWS+GC+L ELC 
Sbjct: 176 ---FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 74
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 75  LGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DL   N L+  +  +KV D+  S     D+ Y         IK                
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIK---------------- 177
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAMM 332
                 + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    M
Sbjct: 178 ------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231
Query: 333 ERVLG 337
           ER  G
Sbjct: 232 ERPEG 236

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPN----LVQL 281
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 341
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            +L   N L+  +  +KV D+  S     D+ Y         IK                
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIK---------------- 384
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAMM 332
                 + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    M
Sbjct: 385 ------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 438
Query: 333 ERVLG 337
           ER  G
Sbjct: 439 ERPEG 443

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 74
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 75  LGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DL   N L+  +  +KV D+  S     D+ Y         IK                
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIK---------------- 177
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAMM 332
                 + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    M
Sbjct: 178 ------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231
Query: 333 ERVLG 337
           ER  G
Sbjct: 232 ERPEG 236

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 266 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPN----LVQL 320
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 321 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 380
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            +L   N L+  +  +KV D+  S     D+ Y         IK                
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIK---------------- 423
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAMM 332
                 + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    M
Sbjct: 424 ------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 477
Query: 333 ERVLG 337
           ER  G
Sbjct: 478 ERPEG 482

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 108/255 (42%), Gaps = 49/255 (19%)
Query: 102 MGEGTFGQVLEC-WDRE---RKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHD--KG 153
           +GEG FG+V  C +D E     E VA+K ++        A +  EIE+L+ L   +  K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 154 GNRCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREI--ARQLLECIA 210
              C +     D  N I ++ E L S SL ++L KN  +   I+L +++  A Q+ + + 
Sbjct: 89  KGICTE-----DGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMD 140
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDY--KSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           ++     +H DL   NVL+ S   +K+ D+    ++ T K+    K    S         
Sbjct: 141 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVF------ 194
Query: 269 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 328
                            + APE ++   +    D+WS G  L EL T         +   
Sbjct: 195 -----------------WYAPECLMQSKFYIASDVWSFGVTLHELLT-----YCDSDSSP 232
Query: 329 LAMMERVLGPLPQHM 343
           +A+  +++GP    M
Sbjct: 233 MALFLKMIGPTHGQM 247

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 109/253 (43%), Gaps = 45/253 (17%)
Query: 102 MGEGTFGQVLEC-WDRE---RKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHD--KG 153
           +GEG FG+V  C +D E     E VA+K ++        A +  EIE+L+ L   +  K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 154 GNRCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREI--ARQLLECIA 210
              C +     D  N I ++ E L S SL ++L KN  +   I+L +++  A Q+ + + 
Sbjct: 77  KGICTE-----DGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMD 128
Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++     +H DL   NVL+ S   +K+ D+  +                 AI+      T
Sbjct: 129 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT----------------KAIETDKEXXT 172
Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
             +  D     S   + APE ++   +    D+WS G  L EL T         +   +A
Sbjct: 173 VKDDRD-----SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-----YCDSDSSPMA 222
Query: 331 MMERVLGPLPQHM 343
           +  +++GP    M
Sbjct: 223 LFLKMIGPTHGQM 235

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 79
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 80  LGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DL   N L+  +  +KV D+  S     D+ Y         IK                
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIK---------------- 182
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAMM 332
                 + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    M
Sbjct: 183 ------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 236
Query: 333 ERVLG 337
           ER  G
Sbjct: 237 ERPEG 241

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 79
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 80  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DL   N L+  +  +KV D+  S     D+ Y         IK                
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIK---------------- 182
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAMM 332
                 + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    M
Sbjct: 183 ------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 236
Query: 333 ERVLG 337
           ER  G
Sbjct: 237 ERPEG 241

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 95/243 (39%), Gaps = 51/243 (20%)
Query: 95  RYKIHSKMGEGTFGQVLEC----WDRERK-EMVAIKIVRGIKKYRE--AAMIEIEVLQQL 147
           R K+   +G G FGQV+E      D+      VA+K+++    + E  A M E+++L  +
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 78
Query: 148 AKHDKGGN---RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNN-----YRSFPIDLVR 199
             H    N    C +          + + F K G+ L  +LR        Y+  P DL +
Sbjct: 79  GHHLNVVNLLGACTKPGGPL----MVIVEFCKFGN-LSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 200 EI---------ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 250
           +          + Q+ + + F+     IH DL   N+LL     +K+ D+  +    KD 
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 193
Query: 251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 310
              ++      +K                      + APE I    +T   D+WS G +L
Sbjct: 194 DXVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 311 VEL 313
            E+
Sbjct: 232 WEI 234

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/163 (22%), Positives = 70/163 (42%), Gaps = 38/163 (23%)
Query: 157 CVQIRNWFDYRNH-----ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
            VQI N+ ++ +        IV E +G      L+++  +  P+        ++L  +++
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQ---SLKRSKGQKLPVAEAIAYLLEILPALSY 197
Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H + +++ DLKPEN++L   +                            +K+ID G+ +
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQ----------------------------LKLIDLGAVS 229
Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
                  Y+  T  ++APE++   G T   DI++VG  L  L 
Sbjct: 230 RIN-SFGYLYGTPGFQAPEIVR-TGPTVATDIYTVGRTLAALT 270

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 95/243 (39%), Gaps = 51/243 (20%)
Query: 95  RYKIHSKMGEGTFGQVLEC----WDRERK-EMVAIKIVRGIKKYRE--AAMIEIEVLQQL 147
           R K+   +G G FGQV+E      D+      VA+K+++    + E  A M E+++L  +
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 87
Query: 148 AKHDKGGN---RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNN-----YRSFPIDLVR 199
             H    N    C +          + + F K G+ L  +LR        Y+  P DL +
Sbjct: 88  GHHLNVVNLLGACTKPGGPL----MVIVEFCKFGN-LSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 200 EI---------ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 250
           +          + Q+ + + F+     IH DL   N+LL     +K+ D+  +    KD 
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202
Query: 251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 310
              ++      +K                      + APE I    +T   D+WS G +L
Sbjct: 203 DXVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 311 VEL 313
            E+
Sbjct: 241 WEI 243

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 59/144 (40%), Gaps = 34/144 (23%)
Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
           + E+  Q+   + ++ +   +H DL   NVLLV+  Y K+                    
Sbjct: 472 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS------------------- 512
Query: 258 KSSAIKVIDFGSTTYERPDQNYIVSTRH------YRAPEVILGLGWTYPCDIWSVGCILV 311
                   DFG +   R D+NY  +  H      + APE I    ++   D+WS G ++ 
Sbjct: 513 --------DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 564
Query: 312 E-LCTGEALFQTHENLEHLAMMER 334
           E    G+  ++  +  E  AM+E+
Sbjct: 565 EAFSYGQKPYRGMKGSEVTAMLEK 588

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 74
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DL   N L+  +  +KV D+  S     D+ Y         IK                
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIK---------------- 177
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAMM 332
                 + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    M
Sbjct: 178 ------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231
Query: 333 ERVLG 337
           ER  G
Sbjct: 232 ERPEG 236

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 41/233 (17%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDR----ERKEM-VAIKIVRG--IKKYREAAMIEIEVLQ 145
            +   I   +G G FG+V  C  R     +KE+ VAIK ++    +K R   + E  ++ 
Sbjct: 44  ATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
           Q    +      +++         + IV E +   SL  FLRK++ +   I LV  + R 
Sbjct: 102 QFDHPN-----IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVG-MLRG 155
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAI 262
           +   + ++ D+  +H DL   N+L+ S+   KV D+  S  L    +++Y  R  K    
Sbjct: 156 IASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK---- 211
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             +  R + +PE I    +T   D+WS G +L E+ +
Sbjct: 212 ------------------IPIR-WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 53/121 (43%), Gaps = 31/121 (25%)
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKV 264
            +  +H   +I+ DLKPEN++L    ++K+ D+   K S+H                   
Sbjct: 133 ALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD------------------ 174
Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
              G+ T+          T  Y APE+++  G     D WS+G ++ ++ TG   F T E
Sbjct: 175 ---GTVTHX------FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGE 224
Query: 325 N 325
           N
Sbjct: 225 N 225

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 93/243 (38%), Gaps = 51/243 (20%)
Query: 95  RYKIHSKMGEGTFGQVLEC----WDRERK-EMVAIKIVRGIKKYRE--AAMIEIEVLQQL 147
           R K+   +G G FGQV+E      D+      VA+K+++    + E  A M E+++L  +
Sbjct: 19  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 78
Query: 148 AKHDKGGN---RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNN-----YRSFPIDLVR 199
             H    N    C +           C    K G+ L  +LR        Y+  P DL +
Sbjct: 79  GHHLNVVNLLGACTKPGGPLMVITEFC----KFGN-LSTYLRSKRNEFVPYKVAPEDLYK 133
Query: 200 EI---------ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 250
           +          + Q+ + + F+     IH DL   N+LL     +K+ D+  +    KD 
Sbjct: 134 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 193
Query: 251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 310
              ++      +K                      + APE I    +T   D+WS G +L
Sbjct: 194 DXVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGVLL 231
Query: 311 VEL 313
            E+
Sbjct: 232 WEI 234

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 53/121 (43%), Gaps = 31/121 (25%)
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKV 264
            +  +H   +I+ DLKPEN++L    ++K+ D+   K S+H                   
Sbjct: 133 ALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD------------------ 174
Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
              G+ T+          T  Y APE+++  G     D WS+G ++ ++ TG   F T E
Sbjct: 175 ---GTVTHT------FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGE 224
Query: 325 N 325
           N
Sbjct: 225 N 225

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 59/144 (40%), Gaps = 34/144 (23%)
Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
           + E+  Q+   + ++ +   +H DL   NVLLV+  Y K+                    
Sbjct: 471 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS------------------- 511
Query: 258 KSSAIKVIDFGSTTYERPDQNYIVSTRH------YRAPEVILGLGWTYPCDIWSVGCILV 311
                   DFG +   R D+NY  +  H      + APE I    ++   D+WS G ++ 
Sbjct: 512 --------DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 563
Query: 312 E-LCTGEALFQTHENLEHLAMMER 334
           E    G+  ++  +  E  AM+E+
Sbjct: 564 EAFSYGQKPYRGMKGSEVTAMLEK 587

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 74
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DL   N L+  +  +KV D+  S     D+ Y         IK                
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIK---------------- 177
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAMM 332
                 + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    M
Sbjct: 178 ------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231
Query: 333 ERVLG 337
           ER  G
Sbjct: 232 ERPEG 236

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 57/251 (22%), Positives = 105/251 (41%), Gaps = 36/251 (14%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRG--IKKYREAAMIEIEVLQ 145
            S  KI   +G G FG+V  C  R     +++  VAIK ++G   ++ R   + E  ++ 
Sbjct: 15  VSYVKIEEVIGAGEFGEV--CRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMG 72
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYD-FLRKNNYRSFPIDLVREIARQ 204
           Q    +      +++         + I+ E + +   D FLR N+ +   I LV  + R 
Sbjct: 73  QFEHPN-----IIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLV-GMLRG 126
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +   + ++ ++  +H DL   N+L+ S+   KV D+  S    ++S        S   + 
Sbjct: 127 IASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENS--------SDPTET 178
Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 323
              G     R           + APE I    +T   D WS G ++ E+ + GE  +   
Sbjct: 179 SSLGGKIPIR-----------WTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDM 227
Query: 324 ENLEHLAMMER 334
            N + +  +E+
Sbjct: 228 SNQDVINAIEQ 238

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 37/219 (16%)
Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           K+   +G+G FG V+      R   VA+K ++      +A + E  V+ QL +H    + 
Sbjct: 15  KLLQTIGKGEFGDVM--LGDYRGNKVAVKCIKN-DATAQAFLAEASVMTQL-RH----SN 66
Query: 157 CVQIRNWF-DYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
            VQ+     + +  + IV E +   SL D+LR         D + + +  + E + ++  
Sbjct: 67  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 126
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
              +H DL   NVL+                            + +  KV DFG T    
Sbjct: 127 NNFVHRDLAARNVLV---------------------------SEDNVAKVSDFGLTKEAS 159
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
             Q+       + APE +    ++   D+WS G +L E+
Sbjct: 160 STQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEI 198

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 113/270 (41%), Gaps = 42/270 (15%)
Query: 56  HVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWD 115
           H  +  L + G+     P   ED     + FA   + T+   I   +G G FG+V  C  
Sbjct: 8   HFGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEV--CSG 64
Query: 116 R----ERKEM-VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 168
           R     +KE+ VAIK ++    +K R   + E  ++ Q    +      +++        
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN-----IIRLEGVVTKSK 119
Query: 169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENV 227
            + IV E +   SL  FLRK++ +   I LV  + R +   + ++ D+  +H DL   N+
Sbjct: 120 PVMIVTEXMENGSLDSFLRKHDAQFTVIQLV-GMLRGIASGMKYLSDMGYVHRDLAARNI 178
Query: 228 LLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRH 285
           L+ S+   KV D+  S  L    +++Y  R  K                      +  R 
Sbjct: 179 LINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK----------------------IPIR- 215
Query: 286 YRAPEVILGLGWTYPCDIWSVGCILVELCT 315
           + +PE I    +T   D+WS G +L E+ +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 78
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 79  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 138
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DL   N L+  +  +KV D+  S     D+ Y         IK                
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIK---------------- 181
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAMM 332
                 + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    M
Sbjct: 182 ------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 235
Query: 333 ERVLG 337
           ER  G
Sbjct: 236 ERPEG 240

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 75
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 76  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DL   N L+  +  +KV D+  S     D+      P  +   +               
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAPAGAKFPI--------------- 177
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAMM 332
                 + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    M
Sbjct: 178 -----KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 232
Query: 333 ERVLG 337
           ER  G
Sbjct: 233 ERPEG 237

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/239 (23%), Positives = 93/239 (38%), Gaps = 47/239 (19%)
Query: 95  RYKIHSKMGEGTFGQVLEC----WDR-ERKEMVAIKIVRGIKKYRE--AAMIEIEVLQQL 147
           R  +   +G G FGQV+E      D+      VA+K+++    + E  A M E+++L  +
Sbjct: 28  RLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHI 87
Query: 148 AKHDKGGN---RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPI-DLVREI-- 201
             H    N    C +          + + F K G+ L  +LR       P  DL ++   
Sbjct: 88  GHHLNVVNLLGACTKPGGPL----MVIVEFCKFGN-LSTYLRSKRNEFVPYKDLYKDFLT 142
Query: 202 -------ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
                  + Q+ + + F+     IH DL   N+LL     +K+ D+  +    KD  Y +
Sbjct: 143 LEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 202
Query: 255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
           +      +K                      + APE I    +T   D+WS G +L E+
Sbjct: 203 KGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGVLLWEI 239

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 79
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 80  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DL   N L+  +  +KV D+  S     D+ Y         IK                
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIK---------------- 182
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAMM 332
                 + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    M
Sbjct: 183 ------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 236
Query: 333 ERVLG 337
           ER  G
Sbjct: 237 ERPEG 241

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 79
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 80  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DL   N L+  +  +KV D+  S     D+ Y         IK                
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIK---------------- 182
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAMM 332
                 + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    M
Sbjct: 183 ------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 236
Query: 333 ERVLG 337
           ER  G
Sbjct: 237 ERPEG 241

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 41/233 (17%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDR----ERKEM-VAIKIVRG--IKKYREAAMIEIEVLQ 145
            +   I   +G G FG+V  C  R     +KE+ VAIK ++    +K R   + E  ++ 
Sbjct: 44  ATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
           Q    +      +++         + IV E +   SL  FLRK++ +   I LV  + R 
Sbjct: 102 QFDHPN-----IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV-GMLRG 155
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAI 262
           +   + ++ D+  +H DL   N+L+ S+   KV D+  S  L    +++Y  R  K    
Sbjct: 156 IASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK---- 211
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             +  R + +PE I    +T   D+WS G +L E+ +
Sbjct: 212 ------------------IPIR-WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 100/246 (40%), Gaps = 38/246 (15%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 75
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 76  LGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 220 TDLKPENVLLVSSEYIKVPDYK-SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 278
            DL   N L+  +  +KV D+  S L T                     G T        
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMT---------------------GDTXTAHAGAK 174
Query: 279 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAM 331
           + +    + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    
Sbjct: 175 FPIK---WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 231
Query: 332 MERVLG 337
           MER  G
Sbjct: 232 MERPEG 237

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 76
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 77  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DL   N L+  +  +KV D+  S     D+      P  +   +               
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAPAGAKFPI--------------- 178
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAMM 332
                 + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    M
Sbjct: 179 -----KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 233
Query: 333 ERVLG 337
           ER  G
Sbjct: 234 ERPEG 238

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 76
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 77  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DL   N L+  +  +KV D+  S     D+ Y         IK                
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIK---------------- 179
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAMM 332
                 + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    M
Sbjct: 180 ------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 233
Query: 333 ERVLG 337
           ER  G
Sbjct: 234 ERPEG 238

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 41/183 (22%), Positives = 79/183 (43%), Gaps = 30/183 (16%)
Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIARQ 204
           L K   G +  +++ +WF+  +   ++ E+      L+DF+ +    +   +L R    Q
Sbjct: 108 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQ 165
Query: 205 LLECIAFMHDLCMIHTDLKPENVLL-VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           +LE +   H+  ++H D+K EN+L+ ++   +K+ D+ S     KD+ Y           
Sbjct: 166 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVY----------- 213
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
             DF  T    P +       H R+  V            WS+G +L ++  G+  F+  
Sbjct: 214 -TDFDGTRVYSPPEWIRYHRYHGRSAAV------------WSLGILLYDMVCGDIPFEHD 260
Query: 324 ENL 326
           E +
Sbjct: 261 EEI 263

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/251 (23%), Positives = 105/251 (41%), Gaps = 36/251 (14%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRG--IKKYREAAMIEIEVLQ 145
            S  KI   +G G FG+V  C  R     +++  VAIK ++G   ++ R   + E  ++ 
Sbjct: 13  VSYVKIEEVIGAGEFGEV--CRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMG 70
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYD-FLRKNNYRSFPIDLVREIARQ 204
           Q    +      +++         + I+ E + +   D FLR N+ +   I LV  + R 
Sbjct: 71  QFEHPN-----IIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLV-GMLRG 124
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +   + ++ ++  +H DL   N+L+ S+   KV D+  S    ++SS             
Sbjct: 125 IASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSS------------- 171
Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 323
                 TY       I     + APE I    +T   D WS G ++ E+ + GE  +   
Sbjct: 172 ----DPTYTSSLGGKI--PIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDM 225
Query: 324 ENLEHLAMMER 334
            N + +  +E+
Sbjct: 226 SNQDVINAIEQ 236

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 76
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 77  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DL   N L+  +  +KV D+  S     D+ Y         IK                
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIK---------------- 179
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAMM 332
                 + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    M
Sbjct: 180 ------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 233
Query: 333 ERVLG 337
           ER  G
Sbjct: 234 ERPEG 238

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/282 (21%), Positives = 113/282 (40%), Gaps = 57/282 (20%)
Query: 66  GVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEM-VAI 124
           G A  G   W  D KD  ++               ++G G FG V   + + R +  VAI
Sbjct: 1   GTAGLGYGSWEIDPKDLTFL--------------KELGTGQFGVVK--YGKWRGQYDVAI 44
Query: 125 KIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSS-LYD 183
           K+++      +  + E +V+  L+ H+K     VQ+      +  I I+ E + +  L +
Sbjct: 45  KMIKEGSMSEDEFIEEAKVMMNLS-HEK----LVQLYGVCTKQRPIFIITEYMANGCLLN 99
Query: 184 FLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 243
           +LR+  +R F    + E+ + + E + ++     +H DL   N L+     +KV D+  S
Sbjct: 100 YLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 158
Query: 244 LHTPKD---SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYP 300
            +   D   SS   + P                            +  PEV++   ++  
Sbjct: 159 RYVLDDEYTSSVGSKFP--------------------------VRWSPPEVLMYSKFSSK 192
Query: 301 CDIWSVGCILVELCTGEAL----FQTHENLEHLAMMERVLGP 338
            DIW+ G ++ E+ +   +    F   E  EH+A   R+  P
Sbjct: 193 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP 234

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/164 (23%), Positives = 67/164 (40%), Gaps = 24/164 (14%)
Query: 201 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 260
           I RQ+   +   H     H D+KPEN+L+ + ++  + D+  +  T  +           
Sbjct: 139 IVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE----------- 187
Query: 261 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
             K+   G+T          V T +Y APE       TY  DI+++ C+L E  TG   +
Sbjct: 188 --KLTQLGNT----------VGTLYYXAPERFSESHATYRADIYALTCVLYECLTGSPPY 235
Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPE 364
           Q  +     A + + + P P  +   +    +  + RG    PE
Sbjct: 236 QGDQLSVXGAHINQAI-PRPSTVRPGIPVAFDAVIARGXAKNPE 278

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 95/243 (39%), Gaps = 51/243 (20%)
Query: 95  RYKIHSKMGEGTFGQVLEC----WDRERK-EMVAIKIVRGIKKYRE--AAMIEIEVLQQL 147
           R K+   +G G FGQV+E      D+      VA+K+++    + E  A M E+++L  +
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 87
Query: 148 AKHDKGGN---RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNN-----YRSFPIDLVR 199
             H    N    C +          + + F K G+ L  +LR        Y+  P DL +
Sbjct: 88  GHHLNVVNLLGACTKPGGPL----MVIVEFCKFGN-LSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 200 EI---------ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 250
           +          + Q+ + + F+     IH DL   N+LL     +K+ D+  +    KD 
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 310
              ++      +K                      + APE I    +T   D+WS G +L
Sbjct: 203 DXVRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 311 VEL 313
            E+
Sbjct: 241 WEI 243

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 111/268 (41%), Gaps = 43/268 (16%)
Query: 77  EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRG-- 129
           ED     + FA  E   S   I   +G G FG+V  C  R     +R+  VAIK ++   
Sbjct: 6   EDPNQAVHEFA-KEIEASCITIERVIGAGEFGEV--CSGRLKLPGKRELPVAIKTLKVGY 62
Query: 130 IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKN 188
            +K R   + E  ++ Q    +      + +         + IV E +   SL  FL+KN
Sbjct: 63  TEKQRRDFLGEASIMGQFDHPN-----IIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKN 117
Query: 189 NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHT 246
           + +   I LV  + R +   + ++ D+  +H DL   N+L+ S+   KV D+  S  L  
Sbjct: 118 DGQFTVIQLVG-MLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 176
Query: 247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSV 306
             +++Y  R  K                      +  R + APE I    +T   D+WS 
Sbjct: 177 DPEAAYTTRGGK----------------------IPIR-WTAPEAIAFRKFTSASDVWSY 213
Query: 307 GCILVELCT-GEALFQTHENLEHLAMME 333
           G ++ E+ + GE  +    N + +  +E
Sbjct: 214 GIVMWEVVSYGERPYWEMTNQDVIKAVE 241

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 74
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DL   N L+  +  +KV D+  S     D+ Y         IK                
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIK---------------- 177
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAMM 332
                 + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    M
Sbjct: 178 ------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231
Query: 333 ERVLG 337
           ER  G
Sbjct: 232 ERPEG 236

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 113/270 (41%), Gaps = 42/270 (15%)
Query: 56  HVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWD 115
           H  +  L + G+     P   ED     + FA   + T+   I   +G G FG+V  C  
Sbjct: 8   HFGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEV--CSG 64
Query: 116 R----ERKEM-VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 168
           R     +KE+ VAIK ++    +K R   + E  ++ Q    +      +++        
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN-----IIRLEGVVTKSK 119
Query: 169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENV 227
            + IV E +   SL  FLRK++ +   I LV  + R +   + ++ D+  +H DL   N+
Sbjct: 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLV-GMLRGIASGMKYLSDMGYVHRDLAARNI 178
Query: 228 LLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRH 285
           L+ S+   KV D+  S  L    +++Y  R  K                      +  R 
Sbjct: 179 LINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK----------------------IPIR- 215
Query: 286 YRAPEVILGLGWTYPCDIWSVGCILVELCT 315
           + +PE I    +T   D+WS G +L E+ +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 87
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 88  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 147
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DL   N L+  +  +KV D+  S     D+ Y         IK                
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIK---------------- 190
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAMM 332
                 + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    M
Sbjct: 191 ------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 244
Query: 333 ERVLG 337
           ER  G
Sbjct: 245 ERPEG 249

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 113/270 (41%), Gaps = 42/270 (15%)
Query: 56  HVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWD 115
           H  +  L + G+     P   ED     + FA   + T+   I   +G G FG+V  C  
Sbjct: 6   HFGNGHLKLPGLRTYVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEV--CSG 62
Query: 116 R----ERKEM-VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 168
           R     +KE+ VAIK ++    +K R   + E  ++ Q    +      +++        
Sbjct: 63  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN-----IIRLEGVVTKSK 117
Query: 169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENV 227
            + IV E +   SL  FLRK++ +   I LV  + R +   + ++ D+  +H DL   N+
Sbjct: 118 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLV-GMLRGIASGMKYLSDMGYVHRDLAARNI 176
Query: 228 LLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRH 285
           L+ S+   KV D+  S  L    +++Y  R  K                      +  R 
Sbjct: 177 LINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK----------------------IPIR- 213
Query: 286 YRAPEVILGLGWTYPCDIWSVGCILVELCT 315
           + +PE I    +T   D+WS G +L E+ +
Sbjct: 214 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 59/144 (40%), Gaps = 34/144 (23%)
Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
           + E+  Q+   + ++ +   +H DL   NVLLV+  Y K+                    
Sbjct: 107 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS------------------- 147
Query: 258 KSSAIKVIDFGSTTYERPDQNYIVSTRH------YRAPEVILGLGWTYPCDIWSVGCILV 311
                   DFG +   R D+NY  +  H      + APE I    ++   D+WS G ++ 
Sbjct: 148 --------DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 199
Query: 312 E-LCTGEALFQTHENLEHLAMMER 334
           E    G+  ++  +  E  AM+E+
Sbjct: 200 EAFSYGQKPYRGMKGSEVTAMLEK 223

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/119 (26%), Positives = 50/119 (42%), Gaps = 29/119 (24%)
Query: 197 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 256
           L  E+  Q+ + + ++H   +IH DLKP N+ LV ++ +K+                   
Sbjct: 137 LALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIG------------------ 178
Query: 257 PKSSAIKVIDFGSTTYERPDQNYIVS--TRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
                    DFG  T  + D     S  T  Y +PE I    +    D++++G IL EL
Sbjct: 179 ---------DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 59/144 (40%), Gaps = 34/144 (23%)
Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
           + E+  Q+   + ++ +   +H DL   NVLLV+  Y K+                    
Sbjct: 127 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS------------------- 167
Query: 258 KSSAIKVIDFGSTTYERPDQNYIVSTRH------YRAPEVILGLGWTYPCDIWSVGCILV 311
                   DFG +   R D+NY  +  H      + APE I    ++   D+WS G ++ 
Sbjct: 168 --------DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 219
Query: 312 E-LCTGEALFQTHENLEHLAMMER 334
           E    G+  ++  +  E  AM+E+
Sbjct: 220 EAFSYGQKPYRGMKGSEVTAMLEK 243

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 59/144 (40%), Gaps = 34/144 (23%)
Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
           + E+  Q+   + ++ +   +H DL   NVLLV+  Y K+                    
Sbjct: 119 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS------------------- 159
Query: 258 KSSAIKVIDFGSTTYERPDQNYIVSTRH------YRAPEVILGLGWTYPCDIWSVGCILV 311
                   DFG +   R D+NY  +  H      + APE I    ++   D+WS G ++ 
Sbjct: 160 --------DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 211
Query: 312 E-LCTGEALFQTHENLEHLAMMER 334
           E    G+  ++  +  E  AM+E+
Sbjct: 212 EAFSYGQKPYRGMKGSEVTAMLEK 235

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 59/144 (40%), Gaps = 34/144 (23%)
Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
           + E+  Q+   + ++ +   +H DL   NVLLV+  Y K+                    
Sbjct: 113 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS------------------- 153
Query: 258 KSSAIKVIDFGSTTYERPDQNYIVSTRH------YRAPEVILGLGWTYPCDIWSVGCILV 311
                   DFG +   R D+NY  +  H      + APE I    ++   D+WS G ++ 
Sbjct: 154 --------DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 205
Query: 312 E-LCTGEALFQTHENLEHLAMMER 334
           E    G+  ++  +  E  AM+E+
Sbjct: 206 EAFSYGQKPYRGMKGSEVTAMLEK 229

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 74
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DL   N L+  +  +KV D+  S     D+ Y         IK                
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIK---------------- 177
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAMM 332
                 + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    M
Sbjct: 178 ------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231
Query: 333 ERVLG 337
           ER  G
Sbjct: 232 ERPEG 236

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 84/191 (43%), Gaps = 18/191 (9%)
Query: 87  ALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ 146
           A+    T+ +    K+G G FG V +C  R    + AIK     KK    ++ E   L++
Sbjct: 2   AMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRS---KKPLAGSVDEQNALRE 58
Query: 147 LAKHDKGGNRCVQIRNWFDYR--NHICIVFEKL-GSSLYDFLRKNNYR---SFPIDLVRE 200
           +  H   G     +R +  +   +H+ I  E   G SL D + +N YR    F    +++
Sbjct: 59  VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISEN-YRIMSYFKEAELKD 117
Query: 201 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 260
           +  Q+   + ++H + ++H D+KP N+ +  +    +P+  S      D +  K M    
Sbjct: 118 LLLQVGRGLRYIHSMSLVHMDIKPSNIFISRT---SIPNAASEEGDEDDWASNKVM---- 170
Query: 261 AIKVIDFGSTT 271
             K+ D G  T
Sbjct: 171 -FKIGDLGHVT 180

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 59/144 (40%), Gaps = 34/144 (23%)
Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
           + E+  Q+   + ++ +   +H DL   NVLLV+  Y K+                    
Sbjct: 109 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS------------------- 149
Query: 258 KSSAIKVIDFGSTTYERPDQNYIVSTRH------YRAPEVILGLGWTYPCDIWSVGCILV 311
                   DFG +   R D+NY  +  H      + APE I    ++   D+WS G ++ 
Sbjct: 150 --------DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 201
Query: 312 E-LCTGEALFQTHENLEHLAMMER 334
           E    G+  ++  +  E  AM+E+
Sbjct: 202 EAFSYGQKPYRGMKGSEVTAMLEK 225

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 41/233 (17%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDR----ERKEM-VAIKIVRG--IKKYREAAMIEIEVLQ 145
            +   I   +G G FG+V  C  R     +KE+ VAIK ++    +K R   + E  ++ 
Sbjct: 44  ATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
           Q    +      +++         + IV E +   SL  FLRK++ +   I LV  + R 
Sbjct: 102 QFDHPN-----IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG-MLRG 155
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAI 262
           +   + ++ D+  +H DL   N+L+ S+   KV D+  S  L    +++Y  R  K    
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK---- 211
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             +  R + +PE I    +T   D+WS G +L E+ +
Sbjct: 212 ------------------IPIR-WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 113/270 (41%), Gaps = 42/270 (15%)
Query: 56  HVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWD 115
           H  +  L + G+     P   ED     + FA   + T+   I   +G G FG+V  C  
Sbjct: 8   HFGNGHLKLPGLRTFVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEV--CSG 64
Query: 116 R----ERKEM-VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 168
           R     +KE+ VAIK ++    +K R   + E  ++ Q    +      +++        
Sbjct: 65  RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN-----IIRLEGVVTKSK 119
Query: 169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENV 227
            + IV E +   SL  FLRK++ +   I LV  + R +   + ++ D+  +H DL   N+
Sbjct: 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG-MLRGIASGMKYLSDMGYVHRDLAARNI 178
Query: 228 LLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRH 285
           L+ S+   KV D+  S  L    +++Y  R  K                      +  R 
Sbjct: 179 LINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK----------------------IPIR- 215
Query: 286 YRAPEVILGLGWTYPCDIWSVGCILVELCT 315
           + +PE I    +T   D+WS G +L E+ +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 41/233 (17%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDR----ERKEM-VAIKIVRG--IKKYREAAMIEIEVLQ 145
            +   I   +G G FG+V  C  R     +KE+ VAIK ++    +K R   + E  ++ 
Sbjct: 44  ATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
           Q    +      +++         + IV E +   SL  FLRK++ +   I LV  + R 
Sbjct: 102 QFDHPN-----IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG-MLRG 155
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAI 262
           +   + ++ D+  +H DL   N+L+ S+   KV D+  S  L    +++Y  R  K    
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK---- 211
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             +  R + +PE I    +T   D+WS G +L E+ +
Sbjct: 212 ------------------IPIR-WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 59/144 (40%), Gaps = 34/144 (23%)
Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
           + E+  Q+   + ++ +   +H DL   NVLLV+  Y K+                    
Sbjct: 129 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS------------------- 169
Query: 258 KSSAIKVIDFGSTTYERPDQNYIVSTRH------YRAPEVILGLGWTYPCDIWSVGCILV 311
                   DFG +   R D+NY  +  H      + APE I    ++   D+WS G ++ 
Sbjct: 170 --------DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 221
Query: 312 E-LCTGEALFQTHENLEHLAMMER 334
           E    G+  ++  +  E  AM+E+
Sbjct: 222 EAFSYGQKPYRGMKGSEVTAMLEK 245

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 59/144 (40%), Gaps = 34/144 (23%)
Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
           + E+  Q+   + ++ +   +H DL   NVLLV+  Y K+                    
Sbjct: 129 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS------------------- 169
Query: 258 KSSAIKVIDFGSTTYERPDQNYIVSTRH------YRAPEVILGLGWTYPCDIWSVGCILV 311
                   DFG +   R D+NY  +  H      + APE I    ++   D+WS G ++ 
Sbjct: 170 --------DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 221
Query: 312 E-LCTGEALFQTHENLEHLAMMER 334
           E    G+  ++  +  E  AM+E+
Sbjct: 222 EAFSYGQKPYRGMKGSEVTAMLEK 245

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 100/246 (40%), Gaps = 38/246 (15%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 79
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 80  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 220 TDLKPENVLLVSSEYIKVPDYK-SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 278
            DL   N L+  +  +KV D+  S L T                     G T        
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMT---------------------GDTXTAHAGAK 178
Query: 279 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAM 331
           + +    + APE +    ++   D+W+ G +L E+ T       G  L Q +E LE    
Sbjct: 179 FPIK---WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 235
Query: 332 MERVLG 337
           MER  G
Sbjct: 236 MERPEG 241

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 102/248 (41%), Gaps = 32/248 (12%)
Query: 94  SRYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLA 148
           S  KI   +G G FG+V     +   +R+  VAIK ++    +K R   + E  ++ Q  
Sbjct: 7   SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 66
Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
             +      + +         + I+ E +   SL  FLR+N+ +   I LV  + R +  
Sbjct: 67  HPN-----VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLV-GMLRGIAA 120
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++ D+  +H  L   N+L+ S+   KV D+  S     D+S                
Sbjct: 121 GMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTS---------------- 164
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 326
              TY       I     + APE I    +T   D+WS G ++ E+ + GE  +    N 
Sbjct: 165 -DPTYTSALGGKI--PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 221
Query: 327 EHLAMMER 334
           + +  +E+
Sbjct: 222 DVINAIEQ 229

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 112/274 (40%), Gaps = 47/274 (17%)
Query: 73  PPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIV 127
           P   ED     + FA  E   S  KI   +G G FG+V  C  R     +R   VAIK +
Sbjct: 23  PETYEDPNRAVHQFA-KELDASCIKIERVIGAGEFGEV--CSGRLKLPGKRDVAVAIKTL 79
Query: 128 RG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYD-F 184
           +    +K R   + E  ++ Q    +      V +         + IV E + +   D F
Sbjct: 80  KVGYTEKQRRDFLCEASIMGQFDHPN-----VVHLEGVVTRGKPVMIVIEFMENGALDAF 134
Query: 185 LRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 244
           LRK++ +   I LV  + R +   + ++ D+  +H DL   N+L+ S+   KV D+  S 
Sbjct: 135 LRKHDGQFTVIQLVG-MLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLS- 192
Query: 245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRH----YRAPEVILGLGWTYP 300
                             +VI+      + P+  Y  +       + APE I    +T  
Sbjct: 193 ------------------RVIE------DDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSA 228
Query: 301 CDIWSVGCILVELCT-GEALFQTHENLEHLAMME 333
            D+WS G ++ E+ + GE  +    N + +  +E
Sbjct: 229 SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE 262

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/246 (22%), Positives = 88/246 (35%), Gaps = 54/246 (21%)
Query: 94  SRYKIHSKMGEGTFGQVLECW-----DRERKEMVAIKIVRGIKKY--REAAMIEIEVLQQ 146
           +R      +G G FG+V+E         +    VA+K+++       REA M E++VL  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 147 LAKHDKGGN---RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNN-----YRSFPIDLV 198
           L  H    N    C           + C         L +FLR+        ++ P  + 
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCY------GDLLNFLRRKRDSFICSKTSPAIME 136
Query: 199 R-----------EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 247
                         + Q+ + +AF+     IH DL   N+LL      K+ D+  +    
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVG 307
            DS+Y  +      +K                      + APE I    +T+  D+WS G
Sbjct: 197 NDSNYVVKGNARLPVK----------------------WMAPESIFNCVYTFESDVWSYG 234
Query: 308 CILVEL 313
             L EL
Sbjct: 235 IFLWEL 240

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 41/232 (17%)
Query: 94  SRYKIHSKMGEGTFGQVLECWDR----ERKEM-VAIKIVRG--IKKYREAAMIEIEVLQQ 146
           +   I   +G G FG+V  C  R     +KE+ VAIK ++    +K R   + E  ++ Q
Sbjct: 16  TNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
               +      +++         + IV E +   SL  FLRK++ +   I LV  + R +
Sbjct: 74  FDHPN-----IIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLV-GMLRGI 127
Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAIK 263
              + ++ D+  +H DL   N+L+ S+   KV D+  S  L    +++Y  R  K     
Sbjct: 128 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK----- 182
Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                            +  R + +PE I    +T   D+WS G +L E+ +
Sbjct: 183 -----------------IPIR-WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 41/233 (17%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDR----ERKEM-VAIKIVRG--IKKYREAAMIEIEVLQ 145
            +   I   +G G FG+V  C  R     +KE+ VAIK ++    +K R   + E  ++ 
Sbjct: 32  ATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 89
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
           Q    +      +++         + IV E +   SL  FLRK++ +   I LV  + R 
Sbjct: 90  QFDHPN-----IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV-GMLRG 143
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAI 262
           +   + ++ D+  +H DL   N+L+ S+   KV D+  S  L    +++Y  R  K    
Sbjct: 144 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK---- 199
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             +  R + +PE I    +T   D+WS G +L E+ +
Sbjct: 200 ------------------IPIR-WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 67/148 (45%), Gaps = 24/148 (16%)
Query: 170 ICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPEN 226
           + I  E   +SL  F ++  +  ++ P D++ +IA  +++ +  +H  L +IH D+KP N
Sbjct: 108 VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSN 167
Query: 227 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHY 286
           VL+ +   +K  D+  S +   D +           K ID G   Y  P+          
Sbjct: 168 VLINALGQVKXCDFGISGYLVDDVA-----------KDIDAGCKPYXAPE---------- 206
Query: 287 RAPEVILGLGWTYPCDIWSVGCILVELC 314
           R    +   G++   DIWS+G   +EL 
Sbjct: 207 RINPELNQKGYSVKSDIWSLGITXIELA 234

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/246 (22%), Positives = 88/246 (35%), Gaps = 54/246 (21%)
Query: 94  SRYKIHSKMGEGTFGQVLECW-----DRERKEMVAIKIVRGIKKY--REAAMIEIEVLQQ 146
           +R      +G G FG+V+E         +    VA+K+++       REA M E++VL  
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 147 LAKHDKGGN---RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNN-----YRSFPIDLV 198
           L  H    N    C           + C         L +FLR+        ++ P  + 
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCY------GDLLNFLRRKRDSFICSKTSPAIME 152
Query: 199 R-----------EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 247
                         + Q+ + +AF+     IH DL   N+LL      K+ D+  +    
Sbjct: 153 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 212
Query: 248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVG 307
            DS+Y  +      +K                      + APE I    +T+  D+WS G
Sbjct: 213 NDSNYVVKGNARLPVK----------------------WMAPESIFNCVYTFESDVWSYG 250
Query: 308 CILVEL 313
             L EL
Sbjct: 251 IFLWEL 256

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 22/235 (9%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 152
           T+ +    K+G G FG V +C  R    + AIK     KK    ++ E   L+++  H  
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK---RSKKPLAGSVDEQNALREVYAHAV 62
Query: 153 GGNRCVQIRNWFDYR--NHICIVFEKL-GSSLYDFLRKNNYR---SFPIDLVREIARQLL 206
            G     +R +  +   +H+ I  E   G SL D + +N YR    F    ++++  Q+ 
Sbjct: 63  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISEN-YRIMSYFKEAELKDLLLQVG 121
Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             + ++H + ++H D+KP N+ +  +    +P+  S      D +  K M      K+ D
Sbjct: 122 RGLRYIHSMSLVHMDIKPSNIFISRT---SIPNAASEEGDEDDWASNKVM-----FKIGD 173
Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEAL 319
            G  T     Q     +R + A EV L   +T+    DI+++   +V     E L
Sbjct: 174 LGHVTRISSPQVEEGDSR-FLANEV-LQENYTHLPKADIFALALTVVXAAGAEPL 226

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 102/236 (43%), Gaps = 51/236 (21%)
Query: 101 KMGEGTFGQVL--ECWD---RERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHD--- 151
           ++GEG FG+V   EC++    + K +VA+K ++      R+    E E+L  L +H+   
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIV 78
Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSF-------PIDLVRE--- 200
           K    CV+        + + +VFE +    L  FLR +   +        P +L +    
Sbjct: 79  KFYGVCVE-------GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQML 131
Query: 201 -IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
            IA+Q+   + ++     +H DL   N L+  +  +K+ D+  S                
Sbjct: 132 HIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR--------------- 176
Query: 260 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                 D  ST Y R   + ++  R +  PE I+   +T   D+WS+G +L E+ T
Sbjct: 177 ------DVYSTDYYRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 37/219 (16%)
Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           K+   +G+G FG V+      R   VA+K ++      +A + E  V+ QL +H    + 
Sbjct: 24  KLLQTIGKGEFGDVM--LGDYRGNKVAVKCIKN-DATAQAFLAEASVMTQL-RH----SN 75
Query: 157 CVQIRNWF-DYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
            VQ+     + +  + IV E +   SL D+LR         D + + +  + E + ++  
Sbjct: 76  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
              +H DL   NVL+                            + +  KV DFG T    
Sbjct: 136 NNFVHRDLAARNVLV---------------------------SEDNVAKVSDFGLTKEAS 168
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
             Q+       + APE +    ++   D+WS G +L E+
Sbjct: 169 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 207

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/246 (22%), Positives = 88/246 (35%), Gaps = 54/246 (21%)
Query: 94  SRYKIHSKMGEGTFGQVLECW-----DRERKEMVAIKIVRGIKKY--REAAMIEIEVLQQ 146
           +R      +G G FG+V+E         +    VA+K+++       REA M E++VL  
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 147 LAKHDKGGN---RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNN-----YRSFPIDLV 198
           L  H    N    C           + C         L +FLR+        ++ P  + 
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCY------GDLLNFLRRKRDSFICSKTSPAIME 159
Query: 199 R-----------EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 247
                         + Q+ + +AF+     IH DL   N+LL      K+ D+  +    
Sbjct: 160 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 219
Query: 248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVG 307
            DS+Y  +      +K                      + APE I    +T+  D+WS G
Sbjct: 220 NDSNYVVKGNARLPVK----------------------WMAPESIFNCVYTFESDVWSYG 257
Query: 308 CILVEL 313
             L EL
Sbjct: 258 IFLWEL 263

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/244 (22%), Positives = 102/244 (41%), Gaps = 37/244 (15%)
Query: 101 KMGEGTFGQVLECWDRERKEM-VAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           ++G G FG V   + + R +  VAIK+++      +  + E +V+  L+ H+K     VQ
Sbjct: 16  ELGTGQFGVVK--YGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEK----LVQ 68
Query: 160 IRNWFDYRNHICIVFEKLGSS-LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           +      +  I I+ E + +  L ++LR+  +R F    + E+ + + E + ++     +
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFL 127
Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 278
           H DL   N L+     +KV D+  S +   D     R  K                    
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPV----------------- 170
Query: 279 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL----FQTHENLEHLAMMER 334
                  +  PEV++   ++   DIW+ G ++ E+ +   +    F   E  EH+A   R
Sbjct: 171 ------RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 224
Query: 335 VLGP 338
           +  P
Sbjct: 225 LYRP 228

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/244 (22%), Positives = 108/244 (44%), Gaps = 37/244 (15%)
Query: 101 KMGEGTFGQVLECWDRERKEM-VAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           ++G G FG V   + + R +  VAIK+++      +  + E +V+  L+ H+K     VQ
Sbjct: 31  ELGTGQFGVVK--YGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEK----LVQ 83
Query: 160 IRNWFDYRNHICIVFEKLGSS-LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           +      +  I I+ E + +  L ++LR+  +R F    + E+ + + E + ++     +
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 278
           H DL   N L+     +KV D+  S +   D        ++S++     GS    R    
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-------ETSSV-----GSKFPVR---- 186
Query: 279 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL----FQTHENLEHLAMMER 334
                  +  PEV++   ++   DIW+ G ++ E+ +   +    F   E  EH+A   R
Sbjct: 187 -------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 239
Query: 335 VLGP 338
           +  P
Sbjct: 240 LYRP 243

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 41/233 (17%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDR----ERKEM-VAIKIVRG--IKKYREAAMIEIEVLQ 145
            +   I   +G G FG+V  C  R     +KE+ VAIK ++    +K R   + E  ++ 
Sbjct: 15  ATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 72
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
           Q    +      +++         + IV E +   SL  FLRK++ +   I LV  + R 
Sbjct: 73  QFDHPN-----IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV-GMLRG 126
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAI 262
           +   + ++ D+  +H DL   N+L+ S+   KV D+  S  L    +++Y  R  K    
Sbjct: 127 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK---- 182
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             +  R + +PE I    +T   D+WS G +L E+ +
Sbjct: 183 ------------------IPIR-WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 82/185 (44%), Gaps = 18/185 (9%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 152
           T+ +    K+G G FG V +C  R    + AIK     KK    ++ E   L+++  H  
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRS---KKPLAGSVDEQNALREVYAHAV 66
Query: 153 GGNRCVQIRNWFDYR--NHICIVFEKL-GSSLYDFLRKNNYR---SFPIDLVREIARQLL 206
            G     +R +  +   +H+ I  E   G SL D + +N YR    F    ++++  Q+ 
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISEN-YRIMSYFKEAELKDLLLQVG 125
Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             + ++H + ++H D+KP N+ +  +    +P+  S      D +  K M      K+ D
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRT---SIPNAASEEGDEDDWASNKVM-----FKIGD 177
Query: 267 FGSTT 271
            G  T
Sbjct: 178 LGHVT 182

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/246 (22%), Positives = 88/246 (35%), Gaps = 54/246 (21%)
Query: 94  SRYKIHSKMGEGTFGQVLECW-----DRERKEMVAIKIVRGIKKY--REAAMIEIEVLQQ 146
           +R      +G G FG+V+E         +    VA+K+++       REA M E++VL  
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 147 LAKHDKGGN---RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNN-----YRSFPIDLV 198
           L  H    N    C           + C         L +FLR+        ++ P  + 
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCY------GDLLNFLRRKRDSFICSKTSPAIME 154
Query: 199 R-----------EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 247
                         + Q+ + +AF+     IH DL   N+LL      K+ D+  +    
Sbjct: 155 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 214
Query: 248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVG 307
            DS+Y  +      +K                      + APE I    +T+  D+WS G
Sbjct: 215 NDSNYVVKGNARLPVK----------------------WMAPESIFNCVYTFESDVWSYG 252
Query: 308 CILVEL 313
             L EL
Sbjct: 253 IFLWEL 258

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 82/185 (44%), Gaps = 18/185 (9%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 152
           T+ +    K+G G FG V +C  R    + AIK     KK    ++ E   L+++  H  
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRS---KKPLAGSVDEQNALREVYAHAV 64
Query: 153 GGNRCVQIRNWFDYR--NHICIVFEKL-GSSLYDFLRKNNYR---SFPIDLVREIARQLL 206
            G     +R +  +   +H+ I  E   G SL D + +N YR    F    ++++  Q+ 
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISEN-YRIMSYFKEAELKDLLLQVG 123
Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             + ++H + ++H D+KP N+ +  +    +P+  S      D +  K M      K+ D
Sbjct: 124 RGLRYIHSMSLVHMDIKPSNIFISRT---SIPNAASEEGDEDDWASNKVM-----FKIGD 175
Query: 267 FGSTT 271
            G  T
Sbjct: 176 LGHVT 180

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 99/233 (42%), Gaps = 41/233 (17%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDR----ERKEM-VAIKIVRG--IKKYREAAMIEIEVLQ 145
            +   I   +G G FG+V  C  R     +KE+ VAIK ++    +K R   + E  ++ 
Sbjct: 44  ATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
           Q    +      +++         + IV E +   SL  FLRK++ +   I LV  + R 
Sbjct: 102 QFDHPN-----IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV-GMLRG 155
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAI 262
           +   + ++ D+  +H DL   N+L+ S+   KV D+  +  L    +++Y  R  K    
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGK---- 211
Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                             +  R + +PE I    +T   D+WS G +L E+ +
Sbjct: 212 ------------------IPIR-WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 37/219 (16%)
Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           K+   +G+G FG V+      R   VA+K ++      +A + E  V+ QL +H    + 
Sbjct: 9   KLLQTIGKGEFGDVM--LGDYRGNKVAVKCIKN-DATAQAFLAEASVMTQL-RH----SN 60
Query: 157 CVQIRNWF-DYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
            VQ+     + +  + IV E +   SL D+LR         D + + +  + E + ++  
Sbjct: 61  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 120
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
              +H DL   NVL+                            + +  KV DFG T    
Sbjct: 121 NNFVHRDLAARNVLV---------------------------SEDNVAKVSDFGLTKEAS 153
Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
             Q+       + APE +    ++   D+WS G +L E+
Sbjct: 154 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 84/218 (38%), Gaps = 35/218 (16%)
Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           K+   +G+G FG V+      R   VA+K ++      +A + E  V+ QL    +  N 
Sbjct: 196 KLLQTIGKGEFGDVM--LGDYRGNKVAVKCIKN-DATAQAFLAEASVMTQL----RHSNL 248
Query: 157 CVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
              +    + +  + IV E +   SL D+LR         D + + +  + E + ++   
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
             +H DL   NVL+                            + +  KV DFG T     
Sbjct: 309 NFVHRDLAARNVLV---------------------------SEDNVAKVSDFGLTKEASS 341
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
            Q+       + APE +    ++   D+WS G +L E+
Sbjct: 342 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 379

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/247 (22%), Positives = 104/247 (42%), Gaps = 43/247 (17%)
Query: 101 KMGEGTFGQVLECWDRERKEM-VAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           ++G G FG V   + + R +  VAIK+++      +  + E +V+  L+ H+K     VQ
Sbjct: 31  ELGTGQFGVVK--YGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEK----LVQ 83
Query: 160 IRNWFDYRNHICIVFEKLGSS-LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           +      +  I I+ E + +  L ++LR+  +R F    + E+ + + E + ++     +
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKD---SSYFKRMPKSSAIKVIDFGSTTYERP 275
           H DL   N L+     +KV D+  S +   D   SS   + P                  
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP------------------ 184
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL----FQTHENLEHLAM 331
                     +  PEV++   ++   DIW+ G ++ E+ +   +    F   E  EH+A 
Sbjct: 185 --------VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236
Query: 332 MERVLGP 338
             R+  P
Sbjct: 237 GLRLYRP 243

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 99/246 (40%), Gaps = 38/246 (15%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G FG+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 72
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 73  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 220 TDLKPENVLLVSSEYIKVPDYK-SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 278
            DL   N L+  +  +KV D+  S L T                     G T        
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMT---------------------GDTXTAHAGAK 171
Query: 279 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAM 331
           + +    + APE +    ++   D+W+ G +L E+ T       G    Q +E LE    
Sbjct: 172 FPIK---WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYR 228
Query: 332 MERVLG 337
           MER  G
Sbjct: 229 MERPEG 234

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/297 (19%), Positives = 115/297 (38%), Gaps = 39/297 (13%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR--EAAMIEIEVLQQLAKHDKGGNRCVQ 159
           +G+G    V     ++  ++ AIK+   I   R  +  M E EVL++L  + K   +   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL--NHKNIVKLFA 74
Query: 160 IRNWFDYRNHICIVFEKLGSSLYDFLRK-NNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           I      R+ + I+      SLY  L + +N    P      + R ++  +  + +  ++
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIV 134
Query: 219 HTDLKPENVLLVSSE----YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           H ++KP N++ V  E      K+ D+ ++     D  +           V  +G+  Y  
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-----------VXLYGTEEYLH 183
Query: 275 PD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN-LEHLAM 331
           PD  +  ++   H +         +    D+WS+G       TG   F+  E    +  +
Sbjct: 184 PDMYERAVLRKDHQKK--------YGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIK---SVMKLPRLQNLI 385
           M +++   P   +  V +        G +DW        S+     V+  P L N++
Sbjct: 236 MYKIITGKPSGAISGVQK-----AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 95/241 (39%), Gaps = 48/241 (19%)
Query: 95  RYKIHSKMGEGTFGQVLEC----WDRERK-EMVAIKIVRGIKKYRE--AAMIEIEVLQQL 147
           R  +   +G G FGQV+E      D+      VA+K+++    + E  A M E+++L  +
Sbjct: 29  RLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 88
Query: 148 AKHDKGGN---RCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSF--PIDLVREI 201
             H    N    C +          + + F K G+ S Y   ++N +  +  P DL ++ 
Sbjct: 89  GHHLNVVNLLGACTKPGGPL----MVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDF 144
Query: 202 ---------ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 252
                    + Q+ + + F+     IH DL   N+LL     +K+ D+  +    KD   
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 253 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 312
            ++      +K                      + APE I    +T   D+WS G +L E
Sbjct: 205 VRKGDARLPLK----------------------WMAPETIFDRVYTIQSDVWSFGVLLWE 242
Query: 313 L 313
           +
Sbjct: 243 I 243

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 97/237 (40%), Gaps = 49/237 (20%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDR----ERKEM-VAIKIVRG--IKKYREAAMIEIEVLQ 145
            +   I   +G G FG+V  C  R     +KE+ VAIK ++    +K R   + E  ++ 
Sbjct: 44  ATNISIDKVVGAGEFGEV--CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
           Q    +      +++         + IV E +   SL  FLRK++ +   I LV  + R 
Sbjct: 102 QFDHPN-----IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV-GMLRG 155
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +   + ++ D+  +H DL   N+L+ S+   KV D+                        
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDF------------------------ 191
Query: 265 IDFGSTTYERPDQNYIVSTR------HYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
              G    + P+  Y  +TR       + +PE I    +T   D+WS G +L E+ +
Sbjct: 192 -GLGRVLEDDPEAAY--TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 90/229 (39%), Gaps = 50/229 (21%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGGNRCVQI 160
           +G G FGQV +   R   +   IK V   K   E A  E++ L +L   +    N C   
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIVHYNGCW-- 73
Query: 161 RNWFDY----------RNHICIVFEKL----GSSLYDFLRKNNYRSFPIDLVREIARQLL 206
            + FDY          R+    +F ++      +L  ++ K         L  E+  Q+ 
Sbjct: 74  -DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
           + + ++H   +I+ DLKP N+ LV ++ +K+                            D
Sbjct: 133 KGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG---------------------------D 165
Query: 267 FGSTTYERPDQNYIVS--TRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
           FG  T  + D     S  T  Y +PE I    +    D++++G IL EL
Sbjct: 166 FGLVTSLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 59/254 (23%), Positives = 104/254 (40%), Gaps = 46/254 (18%)
Query: 93  TSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRG--IKKYREAAMIEIEVLQ 145
            SR  I   +G G  G+V  C+ R     +R   VAIK ++    ++ R   + E  ++ 
Sbjct: 48  ASRIHIEKIIGSGDSGEV--CYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMG 105
Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
           Q    +      +++           IV E +   SL  FLR ++ + F I  +  + R 
Sbjct: 106 QFDHPN-----IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRG 159
Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +   + ++ DL  +H DL   NVL+ S+   KV D+  S                   +V
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS-------------------RV 200
Query: 265 IDFGSTTYERPDQNYIVSTR----HYRAPEVILGLGWTYPCDIWSVGCILVE-LCTGEAL 319
           ++      + PD  Y  +       + APE I    ++   D+WS G ++ E L  GE  
Sbjct: 201 LE------DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
Query: 320 FQTHENLEHLAMME 333
           +    N + ++ +E
Sbjct: 255 YWNMTNRDVISSVE 268

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 99/246 (40%), Gaps = 38/246 (15%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 72
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      I+ E +   +L D+LR+ N +     ++  +A Q+   + ++     IH
Sbjct: 73  LGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 220 TDLKPENVLLVSSEYIKVPDYK-SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 278
            DL   N L+  +  +KV D+  S L T                     G T        
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMT---------------------GDTXTAHAGAK 171
Query: 279 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAM 331
           + +    + APE +    ++   D+W+ G +L E+ T       G    Q +E LE    
Sbjct: 172 FPIK---WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYR 228
Query: 332 MERVLG 337
           MER  G
Sbjct: 229 MERPEG 234

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 59/297 (19%), Positives = 115/297 (38%), Gaps = 39/297 (13%)
Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR--EAAMIEIEVLQQLAKHDKGGNRCVQ 159
           +G+G    V     ++  ++ AIK+   I   R  +  M E EVL++L  + K   +   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL--NHKNIVKLFA 74
Query: 160 IRNWFDYRNHICIVFEKLGSSLYDFLRK-NNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           I      R+ + I+      SLY  L + +N    P      + R ++  +  + +  ++
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIV 134
Query: 219 HTDLKPENVLLVSSE----YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           H ++KP N++ V  E      K+ D+ ++     D  +           V  +G+  Y  
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-----------VSLYGTEEYLH 183
Query: 275 PD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN-LEHLAM 331
           PD  +  ++   H +         +    D+WS+G       TG   F+  E    +  +
Sbjct: 184 PDMYERAVLRKDHQKK--------YGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIK---SVMKLPRLQNLI 385
           M +++   P   +  V +        G +DW        S+     V+  P L N++
Sbjct: 236 MYKIITGKPSGAISGVQK-----AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/247 (22%), Positives = 104/247 (42%), Gaps = 43/247 (17%)
Query: 101 KMGEGTFGQVLECWDRERKEM-VAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           ++G G FG V   + + R +  VAIK+++      +  + E +V+  L+ H+K     VQ
Sbjct: 15  ELGTGQFGVVK--YGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEK----LVQ 67
Query: 160 IRNWFDYRNHICIVFEKLGSS-LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           +      +  I I+ E + +  L ++LR+  +R F    + E+ + + E + ++     +
Sbjct: 68  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFL 126
Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKD---SSYFKRMPKSSAIKVIDFGSTTYERP 275
           H DL   N L+     +KV D+  S +   D   SS   + P                  
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP------------------ 168
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL----FQTHENLEHLAM 331
                     +  PEV++   ++   DIW+ G ++ E+ +   +    F   E  EH+A 
Sbjct: 169 --------VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 220
Query: 332 MERVLGP 338
             R+  P
Sbjct: 221 GLRLYRP 227

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 96/225 (42%), Gaps = 42/225 (18%)
Query: 102 MGEGTFGQV----LECWDRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGN 155
           +G G FG+V    L+    +++  VAIK ++    +K R   + E  ++ Q + H+    
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN---- 107
Query: 156 RCVQIRNWFDYRNHICIVFEKLGSSLYD-FLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             +++         + I+ E + +   D FLR+ +     + LV  + R +   + ++ +
Sbjct: 108 -IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLV-GMLRGIAAGMKYLAN 165
Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +  +H DL   N+L+ S+   KV D+  S                   +V++      + 
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLS-------------------RVLE------DD 200
Query: 275 PDQNYIVSTRH----YRAPEVILGLGWTYPCDIWSVGCILVELCT 315
           P+  Y  S       + APE I    +T   D+WS G ++ E+ T
Sbjct: 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/247 (22%), Positives = 104/247 (42%), Gaps = 43/247 (17%)
Query: 101 KMGEGTFGQVLECWDRERKEM-VAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           ++G G FG V   + + R +  VAIK+++      +  + E +V+  L+ H+K     VQ
Sbjct: 11  ELGTGQFGVVK--YGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEK----LVQ 63
Query: 160 IRNWFDYRNHICIVFEKLGSS-LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           +      +  I I+ E + +  L ++LR+  +R F    + E+ + + E + ++     +
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKD---SSYFKRMPKSSAIKVIDFGSTTYERP 275
           H DL   N L+     +KV D+  S +   D   SS   + P                  
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP------------------ 164
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL----FQTHENLEHLAM 331
                     +  PEV++   ++   DIW+ G ++ E+ +   +    F   E  EH+A 
Sbjct: 165 --------VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216
Query: 332 MERVLGP 338
             R+  P
Sbjct: 217 GLRLYRP 223

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/247 (22%), Positives = 104/247 (42%), Gaps = 43/247 (17%)
Query: 101 KMGEGTFGQVLECWDRERKEM-VAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 159
           ++G G FG V   + + R +  VAIK+++      +  + E +V+  L+ H+K     VQ
Sbjct: 16  ELGTGQFGVVK--YGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEK----LVQ 68
Query: 160 IRNWFDYRNHICIVFEKLGSS-LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 218
           +      +  I I+ E + +  L ++LR+  +R F    + E+ + + E + ++     +
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFL 127
Query: 219 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKD---SSYFKRMPKSSAIKVIDFGSTTYERP 275
           H DL   N L+     +KV D+  S +   D   SS   + P                  
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP------------------ 169
Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL----FQTHENLEHLAM 331
                     +  PEV++   ++   DIW+ G ++ E+ +   +    F   E  EH+A 
Sbjct: 170 --------VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 221
Query: 332 MERVLGP 338
             R+  P
Sbjct: 222 GLRLYRP 228

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 37/228 (16%)
Query: 97  KIHSKMGEGTFGQVLEC----WDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKH 150
           K  S++G+G FG V  C           +VA+K ++  G  + R+    EI++L+ L   
Sbjct: 10  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR-EIQILKALHSD 68
Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSS-LYDFLRKNNYRSFPIDLVREI--ARQLLE 207
                R V   ++   R  + +V E L S  L DFL+++  R   +D  R +  + Q+ +
Sbjct: 69  FIVKYRGV---SYGPGRPELRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICK 122
Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++     +H DL   N+L+ S  ++K+ D+  +   P                 +D 
Sbjct: 123 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP-----------------LDK 165
Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                  P Q+ I     + APE +    ++   D+WS G +L EL T
Sbjct: 166 DXXVVREPGQSPIF----WYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 96/236 (40%), Gaps = 46/236 (19%)
Query: 101 KMGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN-RCV 158
           ++G G FG V L  W  +    VA+K+++      E +M E E  Q+     K  + + V
Sbjct: 15  ELGSGQFGVVKLGKWKGQYD--VAVKMIK------EGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 159 QIRNWFDYRNHICIVFEKLGSS-LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           +          I IV E + +  L ++LR +     P  L+ E+   + E +AF+     
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL-EMCYDVCEGMAFLESHQF 125
Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           IH DL   N L+                            +   +KV DFG T Y   DQ
Sbjct: 126 IHRDLAARNCLV---------------------------DRDLCVKVSDFGMTRYVLDDQ 158
Query: 278 NYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 327
            Y+ S        + APEV     ++   D+W+ G ++ E+ + G+  +  + N E
Sbjct: 159 -YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 57/249 (22%), Positives = 99/249 (39%), Gaps = 36/249 (14%)
Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 160
           K+G G +G+V     ++    VA+K ++      E  + E  V++++ KH       VQ+
Sbjct: 39  KLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQL 93
Query: 161 RNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 219
                      IV E +   +L D+LR+ N       ++  +A Q+   + ++     IH
Sbjct: 94  LGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIH 153
Query: 220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 279
            DL   N L+  +  +KV D+  S     D +Y         IK                
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLMTGD-TYTAHAGAKFPIK---------------- 196
Query: 280 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-------GEALFQTHENLEHLAMM 332
                 + APE +    ++   D+W+ G +L E+ T       G  L Q ++ LE    M
Sbjct: 197 ------WTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRM 250
Query: 333 ERVLGPLPQ 341
           E+  G  P+
Sbjct: 251 EQPEGCPPK 259

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	430
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	0.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	0.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-180
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-151
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-146
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-138
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-119
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-56
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-55
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-51
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-50
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-50
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-50
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-50
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-50
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-49
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-49
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-48
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-48
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-47
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-47
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-47
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-46
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-46
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-45
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-45
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-44
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-44
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-44
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-44
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-44
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-44
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-44
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-43
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-43
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-43
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-43
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-42
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-42
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-42
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-42
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-42
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-42
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-41
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-41
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-41
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-41
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-41
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-41
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-40
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-40
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-40
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-40
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-40
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-40
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-40
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-40
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-40
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-40
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-40
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	9e-40
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-40
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-39
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-39
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-39
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-39
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-39
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-39
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-39
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-39
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-39
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-39
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-39
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-39
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-38
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-38
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-38
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-38
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-37
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-37
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-37
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-36
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-36
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-36
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-36
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-36
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-36
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-36
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-35
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-34
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-34
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-33
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-33
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-33
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-33
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-33
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-32
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-31
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-29
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-28
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-28
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-26
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-26
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-26
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-25
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-25
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-24
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-24
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-23
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-23
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-23
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-23
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-22
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-22
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-22
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-21
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-21
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-20
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-20
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-20
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-20
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-19
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-19
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-19
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-19
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-19
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-19
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-19
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-19
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-19
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-18
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-18
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-18
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-18
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-18
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-18
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-18
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-17
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-17
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-17
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-17
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-17
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-16
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-16
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-16
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-16
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-15
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-15
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-15
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-15
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-15
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-15
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-14
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-14
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-13
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-13
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-13
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-13
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-12
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-12
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-12
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-12
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-11
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-11
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-11
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-11
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-11
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-11
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-11
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-10
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-10
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-10
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-10
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-10
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-10
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-10
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	8e-10
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-09
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-09
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-08
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-08
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-08
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-08
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-08
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-08
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-07
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-07
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-06
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-06
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	3e-06
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-06
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-06
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-05
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-05
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-05
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-05
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-05
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-04
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-04
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-04
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-04
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-04
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-04

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  531 bits (1369), Expect = 0.0
 Identities = 135/359 (37%), Positives = 206/359 (57%), Gaps = 11/359 (3%)

Query: 68  ARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV 127
           +   +  ++ DD+  H+ +  G  L + + +  KMG+GTFG+VL C   + K+  A+K+V
Sbjct: 9   SGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV 68

Query: 128 RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRK 187
           R IKKY  +A IE ++L+++   D   N  V+    F Y +H+C++FE LG SLY+ + +
Sbjct: 69  RNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITR 128

Query: 188 NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 247
           NNY  F I+ ++    ++L+ + ++  + + HTDLKPEN+LL    + K       +   
Sbjct: 129 NNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188

Query: 248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVG 307
           K         KS+ IK+IDFG  T++      I++TR YRAPEVIL LGW    D+WS G
Sbjct: 189 KKIQI--YRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246

Query: 308 CILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDR-HAEKYVRRG--RLDWPE 364
           C+L EL TG  LF+THE++EHLAMME ++ P+P++ML    + +  KYV +   +L WPE
Sbjct: 247 CVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPE 306

Query: 365 GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
            A+S  SIK V K   L  +I   +          L  +L+ DPT R +  E L+H F 
Sbjct: 307 NASSINSIKHVKKCLPLYKIIKHEL------FCDFLYSILQIDPTLRPSPAELLKHKFL 359

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  510 bits (1316), Expect = 0.0
 Identities = 154/346 (44%), Positives = 220/346 (63%), Gaps = 15/346 (4%)

Query: 82  GHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIE 140
            H +   G+ L++RY+I   +GEG FG+V+EC D +     VA+KIV+ + +Y EAA  E
Sbjct: 2   MHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE 61

Query: 141 IEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVR 199
           I+VL+ L   D     RCVQ+  WF++  HICIVFE LG S YDF+++N +  F +D +R
Sbjct: 62  IQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIR 121

Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
           ++A Q+ + + F+H   + HTDLKPEN+L V S+Y +  + K            +R   +
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD--------ERTLIN 173

Query: 260 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
             IKV+DFGS TY+    + +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E   G  +
Sbjct: 174 PDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233

Query: 320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 379
           F TH++ EHLAMMER+LGPLP+HM+++  +   KY    RLDW E +++   +    K P
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKR--KYFHHDRLDWDEHSSAGRYVSRACK-P 290

Query: 380 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
             + ++ Q V+H    L  L+Q +L YDP  R+T REAL+HPFF  
Sbjct: 291 LKEFMLSQDVEHER--LFDLIQKMLEYDPAKRITLREALKHPFFDL 334

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  504 bits (1300), Expect = e-180
 Identities = 154/351 (43%), Positives = 223/351 (63%), Gaps = 15/351 (4%)

Query: 77  EDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRER-KEMVAIKIVRGIKKYRE 135
           EDDK+GH +  +G+ L  RY+I   +GEGTFG+V+EC D  R K  VA+KI+R + KYRE
Sbjct: 2   EDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYRE 61

Query: 136 AAMIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 194
           AA +EI VL+++ + DK     CV + +WF++  H+CI FE LG + ++FL++NN++ +P
Sbjct: 62  AARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYP 121

Query: 195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
           +  VR +A QL   + F+H+  + HTDLKPEN+L V+SE+  + +   S          +
Sbjct: 122 LPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE--------E 173

Query: 255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
           +  K+++I+V DFGS T++      IV+TRHYR PEVIL LGW  PCD+WS+GCIL E  
Sbjct: 174 KSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233

Query: 315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
            G  LFQTHEN EHL MME++LGP+P HM+ R  +   KY  +G L W E ++    +K 
Sbjct: 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQ--KYFYKGGLVWDENSSDGRYVKE 291

Query: 375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
             K P    ++   ++H    L  L++ +L +DP  R+T  EAL HPFF  
Sbjct: 292 NCK-PLKSYMLQDSLEHV--QLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  434 bits (1117), Expect = e-151
 Identities = 115/359 (32%), Positives = 172/359 (47%), Gaps = 36/359 (10%)

Query: 78  DDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA 137
           DD  G Y+    +++  RY++   +G+G+FGQV++ +D +  + VA+K+VR  K++   A
Sbjct: 81  DDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140

Query: 138 MIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPID 196
             EI +L+ L K DK      + +   F +RNHIC+ FE L  +LY+ ++KN ++ F + 
Sbjct: 141 AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLP 200

Query: 197 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 256
           LVR+ A  +L+C+  +H   +IH DLKPEN+LL                           
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ------------------------- 235

Query: 257 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 316
              S IKVIDFGS+ YE       + +R YRAPEVILG  +  P D+WS+GCIL EL TG
Sbjct: 236 QGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

Query: 317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEG----------A 366
             L    +  + LA M  +LG   Q +L    R       +G   +              
Sbjct: 296 YPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLN 355

Query: 367 ASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
             R     +   P  +                 L+  L +DP  R+T  +ALRHP+  R
Sbjct: 356 GGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  419 bits (1079), Expect = e-146
 Identities = 118/366 (32%), Positives = 183/366 (50%), Gaps = 43/366 (11%)

Query: 78  DDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA 137
           DD +  Y+   GE    RY+I S +G+G+FGQV++ +DR  +E VAIKI++  K +   A
Sbjct: 38  DDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA 97

Query: 138 MIEIEVLQQLAKHDKGG-NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPID 196
            IE+ +L+ + KHD       V ++  F +RNH+C+VFE L  +LYD LR  N+R   ++
Sbjct: 98  QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLN 157

Query: 197 LVREIARQLLECIAFMH--DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
           L R+ A+Q+   + F+   +L +IH DLKPEN+LL +                       
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN----------------------- 194

Query: 255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
             PK SAIK++DFGS+          + +R YR+PEV+LG+ +    D+WS+GCILVE+ 
Sbjct: 195 --PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMH 252

Query: 315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
           TGE LF     ++ +  +  VLG  P H+L +  +  + + +     W          + 
Sbjct: 253 TGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREY 312

Query: 375 VMKLPR-LQNLIMQHVDHSAG--------------DLTHLLQGLLRYDPTDRLTAREALR 419
                R L N++        G                  L+  +L YDP  R+    AL+
Sbjct: 313 KPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQ 372

Query: 420 HPFFTR 425
           H FF +
Sbjct: 373 HSFFKK 378

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  401 bits (1031), Expect = e-138
 Identities = 107/370 (28%), Positives = 175/370 (47%), Gaps = 52/370 (14%)

Query: 77  EDDKDGHYMFALGENLT-SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE 135
           +    G++    GE    +RY +  K+G G F  V    D      VA+KIVRG K Y E
Sbjct: 1   DYRPGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE 60

Query: 136 AAMIEIEVLQQLAKHDK------GGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFL 185
           AA  EI++LQ++   D       G N  +++ + F+++     H+ +VFE LG +L   +
Sbjct: 61  AAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALI 120

Query: 186 RKNNYRSFPIDLVREIARQLLECIAFMHDLC-MIHTDLKPENVLLVSSEYIKVPDYKSSL 244
           +K  +R  P+  V++I++QLL  + +MH  C +IHTD+KPENVL+   +  +        
Sbjct: 121 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE-------- 172

Query: 245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIW 304
                            IK+ D G+  +        + TR YR+PEV+LG  W    DIW
Sbjct: 173 -------------NLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIW 219

Query: 305 SVGCILVELCTGEALFQTHE------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG 358
           S  C++ EL TG+ LF+  E      + +H+A +  +LG LP ++L+        +  RG
Sbjct: 220 STACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRG 279

Query: 359 RLDWPEGAASRESIKSVMKLPRLQNLIM---QHVDHSAGDLTHLLQGLLRYDPTDRLTAR 415
            L             S +K   L++++    +     A +++  L  +L+ DP  R  A 
Sbjct: 280 LLRN----------ISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329

Query: 416 EALRHPFFTR 425
             + HP+   
Sbjct: 330 GLVNHPWLKD 339

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  353 bits (906), Expect = e-119
 Identities = 106/389 (27%), Positives = 181/389 (46%), Gaps = 49/389 (12%)

Query: 74  PWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY 133
              +  K G+++  +G+    RY +  K+G G F  V   WD + K+ VA+K+V+  + Y
Sbjct: 17  DPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY 76

Query: 134 REAAMIEIEVLQQLAKHDK---GGNRCVQIRNWFDYR----NHICIVFEKLGSSLYDFLR 186
            E A+ EI +L+ +   D         VQ+ + F        HIC+VFE LG  L  ++ 
Sbjct: 77  TETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWII 136

Query: 187 KNNYRSFPIDLVREIARQLLECIAFMHDLC-MIHTDLKPENVLLVSSEY----------- 234
           K+NY+  P+  V++I +Q+L+ + ++H  C +IHTD+KPEN+LL  +E            
Sbjct: 137 KSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATE 196

Query: 235 -----------IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVST 283
                        V    ++      +    +  +   +K+ D G+  +        + T
Sbjct: 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT 256

Query: 284 RHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE------HLAMMERVLG 337
           R YR+ EV++G G+  P DIWS  C+  EL TG+ LF+ H   E      H+A++  +LG
Sbjct: 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316

Query: 338 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD-- 395
            +P+ ++       E + ++G L               +K   L  ++++  + S  +  
Sbjct: 317 KVPRKLIVAGKYSKEFFTKKGDLKHITK----------LKPWGLFEVLVEKYEWSQEEAA 366

Query: 396 -LTHLLQGLLRYDPTDRLTAREALRHPFF 423
             T  L  +L   P  R TA E LRHP+ 
Sbjct: 367 GFTDFLLPMLELIPEKRATAAECLRHPWL 395

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  186 bits (475), Expect = 4e-56
 Identities = 96/349 (27%), Positives = 157/349 (44%), Gaps = 74/349 (21%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKH 150
           +Y+   K+GEG++G V +C +R+  ++VAIK      +        A+ EI +L+QL KH
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL-ESEDDPVIKKIALREIRMLKQL-KH 61

Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
               N  V +   F  +  + +VFE    ++   L +   R  P  LV+ I  Q L+ + 
Sbjct: 62  P---N-LVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVN 116

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-S 269
           F H    IH D+KPEN +L++                          K S IK+ DFG +
Sbjct: 117 FCHKHNCIHRDVKPEN-ILIT--------------------------KHSVIKLCDFGFA 149

Query: 270 TTYERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHEN 325
                P   Y   V+TR YR+PE+++G    Y  P D+W++GC+  EL +G  L+    +
Sbjct: 150 RLLTGPSDYYDDEVATRWYRSPELLVG-DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD 208

Query: 326 LEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           ++ L ++ + LG  +P+H                         S     S +K+P  +++
Sbjct: 209 VDQLYLIRKTLGDLIPRH-------------------QQVF--STNQYFSGVKIPDPEDM 247

Query: 385 -----IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 428
                   ++ + A  L   L+G L  DPT+RLT  + L HP+F     
Sbjct: 248 EPLELKFPNISYPALGL---LKGCLHMDPTERLTCEQLLHHPYFENIRE 293

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  185 bits (471), Expect = 3e-55
 Identities = 88/351 (25%), Positives = 145/351 (41%), Gaps = 76/351 (21%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLA 148
           +Y+    +GEG++G V++C +++   +VAIK          +KK    AM EI++L+QL 
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK---IAMREIKLLKQL- 81

Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           +H+   N  V +      +    +VFE +  ++ D L           +V++   Q++  
Sbjct: 82  RHE---N-LVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIING 136

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           I F H   +IH D+KPEN +LVS                          +S  +K+ DFG
Sbjct: 137 IGFCHSHNIIHRDIKPEN-ILVS--------------------------QSGVVKLCDFG 169

Query: 269 -STTYERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTH 323
            + T   P + Y   V+TR YRAPE+++G    Y    D+W++GC++ E+  GE LF   
Sbjct: 170 FARTLAAPGEVYDDEVATRWYRAPELLVG-DVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
            +++ L  +   LG L                            +       ++LP ++ 
Sbjct: 229 SDIDQLYHIMMCLGNLIPR------------------HQELFNKNPVFAG--VRLPEIKE 268

Query: 384 L-----IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
                     +     DL    +  L  DP  R    E L H FF  D   
Sbjct: 269 REPLERRYPKLSEVVIDL---AKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  175 bits (445), Expect = 1e-50
 Identities = 97/361 (26%), Positives = 155/361 (42%), Gaps = 86/361 (23%)

Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--REAAMIEIEVLQQ 146
           GE     Y     +G G+FG V +    E  E VAIK V   K++  RE     +++++ 
Sbjct: 35  GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE-----LQIMRI 88

Query: 147 LAKHDKGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLR--KNNYRSFPIDLV 198
           + KH    N  V ++ +F           + +V E +  ++Y   R      ++ P+ L+
Sbjct: 89  V-KHP---N-VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLI 143

Query: 199 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 258
           +    QLL  +A++H + + H D+KP+N+LL                           P 
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLL--------------------------DPP 177

Query: 259 SSAIKVIDFGSTTYERPDQNYI--VSTRHYRAPEVILGLGWTY---PCDIWSVGCILVEL 313
           S  +K+IDFGS       +  +  + +R+YRAPE+I G   T      DIWS GC++ EL
Sbjct: 178 SGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFG--ATNYTTNIDIWSTGCVMAEL 235

Query: 314 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIK 373
             G+ LF     ++ L  + +VLG   +  +K ++ +  ++                   
Sbjct: 236 MQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEH------------------- 276

Query: 374 SVMKLPR-----LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 428
              K P+        +        A DL   +  LL Y P+ RLTA EAL HPFF  D L
Sbjct: 277 ---KFPQIRPHPFSKVFRPRTPPDAIDL---ISRLLEYTPSARLTAIEALCHPFF--DEL 328

Query: 429 R 429
           R
Sbjct: 329 R 329

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  172 bits (439), Expect = 2e-50
 Identities = 88/353 (24%), Positives = 151/353 (42%), Gaps = 85/353 (24%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAK 149
            RY+  +K+GEGT+G+V +  D    E VAIK +R ++   E     A+ E+ +L++L +
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR-LEHEEEGVPGTAIREVSLLKEL-Q 91

Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
           H    N  +++++   + + + ++FE   + L  ++ KN      + +++    QL+  +
Sbjct: 92  HR---N-IIELKSVIHHNHRLHLIFEYAENDLKKYMDKN--PDVSMRVIKSFLYQLINGV 145

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 268
            F H    +H DLKP+N LL+S                          ++  +K+ DFG 
Sbjct: 146 NFCHSRRCLHRDLKPQN-LLLSVS---------------------DASETPVLKIGDFGL 183

Query: 269 STTYERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHE 324
           +  +  P + +   + T  YR PE++LG    Y    DIWS+ CI  E+     LF    
Sbjct: 184 ARAFGIPIRQFTHEIITLWYRPPEILLG-SRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242

Query: 325 NLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP---- 379
            ++ L  +  VLG P                       WP           V  LP    
Sbjct: 243 EIDQLFKIFEVLGLPDDT-------------------TWPG----------VTALPDWKQ 273

Query: 380 --------RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
                    L+ ++   +D    D   LL  +L  DP  R++A+ AL HP+F+
Sbjct: 274 SFPKFRGKTLKRVLGALLDDEGLD---LLTAMLEMDPVKRISAKNALEHPYFS 323

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  174 bits (444), Expect = 2e-50
 Identities = 87/355 (24%), Positives = 149/355 (41%), Gaps = 81/355 (22%)

Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--REAAMIEIEVLQQLAKH 150
              Y     +G G+FG V +    +  E+VAIK V   K++  RE     ++++++L  H
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE-----LQIMRKL-DH 106

Query: 151 DKGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRS--FPIDLVREIA 202
               N  V++R +F          ++ +V + +  ++Y   R  +      P+  V+   
Sbjct: 107 C---N-IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 162

Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
            QL   +A++H   + H D+KP+N+LL                   D       P ++ +
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLL-------------------D-------PDTAVL 196

Query: 263 KVIDFGSTTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEAL 319
           K+ DFGS       +  +  + +R+YRAPE+I G   +T   D+WS GC+L EL  G+ +
Sbjct: 197 KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 256

Query: 320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 379
           F     ++ L  + +VLG   +  ++ ++ +  ++                      K P
Sbjct: 257 FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF----------------------KFP 294

Query: 380 R-----LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
           +        +        A  L      LL Y PT RLT  EA  H FF  D LR
Sbjct: 295 QIKAHPWTKVFRPRTPPEAIAL---CSRLLEYTPTARLTPLEACAHSFF--DELR 344

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  170 bits (433), Expect = 6e-50
 Identities = 68/352 (19%), Positives = 129/352 (36%), Gaps = 99/352 (28%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHD 151
            Y I  ++G G   +V +  + + K++ AIK V       +  ++   EI  L +L +  
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQ- 85

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
              ++ +++ ++     +I +V E     L  +L+K   +S      +   + +LE +  
Sbjct: 86  -HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHT 142

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H   ++H+DLKP N L+V                               +K+IDFG   
Sbjct: 143 IHQHGIVHSDLKPANFLIVDGM----------------------------LKLIDFGIAN 174

Query: 272 YERPDQNYIVS-----TRHYRAPEVILGLGW-----------TYPCDIWSVGCILVELCT 315
             +PD   +V      T +Y  PE I  +             +   D+WS+GCIL  +  
Sbjct: 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234

Query: 316 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV 375
           G+  FQ   N   ++ +  ++ P                     +++P+           
Sbjct: 235 GKTPFQQIIN--QISKLHAIIDP------------------NHEIEFPD----------- 263

Query: 376 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                         +    D   +L+  L+ DP  R++  E L HP+     
Sbjct: 264 ------------IPEKDLQD---VLKCCLKRDPKQRISIPELLAHPYVQIQT 300

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  170 bits (433), Expect = 7e-50
 Identities = 92/364 (25%), Positives = 151/364 (41%), Gaps = 88/364 (24%)

Query: 88  LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEI 141
           LG   TSRY+  +++G G +G V +  D      VA+K VR      G      + + E+
Sbjct: 3   LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREV 62

Query: 142 EVLQQL--AKHDKGGN----RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPI 195
            +L++L   +H    N      V   +  D    + +VFE +   L  +L K      P 
Sbjct: 63  ALLRRLEAFEHP---NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA 119

Query: 196 DLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 255
           + ++++ RQ L  + F+H  C++H DLKPEN +LV+S                       
Sbjct: 120 ETIKDLMRQFLRGLDFLHANCIVHRDLKPEN-ILVTSG---------------------- 156

Query: 256 MPKSSAIKVIDFG-STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 312
                 +K+ DFG +  Y         +V T  YRAPEV+L   +  P D+WSVGCI  E
Sbjct: 157 ----GTVKLADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE 211

Query: 313 LCTGEALFQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRES 371
           +   + LF  +   + L  +  ++G P                      DWP        
Sbjct: 212 MFRRKPLFCGNSEADQLGKIFDLIGLPPED-------------------DWPR------- 245

Query: 372 IKSVMKLPRL-------QNL--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
               + LPR        + +  ++  ++ S      LL  +L ++P  R++A  AL+H +
Sbjct: 246 ---DVSLPRGAFPPRGPRPVQSVVPEMEESGAQ---LLLEMLTFNPHKRISAFRALQHSY 299

Query: 423 FTRD 426
             +D
Sbjct: 300 LHKD 303

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  168 bits (428), Expect = 8e-49
 Identities = 69/354 (19%), Positives = 130/354 (36%), Gaps = 103/354 (29%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-----EIEVLQQLAK 149
            Y I  ++G G   +V +  + E+K++ AIK V    +  +   +     EI  L +L +
Sbjct: 10  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN--LEEADNQTLDSYRNEIAYLNKL-Q 65

Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
                ++ +++ ++     +I +V E     L  +L+K   +S      +   + +LE +
Sbjct: 66  Q--HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAV 121

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
             +H   ++H+DLKP N L+V                               +K+IDFG 
Sbjct: 122 HTIHQHGIVHSDLKPANFLIVDGM----------------------------LKLIDFGI 153

Query: 270 TTYERPDQNYI-----VSTRHYRAPEVILGLG-----------WTYPCDIWSVGCILVEL 313
               +PD   +     V T +Y  PE I  +             +   D+WS+GCIL  +
Sbjct: 154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 213

Query: 314 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIK 373
             G+  FQ   N   ++ +  ++ P                     +++P+         
Sbjct: 214 TYGKTPFQQIIN--QISKLHAIIDP------------------NHEIEFPD--------- 244

Query: 374 SVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                           +    D   +L+  L+ DP  R++  E L HP+     
Sbjct: 245 --------------IPEKDLQD---VLKCCLKRDPKQRISIPELLAHPYVQIQT 281

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  166 bits (424), Expect = 9e-49
 Identities = 94/343 (27%), Positives = 152/343 (44%), Gaps = 71/343 (20%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKH 150
           +Y+   K+GEGT+G V +  +RE  E+VA+K VR +    E    +A+ EI +L++L KH
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKEL-KH 60

Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
               N  V++ +       + +VFE     L  +    N      ++V+    QLL+ + 
Sbjct: 61  K---N-IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLG 115

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-S 269
           F H   ++H DLKP+N LL++                              +K+ +FG +
Sbjct: 116 FCHSRNVLHRDLKPQN-LLINRN--------------------------GELKLANFGLA 148

Query: 270 TTYERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCT-GEALFQTHE 324
             +  P + Y   V T  YR P+V+ G    Y    D+WS GCI  EL   G  LF  ++
Sbjct: 149 RAFGIPVRCYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207

Query: 325 NLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
             + L  + R+LG P  +                    WP         K     P   +
Sbjct: 208 VDDQLKRIFRLLGTPTEE-------------------QWP-SMTKLPDYKPYPMYPATTS 247

Query: 384 L--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
           L  ++  ++ +  DL   LQ LL+ +P  R++A EAL+HP+F+
Sbjct: 248 LVNVVPKLNATGRDL---LQNLLKCNPVQRISAEEALQHPYFS 287

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  167 bits (425), Expect = 2e-48
 Identities = 79/346 (22%), Positives = 147/346 (42%), Gaps = 60/346 (17%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH 150
                Y++  K+G G + +V E  +    E V +KI++ +KK +     EI++L+ L   
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLRGG 90

Query: 151 DKGGNRCVQIRNWF--DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
               N  + + +           +VFE + ++  DF  K  Y++     +R    ++L+ 
Sbjct: 91  P---N-IITLADIVKDPVSRTPALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKA 142

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           + + H + ++H D+KP NV++                   D  + K       +++ID+G
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMI-------------------DHEHRK-------LRLIDWG 176

Query: 269 STTYERPDQNYI--VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTG-EALFQTHE 324
              +  P Q Y   V++R+++ PE+++    + Y  D+WS+GC+L  +    E  F  H+
Sbjct: 177 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236

Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR--LQ 382
           N + L  + +VLG                Y+ +  ++             + +  R   +
Sbjct: 237 NYDQLVRIAKVLGT-ED---------LYDYIDKYNIELD-----PRFNDILGRHSRKRWE 281

Query: 383 NLIMQHVDHSAGDLT-HLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
             +     H         L  LLRYD   RLTAREA+ HP+F    
Sbjct: 282 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  166 bits (422), Expect = 2e-48
 Identities = 92/342 (26%), Positives = 143/342 (41%), Gaps = 71/342 (20%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKH 150
           +Y    K+GEGT+G V +  +    E  A+K +R ++K  E      + EI +L++L KH
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR-LEKEDEGIPSTTIREISILKEL-KH 59

Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
               N  V++ +    +  + +VFE L   L   L             +    QLL  IA
Sbjct: 60  S---N-IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIA 114

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-S 269
           + HD  ++H DLKP+N LL++ E                            +K+ DFG +
Sbjct: 115 YCHDRRVLHRDLKPQN-LLINRE--------------------------GELKIADFGLA 147

Query: 270 TTYERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHEN 325
             +  P + Y   + T  YRAP+V++G    Y    DIWSVGCI  E+  G  LF     
Sbjct: 148 RAFGIPVRKYTHEIVTLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206

Query: 326 LEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
            + L  + R+LG P  +                   +WP              +      
Sbjct: 207 ADQLMRIFRILGTPNSK-------------------NWP-NVTELPKYDPNFTVYEPLPW 246

Query: 385 --IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
              ++ +D S  D   LL  +L+ DP  R+TA++AL H +F 
Sbjct: 247 ESFLKGLDESGID---LLSKMLKLDPNQRITAKQALEHAYFK 285

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  164 bits (418), Expect = 1e-47
 Identities = 92/348 (26%), Positives = 153/348 (43%), Gaps = 70/348 (20%)

Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVL 144
            + L  +Y+   K+GEGT+G V +  D  +  +VA+K +R +    E     A+ EI +L
Sbjct: 16  FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR-LDAEDEGIPSTAIREISLL 73

Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 204
           ++L  H    N  V + +       + +VFE +   L   L +N         ++    Q
Sbjct: 74  KEL-HHP---N-IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQ 127

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           LL  +A  H   ++H DLKP+N LL++S+                           A+K+
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQN-LLINSD--------------------------GALKL 160

Query: 265 IDFG-STTYERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEAL 319
            DFG +  +  P ++Y   V T  YRAP+V++G    Y    DIWS+GCI  E+ TG+ L
Sbjct: 161 ADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG-SKKYSTSVDIWSIGCIFAEMITGKPL 219

Query: 320 FQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 378
           F    + + L  +  +LG P P+                   +WP+        +   ++
Sbjct: 220 FPGVTDDDQLPKIFSILGTPNPR-------------------EWPQVQELPLWKQRTFQV 260

Query: 379 PRLQNL--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
              +    I+        D   LL  +L +DP  R++AR+A+ HP+F 
Sbjct: 261 FEKKPWSSIIPGFCQEGID---LLSNMLCFDPNKRISARDAMNHPYFK 305

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  166 bits (421), Expect = 3e-47
 Identities = 77/402 (19%), Positives = 143/402 (35%), Gaps = 99/402 (24%)

Query: 45  TSFAPPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGE 104
           +S   PR      T+++ F +    +      +DDK               Y I  ++G 
Sbjct: 7   SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGS 66

Query: 105 GTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 161
           G   +V +  + + K++ AIK V       +  ++   EI  L +L +     ++ +++ 
Sbjct: 67  GGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHS--DKIIRLY 122

Query: 162 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 221
           ++     +I +V E     L  +L+K   +S      +   + +LE +  +H   ++H+D
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 180

Query: 222 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 281
           LKP N L+V                               +K+IDFG     +PD   +V
Sbjct: 181 LKPANFLIVDGM----------------------------LKLIDFGIANQMQPDTTSVV 212

Query: 282 S-----TRHYRAPEVILGLGW-----------TYPCDIWSVGCILVELCTGEALFQTHEN 325
                   +Y  PE I  +             +   D+WS+GCIL  +  G+  FQ   N
Sbjct: 213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 272

Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 385
              ++ +  ++ P                     +++P                      
Sbjct: 273 --QISKLHAIIDP------------------NHEIEFP---------------------- 290

Query: 386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
               D    DL  +L+  L+ DP  R++  E L HP+     
Sbjct: 291 ----DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  163 bits (416), Expect = 3e-47
 Identities = 92/355 (25%), Positives = 150/355 (42%), Gaps = 88/355 (24%)

Query: 94  SRYKIHSKMGEGTFGQVLECWD-RERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQL- 147
            +Y+  +++GEG +G+V +  D +     VA+K VR ++   E    + + E+ VL+ L 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLE 69

Query: 148 -AKHDKGGN----RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIA 202
             +H    N      V   +  D    + +VFE +   L  +L K      P + ++++ 
Sbjct: 70  TFEHP---NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126

Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
            QLL  + F+H   ++H DLKP+N +LV+S                             I
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQN-ILVTSS--------------------------GQI 159

Query: 263 KVIDFG-STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
           K+ DFG +  Y         +V T  YRAPEV+L   +  P D+WSVGCI  E+   + L
Sbjct: 160 KLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 218

Query: 320 FQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 378
           F+   +++ L  +  V+G P  +                   DWP            + L
Sbjct: 219 FRGSSDVDQLGKILDVIGLPGEE-------------------DWPR----------DVAL 249

Query: 379 PRL-------QNL--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
           PR        Q +   +  +D    D   LL   L ++P  R++A  AL HP+F 
Sbjct: 250 PRQAFHSKSAQPIEKFVTDIDELGKD---LLLKCLTFNPAKRISAYSALSHPYFQ 301

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  161 bits (411), Expect = 1e-46
 Identities = 93/350 (26%), Positives = 154/350 (44%), Gaps = 75/350 (21%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-----GIKKYREAAMIEIEVLQQLA 148
           S++K   K+G GT+  V +  ++     VA+K V+     G       A+ EI ++++L 
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS---TAIREISLMKEL- 60

Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNY----RSFPIDLVREIARQ 204
           KH+   N  V++ +     N + +VFE + + L  ++         R   ++LV+    Q
Sbjct: 61  KHE---N-IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           LL+ +AF H+  ++H DLKP+N LL++                          K   +K+
Sbjct: 117 LLQGLAFCHENKILHRDLKPQN-LLIN--------------------------KRGQLKL 149

Query: 265 IDFG-STTYERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEAL 319
            DFG +  +  P   +   V T  YRAP+V++G   TY    DIWS GCIL E+ TG+ L
Sbjct: 150 GDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG-SRTYSTSIDIWSCGCILAEMITGKPL 208

Query: 320 FQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 378
           F    + E L ++  ++G P                       WP            ++ 
Sbjct: 209 FPGTNDEEQLKLIFDIMGTPNES-------------------LWP-SVTKLPKYNPNIQQ 248

Query: 379 PRLQNLIMQHVDHSAGDLT----HLLQGLLRYDPTDRLTAREALRHPFFT 424
              ++L      H+   L       L GLL+ +P  RL+A++AL HP+F 
Sbjct: 249 RPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  161 bits (409), Expect = 3e-46
 Identities = 89/341 (26%), Positives = 140/341 (41%), Gaps = 68/341 (19%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-----GIKKYREAAMIEIEVLQQLAK 149
            Y    K+GEGT+  V +   +    +VA+K +R     G       A+ E+ +L+ L K
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC---TAIREVSLLKDL-K 58

Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
           H    N  V + +       + +VFE L   L  +L         +  V+    QLL  +
Sbjct: 59  HA---N-IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGL 113

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 268
           A+ H   ++H DLKP+N LL++                          +   +K+ DFG 
Sbjct: 114 AYCHRQKVLHRDLKPQN-LLIN--------------------------ERGELKLADFGL 146

Query: 269 STTYERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHE 324
           +     P + Y   V T  YR P+++LG    Y    D+W VGCI  E+ TG  LF    
Sbjct: 147 ARAKSIPTKTYDNEVVTLWYRPPDILLG-STDYSTQIDMWGVGCIFYEMATGRPLFPGST 205

Query: 325 NLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
             E L  + R+LG P  +                    WP   ++ E         R + 
Sbjct: 206 VEEQLHFIFRILGTPTEE-------------------TWPGILSNEEFKTYNYPKYRAEA 246

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
           L+  H      D   LL  LL+++  +R++A +A++HPFF 
Sbjct: 247 LL-SHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  160 bits (408), Expect = 1e-45
 Identities = 92/355 (25%), Positives = 149/355 (41%), Gaps = 66/355 (18%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK 149
                R+++    G+GTFG V    ++     VAIK V    ++      E++++Q L  
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDL-A 74

Query: 150 HDKGGNRCVQIRNWF-----DYRNHIC--IVFEKLGSSLYDFLRKNNYR--SFPIDLVRE 200
                N  VQ++++F       R  I   +V E +  +L+   R    R  + P  L++ 
Sbjct: 75  VLHHPN-IVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV 133

Query: 201 IARQLLECIAFMHDLCM--IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 258
              QL+  I  +H   +   H D+KP NVL+                   +         
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV-------------------N-------EA 167

Query: 259 SSAIKVIDFGSTTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCT 315
              +K+ DFGS     P +  +  + +R+YRAPE+I G   +T   DIWSVGCI  E+  
Sbjct: 168 DGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227

Query: 316 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKS 374
           GE +F+   +   L  + RVLG   + +L++++  H +  +                   
Sbjct: 228 GEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYN----------------- 270

Query: 375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
             K     N+   H    A +   LL  LL+Y P +R+   EAL HP+F  D L 
Sbjct: 271 -SKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF--DELH 322

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  158 bits (402), Expect = 6e-45
 Identities = 84/350 (24%), Positives = 148/350 (42%), Gaps = 82/350 (23%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYRE----AAMIEIEVLQQL 147
            RY+    +GEG F  V +  D+   ++VAIK ++     + ++     A+ EI++LQ+L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 148 AKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
             H    N  + + + F ++++I +VF+ + + L   + K+N        ++      L+
Sbjct: 70  -SHP---N-IIGLLDAFGHKSNISLVFDFMETDLEVII-KDNSLVLTPSHIKAYMLMTLQ 123

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   ++H DLKP N LL+                               +K+ DF
Sbjct: 124 GLEYLHQHWILHRDLKPNN-LLLDEN--------------------------GVLKLADF 156

Query: 268 G-STTYERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQT 322
           G + ++  P++ Y   V TR YRAPE++ G    Y    D+W+VGCIL EL         
Sbjct: 157 GLAKSFGSPNRAYTHQVVTRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRVPFLPG 215

Query: 323 HENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 381
             +L+ L  +   LG P  +                    WP+          +  LP  
Sbjct: 216 DSDLDQLTRIFETLGTPTEE-------------------QWPD----------MCSLPDY 246

Query: 382 QNL-------IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
                     +      +  DL  L+QGL  ++P  R+TA +AL+  +F+
Sbjct: 247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  157 bits (400), Expect = 2e-44
 Identities = 85/375 (22%), Positives = 156/375 (41%), Gaps = 83/375 (22%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--RE------------ 135
           E  + +Y +   +G G+FG V E +D E  +  A+K V    +Y  RE            
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNI 62

Query: 136 ----------------AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 179
                                 +  +   K++   N    +        ++ ++ E +  
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122

Query: 180 SLYDFLR--KNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 237
           +L+  L+    + RS P++L+     QL   + F+H L + H D+KP+N+L+        
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV-------- 174

Query: 238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI--VSTRHYRAPEVILG- 294
                      +        K + +K+ DFGS     P +  +  + +R YRAPE++LG 
Sbjct: 175 -----------N-------SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGA 216

Query: 295 LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKY 354
             +T   D+WS+GC+  EL  G+ LF    +++ L  + +++G   +  + R++ H    
Sbjct: 217 TEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPH---- 272

Query: 355 VRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 414
                        +     ++      + ++ +     A D   LL+ +LRY+P  R+  
Sbjct: 273 ------------YTEVRFPTLKAKD-WRKILPEGTPSLAID---LLEQILRYEPDLRINP 316

Query: 415 REALRHPFFTRDHLR 429
            EA+ HPFF  DHLR
Sbjct: 317 YEAMAHPFF--DHLR 329

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  156 bits (396), Expect = 2e-44
 Identities = 76/364 (20%), Positives = 135/364 (37%), Gaps = 85/364 (23%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK------IVRGIKKYREAAMIEIEVL 144
           +L SRY     +G G  G V    D +  + VAIK              RE     I+++
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE-----IKII 62

Query: 145 QQLAKHD----------KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFP 194
           ++L  HD            G++           N + IV E + + L + L +       
Sbjct: 63  RRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE-- 119

Query: 195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
            +  R    QLL  + ++H   ++H DLKP N+ + + +                     
Sbjct: 120 -EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL-------------------- 158

Query: 255 RMPKSSAIKVIDFG---STTYERPDQNYI---VSTRHYRAPEVILGL-GWTYPCDIWSVG 307
                  +K+ DFG           + ++   + T+ YR+P ++L    +T   D+W+ G
Sbjct: 159 ------VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG 212

Query: 308 CILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR----RGRLDWP 363
           CI  E+ TG+ LF     LE + ++   +  + +   + +      Y+R           
Sbjct: 213 CIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLT 272

Query: 364 EGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
           +                    ++  +   A D    L+ +L + P DRLTA EAL HP+ 
Sbjct: 273 Q--------------------LLPGISREAVD---FLEQILTFSPMDRLTAEEALSHPYM 309

Query: 424 TRDH 427
           +   
Sbjct: 310 SIYS 313

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  155 bits (394), Expect = 3e-44
 Identities = 68/345 (19%), Positives = 123/345 (35%), Gaps = 76/345 (22%)

Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD- 151
            S ++  + +G+G FGQV++  +       AIK +R  ++     + E+ +L  L  H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQY 63

Query: 152 --------KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIA 202
                         V+       ++ + I  E     +LYD +   N  +   D    + 
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLF 122

Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF---KRMPKS 259
           RQ+LE ++++H   +IH DLKP N+ +  S  +K+ D             F   K + +S
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD-------------FGLAKNVHRS 169

Query: 260 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEA 318
             I  +D  +      +    + T  Y A EV+ G G      D++S+G I  E+     
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-- 227

Query: 319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 378
            F T     ++                       K +R   +++P      +        
Sbjct: 228 -FSTGMERVNIL----------------------KKLRSVSIEFPPDFDDNKM------- 257

Query: 379 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
              + +I                 L+ +DP  R  AR  L   + 
Sbjct: 258 KVEKKIIRL---------------LIDHDPNKRPGARTLLNSGWL 287

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  155 bits (394), Expect = 3e-44
 Identities = 65/382 (17%), Positives = 114/382 (29%), Gaps = 103/382 (26%)

Query: 49  PPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFG 108
            PR  S    +S           SP +     +  +           ++  S++G G++G
Sbjct: 27  QPRRVSFRGEASETLQ-------SPGYDPSRPESFFQ--------QSFQRLSRLGHGSYG 71

Query: 109 QVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 165
           +V +   +E   + A+K         K R   + E+   +++ +H      CV++   ++
Sbjct: 72  EVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP----CCVRLEQAWE 127

Query: 166 YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPE 225
               + +  E  G SL          S P   V    R  L  +A +H   ++H D+KP 
Sbjct: 128 EGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPA 186

Query: 226 NVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQNY-IVST 283
           N+ L                                 K+ DFG                 
Sbjct: 187 NIFL---------------------------GPRGRCKLGDFGLLVELGTAGAGEVQEGD 219

Query: 284 RHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHM 343
             Y APE++ G  +    D++S+G  ++E+     L    E  + L     +       +
Sbjct: 220 PRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-RQGYLPPEFTAGL 277

Query: 344 LKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 403
                                   S E                         L  +L  +
Sbjct: 278 ------------------------SSE-------------------------LRSVLVMM 288

Query: 404 LRYDPTDRLTAREALRHPFFTR 425
           L  DP  R TA   L  P   +
Sbjct: 289 LEPDPKLRATAEALLALPVLRQ 310

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  156 bits (396), Expect = 4e-44
 Identities = 71/341 (20%), Positives = 124/341 (36%), Gaps = 78/341 (22%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK 149
              T  Y++   +G G++     C  +      A+KI   I K +     EIE+L +  +
Sbjct: 18  IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI---IDKSKRDPTEEIEILLRYGQ 74

Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           H    N  + +++ +D   ++ +V E + G  L D + +   + F       +   + + 
Sbjct: 75  HP---N-IITLKDVYDDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKT 128

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           + ++H   ++H DLKP N+L V                              +I++ DFG
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDES-----------------------GNPESIRICDFG 165

Query: 269 STTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
                R +         T ++ APEV+   G+   CDIWS+G +L  + TG   F    +
Sbjct: 166 FAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225

Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 385
                ++ R+                      G+     G  +                 
Sbjct: 226 DTPEEILARIG--------------------SGKFSLSGGYWN----------------- 248

Query: 386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
              V  +A D   L+  +L  DP  RLTA   LRHP+    
Sbjct: 249 --SVSDTAKD---LVSKMLHVDPHQRLTAALVLRHPWIVHW 284

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  156 bits (397), Expect = 7e-44
 Identities = 86/349 (24%), Positives = 162/349 (46%), Gaps = 30/349 (8%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMI--EIEVLQQL 147
           ++  +Y++  K+G+G +G V +  DR   E+VA+K I    +   +A     EI +L +L
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTEL 65

Query: 148 AKHDKGGNRCVQIRNWF--DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQL 205
           + H+   N  V + N    D    + +VF+ + + L+  +R N          + +  QL
Sbjct: 66  SGHE---N-IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEP---VHKQYVVYQL 118

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY-----KSSLHTPKDSSYFKRMPKSS 260
           ++ I ++H   ++H D+KP N+LL +  ++KV D+       ++    ++        + 
Sbjct: 119 IKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178

Query: 261 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEAL 319
                    T Y        V+TR YRAPE++LG   +T   D+WS+GCIL E+  G+ +
Sbjct: 179 NFDDDQPILTDY--------VATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230

Query: 320 FQTHENLEHLAMMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKSVMKL 378
           F     +  L  +  V+       ++ +    A+  +   +       +++  I +  K 
Sbjct: 231 FPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKN 290

Query: 379 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
             L+       +  A D   LL  LL+++P  R++A +AL+HPF +  H
Sbjct: 291 LLLKINPKADCNEEALD---LLDKLLQFNPNKRISANDALKHPFVSIFH 336

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  157 bits (399), Expect = 9e-44
 Identities = 68/360 (18%), Positives = 131/360 (36%), Gaps = 85/360 (23%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK 149
           ++L +       +G G+ G V+      +   VA+K +     + + A++EI++L +   
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRML--IDFCDIALMEIKLLTESDD 67

Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE-----IARQ 204
           H       ++          + I  E    +L D +   N     + L +E     + RQ
Sbjct: 68  H----PNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +   +A +H L +IH DLKP+N+L+ +S               + ++  +   ++  I +
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSS--------------RFTADQQTGAENLRILI 169

Query: 265 IDFGSTTYERPDQNYIVSTRH-------YRAPEVILGLGW-------TYPCDIWSVGCIL 310
            DFG        Q+   +  +       +RAPE++            T   DI+S+GC+ 
Sbjct: 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229

Query: 311 -VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASR 369
              L  G+  F                                           + +   
Sbjct: 230 YYILSKGKHPF-----------------------------------------GDKYSRES 248

Query: 370 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
             I+ +  L  ++ L  + +   A D   L+  ++ +DP  R TA + LRHP F     +
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEATD---LISQMIDHDPLKRPTAMKVLRHPLFWPKSKK 305

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  157 bits (398), Expect = 3e-43
 Identities = 79/343 (23%), Positives = 142/343 (41%), Gaps = 83/343 (24%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI-EIEVLQQ 146
            +L+  Y+   K+G G +G+VL C D+      AIKI+    +     + ++ E+ VL+ 
Sbjct: 33  GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKL 92

Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
           L  H    N  +++ ++F+ + +  +V E   G  L+D +       F       I +Q+
Sbjct: 93  L-DHP---N-IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQV 145

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L  + ++H   ++H DLKPEN+LL S E                        K + IK++
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKE------------------------KDALIKIV 181

Query: 266 DFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
           DFG +      +     + T +Y APEV+    +   CD+WS+G IL  L  G   F   
Sbjct: 182 DFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQ 240

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
            + E   ++ +V                     +G+  +                     
Sbjct: 241 TDQE---ILRKVE--------------------KGKYTFDSPE----------------- 260

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
              ++V   A D   L++ +L++D   R++A++AL HP+    
Sbjct: 261 --WKNVSEGAKD---LIKQMLQFDSQRRISAQQALEHPWIKEM 298

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  152 bits (386), Expect = 6e-43
 Identities = 66/341 (19%), Positives = 125/341 (36%), Gaps = 79/341 (23%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK 149
           + L  +Y I   +G G FG V  C +   K+    K V+     +     EI +L    +
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-R 59

Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           H       + +   F+    + ++FE + G  +++ +  + +       +     Q+ E 
Sbjct: 60  H----RNILHLHESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEA 114

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           + F+H   + H D++PEN++  +                          +SS IK+I+FG
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQT-------------------------RRSSTIKIIEFG 149

Query: 269 STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
                +P  N+  + +   Y APEV      +   D+WS+G ++  L +G   F    N 
Sbjct: 150 QARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209

Query: 327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 386
           +   ++E ++                         + E A                    
Sbjct: 210 Q---IIENIM--------------------NAEYTFDEEA-------------------F 227

Query: 387 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           + +   A D    +  LL  +   R+TA EAL+HP+  +  
Sbjct: 228 KEISIEAMD---FVDRLLVKERKSRMTASEALQHPWLKQKI 265

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  152 bits (385), Expect = 9e-43
 Identities = 80/343 (23%), Positives = 131/343 (38%), Gaps = 77/343 (22%)

Query: 91  NLTSRYKIHS---KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL 147
                Y +      +GEG+F    +C  ++  +  A+KI+   K+       EI  L+  
Sbjct: 5   PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS--KRMEANTQKEITALKLC 62

Query: 148 AKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLL 206
             H    N  V++   F  + H  +V E L G  L++  R    + F       I R+L+
Sbjct: 63  EGHP---N-IVKLHEVFHDQLHTFLVMELLNGGELFE--RIKKKKHFSETEASYIMRKLV 116

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             ++ MHD+ ++H DLKPEN+L                              +  IK+ID
Sbjct: 117 SAVSHMHDVGVVHRDLKPENLLFTDEN------------------------DNLEIKIID 152

Query: 267 FGSTTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
           FG    + PD         T HY APE++   G+   CD+WS+G IL  + +G+  FQ+H
Sbjct: 153 FGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
           +          +       ++K+        +++G   +   A                 
Sbjct: 213 D--------RSLTCTSAVEIMKK--------IKKGDFSFEGEAWK--------------- 241

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
               +V   A D   L+QGLL  DP  RL       + +    
Sbjct: 242 ----NVSQEAKD---LIQGLLTVDPNKRLKMSGLRYNEWLQDG 277

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  155 bits (394), Expect = 9e-43
 Identities = 84/344 (24%), Positives = 146/344 (42%), Gaps = 84/344 (24%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQ 145
              + RYK    +G+G+FG+V+ C D+   +  A+K++       K  +E+ + E+++L+
Sbjct: 22  AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81

Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
           QL  H    N  +++  +F+ + +  +V E   G  L+D +       F       I RQ
Sbjct: 82  QL-DHP---N-IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQ 134

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +L  I +MH   ++H DLKPEN+LL S                          K + I++
Sbjct: 135 VLSGITYMHKNKIVHRDLKPENLLLESKS------------------------KDANIRI 170

Query: 265 IDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
           IDFG +T+    +     + T +Y APEV+ G  +   CD+WS G IL  L +G   F  
Sbjct: 171 IDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG 229

Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 382
               +   ++++V                     +G+  +                    
Sbjct: 230 ANEYD---ILKKVE--------------------KGKYTFELPQ---------------- 250

Query: 383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
               + V  SA D   L++ +L Y P+ R++AR+AL H +    
Sbjct: 251 ---WKKVSESAKD---LIRKMLTYVPSMRISARDALDHEWIQTY 288

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  151 bits (382), Expect = 2e-42
 Identities = 58/353 (16%), Positives = 112/353 (31%), Gaps = 66/353 (18%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLA 148
                + +   +G+G    V     ++  ++ AIK+       +  +  M E EVL++L 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL- 64

Query: 149 KHDKGGNRCVQIRNWFDYRN--HICIVFEKL-GSSLYDFLRKN-NYRSFPIDLVREIARQ 204
            H       V++    +     H  ++ E     SLY  L +  N    P      + R 
Sbjct: 65  NHK----NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           ++  +  + +  ++H ++KP N++ V  E                          S  K+
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGE-----------------------DGQSVYKL 157

Query: 265 IDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYP--------CDIWSVGCILVELC 314
            DFG+      D+ +  +  T  Y  P++                  D+WS+G       
Sbjct: 158 TDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217

Query: 315 TGEALFQTHENLEHLA-MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIK 373
           TG   F+  E       +M +++   P   +  V +        G +DW        S+ 
Sbjct: 218 TGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQK-----AENGPIDWSGDMPVSCSLS 272

Query: 374 SVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
             ++                  LT +L  +L  D        +          
Sbjct: 273 RGLQ----------------VLLTPVLANILEADQEKCWGFDQFFAETSDILH 309

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  154 bits (392), Expect = 2e-42
 Identities = 84/347 (24%), Positives = 139/347 (40%), Gaps = 83/347 (23%)

Query: 86  FALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIE 142
                    RY I   +G+G+FG+VL+C DR  ++  A+K++       K     + E+E
Sbjct: 14  LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE 73

Query: 143 VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREI 201
           +L++L  H    N  +++    +  +   IV E   G  L+D + K     F       I
Sbjct: 74  LLKKL-DHP---N-IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARI 126

Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            +Q+   I +MH   ++H DLKPEN+LL S E                        K   
Sbjct: 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKE------------------------KDCD 162

Query: 262 IKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
           IK+IDFG +T  + +      + T +Y APEV+ G  +   CD+WS G IL  L +G   
Sbjct: 163 IKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221

Query: 320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 379
           F      +   +++RV                      G+  +                 
Sbjct: 222 FYGKNEYD---ILKRVE--------------------TGKYAFDLPQ------------- 245

Query: 380 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  + +   A D   L++ +L + P+ R+TA + L HP+  + 
Sbjct: 246 ------WRTISDDAKD---LIRKMLTFHPSLRITATQCLEHPWIQKY 283

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  153 bits (387), Expect = 4e-42
 Identities = 67/368 (18%), Positives = 126/368 (34%), Gaps = 88/368 (23%)

Query: 72  SPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK 131
           SP   +DD D      +   +   +     +G G  G ++          VA+K +  + 
Sbjct: 4   SPSLEQDDGDEETSVVIVGKI--SFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRI--LP 58

Query: 132 KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYR 191
           +    A  E+++L++  +H    N  ++       R    I  E   ++L +++ + ++ 
Sbjct: 59  ECFSFADREVQLLRESDEHP---N-VIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFA 114

Query: 192 SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 251
              ++    + +Q    +A +H L ++H DLKP N+L+                 P    
Sbjct: 115 HLGLE-PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISM---------------PNAHG 158

Query: 252 YFKRMPKSSAIKVIDFGSTTYERPDQNY------IVSTRHYRAPEVILGL---GWTYPCD 302
             K         + DFG        ++       +  T  + APE++        TY  D
Sbjct: 159 KIK-------AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVD 211

Query: 303 IWSVGCILVE-LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD 361
           I+S GC+    +  G   F                        K + R A   +    LD
Sbjct: 212 IFSAGCVFYYVISEGSHPFG-----------------------KSLQRQANILLGACSLD 248

Query: 362 WPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHP 421
                                    +H D  A +   L++ ++  DP  R +A+  L+HP
Sbjct: 249 CLH--------------------PEKHEDVIARE---LIEKMIAMDPQKRPSAKHVLKHP 285

Query: 422 FFTRDHLR 429
           FF     +
Sbjct: 286 FFWSLEKQ 293

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  149 bits (377), Expect = 6e-42
 Identities = 57/342 (16%), Positives = 112/342 (32%), Gaps = 71/342 (20%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQL 147
             T+ +    K+G G FG V +C  R    + AIK  +         + A+ E+     L
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 148 AKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQ 204
            +H    +  V+  + +   +H+ I  E   G SL D + +N      F    ++++  Q
Sbjct: 68  GQHS---H-VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +   + ++H + ++H D+KP N+ +  +        +        +            K+
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN--------KVMFKI 175

Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 323
            D G  T              + A EV+          DI+++   +V     E L +  
Sbjct: 176 GDLGHVT-RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
           +    +       G LP+                                    +P    
Sbjct: 235 DQWHEIRQ-----GRLPR------------------------------------IP---- 249

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                    + + T LL+ ++  DP  R +A   ++H     
Sbjct: 250 ------QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  153 bits (389), Expect = 7e-42
 Identities = 73/354 (20%), Positives = 136/354 (38%), Gaps = 94/354 (26%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--------------GIKKYRE 135
             +   Y    K+G G +G+VL C ++      AIK+++               I+K+ E
Sbjct: 32  GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91

Query: 136 AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFP 194
               EI +L+ L  H    N  +++ + F+ + +  +V E   G  L++ +   +   F 
Sbjct: 92  EIYNEISLLKSL-DHP---N-IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FD 144

Query: 195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
                 I +Q+L  I ++H   ++H D+KPEN+LL +                       
Sbjct: 145 ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN--------------------- 183

Query: 255 RMPKSSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 312
                  IK++DFG +++   D      + T +Y APEV+    +   CD+WS G I+  
Sbjct: 184 ---SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYI 239

Query: 313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESI 372
           L  G   F    + +   ++++V                     +G+  +          
Sbjct: 240 LLCGYPPFGGQNDQD---IIKKVE--------------------KGKYYFDFND------ 270

Query: 373 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                         +++   A +   L++ +L YD   R TA EAL   +  + 
Sbjct: 271 -------------WKNISDEAKE---LIKLMLTYDYNKRCTAEEALNSRWIKKY 308

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  149 bits (379), Expect = 8e-42
 Identities = 73/412 (17%), Positives = 133/412 (32%), Gaps = 129/412 (31%)

Query: 70  NGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR- 128
           +         ++ ++       L  +Y +   +G+G++G V    + + + + AIKI+  
Sbjct: 2   HHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNK 61

Query: 129 -----GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLY 182
                   K  E    E+ ++++L  H        ++   ++   +IC+V E   G  L 
Sbjct: 62  NKIRQINPKDVERIKTEVRLMKKL-HH----PNIARLYEVYEDEQYICLVMELCHGGHLL 116

Query: 183 DFLRKNNYR--------------------------------------SFPIDLVREIARQ 204
           D L                                                 L+  I RQ
Sbjct: 117 DKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +   + ++H+  + H D+KPEN L  +++                         S  IK+
Sbjct: 177 IFSALHYLHNQGICHRDIKPENFLFSTNK-------------------------SFEIKL 211

Query: 265 IDFG-STTYERPDQNY------IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCT 315
           +DFG S  + + +            T ++ APEV+     +Y   CD WS G +L  L  
Sbjct: 212 VDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271

Query: 316 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV 375
           G   F    N      + +VL                      +L +     +       
Sbjct: 272 GAVPFP-GVN--DADTISQVL--------------------NKKLCFENPNYN------- 301

Query: 376 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                        +   A D   LL  LL  +  +R  A  AL+HP+ ++  
Sbjct: 302 ------------VLSPLARD---LLSNLLNRNVDERFDAMRALQHPWISQFS 338

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  151 bits (384), Expect = 2e-41
 Identities = 83/356 (23%), Positives = 141/356 (39%), Gaps = 70/356 (19%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQL 147
            +  RY+    +G G  G V   +D      VAIK + R  +    A  A  E+ +++ +
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 118

Query: 148 AKHDKGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
             H    N  + + N F      +    + +V E + ++L   ++         + +  +
Sbjct: 119 -NHK---N-IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYL 169

Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L  I  +H   +IH DLKP N+++ S                              
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---------------------------CT 202

Query: 262 IKVIDFGSTTYERPDQN---YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 318
           +K++DFG             Y V TR+YRAPEVILG+G+    DIWSVGCI+ E+   + 
Sbjct: 203 LKILDFGLARTAGTSFMMTPY-VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261

Query: 319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR----RGRLDWPE---GAASRES 371
           LF   + ++    +   LG      +K++      YV        L +P+    +     
Sbjct: 262 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS----- 316

Query: 372 IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                 L    +   +     A D   LL  +L  DP  R++  +AL+HP+    +
Sbjct: 317 ------LFPADSEHNKLKASQARD---LLSKMLVIDPAKRISVDDALQHPYINVWY 363

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  149 bits (378), Expect = 3e-41
 Identities = 74/342 (21%), Positives = 133/342 (38%), Gaps = 80/342 (23%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLA 148
            ++   Y I  ++G G FG V  C ++    +   K +       +     EI ++ QL 
Sbjct: 47  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL- 105

Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
            H     + + + + F+ +  + ++ E L G  L+D +   +Y       V    RQ  E
Sbjct: 106 HHP----KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACE 160

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            +  MH+  ++H D+KPEN++  +                          K+S++K+IDF
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCET-------------------------KKASSVKIIDF 195

Query: 268 GSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
           G  T   PD+      +T  + APE++      +  D+W++G +   L +G + F   ++
Sbjct: 196 GLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 255

Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 385
           LE    ++ V                     R   ++ E A                   
Sbjct: 256 LE---TLQNVK--------------------RCDWEFDEDA------------------- 273

Query: 386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
              V   A D    ++ LL+ +P  RLT  +AL HP+   DH
Sbjct: 274 FSSVSPEAKD---FIKNLLQKEPRKRLTVHDALEHPWLKGDH 312

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  145 bits (369), Expect = 6e-41
 Identities = 61/355 (17%), Positives = 105/355 (29%), Gaps = 99/355 (27%)

Query: 86  FALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQ 145
             + +     +K    +G G FGQV +   R   +   IK    +K   E A  E++ L 
Sbjct: 3   HTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNNEKAEREVKALA 59

Query: 146 QLAKH------------DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS 192
           +L  H                       +       + I  E     +L  ++ K     
Sbjct: 60  KL-DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118

Query: 193 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 252
               L  E+  Q+ + + ++H   +I+ DLKP N+ LV                      
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---------------------- 156

Query: 253 FKRMPKSSAIKVIDFG-STTYERPDQNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 310
                 +  +K+ DFG  T+ +   +      T  Y +PE I    +    D++++G IL
Sbjct: 157 -----DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLIL 211

Query: 311 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRE 370
            EL     +  T           R  G +                             ++
Sbjct: 212 AELLH---VCDTAFETSKFFTDLR-DGIISDIF------------------------DKK 243

Query: 371 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                      + L+ +               LL   P DR    E LR     +
Sbjct: 244 ----------EKTLLQK---------------LLSKKPEDRPNTSEILRTLTVWK 273

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  147 bits (372), Expect = 7e-41
 Identities = 71/344 (20%), Positives = 120/344 (34%), Gaps = 80/344 (23%)

Query: 89  GENLTSRYKIHSK-MGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVL 144
            EN  + Y + SK +G G F  V +C  +   +  A K +   R  +  R   + EI VL
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82

Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIAR 203
           +          R + +   ++  + I ++ E   G  ++             + V  + +
Sbjct: 83  ELAKSCP----RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK 138

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+LE + ++H   ++H DLKP+N+LL S                              IK
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIY------------------------PLGDIK 174

Query: 264 VIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
           ++DFG +           I+ T  Y APE++     T   D+W++G I   L T  + F 
Sbjct: 175 IVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234

Query: 322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 381
             +N E       +                     +  +D+ E                 
Sbjct: 235 GEDNQE---TYLNIS--------------------QVNVDYSEET--------------- 256

Query: 382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                  V   A D    +Q LL  +P  R TA   L H +  +
Sbjct: 257 ----FSSVSQLATD---FIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  148 bits (375), Expect = 7e-41
 Identities = 87/368 (23%), Positives = 149/368 (40%), Gaps = 61/368 (16%)

Query: 76  REDDKDGHYMFALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIK 131
           R    +  Y   +G++   +  RY+    +G G  G V   +D   +  VAIK + R  +
Sbjct: 4   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 63

Query: 132 KYREA--AMIEIEVLQQLAKHDKGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYD 183
               A  A  E+ +++ +  H    N  + + N F      +    + IV E + ++L  
Sbjct: 64  NQTHAKRAYRELVLMKCV-NHK---N-IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ 118

Query: 184 FLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 243
            ++           +  +  Q+L  I  +H   +IH DLKP N+++ S   +K+ D+   
Sbjct: 119 VIQMELDHER----MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF--G 172

Query: 244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDI 303
           L     +S+                 T Y        V TR+YRAPEVILG+G+    DI
Sbjct: 173 LARTAGTSFM---------------MTPY--------VVTRYYRAPEVILGMGYKENVDI 209

Query: 304 WSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR----RGR 359
           WSVGCI+ E+  G  LF   ++++    +   LG      +K++      YV        
Sbjct: 210 WSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAG 269

Query: 360 LDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 419
             + +             L    +   +     A D   LL  +L  D + R++  EAL+
Sbjct: 270 YSFEK--------LFPDVLFPADSEHNKLKASQARD---LLSKMLVIDASKRISVDEALQ 318

Query: 420 HPFFTRDH 427
           HP+    +
Sbjct: 319 HPYINVWY 326

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  147 bits (373), Expect = 8e-41
 Identities = 78/364 (21%), Positives = 125/364 (34%), Gaps = 119/364 (32%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR---------EAAMIEI 141
                Y++   +G+G F  V  C +RE  +  A+KI   +   +         E    E 
Sbjct: 21  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKI---VDVAKFTSSPGLSTEDLKREA 77

Query: 142 EVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFL--RKNNYRSFPIDLV 198
            +   L KH    +  V++   +     + +VFE + G+ L   +  R +    +   + 
Sbjct: 78  SICHML-KHP---H-IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132

Query: 199 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 258
               RQ+LE + + HD  +IH D+KP  VLL S E                         
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE------------------------N 168

Query: 259 SSAIKVIDFG-STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELC 314
           S+ +K+  FG +             V T H+ APEV+    +  P D+W  G IL + L 
Sbjct: 169 SAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228

Query: 315 -------TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----W 362
                  T E LF+                                 + +G+       W
Sbjct: 229 GCLPFYGTKERLFEG--------------------------------IIKGKYKMNPRQW 256

Query: 363 PEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
                                    H+  SA D   L++ +L  DP +R+T  EAL HP+
Sbjct: 257 S------------------------HISESAKD---LVRRMLMLDPAERITVYEALNHPW 289

Query: 423 FTRD 426
               
Sbjct: 290 LKER 293

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  147 bits (373), Expect = 1e-40
 Identities = 81/366 (22%), Positives = 146/366 (39%), Gaps = 97/366 (26%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAK 149
           S+Y+  +K+G+GTFG+V +   R+  + VA+K V  ++  +E     A+ EI++LQ L K
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLL-K 74

Query: 150 HDKGGN----RCV---QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIA 202
           H+   N      +   +   +   +  I +VF+     L   L     + F +  ++ + 
Sbjct: 75  HE---NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVM 130

Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
           + LL  + ++H   ++H D+K  N +L++ + +                          +
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAAN-VLITRDGV--------------------------L 163

Query: 263 KVIDFG-----STTYERPDQNY--IVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELC 314
           K+ DFG     S         Y   V T  YR PE++LG   +  P D+W  GCI+ E+ 
Sbjct: 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 223

Query: 315 TGEALFQTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIK 373
           T   + Q +     LA++ ++ G   P+                    WP          
Sbjct: 224 TRSPIMQGNTEQHQLALISQLCGSITPE-------------------VWPN--------- 255

Query: 374 SVMKLP-------------RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
            V                 ++++ +  +V         L+  LL  DP  R+ + +AL H
Sbjct: 256 -VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA--LDLIDKLLVLDPAQRIDSDDALNH 312

Query: 421 PFFTRD 426
            FF  D
Sbjct: 313 DFFWSD 318

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  147 bits (372), Expect = 1e-40
 Identities = 85/352 (24%), Positives = 144/352 (40%), Gaps = 74/352 (21%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQL 147
            L   Y   + +G G +G V    D+   E VAIK + R  +    A  A  E+ +L+ +
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80

Query: 148 AKHDKGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
            +H+   N  + + + F             +V   + + L   +       F  + ++ +
Sbjct: 81  -QHE---N-VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK----FSEEKIQYL 131

Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L+ + ++H   ++H DLKP N+ +                                
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNED---------------------------CE 164

Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALF 320
           +K++DFG   +   +    V TR YRAPEVIL         DIWSVGCI+ E+ TG+ LF
Sbjct: 165 LKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224

Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVR----RGRLDWPEGAASRESIKSV 375
           +  + L+ L  + +V G      ++++ D+ A+ Y++      R D+ +           
Sbjct: 225 KGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ----------- 273

Query: 376 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                    +       A D   LL+ +L  D   RLTA +AL HPFF    
Sbjct: 274 ---------LFPRASPQAAD---LLEKMLELDVDKRLTAAQALTHPFFEPFR 313

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  147 bits (374), Expect = 2e-40
 Identities = 78/391 (19%), Positives = 146/391 (37%), Gaps = 95/391 (24%)

Query: 49  PPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKM-GEGTF 107
           PP+ P+  +               P +         +      +   YK+ S++ G G  
Sbjct: 20  PPQPPTPALPHPPAQPPPPPPQQFPQFHVKSG----LQIKKNAIIDDYKVTSQVLGLGIN 75

Query: 108 GQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-- 165
           G+VL+ +++  +E  A+K+++   K R     E+E+  + ++     +  V+I + ++  
Sbjct: 76  GKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCP---H-IVRIVDVYENL 127

Query: 166 --YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 222
              R  + IV E L G  L+  ++    ++F      EI + + E I ++H + + H D+
Sbjct: 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDV 187

Query: 223 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY--I 280
           KPEN+L  S                           ++ +K+ DFG         +    
Sbjct: 188 KPENLLYTSKR------------------------PNAILKLTDFGFAKETTSHNSLTTP 223

Query: 281 VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP 340
             T +Y APEV+    +   CD+WS+G I+  L  G   F ++  L            + 
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----------AIS 272

Query: 341 QHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 395
             M  R        +R G+ +     W                          V      
Sbjct: 273 PGMKTR--------IRMGQYEFPNPEWS------------------------EVSEEVKM 300

Query: 396 LTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
              L++ LL+ +PT R+T  E + HP+  + 
Sbjct: 301 ---LIRNLLKTEPTQRMTITEFMNHPWIMQS 328

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  145 bits (369), Expect = 2e-40
 Identities = 73/347 (21%), Positives = 125/347 (36%), Gaps = 85/347 (24%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-------REAAMIEIE 142
           + +   Y I  ++G G F  V +C ++      A K ++  +         RE    E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67

Query: 143 VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREI 201
           +L+Q+  H       + + + ++ R  + ++ E + G  L+DFL +        +     
Sbjct: 68  ILRQV-LHH----NVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSF 120

Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            +Q+L+ + ++H   + H DLKPEN++L+                               
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKN-----------------------IPIPH 157

Query: 262 IKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
           IK+IDFG          +  I  T  + APE++         D+WS+G I   L +G + 
Sbjct: 158 IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

Query: 320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 379
           F               LG   Q  L          +     D+ E               
Sbjct: 218 F---------------LGDTKQETLAN--------ITSVSYDFDEEF------------- 241

Query: 380 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                   H    A D    ++ LL  +   RLT +EALRHP+ T  
Sbjct: 242 ------FSHTSELAKD---FIRKLLVKETRKRLTIQEALRHPWITPV 279

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  146 bits (371), Expect = 2e-40
 Identities = 90/351 (25%), Positives = 150/351 (42%), Gaps = 59/351 (16%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLA 148
           N++S +++ S +GEG +G V     +   E+VAIK +    K   A     EI++L+   
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF- 66

Query: 149 KHDKGGNRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 203
           KH+   N  + I N       +  N + I+ E + + L+  +          D ++    
Sbjct: 67  KHE---N-IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD---DHIQYFIY 119

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q L  +  +H   +IH DLKP N+L+ S+  +KV D+   L    D S       +    
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDF--GLARIIDESAADNSEPTGQQS 177

Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 322
            +      +        V+TR YRAPEV+L    ++   D+WS GCIL EL     +F  
Sbjct: 178 GM----VEF--------VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225

Query: 323 HENLEHLAMMERVLG-PLPQHMLKRVD-RHAEKYVR----RGRLDWPEGAASRESIKSVM 376
            +    L ++  ++G P   + L+ ++   A +Y++           +            
Sbjct: 226 RDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEK------------ 273

Query: 377 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
             P         V+    DL   LQ +L +DP  R+TA+EAL HP+    H
Sbjct: 274 MFP--------RVNPKGIDL---LQRMLVFDPAKRITAKEALEHPYLQTYH 313

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  146 bits (371), Expect = 2e-40
 Identities = 80/373 (21%), Positives = 136/373 (36%), Gaps = 78/373 (20%)

Query: 80  KDGHYMFALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA 136
           K    M  L      + S Y +   +  G++G V    D E    VAIK V         
Sbjct: 5   KGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRT 63

Query: 137 AMI------------EIEVLQQLAKHDKGGNRCVQIRNWF-----DYRNHICIVFEKLGS 179
             I            EI +L     H    N  + +R+ F        + + +V E + +
Sbjct: 64  VNILSDSFLCKRVLREIRLLNHF-HHP---N-ILGLRDIFVHFEEPAMHKLYLVTELMRT 118

Query: 180 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 239
            L   +            ++     +L  +  +H+  ++H DL P N +L++        
Sbjct: 119 DLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGN-ILLADN------ 170

Query: 240 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN---YIVSTRHYRAPEVILGL- 295
                               + I + DF     +  D N   Y V+ R YRAPE+++   
Sbjct: 171 --------------------NDITICDFNLAREDTADANKTHY-VTHRWYRAPELVMQFK 209

Query: 296 GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVD-RHAEKY 354
           G+T   D+WS GC++ E+   +ALF+       L  +  V+G      +       A  Y
Sbjct: 210 GFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDY 269

Query: 355 VRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 414
           +R    + P       +  +V  +P          D  A D   L+  +L ++P  R++ 
Sbjct: 270 LRNSLSNVP-----ARAWTAV--VP--------TADPVALD---LIAKMLEFNPQRRIST 311

Query: 415 REALRHPFFTRDH 427
            +ALRHP+F    
Sbjct: 312 EQALRHPYFESLF 324

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  146 bits (371), Expect = 2e-40
 Identities = 83/357 (23%), Positives = 152/357 (42%), Gaps = 83/357 (23%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--------KKYREAAMIEIE 142
            +  RY+  S +G G +G V   +D +    VA+K +           + YRE     + 
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LR 80

Query: 143 VLQQLAKHDKGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPID 196
           +L+ + KH+   N  + + + F      +  N + +V   +G+ L + ++         D
Sbjct: 81  LLKHM-KHE---N-VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---D 132

Query: 197 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 256
            V+ +  Q+L  + ++H   +IH DLKP N+ +                           
Sbjct: 133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED------------------------ 168

Query: 257 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT 315
                +K++DFG   +   +    V+TR YRAPE++L    +    DIWSVGCI+ EL T
Sbjct: 169 ---CELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

Query: 316 GEALFQTHENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVR----RGRLDWPEGAASRE 370
           G  LF   ++++ L ++ R++G     +LK++    A  Y++      ++++        
Sbjct: 226 GRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN------ 279

Query: 371 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                         +    +  A D   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 280 --------------VFIGANPLAVD---LLEKMLVLDSDKRITAAQALAHAYFAQYH 319

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  145 bits (368), Expect = 3e-40
 Identities = 70/359 (19%), Positives = 124/359 (34%), Gaps = 88/359 (24%)

Query: 91  NLTSRYKIHSKM-GEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLA 148
                Y++   + GEG   +V  C +    +  A+KI+       R     E+E+L Q  
Sbjct: 9   RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68

Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
            H    N  +++  +F+  +   +VFEK+ G S+   + K   R F       + + +  
Sbjct: 69  GHR---N-VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVAS 122

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + F+H+  + H DLKPEN+L                             + S +K+ DF
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPN------------------------QVSPVKICDF 158

Query: 268 GSTTYERPDQNY----------IVSTRHYRAPEVILGLGWTY-----PCDIWSVGCILVE 312
              +  + + +              +  Y APEV+             CD+WS+G IL  
Sbjct: 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYI 218

Query: 313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAA 367
           L +G   F      +               + +         ++ G+ +     W     
Sbjct: 219 LLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES--------IQEGKYEFPDKDWA---- 266

Query: 368 SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                               H+  +A D   L+  LL  D   RL+A + L+HP+    
Sbjct: 267 --------------------HISCAAKD---LISKLLVRDAKQRLSAAQVLQHPWVQGC 302

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  144 bits (365), Expect = 3e-40
 Identities = 67/346 (19%), Positives = 126/346 (36%), Gaps = 85/346 (24%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-------REAAMIEIEV 143
            +   Y++  ++G G F  V +C  +   +  A K ++  +         RE    E+ +
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 144 LQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIA 202
           L+++ +H       + + + F+ +  + ++ E + G  L+DFL +        D   +  
Sbjct: 62  LREI-RHP----NIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFL 114

Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
           +Q+L+ + ++H   + H DLKPEN++L+                        +   +  I
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLD-----------------------KNVPNPRI 151

Query: 263 KVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
           K+IDFG          +  I  T  + APE++         D+WS+G I   L +G + F
Sbjct: 152 KLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211

Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 380
                          LG   Q  L          +     D+ E                
Sbjct: 212 ---------------LGETKQETLTN--------ISAVNYDFDEEY-------------- 234

Query: 381 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  +    A D    ++ LL  DP  R+T  ++L H +    
Sbjct: 235 -----FSNTSELAKD---FIRRLLVKDPKRRMTIAQSLEHSWIKAI 272

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  143 bits (363), Expect = 5e-40
 Identities = 79/352 (22%), Positives = 125/352 (35%), Gaps = 89/352 (25%)

Query: 82  GHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-- 139
           G         +   +    K+G G FG V    +R       IK    I K R    +  
Sbjct: 10  GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKT---INKDRSQVPMEQ 66

Query: 140 ---EIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFL--RKNNYRSF 193
              EIEVL+ L  H       ++I   F+  +++ IV E   G  L + +   +   ++ 
Sbjct: 67  IEAEIEVLKSL-DHP----NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKAL 121

Query: 194 PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 253
               V E+ +Q++  +A+ H   ++H DLKPEN+L   +                     
Sbjct: 122 SEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS-------------------- 161

Query: 254 KRMPKSSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILV 311
                 S IK+IDFG     + D++      T  Y APEV      T+ CDIWS G ++ 
Sbjct: 162 ----PHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMY 216

Query: 312 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRES 371
            L TG   F    +LE +                       +       ++         
Sbjct: 217 FLLTGCLPFT-GTSLEEVQ----------------------QKATYKEPNYAVEC----- 248

Query: 372 IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                          + +   A D   LL+ +L  DP  R +A + L H +F
Sbjct: 249 ---------------RPLTPQAVD---LLKQMLTKDPERRPSAAQVLHHEWF 282

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  144 bits (365), Expect = 8e-40
 Identities = 66/347 (19%), Positives = 124/347 (35%), Gaps = 85/347 (24%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-------REAAMIEIE 142
           EN+   Y    ++G G F  V +C ++      A K ++  +         RE    E+ 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66

Query: 143 VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREI 201
           +L+++ +H       + +   ++ +  + ++ E + G  L+DFL +        +   E 
Sbjct: 67  ILKEI-QHP----NVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEF 119

Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            +Q+L  + ++H L + H DLKPEN++L+                               
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRN-----------------------VPKPR 156

Query: 262 IKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
           IK+IDFG          +  I  T  + APE++         D+WS+G I   L +G + 
Sbjct: 157 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

Query: 320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 379
           F      E    +  V                         ++ +               
Sbjct: 217 FLGDTKQE---TLANVS--------------------AVNYEFEDEY------------- 240

Query: 380 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                   +    A D    ++ LL  DP  R+T +++L+HP+    
Sbjct: 241 ------FSNTSALAKD---FIRRLLVKDPKKRMTIQDSLQHPWIKPK 278

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  145 bits (367), Expect = 9e-40
 Identities = 72/348 (20%), Positives = 124/348 (35%), Gaps = 85/348 (24%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIE 142
           + +   Y I  ++G G F  V +C ++      A K ++  +         RE    E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67

Query: 143 VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREI 201
           +L+Q+  H       + + + ++ R  + ++ E + G  L+DFL +        +     
Sbjct: 68  ILRQV-LHP----NIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSF 120

Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            +Q+L+ + ++H   + H DLKPEN++L+                               
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKN-----------------------IPIPH 157

Query: 262 IKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
           IK+IDFG          +  I  T  + APE++         D+WS+G I   L +G + 
Sbjct: 158 IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

Query: 320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 379
           F               LG   Q  L          +     D+ E               
Sbjct: 218 F---------------LGDTKQETLAN--------ITAVSYDFDEEF------------- 241

Query: 380 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                        A D    ++ LL  +   RLT +EALRHP+ T   
Sbjct: 242 ------FSQTSELAKD---FIRKLLVKETRKRLTIQEALRHPWITPVD 280

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  143 bits (362), Expect = 9e-40
 Identities = 87/358 (24%), Positives = 138/358 (38%), Gaps = 93/358 (25%)

Query: 80  KDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREA 136
             G            RY I   +G+G+FG+VL+C DR  ++  A+K++       K    
Sbjct: 8   SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67

Query: 137 AMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPI 195
            + E+E+L++L  H    N  +++    +  +   IV E   G  L+D + K     F  
Sbjct: 68  ILREVELLKKL-DHP---N-IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSE 120

Query: 196 DLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 255
                I +Q+   I +MH   ++H DLKPEN+LL S E                      
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE---------------------- 158

Query: 256 MPKSSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 313
             K   IK+IDFG +T  + +      + T +Y APEV+ G  +   CD+WS G IL  L
Sbjct: 159 --KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYIL 215

Query: 314 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAAS 368
            +G   F   +N   +                       K V  G+       W      
Sbjct: 216 LSGTPPF-YGKNEYDIL----------------------KRVETGKYAFDLPQWR----- 247

Query: 369 RESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                               +   A D   L++ +L + P+ R+TA + L HP+  + 
Sbjct: 248 -------------------TISDDAKD---LIRKMLTFHPSLRITATQCLEHPWIQKY 283

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  145 bits (367), Expect = 1e-39
 Identities = 85/356 (23%), Positives = 146/356 (41%), Gaps = 77/356 (21%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLA 148
           ++  RY   S +GEG +G V   +D   K  VAIK +   +          EI++L +  
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF- 82

Query: 149 KHDKGGNRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR 203
           +H+   N  + I +       +    + IV + + + LY  L+  +      D +     
Sbjct: 83  RHE---N-IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLY 135

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L  + ++H   ++H DLKP N LL+++                             +K
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSN-LLLNTT--------------------------CDLK 168

Query: 264 VIDFG---STTYERPDQNYI---VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTG 316
           + DFG       +     ++   V+TR YRAPE++L   G+T   DIWSVGCIL E+ + 
Sbjct: 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

Query: 317 EALFQTHENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVR----RGRLDWPEGAASRES 371
             +F     L+ L  +  +LG   Q  L  + +  A  Y+     + ++ W         
Sbjct: 229 RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR------- 281

Query: 372 IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                  P        + D  A D   LL  +L ++P  R+   +AL HP+  + +
Sbjct: 282 -----LFP--------NADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQYY 321

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  143 bits (362), Expect = 1e-39
 Identities = 73/346 (21%), Positives = 133/346 (38%), Gaps = 91/346 (26%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLA 148
            N+   +     +G G F +V     R   ++ A+K ++    +R++++  EI VL+++ 
Sbjct: 5   TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI- 63

Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
           KH+   N  V + + ++   H  +V + + G  L+D + +     +       + +Q+L 
Sbjct: 64  KHE---N-IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLS 117

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H+  ++H DLKPEN+L ++ E                        ++S I + DF
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPE------------------------ENSKIMITDF 153

Query: 268 GSTTYERPDQNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELCTGEALFQTHEN 325
           G +  E+         T  Y APEV+    ++   D WS+G I  + LC G   F   E 
Sbjct: 154 GLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC-GYPPFYE-ET 211

Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPR 380
              L   E++                      G  +     W                  
Sbjct: 212 ESKL--FEKIK--------------------EGYYEFESPFWD----------------- 232

Query: 381 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                   +  SA D    +  LL  DP +R T  +AL HP+   +
Sbjct: 233 -------DISESAKD---FICHLLEKDPNERYTCEKALSHPWIDGN 268

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  148 bits (376), Expect = 1e-39
 Identities = 75/342 (21%), Positives = 128/342 (37%), Gaps = 80/342 (23%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLA 148
           +++   Y IH ++G G FG V    +R      A K V    +  +E    EI+ +  L 
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL- 211

Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
           +H       V + + F+  N + +++E + G  L++ +   +      D   E  RQ+ +
Sbjct: 212 RHPT----LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCK 266

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            +  MH+   +H DLKPEN++  +                          +S+ +K+IDF
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTT-------------------------KRSNELKLIDF 301

Query: 268 GSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
           G T +  P Q+      T  + APEV  G    Y  D+WSVG +   L +G + F    +
Sbjct: 302 GLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361

Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 385
            E    +  V                         +  + A                   
Sbjct: 362 DE---TLRNVK--------------------SCDWNMDDSA------------------- 379

Query: 386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
              +     D    ++ LL  DP  R+T  +AL HP+ T  +
Sbjct: 380 FSGISEDGKD---FIRKLLLADPNTRMTIHQALEHPWLTPGN 418

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  144 bits (364), Expect = 1e-39
 Identities = 77/345 (22%), Positives = 134/345 (38%), Gaps = 82/345 (23%)

Query: 90  ENLTSRYKIHSKM-GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA 148
             +T  Y++  ++ G G  G+VLEC+ R   +  A+K++    K R+    E++   Q +
Sbjct: 24  YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ----EVDHHWQAS 79

Query: 149 KHDKGGNRCVQIRNWFD----YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIAR 203
                 +  V I + ++     +  + I+ E + G  L+  +++   ++F      EI R
Sbjct: 80  GGP---H-IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
            +   I F+H   + H D+KPEN+L  S E                        K + +K
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKE------------------------KDAVLK 171

Query: 264 VIDFG-STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
           + DFG +    +        T +Y APEV+    +   CD+WS+G I+  L  G   F +
Sbjct: 172 LTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS 231

Query: 323 -HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 381
                    M  R                    +R G+  +P    S             
Sbjct: 232 NTGQAISPGMKRR--------------------IRLGQYGFPNPEWS------------- 258

Query: 382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                  V   A     L++ LL+ DPT+RLT  + + HP+  + 
Sbjct: 259 ------EVSEDAKQ---LIRLLLKTDPTERLTITQFMNHPWINQS 294

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  142 bits (360), Expect = 1e-39
 Identities = 71/349 (20%), Positives = 121/349 (34%), Gaps = 97/349 (27%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQ 145
            ++   Y + + +G G++G+V     +  +   A K    I KY     +    EIE+++
Sbjct: 5   GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKK---IPKYFVEDVDRFKQEIEIMK 61

Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
            L  H       +++   F+    I +V E   G  L++ +       F       I + 
Sbjct: 62  SL-DH----PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKD 114

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +L  +A+ H L + H DLKPEN L ++                            S +K+
Sbjct: 115 VLSAVAYCHKLNVAHRDLKPENFLFLTDS------------------------PDSPLKL 150

Query: 265 IDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 322
           IDFG     +P +     V T +Y +P+V+ G  +   CD WS G ++  L  G   F  
Sbjct: 151 IDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSA 209

Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMK 377
                 +                         +R G        W               
Sbjct: 210 -PTDSEVM----------------------LKIREGTFTFPEKDWL-------------- 232

Query: 378 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                     +V   A     L++ LL   P  R+T+ +AL H +F + 
Sbjct: 233 ----------NVSPQAES---LIRRLLTKSPKQRITSLQALEHEWFEKQ 268

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  144 bits (364), Expect = 2e-39
 Identities = 47/249 (18%), Positives = 94/249 (37%), Gaps = 28/249 (11%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK 149
           +  +    +H  +GEG F QV E    +  +    +    +K  + A   E  +  QL +
Sbjct: 61  QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKF-VLKVQKPANPWEFYIGTQLME 119

Query: 150 HDKGGNR--CVQIRNWFDYRNHICIVFEKL-GSSLYDFL---RKNNYRSFPIDLVREIAR 203
             K   +   ++  +   ++N   +V E     +L + +   +    +  P  LV   A 
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           ++L  I  +HD  +IH D+KP+N +L +    +  +   S                  + 
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG----------------LA 223

Query: 264 VIDFGSTTYER--PDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 318
           +ID G +   +  P      +   T  ++  E++    W Y  D + V   +  +  G  
Sbjct: 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283

Query: 319 LFQTHENLE 327
           +   +E  E
Sbjct: 284 MKVKNEGGE 292

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  146 bits (369), Expect = 2e-39
 Identities = 93/433 (21%), Positives = 160/433 (36%), Gaps = 89/433 (20%)

Query: 50  PRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGE---NLTSRYKIHSKMGEGT 106
             A   H + +   V G  + G    +                  +  RY+I   +G G+
Sbjct: 6   AAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGS 65

Query: 107 FGQVLECWDRERKEMVAIKIVRGI--------KKYREAAMIEIEVLQQLAKHDKGGN--- 155
           +G V E +D+  K +VAIK +  +        +  RE     I +L +L  HD   +   
Sbjct: 66  YGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILRE-----IAILNRL-NHD---HVVK 116

Query: 156 -RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
              + I    +  + + +V E   S      R   Y +     ++ +   LL  + ++H 
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLT--ELHIKTLLYNLLVGVKYVHS 174

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             ++H DLKP N L+     +KV D+  +       +   ++P S     ++  +  + +
Sbjct: 175 AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234

Query: 275 PDQNYI---VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT-----------GEAL 319
             +  +   V TR YRAPE+IL    +T   D+WS+GCI  EL                L
Sbjct: 235 NLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPL 294

Query: 320 F--------------------QTHENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVR-- 356
           F                     T  N + L ++  +LG   +  ++ +    A++Y+R  
Sbjct: 295 FPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIF 354

Query: 357 --RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 414
             R   D  E            + P             A  L   L+ +L ++P  R+T 
Sbjct: 355 PKREGTDLAE------------RFP--------ASSADAIHL---LKRMLVFNPNKRITI 391

Query: 415 REALRHPFFTRDH 427
            E L HPFF    
Sbjct: 392 NECLAHPFFKEVR 404

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  143 bits (362), Expect = 3e-39
 Identities = 67/340 (19%), Positives = 117/340 (34%), Gaps = 91/340 (26%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHD 151
           +Y    K+GEG+FG+ +     E      IK +       K RE +  E+ VL  + KH 
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHP 83

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                 VQ R  F+    + IV +   G  L+  +       F  D + +   Q+   + 
Sbjct: 84  ----NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK 139

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
            +HD  ++H D+K +N+ L                            K   +++ DFG  
Sbjct: 140 HVHDRKILHRDIKSQNIFL---------------------------TKDGTVQLGDFGIA 172

Query: 271 TYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                        + T +Y +PE+     +    DIW++GC+L ELCT +  F+   +++
Sbjct: 173 RVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMK 231

Query: 328 HLAM--MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 385
           +L +  +     P+  H                         S +               
Sbjct: 232 NLVLKIISGSFPPVSLHY------------------------SYD--------------- 252

Query: 386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                     L  L+  L + +P DR +    L   F  +
Sbjct: 253 ----------LRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  144 bits (365), Expect = 4e-39
 Identities = 84/356 (23%), Positives = 137/356 (38%), Gaps = 91/356 (25%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV-------RGIKKYREAAMI--E 140
           + L   Y +   +G G  G+V   ++R+  + VAI+I+          ++   A  +  E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190

Query: 141 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR 199
           IE+L++L  H       ++I+N+FD      IV E + G  L+D +  N          +
Sbjct: 191 IEILKKL-NHP----CIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKR--LKEATCK 242

Query: 200 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 259
               Q+L  + ++H+  +IH DLKPENVLL S E                        + 
Sbjct: 243 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------------------------ED 278

Query: 260 SAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELC 314
             IK+ DFG +           +  T  Y APEV++ +   G+    D WS+G IL    
Sbjct: 279 CLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338

Query: 315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
           +G   F  H                   +  +        +  G+ ++            
Sbjct: 339 SGYPPFSEHRT--------------QVSLKDQ--------ITSGKYNFIP---------- 366

Query: 375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 430
                     +   V   A D   L++ LL  DP  R T  EALRHP+   + ++R
Sbjct: 367 ---------EVWAEVSEKALD---LVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  142 bits (360), Expect = 7e-39
 Identities = 77/346 (22%), Positives = 134/346 (38%), Gaps = 95/346 (27%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQL 147
           + L+  +++ S++G G    V  C  +  ++  A+K+   +KK  +  ++  EI VL +L
Sbjct: 49  DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKV---LKKTVDKKIVRTEIGVLLRL 105

Query: 148 AKHDKGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
             H    N  ++++  F+    I +V E   G  L+D + +  Y  +      +  +Q+L
Sbjct: 106 -SHP---N-IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQIL 158

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
           E +A++H+  ++H DLKPEN+L  +                            + +K+ D
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPA------------------------PDAPLKIAD 194

Query: 267 FGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELCTGEALFQTH 323
           FG +           +  T  Y APE++ G  +    D+WSVG I  + LC G   F   
Sbjct: 195 FGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC-GFEPFYDE 253

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKL 378
              +   M  R+L                              W                
Sbjct: 254 RGDQ--FMFRRIL--------------------NCEYYFISPWWD--------------- 276

Query: 379 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
                     V  +A D   L++ L+  DP  RLT  +AL+HP+ T
Sbjct: 277 ---------EVSLNAKD---LVRKLIVLDPKKRLTTFQALQHPWVT 310

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  142 bits (360), Expect = 7e-39
 Identities = 68/371 (18%), Positives = 126/371 (33%), Gaps = 110/371 (29%)

Query: 76  REDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKK 132
           ++  +   +M       +  Y +  ++G+G F  V  C  +      A KI+   +   +
Sbjct: 11  QQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR 70

Query: 133 YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYR 191
             +    E  + ++L +H    N  V++ +     +   +VF+ + G  L++ +    + 
Sbjct: 71  DFQKLEREARICRKL-QHP---N-IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF- 124

Query: 192 SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 251
            +         +Q+LE IA+ H   ++H +LKPEN+LL S                    
Sbjct: 125 -YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA------------------ 165

Query: 252 YFKRMPKSSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCI 309
                 K +A+K+ DFG        + +     T  Y +PEV+    ++ P DIW+ G I
Sbjct: 166 ------KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 219

Query: 310 L-VELC--------TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRL 360
           L + L             L+                                  ++ G  
Sbjct: 220 LYILLVGYPPFWDEDQHRLYAQ--------------------------------IKAGAY 247

Query: 361 D-----WPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 415
           D     W                          V   A     L+  +L  +P  R+TA 
Sbjct: 248 DYPSPEWD------------------------TVTPEAKS---LIDSMLTVNPKKRITAD 280

Query: 416 EALRHPFFTRD 426
           +AL+ P+    
Sbjct: 281 QALKVPWICNR 291

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  143 bits (361), Expect = 8e-39
 Identities = 58/343 (16%), Positives = 112/343 (32%), Gaps = 66/343 (19%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDK 152
            + +   +G+G    V     ++  ++ AIK+       +  +  M E EVL++L  H  
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHK- 67

Query: 153 GGNRCVQIRNWFDYRN--HICIVFEKL-GSSLYDFLRKN-NYRSFPIDLVREIARQLLEC 208
                V++    +     H  ++ E     SLY  L +  N    P      + R ++  
Sbjct: 68  ---NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +  + +  ++H ++KP N++ V  E                          S  K+ DFG
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGE-----------------------DGQSVYKLTDFG 161

Query: 269 STTYERPDQNY--IVSTRHYRAPEVILGLGWTYP--------CDIWSVGCILVELCTGEA 318
           +      D+ +  +  T  Y  P++                  D+WS+G       TG  
Sbjct: 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

Query: 319 LFQTHENLEHLA-MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 377
            F+  E       +M +++   P   +  V +        G +DW        S+   ++
Sbjct: 222 PFRPFEGPRRNKEVMYKIITGKPSGAISGVQK-----AENGPIDWSGDMPVSCSLSRGLQ 276

Query: 378 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
                             LT +L  +L  D        +    
Sbjct: 277 ----------------VLLTPVLANILEADQEKCWGFDQFFAE 303

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  142 bits (359), Expect = 1e-38
 Identities = 87/352 (24%), Positives = 148/352 (42%), Gaps = 73/352 (20%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQL 147
            + + Y+    +G G +G V    D      VAIK + R  +    A  A  E+ +L+ +
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 81

Query: 148 AKHDKGGNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI 201
            +H+   N  + + + F      D      +V   +G+ L   ++         D ++ +
Sbjct: 82  -RHE---N-VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE---DRIQFL 133

Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             Q+L+ + ++H   +IH DLKP N+ +                                
Sbjct: 134 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNED---------------------------CE 166

Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF 320
           +K++DFG       +    V TR YRAPEVIL    +T   DIWSVGCI+ E+ TG+ LF
Sbjct: 167 LKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226

Query: 321 QTHENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVR----RGRLDWPEGAASRESIKSV 375
           +  ++L+ L  + +V G  P   ++R+    A+ Y++      + D+             
Sbjct: 227 KGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS----------- 275

Query: 376 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                    I+ +    A +   LL+ +L  D   R+TA EAL HP+F   H
Sbjct: 276 ---------ILTNASPLAVN---LLEKMLVLDAEQRVTAGEALAHPYFESLH 315

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  143 bits (362), Expect = 2e-38
 Identities = 72/359 (20%), Positives = 125/359 (34%), Gaps = 111/359 (30%)

Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQ 145
               T  Y++  ++G+G F  V  C      +  A  I+   +   +  +    E  + +
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65

Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
            L KH    N  V++ +      H  ++F+ + G  L++ +    Y  +         +Q
Sbjct: 66  LL-KHP---N-IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQ 118

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +LE +   H + ++H +LKPEN+LL S                          K +A+K+
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKL------------------------KGAAVKL 154

Query: 265 IDFG-STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELC------ 314
            DFG +   E   Q +     T  Y +PEV+    +  P D+W+ G IL + L       
Sbjct: 155 ADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW 214

Query: 315 --TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAA 367
                 L+Q                                 ++ G  D     W     
Sbjct: 215 DEDQHRLYQ--------------------------------QIKAGAYDFPSPEWD---- 238

Query: 368 SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                                V   A D   L+  +L  +P+ R+TA EAL+HP+ +  
Sbjct: 239 --------------------TVTPEAKD---LINKMLTINPSKRITAAEALKHPWISHR 274

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  139 bits (352), Expect = 2e-38
 Identities = 67/357 (18%), Positives = 121/357 (33%), Gaps = 110/357 (30%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQ 146
              +  Y +  ++G+G F  V  C  +      A KI+   +   +  +    E  + ++
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61

Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
           L +H    N  V++ +     +   +VF+ + G  L++ +    +  +         +Q+
Sbjct: 62  L-QHP---N-IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQI 114

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           LE IA+ H   ++H +LKPEN+LL S                          K +A+K+ 
Sbjct: 115 LESIAYCHSNGIVHRNLKPENLLLASKA------------------------KGAAVKLA 150

Query: 266 DFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELC-------- 314
           DFG        + +     T  Y +PEV+    ++ P DIW+ G IL + L         
Sbjct: 151 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210

Query: 315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASR 369
               L+                                  ++ G  D     W       
Sbjct: 211 DQHRLYAQ--------------------------------IKAGAYDYPSPEWD------ 232

Query: 370 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                              V   A     L+  +L  +P  R+TA +AL+ P+    
Sbjct: 233 ------------------TVTPEAKS---LIDSMLTVNPKKRITADQALKVPWICNR 268

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  141 bits (357), Expect = 5e-38
 Identities = 84/368 (22%), Positives = 143/368 (38%), Gaps = 89/368 (24%)

Query: 97  KIHSKMGEGTFGQVLECWDRERK--EMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDK 152
               K+G GT+G V +   ++ K  +  A+K +   GI     +A  EI +L++L KH  
Sbjct: 24  YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLREL-KHP- 78

Query: 153 GGNRCVQIRNWFDYRNHICI--VFE-------KLGSSLYDFLRKNNYRSFPIDLVREIAR 203
             N  + ++  F       +  +F+        +                P  +V+ +  
Sbjct: 79  --N-VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+L+ I ++H   ++H DLKP N +LV  E                       P+   +K
Sbjct: 136 QILDGIHYLHANWVLHRDLKPAN-ILVMGEG----------------------PERGRVK 172

Query: 264 VIDFG-STTYERPDQNY-----IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCT 315
           + D G +  +  P +       +V T  YRAPE++LG    Y    DIW++GCI  EL T
Sbjct: 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLT 231

Query: 316 GEALFQ---------THENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPE- 364
            E +F             + + L  +  V+G P  +                   DW + 
Sbjct: 232 SEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK-------------------DWEDI 272

Query: 365 ------GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 418
                     ++  ++      L   + +H         HLLQ LL  DP  R+T+ +A+
Sbjct: 273 KKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332

Query: 419 RHPFFTRD 426
           + P+F  D
Sbjct: 333 QDPYFLED 340

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  138 bits (349), Expect = 1e-37
 Identities = 88/367 (23%), Positives = 140/367 (38%), Gaps = 103/367 (28%)

Query: 85  MFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV-------RGIKKYREAA 137
           M    + L   Y +   +G G  G+V   ++R+  + VAIKI+          ++   A 
Sbjct: 1   MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60

Query: 138 MI--EIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFP 194
            +  EIE+L++L  H       ++I+N+FD  ++  IV E + G  L+D +  N      
Sbjct: 61  NVETEIEILKKL-NHP----CIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKR--LK 112

Query: 195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
               +    Q+L  + ++H+  +IH DLKPENVLL S E                     
Sbjct: 113 EATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE--------------------- 151

Query: 255 RMPKSSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGL---GWTYPCDIWSVGCI 309
              +   IK+ DFG +           +  T  Y APEV++ +   G+    D WS+G I
Sbjct: 152 ---EDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208

Query: 310 L-VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WP 363
           L + L  G   F  H                   +  +        +  G+ +     W 
Sbjct: 209 LFICLS-GYPPFSEHRT--------------QVSLKDQ--------ITSGKYNFIPEVWA 245

Query: 364 EGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                                    V   A D   L++ LL  DP  R T  EALRHP+ 
Sbjct: 246 ------------------------EVSEKALD---LVKKLLVVDPKARFTTEEALRHPWL 278

Query: 424 TRDHLRR 430
             + ++R
Sbjct: 279 QDEDMKR 285

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  137 bits (346), Expect = 2e-37
 Identities = 79/361 (21%), Positives = 126/361 (34%), Gaps = 107/361 (29%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV----------RGIKKYREAAMI 139
                 Y+    +G G    V  C  +   +  A+KI+            +++ REA + 
Sbjct: 13  HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72

Query: 140 EIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLV 198
           E+++L++++ H    N  +Q+++ ++      +VF+ +    L+D+L +           
Sbjct: 73  EVDILRKVSGHP---N-IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKET 126

Query: 199 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 258
           R+I R LLE I  +H L ++H DLKPEN+LL                             
Sbjct: 127 RKIMRALLEVICALHKLNIVHRDLKPENILLDD--------------------------- 159

Query: 259 SSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGL------GWTYPCDIWSVGCIL 310
              IK+ DFG +    P +    +  T  Y APE+I         G+    D+WS G I+
Sbjct: 160 DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

Query: 311 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEG 365
             L  G   F  H                   ML+         +  G        W   
Sbjct: 220 YTLLAGSPPF-WHRK--------------QMLMLRM--------IMSGNYQFGSPEWD-- 254

Query: 366 AASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                                     +  D   L+   L   P  R TA EAL HPFF +
Sbjct: 255 ----------------------DYSDTVKD---LVSRFLVVQPQKRYTAEEALAHPFFQQ 289

Query: 426 D 426
            
Sbjct: 290 Y 290

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  137 bits (348), Expect = 4e-37
 Identities = 86/414 (20%), Positives = 146/414 (35%), Gaps = 111/414 (26%)

Query: 39  QEVGNVTSFAPPRAPSDHVTSSSLFVKGVARNGSPPWREDD---KDGHYMFALGENLTSR 95
           Q    + S     + S ++ + +  +      G+          +D    +A  +    +
Sbjct: 36  QRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQK 95

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIEIEVLQQ 146
           Y     +G G    V  C  R      A+KI+           +++ REA   E  +L+Q
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
           +A H       + + + ++  + + +VF+ +    L+D+L +           R I R L
Sbjct: 156 VAGH----PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSL 209

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           LE ++F+H   ++H DLKPEN+LL                             +  I++ 
Sbjct: 210 LEAVSFLHANNIVHRDLKPENILLDD---------------------------NMQIRLS 242

Query: 266 DFGSTTYERPDQNY--IVSTRHYRAPEVILGL------GWTYPCDIWSVGCIL-VELCTG 316
           DFG + +  P +    +  T  Y APE++         G+    D+W+ G IL   L  G
Sbjct: 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA-G 301

Query: 317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRES 371
              F  H                   ML+         +  G+       W         
Sbjct: 302 SPPF-WHRR--------------QILMLRM--------IMEGQYQFSSPEWD-------- 330

Query: 372 IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                               +  D   L+  LL+ DP  RLTA +AL+HPFF R
Sbjct: 331 ----------------DRSSTVKD---LISRLLQVDPEARLTAEQALQHPFFER 365

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  137 bits (347), Expect = 7e-37
 Identities = 82/341 (24%), Positives = 133/341 (39%), Gaps = 82/341 (24%)

Query: 90  ENLTSRYKIHSK--MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQ 146
             + S Y +     +G G FGQV +C +      +A KI++    K +E    EI V+ Q
Sbjct: 83  GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQ 142

Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
           L  H       +Q+ + F+ +N I +V E + G  L+D +   +Y +          +Q+
Sbjct: 143 L-DHA----NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY-NLTELDTILFMKQI 196

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
            E I  MH + ++H DLKPEN+L V+                           +  IK+I
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVN-------------------------RDAKQIKII 231

Query: 266 DFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
           DFG     +P +       T  + APEV+     ++P D+WSVG I   L +G + F   
Sbjct: 232 DFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF--- 288

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
                       LG      L          +   R D  +                   
Sbjct: 289 ------------LGDNDAETLNN--------ILACRWDLEDEE----------------- 311

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
              Q +   A +    +  LL  + + R++A EAL+HP+ +
Sbjct: 312 --FQDISEEAKE---FISKLLIKEKSWRISASEALKHPWLS 347

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  135 bits (342), Expect = 1e-36
 Identities = 71/371 (19%), Positives = 120/371 (32%), Gaps = 89/371 (23%)

Query: 70  NGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG 129
              PP  +          +G N  + ++I  K+G G F +V           VA+K V+ 
Sbjct: 8   MQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI 67

Query: 130 IK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDF 184
                 K R   + EI++L+QL  H    N  ++    F   N + IV E      L   
Sbjct: 68  FDLMDAKARADCIKEIDLLKQL-NHP---N-VIKYYASFIEDNELNIVLELADAGDLSRM 122

Query: 185 LR--KNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 242
           ++  K   R  P   V +   QL   +  MH   ++H D+KP NV +             
Sbjct: 123 IKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT------------ 170

Query: 243 SLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQ--NYIVSTRHYRAPEVILGLGWTY 299
                           +  +K+ D G    +       + +V T +Y +PE I   G+ +
Sbjct: 171 ---------------ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 215

Query: 300 PCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL-GPLPQHMLKRVDRHAEKYVRRG 358
             DIWS+GC+L E+   ++ F   + +   ++ +++     P                  
Sbjct: 216 KSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQCDYPP----------------- 257

Query: 359 RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 418
               P    S E          L+ L+                  +  DP  R       
Sbjct: 258 ---LPSDHYSEE----------LRQLVNM---------------CINPDPEKRPDVTYVY 289

Query: 419 RHPFFTRDHLR 429
                      
Sbjct: 290 DVAKRMHACTA 300

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  134 bits (340), Expect = 1e-36
 Identities = 77/349 (22%), Positives = 128/349 (36%), Gaps = 105/349 (30%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKH 150
           RY     +G+G F +  E  D + KE+ A KIV    + K  +   +  EI + + L  H
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AH 74

Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
                  V    +F+  + + +V E     SL +  ++   ++      R   RQ++   
Sbjct: 75  ----QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGC 128

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 268
            ++H   +IH DLK  N+ L         +    +                  K+ DFG 
Sbjct: 129 QYLHRNRVIHRDLKLGNLFL---------NEDLEV------------------KIGDFGL 161

Query: 269 STTYERPDQ---------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
           +T  E   +         NYI       APEV+   G ++  D+WS+GCI+  L  G+  
Sbjct: 162 ATKVEYDGERKKVLCGTPNYI-------APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

Query: 320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 379
           F+T   L              +    R        +++     P+               
Sbjct: 215 FET-SCL--------------KETYLR--------IKKNEYSIPK--------------- 236

Query: 380 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 428
                   H++  A     L+Q +L+ DPT R T  E L   FFT  ++
Sbjct: 237 --------HINPVAAS---LIQKMLQTDPTARPTINELLNDEFFTSGYI 274

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  136 bits (344), Expect = 1e-36
 Identities = 47/424 (11%), Positives = 107/424 (25%), Gaps = 104/424 (24%)

Query: 34  GLFCGQEVGNVTSFAPPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLT 93
           G    +++             + +   +  V+ V     P   E       + +L     
Sbjct: 7   GDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETT-----VDSLLSQGE 61

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--------IKKYREAAMIEIEVLQ 145
            + K+   +  G    V    D ER E  A+K+           +++  EA      +L 
Sbjct: 62  RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121

Query: 146 QLAKHDKGGNRCVQIRNWFDYRNH-----------------ICIVFEKLGSSLYDFLRKN 188
           +  +  +   R +   +    ++                    ++       L       
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181

Query: 189 NYRS-----FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 243
           ++         I  +  +  QL+   A +    ++H    P+N+ ++             
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM------------- 228

Query: 244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTY--PC 301
                             + + D  +                Y   E +     T+    
Sbjct: 229 --------------PDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHAL 274

Query: 302 DIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD 361
           + W +G  +  +      F                G +   +     R + +      L 
Sbjct: 275 NAWQLGLSIYRVWCLFLPF----------------GLVTPGIKGSWKRPSLRVPGTDSLA 318

Query: 362 WPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHP 421
           +       + +K+                        L+   L +D   RL   EA+  P
Sbjct: 319 FGSCTPLPDFVKT------------------------LIGRFLNFDRRRRLLPLEAMETP 354

Query: 422 FFTR 425
            F +
Sbjct: 355 EFLQ 358

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  134 bits (340), Expect = 4e-36
 Identities = 82/395 (20%), Positives = 136/395 (34%), Gaps = 116/395 (29%)

Query: 49  PPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGEGTFG 108
           P +A    V +             P    D +              RY     +G+G F 
Sbjct: 7   PGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRR-----------RYVRGRFLGKGGFA 55

Query: 109 QVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQIRNWF 164
           +  E  D + KE+ A KIV    + K  +   +  EI + + L  H       V    +F
Sbjct: 56  KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AH----QHVVGFHGFF 110

Query: 165 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLK 223
           +  + + +V E     SL +  ++   ++      R   RQ++    ++H   +IH DLK
Sbjct: 111 EDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168

Query: 224 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQ----- 277
             N+ L         +                      +K+ DFG +T  E   +     
Sbjct: 169 LGNLFL---------NEDLE------------------VKIGDFGLATKVEYDGERKKVL 201

Query: 278 ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
               NYI       APEV+   G ++  D+WS+GCI+  L  G+  F+T   L       
Sbjct: 202 CGTPNYI-------APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCL------- 246

Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 393
                  +    R        +++     P+                       H++  A
Sbjct: 247 -------KETYLR--------IKKNEYSIPK-----------------------HINPVA 268

Query: 394 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 428
                L+Q +L+ DPT R T  E L   FFT  ++
Sbjct: 269 ---ASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  136 bits (345), Expect = 4e-36
 Identities = 87/385 (22%), Positives = 146/385 (37%), Gaps = 86/385 (22%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMI--EIEVLQQL 147
           ++   Y I   +G G++G V   +D+  ++ VAIK + R  +   +   I  EI +L +L
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL 82

Query: 148 AKHDKGGNRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIA 202
            K D      +++ +          + + IV E   S L    +   + +   + ++ I 
Sbjct: 83  -KSD---Y-IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT--EEHIKTIL 135

Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD------YKSSLHTPKDSSYFKRM 256
             LL    F+H+  +IH DLKP N LL     +KV D        S   T   +   +  
Sbjct: 136 YNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195

Query: 257 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT 315
                 K +    T++        V TR YRAPE+IL    +T   DIWS GCI  EL  
Sbjct: 196 EPGPHNKNLKKQLTSH--------VVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

Query: 316 G-----------EALFQ-----------------THENLEHLAMMERVLGPLPQHMLKRV 347
                         LF                     N + L ++  ++G   +  LK +
Sbjct: 248 MLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNI 307

Query: 348 -DRHAEKYVR----RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 402
                 KY++    R  ++  +            K P         +     +L   L+ 
Sbjct: 308 NKPEVIKYIKLFPHRKPINLKQ------------KYP--------SISDDGINL---LES 344

Query: 403 LLRYDPTDRLTAREALRHPFFTRDH 427
           +L+++P  R+T  +AL HP+     
Sbjct: 345 MLKFNPNKRITIDQALDHPYLKDVR 369

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  132 bits (335), Expect = 6e-36
 Identities = 64/354 (18%), Positives = 113/354 (31%), Gaps = 101/354 (28%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHD 151
            Y++   +G G++G+  +   +   +++  K +         ++  + E+ +L++L KH 
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHP 65

Query: 152 KGGNRCVQIRNWFDYR--NHICIVFEKL-GSSLYDFLR--KNNYRSFPIDLVREIARQLL 206
              N  V+  +    R    + IV E   G  L   +       +    + V  +  QL 
Sbjct: 66  ---N-IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121

Query: 207 ECIAFMHDLC-----MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
             +   H        ++H DLKP NV L                                
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLD---------------------------GKQN 154

Query: 262 IKVIDFGSTTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 318
           +K+ DFG       D ++    V T +Y +PE +  + +    DIWS+GC+L ELC    
Sbjct: 155 VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214

Query: 319 LFQTHENLEHLAM--MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 376
            F    + + LA    E     +P                           S E      
Sbjct: 215 PFTA-FSQKELAGKIREGKFRRIPYRY------------------------SDE------ 243

Query: 377 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 430
                              L  ++  +L      R +  E L +P    +H   
Sbjct: 244 -------------------LNEIITRMLNLKDYHRPSVEEILENPLI-LEHHHH 277

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  132 bits (335), Expect = 6e-36
 Identities = 65/351 (18%), Positives = 111/351 (31%), Gaps = 83/351 (23%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHD 151
           + ++    +G G FG V E  ++      AIK +R    +  RE  M E++ L +L +H 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHP 63

Query: 152 KGGNRCVQIRNWFD-----------YRNHICIVFEKL--GSSLYDFLRKNNYRSFP-IDL 197
                      W +            + ++ I  + L    +L D++            +
Sbjct: 64  ---GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQ-LCRKENLKDWMNGRCTIEERERSV 119

Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
              I  Q+ E + F+H   ++H DLKP N+     + +KV D+               M 
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV----------TAMD 169

Query: 258 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 317
           +    +     +           V T+ Y +PE I G  +++  DI+S+G IL EL    
Sbjct: 170 QDEEEQ--TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP- 226

Query: 318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 377
             F T                                VR                    K
Sbjct: 227 --FSTQMERVRTLTD----------------------VRNL------------------K 244

Query: 378 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 428
            P L                 ++Q +L   P +R  A   + +  F     
Sbjct: 245 FPPLFTQKYP-------CEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  138 bits (348), Expect = 1e-35
 Identities = 69/341 (20%), Positives = 112/341 (32%), Gaps = 64/341 (18%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDK 152
            +++  ++G G FG VL    ++  E VAIK  R     K RE   +EI+++++L  H  
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHP- 72

Query: 153 GGN-----RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKN-NYRSFPIDLVREIARQL 205
             N                 +   +  E   G  L  +L +  N        +R +   +
Sbjct: 73  --NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
              + ++H+  +IH DLKPEN++L                            +    K+I
Sbjct: 131 SSALRYLHENRIIHRDLKPENIVLQPGP------------------------QRLIHKII 166

Query: 266 DFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
           D G        +     V T  Y APE++    +T   D WS G +  E  TG       
Sbjct: 167 DLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF------ 220

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
                           P     +  +   K   +             ++K    LP   +
Sbjct: 221 ---------------RPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNH 265

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
           L        AG L   LQ +L +    R T  +      F 
Sbjct: 266 LSGI----LAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  131 bits (331), Expect = 2e-35
 Identities = 70/348 (20%), Positives = 127/348 (36%), Gaps = 104/348 (29%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKH 150
            +K+ + +G+G+F  V           VAIK++  + + K      +  E+++  QL KH
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KH 70

Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
                  +++ N+F+  N++ +V E      +  +L+    + F  +  R    Q++  +
Sbjct: 71  ----PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGM 125

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 268
            ++H   ++H DL   N+LL             +                  IK+ DFG 
Sbjct: 126 LYLHSHGILHRDLTLSNLLL---------TRNMN------------------IKIADFGL 158

Query: 269 STTYERPDQ---------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
           +T  + P +         NYI       +PE+          D+WS+GC+   L  G   
Sbjct: 159 ATQLKMPHEKHYTLCGTPNYI-------SPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

Query: 320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 379
           F T + +              ++ L +        V     + P                
Sbjct: 212 FDT-DTV--------------KNTLNK--------VVLADYEMPS--------------- 233

Query: 380 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                    +   A D   L+  LLR +P DRL+    L HPF +R+ 
Sbjct: 234 --------FLSIEAKD---LIHQLLRRNPADRLSLSSVLDHPFMSRNS 270

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  130 bits (328), Expect = 2e-34
 Identities = 65/345 (18%), Positives = 103/345 (29%), Gaps = 92/345 (26%)

Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 152
                   ++G G+FG+V    D++     A+K VR         + E+     L     
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGL-SSP- 110

Query: 153 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
              R V +         + I  E L G SL   +++      P D       Q LE + +
Sbjct: 111 ---RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEY 165

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--- 268
           +H   ++H D+K +NVLL                              S   + DFG   
Sbjct: 166 LHTRRILHGDVKADNVLL--------------------------SSDGSRAALCDFGHAL 199

Query: 269 -----STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
                         +YI  T  + APEV++G       DIWS  C+++ +  G       
Sbjct: 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG------- 252

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
               H         P  Q+                                 +K+     
Sbjct: 253 ---CH---------PWTQY---------------------------FRGPLCLKIASEPP 273

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 428
            I +     A      +Q  LR +P  R +A E  R        +
Sbjct: 274 PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  128 bits (324), Expect = 4e-34
 Identities = 77/398 (19%), Positives = 135/398 (33%), Gaps = 112/398 (28%)

Query: 45  TSFAPPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHYMFALGENLTSRYKIHSKMGE 104
           +S       S  V   S        + +      +K         E L S+Y++   +G 
Sbjct: 3   SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEK---------EPLESQYQVGPLLGS 53

Query: 105 GTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI-----EIEVLQQLAKHDKGGNRC 157
           G FG V           VAIK V    I  + E         E+ +L+++      G   
Sbjct: 54  GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV-SSGFSG--V 110

Query: 158 VQIRNWFDYRNHICIVFEKLGSS--LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
           +++ +WF+  +   ++ E+      L+DF+ +    +   +L R    Q+LE +   H+ 
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC 168

Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
            ++H D+K EN+L+                   D +  +       +K+IDFGS      
Sbjct: 169 GVLHRDIKDENILI-------------------DLNRGE-------LKLIDFGSGALL-K 201

Query: 276 DQNYIVS--TRHYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEALFQTHENLEHLA 330
           D  Y     TR Y  PE I      Y      +WS+G +L ++  G+  F          
Sbjct: 202 DTVYTDFDGTRVYSPPEWIRYHR--YHGRSAAVWSLGILLYDMVCGDIPF---------- 249

Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 390
                                ++ + RG++ +                            
Sbjct: 250 -------------------EHDEEIIRGQVFFR--------------------------Q 264

Query: 391 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 428
             + +  HL++  L   P+DR T  E   HP+     L
Sbjct: 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  127 bits (320), Expect = 1e-33
 Identities = 70/348 (20%), Positives = 130/348 (37%), Gaps = 108/348 (31%)

Query: 90  ENLTSRYKIHSKM-GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA 148
             +   YK+ S++ G G  G+VL+ +++  +E  A+K+++   K R     E+E+  + +
Sbjct: 13  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRAS 68

Query: 149 KHDKGGNRCVQIRNWFD----YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIAR 203
           +     +  V+I + ++     R  + IV E L G  L+  ++    ++F      EI +
Sbjct: 69  QCP---H-IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 124

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
            + E I ++H + + H D+KPEN+L  S                           ++ +K
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKR------------------------PNAILK 160

Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
           + DFG                   A E   G  +   CD+WS+G I+  L  G   F ++
Sbjct: 161 LTDFG------------------FAKET-TGEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKL 378
                          +   M  R        +R G+ +     W                
Sbjct: 202 HG-----------LAISPGMKTR--------IRMGQYEFPNPEWS--------------- 227

Query: 379 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                     V         L++ LL+ +PT R+T  E + HP+  + 
Sbjct: 228 ---------EVSEEVKM---LIRNLLKTEPTQRMTITEFMNHPWIMQS 263

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  125 bits (317), Expect = 2e-33
 Identities = 70/338 (20%), Positives = 128/338 (37%), Gaps = 87/338 (25%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAK 149
             ++I   +G+G FG V    +++ K ++A+K++    ++K      +  E+E+   L +
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-R 67

Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           H       +++  +F     + ++ E     ++Y  L+K     F          +L   
Sbjct: 68  HPN----ILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANA 121

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +++ H   +IH D+KPEN+LL S+  +K+ D+  S+H P      +R             
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRT------------ 165

Query: 269 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 328
                  D         Y  PE+I G       D+WS+G +  E   G+  F+ +     
Sbjct: 166 -DLCGTLD---------YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---- 211

Query: 329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 388
                       Q   KR        + R    +P+                        
Sbjct: 212 -----------YQETYKR--------ISRVEFTFPD-----------------------F 229

Query: 389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
           V   A D   L+  LL+++P+ R   RE L HP+ T +
Sbjct: 230 VTEGARD---LISRLLKHNPSQRPMLREVLEHPWITAN 264

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  126 bits (318), Expect = 3e-33
 Identities = 56/355 (15%), Positives = 102/355 (28%), Gaps = 103/355 (29%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLAKHDKG 153
            Y    K+GEG F  V            A+K +   ++  RE A  E ++ +    H   
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHP-- 86

Query: 154 GNRCVQIRNWF----DYRNHICIVFE-KLGSSLYDFL--RKNNYRSFPIDLVREIARQLL 206
            N  +++  +       ++   ++       +L++ +   K+       D +  +   + 
Sbjct: 87  -N-ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             +  +H     H DLKP N+LL                                  ++D
Sbjct: 145 RGLEAIHAKGYAHRDLKPTNILLG---------------------------DEGQPVLMD 177

Query: 267 FGSTTYERP------------DQNYIVSTRHYRAPEVI---LGLGWTYPCDIWSVGCILV 311
            GS                  D      T  YRAPE+             D+WS+GC+L 
Sbjct: 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLY 237

Query: 312 ELCTGEALFQ-THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRE 370
            +  GE  +    +  + +A+                         + +L  P+    R 
Sbjct: 238 AMMFGEGPYDMVFQKGDSVAL-----------------------AVQNQLSIPQS--PRH 272

Query: 371 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           S         L  L+                 ++  DP  R      L      +
Sbjct: 273 S-------SALWQLL---------------NSMMTVDPHQRPHIPLLLSQLEALQ 305

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  125 bits (316), Expect = 3e-33
 Identities = 66/363 (18%), Positives = 135/363 (37%), Gaps = 92/363 (25%)

Query: 76  REDDKDGHYMFALGENLTSRY-KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIK 131
           ++DD +     A+G +   R+ K   ++G G+F  V +  D E    VA   ++     K
Sbjct: 7   QQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK 66

Query: 132 KYREAAMIEIEVLQQLAKHDKGGNRCVQ-IRNWFDY---RNHICIVFEKLGS-SLYDFLR 186
             R+    E E+L+ L +H       V+   +W      +  I +V E + S +L  +L+
Sbjct: 67  SERQRFKEEAEMLKGL-QHP----NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK 121

Query: 187 KNNYRSFPIDLVREIARQLLECIAFMH--DLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 244
           +  ++   I ++R   RQ+L+ + F+H     +IH DLK +N+ +               
Sbjct: 122 R--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--------------- 164

Query: 245 HTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDI 303
                         + ++K+ D G +T         ++ T  + APE+     +    D+
Sbjct: 165 -----------TGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDV 212

Query: 304 WSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWP 363
           ++ G  ++E+ T E  +   +N     +  RV   +                        
Sbjct: 213 YAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSGVKPASF------------------- 251

Query: 364 EGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                 + +      P ++ +I                  +R +  +R + ++ L H FF
Sbjct: 252 ------DKVAI----PEVKEIIEG---------------CIRQNKDERYSIKDLLNHAFF 286

Query: 424 TRD 426
             +
Sbjct: 287 QEE 289

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  124 bits (313), Expect = 7e-33
 Identities = 69/338 (20%), Positives = 121/338 (35%), Gaps = 87/338 (25%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAK 149
             + I   +G+G FG V    +++ K ++A+K++    ++K      +  EIE+   L +
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-R 72

Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           H       +++ N+F  R  I ++ E      LY  L+K+    F          +L + 
Sbjct: 73  HPN----ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADA 126

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           + + H+  +IH D+KPEN+L+     +K+ D+  S+H P      +R             
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL----RRR------------ 170

Query: 269 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 328
            T     D         Y  PE+I G       D+W  G +  E   G   F +     H
Sbjct: 171 -TMCGTLD---------YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP---SH 217

Query: 329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 388
                R++                       L +P                         
Sbjct: 218 TETHRRIV--------------------NVDLKFPP-----------------------F 234

Query: 389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
           +   + D   L+  LLRY P  RL  +  + HP+   +
Sbjct: 235 LSDGSKD---LISKLLRYHPPQRLPLKGVMEHPWVKAN 269

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  124 bits (313), Expect = 1e-32
 Identities = 63/352 (17%), Positives = 115/352 (32%), Gaps = 101/352 (28%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI-----EIE 142
           E   + Y++   +G+G FG V        +  VAIK++    +  +   +       E+ 
Sbjct: 27  EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA 86

Query: 143 VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVRE 200
           +L ++          +++ +WF+ +    +V E       L+D++ +           R 
Sbjct: 87  LLWKVGAGGGHPG-VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRC 143

Query: 201 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 260
              Q++  I   H   ++H D+K EN+L+                   D        +  
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILI-------------------DL-------RRG 177

Query: 261 AIKVIDFGSTTYERPDQNYIVS--TRHYRAPEVILGLGWTY---PCDIWSVGCILVELCT 315
             K+IDFGS      D+ Y     TR Y  PE I      Y   P  +WS+G +L ++  
Sbjct: 178 CAKLIDFGSGAL-LHDEPYTDFDGTRVYSPPEWISRHQ--YHALPATVWSLGILLYDMVC 234

Query: 316 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV 375
           G+  F                               ++ +    L +P            
Sbjct: 235 GDIPF-----------------------------ERDQEILEAELHFPA----------- 254

Query: 376 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                          H + D   L++  L   P+ R +  E L  P+     
Sbjct: 255 ---------------HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  123 bits (310), Expect = 5e-32
 Identities = 68/357 (19%), Positives = 110/357 (30%), Gaps = 110/357 (30%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKG 153
           R ++   + EG F  V E  D       A+K +    ++   A + E+  +++L+ H   
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHP-- 86

Query: 154 GN------RCVQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQL 205
            N           +   D      ++  +L  G  +    +  +      D V +I  Q 
Sbjct: 87  -NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145

Query: 206 LECIAFMHDL--CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
              +  MH     +IH DLK EN+LL                                IK
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLS---------------------------NQGTIK 178

Query: 264 VIDFGSTTYERPDQNYIVS-----------TRH----YRAPEVI---LGLGWTYPCDIWS 305
           + DFGS T      +Y  S           TR+    YR PE+I            DIW+
Sbjct: 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWA 238

Query: 306 VGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEG 365
           +GCIL  LC  +  F+    L                            +  G+   P  
Sbjct: 239 LGCILYLLCFRQHPFEDGAKLR---------------------------IVNGKYSIP-- 269

Query: 366 AASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
                                 H          L++ +L+ +P +RL+  E +    
Sbjct: 270 ---------------------PHDTQYT-VFHSLIRAMLQVNPEERLSIAEVVHQLQ 304

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  122 bits (307), Expect = 6e-32
 Identities = 59/249 (23%), Positives = 99/249 (39%), Gaps = 41/249 (16%)

Query: 78  DDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREA 136
           ++ D        +           +G+GT+G V    D   +  +AIK +     +Y + 
Sbjct: 6   EEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP 65

Query: 137 AMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPI 195
              EI + + L KH       VQ    F     I I  E++ G SL   L ++ +     
Sbjct: 66  LHEEIALHKHL-KHK----NIVQYLGSFSENGFIKIFMEQVPGGSLSALL-RSKWGPLKD 119

Query: 196 D--LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 253
           +   +    +Q+LE + ++HD  ++H D+K +NVL+                        
Sbjct: 120 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI------------------------ 155

Query: 254 KRMPKSSAIKVIDFGS---TTYERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGC 308
                S  +K+ DFG+        P       T  Y APE+I     G+    DIWS+GC
Sbjct: 156 --NTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGC 213

Query: 309 ILVELCTGE 317
            ++E+ TG+
Sbjct: 214 TIIEMATGK 222

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  122 bits (307), Expect = 2e-31
 Identities = 60/362 (16%), Positives = 123/362 (33%), Gaps = 94/362 (25%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI------------- 139
            Y+I   + +G F +++ C   +  +  A+K      ++K R+                 
Sbjct: 32  DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 140 ---EIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY----- 190
              E++++  + K++     C+         + + I++E +   S+  F           
Sbjct: 90  FKNELQIITDI-KNE---Y-CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY 144

Query: 191 -RSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 248
               PI +++ I + +L   +++H+   + H D+KP N+L+         D         
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM---------DKNGR----- 190

Query: 249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVS--TRHYRAPEVILGLGWTY--PCDIW 304
                        +K+ DFG + Y   D+    S  T  +  PE             DIW
Sbjct: 191 -------------VKLSDFGESEY-MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIW 236

Query: 305 SVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPE 364
           S+G  L  +      F    +L                +           +R   +++P 
Sbjct: 237 SLGICLYVMFYNVVPFSLKISL--------------VELFNN--------IRTKNIEYPL 274

Query: 365 GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
                    +  K     N     + +   D    L+  LR +P +R+T+ +AL+H +  
Sbjct: 275 DRNHFLYPLTNKKSTCSNN----FLSNEDID---FLKLFLRKNPAERITSEDALKHEWLA 327

Query: 425 RD 426
             
Sbjct: 328 DT 329

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  116 bits (292), Expect = 3e-29
 Identities = 49/367 (13%), Positives = 108/367 (29%), Gaps = 127/367 (34%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAM------IEIEVLQQLAKHDKGGNR 156
           G+      LE  D+E  E   + +    ++    A+      +    L +  K+ K    
Sbjct: 82  GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141

Query: 157 CVQIRNWFD--------------------YRNHICIVFEKLGSSLYDFL-----RKNNYR 191
            ++    FD                    +      ++ ++ S+L  F        + ++
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201

Query: 192 SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 251
           S       ++  Q++  +A +H   ++HT L+P +++L                      
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--------------------- 240

Query: 252 YFKRMPKSSAIKVIDFGSTTYERPDQNYIVS--TRHYRAPEVILGLGW-----------T 298
                 +   + +  F        D   +VS  +R +  PE+                 T
Sbjct: 241 ------QRGGVFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMT 291

Query: 299 YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG 358
           +  D W++G ++  +   +    T +     +                      +++ R 
Sbjct: 292 FSFDAWALGLVIYWIWCADLPI-TKDAALGGS----------------------EWIFRS 328

Query: 359 RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 418
             + P+                                  LL+G LRY   DRL   +A+
Sbjct: 329 CKNIPQPVR------------------------------ALLEGFLRYPKEDRLLPLQAM 358

Query: 419 RHPFFTR 425
             P + +
Sbjct: 359 ETPEYEQ 365

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  114 bits (286), Expect = 1e-28
 Identities = 72/390 (18%), Positives = 121/390 (31%), Gaps = 124/390 (31%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLA--- 148
           + ++    MG G FG V E  ++      AIK +R    +  RE  M E++ L +L    
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 149 ----------------------------------KHDKGGNRCVQIRNWFDYRNHICIVF 174
                                                   +         D  +    V 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 175 EKLGSS----LY------------DFLRKNNYRSFP-IDLVREIARQLLECIAFMHDLCM 217
           +   SS    LY            D++ +          +   I  Q+ E + F+H   +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 218 IHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           +H DLKP N+     + +KV D+    +     ++ +    MP  +              
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA-------------- 231

Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 334
                 V T+ Y +PE I G  +++  DI+S+G IL EL      F T         MER
Sbjct: 232 -THTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS---FSTQ--------MER 279

Query: 335 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 394
           V       ++          VR  +   P             K P+   ++         
Sbjct: 280 V------RIITD--------VRNLKF--PLL--------FTQKYPQEHMMVQD------- 308

Query: 395 DLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
                   +L   PT+R  A + + +  F 
Sbjct: 309 --------MLSPSPTERPEATDIIENAIFE 330

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  112 bits (282), Expect = 4e-28
 Identities = 72/347 (20%), Positives = 125/347 (36%), Gaps = 105/347 (30%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----------EIEVL 144
           +Y   S +G G FG V    D+E+ + V +K ++  +K  E   I          EI +L
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAIL 83

Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSS--LYDFLRKNNYRSFPIDLVREIA 202
            ++ +H       +++ + F+ +    +V EK GS   L+ F+ ++        L   I 
Sbjct: 84  SRV-EHAN----IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIF 136

Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
           RQL+  + ++    +IH D+K EN+++                      +         I
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVI-------------------AEDF--------TI 169

Query: 263 KVIDFGSTTYERPDQNYIVS--TRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEAL 319
           K+IDFGS  Y    + +     T  Y APEV++G  +  P  ++WS+G  L  L   E  
Sbjct: 170 KLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE-- 227

Query: 320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 379
                               P   L+              +  P                
Sbjct: 228 -------------------NPFCELEE--------TVEAAIHPP---------------- 244

Query: 380 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                        + +L  L+ GLL+  P  R T  + +  P+ T+ 
Sbjct: 245 ----------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  107 bits (269), Expect = 4e-26
 Identities = 64/338 (18%), Positives = 118/338 (34%), Gaps = 50/338 (14%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKG 153
           ++  S++G G  G V +   +    ++A K++    K      I  E++VL +       
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE------- 87

Query: 154 GNRCVQIRNW---FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
                 I  +   F     I I  E + G SL   L+K      P  ++ +++  +++ +
Sbjct: 88  -CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGL 144

Query: 210 AFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
            ++ +   ++H D+KP N+L+ S                              IK+ DFG
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSR---------------------------GEIKLCDFG 177

Query: 269 -STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
            S        N  V TR Y +PE + G  ++   DIWS+G  LVE+  G       +  E
Sbjct: 178 VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237

Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
              M    +         R         R       +        + +  +       + 
Sbjct: 238 LELMFGCQVEGDAAETPPR----PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP 293

Query: 388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
               S  +    +   L  +P +R   ++ + H F  R
Sbjct: 294 SGVFSL-EFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  106 bits (266), Expect = 7e-26
 Identities = 66/346 (19%), Positives = 117/346 (33%), Gaps = 90/346 (26%)

Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV-RGIKKYREAAMI--EIEVLQ 145
            +     Y++   +G+G F +V           VAIKI+ +          +  E+ +++
Sbjct: 10  EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 69

Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
            L  H       V++    +    + ++ E   G  ++D+L  +          R   RQ
Sbjct: 70  IL-NHP----NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQ 122

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           ++  + + H   ++H DLK EN+LL         D   +                  IK+
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLL---------DADMN------------------IKI 155

Query: 265 IDFGSTTYERPDQNYIVS--TRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQ 321
            DFG +                 Y APE+  G  +  P  D+WS+G IL  L +G   F 
Sbjct: 156 ADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

Query: 322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 381
             +NL+ L                       + V RG+   P                  
Sbjct: 216 -GQNLKEL----------------------RERVLRGKYRIPF----------------- 235

Query: 382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                    + + D  +LL+  L  +P  R T  + ++  +    H
Sbjct: 236 ---------YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  107 bits (268), Expect = 8e-26
 Identities = 57/419 (13%), Positives = 115/419 (27%), Gaps = 131/419 (31%)

Query: 48  APPRAPSDHVTSSSLFVKGVARNGSPPWREDDKDGHY-MFALGENLTSRYKIHSKMGEGT 106
               +      + SL    +   G P   E +          G  L          G+  
Sbjct: 41  VRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVL----------GQED 90

Query: 107 FGQVLECWDRERKEMVAIKIVR--------GIKKYREAAMIE------------IEVLQQ 146
               LE  D+E  E   + +           IK+ +E  +                 L+ 
Sbjct: 91  PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150

Query: 147 LAKHD--KGGNRCVQIRNWFDYRNH----ICIVFEKLGSSLYDFL-----RKNNYRSFPI 195
           +   D  K   +   IR   D R+        ++ ++ S+L  F        + ++S   
Sbjct: 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 210

Query: 196 DLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 255
               ++  Q++  +A +H   ++HT L+P +++L                          
Sbjct: 211 HARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD------------------------- 245

Query: 256 MPKSSAIKVIDFGSTTYE----RPDQNYIVSTRHYRAPEVILGLG-----WTYPCDIWSV 306
             +   + +  F     +            +     A  ++          T+  D W++
Sbjct: 246 --QRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303

Query: 307 GCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGA 366
           G  +  +   +    T +    L   E +                     R   + P+  
Sbjct: 304 GLAIYWIWCADLPN-TDDAA--LGGSEWIF--------------------RSCKNIPQPV 340

Query: 367 ASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
            +                              LL+G LRY   DRL   +A+  P + +
Sbjct: 341 RA------------------------------LLEGFLRYPKEDRLLPLQAMETPEYEQ 369

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  105 bits (263), Expect = 1e-25
 Identities = 69/357 (19%), Positives = 128/357 (35%), Gaps = 115/357 (32%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-----EIEVLQQLAK 149
           +Y +   +GEG++G+V E  D E     A+KI++  K  R          EI++L++L +
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-R 64

Query: 150 HDKGGNRCVQIRN--------WFDYRNHICIVFE--KLGSS-LYDFLRKNNYRSFPIDLV 198
           H          +N        + + +  + +V E    G   + D + +   + FP+   
Sbjct: 65  H----------KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE---KRFPVCQA 111

Query: 199 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 258
                QL++ + ++H   ++H D+KP N+LL             +               
Sbjct: 112 HGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---------TTGGT--------------- 147

Query: 259 SSAIKVIDFG-STTYERPDQNYIVSTR----HYRAPEVILGLGWTY---PCDIWSVGCIL 310
              +K+   G +        +    T      ++ PE+  GL  T+     DIWS G  L
Sbjct: 148 ---LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLD-TFSGFKVDIWSAGVTL 203

Query: 311 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRE 370
             + TG   F+  +N+  L                       + + +G    P       
Sbjct: 204 YNITTGLYPFE-GDNIYKLF----------------------ENIGKGSYAIP------- 233

Query: 371 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                                    L+ LL+G+L Y+P  R + R+  +H +F + H
Sbjct: 234 -------------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  104 bits (262), Expect = 2e-25
 Identities = 73/340 (21%), Positives = 126/340 (37%), Gaps = 90/340 (26%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKH 150
            Y I   +GEG+FG+V      + ++ VA+K +  + +KK      +  EI  L+ L +H
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RH 68

Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                  +++ +       I +V E  G  L+D++ +   +    D  R   +Q++  I 
Sbjct: 69  P----HIIKLYDVITTPTDIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQIICAIE 122

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           + H   ++H DLKPEN+LL         D   +                  +K+ DFG +
Sbjct: 123 YCHRHKIVHRDLKPENLLL---------DDNLN------------------VKIADFGLS 155

Query: 271 TYERPDQNYIVS--TRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHENLE 327
                      S  + +Y APEVI G  +  P  D+WS G +L  +  G   F   E + 
Sbjct: 156 NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD-DEFI- 213

Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
                         ++ K+        V       P                        
Sbjct: 214 -------------PNLFKK--------VNSCVYVMP------------------------ 228

Query: 388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
             D  +     L++ ++  DP  R+T +E  R P+F  + 
Sbjct: 229 --DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNL 266

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  104 bits (262), Expect = 5e-25
 Identities = 57/341 (16%), Positives = 116/341 (34%), Gaps = 33/341 (9%)

Query: 93  TSRYKIHSKMGEG--TFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQL 147
              Y++ + +G+G      V     +   E V ++ +       +       E+ V +  
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 148 AKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLL 206
             H    N  V  R  F   N + +V   +   S  D +  +         +  I + +L
Sbjct: 84  -NHP---N-IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
           + + ++H +  +H  +K  ++L+     + +   +S+       S      +   +    
Sbjct: 139 KALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN------LSMISHGQRQRVVHDF- 191

Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVI--LGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
                       Y V    + +PEV+     G+    DI+SVG    EL  G   F+   
Sbjct: 192 ----------PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241

Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
             +   ++E++ G +P  +        E  +   R     G +   +  +          
Sbjct: 242 ATQ--MLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPS 299

Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
              H   S     H ++  L+ +P  R +A   L H FF +
Sbjct: 300 HPYHRTFSP-HFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  102 bits (255), Expect = 4e-24
 Identities = 71/336 (21%), Positives = 111/336 (33%), Gaps = 79/336 (23%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
           RY     +G G FG      D+  KE+VA+K +       E    EI   + L +H    
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHP--- 76

Query: 155 NRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
              V+ +       H+ I+ E   G  LY+ +       F  D  R   +QLL  +++ H
Sbjct: 77  -NIVRFKEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCH 133

Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
            + + H DLK EN LL                   D S   R      +K+ DFG +   
Sbjct: 134 SMQICHRDLKLENTLL-------------------DGSPAPR------LKICDFGYSKSS 168

Query: 274 RPDQ--NYIVSTRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHENLEHLA 330
                    V T  Y APEV+L   +     D+WS G  L  +  G   F+         
Sbjct: 169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPRDY 227

Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 390
                             R   + +   +   P+                          
Sbjct: 228 ------------------RKTIQRILSVKYSIPDDI------------------------ 245

Query: 391 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
             + +  HL+  +   DP  R++  E   H +F ++
Sbjct: 246 RISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 99.2 bits (248), Expect = 7e-24
 Identities = 76/342 (22%), Positives = 124/342 (36%), Gaps = 95/342 (27%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKH 150
            Y +   +G GTFG+V     +     VA+KI+  + I+       I  EI+ L+   +H
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RH 70

Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
                  +++           +V E + G  L+D++ K+          R + +Q+L  +
Sbjct: 71  P----HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAV 124

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            + H   ++H DLKPENVLL         D   +                   K+ DFG 
Sbjct: 125 DYCHRHMVVHRDLKPENVLL---------DAHMN------------------AKIADFGL 157

Query: 270 TTYERPDQNYIVSTR----HYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHE 324
           +      +   + T     +Y APEVI G  +  P  DIWS G IL  L  G   F   E
Sbjct: 158 SNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD-DE 214

Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           ++                + K+        +R G    P                     
Sbjct: 215 HV--------------PTLFKK--------IRGGVFYIP--------------------- 231

Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                ++    +  LL  +L+ DP  R T ++   H +F +D
Sbjct: 232 -----EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 43/242 (17%)

Query: 97  KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++   +G G FG V +  W   R + VAIK +   +  R+A ++E+  L ++  H     
Sbjct: 11  EVEEVVGRGAFGVVCKAKW---RAKDVAIKQIES-ESERKAFIVELRQLSRV-NHP---- 61

Query: 156 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMH 213
             V++       N +C+V E   G SLY+ L        +          Q  + +A++H
Sbjct: 62  NIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119

Query: 214 DLC---MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
            +    +IH DLKP N+LLV+   +                          +K+ DFG+ 
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTV--------------------------LKICDFGTA 153

Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
              +        +  + APEV  G  ++  CD++S G IL E+ T    F          
Sbjct: 154 CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI 213

Query: 331 MM 332
           M 
Sbjct: 214 MW 215

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 66/332 (19%), Positives = 113/332 (34%), Gaps = 89/332 (26%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 158
           GEG+F  V+   +       AIKI+    I K  +      E +V+ +L  H       V
Sbjct: 39  GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP----FFV 93

Query: 159 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           ++   F     +           L  ++RK    SF     R    +++  + ++H   +
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGI 151

Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           IH DLKPEN+LL    +I++ D+ ++          K +            +        
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTA----------KVLSP------ESKQARANS---- 191

Query: 278 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 337
              V T  Y +PE++         D+W++GCI+ +L  G   F    N     + ++++ 
Sbjct: 192 --FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGN--EYLIFQKII- 245

Query: 338 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 397
                              +   D+P                       +     A D  
Sbjct: 246 -------------------KLEYDFP-----------------------EKFFPKARD-- 261

Query: 398 HLLQGLLRYDPTDRLT------AREALRHPFF 423
            L++ LL  D T RL             HPFF
Sbjct: 262 -LVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 97.3 bits (243), Expect = 3e-23
 Identities = 59/256 (23%), Positives = 94/256 (36%), Gaps = 54/256 (21%)

Query: 97  KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMI-----EIEVLQQLAKH 150
            +   +G G FG+V    W     + VA+K  R       +  I     E ++   L KH
Sbjct: 10  TLEEIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KH 65

Query: 151 D-----KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
                 +G   C++         ++C+V E   G  L   L     +  P D++   A Q
Sbjct: 66  PNIIALRGV--CLK-------EPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQ 113

Query: 205 LLECIAFMHDLC---MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
           +   + ++HD     +IH DLK  N+L+                             +  
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILI-------------------LQKVENGDLSNKI 154

Query: 262 IKVIDFGSTTYERPDQNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 320
           +K+ DFG                  + APEVI    ++   D+WS G +L EL TGE  F
Sbjct: 155 LKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

Query: 321 QTHENLEHLAMMERVL 336
                ++ LA+   V 
Sbjct: 215 ---RGIDGLAVAYGVA 227

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 97.3 bits (243), Expect = 5e-23
 Identities = 59/364 (16%), Positives = 117/364 (32%), Gaps = 112/364 (30%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDK 152
           +Y +  ++G+G++G V   ++       A+K++  + + +             + A    
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 153 GGNRCV--QIRN-------------------WFDY-RNHICIVFEKL-GSSLYDFLRKNN 189
              R    Q+                       D   +H+ +VFE +    + +      
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK- 132

Query: 190 YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 249
                 D  R   + L++ I ++H   +IH D+KP N+L+                    
Sbjct: 133 --PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV-------------------G 171

Query: 250 SSYFKRMPKSSAIKVIDFG-STTYERPDQNYIVSTR----HYRAPEVILGLGWTY---PC 301
                       IK+ DFG S  ++  D   ++S       + APE +      +     
Sbjct: 172 EDG--------HIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKAL 221

Query: 302 DIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD 361
           D+W++G  L     G+  F   E +                +  +        ++   L+
Sbjct: 222 DVWAMGVTLYCFVFGQCPFM-DERI--------------MCLHSK--------IKSQALE 258

Query: 362 WPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHP 421
           +P+                         D +  DL  L+  +L  +P  R+   E   HP
Sbjct: 259 FPD-----------------------QPDIAE-DLKDLITRMLDKNPESRIVVPEIKLHP 294

Query: 422 FFTR 425
           + TR
Sbjct: 295 WVTR 298

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 96.5 bits (241), Expect = 6e-23
 Identities = 62/343 (18%), Positives = 118/343 (34%), Gaps = 93/343 (27%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDK 152
            + +   +GEG +G+V    +R  +E VA+KIV   +       I  EI + + L  H+ 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE- 65

Query: 153 GGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                V+        N   +  E   G  L+D +  +     P    +    QL+  + +
Sbjct: 66  ---NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVY 120

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-ST 270
           +H + + H D+KPEN+LL                   D            +K+ DFG +T
Sbjct: 121 LHGIGITHRDIKPENLLL-------------------DERD--------NLKISDFGLAT 153

Query: 271 TYERPDQNYIVSTR----HYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEALFQTH 323
            +   ++  +++       Y APE++      +   P D+WS G +L  +  GE  +   
Sbjct: 154 VFRYNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPWDQP 211

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
            +                          + Y       W                     
Sbjct: 212 SD--------------SCQEYSDWKE-KKTY----LNPW--------------------- 231

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
              + +D +      LL  +L  +P+ R+T  +  +  ++ + 
Sbjct: 232 ---KKIDSAP---LALLHKILVENPSARITIPDIKKDRWYNKP 268

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 97.0 bits (242), Expect = 9e-23
 Identities = 81/348 (23%), Positives = 127/348 (36%), Gaps = 91/348 (26%)

Query: 85  MFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIE 142
           M  L  +    +    K+G+G+FG+V +  D   +++VAIKI+   +   E   I  EI 
Sbjct: 13  MQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEIT 72

Query: 143 VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREI 201
           VL Q            +    +     + I+ E L G S  D L            +  I
Sbjct: 73  VLSQC-DSPY----VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATI 124

Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            R++L+ + ++H    IH D+K  NVLL                                
Sbjct: 125 LREILKGLDYLHSEKKIHRDIKAANVLLSE---------------------------HGE 157

Query: 262 IKVIDFG---STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 318
           +K+ DFG     T  +  +N  V T  + APEVI    +    DIWS+G   +EL  GE 
Sbjct: 158 VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP 217

Query: 319 -LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 377
              + H       M  +VL  +P++                                   
Sbjct: 218 PHSELH------PM--KVLFLIPKN----------------------------------N 235

Query: 378 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
            P L+       ++S   L   ++  L  +P+ R TA+E L+H F  R
Sbjct: 236 PPTLEG------NYSK-PLKEFVEACLNKEPSFRPTAKELLKHKFILR 276

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 95.1 bits (237), Expect = 3e-22
 Identities = 48/253 (18%), Positives = 82/253 (32%), Gaps = 56/253 (22%)

Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--------EIEVLQQLA 148
           +   ++G+G FG V +    + K +VAIK +       E  MI        E+ ++  L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL- 80

Query: 149 KHD-----KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIA 202
            H       G                  +V E +    LY  L           +   + 
Sbjct: 81  NHPNIVKLYGL--MHN---------PPRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLM 128

Query: 203 RQLLECIAFMHDL--CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 260
             +   I +M +    ++H DL+  N+ L S +                           
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD----------------------ENAPV 166

Query: 261 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEA 318
             KV DFG +       + ++    + APE I     +Y    D +S   IL  + TGE 
Sbjct: 167 CAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226

Query: 319 LFQTHENLEHLAM 331
            F   +   +  +
Sbjct: 227 PF---DEYSYGKI 236

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 97.6 bits (243), Expect = 3e-22
 Identities = 76/342 (22%), Positives = 124/342 (36%), Gaps = 95/342 (27%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKH 150
            Y +   +G GTFG+V           VA+KI+  + I+       I  EI+ L+   +H
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RH 75

Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
                  +++       + I +V E + G  L+D++ KN          R + +Q+L  +
Sbjct: 76  P----HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGV 129

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            + H   ++H DLKPENVLL         D   +                   K+ DFG 
Sbjct: 130 DYCHRHMVVHRDLKPENVLL---------DAHMN------------------AKIADFGL 162

Query: 270 TTYERPDQNYIVSTR----HYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHE 324
           +      +   + T     +Y APEVI G  +  P  DIWS G IL  L  G   F   +
Sbjct: 163 SNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD-DD 219

Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           ++                + K+        +  G    P                     
Sbjct: 220 HV--------------PTLFKK--------ICDGIFYTP--------------------- 236

Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                 +    +  LL+ +L+ DP  R T ++   H +F +D
Sbjct: 237 -----QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 95.5 bits (238), Expect = 4e-22
 Identities = 49/244 (20%), Positives = 97/244 (39%), Gaps = 54/244 (22%)

Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD- 151
              +++   +G GT+GQV +    +  ++ AIK++       E    EI +L++ + H  
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82

Query: 152 ---------KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREI 201
                    K     +  + W        +V E     S+ D ++     +   + +  I
Sbjct: 83  IATYYGAFIKKNPPGMDDQLW--------LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134

Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            R++L  ++ +H   +IH D+K +NVLL                            +++ 
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLT---------------------------ENAE 167

Query: 262 IKVIDFG---STTYERPDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVEL 313
           +K++DFG           +N  + T ++ APEVI         + +  D+WS+G   +E+
Sbjct: 168 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

Query: 314 CTGE 317
             G 
Sbjct: 228 AEGA 231

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 95.1 bits (237), Expect = 4e-22
 Identities = 63/343 (18%), Positives = 119/343 (34%), Gaps = 93/343 (27%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDK 152
            + +   +GEG +G+V    +R  +E VA+KIV   +       I  EI + + L  H+ 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE- 65

Query: 153 GGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
             N  V+        N   +  E   G  L+D +  +     P    +    QL+  + +
Sbjct: 66  --N-VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVY 120

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-ST 270
           +H + + H D+KPEN+LL                   D            +K+ DFG +T
Sbjct: 121 LHGIGITHRDIKPENLLL-------------------DERD--------NLKISDFGLAT 153

Query: 271 TYERPDQNYIVSTR----HYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEALFQTH 323
            +   ++  +++       Y APE++      +   P D+WS G +L  +  GE  +   
Sbjct: 154 VFRYNNRERLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPWDQP 211

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
            +                          + Y       W                     
Sbjct: 212 SD--------------SCQEYSDWKE-KKTY----LNPW--------------------- 231

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
              + +D +      LL  +L  +P+ R+T  +  +  ++ + 
Sbjct: 232 ---KKIDSAP---LALLHKILVENPSARITIPDIKKDRWYNKP 268

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 94.7 bits (236), Expect = 6e-22
 Identities = 69/341 (20%), Positives = 123/341 (36%), Gaps = 92/341 (26%)

Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 152
              + +  K+GEG++G V +   +E  ++VAIK V  ++   +  + EI ++QQ      
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQEIIKEISIMQQC----- 81

Query: 153 GGNRCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
                  +  ++        + IV E     S+ D +R  N ++   D +  I +  L+ 
Sbjct: 82  ---DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKG 137

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           + ++H +  IH D+K  N+LL +                               K+ DFG
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNT---------------------------EGHAKLADFG 170

Query: 269 ST---TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA-LFQTHE 324
                T     +N ++ T  + APEVI  +G+    DIWS+G   +E+  G+      H 
Sbjct: 171 VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH- 229

Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
                 M  R +  +P                                      P  +  
Sbjct: 230 -----PM--RAIFMIPT----------------------------------NPPPTFRK- 247

Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                +  + + T  ++  L   P  R TA + L+HPF   
Sbjct: 248 ----PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 95.6 bits (238), Expect = 2e-21
 Identities = 72/332 (21%), Positives = 121/332 (36%), Gaps = 87/332 (26%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIE--VLQQLAKHDKGGNRCV 158
           G+G FG+V  C  R   +M A K +    IKK +  AM   E  +L++           V
Sbjct: 193 GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK-VNS----RFVV 247

Query: 159 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
            +   ++ ++ +C+V   + G  L   +       FP       A ++   +  +H   +
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307

Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           ++ DLKPEN+LL    +I++ D   +                     +  G T   R   
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLA-------------------VHVPEGQTIKGR--- 345

Query: 278 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAMMERVL 336
              V T  Y APEV+    +T+  D W++GC+L E+  G++ FQ   + ++   +   V 
Sbjct: 346 ---VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402

Query: 337 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 396
                                   ++ E   S ++                         
Sbjct: 403 --------------------EVPEEYSER-FSPQAR------------------------ 417

Query: 397 THLLQGLLRYDPTDRL-----TAREALRHPFF 423
             L   LL  DP +RL     +ARE   HP F
Sbjct: 418 -SLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 92.4 bits (230), Expect = 3e-21
 Identities = 57/236 (24%), Positives = 103/236 (43%), Gaps = 46/236 (19%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLA 148
            +   +Y    K+G+G  G V    D    + VAI+ +   ++ ++  +I EI V+++  
Sbjct: 16  GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN- 74

Query: 149 KHDKGGNRCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
           K+         I N+ D     + + +V E L G SL D + +       I     + R+
Sbjct: 75  KNP-------NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI---AAVCRE 124

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
            L+ + F+H   +IH D+K +N+LL                               ++K+
Sbjct: 125 CLQALEFLHSNQVIHRDIKSDNILLGM---------------------------DGSVKL 157

Query: 265 IDFGST---TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 317
            DFG     T E+  ++ +V T ++ APEV+    +    DIWS+G + +E+  GE
Sbjct: 158 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 92.4 bits (230), Expect = 4e-21
 Identities = 48/236 (20%), Positives = 97/236 (41%), Gaps = 46/236 (19%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLA 148
            +       + K+GEG+ G V    ++     VA+K++   K+ R   +  E+ +++   
Sbjct: 41  GDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY- 99

Query: 149 KHDKGGNRCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
           +H         +   +        + ++ E L G +L D + +       I     +   
Sbjct: 100 QHF-------NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI---ATVCEA 149

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +L+ +A++H   +IH D+K +++LL                                +K+
Sbjct: 150 VLQALAYLHAQGVIHRDIKSDSILLTL---------------------------DGRVKL 182

Query: 265 IDFG---STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 317
            DFG     + + P +  +V T ++ APEVI    +    DIWS+G +++E+  GE
Sbjct: 183 SDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 94.6 bits (235), Expect = 5e-21
 Identities = 66/335 (19%), Positives = 118/335 (35%), Gaps = 93/335 (27%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIE--VLQQLAKHDKGGNRC- 157
           G G FG+V  C   +  +M A+K +    IK  +   +   E  +L  ++  D     C 
Sbjct: 198 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-----CP 252

Query: 158 --VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             V +   F   + +  + + + G  L+  L ++    F    +R  A +++  +  MH+
Sbjct: 253 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHN 310

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             +++ DLKP N+LL    ++++ D   +    K                       +  
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------------------KPHAS 350

Query: 275 PDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
                 V T  Y APEV+  G+ +    D +S+GC+L +L  G + F+ H+  +   +  
Sbjct: 351 ------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 404

Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 393
             L                       ++ P                              
Sbjct: 405 MTL--------------------TMAVELP-----------------------DSFSPEL 421

Query: 394 GDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
                LL+GLL+ D   RL      A+E    PFF
Sbjct: 422 RS---LLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 67/347 (19%), Positives = 122/347 (35%), Gaps = 97/347 (27%)

Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHD 151
              ++I  ++G+G FG+V +  ++E   + A K++    +      I EIE+L     H 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHP 76

Query: 152 KGGNRCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
                   I        +   + I+ E   G ++   + + + R      ++ + RQ+LE
Sbjct: 77  -------YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLE 128

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + F+H   +IH DLK  NVL+                                I++ DF
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTL---------------------------EGDIRLADF 161

Query: 268 GST---TYERPDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEA- 318
           G +         ++  + T ++ APEV++        + Y  DIWS+G  L+E+   E  
Sbjct: 162 GVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

Query: 319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 378
             + +       M  RVL  + +                                     
Sbjct: 222 HHELN------PM--RVLLKIAKS----------------------------------DP 239

Query: 379 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
           P L           + +    L+  L  +P  R +A + L HPF + 
Sbjct: 240 PTLLT-----PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 72/348 (20%), Positives = 120/348 (34%), Gaps = 98/348 (28%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQ 145
           ++    +    ++G G+FG V    D    E+VAIK +   G +   +   I  E+  LQ
Sbjct: 50  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109

Query: 146 QLAKHDKGGNRCVQIRNWFD---YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIA 202
           +L        R      +       +   +V E    S  D L  +  +      +  + 
Sbjct: 110 KL--------RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVT 160

Query: 203 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
              L+ +A++H   MIH D+K  N+LL                                +
Sbjct: 161 HGALQGLAYLHSHNMIHRDVKAGNILLSE---------------------------PGLV 193

Query: 263 KVIDFG-STTYERPDQNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEA 318
           K+ DFG ++       N  V T ++ APEVIL +    +    D+WS+G   +EL   + 
Sbjct: 194 KLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251

Query: 319 -LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 377
            LF  +      AM    L  + Q+                                  +
Sbjct: 252 PLFNMN------AM--SALYHIAQN----------------------------------E 269

Query: 378 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
            P LQ+       H +    + +   L+  P DR T+   L+H F  R
Sbjct: 270 SPALQS------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 92.2 bits (229), Expect = 3e-20
 Identities = 62/336 (18%), Positives = 113/336 (33%), Gaps = 92/336 (27%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIE--VLQQLAKHDKGGNRCV 158
           G G FG+V  C  +   ++ A K +    +KK +      +E  +L +           V
Sbjct: 194 GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK-VHS----RFIV 248

Query: 159 QIRNWFDYRNHICIVFE-----KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
            +   F+ +  +C+V        +   +Y+    N    F          Q++  +  +H
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN--PGFQEPRAIFYTAQIVSGLEHLH 306

Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
              +I+ DLKPENVLL     +++ D                     A+++    + T  
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDL------------------GLAVELKAGQTKTKG 348

Query: 274 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAMM 332
                    T  + APE++LG  + +  D +++G  L E+      F+   E +E+  + 
Sbjct: 349 Y------AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

Query: 333 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 392
           +RVL                       + +P+   S  S                     
Sbjct: 403 QRVL--------------------EQAVTYPDK-FSPASK-------------------- 421

Query: 393 AGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
                   + LL+ DP  RL     +      HP F
Sbjct: 422 -----DFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 89.0 bits (221), Expect = 5e-20
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 8/136 (5%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
           RY++  K+G G+FG +    D    E VAIK+     K+ +  + E ++ + +    +GG
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI-ESKIYKMM----QGG 64

Query: 155 NRCVQIRNWF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
                IR W     ++  +V E LG SL D L     R F +  V  +A Q++  I ++H
Sbjct: 65  VGIPTIR-WCGAEGDYNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 214 DLCMIHTDLKPENVLL 229
               IH D+KP+N L+
Sbjct: 123 SKNFIHRDVKPDNFLM 138

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 50/230 (21%), Positives = 95/230 (41%), Gaps = 38/230 (16%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKG 153
            +   +MG GT GQV +   R+   ++A+K +R  G K+  +  +++++V+ +       
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP-- 84

Query: 154 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
               VQ    F     + I  E +G+      ++      P  ++ ++   +++ + ++ 
Sbjct: 85  --YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLK 141

Query: 214 D-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           +   +IH D+KP N+LL     IK+ D+  S           R+    A           
Sbjct: 142 EKHGVIHRDVKPSNILLDERGQIKLCDFGIS----------GRLVDDKA----------- 180

Query: 273 ERPDQNYIVSTRHYRAPEVI-----LGLGWTYPCDIWSVGCILVELCTGE 317
               ++       Y APE I         +    D+WS+G  LVEL TG+
Sbjct: 181 ----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 39/136 (28%), Positives = 65/136 (47%), Gaps = 8/136 (5%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
            +++  K+G G FG++    +    E VAIK+     +      +E    +QL      G
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-QLHLEYRFYKQL----GSG 64

Query: 155 NRCVQIRNWF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
           +   Q+  +F     +  +V E LG SL D L     R+F +  V  IA QL+  + ++H
Sbjct: 65  DGIPQVY-YFGPCGKYNAMVLELLGPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 214 DLCMIHTDLKPENVLL 229
              +I+ D+KPEN L+
Sbjct: 123 SKNLIYRDVKPENFLI 138

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 67/331 (20%), Positives = 119/331 (35%), Gaps = 93/331 (28%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 158
           G G+FG+V+    +E     A+KI+    + K ++    + E  +LQ +          V
Sbjct: 50  GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFP----FLV 104

Query: 159 QIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           ++   F   +++ +V E   G  ++  LR+     F     R  A Q++    ++H L +
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDL 162

Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           I+ DLKPEN+L+    Y                           I+V DFG     +   
Sbjct: 163 IYRDLKPENLLIDQQGY---------------------------IQVTDFGFAKRVKGRT 195

Query: 278 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 337
             +  T    APE+IL  G+    D W++G ++ E+  G   F   +    + + E+++ 
Sbjct: 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQ--PIQIYEKIV- 251

Query: 338 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 397
                               G++ +P                        H      D  
Sbjct: 252 -------------------SGKVRFP-----------------------SHFSSDLKD-- 267

Query: 398 HLLQGLLRYDPTDRL-----TAREALRHPFF 423
            LL+ LL+ D T R         +   H +F
Sbjct: 268 -LLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 62/336 (18%), Positives = 118/336 (35%), Gaps = 86/336 (25%)

Query: 100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 157
            ++G G +G V +       +++A+K +R     +E   +  ++++  +           
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP----FT 68

Query: 158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHD- 214
           V           + I  E + +SL  F ++  +  ++ P D++ +IA  +++ +  +H  
Sbjct: 69  VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
           L +IH D+KP NVL+ +   +K+ D+  S            +    A             
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGIS----------GYLVDDVA-------KDID-- 169

Query: 275 PDQNYIVSTRHYRAPEVILG----LGWTYPCDIWSVGCILVELCTGEALFQTHEN-LEHL 329
                    + Y APE I       G++   DIWS+G  ++EL      + +     + L
Sbjct: 170 ------AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL 223

Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
             +  V  P P                  +L  P    S E                   
Sbjct: 224 KQV--VEEPSP------------------QL--PADKFSAE------------------- 242

Query: 390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                         L+ +  +R T  E ++HPFFT 
Sbjct: 243 ------FVDFTSQCLKKNSKERPTYPELMQHPFFTL 272

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 58/250 (23%), Positives = 96/250 (38%), Gaps = 49/250 (19%)

Query: 97  KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDK 152
            I  K+G G+FG V    W       VA+KI+       +     + E+ ++++L +H  
Sbjct: 40  NIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHP- 94

Query: 153 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYR-SFPIDLVREIARQLLECIA 210
             N  V          ++ IV E L   SLY  L K+  R          +A  + + + 
Sbjct: 95  --N-IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151

Query: 211 FMH--DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           ++H  +  ++H +LK  N+L+                   D  Y         +KV DFG
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLV-------------------DKKY--------TVKVCDFG 184

Query: 269 STTYERPDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
            +  +        S   T  + APEV+         D++S G IL EL T +  +    N
Sbjct: 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW---GN 241

Query: 326 LEHLAMMERV 335
           L    ++  V
Sbjct: 242 LNPAQVVAAV 251

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 86.6 bits (215), Expect = 3e-19
 Identities = 72/354 (20%), Positives = 123/354 (34%), Gaps = 97/354 (27%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHD 151
             Y++   +G G    V   +   +KE VAIK +   K       +  EI+ + Q   H 
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHP 73

Query: 152 KGGNRCVQIRNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLV---REIA-- 202
                   I +++     ++ + +V + L G S+ D ++    +      V     IA  
Sbjct: 74  -------NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126

Query: 203 -RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            R++LE + ++H    IH D+K  N+LL                               +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGE---------------------------DGS 159

Query: 262 IKVIDFG-----STTYERPDQ---NYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVE 312
           +++ DFG     +T  +          V T  + APEV+    G+ +  DIWS G   +E
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219

Query: 313 LCTGEA-LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRES 371
           L TG A   +         M  +VL    Q+    ++   +      +         +  
Sbjct: 220 LATGAAPYHKYP------PM--KVLMLTLQNDPPSLETGVQDKEMLKKY-------GKS- 263

Query: 372 IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                                      ++   L+ DP  R TA E LRH FF +
Sbjct: 264 ------------------------FRKMISLCLQKDPEKRPTAAELLRHKFFQK 293

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 86.6 bits (215), Expect = 3e-19
 Identities = 36/136 (26%), Positives = 61/136 (44%), Gaps = 8/136 (5%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
            YK+  ++GEG+FG + E  +    + VAIK         +    E    + L     G 
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD-EYRTYKLL----AGC 65

Query: 155 NRCVQIRNWF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
                +  +F     H  +V + LG SL D L     R F +  V   A+Q+L  +  +H
Sbjct: 66  TGIPNVY-YFGQEGLHNVLVIDLLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 214 DLCMIHTDLKPENVLL 229
           +  +++ D+KP+N L+
Sbjct: 124 EKSLVYRDIKPDNFLI 139

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 88.1 bits (218), Expect = 5e-19
 Identities = 37/136 (27%), Positives = 69/136 (50%), Gaps = 8/136 (5%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
           ++++  K+G G+FG++    + +  E VAIK+     K+ +    E ++ + L    +GG
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY-ESKIYRIL----QGG 62

Query: 155 NRCVQIRNWF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
                +R WF    ++  +V + LG SL D L     R   +  V  +A Q++  + F+H
Sbjct: 63  TGIPNVR-WFGVEGDYNVLVMDLLGPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 214 DLCMIHTDLKPENVLL 229
               +H D+KP+N L+
Sbjct: 121 SKSFLHRDIKPDNFLM 136

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 85.4 bits (212), Expect = 7e-19
 Identities = 52/250 (20%), Positives = 94/250 (37%), Gaps = 63/250 (25%)

Query: 97  KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHD 151
            +  ++G G+FG V +  W  +    VA+K++  +       +     E+ VL++  +H 
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHGD----VAVKMLN-VTAPTPQQLQAFKNEVGVLRKT-RHV 80

Query: 152 K-----GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
                 G                + IV +   GSSLY  L  +    F +  + +IARQ 
Sbjct: 81  NILLFMGY--STA--------PQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQT 129

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
              + ++H   +IH DLK  N + +  +                            +K+ 
Sbjct: 130 ARGMDYLHAKSIIHRDLKSNN-IFLHEDNT--------------------------VKIG 162

Query: 266 DFG-----STTYERPDQNYIVSTRHYRAPEVILGLGW---TYPCDIWSVGCILVELCTGE 317
           DFG     S          +  +  + APEVI        ++  D+++ G +L EL TG+
Sbjct: 163 DFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

Query: 318 ALFQTHENLE 327
             +    N +
Sbjct: 223 LPYSNINNRD 232

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 65/343 (18%), Positives = 115/343 (33%), Gaps = 88/343 (25%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKG 153
            K   ++G G +G V +   +   +++A+K +R     +E   +  +++V+ + +     
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP-- 81

Query: 154 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRK---NNYRSFPIDLVREIARQLLECIA 210
               VQ            I  E + +S   F +          P +++ +I    ++ + 
Sbjct: 82  --YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139

Query: 211 FMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            + + L +IH D+KP N+LL                             S  IK+ DFG 
Sbjct: 140 HLKENLKIIHRDIKPSNILLDR---------------------------SGNIKLCDFGI 172

Query: 270 TTY--ERPDQNYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVELCTGEA-LFQT 322
           +    +   +      R Y APE I       G+    D+WS+G  L EL TG     + 
Sbjct: 173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232

Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 382
           +   + L  +  V G  PQ  L                +  E   S              
Sbjct: 233 NSVFDQLTQV--VKGDPPQ--LS---------------NSEEREFSPS------------ 261

Query: 383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                          + +   L  D + R   +E L+HPF   
Sbjct: 262 -------------FINFVNLCLTKDESKRPKYKELLKHPFILM 291

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 72/346 (20%), Positives = 119/346 (34%), Gaps = 92/346 (26%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 158
           G G F +V     ++  ++ A+KI+    + K  E +    E +VL              
Sbjct: 70  GRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN-GDRR----WIT 124

Query: 159 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           Q+   F   N++ +V E   G  L   L K   R  P ++ R    +++  I  +H L  
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAIDSVHRLGY 183

Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           +H D+KP+N+LL    +I++ D+ S L                  K+   G+        
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCL------------------KLRADGTVR-----S 220

Query: 278 NYIVSTRHYRAPEVILGLGWTY-------PCDIWSVGCILVELCTGEALFQTHENLEHLA 330
              V T  Y +PE++  +G           CD W++G    E+  G+  F   ++     
Sbjct: 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADSTA--E 277

Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 390
              +++                    +  L  P                       + V 
Sbjct: 278 TYGKIVH------------------YKEHLSLPLVD--------------------EGVP 299

Query: 391 HSAGDLTHLLQGLLRYDPTDRLT---AREALRHPFFTR---DHLRR 430
             A D    +Q LL   P  RL    A +   HPFF     D LR 
Sbjct: 300 EEARD---FIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRD 341

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 31/152 (20%), Positives = 63/152 (41%), Gaps = 22/152 (14%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
           ++ +  K+G G FG +   +   + E  A  +V+   +       E++  Q++AK D   
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97

Query: 155 NRCVQIRN---------WF--------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDL 197
               + +                     YR    +V E+LG  L     +N   +F    
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYR---FMVMERLGIDLQKISGQN--GTFKKST 152

Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLL 229
           V ++  ++L+ + ++H+   +H D+K  N+LL
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLL 184

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 65/333 (19%), Positives = 116/333 (34%), Gaps = 97/333 (29%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 158
           G+G+FG+V     ++  +  AIK ++   +    +    M+E  VL    +H        
Sbjct: 26  GKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP----FLT 81

Query: 159 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
            +   F  + ++  V E L G  L       +   F +      A +++  + F+H   +
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 139

Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE---R 274
           ++ DLK +N+LL    +IK+ D+               M K +    +   + T      
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFG--------------MCKEN----MLGDAKTNTFCGT 181

Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 334
           PD         Y APE++LG  + +  D WS G +L E+  G++ F   +  E   +   
Sbjct: 182 PD---------YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHS 229

Query: 335 VLG---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           +       P+ +                         +E+                    
Sbjct: 230 IRMDNPFYPRWL------------------------EKEAK------------------- 246

Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALR-HPFF 423
                  LL  L   +P  RL  R  +R HP F
Sbjct: 247 ------DLLVKLFVREPEKRLGVRGDIRQHPLF 273

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 85.8 bits (212), Expect = 4e-18
 Identities = 69/335 (20%), Positives = 117/335 (34%), Gaps = 95/335 (28%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRC 157
           +G+G+FG+V+    +   E+ A+KI++          E  M+E  VL    K        
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP----FL 404

Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
            Q+ + F   + +  V E + G  L           F        A ++   + F+    
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462

Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 276
           +I+ DLK +NV+L S  +IK+ D+               M K +    I  G TT     
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFG--------------MCKEN----IWDGVTT----- 499

Query: 277 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 336
                 T  Y APE+I    +    D W+ G +L E+  G+A F+  +  E   + + ++
Sbjct: 500 -KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIM 555

Query: 337 G---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 393
                 P+ M                        S+E++                     
Sbjct: 556 EHNVAYPKSM------------------------SKEAV--------------------- 570

Query: 394 GDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
                + +GL+   P  RL       R+   H FF
Sbjct: 571 ----AICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 85.3 bits (211), Expect = 6e-18
 Identities = 53/256 (20%), Positives = 98/256 (38%), Gaps = 59/256 (23%)

Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVR--GIKKYREAAMIEIEV 143
           G+ +  +Y++   +  G  G +    DR    R   V +K +   G  + +  AM E + 
Sbjct: 75  GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRP--VVLKGLVHSGDAEAQAMAMAERQF 132

Query: 144 LQQLAKHDKGGNRCVQIRNWFDYRNHIC-----IVFEKL-GSSLYDFLRKNNYRSFPIDL 197
           L ++  H       VQI N+ ++ +        IV E + G SL         +  P+  
Sbjct: 133 LAEV-VHP----SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG----QKLPVAE 183

Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
                 ++L  ++++H + +++ DLKPEN++L   +                        
Sbjct: 184 AIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ------------------------ 219

Query: 258 KSSAIKVIDFG---STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
               +K+ID G             Y+  T  ++APE++   G T   DI++VG  L  L 
Sbjct: 220 ----LKLIDLGAVSRIN----SFGYLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALT 270

Query: 315 TGEALFQTHENLEHLA 330
                      ++ L 
Sbjct: 271 LDLPTR-NGRYVDGLP 285

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 83.4 bits (207), Expect = 6e-18
 Identities = 64/332 (19%), Positives = 125/332 (37%), Gaps = 81/332 (24%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 158
           G G++ +VL    ++   + A+K+V+       +  +    E  V +Q + H       V
Sbjct: 18  GRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH----PFLV 73

Query: 159 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
            + + F   + +  V E + G  L         R  P +  R  + ++   + ++H+  +
Sbjct: 74  GLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 131

Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           I+ DLK +NVLL S  +IK+ DY               M K      +  G TT      
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYG--------------MCKEG----LRPGDTT------ 167

Query: 278 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 337
           +    T +Y APE++ G  + +  D W++G ++ E+  G + F    + ++         
Sbjct: 168 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE--- 224

Query: 338 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 397
               ++ + +                        ++  +++PR        +   A    
Sbjct: 225 ---DYLFQVI------------------------LEKQIRIPR-------SLSVKAAS-- 248

Query: 398 HLLQGLLRYDPTDRL------TAREALRHPFF 423
            +L+  L  DP +RL         +   HPFF
Sbjct: 249 -VLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 83.2 bits (206), Expect = 6e-18
 Identities = 52/260 (20%), Positives = 93/260 (35%), Gaps = 60/260 (23%)

Query: 97  KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDK 152
           +I   +G+G FGQV    W  E    VAI+++      +   +A   E+   +Q  +H+ 
Sbjct: 36  EIGELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQT-RHEN 90

Query: 153 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                V          H+ I+     G +LY  +R        ++  R+IA+++++ + +
Sbjct: 91  ----VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGY 145

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H   ++H DLK +NV           D                      + + DFG  +
Sbjct: 146 LHAKGILHKDLKSKNVFY---------DNGK-------------------VVITDFGLFS 177

Query: 272 YERPDQNYIVS--------TRHYRAPEVILGLGWTYP---------CDIWSVGCILVELC 314
                Q                + APE+I  L               D++++G I  EL 
Sbjct: 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237

Query: 315 TGEALFQTHENLEHLAMMER 334
             E  F+T      +  M  
Sbjct: 238 AREWPFKTQPAEAIIWQMGT 257

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 83.0 bits (206), Expect = 7e-18
 Identities = 69/340 (20%), Positives = 115/340 (33%), Gaps = 111/340 (32%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 158
           G G+FG+V     R      A+K+++   + + ++      E  +L  +  H       +
Sbjct: 15  GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THP----FII 69

Query: 159 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           ++   F     I ++ + + G  L+  LRK   + FP  + +  A ++   + ++H   +
Sbjct: 70  RMWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDI 127

Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG------STT 271
           I+ DLKPEN+LL         D     H                IK+ DFG        T
Sbjct: 128 IYRDLKPENILL---------DKNG--H----------------IKITDFGFAKYVPDVT 160

Query: 272 YER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 328
           Y     PD         Y APEV+    +    D WS G ++ E+  G   F    N   
Sbjct: 161 YTLCGTPD---------YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSN--T 208

Query: 329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 388
           +   E++L                       L +P                         
Sbjct: 209 MKTYEKIL--------------------NAELRFP-----------------------PF 225

Query: 389 VDHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
            +    D   LL  L+  D + RL        +   HP+F
Sbjct: 226 FNEDVKD---LLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 83.6 bits (207), Expect = 7e-18
 Identities = 29/157 (18%), Positives = 59/157 (37%), Gaps = 29/157 (18%)

Query: 95  RYKIHSKMGEGTFGQV--------LECWDRERKEMVAIKI-------VRGIKKY-REAAM 138
           ++K+ S       G +        L C    +K+  ++K+             + R A  
Sbjct: 43  QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102

Query: 139 IEIEVLQQLAKHDKGG-NRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRS 192
           +++   ++L          C+     F      YR    +V   LG SL   L  +    
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCM----GFGVHQDKYR---FLVLPSLGRSLQSALDVSPKHV 155

Query: 193 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLL 229
                V ++A +LL+ + F+H+   +H ++  EN+ +
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 37/255 (14%), Positives = 77/255 (30%), Gaps = 60/255 (23%)

Query: 97  KIHSKMGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHD 151
              +K+ E   G++ +  W   +   + +K+++ ++ +          E   L+    H 
Sbjct: 13  NFLTKLNENHSGELWKGRW---QGNDIVVKVLK-VRDWSTRKSRDFNEECPRLRIF-SHP 67

Query: 152 -----KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
                 G   C           H  ++   +   SLY+ L +            + A  +
Sbjct: 68  NVLPVLGA--CQS-----PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120

Query: 206 LECIAFMHDL--CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
              +AF+H L   +    L   +V++                   D             +
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMI-------------------DEDM--------TAR 153

Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYP---CDIWSVGCILVELCTGEALF 320
           +                +    + APE +            D+WS   +L EL T E  F
Sbjct: 154 ISMADVKFSF--QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211

Query: 321 QTHENLEHLAMMERV 335
               +L ++ +  +V
Sbjct: 212 ---ADLSNMEIGMKV 223

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 63/332 (18%), Positives = 125/332 (37%), Gaps = 81/332 (24%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 158
           G G++ +VL    ++   + A+++V+       +  +    E  V +Q + H       V
Sbjct: 61  GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH----PFLV 116

Query: 159 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
            + + F   + +  V E + G  L         R  P +  R  + ++   + ++H+  +
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 174

Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           I+ DLK +NVLL S  +IK+ DY               M K      +  G TT      
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYG--------------MCKEG----LRPGDTT------ 210

Query: 278 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 337
           +    T +Y APE++ G  + +  D W++G ++ E+  G + F    + ++         
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE--- 267

Query: 338 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 397
               ++ + +                        ++  +++PR        +   A    
Sbjct: 268 ---DYLFQVI------------------------LEKQIRIPR-------SLSVKAAS-- 291

Query: 398 HLLQGLLRYDPTDRL------TAREALRHPFF 423
            +L+  L  DP +RL         +   HPFF
Sbjct: 292 -VLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 43/231 (18%), Positives = 91/231 (39%), Gaps = 34/231 (14%)

Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDK--- 152
                +G+G FGQ ++   RE  E++ +K +    +  +   + E++V++ L +H     
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLK 71

Query: 153 --GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
             G     +          +  + E + G +L   ++  +   +P       A+ +   +
Sbjct: 72  FIGV--LYK-------DKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGM 121

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF---KRMPKSSAIKVID 266
           A++H + +IH DL   N L+  ++ + V D             F   + M          
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKNVVVAD-------------FGLARLMVDEKTQPEGL 168

Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 317
                 +R  +  +V   ++ APE+I G  +    D++S G +L E+    
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 69/337 (20%), Positives = 119/337 (35%), Gaps = 101/337 (29%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 158
           G+G+FG+V+    +   E+ A+KI++   + +  +    M+E  VL    K         
Sbjct: 29  GKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP----FLT 84

Query: 159 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           Q+ + F   + +  V E + G  L           F        A ++   + F+    +
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 142

Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE---R 274
           I+ DLK +NV+L S  +IK+ D+               M K +    I  G TT      
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFG--------------MCKEN----IWDGVTTKTFCGT 184

Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 334
           PD         Y APE+I    +    D W+ G +L E+  G+A F   E+ +   + + 
Sbjct: 185 PD---------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDE--LFQS 232

Query: 335 VLG---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           ++      P+ M                        S+E++                   
Sbjct: 233 IMEHNVAYPKSM------------------------SKEAV------------------- 249

Query: 392 SAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
                  + +GL+   P  RL       R+   H FF
Sbjct: 250 ------AICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 55/333 (16%), Positives = 113/333 (33%), Gaps = 93/333 (27%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRC- 157
           G+G+FG+V      + K+M A+K +      +  E      E++++Q L           
Sbjct: 24  GKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL--------EHP 75

Query: 158 --VQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
             V +   F     + +V +  LG  L   L++N    F  + V+    +L+  + ++ +
Sbjct: 76  FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQN 133

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             +IH D+KP+N+LL    ++ + D+  +                    ++   +     
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIA-------------------AMLPRETQITT- 173

Query: 275 PDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                +  T+ Y APE+     G G+++  D WS+G    EL  G   +    +     +
Sbjct: 174 -----MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI 228

Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
           +                           + +P   +                        
Sbjct: 229 VHTFE--------------------TTVVTYPSAWSQ----------------------- 245

Query: 392 SAGDLTHLLQGLLRYDPTDRL-TAREALRHPFF 423
              ++  LL+ LL  +P  R     +    P+ 
Sbjct: 246 ---EMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 80.9 bits (200), Expect = 7e-17
 Identities = 66/333 (19%), Positives = 119/333 (35%), Gaps = 89/333 (26%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 158
           G G FG+V     +  +++ A+K++    + K  ++A    E +++   A         V
Sbjct: 78  GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-ANSP----WVV 132

Query: 159 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           Q+   F    ++ +V E + G  L + +        P    R    +++  +  +H +  
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGF 189

Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           IH D+KP+N+LL  S ++K+ D+ +            +M K   ++      T    PD 
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTC----------MKMNKEGMVRCDTAVGT----PD- 234

Query: 278 NYIVSTRHYRAPEVILGLGWTYP----CDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
                   Y +PEV+   G        CD WSVG  L E+  G+  F   ++L       
Sbjct: 235 --------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLV--GTYS 283

Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 393
           +++                    +  L +P+     +  K+                   
Sbjct: 284 KIMN------------------HKNSLTFPDDNDISKEAKN------------------- 306

Query: 394 GDLTHLLQGLLRYDPTDRLT---AREALRHPFF 423
                L+   L  D   RL      E  RH FF
Sbjct: 307 -----LICAFLT-DREVRLGRNGVEEIKRHLFF 333

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 80.3 bits (199), Expect = 8e-17
 Identities = 77/336 (22%), Positives = 122/336 (36%), Gaps = 100/336 (29%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRC- 157
           G+GTFG+V+   ++      A+KI+R   I    E A  + E  VLQ          R  
Sbjct: 14  GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT--------RHP 65

Query: 158 --VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
               ++  F   + +C V E   G  L  F   +  R F  +  R    +++  + ++H 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             +++ D+K EN++L    +IK+ D+               + K      I  G+T    
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDF--------------GLCKEG----ISDGATM--- 162

Query: 275 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMM 332
                   T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  L +M
Sbjct: 163 ---KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219

Query: 333 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 392
           E +    P+ +                        S E+                     
Sbjct: 220 EEI--RFPRTL------------------------SPEAK-------------------- 233

Query: 393 AGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
                 LL GLL+ DP  RL      A+E + H FF
Sbjct: 234 -----SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 81.0 bits (200), Expect = 9e-17
 Identities = 66/344 (19%), Positives = 124/344 (36%), Gaps = 90/344 (26%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 158
           G G FG+V     +   ++ A+KI+    + K  E A    E +VL              
Sbjct: 83  GRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDSK----WIT 137

Query: 159 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
            +   F   N++ +V +   G  L   L K   R  P ++ R    +++  I  +H L  
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIAIDSVHQLHY 196

Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           +H D+KP+N+L+  + +I++ D+ S            ++ +   ++      T    PD 
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSC----------LKLMEDGTVQSSVAVGT----PD- 241

Query: 278 NYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 332
                   Y +PE++  +      +   CD WS+G  + E+  GE  F   E+L      
Sbjct: 242 --------YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESLV--ETY 290

Query: 333 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 392
            +++                    + R  +P                         V   
Sbjct: 291 GKIMN------------------HKERFQFP-----------------------TQVTDV 309

Query: 393 AGDLTHLLQGLLRYDPTDRLT---AREALRHPFFTR---DHLRR 430
           + +   L++ L+      RL      +  +HPFF+    D++R 
Sbjct: 310 SENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFSGIDWDNIRN 352

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 69/335 (20%), Positives = 117/335 (34%), Gaps = 96/335 (28%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 158
           G+G+FG+V+    +E  ++ A+K+++   I +  +    M E  +L     H        
Sbjct: 32  GKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP----FLT 87

Query: 159 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
           Q+   F   + +  V E + G  L         R F     R  A +++  + F+HD  +
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISALMFLHDKGI 145

Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           I+ DLK +NVLL    + K+ D+               M K      I  G TT      
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFG--------------MCKEG----ICNGVTT------ 181

Query: 278 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 337
                T  Y APE++  + +    D W++G +L E+  G A F+     +   + E +L 
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEAILN 238

Query: 338 ---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 394
                P  +                          ++                       
Sbjct: 239 DEVVYPTWL------------------------HEDAT---------------------- 252

Query: 395 DLTHLLQGLLRYDPTDRL------TAREALRHPFF 423
               +L+  +  +PT RL           LRHPFF
Sbjct: 253 ---GILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 35/188 (18%), Positives = 71/188 (37%), Gaps = 32/188 (17%)

Query: 69  RNGSPPWREDDKDGHYM---FALGENLT----SRYKIHSKMGEGTFGQVLECWDRERKEM 121
           R  +           ++   FA+GE +T    + +K+   +G+G FG +    D    E 
Sbjct: 3   RVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLA-DMNSSES 61

Query: 122 VAIKIVRGIKKYREAA---MIEIEVLQQLAKHDKGGNRCVQIRN---------WF----- 164
           V       +K           E++  Q+ AK ++        +                 
Sbjct: 62  VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDK 121

Query: 165 ---DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 221
               YR    ++ ++ GS L      N  + F    V +++ ++L+ + ++H+   +H D
Sbjct: 122 NGKSYR---FMIMDRFGSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGD 177

Query: 222 LKPENVLL 229
           +K  N+LL
Sbjct: 178 IKASNLLL 185

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 77/333 (23%), Positives = 122/333 (36%), Gaps = 94/333 (28%)

Query: 103 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 158
           G+G+FG+VL    +  +   A+K+++   I K +E    M E  VL +  KH       V
Sbjct: 47  GKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP----FLV 102

Query: 159 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 217
            +   F   + +  V + + G  L  F      R F     R  A ++   + ++H L +
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 160

Query: 218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 277
           ++ DLKPEN+LL S  +I + D+               + K +    I+  STT      
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFG--------------LCKEN----IEHNSTTST---- 198

Query: 278 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL- 336
                T  Y APEV+    +    D W +G +L E+  G   F +    E   M + +L 
Sbjct: 199 --FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNILN 253

Query: 337 GPL--PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 394
            PL    ++                        +  +                       
Sbjct: 254 KPLQLKPNI------------------------TNSAR---------------------- 267

Query: 395 DLTHLLQGLLRYDPTDRL----TAREALRHPFF 423
              HLL+GLL+ D T RL       E   H FF
Sbjct: 268 ---HLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 77/335 (22%), Positives = 126/335 (37%), Gaps = 95/335 (28%)

Query: 102 MGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRC 157
           +G+GTFG+V+   ++      A+KI++   I    E A  + E  VLQ  ++H       
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHP----FL 210

Query: 158 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DL 215
             ++  F   + +C V E   G  L  F   +  R F  D  R    +++  + ++H + 
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268

Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
            +++ DLK EN++L    +IK+ D+               + K      I  G+T     
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDF--------------GLCKEG----IKDGATM---- 306

Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMME 333
                  T  Y APEV+    +    D W +G ++ E+  G   F  Q HE L  L +ME
Sbjct: 307 --KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364

Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 393
            +    P+ +                          E+                      
Sbjct: 365 EI--RFPRTL------------------------GPEAK--------------------- 377

Query: 394 GDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
                LL GLL+ DP  RL      A+E ++H FF
Sbjct: 378 ----SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 65/360 (18%), Positives = 112/360 (31%), Gaps = 104/360 (28%)

Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD- 151
           +   ++      G FG V +       E VA+KI     K       E+  L  + KH+ 
Sbjct: 23  SMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHEN 79

Query: 152 ---------KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREI 201
                    +G +  V +           ++       SL DFL+ N       + +  I
Sbjct: 80  ILQFIGAEKRGTSVDVDL----------WLITAFHEKGSLSDFLKAN---VVSWNELCHI 126

Query: 202 ARQLLECIAFMHD----------LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 251
           A  +   +A++H+            + H D+K +NVLL                    ++
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL-------------------KNN 167

Query: 252 YFKRMPKSSAIKVIDFG-----STTYERPDQNYIVSTRHYRAPEVI-----LGLGWTYPC 301
                       + DFG            D +  V TR Y APEV+              
Sbjct: 168 LT--------ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRI 219

Query: 302 DIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP--QHMLKRVDRHAEKYVRRGR 359
           D++++G +L EL +           E++   E  +G  P  + M + V        ++ R
Sbjct: 220 DMYAMGLVLWELASRCTAA-DGPVDEYMLPFEEEIGQHPSLEDMQEVVVH------KKKR 272

Query: 360 LDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 419
                     +  +    +  L   I +  DH               D   RL+A     
Sbjct: 273 PVLR------DYWQKHAGMAMLCETIEECWDH---------------DAEARLSAGCVGE 311

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 66/285 (23%), Positives = 117/285 (41%), Gaps = 57/285 (20%)

Query: 97  KIHSKMGEGTFGQVLEC-WDRE---RKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 151
           K   ++G+G FG V  C +D       E+VA+K ++   +++      EIE+L+ L +HD
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 71

Query: 152 KGGNRCVQIRN--WFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
                 V+ +   +   R ++ ++ E    GS L D+L+K+  R   I L+ +   Q+ +
Sbjct: 72  N----IVKYKGVCYSAGRRNLKLIMEYLPYGS-LRDYLQKHKERIDHIKLL-QYTSQICK 125

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++     IH DL   N+ LV +E                            +K+ DF
Sbjct: 126 GMEYLGTKRYIHRDLATRNI-LVENENR--------------------------VKIGDF 158

Query: 268 GSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
           G T     D+ +              APE +    ++   D+WS G +L EL T      
Sbjct: 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--- 215

Query: 322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEG 365
             ++    A   R++G   Q  +     H  + ++   RL  P+G
Sbjct: 216 --KSKSPPAEFMRMIGNDKQGQMI--VFHLIELLKNNGRLPRPDG 256

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 76.8 bits (190), Expect = 1e-15
 Identities = 66/341 (19%), Positives = 127/341 (37%), Gaps = 106/341 (31%)

Query: 103 GEGTFGQVL---ECWDRERKEMVAIKIVRG---IKKYREAA--MIEIEVLQQLAKHDKGG 154
           G+G +G+V    +       ++ A+K+++    ++  ++ A    E  +L+++       
Sbjct: 26  GKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV------- 78

Query: 155 NRC---VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
            +    V +   F     + ++ E L G  L  F++      F  D       ++   + 
Sbjct: 79  -KHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALG 135

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
            +H   +I+ DLKPEN++L    ++K+ D+       K+S              I  G+ 
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC----KES--------------IHDGTV 177

Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
           T+          T  Y APE+++  G     D WS+G ++ ++ TG   F T EN +   
Sbjct: 178 THT------FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGENRK--K 228

Query: 331 MMERVLG---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            ++++L     LP ++                        ++E+                
Sbjct: 229 TIDKILKCKLNLPPYL------------------------TQEAR--------------- 249

Query: 388 HVDHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
                      LL+ LL+ +   RL      A E   HPFF
Sbjct: 250 ----------DLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 54/247 (21%), Positives = 97/247 (39%), Gaps = 61/247 (24%)

Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--------IKKY-REAAMI 139
           G+ +  RYKI  K+G G    V    D      VAIK +          +K++ RE    
Sbjct: 6   GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREV--- 62

Query: 140 EIEVLQQLAK--HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPID 196
                   ++  H       V + +  +  +   +V E + G +L +++  +      +D
Sbjct: 63  -----HNSSQLSH----QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVD 111

Query: 197 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 256
                  Q+L+ I   HD+ ++H D+KP+N+L                           +
Sbjct: 112 TAINFTNQILDGIKHAHDMRIVHRDIKPQNIL---------------------------I 144

Query: 257 PKSSAIKVIDFG------STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 310
             +  +K+ DFG       T+  +   N+++ T  Y +PE   G       DI+S+G +L
Sbjct: 145 DSNKTLKIFDFGIAKALSETSLTQT--NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVL 202

Query: 311 VELCTGE 317
            E+  GE
Sbjct: 203 YEMLVGE 209

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 67/285 (23%), Positives = 117/285 (41%), Gaps = 57/285 (20%)

Query: 97  KIHSKMGEGTFGQVLEC-WDRE---RKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHD 151
           K   ++G+G FG V  C +D       E+VA+K ++   +++      EIE+L+ L +HD
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 102

Query: 152 KGGNRCVQIRN--WFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
                 V+ +   +   R ++ ++ E    GS L D+L+K+  R   I L+ +   Q+ +
Sbjct: 103 N----IVKYKGVCYSAGRRNLKLIMEYLPYGS-LRDYLQKHKERIDHIKLL-QYTSQICK 156

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++     IH DL   N+ LV +E                            +K+ DF
Sbjct: 157 GMEYLGTKRYIHRDLATRNI-LVENENR--------------------------VKIGDF 189

Query: 268 GSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
           G T     D+ Y              APE +    ++   D+WS G +L EL T      
Sbjct: 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE--- 246

Query: 322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEG 365
             ++    A   R++G   Q  +     H  + ++   RL  P+G
Sbjct: 247 --KSKSPPAEFMRMIGNDKQGQMI--VFHLIELLKNNGRLPRPDG 287

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 55/302 (18%), Positives = 109/302 (36%), Gaps = 57/302 (18%)

Query: 97  KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
            +   +G+G FG+V    W   R E VA+KI    ++       EI     L +H+   N
Sbjct: 45  VLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREERSWFREAEIYQTVML-RHE---N 97

Query: 156 ----RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                    ++       + +V +     SL+D+L +    +  ++ + ++A      +A
Sbjct: 98  ILGFIAADNKD-NGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLA 153

Query: 211 FMHD--------LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
            +H           + H DLK +N+L+  +    + D   ++     +      P     
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-- 211

Query: 263 KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYP------CDIWSVGCILVELCTG 316
                             V T+ Y APEV+               DI+++G +  E+   
Sbjct: 212 ------------------VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

Query: 317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 376
            ++   HE+ +          P  + M K V        ++ R + P    S E+++ + 
Sbjct: 254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV------CEQKLRPNIPNRWQSCEALRVMA 307

Query: 377 KL 378
           K+
Sbjct: 308 KI 309

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 48/264 (18%), Positives = 82/264 (31%), Gaps = 77/264 (29%)

Query: 97  KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD---- 151
            +   +G+G +G+V    W   + E VA+KI     +       E+     L +H+    
Sbjct: 11  TLLECVGKGRYGEVWRGSW---QGENVAVKIFSSRDEKSWFRETELYNTVML-RHENILG 66

Query: 152 ------KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
                    +   Q+           ++       SLYD+L+     +        I   
Sbjct: 67  FIASDMTSRHSSTQL----------WLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLS 113

Query: 205 LLECIAFMHDL--------CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 256
           +   +A +H           + H DLK +N+L+           K +             
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV-----------KKNGQ----------- 151

Query: 257 PKSSAIKVIDFG-------STTYERPDQNYIVSTRHYRAPEVILGLGWTYP------CDI 303
                  + D G       ST       N  V T+ Y APEV+               DI
Sbjct: 152 -----CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206

Query: 304 WSVGCILVELCTGEALFQTHENLE 327
           W+ G +L E+          E+ +
Sbjct: 207 WAFGLVLWEVARRMVSNGIVEDYK 230

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 75/339 (22%), Positives = 125/339 (36%), Gaps = 104/339 (30%)

Query: 103 GEGTFGQVL---ECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNR 156
           G+G+FG+V    +    + +++ A+K+++      + R    +E ++L ++         
Sbjct: 33  GQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV--------N 84

Query: 157 C---VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
               V++   F     + ++ + L G  L  F R +    F  + V+    +L   +  +
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALALDHL 142

Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H L +I+ DLKPEN+LL    +IK+ D+  S    K+S              ID     Y
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLS----KES--------------IDHEKKAY 184

Query: 273 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 332
                     T  Y APEV+   G T   D WS G ++ E+ TG   FQ  +  E    M
Sbjct: 185 S------FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TM 235

Query: 333 ERVLG---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
             +L     +PQ +                        S E+                  
Sbjct: 236 TMILKAKLGMPQFL------------------------SPEAQ----------------- 254

Query: 390 DHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
                    LL+ L + +P +RL        E  RH FF
Sbjct: 255 --------SLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 53/254 (20%), Positives = 90/254 (35%), Gaps = 69/254 (27%)

Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--------IKKY-REAAMI 139
             +L+ RY++   +G G   +V    D      VA+K++R           ++ REA   
Sbjct: 7   PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREA--- 63

Query: 140 EIEVLQQLAK---------HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNN 189
                Q  A          +D G          +       IV E + G +L D +    
Sbjct: 64  -----QNAAALNHPAIVAVYDTGEAETPAGPLPY-------IVMEYVDGVTLRDIVHTE- 110

Query: 190 YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 249
                     E+     + + F H   +IH D+KP N++                     
Sbjct: 111 -GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIM--------------------- 148

Query: 250 SSYFKRMPKSSAIKVIDFG------STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDI 303
                 +  ++A+KV+DFG       +         ++ T  Y +PE   G       D+
Sbjct: 149 ------ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDV 202

Query: 304 WSVGCILVELCTGE 317
           +S+GC+L E+ TGE
Sbjct: 203 YSLGCVLYEVLTGE 216

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 69/338 (20%), Positives = 121/338 (35%), Gaps = 92/338 (27%)

Query: 103 GEGTFGQVL---ECWDRERKEMVAIKIVR-----GIKKYREAAMIEIEVLQQLAKHDKGG 154
           G G +G+V    +    +  ++ A+K+++        K  E    E +VL+ + +     
Sbjct: 63  GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP--- 119

Query: 155 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
              V +   F     + ++ + + G  L+  L +     F    V+    +++  +  +H
Sbjct: 120 -FLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLH 176

Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
            L +I+ D+K EN+LL S+ ++ + D+  S    K+              V D     Y+
Sbjct: 177 KLGIIYRDIKLENILLDSNGHVVLTDFGLS----KEF-------------VADETERAYD 219

Query: 274 RPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQT-HENLEHLA 330
                    T  Y AP+++ G   G     D WS+G ++ EL TG + F    E      
Sbjct: 220 ------FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 273

Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 390
           +  R+L                    +    +P                       Q + 
Sbjct: 274 ISRRIL--------------------KSEPPYP-----------------------QEMS 290

Query: 391 HSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
             A D   L+Q LL  DP  RL      A E   H FF
Sbjct: 291 ALAKD---LIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 65/361 (18%), Positives = 114/361 (31%), Gaps = 114/361 (31%)

Query: 97  KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD---- 151
           ++  ++G+G +G+V    W   R E VA+K+    ++       EI     + +H+    
Sbjct: 40  QMVKQIGKGRYGEVWMGKW---RGEKVAVKVFFTTEEASWFRETEIYQTVLM-RHENILG 95

Query: 152 ------KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQ 204
                 KG     Q+           ++ +     SLYD+L+     +     + ++A  
Sbjct: 96  FIAADIKGTGSWTQL----------YLITDYHENGSLYDYLKST---TLDAKSMLKLAYS 142

Query: 205 LLECIAFMHDL--------CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 256
            +  +  +H           + H DLK +N+L+           K +             
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV-----------KKNGT----------- 180

Query: 257 PKSSAIKVIDFG-------STTYERPDQNYIVSTRHYRAPEVILGLGWTYP------CDI 303
                  + D G        T       N  V T+ Y  PEV+               D+
Sbjct: 181 -----CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM 235

Query: 304 WSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV-----RRG 358
           +S G IL E+          E  +           LP H L   D   E        ++ 
Sbjct: 236 YSFGLILWEVARRCVSGGIVEEYQ-----------LPYHDLVPSDPSYEDMREIVCIKKL 284

Query: 359 RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 418
           R  +P   +S E       L ++  L+ +   H               +P  RLTA    
Sbjct: 285 RPSFPNRWSSDEC------LRQMGKLMTECWAH---------------NPASRLTALRVK 323

Query: 419 R 419
           +
Sbjct: 324 K 324

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 56/234 (23%), Positives = 95/234 (40%), Gaps = 49/234 (20%)

Query: 97  KIHSKMGEGTFGQVLEC-WDRE---RKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHD 151
           K  S++G+G FG V  C +D        +VA+K ++     ++     EI++L+ L   D
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSD 84

Query: 152 KGGNRCVQIRN--WFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
                 V+ R   +   R  + +V E    G  L DFL+++  R     L+   + Q+ +
Sbjct: 85  F----IVKYRGVSYGPGRQSLRLVMEYLPSGC-LRDFLQRHRARLDASRLL-LYSSQICK 138

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++     +H DL   N+ LV SE                            +K+ DF
Sbjct: 139 GMEYLGSRRCVHRDLAARNI-LVESEAH--------------------------VKIADF 171

Query: 268 GSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT 315
           G       D++Y V     +      APE +    ++   D+WS G +L EL T
Sbjct: 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 52/252 (20%), Positives = 83/252 (32%), Gaps = 75/252 (29%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--------IKKY-REAAMIEIEVLQ 145
            Y++   +G G  G V E  D  R+ +VA+K++            +  REA        +
Sbjct: 35  PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREA--------R 86

Query: 146 QLAK---------HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPI 195
              +         HD G           +    + +    + G  L   LR+        
Sbjct: 87  TAGRLQEPHVVPIHDFG-----------EIDGQLYVDMRLINGVDLAAMLRRQ--GPLAP 133

Query: 196 DLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 255
                I RQ+   +   H     H D+KPEN+L+                +  D      
Sbjct: 134 PRAVAIVRQIGSALDAAHAAGATHRDVKPENILV----------------SADD------ 171

Query: 256 MPKSSAIKVIDFG------STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI 309
                   ++DFG           +      V T +Y APE       TY  DI+++ C+
Sbjct: 172 -----FAYLVDFGIASATTDEKLTQL--GNTVGTLYYMAPERFSESHATYRADIYALTCV 224

Query: 310 LVELCTGEALFQ 321
           L E  TG   +Q
Sbjct: 225 LYECLTGSPPYQ 236

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 67/289 (23%), Positives = 109/289 (37%), Gaps = 65/289 (22%)

Query: 97  KIHSKMGEGTFGQVLEC-WDRER---KEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKH 150
           K    +GEG FG+V  C +D E     E VA+K ++      +      EIE+L+ L  H
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YH 82

Query: 151 DK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 203
           +      G   C +     D  N I ++ E    G SL ++L KN  +      + + A 
Sbjct: 83  ENIVKYKG--ICTE-----DGGNGIKLIMEFLPSG-SLKEYLPKNKNKINLKQQL-KYAV 133

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+ + + ++     +H DL   NV LV SE+                           +K
Sbjct: 134 QICKGMDYLGSRQYVHRDLAARNV-LVESEHQ--------------------------VK 166

Query: 264 VIDFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGE 317
           + DFG T     D+ Y              APE ++   +    D+WS G  L EL T  
Sbjct: 167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-- 224

Query: 318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEG 365
             +   ++      ++ +     Q  + R+       ++ G RL  P  
Sbjct: 225 --YCDSDSSPMALFLKMIGPTHGQMTVTRL----VNTLKEGKRLPCPPN 267

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 69.1 bits (168), Expect = 3e-13
 Identities = 52/259 (20%), Positives = 81/259 (31%), Gaps = 62/259 (23%)

Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---------GIKKYREAAMIEIEV 143
           T + +   K+GEG FG+V +         VAIKI+            +K  E  + EI +
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 144 LQQLAKHDKG------------GNRCVQ-------IRNWFDYRN---------------- 168
            ++L+                    CVQ       ++ W  Y +                
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 169 -HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI-HTDLKPEN 226
             I + FE  G  L     K +     +   + I  QL   +A         H DL   N
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLS----SLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192

Query: 227 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHY 286
           VLL  +   K       LH   +            + +ID+  +  ER            
Sbjct: 193 VLLKKTSLKK-------LHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDV--S 243

Query: 287 RAPEVILGLGWTYPCDIWS 305
              ++  G G  Y  DI+ 
Sbjct: 244 MDEDLFTGDG-DYQFDIYR 261

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 69.0 bits (169), Expect = 7e-13
 Identities = 49/249 (19%), Positives = 98/249 (39%), Gaps = 42/249 (16%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK- 152
           +   +  K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH   
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNL 278

Query: 153 ----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
               G   C +            I+ E    G+ L D+LR+ N +     ++  +A Q+ 
Sbjct: 279 VQLLG--VCTR-------EPPFYIITEFMTYGN-LLDYLRECNRQEVSAVVLLYMATQIS 328

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             + ++     IH +L   N L+  +  +KV D+  S       +Y         IK   
Sbjct: 329 SAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIK--- 384

Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN 325
                              + APE +    ++   D+W+ G +L E+ T G + +   + 
Sbjct: 385 -------------------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425

Query: 326 LEHLAMMER 334
            +   ++E+
Sbjct: 426 SQVYELLEK 434

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 65/349 (18%), Positives = 112/349 (32%), Gaps = 79/349 (22%)

Query: 97  KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           K+   +G G +G V +       +  VA+K+     +        I  +  + +HD   N
Sbjct: 16  KLLELIGRGRYGAVYKGSL---DERPVAVKVFSFANRQNFINEKNIYRVPLM-EHD---N 68

Query: 156 --RCV--QIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
             R +    R   D R    +V E    GS L  +L  +   +        +A  +   +
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGS-LXKYLSLH---TSDWVSSCRLAHSVTRGL 124

Query: 210 AFMHD---------LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 260
           A++H            + H DL   NVL+ +     + D+  S+    +         ++
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184

Query: 261 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-------GWTYPCDIWSVGCILVEL 313
           A                   V T  Y APEV+ G              D++++G I  E+
Sbjct: 185 A----------------ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

Query: 314 CTGEALFQTHENLEHLAM-MERVLGPLP--QHMLKRVDRHAEKYVRRGRLDWPEGAASRE 370
                     E++    M  +  +G  P  + M   V R       + R  +PE      
Sbjct: 229 FMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSR------EKQRPKFPEAWKENS 282

Query: 371 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 419
                + +  L+  I    D                D   RLTA+ A  
Sbjct: 283 -----LAVRSLKETIEDCWDQ---------------DAEARLTAQXAEE 311

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 51/261 (19%), Positives = 96/261 (36%), Gaps = 61/261 (23%)

Query: 97  KIHSKMGEGTFGQVLE-------CWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLA 148
             +  +G+GTF ++ +        + +  +  V +K++    + Y E+      ++ +L 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL- 69

Query: 149 KHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREI 201
            H       G   CV         +   +V E  K GS L  +L+KN      +  + E+
Sbjct: 70  SHKHLVLNYG--VCVC-------GDENILVQEFVKFGS-LDTYLKKNKNCINILWKL-EV 118

Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
           A+QL   + F+ +  +IH ++  +N+LL+  E  K  +                      
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGN-------------------PPF 159

Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYR------APEVIL-GLGWTYPCDIWSVGCILVELC 314
           IK+ D G +         ++     +       PE I          D WS G  L E+C
Sbjct: 160 IKLSDPGIS---I----TVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212

Query: 315 T-GEALFQTHENLEHLAMMER 334
           + G+      ++   L   E 
Sbjct: 213 SGGDKPLSALDSQRKLQFYED 233

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 66.1 bits (162), Expect = 3e-12
 Identities = 53/251 (21%), Positives = 99/251 (39%), Gaps = 56/251 (22%)

Query: 101 KMGEGTFGQVLE-CWDRERKEM-VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNR 156
           ++G G FG V +  +   +K++ VAIK+++    K   E  M E +++ QL  +      
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPY---- 71

Query: 157 CVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
            V++             + +V E    G  L+ FL          ++  E+  Q+   + 
Sbjct: 72  IVRL-----IGVCQAEALMLVMEMAGGGP-LHKFLVGKREEIPVSNVA-ELLHQVSMGMK 124

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++ +   +H DL   NVLLV+  Y K+                            DFG +
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYAKIS---------------------------DFGLS 157

Query: 271 TYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 323
                D +Y  +    +      APE I    ++   D+WS G  + E  + G+  ++  
Sbjct: 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217

Query: 324 ENLEHLAMMER 334
           +  E +A +E+
Sbjct: 218 KGPEVMAFIEQ 228

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 65.4 bits (160), Expect = 6e-12
 Identities = 67/289 (23%), Positives = 107/289 (37%), Gaps = 67/289 (23%)

Query: 97  KIHSKMGEGTFGQVLEC-WDRE---RKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKH 150
           K    +GEG FG+V    +D       EMVA+K ++     ++R     EI++L+ L  H
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YH 92

Query: 151 DK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 203
           +      G   C            + +V E   LG SL D+L +++       L+   A+
Sbjct: 93  EHIIKYKG--CCED-----AGAASLQLVMEYVPLG-SLRDYLPRHSIG--LAQLL-LFAQ 141

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+ E +A++H    IH DL   NV L+ ++ +                          +K
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNV-LLDNDRL--------------------------VK 174

Query: 264 VIDFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGE 317
           + DFG          Y              APE +    + Y  D+WS G  L EL T  
Sbjct: 175 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-- 232

Query: 318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEG 365
                         +E +     Q  + R+     + + RG RL  P+ 
Sbjct: 233 --HCDSSQSPPTKFLELIGIAQGQMTVLRL----TELLERGERLPRPDK 275

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 51/254 (20%), Positives = 98/254 (38%), Gaps = 52/254 (20%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK- 152
           +   +  K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH   
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNL 71

Query: 153 ----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
               G   C +            I+ E    G +L D+LR+ N +     ++  +A Q+ 
Sbjct: 72  VQLLG--VCTR-------EPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQIS 121

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             + ++     IH DL   N  LV   ++                          +KV D
Sbjct: 122 SAMEYLEKKNFIHRDLAARNC-LVGENHL--------------------------VKVAD 154

Query: 267 FGSTTYERPDQNYIVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF 320
           FG +     D  Y           + APE +    ++   D+W+ G +L E+ T G + +
Sbjct: 155 FGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

Query: 321 QTHENLEHLAMMER 334
              +  +   ++E+
Sbjct: 214 PGIDLSQVYELLEK 227

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 66/249 (26%), Positives = 109/249 (43%), Gaps = 44/249 (17%)

Query: 94  SRYKIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 152
              ++  K+G+G FG+V    W+   +  VAIK ++      EA + E +V+++L +H+K
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK 240

Query: 153 GGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
                VQ+     Y       I IV E    GS L DFL+    +   +  + ++A Q+ 
Sbjct: 241 ----LVQL-----YAVVSEEPIYIVTEYMSKGS-LLDFLKGETGKYLRLPQLVDMAAQIA 290

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             +A++  +  +H DL+  N+L+  +   KV D+  +    +D+ Y  R      IK   
Sbjct: 291 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIK--- 346

Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN 325
                              + APE  L   +T   D+WS G +L EL T G   +    N
Sbjct: 347 -------------------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387

Query: 326 LEHLAMMER 334
            E L  +ER
Sbjct: 388 REVLDQVER 396

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 57/252 (22%), Positives = 104/252 (41%), Gaps = 58/252 (23%)

Query: 101 KMGEGTFGQVLE-CWDRERKEM-VAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++G G FG V +  +  ++    VA+KI++        ++  + E  V+QQL  +     
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPY--- 79

Query: 156 RCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
             V++               +V E  +LG  L  +L++N  R      + E+  Q+   +
Sbjct: 80  -IVRM-----IGICEAESWMLVMEMAELGP-LNKYLQQN--RHVKDKNIIELVHQVSMGM 130

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            ++ +   +H DL   NVLLV+  Y K+                            DFG 
Sbjct: 131 KYLEESNFVHRDLAARNVLLVTQHYAKIS---------------------------DFGL 163

Query: 270 TTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 322
           +   R D+NY  +  H +      APE I    ++   D+WS G ++ E  + G+  ++ 
Sbjct: 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223

Query: 323 HENLEHLAMMER 334
            +  E  AM+E+
Sbjct: 224 MKGSEVTAMLEK 235

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 66/249 (26%), Positives = 109/249 (43%), Gaps = 44/249 (17%)

Query: 94  SRYKIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 152
              ++  K+G+G FG+V    W+   +  VAIK ++      EA + E +V+++L +H+K
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK 323

Query: 153 GGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
                VQ+     Y       I IV E    GS L DFL+    +   +  + ++A Q+ 
Sbjct: 324 ----LVQL-----YAVVSEEPIYIVTEYMSKGS-LLDFLKGETGKYLRLPQLVDMAAQIA 373

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             +A++  +  +H DL+  N+L+  +   KV D+  +    +D+ Y  R      IK   
Sbjct: 374 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIK--- 429

Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN 325
                              + APE  L   +T   D+WS G +L EL T G   +    N
Sbjct: 430 -------------------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470

Query: 326 LEHLAMMER 334
            E L  +ER
Sbjct: 471 REVLDQVER 479

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 63/246 (25%), Positives = 105/246 (42%), Gaps = 44/246 (17%)

Query: 97  KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
           K+  K+G G FG+V    +++  K  VA+K ++      EA + E  V++ L +HD    
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTL-QHD---- 243

Query: 156 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
           + V++      +  I I+ E +   SL DFL+ +     P+  + + + Q+ E +AF+  
Sbjct: 244 KLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
              IH DL+  N+ LVS+  +                           K+ DFG      
Sbjct: 303 RNYIHRDLRAANI-LVSASLV--------------------------CKIADFGLARVIE 335

Query: 275 PDQNYIVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 328
            D  Y           + APE I    +T   D+WS G +L+E+ T G   +    N E 
Sbjct: 336 -DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV 394

Query: 329 LAMMER 334
           +  +ER
Sbjct: 395 IRALER 400

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 55/265 (20%), Positives = 100/265 (37%), Gaps = 59/265 (22%)

Query: 97  KIHSKMGEGTFGQVLE-CWDRERKEM--VAIKIVR----GIKKYREAAMIEIEVLQQLAK 149
           ++  K+G+G+FG V    WD    +   VA+K ++       +  +  + E+  +  L  
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-D 79

Query: 150 HDKGGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIAR 203
           H       +++     Y       + +V E   LGS L D LRK+        L    A 
Sbjct: 80  HRN----LIRL-----YGVVLTPPMKMVTELAPLGS-LLDRLRKHQGHFLLGTLS-RYAV 128

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
           Q+ E + ++     IH DL   N+LL + + +K+                          
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIG------------------------- 163

Query: 264 VIDFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-G 316
             DFG       + ++ V   H +      APE +    +++  D W  G  L E+ T G
Sbjct: 164 --DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 221

Query: 317 EALFQTHENLEHLAMMERVLGPLPQ 341
           +  +      + L  +++    LP+
Sbjct: 222 QEPWIGLNGSQILHKIDKEGERLPR 246

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 61.8 bits (151), Expect = 5e-11
 Identities = 63/254 (24%), Positives = 105/254 (41%), Gaps = 54/254 (21%)

Query: 94  SRYKIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK 152
              K+  ++G G FG+V    ++   K  VA+K ++      +A + E  +++QL +H +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQL-QHQR 69

Query: 153 GGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
                V++     Y    +  I I+ E  + GS L DFL+  +     I+ + ++A Q+ 
Sbjct: 70  ----LVRL-----YAVVTQEPIYIITEYMENGS-LVDFLKTPSGIKLTINKLLDMAAQIA 119

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
           E +AF+ +   IH DL+  N+ LVS                               K+ D
Sbjct: 120 EGMAFIEERNYIHRDLRAANI-LVSDTLS--------------------------CKIAD 152

Query: 267 FGSTTYERPDQNYIVSTRH---YR--APEVILGLGWTYPCDIWSVGCILVELCT-GEALF 320
           FG       D  Y          +  APE I    +T   D+WS G +L E+ T G   +
Sbjct: 153 FGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

Query: 321 QTHENLEHLAMMER 334
               N E +  +ER
Sbjct: 212 PGMTNPEVIQNLER 225

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 52/251 (20%), Positives = 99/251 (39%), Gaps = 56/251 (22%)

Query: 101 KMGEGTFGQVLE-CWDRERKEM-VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNR 156
           ++G G FG V +  +   +K++ VAIK+++    K   E  M E +++ QL  +      
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPY---- 397

Query: 157 CVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
            V++             + +V E    G  L+ FL          ++  E+  Q+   + 
Sbjct: 398 IVRL-----IGVCQAEALMLVMEMAGGGP-LHKFLVGKREEIPVSNVA-ELLHQVSMGMK 450

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++ +   +H +L   NVLLV+  Y K+                            DFG +
Sbjct: 451 YLEEKNFVHRNLAARNVLLVNRHYAKIS---------------------------DFGLS 483

Query: 271 TYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 323
                D +Y  +    +      APE I    ++   D+WS G  + E  + G+  ++  
Sbjct: 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543

Query: 324 ENLEHLAMMER 334
           +  E +A +E+
Sbjct: 544 KGPEVMAFIEQ 554

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 57/257 (22%), Positives = 95/257 (36%), Gaps = 58/257 (22%)

Query: 97  KIHSKMGEGTFGQVLE-CW--DRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHD 151
            I   +G G  G+V         +R   VAIK ++    ++ R   + E  ++ Q   H 
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHP 110

Query: 152 K-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQ 204
                 G     +            IV E  + GS L  FLR ++ +   + LV  + R 
Sbjct: 111 NIIRLEG--VVTR-------GRLAMIVTEYMENGS-LDTFLRTHDGQFTIMQLV-GMLRG 159

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +   + ++ DL  +H DL   NV LV S  +                           KV
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNV-LVDSNLV--------------------------CKV 192

Query: 265 IDFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GE 317
            DFG +     D +   +T   +      APE I    ++   D+WS G ++ E+   GE
Sbjct: 193 SDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE 252

Query: 318 ALFQTHENLEHLAMMER 334
             +    N + ++ +E 
Sbjct: 253 RPYWNMTNRDVISSVEE 269

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 63/247 (25%), Positives = 99/247 (40%), Gaps = 46/247 (18%)

Query: 97  KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
               ++G G FG V    W  + K  VAIK +R      E  + E EV+ +L  H K   
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDK--VAIKTIREGAMSEEDFIEEAEVMMKL-SHPK--- 64

Query: 156 RCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
             VQ+      +  IC+V E  + G  L D+LR          L+  +   + E +A++ 
Sbjct: 65  -LVQLYGVCLEQAPICLVTEFMEHGC-LSDYLRTQRGLFAAETLL-GMCLDVCEGMAYLE 121

Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
           + C+IH DL   N  LV    +                          IKV DFG T + 
Sbjct: 122 EACVIHRDLAARNC-LVGENQV--------------------------IKVSDFGMTRFV 154

Query: 274 RPDQNYIVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 327
             D  Y  ST       + +PEV     ++   D+WS G ++ E+ + G+  ++   N E
Sbjct: 155 -LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

Query: 328 HLAMMER 334
            +  +  
Sbjct: 214 VVEDIST 220

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 56/247 (22%), Positives = 95/247 (38%), Gaps = 46/247 (18%)

Query: 97  KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
            +  ++G G FG V    W  +    VA+K+++      +    E + + +L  H K   
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYD--VAVKMIKEGSMSEDEFFQEAQTMMKL-SHPK--- 64

Query: 156 RCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
             V+          I IV E    G  L ++LR +     P  L+ E+   + E +AF+ 
Sbjct: 65  -LVKFYGVCSKEYPIYIVTEYISNGC-LLNYLRSHGKGLEPSQLL-EMCYDVCEGMAFLE 121

Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
               IH DL   N  LV  +                            +KV DFG T Y 
Sbjct: 122 SHQFIHRDLAARNC-LVDRDLC--------------------------VKVSDFGMTRYV 154

Query: 274 RPDQNYIVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 327
             D  Y+ S        + APEV     ++   D+W+ G ++ E+ + G+  +  + N E
Sbjct: 155 L-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213

Query: 328 HLAMMER 334
            +  + +
Sbjct: 214 VVLKVSQ 220

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 57/255 (22%), Positives = 101/255 (39%), Gaps = 48/255 (18%)

Query: 94  SRYKIHSKMGEGTFGQVLE-CW--DRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLA 148
           +   I   +G G FG+V         +++  VAIK ++    +K R   + E  ++ Q  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF- 103

Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
            H       +++         + IV E  + GS L  FLRK++ +   I LV  + R + 
Sbjct: 104 DHPN----IIRLEGVVTKSKPVMIVTEYMENGS-LDSFLRKHDAQFTVIQLV-GMLRGIA 157

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             + ++ D+  +H DL   N+ L++S  +                           KV D
Sbjct: 158 SGMKYLSDMGYVHRDLAARNI-LINSNLV--------------------------CKVSD 190

Query: 267 FGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEAL 319
           FG       D     +TR  +      +PE I    +T   D+WS G +L E+ + GE  
Sbjct: 191 FGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

Query: 320 FQTHENLEHLAMMER 334
           +    N + +  ++ 
Sbjct: 251 YWEMSNQDVIKAVDE 265

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 60.3 bits (147), Expect = 4e-10
 Identities = 53/254 (20%), Positives = 91/254 (35%), Gaps = 56/254 (22%)

Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGG 154
            +  ++G G FG+V     R    +VA+K  R       +   + E  +L+Q   H    
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPN-- 173

Query: 155 NRCVQIRNWFDY-----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
              V++           +  I IV E  + G     FLR    R     L+ ++      
Sbjct: 174 --IVRL-----IGVCTQKQPIYIVMELVQGG-DFLTFLRTEGARLRVKTLL-QMVGDAAA 224

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++   C IH DL   N  LV+ + +                          +K+ DF
Sbjct: 225 GMEYLESKCCIHRDLAARNC-LVTEKNV--------------------------LKISDF 257

Query: 268 GSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALF 320
           G +  E  D  Y  S    +      APE +    ++   D+WS G +L E  + G + +
Sbjct: 258 GMSREEA-DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316

Query: 321 QTHENLEHLAMMER 334
               N +    +E+
Sbjct: 317 PNLSNQQTREFVEK 330

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 59.6 bits (145), Expect = 5e-10
 Identities = 49/255 (19%), Positives = 101/255 (39%), Gaps = 55/255 (21%)

Query: 97  KIHSKMGEGTFGQVLEC-WDRERKEM---VAIKIVRG--IKKYREAAMIEIEVLQQLAKH 150
           K    +G G FG V +  W  E +++   VAIK +R     K  +  + E  V+  +  +
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DN 76

Query: 151 DKGGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQ 204
                   ++           + + ++ +    G  L D++R++        L+     Q
Sbjct: 77  PH----VCRL-----LGICLTSTVQLITQLMPFGC-LLDYVREHKDNIGSQYLL-NWCVQ 125

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK----RMPKSS 260
           + + + ++ D  ++H DL   NVL+ + +++K+ D+  +     +   +     ++P   
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--- 182

Query: 261 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 319
            IK                      + A E IL   +T+  D+WS G  + EL T G   
Sbjct: 183 -IK----------------------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

Query: 320 FQTHENLEHLAMMER 334
           +      E  +++E+
Sbjct: 220 YDGIPASEISSILEK 234

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 58.4 bits (142), Expect = 8e-10
 Identities = 54/247 (21%), Positives = 101/247 (40%), Gaps = 46/247 (18%)

Query: 97  KIHSKMGEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
               ++G G FG V    W  +    VAIK+++      +  + E +V+  L  H+K   
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSEDEFIEEAKVMMNL-SHEK--- 80

Query: 156 RCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
             VQ+      +  I I+ E    G  L ++LR+  +R     L+ E+ + + E + ++ 
Sbjct: 81  -LVQLYGVCTKQRPIFIITEYMANGC-LLNYLREMRHRFQTQQLL-EMCKDVCEAMEYLE 137

Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
               +H DL   N  LV+ + +                          +KV DFG + Y 
Sbjct: 138 SKQFLHRDLAARNC-LVNDQGV--------------------------VKVSDFGLSRYV 170

Query: 274 RPDQNYIVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 327
             D+ Y  S        +  PEV++   ++   DIW+ G ++ E+ + G+  ++   N E
Sbjct: 171 LDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229

Query: 328 HLAMMER 334
               + +
Sbjct: 230 TAEHIAQ 236

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 55/261 (21%), Positives = 97/261 (37%), Gaps = 59/261 (22%)

Query: 94  SRYKIHSKMGEGTFGQVLE-CW---DRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQL 147
           S       +G G FG+V +        +++  VAIK ++    +K R   + E  ++ Q 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 148 AKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVRE 200
             H       G     +          + I+ E  + G+ L  FLR+ +     + LV  
Sbjct: 104 -SHHNIIRLEG--VISK-------YKPMMIITEYMENGA-LDKFLREKDGEFSVLQLV-G 151

Query: 201 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 260
           + R +   + ++ ++  +H DL   N+ LV+S  +                         
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNI-LVNSNLV------------------------- 185

Query: 261 AIKVIDFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELC 314
             KV DFG +     D     +T   +      APE I    +T   D+WS G ++ E+ 
Sbjct: 186 -CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM 244

Query: 315 T-GEALFQTHENLEHLAMMER 334
           T GE  +    N E +  +  
Sbjct: 245 TYGERPYWELSNHEVMKAIND 265

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 53/258 (20%), Positives = 98/258 (37%), Gaps = 55/258 (21%)

Query: 94  SRYKIHSKMGEGTFGQVLEC-WDRERKEM---VAIKIVRGI--KKYREAAMIEIEVLQQL 147
           +  +    +G G FG V +  W  E + +   V IK++     ++  +A    +  +  L
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72

Query: 148 AKHDKGGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREI 201
             H       V++           + + +V +   LGS L D +R++     P  L+   
Sbjct: 73  -DHAH----IVRL-----LGLCPGSSLQLVTQYLPLGS-LLDHVRQHRGALGPQLLL-NW 120

Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK----RMP 257
             Q+ + + ++ +  M+H +L   NVLL S   ++V D+  +   P D         + P
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180

Query: 258 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-G 316
               IK                      + A E I    +T+  D+WS G  + EL T G
Sbjct: 181 ----IK----------------------WMALESIHFGKYTHQSDVWSYGVTVWELMTFG 214

Query: 317 EALFQTHENLEHLAMMER 334
              +      E   ++E+
Sbjct: 215 AEPYAGLRLAEVPDLLEK 232

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 54.9 bits (133), Expect = 1e-08
 Identities = 59/250 (23%), Positives = 98/250 (39%), Gaps = 47/250 (18%)

Query: 97  KIHSKMGEGTFGQVLE-CWDRERKE--MVAIKIVRG--IKKYREAAMIEIEVLQQLAKHD 151
           ++   +GEG FG V +  +         VAIK  +       RE  + E   ++Q   H 
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHP 76

Query: 152 KGGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQL 205
                 V++           N + I+ E   LG  L  FL+   Y      L+   A QL
Sbjct: 77  H----IVKL-----IGVITENPVWIIMELCTLGE-LRSFLQVRKYSLDLASLI-LYAYQL 125

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
              +A++     +H D+   NVL+ S++ +K+ D+  S +  +DS+Y+K       IK  
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIK-- 182

Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE 324
                               + APE I    +T   D+W  G  + E+   G   FQ  +
Sbjct: 183 --------------------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222

Query: 325 NLEHLAMMER 334
           N + +  +E 
Sbjct: 223 NNDVIGRIEN 232

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 31/254 (12%), Positives = 54/254 (21%), Gaps = 65/254 (25%)

Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQL 147
              RY++    G     Q  +  D      VA+  V           +  +     L ++
Sbjct: 29  ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88

Query: 148 AKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLL 206
                      ++ +    R    +V E + G SL +          P+  +R   + L 
Sbjct: 89  D-KP----GVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT---SPSPVGAIR-AMQSLA 139

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
                 H   +  +   P  V +                                + +  
Sbjct: 140 AAADAAHRAGVALSIDHPSRVRVSI---------------------------DGDVVLAY 172

Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
                                              DI  +G  L  L             
Sbjct: 173 PA-----------------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVR 208

Query: 327 EHLAMMERVLGPLP 340
             LA  ER     P
Sbjct: 209 SGLAPAERDTAGQP 222

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 49/255 (19%), Positives = 101/255 (39%), Gaps = 55/255 (21%)

Query: 97  KIHSKMGEGTFGQVLEC-WDRERKEM---VAIKIVRG--IKKYREAAMIEIEVLQQLAKH 150
           K    +G G FG V +  W  E +++   VAIK +R     K  +  + E  V+  +  +
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DN 76

Query: 151 DKGGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQ 204
                   ++           + + ++ +    G  L D++R++        L+     Q
Sbjct: 77  PH----VCRL-----LGICLTSTVQLITQLMPFGC-LLDYVREHKDNIGSQYLL-NWCVQ 125

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK----RMPKSS 260
           + + + ++ D  ++H DL   NVL+ + +++K+ D+  +     +   +     ++P   
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--- 182

Query: 261 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 319
            IK                      + A E IL   +T+  D+WS G  + EL T G   
Sbjct: 183 -IK----------------------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

Query: 320 FQTHENLEHLAMMER 334
           +      E  +++E+
Sbjct: 220 YDGIPASEISSILEK 234

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 53.7 bits (130), Expect = 3e-08
 Identities = 52/256 (20%), Positives = 97/256 (37%), Gaps = 59/256 (23%)

Query: 97  KIHSKMGEGTFGQVLE-CW--DRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHD 151
            ++  +GEG FG+V E  +   +  K  VA+K  +       +E  M E  +++ L  H 
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHP 73

Query: 152 KGGNRCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQL 205
                 V++               I+ E    G  L  +L +N      + LV   + Q+
Sbjct: 74  H----IVKL-----IGIIEEEPTWIIMELYPYGE-LGHYLERNKNSLKVLTLV-LYSLQI 122

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
            + +A++  +  +H D+   N+ LV+S                             +K+ 
Sbjct: 123 CKAMAYLESINCVHRDIAVRNI-LVASPEC--------------------------VKLG 155

Query: 266 DFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEA 318
           DFG + Y   +  Y       R      +PE I    +T   D+W     + E+ + G+ 
Sbjct: 156 DFGLSRYIEDEDYY--KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

Query: 319 LFQTHENLEHLAMMER 334
            F   EN + + ++E+
Sbjct: 214 PFFWLENKDVIGVLEK 229

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 39/153 (25%), Positives = 63/153 (41%), Gaps = 20/153 (13%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK- 152
              K+   +G+G FG V+    R  K  VA+K ++      +A + E  V+ QL +H   
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-AQAFLAEASVMTQL-RHSNL 248

Query: 153 ----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
               G    V+       +  + IV E    GS L D+LR         D + + +  + 
Sbjct: 249 VQLLG--VIVE------EKGGLYIVTEYMAKGS-LVDYLRSRGRSVLGGDCLLKFSLDVC 299

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 239
           E + ++     +H DL   NVL+      KV D
Sbjct: 300 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 332

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 53.3 bits (128), Expect = 8e-08
 Identities = 58/251 (23%), Positives = 97/251 (38%), Gaps = 49/251 (19%)

Query: 97  KIHSKMGEGTFGQVLE-CW--DRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHD 151
           ++   +GEG FG V +  +         VAIK  +       RE  + E   ++Q   H 
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHP 451

Query: 152 K-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQ 204
                 G     +        N + I+ E   LG  L  FL+   +      L+   A Q
Sbjct: 452 HIVKLIG--VITE--------NPVWIIMELCTLGE-LRSFLQVRKFSLDLASLI-LYAYQ 499

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           L   +A++     +H D+   NVL+ S++ +K+ D+  S +  +DS+Y+K       IK 
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIK- 557

Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 323
                                + APE I    +T   D+W  G  + E+   G   FQ  
Sbjct: 558 ---------------------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596

Query: 324 ENLEHLAMMER 334
           +N + +  +E 
Sbjct: 597 KNNDVIGRIEN 607

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 60/253 (23%), Positives = 89/253 (35%), Gaps = 72/253 (28%)

Query: 94  SRYKIHSKMGEGTFGQVLEC-WDRERKEM-VAIKIVRGI--KKYREAAMIEIEVLQQLAK 149
           +  K    +GEG FGQVL+    ++   M  AIK ++    K        E+EVL +L  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 150 HDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIA 202
           H       G   C         R ++ +  E    G +L DFLRK+             +
Sbjct: 85  HPNIINLLG--ACEH-------RGYLYLAIEYAPHG-NLLDFLRKSRVLETDPAFAIANS 134

Query: 203 -------RQLLEC---IA----FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 248
                  +QLL     +A    ++     IH DL   N+ LV   Y+             
Sbjct: 135 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI-LVGENYV------------- 180

Query: 249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCD 302
                         K+ DFG +   R  Q   V     R      A E +    +T   D
Sbjct: 181 -------------AKIADFGLS---R-GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSD 223

Query: 303 IWSVGCILVELCT 315
           +WS G +L E+ +
Sbjct: 224 VWSYGVLLWEIVS 236

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 51.4 bits (124), Expect = 2e-07
 Identities = 54/254 (21%), Positives = 93/254 (36%), Gaps = 58/254 (22%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK- 152
              K+   +G+G FG V+    R  K  VA+K ++      +A + E  V+ QL +H   
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHSNL 76

Query: 153 ----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
               G    +      + +  + IV E    GS L D+LR         D + + +  + 
Sbjct: 77  VQLLG---VI-----VEEKGGLYIVTEYMAKGS-LVDYLRSRGRSVLGGDCLLKFSLDVC 127

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
           E + ++     +H DL   NV LVS + +                           KV D
Sbjct: 128 EAMEYLEGNNFVHRDLAARNV-LVSEDNV--------------------------AKVSD 160

Query: 267 FGSTTYERPDQNYIVSTRH---YR--APEVILGLGWTYPCDIWSVGCILVELCT-GEALF 320
           FG T                   +  APE +    ++   D+WS G +L E+ + G   +
Sbjct: 161 FGLTKEA-----SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215

Query: 321 QTHENLEHLAMMER 334
                 + +  +E+
Sbjct: 216 PRIPLKDVVPRVEK 229

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 54/257 (21%), Positives = 80/257 (31%), Gaps = 72/257 (28%)

Query: 94  SRYKIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQ 146
           +R      +G G FG+V+E         +    VA+K+++      E    M E++VL  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 147 LAKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVR 199
           L  H       G   C              ++ E    G  L +FLR+            
Sbjct: 83  LGNHMNIVNLLG--ACTI-------GGPTLVITEYCCYG-DLLNFLRRKRDSFICSKTSP 132

Query: 200 EIARQLLECIAFMHDLCM----------------IHTDLKPENVLLVSSEYIKVPDYKSS 243
            I       +     L                  IH DL   N+ L++   I        
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI-LLTHGRI-------- 183

Query: 244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR-----APEVILGLGWT 298
                              K+ DFG     + D NY+V           APE I    +T
Sbjct: 184 ------------------TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 225

Query: 299 YPCDIWSVGCILVELCT 315
           +  D+WS G  L EL +
Sbjct: 226 FESDVWSYGIFLWELFS 242

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 61/305 (20%), Positives = 107/305 (35%), Gaps = 90/305 (29%)

Query: 94  SRYKIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQ 146
           +  +    +G G FG+V+E         +    VA+K+++       +EA M E++++  
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 147 LAKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKN--NYRSFPIDL 197
           L +H+      G   C            + ++ E    G  L +FLR+      + P   
Sbjct: 106 LGQHENIVNLLGA--CTH-------GGPVLVITEYCCYG-DLLNFLRRKSRVLETDPAFA 155

Query: 198 VREIARQLLECIAFMHDLC--M--------IHTDLKPENVLLVSSEYIKVPDYKSSLHTP 247
           +        + + F   +   M        IH D+   NV L+++ ++            
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV-LLTNGHV------------ 202

Query: 248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWTYPCD 302
                          K+ DFG       D NYIV         + APE I    +T   D
Sbjct: 203 --------------AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSD 248

Query: 303 IWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLD 361
           +WS G +L E+ +             L +      P P  +   V+    K V+ G ++ 
Sbjct: 249 VWSYGILLWEIFS-------------LGLN-----PYPGIL---VNSKFYKLVKDGYQMA 287

Query: 362 WPEGA 366
            P  A
Sbjct: 288 QPAFA 292

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258

 Score = 47.4 bits (112), Expect = 3e-06
 Identities = 26/161 (16%), Positives = 57/161 (35%), Gaps = 12/161 (7%)

Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           KI+ ++    F ++ E       E   ++ +   +K       E   L++  +    G  
Sbjct: 80  KIY-RIETSEFDKMDEY--LYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA---GVS 133

Query: 157 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
             Q    + Y  ++ ++       L         R      V  I   ++E +  ++   
Sbjct: 134 VPQP---YTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEA 190

Query: 217 -MIHTDLKPENVLLVSS-EYIKVPDYKSSLHTPKDSSYFKR 255
            ++H DL   N++ +    +I +    +  H P   SY +R
Sbjct: 191 ELVHADLSEYNIMYIDKVYFIDMGQAVTLRH-PMAESYLER 230

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 55/333 (16%), Positives = 110/333 (33%), Gaps = 64/333 (19%)

Query: 16  RRPRKRARLGWDVPQAQVGLFCGQEVGNVTSFAPPRAPSDHVTSSSLFVKGVARNG-SPP 74
            R R     G  VP+   GL     +  +++    +A S+++         +  +  +P 
Sbjct: 15  GRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPE 74

Query: 75  WREDDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLE--CWDRERKEM-VAIKIVRGIK 131
             +  +       +    +     +  +G G FG V      D + K++  A+K +  I 
Sbjct: 75  LVQAVQH-----VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 129

Query: 132 KYREAA--MIEIEVLQQLAKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLY 182
              E +  + E  +++    H       G                  +V    K G  L 
Sbjct: 130 DIGEVSQFLTEGIIMKDF-SHPNVLSLLG---IC-----LRSEGSPLVVLPYMKHG-DLR 179

Query: 183 DFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 242
           +F+R   +     DL+     Q+ + + F+     +H DL   N  ++  ++        
Sbjct: 180 NFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKFVHRDLAARNC-MLDEKFT------- 230

Query: 243 SLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQNYIVSTRHYR------APEVILGL 295
                              +KV DFG +      + + + +    +      A E +   
Sbjct: 231 -------------------VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271

Query: 296 GWTYPCDIWSVGCILVELCT-GEALFQTHENLE 327
            +T   D+WS G +L EL T G   +      +
Sbjct: 272 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 51/255 (20%), Positives = 86/255 (33%), Gaps = 69/255 (27%)

Query: 94  SRYKIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQ 146
            R K+   +G G FGQV+E              VA+K+++    + E    M E+++L  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 147 LAKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKN----NYRSFPI 195
           +  H       G                + ++ E  K G +L  +LR             
Sbjct: 87  IGHHLNVVNLLG---AC-----TKPGGPLMVIVEFCKFG-NLSTYLRSKRNEFVPYKVAP 137

Query: 196 DLVREIARQLLECIAFMHDLC--M--------IHTDLKPENVLLVSSEYIKVPDYKSSLH 245
           + + +    L   I +   +   M        IH DL   N+ L+S + +          
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI-LLSEKNV---------- 186

Query: 246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR-----APEVILGLGWTYP 300
                           +K+ DFG       D +Y+            APE I    +T  
Sbjct: 187 ----------------VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 230

Query: 301 CDIWSVGCILVELCT 315
            D+WS G +L E+ +
Sbjct: 231 SDVWSFGVLLWEIFS 245

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 58/339 (17%), Positives = 105/339 (30%), Gaps = 91/339 (26%)

Query: 97  KIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAK 149
           K+   +G G FGQV+E              VA+K+++         A M E+++L  +  
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84

Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           H    N    +         + ++ E     +L  +LR    R+  +    + AR     
Sbjct: 85  HL---NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK--RNEFVPYKTKGARFR--- 136

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY--KSSLHTPKDSSYFKRMPKSSA----- 261
                 +  I  DLK     + SS+      +  + SL   ++    + + K        
Sbjct: 137 -QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195

Query: 262 ------------------------------------IKVIDFGSTTYERPDQNYIVSTRH 285
                                               +K+ DFG       D +Y+     
Sbjct: 196 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255

Query: 286 YR-----APEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP 340
                  APE I    +T   D+WS G +L E+ +                    LG  P
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--------------------LGASP 295

Query: 341 -QHMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMK 377
              +  ++D    + ++ G R+  P+       +   M 
Sbjct: 296 YPGV--KIDEEFCRRLKEGTRMRAPDYT--TPEMYQTML 330

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 45.3 bits (108), Expect = 2e-05
 Identities = 30/155 (19%), Positives = 54/155 (34%), Gaps = 23/155 (14%)

Query: 97  KIHSKMGEGTFGQVLEC---WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQLAKHD 151
             +  +G G FG V       +  +K   A+K +  I    E +  + E  +++    H 
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHP 86

Query: 152 K-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQ 204
                 G                  +V    K G  L +F+R   +     DL+     Q
Sbjct: 87  NVLSLLG---IC-----LRSEGSPLVVLPYMKHG-DLRNFIRNETHNPTVKDLIG-FGLQ 136

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 239
           + + + ++     +H DL   N +L     +KV D
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD 171

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 51/257 (19%), Positives = 93/257 (36%), Gaps = 72/257 (28%)

Query: 94  SRYKIHSKMGEGTFGQVLEC-------WDRERKEMVAIKIVRGIKKYREAA--MIEIEVL 144
            R  +   +GEG FGQV+             R   VA+K+++     ++ +  + E+E++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 145 QQLAKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKN----NYRSF 193
           + + KH       G   C Q          + ++ E    G +L ++L+         S+
Sbjct: 129 KMIGKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLQARRPPGLEYSY 178

Query: 194 PIDLVREIARQLLECIAFMHDLC--M--------IHTDLKPENVLLVSSEYIKVPDYKSS 243
                 E      + ++  + +   M        IH DL   NV LV+ + +        
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV-LVTEDNV-------- 229

Query: 244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWT 298
                             +K+ DFG          Y  +T       + APE +    +T
Sbjct: 230 ------------------MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 271

Query: 299 YPCDIWSVGCILVELCT 315
           +  D+WS G +L E+ T
Sbjct: 272 HQSDVWSFGVLLWEIFT 288

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 44.5 bits (106), Expect = 4e-05
 Identities = 31/121 (25%), Positives = 47/121 (38%), Gaps = 37/121 (30%)

Query: 201 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 260
            A  +     F+H+   IH D+K  N+LL                   D ++     K S
Sbjct: 142 AANGI----NFLHENHHIHRDIKSANILL-------------------DEAF---TAKIS 175

Query: 261 AIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                DFG           ++++R      Y APE + G   T   DI+S G +L+E+ T
Sbjct: 176 -----DFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIIT 229

Query: 316 G 316
           G
Sbjct: 230 G 230

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 43.4 bits (103), Expect = 8e-05
 Identities = 57/260 (21%), Positives = 90/260 (34%), Gaps = 83/260 (31%)

Query: 94  SRYKIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQL 147
               +  ++GEG FG+V           + K +VA+K ++   +  R+    E E+L  L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100

Query: 148 AKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVRE 200
            +H       G   C +          + +VFE  + G  L  FLR +   +  +    +
Sbjct: 101 -QHQHIVRFFG--VCTE-------GRPLLMVFEYMRHG-DLNRFLRSHGPDAKLLAGGED 149

Query: 201 IARQLLECIAFMH-------------DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 247
           +A   L     +               L  +H DL   N  LV    +            
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNC-LVGQGLV------------ 196

Query: 248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR------------APEVILGL 295
                         +K+ DFG +   R     I ST +YR             PE IL  
Sbjct: 197 --------------VKIGDFGMS---R----DIYSTDYYRVGGRTMLPIRWMPPESILYR 235

Query: 296 GWTYPCDIWSVGCILVELCT 315
            +T   D+WS G +L E+ T
Sbjct: 236 KFTTESDVWSFGVVLWEIFT 255

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 44/255 (17%), Positives = 83/255 (32%), Gaps = 60/255 (23%)

Query: 101 KMGEGTFGQVLEC---WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQLAKHDK--- 152
            +G+G FG V         + +   AIK +  I + ++    + E  +++ L  H     
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLA 86

Query: 153 --GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
             G    +             ++      G  L  F+R         DL+     Q+   
Sbjct: 87  LIG---IM-----LPPEGLPHVLLPYMCHGD-LLQFIRSPQRNPTVKDLI-SFGLQVARG 136

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           + ++ +   +H DL   N  ++   +                           +KV DFG
Sbjct: 137 MEYLAEQKFVHRDLAARNC-MLDESFT--------------------------VKVADFG 169

Query: 269 STTYERPDQNYIVSTRHYR--------APEVILGLGWTYPCDIWSVGCILVELCT-GEAL 319
                  D+ Y    +H          A E +    +T   D+WS G +L EL T G   
Sbjct: 170 LARDIL-DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

Query: 320 FQTHENLEHLAMMER 334
           ++  +  +    + +
Sbjct: 229 YRHIDPFDLTHFLAQ 243

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 51/259 (19%), Positives = 93/259 (35%), Gaps = 76/259 (29%)

Query: 94  SRYKIHSKMGEGTFGQVLEC-------WDRERKEMVAIKIVRGIKKYREAA--MIEIEVL 144
            +  +   +GEG FGQV+            +    VA+K+++     ++ +  + E+E++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 145 QQLAKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDL 197
           + + KH       G   C Q          + ++ E    G +L ++LR    R   ++ 
Sbjct: 95  KMIGKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLRAR--RPPGMEY 142

Query: 198 VREIARQLLECIAFMHDLCM----------------IHTDLKPENVLLVSSEYIKVPDYK 241
             +I R   E + F   +                  IH DL   NV LV+   +      
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV-LVTENNV------ 195

Query: 242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLG 296
                               +K+ DFG          Y  +T       + APE +    
Sbjct: 196 --------------------MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235

Query: 297 WTYPCDIWSVGCILVELCT 315
           +T+  D+WS G ++ E+ T
Sbjct: 236 YTHQSDVWSFGVLMWEIFT 254

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 55/262 (20%), Positives = 89/262 (33%), Gaps = 77/262 (29%)

Query: 94  SRYKIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQ 146
              +    +G G FG+V+               VA+K+++       REA M E++++ Q
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 147 LAKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVR 199
           L  H+      G   C            I ++FE    G  L ++LR    +    ++  
Sbjct: 105 LGSHENIVNLLGA--CTL-------SGPIYLIFEYCCYG-DLLNYLRSKREKFSEDEIEY 154

Query: 200 EIARQLLECIAF----MHDLCM-----------------IHTDLKPENVLLVSSEYIKVP 238
           E  ++L E          DL                   +H DL   NV LV+   +   
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV-LVTHGKV--- 210

Query: 239 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR-----APEVIL 293
                                  +K+ DFG       D NY+V           APE + 
Sbjct: 211 -----------------------VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 247

Query: 294 GLGWTYPCDIWSVGCILVELCT 315
              +T   D+WS G +L E+ +
Sbjct: 248 EGIYTIKSDVWSYGILLWEIFS 269

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 41.4 bits (98), Expect = 3e-04
 Identities = 57/262 (21%), Positives = 93/262 (35%), Gaps = 86/262 (32%)

Query: 94  SRYKIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQL 147
               +  ++GEG FG+V           + K +VA+K ++      R+    E E+L  L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74

Query: 148 AKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSF------- 193
            +H+      G   C          + + +VFE  K G  L  FLR +   +        
Sbjct: 75  -QHEHIVKFYG--VCGD-------GDPLIMVFEYMKHG-DLNKFLRAHGPDAMILVDGQP 123

Query: 194 --------PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 245
                      ++  IA Q+   + ++     +H DL   N  LV +  +          
Sbjct: 124 RQAKGELGLSQML-HIASQIASGMVYLASQHFVHRDLATRNC-LVGANLL---------- 171

Query: 246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR------------APEVIL 293
                           +K+ DFG +   R     + ST +YR             PE I+
Sbjct: 172 ----------------VKIGDFGMS---R----DVYSTDYYRVGGHTMLPIRWMPPESIM 208

Query: 294 GLGWTYPCDIWSVGCILVELCT 315
              +T   D+WS G IL E+ T
Sbjct: 209 YRKFTTESDVWSFGVILWEIFT 230

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 51/256 (19%), Positives = 92/256 (35%), Gaps = 76/256 (29%)

Query: 97  KIHSKMGEGTFGQVLEC-------WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQL 147
            +   +GEG FGQV+            +    VA+K+++     ++ +  + E+E+++ +
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143

Query: 148 AKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVRE 200
            KH       G   C Q          + ++ E    G +L ++LR    R   ++   +
Sbjct: 144 GKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLRAR--RPPGMEYSYD 191

Query: 201 IARQLLECIAFMHDLCM----------------IHTDLKPENVLLVSSEYIKVPDYKSSL 244
           I R   E + F   +                  IH DL   NV LV+   +         
Sbjct: 192 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV-LVTENNV--------- 241

Query: 245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWTY 299
                            +K+ DFG          Y  +T       + APE +    +T+
Sbjct: 242 -----------------MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 284

Query: 300 PCDIWSVGCILVELCT 315
             D+WS G ++ E+ T
Sbjct: 285 QSDVWSFGVLMWEIFT 300

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.8 bits (97), Expect = 4e-04
 Identities = 60/433 (13%), Positives = 116/433 (26%), Gaps = 124/433 (28%)

Query: 27  DVPQAQVGLFCGQEVGNVTSFAPPRAPSDHVTSSSLFVKGVARNGSPPW--REDDKDGHY 84
           DV      +   +E+ ++       +      +  LF           W      ++   
Sbjct: 37  DVQDMPKSILSKEEIDHII-----MSKDAVSGTLRLF-----------WTLLSKQEEMVQ 80

Query: 85  MF---ALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY---RE 135
            F    L  N   L S  K   +         +E  DR   +       +   KY   R 
Sbjct: 81  KFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND------NQVFAKYNVSRL 134

Query: 136 AAMIEI-EVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG---SSL-------YDF 184
              +++ + L +L +  K                   ++   LG   + +       Y  
Sbjct: 135 QPYLKLRQALLEL-RPAKN-----------------VLIDGVLGSGKTWVALDVCLSYKV 176

Query: 185 LRKNNYRSFPIDLVR-EIARQLLE-----CIAFMHDLC-----MIHTDLKPENVLLVSSE 233
             K +++ F ++L        +LE           +         +  L+  ++      
Sbjct: 177 QCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236

Query: 234 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL 293
            +K   Y++ L    +         + A    +             +++TR     +V  
Sbjct: 237 LLKSKPYENCLLVLLNVQN------AKAWNAFNLSCKI--------LLTTRF---KQVTD 279

Query: 294 GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG----PLPQHMLKRVDR 349
            L       I      L             E    L    + L      LP+ +L    R
Sbjct: 280 FLSAATTTHI-----SLDHHSMT---LTPDEVKSLLL---KYLDCRPQDLPREVLTTNPR 328

Query: 350 H----AEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGL- 403
                AE  +R G   W       ++ K V    +L  +I   ++     +   +   L 
Sbjct: 329 RLSIIAES-IRDGLATW-------DNWKHV-NCDKLTTIIESSLNVLEPAEYRKMFDRLS 379

Query: 404 -LRYD---PTDRL 412
                   PT  L
Sbjct: 380 VFPPSAHIPTILL 392

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 43/267 (16%), Positives = 84/267 (31%), Gaps = 61/267 (22%)

Query: 94  SRYKIHSKMGEGTFGQVLEC---WDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQL 147
            ++ +   +G+G FG V E     +      VA+K+++         E  + E   +++ 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 148 AKHDK-----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVRE 200
             H       G                  ++    K G  L+ FL  +     P +L  +
Sbjct: 83  -DHPHVAKLVG---VSLRSRAKGRLPIPMVILPFMKHG-DLHAFLLASRIGENPFNLPLQ 137

Query: 201 ----IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 256
                   +   + ++     IH DL   N  +++ +                       
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNC-MLAEDMT--------------------- 175

Query: 257 PKSSAIKVIDFGSTTYERP--DQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGC 308
                + V DFG +   R     +Y       +      A E +    +T   D+W+ G 
Sbjct: 176 -----VCVADFGLS---RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGV 227

Query: 309 ILVELCT-GEALFQTHENLEHLAMMER 334
            + E+ T G+  +   EN E    +  
Sbjct: 228 TMWEIMTRGQTPYAGIENAEIYNYLIG 254

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	430
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.22
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.11
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.1
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.75
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.67
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.62
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.38
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.37
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.33
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.14
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.04
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.8
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.77
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.7
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.64
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.61
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.53
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.42
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.1
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.08
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.04
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.03
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.99
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.76
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.4
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.89
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.21

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.1e-63  Score=474.84  Aligned_cols=253  Identities=27%  Similarity=0.450  Sum_probs=216.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ...|+++++||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+.+|+.+.     |+||+++++++.+.+.+|
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~-----HpnIV~l~~~~~~~~~~~  147 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-----HENVVEMYNSYLVGDELW  147 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCC-----CTTBCCEEEEEEETTEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCC-----CCCCCcEEEEEEECCEEE
Confidence            356999999999999999999999999999999996432 33456778999999984     589999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      |||||| ||+|.+++...   .+++..++.|+.||+.||+|||++|||||||||+||||+                    
T Consensus       148 ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~--------------------  204 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT--------------------  204 (346)
T ss_dssp             EEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--------------------
T ss_pred             EEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC--------------------
Confidence            999999 88999999764   699999999999999999999999999999999999994                    


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                             .++.+||+|||+|+.....   ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+
T Consensus       205 -------~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~  277 (346)
T 4fih_A          205 -------HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK  277 (346)
T ss_dssp             -------TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             -------CCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence                   4556777777777654322   245789999999999999999999999999999999999999999888877


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      .+..|.....+..                                              ..+..+++++++||.+||++|
T Consensus       278 ~~~~i~~~~~~~~----------------------------------------------~~~~~~s~~~~dli~~~L~~d  311 (346)
T 4fih_A          278 AMKMIRDNLPPRL----------------------------------------------KNLHKVSPSLKGFLDRLLVRD  311 (346)
T ss_dssp             HHHHHHHSSCCCC----------------------------------------------SCGGGSCHHHHHHHHHHSCSS
T ss_pred             HHHHHHcCCCCCC----------------------------------------------CccccCCHHHHHHHHHHcCCC
Confidence            7766654322111                                              012346778999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~  426 (430)
                      |++|||++|+|+||||++.
T Consensus       312 P~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          312 PAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             TTTSCCHHHHTTCGGGGGC
T ss_pred             hhHCcCHHHHhcCHhhcCC
Confidence            9999999999999999864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.1e-63  Score=477.19  Aligned_cols=253  Identities=25%  Similarity=0.403  Sum_probs=213.5

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ++|+++++||+|+||+||+|+++.+|+.||||+++..   ....+.+.+|+++++++.     |+||+++++++++.+.+
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-----HpnIV~~~~~~~~~~~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK-----HPNIVQYRESFEENGSL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCC-----CTTBCCEEEEEEETTEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCC-----CCCCCcEEEEEEECCEE
Confidence            5799999999999999999999999999999999643   334567889999999984     58999999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      ||||||| ||+|.++|.......+++..++.|+.||+.||+|||++|||||||||+||||                    
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl--------------------  158 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL--------------------  158 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE--------------------
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE--------------------
Confidence            9999999 8999999987766678999999999999999999999999999999999999                    


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                             +.++.+||+|||+|+......   ...+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..
T Consensus       159 -------~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~  231 (350)
T 4b9d_A          159 -------TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK  231 (350)
T ss_dssp             -------CTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             -------CCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence                   455677888888877554322   3468999999999999999999999999999999999999999988877


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +.+..|....  .|+                                              .+..++.++.+||.+||++
T Consensus       232 ~~~~~i~~~~--~~~----------------------------------------------~~~~~s~~~~~li~~~L~~  263 (350)
T 4b9d_A          232 NLVLKIISGS--FPP----------------------------------------------VSLHYSYDLRSLVSQLFKR  263 (350)
T ss_dssp             HHHHHHHHTC--CCC----------------------------------------------CCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHcCC--CCC----------------------------------------------CCccCCHHHHHHHHHHccC
Confidence            7766654421  110                                              1235677899999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||++|||++|+|+||||++.
T Consensus       264 dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          264 NPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             SGGGSCCHHHHHTSHHHHTT
T ss_pred             ChhHCcCHHHHhcCHHhhcC
Confidence            99999999999999999764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.8e-63  Score=467.79  Aligned_cols=251  Identities=25%  Similarity=0.403  Sum_probs=216.1

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++++.||+|+||+||+|+++.+++.||||++++..    ...+.+.+|+++|+++     .||||+++++++++.+.
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-----DHPFFVKLYFTFQDDEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEeCCE
Confidence            46999999999999999999999999999999997432    2345678899999888     45899999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +||||||| ||+|.+++.+.+  .+++..++.|+.||+.||+|||++|||||||||+||||+                  
T Consensus       107 ~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~------------------  166 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN------------------  166 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred             EEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc------------------
Confidence            99999999 889999998765  799999999999999999999999999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                               .++.+||+|||+|+.....     ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.
T Consensus       167 ---------~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~  237 (311)
T 4aw0_A          167 ---------EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG  237 (311)
T ss_dssp             ---------TTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ---------CCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                     4556777777777644321     23468999999999999999999999999999999999999999988


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +..+.+..|......                                                 +++.+++++++||.+|
T Consensus       238 ~~~~~~~~i~~~~~~-------------------------------------------------~p~~~s~~~~dli~~l  268 (311)
T 4aw0_A          238 NEGLIFAKIIKLEYD-------------------------------------------------FPEKFFPKARDLVEKL  268 (311)
T ss_dssp             SHHHHHHHHHHTCCC-------------------------------------------------CCTTCCHHHHHHHHHH
T ss_pred             CHHHHHHHHHcCCCC-------------------------------------------------CCcccCHHHHHHHHHH
Confidence            877776666543221                                                 2335677899999999


Q ss_pred             hhcCCCCCCCHHH------HhcCCCCCCCC
Q 014117          404 LRYDPTDRLTARE------ALRHPFFTRDH  427 (430)
Q Consensus       404 L~~dP~~R~ta~e------lL~hp~f~~~~  427 (430)
                      |++||++|||++|      +++||||+.-+
T Consensus       269 L~~dp~~R~t~~e~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          269 LVLDATKRLGCEEMEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             SCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             ccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence            9999999999987      58999998753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.1e-62  Score=460.33  Aligned_cols=250  Identities=24%  Similarity=0.408  Sum_probs=203.2

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||+|+||+||+|+++.+++.||||++++..    .....+.+|+++++.+.     ||||+++++++++.+.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~~~~~~~~~~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-----HPHIIKLYDVIKSKDE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-----CTTBCCEEEEEECSSE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-----CCCCCeEEEEEEECCE
Confidence            57999999999999999999999999999999996432    23456788999999984     5899999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          170 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       170 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      +|||||||+|+|.+++.+.+  .+++..++.++.||+.||+|||++|||||||||+|||++                   
T Consensus        88 ~~ivmEy~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~-------------------  146 (275)
T 3hyh_A           88 IIMVIEYAGNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD-------------------  146 (275)
T ss_dssp             EEEEEECCCEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC-------------------
T ss_pred             EEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC-------------------
Confidence            99999999999999998765  799999999999999999999999999999999999994                   


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                              .++.+||+|||+|+.....  ....+||+.|||||++.+..| +.++|||||||++|+|++|++||.+.+..
T Consensus       147 --------~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~  218 (275)
T 3hyh_A          147 --------EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP  218 (275)
T ss_dssp             --------TTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             --------CCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH
Confidence                    4556777777777654332  244689999999999999886 57999999999999999999999987776


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +.+..+......                                                 ++...++++++||.+||++
T Consensus       219 ~~~~~i~~~~~~-------------------------------------------------~p~~~s~~~~~li~~~L~~  249 (275)
T 3hyh_A          219 VLFKNISNGVYT-------------------------------------------------LPKFLSPGAAGLIKRMLIV  249 (275)
T ss_dssp             HHHHHHHHTCCC-------------------------------------------------CCTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHcCCCC-------------------------------------------------CCCCCCHHHHHHHHHHccC
Confidence            666555432211                                                 2234577899999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||++|||++|+|+||||+.+
T Consensus       250 dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          250 NPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             SGGGSCCHHHHHHCHHHHTT
T ss_pred             ChhHCcCHHHHHcCcccccC
Confidence            99999999999999999754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.8e-61  Score=476.21  Aligned_cols=253  Identities=27%  Similarity=0.450  Sum_probs=217.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      .+.|+++++||+|+||.||+|+++.+|+.||||++.... ...+.+.+|+.+|+.+.     |+||++++++|.+.+.+|
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~-----HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-----HENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCC-----CTTBCCEEEEEEETTEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCC-----CCCCCceEEEEEECCEEE
Confidence            457999999999999999999999999999999996433 33456788999999984     589999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      |||||| ||+|.+++...   .+++..++.|+.||+.||+|||++|||||||||+||||+                    
T Consensus       225 iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~--------------------  281 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT--------------------  281 (423)
T ss_dssp             EEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC--------------------
T ss_pred             EEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc--------------------
Confidence            999999 89999999764   599999999999999999999999999999999999994                    


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                             .++.+||+|||+|+.....   ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+
T Consensus       282 -------~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~  354 (423)
T 4fie_A          282 -------HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK  354 (423)
T ss_dssp             -------TTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             -------CCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence                   4556777777777654322   245799999999999999999999999999999999999999999888877


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      .+..|.....+..                                              ..+..++.++++||.+||++|
T Consensus       355 ~~~~i~~~~~~~~----------------------------------------------~~~~~~s~~~~dli~~~L~~d  388 (423)
T 4fie_A          355 AMKMIRDNLPPRL----------------------------------------------KNLHKVSPSLKGFLDRLLVRD  388 (423)
T ss_dssp             HHHHHHHSCCCCC----------------------------------------------SCTTSSCHHHHHHHHHHSCSS
T ss_pred             HHHHHHcCCCCCC----------------------------------------------cccccCCHHHHHHHHHHcCCC
Confidence            7766654321111                                              112456788999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~  426 (430)
                      |++|||++|+|+||||++.
T Consensus       389 P~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          389 PAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             TTTSCCHHHHTTCGGGGGC
T ss_pred             hhHCcCHHHHhcCHHhcCC
Confidence            9999999999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.1e-61  Score=452.87  Aligned_cols=253  Identities=23%  Similarity=0.426  Sum_probs=206.6

Q ss_pred             CcE-EEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 014117           94 SRY-KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---  166 (430)
Q Consensus        94 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~---  166 (430)
                      ++| ++.++||+|+||+||+|.++.+++.||+|++...   ....+.+.+|+++++++     .||||+++++++++   
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIV~~~~~~~~~~~   99 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-----QHPNIVRFYDSWESTVK   99 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEEEET
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEeeccC
Confidence            455 7888999999999999999999999999998633   33456688899999998     45899999998865   


Q ss_pred             -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeccCCCCceEEeecCccccCCCcC
Q 014117          167 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       167 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                       .+.+||||||| ||+|.+++.+.+  .+++..++.|+.||+.||+|||++|  ||||||||+||||+.           
T Consensus       100 ~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~-----------  166 (290)
T 3fpq_A          100 GKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-----------  166 (290)
T ss_dssp             TEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS-----------
T ss_pred             CCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC-----------
Confidence             46799999999 899999998765  7999999999999999999999999  999999999999942           


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                                     .++.+||+|||+|+...... ...+||+.|||||++.+ .|+.++|||||||++|||+||++||.
T Consensus       167 ---------------~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~  230 (290)
T 3fpq_A          167 ---------------PTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS  230 (290)
T ss_dssp             ---------------TTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ---------------CCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence                           34578888888887543332 45689999999998875 69999999999999999999999998


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      +.+....+...... +..|.                                             ..+...++++.+||.
T Consensus       231 ~~~~~~~~~~~i~~-~~~~~---------------------------------------------~~~~~~~~~~~~li~  264 (290)
T 3fpq_A          231 ECQNAAQIYRRVTS-GVKPA---------------------------------------------SFDKVAIPEVKEIIE  264 (290)
T ss_dssp             TCSSHHHHHHHHTT-TCCCG---------------------------------------------GGGGCCCHHHHHHHH
T ss_pred             CCCcHHHHHHHHHc-CCCCC---------------------------------------------CCCccCCHHHHHHHH
Confidence            76554433221110 11111                                             123455678999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          402 GLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +||+.||++|||++|+|+||||+++
T Consensus       265 ~~L~~dP~~R~s~~e~l~Hp~~~~~  289 (290)
T 3fpq_A          265 GCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHccCChhHCcCHHHHhcCccccCC
Confidence            9999999999999999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-60  Score=469.53  Aligned_cols=283  Identities=27%  Similarity=0.460  Sum_probs=223.9

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee---
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD---  165 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~---  165 (430)
                      +.++|++++.||+|+||+||+|+++.+|+.||||+++...   ...+.+.+|+++|+.+.     |+||+++++++.   
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~~~~~~~~  126 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK-----HDNIIAIKDILRPTV  126 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCC-----CTTBCCEEEECCCSS
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcC-----CCCcceEeeeeeccc
Confidence            4568999999999999999999999999999999997432   33456778999999984     488999998765   


Q ss_pred             ---cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          166 ---YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       166 ---~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                         +.+.+|||||||+|+|.+++.+.+  .+++..++.|+.||+.||+|||++|||||||||+|||++.+          
T Consensus       127 ~~~~~~~~~ivmE~~~g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~----------  194 (398)
T 4b99_A          127 PYGEFKSVYVVLDLMESDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNEN----------  194 (398)
T ss_dssp             CTTTCCCEEEEEECCSEEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT----------
T ss_pred             ccccCCEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCC----------
Confidence               347899999999889999997754  89999999999999999999999999999999999999544          


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCC-------CCCeeeecCcccchhhhhCCC-CCCcchHHHHHHHHHHHH
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-------DQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELC  314 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~  314 (430)
                                       +.+||+|||+|+....       .....+||+.|||||++.+.. |+.++||||+||++|||+
T Consensus       195 -----------------~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell  257 (398)
T 4b99_A          195 -----------------CELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML  257 (398)
T ss_dssp             -----------------CCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             -----------------CCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHH
Confidence                             4556666666543211       123468999999999998864 699999999999999999


Q ss_pred             hCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchh
Q 014117          315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG  394 (430)
Q Consensus       315 tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (430)
                      +|++||.+.+..+++..|....|.++...+..+..........   ..+...               ........+..+.
T Consensus       258 ~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~---~~~~~~---------------~~~~~~~~~~~s~  319 (398)
T 4b99_A          258 ARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQ---SLPPRQ---------------PVPWETVYPGADR  319 (398)
T ss_dssp             HTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHH---SSCCCC---------------CCCHHHHSTTCCH
T ss_pred             HCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhh---cCCCcC---------------CCCHHHhCCCCCH
Confidence            9999999999999999999999998875433221111110000   000000               0001123456788


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          395 DLTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       395 ~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ++.+||.+||++||++||||+|+|+||||++.
T Consensus       320 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          320 QALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence            99999999999999999999999999999864

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.1e-61  Score=457.81  Aligned_cols=251  Identities=27%  Similarity=0.446  Sum_probs=208.5

Q ss_pred             CcEEEEeeeccccceEEEEEEEC---CCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      ++|++++.||+|+||+||+|++.   .+++.||||++++..   .....+..|+++++++     .||||+++++++++.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-----NHPFIVKLHYAFQTE   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-----CCTTEECEEEEEEET
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-----CCCCCCeEEEEEEEC
Confidence            57999999999999999999874   468899999996432   2233566788888777     458999999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +.+||||||| ||+|.+++.+.+  .+++..++.++.||+.||+|||++|||||||||+|||+                 
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl-----------------  159 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL-----------------  159 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE-----------------
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE-----------------
Confidence            9999999999 899999998865  79999999999999999999999999999999999999                 


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                +.++.+||+|||+|+....   .....+||+.|||||++.+..|+.++|||||||++|||+||++||.+.
T Consensus       160 ----------~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~  229 (304)
T 3ubd_A          160 ----------DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK  229 (304)
T ss_dssp             ----------CTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ----------cCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence                      4556778888887764322   224568999999999999999999999999999999999999999988


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +..+.+..|.+....                                                 ++..+++++.+||.+|
T Consensus       230 ~~~~~~~~i~~~~~~-------------------------------------------------~p~~~s~~~~~li~~~  260 (304)
T 3ubd_A          230 DRKETMTMILKAKLG-------------------------------------------------MPQFLSPEAQSLLRML  260 (304)
T ss_dssp             SHHHHHHHHHHCCCC-------------------------------------------------CCTTSCHHHHHHHHHH
T ss_pred             CHHHHHHHHHcCCCC-------------------------------------------------CCCcCCHHHHHHHHHH
Confidence            887777666543222                                                 2335677899999999


Q ss_pred             hhcCCCCCCC-----HHHHhcCCCCCCCC
Q 014117          404 LRYDPTDRLT-----AREALRHPFFTRDH  427 (430)
Q Consensus       404 L~~dP~~R~t-----a~elL~hp~f~~~~  427 (430)
                      |++||++|||     ++|+++||||+.-+
T Consensus       261 L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          261 FKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             TCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             cccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence            9999999998     58999999998743

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.1e-60  Score=456.24  Aligned_cols=250  Identities=27%  Similarity=0.355  Sum_probs=208.5

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      +.|++.++||+|+||+||+|+++.+|+.||||+++....    ..+|+.+++.+     .||||+++++++.+.+.+|||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l-----~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGL-----SSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTC-----CCTTBCCEEEEEEETTEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhC-----CCCCCCcEEEEEEECCEEEEE
Confidence            569999999999999999999999999999999975432    23588888877     458999999999999999999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      |||| ||+|.++|.+.+  .+++..++.|+.||+.||+|||++|||||||||+||||+.+|                   
T Consensus       129 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-------------------  187 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG-------------------  187 (336)
T ss_dssp             ECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTS-------------------
T ss_pred             EeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCC-------------------
Confidence            9999 899999998765  799999999999999999999999999999999999995433                   


Q ss_pred             cccCCCCCCeEEEeCCCccccCCC--------CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPD--------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                             ..+||+|||+|+.....        ...++||+.|||||++.+..|+.++|||||||++|||++|++||.+.+
T Consensus       188 -------~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~  260 (336)
T 4g3f_A          188 -------SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF  260 (336)
T ss_dssp             -------CCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred             -------CEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence                   14677777776643321        123589999999999999999999999999999999999999998766


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+....|...  ++|                                            ....++.+++++.+||.+||
T Consensus       261 ~~~~~~~i~~~--~~~--------------------------------------------~~~~~~~~s~~~~~li~~~L  294 (336)
T 4g3f_A          261 RGPLCLKIASE--PPP--------------------------------------------IREIPPSCAPLTAQAIQEGL  294 (336)
T ss_dssp             CSCCHHHHHHS--CCG--------------------------------------------GGGSCTTSCHHHHHHHHHHT
T ss_pred             HHHHHHHHHcC--CCC--------------------------------------------chhcCccCCHHHHHHHHHHc
Confidence            65554444331  111                                            11235677889999999999


Q ss_pred             hcCCCCCCCHHHH-------------hcCCCCCCC
Q 014117          405 RYDPTDRLTAREA-------------LRHPFFTRD  426 (430)
Q Consensus       405 ~~dP~~R~ta~el-------------L~hp~f~~~  426 (430)
                      ++||.+|||++|+             |+|||+..-
T Consensus       295 ~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          295 RKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             cCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            9999999999997             689999764

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.9e-58  Score=447.19  Aligned_cols=321  Identities=23%  Similarity=0.335  Sum_probs=221.6

Q ss_pred             eecCcEEEEeeeccccceEEEEEEEC---CCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .+.++|++.++||+|+||+||+|+++   .+++.||+|.+.... .......|+++|+.+.    +|+||+++++++++.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~----~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAG----GQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTC----SBTTBCCCSEEEEET
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhc----CCCCCceEEEEEEEC
Confidence            45678999999999999999999875   467899999986543 3455778999988874    347899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeec-CccccCCCcCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS-EYIKVPDYKSSLH  245 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~-~~~~i~dfg~~~~  245 (430)
                      +++||||||| +++|.+++.     .+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|..
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            9999999999 899999983     58999999999999999999999999999999999999876 7888888888764


Q ss_pred             CCCCCcccccCCC--CCCeEEEeCCCc--cccCCCCCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          246 TPKDSSYFKRMPK--SSAIKVIDFGST--TYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       246 ~~~~~~~~~~~~~--~~~~kl~Dfg~a--~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                      .............  ....+..+-..+  ..........+||+.|||||++.+. .|+.++||||+||++|||++|++||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            4322111000000  000000000000  0001112345899999999999886 4899999999999999999999999


Q ss_pred             C-CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhc-----------CchhHHHHHhhh
Q 014117          321 Q-THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM-----------KLPRLQNLIMQH  388 (430)
Q Consensus       321 ~-~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~  388 (430)
                      . +.++.+++..|...+|..+........  ........  ..|..  .........           ............
T Consensus       248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~--~~~~~~~~--~~p~~--~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  321 (361)
T 4f9c_A          248 YKASDDLTALAQIMTIRGSRETIQAAKTF--GKSILCSK--EVPAQ--DLRKLCERLRGMDSSTPKLTSDIQGHATNLEG  321 (361)
T ss_dssp             SCCSSHHHHHHHHHHHHCHHHHHHHHHHT--TEEEEESS--CCCCC--CHHHHHHHHC----------------------
T ss_pred             CCCCCHHHHHHHHHHhcCCccchhhhhhc--cccccccc--cCcch--hhhHHHHhhccccccccccccccccccccccc
Confidence            4 567788899999998864432221110  00000000  00000  000000000           000001112234


Q ss_pred             cCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       389 ~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      +...++++.|||.+||++||++|+||+|+|+||||++-+
T Consensus       322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          322 WNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             cccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            567788999999999999999999999999999998754

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6.4e-57  Score=428.13  Aligned_cols=266  Identities=24%  Similarity=0.307  Sum_probs=191.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC---
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN---  168 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~---  168 (430)
                      ++|++++.||+|+||+||+|+++.+++.||||+++..  ....+.+.+|+.+|+++     .||||+++++++.+.+   
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-----~HpnIV~~~~~~~~~~~~~   79 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-----EHPGIVRYFNAWLEKNTTE   79 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEEEC---
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEecCccc
Confidence            4699999999999999999999999999999998633  33446678899999888     4589999999886533   


Q ss_pred             ---------eEEEEEecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCcccc
Q 014117          169 ---------HICIVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV  237 (430)
Q Consensus       169 ---------~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i  237 (430)
                               ++||||||| +|+|.+++..... ...++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||
T Consensus        80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence                     589999999 8999999987542 23456678899999999999999999999999999999976666666


Q ss_pred             CCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCC
Q 014117          238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       238 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~  317 (430)
                      +|||+|..........+.        ...    ..........+||+.|||||++.+..|+.++|||||||++|||++  
T Consensus       160 ~DFGla~~~~~~~~~~~~--------~~~----~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~--  225 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTV--------LTP----MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--  225 (299)
T ss_dssp             CCCCCC--------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS--
T ss_pred             ccCccceecCCCcccccc--------ccc----cccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc--
Confidence            666655433221110000        000    000001133589999999999999999999999999999999996  


Q ss_pred             CCCCCCchHHHHHHHHHHh-CCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHH
Q 014117          318 ALFQTHENLEHLAMMERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL  396 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (430)
                       ||...  .+....+.... +..|+.+                                              ...++++
T Consensus       226 -Pf~~~--~~~~~~~~~~~~~~~p~~~----------------------------------------------~~~~~~~  256 (299)
T 4g31_A          226 -PFSTQ--MERVRTLTDVRNLKFPPLF----------------------------------------------TQKYPCE  256 (299)
T ss_dssp             -CCSSH--HHHHHHHHHHHTTCCCHHH----------------------------------------------HHHCHHH
T ss_pred             -CCCCc--cHHHHHHHHHhcCCCCCCC----------------------------------------------cccCHHH
Confidence             88643  22222222211 2222211                                              1123457


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          397 THLLQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       397 ~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      .+||.+||+.||++|||++|+|+||||++-+
T Consensus       257 ~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          257 YVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            8899999999999999999999999998653

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.9e-56  Score=461.00  Aligned_cols=261  Identities=28%  Similarity=0.452  Sum_probs=225.1

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      .+.++|++++.||+|+||.||+|.++.+|+.||+|++.... ...+.+.+|+.+|+.+.     |+||++++++|++.+.
T Consensus       154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~~~~~~~~~  228 (573)
T 3uto_A          154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-----HPTLVNLHDAFEDDNE  228 (573)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTC-----CTTBCCEEEEEECSSE
T ss_pred             cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCC-----CCCCCeEEEEEEECCE
Confidence            44578999999999999999999999999999999986543 34566778999999984     5899999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +||||||| ||+|.++|.... ..+++..++.|+.||+.||+|||++|||||||||+|||++.                 
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-----------------  290 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-----------------  290 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-----------------
T ss_pred             EEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-----------------
Confidence            99999999 899999996543 37999999999999999999999999999999999999953                 


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                              +..+.+||+|||+|+......  ...+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..
T Consensus       291 --------~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~  362 (573)
T 3uto_A          291 --------KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD  362 (573)
T ss_dssp             --------SSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred             --------CCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence                    234678999999888665443  3468999999999999999999999999999999999999999998888


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +.+..|......++..                                             .+..++.++++||.+||++
T Consensus       363 ~~~~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~dli~~~L~~  397 (573)
T 3uto_A          363 ETLRNVKSCDWNMDDS---------------------------------------------AFSGISEDGKDFIRKLLLA  397 (573)
T ss_dssp             HHHHHHHTTCCCCCSG---------------------------------------------GGTTSCHHHHHHHHTTSCS
T ss_pred             HHHHHHHhCCCCCCcc---------------------------------------------cccCCCHHHHHHHHHHccC
Confidence            8777766544333321                                             2345678899999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~~  427 (430)
                      ||.+|||++|+|+||||+..+
T Consensus       398 dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          398 DPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             SGGGSCCHHHHHHSTTTSCCC
T ss_pred             ChhHCcCHHHHhcCcCcCCCC
Confidence            999999999999999998653

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.8e-56  Score=459.95  Aligned_cols=258  Identities=25%  Similarity=0.407  Sum_probs=208.1

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++++.||+|+||+||+|+++.+|+.||||++++..    ........|..++..+..  .+||||++++++|++.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~--~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSS--SCCTTBCCEEEEEECSS
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhh--CCCCCEeEEEEEEEECC
Confidence            367999999999999999999999999999999996432    222334556555555533  35699999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+||||||| ||+|.++|.+.+  .|++..++.|+.||+.||+|||++|||||||||+||||+                 
T Consensus       266 ~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld-----------------  326 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD-----------------  326 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC-----------------
T ss_pred             EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEe-----------------
Confidence            999999999 999999998875  799999999999999999999999999999999999994                 


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCC-CCCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                                .++.+||+|||+|+.... .....+||+.|||||++.+ ..|+.++|||||||+||||++|.+||.+.+.
T Consensus       327 ----------~~G~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~  396 (689)
T 3v5w_A          327 ----------EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT  396 (689)
T ss_dssp             ----------TTSCEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC
T ss_pred             ----------CCCCEEecccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                      455667777777654332 3345799999999999974 5799999999999999999999999976433


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+...........                                              ...++..+++++++||.+||+
T Consensus       397 ~~~~~i~~~i~~~----------------------------------------------~~~~p~~~S~~a~dLI~~lL~  430 (689)
T 3v5w_A          397 KDKHEIDRMTLTM----------------------------------------------AVELPDSFSPELRSLLEGLLQ  430 (689)
T ss_dssp             CCHHHHHHHHHHC----------------------------------------------CCCCCTTSCHHHHHHHHHHTC
T ss_pred             HHHHHHHHhhcCC----------------------------------------------CCCCCccCCHHHHHHHHHHcc
Confidence            2221111111100                                              112345678899999999999


Q ss_pred             cCCCCCCC-----HHHHhcCCCCCCCC
Q 014117          406 YDPTDRLT-----AREALRHPFFTRDH  427 (430)
Q Consensus       406 ~dP~~R~t-----a~elL~hp~f~~~~  427 (430)
                      +||.+|++     ++||++||||+.-+
T Consensus       431 ~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          431 RDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             SCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             CCHhHCCCCCCCCHHHHhcCccccCCC
Confidence            99999998     89999999998753

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6.9e-56  Score=420.54  Aligned_cols=246  Identities=22%  Similarity=0.325  Sum_probs=203.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEEC-----CCCeEEEEEEecCc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      .++|.+.++||+|+||+||+|++.     .++..||||+++.. ....+.+.+|+++|.++     .|+||+++++++.+
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-----~HpnIV~l~g~~~~   86 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-----QHEHIVKFYGVCVE   86 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-----CCCCCccEEEEEee
Confidence            467999999999999999999875     35789999999743 34456788999999988     45899999999999


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCc
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNN-----------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY  234 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~  234 (430)
                      .+.+||||||| +|+|.++|...+           ...+++..+..|+.||+.||.|||+++||||||||+||||+.   
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~---  163 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE---  163 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG---
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECC---
Confidence            99999999999 999999997642           347999999999999999999999999999999999999954   


Q ss_pred             cccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHH
Q 014117          235 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI  309 (430)
Q Consensus       235 ~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~  309 (430)
                                              ++.+||+|||+|+......     ...+||+.|||||++.+..|+.++|||||||+
T Consensus       164 ------------------------~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvv  219 (299)
T 4asz_A          164 ------------------------NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVV  219 (299)
T ss_dssp             ------------------------GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred             ------------------------CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHH
Confidence                                    4566777777765432221     23479999999999999999999999999999


Q ss_pred             HHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhh
Q 014117          310 LVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH  388 (430)
Q Consensus       310 l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (430)
                      +|||+| |+.||.+.+..+....+....  .+                                              ..
T Consensus       220 l~Ellt~G~~Pf~~~~~~~~~~~i~~~~--~~----------------------------------------------~~  251 (299)
T 4asz_A          220 LWEIFTYGKQPWYQLSNNEVIECITQGR--VL----------------------------------------------QR  251 (299)
T ss_dssp             HHHHHTTTCCTTTTSCHHHHHHHHHHTC--CC----------------------------------------------CC
T ss_pred             HHHHHcCCCCCCCCCCHHHHHHHHHcCC--CC----------------------------------------------CC
Confidence            999998 999999887777665554321  11                                              12


Q ss_pred             cCCchhHHHHHHHHhhhcCCCCCCCHHHHh
Q 014117          389 VDHSAGDLTHLLQGLLRYDPTDRLTAREAL  418 (430)
Q Consensus       389 ~~~~~~~~~~ll~~~L~~dP~~R~ta~elL  418 (430)
                      |..++.++.+||.+||+.||++|||++||+
T Consensus       252 p~~~~~~~~~li~~cl~~dP~~RPs~~~i~  281 (299)
T 4asz_A          252 PRTCPQEVYELMLGCWQREPHMRKNIKGIH  281 (299)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            345678899999999999999999999984

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.4e-55  Score=422.41  Aligned_cols=248  Identities=21%  Similarity=0.334  Sum_probs=200.5

Q ss_pred             cCcEEEEeeeccccceEEEEEEEC-----CCCeEEEEEEecCc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      .++|.+.++||+|+||+||+|+.+     .+++.||||+++.. ....+.+.+|+++|.++     .|+||+++++++.+
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-----~HpnIV~l~g~~~~  114 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-----QHQHIVRFFGVCTE  114 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEE
Confidence            357999999999999999999865     36889999999743 34456788999999988     45899999999999


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeec
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNN-------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS  232 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~-------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~  232 (430)
                      .+.+||||||| +|+|.++|....             ..++++..+..|+.||+.||.|||+++||||||||+||||+.+
T Consensus       115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence            99999999999 999999997643             1359999999999999999999999999999999999999655


Q ss_pred             CccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchHHHHH
Q 014117          233 EYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVG  307 (430)
Q Consensus       233 ~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  307 (430)
                      +                           .+||+|||+|+.....     ....+||+.|||||++.+..|+.++||||||
T Consensus       195 ~---------------------------~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~G  247 (329)
T 4aoj_A          195 L---------------------------VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFG  247 (329)
T ss_dssp             T---------------------------EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHH
T ss_pred             C---------------------------cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchH
Confidence            4                           4555555555432211     1235799999999999999999999999999


Q ss_pred             HHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHh
Q 014117          308 CILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM  386 (430)
Q Consensus       308 v~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (430)
                      |+||||+| |+.||.+.+..+.+..+.+..  .                                              .
T Consensus       248 vvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~--~----------------------------------------------~  279 (329)
T 4aoj_A          248 VVLWEIFTYGKQPWYQLSNTEAIDCITQGR--E----------------------------------------------L  279 (329)
T ss_dssp             HHHHHHHTTSCCTTCSSCHHHHHHHHHHTC--C----------------------------------------------C
T ss_pred             HHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--C----------------------------------------------C
Confidence            99999999 999999887776665554321  0                                              0


Q ss_pred             hhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          387 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       387 ~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      ..+..+++++.+|+.+||+.||++|||++||+++
T Consensus       280 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          280 ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            1234567889999999999999999999999764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-55  Score=417.35  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=196.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      .+++++.++||+|+||+||+|+.+.   .||||+++..   ....+.+.+|+.+++++     .|+||+++++++.. +.
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-----~HpNIV~l~g~~~~-~~  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKT-----RHVNILLFMGYMTK-DN  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECS-SS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEC-Ce
Confidence            4578899999999999999998643   4999998632   34456788899999988     45899999998754 56


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +||||||| +|+|.++|.... ..+++..+..|+.||+.||+|||+++||||||||+||||++++.              
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--------------  170 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--------------  170 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--------------
T ss_pred             EEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--------------
Confidence            89999999 899999997654 47999999999999999999999999999999999999965554              


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCC-----CCCeeeecCcccchhhhhCC---CCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERP-----DQNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                   +||+|||+|+....     .....+||+.|||||++.+.   .|+.++|||||||+||||+||+.||
T Consensus       171 -------------~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf  237 (307)
T 3omv_A          171 -------------VKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY  237 (307)
T ss_dssp             -------------EEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             -------------EEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCC
Confidence                         55555555543221     11335899999999999754   5899999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .+.+.......+.......|.                                           ....+..++.++.+||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~p~-------------------------------------------~~~~~~~~~~~l~~li  274 (307)
T 3omv_A          238 SHINNRDQIIFMVGRGYASPD-------------------------------------------LSKLYKNCPKAMKRLV  274 (307)
T ss_dssp             TTCCCHHHHHHHHHTTCCCCC-------------------------------------------STTSCTTSCHHHHHHH
T ss_pred             CCCChHHHHHHHHhcCCCCCC-------------------------------------------cccccccchHHHHHHH
Confidence            887665555443322111110                                           0112346678899999


Q ss_pred             HHhhhcCCCCCCCHHHH------hcCCCC
Q 014117          401 QGLLRYDPTDRLTAREA------LRHPFF  423 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~el------L~hp~f  423 (430)
                      .+||+.||++|||++||      |+|++-
T Consensus       275 ~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          275 ADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             HHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             HHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence            99999999999999876      567764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.2e-54  Score=422.56  Aligned_cols=339  Identities=38%  Similarity=0.675  Sum_probs=264.8

Q ss_pred             CCCCCCceeecCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCce
Q 014117           78 DDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRC  157 (430)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i  157 (430)
                      ++....+.+..+..+.++|+++++||+|+||+||+|.+..+++.||||+++...........|+.+++.+.+....|+||
T Consensus        19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~i   98 (360)
T 3llt_A           19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNI   98 (360)
T ss_dssp             -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred             CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence            34445677888899999999999999999999999999999999999999876666677788999999998766668999


Q ss_pred             EEecceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCcccc
Q 014117          158 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV  237 (430)
Q Consensus       158 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i  237 (430)
                      +++++++...+.+|+||||++++|.+++.......+++..++.++.||+.||.|||++|||||||||+|||++.....+-
T Consensus        99 v~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~  178 (360)
T 3llt_A           99 VKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKS  178 (360)
T ss_dssp             CCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEE
T ss_pred             ecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccc
Confidence            99999999999999999999999999999876667999999999999999999999999999999999999964321000


Q ss_pred             CCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCC
Q 014117          238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       238 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~  317 (430)
                      . ...... ...............+||+|||++..........+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       179 ~-~~~~~~-~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  256 (360)
T 3llt_A          179 L-ITVRRV-TDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS  256 (360)
T ss_dssp             E-EEEECT-TTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             c-cchhcc-cccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence            0 000000 00000000002367899999999987666666778999999999999999999999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhh-hhc--cCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchh
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEK-YVR--RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG  394 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (430)
                      .||...+..+....+....+++|..++......... +..  .....||+............      ..........+.
T Consensus       257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~------~~~~~~~~~~~~  330 (360)
T 3llt_A          257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK------KCLPLYKIIKHE  330 (360)
T ss_dssp             CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHH------TCCCHHHHCCCH
T ss_pred             CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhh------hcccccccchHH
Confidence            999999999999999999999998877655332221 111  12334555444333222211      111122334457


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCCCCC
Q 014117          395 DLTHLLQGLLRYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       395 ~~~~ll~~~L~~dP~~R~ta~elL~hp~f~  424 (430)
                      .+.+||.+||+.||++|||++|||+||||+
T Consensus       331 ~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          331 LFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            899999999999999999999999999996

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3e-55  Score=417.91  Aligned_cols=248  Identities=19%  Similarity=0.240  Sum_probs=203.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEEC-----CCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .+++++.++||+|+||+||+|...     .+++.||||+++..  ....+.+.+|+.++.++.     ||||+++++++.
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~-----HpNIV~l~g~~~   99 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ-----HPNVVCLLGVVT   99 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCC-----CTTBCCEEEEEC
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCC-----CCCCCCcceEEE
Confidence            457899999999999999999853     46789999999643  234567889999999984     489999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEe
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV  230 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~  230 (430)
                      ..+.+||||||| +|+|.++|....              ...+++..+..|+.||+.||+|||+++||||||||+||||+
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence            999999999999 999999997542              13589999999999999999999999999999999999995


Q ss_pred             ecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCC-----CCCeeeecCcccchhhhhCCCCCCcchHHH
Q 014117          231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-----DQNYIVSTRHYRAPEVILGLGWTYPCDIWS  305 (430)
Q Consensus       231 ~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws  305 (430)
                      ++                           +.+||+|||+|+....     .....+||+.|||||++.+..|+.++||||
T Consensus       180 ~~---------------------------~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwS  232 (308)
T 4gt4_A          180 DK---------------------------LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWS  232 (308)
T ss_dssp             GG---------------------------GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred             CC---------------------------CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhh
Confidence            54                           4566666666553221     123357999999999999999999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHH
Q 014117          306 VGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL  384 (430)
Q Consensus       306 lGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (430)
                      |||+||||+| |..||.+.+..+....+...  ..+                                            
T Consensus       233 fGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~--~~~--------------------------------------------  266 (308)
T 4gt4_A          233 YGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR--QVL--------------------------------------------  266 (308)
T ss_dssp             HHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT--CCC--------------------------------------------
T ss_pred             HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--CCC--------------------------------------------
Confidence            9999999998 89999988777665554321  100                                            


Q ss_pred             HhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       385 ~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                        ..++.++.++.+|+.+||+.||++|||++||+++
T Consensus       267 --~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          267 --PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence              1234667889999999999999999999999875

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.5e-53  Score=426.52  Aligned_cols=320  Identities=35%  Similarity=0.620  Sum_probs=256.1

Q ss_pred             CCceeecCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcC-CCCCceEEe
Q 014117           82 GHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGGNRCVQI  160 (430)
Q Consensus        82 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~-~~~~~i~~~  160 (430)
                      +.+.....+.+..+|++++.||+|+||+||+|.+..+++.||||+++...........|+.+++.+.+.. .+++||+.+
T Consensus        85 ~~~~~~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~  164 (429)
T 3kvw_A           85 GSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM  164 (429)
T ss_dssp             SCBCCCTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred             CCccccCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence            3445555677889999999999999999999999999999999999877666777888999999997653 356789999


Q ss_pred             cceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCC
Q 014117          161 RNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY  240 (430)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~df  240 (430)
                      ++.+...+.+|+||||++++|.+++.......+++..++.++.||+.||.|||++|||||||||+|||++.++       
T Consensus       165 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~-------  237 (429)
T 3kvw_A          165 LENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG-------  237 (429)
T ss_dssp             EEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTT-------
T ss_pred             EeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCC-------
Confidence            9999999999999999988999999887766799999999999999999999999999999999999995422       


Q ss_pred             cCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          241 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       241 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                        ...+||+|||++..........+||+.|+|||++.+..|+.++|||||||++|||++|.+||
T Consensus       238 ------------------~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf  299 (429)
T 3kvw_A          238 ------------------RSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLL  299 (429)
T ss_dssp             ------------------SCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ------------------CcceEEeecccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCC
Confidence                              12389999998877666666678999999999999999999999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChh-h---------HHhhcCchhHHHHHhhhcC
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRE-S---------IKSVMKLPRLQNLIMQHVD  390 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---------~~~~~~~~~~~~~~~~~~~  390 (430)
                      .+.+..+.+..+...++.++..++.........+...+...+........ .         ............+......
T Consensus       300 ~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  379 (429)
T 3kvw_A          300 PGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG  379 (429)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTT
T ss_pred             CCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccc
Confidence            99999999999999999999988776544333332222211111000000 0         0000001111223333445


Q ss_pred             CchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          391 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       391 ~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ..++++.+||.+||++||++|||++|||+||||++.
T Consensus       380 ~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~  415 (429)
T 3kvw_A          380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR  415 (429)
T ss_dssp             CCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred             cchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence            667889999999999999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.3e-54  Score=417.79  Aligned_cols=252  Identities=22%  Similarity=0.294  Sum_probs=201.1

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCC-----CeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRER-----KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW  163 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~  163 (430)
                      .-.++|++.++||+|+||+||+|.+..+     ++.||||+++..  ....+.+..|+++|.++.|    ++||++++++
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~h----hpnIV~l~g~  136 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH----HLNVVNLLGA  136 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC----CTTBCCEEEE
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCC----CCcEEEEEEE
Confidence            3457899999999999999999987654     468999998643  2345668889999999954    3789999998


Q ss_pred             eec-CCeEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCce
Q 014117          164 FDY-RNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENV  227 (430)
Q Consensus       164 ~~~-~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NI  227 (430)
                      +.. .+.+||||||| +|+|.++|+...              ...+++..+..|+.||+.||+|||+++||||||||+||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI  216 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  216 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence            755 56799999999 899999997642              23589999999999999999999999999999999999


Q ss_pred             EEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcch
Q 014117          228 LLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCD  302 (430)
Q Consensus       228 Ll~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~D  302 (430)
                      |++.++                           .+||+|||+|+......     ...+||+.|||||++.+..|+.++|
T Consensus       217 Ll~~~~---------------------------~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksD  269 (353)
T 4ase_A          217 LLSEKN---------------------------VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD  269 (353)
T ss_dssp             EECGGG---------------------------CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHH
T ss_pred             eeCCCC---------------------------CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCccc
Confidence            996555                           45555555554332221     2357899999999999999999999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhH
Q 014117          303 IWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL  381 (430)
Q Consensus       303 vwslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (430)
                      ||||||+||||+| |..||.+.+..+.+..+...-..                                           
T Consensus       270 VwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~-------------------------------------------  306 (353)
T 4ase_A          270 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-------------------------------------------  306 (353)
T ss_dssp             HHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-------------------------------------------
T ss_pred             EeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCC-------------------------------------------
Confidence            9999999999998 99999876544333222211100                                           


Q ss_pred             HHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       382 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                          ...++.+++++.+||.+||+.||++|||++||++|
T Consensus       307 ----~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          307 ----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence                11234567889999999999999999999999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.9e-52  Score=411.15  Aligned_cols=318  Identities=37%  Similarity=0.689  Sum_probs=247.2

Q ss_pred             CCceeecCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcC-CCCCceEEe
Q 014117           82 GHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGGNRCVQI  160 (430)
Q Consensus        82 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~-~~~~~i~~~  160 (430)
                      ..+.+..++.+.++|++.+.||+|+||+||+|.++.+++.||||+++...........|+.+++.+.++. ..+++++.+
T Consensus        42 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~  121 (382)
T 2vx3_A           42 YDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL  121 (382)
T ss_dssp             SCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred             CcEEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence            3466778889999999999999999999999999999999999999866666677788999999997543 234568999


Q ss_pred             cceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hcCeeeccCCCCceEEeecCccccC
Q 014117          161 RNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH--DLCMIHTDLKPENVLLVSSEYIKVP  238 (430)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlKp~NILl~~~~~~~i~  238 (430)
                      ++++...+.+||||||++++|.+++.......+++..++.++.||+.||.|||  +.|||||||||+|||++.       
T Consensus       122 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-------  194 (382)
T 2vx3_A          122 KRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-------  194 (382)
T ss_dssp             EEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-------
T ss_pred             eeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-------
Confidence            99999999999999999889999998876567999999999999999999999  579999999999999953       


Q ss_pred             CCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCC
Q 014117          239 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       239 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                        +..+.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|.+
T Consensus       195 ------------------~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~  256 (382)
T 2vx3_A          195 ------------------PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP  256 (382)
T ss_dssp             ------------------TTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ------------------CCCCcEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence                              23567899999998876665566789999999999999999999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhcc---CcccCCCCCCChhhHHhhcCchhHHHHHhh--------
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR---GRLDWPEGAASRESIKSVMKLPRLQNLIMQ--------  387 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  387 (430)
                      ||.+.+..+.+..+...++.+|..++...... ..+...   +.+............. ......+......        
T Consensus       257 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~  334 (382)
T 2vx3_A          257 LFSGANEVDQMNKIVEVLGIPPAHILDQAPKA-RKFFEKLPDGTWNLKKTKDGKREYK-PPGTRKLHNILGVETGGPGGR  334 (382)
T ss_dssp             SSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTH-HHHEEECTTSCEEECCCCTTCCCSC-CTTCSCHHHHHTTTTTSGGGT
T ss_pred             CCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHH-HHHHHhccccccccccccccccccC-CcchhhHHHHhhccccCCCcc
Confidence            99999999999999999999998776543222 111111   1000000000000000 0000000000000        


Q ss_pred             ------hcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          388 ------HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       388 ------~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                            .......++.+||.+||++||++|||++|+|+||||++.
T Consensus       335 ~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          335 RAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             TTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             ccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence                  001122478999999999999999999999999999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.2e-52  Score=413.12  Aligned_cols=339  Identities=30%  Similarity=0.546  Sum_probs=253.1

Q ss_pred             CCCCceeecCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCC---CCCc
Q 014117           80 KDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK---GGNR  156 (430)
Q Consensus        80 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~---~~~~  156 (430)
                      ..+.+.+..++.+.++|++.+.||+|+||+||+|++..+++.||||+++........+..|+.+++.+.+...   ++++
T Consensus        23 ~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~  102 (397)
T 1wak_A           23 KGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM  102 (397)
T ss_dssp             C--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGG
T ss_pred             CCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcce
Confidence            3456678888999999999999999999999999999999999999998766666778899999999987543   2567


Q ss_pred             eEEecceee----cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeccCCCCceEEee
Q 014117          157 CVQIRNWFD----YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVS  231 (430)
Q Consensus       157 i~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlKp~NILl~~  231 (430)
                      |+++++.+.    ....+|+||||++++|.+++.......+++..++.++.||+.||.|||++ |||||||||+|||++.
T Consensus       103 iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~  182 (397)
T 1wak_A          103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSV  182 (397)
T ss_dssp             BCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECC
T ss_pred             eeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEec
Confidence            999999887    56789999999999998888776656799999999999999999999998 9999999999999987


Q ss_pred             cCccccCCCc------CCCCCCCC----------Cc------ccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccch
Q 014117          232 SEYIKVPDYK------SSLHTPKD----------SS------YFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAP  289 (430)
Q Consensus       232 ~~~~~i~dfg------~~~~~~~~----------~~------~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aP  289 (430)
                      ++.....+++      .....+..          ..      ..........+||+|||++..........+||+.|+||
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aP  262 (397)
T 1wak_A          183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSL  262 (397)
T ss_dssp             CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCH
T ss_pred             cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCC
Confidence            6532111110      00000000          00      00000123479999999998766655667899999999


Q ss_pred             hhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc------hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCC
Q 014117          290 EVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWP  363 (430)
Q Consensus       290 E~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~------~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  363 (430)
                      |++.+..++.++|||||||++|||++|..||...+      ..+....+.+.+|.+|..++.........+...+.....
T Consensus       263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  342 (397)
T 1wak_A          263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI  342 (397)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence            99999999999999999999999999999997654      567788899999999987765443332222222222111


Q ss_pred             CCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          364 EGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      ...........       .......+...+.++.+||.+||+.||++|||++|||+||||++
T Consensus       343 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          343 TKLKPWGLFEV-------LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCCCCHHHH-------HHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             cccCCcchhHh-------hhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            11111100000       00011123445677999999999999999999999999999974

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.7e-52  Score=403.80  Aligned_cols=336  Identities=45%  Similarity=0.846  Sum_probs=264.4

Q ss_pred             CCCCCCceeecCceecCcEEEEeeeccccceEEEEEEECCCC-eEEEEEEecCchhhHHHHHHHHHHHHHHHhcCC-CCC
Q 014117           78 DDKDGHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK-GGN  155 (430)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~-~~~  155 (430)
                      ++..+.+....++.+.++|++.+.||+|+||+||+|.+..++ +.||+|+++...........|+.+++.+.+... .+.
T Consensus         3 ~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~   82 (355)
T 2eu9_A            3 DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKF   82 (355)
T ss_dssp             BCTTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCS
T ss_pred             cccCCCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCce
Confidence            456677888899999999999999999999999999998776 789999998766667778889999999987543 334


Q ss_pred             ceEEecceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCcc
Q 014117          156 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI  235 (430)
Q Consensus       156 ~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~  235 (430)
                      +++.+++++...+.+|+||||++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+...+..
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~  162 (355)
T 2eu9_A           83 LCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFE  162 (355)
T ss_dssp             CBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEE
T ss_pred             eEEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccc
Confidence            57888999999999999999999999999887765679999999999999999999999999999999999999765543


Q ss_pred             ccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh
Q 014117          236 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT  315 (430)
Q Consensus       236 ~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t  315 (430)
                      .+.+.....        ....+....+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       163 ~~~~~~~~~--------~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  234 (355)
T 2eu9_A          163 TLYNEHKSC--------EEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR  234 (355)
T ss_dssp             EEECCC-CC--------CEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred             ccccccccc--------cccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence            332222111        011145678999999999876666666789999999999999999999999999999999999


Q ss_pred             CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhH
Q 014117          316 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD  395 (430)
Q Consensus       316 G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (430)
                      |..||...+..+....+....+++|..++.....  ..+...+...|+............+...  . .........+.+
T Consensus       235 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~  309 (355)
T 2eu9_A          235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRK--QKYFYKGGLVWDENSSDGRYVKENCKPL--K-SYMLQDSLEHVQ  309 (355)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSC--GGGEETTEECCCTTSHHHHHHHHHCCCG--G-GGCSCCSHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccc--hhhhcccccccccccchhccccccCCcc--c-ccccccchhHHH
Confidence            9999999999999999999999999988765432  2223334444444321111111110000  0 000111233567


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          396 LTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       396 ~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +.+||.+||+.||++|||++|+|+||||+..
T Consensus       310 l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          310 LFDLMRRMLEFDPAQRITLAEALLHPFFAGL  340 (355)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence            9999999999999999999999999999864

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.1e-52  Score=400.34  Aligned_cols=330  Identities=46%  Similarity=0.841  Sum_probs=258.8

Q ss_pred             ceeecCceecCcEEEEeeeccccceEEEEEEE-CCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcC-CCCCceEEec
Q 014117           84 YMFALGENLTSRYKIHSKMGEGTFGQVLECWD-RERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGGNRCVQIR  161 (430)
Q Consensus        84 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~-~~~~~i~~~~  161 (430)
                      .....++.+.++|++.+.||+|+||.||+|.+ ..+++.||+|+++...........|+.+++.+.+.. ..++++++++
T Consensus         4 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~   83 (339)
T 1z57_A            4 LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQML   83 (339)
T ss_dssp             GTCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred             eeeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence            44566788889999999999999999999998 568899999999876666677889999999998754 3445789999


Q ss_pred             ceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          162 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      +++...+.+|+||||++++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++..+.....+.+
T Consensus        84 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           84 EWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             EEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             cccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence            99999999999999999999999988766679999999999999999999999999999999999999764432221111


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                      ...        ......++.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus       164 ~~~--------~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  235 (339)
T 1z57_A          164 IKR--------DERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP  235 (339)
T ss_dssp             --C--------EEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccc--------ccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence            100        000012567999999999877666666789999999999999999999999999999999999999999


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      ..+..+....+....+++|..++.....  ..+...+...|+...............  + .......+..+.++.+||.
T Consensus       236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~l~~li~  310 (339)
T 1z57_A          236 THDSKEHLAMMERILGPLPKHMIQKTRK--RKYFHHDRLDWDEHSSAGRYVSRACKP--L-KEFMLSQDVEHERLFDLIQ  310 (339)
T ss_dssp             CSCHHHHHHHHHHHHCSCCHHHHHHCSC--GGGEETTEECCCTTSHHHHHHHHHCCC--G-GGGCSCCSHHHHHHHHHHH
T ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhccc--hhHHhhccccccccccccchhhhcCcc--h-hhhcccchhhHHHHHHHHH
Confidence            9999999999999999999988775432  223333444555432211111111000  0 0011122344678999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          402 GLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +||+.||.+|||++|+|+||||+..
T Consensus       311 ~~L~~dP~~Rpt~~ell~hp~f~~~  335 (339)
T 1z57_A          311 KMLEYDPAKRITLREALKHPFFDLL  335 (339)
T ss_dssp             HHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred             HHhCcCcccccCHHHHhcCHHHHHH
Confidence            9999999999999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-51  Score=394.76  Aligned_cols=287  Identities=29%  Similarity=0.539  Sum_probs=223.9

Q ss_pred             CceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch------hhHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 014117           89 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRN  162 (430)
Q Consensus        89 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~  162 (430)
                      ++.+.++|++.+.||+|+||+||+|++..+++.||+|+++...      ........|+.+++.+...  .|+||+++++
T Consensus         4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~h~niv~~~~   81 (308)
T 3g33_A            4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF--EHPNVVRLMD   81 (308)
T ss_dssp             ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHH--CCTTBCCEEE
T ss_pred             CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhc--CCCCeEEeee
Confidence            4566789999999999999999999999999999999986321      1234566788888888642  3488999999


Q ss_pred             eeecCC-----eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCcccc
Q 014117          163 WFDYRN-----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV  237 (430)
Q Consensus       163 ~~~~~~-----~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i  237 (430)
                      ++....     .+++||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++       
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~-------  154 (308)
T 3g33_A           82 VCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT-------  154 (308)
T ss_dssp             EEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEEC-------
T ss_pred             eeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc-------
Confidence            887654     68999999988999999987656699999999999999999999999999999999999994       


Q ss_pred             CCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh
Q 014117          238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT  315 (430)
Q Consensus       238 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t  315 (430)
                                          .++.+||+|||++.......  ...+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       155 --------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~  214 (308)
T 3g33_A          155 --------------------SGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR  214 (308)
T ss_dssp             --------------------TTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTT
T ss_pred             --------------------CCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHh
Confidence                                45567777777776443222  34578999999999999999999999999999999999


Q ss_pred             CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCC-hhhHHhhcCchhHHHHHhhhcCCchh
Q 014117          316 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAAS-RESIKSVMKLPRLQNLIMQHVDHSAG  394 (430)
Q Consensus       316 G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (430)
                      |.+||.+.+..+....+....+.++...                  |+..... ...+     ............+..+.
T Consensus       215 g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------------~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  271 (308)
T 3g33_A          215 RKPLFCGNSEADQLGKIFDLIGLPPEDD------------------WPRDVSLPRGAF-----PPRGPRPVQSVVPEMEE  271 (308)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHHCCCCTTT------------------SCSSCSSCGGGS-----CCCCCCCHHHHSCSCCH
T ss_pred             CCCCCCCCCHHHHHHHHHHHhCCCChhh------------------ccchhhcccccc-----CCCCCCcHHHhCccccH
Confidence            9999999999999999998888877542                  1111100 0000     00001112234567788


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          395 DLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       395 ~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      ++.+||.+||+.||++|||++|+|+||||++..
T Consensus       272 ~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          272 SGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             HHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            999999999999999999999999999998753

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.7e-51  Score=415.31  Aligned_cols=301  Identities=25%  Similarity=0.437  Sum_probs=230.2

Q ss_pred             CCceeecCc---eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCC
Q 014117           82 GHYMFALGE---NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGN  155 (430)
Q Consensus        82 ~~~~~~~~~---~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~  155 (430)
                      +.+.+..++   .+.++|++++.||+|+||+||+|.+..+++.||||++...   ......+.+|+.+++.+     .|+
T Consensus        47 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp  121 (464)
T 3ttj_A           47 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHK  121 (464)
T ss_dssp             CEEEEEC--CEEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-----CCT
T ss_pred             cceeeecCCcceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-----CCC
Confidence            345555555   4578999999999999999999999999999999999743   23445677899999888     348


Q ss_pred             ceEEecceeecC------CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEE
Q 014117          156 RCVQIRNWFDYR------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLL  229 (430)
Q Consensus       156 ~i~~~~~~~~~~------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl  229 (430)
                      ||+++++++...      ..+||||||++++|.+.+..    .+++..++.++.||+.||+|||++|||||||||+|||+
T Consensus       122 nIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll  197 (464)
T 3ttj_A          122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV  197 (464)
T ss_dssp             TBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred             CCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE
Confidence            899999988544      57899999998888888753    48999999999999999999999999999999999999


Q ss_pred             eecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHH
Q 014117          230 VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVG  307 (430)
Q Consensus       230 ~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  307 (430)
                      +                           .++.+||+|||+++.....  ....+||+.|+|||++.+..|+.++||||||
T Consensus       198 ~---------------------------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  250 (464)
T 3ttj_A          198 K---------------------------SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG  250 (464)
T ss_dssp             C---------------------------TTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHH
T ss_pred             e---------------------------CCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHH
Confidence            4                           4556777777777654432  2346899999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhh
Q 014117          308 CILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ  387 (430)
Q Consensus       308 v~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (430)
                      |++|||++|++||.+.+..+++..|.+.+|.++++.+..+......+...... +...     .+........ ......
T Consensus       251 ~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~-~~~~~~  323 (464)
T 3ttj_A          251 CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK-YAGL-----TFPKLFPDSL-FPADSE  323 (464)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCC-CCCC-----CHHHHSCGGG-SCCSSH
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccc-cCCC-----ChHHhCcccc-cccccc
Confidence            99999999999999999999999999999999998887776665555543211 1100     0000000000 000000


Q ss_pred             hcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       388 ~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      .....+.++.+||.+||++||++|||++|+|+||||+.
T Consensus       324 ~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          324 HNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             HHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             cccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence            01112667999999999999999999999999999974

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.3e-51  Score=403.04  Aligned_cols=262  Identities=26%  Similarity=0.452  Sum_probs=222.3

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh-------hHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRN  162 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~  162 (430)
                      ..+.++|++.+.||+|+||.||+|.++.+++.||+|+++....       ..+.+..|+.+++.+.     |+||+++++
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-----hpnIv~l~~   82 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-----HPNIITLHD   82 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-----CTTBCCEEE
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-----CcCCCcEEE
Confidence            4567789999999999999999999999999999999864321       2456788999988873     588999999


Q ss_pred             eeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          163 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       163 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      ++.+.+.+|+||||+ |++|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||++.++        
T Consensus        83 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~--------  152 (361)
T 2yab_A           83 VYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN--------  152 (361)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT--------
T ss_pred             EEEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCC--------
Confidence            999999999999999 899999997654  799999999999999999999999999999999999995433        


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL  319 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~P  319 (430)
                                     .....+||+|||++......  ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+|
T Consensus       153 ---------------~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~P  217 (361)
T 2yab_A          153 ---------------IPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP  217 (361)
T ss_dssp             ---------------SSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred             ---------------CCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence                           12236888888888754433  2446899999999999999999999999999999999999999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |.+.+..+.+..+......++..                                             .+...+.++.+|
T Consensus       218 f~~~~~~~~~~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~l  252 (361)
T 2yab_A          218 FLGDTKQETLANITAVSYDFDEE---------------------------------------------FFSQTSELAKDF  252 (361)
T ss_dssp             SCCSSHHHHHHHHHTTCCCCCHH---------------------------------------------HHTTSCHHHHHH
T ss_pred             CCCCCHHHHHHHHHhcCCCCCch---------------------------------------------hccCCCHHHHHH
Confidence            99888777776665544333322                                             234567789999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          400 LQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      |.+||+.||.+|||++|+|+||||+..
T Consensus       253 i~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          253 IRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             HHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            999999999999999999999999854

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.8e-51  Score=395.69  Aligned_cols=252  Identities=23%  Similarity=0.355  Sum_probs=213.2

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....   .....+.+|+++++.+.     |+||+++++++...+
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~l~~~~~~~~   87 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN-----HPNIVKLFEVIETEK   87 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-----CTTBCCEEEEEECSS
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC-----CCCEeeEEEEEEECC
Confidence            4568999999999999999999999999999999986432   33456778999998884     488999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+|+||||+ +++|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||+                  
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll------------------  147 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL------------------  147 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------------
T ss_pred             EEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE------------------
Confidence            999999999 889999998765  79999999999999999999999999999999999999                  


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                               +.++.+||+|||++.......  ...+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+
T Consensus       148 ---------~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  218 (328)
T 3fe3_A          148 ---------DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN  218 (328)
T ss_dssp             ---------CTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ---------cCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence                     455667777777776443322  345899999999999998875 79999999999999999999999877


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+....+......                                                 .+...+.++.+||.+||
T Consensus       219 ~~~~~~~i~~~~~~-------------------------------------------------~p~~~s~~~~~li~~~L  249 (328)
T 3fe3_A          219 LKELRERVLRGKYR-------------------------------------------------IPFYMSTDCENLLKRFL  249 (328)
T ss_dssp             HHHHHHHHHHCCCC-------------------------------------------------CCTTSCHHHHHHHHHHC
T ss_pred             HHHHHHHHHhCCCC-------------------------------------------------CCCCCCHHHHHHHHHHC
Confidence            66655544332111                                                 12245678999999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +.||.+|||++|+|+||||+..
T Consensus       250 ~~dP~~R~t~~eil~h~~~~~~  271 (328)
T 3fe3_A          250 VLNPIKRGTLEQIMKDRWINAG  271 (328)
T ss_dssp             CSSTTTSCCHHHHTTCTTTTTT
T ss_pred             CCChhHCcCHHHHhcCHhhcCC
Confidence            9999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.9e-51  Score=394.04  Aligned_cols=286  Identities=28%  Similarity=0.436  Sum_probs=226.1

Q ss_pred             CceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           89 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        89 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      ++.+.++|+++++||+|+||+||+|.+. +++.||+|+++...   .....+..|+++++.+.     |+||+++++++.
T Consensus        16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~~~~~~~   89 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELH-----HPNIVSLIDVIH   89 (311)
T ss_dssp             EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCC-----CTTBCCEEEEEC
T ss_pred             ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcC-----CCCEeeeeeEEc
Confidence            4567789999999999999999999985 58899999986432   23456778999999983     488999999999


Q ss_pred             cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          166 YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       166 ~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      ..+.+|+||||+.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++               
T Consensus        90 ~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~---------------  153 (311)
T 3niz_A           90 SERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN---------------  153 (311)
T ss_dssp             CSSCEEEEEECCSEEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---------------
T ss_pred             cCCEEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC---------------
Confidence            999999999999889999987654 4699999999999999999999999999999999999994               


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                                  .++.+||+|||++......   ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus       154 ------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  221 (311)
T 3niz_A          154 ------------SDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP  221 (311)
T ss_dssp             ------------TTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ------------CCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCC
Confidence                        4556777777777654322   233478999999999987 468999999999999999999999999


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      +.+..+....+...++.++...+..+.......  ...+....                 ........+.++.++.+||.
T Consensus       222 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-----------------~~~~~~~~~~~~~~~~~li~  282 (311)
T 3niz_A          222 GVTDDDQLPKIFSILGTPNPREWPQVQELPLWK--QRTFQVFE-----------------KKPWSSIIPGFCQEGIDLLS  282 (311)
T ss_dssp             CSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH--SCCCCCCC-----------------CCCHHHHSTTCCHHHHHHHH
T ss_pred             CCChHHHHHHHHHHHCCCChHHhhhhhccchhh--hccccccc-----------------CCcHHHhCcccCHHHHHHHH
Confidence            988888888888888887654333222111100  00000000                 00112234567788999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          402 GLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      +||++||++|||++|+|+||||++-+
T Consensus       283 ~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          283 NMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             HHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             HHcCCChhHCCCHHHHhcCcccccCC
Confidence            99999999999999999999998754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-51  Score=396.54  Aligned_cols=260  Identities=23%  Similarity=0.402  Sum_probs=223.2

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .+.++|++.+.||+|+||.||+|.++.+++.||+|+++........+..|+.+++.+.     |+||+++++++.+.+.+
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-----HRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSC-----CTTBCCEEEEEEETTEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCC-----CCCCCeEeEEEecCCEE
Confidence            3567899999999999999999999999999999999866555667788999999884     58899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.                  
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~------------------  137 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT------------------  137 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS------------------
T ss_pred             EEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc------------------
Confidence            9999999 889999997643 46999999999999999999999999999999999999953                  


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                             +.++.+||+|||++.......  ....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+
T Consensus       138 -------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  210 (321)
T 1tki_A          138 -------RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ  210 (321)
T ss_dssp             -------SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             -------CCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH
Confidence                   125678899999887654433  33579999999999999889999999999999999999999999888777


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+......++..                                             .+...+.++.+||.+||+.|
T Consensus       211 ~~~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li~~~L~~d  245 (321)
T 1tki_A          211 IIENIMNAEYTFDEE---------------------------------------------AFKEISIEAMDFVDRLLVKE  245 (321)
T ss_dssp             HHHHHHHTCCCCCHH---------------------------------------------HHTTSCHHHHHHHHTTSCSS
T ss_pred             HHHHHHcCCCCCChh---------------------------------------------hhccCCHHHHHHHHHHcCCC
Confidence            776665544433322                                             12356778999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~  426 (430)
                      |.+|||+.|+|+||||++.
T Consensus       246 p~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          246 RKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             GGGSCCHHHHHHSHHHHSC
T ss_pred             hhHCcCHHHHhcChhhccC
Confidence            9999999999999999764

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.7e-51  Score=413.83  Aligned_cols=311  Identities=26%  Similarity=0.451  Sum_probs=216.4

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee--
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--  165 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~--  165 (430)
                      .+.++|++++.||+|+||+||+|+++.+++.||||++...   ......+.+|+.+|+.+.     |+||+++++++.  
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~  124 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN-----HDHVVKVLDIVIPK  124 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-----CTTBCCEEEECCCS
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCC-----CCCCCceEEEEecC
Confidence            3457899999999999999999999999999999998642   234456778999999983     588999999883  


Q ss_pred             ---cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          166 ---YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       166 ---~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                         ....+|+||||++++|.+++....  .+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+
T Consensus       125 ~~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          125 DVEKFDELYVVLEIADSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             CTTTCCCEEEEECCCSEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CcccCceEEEEEeccccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeeccccc
Confidence               346899999999999999997654  799999999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCCCccccc---CCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhh-CCCCCCcchHHHHHHHHHHHHh---
Q 014117          243 SLHTPKDSSYFKR---MPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCT---  315 (430)
Q Consensus       243 ~~~~~~~~~~~~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~t---  315 (430)
                      +............   ........+++|+............+||+.|+|||++. +..|+.++|||||||++|||++   
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            8765432211000   01112234455554433333344568999999999874 5679999999999999999998   


Q ss_pred             --------CCCCCCCCc--------------------hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCC
Q 014117          316 --------GEALFQTHE--------------------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA  367 (430)
Q Consensus       316 --------G~~Pf~~~~--------------------~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (430)
                              |.++|.+.+                    ..+++..|...+|.++.+.+..+...........   .+... 
T Consensus       283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~---~~~~~-  358 (458)
T 3rp9_A          283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRI---FPKRE-  358 (458)
T ss_dssp             TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTT---SCCCC-
T ss_pred             ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHh---cCCCC-
Confidence                    778886643                    3678888999999999877654432211111110   00000 


Q ss_pred             ChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          368 SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                                    .......++..+.++.+||.+||++||.+|||++|+|+||||+.-
T Consensus       359 --------------~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          359 --------------GTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             --------------CCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             --------------CCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence                          001122345668899999999999999999999999999999865

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-51  Score=400.67  Aligned_cols=281  Identities=27%  Similarity=0.503  Sum_probs=225.3

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-  167 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~-  167 (430)
                      +.++|++++.||+|+||.||+|.+..+++.||||++...   ......+.+|+.+++.+.     |+||+++++++... 
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~l~~~~~~~~   97 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-----HENVIGLLDVFTPDE   97 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-----BTTBCCCSEEECSCS
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-----CcCCCCceeeEecCC
Confidence            467899999999999999999999999999999998532   234456778999999984     48899999988765 


Q ss_pred             -----CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          168 -----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       168 -----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                           ..+|+||||++++|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||+             
T Consensus        98 ~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll-------------  161 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV-------------  161 (367)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE-------------
T ss_pred             ccccCceEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE-------------
Confidence                 356999999999999999863   69999999999999999999999999999999999999             


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCC
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                                    +.++.+||+|||+++.........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus       162 --------------~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  227 (367)
T 1cm8_A          162 --------------NEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK  227 (367)
T ss_dssp             --------------CTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             --------------cCCCCEEEEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence                          44566788888887765555555689999999999987 679999999999999999999999999


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhh-hhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      +.+..+++..+.+..|.+|..++..+..... .+... ....+.                  ......+...+.++.+||
T Consensus       228 ~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~------------------~~~~~~~~~~~~~~~~ll  288 (367)
T 1cm8_A          228 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG-LPELEK------------------KDFASILTNASPLAVNLL  288 (367)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHH-SCCCCC------------------CCGGGTCTTCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHh-CCCCCC------------------CCHHHHCCCCCHHHHHHH
Confidence            9999999999999999999887665432211 11111 000000                  001123456678899999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          401 QGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      .+||+.||.+|||++|+|+||||+..
T Consensus       289 ~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          289 EKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             HHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHccCChhHCCCHHHHhcChHHHhh
Confidence            99999999999999999999999864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.1e-51  Score=400.40  Aligned_cols=252  Identities=25%  Similarity=0.377  Sum_probs=209.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++++.||+|+||.||+|+++.+++.||||++++..    ........|..++..+.    +|++|+++++++.+.+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~----~hp~Iv~l~~~~~~~~   97 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR----NHPFLTQLFCCFQTPD   97 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTT----TCTTBCCEEEEEECSS
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhcc----CCCceeeEEEEEEeCC
Confidence            467999999999999999999999999999999997432    23345667888887764    3588999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+||||||+ |++|.+++....  .+++..++.++.||+.||+|||++|||||||||+|||++                 
T Consensus        98 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~-----------------  158 (353)
T 3txo_A           98 RLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD-----------------  158 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC-----------------
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC-----------------
Confidence            999999999 889999998764  799999999999999999999999999999999999994                 


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                .++.+||+|||+++....   .....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus       159 ----------~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~  228 (353)
T 3txo_A          159 ----------HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN  228 (353)
T ss_dssp             ----------TTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ----------CCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence                      445667777776654221   2234689999999999999899999999999999999999999999888


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+....|......                                                 ++...+.++.+||.+||
T Consensus       229 ~~~~~~~i~~~~~~-------------------------------------------------~p~~~~~~~~~li~~lL  259 (353)
T 3txo_A          229 EDDLFEAILNDEVV-------------------------------------------------YPTWLHEDATGILKSFM  259 (353)
T ss_dssp             HHHHHHHHHHCCCC-------------------------------------------------CCTTSCHHHHHHHHHHT
T ss_pred             HHHHHHHHHcCCCC-------------------------------------------------CCCCCCHHHHHHHHHHh
Confidence            77766665442222                                                 12345678999999999


Q ss_pred             hcCCCCCCCH------HHHhcCCCCCCC
Q 014117          405 RYDPTDRLTA------REALRHPFFTRD  426 (430)
Q Consensus       405 ~~dP~~R~ta------~elL~hp~f~~~  426 (430)
                      ++||.+||++      +|+++||||+..
T Consensus       260 ~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          260 TKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             CSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             hhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            9999999998      899999999864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9.5e-51  Score=393.25  Aligned_cols=250  Identities=24%  Similarity=0.408  Sum_probs=210.2

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++++.||+|+||.||+|+++.+++.||+|++++..    ........|+.+++.+     .|++|+++++++...+.
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~l~~~~~~~~~   79 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-----RHPFLTALKYAFQTHDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-----CCTTBCCEEEEEECSSE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-----CCCcCcceEEEEEeCCE
Confidence            57999999999999999999999999999999997432    2345567788888776     45889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|+||||+ |++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++                  
T Consensus        80 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~------------------  139 (337)
T 1o6l_A           80 LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD------------------  139 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC------------------
T ss_pred             EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC------------------
Confidence            99999999 889999998764  799999999999999999999999999999999999995                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                               .++.+||+|||++.....   .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+.
T Consensus       140 ---------~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~  210 (337)
T 1o6l_A          140 ---------KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH  210 (337)
T ss_dssp             ---------TTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ---------CCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH
Confidence                     445666666776653221   22346899999999999999999999999999999999999999988766


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+....+.....                                                 .++...+.++.+||.+||+
T Consensus       211 ~~~~~~i~~~~~-------------------------------------------------~~p~~~s~~~~~li~~lL~  241 (337)
T 1o6l_A          211 ERLFELILMEEI-------------------------------------------------RFPRTLSPEAKSLLAGLLK  241 (337)
T ss_dssp             HHHHHHHHHCCC-------------------------------------------------CCCTTSCHHHHHHHHHHTC
T ss_pred             HHHHHHHHcCCC-------------------------------------------------CCCCCCCHHHHHHHHHHhh
Confidence            655544432111                                                 1233567789999999999


Q ss_pred             cCCCCCC-----CHHHHhcCCCCCCC
Q 014117          406 YDPTDRL-----TAREALRHPFFTRD  426 (430)
Q Consensus       406 ~dP~~R~-----ta~elL~hp~f~~~  426 (430)
                      .||.+||     +++|+++||||+..
T Consensus       242 ~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          242 KDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             SSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             cCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            9999999     99999999999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-51  Score=390.59  Aligned_cols=250  Identities=25%  Similarity=0.407  Sum_probs=213.8

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++++.||+|+||.||+|+++.+++.||+|++++..    ...+....|..++..+     .|+||+++++++.+...
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~Iv~~~~~~~~~~~   80 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-----THPFIIRMWGTFQDAQQ   80 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-----CBTTBCCEEEEEECSSE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-----CCCCCceEeEEEEeCCE
Confidence            57999999999999999999999999999999997432    2334566788887776     45889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|+||||+ |++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||+                   
T Consensus        81 ~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll-------------------  139 (318)
T 1fot_A           81 IFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL-------------------  139 (318)
T ss_dssp             EEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE-------------------
T ss_pred             EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE-------------------
Confidence            99999999 889999998764  79999999999999999999999999999999999999                   


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                              +.++.+||+|||++..........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.
T Consensus       140 --------~~~g~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  211 (318)
T 1fot_A          140 --------DKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT  211 (318)
T ss_dssp             --------CTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             --------cCCCCEEEeecCcceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence                    445667777778776655555567899999999999999999999999999999999999999988776666


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      ...+......                                                 ++...+.++.+||.+||+.||
T Consensus       212 ~~~i~~~~~~-------------------------------------------------~p~~~~~~~~~li~~lL~~dp  242 (318)
T 1fot_A          212 YEKILNAELR-------------------------------------------------FPPFFNEDVKDLLSRLITRDL  242 (318)
T ss_dssp             HHHHHHCCCC-------------------------------------------------CCTTSCHHHHHHHHHHTCSCT
T ss_pred             HHHHHhCCCC-------------------------------------------------CCCCCCHHHHHHHHHHhccCH
Confidence            5554432111                                                 233456789999999999999


Q ss_pred             CCCC-----CHHHHhcCCCCCCC
Q 014117          409 TDRL-----TAREALRHPFFTRD  426 (430)
Q Consensus       409 ~~R~-----ta~elL~hp~f~~~  426 (430)
                      .+||     +++|+++||||+..
T Consensus       243 ~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          243 SQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             TTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHcCCCcCCCHHHHhcCccccCC
Confidence            9999     89999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-50  Score=389.85  Aligned_cols=263  Identities=25%  Similarity=0.461  Sum_probs=221.5

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh-------hHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRN  162 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~  162 (430)
                      +.+.++|++.+.||+|+||.||+|.++.+++.||+|+++....       ..+.+..|+.+++.+.     |+||+++++
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~~~~   81 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-----HPNVITLHE   81 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-----CTTBCCEEE
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-----CCCCCcEEE
Confidence            3456789999999999999999999999999999999864321       3466788999999984     488999999


Q ss_pred             eeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          163 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       163 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      ++.....+|+||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++        
T Consensus        82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~--------  151 (326)
T 2y0a_A           82 VYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN--------  151 (326)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSS--------
T ss_pred             EEEeCCEEEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCC--------
Confidence            999999999999999 889999997654  799999999999999999999999999999999999996543        


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL  319 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~P  319 (430)
                                     .....+||+|||++......  ....+||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       152 ---------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p  216 (326)
T 2y0a_A          152 ---------------VPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP  216 (326)
T ss_dssp             ---------------SSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred             ---------------CCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCC
Confidence                           12337888888888754322  2346799999999999999999999999999999999999999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |.+.+..+....+.......+..                                             .+...+.++.+|
T Consensus       217 f~~~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~l  251 (326)
T 2y0a_A          217 FLGDTKQETLANVSAVNYEFEDE---------------------------------------------YFSNTSALAKDF  251 (326)
T ss_dssp             SCCSSHHHHHHHHHHTCCCCCHH---------------------------------------------HHTTSCHHHHHH
T ss_pred             CCCCCHHHHHHHHHhcCCCcCcc---------------------------------------------ccccCCHHHHHH
Confidence            99877777666655443333321                                             224567789999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          400 LQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      |.+||+.||.+|||++|+|+||||+...
T Consensus       252 i~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          252 IRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             HHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            9999999999999999999999998653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.1e-51  Score=393.53  Aligned_cols=191  Identities=23%  Similarity=0.311  Sum_probs=152.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHH--HHHHHhcCCCCCceEEecceeecCC--
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV--LQQLAKHDKGGNRCVQIRNWFDYRN--  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~--l~~l~~~~~~~~~i~~~~~~~~~~~--  168 (430)
                      ..+|.+.++||+|+||+||+|.+  +|+.||||+++....  .....|.++  +.++     .|+||+++++++...+  
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~l-----~HpNIv~l~g~~~~~~~~   72 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVML-----RHENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTC-----CCTTBCCEEEEEEEECSS
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hhHHHHHHHHHHhcC-----CCCCCCcEEEEEEecCCC
Confidence            35689999999999999999987  588999999975433  233334433  3333     5689999999987543  


Q ss_pred             --eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CeeeccCCCCceEEeecCcccc
Q 014117          169 --HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL--------CMIHTDLKPENVLLVSSEYIKV  237 (430)
Q Consensus       169 --~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--------~ivHrDlKp~NILl~~~~~~~i  237 (430)
                        .+||||||| +|+|.++|+..   .+++..+..++.|++.||+|||++        +||||||||+||||+       
T Consensus        73 ~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~-------  142 (303)
T 3hmm_A           73 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-------  142 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC-------
T ss_pred             ceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC-------
Confidence              689999999 89999999865   599999999999999999999987        899999999999994       


Q ss_pred             CCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-------CeeeecCcccchhhhhCC------CCCCcchHH
Q 014117          238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGL------GWTYPCDIW  304 (430)
Q Consensus       238 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~------~~~~~~Dvw  304 (430)
                                          .++.+||+|||+|+......       ...+||+.|||||++.+.      .|+.++|||
T Consensus       143 --------------------~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVw  202 (303)
T 3hmm_A          143 --------------------KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY  202 (303)
T ss_dssp             --------------------TTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHH
T ss_pred             --------------------CCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhh
Confidence                                45566677777665433221       235799999999999765      367899999


Q ss_pred             HHHHHHHHHHhCCCCCCC
Q 014117          305 SVGCILVELCTGEALFQT  322 (430)
Q Consensus       305 slGv~l~el~tG~~Pf~~  322 (430)
                      ||||+||||+||.+||..
T Consensus       203 S~Gvvl~El~tg~~~~~~  220 (303)
T 3hmm_A          203 AMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             HHHHHHHHHHHTBCBTTB
T ss_pred             hHHHHHHHHHHCCCCCCc
Confidence            999999999999888754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-50  Score=400.50  Aligned_cols=315  Identities=26%  Similarity=0.454  Sum_probs=219.5

Q ss_pred             CceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           89 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        89 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      +..+.++|++++.||+|+||.||+|.++.+++.||||++...   .........|+.++..+.    +|+||+++++++.
T Consensus         4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~l~~~~~   79 (388)
T 3oz6_A            4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS----GHENIVNLLNVLR   79 (388)
T ss_dssp             CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTT----TCTTBCCEEEEEE
T ss_pred             cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhcc----CCCCCCeeeeEEe
Confidence            345678899999999999999999999999999999998532   334456678888888885    3478999999986


Q ss_pred             cC--CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCC
Q 014117          166 YR--NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       166 ~~--~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                      ..  ..+|+||||++++|.+++...   .+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||++
T Consensus        80 ~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           80 ADNDRDVYLVFDYMETDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             CTTSSCEEEEEECCSEEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cCCCCEEEEEecccCcCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            54  489999999988999999864   6999999999999999999999999999999999999977777777776666


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                      ..................-....+.   .........+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFD---DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC------------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccccccccccccccccccccc---cccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence            4332211000000000000000000   00111133589999999999987 5799999999999999999999999999


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhh-----ccC---cccCCCCCCChhhHHhhcCchhHHHHH--hhhcCCc
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV-----RRG---RLDWPEGAASRESIKSVMKLPRLQNLI--MQHVDHS  392 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~-----~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  392 (430)
                      .+..+++..+...++.++...+..+........     ...   ...+..   .         ........  .......
T Consensus       234 ~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~---------~~~~~~~~~~~~~~~~~  301 (388)
T 3oz6_A          234 SSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRD---I---------FTKWKNLLLKINPKADC  301 (388)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCC---C---------HHHHHHHHHHHCTTCCC
T ss_pred             CCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHH---h---------CcchhhhcccccccccC
Confidence            999999999999999888766543221110000     000   000000   0         00011111  1123467


Q ss_pred             hhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       393 ~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      +.++.+||.+||+.||++|||++|+|+||||+.
T Consensus       302 ~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~  334 (388)
T 3oz6_A          302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSI  334 (388)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTT
T ss_pred             CHHHHHHHHHhhccCcccCCCHHHHhCCHHHHH
Confidence            889999999999999999999999999999975

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.1e-50  Score=385.02  Aligned_cols=280  Identities=28%  Similarity=0.483  Sum_probs=220.8

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ++|+++++||+|+||+||+|.++.+++.||+|+++...   .......+|+.+++++.     |+||+++++++...+.+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-----HKNIVRLHDVLHSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-----CTTBCCEEEEEEETTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCC-----CCCEeeEEeEEEeCCEE
Confidence            57999999999999999999999999999999986432   33456778888888873     48899999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      |+||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++                    
T Consensus        77 ~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~--------------------  135 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN--------------------  135 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--------------------
T ss_pred             EEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--------------------
Confidence            9999999888888877643 4799999999999999999999999999999999999994                    


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCC-CCCcchHHHHHHHHHHHHhCCCC-CCCCch
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEAL-FQTHEN  325 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~tG~~P-f~~~~~  325 (430)
                             .++.+||+|||++......   .....||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+.
T Consensus       136 -------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~  208 (292)
T 3o0g_A          136 -------RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV  208 (292)
T ss_dssp             -------TTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH
T ss_pred             -------CCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH
Confidence                   4556777777777643322   23357899999999998776 89999999999999999987766 667777


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+....+....+.++...+.........      ..++...              .........+..+.++.+||.+||+
T Consensus       209 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~------~~~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~L~  268 (292)
T 3o0g_A          209 DDQLKRIFRLLGTPTEEQWPSMTKLPDY------KPYPMYP--------------ATTSLVNVVPKLNATGRDLLQNLLK  268 (292)
T ss_dssp             HHHHHHHHHHHCCCCTTTCTTGGGSTTC------CCCCCCC--------------TTCCCTTTSTTCCHHHHHHHHHHSC
T ss_pred             HHHHHHHHHHhCCCChhhhhhhcccccc------ccccccc--------------CCcchhhcccccChHHHHHHHHHhc
Confidence            8888888888888776543322111000      0000000              0001112334677889999999999


Q ss_pred             cCCCCCCCHHHHhcCCCCCCC
Q 014117          406 YDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f~~~  426 (430)
                      .||++|||++|+|+||||++-
T Consensus       269 ~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          269 CNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             SSGGGSCCHHHHHTSGGGTTC
T ss_pred             cChhhCCCHHHHhcCcccccC
Confidence            999999999999999999863

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.2e-50  Score=404.47  Aligned_cols=260  Identities=25%  Similarity=0.415  Sum_probs=219.0

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      ..+.++|++.+.||+|+||.||+|.++.+++.||+|++....   .....+..|+.+++.+.     |+||+++++++.+
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~-----hpnIv~l~~~~~~   81 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK-----HPNIVRLHDSISE   81 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCC-----BTTBCCEEEEEEC
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-----CcCCCeEEEEEEE
Confidence            345678999999999999999999999999999999986432   33456778999999984     4889999999999


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      .+..|+||||+ |++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++..             
T Consensus        82 ~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~-------------  146 (444)
T 3soa_A           82 EGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASK-------------  146 (444)
T ss_dssp             SSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBS-------------
T ss_pred             CCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecc-------------
Confidence            99999999999 889999998765  79999999999999999999999999999999999999642             


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                 ..++.+||+|||++.......   ...+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+
T Consensus       147 -----------~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~  215 (444)
T 3soa_A          147 -----------LKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD  215 (444)
T ss_dssp             -----------STTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             -----------CCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence                       245678899999886554332   235899999999999999999999999999999999999999998


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      .+..+....+......+|..                                             .++..++++.+||.+
T Consensus       216 ~~~~~~~~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li~~  250 (444)
T 3soa_A          216 EDQHRLYQQIKAGAYDFPSP---------------------------------------------EWDTVTPEAKDLINK  250 (444)
T ss_dssp             SSHHHHHHHHHHTCCCCCTT---------------------------------------------TTTTSCHHHHHHHHH
T ss_pred             ccHHHHHHHHHhCCCCCCcc---------------------------------------------ccccCCHHHHHHHHH
Confidence            87777666655433332211                                             123567789999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      ||+.||++|||++|+|+||||+.
T Consensus       251 ~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          251 MLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HcCCChhHCCCHHHHhcCccccC
Confidence            99999999999999999999963

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.2e-50  Score=393.67  Aligned_cols=252  Identities=25%  Similarity=0.384  Sum_probs=211.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++++..    ........|..++..+.    .|++|+++++++.+.+
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~----~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW----EHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT----TCTTBCCEEEEEECSS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcC----CCCCCCcEEEEEEeCC
Confidence            467999999999999999999999999999999997432    23445667888887763    3488999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+|+||||+ |++|.+++...+  .+++..++.++.||+.||+|||++|||||||||+|||++.                
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~----------------  153 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK----------------  153 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT----------------
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECC----------------
Confidence            999999999 899999998764  7999999999999999999999999999999999999954                


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccC---CCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                 ++.+||+|||+++...   ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+
T Consensus       154 -----------~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  222 (345)
T 1xjd_A          154 -----------DGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD  222 (345)
T ss_dssp             -----------TSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             -----------CCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence                       4556666666665322   12244689999999999999999999999999999999999999999877


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+....+......                                                 ++...+.++.+||.+||
T Consensus       223 ~~~~~~~i~~~~~~-------------------------------------------------~p~~~s~~~~~li~~lL  253 (345)
T 1xjd_A          223 EEELFHSIRMDNPF-------------------------------------------------YPRWLEKEAKDLLVKLF  253 (345)
T ss_dssp             HHHHHHHHHHCCCC-------------------------------------------------CCTTSCHHHHHHHHHHS
T ss_pred             HHHHHHHHHhCCCC-------------------------------------------------CCcccCHHHHHHHHHHh
Confidence            76666555332111                                                 12345678999999999


Q ss_pred             hcCCCCCCCHH-HHhcCCCCCCC
Q 014117          405 RYDPTDRLTAR-EALRHPFFTRD  426 (430)
Q Consensus       405 ~~dP~~R~ta~-elL~hp~f~~~  426 (430)
                      +.||++|||+. ++++||||+..
T Consensus       254 ~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          254 VREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             CSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             cCCHhHcCCChHHHHcCccccCC
Confidence            99999999998 99999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.9e-50  Score=393.22  Aligned_cols=251  Identities=26%  Similarity=0.417  Sum_probs=215.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++++.||+|+||.||+|.++.+++.||+|+++...    ........|+.+++.+     .|++|+++++++.+.+
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~  114 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSS
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEcCC
Confidence            467999999999999999999999999999999986432    2334566788887776     4588999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+|+||||+ |++|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||+                  
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll------------------  174 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI------------------  174 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------------
T ss_pred             EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE------------------
Confidence            999999999 899999998765  79999999999999999999999999999999999999                  


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                               +.++.+||+|||++..........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+
T Consensus       175 ---------~~~g~~kL~DFg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~  245 (350)
T 1rdq_E          175 ---------DQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ  245 (350)
T ss_dssp             ---------CTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ---------CCCCCEEEcccccceeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH
Confidence                     45566788888877765555556789999999999999999999999999999999999999999877766


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+......                                                 ++..++.++.+||.+||+.|
T Consensus       246 ~~~~i~~~~~~-------------------------------------------------~p~~~~~~~~~li~~lL~~d  276 (350)
T 1rdq_E          246 IYEKIVSGKVR-------------------------------------------------FPSHFSSDLKDLLRNLLQVD  276 (350)
T ss_dssp             HHHHHHHCCCC-------------------------------------------------CCTTCCHHHHHHHHHHSCSC
T ss_pred             HHHHHHcCCCC-------------------------------------------------CCCCCCHHHHHHHHHHhhcC
Confidence            65554432111                                                 22355778999999999999


Q ss_pred             CCCCCC-----HHHHhcCCCCCCC
Q 014117          408 PTDRLT-----AREALRHPFFTRD  426 (430)
Q Consensus       408 P~~R~t-----a~elL~hp~f~~~  426 (430)
                      |.+||+     ++|+++||||+..
T Consensus       277 p~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          277 LTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             TTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHhccCCccCCHHHHHhCcCcCCC
Confidence            999998     9999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.7e-50  Score=384.97  Aligned_cols=254  Identities=26%  Similarity=0.409  Sum_probs=212.1

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+..|+.+++.+     .|+||+++++++...+.+
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-----KNPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-----CCCCCCeEeEEEEECCEE
Confidence            3567999999999999999999999999999999986432 3345677899988887     448899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||+ +++|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||++                   
T Consensus        93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~-------------------  150 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG-------------------  150 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-------------------
T ss_pred             EEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC-------------------
Confidence            9999999 99999999875   599999999999999999999999999999999999994                   


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                              .++.+||+|||++.......   ...+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus       151 --------~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  222 (297)
T 3fxz_A          151 --------MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL  222 (297)
T ss_dssp             --------TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             --------CCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence                    45567777777765433222   3357999999999999999999999999999999999999999887665


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      .....+.....+..                                              ..+...+..+.+||.+||+.
T Consensus       223 ~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~li~~~l~~  256 (297)
T 3fxz_A          223 RALYLIATNGTPEL----------------------------------------------QNPEKLSAIFRDFLNRCLEM  256 (297)
T ss_dssp             HHHHHHHHHCSCCC----------------------------------------------SCGGGSCHHHHHHHHHHSCS
T ss_pred             HHHHHHHhCCCCCC----------------------------------------------CCccccCHHHHHHHHHHccC
Confidence            55544332211100                                              01234567899999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||++|||++|+|+||||+..
T Consensus       257 dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          257 DVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             STTTSCCHHHHTTCGGGGGC
T ss_pred             ChhHCcCHHHHhhChhhccc
Confidence            99999999999999999854

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.5e-50  Score=393.57  Aligned_cols=314  Identities=33%  Similarity=0.541  Sum_probs=241.6

Q ss_pred             eeecCcee-cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCC------CCCce
Q 014117           85 MFALGENL-TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK------GGNRC  157 (430)
Q Consensus        85 ~~~~~~~~-~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~------~~~~i  157 (430)
                      +...++.+ .++|++.+.||+|+||.||+|.+..+++.||||++............|+.+++++.+...      .++||
T Consensus         9 p~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i   88 (373)
T 1q8y_A            9 PAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI   88 (373)
T ss_dssp             CCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             eeecCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchH
Confidence            33444444 468999999999999999999999999999999998766666778889999999975421      14789


Q ss_pred             EEecceeecCC----eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeccCCCCceEEeec
Q 014117          158 VQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSS  232 (430)
Q Consensus       158 ~~~~~~~~~~~----~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlKp~NILl~~~  232 (430)
                      +++++++...+    .+++|||+++++|.+++.......+++..+..++.||+.||.|||++ ||+||||||+|||++..
T Consensus        89 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           89 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             HHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEecc
Confidence            99999887644    89999999999999999886656799999999999999999999998 99999999999999654


Q ss_pred             CccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHH
Q 014117          233 EYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE  312 (430)
Q Consensus       233 ~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~e  312 (430)
                      +.                     .+....+||+|||++...........||+.|+|||++.+..++.++|||||||++||
T Consensus       169 ~~---------------------~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e  227 (373)
T 1q8y_A          169 DS---------------------PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFE  227 (373)
T ss_dssp             ET---------------------TTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHH
T ss_pred             CC---------------------CcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHH
Confidence            31                     023447899999988766555555689999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCc------hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHh
Q 014117          313 LCTGEALFQTHE------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM  386 (430)
Q Consensus       313 l~tG~~Pf~~~~------~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (430)
                      |++|..||...+      +.+....+...+|.+|..++.........+...+..........       ...........
T Consensus       228 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~  300 (373)
T 1q8y_A          228 LITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF-------WPLEDVLTEKY  300 (373)
T ss_dssp             HHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCB-------CCHHHHHHHTT
T ss_pred             HHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccc-------cchhhhhhhcc
Confidence            999999998644      56678888999999998876654332222221211111100000       00001111112


Q ss_pred             hhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          387 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       387 ~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      .++...+.++.+||.+||+.||.+|||++|||+||||++.
T Consensus       301 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  340 (373)
T 1q8y_A          301 KFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT  340 (373)
T ss_dssp             CCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred             cCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcc
Confidence            2344567789999999999999999999999999999865

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.2e-50  Score=396.68  Aligned_cols=265  Identities=25%  Similarity=0.417  Sum_probs=219.7

Q ss_pred             eeecCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEec
Q 014117           85 MFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIR  161 (430)
Q Consensus        85 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~  161 (430)
                      .......+.++|++.+.||+|+||.||+|.++.+++.||+|++....   ...+.+..|+.+++.+.     |+||++++
T Consensus        20 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~-----hpnIv~~~   94 (362)
T 2bdw_A           20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-----HPNIVRLH   94 (362)
T ss_dssp             ----CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCC-----CTTBCCEE
T ss_pred             eecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-----CCCCCeEE
Confidence            33445566788999999999999999999999999999999996432   33456778999999883     48899999


Q ss_pred             ceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCC
Q 014117          162 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY  240 (430)
Q Consensus       162 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~df  240 (430)
                      +++.+.+..|+||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++..+       
T Consensus        95 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~-------  165 (362)
T 2bdw_A           95 DSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA-------  165 (362)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSS-------
T ss_pred             EEEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC-------
Confidence            9999999999999999 889999997654  799999999999999999999999999999999999996432       


Q ss_pred             cCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCC
Q 014117          241 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       241 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                       ....+||+|||++.......  ...+||+.|+|||++.+..|+.++|||||||++|+|++|.+
T Consensus       166 -----------------~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  228 (362)
T 2bdw_A          166 -----------------KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP  228 (362)
T ss_dssp             -----------------TTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             -----------------CCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCC
Confidence                             23568899999887554332  34589999999999999999999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||.+.+..+....+.......|..                                             .+...+.++.+
T Consensus       229 Pf~~~~~~~~~~~i~~~~~~~~~~---------------------------------------------~~~~~~~~~~~  263 (362)
T 2bdw_A          229 PFWDEDQHRLYAQIKAGAYDYPSP---------------------------------------------EWDTVTPEAKS  263 (362)
T ss_dssp             SSCCSSHHHHHHHHHHTCCCCCTT---------------------------------------------GGGGSCHHHHH
T ss_pred             CCCCCCHHHHHHHHHhCCCCCCcc---------------------------------------------cccCCCHHHHH
Confidence            999877766665554432222211                                             12345678999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          399 LLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      ||.+||+.||++|||++|+|+||||..
T Consensus       264 li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          264 LIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            999999999999999999999999964

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=8e-51  Score=390.77  Aligned_cols=287  Identities=29%  Similarity=0.487  Sum_probs=212.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .++|++++.||+|+||.||+|.++.+++.||+|+++...  .....+..|+.+++++.     |+||+++++++...+.+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~~~~~~~~~~~~   78 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK-----HENIVRLYDVIHTENKL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCC-----BTTBCCEEEEECCTTEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcC-----CCCcceEEEEEEECCeE
Confidence            357999999999999999999999999999999986432  23356778999988884     48899999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNN----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      |+||||+.++|.+++....    ...+++..++.++.||+.||.|||++||+||||||+|||++                
T Consensus        79 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~----------------  142 (317)
T 2pmi_A           79 TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN----------------  142 (317)
T ss_dssp             EEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----------------
T ss_pred             EEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEc----------------
Confidence            9999999889999987542    13589999999999999999999999999999999999994                


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                 .++.+||+|||++......   ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+
T Consensus       143 -----------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  211 (317)
T 2pmi_A          143 -----------KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG  211 (317)
T ss_dssp             -----------TTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             -----------CCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                       4556777777777643322   2335789999999999874 689999999999999999999999999


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      .+..+....+...++.++...+..+...... ..    ..+.  ..        ...-...+........+.++.+||.+
T Consensus       212 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~----~~~~--~~--------~~~~~~~~~~~~~~~~~~~l~~li~~  276 (317)
T 2pmi_A          212 TNDEEQLKLIFDIMGTPNESLWPSVTKLPKY-NP----NIQQ--RP--------PRDLRQVLQPHTKEPLDGNLMDFLHG  276 (317)
T ss_dssp             SSHHHHHHHHHHHHCSCCTTTCGGGGGCTTC-CT----TCCC--CC--------CCCSHHHHGGGCSSCCCHHHHHHHHH
T ss_pred             CChHHHHHHHHHHhCCCChhHhhhhhhhhhc-cc----cccc--cc--------chhHHHhhcccccccCCHHHHHHHHH
Confidence            9999999999998888776554332211100 00    0000  00        00000111222345678899999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||+.||++|||++|+|+||||++-
T Consensus       277 ~L~~dP~~Rpt~~e~l~hp~f~~~  300 (317)
T 2pmi_A          277 LLQLNPDMRLSAKQALHHPWFAEY  300 (317)
T ss_dssp             HSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             HCCCCcccCCCHHHHhCChhhhcc
Confidence            999999999999999999999753

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2e-50  Score=395.79  Aligned_cols=282  Identities=27%  Similarity=0.491  Sum_probs=212.5

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .+.++|++++.||+|+||.||+|.+..+++.||||++...   ......+.+|+.+++.+.     |+||+++++++...
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~~~~~~~~~  100 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-----HENVIGLLDVFTPA  100 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-----CTTBCCCSEEECSC
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-----CCCCCcEEEEEecC
Confidence            4568899999999999999999999999999999998642   234456778999999884     48899999988653


Q ss_pred             ------CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          168 ------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       168 ------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                            ..+|+|||+++++|.+++..   ..+++..++.++.||+.||.|||++||+||||||+|||++           
T Consensus       101 ~~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~-----------  166 (367)
T 2fst_X          101 RSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-----------  166 (367)
T ss_dssp             SSGGGCCCCEEEEECCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-----------
T ss_pred             CccccCCeEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC-----------
Confidence                  67899999999999998875   3699999999999999999999999999999999999994           


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                      .++.+||+|||+++.........+||+.|+|||++.+ ..++.++|||||||++|||++|++||
T Consensus       167 ----------------~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  230 (367)
T 2fst_X          167 ----------------EDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF  230 (367)
T ss_dssp             ----------------TTCCEEECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             ----------------CCCCEEEeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC
Confidence                            4556777778777655544455689999999999987 67999999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhh-hhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      .+.+..+++..+.+.+|.++...+..+..... .++.. ....+.                  ..........++++.+|
T Consensus       231 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~-~~~~~~------------------~~~~~~~~~~~~~~~dL  291 (367)
T 2fst_X          231 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS-LTQMPK------------------MNFANVFIGANPLAVDL  291 (367)
T ss_dssp             CCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHT-SCCCCC------------------CCHHHHTTTCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhc-cCCCCC------------------CCHHHHCCCCCHHHHHH
Confidence            99999999999999999998876654432211 11111 000000                  00112334667889999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          400 LQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      |.+||+.||++|||++|+|+||||+..
T Consensus       292 l~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          292 LEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHhCCCCcccCcCHHHHhcChhhhhc
Confidence            999999999999999999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=8.8e-50  Score=399.67  Aligned_cols=301  Identities=27%  Similarity=0.425  Sum_probs=221.4

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .+.++|++.+.||+|+||.||+|.++.+++.||||+++..   ......+.+|+.+++.+.     |+||+++++++...
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv~l~~~~~~~   97 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK-----SDYIIRLYDLIIPD   97 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCC-----CTTBCCEEEECCCS
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcC-----CCCcceEEEEEecC
Confidence            3567899999999999999999999999999999999643   233456778999999984     48899999988765


Q ss_pred             -----CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          168 -----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       168 -----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                           ..+|+||||++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        98 ~~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A           98 DLLKFDELYIVLEIADSDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             CTTTCCCEEEEEECCSEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CCCcCCeEEEEEecCCcCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence                 6799999999889999998653  799999999999999999999999999999999999997766666666666


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCc-------cccCCCCCeeeecCcccchhhhh-CCCCCCcchHHHHHHHHHHHH
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGST-------TYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELC  314 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a-------~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~  314 (430)
                      +..........         ...++...       ..........+||+.|+|||++. +..|+.++|||||||++|||+
T Consensus       176 a~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell  246 (432)
T 3n9x_A          176 ARTINSEKDTN---------IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL  246 (432)
T ss_dssp             CEEC----------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             ccccccccccc---------ccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHH
Confidence            54332211100         00000000       00001123458999999999874 556999999999999999999


Q ss_pred             h-----------CCCCCCCCc-----------------hHHHHHHHHHHhCCCCHHHHHHHHhh-hhhhhccCcccCCCC
Q 014117          315 T-----------GEALFQTHE-----------------NLEHLAMMERVLGPLPQHMLKRVDRH-AEKYVRRGRLDWPEG  365 (430)
Q Consensus       315 t-----------G~~Pf~~~~-----------------~~~~~~~i~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~  365 (430)
                      +           |.++|.+.+                 ..+++..|...+|.++...+..+... ...++.......+  
T Consensus       247 ~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~--  324 (432)
T 3n9x_A          247 NMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP--  324 (432)
T ss_dssp             TTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCC--
T ss_pred             hcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCC--
Confidence            8           455555433                 46788899999999998766543211 1111111100000  


Q ss_pred             CCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          366 AASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                                       ......++..++++.+||.+||+.||.+|||++|+|+||||+.-
T Consensus       325 -----------------~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  368 (432)
T 3n9x_A          325 -----------------INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV  368 (432)
T ss_dssp             -----------------CCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred             -----------------CCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence                             00112335678899999999999999999999999999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.1e-50  Score=382.30  Aligned_cols=279  Identities=28%  Similarity=0.467  Sum_probs=217.5

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ++|++++.||+|+||+||+|.+ .+++.||+|+++....   ....+.+|+.+++.+.     |+||+++++++...+.+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK-----HSNIVKLYDVIHTKKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-----CTTBCCEEEEEECSSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcC-----CCCEeeeeeEEccCCeE
Confidence            4799999999999999999998 6788999999864322   2356778898888873     58899999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      |+||||+.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+                     
T Consensus        76 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---------------------  133 (288)
T 1ob3_A           76 VLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---------------------  133 (288)
T ss_dssp             EEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---------------------
T ss_pred             EEEEEecCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---------------------
Confidence            9999999889999998653 469999999999999999999999999999999999999                     


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                            +.++.+||+|||++......   .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..
T Consensus       134 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  207 (288)
T 1ob3_A          134 ------NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA  207 (288)
T ss_dssp             ------CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ------cCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence                  44556788888877643322   1234789999999999865 5899999999999999999999999998888


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +....+...++..+...++.+..... +..  .+...    ..             ..........+.++.+||.+||+.
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~----~~-------------~~~~~~~~~~~~~~~~li~~~L~~  267 (288)
T 1ob3_A          208 DQLMRIFRILGTPNSKNWPNVTELPK-YDP--NFTVY----EP-------------LPWESFLKGLDESGIDLLSKMLKL  267 (288)
T ss_dssp             HHHHHHHHHHCCCCTTTSTTGGGSTT-CCT--TCCCC----CC-------------CCGGGTCCSCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHHHCCCChhhchhhhcccc-ccc--ccccc----cC-------------ccHHHHhhhcCHHHHHHHHHHcCC
Confidence            88888888887766432221111000 000  00000    00             001123356788899999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||++|||++|+|+||||++.
T Consensus       268 dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          268 DPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             STTTSCCHHHHHTSGGGGC-
T ss_pred             CcccCCCHHHHhcCcchhhc
Confidence            99999999999999999875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.6e-50  Score=391.58  Aligned_cols=252  Identities=24%  Similarity=0.344  Sum_probs=209.6

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++++.||+|+||.||+|+++.+++.||+|++++..    ........|..++..+.    ++++|+.+++++...+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~----~hp~iv~l~~~~~~~~   94 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG----KPPFLTQLHSCFQTMD   94 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTT----CCTTBCCEEEEEECSS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcC----CCCEEeeEEEEEEcCC
Confidence            467999999999999999999999999999999997432    22344556776665542    4588999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+|+||||+ |++|.+++...+  .+++..++.++.||+.||+|||++|||||||||+|||++.                
T Consensus        95 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~----------------  156 (353)
T 2i0e_A           95 RLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS----------------  156 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT----------------
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcC----------------
Confidence            999999999 889999998765  7999999999999999999999999999999999999954                


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccC---CCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                 ++.+||+|||++....   ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus       157 -----------~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~  225 (353)
T 2i0e_A          157 -----------EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED  225 (353)
T ss_dssp             -----------TSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             -----------CCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence                       4556666666665421   12234689999999999999999999999999999999999999999877


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+....|......                                                 ++...+.++.+||.+||
T Consensus       226 ~~~~~~~i~~~~~~-------------------------------------------------~p~~~s~~~~~li~~lL  256 (353)
T 2i0e_A          226 EDELFQSIMEHNVA-------------------------------------------------YPKSMSKEAVAICKGLM  256 (353)
T ss_dssp             HHHHHHHHHHCCCC-------------------------------------------------CCTTSCHHHHHHHHHHT
T ss_pred             HHHHHHHHHhCCCC-------------------------------------------------CCCCCCHHHHHHHHHHh
Confidence            76666555432111                                                 22356778999999999


Q ss_pred             hcCCCCCC-----CHHHHhcCCCCCCC
Q 014117          405 RYDPTDRL-----TAREALRHPFFTRD  426 (430)
Q Consensus       405 ~~dP~~R~-----ta~elL~hp~f~~~  426 (430)
                      +.||.+||     +++++++||||+.-
T Consensus       257 ~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          257 TKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             CSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             hcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            99999999     47999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-50  Score=391.94  Aligned_cols=288  Identities=27%  Similarity=0.464  Sum_probs=221.6

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      ..++|++++.||+|+||+||+|.+..+++.||||+++....   ....+..|+.+++.+.     |+||+++++++...+
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~  106 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ-----HRNIIELKSVIHHNH  106 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCC-----CTTBCCEEEEEEETT
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcC-----CCCcceEEEEEecCC
Confidence            35689999999999999999999999999999999964322   2344567888888873     488999999999999


Q ss_pred             eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          169 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       169 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .+|+||||+.++|.+++....  .+++..++.++.||+.||.|||++|||||||||+|||++.++.              
T Consensus       107 ~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~--------------  170 (329)
T 3gbz_A          107 RLHLIFEYAENDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDA--------------  170 (329)
T ss_dssp             EEEEEEECCSEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----------------
T ss_pred             EEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCC--------------
Confidence            999999999889999998765  6999999999999999999999999999999999999965431              


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                              +....+||+|||++......   ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+
T Consensus       171 --------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  242 (329)
T 3gbz_A          171 --------SETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS  242 (329)
T ss_dssp             ----------CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             --------CccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence                    34456899999988654322   2335789999999999875 48999999999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+....+...++.++...+.........     ...++..              ....+........+.++.+||.+||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~--------------~~~~~~~~~~~~~~~~~~~li~~~L  303 (329)
T 3gbz_A          243 EIDQLFKIFEVLGLPDDTTWPGVTALPDW-----KQSFPKF--------------RGKTLKRVLGALLDDEGLDLLTAML  303 (329)
T ss_dssp             HHHHHHHHHHHHCCCCTTTSTTGGGSTTC-----CTTCCCC--------------CCCCHHHHHGGGSCHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCchhhhhhhhhhhhh-----hhhhhhh--------------ccccHhhhcccccCHHHHHHHHHHc
Confidence            98888888888887765432211110000     0000000              0011112223446788999999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      +.||++|||++|+|+||||+..+
T Consensus       304 ~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          304 EMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             CSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             cCChhhCCCHHHHhCCcccCCCC
Confidence            99999999999999999999764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.9e-50  Score=396.40  Aligned_cols=261  Identities=20%  Similarity=0.360  Sum_probs=206.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++++.||+|+||.||+|+++.+++.||+|++++...    .......|..++.++.    .|+||+++++++.+.+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~----~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS----NHPFLVGLHSCFQTES  126 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHT----TCTTBCCEEEEEECSS
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcC----CCCCcCeeEEEEEECC
Confidence            3579999999999999999999999999999999974321    2234667888888774    3488999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+||||||+ |++|.+++....  .+++..++.++.||+.||+|||++|||||||||+|||++                 
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~-----------------  187 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD-----------------  187 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC-----------------
T ss_pred             EEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC-----------------
Confidence            999999999 889999998764  799999999999999999999999999999999999994                 


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccC---CCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                .++.+||+|||+++...   ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||....
T Consensus       188 ----------~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~  257 (396)
T 4dc2_A          188 ----------SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG  257 (396)
T ss_dssp             ----------TTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTT
T ss_pred             ----------CCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence                      45566777777665421   12244689999999999999999999999999999999999999997532


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+...       ....       ......+..+.                          ..++...+.++.+||.+||
T Consensus       258 ~~~~~~-------~~~~-------~~~~~~i~~~~--------------------------~~~p~~~s~~~~~li~~lL  297 (396)
T 4dc2_A          258 SSDNPD-------QNTE-------DYLFQVILEKQ--------------------------IRIPRSLSVKAASVLKSFL  297 (396)
T ss_dssp             C-------------CCH-------HHHHHHHHHCC--------------------------CCCCTTSCHHHHHHHHHHT
T ss_pred             cccccc-------hhhH-------HHHHHHHhccc--------------------------cCCCCcCCHHHHHHHHHHh
Confidence            211000       0000       00000000111                          1234566788999999999


Q ss_pred             hcCCCCCCCH------HHHhcCCCCCCC
Q 014117          405 RYDPTDRLTA------REALRHPFFTRD  426 (430)
Q Consensus       405 ~~dP~~R~ta------~elL~hp~f~~~  426 (430)
                      +.||.+||++      +|+++||||+..
T Consensus       298 ~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          298 NKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             CSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             cCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            9999999985      899999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-50  Score=390.07  Aligned_cols=281  Identities=27%  Similarity=0.478  Sum_probs=218.7

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhH--HHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR--EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~--~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ++|++++.||+|+||+||+|.+..+++.||+|+++......  ..+..|+.+++.+.     ++||+++++++...+.+|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-----HANIVTLHDIIHTEKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCC-----CTTBCCEEEEEECSSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcC-----CCCCCeeeeEEeeCCEEE
Confidence            57999999999999999999999999999999986433211  13345888887773     588999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          172 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       172 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      +||||++++|.+++...+ ..+++..++.++.||+.||.|||++||+||||||+|||++                     
T Consensus        77 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---------------------  134 (324)
T 3mtl_A           77 LVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN---------------------  134 (324)
T ss_dssp             EEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC---------------------
T ss_pred             EEecccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC---------------------
Confidence            999999889999998764 4699999999999999999999999999999999999994                     


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                            .++.+||+|||++.......   ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+
T Consensus       135 ------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  208 (324)
T 3mtl_A          135 ------ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE  208 (324)
T ss_dssp             ------TTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ------CCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                  44567777777765433222   23478999999999987 568999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+...++.++...++..........    +.++..               .........+..+.++.+||.+||+.|
T Consensus       209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------------~~~~~~~~~~~~~~~~~~li~~~L~~d  269 (324)
T 3mtl_A          209 QLHFIFRILGTPTEETWPGILSNEEFKT----YNYPKY---------------RAEALLSHAPRLDSDGADLLTKLLQFE  269 (324)
T ss_dssp             HHHHHHHHHCCCCTTTSTTGGGCHHHHH----TCCCCC---------------CCCCHHHHCTTSCHHHHHHHHHHSCSS
T ss_pred             HHHHHHHHhCCCChHhchhhhcchhhcc----cccccc---------------cchhhhhhcCCCCHHHHHHHHHHcCcC
Confidence            9999999999887654332211110000    000000               001122334567889999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~  426 (430)
                      |++|||++|+|+||||+..
T Consensus       270 P~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          270 GRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             GGGSCCHHHHTTSGGGGGG
T ss_pred             cccCCCHHHHhcChhhhhc
Confidence            9999999999999999754

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.6e-49  Score=389.99  Aligned_cols=293  Identities=28%  Similarity=0.496  Sum_probs=230.6

Q ss_pred             CCCCCceeecCc---eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCC
Q 014117           79 DKDGHYMFALGE---NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDK  152 (430)
Q Consensus        79 ~~~~~~~~~~~~---~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~  152 (430)
                      .+.+.+......   .+.++|.+.+.||+|+||.||+|.++.+++.||||++...   ......+..|+.+++.+.    
T Consensus        24 ~~~g~~~~~~~~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~----   99 (371)
T 4exu_A           24 RKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ----   99 (371)
T ss_dssp             SCTTEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC----
T ss_pred             ccccceeeeeccceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcC----
Confidence            344555544443   3678999999999999999999999999999999999743   233466778999998884    


Q ss_pred             CCCceEEecceeecCCeE------EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCc
Q 014117          153 GGNRCVQIRNWFDYRNHI------CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPEN  226 (430)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~------~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~N  226 (430)
                       ++||+++++++...+..      |+||||++++|.+++.    ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus       100 -h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N  174 (371)
T 4exu_A          100 -HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGN  174 (371)
T ss_dssp             -CTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             -CCCchhhhhheeccCCcccceeEEEEEccccccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHH
Confidence             48899999999876654      9999999889988773    359999999999999999999999999999999999


Q ss_pred             eEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC-CCCCCcchHHH
Q 014117          227 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWS  305 (430)
Q Consensus       227 ILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws  305 (430)
                      ||+                           +.++.+||+|||++..........+||+.|+|||++.+ ..++.++||||
T Consensus       175 Ill---------------------------~~~~~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  227 (371)
T 4exu_A          175 LAV---------------------------NEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWS  227 (371)
T ss_dssp             EEE---------------------------CTTCCEEECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHH
T ss_pred             eEE---------------------------CCCCCEEEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHH
Confidence            999                           44566788888877765555555688999999999987 67999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHH
Q 014117          306 VGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI  385 (430)
Q Consensus       306 lGv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (430)
                      |||++|+|++|..||.+.+..+.+..+....+.++..+...+...............+                  ....
T Consensus       228 lG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~  289 (371)
T 4exu_A          228 VGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTP------------------RKDF  289 (371)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCC------------------CCCH
T ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCc------------------chhH
Confidence            9999999999999999999999999999999999887655432221111100000000                  0111


Q ss_pred             hhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       386 ~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      ...++..+.++.+||.+||+.||++|||++|+|+||||+.
T Consensus       290 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  329 (371)
T 4exu_A          290 TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP  329 (371)
T ss_dssp             HHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence            2334567889999999999999999999999999999985

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-50  Score=393.12  Aligned_cols=260  Identities=26%  Similarity=0.476  Sum_probs=218.0

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      +.++|++.+.||+|+||.||+|.++.+++.||+|++.... .....+..|+.+++.+     .|+||+++++++.....+
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-----HHPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-----CSTTBCCEEEEEECSSEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-----CCcCCCeEEEEEEeCCEE
Confidence            4578999999999999999999999999999999987543 2345677899988887     358899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.                  
T Consensus       124 ~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~------------------  184 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET------------------  184 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS------------------
T ss_pred             EEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec------------------
Confidence            9999999 889999987543 46999999999999999999999999999999999999953                  


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                             +..+.+||+|||++.......  ...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+
T Consensus       185 -------~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~  257 (387)
T 1kob_A          185 -------KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE  257 (387)
T ss_dssp             -------TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred             -------CCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH
Confidence                   234578899999887654433  33579999999999999999999999999999999999999999877766


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+......++.                                             ..+...+.++.+||.+||+.|
T Consensus       258 ~~~~i~~~~~~~~~---------------------------------------------~~~~~~s~~~~~li~~~L~~d  292 (387)
T 1kob_A          258 TLQNVKRCDWEFDE---------------------------------------------DAFSSVSPEAKDFIKNLLQKE  292 (387)
T ss_dssp             HHHHHHHCCCCCCS---------------------------------------------STTTTSCHHHHHHHHTTSCSS
T ss_pred             HHHHHHhCCCCCCc---------------------------------------------cccccCCHHHHHHHHHHcCCC
Confidence            66554432211111                                             112356778999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~~  427 (430)
                      |++|||++|+|+||||+...
T Consensus       293 P~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          293 PRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             GGGSCCHHHHHTSTTTSSCC
T ss_pred             hhHCcCHHHHhhCccccCCc
Confidence            99999999999999998653

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.8e-49  Score=385.73  Aligned_cols=261  Identities=21%  Similarity=0.366  Sum_probs=205.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++++.||+|+||.||+|+++.+++.||+|++++..    ........|..++.++.    .|+||+++++++.+.+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~----~hp~iv~l~~~~~~~~   83 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS----NHPFLVGLHSCFQTES   83 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTT----TCTTBCCEEEEEECSS
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcC----CCCccCeEEEEEEeCC
Confidence            357999999999999999999999999999999997432    23345667888887763    3588999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.                
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~----------------  145 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS----------------  145 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT----------------
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECC----------------
Confidence            999999999 889999998764  7999999999999999999999999999999999999954                


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccC---CCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                 ++.+||+|||+++...   ......+||+.|+|||++.+..|+.++|||||||++|||++|..||....
T Consensus       146 -----------~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  214 (345)
T 3a8x_A          146 -----------EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG  214 (345)
T ss_dssp             -----------TSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTT
T ss_pred             -----------CCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcc
Confidence                       4556666666665321   12234689999999999999999999999999999999999999997532


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      .......       ...       ......+..+.                          ..++...+.++.+||.+||
T Consensus       215 ~~~~~~~-------~~~-------~~~~~~i~~~~--------------------------~~~p~~~s~~~~~li~~lL  254 (345)
T 3a8x_A          215 SSDNPDQ-------NTE-------DYLFQVILEKQ--------------------------IRIPRSLSVKAASVLKSFL  254 (345)
T ss_dssp             C--------------CH-------HHHHHHHHHCC--------------------------CCCCTTSCHHHHHHHHHHT
T ss_pred             ccccccc-------ccH-------HHHHHHHHcCC--------------------------CCCCCCCCHHHHHHHHHHh
Confidence            1110000       000       00000000111                          1133456788999999999


Q ss_pred             hcCCCCCCCH------HHHhcCCCCCCC
Q 014117          405 RYDPTDRLTA------REALRHPFFTRD  426 (430)
Q Consensus       405 ~~dP~~R~ta------~elL~hp~f~~~  426 (430)
                      +.||.+|||+      +|+++||||+..
T Consensus       255 ~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          255 NKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             CSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             cCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            9999999995      899999999864

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.6e-50  Score=382.92  Aligned_cols=260  Identities=22%  Similarity=0.326  Sum_probs=204.4

Q ss_pred             CceeecCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEE
Q 014117           83 HYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQ  159 (430)
Q Consensus        83 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~  159 (430)
                      .++...++.+.++|++.++||+|+||+||+|.++.+++.||||++....   ........|+..+..+.    .++||++
T Consensus        46 ~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~----~h~~iv~  121 (311)
T 3p1a_A           46 YDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG----QHPCCVR  121 (311)
T ss_dssp             CCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHC----CCTTBCC
T ss_pred             CCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhc----CCCcEEE
Confidence            3444556667789999999999999999999999999999999986432   22333444555554442    4588999


Q ss_pred             ecceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCC
Q 014117          160 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD  239 (430)
Q Consensus       160 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~d  239 (430)
                      +++++...+.+|+||||++++|.+++...+ ..+++..+..++.||+.||.|||++|||||||||+|||++.        
T Consensus       122 l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~--------  192 (311)
T 3p1a_A          122 LEQAWEEGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGP--------  192 (311)
T ss_dssp             EEEEEEETTEEEEEEECCCCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECG--------
T ss_pred             EEEEEEeCCEEEEEEeccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC--------
Confidence            999999999999999999999999988764 46999999999999999999999999999999999999954        


Q ss_pred             CcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCC
Q 014117          240 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       240 fg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~  317 (430)
                                         ++.+||+|||++.......  ....||+.|+|||++.+ .++.++|||||||++|||++|.
T Consensus       193 -------------------~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~  252 (311)
T 3p1a_A          193 -------------------RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNM  252 (311)
T ss_dssp             -------------------GGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTC
T ss_pred             -------------------CCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCC
Confidence                               4456666666665433222  23468999999999887 7999999999999999999997


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      .||........   +.  .+..+.                                             ..+...+.++.
T Consensus       253 ~~~~~~~~~~~---~~--~~~~~~---------------------------------------------~~~~~~~~~l~  282 (311)
T 3p1a_A          253 ELPHGGEGWQQ---LR--QGYLPP---------------------------------------------EFTAGLSSELR  282 (311)
T ss_dssp             CCCSSHHHHHH---HT--TTCCCH---------------------------------------------HHHTTSCHHHH
T ss_pred             CCCCCccHHHH---Hh--ccCCCc---------------------------------------------ccccCCCHHHH
Confidence            77654322111   10  011111                                             12345678899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          398 HLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      +||.+||+.||++|||++|+|+||||++
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          283 SVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            9999999999999999999999999986

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.2e-49  Score=388.09  Aligned_cols=260  Identities=27%  Similarity=0.404  Sum_probs=212.8

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch------hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      .+.++|++.+.||+|+||.||+|.++.+++.||||++....      ...+.+.+|+.+++.+.     |+||+++++++
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~~~~~~   95 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-----HPHIVELLETY   95 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-----CTTBCCEEEEE
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-----CCCCCcEEEEE
Confidence            34678999999999999999999999999999999986322      13466788999999883     48899999999


Q ss_pred             ecCCeEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          165 DYRNHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       165 ~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      ...+.+|+||||+ +++|.+++...  ....+++..+..++.||+.||.|||++||+||||||+|||++.++        
T Consensus        96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~--------  167 (351)
T 3c0i_A           96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE--------  167 (351)
T ss_dssp             EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSS--------
T ss_pred             EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCC--------
Confidence            9999999999999 89998887643  224589999999999999999999999999999999999996432        


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                      ....+||+|||++.......   ...+||+.|+|||++.+..|+.++|||||||++|+|++|..
T Consensus       168 ----------------~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  231 (351)
T 3c0i_A          168 ----------------NSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL  231 (351)
T ss_dssp             ----------------TTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ----------------CCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCC
Confidence                            23458888888886544332   33579999999999999999999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||.+.. .+....+.......+.                                             ..+...+.++.+
T Consensus       232 pf~~~~-~~~~~~i~~~~~~~~~---------------------------------------------~~~~~~s~~~~~  265 (351)
T 3c0i_A          232 PFYGTK-ERLFEGIIKGKYKMNP---------------------------------------------RQWSHISESAKD  265 (351)
T ss_dssp             SSCSSH-HHHHHHHHHTCCCCCH---------------------------------------------HHHTTSCHHHHH
T ss_pred             CCCCcH-HHHHHHHHcCCCCCCc---------------------------------------------cccccCCHHHHH
Confidence            998743 3333333222111111                                             112356778999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          399 LLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      ||.+||+.||++|||+.|+|+||||+.
T Consensus       266 li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          266 LVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             HHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            999999999999999999999999975

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.5e-49  Score=389.88  Aligned_cols=252  Identities=26%  Similarity=0.393  Sum_probs=204.1

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhh----HHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY----REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++++.||+|+||.||+|+++.+++.||+|++++....    ......|..++    .....|++|+++++++.+.+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~l----l~~~~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVL----LKNVKHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CC----BCCCCCTTBCCEEEEEECSS
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHH----HHhCCCCCCCCEEEEEEeCC
Confidence            46799999999999999999999999999999999754321    12223333321    12346789999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+|+||||+ |++|.+++....  .+++..++.++.||+.||+|||++|||||||||+|||++                 
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~-----------------  173 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD-----------------  173 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-----------------
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC-----------------
Confidence            999999999 889999998764  799999999999999999999999999999999999994                 


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccC---CCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                .++.+||+|||+++...   ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+
T Consensus       174 ----------~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~  243 (373)
T 2r5t_A          174 ----------SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN  243 (373)
T ss_dssp             ----------TTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred             ----------CCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence                      45567777777765422   12345689999999999999999999999999999999999999999877


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+....|....-                                                 .++...+.++.+||.+||
T Consensus       244 ~~~~~~~i~~~~~-------------------------------------------------~~~~~~~~~~~~li~~lL  274 (373)
T 2r5t_A          244 TAEMYDNILNKPL-------------------------------------------------QLKPNITNSARHLLEGLL  274 (373)
T ss_dssp             HHHHHHHHHHSCC-------------------------------------------------CCCSSSCHHHHHHHHHHT
T ss_pred             HHHHHHHHHhccc-------------------------------------------------CCCCCCCHHHHHHHHHHc
Confidence            7666655543211                                                 123456778999999999


Q ss_pred             hcCCCCCCCH----HHHhcCCCCCCC
Q 014117          405 RYDPTDRLTA----REALRHPFFTRD  426 (430)
Q Consensus       405 ~~dP~~R~ta----~elL~hp~f~~~  426 (430)
                      +.||.+||++    .++++||||+..
T Consensus       275 ~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          275 QKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             CSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             ccCHHhCCCCCCCHHHHhCCccccCC
Confidence            9999999986    699999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.4e-50  Score=396.41  Aligned_cols=255  Identities=24%  Similarity=0.414  Sum_probs=211.1

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      ..++|++++.||+|+||+||+|+++.+++.||+|++++...    ....+..|+.++..+     .|+||+++++++.+.
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-----NSPWVVQLFYAFQDD  141 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-----CCTTBCCEEEEEECS
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEEC
Confidence            35689999999999999999999999999999999864221    223466788888887     458899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +.+||||||+ |++|.+++...   .+++..++.++.||+.||+|||++|||||||||+|||++                
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~----------------  202 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----------------  202 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----------------
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC----------------
Confidence            9999999999 89999999764   599999999999999999999999999999999999994                


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCC----CCCcchHHHHHHHHHHHHhCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGv~l~el~tG~~  318 (430)
                                 .++.+||+|||+++......    ...+||+.|+|||++.+..    |+.++|||||||++|||++|.+
T Consensus       203 -----------~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~  271 (410)
T 3v8s_A          203 -----------KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT  271 (410)
T ss_dssp             -----------TTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSC
T ss_pred             -----------CCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCC
Confidence                       45566777777765443322    2458999999999998765    8899999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||.+.+..+....|......                     +.+|                        .+...+.++++
T Consensus       272 Pf~~~~~~~~~~~i~~~~~~---------------------~~~p------------------------~~~~~s~~~~~  306 (410)
T 3v8s_A          272 PFYADSLVGTYSKIMNHKNS---------------------LTFP------------------------DDNDISKEAKN  306 (410)
T ss_dssp             TTCCSSHHHHHHHHHTHHHH---------------------CCCC------------------------TTCCCCHHHHH
T ss_pred             CCCCCChhhHHHHHHhcccc---------------------ccCC------------------------CcccccHHHHH
Confidence            99988777766655432100                     0011                        11356788999


Q ss_pred             HHHHhhhcCCCC--CCCHHHHhcCCCCCCC
Q 014117          399 LLQGLLRYDPTD--RLTAREALRHPFFTRD  426 (430)
Q Consensus       399 ll~~~L~~dP~~--R~ta~elL~hp~f~~~  426 (430)
                      ||.+||+.+|.+  |++++||++||||+..
T Consensus       307 li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          307 LICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             HHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            999999999998  9999999999999875

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.9e-50  Score=399.16  Aligned_cols=258  Identities=23%  Similarity=0.380  Sum_probs=211.3

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      ..++|+++++||+|+||+||+|.++.+++.||+|++++...    ....+..|..++..+     .+++|+++++++.+.
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-----~hp~Iv~l~~~~~~~  146 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-----DSKWITTLHYAFQDD  146 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-----CTTTBCCEEEEEECS
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEeeC
Confidence            35789999999999999999999999999999999974321    122367788888876     458899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +.+||||||+ +++|.+++.... ..+++..++.++.||+.||.|||++|||||||||+||||+                
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~----------------  209 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD----------------  209 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----------------
T ss_pred             CEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc----------------
Confidence            9999999999 999999998743 4799999999999999999999999999999999999994                


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhh-----CCCCCCcchHHHHHHHHHHHHhCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tG~  317 (430)
                                 .++.+||+|||+++......    ...+||+.|+|||++.     ...|+.++|||||||++|||++|.
T Consensus       210 -----------~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~  278 (437)
T 4aw2_A          210 -----------MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE  278 (437)
T ss_dssp             -----------TTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSS
T ss_pred             -----------CCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCC
Confidence                       45566777777665433222    2358999999999997     456999999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      +||.+.+..+....|......                     +.+|.                       .....+.++.
T Consensus       279 ~Pf~~~~~~~~~~~i~~~~~~---------------------~~~p~-----------------------~~~~~s~~~~  314 (437)
T 4aw2_A          279 TPFYAESLVETYGKIMNHKER---------------------FQFPT-----------------------QVTDVSENAK  314 (437)
T ss_dssp             CTTCCSSHHHHHHHHHTHHHH---------------------CCCCS-----------------------SCCCSCHHHH
T ss_pred             CCCCCCChhHHHHhhhhcccc---------------------ccCCc-----------------------ccccCCHHHH
Confidence            999988877766655432100                     01111                       1234678899


Q ss_pred             HHHHHhhhcCCCC--CCCHHHHhcCCCCCCC
Q 014117          398 HLLQGLLRYDPTD--RLTAREALRHPFFTRD  426 (430)
Q Consensus       398 ~ll~~~L~~dP~~--R~ta~elL~hp~f~~~  426 (430)
                      +||++||+.+|++  |++++|+++||||+.-
T Consensus       315 dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          315 DLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             HHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             HHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence            9999999999888  9999999999999864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.1e-50  Score=398.86  Aligned_cols=258  Identities=26%  Similarity=0.480  Sum_probs=199.8

Q ss_pred             ecCcEEEE-eeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec----
Q 014117           92 LTSRYKIH-SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----  166 (430)
Q Consensus        92 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~----  166 (430)
                      +.++|.+. +.||+|+||+||+|.++.+++.||||+++..    .....|+.++.++.    .|+||+++++++..    
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~----~hp~iv~l~~~~~~~~~~  130 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS----QCPHIVRIVDVYENLYAG  130 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT----TSTTBCCEEEEEEEEETT
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhc----CCCCcceEeEEEeecccC
Confidence            34567776 7899999999999999999999999999743    34556788776654    34789999988765    


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      ..++||||||+ +++|.+++...+...+++..++.++.||+.||.|||++|||||||||+|||++..             
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-------------  197 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK-------------  197 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-------------
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecC-------------
Confidence            67899999999 8899999987665679999999999999999999999999999999999999542             


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                 ..++.+||+|||++......  ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.
T Consensus       198 -----------~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  266 (400)
T 1nxk_A          198 -----------RPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN  266 (400)
T ss_dssp             -----------STTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             -----------CCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence                       12567888888888754332  23468999999999999999999999999999999999999999764


Q ss_pred             chHH----HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          324 ENLE----HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       324 ~~~~----~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      ....    ....+.                       .+.+..+.                      ..+..++.++.+|
T Consensus       267 ~~~~~~~~~~~~i~-----------------------~~~~~~~~----------------------~~~~~~s~~~~~l  301 (400)
T 1nxk_A          267 HGLAISPGMKTRIR-----------------------MGQYEFPN----------------------PEWSEVSEEVKML  301 (400)
T ss_dssp             TTCSSCCSHHHHHH-----------------------HTCCCCCT----------------------TTTTTSCHHHHHH
T ss_pred             ccccccHHHHHHHH-----------------------cCcccCCC----------------------cccccCCHHHHHH
Confidence            4321    111111                       11111111                      0123567789999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          400 LQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      |.+||+.||++|||++|+|+||||.+.
T Consensus       302 i~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          302 IRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHCCCChhHCcCHHHHhcCccccCC
Confidence            999999999999999999999999754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.7e-49  Score=376.29  Aligned_cols=282  Identities=31%  Similarity=0.553  Sum_probs=221.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      .++|++++.||+|+||+||+|.+..+++.||+|++....   .....+..|+.+++++.     |+||+++++++...+.
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~   76 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-----HPNLVNLLEVFRRKRR   76 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCC-----CTTBCCEEEEEEETTE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCC-----CCCccchhheeecCCe
Confidence            467999999999999999999999999999999886432   23455678999999884     4889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .++||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++                  
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~------------------  136 (311)
T 4agu_A           77 LHLVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT------------------  136 (311)
T ss_dssp             EEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC------------------
T ss_pred             EEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc------------------
Confidence            99999999 667777776543  799999999999999999999999999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                               .++.+||+|||++.......   ...+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+
T Consensus       137 ---------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  207 (311)
T 4agu_A          137 ---------KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS  207 (311)
T ss_dssp             ---------TTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ---------CCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                     45567777777776443221   23578999999999987 568999999999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+....+...++..++.........  .+........+.....                .....+..+.++.+||.+||
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~li~~~L  269 (311)
T 4agu_A          208 DVDQLYLIRKTLGDLIPRHQQVFSTN--QYFSGVKIPDPEDMEP----------------LELKFPNISYPALGLLKGCL  269 (311)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHHHTC--GGGTTCCCCCCSSCCC----------------HHHHCTTCCHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHhcccccccccccccc--cccccCcCCCccccch----------------hhhhcccccHHHHHHHHHHc
Confidence            99999999999998887654433211  1111111111111000                11123467788999999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +.||.+|||++|+|+||||++.
T Consensus       270 ~~dP~~Rpt~~ell~hp~f~~~  291 (311)
T 4agu_A          270 HMDPTERLTCEQLLHHPYFENI  291 (311)
T ss_dssp             CSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cCChhhcCCHHHHhcChHHHhc
Confidence            9999999999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.5e-49  Score=387.02  Aligned_cols=261  Identities=25%  Similarity=0.437  Sum_probs=202.1

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      +.+.++|++.+.||+|+||.||+|.+..+++.||||+++... ..+.+..|+.+++++.     |+||+++++++...+.
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~  122 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLS-----HPNIIKLKEIFETPTE  122 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCC-----CTTBCCEEEEEECSSE
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCC-----CCCCcceeeeEecCCe
Confidence            456778999999999999999999999999999999997543 3455678999999984     4889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +++||||+ +++|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||++..                
T Consensus       123 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~----------------  184 (349)
T 2w4o_A          123 ISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATP----------------  184 (349)
T ss_dssp             EEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSS----------------
T ss_pred             EEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecC----------------
Confidence            99999999 889999997654  69999999999999999999999999999999999999531                


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                              +.++.+||+|||++.......  ...+||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus       185 --------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  256 (349)
T 2w4o_A          185 --------APDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD  256 (349)
T ss_dssp             --------STTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH
T ss_pred             --------CCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc
Confidence                    235678888888877543322  3457999999999999999999999999999999999999999765544


Q ss_pred             H-HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          327 E-HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       327 ~-~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      + ....+.......+                                             ...++..+.++.+||.+||+
T Consensus       257 ~~~~~~i~~~~~~~~---------------------------------------------~~~~~~~~~~~~~li~~~L~  291 (349)
T 2w4o_A          257 QFMFRRILNCEYYFI---------------------------------------------SPWWDEVSLNAKDLVRKLIV  291 (349)
T ss_dssp             HHHHHHHHTTCCCCC---------------------------------------------TTTTTTSCHHHHHHHHTTSC
T ss_pred             HHHHHHHHhCCCccC---------------------------------------------CchhhhCCHHHHHHHHHHcc
Confidence            3 2222221111110                                             01224567789999999999


Q ss_pred             cCCCCCCCHHHHhcCCCCCCCC
Q 014117          406 YDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      .||++|||+.|+|+||||+...
T Consensus       292 ~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          292 LDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             SSGGGSCCHHHHHHSTTTTSTT
T ss_pred             CChhhCcCHHHHhcCcccCCCc
Confidence            9999999999999999998653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.5e-49  Score=390.26  Aligned_cols=300  Identities=26%  Similarity=0.451  Sum_probs=224.0

Q ss_pred             CceeecCc---eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCc
Q 014117           83 HYMFALGE---NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNR  156 (430)
Q Consensus        83 ~~~~~~~~---~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~  156 (430)
                      .+.+..++   .+.++|++++.||+|+||.||+|.+..+++.||||++...   ......+..|+.+++.+.     |+|
T Consensus        11 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpn   85 (371)
T 2xrw_A           11 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-----HKN   85 (371)
T ss_dssp             EEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCC-----CTT
T ss_pred             ceEeecCCcccchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcC-----CCC
Confidence            34555555   3568999999999999999999999999999999998642   233456778999988883     488


Q ss_pred             eEEecceeecCC------eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEe
Q 014117          157 CVQIRNWFDYRN------HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV  230 (430)
Q Consensus       157 i~~~~~~~~~~~------~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~  230 (430)
                      |+++++++...+      .+|+||||+.++|.+++..    .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        86 iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~  161 (371)
T 2xrw_A           86 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  161 (371)
T ss_dssp             BCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             ccceEEeeccccccccccceEEEEEcCCCCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence            999999887654      8999999998899998863    589999999999999999999999999999999999994


Q ss_pred             ecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHH
Q 014117          231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC  308 (430)
Q Consensus       231 ~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv  308 (430)
                                                 .++.+||+|||++......  ....+||+.|+|||++.+..++.++|||||||
T Consensus       162 ---------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  214 (371)
T 2xrw_A          162 ---------------------------SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC  214 (371)
T ss_dssp             ---------------------------TTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHH
T ss_pred             ---------------------------CCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHH
Confidence                                       4456777777776544332  23357899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhh
Q 014117          309 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH  388 (430)
Q Consensus       309 ~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (430)
                      ++|+|++|..||.+.+..+.+..+.+.++.+++.++..+......+..+.. .+...     .+......... ......
T Consensus       215 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~-~~~~~~  287 (371)
T 2xrw_A          215 IMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRP-KYAGY-----SFEKLFPDVLF-PADSEH  287 (371)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSC-CCCCC-----CHHHHSCGGGS-CCSSHH
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCc-ccccc-----chhhhcccccC-cccccc
Confidence            999999999999999999999999999998888777666555444443311 01000     00000000000 000000


Q ss_pred             cCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       389 ~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      ....+.++.+||.+||+.||.+|||++|+|+||||+.
T Consensus       288 ~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          288 NKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             HHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             cccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence            1123567999999999999999999999999999974

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-49  Score=391.72  Aligned_cols=280  Identities=28%  Similarity=0.553  Sum_probs=222.9

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee------
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD------  165 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~------  165 (430)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++......   ..+|+++++.+     .|+||+++++++.      
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l-----~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVL-----DHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTC-----CCTTBCCEEEEEEEC----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHc-----CCCCccchhheeeecCccc
Confidence            456899999999999999999999999999999998644322   23588888887     4588999999883      


Q ss_pred             --------------------------------cCCeEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHH
Q 014117          166 --------------------------------YRNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAF  211 (430)
Q Consensus       166 --------------------------------~~~~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~  211 (430)
                                                      ...++++||||+.++|.+.+..  .....+++..++.++.||+.||.|
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            3445999999998898887764  233579999999999999999999


Q ss_pred             HHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccch
Q 014117          212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAP  289 (430)
Q Consensus       212 lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aP  289 (430)
                      ||++||+||||||+|||++.                          .++.+||+|||++......  .....||+.|+||
T Consensus       157 LH~~gi~H~Dikp~Nil~~~--------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aP  210 (383)
T 3eb0_A          157 IHSLGICHRDIKPQNLLVNS--------------------------KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAP  210 (383)
T ss_dssp             HHTTTEECSCCCGGGEEEET--------------------------TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCH
T ss_pred             HHHCcCccCccCHHHEEEcC--------------------------CCCcEEEEECCCCcccCCCCCCcCcccCCCccCH
Confidence            99999999999999999952                          3456788888877644322  2345789999999


Q ss_pred             hhhhCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCC
Q 014117          290 EVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAAS  368 (430)
Q Consensus       290 E~~~~~~-~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (430)
                      |++.+.. ++.++|||||||++|||++|.+||.+.+..+.+..+.+.+|.++.+.+.........      ..++..   
T Consensus       211 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~------~~~~~~---  281 (383)
T 3eb0_A          211 ELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE------VRFPTL---  281 (383)
T ss_dssp             HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--------CCCCCC---
T ss_pred             HHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc------ccCCcc---
Confidence            9998754 999999999999999999999999999999999999999999988766544321111      111110   


Q ss_pred             hhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          369 RESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                                 ....+...++...+.++.+||.+||++||++|||+.|+|+||||+.
T Consensus       282 -----------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          282 -----------KAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH  327 (383)
T ss_dssp             -----------CCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred             -----------CcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence                       0112233355678889999999999999999999999999999963

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.4e-51  Score=393.74  Aligned_cols=254  Identities=25%  Similarity=0.394  Sum_probs=208.3

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++....    .....+..|+.+++.+.     |+||+++++++.
T Consensus         5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~l~~~~~   79 (336)
T 3h4j_B            5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-----HPHIIKLYDVIT   79 (336)
T ss_dssp             CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-----CTTBCCEEEEEE
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-----CCCCCeEEEEEE
Confidence            344578999999999999999999999999999999986432    22346778898888874     588999999999


Q ss_pred             cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          166 YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       166 ~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      ..+.+|+||||++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++               
T Consensus        80 ~~~~~~lv~E~~~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---------------  142 (336)
T 3h4j_B           80 TPTDIVMVIEYAGGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD---------------  142 (336)
T ss_dssp             CSSEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC---------------
T ss_pred             eCCEEEEEEECCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc---------------
Confidence            999999999999999999998765  799999999999999999999999999999999999994               


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCC-CCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                  .++.+||+|||++......  ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+
T Consensus       143 ------------~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~  210 (336)
T 3h4j_B          143 ------------DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD  210 (336)
T ss_dssp             ------------TTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred             ------------CCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC
Confidence                        4556777777777644332  234579999999999998876 6899999999999999999999976


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      ....+...                       .+..+.                          ...++..+.++.+||.+
T Consensus       211 ~~~~~~~~-----------------------~i~~~~--------------------------~~~p~~~s~~~~~li~~  241 (336)
T 3h4j_B          211 EFIPNLFK-----------------------KVNSCV--------------------------YVMPDFLSPGAQSLIRR  241 (336)
T ss_dssp             SSSTTCBC-----------------------CCCSSC--------------------------CCCCTTSCHHHHHHHHT
T ss_pred             ccHHHHHH-----------------------HHHcCC--------------------------CCCcccCCHHHHHHHHH
Confidence            43211100                       000111                          11234567889999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||+.||.+|||++|+++||||+..
T Consensus       242 ~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          242 MIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             TSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HcCCChhHCcCHHHHHhChhhccC
Confidence            999999999999999999999754

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.4e-49  Score=389.00  Aligned_cols=257  Identities=27%  Similarity=0.423  Sum_probs=201.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      .++|++++.||+|+||+||+|.++.+++.||||++...........+|+.+++.+.     |+||+++++++...+.+|+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR-----HPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCC-----CTTBCCEEEEEECSSEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCC-----CCCCCcEEEEEeeCCEEEE
Confidence            46799999999999999999999999999999999866555667888999998884     4889999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+ +++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.++                  
T Consensus        94 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~------------------  153 (361)
T 3uc3_A           94 IMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSP------------------  153 (361)
T ss_dssp             EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSS------------------
T ss_pred             EEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC------------------
Confidence            99999 889999998765  799999999999999999999999999999999999995422                  


Q ss_pred             ccccCCCCCCeEEEeCCCccccC--CCCCeeeecCcccchhhhhCCCCCCc-chHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYER--PDQNYIVSTRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                             ...+||+|||+++...  ......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+......
T Consensus       154 -------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~  226 (361)
T 3uc3_A          154 -------APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD  226 (361)
T ss_dssp             -------SCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC
T ss_pred             -------CceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH
Confidence                   2358888888876322  22244679999999999999888755 8999999999999999999986443222


Q ss_pred             HHHH-HHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          329 LAMM-ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       329 ~~~i-~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ...+ .....                    .....+.                        ....+.++.+||.+||+.|
T Consensus       227 ~~~~~~~~~~--------------------~~~~~~~------------------------~~~~s~~~~~li~~~L~~d  262 (361)
T 3uc3_A          227 YRKTIQRILS--------------------VKYSIPD------------------------DIRISPECCHLISRIFVAD  262 (361)
T ss_dssp             HHHHHHHHHT--------------------TCCCCCT------------------------TSCCCHHHHHHHHHHSCSC
T ss_pred             HHHHHHHHhc--------------------CCCCCCC------------------------cCCCCHHHHHHHHHHccCC
Confidence            2111 11110                    0111111                        1245678999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTR  425 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~  425 (430)
                      |.+|||++|+|+||||.+
T Consensus       263 P~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          263 PATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             TTTSCCHHHHHTSHHHHT
T ss_pred             hhHCcCHHHHHhCcchhc
Confidence            999999999999999954

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.9e-50  Score=387.78  Aligned_cols=258  Identities=26%  Similarity=0.465  Sum_probs=209.6

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .+.++|++.+.||+|+||.||+|.++.+++.||+|+++....   ....|++++.++.    .|+||+++++++.+.+.+
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~----~hp~iv~~~~~~~~~~~~   91 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYG----QHPNIITLKDVYDDGKYV   91 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHT----TSTTBCCEEEEEECSSEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhc----CCCCcCeEEEEEEcCCEE
Confidence            456789999999999999999999999999999999975432   2345788888774    348899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||+ |++|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||+...+                
T Consensus        92 ~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~----------------  153 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDES----------------  153 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS----------------
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCC----------------
Confidence            9999999 889999998764  799999999999999999999999999999999999984321                


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc--
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE--  324 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~--  324 (430)
                             .....+||+|||++.......   ...+||+.|+|||++.+..|+.++|||||||++|+|++|..||....  
T Consensus       154 -------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~  226 (342)
T 2qr7_A          154 -------GNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD  226 (342)
T ss_dssp             -------CSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS
T ss_pred             -------CCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC
Confidence                   122458899999887543322   34578999999999998889999999999999999999999997632  


Q ss_pred             -hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          325 -NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       325 -~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                       ..+.+..+..                       +.+..+.                      ..+...+.++.+||.+|
T Consensus       227 ~~~~~~~~i~~-----------------------~~~~~~~----------------------~~~~~~s~~~~~li~~~  261 (342)
T 2qr7_A          227 TPEEILARIGS-----------------------GKFSLSG----------------------GYWNSVSDTAKDLVSKM  261 (342)
T ss_dssp             CHHHHHHHHHH-----------------------CCCCCCS----------------------TTTTTSCHHHHHHHHHH
T ss_pred             CHHHHHHHHcc-----------------------CCcccCc----------------------cccccCCHHHHHHHHHH
Confidence             2222222221                       1111111                      12345678899999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      |+.||++|||++|+|+||||..
T Consensus       262 L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          262 LHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             TCSSTTTSCCHHHHTTSHHHHT
T ss_pred             CCCChhHCcCHHHHhcCCeecC
Confidence            9999999999999999999954

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=9.7e-49  Score=383.47  Aligned_cols=280  Identities=29%  Similarity=0.519  Sum_probs=224.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC---
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~---  167 (430)
                      .++|++++.||+|+||.||+|.+..+++.||||++...  ......+..|++++.++.     |+||+++++++...   
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~  100 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-----HENIIGINDIIRAPTIE  100 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCC-----CTTBCCCCEEECCSSTT
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcC-----CCCCccceeEEecCCcc
Confidence            46899999999999999999999999999999998743  233466778999999984     48899999988654   


Q ss_pred             --CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          168 --NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       168 --~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                        ...|+||||++++|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||++               
T Consensus       101 ~~~~~~iv~e~~~~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---------------  162 (364)
T 3qyz_A          101 QMKDVYIVQDLMETDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---------------  162 (364)
T ss_dssp             TCCCEEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---------------
T ss_pred             ccceEEEEEcccCcCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC---------------
Confidence              479999999988999999764   599999999999999999999999999999999999994               


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCC------CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                  .++.+||+|||++......      ....+||+.|+|||++.+. .++.++|||||||++|+|++|.+
T Consensus       163 ------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  230 (364)
T 3qyz_A          163 ------------TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP  230 (364)
T ss_dssp             ------------TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSC
T ss_pred             ------------CCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCC
Confidence                        4456777777776543322      1335799999999987654 58999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhh-hhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      ||.+.+..+....+...++.++.+.+..+..... .+...    .+...               ........+..+.++.
T Consensus       231 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~---------------~~~~~~~~~~~~~~~~  291 (364)
T 3qyz_A          231 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS----LPHKN---------------KVPWNRLFPNADSKAL  291 (364)
T ss_dssp             SSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT----SCCCC---------------CCCHHHHCTTSCHHHH
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHh----cCCcc---------------CCCHHHhCCCCCHHHH
Confidence            9999999999999999999988776543211110 11000    00000               0001223456778899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          398 HLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +||.+||++||++|||++|+|+||||++.
T Consensus       292 ~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          292 DLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence            99999999999999999999999999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-49  Score=392.74  Aligned_cols=255  Identities=25%  Similarity=0.369  Sum_probs=208.9

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      ..++|++++.||+|+||.||+|+++.+++.||+|++++..    .....+..|..++..+     .|++|+++++++.+.
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-----~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-----DRRWITQLHFAFQDE  133 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-----CTTTBCCEEEEEECS
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEeeC
Confidence            3578999999999999999999999999999999997432    1223466788888776     458899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +.+||||||+ |++|.+++.+.+ ..+++..++.++.||+.||+|||++|||||||||+|||++                
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld----------------  196 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD----------------  196 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----------------
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeec----------------
Confidence            9999999999 999999998754 3799999999999999999999999999999999999994                


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhh-------CCCCCCcchHHHHHHHHHHHHh
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVIL-------GLGWTYPCDIWSVGCILVELCT  315 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslGv~l~el~t  315 (430)
                                 .++.+||+|||++.......    ...+||+.|+|||++.       +..|+.++|||||||++|||++
T Consensus       197 -----------~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyellt  265 (412)
T 2vd5_A          197 -----------RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY  265 (412)
T ss_dssp             -----------TTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHH
T ss_pred             -----------CCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHh
Confidence                       44566666777665433322    2358999999999998       3568999999999999999999


Q ss_pred             CCCCCCCCchHHHHHHHHHHh--CCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCch
Q 014117          316 GEALFQTHENLEHLAMMERVL--GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA  393 (430)
Q Consensus       316 G~~Pf~~~~~~~~~~~i~~~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (430)
                      |+.||.+.+..+....|....  ..+|                                              ..+...+
T Consensus       266 G~~Pf~~~~~~~~~~~i~~~~~~~~~p----------------------------------------------~~~~~~s  299 (412)
T 2vd5_A          266 GQTPFYADSTAETYGKIVHYKEHLSLP----------------------------------------------LVDEGVP  299 (412)
T ss_dssp             SSCTTCCSSHHHHHHHHHTHHHHCCCC--------------------------------------------------CCC
T ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCC----------------------------------------------ccccCCC
Confidence            999999887777666554311  0111                                              0123567


Q ss_pred             hHHHHHHHHhhhcCCCCC---CCHHHHhcCCCCCCC
Q 014117          394 GDLTHLLQGLLRYDPTDR---LTAREALRHPFFTRD  426 (430)
Q Consensus       394 ~~~~~ll~~~L~~dP~~R---~ta~elL~hp~f~~~  426 (430)
                      .++++||++||+ +|.+|   ++++|+++||||+.-
T Consensus       300 ~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          300 EEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             HHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence            889999999999 99998   499999999999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.7e-49  Score=389.10  Aligned_cols=251  Identities=22%  Similarity=0.417  Sum_probs=207.3

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++++.||+|+||.||+|.++.+++.||+|++....    .....+..|+.+++.+     .|+||+++++++.+.+
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~~~~~~   88 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-----EHPFLVNLWYSFQDEE   88 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEeCC
Confidence            468999999999999999999999999999999986432    2335667899998887     4588999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+|+||||+ |++|.+++....  .+++..++.++.||+.||.|||++|||||||||+|||++                 
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~-----------------  149 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD-----------------  149 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-----------------
T ss_pred             EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC-----------------
Confidence            999999999 889999998754  799999999999999999999999999999999999994                 


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhC---CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                .++.+||+|||++......  ....+||+.|+|||++.+   ..|+.++|||||||++|+|++|..||..
T Consensus       150 ----------~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~  219 (384)
T 4fr4_A          150 ----------EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI  219 (384)
T ss_dssp             ----------TTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ----------CCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence                      4556777777777644322  244689999999999974   4589999999999999999999999975


Q ss_pred             CchHH---HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          323 HENLE---HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       323 ~~~~~---~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      .+...   ....+....                                                 ..++..++.++.+|
T Consensus       220 ~~~~~~~~~~~~~~~~~-------------------------------------------------~~~p~~~s~~~~~l  250 (384)
T 4fr4_A          220 RSSTSSKEIVHTFETTV-------------------------------------------------VTYPSAWSQEMVSL  250 (384)
T ss_dssp             CTTSCHHHHHHHHHHCC-------------------------------------------------CCCCTTSCHHHHHH
T ss_pred             CCCccHHHHHHHHhhcc-------------------------------------------------cCCCCcCCHHHHHH
Confidence            43322   111111111                                                 11234567789999


Q ss_pred             HHHhhhcCCCCCCC-HHHHhcCCCCCCC
Q 014117          400 LQGLLRYDPTDRLT-AREALRHPFFTRD  426 (430)
Q Consensus       400 l~~~L~~dP~~R~t-a~elL~hp~f~~~  426 (430)
                      |.+||+.||.+||+ ++++++||||+..
T Consensus       251 i~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          251 LKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             HHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             HHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            99999999999998 9999999999864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8.1e-49  Score=377.31  Aligned_cols=262  Identities=26%  Similarity=0.462  Sum_probs=219.7

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh-------hHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRN  162 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~  162 (430)
                      +.+.++|++.+.||+|+||.||+|.++.+++.||+|+++....       ..+.+..|+.+++.+.     |+||+++++
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~   82 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-----HHNVITLHD   82 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-----CTTBCCEEE
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-----CCCcceEEE
Confidence            4456789999999999999999999999999999999864321       3466788999999984     478999999


Q ss_pred             eeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          163 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       163 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      ++...+.+|+||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++        
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~--------  152 (321)
T 2a2a_A           83 VYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN--------  152 (321)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT--------
T ss_pred             EEecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCC--------
Confidence            999999999999999 889999998654  799999999999999999999999999999999999996433        


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL  319 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~P  319 (430)
                                     .....+||+|||++.......  ....||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       153 ---------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  217 (321)
T 2a2a_A          153 ---------------IPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP  217 (321)
T ss_dssp             ---------------SSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred             ---------------CCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCC
Confidence                           112268888888886543322  345799999999999999999999999999999999999999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |.+.+..+....+.......+..                                             .+...+..+.+|
T Consensus       218 f~~~~~~~~~~~i~~~~~~~~~~---------------------------------------------~~~~~~~~~~~l  252 (321)
T 2a2a_A          218 FLGDTKQETLANITSVSYDFDEE---------------------------------------------FFSHTSELAKDF  252 (321)
T ss_dssp             SCCSSHHHHHHHHHTTCCCCCHH---------------------------------------------HHTTCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHhcccccChh---------------------------------------------hhcccCHHHHHH
Confidence            99877766666554433333321                                             224566789999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          400 LQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      |.+||+.||++|||++|+|+||||+..
T Consensus       253 i~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          253 IRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             HHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             HHHHcCCChhhCcCHHHHhcCccccCC
Confidence            999999999999999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.5e-49  Score=383.53  Aligned_cols=272  Identities=24%  Similarity=0.372  Sum_probs=223.8

Q ss_pred             ceeecCceecCcEEEE-eeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEE
Q 014117           84 YMFALGENLTSRYKIH-SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQ  159 (430)
Q Consensus        84 ~~~~~~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~  159 (430)
                      ..+...+.+.++|.+. +.||+|+||.||+|.++.+++.||+|+++...   .....+..|+.++..+.+    +++|++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~----~~~iv~   93 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS----CPRVIN   93 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTT----CTTBCC
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccC----CCCEEE
Confidence            4556667788899998 89999999999999999999999999987432   234667789999888854    478999


Q ss_pred             ecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccC
Q 014117          160 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP  238 (430)
Q Consensus       160 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~  238 (430)
                      +++++...+.+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++..      
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~------  167 (327)
T 3lm5_A           94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSI------  167 (327)
T ss_dssp             EEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCB------
T ss_pred             EEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecC------
Confidence            999999999999999999 8899999876555689999999999999999999999999999999999999541      


Q ss_pred             CCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhC
Q 014117          239 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG  316 (430)
Q Consensus       239 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG  316 (430)
                                        ...+.+||+|||++.......  ...+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       168 ------------------~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  229 (327)
T 3lm5_A          168 ------------------YPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH  229 (327)
T ss_dssp             ------------------TTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ------------------CCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhC
Confidence                              124678888888887544332  335799999999999999999999999999999999999


Q ss_pred             CCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHH
Q 014117          317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL  396 (430)
Q Consensus       317 ~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (430)
                      ..||.+.+..+....+.......+..                                             .+...+..+
T Consensus       230 ~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------------------------------~~~~~~~~~  264 (327)
T 3lm5_A          230 TSPFVGEDNQETYLNISQVNVDYSEE---------------------------------------------TFSSVSQLA  264 (327)
T ss_dssp             SCSSCCSSHHHHHHHHHHTCCCCCTT---------------------------------------------TTTTSCHHH
T ss_pred             CCCCCCCCchHHHHHHHhcccccCch---------------------------------------------hhcccCHHH
Confidence            99999887777666655543333221                                             123456789


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCCCCCCCCC
Q 014117          397 THLLQGLLRYDPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       397 ~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      .+||.+||+.||.+|||++|+|+||||++...
T Consensus       265 ~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~  296 (327)
T 3lm5_A          265 TDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF  296 (327)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred             HHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence            99999999999999999999999999987543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.5e-49  Score=389.23  Aligned_cols=307  Identities=18%  Similarity=0.240  Sum_probs=209.5

Q ss_pred             cCcEEEEeeeccc--cceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           93 TSRYKIHSKMGEG--TFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .++|++++.||+|  +||.||+|.++.+++.||||+++...   .....+..|+.+++.+.     |+||+++++++...
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~   98 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-----HPNIVPYRATFIAD   98 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-----CTTBCCEEEEEEET
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCC-----CCCCCcEeEEEEEC
Confidence            3579999999999  99999999999999999999997432   33456677999999884     48899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +.+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++|||||||||+|||++.++.++++|||.+.. 
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~-  177 (389)
T 3gni_B           99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS-  177 (389)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE-
T ss_pred             CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee-
Confidence            9999999999 89999999887556799999999999999999999999999999999999997666655555554321 


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccc-cCCCCCeeeecCcccchhhhhC--CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTY-ERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                       +.+.|.... ........+||+.|+|||++.+  ..|+.++|||||||++|+|++|..||.+.
T Consensus       178 -----------------~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  240 (389)
T 3gni_B          178 -----------------MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  240 (389)
T ss_dssp             -----------------CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             -----------------eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence                             122221111 1111233478999999999987  57999999999999999999999999876


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcC-chhHHHHHhhhcCCchhHHHHHHHH
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK-LPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      +..+....+..  +..+. .........+.+....... ............... ...........+..++.++.+||.+
T Consensus       241 ~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  316 (389)
T 3gni_B          241 PATQMLLEKLN--GTVPC-LLDTSTIPAEELTMSPSRS-VANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ  316 (389)
T ss_dssp             CSTTHHHHC------------------------------------------------------------CCHHHHHHHHH
T ss_pred             CHHHHHHHHhc--CCCCc-ccccccccccccccccccc-ccccccccccccCccccccCCCCCCccccccCHHHHHHHHH
Confidence            65554433221  11111 0000000000000000000 000000000000000 0000111223456778899999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||+.||++|||++|+|+||||++.
T Consensus       317 ~L~~dP~~Rpta~ell~hp~f~~~  340 (389)
T 3gni_B          317 CLQRNPDARPSASTLLNHSFFKQI  340 (389)
T ss_dssp             HTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred             HhhcCcccCCCHHHHhcCHHHHHH
Confidence            999999999999999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.8e-49  Score=382.41  Aligned_cols=254  Identities=24%  Similarity=0.379  Sum_probs=204.1

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      +.++|++.+.||+|+||.||+|.++.+++.||+|++....  ...+.+..|+.+++.+.     |+||+++++++...+.
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~~~~~~~~~~~   79 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-----HENVVKFYGHRREGNI   79 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCC-----CTTBCCEEEEEECSSE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCC-----CCCCCeEEEEEecCCe
Confidence            3468999999999999999999999999999999986432  23356778999998883     4889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .|+||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++                  
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~------------------  139 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD------------------  139 (323)
T ss_dssp             EEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred             EEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe------------------
Confidence            99999999 889999987553  699999999999999999999999999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCC-CCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                               .++.+||+|||++......     ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus       140 ---------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  210 (323)
T 3tki_A          140 ---------ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ  210 (323)
T ss_dssp             ---------TTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             ---------CCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence                     4556777777777543211     124579999999999998775 7889999999999999999999986


Q ss_pred             CchHHHH-HHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          323 HENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       323 ~~~~~~~-~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      ....... ..+......                                               ...+...+.++.+||.
T Consensus       211 ~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~li~  243 (323)
T 3tki_A          211 PSDSCQEYSDWKEKKTY-----------------------------------------------LNPWKKIDSAPLALLH  243 (323)
T ss_dssp             SCTTSHHHHHHHTTCTT-----------------------------------------------STTGGGSCHHHHHHHH
T ss_pred             CchHHHHHHHHhccccc-----------------------------------------------CCccccCCHHHHHHHH
Confidence            5442211 111100000                                               0011345678899999


Q ss_pred             HhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          402 GLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +||+.||++|||++|+|+||||+..
T Consensus       244 ~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          244 KILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             HHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHccCChhhCcCHHHHhhChhhccc
Confidence            9999999999999999999999865

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6.4e-49  Score=401.08  Aligned_cols=267  Identities=26%  Similarity=0.452  Sum_probs=221.0

Q ss_pred             CCceeecCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--------------hhHHHHHHHHHHHHHH
Q 014117           82 GHYMFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--------------KYREAAMIEIEVLQQL  147 (430)
Q Consensus        82 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--------------~~~~~~~~E~~~l~~l  147 (430)
                      +.+.......+.++|+++++||+|+||+||+|.++.+++.||+|++....              .....+..|+.+++++
T Consensus        24 ~~~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  103 (504)
T 3q5i_A           24 GMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL  103 (504)
T ss_dssp             GGGCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC
T ss_pred             hheeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC
Confidence            33445555667889999999999999999999999999999999986432              2345677899999888


Q ss_pred             HhcCCCCCceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCc
Q 014117          148 AKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPEN  226 (430)
Q Consensus       148 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~N  226 (430)
                      .     |+||+++++++.....+|+||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|
T Consensus       104 ~-----hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~N  176 (504)
T 3q5i_A          104 D-----HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPEN  176 (504)
T ss_dssp             C-----CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             C-----CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHH
Confidence            3     488999999999999999999999 889999998764  79999999999999999999999999999999999


Q ss_pred             eEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHH
Q 014117          227 VLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIW  304 (430)
Q Consensus       227 ILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dvw  304 (430)
                      ||++.++                        ....+||+|||++.......  ...+||+.|+|||++.+ .|+.++|||
T Consensus       177 il~~~~~------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Diw  231 (504)
T 3q5i_A          177 ILLENKN------------------------SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVW  231 (504)
T ss_dssp             EEESSTT------------------------CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHH
T ss_pred             EEEecCC------------------------CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHH
Confidence            9995432                        23468999999887554332  34579999999999874 699999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHH
Q 014117          305 SVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL  384 (430)
Q Consensus       305 slGv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (430)
                      ||||++|+|++|.+||.+.+..+....+......++..                                          
T Consensus       232 slG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------------------------------------  269 (504)
T 3q5i_A          232 SCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN------------------------------------------  269 (504)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH------------------------------------------
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc------------------------------------------
Confidence            99999999999999999888777776665433322221                                          


Q ss_pred             HhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       385 ~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                         .+...+.++.+||.+||++||.+|||++|+|+||||+.
T Consensus       270 ---~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  307 (504)
T 3q5i_A          270 ---DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK  307 (504)
T ss_dssp             ---HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ---ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence               12456778999999999999999999999999999964

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.5e-49  Score=379.16  Aligned_cols=251  Identities=23%  Similarity=0.387  Sum_probs=203.6

Q ss_pred             cCcEEEEeeeccccceEEEEEEEC---CCCeEEEEEEecCch-----hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      .++|++.+.||+|+||.||+|++.   .+++.||+|++++..     ........|+.+++.+.     |+||+++++++
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~~~~~~   90 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-----HPFIVDLIYAF   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-----CTTBCCEEEEE
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-----CCCccceeEEE
Confidence            467999999999999999999985   688999999987532     23344667899998884     58899999999


Q ss_pred             ecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCC
Q 014117          165 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       165 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                      ...+.+|+||||+ +++|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||++             
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~-------------  155 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN-------------  155 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC-------------
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEEC-------------
Confidence            9999999999999 889999998764  799999999999999999999999999999999999995             


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                    .++.+||+|||++......   ....+||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       156 --------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf  221 (327)
T 3a62_A          156 --------------HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF  221 (327)
T ss_dssp             --------------TTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             --------------CCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCC
Confidence                          4456666777766532211   23357999999999999999999999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .+.+..+....+......                                                 .+...+.++.+||
T Consensus       222 ~~~~~~~~~~~i~~~~~~-------------------------------------------------~p~~~~~~~~~li  252 (327)
T 3a62_A          222 TGENRKKTIDKILKCKLN-------------------------------------------------LPPYLTQEARDLL  252 (327)
T ss_dssp             CCSSHHHHHHHHHHTCCC-------------------------------------------------CCTTSCHHHHHHH
T ss_pred             CCCCHHHHHHHHHhCCCC-------------------------------------------------CCCCCCHHHHHHH
Confidence            987776655554432211                                                 2234567899999


Q ss_pred             HHhhhcCCCCCC-----CHHHHhcCCCCCCC
Q 014117          401 QGLLRYDPTDRL-----TAREALRHPFFTRD  426 (430)
Q Consensus       401 ~~~L~~dP~~R~-----ta~elL~hp~f~~~  426 (430)
                      .+||+.||.+||     +++|+++||||+..
T Consensus       253 ~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          253 KKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             HHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            999999999999     89999999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.3e-48  Score=368.71  Aligned_cols=261  Identities=25%  Similarity=0.417  Sum_probs=218.2

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .+.++|++.+.||+|+||.||+|.++.+++.||+|++....   .....+..|+.+++++.     |+||+++++++...
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~   77 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-----HPNIVRLHDSIQEE   77 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCC-----CTTBCCEEEEEECS
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcC-----CCCcCeEEEEEEcC
Confidence            35678999999999999999999999999999999986432   23455678999999883     48899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +..++||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++             
T Consensus        78 ~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-------------  142 (284)
T 3kk8_A           78 SFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA-------------  142 (284)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS-------------
T ss_pred             CEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCC-------------
Confidence            9999999999 889999887764  799999999999999999999999999999999999995432             


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                 ....+||+|||.+.......  ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus       143 -----------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  211 (284)
T 3kk8_A          143 -----------KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED  211 (284)
T ss_dssp             -----------TTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             -----------CCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence                       23458889998886544333  33578999999999999999999999999999999999999998877


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+....+.......|..                                             .+...+.++.+||.+||
T Consensus       212 ~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~li~~~l  246 (284)
T 3kk8_A          212 QHRLYAQIKAGAYDYPSP---------------------------------------------EWDTVTPEAKSLIDSML  246 (284)
T ss_dssp             HHHHHHHHHHTCCCCCTT---------------------------------------------TTTTSCHHHHHHHHHHS
T ss_pred             hhHHHHHHHhccccCCch---------------------------------------------hhcccCHHHHHHHHHHc
Confidence            766665554433222210                                             12345678999999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      +.||++|||++|+|+||||++..
T Consensus       247 ~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          247 TVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             CSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             ccChhhCCCHHHHhcCccccCCh
Confidence            99999999999999999998653

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8.8e-49  Score=381.68  Aligned_cols=286  Identities=27%  Similarity=0.460  Sum_probs=220.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---  166 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~---  166 (430)
                      .++|++++.||+|+||.||+|+++.+++.||+|++....   .....+..|+.+++.+.     ++||+++++++..   
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~   90 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-----HENVVNLIEICRTKAS   90 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCC-----CTTBCCEEEEEEEC--
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhcc-----CCCcccHhheeecccc
Confidence            468999999999999999999999999999999985332   23346678999999984     4889999998876   


Q ss_pred             -----CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          167 -----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       167 -----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                           .+.+|+||||+.++|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.          
T Consensus        91 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~----------  159 (351)
T 3mi9_A           91 PYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR----------  159 (351)
T ss_dssp             ------CEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT----------
T ss_pred             ccccCCceEEEEEeccCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC----------
Confidence                 45799999999889988887654 46999999999999999999999999999999999999954          


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCC-------CCCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHH
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-------DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVEL  313 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el  313 (430)
                                       ++.+||+|||++.....       .....+||+.|+|||++.+. .++.++|||||||++|+|
T Consensus       160 -----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el  222 (351)
T 3mi9_A          160 -----------------DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM  222 (351)
T ss_dssp             -----------------TSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHH
T ss_pred             -----------------CCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHH
Confidence                             44566666666643221       11234789999999999874 589999999999999999


Q ss_pred             HhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCch
Q 014117          314 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA  393 (430)
Q Consensus       314 ~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (430)
                      ++|.+||.+.+..+....+....+.++...+..+......    ..........           .........  ...+
T Consensus       223 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~-----------~~~~~~~~~--~~~~  285 (351)
T 3mi9_A          223 WTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELY----EKLELVKGQK-----------RKVKDRLKA--YVRD  285 (351)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGG----TSSCCCSSCC-----------CCHHHHHHH--HHCC
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhh----cccccccccc-----------cCHHHHhhh--ccCC
Confidence            9999999999999999999999999887654432211100    0000000000           000010110  0135


Q ss_pred             hHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCCC
Q 014117          394 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       394 ~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      +++.+||.+||+.||.+|||++|+|+||||+....
T Consensus       286 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  320 (351)
T 3mi9_A          286 PYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  320 (351)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred             hHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence            67899999999999999999999999999987643

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.2e-49  Score=394.09  Aligned_cols=279  Identities=28%  Similarity=0.492  Sum_probs=220.3

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec------
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY------  166 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~------  166 (430)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++.....   ...+|+++++.+.     |+||+++++++..      
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~-----hpniv~l~~~~~~~~~~~~  124 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLD-----HCNIVRLRYFFYSSGEKKD  124 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCC-----CTTBCCEEEEEEEEETTTT
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcC-----CCCccceeeEEeccCCCCc
Confidence            3479999999999999999999999999999999865432   2335888888873     4889999887742      


Q ss_pred             CCeEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          167 RNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       167 ~~~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                      ..++++||||+.++|.+++..  .....+++..++.++.||+.||.|||++||+||||||+||||+.             
T Consensus       125 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-------------  191 (420)
T 1j1b_A          125 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP-------------  191 (420)
T ss_dssp             EEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET-------------
T ss_pred             ceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC-------------
Confidence            235789999998888877653  22357999999999999999999999999999999999999953             


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                                   ....+||+|||+++.....  ....+||+.|+|||++.+. .|+.++|||||||++|||++|++||.
T Consensus       192 -------------~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~  258 (420)
T 1j1b_A          192 -------------DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP  258 (420)
T ss_dssp             -------------TTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             -------------CCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence                         2345678888877643322  2345789999999999875 79999999999999999999999999


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      +.+..+++..+.+.+|.++.+.+........      .+.++...              ...+...+....+.++.+||.
T Consensus       259 ~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~------~~~~p~~~--------------~~~~~~~~~~~~~~~~~~Li~  318 (420)
T 1j1b_A          259 GDSGVDQLVEIIKVLGTPTREQIREMNPNYT------EFKFPQIK--------------AHPWTKVFRPRTPPEAIALCS  318 (420)
T ss_dssp             CSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC------CCCCCCCC--------------CCCHHHHSCTTSCHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHhCCCCHHHHHhhChhhh------hhccCccC--------------CCCHHHhcCCCCCHHHHHHHH
Confidence            9999999999999999988766554321111      11111100              001122234567789999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          402 GLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      +||++||.+|||+.|+|+||||+.
T Consensus       319 ~~L~~dP~~R~t~~e~l~hp~f~~  342 (420)
T 1j1b_A          319 RLLEYTPTARLTPLEACAHSFFDE  342 (420)
T ss_dssp             HHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred             HhccCChhHCCCHHHHhCCHhhcc
Confidence            999999999999999999999964

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.6e-49  Score=386.91  Aligned_cols=258  Identities=29%  Similarity=0.455  Sum_probs=209.7

Q ss_pred             cCcEEE--EeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           93 TSRYKI--HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        93 ~~~y~~--~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      .+.|.+  .+.||+|+||.||+|.+..+++.||+|+++... ...+.+..|+.+++++     .|+||+++++++...+.
T Consensus        86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~  160 (373)
T 2x4f_A           86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-----DHANLIQLYDAFESKND  160 (373)
T ss_dssp             GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSE
T ss_pred             ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-----CCCCCCeEEEEEEECCE
Confidence            344555  678999999999999999999999999997543 3456678899998888     35889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +||||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+..                 
T Consensus       161 ~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-----------------  222 (373)
T 2x4f_A          161 IVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-----------------  222 (373)
T ss_dssp             EEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-----------------
T ss_pred             EEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-----------------
Confidence            99999999 889999887643 36999999999999999999999999999999999999954                 


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                              +..+.+||+|||++.......  ...+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..
T Consensus       223 --------~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  294 (373)
T 2x4f_A          223 --------RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA  294 (373)
T ss_dssp             --------TTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             --------CCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence                    234568888888877544332  3357999999999999989999999999999999999999999988877


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +.+..+......++.                                             ..+...+.++.+||.+||+.
T Consensus       295 ~~~~~i~~~~~~~~~---------------------------------------------~~~~~~~~~~~~li~~~L~~  329 (373)
T 2x4f_A          295 ETLNNILACRWDLED---------------------------------------------EEFQDISEEAKEFISKLLIK  329 (373)
T ss_dssp             HHHHHHHHTCCCSCS---------------------------------------------GGGTTSCHHHHHHHHTTSCS
T ss_pred             HHHHHHHhccCCCCh---------------------------------------------hhhccCCHHHHHHHHHHcCC
Confidence            766665543322221                                             11235577899999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||.+|||++|+|+||||+..
T Consensus       330 dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          330 EKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             SGGGSCCHHHHHHSHHHHCH
T ss_pred             ChhhCCCHHHHhcCcCcCCC
Confidence            99999999999999999754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.1e-49  Score=396.55  Aligned_cols=251  Identities=25%  Similarity=0.408  Sum_probs=203.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++++.||+|+||.||+|.++.+++.||||+++...    ........|+.+++.+     .|+||+.+++++...+
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~l~~~~~~~~  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-----RHPFLTALKYSFQTHD  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-----SCTTSCCEEEEEEETT
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-----CCCeEeeEEEEEeeCC
Confidence            468999999999999999999999999999999987432    2223445566666555     4588999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      .+||||||+ +++|.+++....  .+++..++.++.||+.||+|||+ .|||||||||+||||+.               
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~---------------  284 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK---------------  284 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECS---------------
T ss_pred             EEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECC---------------
Confidence            999999999 889999998764  79999999999999999999998 99999999999999954               


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                  ++.+||+|||++......   ....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.
T Consensus       285 ------------~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  352 (446)
T 4ejn_A          285 ------------DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  352 (446)
T ss_dssp             ------------SSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ------------CCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence                        456677777766542221   23468999999999999999999999999999999999999999887


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +..+....+......                                                 ++...++++.+||.+|
T Consensus       353 ~~~~~~~~i~~~~~~-------------------------------------------------~p~~~~~~~~~li~~~  383 (446)
T 4ejn_A          353 DHEKLFELILMEEIR-------------------------------------------------FPRTLGPEAKSLLSGL  383 (446)
T ss_dssp             SHHHHHHHHHHCCCC-------------------------------------------------CCTTSCHHHHHHHHHH
T ss_pred             CHHHHHHHHHhCCCC-------------------------------------------------CCccCCHHHHHHHHHH
Confidence            766655544332211                                                 2234567899999999


Q ss_pred             hhcCCCCCC-----CHHHHhcCCCCCCC
Q 014117          404 LRYDPTDRL-----TAREALRHPFFTRD  426 (430)
Q Consensus       404 L~~dP~~R~-----ta~elL~hp~f~~~  426 (430)
                      |+.||.+||     |++|+|+||||+..
T Consensus       384 L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          384 LKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             TCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             cccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            999999999     99999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=395.18  Aligned_cols=299  Identities=26%  Similarity=0.485  Sum_probs=213.4

Q ss_pred             ceecCcEEEE-eeeccccceEEEEEEEC--CCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee--
Q 014117           90 ENLTSRYKIH-SKMGEGTFGQVLECWDR--ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF--  164 (430)
Q Consensus        90 ~~~~~~y~~~-~~lG~G~~g~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~--  164 (430)
                      +.+.+.|++. ++||+|+||+||+|.++  .+++.||||++.... ....+.+|+.+++.+.     |+||+++++++  
T Consensus        16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~-----hpniv~~~~~~~~   89 (405)
T 3rgf_A           16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELK-----HPNVISLQKVFLS   89 (405)
T ss_dssp             CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCC-----CTTBCCCCEEEEE
T ss_pred             hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcC-----CCCeeeEeeEEec
Confidence            3455678874 57999999999999966  568899999997543 3345778999999984     48899999998  


Q ss_pred             ecCCeEEEEEecCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCcccc
Q 014117          165 DYRNHICIVFEKLGSSLYDFLRKNN-------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV  237 (430)
Q Consensus       165 ~~~~~~~lv~e~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i  237 (430)
                      .....+||||||++++|.+++....       ...+++..++.++.||+.||.|||++|||||||||+||||...+    
T Consensus        90 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~----  165 (405)
T 3rgf_A           90 HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG----  165 (405)
T ss_dssp             TTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSS----
T ss_pred             CCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCC----
Confidence            4578999999999889998886321       12499999999999999999999999999999999999995432    


Q ss_pred             CCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC------CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHH
Q 014117          238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCIL  310 (430)
Q Consensus       238 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l  310 (430)
                                         +..+.+||+|||+++.....      ....+||+.|+|||++.+. .++.++|||||||++
T Consensus       166 -------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il  226 (405)
T 3rgf_A          166 -------------------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF  226 (405)
T ss_dssp             -------------------TTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHH
T ss_pred             -------------------CCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHH
Confidence                               34567888888888654322      1335889999999999885 499999999999999


Q ss_pred             HHHHhCCCCCCCCch---------HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhH
Q 014117          311 VELCTGEALFQTHEN---------LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL  381 (430)
Q Consensus       311 ~el~tG~~Pf~~~~~---------~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (430)
                      |+|++|.+||.+...         .+++..+...+|.++...+..+....+.......+.           .........
T Consensus       227 ~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~  295 (405)
T 3rgf_A          227 AELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFR-----------RNTYTNCSL  295 (405)
T ss_dssp             HHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCC-----------GGGGTTCCH
T ss_pred             HHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhcc-----------ccCCCcchh
Confidence            999999999976544         477888888888877654332211111000000000           000011112


Q ss_pred             HHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCCC
Q 014117          382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       382 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      ...........+.++.+||.+||++||.+|||++|||+||||+...+
T Consensus       296 ~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~  342 (405)
T 3rgf_A          296 IKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL  342 (405)
T ss_dssp             HHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred             hhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence            22223333445778999999999999999999999999999987643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.7e-49  Score=376.52  Aligned_cols=251  Identities=24%  Similarity=0.410  Sum_probs=199.5

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh---------------------------hHHHHHHHHHHHH
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---------------------------YREAAMIEIEVLQ  145 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---------------------------~~~~~~~E~~~l~  145 (430)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.....                           ..+.+..|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4679999999999999999999999999999999864321                           1234677999988


Q ss_pred             HHHhcCCCCCceEEecceeec--CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccC
Q 014117          146 QLAKHDKGGNRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL  222 (430)
Q Consensus       146 ~l~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDl  222 (430)
                      .+.     |+||+++++++..  .+.+|+||||+ +++|.+++..   ..+++..+..++.||+.||.|||++||+||||
T Consensus        92 ~l~-----h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl  163 (298)
T 2zv2_A           92 KLD-----HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDI  163 (298)
T ss_dssp             TCC-----CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             hCC-----CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence            883     4889999999876  67899999999 7888776432   47999999999999999999999999999999


Q ss_pred             CCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCC---
Q 014117          223 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG---  296 (430)
Q Consensus       223 Kp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~---  296 (430)
                      ||+|||++                           .++.+||+|||++.......   ....||+.|+|||++.+..   
T Consensus       164 kp~Nil~~---------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  216 (298)
T 2zv2_A          164 KPSNLLVG---------------------------EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIF  216 (298)
T ss_dssp             CGGGEEEC---------------------------TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCE
T ss_pred             CHHHEEEC---------------------------CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCC
Confidence            99999994                           45567777777776443322   2357899999999998765   


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhc
Q 014117          297 WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM  376 (430)
Q Consensus       297 ~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (430)
                      ++.++|||||||++|+|++|..||...........+......                       ++             
T Consensus       217 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------------------~~-------------  260 (298)
T 2zv2_A          217 SGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALE-----------------------FP-------------  260 (298)
T ss_dssp             ESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------------------CC-------------
T ss_pred             CCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCC-----------------------CC-------------
Confidence            478899999999999999999999876654443333221111                       11             


Q ss_pred             CchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          377 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                                 .....+.++.+||.+||+.||++|||++|+|+||||++
T Consensus       261 -----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          261 -----------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             -----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             -----------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence                       01345678999999999999999999999999999964

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.1e-48  Score=381.91  Aligned_cols=286  Identities=30%  Similarity=0.468  Sum_probs=215.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC----
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~----  168 (430)
                      .++|++.+.||+|+||.||+|.++.+++.||||++............|++.+..+     .|+||+++++++...+    
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-----~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-----HHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-----CCTTBCCEEEEEEEECSSCT
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-----CCCCcccHHHhhhccccccc
Confidence            4679999999999999999999999999999999875554445556677777777     3488999999885433    


Q ss_pred             ---eEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH--hcCeeeccCCCCceEEeecCccccCCCc
Q 014117          169 ---HICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMH--DLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       169 ---~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                         .+++||||+.++|.+.+..  .....+++..+..++.||+.||.|||  ++||+||||||+|||++.          
T Consensus        97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~----------  166 (360)
T 3e3p_A           97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE----------  166 (360)
T ss_dssp             TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET----------
T ss_pred             cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC----------
Confidence               3899999998787766653  23357899999999999999999999  999999999999999953          


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCC-CCCcchHHHHHHHHHHHHhCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~tG~~  318 (430)
                                      .++.+||+|||++.......  ....||+.|+|||++.+.. ++.++|||||||++|+|++|..
T Consensus       167 ----------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~  230 (360)
T 3e3p_A          167 ----------------ADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP  230 (360)
T ss_dssp             ----------------TTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ----------------CCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence                            24567777777776443322  3357899999999997655 8999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||.+.+..+.+..+...++.++...+..+......+....     .            ................+.++.+
T Consensus       231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~------------~~~~~~~~~~~~~~~~~~~~~~  293 (360)
T 3e3p_A          231 IFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYN-----S------------KGIPWSNVFSDHSLKDAKEAYD  293 (360)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGC-----C------------CCCCHHHHTTTCCCTTHHHHHH
T ss_pred             CcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccc-----c------------ccCCcccccchhhccccHHHHH
Confidence            9999999999999999999999888776543222111000     0            0001122223334457889999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          399 LLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||.+||+.||.+|||+.|+|+||||++.
T Consensus       294 li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          294 LLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             HHHHHhccCccccCCHHHHhcCcccccc
Confidence            9999999999999999999999999754

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.6e-49  Score=379.25  Aligned_cols=257  Identities=29%  Similarity=0.547  Sum_probs=191.1

Q ss_pred             cCcEEEE---eeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           93 TSRYKIH---SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        93 ~~~y~~~---~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      .++|++.   +.||+|+||.||+|.++.+++.||||++...  .......|+.+++.+.    +|+||+++++++.+...
T Consensus         7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~----~h~niv~~~~~~~~~~~   80 (325)
T 3kn6_A            7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCE----GHPNIVKLHEVFHDQLH   80 (325)
T ss_dssp             HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTT----TCTTBCCEEEEEECSSE
T ss_pred             hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhc----CCCCeeEEEEEEEcCCE
Confidence            3567775   7899999999999999999999999999643  3455678899988885    35889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .|+||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++               
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~---------------  143 (325)
T 3kn6_A           81 TFLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN---------------  143 (325)
T ss_dssp             EEEEECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-----------------
T ss_pred             EEEEEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCC---------------
Confidence            99999999 889999998764  799999999999999999999999999999999999996432               


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                               ....+||+|||++.......   ...+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+.
T Consensus       144 ---------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  214 (325)
T 3kn6_A          144 ---------DNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR  214 (325)
T ss_dssp             -----------CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred             ---------CcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence                     23368888888886543322   345789999999999999999999999999999999999999986432


Q ss_pred             H-------HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          326 L-------EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       326 ~-------~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      .       +....+                       ..+.+.++.                      ..+...+.++.+
T Consensus       215 ~~~~~~~~~~~~~i-----------------------~~~~~~~~~----------------------~~~~~~s~~~~~  249 (325)
T 3kn6_A          215 SLTCTSAVEIMKKI-----------------------KKGDFSFEG----------------------EAWKNVSQEAKD  249 (325)
T ss_dssp             ---CCCHHHHHHHH-----------------------TTTCCCCCS----------------------HHHHTSCHHHHH
T ss_pred             ccccccHHHHHHHH-----------------------HcCCCCCCc----------------------ccccCCCHHHHH
Confidence            1       111111                       111111110                      112356778999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          399 LLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||.+||+.||.+|||++|+++||||+..
T Consensus       250 li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          250 LIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             HHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             HHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            9999999999999999999999999865

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-49  Score=383.13  Aligned_cols=280  Identities=27%  Similarity=0.483  Sum_probs=215.9

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh------hHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++....      ....+..|+.+++.+.     |+||+++++++..
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~   83 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-----HPNIIGLLDAFGH   83 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-----CTTBCCEEEEECC
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-----CCCCCeEEEEEee
Confidence            4679999999999999999999999999999999864221      1235678999998884     4889999999999


Q ss_pred             CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          167 RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       167 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      .+..++||||+.++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++                
T Consensus        84 ~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~----------------  146 (346)
T 1ua2_A           84 KSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD----------------  146 (346)
T ss_dssp             TTCCEEEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----------------
T ss_pred             CCceEEEEEcCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc----------------
Confidence            99999999999879999887653 4689999999999999999999999999999999999994                


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                 .++.+||+|||++......   ....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+
T Consensus       147 -----------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~  215 (346)
T 1ua2_A          147 -----------ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG  215 (346)
T ss_dssp             -----------TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             -----------CCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence                       4456677777766543222   1335789999999999765 589999999999999999999999999


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      .+..+.+..+....+.++...+......... .     ....             .+.  ......+...+.++.+||.+
T Consensus       216 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~-----~~~~-------------~~~--~~~~~~~~~~~~~~~~li~~  274 (346)
T 1ua2_A          216 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDY-V-----TFKS-------------FPG--IPLHHIFSAAGDDLLDLIQG  274 (346)
T ss_dssp             SSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC-C-----CCCC-------------CCC--CCHHHHCTTCCHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHcCCCChhhhhhhccCccc-c-----cccc-------------cCC--CChHHhhccCCHHHHHHHHH
Confidence            9998888888888877665322111000000 0     0000             000  00112345677889999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||+.||++|||++|+|+||||+..
T Consensus       275 ~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          275 LFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             HHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             HhccChhhCCCHHHHhcChhhhcC
Confidence            999999999999999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.1e-49  Score=399.35  Aligned_cols=262  Identities=28%  Similarity=0.484  Sum_probs=215.8

Q ss_pred             ecCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 014117           87 ALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW  163 (430)
Q Consensus        87 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~  163 (430)
                      .....+.++|++++.||+|+||+||+|.++.++..||+|+++...   .....+..|+.+++.+     .|+||++++++
T Consensus        30 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~  104 (494)
T 3lij_A           30 SKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-----DHPNIMKLYDF  104 (494)
T ss_dssp             CCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-----CCTTBCCEEEE
T ss_pred             cCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-----CCCCCCeEEEE
Confidence            334456778999999999999999999999999999999987432   2345677899998887     45899999999


Q ss_pred             eecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          164 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       164 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                      +...+.+|+||||+ +++|.+++....  .+++..+..++.||+.||.|||++|||||||||+|||++..          
T Consensus       105 ~~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~----------  172 (494)
T 3lij_A          105 FEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK----------  172 (494)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS----------
T ss_pred             EEeCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCC----------
Confidence            99999999999999 889999987764  79999999999999999999999999999999999999543          


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                    .....+||+|||++.......  ...+||+.|+|||++. ..|+.++|||||||++|+|++|.+||
T Consensus       173 --------------~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf  237 (494)
T 3lij_A          173 --------------EKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPF  237 (494)
T ss_dssp             --------------STTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             --------------CCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCC
Confidence                          234568999999887544332  3457999999999886 46999999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .+.+..+....+......++..                                             .+...+.++.+||
T Consensus       238 ~~~~~~~~~~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li  272 (494)
T 3lij_A          238 GGQTDQEILRKVEKGKYTFDSP---------------------------------------------EWKNVSEGAKDLI  272 (494)
T ss_dssp             CCSSHHHHHHHHHHTCCCCCSG---------------------------------------------GGTTSCHHHHHHH
T ss_pred             CCCCHHHHHHHHHhCCCCCCch---------------------------------------------hcccCCHHHHHHH
Confidence            9888777766665433332211                                             1235677899999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          401 QGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      .+||+.||.+|||+.|+|+||||+.
T Consensus       273 ~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          273 KQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             HHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             HHHCCCChhhCccHHHHhcCccccc
Confidence            9999999999999999999999964

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-48  Score=368.60  Aligned_cols=260  Identities=28%  Similarity=0.416  Sum_probs=208.4

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .+.++|.+.+.||+|+||.||+|.++.+++.||+|++....  ...+.+..|+++++.+.     ++||+++++++....
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~~~~~~~~~~   93 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD-----HPNIIKIFEVFEDYH   93 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCC-----CTTBCCEEEEEECSS
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCC-----CchHHhHHHheecCC
Confidence            45678999999999999999999999999999999986433  23466788999998883     488999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      ..|+||||+ +++|.+++...  ....+++..+..++.||+.||.|||++||+||||||+|||++..             
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~-------------  160 (285)
T 3is5_A           94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDT-------------  160 (285)
T ss_dssp             EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSS-------------
T ss_pred             eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecC-------------
Confidence            999999999 88999988643  22479999999999999999999999999999999999999532             


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                 +..+.+||+|||++......  .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.
T Consensus       161 -----------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~  228 (285)
T 3is5_A          161 -----------SPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT  228 (285)
T ss_dssp             -----------STTCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             -----------CCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence                       23467889999988654332  23457899999999876 46899999999999999999999999886


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +..+....+.......+.                                              .....++++.+||.+|
T Consensus       229 ~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~li~~~  262 (285)
T 3is5_A          229 SLEEVQQKATYKEPNYAV----------------------------------------------ECRPLTPQAVDLLKQM  262 (285)
T ss_dssp             SHHHHHHHHHHCCCCCCC------------------------------------------------CCCCHHHHHHHHHH
T ss_pred             CHHHHHhhhccCCccccc----------------------------------------------ccCcCCHHHHHHHHHH
Confidence            655544332221111100                                              0123567899999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      |+.||++|||++|+|+||||++.
T Consensus       263 L~~dP~~Rps~~e~l~hp~f~~a  285 (285)
T 3is5_A          263 LTKDPERRPSAAQVLHHEWFKQA  285 (285)
T ss_dssp             TCSCTTTSCCHHHHHTSGGGGC-
T ss_pred             ccCChhhCcCHHHHhcCHHhhcC
Confidence            99999999999999999999863

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.3e-48  Score=410.72  Aligned_cols=252  Identities=23%  Similarity=0.342  Sum_probs=211.6

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++++.||+|+||.||+|.++.+++.||||++++..    ........|..++..+.    ++++|+.++.++++.+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~----~~~~i~~l~~~~~~~~  415 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG----KPPFLTQLHSCFQTMD  415 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTT----CCTTBCCEEEECBCSS
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhcc----CCCeEEEEEEEEEeCC
Confidence            467999999999999999999999999999999987432    22344566776666553    4588999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+||||||+ +++|.+++...+  .+++..++.|+.||+.||+|||++|||||||||+||||+                 
T Consensus       416 ~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~-----------------  476 (674)
T 3pfq_A          416 RLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD-----------------  476 (674)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC-----------------
T ss_pred             EEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc-----------------
Confidence            999999999 899999998765  799999999999999999999999999999999999995                 


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccC---CCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                .++.+||+|||+++...   ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus       477 ----------~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~  546 (674)
T 3pfq_A          477 ----------SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED  546 (674)
T ss_dssp             ----------SSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ----------CCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence                      44566777777665321   12244689999999999999999999999999999999999999999887


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+.+..|......                                                 ++..++.++.+||.+||
T Consensus       547 ~~~~~~~i~~~~~~-------------------------------------------------~p~~~s~~~~~li~~lL  577 (674)
T 3pfq_A          547 EDELFQSIMEHNVA-------------------------------------------------YPKSMSKEAVAICKGLM  577 (674)
T ss_dssp             HHHHHHHHHSSCCC-------------------------------------------------CCTTSCHHHHHHHHHHS
T ss_pred             HHHHHHHHHhCCCC-------------------------------------------------CCccCCHHHHHHHHHHc
Confidence            77766655432211                                                 23456778999999999


Q ss_pred             hcCCCCCCCH-----HHHhcCCCCCCC
Q 014117          405 RYDPTDRLTA-----REALRHPFFTRD  426 (430)
Q Consensus       405 ~~dP~~R~ta-----~elL~hp~f~~~  426 (430)
                      ++||.+||++     +||++||||+..
T Consensus       578 ~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          578 TKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             CSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             cCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            9999999997     999999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.8e-49  Score=402.72  Aligned_cols=254  Identities=26%  Similarity=0.420  Sum_probs=210.5

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      ..++|++.+.||+|+||.||+|.++.+++.||+|++.+..    .....+..|+.++..+     .|+||+++++++.+.
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-----~hp~Iv~l~~~~~~~  256 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-----NSRFVVSLAYAYETK  256 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECS
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-----CCCCEeeEEEEEeeC
Confidence            3567999999999999999999999999999999986432    2334567899999888     348899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +.+||||||+ |++|.+++...+...+++..++.++.||+.||+|||++|||||||||+||||+                
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld----------------  320 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD----------------  320 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----------------
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEe----------------
Confidence            9999999999 89999999877656799999999999999999999999999999999999994                


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                 .++.+||+|||++.......  ...+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+..
T Consensus       321 -----------~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~  389 (576)
T 2acx_A          321 -----------DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK  389 (576)
T ss_dssp             -----------TTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred             -----------CCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence                       45566777777765443322  23589999999999999999999999999999999999999998653


Q ss_pred             h----HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          325 N----LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       325 ~----~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .    .+....+...                                                 ...++..++.++.+||
T Consensus       390 ~~~~~~~i~~~i~~~-------------------------------------------------~~~~p~~~s~~~~dLI  420 (576)
T 2acx_A          390 KKIKREEVERLVKEV-------------------------------------------------PEEYSERFSPQARSLC  420 (576)
T ss_dssp             SCCCHHHHHHHHHHC-------------------------------------------------CCCCCTTSCHHHHHHH
T ss_pred             cchhHHHHHHHhhcc-------------------------------------------------cccCCccCCHHHHHHH
Confidence            2    1111111110                                                 0112345678899999


Q ss_pred             HHhhhcCCCCCC-----CHHHHhcCCCCCCC
Q 014117          401 QGLLRYDPTDRL-----TAREALRHPFFTRD  426 (430)
Q Consensus       401 ~~~L~~dP~~R~-----ta~elL~hp~f~~~  426 (430)
                      .+||+.||.+||     |++|+++||||+..
T Consensus       421 ~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          421 SQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             HHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             HHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            999999999999     89999999999864

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.1e-48  Score=366.14  Aligned_cols=258  Identities=25%  Similarity=0.441  Sum_probs=217.4

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      .+.++|++.+.||+|+||.||+|.++.++..||+|++... ....+.+..|+++++.+     .|+||+++++++...+.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-----DHPNIIRLYETFEDNTD   80 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSSE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-----CCCCEeeEEEEEecCCe
Confidence            3567899999999999999999999999999999998643 23456678899999888     34889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .|+||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||+..+                
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~----------------  142 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD----------------  142 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS----------------
T ss_pred             EEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecC----------------
Confidence            99999999 889999988764  69999999999999999999999999999999999999432                


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                              +.++.+||+|||++.......  ....||+.|+|||++.+. ++.++|||||||++|+|++|..||...+..
T Consensus       143 --------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  213 (277)
T 3f3z_A          143 --------SPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS  213 (277)
T ss_dssp             --------STTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             --------CCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH
Confidence                    345678888888876543322  345799999999998764 999999999999999999999999988877


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +....+.......|...                                             +...+.++.+||.+||+.
T Consensus       214 ~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~li~~~l~~  248 (277)
T 3f3z_A          214 EVMLKIREGTFTFPEKD---------------------------------------------WLNVSPQAESLIRRLLTK  248 (277)
T ss_dssp             HHHHHHHHCCCCCCHHH---------------------------------------------HTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHhCCCCCCchh---------------------------------------------hhcCCHHHHHHHHHHccC
Confidence            77666655444444321                                             124567899999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~  425 (430)
                      ||++|||+.|+|+||||++
T Consensus       249 dp~~R~s~~~~l~h~~~~~  267 (277)
T 3f3z_A          249 SPKQRITSLQALEHEWFEK  267 (277)
T ss_dssp             STTTSCCHHHHTTSHHHHH
T ss_pred             ChhhCcCHHHHhcCHHHhc
Confidence            9999999999999999964

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8.6e-49  Score=395.56  Aligned_cols=254  Identities=27%  Similarity=0.386  Sum_probs=211.9

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      ....++|.+.+.||+|+||.||+|.+..+|+.||||+++...    .....+.+|+.+++.+     .|+||+++++++.
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-----~HpnIv~l~~~~~   86 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-----RHPHIIKLYQVIS   86 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-----CCTTBCCEEEEEE
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEE
Confidence            344578999999999999999999999999999999996432    2235677888888877     3588999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                      ..+.+|+||||+ +++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++              
T Consensus        87 ~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~--------------  150 (476)
T 2y94_A           87 TPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD--------------  150 (476)
T ss_dssp             CSSEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC--------------
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe--------------
Confidence            999999999999 889999997654  799999999999999999999999999999999999994              


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCC-CCcchHHHHHHHHHHHHhCCCCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                                   .++.+||+|||++.......  ...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.
T Consensus       151 -------------~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~  217 (476)
T 2y94_A          151 -------------AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD  217 (476)
T ss_dssp             -------------TTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             -------------cCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCC
Confidence                         45567777777776543322  34589999999999998876 689999999999999999999998


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      +.+..+....+......                                                 .+...+.++.+||.
T Consensus       218 ~~~~~~~~~~i~~~~~~-------------------------------------------------~p~~~s~~~~~Li~  248 (476)
T 2y94_A          218 DDHVPTLFKKICDGIFY-------------------------------------------------TPQYLNPSVISLLK  248 (476)
T ss_dssp             CSSSHHHHHHHHTTCCC-------------------------------------------------CCTTCCHHHHHHHH
T ss_pred             CCCHHHHHHHHhcCCcC-------------------------------------------------CCccCCHHHHHHHH
Confidence            87665555444322111                                                 12345678999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          402 GLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +||+.||.+|||++|+++||||+..
T Consensus       249 ~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          249 HMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HHcCCCchhCcCHHHHHhCHHhhhc
Confidence            9999999999999999999999764

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2e-48  Score=385.20  Aligned_cols=283  Identities=31%  Similarity=0.535  Sum_probs=220.5

Q ss_pred             CceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-
Q 014117           89 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-  167 (430)
Q Consensus        89 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~-  167 (430)
                      ++....+|++.+.||+|+||.||+|.+..+++ ||+|.+......   ..+|+++++.+.     |+||+++++++... 
T Consensus        35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~-----h~niv~l~~~~~~~~  105 (394)
T 4e7w_A           35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVK-----HPNVVDLKAFFYSNG  105 (394)
T ss_dssp             CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCC-----CTTBCCEEEEEEEES
T ss_pred             CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCC-----CCCcceEEEEEEecC
Confidence            34556789999999999999999999988776 788877543322   235888888873     58899999988443 


Q ss_pred             -----CeEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCC
Q 014117          168 -----NHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY  240 (430)
Q Consensus       168 -----~~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~df  240 (430)
                           ..+|+||||+.+++.+.+..  .....+++..++.++.||+.||.|||++||+||||||+|||++          
T Consensus       106 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~----------  175 (394)
T 4e7w_A          106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD----------  175 (394)
T ss_dssp             SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----------
T ss_pred             CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc----------
Confidence                 34899999997777665542  1234799999999999999999999999999999999999995          


Q ss_pred             cCCCCCCCCCcccccCCCCCCeEEEeCCCccccCC--CCCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCC
Q 014117          241 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP--DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       241 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~  317 (430)
                                      ..++.+||+|||+++....  .....+||+.|+|||++.+. .|+.++|||||||++|||++|.
T Consensus       176 ----------------~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~  239 (394)
T 4e7w_A          176 ----------------PPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ  239 (394)
T ss_dssp             ----------------TTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ----------------CCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence                            1345677777777764322  22345789999999999875 5999999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      +||.+.+..+.+..+.+.+|.++...+.........   .   .++...              ...+...++...++++.
T Consensus       240 ~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~---~---~~~~~~--------------~~~~~~~~~~~~~~~~~  299 (394)
T 4e7w_A          240 PLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME---H---KFPQIR--------------PHPFSKVFRPRTPPDAI  299 (394)
T ss_dssp             CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSS---S---CCCCCC--------------CCCHHHHSCTTCCHHHH
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh---h---cccccc--------------CCcHHHhccccCCHHHH
Confidence            999999999999999999999988766554322111   0   111100              01112234456788999


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          398 HLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +||.+||++||.+|||+.|+|+||||+..
T Consensus       300 ~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          300 DLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             HHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence            99999999999999999999999999853

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.6e-49  Score=398.06  Aligned_cols=258  Identities=31%  Similarity=0.527  Sum_probs=216.7

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .+.++|++++.||+|+||+||+|.++.+++.||||++...   ......+..|+++++++     .|+||+++++++...
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~   93 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-----DHPNIMKLFEILEDS   93 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECS
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-----CCCCcCeEEEEEEcC
Confidence            4567899999999999999999999999999999998632   23346678899999998     348899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      ..+|+||||+ +++|.+++....  .+++..+..++.||+.||.|||++|||||||||+|||++..              
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~--------------  157 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK--------------  157 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSS--------------
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecC--------------
Confidence            9999999999 889999987764  79999999999999999999999999999999999999542              


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                +....+||+|||++.......  ...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+
T Consensus       158 ----------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~  226 (486)
T 3mwu_A          158 ----------EKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN  226 (486)
T ss_dssp             ----------STTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ----------CCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                      234578899999887544332  34579999999999886 59999999999999999999999999888


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+....+.......+.                                             ..+...+.++.+||.+||
T Consensus       227 ~~~~~~~i~~~~~~~~~---------------------------------------------~~~~~~s~~~~~li~~~L  261 (486)
T 3mwu_A          227 EYDILKRVETGKYAFDL---------------------------------------------PQWRTISDDAKDLIRKML  261 (486)
T ss_dssp             HHHHHHHHHHTCCCSCS---------------------------------------------GGGGGSCHHHHHHHHHHT
T ss_pred             HHHHHHHHHhCCCCCCC---------------------------------------------cccCCCCHHHHHHHHHHc
Confidence            77766655443222211                                             012345778999999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~  425 (430)
                      +.||.+|||+.|+|+||||+.
T Consensus       262 ~~dp~~R~t~~~~l~hp~~~~  282 (486)
T 3mwu_A          262 TFHPSLRITATQCLEHPWIQK  282 (486)
T ss_dssp             CSSTTTSCCHHHHHHCHHHHH
T ss_pred             CCChhhCcCHHHHhcCHhhcc
Confidence            999999999999999999974

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.7e-48  Score=372.48  Aligned_cols=276  Identities=24%  Similarity=0.407  Sum_probs=203.3

Q ss_pred             eecCcEEEE-eeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           91 NLTSRYKIH-SKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        91 ~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .+.++|++. +.||+|+||.||+|.+..+++.||||++.... .....+..|++++.++.    .|+||+++++++...+
T Consensus         9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~----~h~~i~~~~~~~~~~~   84 (316)
T 2ac3_A            9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ----GHRNVLELIEFFEEED   84 (316)
T ss_dssp             CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTC----CCTTBCCEEEEEEETT
T ss_pred             ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhc----CCCCeeeEEEEEeeCC
Confidence            445679995 78999999999999999999999999996443 34566788999888763    4588999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+|+||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.             
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-------------  149 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQ-------------  149 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSS-------------
T ss_pred             EEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCC-------------
Confidence            999999999 899999998764  7999999999999999999999999999999999999965432             


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCC----------CCCeeeecCcccchhhhhC-----CCCCCcchHHHHHHHHHH
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERP----------DQNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVE  312 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~e  312 (430)
                                 ...+||+|||++.....          .....+||+.|+|||++.+     ..++.++|||||||++|+
T Consensus       150 -----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~  218 (316)
T 2ac3_A          150 -----------VSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYI  218 (316)
T ss_dssp             -----------SCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHH
T ss_pred             -----------cCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHH
Confidence                       22367777776653221          1123469999999999975     458899999999999999


Q ss_pred             HHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCc
Q 014117          313 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS  392 (430)
Q Consensus       313 l~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  392 (430)
                      |++|..||.+....+.....    .....    .........+..+...++                      ...+...
T Consensus       219 l~~g~~pf~~~~~~~~~~~~----~~~~~----~~~~~~~~~i~~~~~~~~----------------------~~~~~~~  268 (316)
T 2ac3_A          219 LLSGYPPFVGRCGSDCGWDR----GEACP----ACQNMLFESIQEGKYEFP----------------------DKDWAHI  268 (316)
T ss_dssp             HHHSSCSCCCCCCSCSCC--------CCH----HHHHHHHHHHHHCCCCCC----------------------HHHHTTS
T ss_pred             HHHCCCCCcccccccccccc----cccch----hHHHHHHHHHhccCcccC----------------------chhcccC
Confidence            99999999765321100000    00000    000000001111111111                      0112346


Q ss_pred             hhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       393 ~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +.++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       269 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          269 SCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             CHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence            7789999999999999999999999999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.5e-49  Score=400.30  Aligned_cols=261  Identities=30%  Similarity=0.501  Sum_probs=219.9

Q ss_pred             cCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 014117           88 LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW  163 (430)
Q Consensus        88 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~  163 (430)
                      .+..+.++|++.+.||+|+||.||+|.++.+++.||||++...    ......+..|+.+++++     .|+||++++++
T Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~   94 (484)
T 3nyv_A           20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-----DHPNIMKLYEF   94 (484)
T ss_dssp             CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-----CCTTBCCEEEE
T ss_pred             CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-----CCCCCCcEEEE
Confidence            3455678999999999999999999999999999999998632    23456678899998888     45889999999


Q ss_pred             eecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          164 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       164 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                      +...+.+|+||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++..          
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~----------  162 (484)
T 3nyv_A           95 FEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK----------  162 (484)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS----------
T ss_pred             EEeCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecC----------
Confidence            99999999999999 899999998764  79999999999999999999999999999999999999532          


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                    +..+.+||+|||++.......  ...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||
T Consensus       163 --------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf  227 (484)
T 3nyv_A          163 --------------SKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPF  227 (484)
T ss_dssp             --------------STTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             --------------CCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCC
Confidence                          345679999999887554433  23579999999999987 6999999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .+.+..+....+......++.                                             ..+...+.++.+||
T Consensus       228 ~~~~~~~~~~~i~~~~~~~~~---------------------------------------------~~~~~~s~~~~~li  262 (484)
T 3nyv_A          228 NGANEYDILKKVEKGKYTFEL---------------------------------------------PQWKKVSESAKDLI  262 (484)
T ss_dssp             CCSSHHHHHHHHHHCCCCCCS---------------------------------------------GGGGGSCHHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCCCCCC---------------------------------------------cccccCCHHHHHHH
Confidence            988877766665543222211                                             01234577899999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          401 QGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      .+||++||.+|||++|+|+||||+.
T Consensus       263 ~~~L~~dp~~R~s~~e~l~h~~~~~  287 (484)
T 3nyv_A          263 RKMLTYVPSMRISARDALDHEWIQT  287 (484)
T ss_dssp             HHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred             HHHCCCChhHCcCHHHHhhChhhcc
Confidence            9999999999999999999999964

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.6e-48  Score=378.71  Aligned_cols=282  Identities=28%  Similarity=0.485  Sum_probs=221.8

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .+.++|.+.+.||+|+||.||+|.++.+++.||||++...   ......+..|+.+++.+.     |+||+++++++...
T Consensus        21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~   95 (353)
T 3coi_A           21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-----HENVIGLLDVFTPA   95 (353)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCC-----CTTBCCCSEEECSC
T ss_pred             ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcC-----CCCcccHhheEecc
Confidence            3567899999999999999999999999999999998643   233456778999998883     48899999998776


Q ss_pred             Ce------EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          168 NH------ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       168 ~~------~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      ..      +|+||||+.++|.+++.    ..+++..+..++.||+.||.|||++||+||||||+|||++           
T Consensus        96 ~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~-----------  160 (353)
T 3coi_A           96 SSLRNFYDFYLVMPFMQTDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN-----------  160 (353)
T ss_dssp             SSGGGCCCCEEEEECCSEEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC-----------
T ss_pred             cccccceeEEEEeccccCCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC-----------
Confidence            53      59999999888887763    2599999999999999999999999999999999999994           


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                      .++.+||+|||++...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus       161 ----------------~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf  224 (353)
T 3coi_A          161 ----------------EDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF  224 (353)
T ss_dssp             ----------------TTCCEEECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             ----------------CCCcEEEeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence                            4556777777777655444455688999999999987 67899999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .+.+..+.+..+.+..|.++..+...+...............+.                  ......++..+.++.+||
T Consensus       225 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~li  286 (353)
T 3coi_A          225 KGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPR------------------KDFTQLFPRASPQAADLL  286 (353)
T ss_dssp             BSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSS------------------CCTTTTCTTSCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCC------------------ccHHHhcCCcCHHHHHHH
Confidence            99998999999999999988876554332211111000000000                  001122346678899999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          401 QGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      .+||+.||++|||++|+|+||||+.-
T Consensus       287 ~~~L~~dp~~Rpt~~e~l~hp~f~~~  312 (353)
T 3coi_A          287 EKMLELDVDKRLTAAQALTHPFFEPF  312 (353)
T ss_dssp             HHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHcCCCcccCCCHHHHhcCcchhhc
Confidence            99999999999999999999999753

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.9e-48  Score=376.28  Aligned_cols=283  Identities=28%  Similarity=0.458  Sum_probs=222.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      .++|++++.||+|+||.||+|.+..+++.||+|++....   .....+..|+.+++.+.     |+||+++++++...+.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~   98 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-----HENLVNLLEVCKKKKR   98 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCC-----CTTBCCEEEEEEETTE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCC-----CCCEeeEEEEeecCCE
Confidence            467999999999999999999999999999999985332   23455678999999884     4889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .|+||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++                  
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~------------------  158 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS------------------  158 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC------------------
T ss_pred             EEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc------------------
Confidence            99999999 556666655443  699999999999999999999999999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                               .++.+||+|||++......   .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+
T Consensus       159 ---------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  229 (331)
T 4aaa_A          159 ---------QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS  229 (331)
T ss_dssp             ---------TTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ---------CCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                     4556777777776543222   1234789999999999876 68999999999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+....+....+..++............    .....+.....              .......+..+.++.+||.+||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~L  291 (331)
T 4aaa_A          230 DIDQLYHIMMCLGNLIPRHQELFNKNPVF----AGVRLPEIKER--------------EPLERRYPKLSEVVIDLAKKCL  291 (331)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHHHHCGGG----TTCCCCCCSSC--------------CCHHHHSTTSCHHHHHHHHHHT
T ss_pred             cHHHHHHHHHHhCCCChhhhhHhhhcccc----ccccCcccccc--------------chhhhcccchhHHHHHHHHHHh
Confidence            99999999999998887654433222110    11111111100              0112234567889999999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      +.||++|||++|+|+||||+...
T Consensus       292 ~~dP~~Rpt~~ell~hp~f~~~~  314 (331)
T 4aaa_A          292 HIDPDKRPFCAELLHHDFFQMDG  314 (331)
T ss_dssp             CSSGGGSCCGGGGGGSHHHHGGG
T ss_pred             ccCcccCCCHHHHhcCchhccCC
Confidence            99999999999999999998653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.1e-48  Score=371.40  Aligned_cols=252  Identities=25%  Similarity=0.418  Sum_probs=208.0

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      .|...+.||+|+||.||+|.++.+|+.||||++.... ...+.+..|+.+++.+.     |+||+++++++...+..++|
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-----HFNVVEMYKSYLVGEELWVL  120 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC-----CTTBCCEEEEEEETTEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC-----CCCcceEEEEEEECCEEEEE
Confidence            4888899999999999999999999999999986433 33456778998888873     48899999999999999999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      |||+ +++|.+++...   .+++..+..++.||+.||.|||+.||+||||||+|||++                      
T Consensus       121 ~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----------------------  175 (321)
T 2c30_A          121 MEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT----------------------  175 (321)
T ss_dssp             ECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----------------------
T ss_pred             EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----------------------
Confidence            9999 88999998653   699999999999999999999999999999999999994                      


Q ss_pred             cccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL  329 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~  329 (430)
                           .++.+||+|||++......   ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+..
T Consensus       176 -----~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~  250 (321)
T 2c30_A          176 -----LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM  250 (321)
T ss_dssp             -----TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             -----CCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence                 4456777777776543322   23457999999999999999999999999999999999999999887665554


Q ss_pred             HHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCC
Q 014117          330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT  409 (430)
Q Consensus       330 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~  409 (430)
                      ..+.....+..                                              ......+.++.+||.+||+.||+
T Consensus       251 ~~~~~~~~~~~----------------------------------------------~~~~~~~~~l~~li~~~l~~dp~  284 (321)
T 2c30_A          251 KRLRDSPPPKL----------------------------------------------KNSHKVSPVLRDFLERMLVRDPQ  284 (321)
T ss_dssp             HHHHHSSCCCC----------------------------------------------TTGGGSCHHHHHHHHHHSCSSTT
T ss_pred             HHHhcCCCCCc----------------------------------------------CccccCCHHHHHHHHHHccCChh
Confidence            44332111000                                              01123466799999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCC
Q 014117          410 DRLTAREALRHPFFTRDH  427 (430)
Q Consensus       410 ~R~ta~elL~hp~f~~~~  427 (430)
                      +|||++|+|+||||.+..
T Consensus       285 ~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          285 ERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             TSCCHHHHHTSGGGGGCC
T ss_pred             hCcCHHHHhcChhhccCC
Confidence            999999999999998654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.2e-48  Score=365.45  Aligned_cols=251  Identities=24%  Similarity=0.425  Sum_probs=207.8

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....    .....+..|+.+++.+.     |+||+++++++...+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~   82 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-----HPNILRLYGYFHDAT   82 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-----CTTBCCEEEEEECSS
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-----CCCCcchhheEecCC
Confidence            467999999999999999999999999999999986432    22345667888877773     588999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      ..++||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++                 
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~-----------------  143 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG-----------------  143 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC-----------------
T ss_pred             EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc-----------------
Confidence            999999999 789999998764  799999999999999999999999999999999999994                 


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCC-CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                                .++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus       144 ----------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  213 (279)
T 3fdn_A          144 ----------SAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ  213 (279)
T ss_dssp             ----------TTSCEEECSCCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             ----------CCCCEEEEeccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH
Confidence                      4556777777766443322 23457899999999999999999999999999999999999999987766


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +....+......                                                 .+...+.++.+||.+||+.
T Consensus       214 ~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~li~~~l~~  244 (279)
T 3fdn_A          214 ETYKRISRVEFT-------------------------------------------------FPDFVTEGARDLISRLLKH  244 (279)
T ss_dssp             HHHHHHHHTCCC-------------------------------------------------CCTTSCHHHHHHHHHHCCS
T ss_pred             HHHHHHHhCCCC-------------------------------------------------CCCcCCHHHHHHHHHHhcc
Confidence            655544432222                                                 2234567899999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||.+|||+.|+|+||||+..
T Consensus       245 ~p~~Rps~~e~l~h~~~~~~  264 (279)
T 3fdn_A          245 NPSQRPMLREVLEHPWITAN  264 (279)
T ss_dssp             SGGGSCCHHHHHHCHHHHHH
T ss_pred             ChhhCCCHHHHhhCccccCC
Confidence            99999999999999999753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.7e-48  Score=393.69  Aligned_cols=253  Identities=22%  Similarity=0.364  Sum_probs=208.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++++..    .....+..|+.+++.+     +|++|+++++++....
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-----~hp~Iv~l~~~~~~~~  258 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-----HSRFIVSLAYAFETKT  258 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSS
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-----CCCCEeeEEEEEeeCC
Confidence            468999999999999999999999999999999996432    2235577899999888     4588999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      .+|+||||+ |++|.+++....  ...+++..++.++.||+.||.|||++|||||||||+|||++               
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~---------------  323 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD---------------  323 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---------------
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEe---------------
Confidence            999999999 899999997653  34699999999999999999999999999999999999994               


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                  .++.+||+|||++.......   ...+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+
T Consensus       324 ------------~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~  391 (543)
T 3c4z_A          324 ------------DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA  391 (543)
T ss_dssp             ------------TTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ------------CCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCC
Confidence                        45567777777765433222   235899999999999999999999999999999999999999986


Q ss_pred             Cch----HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          323 HEN----LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       323 ~~~----~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      .+.    .+....+....                                                 ..++..++.++.+
T Consensus       392 ~~~~~~~~~~~~~i~~~~-------------------------------------------------~~~p~~~s~~~~~  422 (543)
T 3c4z_A          392 RGEKVENKELKQRVLEQA-------------------------------------------------VTYPDKFSPASKD  422 (543)
T ss_dssp             TTCCCCHHHHHHHHHHCC-------------------------------------------------CCCCTTSCHHHHH
T ss_pred             CccchhHHHHHHHHhhcc-------------------------------------------------cCCCcccCHHHHH
Confidence            532    22222221110                                                 1123456788999


Q ss_pred             HHHHhhhcCCCCCCC-----HHHHhcCCCCCCC
Q 014117          399 LLQGLLRYDPTDRLT-----AREALRHPFFTRD  426 (430)
Q Consensus       399 ll~~~L~~dP~~R~t-----a~elL~hp~f~~~  426 (430)
                      ||.+||+.||.+||+     ++++++||||+..
T Consensus       423 li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          423 FCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             HHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             HHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            999999999999995     5899999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.7e-48  Score=375.57  Aligned_cols=253  Identities=28%  Similarity=0.450  Sum_probs=199.6

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      .++|++++.||+|+||.||+|.+. +++.||||++...   ......+..|+.++..+.++   ++||+++++++...+.
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~---~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH---SDKIIRLYDYEITDQY   83 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTT---CTTBCCEEEEEECSSE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhc---CCceEEEeeeEeeCCE
Confidence            457999999999999999999884 6889999998643   23345677899999999763   3789999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          170 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       170 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      +|||||+.+++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++ +                 
T Consensus        84 ~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~-----------------  143 (343)
T 3dbq_A           84 IYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D-----------------  143 (343)
T ss_dssp             EEEEECCCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-T-----------------
T ss_pred             EEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-C-----------------
Confidence            99999987999999998764  799999999999999999999999999999999999994 2                 


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhC-----------CCCCCcchHHHHHHHHHHH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILG-----------LGWTYPCDIWSVGCILVEL  313 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGv~l~el  313 (430)
                                +.+||+|||++.......     ...+||+.|+|||++.+           ..++.++|||||||++|+|
T Consensus       144 ----------~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~el  213 (343)
T 3dbq_A          144 ----------GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM  213 (343)
T ss_dssp             ----------TEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHH
T ss_pred             ----------CcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHH
Confidence                      346777777665443222     23579999999999975           5789999999999999999


Q ss_pred             HhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCch
Q 014117          314 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA  393 (430)
Q Consensus       314 ~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (430)
                      ++|..||....+..  ..+.......                  ..                          ..++...+
T Consensus       214 l~g~~pf~~~~~~~--~~~~~~~~~~------------------~~--------------------------~~~~~~~~  247 (343)
T 3dbq_A          214 TYGKTPFQQIINQI--SKLHAIIDPN------------------HE--------------------------IEFPDIPE  247 (343)
T ss_dssp             HHSSCTTTTCCSHH--HHHHHHHCTT------------------SC--------------------------CCCCCCSC
T ss_pred             HhCCCcchhhhhHH--HHHHHHhcCC------------------cc--------------------------cCCcccCC
Confidence            99999997643321  1111111100                  00                          11234456


Q ss_pred             hHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          394 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       394 ~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      .++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       248 ~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          248 KDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             HHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence            67999999999999999999999999999974

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.9e-47  Score=374.37  Aligned_cols=258  Identities=30%  Similarity=0.522  Sum_probs=212.0

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---------hhHHHHHHHHHHHHHHHhcCCCCCceEEe
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHDKGGNRCVQI  160 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~  160 (430)
                      ..+.++|++.+.||+|+||.||+|.++.+|+.||||+++...         ...+.+..|+.+++++.    .++||+.+
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~  165 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA----GHPHIITL  165 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT----TCTTBCCE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc----CCCCEeEE
Confidence            345578999999999999999999999999999999986332         12345678899998884    24789999


Q ss_pred             cceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCC
Q 014117          161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD  239 (430)
Q Consensus       161 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~d  239 (430)
                      ++++...+..|+||||+ +++|.+++....  .+++..+..++.||+.||.|||+.||+||||||+|||++         
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~---------  234 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD---------  234 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---------
Confidence            99999999999999999 889999998754  799999999999999999999999999999999999994         


Q ss_pred             CcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhC------CCCCCcchHHHHHHHHH
Q 014117          240 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG------LGWTYPCDIWSVGCILV  311 (430)
Q Consensus       240 fg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGv~l~  311 (430)
                                        .++.+||+|||++.......  ...+||+.|+|||++.+      ..++.++|||||||++|
T Consensus       235 ------------------~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~  296 (365)
T 2y7j_A          235 ------------------DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF  296 (365)
T ss_dssp             ------------------TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHH
T ss_pred             ------------------CCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHH
Confidence                              45567777777765443322  34579999999999874      35889999999999999


Q ss_pred             HHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCC
Q 014117          312 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH  391 (430)
Q Consensus       312 el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (430)
                      +|++|..||...+.......+.......+..                                             .+..
T Consensus       297 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------------------------------~~~~  331 (365)
T 2y7j_A          297 TLLAGSPPFWHRRQILMLRMIMEGQYQFSSP---------------------------------------------EWDD  331 (365)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH---------------------------------------------HHSS
T ss_pred             HHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc---------------------------------------------cccc
Confidence            9999999998877666555544332222211                                             1235


Q ss_pred             chhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       392 ~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      .+.++.+||.+||+.||++|||++|+|+||||++
T Consensus       332 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            5678999999999999999999999999999974

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.9e-48  Score=375.76  Aligned_cols=285  Identities=24%  Similarity=0.421  Sum_probs=219.3

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch------------hhHHHHHHHHHHHHHHHhcCCCCCce
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK------------KYREAAMIEIEVLQQLAKHDKGGNRC  157 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~------------~~~~~~~~E~~~l~~l~~~~~~~~~i  157 (430)
                      ..+.++|++.+.||+|+||.||+|.+.. ++.||||++....            ...+.+..|+.+++++.     |+||
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i   91 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-----HPNI   91 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-----CTTB
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-----CcCc
Confidence            3456789999999999999999999865 8899999985321            12366788999999984     4889


Q ss_pred             EEecceee-----cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeec
Q 014117          158 VQIRNWFD-----YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS  232 (430)
Q Consensus       158 ~~~~~~~~-----~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~  232 (430)
                      +++++++.     ....+|+||||++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++  
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~--  168 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA--  168 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC--
T ss_pred             cceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc--
Confidence            99999883     345899999999889999987543 4799999999999999999999999999999999999994  


Q ss_pred             CccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhC-CCCCCcchHHHHHHH
Q 014117          233 EYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCI  309 (430)
Q Consensus       233 ~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~  309 (430)
                                               .++.+||+|||++......  .....||+.|+|||++.+ ..++.++|||||||+
T Consensus       169 -------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  223 (362)
T 3pg1_A          169 -------------------------DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCV  223 (362)
T ss_dssp             -------------------------TTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHH
T ss_pred             -------------------------CCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHH
Confidence                                     4556777777777533222  233578999999999987 679999999999999


Q ss_pred             HHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhh-hhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhh
Q 014117          310 LVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRH-AEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH  388 (430)
Q Consensus       310 l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (430)
                      +|+|++|..||.+.+..+....+....+.++.......... ...+........+.                  ......
T Consensus       224 l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~  285 (362)
T 3pg1_A          224 MAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA------------------RAWTAV  285 (362)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCC------------------CCHHHH
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCCh------------------hhHHhh
Confidence            99999999999999999999999999998876544332111 11222121111111                  011223


Q ss_pred             cCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       389 ~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      .+..++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus       286 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          286 VPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             STTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence            45667889999999999999999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.1e-48  Score=364.01  Aligned_cols=259  Identities=24%  Similarity=0.459  Sum_probs=214.4

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-------hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|+++...       ...+.+..|+.+++++.     |+||+++++++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~   77 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-----HPNIITLHDIF   77 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-----CTTBCCEEEEE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-----CCCeeehhhee
Confidence            3467999999999999999999999999999999986432       13566788999999884     48899999999


Q ss_pred             ecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCC
Q 014117          165 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       165 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                      ...+..++||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++          
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~----------  145 (283)
T 3bhy_A           78 ENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKN----------  145 (283)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS----------
T ss_pred             cCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCC----------
Confidence            9999999999999 899999998754  799999999999999999999999999999999999996543          


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                                   .....+||+|||.+.......  ....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       146 -------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  212 (283)
T 3bhy_A          146 -------------VPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL  212 (283)
T ss_dssp             -------------SSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             -------------CCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCC
Confidence                         223478888888886543322  33578999999999999999999999999999999999999999


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      ..+..+....+.......+..                                             .+...+..+.+||.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~li~  247 (283)
T 3bhy_A          213 GETKQETLTNISAVNYDFDEE---------------------------------------------YFSNTSELAKDFIR  247 (283)
T ss_dssp             CSSHHHHHHHHHTTCCCCCHH---------------------------------------------HHTTCCHHHHHHHH
T ss_pred             CcchHHHHHHhHhcccCCcch---------------------------------------------hcccCCHHHHHHHH
Confidence            877666555544332222211                                             22455678999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          402 GLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      +||+.||++|||++|+|+||||+.
T Consensus       248 ~~l~~dp~~Rps~~~~l~h~~~~~  271 (283)
T 3bhy_A          248 RLLVKDPKRRMTIAQSLEHSWIKA  271 (283)
T ss_dssp             TTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred             HHccCCHhHCcCHHHHHhCHHHHH
Confidence            999999999999999999999974

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.4e-47  Score=366.26  Aligned_cols=284  Identities=29%  Similarity=0.512  Sum_probs=223.5

Q ss_pred             ecCcEEEEeeeccccceEEEEEEEC-CCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee--
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDR-ERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--  165 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~--  165 (430)
                      ..++|++.+.||+|+||.||+|.+. .+++.||+|+++...   ........|+.+++.+...  .|+||+++++++.  
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF--EHPNVVRLFDVCTVS   86 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT--CCTTBCCEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhcc--CCCCeEeeeeeeeec
Confidence            3568999999999999999999995 678999999986322   1223566788888888542  3588999999886  


Q ss_pred             ---cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          166 ---YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       166 ---~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                         ....+++||||++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++            
T Consensus        87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~------------  154 (326)
T 1blx_A           87 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT------------  154 (326)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC------------
T ss_pred             ccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEc------------
Confidence               56789999999988999999887656799999999999999999999999999999999999994            


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                     .++.+||+|||++......  .....||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       155 ---------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  219 (326)
T 1blx_A          155 ---------------SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF  219 (326)
T ss_dssp             ---------------TTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ---------------CCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCC
Confidence                           4456677777766543322  12357899999999999999999999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCC-hhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAAS-RESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      .+.+..+....+....+.++...                  |+..... ...+.     .........+....+.++.+|
T Consensus       220 ~~~~~~~~~~~i~~~~~~~~~~~------------------~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l  276 (326)
T 1blx_A          220 RGSSDVDQLGKILDVIGLPGEED------------------WPRDVALPRQAFH-----SKSAQPIEKFVTDIDELGKDL  276 (326)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCGGG------------------SCTTCSSCGGGSC-----CCCCCCGGGTCCSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHHcCCCCccc------------------Cccccccchhhhc-----ccCcchhhhccccCCHHHHHH
Confidence            99888888888888777665432                  1111100 00000     000011223456778899999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          400 LQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      |.+||+.||++|||+.|+|+||||++..
T Consensus       277 i~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          277 LLKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             HHHHcCCCcccCCCHHHHhcCccccccc
Confidence            9999999999999999999999998653

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.3e-47  Score=371.68  Aligned_cols=297  Identities=27%  Similarity=0.424  Sum_probs=216.8

Q ss_pred             CceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           89 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        89 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      +..+.++|++.+.||+|+||.||+|.+..+++.||||++...  ......+..|+.+++.+.     |+||+++++++..
T Consensus         6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~   80 (353)
T 2b9h_A            6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK-----HENIITIFNIQRP   80 (353)
T ss_dssp             CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCC-----CTTBCCEEEECCC
T ss_pred             ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCc-----CCCcCCeeeeecc
Confidence            345678899999999999999999999999999999998633  233456678999999884     4789999887654


Q ss_pred             C-----CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          167 R-----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       167 ~-----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      .     ...|+||||++++|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus        81 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (353)
T 2b9h_A           81 DSFENFNEVYIIQELMQTDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFG  157 (353)
T ss_dssp             SCSTTCCCEEEEECCCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             cccCccceEEEEEeccCccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecc
Confidence            3     789999999988999999863   69999999999999999999999999999999999999655555444444


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                      ++............              ...........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||
T Consensus       158 ~a~~~~~~~~~~~~--------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  223 (353)
T 2b9h_A          158 LARIIDESAADNSE--------------PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF  223 (353)
T ss_dssp             TCEECC------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccccccccccC--------------ccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCC
Confidence            44322111000000              0000001122478999999999875 67999999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHH--HhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRV--DRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      .+.+..+....+....+.++.......  ......+.                 .......  .......++..+.++.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~--~~~~~~~~~~~~~~~~~  284 (353)
T 2b9h_A          224 PGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYI-----------------KSLPMYP--AAPLEKMFPRVNPKGID  284 (353)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHH-----------------HTSCCCC--CCCHHHHSTTSCHHHHH
T ss_pred             CCCCcHHHHHHHHHHhCCCchhccccccccchhhHHh-----------------hcccCCC--CcchhhhcccCCHHHHH
Confidence            998888888888888776652110000  00000000                 0000000  00112234567889999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          399 LLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||.+||+.||++|||++|+|+||||+..
T Consensus       285 li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (353)
T 2b9h_A          285 LLQRMLVFDPAKRITAKEALEHPYLQTY  312 (353)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            9999999999999999999999999864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7.9e-48  Score=380.40  Aligned_cols=252  Identities=27%  Similarity=0.445  Sum_probs=200.9

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .+|++.+.||+|+||.||+|.+.. ++.||||++...   ......+..|+.++..+.+   +++||+++++++...+.+
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~---~~~~iv~~~~~~~~~~~~  131 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ---HSDKIIRLYDYEITDQYI  131 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT---TCTTBCCEEEEEECSSEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHccc---CCCeEEEEEEEEecCCEE
Confidence            469999999999999999999865 889999998643   2344667889999999965   347899999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      |||||+.+++|.+++....  .+++..+..++.||+.||.|||++|||||||||+|||++ +                  
T Consensus       132 ~lv~E~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~------------------  190 (390)
T 2zmd_A          132 YMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D------------------  190 (390)
T ss_dssp             EEEEECCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-S------------------
T ss_pred             EEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-C------------------
Confidence            9999977899999998765  789999999999999999999999999999999999993 2                  


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhC-----------CCCCCcchHHHHHHHHHHHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILG-----------LGWTYPCDIWSVGCILVELC  314 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGv~l~el~  314 (430)
                               +.+||+|||++.......     ...+||+.|+|||++.+           ..|+.++|||||||++|||+
T Consensus       191 ---------~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell  261 (390)
T 2zmd_A          191 ---------GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT  261 (390)
T ss_dssp             ---------SCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHH
T ss_pred             ---------CeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHH
Confidence                     356777777766443221     23579999999999976           36899999999999999999


Q ss_pred             hCCCCCCCCchH-HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCch
Q 014117          315 TGEALFQTHENL-EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA  393 (430)
Q Consensus       315 tG~~Pf~~~~~~-~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (430)
                      +|..||....+. ..+..+   ..+.                  ..                          ..++...+
T Consensus       262 ~G~~Pf~~~~~~~~~~~~~---~~~~------------------~~--------------------------~~~~~~~~  294 (390)
T 2zmd_A          262 YGKTPFQQIINQISKLHAI---IDPN------------------HE--------------------------IEFPDIPE  294 (390)
T ss_dssp             HSSCTTTTCCCHHHHHHHH---HCTT------------------SC--------------------------CCCCCCSC
T ss_pred             HCCCcchhhhHHHHHHHHH---hCcc------------------cc--------------------------CCCCccch
Confidence            999999764332 222111   1100                  00                          01223446


Q ss_pred             hHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          394 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       394 ~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      .++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       295 ~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          295 KDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            679999999999999999999999999999643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=367.41  Aligned_cols=286  Identities=27%  Similarity=0.442  Sum_probs=218.9

Q ss_pred             CceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee---
Q 014117           89 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF---  164 (430)
Q Consensus        89 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~---  164 (430)
                      +..+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+..|+.+++.+.     |+||+++++++   
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~   80 (320)
T 2i6l_A            6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD-----HDNIVKVFEILGPS   80 (320)
T ss_dssp             CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCC-----CTTBCCEEEEECTT
T ss_pred             cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcC-----CCCeeEEEEecccc
Confidence            4567789999999999999999999999999999999986433 34466778999988883     47899998776   


Q ss_pred             -----------ecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecC
Q 014117          165 -----------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE  233 (430)
Q Consensus       165 -----------~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~  233 (430)
                                 ......|+||||++++|.+++..   ..+++..++.++.||+.||+|||++||+||||||+|||++.  
T Consensus        81 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--  155 (320)
T 2i6l_A           81 GSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--  155 (320)
T ss_dssp             SCBCCC----CCSCSEEEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--
T ss_pred             ccccccccccccccCceeEEeeccCCCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--
Confidence                       34578999999998899999865   36999999999999999999999999999999999999952  


Q ss_pred             ccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC------CCeeeecCcccchhhhhC-CCCCCcchHHHH
Q 014117          234 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSV  306 (430)
Q Consensus       234 ~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~Dvwsl  306 (430)
                                              .+..+||+|||++......      .....||..|+|||++.+ ..++.++|||||
T Consensus       156 ------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  211 (320)
T 2i6l_A          156 ------------------------EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA  211 (320)
T ss_dssp             ------------------------TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHH
T ss_pred             ------------------------CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhH
Confidence                                    2345666667666543221      122467999999999876 679999999999


Q ss_pred             HHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHh
Q 014117          307 GCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM  386 (430)
Q Consensus       307 Gv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  386 (430)
                      ||++|+|++|..||.+.+..+....+....+................+..... ..+                  .....
T Consensus       212 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~------------------~~~~~  272 (320)
T 2i6l_A          212 GCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDM-TEP------------------HKPLT  272 (320)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHT-TSC------------------CCCHH
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccc-cCC------------------CCChh
Confidence            99999999999999998888888888887777766554443322222211100 000                  00012


Q ss_pred             hhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          387 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       387 ~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      ......+.++.+||.+||+.||++|||++|+|+||||+...
T Consensus       273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          273 QLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             HHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             HhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence            23456788999999999999999999999999999998643

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.3e-48  Score=375.33  Aligned_cols=255  Identities=26%  Similarity=0.376  Sum_probs=208.7

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      ....+|++.+.||+|+||+||+|++..+++.||||++...    ......+..|+++++.+.     |+||+++++++..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~~~~~~~~  125 (348)
T 1u5q_A           51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-----HPNTIQYRGCYLR  125 (348)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-----CTTBCCEEEEEEE
T ss_pred             chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-----CCCEeeEEEEEEE
Confidence            3456799999999999999999999999999999998643    223356778999999884     4889999999999


Q ss_pred             CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          167 RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       167 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      .+..++||||+.|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+              
T Consensus       126 ~~~~~lv~e~~~g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~--------------  190 (348)
T 1u5q_A          126 EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP--------------  190 (348)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT--------------
T ss_pred             CCeEEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC--------------
Confidence            99999999999889998886543 479999999999999999999999999999999999999544              


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhh---CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                   +.+||+|||++...... ...+||+.|+|||++.   +..++.++|||||||++|||++|..||...
T Consensus       191 -------------~~~kL~DfG~a~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  256 (348)
T 1u5q_A          191 -------------GLVKLGDFGSASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  256 (348)
T ss_dssp             -------------TEEEECCCTTCBSSSSB-CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             -------------CCEEEeeccCceecCCC-CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                         45666677766544322 3357999999999986   457899999999999999999999999887


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +..+....+.....+..                                               .....+..+.+||.+|
T Consensus       257 ~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~l~~li~~~  289 (348)
T 1u5q_A          257 NAMSALYHIAQNESPAL-----------------------------------------------QSGHWSEYFRNFVDSC  289 (348)
T ss_dssp             CHHHHHHHHHHSCCCCC-----------------------------------------------CCTTSCHHHHHHHHHH
T ss_pred             ChHHHHHHHHhcCCCCC-----------------------------------------------CCCCCCHHHHHHHHHH
Confidence            66555444332111000                                               0124566799999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      |+.||++|||++++|+||||...
T Consensus       290 l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          290 LQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             TCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             cccChhhCcCHHHHhhChhhhcc
Confidence            99999999999999999999765

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.1e-48  Score=368.75  Aligned_cols=260  Identities=23%  Similarity=0.413  Sum_probs=213.7

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh-hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||+|+++.... ....+..|+.+++.+.     |+||+++++++...+.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~   80 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK-----HENIVTLEDIYESTTH   80 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCC-----CTTBCCEEEEEECSSE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCC-----CCCeeehhhhcccCCE
Confidence            456789999999999999999999999999999999975432 3345678999999883     4889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .|+||||+ +++|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||+...                
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~----------------  142 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTP----------------  142 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSS----------------
T ss_pred             EEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecC----------------
Confidence            99999999 889999997764  79999999999999999999999999999999999999321                


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC-CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                              +..+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus       143 --------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  214 (304)
T 2jam_A          143 --------EENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK  214 (304)
T ss_dssp             --------STTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             --------CCCCCEEEccCCcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence                    234567778888776443322 33578999999999999999999999999999999999999998877666


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+.......+.                                             ..++..+.++.+||.+||+.|
T Consensus       215 ~~~~i~~~~~~~~~---------------------------------------------~~~~~~~~~~~~li~~~l~~d  249 (304)
T 2jam_A          215 LFEKIKEGYYEFES---------------------------------------------PFWDDISESAKDFICHLLEKD  249 (304)
T ss_dssp             HHHHHHHCCCCCCT---------------------------------------------TTTTTSCHHHHHHHHHHHCSS
T ss_pred             HHHHHHcCCCCCCc---------------------------------------------cccccCCHHHHHHHHHHcCCC
Confidence            55544432221111                                             122456778999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~  426 (430)
                      |++|||++|+|+||||+..
T Consensus       250 p~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          250 PNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             TTTSCCHHHHHTSHHHHSS
T ss_pred             hhHCcCHHHHhcCccccCC
Confidence            9999999999999999754

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.5e-48  Score=365.06  Aligned_cols=275  Identities=20%  Similarity=0.277  Sum_probs=206.5

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|+++..   .........|+..+..+.    .|+||+++++++..
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~----~h~~iv~~~~~~~~   82 (289)
T 1x8b_A            7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG----QHSHVVRYFSAWAE   82 (289)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSC----SCTTBCCEEEEEEE
T ss_pred             ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhC----CCCCeeeeeeeeec
Confidence            34567899999999999999999999999999999998743   233455667777777763    34889999999999


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNY--RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                      .+.+++||||+ +++|.+++.....  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.....+....
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~  162 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD  162 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccc
Confidence            99999999999 8899999976421  46999999999999999999999999999999999999987765544433211


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                      ...        .......+||+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+|+..
T Consensus       163 ~~~--------~~~~~~~~kl~Dfg~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~  233 (289)
T 1x8b_A          163 EDD--------WASNKVMFKIGDLGHVTRISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN  233 (289)
T ss_dssp             ---------------CCCEEECCCTTCEETTCSC-CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred             ccc--------ccCCceEEEEcccccccccCCcc-ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence            100        01345689999999987655433 34699999999999876 567899999999999999999988764


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      .....   .+..  +..                                              ...+...+.++.+||.+
T Consensus       234 ~~~~~---~~~~--~~~----------------------------------------------~~~~~~~~~~~~~li~~  262 (289)
T 1x8b_A          234 GDQWH---EIRQ--GRL----------------------------------------------PRIPQVLSQEFTELLKV  262 (289)
T ss_dssp             SHHHH---HHHT--TCC----------------------------------------------CCCSSCCCHHHHHHHHH
T ss_pred             hhHHH---HHHc--CCC----------------------------------------------CCCCcccCHHHHHHHHH
Confidence            33211   1110  000                                              01234567789999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      ||+.||++|||+.|+|+||||+....
T Consensus       263 ~l~~dp~~Rps~~~ll~h~~~~~~~~  288 (289)
T 1x8b_A          263 MIHPDPERRPSAMALVKHSVLLSASR  288 (289)
T ss_dssp             HTCSSGGGSCCHHHHHTCTTC-----
T ss_pred             HhCCCcccCCCHHHHhhChHhhhhcc
Confidence            99999999999999999999997643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.5e-47  Score=370.80  Aligned_cols=253  Identities=28%  Similarity=0.418  Sum_probs=211.0

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++....    ...+.+..|+.+++.+     .|+||+++++++.+.
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~  113 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-----AHQHVVGFHGFFEDN  113 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEECS
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEecC
Confidence            3468999999999999999999999999999999986432    3445667788888877     458899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +.+|+||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++                
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----------------  175 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN----------------  175 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----------------
T ss_pred             CeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc----------------
Confidence            9999999999 789999988754  799999999999999999999999999999999999994                


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                 .++.+||+|||++.....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       176 -----------~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  244 (335)
T 2owb_A          176 -----------EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS  244 (335)
T ss_dssp             -----------TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             -----------CCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence                       455677777777754322   123357899999999999999999999999999999999999999876


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      ...+....+......                                                 .+...+.++.+||.+|
T Consensus       245 ~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~li~~~  275 (335)
T 2owb_A          245 CLKETYLRIKKNEYS-------------------------------------------------IPKHINPVAASLIQKM  275 (335)
T ss_dssp             SHHHHHHHHHHTCCC-------------------------------------------------CCTTSCHHHHHHHHHH
T ss_pred             CHHHHHHHHhcCCCC-------------------------------------------------CCccCCHHHHHHHHHH
Confidence            655544433321111                                                 1234566799999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      |+.||++|||++|+|+||||+...
T Consensus       276 l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          276 LQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             TCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             ccCChhHCcCHHHHhcCccccCCC
Confidence            999999999999999999998653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-48  Score=377.32  Aligned_cols=261  Identities=25%  Similarity=0.391  Sum_probs=209.4

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc------hhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++...      ......+..|+.+++.+.     |+||+++++++
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~~~~~~   97 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-----HPNIARLYEVY   97 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-----CTTBCCEEEEE
T ss_pred             hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-----CCCcceeehhh
Confidence            4567899999999999999999999999999999998633      234466788999999984     48899999999


Q ss_pred             ecCCeEEEEEecC-CCCHHHHHHhcC--------------------------------------CCCCCHHHHHHHHHHH
Q 014117          165 DYRNHICIVFEKL-GSSLYDFLRKNN--------------------------------------YRSFPIDLVREIARQL  205 (430)
Q Consensus       165 ~~~~~~~lv~e~~-~~~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~~qi  205 (430)
                      ...+..|+||||+ +++|.+++....                                      ...+++..++.++.||
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  177 (345)
T 3hko_A           98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI  177 (345)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred             ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence            9999999999999 999999985210                                      1124677888999999


Q ss_pred             HHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCC-------CCC
Q 014117          206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-------DQN  278 (430)
Q Consensus       206 ~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~  278 (430)
                      +.||.|||++||+||||||+|||++.++                         ...+||+|||++.....       ...
T Consensus       178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~  232 (345)
T 3hko_A          178 FSALHYLHNQGICHRDIKPENFLFSTNK-------------------------SFEIKLVDFGLSKEFYKLNNGEYYGMT  232 (345)
T ss_dssp             HHHHHHHHHTTEECCCCCGGGEEESCSS-------------------------SCCEEECCCTTCEEGGGTTCC------
T ss_pred             HHHHHHHHHCCccccCCChhhEEEecCC-------------------------CceEEEeeccccccccccCcccccccc
Confidence            9999999999999999999999995422                         23688888888764321       113


Q ss_pred             eeeecCcccchhhhhC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhc
Q 014117          279 YIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR  356 (430)
Q Consensus       279 ~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~  356 (430)
                      ...||+.|+|||++.+  ..++.++|||||||++|+|++|..||.+.+..+....+......++.               
T Consensus       233 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------  297 (345)
T 3hko_A          233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN---------------  297 (345)
T ss_dssp             --CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS---------------
T ss_pred             ccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC---------------
Confidence            3578999999999975  67899999999999999999999999987776665554432221111               


Q ss_pred             cCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          357 RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                                                    ......+.++.+||.+||+.||.+|||+.|+|+||||++-
T Consensus       298 ------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~  337 (345)
T 3hko_A          298 ------------------------------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF  337 (345)
T ss_dssp             ------------------------------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred             ------------------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence                                          0112356789999999999999999999999999999764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.2e-47  Score=366.36  Aligned_cols=286  Identities=24%  Similarity=0.472  Sum_probs=214.5

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--CCe
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNH  169 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--~~~  169 (430)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|+++..  ....+..|+.+++.+.+    ++||+.+++++..  ...
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~----~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRG----GPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTT----STTBCCEEEEEECTTTCC
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCC----CCCEEEeeeeeccCCCCc
Confidence            357899999999999999999999999999999999743  34567889999999963    4789999999887  678


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .++||||+ +++|.+++.     .+++..++.++.||+.||.|||++||+||||||+|||++.+                
T Consensus       108 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~----------------  166 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE----------------  166 (330)
T ss_dssp             EEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT----------------
T ss_pred             eEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCC----------------
Confidence            99999999 789988874     48899999999999999999999999999999999999532                


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCC-CCc
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ-THE  324 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~-~~~  324 (430)
                                ...+||+|||++.......  ....||..|+|||++.+ ..++.++|||||||++|+|++|..||. +..
T Consensus       167 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~  236 (330)
T 3nsz_A          167 ----------HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD  236 (330)
T ss_dssp             ----------TTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             ----------CCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence                      2367888888776443322  34578999999999987 679999999999999999999999994 455


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHh-hcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS-VMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      ..+.+..+...++..+  ....        +.......+..   ...... ..............+...+.++.+||.+|
T Consensus       237 ~~~~l~~~~~~~~~~~--~~~~--------~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  303 (330)
T 3nsz_A          237 NYDQLVRIAKVLGTED--LYDY--------IDKYNIELDPR---FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL  303 (330)
T ss_dssp             HHHHHHHHHHHHCHHH--HHHH--------HHHTTCCCCTH---HHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTT
T ss_pred             hHHHHHHHHHhcCCch--hhhH--------HHHhccccccc---hhhhhhhccccchhhhccccccccCCHHHHHHHHHH
Confidence            6666666666665321  1111        11111110000   000000 00000000001112234678899999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      |+.||++|||++|+|+||||++-.
T Consensus       304 L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          304 LRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             SCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             hcCCcccCCCHHHHhcCccHhhhc
Confidence            999999999999999999998753

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.2e-47  Score=362.54  Aligned_cols=251  Identities=24%  Similarity=0.423  Sum_probs=209.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....    .....+..|+++++.+.     |+||+++++++...+
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~   87 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-----HPNILRMYNYFHDRK   87 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-----CTTBCCEEEEEECSS
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-----CCCEeeEEEEEEcCC
Confidence            467999999999999999999999999999999986432    22356778888888873     488999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      ..|+||||+ +++|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||++                 
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~-----------------  148 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG-----------------  148 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC-----------------
T ss_pred             EEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEc-----------------
Confidence            999999999 789999998764  699999999999999999999999999999999999994                 


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCC-CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                                .++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus       149 ----------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  218 (284)
T 2vgo_A          149 ----------YKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT  218 (284)
T ss_dssp             ----------TTCCEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             ----------CCCCEEEecccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh
Confidence                      4456777777766543322 23457899999999999999999999999999999999999999877665


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +....+.....                                                 .++...+.++.+||.+||+.
T Consensus       219 ~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~li~~~l~~  249 (284)
T 2vgo_A          219 ETHRRIVNVDL-------------------------------------------------KFPPFLSDGSKDLISKLLRY  249 (284)
T ss_dssp             HHHHHHHTTCC-------------------------------------------------CCCTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHHhcccc-------------------------------------------------CCCCcCCHHHHHHHHHHhhc
Confidence            54443322111                                                 12234567899999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||.+|||++|+++||||+..
T Consensus       250 ~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          250 HPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             SGGGSCCHHHHHTCHHHHHH
T ss_pred             CHhhCCCHHHHhhCHHHHhh
Confidence            99999999999999999754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.9e-47  Score=368.40  Aligned_cols=251  Identities=25%  Similarity=0.340  Sum_probs=193.5

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC-
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-  168 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~-  168 (430)
                      +.++|++.+.||+|+||.||+|+++.+++.||||+++..  ....+.+..|+.+++++.     |+||+++++++.+.. 
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~~~~~~~~~~~   78 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE-----HPGIVRYFNAWLETPP   78 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCC-----CTTBCCEEEEEEECCS
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCC-----CCCEeeEEEEEEEecc
Confidence            346799999999999999999999999999999998632  334567788999998883     588999998774432 


Q ss_pred             --------------------------------------------------------eEEEEEecC-CCCHHHHHHhcCC-
Q 014117          169 --------------------------------------------------------HICIVFEKL-GSSLYDFLRKNNY-  190 (430)
Q Consensus       169 --------------------------------------------------------~~~lv~e~~-~~~L~~~l~~~~~-  190 (430)
                                                                              ++++||||+ +++|.+++..... 
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  158 (332)
T 3qd2_B           79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL  158 (332)
T ss_dssp             CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred             chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence                                                                    489999999 8899999987542 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCc
Q 014117          191 RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST  270 (430)
Q Consensus       191 ~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a  270 (430)
                      ...++..+..++.||+.||.|||++||+||||||+|||++.++.                           +||+|||++
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---------------------------~kL~DfG~a  211 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---------------------------VKVGDFGLV  211 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---------------------------EEECCCTTC
T ss_pred             cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC---------------------------EEEeecCcc
Confidence            23566678999999999999999999999999999999965554                           555555554


Q ss_pred             cccCCC---------------CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHH
Q 014117          271 TYERPD---------------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV  335 (430)
Q Consensus       271 ~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~~  335 (430)
                      ......               ....+||+.|+|||++.+..++.++|||||||++|+|++|..|+..     ....+...
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~  286 (332)
T 3qd2_B          212 TAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDV  286 (332)
T ss_dssp             EECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHH
T ss_pred             cccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHh
Confidence            432221               1234799999999999999999999999999999999998776531     11111111


Q ss_pred             -hCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCH
Q 014117          336 -LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA  414 (430)
Q Consensus       336 -~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta  414 (430)
                       .+..|..                                              +...++++.+||.+||+.||++|||+
T Consensus       287 ~~~~~~~~----------------------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~  320 (332)
T 3qd2_B          287 RNLKFPLL----------------------------------------------FTQKYPQEHMMVQDMLSPSPTERPEA  320 (332)
T ss_dssp             HTTCCCHH----------------------------------------------HHHHCHHHHHHHHHHHCSSGGGSCCH
T ss_pred             hccCCCcc----------------------------------------------cccCChhHHHHHHHHccCCCCcCCCH
Confidence             1111111                                              11224567899999999999999999


Q ss_pred             HHHhcCCCCCC
Q 014117          415 REALRHPFFTR  425 (430)
Q Consensus       415 ~elL~hp~f~~  425 (430)
                      +|+|+||||++
T Consensus       321 ~~~l~~~~f~~  331 (332)
T 3qd2_B          321 TDIIENAIFEN  331 (332)
T ss_dssp             HHHHHSTTCCC
T ss_pred             HHHhhchhhhc
Confidence            99999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.8e-47  Score=359.51  Aligned_cols=259  Identities=29%  Similarity=0.499  Sum_probs=212.2

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----------hhHHHHHHHHHHHHHHHhcCCCCCceEEe
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----------KYREAAMIEIEVLQQLAKHDKGGNRCVQI  160 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~  160 (430)
                      .+.++|++.+.||+|+||.||+|.++.+++.||||+++...          ...+.+..|+.+++++.    +|+||+++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~   89 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS----GHPNIIQL   89 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT----TCTTBCCE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhc----CCCCEeee
Confidence            34578999999999999999999999999999999986331          23455678999999885    24789999


Q ss_pred             cceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCC
Q 014117          161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD  239 (430)
Q Consensus       161 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~d  239 (430)
                      ++++...+..++||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++         
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---------  158 (298)
T 1phk_A           90 KDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---------  158 (298)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------
T ss_pred             eeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc---------
Confidence            99999999999999999 789999998754  799999999999999999999999999999999999994         


Q ss_pred             CcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhh------CCCCCCcchHHHHHHHHH
Q 014117          240 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVIL------GLGWTYPCDIWSVGCILV  311 (430)
Q Consensus       240 fg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGv~l~  311 (430)
                                        .++.+||+|||++.......  ....||+.|+|||++.      ...++.++|||||||++|
T Consensus       159 ------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~  220 (298)
T 1phk_A          159 ------------------DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY  220 (298)
T ss_dssp             ------------------TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHH
T ss_pred             ------------------CCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHH
Confidence                              45567777777765443322  3357899999999986      456889999999999999


Q ss_pred             HHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCC
Q 014117          312 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH  391 (430)
Q Consensus       312 el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (430)
                      +|++|..||...+..+....+.......+.                                             ..+..
T Consensus       221 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~  255 (298)
T 1phk_A          221 TLLAGSPPFWHRKQMLMLRMIMSGNYQFGS---------------------------------------------PEWDD  255 (298)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHTCCCCCT---------------------------------------------TTGGG
T ss_pred             HHHHCCCCCcCccHHHHHHHHhcCCcccCc---------------------------------------------ccccc
Confidence            999999999887766655544432221111                                             01124


Q ss_pred             chhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          392 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       392 ~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      .+.++.+||.+||+.||++|||++|+|+||||++..
T Consensus       256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            567899999999999999999999999999998653

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.8e-48  Score=375.03  Aligned_cols=247  Identities=26%  Similarity=0.457  Sum_probs=205.6

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh---------hHHHHHHHHHHHHHHHhcCCCCCceEEec
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---------YREAAMIEIEVLQQLAKHDKGGNRCVQIR  161 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~  161 (430)
                      .+.++|++.+.||+|+||.||+|.++.+++.||||+++....         ....+..|+.+++.+.     |+||++++
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~Iv~~~   95 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-----HANIIKVL   95 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-----CTTBCCEE
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-----CCCEeeEE
Confidence            456789999999999999999999999999999999874321         2234566898888883     48899999


Q ss_pred             ceeecCCeEEEEEecC-CC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCC
Q 014117          162 NWFDYRNHICIVFEKL-GS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD  239 (430)
Q Consensus       162 ~~~~~~~~~~lv~e~~-~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~d  239 (430)
                      +++...+.+++||||+ ++ +|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||+          
T Consensus        96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll----------  163 (335)
T 3dls_A           96 DIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI----------  163 (335)
T ss_dssp             EEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----------
T ss_pred             EEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE----------
Confidence            9999999999999998 44 9999998764  79999999999999999999999999999999999999          


Q ss_pred             CcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCC-CCcchHHHHHHHHHHHHhC
Q 014117          240 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTG  316 (430)
Q Consensus       240 fg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tG  316 (430)
                                       +.++.+||+|||++.......  ...+||+.|+|||++.+..+ +.++|||||||++|+|++|
T Consensus       164 -----------------~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g  226 (335)
T 3dls_A          164 -----------------AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE  226 (335)
T ss_dssp             -----------------CTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHS
T ss_pred             -----------------cCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhC
Confidence                             445677888888776544332  34679999999999998876 7899999999999999999


Q ss_pred             CCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHH
Q 014117          317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL  396 (430)
Q Consensus       317 ~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (430)
                      ..||.......                             ...                          ...+...+.++
T Consensus       227 ~~pf~~~~~~~-----------------------------~~~--------------------------~~~~~~~~~~l  251 (335)
T 3dls_A          227 ENPFCELEETV-----------------------------EAA--------------------------IHPPYLVSKEL  251 (335)
T ss_dssp             SCSCSSGGGGT-----------------------------TTC--------------------------CCCSSCCCHHH
T ss_pred             CCchhhHHHHH-----------------------------hhc--------------------------cCCCcccCHHH
Confidence            99997522100                             000                          01123457789


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          397 THLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       397 ~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      .+||.+||+.||++|||++|+|+||||++.
T Consensus       252 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            999999999999999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.3e-48  Score=386.73  Aligned_cols=260  Identities=30%  Similarity=0.459  Sum_probs=201.8

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh---------hHHHHHHHHHHHHHHHhcCCCCCceEEec
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK---------YREAAMIEIEVLQQLAKHDKGGNRCVQIR  161 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~---------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~  161 (430)
                      .+.++|.+.+.||+|+||+||+|.++.+++.||+|++.....         ....+..|+.+++++     .|+||++++
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~  206 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-----NHPCIIKIK  206 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-----CCTTBCCCC
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-----CCCCEeeEE
Confidence            346789999999999999999999999999999999864321         112467899999998     448899999


Q ss_pred             ceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCC
Q 014117          162 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY  240 (430)
Q Consensus       162 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~df  240 (430)
                      ++++. +..|+||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++..        
T Consensus       207 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~--------  275 (419)
T 3i6u_A          207 NFFDA-EDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ--------  275 (419)
T ss_dssp             EEEES-SEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS--------
T ss_pred             EEEec-CceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecC--------
Confidence            98864 5689999999 889999887654  79999999999999999999999999999999999999543        


Q ss_pred             cCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhC---CCCCCcchHHHHHHHHHHHHh
Q 014117          241 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCT  315 (430)
Q Consensus       241 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~t  315 (430)
                                      +....+||+|||++.......  ...+||+.|+|||++.+   ..|+.++|||||||++|+|++
T Consensus       276 ----------------~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~llt  339 (419)
T 3i6u_A          276 ----------------EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS  339 (419)
T ss_dssp             ----------------SSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHH
T ss_pred             ----------------CCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHH
Confidence                            234468888998887654332  34689999999999864   568899999999999999999


Q ss_pred             CCCCCCCCchHH-HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchh
Q 014117          316 GEALFQTHENLE-HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG  394 (430)
Q Consensus       316 G~~Pf~~~~~~~-~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (430)
                      |.+||....... ....+.......+                                             ...+...+.
T Consensus       340 g~~pf~~~~~~~~~~~~i~~~~~~~~---------------------------------------------~~~~~~~~~  374 (419)
T 3i6u_A          340 GYPPFSEHRTQVSLKDQITSGKYNFI---------------------------------------------PEVWAEVSE  374 (419)
T ss_dssp             SSCSSCCCSSSCCHHHHHHTTCCCCC---------------------------------------------HHHHTTSCH
T ss_pred             CCCCCCCCcchHHHHHHHhcCCCCCC---------------------------------------------chhhcccCH
Confidence            999997643322 1122211111111                                             112345677


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          395 DLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       395 ~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      ++.+||.+||+.||++|||++|+|+||||++..
T Consensus       375 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  407 (419)
T 3i6u_A          375 KALDLVKKLLVVDPKARFTTEEALRHPWLQDED  407 (419)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence            899999999999999999999999999998754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=361.35  Aligned_cols=252  Identities=24%  Similarity=0.434  Sum_probs=184.1

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh----hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....    ....+..|+.++.++     .|+||+++++++...+.
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~   85 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-----KHPSILELYNYFEDSNY   85 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-----CCTTBCCEEEEEECSSE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-----CCCCeEeEEEEEccCCe
Confidence            579999999999999999999999999999999864321    235567788888777     34889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++                  
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~------------------  146 (278)
T 3cok_A           86 VYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT------------------  146 (278)
T ss_dssp             EEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC------------------
T ss_pred             EEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc------------------
Confidence            99999999 789999998653 4799999999999999999999999999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                               .++.+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus       147 ---------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  217 (278)
T 3cok_A          147 ---------RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV  217 (278)
T ss_dssp             ---------TTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred             ---------CCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence                     4556777777776643321   1235789999999999998999999999999999999999999986543


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+....+.                       ....                          ..+...+.++.+||.+||+
T Consensus       218 ~~~~~~~~-----------------------~~~~--------------------------~~~~~~~~~~~~li~~~l~  248 (278)
T 3cok_A          218 KNTLNKVV-----------------------LADY--------------------------EMPSFLSIEAKDLIHQLLR  248 (278)
T ss_dssp             C-----CC-----------------------SSCC--------------------------CCCTTSCHHHHHHHHHHSC
T ss_pred             HHHHHHHh-----------------------hccc--------------------------CCccccCHHHHHHHHHHcc
Confidence            32221100                       0000                          1223456789999999999


Q ss_pred             cCCCCCCCHHHHhcCCCCCCCC
Q 014117          406 YDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      .||++|||++++|+||||++..
T Consensus       249 ~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          249 RNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             SSGGGSCCHHHHTTSTTTC---
T ss_pred             cCHhhCCCHHHHhcCccccCCC
Confidence            9999999999999999998653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=366.90  Aligned_cols=260  Identities=22%  Similarity=0.408  Sum_probs=206.7

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---  166 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~---  166 (430)
                      ....++|++.+.||+|+||.||+|.+..+++.||||++.........+..|+.+++++.    .|+||+++++++..   
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~~~~~~~~~~   95 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS----HHRNIATYYGAFIKKNP   95 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHC----CSTTBCCEEEEEEECC-
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhcc----CCCCeeeeeeEEeeccC
Confidence            34567899999999999999999999999999999999765555677888999999884    34789999998876   


Q ss_pred             ---CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          167 ---RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       167 ---~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                         .+.+|+||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++            
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~------------  163 (326)
T 2x7f_A           96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT------------  163 (326)
T ss_dssp             -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC------------
T ss_pred             ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEc------------
Confidence               56899999999 77999999876545799999999999999999999999999999999999994            


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhh-----CCCCCCcchHHHHHHHHHHHH
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELC  314 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~  314 (430)
                                     .++.+||+|||++......   .....||+.|+|||++.     +..++.++|||||||++|+|+
T Consensus       164 ---------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~  228 (326)
T 2x7f_A          164 ---------------ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA  228 (326)
T ss_dssp             ---------------TTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHH
T ss_pred             ---------------CCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHH
Confidence                           4456677777766543221   23357899999999997     556899999999999999999


Q ss_pred             hCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchh
Q 014117          315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG  394 (430)
Q Consensus       315 tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (430)
                      +|..||...........+...  ..+.                                             ......+.
T Consensus       229 ~g~~p~~~~~~~~~~~~~~~~--~~~~---------------------------------------------~~~~~~~~  261 (326)
T 2x7f_A          229 EGAPPLCDMHPMRALFLIPRN--PAPR---------------------------------------------LKSKKWSK  261 (326)
T ss_dssp             HSSCTTTTSCHHHHHHHHHHS--CCCC---------------------------------------------CSCSCSCH
T ss_pred             hCCCCCCCCcHHHHHHHhhcC--cccc---------------------------------------------CCccccCH
Confidence            999999876655444332211  1000                                             01234567


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          395 DLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       395 ~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      ++.+||.+||+.||.+|||++++|+||||++..
T Consensus       262 ~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          262 KFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             HHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence            899999999999999999999999999998653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6e-48  Score=377.12  Aligned_cols=294  Identities=22%  Similarity=0.342  Sum_probs=212.0

Q ss_pred             cCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           88 LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        88 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .++...++|++.+.||+|+||.||+|.+..+++.||+|++...  ......+..|+.+++.+     .|+||+++++++.
T Consensus        27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~  101 (360)
T 3eqc_A           27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-----NSPYIVGFYGAFY  101 (360)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-----CCTTBCCEEEEEE
T ss_pred             ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-----CCCCEEEEeEEEE
Confidence            3455677899999999999999999999999999999998743  33445677888888777     3588999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeccCCCCceEEeecCccccCCCcCC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                      ..+.+|+||||+ +++|.+++....  .+++..+..++.||+.||.|||+. ||+||||||+|||+              
T Consensus       102 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~--------------  165 (360)
T 3eqc_A          102 SDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV--------------  165 (360)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE--------------
T ss_pred             ECCEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE--------------
Confidence            999999999999 889999998765  799999999999999999999996 99999999999999              


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccC-CCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYER-PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                   +.++.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       166 -------------~~~~~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          166 -------------NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             -------------CTTCCEEECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             -------------CCCCCEEEEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                         455678888888775322 222345799999999999999999999999999999999999999988


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhh-----hcCCchhHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ-----HVDHSAGDLT  397 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~  397 (430)
                      .+..+....+.......+.............+...+....+.     ....     .........     ....++.++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~  302 (360)
T 3eqc_A          233 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPP-----MAIF-----ELLDYIVNEPPPKLPSGVFSLEFQ  302 (360)
T ss_dssp             CCHHHHHHHHC------------------------------C-----CCHH-----HHHHHHHHSCCCCCCTTTSCHHHH
T ss_pred             CCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCc-----ccch-----hhhhHHhccCCCCCCcccccHHHH
Confidence            665554333221111111111000000000000000000000     0000     000001111     1124577899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          398 HLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      +||.+||+.||++|||++|+|+||||+.
T Consensus       303 ~li~~~L~~dP~~Rpt~~ell~hp~~~~  330 (360)
T 3eqc_A          303 DFVNKCLIKNPAERADLKQLMVHAFIKR  330 (360)
T ss_dssp             HHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred             HHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence            9999999999999999999999999974

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.5e-47  Score=360.29  Aligned_cols=253  Identities=28%  Similarity=0.420  Sum_probs=210.0

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++...    ....+.+..|+.+++.+     .|+||+++++++...
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~   87 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-----AHQHVVGFHGFFEDN   87 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEECS
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-----CCCCEeeeeeeeccC
Confidence            346899999999999999999999999999999998643    23345667788888877     458899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +..++||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++                
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----------------  149 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN----------------  149 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----------------
T ss_pred             CEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc----------------
Confidence            9999999999 789999988754  799999999999999999999999999999999999994                


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCC---CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                 .++.+||+|||++.....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       150 -----------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  218 (294)
T 2rku_A          150 -----------EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS  218 (294)
T ss_dssp             -----------TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             -----------CCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                       445677777777654321   123357899999999999989999999999999999999999999876


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      ...+....+.....                                                 ..+...+.++.+||.+|
T Consensus       219 ~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~li~~~  249 (294)
T 2rku_A          219 CLKETYLRIKKNEY-------------------------------------------------SIPKHINPVAASLIQKM  249 (294)
T ss_dssp             SHHHHHHHHHTTCC-------------------------------------------------CCCTTSCHHHHHHHHHH
T ss_pred             CHHHHHHHHhhccC-------------------------------------------------CCccccCHHHHHHHHHH
Confidence            65554433321111                                                 11234566799999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      |+.||++|||++|+|+||||++..
T Consensus       250 l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          250 LQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             TCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             cccChhhCcCHHHHhhChheecCC
Confidence            999999999999999999997653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.3e-48  Score=381.77  Aligned_cols=261  Identities=14%  Similarity=0.123  Sum_probs=191.1

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecc-------
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN-------  162 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~-------  162 (430)
                      .+|++.+.||+|+||.||+|.+..+++.||||+++..    ......+..|+.+++.+..   .|+|+++++.       
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~---~hp~iv~~~~~~~~p~d  138 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG---ESPEEARDRRRLLLPSD  138 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-------------CBCCCCE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc---cChhhhhhceeEEeeeh
Confidence            3599999999999999999999999999999999753    2344566778888888865   3477666442       


Q ss_pred             eeecC-----------------CeEEEEEecCCCCHHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHHhcCeee
Q 014117          163 WFDYR-----------------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLV------REIARQLLECIAFMHDLCMIH  219 (430)
Q Consensus       163 ~~~~~-----------------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~------~~i~~qi~~aL~~lH~~~ivH  219 (430)
                      .+...                 ..+||||||+.++|.+++...+ ..+++...      ..++.||+.||+|||++||||
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH  217 (371)
T 3q60_A          139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH  217 (371)
T ss_dssp             EEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             heecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence            22221                 4589999999999999998753 23455555      677799999999999999999


Q ss_pred             ccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC--CCC
Q 014117          220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG--LGW  297 (430)
Q Consensus       220 rDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~  297 (430)
                      |||||+|||+                           +.++.+||+|||+++..........+|+.|+|||++.+  ..|
T Consensus       218 rDikp~NIll---------------------------~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  270 (371)
T 3q60_A          218 GHFTPDNLFI---------------------------MPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATF  270 (371)
T ss_dssp             TTCSGGGEEE---------------------------CTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEEC
T ss_pred             CcCCHHHEEE---------------------------CCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCc
Confidence            9999999999                           45566888888887765443334567899999999987  679


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcC
Q 014117          298 TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK  377 (430)
Q Consensus       298 ~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (430)
                      +.++|||||||++|||++|+.||.+.......                       .+ ...  .......          
T Consensus       271 ~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-----------------------~~-~~~--~~~~~~~----------  314 (371)
T 3q60_A          271 THALNAWQLGLSIYRVWCLFLPFGLVTPGIKG-----------------------SW-KRP--SLRVPGT----------  314 (371)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT-----------------------CC-CBC--CTTSCCC----------
T ss_pred             CccccHHHHHHHHHHHHhCCCCCCCcCccccc-----------------------ch-hhh--hhhhccc----------
Confidence            99999999999999999999999764321000                       00 000  0000000          


Q ss_pred             chhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          378 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                          .......+...+.++.+||.+||+.||++|||++|+|+||||++
T Consensus       315 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          315 ----DSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             ----CSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             ----cccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence                00001112466788999999999999999999999999999974

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8.6e-47  Score=357.69  Aligned_cols=253  Identities=23%  Similarity=0.405  Sum_probs=203.5

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec----
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----  166 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~----  166 (430)
                      ..|++.+.||+|+||.||+|.+..++..||+|++...   ......+..|+.+++.+     .|+||+++++++..    
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~  100 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-----QHPNIVRFYDSWESTVKG  100 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEEESSS
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-----CCCCeeeeeeeeccccCC
Confidence            3589999999999999999999999999999998643   23445677888888887     34889999988764    


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeccCCCCceEEeecCccccCCCcCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                      ...+|+||||+ +++|.+++....  .+++..+..++.||+.||.|||++|  |+||||||+|||++             
T Consensus       101 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~-------------  165 (290)
T 1t4h_A          101 KKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT-------------  165 (290)
T ss_dssp             CEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES-------------
T ss_pred             CceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE-------------
Confidence            46799999999 889999998754  7999999999999999999999999  99999999999994             


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                   ..++.+||+|||++....... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus       166 -------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~  231 (290)
T 1t4h_A          166 -------------GPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE  231 (290)
T ss_dssp             -------------STTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             -------------CCCCCEEEeeCCCcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence                         145578888888876544333 33578999999998875 599999999999999999999999987


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      ............. +..+                                             ...+...++++.+||.+
T Consensus       232 ~~~~~~~~~~~~~-~~~~---------------------------------------------~~~~~~~~~~l~~li~~  265 (290)
T 1t4h_A          232 CQNAAQIYRRVTS-GVKP---------------------------------------------ASFDKVAIPEVKEIIEG  265 (290)
T ss_dssp             CSSHHHHHHHHTT-TCCC---------------------------------------------GGGGGCCCHHHHHHHHH
T ss_pred             cCcHHHHHHHHhc-cCCc---------------------------------------------cccCCCCCHHHHHHHHH
Confidence            5544332211110 0000                                             01233456789999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||+.||.+|||++|+|+||||+++
T Consensus       266 ~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          266 CIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HccCChhhCCCHHHHhhCcccccC
Confidence            999999999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.4e-47  Score=357.60  Aligned_cols=254  Identities=26%  Similarity=0.378  Sum_probs=202.8

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++....    .....+..|+.+++.+.     |+||+++++++.
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~   81 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-----HPHIIKLYQVIS   81 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-----CTTBCCEEEEEE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-----CCCEeEEEEEEe
Confidence            445678999999999999999999999999999999986432    22346677888888773     488999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                      ..+..|+||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++              
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--------------  145 (276)
T 2h6d_A           82 TPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD--------------  145 (276)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC--------------
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC--------------
Confidence            999999999999 789999998764  699999999999999999999999999999999999994              


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCC-CCcchHHHHHHHHHHHHhCCCCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                                   .++.+||+|||++.......  ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.
T Consensus       146 -------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  212 (276)
T 2h6d_A          146 -------------AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD  212 (276)
T ss_dssp             -------------TTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             -------------CCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence                         45567777777766443322  23478999999999988765 689999999999999999999998


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      .....+....+......                                                 .+...+.++.+||.
T Consensus       213 ~~~~~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~l~~li~  243 (276)
T 2h6d_A          213 DEHVPTLFKKIRGGVFY-------------------------------------------------IPEYLNRSVATLLM  243 (276)
T ss_dssp             CSSHHHHHHHHHHCCCC-------------------------------------------------CCTTSCHHHHHHHH
T ss_pred             CCcHHHHHHHhhcCccc-------------------------------------------------CchhcCHHHHHHHH
Confidence            76655544433321111                                                 12344667999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          402 GLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +||+.||++|||++|+++||||++.
T Consensus       244 ~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          244 HMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHccCChhhCCCHHHHHhChhhccC
Confidence            9999999999999999999999865

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.3e-47  Score=360.06  Aligned_cols=256  Identities=23%  Similarity=0.406  Sum_probs=188.8

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHH--HHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE--AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~--~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|+++.......  ....|...+  +  ....|+||+++++++...+.
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~--~--~~~~h~~iv~~~~~~~~~~~   80 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS--M--RTVDCPFTVTFYGALFREGD   80 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHH--H--TTCCCTTBCCEEEEEECSSS
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHH--H--HhCCCCeEEEEeeeeeccCC
Confidence            45789999999999999999999999999999999974422222  222222221  1  22356899999999999999


Q ss_pred             EEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          170 ICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       170 ~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      .|+||||+.++|.+++..  .....+++..++.++.||+.||.|||++ ||+||||||+|||++.               
T Consensus        81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~---------------  145 (290)
T 3fme_A           81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA---------------  145 (290)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECT---------------
T ss_pred             EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC---------------
Confidence            999999998899888764  1235799999999999999999999998 9999999999999954               


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhh----hCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~----~~~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                  ++.+||+|||++.......  ....||+.|+|||++    .+..++.++|||||||++|+|++|..||
T Consensus       146 ------------~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  213 (290)
T 3fme_A          146 ------------LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY  213 (290)
T ss_dssp             ------------TCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSS
T ss_pred             ------------CCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence                        4456666666665433222  224789999999997    4557899999999999999999999999


Q ss_pred             CCCch-HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          321 QTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       321 ~~~~~-~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      ..... ......+....  .+                    ..                         .....+.++.+|
T Consensus       214 ~~~~~~~~~~~~~~~~~--~~--------------------~~-------------------------~~~~~~~~~~~l  246 (290)
T 3fme_A          214 DSWGTPFQQLKQVVEEP--SP--------------------QL-------------------------PADKFSAEFVDF  246 (290)
T ss_dssp             CCCSCHHHHHHHHHHSC--CC--------------------CC-------------------------CTTTSCHHHHHH
T ss_pred             cccCchHHHHHHHhccC--CC--------------------Cc-------------------------ccccCCHHHHHH
Confidence            86332 22222211110  00                    00                         012456789999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          400 LQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      |.+||+.||++|||++|+|+||||+.
T Consensus       247 i~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          247 TSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             HHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHHhhcChhhCcCHHHHHhCccccc
Confidence            99999999999999999999999974

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4e-49  Score=388.08  Aligned_cols=248  Identities=18%  Similarity=0.250  Sum_probs=195.5

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecC----chhhHHHHHHHHHHHHHHHhcCCCCCceEEec-------
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR-------  161 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~-------  161 (430)
                      .++|++.+.||+|+||+||+|.++.+++.||||++..    .....+.+..|+.+++.+...  .|+||++++       
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l--~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI--KNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTC--CSHHHHHHHHCBCCCS
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhcccc--CCHHHHHHHhhhhhhh
Confidence            4689999999999999999999999999999999863    223446677888776666432  458898887       


Q ss_pred             ceeecCC-----------------eEEEEEecCCCCHHHHHHhcCCCCCC-------HHHHHHHHHHHHHHHHHHHhcCe
Q 014117          162 NWFDYRN-----------------HICIVFEKLGSSLYDFLRKNNYRSFP-------IDLVREIARQLLECIAFMHDLCM  217 (430)
Q Consensus       162 ~~~~~~~-----------------~~~lv~e~~~~~L~~~l~~~~~~~l~-------~~~~~~i~~qi~~aL~~lH~~~i  217 (430)
                      ++++..+                 ..||||||++|+|.+++...+  .++       +..+..++.||+.||+|||++||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  227 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL--SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL  227 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH--HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc--ccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence            5554443                 389999999999999998653  344       47888899999999999999999


Q ss_pred             eeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCC--
Q 014117          218 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL--  295 (430)
Q Consensus       218 vHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--  295 (430)
                      |||||||+|||+                           +.++.+||+|||++..........+| +.|+|||++.+.  
T Consensus       228 vHrDikp~NIll---------------------------~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~  279 (377)
T 3byv_A          228 VHTYLRPVDIVL---------------------------DQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRAT  279 (377)
T ss_dssp             ECSCCCGGGEEE---------------------------CTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTS
T ss_pred             ecCCCCHHHEEE---------------------------cCCCCEEEEechhheecCCcccCCCC-cCccChhhhccccc
Confidence            999999999999                           44557788888877755444445578 999999999987  


Q ss_pred             ---------CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCC
Q 014117          296 ---------GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGA  366 (430)
Q Consensus       296 ---------~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (430)
                               .|+.++|||||||++|||++|..||.+.+..+...                                    
T Consensus       280 ~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~------------------------------------  323 (377)
T 3byv_A          280 ISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE------------------------------------  323 (377)
T ss_dssp             THHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG------------------------------------
T ss_pred             ccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh------------------------------------
Confidence                     89999999999999999999999997533211000                                    


Q ss_pred             CChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          367 ASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                                       .....+...+.++.+||.+||+.||++|||+.|+|+||||++
T Consensus       324 -----------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          324 -----------------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             -----------------GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             -----------------hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence                             001112456778999999999999999999999999999964

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9.5e-48  Score=368.20  Aligned_cols=257  Identities=23%  Similarity=0.331  Sum_probs=202.4

Q ss_pred             CceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           89 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        89 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||||+++...    .....+..|+.++.++     .|+||+++++++
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~   81 (311)
T 3ork_A            7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-----NHPAIVAVYDTG   81 (311)
T ss_dssp             CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-----CCTTBCCEEEEE
T ss_pred             cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-----CCCCcceEEEee
Confidence            3567789999999999999999999999999999999997432    2234556677766666     458899999988


Q ss_pred             ecCC----eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCC
Q 014117          165 DYRN----HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD  239 (430)
Q Consensus       165 ~~~~----~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~d  239 (430)
                      ....    ..|+||||+ +++|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||++.++      
T Consensus        82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~------  153 (311)
T 3ork_A           82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN------  153 (311)
T ss_dssp             EEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS------
T ss_pred             eccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC------
Confidence            6543    459999999 889999998765  799999999999999999999999999999999999996544      


Q ss_pred             CcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC------CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHH
Q 014117          240 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL  313 (430)
Q Consensus       240 fg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el  313 (430)
                                           .+||+|||++......      ....+||+.|+|||++.+..++.++|||||||++|+|
T Consensus       154 ---------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~l  212 (311)
T 3ork_A          154 ---------------------AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV  212 (311)
T ss_dssp             ---------------------CEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred             ---------------------CEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHH
Confidence                                 5666666665433221      1234789999999999999999999999999999999


Q ss_pred             HhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCch
Q 014117          314 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA  393 (430)
Q Consensus       314 ~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (430)
                      ++|..||.+.+..+....+...... +.                                            .......+
T Consensus       213 l~g~~pf~~~~~~~~~~~~~~~~~~-~~--------------------------------------------~~~~~~~~  247 (311)
T 3ork_A          213 LTGEPPFTGDSPVSVAYQHVREDPI-PP--------------------------------------------SARHEGLS  247 (311)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHCCCC-CH--------------------------------------------HHHSTTCC
T ss_pred             HhCCCCCCCCChHHHHHHHhcCCCC-Cc--------------------------------------------ccccCCCC
Confidence            9999999887766554443322111 11                                            11234567


Q ss_pred             hHHHHHHHHhhhcCCCCCCCHHHHhcCCCCC
Q 014117          394 GDLTHLLQGLLRYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       394 ~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~  424 (430)
                      .++.+||.+||+.||++||++.++|.|+|++
T Consensus       248 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          248 ADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            8899999999999999999999999999985

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=7.2e-47  Score=359.32  Aligned_cols=258  Identities=22%  Similarity=0.346  Sum_probs=204.2

Q ss_pred             ecCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 014117           87 ALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN  162 (430)
Q Consensus        87 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~  162 (430)
                      ..++.+.++|++.+.||+|+||.||+|.+..+++.||+|++...    ......+..|+.++.++.     |+||+++++
T Consensus         4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----hp~iv~~~~   78 (294)
T 4eqm_A            4 MIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-----HQNIVSMID   78 (294)
T ss_dssp             CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-----BTTBCCEEE
T ss_pred             chhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-----CCCCceEEE
Confidence            35677889999999999999999999999999999999998532    233456677888888774     488999999


Q ss_pred             eeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          163 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       163 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      ++...+.+|+||||+ +++|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||++           
T Consensus        79 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~-----------  145 (294)
T 4eqm_A           79 VDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID-----------  145 (294)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-----------
T ss_pred             eeeeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC-----------
Confidence            999999999999999 889999998765  799999999999999999999999999999999999994           


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC----CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~  317 (430)
                                      .++.+||+|||++......    ....+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       146 ----------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~  209 (294)
T 4eqm_A          146 ----------------SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE  209 (294)
T ss_dssp             ----------------TTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             ----------------CCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence                            4456677777766543322    12357999999999999999999999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      .||.+.+..+......  ....|.                                          .........+..+.
T Consensus       210 ~pf~~~~~~~~~~~~~--~~~~~~------------------------------------------~~~~~~~~~~~~l~  245 (294)
T 4eqm_A          210 PPFNGETAVSIAIKHI--QDSVPN------------------------------------------VTTDVRKDIPQSLS  245 (294)
T ss_dssp             CSSCSSCHHHHHHHHH--SSCCCC------------------------------------------HHHHSCTTSCHHHH
T ss_pred             CCCCCCChHHHHHHHh--hccCCC------------------------------------------cchhcccCCCHHHH
Confidence            9998876554432221  111111                                          11223456778899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCCC
Q 014117          398 HLLQGLLRYDPTDRLTAREALRHPF  422 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~hp~  422 (430)
                      ++|.+||+.||.+||+..+.+.+.|
T Consensus       246 ~li~~~l~~dp~~R~~~~~~l~~~l  270 (294)
T 4eqm_A          246 NVILRATEKDKANRYKTIQEMKDDL  270 (294)
T ss_dssp             HHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred             HHHHHHhcCCHhHccccHHHHHHHH
Confidence            9999999999999995555555544

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.5e-47  Score=364.62  Aligned_cols=260  Identities=30%  Similarity=0.473  Sum_probs=206.1

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---------hhHHHHHHHHHHHHHHHhcCCCCCceEEe
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHDKGGNRCVQI  160 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~  160 (430)
                      ..+.++|++.+.||+|+||.||+|.++.+++.||||++....         .....+..|+++++.+     .|+||+++
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~   80 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-----NHPCIIKI   80 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-----CCTTBCCE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-----CCCCCceE
Confidence            345678999999999999999999999999999999986432         1123467899999988     34889999


Q ss_pred             cceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCC
Q 014117          161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD  239 (430)
Q Consensus       161 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~d  239 (430)
                      ++++.... .|+||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++      
T Consensus        81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~------  151 (322)
T 2ycf_A           81 KNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------  151 (322)
T ss_dssp             EEEEESSS-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS------
T ss_pred             eeEEcCCc-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCC------
Confidence            99987655 89999999 789999987653  799999999999999999999999999999999999995432      


Q ss_pred             CcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhh---CCCCCCcchHHHHHHHHHHHH
Q 014117          240 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELC  314 (430)
Q Consensus       240 fg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~  314 (430)
                                        ....+||+|||++.......  ....||+.|+|||++.   ...++.++|||||||++|+|+
T Consensus       152 ------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~  213 (322)
T 2ycf_A          152 ------------------EDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL  213 (322)
T ss_dssp             ------------------SSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHH
T ss_pred             ------------------CCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHH
Confidence                              23468999999887654332  2357899999999985   456899999999999999999


Q ss_pred             hCCCCCCCCchH-HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCch
Q 014117          315 TGEALFQTHENL-EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA  393 (430)
Q Consensus       315 tG~~Pf~~~~~~-~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (430)
                      +|..||...... .....+........                                             ...+...+
T Consensus       214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~  248 (322)
T 2ycf_A          214 SGYPPFSEHRTQVSLKDQITSGKYNFI---------------------------------------------PEVWAEVS  248 (322)
T ss_dssp             HSSCSSCSTTCSSCHHHHHHHTCCCCC---------------------------------------------HHHHTTSC
T ss_pred             hCCCCCcccchHHHHHHHHHhCccccC---------------------------------------------chhhhhcC
Confidence            999999764432 12222221111111                                             11234567


Q ss_pred             hHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          394 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       394 ~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      .++.+||.+||+.||++|||++++|+||||+..
T Consensus       249 ~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             HHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            789999999999999999999999999999864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=6.1e-47  Score=355.68  Aligned_cols=255  Identities=24%  Similarity=0.374  Sum_probs=204.6

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++....  ...+.+..|+.+++.+     .|+||+++++++...+..
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~   80 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-----NHENVVKFYGHRREGNIQ   80 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEETTEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-----CCCCceeeeeEEEcCCEE
Confidence            467999999999999999999999999999999986332  3346677888888877     358899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||+ +++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++                   
T Consensus        81 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~-------------------  139 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD-------------------  139 (276)
T ss_dssp             EEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred             EEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc-------------------
Confidence            9999999 77999988654  3799999999999999999999999999999999999994                   


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCC-CCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                              .++.+||+|||.+......     .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus       140 --------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  211 (276)
T 2yex_A          140 --------ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP  211 (276)
T ss_dssp             --------TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred             --------cCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Confidence                    4456777777766533211     133578999999999988775 78899999999999999999999865


Q ss_pred             chHH-HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          324 ENLE-HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       324 ~~~~-~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      .... ....+......                                               ...+...+.++.+||.+
T Consensus       212 ~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~li~~  244 (276)
T 2yex_A          212 SDSCQEYSDWKEKKTY-----------------------------------------------LNPWKKIDSAPLALLHK  244 (276)
T ss_dssp             CTTSHHHHHHHTTCTT-----------------------------------------------STTGGGSCHHHHHHHHH
T ss_pred             chHHHHHHHhhhcccc-----------------------------------------------cCchhhcCHHHHHHHHH
Confidence            4321 11111100000                                               00112456789999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~~~~  428 (430)
                      ||+.||++|||++|+++||||++...
T Consensus       245 ~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          245 ILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             HSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HCCCCchhCCCHHHHhcCccccChhh
Confidence            99999999999999999999987644

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=360.28  Aligned_cols=281  Identities=20%  Similarity=0.325  Sum_probs=207.3

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC-
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-  168 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~-  168 (430)
                      ..++|++.+.||+|+||+||+|.+..+++.||||+++...  .....+..|+++++++.     ++||+++++++.... 
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~   81 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-----HKNIVKLFAIEEETTT   81 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC-----CTTBCCEEEEEECTTT
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-----CCCcceEEEEeecCCC
Confidence            4568999999999999999999999999999999987432  23456778999999984     488999999887654 


Q ss_pred             -eEEEEEecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          169 -HICIVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       169 -~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                       ..|+||||+ +++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||+....            
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~------------  149 (319)
T 4euu_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE------------  149 (319)
T ss_dssp             CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECT------------
T ss_pred             ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccC------------
Confidence             889999999 8999999986532 2399999999999999999999999999999999999984321            


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhh--------CCCCCCcchHHHHHHHHHHHHh
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVIL--------GLGWTYPCDIWSVGCILVELCT  315 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslGv~l~el~t  315 (430)
                                 +....+||+|||++.......  ....||+.|+|||++.        +..++.++|||||||++|||++
T Consensus       150 -----------~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~  218 (319)
T 4euu_A          150 -----------DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT  218 (319)
T ss_dssp             -----------TSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHH
T ss_pred             -----------CCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHh
Confidence                       344568888888886544333  3357999999999987        5679999999999999999999


Q ss_pred             CCCCCCCCch-HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchh
Q 014117          316 GEALFQTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG  394 (430)
Q Consensus       316 G~~Pf~~~~~-~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (430)
                      |..||..... ......+.......|...+..+     .....+.+.|.......                .......+.
T Consensus       219 g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~----------------~~~~~~~~~  277 (319)
T 4euu_A          219 GSLPFRPFEGPRRNKEVMYKIITGKPSGAISGV-----QKAENGPIDWSGDMPVS----------------CSLSRGLQV  277 (319)
T ss_dssp             SSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEE-----ECSTTCCEEEESSCCTT----------------CSSCHHHHH
T ss_pred             CCCCCCCCCccchhHHHHHHHhcCCCcccchhh-----hcccCCccccCccCCcc----------------cccchhHHH
Confidence            9999975332 1111222222222221110000     00011111121111000                011234466


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCC
Q 014117          395 DLTHLLQGLLRYDPTDRLTAREALRHP  421 (430)
Q Consensus       395 ~~~~ll~~~L~~dP~~R~ta~elL~hp  421 (430)
                      .+.+||.+||+.||++|||++|+|+||
T Consensus       278 ~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          278 LLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             HhHHHHHHhccCChhhhccHHHhhhcc
Confidence            789999999999999999999999997

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-47  Score=369.76  Aligned_cols=255  Identities=24%  Similarity=0.407  Sum_probs=202.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEEC---CCCeEEEEEEecCch-----hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      .++|++.+.||+|+||.||+|++.   .+++.||||+++...     .....+..|++++..+.+    +++|+.+++++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~----h~~iv~~~~~~  128 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ----SPFLVTLHYAF  128 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHT----CTTBCCEEEEE
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccC----CCceeEEEEEE
Confidence            368999999999999999999984   588999999986421     233456678999999864    37799999999


Q ss_pred             ecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCC
Q 014117          165 DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       165 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                      ...+.+||||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++             
T Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~-------------  193 (355)
T 1vzo_A          129 QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD-------------  193 (355)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC-------------
T ss_pred             eeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC-------------
Confidence            9999999999999 889999998764  799999999999999999999999999999999999994             


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccCCC----CCeeeecCcccchhhhhCC--CCCCcchHHHHHHHHHHHHhCC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~tG~  317 (430)
                                    .++.+||+|||+++.....    ....+||+.|+|||++.+.  .++.++|||||||++|||++|.
T Consensus       194 --------------~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~  259 (355)
T 1vzo_A          194 --------------SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA  259 (355)
T ss_dssp             --------------TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred             --------------CCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCC
Confidence                          4556777777776543221    1235799999999999863  4789999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHH-HhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHH
Q 014117          318 ALFQTHENLEHLAMMER-VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL  396 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~-~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (430)
                      .||...........+.. ....                                              ....+...+..+
T Consensus       260 ~pf~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~  293 (355)
T 1vzo_A          260 SPFTVDGEKNSQAEISRRILKS----------------------------------------------EPPYPQEMSALA  293 (355)
T ss_dssp             CTTSCTTSCCCHHHHHHHHHHC----------------------------------------------CCCCCTTSCHHH
T ss_pred             CCCccCCccchHHHHHHHHhcc----------------------------------------------CCCCCcccCHHH
Confidence            99975432111111110 0000                                              011234566789


Q ss_pred             HHHHHHhhhcCCCCCC-----CHHHHhcCCCCCCC
Q 014117          397 THLLQGLLRYDPTDRL-----TAREALRHPFFTRD  426 (430)
Q Consensus       397 ~~ll~~~L~~dP~~R~-----ta~elL~hp~f~~~  426 (430)
                      .+||.+||+.||.+||     |++|+++||||+..
T Consensus       294 ~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             HHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            9999999999999999     99999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.2e-46  Score=358.38  Aligned_cols=261  Identities=24%  Similarity=0.408  Sum_probs=207.6

Q ss_pred             cCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           88 LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        88 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      .+....++|++++.||+|+||.||+|.+..+++.||+|++... ......+..|+.++..+     .|+||+++++++..
T Consensus        13 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~   87 (302)
T 2j7t_A           13 RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-----DHPYIVKLLGAYYH   87 (302)
T ss_dssp             SSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEC
T ss_pred             cccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-----CCCCEeeeeeeeee
Confidence            3445667899999999999999999999999999999998643 23446677899999887     34889999999999


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      .+.+++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+                
T Consensus        88 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~----------------  150 (302)
T 2j7t_A           88 DGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM----------------  150 (302)
T ss_dssp             C-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE----------------
T ss_pred             CCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE----------------
Confidence            99999999999 889999887643 469999999999999999999999999999999999999                


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccC---CCCCeeeecCcccchhhhh-----CCCCCCcchHHHHHHHHHHHHhCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tG~  317 (430)
                                 +.++.+||+|||++....   .......||+.|+|||++.     +..++.++|||||||++|+|++|.
T Consensus       151 -----------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~  219 (302)
T 2j7t_A          151 -----------TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE  219 (302)
T ss_dssp             -----------CTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSS
T ss_pred             -----------CCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCC
Confidence                       445567888888654211   1123357899999999984     567899999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      .||...+..+....+.....+..                                              ..+...+.++.
T Consensus       220 ~p~~~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~l~  253 (302)
T 2j7t_A          220 PPHHELNPMRVLLKIAKSDPPTL----------------------------------------------LTPSKWSVEFR  253 (302)
T ss_dssp             CTTTTSCHHHHHHHHHHSCCCCC----------------------------------------------SSGGGSCHHHH
T ss_pred             CCCccCCHHHHHHHHhccCCccc----------------------------------------------CCccccCHHHH
Confidence            99988766554443332111000                                              01234466799


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          398 HLLQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      +||.+||+.||.+|||++++++||||+...
T Consensus       254 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          254 DFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             HHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             HHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            999999999999999999999999998753

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.2e-47  Score=369.88  Aligned_cols=263  Identities=29%  Similarity=0.485  Sum_probs=182.8

Q ss_pred             eecCcEEEEe-eeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 014117           91 NLTSRYKIHS-KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---  166 (430)
Q Consensus        91 ~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~---  166 (430)
                      .+.++|++.+ .||+|+||.||+|.++.+++.||||++......    ..|+..+.+..    .++|++++++++..   
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~e~~~~~~~~----~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA----RQEVDHHWQAS----GGPHIVCILDVYENMHH   96 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH----HHHHHHHHHHT----TSTTBCCEEEEEEEEET
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH----HHHHHHHHHhc----CCCChHHHHHHHhhccC
Confidence            4567899965 599999999999999999999999999754332    23333333332    44788999888875   


Q ss_pred             -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          167 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       167 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                       ...+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+            
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~------------  164 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSK------------  164 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS------------
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEec------------
Confidence             56799999999 7899999998766689999999999999999999999999999999999999543            


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCC-CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                  +....+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       165 ------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (336)
T 3fhr_A          165 ------------EKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN  232 (336)
T ss_dssp             ------------STTCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             ------------CCCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence                        23456899999988754432 24457899999999998888999999999999999999999999765


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      ........+...                   +..+....+                      ...+...+.++.+||.+|
T Consensus       233 ~~~~~~~~~~~~-------------------~~~~~~~~~----------------------~~~~~~~~~~~~~li~~~  271 (336)
T 3fhr_A          233 TGQAISPGMKRR-------------------IRLGQYGFP----------------------NPEWSEVSEDAKQLIRLL  271 (336)
T ss_dssp             -------------------------------------CCC----------------------TTTSTTCCHHHHHHHHHH
T ss_pred             cchhhhhhHHHh-------------------hhccccccC----------------------chhhccCCHHHHHHHHHH
Confidence            433221111000                   000000100                      011245677899999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      |+.||.+|||++|+|+||||++.
T Consensus       272 L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          272 LKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             SCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             CCCChhHCcCHHHHhcCcccccc
Confidence            99999999999999999999754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.3e-46  Score=352.67  Aligned_cols=259  Identities=19%  Similarity=0.247  Sum_probs=207.4

Q ss_pred             CceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           89 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        89 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      ++.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+..|+.+++.+.+    +++++.+++++....
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~----~~~i~~~~~~~~~~~   79 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAG----CTGIPNVYYFGQEGL   79 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTT----CTTCCCEEEEEEETT
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhc----CCCCCeEEeecCCCc
Confidence            4566788999999999999999999999999999999986433 33456778999988854    356788888899999


Q ss_pred             eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          169 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       169 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      ..++||||++++|.+++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.              
T Consensus        80 ~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--------------  144 (298)
T 1csn_A           80 HNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS--------------  144 (298)
T ss_dssp             EEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS--------------
T ss_pred             eeEEEEEecCCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCC--------------
Confidence            999999999999999998754 46999999999999999999999999999999999999965542              


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC----------CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~  318 (430)
                              .....+||+|||++......          .....||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus       145 --------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  216 (298)
T 1csn_A          145 --------KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL  216 (298)
T ss_dssp             --------TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             --------CCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCC
Confidence                    23345788888877644322          233579999999999999999999999999999999999999


Q ss_pred             CCCCCch---HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhH
Q 014117          319 LFQTHEN---LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD  395 (430)
Q Consensus       319 Pf~~~~~---~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (430)
                      ||.+.+.   .+....+.......+                                            .......++.+
T Consensus       217 pf~~~~~~~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~  252 (298)
T 1csn_A          217 PWQGLKAATNKQKYERIGEKKQSTP--------------------------------------------LRELCAGFPEE  252 (298)
T ss_dssp             TTSSCCSCCHHHHHHHHHHHHHHSC--------------------------------------------HHHHTTTSCHH
T ss_pred             CcchhhccccHHHHHHHHhhccCcc--------------------------------------------HHHHHhhCcHH
Confidence            9987432   222222222111111                                            11223456788


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          396 LTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       396 ~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      +.+||.+||+.||++|||+++|++
T Consensus       253 l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          253 FYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhcCCcccCCCHHHHHH
Confidence            999999999999999999998875

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=9.8e-47  Score=359.63  Aligned_cols=254  Identities=24%  Similarity=0.440  Sum_probs=203.6

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-----hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee--
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF--  164 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~--  164 (430)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|+++...     .....+..|+.+++.+.     |+||+++++++  
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~   77 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-----HKNVIQLVDVLYN   77 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-----CTTBCCEEEEEEC
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-----CCCeeEEEEEEEc
Confidence            4568999999999999999999999999999999987432     23456778888888873     48899999987  


Q ss_pred             ecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          165 DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       165 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                      ......|+||||+.++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.             
T Consensus        78 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~-------------  144 (305)
T 2wtk_C           78 EEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTT-------------  144 (305)
T ss_dssp             C---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-------------
T ss_pred             CCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcC-------------
Confidence            4567899999999777989888766678999999999999999999999999999999999999954             


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCC--CCCcchHHHHHHHHHHHHhCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLG--WTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGv~l~el~tG~  317 (430)
                                    ++.+||+|||++.......     ....||+.|+|||++.+..  ++.++|||||||++|+|++|.
T Consensus       145 --------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~  210 (305)
T 2wtk_C          145 --------------GGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL  210 (305)
T ss_dssp             --------------TCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSS
T ss_pred             --------------CCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCC
Confidence                          4556666776665432211     2346899999999998754  378999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      .||...+..+....+.....                                                 ..+...+.++.
T Consensus       211 ~p~~~~~~~~~~~~i~~~~~-------------------------------------------------~~~~~~~~~l~  241 (305)
T 2wtk_C          211 YPFEGDNIYKLFENIGKGSY-------------------------------------------------AIPGDCGPPLS  241 (305)
T ss_dssp             CSCCCSSHHHHHHHHHHCCC-------------------------------------------------CCCSSSCHHHH
T ss_pred             CCCCCchHHHHHHHHhcCCC-------------------------------------------------CCCCccCHHHH
Confidence            99988665554443322111                                                 12234567899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          398 HLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +||.+||+.||.+|||++|+++||||++.
T Consensus       242 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHccCChhhCCCHHHHhcCcccccC
Confidence            99999999999999999999999999765

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=359.53  Aligned_cols=258  Identities=26%  Similarity=0.434  Sum_probs=203.9

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      +...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+..|+.+++.+     .|+||+++++++...+.
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~   98 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQC-----DSPHVVKYYGSYFKNTD   98 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTC-----CCTTBCCEEEEEEETTE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhC-----CCCCCccEEEEEEeCCE
Confidence            344568999999999999999999999999999999997543 335677899988887     45889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++                  
T Consensus        99 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~------------------  159 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN------------------  159 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC------------------
T ss_pred             EEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC------------------
Confidence            99999999 779999997543 4799999999999999999999999999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                               .++.+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus       160 ---------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  230 (314)
T 3com_A          160 ---------TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP  230 (314)
T ss_dssp             ---------TTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             ---------CCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh
Confidence                     4456777777776543322   2335789999999999999999999999999999999999999987665


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      ......+.....+.                      +                        ..+...+.++.+||.+||+
T Consensus       231 ~~~~~~~~~~~~~~----------------------~------------------------~~~~~~~~~l~~li~~~l~  264 (314)
T 3com_A          231 MRAIFMIPTNPPPT----------------------F------------------------RKPELWSDNFTDFVKQCLV  264 (314)
T ss_dssp             HHHHHHHHHSCCCC----------------------C------------------------SSGGGSCHHHHHHHHHHTC
T ss_pred             HHHHHHHhcCCCcc----------------------c------------------------CCcccCCHHHHHHHHHHcc
Confidence            44333222111000                      0                        0122346679999999999


Q ss_pred             cCCCCCCCHHHHhcCCCCCCCC
Q 014117          406 YDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      .||.+|||++++|+||||+...
T Consensus       265 ~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          265 KSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             SCTTTSCCHHHHTTSHHHHTCC
T ss_pred             CChhhCcCHHHHHhCHHHhcCC
Confidence            9999999999999999998653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.3e-46  Score=359.67  Aligned_cols=256  Identities=21%  Similarity=0.262  Sum_probs=203.5

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++++.+    +++|+.+++++...+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~----h~~i~~~~~~~~~~~~~   80 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGS----GDGIPQVYYFGPCGKYN   80 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCS----CTTSCCEEEEEEETTEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhC----CCCCCEEEEEEecCCcc
Confidence            34578999999999999999999999999999999986432 23457789999999843    37899999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      |+||||++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.                
T Consensus        81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~----------------  143 (330)
T 2izr_A           81 AMVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGN----------------  143 (330)
T ss_dssp             EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGG----------------
T ss_pred             EEEEEeCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCC----------------
Confidence            9999999999999998753 47999999999999999999999999999999999999976543                


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC----------CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                            .....+||+|||++......          ....+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus       144 ------~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf  217 (330)
T 2izr_A          144 ------KTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW  217 (330)
T ss_dssp             ------TCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ------CCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCc
Confidence                  12233777777777643221          13468999999999999999999999999999999999999999


Q ss_pred             CCCchH---HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          321 QTHENL---EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       321 ~~~~~~---~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      .+.+..   +.+..+.......|.                                            .......+ ++.
T Consensus       218 ~~~~~~~~~~~~~~i~~~~~~~~~--------------------------------------------~~~~~~~p-~~~  252 (330)
T 2izr_A          218 QGLKADTLKERYQKIGDTKRATPI--------------------------------------------EVLCENFP-EMA  252 (330)
T ss_dssp             TTCCCSSHHHHHHHHHHHHHHSCH--------------------------------------------HHHTTTCH-HHH
T ss_pred             cccccccHHHHHHHHHhhhccCCH--------------------------------------------HHHhccCh-HHH
Confidence            874432   222222221111111                                            11123345 899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhc
Q 014117          398 HLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      +||..||+.||.+||++++|++
T Consensus       253 ~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          253 TYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhCCCCCCCCHHHHHH
Confidence            9999999999999999988875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.5e-46  Score=355.50  Aligned_cols=260  Identities=30%  Similarity=0.520  Sum_probs=214.0

Q ss_pred             CceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           89 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        89 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||+|++....   .....+..|+++++++     .++||+++++++.
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~   91 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-----DHPNIMKLFEILE   91 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-----CCTTBCCEEEEEE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-----cCCCccEEEEEEe
Confidence            3456678999999999999999999999999999999986432   2446677899998887     3488999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                      ..+..++||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++..            
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~------------  157 (287)
T 2wei_A           92 DSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK------------  157 (287)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS------------
T ss_pred             CCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecC------------
Confidence            999999999999 889999987654  79999999999999999999999999999999999999543            


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                  +....+||+|||++.......  ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+
T Consensus       158 ------------~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~  224 (287)
T 2wei_A          158 ------------EKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG  224 (287)
T ss_dssp             ------------STTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ------------CCcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCC
Confidence                        234578999999887544332  33468999999999876 489999999999999999999999988


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      .+..+....+.......+.                                             ..+...+.++.+||.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~li~~  259 (287)
T 2wei_A          225 KNEYDILKRVETGKYAFDL---------------------------------------------PQWRTISDDAKDLIRK  259 (287)
T ss_dssp             SSHHHHHHHHHHCCCCCCS---------------------------------------------GGGTTSCHHHHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCCCc---------------------------------------------hhhhhcCHHHHHHHHH
Confidence            7766555444332111110                                             0123457789999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      ||+.||++|||++|+|+||||++
T Consensus       260 ~l~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          260 MLTFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             HTCSSGGGSCCHHHHHHSHHHHH
T ss_pred             HcccChhhCcCHHHHhcCHHHhc
Confidence            99999999999999999999964

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.7e-47  Score=364.99  Aligned_cols=256  Identities=26%  Similarity=0.449  Sum_probs=206.3

Q ss_pred             eecCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh-------hHHHHHHHHHHHHHHHhcCCCCCceE
Q 014117           86 FALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCV  158 (430)
Q Consensus        86 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~E~~~l~~l~~~~~~~~~i~  158 (430)
                      ...++.+.++|++.+.||+|+||.||+|.+..+++.||||+++....       ....+..|+.+++++.+   .+++++
T Consensus        35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~---~~~~i~  111 (320)
T 3a99_A           35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS---GFSGVI  111 (320)
T ss_dssp             -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS---SSCSBC
T ss_pred             ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhcc---CCCCce
Confidence            34456677899999999999999999999999999999999864321       22345678999999864   457899


Q ss_pred             EecceeecCCeEEEEEecC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccc
Q 014117          159 QIRNWFDYRNHICIVFEKL-G-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK  236 (430)
Q Consensus       159 ~~~~~~~~~~~~~lv~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~  236 (430)
                      ++++++...+..++|||++ + ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.     
T Consensus       112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~-----  184 (320)
T 3a99_A          112 RLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-----  184 (320)
T ss_dssp             CEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-----
T ss_pred             EEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC-----
Confidence            9999999999999999999 4 79999998764  7999999999999999999999999999999999999951     


Q ss_pred             cCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-CeeeecCcccchhhhhCCCC-CCcchHHHHHHHHHHHH
Q 014117          237 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELC  314 (430)
Q Consensus       237 i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~  314 (430)
                                           .++.+||+|||++....... ....||+.|+|||++.+..+ +.++|||||||++|||+
T Consensus       185 ---------------------~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~  243 (320)
T 3a99_A          185 ---------------------NRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV  243 (320)
T ss_dssp             ---------------------TTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred             ---------------------CCCCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHH
Confidence                                 34467777777765443322 33578999999999987765 68899999999999999


Q ss_pred             hCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchh
Q 014117          315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG  394 (430)
Q Consensus       315 tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (430)
                      +|..||.....      +..  +                     ..                          ..+...+.
T Consensus       244 ~g~~pf~~~~~------~~~--~---------------------~~--------------------------~~~~~~~~  268 (320)
T 3a99_A          244 CGDIPFEHDEE------IIR--G---------------------QV--------------------------FFRQRVSS  268 (320)
T ss_dssp             HSSCSCCSHHH------HHH--C---------------------CC--------------------------CCSSCCCH
T ss_pred             HCCCCCCChhh------hhc--c---------------------cc--------------------------cccccCCH
Confidence            99999975221      000  0                     00                          01235677


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          395 DLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       395 ~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      ++.+||.+||+.||++|||++|+++||||++..
T Consensus       269 ~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          269 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            899999999999999999999999999998753

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.8e-46  Score=355.38  Aligned_cols=272  Identities=24%  Similarity=0.368  Sum_probs=196.2

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec-----
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-----  166 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~-----  166 (430)
                      +.++|++.+.||+|+||.||+|.+..+++.||||+++........+..|+.+++.+     .|+||+++++++..     
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-----NHQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEECCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-----CchHHHHHHHHHHhhcchh
Confidence            34679999999999999999999999999999999976655666778899988887     34789998887643     


Q ss_pred             --------CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCcccc
Q 014117          167 --------RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV  237 (430)
Q Consensus       167 --------~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i  237 (430)
                              .+.+|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+++
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence                    56899999999 789999998654 46888999999999999999999999999999999999976666666


Q ss_pred             CCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhC
Q 014117          238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTG  316 (430)
Q Consensus       238 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG  316 (430)
                      +|||++..........         .+ +-..............||+.|+|||++.+. .++.++|||||||++|+|++ 
T Consensus       158 ~dfg~~~~~~~~~~~~---------~~-~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-  226 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDIL---------KL-DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-  226 (303)
T ss_dssp             CCCCCCSCTTC-----------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS-
T ss_pred             eeCcchhhcccccchh---------cc-ccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh-
Confidence            5555554332211000         00 000000000111235789999999999875 68999999999999999998 


Q ss_pred             CCCCCCCch-HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhH
Q 014117          317 EALFQTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD  395 (430)
Q Consensus       317 ~~Pf~~~~~-~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (430)
                        ||....+ .+....+....                       ..++.                      .++...+..
T Consensus       227 --p~~~~~~~~~~~~~~~~~~-----------------------~~~~~----------------------~~~~~~~~~  259 (303)
T 1zy4_A          227 --PFSTGMERVNILKKLRSVS-----------------------IEFPP----------------------DFDDNKMKV  259 (303)
T ss_dssp             --CCSSHHHHHHHHHHHHSTT-----------------------CCCCT----------------------TCCTTTSHH
T ss_pred             --ccCCchhHHHHHHhccccc-----------------------cccCc----------------------cccccchHH
Confidence              6653221 22222211111                       11111                      122345667


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          396 LTHLLQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       396 ~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      +.+||.+||+.||.+|||++++|+||||+...
T Consensus       260 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (303)
T 1zy4_A          260 EKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH  291 (303)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred             HHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence            89999999999999999999999999998653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.8e-46  Score=354.08  Aligned_cols=247  Identities=21%  Similarity=0.282  Sum_probs=195.8

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      ..++|++.+.||+|+||+||+|.+  +++.||+|++....   .....+..|+++++++.     |+||+++++++...+
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-----HPNIVLFMGAVTQPP  107 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC-----CTTBCCEEEEECSTT
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-----CCCEeeEEEEEEECC
Confidence            356899999999999999999976  57889999986432   33356778999999984     488999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcC--eeeccCCCCceEEeecCccccCCCcCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                      .+++||||+ +++|.+++..... ..+++..+..++.||+.||.|||++|  |+||||||+|||++              
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~--------------  173 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD--------------  173 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC--------------
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe--------------
Confidence            999999999 8899999986531 23899999999999999999999999  99999999999994              


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                                   .++.+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       174 -------------~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~  240 (309)
T 3p86_A          174 -------------KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG  240 (309)
T ss_dssp             -------------TTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTT
T ss_pred             -------------CCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence                         4556777777776543322   233579999999999999999999999999999999999999998


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      ..+..+....+......                                               ...+...+.++.+||.
T Consensus       241 ~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~l~~li~  273 (309)
T 3p86_A          241 NLNPAQVVAAVGFKCKR-----------------------------------------------LEIPRNLNPQVAAIIE  273 (309)
T ss_dssp             TSCHHHHHHHHHHSCCC-----------------------------------------------CCCCTTSCHHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCC-----------------------------------------------CCCCccCCHHHHHHHH
Confidence            87665544433211111                                               0123456778999999


Q ss_pred             HhhhcCCCCCCCHHHHhc
Q 014117          402 GLLRYDPTDRLTAREALR  419 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~  419 (430)
                      +||+.||.+|||++++++
T Consensus       274 ~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          274 GCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHccCChhhCcCHHHHHH
Confidence            999999999999999987

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.4e-46  Score=353.48  Aligned_cols=251  Identities=28%  Similarity=0.417  Sum_probs=208.1

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|++...  ......+..|+.++..+     .+++|+++++++...+.+
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~   95 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYVTKYYGSYLKDTKL   95 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-----CCCCEeEEEEEEecCCeE
Confidence            45699999999999999999999999999999998643  23456678899988887     348899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||+ +++|.+++...   .+++..+..++.||+.||.|||+.||+||||||+|||++                   
T Consensus        96 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~-------------------  153 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS-------------------  153 (303)
T ss_dssp             EEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-------------------
T ss_pred             EEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC-------------------
Confidence            9999999 77999998653   699999999999999999999999999999999999994                   


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                              .++.+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus       154 --------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  225 (303)
T 3a7i_A          154 --------EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM  225 (303)
T ss_dssp             --------TTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             --------CCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH
Confidence                    4556777777777543322   23357899999999999999999999999999999999999999876655


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +....+....  .                                              ...+...+.++.+||.+||+.
T Consensus       226 ~~~~~~~~~~--~----------------------------------------------~~~~~~~~~~l~~li~~~l~~  257 (303)
T 3a7i_A          226 KVLFLIPKNN--P----------------------------------------------PTLEGNYSKPLKEFVEACLNK  257 (303)
T ss_dssp             HHHHHHHHSC--C----------------------------------------------CCCCSSCCHHHHHHHHHHCCS
T ss_pred             HHHHHhhcCC--C----------------------------------------------CCCccccCHHHHHHHHHHcCC
Confidence            4433322110  0                                              012235567899999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||.+|||+.|+|+||||...
T Consensus       258 dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          258 EPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             SGGGSCCHHHHTTCHHHHHH
T ss_pred             ChhhCcCHHHHhhChhhhcC
Confidence            99999999999999999643

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=8.5e-46  Score=354.80  Aligned_cols=255  Identities=28%  Similarity=0.446  Sum_probs=199.8

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|++...   ......+..|+.++.++.++   +++|+++++++...
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~---~~~iv~~~~~~~~~  100 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH---SDKIIRLYDYEITD  100 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGG---CTTBCCEEEEEECS
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhcccc---CCceEEEEEEeecC
Confidence            33567999999999999999999985 5888999998632   23446678899999999762   37899999999999


Q ss_pred             CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          168 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       168 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      +.+|+|||+.+++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||+++ +              
T Consensus       101 ~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~--------------  163 (313)
T 3cek_A          101 QYIYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--------------  163 (313)
T ss_dssp             SEEEEEECCCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--------------
T ss_pred             CEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C--------------
Confidence            9999999977999999998764  7999999999999999999999999999999999999942 3              


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhC-----------CCCCCcchHHHHHHHHH
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILG-----------LGWTYPCDIWSVGCILV  311 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslGv~l~  311 (430)
                                   .+||+|||++.......     ....||+.|+|||++.+           ..++.++|||||||++|
T Consensus       164 -------------~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~  230 (313)
T 3cek_A          164 -------------MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY  230 (313)
T ss_dssp             -------------EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHH
T ss_pred             -------------eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHH
Confidence                         46666666665432221     23478999999999976           46889999999999999


Q ss_pred             HHHhCCCCCCCCchH-HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcC
Q 014117          312 ELCTGEALFQTHENL-EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD  390 (430)
Q Consensus       312 el~tG~~Pf~~~~~~-~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  390 (430)
                      +|++|..||...... .....   .....                  ..                          ..++.
T Consensus       231 el~~g~~pf~~~~~~~~~~~~---~~~~~------------------~~--------------------------~~~~~  263 (313)
T 3cek_A          231 YMTYGKTPFQQIINQISKLHA---IIDPN------------------HE--------------------------IEFPD  263 (313)
T ss_dssp             HHHHSSCTTTTCCSHHHHHHH---HHCTT------------------SC--------------------------CCCCC
T ss_pred             HHHhCCCchhhHHHHHHHHHH---HHhcc------------------cc--------------------------cCCcc
Confidence            999999999764332 11111   11000                  00                          01233


Q ss_pred             CchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          391 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       391 ~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ..+.++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       264 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          264 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             cchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            446689999999999999999999999999999765

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.7e-46  Score=349.76  Aligned_cols=254  Identities=22%  Similarity=0.357  Sum_probs=207.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee--ecC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF--DYR  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~--~~~  167 (430)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++...   ....+.+..|+.+++++.     |+||+++++++  ...
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~   79 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-----HPNIVRYYDRIIDRTN   79 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-----CTTBCCEEEEEEEGGG
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcC-----CCCCCeEEEEEecCCC
Confidence            46799999999999999999999999999999998643   234556778999999883     48899999976  456


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcC-----eeeccCCCCceEEeecCccccCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLC-----MIHTDLKPENVLLVSSEYIKVPD  239 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~-----ivHrDlKp~NILl~~~~~~~i~d  239 (430)
                      ..+|+||||+ +++|.+++....  ...+++..+..++.||+.||.|||+.|     |+||||||+|||+          
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~----------  149 (279)
T 2w5a_A           80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL----------  149 (279)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE----------
T ss_pred             ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE----------
Confidence            7999999999 779999997532  245999999999999999999999999     9999999999999          


Q ss_pred             CcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhC
Q 014117          240 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG  316 (430)
Q Consensus       240 fg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG  316 (430)
                                       +.++.+||+|||++.......   ....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       150 -----------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  212 (279)
T 2w5a_A          150 -----------------DGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL  212 (279)
T ss_dssp             -----------------CSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHS
T ss_pred             -----------------cCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHC
Confidence                             445678888888776544332   224789999999999999999999999999999999999


Q ss_pred             CCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHH
Q 014117          317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL  396 (430)
Q Consensus       317 ~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (430)
                      ..||...+..+....+.....  +                                              ..+...+.++
T Consensus       213 ~~p~~~~~~~~~~~~i~~~~~--~----------------------------------------------~~~~~~~~~l  244 (279)
T 2w5a_A          213 MPPFTAFSQKELAGKIREGKF--R----------------------------------------------RIPYRYSDEL  244 (279)
T ss_dssp             SCSSCCSSHHHHHHHHHHTCC--C----------------------------------------------CCCTTSCHHH
T ss_pred             CCCCcccCHHHHHHHHhhccc--c----------------------------------------------cCCcccCHHH
Confidence            999988765554443322110  0                                              1123456789


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          397 THLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       397 ~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      .+||.+||+.||++|||++|+|+|+|++..
T Consensus       245 ~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          245 NEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             HHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            999999999999999999999999999865

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.1e-45  Score=362.61  Aligned_cols=250  Identities=19%  Similarity=0.299  Sum_probs=200.7

Q ss_pred             ecCcEEEEeeeccccceEEEEEEEC-------CCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDR-------ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN  162 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~  162 (430)
                      ..++|++.+.||+|+||.||+|.+.       .++..||||+++..  ......+..|+.+++.+.    .|+||+++++
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~hpnIv~~~~  154 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG----KHKNIINLLG  154 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSC----CCTTBCCEEE
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhc----CCCCEeeEEE
Confidence            3568999999999999999999874       34568999999743  234456788999999883    2478999999


Q ss_pred             eeecCCeEEEEEecC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCce
Q 014117          163 WFDYRNHICIVFEKL-GSSLYDFLRKNNY--------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENV  227 (430)
Q Consensus       163 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NI  227 (430)
                      ++...+.+|+||||+ +++|.+++.....              ..+++..+..++.||+.||.|||++|||||||||+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            999999999999999 8899999987531              3589999999999999999999999999999999999


Q ss_pred             EEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcch
Q 014117          228 LLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCD  302 (430)
Q Consensus       228 Ll~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D  302 (430)
                      |++.                           ++.+||+|||++......     .....||+.|+|||++.+..|+.++|
T Consensus       235 ll~~---------------------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D  287 (370)
T 2psq_A          235 LVTE---------------------------NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD  287 (370)
T ss_dssp             EECT---------------------------TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHH
T ss_pred             EECC---------------------------CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHH
Confidence            9954                           455666666666533221     12235688999999999999999999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhH
Q 014117          303 IWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL  381 (430)
Q Consensus       303 vwslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (430)
                      ||||||++|||++ |..||.+....+....+.....                                            
T Consensus       288 vwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--------------------------------------------  323 (370)
T 2psq_A          288 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--------------------------------------------  323 (370)
T ss_dssp             HHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--------------------------------------------
T ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--------------------------------------------
Confidence            9999999999999 9999987665444433221100                                            


Q ss_pred             HHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       382 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                          ...+..++.++.+||.+||+.||.+|||+.|++++
T Consensus       324 ----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          324 ----MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                01234567789999999999999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=352.36  Aligned_cols=265  Identities=17%  Similarity=0.226  Sum_probs=199.3

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecC-chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG-IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++.. .......+..|+++++++.     |+||+++++++...+..+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE-----HPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCC-----CTTBCCEEEEEEETTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC-----CcCcccEEEEEecCCeeE
Confidence            4679999999999999999999999999999998754 3345567788999988883     588999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        84 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999 889999998754 479999999999999999999999999999999999999665555555555443221111


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA  330 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~  330 (430)
                      .....        .  -.............+||+.|+|||++.+..++.++|||||||++|+|++|..||......... 
T Consensus       163 ~~~~~--------~--~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~-  231 (310)
T 3s95_A          163 TQPEG--------L--RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD-  231 (310)
T ss_dssp             ---------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT-
T ss_pred             ccccc--------c--ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH-
Confidence            00000        0  000000000112457999999999999999999999999999999999999999653211000 


Q ss_pred             HHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCC
Q 014117          331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD  410 (430)
Q Consensus       331 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~  410 (430)
                                                                   .............+..++.++.+||.+||+.||++
T Consensus       232 ---------------------------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~  266 (310)
T 3s95_A          232 ---------------------------------------------FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEK  266 (310)
T ss_dssp             ---------------------------------------------SSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGG
T ss_pred             ---------------------------------------------HhhhhhccccccCCCCCCHHHHHHHHHHccCChhh
Confidence                                                         00000011112235667788999999999999999


Q ss_pred             CCCHHHHhc
Q 014117          411 RLTAREALR  419 (430)
Q Consensus       411 R~ta~elL~  419 (430)
                      |||++++++
T Consensus       267 Rps~~~l~~  275 (310)
T 3s95_A          267 RPSFVKLEH  275 (310)
T ss_dssp             SCCHHHHHH
T ss_pred             CcCHHHHHH
Confidence            999999976

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.2e-46  Score=363.96  Aligned_cols=276  Identities=20%  Similarity=0.381  Sum_probs=211.5

Q ss_pred             cCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhh------------------HHHHHHHHHHHHHHHh
Q 014117           88 LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY------------------REAAMIEIEVLQQLAK  149 (430)
Q Consensus        88 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~------------------~~~~~~E~~~l~~l~~  149 (430)
                      .++...++|++.+.||+|+||.||+|.+  +++.||+|++......                  ...+..|+.++..+. 
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-  101 (348)
T 2pml_X           25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-  101 (348)
T ss_dssp             SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-
T ss_pred             hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-
Confidence            3455668999999999999999999998  8999999998633211                  167788999988883 


Q ss_pred             cCCCCCceEEecceeecCCeEEEEEecC-CCCHHHH------HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecc
Q 014117          150 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDF------LRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTD  221 (430)
Q Consensus       150 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~------l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrD  221 (430)
                          |+||+++++++...+.+|+||||+ +++|.++      +.......+++..+..++.||+.||.|||+ +||+|||
T Consensus       102 ----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~d  177 (348)
T 2pml_X          102 ----NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRD  177 (348)
T ss_dssp             ----CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCC
T ss_pred             ----CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecC
Confidence                588999999999999999999999 7799998      665445689999999999999999999999 9999999


Q ss_pred             CCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-CCeeeecCcccchhhhhCC-CCCC
Q 014117          222 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGL-GWTY  299 (430)
Q Consensus       222 lKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~  299 (430)
                      |||+|||++                           .++.+||+|||.+...... .....||+.|+|||++.+. .++.
T Consensus       178 l~p~Nil~~---------------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  230 (348)
T 2pml_X          178 VKPSNILMD---------------------------KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNG  230 (348)
T ss_dssp             CCGGGEEEC---------------------------TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEH
T ss_pred             CChHhEEEc---------------------------CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCc
Confidence            999999994                           4556777777777643322 2335789999999999887 6666


Q ss_pred             -cchHHHHHHHHHHHHhCCCCCCCCch-HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcC
Q 014117          300 -PCDIWSVGCILVELCTGEALFQTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK  377 (430)
Q Consensus       300 -~~DvwslGv~l~el~tG~~Pf~~~~~-~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (430)
                       ++|||||||++|+|++|..||..... .+....+....                       ..++.......   .   
T Consensus       231 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~-----------------------~~~~~~~~~~~---~---  281 (348)
T 2pml_X          231 AKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKN-----------------------IEYPLDRNHFL---Y---  281 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCC-----------------------CCCCCSSSSST---T---
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccC-----------------------cCCccchhhhh---c---
Confidence             99999999999999999999987665 44443332211                       11111100000   0   


Q ss_pred             chhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          378 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                       ..............+.++.+||.+||+.||.+|||++|+|+||||+...
T Consensus       282 -~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          282 -PLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             -TTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             -cccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence             0000001112356778899999999999999999999999999998754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.2e-46  Score=347.08  Aligned_cols=246  Identities=26%  Similarity=0.387  Sum_probs=203.8

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.......+.+..|+++++++.     |+||+++++++.+.+..|+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~l   82 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-----HPKLVQLYGVCLEQAPICL   82 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCC-----CTTBCCEEEEECSSSSEEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCC-----CCCEeeEEEEEecCCceEE
Confidence            357999999999999999999987 4677999999866555677889999999884     4889999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.                    
T Consensus        83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~--------------------  141 (269)
T 4hcu_A           83 VFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE--------------------  141 (269)
T ss_dssp             EEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG--------------------
T ss_pred             EEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcC--------------------
Confidence            99999 889999997654 46999999999999999999999999999999999999954                    


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCC----CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL  326 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~  326 (430)
                             ++.+||+|||++......    .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus       142 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~  214 (269)
T 4hcu_A          142 -------NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS  214 (269)
T ss_dssp             -------GGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             -------CCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH
Confidence                   445777777776543221    122356788999999999999999999999999999999 99999887766


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +....+.......                                                .+...+.++.+||.+||+.
T Consensus       215 ~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~li~~~l~~  246 (269)
T 4hcu_A          215 EVVEDISTGFRLY------------------------------------------------KPRLASTHVYQIMNHCWRE  246 (269)
T ss_dssp             HHHHHHHTTCCCC------------------------------------------------CCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHhcCccCC------------------------------------------------CCCcCCHHHHHHHHHHccC
Confidence            6554443221110                                                1234567799999999999


Q ss_pred             CCCCCCCHHHHhcC
Q 014117          407 DPTDRLTAREALRH  420 (430)
Q Consensus       407 dP~~R~ta~elL~h  420 (430)
                      ||++|||+.|+++|
T Consensus       247 ~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          247 RPEDRPAFSRLLRQ  260 (269)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             CcccCcCHHHHHHH
Confidence            99999999999875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.4e-45  Score=348.78  Aligned_cols=250  Identities=21%  Similarity=0.321  Sum_probs=209.2

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      +...++|++.+.||+|+||.||+|.++.+++.||+|++.......+.+..|+.+++++.     |+||+++++++...+.
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~   83 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-----HPNLVQLLGVCTREPP   83 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCC-----CTTBCCEEEEECSSSS
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCC-----CCCEeeEEEEEccCCC
Confidence            44567899999999999999999999999999999999876666677889999999984     4889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .|+||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.                 
T Consensus        84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~-----------------  146 (288)
T 3kfa_A           84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE-----------------  146 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECG-----------------
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcC-----------------
Confidence            99999999 789999998876667999999999999999999999999999999999999954                 


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH  323 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~  323 (430)
                                ++.+||+|||++.......    ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus       147 ----------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~  216 (288)
T 3kfa_A          147 ----------NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI  216 (288)
T ss_dssp             ----------GGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ----------CCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                      4456777777665443322    12357889999999999999999999999999999999 99999876


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +..+....+.....                                                ...+...+.++.+||.+|
T Consensus       217 ~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~l~~li~~~  248 (288)
T 3kfa_A          217 DLSQVYELLEKDYR------------------------------------------------MERPEGCPEKVYELMRAC  248 (288)
T ss_dssp             CGGGHHHHHHTTCC------------------------------------------------CCCCTTCCHHHHHHHHHH
T ss_pred             CHHHHHHHHhccCC------------------------------------------------CCCCCCCCHHHHHHHHHH
Confidence            55443333221110                                                012245677899999999


Q ss_pred             hhcCCCCCCCHHHHhc
Q 014117          404 LRYDPTDRLTAREALR  419 (430)
Q Consensus       404 L~~dP~~R~ta~elL~  419 (430)
                      |+.||.+|||++++++
T Consensus       249 l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          249 WQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             TCSSGGGSCCHHHHHH
T ss_pred             hCCChhhCcCHHHHHH
Confidence            9999999999999975

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.5e-46  Score=357.76  Aligned_cols=264  Identities=25%  Similarity=0.411  Sum_probs=185.3

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....  .....+..|+.++.++     .|+||+++++++...+..
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-----HHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-----CCTTBCCEEEEEESSSCE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-----CCCCEeeEEEEEeecCCc
Confidence            467999999999999999999999999999999886432  2234455677666665     458899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCC
Q 014117          171 CIVFEKL-GSSLYDFLRKN------NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~------~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                      ++||||+ +++|.+++...      ....+++..+..++.||+.||.|||++||+||||||+|||++.+           
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-----------  157 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-----------  157 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-----------
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCC-----------
Confidence            9999999 88999998741      22469999999999999999999999999999999999999544           


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccCCC--------CCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHH
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELC  314 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~  314 (430)
                                      +.+||+|||++......        .....||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus       158 ----------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~  221 (303)
T 2vwi_A          158 ----------------GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA  221 (303)
T ss_dssp             ----------------CCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHH
T ss_pred             ----------------CCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHH
Confidence                            45566666655432211        123478999999999876 56899999999999999999


Q ss_pred             hCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchh
Q 014117          315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG  394 (430)
Q Consensus       315 tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (430)
                      +|..||...............  ..+.                    ...                 ...........+.
T Consensus       222 ~g~~pf~~~~~~~~~~~~~~~--~~~~--------------------~~~-----------------~~~~~~~~~~~~~  262 (303)
T 2vwi_A          222 TGAAPYHKYPPMKVLMLTLQN--DPPS--------------------LET-----------------GVQDKEMLKKYGK  262 (303)
T ss_dssp             HSSCTTTTSCGGGHHHHHHTS--SCCC--------------------TTC----------------------CCCCCCCH
T ss_pred             hCCCCCccCchhhHHHHHhcc--CCCc--------------------ccc-----------------ccccchhhhhhhH
Confidence            999999876554433221111  0000                    000                 0000112345677


Q ss_pred             HHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          395 DLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       395 ~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      ++.+||.+||+.||.+|||++|+++||||++..
T Consensus       263 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          263 SFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence            899999999999999999999999999998653

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.5e-46  Score=361.78  Aligned_cols=252  Identities=21%  Similarity=0.304  Sum_probs=198.8

Q ss_pred             eecCcEEEEeeeccccceEEEEEE-----ECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECW-----DRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW  163 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~  163 (430)
                      ...++|++.+.||+|+||.||+|.     +..+++.||||+++..  ......+..|++++.++.+    |+||++++++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~----hpniv~~~~~   94 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH----HLNVVNLLGA   94 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC----CTTBCCEEEE
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcC----Ccceeeeeee
Confidence            345789999999999999999998     5667799999999743  2334567889999999843    4789999998


Q ss_pred             eecC-CeEEEEEecC-CCCHHHHHHhcCC---------------------------------------------------
Q 014117          164 FDYR-NHICIVFEKL-GSSLYDFLRKNNY---------------------------------------------------  190 (430)
Q Consensus       164 ~~~~-~~~~lv~e~~-~~~L~~~l~~~~~---------------------------------------------------  190 (430)
                      +... ..+++||||+ +++|.+++.....                                                   
T Consensus        95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (359)
T 3vhe_A           95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS  174 (359)
T ss_dssp             ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred             eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence            8765 4599999999 8899999986542                                                   


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCC
Q 014117          191 -------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP  257 (430)
Q Consensus       191 -------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~  257 (430)
                                   ..+++..+..++.||+.||.|||++|||||||||+|||++.++                        
T Consensus       175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~------------------------  230 (359)
T 3vhe_A          175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN------------------------  230 (359)
T ss_dssp             ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG------------------------
T ss_pred             hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC------------------------
Confidence                         1289999999999999999999999999999999999996554                        


Q ss_pred             CCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHHHH
Q 014117          258 KSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAM  331 (430)
Q Consensus       258 ~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~~  331 (430)
                         .+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....
T Consensus       231 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  307 (359)
T 3vhe_A          231 ---VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  307 (359)
T ss_dssp             ---CEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred             ---cEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH
Confidence               4555555555432211     123468999999999999999999999999999999998 9999987654433322


Q ss_pred             HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCC
Q 014117          332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR  411 (430)
Q Consensus       332 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R  411 (430)
                      ........                                               ..+...+.++.+||.+||+.||.+|
T Consensus       308 ~~~~~~~~-----------------------------------------------~~~~~~~~~l~~li~~~l~~dP~~R  340 (359)
T 3vhe_A          308 RLKEGTRM-----------------------------------------------RAPDYTTPEMYQTMLDCWHGEPSQR  340 (359)
T ss_dssp             HHHHTCCC-----------------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred             HHHcCCCC-----------------------------------------------CCCCCCCHHHHHHHHHHccCChhhC
Confidence            22111110                                               1123456789999999999999999


Q ss_pred             CCHHHHhcC
Q 014117          412 LTAREALRH  420 (430)
Q Consensus       412 ~ta~elL~h  420 (430)
                      ||++|+++|
T Consensus       341 ps~~ell~~  349 (359)
T 3vhe_A          341 PTFSELVEH  349 (359)
T ss_dssp             CCHHHHHHH
T ss_pred             CCHHHHHHH
Confidence            999999976

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.9e-45  Score=344.22  Aligned_cols=247  Identities=21%  Similarity=0.298  Sum_probs=203.5

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ..++|++.+.||+|+||.||+|.++ ++..||+|+++........+..|++++.++.     |+||+++++++...+..+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS-----HPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCC-----CTTBCCEEEEECSSSSEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCC-----CCCEeeEEEEEccCCceE
Confidence            3568999999999999999999876 5677999999866555677889999999984     488999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|.+++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++                    
T Consensus        80 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~--------------------  138 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD--------------------  138 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC--------------------
T ss_pred             EEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC--------------------
Confidence            999999 889999998754 3699999999999999999999999999999999999994                    


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCch
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN  325 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~  325 (430)
                             .++.+||+|||++.......    ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus       139 -------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~  211 (268)
T 3sxs_A          139 -------RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN  211 (268)
T ss_dssp             -------TTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             -------CCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh
Confidence                   45567777777665443322    11245778999999999899999999999999999999 9999988766


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+....+.......                                                .+...+.++.+||.+||+
T Consensus       212 ~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~l~~li~~~l~  243 (268)
T 3sxs_A          212 SEVVLKVSQGHRLY------------------------------------------------RPHLASDTIYQIMYSCWH  243 (268)
T ss_dssp             HHHHHHHHTTCCCC------------------------------------------------CCTTSCHHHHHHHHHTTC
T ss_pred             HHHHHHHHcCCCCC------------------------------------------------CCCcChHHHHHHHHHHcC
Confidence            65544332211110                                                123346679999999999


Q ss_pred             cCCCCCCCHHHHhcC
Q 014117          406 YDPTDRLTAREALRH  420 (430)
Q Consensus       406 ~dP~~R~ta~elL~h  420 (430)
                      .||++|||+.|+++|
T Consensus       244 ~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          244 ELPEKRPTFQQLLSS  258 (268)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999975

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=350.20  Aligned_cols=255  Identities=24%  Similarity=0.349  Sum_probs=199.3

Q ss_pred             EEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEe
Q 014117           97 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE  175 (430)
Q Consensus        97 ~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e  175 (430)
                      .....||+|+||.||+|.+..+++.||+|++.... ...+.+..|+.+++.+     .|+||+++++++...+..++|||
T Consensus        25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-----KHKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             SSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-----CCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-----CCCCEeeEeeEEEeCCcEEEEEE
Confidence            33458999999999999999999999999987433 3446677889888887     35889999999999999999999


Q ss_pred             cC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          176 KL-GSSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       176 ~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      |+ +++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.                      
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~----------------------  157 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT----------------------  157 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET----------------------
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC----------------------
Confidence            99 889999998753 235678999999999999999999999999999999999953                      


Q ss_pred             ccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          254 KRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLG--WTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                          .++.+||+|||++......   .....||+.|+|||++.+..  ++.++|||||||++|+|++|..||........
T Consensus       158 ----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  233 (295)
T 2clq_A          158 ----YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA  233 (295)
T ss_dssp             ----TTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH
T ss_pred             ----CCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH
Confidence                2456777777777543321   23457899999999998653  88999999999999999999999975433221


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      ..........                                              ....+...+.++.+||.+||+.||
T Consensus       234 ~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~~li~~~l~~dp  267 (295)
T 2clq_A          234 AMFKVGMFKV----------------------------------------------HPEIPESMSAEAKAFILKCFEPDP  267 (295)
T ss_dssp             HHHHHHHHCC----------------------------------------------CCCCCTTSCHHHHHHHHHTTCSST
T ss_pred             HHHhhccccc----------------------------------------------cccccccCCHHHHHHHHHHccCCh
Confidence            1111100000                                              011234567789999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCCCC
Q 014117          409 TDRLTAREALRHPFFTRDHL  428 (430)
Q Consensus       409 ~~R~ta~elL~hp~f~~~~~  428 (430)
                      ++|||++|+|+||||+....
T Consensus       268 ~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          268 DKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             TTSCCHHHHHTSGGGCC---
T ss_pred             hhCCCHHHHhcChhhhhccc
Confidence            99999999999999987643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-46  Score=364.19  Aligned_cols=257  Identities=19%  Similarity=0.262  Sum_probs=208.1

Q ss_pred             ceecCcEEEEeeeccccceEEEEEE-----ECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECW-----DRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN  162 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~  162 (430)
                      +...++|++.+.||+|+||.||+|.     +..+++.||||+++..  ......+..|+.++.++     .|+||+++++
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~  141 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-----NHQNIVRCIG  141 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-----CCCCCCeEEE
Confidence            3445789999999999999999999     4557889999998643  33445677899999888     3488999999


Q ss_pred             eeecCCeEEEEEecC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccc
Q 014117          163 WFDYRNHICIVFEKL-GSSLYDFLRKNNY-----RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK  236 (430)
Q Consensus       163 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~  236 (430)
                      ++......|+||||+ +++|.+++.....     ..+++..+..++.||+.||.|||++||+||||||+|||++.+|   
T Consensus       142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---  218 (367)
T 3l9p_A          142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG---  218 (367)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS---
T ss_pred             EEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC---
Confidence            999999999999999 8899999986532     3589999999999999999999999999999999999996432   


Q ss_pred             cCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccC-----CCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHH
Q 014117          237 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER-----PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILV  311 (430)
Q Consensus       237 i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~  311 (430)
                                           ....+||+|||+++...     .......||+.|+|||++.+..++.++|||||||++|
T Consensus       219 ---------------------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~  277 (367)
T 3l9p_A          219 ---------------------PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW  277 (367)
T ss_dssp             ---------------------TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             ---------------------CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHH
Confidence                                 34468999999886321     1223356899999999999999999999999999999


Q ss_pred             HHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcC
Q 014117          312 ELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD  390 (430)
Q Consensus       312 el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  390 (430)
                      ||++ |..||...+..+....+......                                                ..+.
T Consensus       278 ellt~g~~pf~~~~~~~~~~~i~~~~~~------------------------------------------------~~~~  309 (367)
T 3l9p_A          278 EIFSLGYMPYPSKSNQEVLEFVTSGGRM------------------------------------------------DPPK  309 (367)
T ss_dssp             HHHTTSCCSSTTCCHHHHHHHHHTTCCC------------------------------------------------CCCT
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHcCCCC------------------------------------------------CCCc
Confidence            9998 99999987766655444321111                                                0123


Q ss_pred             CchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCC
Q 014117          391 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       391 ~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      ..+.++.+||.+||+.||.+|||+++|++|.++
T Consensus       310 ~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          310 NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            456789999999999999999999999998654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.8e-45  Score=346.12  Aligned_cols=255  Identities=22%  Similarity=0.267  Sum_probs=194.2

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+..|+.+++.+.++    +++..+..++...+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~----~~i~~~~~~~~~~~~~   80 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGG----VGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTS----TTCCCEEEEEEETTEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCC----CCCCeeeeecCCCCce
Confidence            34578999999999999999999999999999999876432 234577899999999654    3455556666788999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      ++||||++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+                  
T Consensus        81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~------------------  141 (296)
T 4hgt_A           81 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG------------------  141 (296)
T ss_dssp             EEEEECCCCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCG------------------
T ss_pred             EEEEEccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeecc------------------
Confidence            9999999999999998644 469999999999999999999999999999999999999311                  


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC----------CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                            +..+.+||+|||++......          .....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       142 ------~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  215 (296)
T 4hgt_A          142 ------KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW  215 (296)
T ss_dssp             ------GGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ------CCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCC
Confidence                  22345666666666533222          12457899999999999999999999999999999999999999


Q ss_pred             CCCchH---HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          321 QTHENL---EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       321 ~~~~~~---~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      .+.+..   .....+.......                                            ........++.++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~~l~  251 (296)
T 4hgt_A          216 QGLKAATKRQKYERISEKKMST--------------------------------------------PIEVLCKGYPSEFA  251 (296)
T ss_dssp             SSCCCSSSSSHHHHHHHHHHHS--------------------------------------------CHHHHTTTSCHHHH
T ss_pred             cccchhhhhhhhhhhhcccccc--------------------------------------------hhhhhhccCCHHHH
Confidence            764322   1111111110000                                            01112345678899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhc
Q 014117          398 HLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      +||.+||+.||++|||++++++
T Consensus       252 ~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          252 TYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCHHHHHH
Confidence            9999999999999999999876

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.4e-45  Score=344.26  Aligned_cols=255  Identities=23%  Similarity=0.285  Sum_probs=199.2

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+..|+.+++.+.++.    ++..+..+....+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~----~i~~~~~~~~~~~~~   80 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGV----GIPTIRWCGAEGDYN   80 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTST----TCCCEEEEEEETTEE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCC----CCCccccccCCCCce
Confidence            456789999999999999999999999999999999864332 345778999999997643    344455556778899


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      ++||||++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+                  
T Consensus        81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~------------------  141 (296)
T 3uzp_A           81 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG------------------  141 (296)
T ss_dssp             EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG------------------
T ss_pred             EEEEEecCCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecC------------------
Confidence            9999999999999998543 479999999999999999999999999999999999999421                  


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC----------CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                            +.++.+||+|||++......          .....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       142 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  215 (296)
T 3uzp_A          142 ------KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW  215 (296)
T ss_dssp             ------GGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ------CCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence                  13345667777766543322          13457999999999999999999999999999999999999999


Q ss_pred             CCCch---HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          321 QTHEN---LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       321 ~~~~~---~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      ...+.   .+....+.......|                                            ........+.++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~l~  251 (296)
T 3uzp_A          216 QGLKAATKRQKYERISEKKMSTP--------------------------------------------IEVLCKGYPSEFA  251 (296)
T ss_dssp             SSCCCSSSSSHHHHHHHHHHHSC--------------------------------------------HHHHTTTSCHHHH
T ss_pred             CCcCchhhhhhhhhhcccccCCc--------------------------------------------hHHHHhhCCHHHH
Confidence            86332   122222211110000                                            1112346678899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhc
Q 014117          398 HLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      +||.+||+.||++|||++++++
T Consensus       252 ~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          252 TYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHHHHHHhcCcCcCCCHHHHHH
Confidence            9999999999999999998875

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-46  Score=355.52  Aligned_cols=253  Identities=23%  Similarity=0.455  Sum_probs=195.5

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh-------hHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRN  162 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~  162 (430)
                      +.+.++|++.+.||+|+||.||+|.+..+++.||||++.....       .......|+.++.++.... .|+||+++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-~h~~i~~~~~  105 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG-GHPGVIRLLD  105 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSC-CCSSBCCEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccC-CCCCeeeEEE
Confidence            4567789999999999999999999999999999999864322       1223446888998885432 4588999999


Q ss_pred             eeecCCeEEEEEec-C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCC
Q 014117          163 WFDYRNHICIVFEK-L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY  240 (430)
Q Consensus       163 ~~~~~~~~~lv~e~-~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~df  240 (430)
                      ++...+..++|||+ + +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.         
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~---------  174 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL---------  174 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET---------
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC---------
Confidence            99999999999998 5 789999998764  6999999999999999999999999999999999999951         


Q ss_pred             cCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-CeeeecCcccchhhhhCCCCC-CcchHHHHHHHHHHHHhCCC
Q 014117          241 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       241 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~tG~~  318 (430)
                                       .++.+||+|||++....... ....||..|+|||++.+..+. .++|||||||++|+|++|+.
T Consensus       175 -----------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~  237 (312)
T 2iwi_A          175 -----------------RRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI  237 (312)
T ss_dssp             -----------------TTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred             -----------------CCCeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCC
Confidence                             34457777777765443322 335789999999999877764 58999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||.....      +...                       .                          ..++...+.++.+
T Consensus       238 pf~~~~~------~~~~-----------------------~--------------------------~~~~~~~~~~~~~  262 (312)
T 2iwi_A          238 PFERDQE------ILEA-----------------------E--------------------------LHFPAHVSPDCCA  262 (312)
T ss_dssp             SCCSHHH------HHHT-----------------------C--------------------------CCCCTTSCHHHHH
T ss_pred             CCCChHH------Hhhh-----------------------c--------------------------cCCcccCCHHHHH
Confidence            9975211      0000                       0                          0122355678999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          399 LLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||.+||+.||++|||++|+|+||||+..
T Consensus       263 li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          263 LIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             HHHHHccCChhhCcCHHHHhcChhhcCc
Confidence            9999999999999999999999999865

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=353.22  Aligned_cols=248  Identities=23%  Similarity=0.279  Sum_probs=200.6

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCe---EEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      ...++|++.+.||+|+||.||+|.+..+++   .||||+++..  ......+..|+.+++.+     .|+||+++++++.
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~  120 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-----DHPNIIRLEGVVT  120 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEC
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEE
Confidence            345789999999999999999999986544   5999999743  33456678899998888     3588999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                      ..+..|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++              
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--------------  185 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD--------------  185 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------
T ss_pred             eCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEC--------------
Confidence            999999999999 889999997653 4799999999999999999999999999999999999994              


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCC------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE  317 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~  317 (430)
                                   .++.+||+|||++.......      ....+|+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus       186 -------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~  252 (325)
T 3kul_A          186 -------------SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE  252 (325)
T ss_dssp             -------------TTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred             -------------CCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCC
Confidence                         44566777777665433221      11245778999999999999999999999999999999 99


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      .||......+....+......                                                ..+..++.++.
T Consensus       253 ~p~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~l~  284 (325)
T 3kul_A          253 RPYWNMTNRDVISSVEEGYRL------------------------------------------------PAPMGCPHALH  284 (325)
T ss_dssp             CTTTTSCHHHHHHHHHTTCCC------------------------------------------------CCCTTCCHHHH
T ss_pred             CCcccCCHHHHHHHHHcCCCC------------------------------------------------CCCCCcCHHHH
Confidence            999887766655444321110                                                11235677899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhc
Q 014117          398 HLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      +||.+||+.||.+|||+.++++
T Consensus       285 ~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          285 QLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHHH
Confidence            9999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.6e-45  Score=346.12  Aligned_cols=246  Identities=21%  Similarity=0.328  Sum_probs=201.3

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      .++|++++.||+|+||.||+|.+. ++..||+|+++........+..|++++..+.     |+||+++++++...+.+|+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~l   96 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-----HEKLVQLYGVCTKQRPIFI   96 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCC-----CTTBCCEEEEECSSSSEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCC-----CCCEeeEEEEEecCCCeEE
Confidence            467999999999999999999876 6778999999866555677888999999884     4889999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++                     
T Consensus        97 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~---------------------  154 (283)
T 3gen_A           97 ITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---------------------  154 (283)
T ss_dssp             EECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---------------------
T ss_pred             EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc---------------------
Confidence            99999 889999997643 3699999999999999999999999999999999999994                     


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL  326 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~  326 (430)
                            .++.+||+|||++.......    ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus       155 ------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~  228 (283)
T 3gen_A          155 ------DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS  228 (283)
T ss_dssp             ------TTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             ------CCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh
Confidence                  45567777777776433221    12346788999999999999999999999999999998 99999887766


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +....+.......                                                .+...+.++.+||.+||+.
T Consensus       229 ~~~~~~~~~~~~~------------------------------------------------~~~~~~~~l~~li~~~l~~  260 (283)
T 3gen_A          229 ETAEHIAQGLRLY------------------------------------------------RPHLASEKVYTIMYSCWHE  260 (283)
T ss_dssp             HHHHHHHTTCCCC------------------------------------------------CCTTCCHHHHHHHHHTTCS
T ss_pred             HHHHHHhcccCCC------------------------------------------------CCCcCCHHHHHHHHHHccC
Confidence            5555443321111                                                1234466799999999999


Q ss_pred             CCCCCCCHHHHhcC
Q 014117          407 DPTDRLTAREALRH  420 (430)
Q Consensus       407 dP~~R~ta~elL~h  420 (430)
                      ||.+|||++++++|
T Consensus       261 ~p~~Rps~~~ll~~  274 (283)
T 3gen_A          261 KADERPTFKILLSN  274 (283)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhHCcCHHHHHHH
Confidence            99999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.1e-45  Score=357.70  Aligned_cols=257  Identities=14%  Similarity=0.215  Sum_probs=194.1

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCC-----CeEEEEEEecCchhhHHHHHHHHHHHHHHHh----------cCCCCCce
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRER-----KEMVAIKIVRGIKKYREAAMIEIEVLQQLAK----------HDKGGNRC  157 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~----------~~~~~~~i  157 (430)
                      .++|++.+.||+|+||.||+|.++.+     ++.||||++....   .....|++++.++.+          ....|+||
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i  110 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV  110 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC---HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc---hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence            45899999999999999999998765     5789999987443   234556666665533          34467899


Q ss_pred             EEecceeecC----CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecC
Q 014117          158 VQIRNWFDYR----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE  233 (430)
Q Consensus       158 ~~~~~~~~~~----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~  233 (430)
                      +++++++...    .+.||||||++++|.+++.... ..+++..+..++.||+.||.|||++|||||||||+|||++.  
T Consensus       111 v~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~--  187 (364)
T 3op5_A          111 PKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY--  187 (364)
T ss_dssp             CCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES--
T ss_pred             CeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec--
Confidence            9999988664    5689999999999999998753 47999999999999999999999999999999999999962  


Q ss_pred             ccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC----------CCeeeecCcccchhhhhCCCCCCcchH
Q 014117          234 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDI  303 (430)
Q Consensus       234 ~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Dv  303 (430)
                                             +..+.+||+|||+++.....          ....+||+.|+|||++.+..++.++||
T Consensus       188 -----------------------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  244 (364)
T 3op5_A          188 -----------------------KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDL  244 (364)
T ss_dssp             -----------------------SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHH
T ss_pred             -----------------------CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhH
Confidence                                   13445666666666432211          123469999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCchH-HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHH
Q 014117          304 WSVGCILVELCTGEALFQTHENL-EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ  382 (430)
Q Consensus       304 wslGv~l~el~tG~~Pf~~~~~~-~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (430)
                      |||||++|||++|..||.+.... .............                                         +.
T Consensus       245 ~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~  283 (364)
T 3op5_A          245 EILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYREN-----------------------------------------IA  283 (364)
T ss_dssp             HHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHC-----------------------------------------HH
T ss_pred             HHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhh-----------------------------------------HH
Confidence            99999999999999999853322 2221111111000                                         00


Q ss_pred             HHHhhh--cCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          383 NLIMQH--VDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       383 ~~~~~~--~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      .+....  ....+.++.+||..||+.||.+|||+.++++
T Consensus       284 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          284 SLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            111111  1456788999999999999999999998874

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.8e-45  Score=352.61  Aligned_cols=256  Identities=17%  Similarity=0.236  Sum_probs=187.2

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCe---EEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      ...++|++.+.||+|+||.||+|.+..++.   .||+|+++..   ....+.+..|+++++++     .|+||+++++++
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~   94 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-----DHPHVAKLVGVS   94 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-----CCTTBCCCCEEE
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-----CCCceehhhcee
Confidence            345689999999999999999999887765   7999998643   23446677888888887     358899999998


Q ss_pred             ecCCeE------EEEEecC-CCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecC
Q 014117          165 DYRNHI------CIVFEKL-GSSLYDFLRKNNY----RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE  233 (430)
Q Consensus       165 ~~~~~~------~lv~e~~-~~~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~  233 (430)
                      ......      ++||||+ +++|.+++.....    ..+++..+..++.||+.||.|||++||+||||||+|||++.  
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~--  172 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE--  172 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcC--
Confidence            876655      9999999 8899999865321    25899999999999999999999999999999999999954  


Q ss_pred             ccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHH
Q 014117          234 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGC  308 (430)
Q Consensus       234 ~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv  308 (430)
                                               ++.+||+|||++.......     ....+|+.|+|||++.+..++.++|||||||
T Consensus       173 -------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  227 (323)
T 3qup_A          173 -------------------------DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGV  227 (323)
T ss_dssp             -------------------------TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred             -------------------------CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHH
Confidence                                     4566667777665432221     1235678899999999999999999999999


Q ss_pred             HHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhh
Q 014117          309 ILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ  387 (430)
Q Consensus       309 ~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (430)
                      ++|+|++ |..||.+.+..+....+.....                                                ..
T Consensus       228 il~ell~~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------------~~  259 (323)
T 3qup_A          228 TMWEIMTRGQTPYAGIENAEIYNYLIGGNR------------------------------------------------LK  259 (323)
T ss_dssp             HHHHHHTTSCCTTTTCCGGGHHHHHHTTCC------------------------------------------------CC
T ss_pred             HHHHHHhCCCCCccccChHHHHHHHhcCCC------------------------------------------------CC
Confidence            9999999 9999988766555443322110                                                01


Q ss_pred             hcCCchhHHHHHHHHhhhcCCCCCCC-------HHHHhcCCCCCCC
Q 014117          388 HVDHSAGDLTHLLQGLLRYDPTDRLT-------AREALRHPFFTRD  426 (430)
Q Consensus       388 ~~~~~~~~~~~ll~~~L~~dP~~R~t-------a~elL~hp~f~~~  426 (430)
                      .+...+.++.+||.+||+.||++|||       +++++.|||+...
T Consensus       260 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          260 QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            12455678999999999999999999       7899999999754

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.3e-45  Score=346.34  Aligned_cols=253  Identities=23%  Similarity=0.342  Sum_probs=204.9

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCC-------eEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERK-------EMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW  163 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~  163 (430)
                      ..++|++.+.||+|+||.||+|.++.++       ..||+|++.... ...+.+..|+.+++++.     |+||++++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~   80 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS-----HKHLVLNYGV   80 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSC-----CTTBCCEEEE
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCC-----CCCEeEEEEE
Confidence            4568999999999999999999998877       579999986433 44567788999998884     5889999999


Q ss_pred             eecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          164 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       164 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                      +...+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++..++.++  
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~--  157 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNP--  157 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBC--
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccc--
Confidence            99999999999999 789999998754 34999999999999999999999999999999999999988776555443  


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhC-CCCC
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTG-EALF  320 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG-~~Pf  320 (430)
                                       ..+||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||
T Consensus       158 -----------------~~~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~  219 (289)
T 4fvq_A          158 -----------------PFIKLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL  219 (289)
T ss_dssp             -----------------CEEEECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             -----------------ceeeeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCc
Confidence                             35899999988654332 33468999999999988 6799999999999999999995 4555


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .......... +.....                                                 ..+...+.++.+||
T Consensus       220 ~~~~~~~~~~-~~~~~~-------------------------------------------------~~~~~~~~~l~~li  249 (289)
T 4fvq_A          220 SALDSQRKLQ-FYEDRH-------------------------------------------------QLPAPKAAELANLI  249 (289)
T ss_dssp             TTSCHHHHHH-HHHTTC-------------------------------------------------CCCCCSSCTTHHHH
T ss_pred             cccchHHHHH-HhhccC-------------------------------------------------CCCCCCCHHHHHHH
Confidence            5443332221 111111                                                 11234456789999


Q ss_pred             HHhhhcCCCCCCCHHHHhcC
Q 014117          401 QGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~h  420 (430)
                      .+||+.||++|||+.|+++|
T Consensus       250 ~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          250 NNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             HHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHHH
Confidence            99999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=355.48  Aligned_cols=252  Identities=20%  Similarity=0.295  Sum_probs=203.4

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECC-------CCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEe
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRE-------RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQI  160 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~  160 (430)
                      +...++|++.+.||+|+||.||+|.+..       .+..||+|+++..  ......+..|+++++++.    .++||+++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~hpnIv~~  140 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG----KHKNIINL  140 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhc----CCchhhhh
Confidence            3445789999999999999999999754       3367999999743  233466788999999984    24789999


Q ss_pred             cceeecCCeEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCC
Q 014117          161 RNWFDYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPE  225 (430)
Q Consensus       161 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~  225 (430)
                      ++++...+.+|+||||+ +++|.+++....              ...+++..++.++.||+.||.|||++|||||||||+
T Consensus       141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  220 (382)
T 3tt0_A          141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR  220 (382)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence            99999999999999999 889999998754              135999999999999999999999999999999999


Q ss_pred             ceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCc
Q 014117          226 NVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYP  300 (430)
Q Consensus       226 NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~  300 (430)
                      |||++.                           ++.+||+|||++......     .....||+.|+|||++.+..++.+
T Consensus       221 NIll~~---------------------------~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  273 (382)
T 3tt0_A          221 NVLVTE---------------------------DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ  273 (382)
T ss_dssp             GEEECT---------------------------TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHH
T ss_pred             eEEEcC---------------------------CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCch
Confidence            999954                           445666666666543321     122357889999999999999999


Q ss_pred             chHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCch
Q 014117          301 CDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP  379 (430)
Q Consensus       301 ~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (430)
                      +|||||||++|+|++ |..||.+.+..+....+.....                                          
T Consensus       274 ~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------  311 (382)
T 3tt0_A          274 SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR------------------------------------------  311 (382)
T ss_dssp             HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC------------------------------------------
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------------------------------------
Confidence            999999999999999 9999988766554443322110                                          


Q ss_pred             hHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          380 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                            ...+..++.++.+||.+||+.||++|||+.|++++
T Consensus       312 ------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          312 ------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             ------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                  01234567789999999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1e-44  Score=342.81  Aligned_cols=251  Identities=20%  Similarity=0.237  Sum_probs=200.7

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhh--------HHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--------REAAMIEIEVLQQLAKHDKGGNRCVQIRNW  163 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~--------~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~  163 (430)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++......        .+.+..|+.+++++     .|+||++++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~   91 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-----NHPNIVKLYGL   91 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-----CCTTBCCEEEE
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-----CCCCchhhhee
Confidence            356899999999999999999999999999999998532211        15677888888887     35889999999


Q ss_pred             eecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeccCCCCceEEeecCccccCCC
Q 014117          164 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDY  240 (430)
Q Consensus       164 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlKp~NILl~~~~~~~i~df  240 (430)
                      +....  ++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++|  |+||||||+|||++.++.      
T Consensus        92 ~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~------  162 (287)
T 4f0f_A           92 MHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE------  162 (287)
T ss_dssp             ETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCT------
T ss_pred             ecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCC------
Confidence            87665  6999999 799999887654 47999999999999999999999999  999999999999964431      


Q ss_pred             cCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhh--CCCCCCcchHHHHHHHHHHHHhCCC
Q 014117          241 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL--GLGWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       241 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                      +....+||+|||++...........||+.|+|||++.  ...++.++|||||||++|+|++|..
T Consensus       163 ----------------~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  226 (287)
T 4f0f_A          163 ----------------NAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG  226 (287)
T ss_dssp             ----------------TCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSC
T ss_pred             ----------------CCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCC
Confidence                            2233489999998876655555578999999999984  4457899999999999999999999


Q ss_pred             CCCCCchHHH--HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHH
Q 014117          319 LFQTHENLEH--LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL  396 (430)
Q Consensus       319 Pf~~~~~~~~--~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (430)
                      ||...+....  ...+.. .+..                                              ...+...+.++
T Consensus       227 pf~~~~~~~~~~~~~~~~-~~~~----------------------------------------------~~~~~~~~~~l  259 (287)
T 4f0f_A          227 PFDEYSYGKIKFINMIRE-EGLR----------------------------------------------PTIPEDCPPRL  259 (287)
T ss_dssp             TTTTCCCCHHHHHHHHHH-SCCC----------------------------------------------CCCCTTSCHHH
T ss_pred             CCccccccHHHHHHHHhc-cCCC----------------------------------------------CCCCcccCHHH
Confidence            9986543322  111111 1100                                              01234567789


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhc
Q 014117          397 THLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       397 ~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      .+||.+||+.||.+|||++|+++
T Consensus       260 ~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          260 RNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.3e-45  Score=369.55  Aligned_cols=249  Identities=20%  Similarity=0.313  Sum_probs=206.0

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ....+|++.+.||+|+||.||+|.++.++..||||+++......+.+..|+.+++++.     |+||+++++++...+.+
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-----HPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCC-----CTTBCCEEEEECSSSSC
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcC-----CCCEeeEEEEEecCCcE
Confidence            3456899999999999999999999999999999999866556677889999999984     48899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      ||||||+ +++|.+++.......+++..+..++.||+.||+|||++|||||||||+|||++.++                
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~----------------  355 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH----------------  355 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG----------------
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC----------------
Confidence            9999999 89999999886666799999999999999999999999999999999999995544                


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCc
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE  324 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~  324 (430)
                                 .+||+|||+++......    ....+|..|+|||++.+..++.++|||||||++|||++ |..||.+.+
T Consensus       356 -----------~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~  424 (495)
T 1opk_A          356 -----------LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID  424 (495)
T ss_dssp             -----------CEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             -----------cEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence                       45555666554332211    11245788999999999899999999999999999999 999998766


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+....+....                                                ....+..++.++.+||.+||
T Consensus       425 ~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~l~~li~~cl  456 (495)
T 1opk_A          425 LSQVYELLEKDY------------------------------------------------RMERPEGCPEKVYELMRACW  456 (495)
T ss_dssp             GGGHHHHHHTTC------------------------------------------------CCCCCTTCCHHHHHHHHHHT
T ss_pred             HHHHHHHHHcCC------------------------------------------------CCCCCCCCCHHHHHHHHHHc
Confidence            544433322110                                                01123456778999999999


Q ss_pred             hcCCCCCCCHHHHhc
Q 014117          405 RYDPTDRLTAREALR  419 (430)
Q Consensus       405 ~~dP~~R~ta~elL~  419 (430)
                      +.||++|||+.+|++
T Consensus       457 ~~dP~~RPs~~el~~  471 (495)
T 1opk_A          457 QWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             CcChhHCcCHHHHHH
Confidence            999999999999975

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4e-45  Score=359.54  Aligned_cols=246  Identities=21%  Similarity=0.376  Sum_probs=199.5

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .++|++.+.||+|+||.||+|.++.+++.||||+++..  ......+..|+++++++     .|+||+++++++...+.+
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~  187 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-----SHPNIVRLIGVCTQKQPI  187 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-----CCTTBCCEEEEECSSSSC
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEecCCCc
Confidence            46899999999999999999999999999999998743  22334567899988887     358899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||+ +++|.+++...+ ..+++..+..++.||+.||+|||++||+||||||+|||++.+                 
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~-----------------  249 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK-----------------  249 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-----------------
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCC-----------------
Confidence            9999999 899999998654 369999999999999999999999999999999999999544                 


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH  323 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~  323 (430)
                                +.+||+|||++.......     ....+|..|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus       250 ----------~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~  319 (377)
T 3cbl_A          250 ----------NVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL  319 (377)
T ss_dssp             ----------CCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred             ----------CcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                      455666666554322211     12246788999999998899999999999999999998 99999887


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +..+....+... ..+                                               ..+..++.++.+||.+|
T Consensus       320 ~~~~~~~~~~~~-~~~-----------------------------------------------~~~~~~~~~l~~li~~c  351 (377)
T 3cbl_A          320 SNQQTREFVEKG-GRL-----------------------------------------------PCPELCPDAVFRLMEQC  351 (377)
T ss_dssp             CHHHHHHHHHTT-CCC-----------------------------------------------CCCTTCCHHHHHHHHHH
T ss_pred             CHHHHHHHHHcC-CCC-----------------------------------------------CCCCCCCHHHHHHHHHH
Confidence            665544332211 000                                               12234567899999999


Q ss_pred             hhcCCCCCCCHHHHhc
Q 014117          404 LRYDPTDRLTAREALR  419 (430)
Q Consensus       404 L~~dP~~R~ta~elL~  419 (430)
                      |+.||++|||++++++
T Consensus       352 l~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          352 WAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             TCSSGGGSCCHHHHHH
T ss_pred             cCCCchhCcCHHHHHH
Confidence            9999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.6e-44  Score=365.14  Aligned_cols=258  Identities=20%  Similarity=0.291  Sum_probs=201.2

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .+.++|++.++||+|+||.||+|.+..+++.||||++..... ...+..|+++++.+.++    +++..+..++...+..
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~----~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGG----TGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTS----TTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCC----CCCCeEEEEEeeCCEE
Confidence            466789999999999999999999999999999998864332 34577899999998654    3455566667788999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +|||||++++|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+||||+..                  
T Consensus        79 ~lvme~~g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~------------------  139 (483)
T 3sv0_A           79 VLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG------------------  139 (483)
T ss_dssp             EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG------------------
T ss_pred             EEEEECCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecC------------------
Confidence            9999999999999998644 479999999999999999999999999999999999999421                  


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC----------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                            +..+.+||+|||+++......          ...+||+.|+|||++.+..++.++|||||||+||||++|..||
T Consensus       140 ------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf  213 (483)
T 3sv0_A          140 ------RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW  213 (483)
T ss_dssp             ------GGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ------CCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence                  234566777777665433221          2457999999999999999999999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .+.........+.....                                         .............++.++.+||
T Consensus       214 ~~~~~~~~~~~~~~i~~-----------------------------------------~~~~~~~~~l~~~~p~~l~~li  252 (483)
T 3sv0_A          214 QGLKAGTKKQKYEKISE-----------------------------------------KKVATSIEALCRGYPTEFASYF  252 (483)
T ss_dssp             SSCCCSSHHHHHHHHHH-----------------------------------------HHHHSCHHHHHTTSCHHHHHHH
T ss_pred             ccccchhHHHHHHHHhh-----------------------------------------ccccccHHHHhcCCcHHHHHHH
Confidence            87543222211111100                                         0001111223356678899999


Q ss_pred             HHhhhcCCCCCCCHHHHhc
Q 014117          401 QGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~  419 (430)
                      ..||+.||++||++++|++
T Consensus       253 ~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          253 HYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhcCChhhCcCHHHHHH
Confidence            9999999999999987764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.5e-44  Score=361.90  Aligned_cols=244  Identities=23%  Similarity=0.314  Sum_probs=199.1

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC-CeEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-NHIC  171 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~-~~~~  171 (430)
                      .++|++.+.||+|+||.||+|.+.  ++.||||+++... ..+.+..|+.+++++.     |+||+++++++... +.+|
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~~  263 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLR-----HSNLVQLLGVIVEEKGGLY  263 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCC-----CTTBCCEEEEEECTTSCEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhcc-----CCCEEEEEEEEEcCCCceE
Confidence            468999999999999999999875  6789999997543 4567889999999884     48899999987654 4899


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      |||||+ +++|.+++...+...+++..+..++.||+.||+|||++|||||||||+|||++                    
T Consensus       264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~--------------------  323 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS--------------------  323 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC--------------------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC--------------------
Confidence            999999 88999999987655689999999999999999999999999999999999994                    


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHL  329 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~  329 (430)
                             .++.+||+|||+++..........+|..|+|||++.+..++.++|||||||++|||++ |..||...+..+..
T Consensus       324 -------~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~  396 (450)
T 1k9a_A          324 -------EDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV  396 (450)
T ss_dssp             -------TTSCEEECCCTTCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH
T ss_pred             -------CCCCEEEeeCCCcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence                   4556777777777654433333467889999999999999999999999999999998 99999876554444


Q ss_pred             HHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCC
Q 014117          330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT  409 (430)
Q Consensus       330 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~  409 (430)
                      ..+....                                                ....+..++.++.+||.+||+.||.
T Consensus       397 ~~i~~~~------------------------------------------------~~~~p~~~~~~l~~li~~cl~~dp~  428 (450)
T 1k9a_A          397 PRVEKGY------------------------------------------------KMDAPDGCPPAVYDVMKNCWHLDAA  428 (450)
T ss_dssp             HHHHTTC------------------------------------------------CCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHcCC------------------------------------------------CCCCCCcCCHHHHHHHHHHcCCChh
Confidence            3332110                                                0112345678899999999999999


Q ss_pred             CCCCHHHHhc
Q 014117          410 DRLTAREALR  419 (430)
Q Consensus       410 ~R~ta~elL~  419 (430)
                      +|||+.++++
T Consensus       429 ~Rpt~~~l~~  438 (450)
T 1k9a_A          429 TRPTFLQLRE  438 (450)
T ss_dssp             GSCCHHHHHH
T ss_pred             HCcCHHHHHH
Confidence            9999999874

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.9e-44  Score=337.87  Aligned_cols=252  Identities=23%  Similarity=0.318  Sum_probs=193.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .++|++.+.||+|+||.||+|.+.  ++.||+|+++...     ...+.+..|+++++.+.     |+||+++++++...
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-----HPNIIALRGVCLKE   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCC-----CTTBCCEEEEECCC
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-----CCCEeeEEEEEecC
Confidence            467999999999999999999874  7889999986432     22356778899888884     48899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeeccCCCCceEEeecCccccCCCcCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC---MIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                      +..|+||||+ +++|.+++..   ..+++..+..++.||+.||.|||++|   |+||||||+|||++..+..        
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~--------  147 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN--------  147 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS--------
T ss_pred             CceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc--------
Confidence            9999999999 8899999854   37999999999999999999999999   9999999999999642100        


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                 .....+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus       148 -----------~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  216 (271)
T 3dtc_A          148 -----------GDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG  216 (271)
T ss_dssp             -----------SCCSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred             -----------ccccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                       00135679999999887543332 345789999999999999999999999999999999999999987


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      .+.......+......                                               ...+...+.++.+||.+
T Consensus       217 ~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~li~~  249 (271)
T 3dtc_A          217 IDGLAVAYGVAMNKLA-----------------------------------------------LPIPSTCPEPFAKLMED  249 (271)
T ss_dssp             SCHHHHHHHHHTSCCC-----------------------------------------------CCCCTTCCHHHHHHHHH
T ss_pred             CCHHHHHHhhhcCCCC-----------------------------------------------CCCCcccCHHHHHHHHH
Confidence            6655443322211000                                               01234556789999999


Q ss_pred             hhhcCCCCCCCHHHHhcC
Q 014117          403 LLRYDPTDRLTAREALRH  420 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~h  420 (430)
                      ||+.||++|||+.|+++|
T Consensus       250 ~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          250 CWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCcccCcCHHHHHHH
Confidence            999999999999999874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.3e-44  Score=343.98  Aligned_cols=254  Identities=24%  Similarity=0.386  Sum_probs=182.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhh--HHHHHHHHH-HHHHHHhcCCCCCceEEecceeecCCe
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--REAAMIEIE-VLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~--~~~~~~E~~-~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      .++|++.+.||+|+||.||+|.++.+++.||||++......  ......|.. +++.+     .|+||+++++++...+.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-----~h~~i~~~~~~~~~~~~   98 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-----DCPYIVQCFGTFITNTD   98 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-----TCTTBCCEEEEEECSSE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-----CCCceeeEEEEEecCCc
Confidence            46799999999999999999999999999999999743221  222223332 23322     45889999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|+||||+++.+..++.... ..+++..+..++.||+.||.|||++ ||+||||||+|||++                  
T Consensus        99 ~~lv~e~~~~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~------------------  159 (318)
T 2dyl_A           99 VFIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD------------------  159 (318)
T ss_dssp             EEEEECCCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEEC------------------
T ss_pred             EEEEEeccCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEEC------------------
Confidence            99999999777766665432 4799999999999999999999995 999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhh-----CCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                               .++.+||+|||++......  .....||+.|+|||++.     +..++.++|||||||++|+|++|..||.
T Consensus       160 ---------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  230 (318)
T 2dyl_A          160 ---------ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK  230 (318)
T ss_dssp             ---------TTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ---------CCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCC
Confidence                     4456777777766543222  22347899999999994     4568999999999999999999999998


Q ss_pred             CCc-hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          322 THE-NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       322 ~~~-~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      ... ..+....+.....+                      ..+                        .....+.++.+||
T Consensus       231 ~~~~~~~~~~~~~~~~~~----------------------~~~------------------------~~~~~~~~l~~li  264 (318)
T 2dyl_A          231 NCKTDFEVLTKVLQEEPP----------------------LLP------------------------GHMGFSGDFQSFV  264 (318)
T ss_dssp             TCCSHHHHHHHHHHSCCC----------------------CCC------------------------SSSCCCHHHHHHH
T ss_pred             CCCccHHHHHHHhccCCC----------------------CCC------------------------ccCCCCHHHHHHH
Confidence            643 33333332221100                      000                        0124567899999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          401 QGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      .+||+.||.+|||++|+|+||||++
T Consensus       265 ~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          265 KDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             HHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             HHHccCChhHCcCHHHHhhCHHHHh
Confidence            9999999999999999999999964

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-44  Score=350.33  Aligned_cols=251  Identities=21%  Similarity=0.304  Sum_probs=202.4

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEEC-----CCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN  162 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~  162 (430)
                      +...++|++.+.||+|+||.||+|.+.     .+++.||+|+++..  ......+..|+.+++++     .|+||+++++
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~  117 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-----DNPNIVKLLG  117 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEE
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-----CCCCEEEEEE
Confidence            344678999999999999999999987     45589999999743  23445678899999888     3488999999


Q ss_pred             eeecCCeEEEEEecC-CCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeee
Q 014117          163 WFDYRNHICIVFEKL-GSSLYDFLRKNN----------------------YRSFPIDLVREIARQLLECIAFMHDLCMIH  219 (430)
Q Consensus       163 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH  219 (430)
                      ++...+.+|+||||+ +++|.+++....                      ...+++..++.++.||+.||.|||++||+|
T Consensus       118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH  197 (343)
T 1luf_A          118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH  197 (343)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            999999999999999 889999998742                      146999999999999999999999999999


Q ss_pred             ccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCC-----CCCeeeecCcccchhhhhC
Q 014117          220 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-----DQNYIVSTRHYRAPEVILG  294 (430)
Q Consensus       220 rDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~  294 (430)
                      |||||+|||++.                           ++.+||+|||++.....     ......||+.|+|||++.+
T Consensus       198 ~Dlkp~NIl~~~---------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  250 (343)
T 1luf_A          198 RDLATRNCLVGE---------------------------NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY  250 (343)
T ss_dssp             SCCSGGGEEECG---------------------------GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred             CCCCcceEEECC---------------------------CCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc
Confidence            999999999954                           44567777776653221     1123467899999999999


Q ss_pred             CCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHH
Q 014117          295 LGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIK  373 (430)
Q Consensus       295 ~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (430)
                      ..++.++|||||||++|+|++ |..||.+.+..+....+....  .                                  
T Consensus       251 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--~----------------------------------  294 (343)
T 1luf_A          251 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN--I----------------------------------  294 (343)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--C----------------------------------
T ss_pred             CCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCC--c----------------------------------
Confidence            999999999999999999999 999998876655444332210  0                                  


Q ss_pred             hhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          374 SVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                                  ...+...+.++.+||.+||+.||++|||+.+++++
T Consensus       295 ------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          295 ------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             ------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence                        01223556789999999999999999999999863

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.1e-45  Score=352.57  Aligned_cols=263  Identities=21%  Similarity=0.207  Sum_probs=190.9

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC----Ce
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR----NH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~----~~  169 (430)
                      ++|++.+.||+|+||+||+|.+.  ++.||||+++...........|+.++.++     .|+||+++++++...    ..
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-----KHENILQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTC-----CCTTBCCEEEEEEEECSSSEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcC-----CCCCchhhcceeccCCCCCce
Confidence            57999999999999999999875  78999999976555555555677767666     458899999998764    35


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CeeeccCCCCceEEeecCccccC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL----------CMIHTDLKPENVLLVSSEYIKVP  238 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----------~ivHrDlKp~NILl~~~~~~~i~  238 (430)
                      +|+||||+ +++|.+++...   .+++..+..++.||+.||.|||+.          ||+||||||+|||++        
T Consensus        97 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~--------  165 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK--------  165 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC--------
T ss_pred             EEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC--------
Confidence            89999999 88999999874   599999999999999999999999          999999999999994        


Q ss_pred             CCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCC-----CCCCcchHHHHHH
Q 014117          239 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGC  308 (430)
Q Consensus       239 dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGv  308 (430)
                                         .++.+||+|||++......     ....+||+.|+|||++.+.     .++.++|||||||
T Consensus       166 -------------------~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~  226 (322)
T 3soc_A          166 -------------------NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGL  226 (322)
T ss_dssp             -------------------TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHH
T ss_pred             -------------------CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHH
Confidence                               4456777777776543221     1225789999999999873     4567889999999


Q ss_pred             HHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhh
Q 014117          309 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH  388 (430)
Q Consensus       309 ~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (430)
                      ++|||++|+.||.+..+.............+......      .............     ..               ..
T Consensus       227 il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~-----~~---------------~~  280 (322)
T 3soc_A          227 VLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQ------EVVVHKKKRPVLR-----DY---------------WQ  280 (322)
T ss_dssp             HHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHH------HHHTTSCCCCCCC-----GG---------------GG
T ss_pred             HHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhh------hhhhcccCCCCcc-----cc---------------cc
Confidence            9999999999998654322111111111111111000      0000000000000     00               00


Q ss_pred             cCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       389 ~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      ....+.++.+||.+||+.||++|||+.|+++
T Consensus       281 ~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          281 KHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            1123456999999999999999999999986

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-44  Score=349.41  Aligned_cols=251  Identities=20%  Similarity=0.285  Sum_probs=197.8

Q ss_pred             ecCcEEEEeeeccccceEEEEEEE-----CCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      ..++|++.+.||+|+||.||+|.+     ..+++.||+|+++..  ......+..|+.++.++.    .|+||+++++++
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~~~~  118 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG----SHENIVNLLGAC  118 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC----CCTTBCCEEEEE
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhc----CCCCeeeEEEEE
Confidence            356899999999999999999997     346678999998743  233466788999999983    247899999999


Q ss_pred             ecCCeEEEEEecC-CCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccC
Q 014117          165 DYRNHICIVFEKL-GSSLYDFLRKNNY---------------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDL  222 (430)
Q Consensus       165 ~~~~~~~lv~e~~-~~~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDl  222 (430)
                      ...+.+|+||||+ +++|.+++.....                     ..+++..+..++.||+.||.|||++||+||||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di  198 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  198 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            9999999999999 8899999986542                     23899999999999999999999999999999


Q ss_pred             CCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCC
Q 014117          223 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGW  297 (430)
Q Consensus       223 Kp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~  297 (430)
                      ||+|||++.++                           .+||+|||++.......     ....||+.|+|||++.+..+
T Consensus       199 kp~NIll~~~~---------------------------~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  251 (344)
T 1rjb_A          199 AARNVLVTHGK---------------------------VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY  251 (344)
T ss_dssp             SGGGEEEETTT---------------------------EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred             ChhhEEEcCCC---------------------------cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC
Confidence            99999996544                           45555555554332221     22467889999999999999


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhc
Q 014117          298 TYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM  376 (430)
Q Consensus       298 ~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (430)
                      +.++|||||||++|+|++ |..||.+.........+......                                      
T Consensus       252 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------------------------------------  293 (344)
T 1rjb_A          252 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK--------------------------------------  293 (344)
T ss_dssp             CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCC--------------------------------------
T ss_pred             ChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCC--------------------------------------
Confidence            999999999999999998 99999876544333222211000                                      


Q ss_pred             CchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          377 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                               ...+...+.++.+||.+||+.||.+|||+.++++|
T Consensus       294 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          294 ---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence                     01123456789999999999999999999999876

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.4e-44  Score=345.92  Aligned_cols=249  Identities=19%  Similarity=0.313  Sum_probs=199.6

Q ss_pred             ecCcEEEEeeeccccceEEEEEEEC-----CCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      ..++|++.+.||+|+||.||+|.+.     .+++.||+|+++..  ......+..|+++++.+     .|+||+++++++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~   95 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-----NHPHVIKLYGAC   95 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEE
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-----CCCceeeEEEEE
Confidence            3568999999999999999999883     45689999999743  23345677888888887     358899999999


Q ss_pred             ecCCeEEEEEecC-CCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecc
Q 014117          165 DYRNHICIVFEKL-GSSLYDFLRKNNY----------------------RSFPIDLVREIARQLLECIAFMHDLCMIHTD  221 (430)
Q Consensus       165 ~~~~~~~lv~e~~-~~~L~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrD  221 (430)
                      ...+..|+||||+ +++|.+++.....                      ..+++..+..++.||+.||.|||++||+|||
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d  175 (314)
T 2ivs_A           96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD  175 (314)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence            9999999999999 8999999987542                      2489999999999999999999999999999


Q ss_pred             CCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCC
Q 014117          222 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLG  296 (430)
Q Consensus       222 lKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~  296 (430)
                      |||+|||++.++                           .+||+|||++.......     ....+|+.|+|||++.+..
T Consensus       176 ikp~NIli~~~~---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  228 (314)
T 2ivs_A          176 LAARNILVAEGR---------------------------KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI  228 (314)
T ss_dssp             CSGGGEEEETTT---------------------------EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE
T ss_pred             cchheEEEcCCC---------------------------CEEEccccccccccccccceeccCCCCcccccChhhhcCCC
Confidence            999999996544                           45666666554332221     2235688899999999989


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhh
Q 014117          297 WTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV  375 (430)
Q Consensus       297 ~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (430)
                      ++.++|||||||++|+|++ |..||.+....+....+.....                                      
T Consensus       229 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--------------------------------------  270 (314)
T 2ivs_A          229 YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR--------------------------------------  270 (314)
T ss_dssp             ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--------------------------------------
T ss_pred             cCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCc--------------------------------------
Confidence            9999999999999999999 9999987665443332221100                                      


Q ss_pred             cCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          376 MKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                                ...+...+.++.+||.+||+.||++|||++|++++
T Consensus       271 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          271 ----------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                      01234567789999999999999999999999874

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=366.79  Aligned_cols=256  Identities=21%  Similarity=0.281  Sum_probs=193.0

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      .+|.+.+.||+|+||+||. ....+++.||||++....  ......|+.+++.+.    .|+||+++++++.+...+|||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~----~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC--FSFADREVQLLRESD----EHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT--EEECHHHHHHHHHSC----CCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhcc----CCCCcCeEEEEEecCCEEEEE
Confidence            3699999999999999764 345678899999986432  123456888888873    358899999999999999999


Q ss_pred             EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          174 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       174 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      |||++++|.+++.... ..+++..+..++.||+.||.|||++|||||||||+|||++.++.                   
T Consensus        97 ~E~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~-------------------  156 (432)
T 3p23_A           97 IELCAATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNA-------------------  156 (432)
T ss_dssp             EECCSEEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBT-------------------
T ss_pred             EECCCCCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCC-------------------
Confidence            9999889999998764 34556667889999999999999999999999999999954321                   


Q ss_pred             ccCCCCCCeEEEeCCCccccCCC------CCeeeecCcccchhhhh---CCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 014117          254 KRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCT-GEALFQTH  323 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~  323 (430)
                         +....+||+|||++......      ....+||+.|+|||++.   ...++.++|||||||++|||++ |..||...
T Consensus       157 ---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~  233 (432)
T 3p23_A          157 ---HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS  233 (432)
T ss_dssp             ---TTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred             ---CCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence               23446788999988654422      23357999999999998   4567889999999999999999 99999654


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      .......    ..+...                   .....                       .....+..+.+||.+|
T Consensus       234 ~~~~~~~----~~~~~~-------------------~~~~~-----------------------~~~~~~~~~~~li~~~  267 (432)
T 3p23_A          234 LQRQANI----LLGACS-------------------LDCLH-----------------------PEKHEDVIARELIEKM  267 (432)
T ss_dssp             TTHHHHH----HTTCCC-------------------CTTSC-----------------------TTCHHHHHHHHHHHHH
T ss_pred             hHHHHHH----HhccCC-------------------ccccC-----------------------ccccccHHHHHHHHHH
Confidence            3322111    111100                   00000                       0012244588999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      |+.||.+|||++|||+||||..
T Consensus       268 L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          268 IAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             SCSSGGGSCCHHHHHTSTTTCC
T ss_pred             HhCCHhhCCCHHHHHhCccccC
Confidence            9999999999999999999975

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.6e-44  Score=342.94  Aligned_cols=251  Identities=23%  Similarity=0.339  Sum_probs=199.7

Q ss_pred             ecCcEEEEeeeccccceEEEEEEE-----CCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      ..++|++.+.||+|+||.||+|.+     ..+++.||+|+++...  ...+.+..|+.++.++.    .|+||+++++++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~i~~~~~~~   96 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG----NHMNIVNLLGAC   96 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEEE
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcc----cCCCeeeEEEEE
Confidence            346899999999999999999985     4577899999997432  34466788999999983    347899999999


Q ss_pred             ecCCeEEEEEecC-CCCHHHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCce
Q 014117          165 DYRNHICIVFEKL-GSSLYDFLRKNNY----------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENV  227 (430)
Q Consensus       165 ~~~~~~~lv~e~~-~~~L~~~l~~~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NI  227 (430)
                      ...+..++||||+ +++|.+++.....                ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  176 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI  176 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence            9999999999999 7899999987542                2489999999999999999999999999999999999


Q ss_pred             EEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcch
Q 014117          228 LLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCD  302 (430)
Q Consensus       228 Ll~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~D  302 (430)
                      |++.++.                           +||+|||++.......     ....||+.|+|||++.+..++.++|
T Consensus       177 l~~~~~~---------------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  229 (313)
T 1t46_A          177 LLTHGRI---------------------------TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD  229 (313)
T ss_dssp             EEETTTE---------------------------EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHH
T ss_pred             EEcCCCC---------------------------EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHH
Confidence            9965554                           4555555444332221     1235788999999999999999999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhH
Q 014117          303 IWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL  381 (430)
Q Consensus       303 vwslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (430)
                      ||||||++|+|++ |..||.+.........+.......                                          
T Consensus       230 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------------------  267 (313)
T 1t46_A          230 VWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM------------------------------------------  267 (313)
T ss_dssp             HHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC------------------------------------------
T ss_pred             HHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCC------------------------------------------
Confidence            9999999999999 999998765443332222111000                                          


Q ss_pred             HHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       382 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                           ..+...+.++.+||.+||+.||.+|||++|++++
T Consensus       268 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          268 -----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence                 0123456789999999999999999999999864

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.5e-44  Score=336.23  Aligned_cols=246  Identities=25%  Similarity=0.373  Sum_probs=202.1

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.......+.+..|+++++.+.     |+||+++++++...+..|+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-----HPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCC-----CTTBCCEEEEECSSSSCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCC-----CCCEeeEEEEEccCCCeEE
Confidence            357999999999999999999986 6678999999866555677888999998883     5889999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.                    
T Consensus        81 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~--------------------  139 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE--------------------  139 (267)
T ss_dssp             EECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECG--------------------
T ss_pred             EEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECC--------------------
Confidence            99999 889999998754 46899999999999999999999999999999999999954                    


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCC----CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL  326 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~  326 (430)
                             ++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus       140 -------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~  212 (267)
T 3t9t_A          140 -------NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS  212 (267)
T ss_dssp             -------GGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             -------CCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH
Confidence                   445677777766543221    122356788999999999999999999999999999999 89999887665


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +....+......                                                ..+...+.++.+||.+||+.
T Consensus       213 ~~~~~i~~~~~~------------------------------------------------~~~~~~~~~l~~li~~~l~~  244 (267)
T 3t9t_A          213 EVVEDISTGFRL------------------------------------------------YKPRLASTHVYQIMNHCWRE  244 (267)
T ss_dssp             HHHHHHHTTCCC------------------------------------------------CCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHhcCCcC------------------------------------------------CCCccCcHHHHHHHHHHccC
Confidence            544433221100                                                01234566799999999999


Q ss_pred             CCCCCCCHHHHhcC
Q 014117          407 DPTDRLTAREALRH  420 (430)
Q Consensus       407 dP~~R~ta~elL~h  420 (430)
                      ||++|||+.+++++
T Consensus       245 ~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          245 RPEDRPAFSRLLRQ  258 (267)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=352.26  Aligned_cols=255  Identities=16%  Similarity=0.232  Sum_probs=188.5

Q ss_pred             cCcEEEEeeeccccceEEEEEEECC---CCeEEEEEEecCchhhH------------HHHHHHHHHHHHHHhcCCCCCce
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRE---RKEMVAIKIVRGIKKYR------------EAAMIEIEVLQQLAKHDKGGNRC  157 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vAiK~~~~~~~~~------------~~~~~E~~~l~~l~~~~~~~~~i  157 (430)
                      .++|++.+.||+|+||.||+|.+..   ++..||+|++.......            ..+..|+..+..+     .++||
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-----~h~ni  110 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-----DYLGI  110 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-----SCCCC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-----cccCc
Confidence            4689999999999999999999987   78899999987442210            1122333333333     56889


Q ss_pred             EEecceeec----CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecC
Q 014117          158 VQIRNWFDY----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE  233 (430)
Q Consensus       158 ~~~~~~~~~----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~  233 (430)
                      +++++++..    ....|+||||++++|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus       111 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          111 PLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             CCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS
T ss_pred             ceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC
Confidence            999998877    78999999999889999998765  799999999999999999999999999999999999996543


Q ss_pred             ccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC----------CCeeeecCcccchhhhhCCCCCCcchH
Q 014117          234 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDI  303 (430)
Q Consensus       234 ~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Dv  303 (430)
                                               ...+||+|||+++.....          .....||+.|+|||++.+..++.++||
T Consensus       189 -------------------------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  243 (345)
T 2v62_A          189 -------------------------PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDV  243 (345)
T ss_dssp             -------------------------TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHH
T ss_pred             -------------------------CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhH
Confidence                                     226777777776533211          133578999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCC--chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhH
Q 014117          304 WSVGCILVELCTGEALFQTH--ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL  381 (430)
Q Consensus       304 wslGv~l~el~tG~~Pf~~~--~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (430)
                      |||||++|||++|..||...  ...............+|..+...                                   
T Consensus       244 ~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------------  288 (345)
T 2v62_A          244 EILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKW-----------------------------------  288 (345)
T ss_dssp             HHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHH-----------------------------------
T ss_pred             HHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhh-----------------------------------
Confidence            99999999999999999642  22222222223333333221110                                   


Q ss_pred             HHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       382 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                           .-....+.++.+||.+||+.||++|||++++++
T Consensus       289 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          289 -----APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             -----SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             -----ccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                 001256778999999999999999999998875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.9e-44  Score=340.10  Aligned_cols=248  Identities=24%  Similarity=0.303  Sum_probs=191.1

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCC---CeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      ...++|++.+.||+|+||.||+|.+..+   +..||+|+++..  ....+.+..|+.+++.+     .|+||+++++++.
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~   86 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-----DHPHIVKLIGVIT   86 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEC
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCccceEEEEEc
Confidence            4457899999999999999999998654   567999998643  23445677888888887     3588999999875


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                       .+..|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+         
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~---------  155 (281)
T 1mp8_A           87 -ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV---------  155 (281)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE---------
T ss_pred             -cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCE---------
Confidence             56789999999 779999998653 469999999999999999999999999999999999999765554         


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL  319 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~P  319 (430)
                                        ||+|||++.......    ....+|+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus       156 ------------------kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p  217 (281)
T 1mp8_A          156 ------------------KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP  217 (281)
T ss_dssp             ------------------EECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ------------------EECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCC
Confidence                              555555444322211    12356789999999999999999999999999999996 9999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |.+.+..+....+.....                                                ...+...+.++.+|
T Consensus       218 f~~~~~~~~~~~i~~~~~------------------------------------------------~~~~~~~~~~l~~l  249 (281)
T 1mp8_A          218 FQGVKNNDVIGRIENGER------------------------------------------------LPMPPNCPPTLYSL  249 (281)
T ss_dssp             TTTCCGGGHHHHHHTTCC------------------------------------------------CCCCTTCCHHHHHH
T ss_pred             CCcCCHHHHHHHHHcCCC------------------------------------------------CCCCCCCCHHHHHH
Confidence            987666554433321100                                                01234567789999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcC
Q 014117          400 LQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~h  420 (430)
                      |.+||+.||++|||+.|++++
T Consensus       250 i~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          250 MTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999863

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.7e-44  Score=348.18  Aligned_cols=246  Identities=20%  Similarity=0.272  Sum_probs=190.8

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEE----EEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMV----AIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----AiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      .++|++.+.||+|+||+||+|.+..+++.+    |+|.++..  ......+..|+.++.++.     |+||+++++++..
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~   88 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-----NPHVCRLLGICLT   88 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCC-----BTTBCCEEEEEES
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-----CCCEeEEEEEEec
Confidence            467999999999999999999998877654    77776532  234466788999999984     4889999999887


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      .. .++|+|++ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++            
T Consensus        89 ~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~------------  154 (327)
T 3poz_A           89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ------------  154 (327)
T ss_dssp             SS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT------------
T ss_pred             CC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC------------
Confidence            55 77888888 899999998754 4799999999999999999999999999999999999996554            


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL  319 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~P  319 (430)
                                     .+||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus       155 ---------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p  219 (327)
T 3poz_A          155 ---------------HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP  219 (327)
T ss_dssp             ---------------EEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ---------------CEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCC
Confidence                           45666666654332221     12356889999999999999999999999999999999 9999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |.+.+..+....+.....                                                ...+...+.++.+|
T Consensus       220 ~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~l  251 (327)
T 3poz_A          220 YDGIPASEISSILEKGER------------------------------------------------LPQPPICTIDVYMI  251 (327)
T ss_dssp             TTTCCGGGHHHHHHTTCC------------------------------------------------CCCCTTBCHHHHHH
T ss_pred             ccCCCHHHHHHHHHcCCC------------------------------------------------CCCCccCCHHHHHH
Confidence            987665544333221110                                                01123456789999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcC
Q 014117          400 LQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~h  420 (430)
                      +.+||+.||.+|||+.|++++
T Consensus       252 i~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          252 MVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999865

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.5e-44  Score=361.33  Aligned_cols=248  Identities=25%  Similarity=0.366  Sum_probs=203.2

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      +...++|++.+.||+|+||.||+|.+. ++..||||+++......+.+..|+.+++++.     |+||+++++++. .+.
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~l~~~~~-~~~  256 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-----HDKLVKLHAVVT-KEP  256 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCC-----CTTBCCEEEEEC-SSS
T ss_pred             eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCC-----CCCEeeEEEEEe-CCc
Confidence            344678999999999999999999886 4677999999865556678889999998883     488999999886 667


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +||||||+ +++|.+++.......+++..+..++.||+.||.|||++|||||||||+|||++                  
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~------------------  318 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS------------------  318 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC------------------
T ss_pred             cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC------------------
Confidence            89999999 88999999865434689999999999999999999999999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC----CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH  323 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~  323 (430)
                               .++.+||+|||+++.....    .....+|..|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus       319 ---------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~  389 (454)
T 1qcf_A          319 ---------ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM  389 (454)
T ss_dssp             ---------TTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ---------CCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence                     4556777777777643321    122346788999999999999999999999999999999 99999987


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +..+....+......                                                ..+..++.++.+||.+|
T Consensus       390 ~~~~~~~~i~~~~~~------------------------------------------------~~~~~~~~~l~~li~~c  421 (454)
T 1qcf_A          390 SNPEVIRALERGYRM------------------------------------------------PRPENCPEELYNIMMRC  421 (454)
T ss_dssp             CHHHHHHHHHHTCCC------------------------------------------------CCCTTSCHHHHHHHHHH
T ss_pred             CHHHHHHHHHcCCCC------------------------------------------------CCCCCCCHHHHHHHHHH
Confidence            776655544322110                                                11235677899999999


Q ss_pred             hhcCCCCCCCHHHHhc
Q 014117          404 LRYDPTDRLTAREALR  419 (430)
Q Consensus       404 L~~dP~~R~ta~elL~  419 (430)
                      |+.||++|||+++|+.
T Consensus       422 l~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          422 WKNRPEERPTFEYIQS  437 (454)
T ss_dssp             TCSSGGGSCCHHHHHH
T ss_pred             ccCChhHCcCHHHHHH
Confidence            9999999999998874

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.5e-44  Score=361.89  Aligned_cols=271  Identities=24%  Similarity=0.308  Sum_probs=197.8

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      +.+.+.|.+.+.||+|+||+||.+ ...+++.||||++...  ..+....|+.++.++.    .|+||+++++++...+.
T Consensus        11 ~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~----~HpnIv~~~~~~~~~~~   83 (434)
T 2rio_A           11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID--FCDIALMEIKLLTESD----DHPNVIRYYCSETTDRF   83 (434)
T ss_dssp             CSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHT----TSTTBCCEEEEEECSSE
T ss_pred             hhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH--HHHHHHHHHHHHHhcc----CCCCcCeEEEEEecCCe
Confidence            445567888899999999999875 4567899999998643  3345678999988774    34889999999999999


Q ss_pred             EEEEEecCCCCHHHHHHhcCCCC-----CCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          170 ICIVFEKLGSSLYDFLRKNNYRS-----FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       170 ~~lv~e~~~~~L~~~l~~~~~~~-----l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                      +||||||++++|.+++.......     .++..+..++.||+.||+|||++|||||||||+|||++.++.......    
T Consensus        84 ~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~----  159 (434)
T 2rio_A           84 LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ----  159 (434)
T ss_dssp             EEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCT----
T ss_pred             EEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccc----
Confidence            99999999889999998654211     123345789999999999999999999999999999976543211100    


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCC-------CeeeecCcccchhhhhC-------CCCCCcchHHHHHHHH
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILG-------LGWTYPCDIWSVGCIL  310 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGv~l  310 (430)
                                ..+....+||+|||++.......       ...+||+.|+|||++.+       ..++.++|||||||++
T Consensus       160 ----------~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il  229 (434)
T 2rio_A          160 ----------TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF  229 (434)
T ss_dssp             ----------TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHH
T ss_pred             ----------cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHH
Confidence                      00345678999999887554322       23579999999999976       5689999999999999


Q ss_pred             HHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhc
Q 014117          311 VELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV  389 (430)
Q Consensus       311 ~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (430)
                      |||++ |..||......+  ..+....                       ...+.....                   ..
T Consensus       230 ~ellt~g~~Pf~~~~~~~--~~i~~~~-----------------------~~~~~~~~~-------------------~~  265 (434)
T 2rio_A          230 YYILSKGKHPFGDKYSRE--SNIIRGI-----------------------FSLDEMKCL-------------------HD  265 (434)
T ss_dssp             HHHHTTSCCTTCSTTTHH--HHHHHTC-----------------------CCCCCCTTC-------------------CC
T ss_pred             HHHHhCCCCCCCCchhhH--HHHhcCC-----------------------CCccccccc-------------------cc
Confidence            99999 999997644322  1111111                       111110000                   01


Q ss_pred             CCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       390 ~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      ...+.++.+||.+||+.||.+|||+.|+|+||||..
T Consensus       266 ~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          266 RSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             ccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            123567999999999999999999999999999975

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.3e-44  Score=340.71  Aligned_cols=270  Identities=21%  Similarity=0.296  Sum_probs=196.2

Q ss_pred             eecCcEEEEeeeccccceEEEEEE----ECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      ...++|++++.||+|+||+||+|+    +..+++.||+|++.... ...+.+..|+.+++++.     |+||+++++++.
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~   81 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-----HDNIVKYKGVCY   81 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCC-----CTTBCCEEEEEC
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCC-----CCCEeeEEEEEe
Confidence            345789999999999999999998    66789999999987533 34456778999999884     488999999875


Q ss_pred             c--CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          166 Y--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       166 ~--~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                      .  ...+++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence            4  46799999999 889999998754 3599999999999999999999999999999999999997666555555554


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                      +.........                     ........||..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       161 ~~~~~~~~~~---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~  219 (295)
T 3ugc_A          161 TKVLPQDKEF---------------------FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS  219 (295)
T ss_dssp             CC----------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred             cccccCCcce---------------------eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence            4322111000                     0001112467889999999999999999999999999999999999975


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      ....     .....+..+..... .............                          ...+..++.++.+||.+
T Consensus       220 ~~~~-----~~~~~~~~~~~~~~-~~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~  267 (295)
T 3ugc_A          220 PPAE-----FMRMIGNDKQGQMI-VFHLIELLKNNGR--------------------------LPRPDGCPDEIYMIMTE  267 (295)
T ss_dssp             HHHH-----HHHHHCTTCCTHHH-HHHHHHHHHTTCC--------------------------CCCCTTCCHHHHHHHHH
T ss_pred             ChHH-----HHhhhcCccccchh-HHHHHHHHhccCc--------------------------CCCCcCcCHHHHHHHHH
Confidence            3211     11112222111000 0000000001111                          11245677889999999


Q ss_pred             hhhcCCCCCCCHHHHhc
Q 014117          403 LLRYDPTDRLTAREALR  419 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~  419 (430)
                      ||+.||++|||+.|+++
T Consensus       268 ~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          268 CWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HSCSSGGGSCCHHHHHH
T ss_pred             HcCCChhhCCCHHHHHH
Confidence            99999999999999975

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1e-44  Score=349.45  Aligned_cols=246  Identities=22%  Similarity=0.263  Sum_probs=192.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeE----EEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEM----VAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      .++|++.+.||+|+||.||+|.+..+++.    ||+|.+....  .....+..|+.++..+     .|+||+++++++. 
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~-   85 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-----DHAHIVRLLGLCP-   85 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-----CCTTBCCEEEEEC-
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-----CCCCcCeEEEEEc-
Confidence            46799999999999999999999888775    7777764321  2223456688888777     4588999999886 


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      .+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.              
T Consensus        86 ~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--------------  150 (325)
T 3kex_A           86 GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKS--------------  150 (325)
T ss_dssp             BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESS--------------
T ss_pred             CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECC--------------
Confidence            56789999999 899999997653 47999999999999999999999999999999999999954              


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL  319 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~P  319 (430)
                                   ++.+||+|||+++......     ....||..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       151 -------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p  217 (325)
T 3kex_A          151 -------------PSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP  217 (325)
T ss_dssp             -------------SSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             -------------CCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCC
Confidence                         4556677777665433221     23467889999999999999999999999999999999 9999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |.+....+....+.....                                                ...+...+.++.+|
T Consensus       218 ~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~l  249 (325)
T 3kex_A          218 YAGLRLAEVPDLLEKGER------------------------------------------------LAQPQICTIDVYMV  249 (325)
T ss_dssp             TTTSCTTHHHHHHHTTCB------------------------------------------------CCCCTTBCTTTTHH
T ss_pred             ccccCHHHHHHHHHcCCC------------------------------------------------CCCCCcCcHHHHHH
Confidence            987665444333321100                                                01123445678999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcC
Q 014117          400 LQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~h  420 (430)
                      |.+||+.||.+|||+.++++|
T Consensus       250 i~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          250 MVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             HHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.6e-44  Score=334.24  Aligned_cols=244  Identities=15%  Similarity=0.134  Sum_probs=197.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~--  167 (430)
                      .++|++.+.||+|+||.||+|.+.  ++.||+|+++...   ...+.+..|+.+++++     .|+||+++++++...  
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-----SHPNVLPVLGACQSPPA   81 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-----SCTTEECEEEEECTTTS
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-----CCCchhheEEEEccCCC
Confidence            467999999999999999999985  7889999987432   3345567788777776     358999999998876  


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeccCCCCceEEeecCccccCCCcCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                      +..++||||+ +++|.+++.......+++..+..++.||+.||.|||++|  |+||||||+|||++              
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--------------  147 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID--------------  147 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC--------------
T ss_pred             CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc--------------
Confidence            8899999999 789999998876557999999999999999999999999  99999999999994              


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCC---cchHHHHHHHHHHHHhCCCCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslGv~l~el~tG~~Pf~  321 (430)
                                   .++.++|+|||++.....  ....||+.|+|||++.+..++.   ++|||||||++|+|++|..||.
T Consensus       148 -------------~~~~~~l~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  212 (271)
T 3kmu_A          148 -------------EDMTARISMADVKFSFQS--PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA  212 (271)
T ss_dssp             -------------TTSCEEEEGGGSCCTTSC--TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT
T ss_pred             -------------CCcceeEEeccceeeecc--cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence                         445566666665543222  2247899999999999876554   7999999999999999999998


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      ..+..+....+......                                               ...+...+.++.+||.
T Consensus       213 ~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~li~  245 (271)
T 3kmu_A          213 DLSNMEIGMKVALEGLR-----------------------------------------------PTIPPGISPHVSKLMK  245 (271)
T ss_dssp             TSCHHHHHHHHHHSCCC-----------------------------------------------CCCCTTCCHHHHHHHH
T ss_pred             ccChHHHHHHHHhcCCC-----------------------------------------------CCCCCCCCHHHHHHHH
Confidence            87665544333221100                                               0123456778999999


Q ss_pred             HhhhcCCCCCCCHHHHhc
Q 014117          402 GLLRYDPTDRLTAREALR  419 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~  419 (430)
                      +||+.||++|||++|+++
T Consensus       246 ~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          246 ICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6e-44  Score=341.57  Aligned_cols=247  Identities=23%  Similarity=0.322  Sum_probs=190.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....    .....+..|+.+++.+     .++||+++++++...+
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-----QEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETT
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-----CCCCeeEEEEEEeeCC
Confidence            467999999999999999999999999999999987432    2235667788888777     3488999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+|+||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.                
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~----------------  169 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA----------------  169 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT----------------
T ss_pred             eEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcC----------------
Confidence            999999999 779999998764  7999999999999999999999999999999999999954                


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                 ++.+||+|||++.......    ....||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       170 -----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  238 (309)
T 2h34_A          170 -----------DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD  238 (309)
T ss_dssp             -----------TSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred             -----------CCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence                       4456666666665433221    2347899999999999999999999999999999999999999875


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +.......+.. ..+.                                             ....+...+.++.+||.+|
T Consensus       239 ~~~~~~~~~~~-~~~~---------------------------------------------~~~~~~~~~~~l~~li~~~  272 (309)
T 2h34_A          239 QLSVMGAHINQ-AIPR---------------------------------------------PSTVRPGIPVAFDAVIARG  272 (309)
T ss_dssp             HHHHHHHHHHS-CCCC---------------------------------------------GGGTSTTCCTHHHHHHHHH
T ss_pred             hHHHHHHHhcc-CCCC---------------------------------------------ccccCCCCCHHHHHHHHHh
Confidence            54322221111 0000                                             0112346677899999999


Q ss_pred             hhcCCCCCC-CHHHHhc
Q 014117          404 LRYDPTDRL-TAREALR  419 (430)
Q Consensus       404 L~~dP~~R~-ta~elL~  419 (430)
                      |+.||++|| |++++++
T Consensus       273 l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          273 MAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             TCSSGGGSCSSHHHHHH
T ss_pred             ccCCHHHHHHhHHHHHH
Confidence            999999999 8887764

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.8e-44  Score=344.44  Aligned_cols=251  Identities=22%  Similarity=0.325  Sum_probs=202.2

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEEC-----CCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRN  162 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~  162 (430)
                      +...++|++.+.||+|+||.||+|.++     .+++.||+|++....  .....+..|+.+++.+     .|+||+++++
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~   95 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-----NCHHVVRLLG   95 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-----CCTTBCCEEE
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-----CCCCEeeeEE
Confidence            455678999999999999999999876     457889999987432  2344567788888877     3478999999


Q ss_pred             eeecCCeEEEEEecC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecC
Q 014117          163 WFDYRNHICIVFEKL-GSSLYDFLRKNN--------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE  233 (430)
Q Consensus       163 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~  233 (430)
                      ++...+..++||||+ +++|.+++....        ...+++..+..++.||+.||.|||++||+||||||+|||++   
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~---  172 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---  172 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC---
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc---
Confidence            999999999999999 789999987532        13579999999999999999999999999999999999994   


Q ss_pred             ccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHH
Q 014117          234 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGC  308 (430)
Q Consensus       234 ~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv  308 (430)
                                              .++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||
T Consensus       173 ------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  228 (322)
T 1p4o_A          173 ------------------------EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV  228 (322)
T ss_dssp             ------------------------TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred             ------------------------CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHH
Confidence                                    44567777777765432221     2236788999999999999999999999999


Q ss_pred             HHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhh
Q 014117          309 ILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ  387 (430)
Q Consensus       309 ~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (430)
                      ++|+|++ |..||.+.+..+....+...  ..                                              ..
T Consensus       229 il~el~~~g~~p~~~~~~~~~~~~~~~~--~~----------------------------------------------~~  260 (322)
T 1p4o_A          229 VLWEIATLAEQPYQGLSNEQVLRFVMEG--GL----------------------------------------------LD  260 (322)
T ss_dssp             HHHHHHHTSCCTTTTSCHHHHHHHHHTT--CC----------------------------------------------CC
T ss_pred             HHHHHHhcCCCccccCCHHHHHHHHHcC--Cc----------------------------------------------CC
Confidence            9999999 89999876665544333211  00                                              01


Q ss_pred             hcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       388 ~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      .+...+.++.+||.+||+.||.+|||+.|+++|
T Consensus       261 ~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          261 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            123556789999999999999999999999987

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.5e-44  Score=342.13  Aligned_cols=251  Identities=22%  Similarity=0.307  Sum_probs=197.3

Q ss_pred             ecCcEEEEeeeccccceEEEEEEE-----CCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      ..++|++.+.||+|+||.||+|.+     ..+++.||||+++...  .....+..|+.++.++.+    |+||+++++++
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~----hp~iv~~~~~~  100 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH----HLNVVNLLGAC  100 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC----CTTBCCEEEEE
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhccc----CCCeeeEEEEE
Confidence            357899999999999999999985     4567899999997432  334567789999999843    47899999987


Q ss_pred             ecC-CeEEEEEecC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceE
Q 014117          165 DYR-NHICIVFEKL-GSSLYDFLRKNNY--------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL  228 (430)
Q Consensus       165 ~~~-~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NIL  228 (430)
                      ... ..+++||||+ +++|.+++.....              ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil  180 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  180 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence            764 4699999999 7899999987542              12889999999999999999999999999999999999


Q ss_pred             EeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchH
Q 014117          229 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDI  303 (430)
Q Consensus       229 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Dv  303 (430)
                      ++.++                           .+||+|||++.......     ....||+.|+|||++.+..++.++||
T Consensus       181 ~~~~~---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di  233 (316)
T 2xir_A          181 LSEKN---------------------------VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV  233 (316)
T ss_dssp             ECGGG---------------------------CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred             ECCCC---------------------------CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHH
Confidence            96554                           45555555554332221     22467899999999999999999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHH
Q 014117          304 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ  382 (430)
Q Consensus       304 wslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (430)
                      |||||++|+|++ |..||.+....+...........                                            
T Consensus       234 ~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------------------------------------------  269 (316)
T 2xir_A          234 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR--------------------------------------------  269 (316)
T ss_dssp             HHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC--------------------------------------------
T ss_pred             HHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCcc--------------------------------------------
Confidence            999999999998 99999876543322221111100                                            


Q ss_pred             HHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       383 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                         ...+...+.++.++|.+||+.||.+|||+.|+++|
T Consensus       270 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          270 ---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               01123456789999999999999999999999976

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=6.2e-44  Score=335.98  Aligned_cols=248  Identities=26%  Similarity=0.373  Sum_probs=200.3

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      +...++|++.+.||+|+||.||+|.+. ++..||+|+++......+.+..|+++++.+.     |+||+++++++. .+.
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~-~~~   81 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ-----HQRLVRLYAVVT-QEP   81 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCC-----CTTBCCEEEEEC-SSS
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCC-----CcCcceEEEEEc-CCC
Confidence            344578999999999999999999975 5678999999765555677889999999984     478999998876 456


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      .++||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++                  
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~------------------  143 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS------------------  143 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred             cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc------------------
Confidence            89999999 88999998754334699999999999999999999999999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH  323 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~  323 (430)
                               .++.+||+|||++.......    ....+|..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus       144 ---------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  214 (279)
T 1qpc_A          144 ---------DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM  214 (279)
T ss_dssp             ---------TTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ---------CCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence                     44566777777665443222    12356889999999998889999999999999999999 99999887


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +..+....+.....                                                ...+...+.++.+||.+|
T Consensus       215 ~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~l~~li~~~  246 (279)
T 1qpc_A          215 TNPEVIQNLERGYR------------------------------------------------MVRPDNCPEELYQLMRLC  246 (279)
T ss_dssp             CHHHHHHHHHTTCC------------------------------------------------CCCCTTCCHHHHHHHHHH
T ss_pred             CHHHHHHHHhcccC------------------------------------------------CCCcccccHHHHHHHHHH
Confidence            66554443322100                                                001235567899999999


Q ss_pred             hhcCCCCCCCHHHHhc
Q 014117          404 LRYDPTDRLTAREALR  419 (430)
Q Consensus       404 L~~dP~~R~ta~elL~  419 (430)
                      |+.||++|||++++++
T Consensus       247 l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          247 WKERPEDRPTFDYLRS  262 (279)
T ss_dssp             TCSSGGGSCCHHHHHH
T ss_pred             hccChhhCCCHHHHHH
Confidence            9999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.9e-44  Score=339.98  Aligned_cols=249  Identities=26%  Similarity=0.328  Sum_probs=199.3

Q ss_pred             CceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--
Q 014117           89 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--  166 (430)
Q Consensus        89 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--  166 (430)
                      +..+.++|++.+.||+|+||.||+|.+..+++.||+|+++...   .....|+++++.+.     |+||+++++++..  
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~   77 (284)
T 2a19_B            6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLD-----HVNIVHYNGCWDGFD   77 (284)
T ss_dssp             CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCC-----CTTBCCEEEEEEEEE
T ss_pred             cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCC-----CCCEEEEeeeEeccc
Confidence            4556678999999999999999999999999999999987543   34567899998884     4789998887754  


Q ss_pred             --------------CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEee
Q 014117          167 --------------RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS  231 (430)
Q Consensus       167 --------------~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~  231 (430)
                                    ...+++||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus        78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVD  157 (284)
T ss_dssp             EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred             cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcC
Confidence                          45689999999 779999998765567999999999999999999999999999999999999965


Q ss_pred             cCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHH
Q 014117          232 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI  309 (430)
Q Consensus       232 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~  309 (430)
                      ++                           .+||+|||++......  .....||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~---------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i  210 (284)
T 2a19_B          158 TK---------------------------QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLI  210 (284)
T ss_dssp             TT---------------------------EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHH
T ss_pred             CC---------------------------CEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHH
Confidence            54                           4566666655433222  223468999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhc
Q 014117          310 LVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV  389 (430)
Q Consensus       310 l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (430)
                      +|+|++|..||....  .....+.                       .+                            ..+
T Consensus       211 l~~l~~~~~~~~~~~--~~~~~~~-----------------------~~----------------------------~~~  237 (284)
T 2a19_B          211 LAELLHVCDTAFETS--KFFTDLR-----------------------DG----------------------------IIS  237 (284)
T ss_dssp             HHHHHSCCSSHHHHH--HHHHHHH-----------------------TT----------------------------CCC
T ss_pred             HHHHHhcCCcchhHH--HHHHHhh-----------------------cc----------------------------ccc
Confidence            999999998874211  1110000                       00                            012


Q ss_pred             CCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       390 ~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      ...+.++.+||.+||+.||.+|||+.|+++|.|.-.
T Consensus       238 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            345677999999999999999999999999976543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.4e-44  Score=346.92  Aligned_cols=257  Identities=19%  Similarity=0.260  Sum_probs=203.7

Q ss_pred             ceecCcEEEEeeeccccceEEEEEE-----ECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECW-----DRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN  162 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~  162 (430)
                      +...++|++.+.||+|+||.||+|.     +..+++.||+|++...  ......+..|+.+++++     .|+||+++++
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~  100 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-----NHQNIVRCIG  100 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-----CCCCCCeEEE
Confidence            3445789999999999999999999     5567889999998632  33445677899998888     3488999999


Q ss_pred             eeecCCeEEEEEecC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccc
Q 014117          163 WFDYRNHICIVFEKL-GSSLYDFLRKNNY-----RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK  236 (430)
Q Consensus       163 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~  236 (430)
                      ++...+..|+||||+ +++|.+++.....     ..+++..+..++.||+.||.|||++||+||||||+|||++.++   
T Consensus       101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~---  177 (327)
T 2yfx_A          101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG---  177 (327)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS---
T ss_pred             EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCC---
Confidence            999999999999999 8899999987542     3589999999999999999999999999999999999996432   


Q ss_pred             cCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHH
Q 014117          237 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILV  311 (430)
Q Consensus       237 i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~  311 (430)
                                           ....+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|
T Consensus       178 ---------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  236 (327)
T 2yfx_A          178 ---------------------PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW  236 (327)
T ss_dssp             ---------------------TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             ---------------------CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHH
Confidence                                 3446888899887633221     22346789999999999999999999999999999


Q ss_pred             HHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcC
Q 014117          312 ELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD  390 (430)
Q Consensus       312 el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  390 (430)
                      +|++ |..||......+....+......                                                ..+.
T Consensus       237 ellt~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~  268 (327)
T 2yfx_A          237 EIFSLGYMPYPSKSNQEVLEFVTSGGRM------------------------------------------------DPPK  268 (327)
T ss_dssp             HHHTTSCCSSTTCCHHHHHHHHHTTCCC------------------------------------------------CCCT
T ss_pred             HHHcCCCCCCCCcCHHHHHHHHhcCCCC------------------------------------------------CCCC
Confidence            9998 99999877665544433221100                                                0123


Q ss_pred             CchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCC
Q 014117          391 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       391 ~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      ..+..+.+||.+||+.||.+|||++++++|.|+
T Consensus       269 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          269 NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            456789999999999999999999999998764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.5e-43  Score=342.50  Aligned_cols=249  Identities=19%  Similarity=0.306  Sum_probs=199.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEEC-------CCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDR-------ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW  163 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~  163 (430)
                      .++|++.+.||+|+||.||+|.+.       .++..||+|+++...  .....+..|+.+++++.    .|+||++++++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~~~  109 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG----KHKNIINLLGA  109 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEE
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhh----cCCCEeeEEEE
Confidence            568999999999999999999976       456789999997432  34456778999999984    34789999999


Q ss_pred             eecCCeEEEEEecC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceE
Q 014117          164 FDYRNHICIVFEKL-GSSLYDFLRKNNY--------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL  228 (430)
Q Consensus       164 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NIL  228 (430)
                      +...+.+|+||||+ +++|.+++.....              ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus       110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  189 (334)
T ss_dssp             ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence            99999999999999 8899999986532              24899999999999999999999999999999999999


Q ss_pred             EeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchH
Q 014117          229 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDI  303 (430)
Q Consensus       229 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Dv  303 (430)
                      ++                           .++.+||+|||++.......     ....+|+.|+|||++.+..++.++||
T Consensus       190 l~---------------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  242 (334)
T 2pvf_A          190 VT---------------------------ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV  242 (334)
T ss_dssp             EC---------------------------TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHH
T ss_pred             Ec---------------------------CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHH
Confidence            94                           44556677777665433221     22356889999999999899999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHH
Q 014117          304 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ  382 (430)
Q Consensus       304 wslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (430)
                      |||||++|+|++ |..||.+.+..+....+.....                                             
T Consensus       243 ~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~---------------------------------------------  277 (334)
T 2pvf_A          243 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR---------------------------------------------  277 (334)
T ss_dssp             HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC---------------------------------------------
T ss_pred             HHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCC---------------------------------------------
Confidence            999999999999 9999988766554443322110                                             


Q ss_pred             HHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       383 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                         ...+...+.++.+||.+||+.||.+|||+.|++++
T Consensus       278 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          278 ---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence               01123556789999999999999999999999864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.8e-44  Score=340.89  Aligned_cols=252  Identities=22%  Similarity=0.283  Sum_probs=188.6

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---  166 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~---  166 (430)
                      ..+.++|++.+.||+|+||+||+|.+  +++.||||++...  .......|.+++....   ..|+||+++++++..   
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~---l~h~niv~~~~~~~~~~~   76 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR--DEKSWFRETELYNTVM---LRHENILGFIASDMTSRH   76 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHTC---CCCTTBCCEEEEEEEEET
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc--cchhhHHHHHHHHHhh---ccCcCeeeEEEeeccccC
Confidence            45678899999999999999999987  6889999998743  3344556777766642   245889999887543   


Q ss_pred             -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCeeeccCCCCceEEeecCccc
Q 014117          167 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH--------DLCMIHTDLKPENVLLVSSEYIK  236 (430)
Q Consensus       167 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH--------~~~ivHrDlKp~NILl~~~~~~~  236 (430)
                       ...+|+||||+ +++|.++++..   .+++..+..++.||+.||.|||        +.||+||||||+|||++      
T Consensus        77 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~------  147 (301)
T 3q4u_A           77 SSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK------  147 (301)
T ss_dssp             TEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC------
T ss_pred             CCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc------
Confidence             46799999999 88999999543   6999999999999999999999        99999999999999994      


Q ss_pred             cCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-------CeeeecCcccchhhhhCC------CCCCcchH
Q 014117          237 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGL------GWTYPCDI  303 (430)
Q Consensus       237 i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~------~~~~~~Dv  303 (430)
                                           .++.+||+|||++.......       ...+||+.|+|||++.+.      .++.++||
T Consensus       148 ---------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dv  206 (301)
T 3q4u_A          148 ---------------------KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI  206 (301)
T ss_dssp             ---------------------TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHH
T ss_pred             ---------------------CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhH
Confidence                                 44566777777665332222       224799999999999876      45579999


Q ss_pred             HHHHHHHHHHHhC----------CCCCCCCch----HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCCh
Q 014117          304 WSVGCILVELCTG----------EALFQTHEN----LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASR  369 (430)
Q Consensus       304 wslGv~l~el~tG----------~~Pf~~~~~----~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (430)
                      |||||++|||++|          ..||.....    ......+....+..+                    ..+.     
T Consensus       207 wslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~-----  261 (301)
T 3q4u_A          207 WAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRP--------------------NIPN-----  261 (301)
T ss_dssp             HHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC--------------------CCCG-----
T ss_pred             HHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCC--------------------CCCh-----
Confidence            9999999999999          888864321    111111111000000                    0000     


Q ss_pred             hhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          370 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                                      .......+.++.+||.+||+.||++|||++|+++
T Consensus       262 ----------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          262 ----------------RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             ----------------GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ----------------hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence                            0012334677999999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.2e-43  Score=337.43  Aligned_cols=251  Identities=26%  Similarity=0.389  Sum_probs=189.7

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|+++..    ......+..|+.+++.+     .++||+++++++.
T Consensus        28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~  102 (310)
T 2wqm_A           28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-----NHPNVIKYYASFI  102 (310)
T ss_dssp             TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEE
T ss_pred             cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEE
Confidence            34456899999999999999999999999999999998642    33445677889888887     3488999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                      ..+..++||||+ +++|.+++...  ....+++..+..++.||+.||.|||+.||+||||||+|||++            
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~------------  170 (310)
T 2wqm_A          103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT------------  170 (310)
T ss_dssp             ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC------------
T ss_pred             cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEc------------
Confidence            999999999999 77999998742  235799999999999999999999999999999999999994            


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCC
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL  319 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~P  319 (430)
                                     .++.+||+|||++.......   ....||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       171 ---------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p  235 (310)
T 2wqm_A          171 ---------------ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP  235 (310)
T ss_dssp             ---------------TTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ---------------CCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence                           44566677777665433221   234789999999999999999999999999999999999999


Q ss_pred             CCCCch--HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          320 FQTHEN--LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       320 f~~~~~--~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      |.+...  .+....+..                       +.+  +.                      ......+.++.
T Consensus       236 ~~~~~~~~~~~~~~~~~-----------------------~~~--~~----------------------~~~~~~~~~l~  268 (310)
T 2wqm_A          236 FYGDKMNLYSLCKKIEQ-----------------------CDY--PP----------------------LPSDHYSEELR  268 (310)
T ss_dssp             TC---CCHHHHHHHHHT-----------------------TCS--CC----------------------CCTTTSCHHHH
T ss_pred             CcccchhHHHHHHHhhc-----------------------ccC--CC----------------------CcccccCHHHH
Confidence            975322  111111110                       000  00                      00134567899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhc
Q 014117          398 HLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      +||.+||+.||.+|||++++++
T Consensus       269 ~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          269 QLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCChhhCCCHHHHHH
Confidence            9999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.5e-45  Score=361.50  Aligned_cols=280  Identities=20%  Similarity=0.326  Sum_probs=204.4

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      ...++|++.+.||+|+||+||+|.+..+++.||||+++...  .....+..|+++++++.     |+||+++++++...+
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~~~~~~~~~~   80 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-----HKNIVKLFAIEEETT   80 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC-----CTTBCCEEEEEECTT
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-----CCCCCeEEEeeccCC
Confidence            34568999999999999999999999999999999997432  23456678999999984     488999999887654


Q ss_pred             --eEEEEEecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          169 --HICIVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       169 --~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                        ..|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||++|||||||||+|||+....           
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-----------  149 (396)
T 4eut_A           81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE-----------  149 (396)
T ss_dssp             TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECT-----------
T ss_pred             CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecC-----------
Confidence              889999999 8899999976432 2399999999999999999999999999999999999984321           


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhC--------CCCCCcchHHHHHHHHHHHH
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG--------LGWTYPCDIWSVGCILVELC  314 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGv~l~el~  314 (430)
                                  +....+||+|||++.......  ...+||+.|+|||++.+        ..++.++|||||||++|||+
T Consensus       150 ------------~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~  217 (396)
T 4eut_A          150 ------------DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA  217 (396)
T ss_dssp             ------------TSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ------------CCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHH
Confidence                        344567888888876543322  33579999999999875        46788999999999999999


Q ss_pred             hCCCCCCCCch-HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCch
Q 014117          315 TGEALFQTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA  393 (430)
Q Consensus       315 tG~~Pf~~~~~-~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (430)
                      +|..||..... ......+.......|...+..+     .....+.+.|.......                .......+
T Consensus       218 tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~----------------~~l~~~~~  276 (396)
T 4eut_A          218 TGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGV-----QKAENGPIDWSGDMPVS----------------CSLSRGLQ  276 (396)
T ss_dssp             HSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEE-----ECSTTCCEEEESSCCTT----------------CSSCHHHH
T ss_pred             HCCCCCCCCCcccchHHHHHHHhcCCCcccchhh-----eeccCCCcccCccCCcc----------------cccchHHH
Confidence            99999964322 1111222222222232111000     00111222222211100                01123345


Q ss_pred             hHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          394 GDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       394 ~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      ..+.+||.+||+.||++|||++|+++
T Consensus       277 ~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          277 VLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             HHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             hhchHHHHHhhccChhhhccHHHHHH
Confidence            67899999999999999999999865

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.2e-43  Score=342.68  Aligned_cols=255  Identities=20%  Similarity=0.299  Sum_probs=199.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCe-----EEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKE-----MVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .++|++.+.||+|+||.||+|.+..+++     .||+|+++...  .....+..|+.++..+.    .|+||+++++++.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~~~  120 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG----QHENIVNLLGACT  120 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEEEC
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhc----CCCCeeeEEEEEe
Confidence            4679999999999999999999877654     79999987432  34466788999999983    2478999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeec
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNN------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS  232 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~  232 (430)
                      ..+.+|+||||+ +++|.+++....            ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence            999999999999 789999997532            2468999999999999999999999999999999999999776


Q ss_pred             CccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHH
Q 014117          233 EYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE  312 (430)
Q Consensus       233 ~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~e  312 (430)
                      +.++|+|||++.........                      .......||+.|+|||++.+..++.++|||||||++|+
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  258 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNY----------------------IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE  258 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTS----------------------EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             CeEEECccccccccccccce----------------------eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHH
Confidence            66666666655322111000                      00122357889999999999999999999999999999


Q ss_pred             HHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCC
Q 014117          313 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH  391 (430)
Q Consensus       313 l~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (430)
                      |++ |..||.+.........+.......                                               ..+..
T Consensus       259 l~t~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~  291 (333)
T 2i1m_A          259 IFSLGLNPYPGILVNSKFYKLVKDGYQM-----------------------------------------------AQPAF  291 (333)
T ss_dssp             HTTTSCCSSTTCCSSHHHHHHHHHTCCC-----------------------------------------------CCCTT
T ss_pred             HHcCCCCCCcccchhHHHHHHHhcCCCC-----------------------------------------------CCCCC
Confidence            998 999998765444333222211110                                               01234


Q ss_pred             chhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          392 SAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       392 ~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      .+.++.+||.+||+.||.+|||+.|++++
T Consensus       292 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          292 APKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            46779999999999999999999999863

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.3e-44  Score=345.06  Aligned_cols=261  Identities=25%  Similarity=0.356  Sum_probs=178.8

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee-------
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-------  164 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-------  164 (430)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++... ......+..|+.++.++.    +|+||+++++++       
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS----GHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHT----TSTTBCCEEEEEEECTTTS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhc----cCCChhhcccccccccccc
Confidence            35899999999999999999999999999999988533 334456778999999985    247899998887       


Q ss_pred             -ecCCeEEEEEecCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeccCCCCceEEeecCccccCCC
Q 014117          165 -DYRNHICIVFEKLGSSLYDFLRKN-NYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDY  240 (430)
Q Consensus       165 -~~~~~~~lv~e~~~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlKp~NILl~~~~~~~i~df  240 (430)
                       .....+++||||++++|.+++... ....+++..+..++.||+.||.|||+.|  |+||||||+|||++.++.++|+||
T Consensus       103 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          103 DTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             TTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecC
Confidence             445679999999999999998752 2346999999999999999999999999  999999999999976666666666


Q ss_pred             cCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhh---hCCCCCCcchHHHHHHHHHHHHhCC
Q 014117          241 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVI---LGLGWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       241 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslGv~l~el~tG~  317 (430)
                      |++............            ..............||+.|+|||++   .+..++.++|||||||++|+|++|.
T Consensus       183 g~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~  250 (337)
T 3ll6_A          183 GSATTISHYPDYSWS------------AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ  250 (337)
T ss_dssp             TTCBCCSSCC-------------------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSS
T ss_pred             ccceeccccCccccc------------ccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCC
Confidence            655433221110000            0000000011234689999999998   5667899999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      .||..........                           +....+                        .....+..+.
T Consensus       251 ~p~~~~~~~~~~~---------------------------~~~~~~------------------------~~~~~~~~~~  279 (337)
T 3ll6_A          251 HPFEDGAKLRIVN---------------------------GKYSIP------------------------PHDTQYTVFH  279 (337)
T ss_dssp             CCC---------------------------------------CCCC------------------------TTCCSSGGGH
T ss_pred             CCCcchhHHHhhc---------------------------CcccCC------------------------cccccchHHH
Confidence            9997543322110                           000000                        1133455689


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcC
Q 014117          398 HLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      +||.+||+.||.+|||++|+++|
T Consensus       280 ~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          280 SLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=338.11  Aligned_cols=245  Identities=26%  Similarity=0.388  Sum_probs=188.3

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      .++|++.+.||+|+||.||+|.+.  ++.||+|++... ...+.+..|+.+++++.     |+||+++++++.  +..|+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~-----hp~iv~~~~~~~--~~~~l   76 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVN-----HPNIVKLYGACL--NPVCL   76 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCC-----CTTBCCEEEBCT--TTTEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCC-----CCCcCeEEEEEc--CCcEE
Confidence            357999999999999999999874  688999998743 34567788999999883     488999999876  34799


Q ss_pred             EEecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---cCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          173 VFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHD---LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      ||||+ +++|.+++..... ..+++..+..++.||+.||.|||+   +||+||||||+|||++.++              
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~--------------  142 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG--------------  142 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTT--------------
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCC--------------
Confidence            99999 8899999986542 247899999999999999999999   8999999999999996433              


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                                  ..+||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus       143 ------------~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~  210 (307)
T 2eva_A          143 ------------TVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA  210 (307)
T ss_dssp             ------------TEEEECCCCC------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH
T ss_pred             ------------CEEEEcccccccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH
Confidence                        23677777777654444444579999999999999999999999999999999999999997643322


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      .........+..+                                              ..+...+.++.+||.+||+.|
T Consensus       211 ~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~l~~li~~~l~~d  244 (307)
T 2eva_A          211 FRIMWAVHNGTRP----------------------------------------------PLIKNLPKPIESLMTRCWSKD  244 (307)
T ss_dssp             HHHHHHHHTTCCC----------------------------------------------CCBTTCCHHHHHHHHHHTCSS
T ss_pred             HHHHHHHhcCCCC----------------------------------------------CcccccCHHHHHHHHHHhcCC
Confidence            1111111111100                                              122456778999999999999


Q ss_pred             CCCCCCHHHHhc
Q 014117          408 PTDRLTAREALR  419 (430)
Q Consensus       408 P~~R~ta~elL~  419 (430)
                      |.+|||++++++
T Consensus       245 p~~Rps~~ell~  256 (307)
T 2eva_A          245 PSQRPSMEEIVK  256 (307)
T ss_dssp             GGGSCCHHHHHH
T ss_pred             hhhCcCHHHHHH
Confidence            999999999987

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.3e-44  Score=337.54  Aligned_cols=251  Identities=23%  Similarity=0.342  Sum_probs=188.3

Q ss_pred             CceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           89 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        89 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      ++...++|++.++||+|+||.||+|.+..   .||+|+++..   ....+.+..|+.+++++.     |+||+.++++. 
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~-   89 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-----HVNILLFMGYS-   89 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCC-----CTTBCCEEEEE-
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCC-----CCcEEEEEeec-
Confidence            45567789999999999999999998653   4999998633   233456778888888874     47899998854 


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                      .....++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++           
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~-----------  157 (289)
T 3og7_A           90 TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-----------  157 (289)
T ss_dssp             CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-----------
T ss_pred             cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC-----------
Confidence            556789999999 789999997554 4799999999999999999999999999999999999996544           


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCC-----CCCeeeecCcccchhhhh---CCCCCCcchHHHHHHHHHHHHhC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-----DQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTG  316 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~el~tG  316 (430)
                                      .+||+|||++.....     ......||+.|+|||++.   +..++.++|||||||++|+|++|
T Consensus       158 ----------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g  221 (289)
T 3og7_A          158 ----------------TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG  221 (289)
T ss_dssp             ----------------EEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHS
T ss_pred             ----------------CEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHC
Confidence                            455555655543221     112347899999999997   56788999999999999999999


Q ss_pred             CCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHH
Q 014117          317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL  396 (430)
Q Consensus       317 ~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (430)
                      ..||......+....+.......+.                                           .......++.++
T Consensus       222 ~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~l  258 (289)
T 3og7_A          222 QLPYSNINNRDQIIEMVGRGSLSPD-------------------------------------------LSKVRSNCPKRM  258 (289)
T ss_dssp             SCTTSSCCCHHHHHHHHHHTSCCCC-------------------------------------------TTSSCTTSCHHH
T ss_pred             CCCccccchHHHHHHHhcccccCcc-------------------------------------------hhhccccCCHHH
Confidence            9999876665544433322111110                                           001223567789


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhc
Q 014117          397 THLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       397 ~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      .+||.+||+.||.+|||++++++
T Consensus       259 ~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          259 KRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhhCCCHHHHHH
Confidence            99999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.7e-44  Score=347.96  Aligned_cols=258  Identities=15%  Similarity=0.149  Sum_probs=190.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCC--------CeEEEEEEecCchhhHHHHHHHHHHHHHHHhcC----------CCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRER--------KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD----------KGG  154 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~--------~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~----------~~~  154 (430)
                      .++|++.+.||+|+||.||+|.+..+        ++.||+|++...    ..+..|+++++++.|.+          ...
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            36899999999999999999999874        789999998744    34667888888885411          111


Q ss_pred             CceEEecceeec-CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecC
Q 014117          155 NRCVQIRNWFDY-RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE  233 (430)
Q Consensus       155 ~~i~~~~~~~~~-~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~  233 (430)
                      .+++.+++++.. ....|+||||++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~  196 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED  196 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTE
T ss_pred             cCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCC
Confidence            233446666655 7899999999999999999876445799999999999999999999999999999999999997654


Q ss_pred             ccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCC----------CCCeeeecCcccchhhhhCCCCCCcchH
Q 014117          234 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP----------DQNYIVSTRHYRAPEVILGLGWTYPCDI  303 (430)
Q Consensus       234 ~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  303 (430)
                                               ...+||+|||++.....          ......||+.|+|||++.+..++.++||
T Consensus       197 -------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  251 (352)
T 2jii_A          197 -------------------------QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDL  251 (352)
T ss_dssp             -------------------------EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHH
T ss_pred             -------------------------CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhH
Confidence                                     01445555555432211          1122478999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCc-hHHHHHH-HHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhH
Q 014117          304 WSVGCILVELCTGEALFQTHE-NLEHLAM-MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL  381 (430)
Q Consensus       304 wslGv~l~el~tG~~Pf~~~~-~~~~~~~-i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (430)
                      |||||++|+|++|..||.... ..+.... ........+.                    ....                
T Consensus       252 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~----------------  295 (352)
T 2jii_A          252 QSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGP--------------------FVGP----------------  295 (352)
T ss_dssp             HHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCC--------------------EECT----------------
T ss_pred             HHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhh--------------------hhhh----------------
Confidence            999999999999999998643 2222221 1111111100                    0000                


Q ss_pred             HHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          382 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       382 ~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                          ...+...+.++.+||.+||+.||++|||++++++
T Consensus       296 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          296 ----CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             ----TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ----ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence                0012245778999999999999999999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.8e-44  Score=345.49  Aligned_cols=259  Identities=22%  Similarity=0.347  Sum_probs=178.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .++|++.+.||+|+||.||+|.++.+++.||||+++...  ........|+..+.+    ...|+||+++++++...+..
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~----~~~h~niv~~~~~~~~~~~~   96 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMR----SSDCPYIVQFYGALFREGDC   96 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHS----SCCCTTBCCEEEEEECSSEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHH----cCCCCcEeeeeeEEEeCCce
Confidence            467999999999999999999999999999999997532  222333444442222    23568999999999999999


Q ss_pred             EEEEecCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRK---NNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~---~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      ++||||+.++|.+++..   .....+++..+..++.|++.||.|||+. ||+||||||+|||++.++             
T Consensus        97 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-------------  163 (327)
T 3aln_A           97 WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-------------  163 (327)
T ss_dssp             EEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-------------
T ss_pred             EEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-------------
Confidence            99999998898888763   2235799999999999999999999998 999999999999996544             


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhh----hCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~----~~~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                    .+||+|||++.......  ....||+.|+|||++    .+..++.++|||||||++|+|++|..||
T Consensus       164 --------------~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  229 (327)
T 3aln_A          164 --------------NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY  229 (327)
T ss_dssp             --------------EEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCS
T ss_pred             --------------CEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence                          45666666554332221  223689999999998    4567999999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .......  ..+...                   ........+                      .......+.++.+||
T Consensus       230 ~~~~~~~--~~~~~~-------------------~~~~~~~~~----------------------~~~~~~~~~~l~~li  266 (327)
T 3aln_A          230 PKWNSVF--DQLTQV-------------------VKGDPPQLS----------------------NSEEREFSPSFINFV  266 (327)
T ss_dssp             SCC---------CCC-------------------CCSCCCCCC----------------------CCSSCCCCHHHHHHH
T ss_pred             CCcchHH--HHHHHH-------------------hcCCCCCCC----------------------CcccccCCHHHHHHH
Confidence            7643211  000000                   000000000                      011235677899999


Q ss_pred             HHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          401 QGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      .+||+.||.+|||+.|+++||||..
T Consensus       267 ~~~l~~dp~~Rps~~ell~hp~~~~  291 (327)
T 3aln_A          267 NLCLTKDESKRPKYKELLKHPFILM  291 (327)
T ss_dssp             HHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHhhCChhhCcCHHHHHhChHHHH
Confidence            9999999999999999999999964

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.8e-44  Score=358.95  Aligned_cols=253  Identities=26%  Similarity=0.348  Sum_probs=200.4

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ...++|++.++||+|+||.||+|.+.. +..||||+++......+.+..|+.+++++.     |+||+++++++.. +.+
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~~~~~~~~-~~~  253 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-----HEKLVQLYAVVSE-EPI  253 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCC-----CTTBCCEEEEECS-SSC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCC-----CCCEeeEEEEEcC-Cce
Confidence            345689999999999999999999875 466999999865555677889999999984     4889999998876 778


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      ||||||+ +++|.+++.......+++..+..++.||+.||+|||++|||||||||+|||++.++                
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~----------------  317 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL----------------  317 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG----------------
T ss_pred             EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC----------------
Confidence            9999999 88999999764435699999999999999999999999999999999999995544                


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCc
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE  324 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~  324 (430)
                                 .+||+|||+++......    ....+|..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus       318 -----------~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~  386 (452)
T 1fmk_A          318 -----------VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV  386 (452)
T ss_dssp             -----------CEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             -----------CEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence                       45555555554332211    12346788999999999999999999999999999999 999998877


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+....+.....                                                ...+..++.++.+||.+||
T Consensus       387 ~~~~~~~i~~~~~------------------------------------------------~~~~~~~~~~l~~li~~cl  418 (452)
T 1fmk_A          387 NREVLDQVERGYR------------------------------------------------MPCPPECPESLHDLMCQCW  418 (452)
T ss_dssp             HHHHHHHHHTTCC------------------------------------------------CCCCTTSCHHHHHHHHHHT
T ss_pred             HHHHHHHHHcCCC------------------------------------------------CCCCCCCCHHHHHHHHHHc
Confidence            6655544322110                                                0112456778999999999


Q ss_pred             hcCCCCCCCHHHHhcC--CCCCC
Q 014117          405 RYDPTDRLTAREALRH--PFFTR  425 (430)
Q Consensus       405 ~~dP~~R~ta~elL~h--p~f~~  425 (430)
                      +.||++|||++++++.  .+|+.
T Consensus       419 ~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          419 RKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             CSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             cCChhhCcCHHHHHHHHHHHhcc
Confidence            9999999999998863  55543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-43  Score=334.04  Aligned_cols=247  Identities=24%  Similarity=0.337  Sum_probs=196.5

Q ss_pred             cCcEEEEe-eeccccceEEEEEEEC--CCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           93 TSRYKIHS-KMGEGTFGQVLECWDR--ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        93 ~~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .++|.+.+ .||+|+||.||+|.++  .++..||+|+++..  ....+.+..|+++++.+.     ++||+++++++ ..
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~-~~   81 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-----NPYIVRLIGVC-QA   81 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC-----CTTBCCEEEEE-ES
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCC-----CCCEeEEEEEe-cC
Confidence            45788887 9999999999999864  46788999999753  334566788999999983     48899999998 45


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++++||      
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Df------  154 (287)
T 1u59_A           82 EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF------  154 (287)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCC------
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcc------
Confidence            6799999999 779999997543 46999999999999999999999999999999999999976655555554      


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL  319 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~P  319 (430)
                                           |++.......      ....||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       155 ---------------------g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p  213 (287)
T 1u59_A          155 ---------------------GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP  213 (287)
T ss_dssp             ---------------------TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ---------------------cceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence                                 4443322111      12356889999999998899999999999999999998 9999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |...+..+....+....  .                                              ...+...+.++.+|
T Consensus       214 ~~~~~~~~~~~~i~~~~--~----------------------------------------------~~~~~~~~~~l~~l  245 (287)
T 1u59_A          214 YKKMKGPEVMAFIEQGK--R----------------------------------------------MECPPECPPELYAL  245 (287)
T ss_dssp             TTTCCTHHHHHHHHTTC--C----------------------------------------------CCCCTTCCHHHHHH
T ss_pred             cccCCHHHHHHHHhcCC--c----------------------------------------------CCCCCCcCHHHHHH
Confidence            98876655444332210  0                                              01234567789999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCC
Q 014117          400 LQGLLRYDPTDRLTAREALRHP  421 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~hp  421 (430)
                      |.+||+.||.+|||+.++++|.
T Consensus       246 i~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          246 MSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHHH
Confidence            9999999999999999999863

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.2e-43  Score=332.72  Aligned_cols=246  Identities=23%  Similarity=0.318  Sum_probs=194.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECC---CCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRE---RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .++|++.+.||+|+||.||+|.+..   ++..||+|+++..  ....+.+..|+.+++.+.     |+||+++++++.. 
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~-   84 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD-----HPHIVKLIGIIEE-   84 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHC-----CTTBCCEEEEECS-
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCC-----CCCcceEEEEEcC-
Confidence            4689999999999999999998654   3457999998743  234567788999999993     4889999998875 


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +..|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+           
T Consensus        85 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~-----------  152 (281)
T 3cc6_A           85 EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECV-----------  152 (281)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEE-----------
T ss_pred             CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcE-----------
Confidence            4568999999 789999998754 469999999999999999999999999999999999999765554           


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQ  321 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~  321 (430)
                                      ||+|||++.......    ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus       153 ----------------kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~  216 (281)
T 3cc6_A          153 ----------------KLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF  216 (281)
T ss_dssp             ----------------EECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             ----------------EeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcc
Confidence                            555555444322211    22356889999999999999999999999999999998 999998


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      .....+....+......                                                ..+...+..+.+||.
T Consensus       217 ~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~l~~li~  248 (281)
T 3cc6_A          217 WLENKDVIGVLEKGDRL------------------------------------------------PKPDLCPPVLYTLMT  248 (281)
T ss_dssp             TSCGGGHHHHHHHTCCC------------------------------------------------CCCTTCCHHHHHHHH
T ss_pred             cCChHHHHHHHhcCCCC------------------------------------------------CCCCCCCHHHHHHHH
Confidence            76555444333221100                                                012345678999999


Q ss_pred             HhhhcCCCCCCCHHHHhcC
Q 014117          402 GLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~h  420 (430)
                      +||+.||++|||+.|++++
T Consensus       249 ~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          249 RCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCCchhCcCHHHHHHH
Confidence            9999999999999999864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.8e-44  Score=351.20  Aligned_cols=246  Identities=22%  Similarity=0.317  Sum_probs=190.8

Q ss_pred             cCcEEEEeeeccccceEEEEEEEC---CCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .++|.+.+.||+|+||.||+|.++   .++..||||+++..  ......+..|+.++.++     .|+||+++++++...
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~  118 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-----DHPNIIRLEGVVTKS  118 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEeeC
Confidence            468999999999999999999887   46778999998743  33455678899998888     358899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +.+++||||+ +++|.+++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.               
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---------------  182 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS---------------  182 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---------------
T ss_pred             CceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcC---------------
Confidence            9999999999 899999998654 46999999999999999999999999999999999999954               


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL  319 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~P  319 (430)
                                  ++.+||+|||++.......      ....+|..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus       183 ------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P  250 (373)
T 2qol_A          183 ------------NLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP  250 (373)
T ss_dssp             ------------TCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CT
T ss_pred             ------------CCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCC
Confidence                        4456666666655432221      11235778999999999999999999999999999998 9999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |...+..+....+......                                                ..+...+.++.+|
T Consensus       251 ~~~~~~~~~~~~i~~~~~~------------------------------------------------~~~~~~~~~l~~l  282 (373)
T 2qol_A          251 YWEMSNQDVIKAVDEGYRL------------------------------------------------PPPMDCPAALYQL  282 (373)
T ss_dssp             TTTCCHHHHHHHHHTTEEC------------------------------------------------CCCTTCBHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCCCC------------------------------------------------CCCccccHHHHHH
Confidence            9877665544433221100                                                0123456789999


Q ss_pred             HHHhhhcCCCCCCCHHHHhc
Q 014117          400 LQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~  419 (430)
                      |.+||+.||.+|||+.++++
T Consensus       283 i~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          283 MLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhCcChhhCcCHHHHHH
Confidence            99999999999999998875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.3e-44  Score=346.19  Aligned_cols=266  Identities=22%  Similarity=0.255  Sum_probs=199.2

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      +...++|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+..|+.+++.+     .|+||+++++++...+
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFC-----RHPHLVSLIGFCDERN  108 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-----CCTTBCCEEEECCCTT
T ss_pred             HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEcCCC
Confidence            456678999999999999999999964 68899999886432 3445677888888777     3588999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNY--RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      ..++||||+ +++|.+++.....  ..+++..+..++.||+.||.|||++||+||||||+|||++               
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---------------  173 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD---------------  173 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC---------------
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC---------------
Confidence            999999999 8899999865432  3589999999999999999999999999999999999994               


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                  .++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       174 ------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~  241 (321)
T 2qkw_B          174 ------------ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI  241 (321)
T ss_dssp             ------------TTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTC
T ss_pred             ------------CCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcc
Confidence                        4556777777766543211     12346899999999999999999999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      ......+....+..                .......+.+...  ...              ..........+.++.+++
T Consensus       242 ~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~--~~~--------------~~~~~~~~~~~~~l~~li  289 (321)
T 2qkw_B          242 VQSLPREMVNLAEW----------------AVESHNNGQLEQI--VDP--------------NLADKIRPESLRKFGDTA  289 (321)
T ss_dssp             SCSSSSSCCCHHHH----------------THHHHTTTCCCSS--SSS--------------SCTTCSCHHHHHHHHHHH
T ss_pred             cccCcHHHHHHHHH----------------hhhccccccHHHh--cCh--------------hhccccCHHHHHHHHHHH
Confidence            76433211100000                0000000100000  000              000011223456799999


Q ss_pred             HHhhhcCCCCCCCHHHHhcC
Q 014117          401 QGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~h  420 (430)
                      .+||+.||++|||+.|+++|
T Consensus       290 ~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          290 VKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCcccCcCHHHHHHH
Confidence            99999999999999999976

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=342.33  Aligned_cols=245  Identities=20%  Similarity=0.273  Sum_probs=191.1

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEE----EEEEecC--chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMV----AIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----AiK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      .++|++++.||+|+||.||+|.+..+++.|    |+|.+..  .......+..|+.+++.+.     |+||+++++++..
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~~~~~~~~   88 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-----NPHVCRLLGICLT   88 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCC-----BTTBCCCCEEEES
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-----CCCeeEEEEEEec
Confidence            468999999999999999999998887755    6666542  2234567788999988884     4889999999887


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      .. .++|++++ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+          
T Consensus        89 ~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~----------  156 (327)
T 3lzb_A           89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV----------  156 (327)
T ss_dssp             SS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEE----------
T ss_pred             CC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCE----------
Confidence            65 77888888 899999998754 469999999999999999999999999999999999999766554          


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL  319 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~P  319 (430)
                                       ||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       157 -----------------kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p  219 (327)
T 3lzb_A          157 -----------------KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP  219 (327)
T ss_dssp             -----------------EECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             -----------------EEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCC
Confidence                             555555444322111     12346889999999999999999999999999999999 9999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |.+....+....+.....                                                ...+...+.++.+|
T Consensus       220 ~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~l~~l  251 (327)
T 3lzb_A          220 YDGIPASEISSILEKGER------------------------------------------------LPQPPICTIDVYMI  251 (327)
T ss_dssp             TTTCCGGGHHHHHHTTCC------------------------------------------------CCCCTTBCHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCCC------------------------------------------------CCCCccCCHHHHHH
Confidence            987665554433322110                                                01123456789999


Q ss_pred             HHHhhhcCCCCCCCHHHHhc
Q 014117          400 LQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~  419 (430)
                      |.+||+.||.+|||+.|+++
T Consensus       252 i~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          252 MRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=7.2e-44  Score=343.59  Aligned_cols=249  Identities=21%  Similarity=0.284  Sum_probs=196.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEE--EEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMV--AIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v--AiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .++|++.+.||+|+||.||+|.++.++..+  |+|.++..  ......+..|++++.++.    .|+||+++++++...+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG----HHPNIINLLGACEHRG   99 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC----CCTTBCCEEEEEEETT
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhcc----CCCchhhhceeeeeCC
Confidence            367999999999999999999999888865  99988642  223345677888887773    3488999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE  233 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~  233 (430)
                      .+|+||||+ +++|.+++....              ...+++..++.++.||+.||.|||++||+||||||+|||++.+ 
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-  178 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-  178 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC-
Confidence            999999999 889999997643              2469999999999999999999999999999999999999544 


Q ss_pred             ccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCC--CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHH
Q 014117          234 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP--DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILV  311 (430)
Q Consensus       234 ~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~  311 (430)
                                                +.+||+|||++.....  ......+|+.|+|||++.+..++.++|||||||++|
T Consensus       179 --------------------------~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  232 (327)
T 1fvr_A          179 --------------------------YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW  232 (327)
T ss_dssp             --------------------------GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred             --------------------------CeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHH
Confidence                                      4566666666543221  112235688999999999988999999999999999


Q ss_pred             HHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcC
Q 014117          312 ELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD  390 (430)
Q Consensus       312 el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  390 (430)
                      +|++ |..||.+.+..+....+....                                                ....+.
T Consensus       233 ellt~g~~pf~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~  264 (327)
T 1fvr_A          233 EIVSLGGTPYCGMTCAELYEKLPQGY------------------------------------------------RLEKPL  264 (327)
T ss_dssp             HHHTTSCCTTTTCCHHHHHHHGGGTC------------------------------------------------CCCCCT
T ss_pred             HHHcCCCCCCCCCcHHHHHHHhhcCC------------------------------------------------CCCCCC
Confidence            9998 999998766544333221100                                                001123


Q ss_pred             CchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          391 HSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       391 ~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      ..+.++.+||.+||+.||.+|||++|+++|
T Consensus       265 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          265 NCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            556789999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-43  Score=339.54  Aligned_cols=248  Identities=21%  Similarity=0.296  Sum_probs=194.6

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCC----eEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERK----EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      ..++|.+.+.||+|+||.||+|.++.++    ..||+|+++..  ......+..|+.+++.+     .|+||+++++++.
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~  116 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-----SHHNIIRLEGVIS  116 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEC
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEe
Confidence            3568999999999999999999987553    46999998743  23345677889888887     3588999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                      ..+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.             
T Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~-------------  182 (333)
T 1mqb_A          117 KYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS-------------  182 (333)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-------------
T ss_pred             cCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECC-------------
Confidence            999999999999 779999998653 47999999999999999999999999999999999999954             


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCC------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE  317 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~  317 (430)
                                    ++.+||+|||++.......      ....+|+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus       183 --------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~  248 (333)
T 1mqb_A          183 --------------NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE  248 (333)
T ss_dssp             --------------TCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             --------------CCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCC
Confidence                          4456666666665432211      11245788999999999999999999999999999999 99


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      .||...+..+....+..... +                                               ..+...+.++.
T Consensus       249 ~pf~~~~~~~~~~~~~~~~~-~-----------------------------------------------~~~~~~~~~l~  280 (333)
T 1mqb_A          249 RPYWELSNHEVMKAINDGFR-L-----------------------------------------------PTPMDCPSAIY  280 (333)
T ss_dssp             CTTTTCCHHHHHHHHHTTCC-C-----------------------------------------------CCCTTCBHHHH
T ss_pred             CCcccCCHHHHHHHHHCCCc-C-----------------------------------------------CCcccCCHHHH
Confidence            99987766554443322100 0                                               01234567899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcC
Q 014117          398 HLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      +||.+||+.||++|||+.+++++
T Consensus       281 ~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          281 QLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999998764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.8e-44  Score=336.13  Aligned_cols=244  Identities=23%  Similarity=0.312  Sum_probs=189.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee-cCCeEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-YRNHIC  171 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~-~~~~~~  171 (430)
                      .++|++.+.||+|+||.||+|.+.  ++.||+|+++... ..+.+..|+.+++++.     |+|++++++++. ..+.+|
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLR-----HSNLVQLLGVIVEEKGGLY   91 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCC-----CTTBCCEEEEECCC--CCE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCC-----CCCEeeEEEEEEcCCCceE
Confidence            468999999999999999999874  7899999997543 4456778999888873     488999999854 456899


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++                    
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~--------------------  151 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS--------------------  151 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--------------------
T ss_pred             EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe--------------------
Confidence            999999 77999999876433489999999999999999999999999999999999994                    


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHL  329 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~  329 (430)
                             .++.+||+|||++...........+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+..
T Consensus       152 -------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~  224 (278)
T 1byg_A          152 -------EDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV  224 (278)
T ss_dssp             -------TTSCEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH
T ss_pred             -------CCCcEEEeeccccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence                   4556777777777655444444567899999999999999999999999999999998 99999876544433


Q ss_pred             HHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCC
Q 014117          330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT  409 (430)
Q Consensus       330 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~  409 (430)
                      ..+....                                                ....+...+.++.++|.+||+.||.
T Consensus       225 ~~~~~~~------------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~  256 (278)
T 1byg_A          225 PRVEKGY------------------------------------------------KMDAPDGCPPAVYEVMKNCWHLDAA  256 (278)
T ss_dssp             HHHTTTC------------------------------------------------CCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHhcCC------------------------------------------------CCCCcccCCHHHHHHHHHHhcCChh
Confidence            2221100                                                0012345677899999999999999


Q ss_pred             CCCCHHHHhc
Q 014117          410 DRLTAREALR  419 (430)
Q Consensus       410 ~R~ta~elL~  419 (430)
                      +|||+.|+++
T Consensus       257 ~Rps~~~l~~  266 (278)
T 1byg_A          257 MRPSFLQLRE  266 (278)
T ss_dssp             GSCCHHHHHH
T ss_pred             hCCCHHHHHH
Confidence            9999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.9e-43  Score=333.56  Aligned_cols=261  Identities=24%  Similarity=0.345  Sum_probs=196.2

Q ss_pred             cCcEEEEeeeccccceEEEEEE----ECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           93 TSRYKIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      ..+|++.+.||+|+||.||+|+    +..+++.||+|+++...  .....+..|+.+++.+.     |+||+++++++..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~   94 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-----HENIVKYKGICTE   94 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCC-----CTTBCCEEEEEEC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCC-----CCCeeeeeeEEec
Confidence            4579999999999999999998    67789999999987432  23466778999998884     4889999999877


Q ss_pred             C--CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCC
Q 014117          167 R--NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       167 ~--~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                      .  ..+++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.         
T Consensus        95 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~---------  164 (302)
T 4e5w_A           95 DGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---------  164 (302)
T ss_dssp             ---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---------
T ss_pred             CCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC---------
Confidence            6  7799999999 889999996654 46999999999999999999999999999999999999976554         


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccCCCC------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~  317 (430)
                                        +||+|||++.......      ....||..|+|||++.+..++.++|||||||++|+|++|.
T Consensus       165 ------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  226 (302)
T 4e5w_A          165 ------------------VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYC  226 (302)
T ss_dssp             ------------------EEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred             ------------------EEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHcc
Confidence                              5555555554332221      2235788899999999999999999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      .|+....     ..+....++........  .. ......+                         .....+...+.++.
T Consensus       227 ~p~~~~~-----~~~~~~~~~~~~~~~~~--~~-~~~~~~~-------------------------~~~~~~~~~~~~l~  273 (302)
T 4e5w_A          227 DSDSSPM-----ALFLKMIGPTHGQMTVT--RL-VNTLKEG-------------------------KRLPCPPNCPDEVY  273 (302)
T ss_dssp             CGGGSHH-----HHHHHHHCSCCGGGHHH--HH-HHHHHTT-------------------------CCCCCCTTCCHHHH
T ss_pred             CCCcchh-----hHHhhccCCcccccCHH--HH-HHHHhcc-------------------------CCCCCCCCCCHHHH
Confidence            9875321     12222333332211100  00 0000000                         01112456778899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhc
Q 014117          398 HLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      +||.+||+.||.+|||++++++
T Consensus       274 ~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          274 QLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCCCCCCCHHHHHH
Confidence            9999999999999999999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.3e-43  Score=332.48  Aligned_cols=244  Identities=23%  Similarity=0.337  Sum_probs=193.2

Q ss_pred             cCcEEEEe-eeccccceEEEEEE--ECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           93 TSRYKIHS-KMGEGTFGQVLECW--DRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        93 ~~~y~~~~-~lG~G~~g~V~~~~--~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      .++|++.+ .||+|+||.||+|.  ...+++.||+|+++...   ...+.+..|+.+++.+.     |+||+++++++ .
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~-~   88 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-----NPYIVRMIGIC-E   88 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-----CTTBCCEEEEE-E
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCC-----CCCEEEEEEEE-C
Confidence            45799998 99999999999995  45678899999987432   23456778999988883     48899999988 5


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      .+..++||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+          
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~----------  156 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA----------  156 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE----------
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcE----------
Confidence            67889999999 789999998754  69999999999999999999999999999999999999765554          


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCC------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA  318 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~  318 (430)
                                       ||+|||++.......      ....+|+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus       157 -----------------kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~  219 (291)
T 1xbb_A          157 -----------------KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK  219 (291)
T ss_dssp             -----------------EECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -----------------EEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCC
Confidence                             455555444332221      11245788999999999889999999999999999999 999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||...+..+....+....  .                                              ...+...+.++.+
T Consensus       220 p~~~~~~~~~~~~~~~~~--~----------------------------------------------~~~~~~~~~~l~~  251 (291)
T 1xbb_A          220 PYRGMKGSEVTAMLEKGE--R----------------------------------------------MGCPAGCPREMYD  251 (291)
T ss_dssp             SSTTCCHHHHHHHHHTTC--C----------------------------------------------CCCCTTCCHHHHH
T ss_pred             CCCCCCHHHHHHHHHcCC--C----------------------------------------------CCCCCCCCHHHHH
Confidence            998876655443332110  0                                              0123456778999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhc
Q 014117          399 LLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~  419 (430)
                      ||.+||+.||.+|||+.++++
T Consensus       252 li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          252 LMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=6.8e-44  Score=343.79  Aligned_cols=262  Identities=22%  Similarity=0.282  Sum_probs=195.7

Q ss_pred             cCcEEEEeeeccccceEEEEEE----ECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee--
Q 014117           93 TSRYKIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~--  165 (430)
                      .++|++.+.||+|+||.||+|+    +..+++.||+|++.... ...+.+..|+++++++     .++||+.+++++.  
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-----HSDFIVKYRGVSYGP   96 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEECS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-----CCCceeEEEEEEecC
Confidence            3689999999999999999998    57789999999987543 3445678899999888     3478999988775  


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                      ....+|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++++|     
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~D-----  170 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIAD-----  170 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC-----
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcc-----
Confidence            567899999999 899999998643 3699999999999999999999999999999999999997665555555     


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCC------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                            ||++.......      ....||..|+|||++.+..++.++|||||||++|+|++|..
T Consensus       171 ----------------------fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~  228 (327)
T 3lxl_A          171 ----------------------FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD  228 (327)
T ss_dssp             ----------------------GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred             ----------------------cccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCC
Confidence                                  44444322211      12357888999999999999999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||...........  ......+.  ...    .......+                         .....+..++.++.+
T Consensus       229 p~~~~~~~~~~~~--~~~~~~~~--~~~----~~~~~~~~-------------------------~~~~~~~~~~~~l~~  275 (327)
T 3lxl_A          229 KSCSPSAEFLRMM--GCERDVPA--LSR----LLELLEEG-------------------------QRLPAPPACPAEVHE  275 (327)
T ss_dssp             GGGSHHHHHHHHC--C----CCH--HHH----HHHHHHTT-------------------------CCCCCCTTCCHHHHH
T ss_pred             CCccccchhhhhc--cccccccc--HHH----HHHHhhcc-------------------------cCCCCCCcccHHHHH
Confidence            9975332211100  00000000  000    00000000                         011124567788999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhcC
Q 014117          399 LLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      ||.+||+.||++|||++|++++
T Consensus       276 li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          276 LMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7.6e-43  Score=334.18  Aligned_cols=249  Identities=17%  Similarity=0.235  Sum_probs=190.0

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECC---CCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRE---RKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      ..++|.+.+.||+|+||.||+|.+..   +++.||+|+++..   ......+..|+.+++++.     |+||+++++++.
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~  106 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS-----HPNVIRLLGVCI  106 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCC-----CTTBCCCCEEEE
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCC-----CCCeeeeeEEEe
Confidence            35689999999999999999998765   5668999998643   233456778888888883     588999999887


Q ss_pred             cCC-----eEEEEEecC-CCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCcc
Q 014117          166 YRN-----HICIVFEKL-GSSLYDFLRKN----NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI  235 (430)
Q Consensus       166 ~~~-----~~~lv~e~~-~~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~  235 (430)
                      ...     ..++||||+ +++|.+++...    ....+++..+..++.||+.||.|||++||+||||||+|||++.+   
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~---  183 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD---  183 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT---
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC---
Confidence            654     459999999 88999998542    23579999999999999999999999999999999999999544   


Q ss_pred             ccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchHHHHHHHH
Q 014117          236 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL  310 (430)
Q Consensus       236 ~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l  310 (430)
                                              +.+||+|||++......     .....+|+.|+|||++.+..++.++|||||||++
T Consensus       184 ------------------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  239 (313)
T 3brb_A          184 ------------------------MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM  239 (313)
T ss_dssp             ------------------------SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHH
T ss_pred             ------------------------CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHH
Confidence                                    45666666665433221     1223568899999999999999999999999999


Q ss_pred             HHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhc
Q 014117          311 VELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV  389 (430)
Q Consensus       311 ~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (430)
                      |+|++ |..||......+....+.....                                                ...+
T Consensus       240 ~el~~~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~  271 (313)
T 3brb_A          240 WEIATRGMTPYPGVQNHEMYDYLLHGHR------------------------------------------------LKQP  271 (313)
T ss_dssp             HHHHTTSCCSSTTCCGGGHHHHHHTTCC------------------------------------------------CCCB
T ss_pred             HHHHhcCCCCCccCCHHHHHHHHHcCCC------------------------------------------------CCCC
Confidence            99999 9999987666544433321100                                                0123


Q ss_pred             CCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       390 ~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      ...+.++.+||.+||+.||.+|||+.+++++
T Consensus       272 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          272 EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4566789999999999999999999999864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.9e-43  Score=332.47  Aligned_cols=245  Identities=16%  Similarity=0.203  Sum_probs=190.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCC---CeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecce-eecC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW-FDYR  167 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~-~~~~  167 (430)
                      .+|++.+.||+|+||.||+|.+..+   ...||+|.++...  .....+..|+.+++++.     |+||++++++ +...
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~   99 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-----HPNVLSLLGICLRSE   99 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC-----CTTBCCCCEEECCSS
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCC-----CCCEeeeeeEEEcCC
Confidence            4699999999999999999997543   3468999987432  34456778999888883     5889999997 4567


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++             
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~-------------  165 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF-------------  165 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-------------
T ss_pred             CceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC-------------
Confidence            7899999999 779999997643 5689999999999999999999999999999999999995544             


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCC-------CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA  318 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~  318 (430)
                                    .+||+|||++......       .....||+.|+|||++.+..++.++|||||||++|+|++ |.+
T Consensus       166 --------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~  231 (298)
T 3f66_A          166 --------------TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP  231 (298)
T ss_dssp             --------------CEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             --------------CEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence                          4555555555432211       122467889999999999999999999999999999999 677


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||...+..+....+......                                                ..+...+.++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~l~~  263 (298)
T 3f66_A          232 PYPDVNTFDITVYLLQGRRL------------------------------------------------LQPEYCPDPLYE  263 (298)
T ss_dssp             SSTTSCTTTHHHHHHTTCCC------------------------------------------------CCCTTCCHHHHH
T ss_pred             CCccCCHHHHHHHHhcCCCC------------------------------------------------CCCccCCHHHHH
Confidence            88765554443332221111                                                012345677999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhc
Q 014117          399 LLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~  419 (430)
                      ||.+||+.||++|||+.|+++
T Consensus       264 li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          264 VMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999886

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-43  Score=342.06  Aligned_cols=257  Identities=20%  Similarity=0.279  Sum_probs=189.0

Q ss_pred             eecCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           86 FALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        86 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      ......+.++|++.+.||+|+||.||+|.++  ++.||||++....  ......|.+++..+.   ..|+||+++++++.
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~e~~~~~~~~---~~h~~i~~~~~~~~  101 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE--EASWFRETEIYQTVL---MRHENILGFIAADI  101 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG--HHHHHHHHHHHTSTT---CCCTTBCCEEEEEE
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc--cchhhhHHHHHHHHh---hcCCCeeeEEEEEc
Confidence            3444566789999999999999999999875  8899999986433  233444555544432   25688999999887


Q ss_pred             cC----CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CeeeccCCCCceEEeec
Q 014117          166 YR----NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL--------CMIHTDLKPENVLLVSS  232 (430)
Q Consensus       166 ~~----~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--------~ivHrDlKp~NILl~~~  232 (430)
                      ..    ..+|+||||+ +++|.+++...   .+++..+..++.||+.||.|||+.        |||||||||+|||++. 
T Consensus       102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~-  177 (337)
T 3mdy_A          102 KGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK-  177 (337)
T ss_dssp             ESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT-
T ss_pred             cCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC-
Confidence            76    7899999999 88999999764   599999999999999999999998        9999999999999954 


Q ss_pred             CccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-------CeeeecCcccchhhhhCCCCCCc-----
Q 014117          233 EYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLGWTYP-----  300 (430)
Q Consensus       233 ~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~-----  300 (430)
                                                ++.+||+|||++.......       ...+||+.|+|||++.+..++..     
T Consensus       178 --------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  231 (337)
T 3mdy_A          178 --------------------------NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYI  231 (337)
T ss_dssp             --------------------------TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHH
T ss_pred             --------------------------CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCcc
Confidence                                      4456666666664332211       23479999999999988776665     


Q ss_pred             -chHHHHHHHHHHHHhC----------CCCCCCCch----HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCC
Q 014117          301 -CDIWSVGCILVELCTG----------EALFQTHEN----LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEG  365 (430)
Q Consensus       301 -~DvwslGv~l~el~tG----------~~Pf~~~~~----~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  365 (430)
                       +|||||||++|||++|          ..||.....    ......+......                    ....+. 
T Consensus       232 ~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~-  290 (337)
T 3mdy_A          232 MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKL--------------------RPSFPN-  290 (337)
T ss_dssp             HHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC--------------------CCCCCG-
T ss_pred             ccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhcc--------------------Cccccc-
Confidence             9999999999999999          666654211    1111111000000                    000000 


Q ss_pred             CCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          366 AASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                                          ....+.++.++.+||.+||+.||++|||++|+++|
T Consensus       291 --------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          291 --------------------RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             --------------------GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             --------------------cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence                                00112456679999999999999999999999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-43  Score=347.29  Aligned_cols=245  Identities=17%  Similarity=0.209  Sum_probs=186.5

Q ss_pred             cEEEEeeeccccceEEEEEEECCC---CeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee-ecCC
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-DYRN  168 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-~~~~  168 (430)
                      .|++.+.||+|+||.||+|.+..+   +..||+|.++..  ......+..|+.+++++     .|+||+++++++ ...+
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~  164 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-----SHPNVLSLLGICLRSEG  164 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-----CCTTBCCCCEEECCCSS
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEEcCCC
Confidence            588999999999999999987543   346899998643  23446677888888877     358899999975 4567


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      ..|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+               
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---------------  228 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK---------------  228 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---------------
T ss_pred             CeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCC---------------
Confidence            889999999 889999997654 468999999999999999999999999999999999999544               


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCC-------CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL  319 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~P  319 (430)
                                  +.+||+|||+++.....       .....+|+.|+|||++.+..++.++|||||||++|||++ |.+|
T Consensus       229 ------------~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p  296 (373)
T 3c1x_A          229 ------------FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP  296 (373)
T ss_dssp             ------------CCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ------------CCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCC
Confidence                        45566666655432211       122356889999999999999999999999999999999 7888


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |...+..+....+.....                                                ...+..++.++.+|
T Consensus       297 ~~~~~~~~~~~~~~~~~~------------------------------------------------~~~p~~~~~~l~~l  328 (373)
T 3c1x_A          297 YPDVNTFDITVYLLQGRR------------------------------------------------LLQPEYCPDPLYEV  328 (373)
T ss_dssp             CTTSCSSCHHHHHHTTCC------------------------------------------------CCCCTTCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCCC------------------------------------------------CCCCCCCCHHHHHH
Confidence            976554433332221100                                                00123456789999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcC
Q 014117          400 LQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~h  420 (430)
                      |.+||+.||++|||+.|++++
T Consensus       329 i~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          329 MLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999864

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-42  Score=330.15  Aligned_cols=244  Identities=19%  Similarity=0.250  Sum_probs=190.3

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCe---EEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~---~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      .|.+.+.||+|+||+||+|.+..+++   .||+|++....  ...+.+..|+.+++.+     .|+||+++++++...+.
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~   96 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-----NHPNVLALIGIMLPPEG   96 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-----CCTTBCCCCEEECCSSS
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEecCCC
Confidence            57888999999999999999755443   79999987433  3345677899988888     35889999999876655


Q ss_pred             E-EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          170 I-CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       170 ~-~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      . ++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+               
T Consensus        97 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~---------------  160 (298)
T 3pls_A           97 LPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES---------------  160 (298)
T ss_dssp             CCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---------------
T ss_pred             CcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC---------------
Confidence            4 9999999 899999997643 578999999999999999999999999999999999999544               


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCC-------CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhC-CCC
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERP-------DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG-EAL  319 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG-~~P  319 (430)
                                  +.+||+|||++.....       ......+|+.|+|||.+.+..++.++|||||||++|+|++| .+|
T Consensus       161 ------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~  228 (298)
T 3pls_A          161 ------------FTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP  228 (298)
T ss_dssp             ------------CCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred             ------------CcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence                        4566666666543211       12234678999999999999999999999999999999995 555


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |...+..+....+......                                                ..+...+.++.+|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~l~~l  260 (298)
T 3pls_A          229 YRHIDPFDLTHFLAQGRRL------------------------------------------------PQPEYCPDSLYQV  260 (298)
T ss_dssp             TTTSCGGGHHHHHHTTCCC------------------------------------------------CCCTTCCHHHHHH
T ss_pred             CccCCHHHHHHHhhcCCCC------------------------------------------------CCCccchHHHHHH
Confidence            6554444433322211100                                                0123456789999


Q ss_pred             HHHhhhcCCCCCCCHHHHhc
Q 014117          400 LQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~  419 (430)
                      |.+||+.||.+|||+.++++
T Consensus       261 i~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          261 MQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHH
Confidence            99999999999999998875

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-44  Score=359.00  Aligned_cols=251  Identities=17%  Similarity=0.203  Sum_probs=188.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCC-----------CCCceE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDK-----------GGNRCV  158 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~-----------~~~~i~  158 (430)
                      ..|.+.+.||+|+||+||+|.+..+++.||||+++...    ...+.+.+|+.+++.+.+..+           ....++
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            45889999999999999999999999999999987322    223557778888777754210           000111


Q ss_pred             Ee------cceeec-----CCeEEEEEecCCCCHHHHHH-----hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccC
Q 014117          159 QI------RNWFDY-----RNHICIVFEKLGSSLYDFLR-----KNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL  222 (430)
Q Consensus       159 ~~------~~~~~~-----~~~~~lv~e~~~~~L~~~l~-----~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDl  222 (430)
                      .+      ...+..     ...++++|++++++|.++++     ......+++..+..++.||+.||+|||++|||||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence            11      111111     23578999999999999985     222345788899999999999999999999999999


Q ss_pred             CCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhh----------
Q 014117          223 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVI----------  292 (430)
Q Consensus       223 Kp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~----------  292 (430)
                      ||+||||+                           .++.+||+|||+++.........+| +.|+|||++          
T Consensus       238 Kp~NILl~---------------------------~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~  289 (413)
T 3dzo_A          238 RPVDIVLD---------------------------QRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQH  289 (413)
T ss_dssp             CGGGEEEC---------------------------TTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGG
T ss_pred             ccceEEEe---------------------------cCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccc
Confidence            99999994                           4556788888877655444445678 999999999          


Q ss_pred             hCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhH
Q 014117          293 LGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESI  372 (430)
Q Consensus       293 ~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (430)
                      .+..|+.++|||||||++|||++|+.||...+..+....                                         
T Consensus       290 ~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~-----------------------------------------  328 (413)
T 3dzo_A          290 HPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW-----------------------------------------  328 (413)
T ss_dssp             CCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGG-----------------------------------------
T ss_pred             cCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHH-----------------------------------------
Confidence            455688999999999999999999999976543211000                                         


Q ss_pred             HhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          373 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                                  ........+.++.+||.+||+.||++|||+.++|+||||+.
T Consensus       329 ------------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          329 ------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             ------------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             ------------HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence                        00111345678999999999999999999999999999964

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.3e-43  Score=334.00  Aligned_cols=243  Identities=26%  Similarity=0.492  Sum_probs=188.7

Q ss_pred             ecCcEEEE-eeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec----
Q 014117           92 LTSRYKIH-SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----  166 (430)
Q Consensus        92 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~----  166 (430)
                      +.++|.+. +.||+|+||.||+|.++.+++.||+|+++..    .....|+.++.++.    .|+||+++++++..    
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~----~h~~i~~~~~~~~~~~~~   86 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS----QCPHIVRIVDVYENLYAG   86 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT----TSTTBCCEEEEEEEEETT
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhc----cCCCchhHHhhhhhhcCC
Confidence            45668887 7899999999999999999999999998743    34566888876654    34789999998876    


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      ...+|+||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++..             
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-------------  153 (299)
T 3m2w_A           87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK-------------  153 (299)
T ss_dssp             EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS-------------
T ss_pred             CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecC-------------
Confidence            77899999999 7899999998766679999999999999999999999999999999999999542             


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                                 ..++.+||+|||++....                   +..++.++|||||||++|+|++|..||.....
T Consensus       154 -----------~~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~  203 (299)
T 3m2w_A          154 -----------RPNAILKLTDFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG  203 (299)
T ss_dssp             -----------STTCCEEECCCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred             -----------CCCCcEEEeccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence                       125679999999876432                   23578899999999999999999999976443


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      ......+                   ...+..+....                      ....+...+.++.+||.+||+
T Consensus       204 ~~~~~~~-------------------~~~~~~~~~~~----------------------~~~~~~~~~~~~~~li~~~l~  242 (299)
T 3m2w_A          204 LAISPGM-------------------KTRIRMGQYEF----------------------PNPEWSEVSEEVKMLIRNLLK  242 (299)
T ss_dssp             ----CCS-------------------CCSSCTTCCSS----------------------CHHHHTTSCHHHHHHHHHHTC
T ss_pred             hhhhHHH-------------------HHHHhhccccC----------------------CchhcccCCHHHHHHHHHHcc
Confidence            2211000                   00000000000                      011124567889999999999


Q ss_pred             cCCCCCCCHHHHhcCCCCCCC
Q 014117          406 YDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       406 ~dP~~R~ta~elL~hp~f~~~  426 (430)
                      .||.+|||++|+|+||||++.
T Consensus       243 ~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          243 TEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             SSTTTSCCHHHHHTSHHHHTG
T ss_pred             cChhhCCCHHHHhcChhhccc
Confidence            999999999999999999765

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=9.5e-44  Score=343.75  Aligned_cols=271  Identities=21%  Similarity=0.226  Sum_probs=184.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee-----ecC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-----DYR  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-----~~~  167 (430)
                      .++|++.+.||+|+||.||+|.+  +++.||||+++....  .....|.+++..   ....|+||+++++.+     ...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~e~~~~~~---~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR--QNFINEKNIYRV---PLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH--HHHHHHHHHHTS---TTCCCTTBCCEEEEEEEECTTSC
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch--hhHHHHHHHHHH---HhccCcchhhheecccccccCCC
Confidence            46799999999999999999976  688999999974432  333344443322   123568888887643     334


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CeeeccCCCCceEEeecCcccc
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL---------CMIHTDLKPENVLLVSSEYIKV  237 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---------~ivHrDlKp~NILl~~~~~~~i  237 (430)
                      ..+|+||||+ +++|.+++...   .+++..+..++.||+.||.|||+.         |||||||||+|||++.+     
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~-----  156 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-----  156 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT-----
T ss_pred             ceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC-----
Confidence            5789999999 88999999775   468999999999999999999999         99999999999999544     


Q ss_pred             CCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----------CCeeeecCcccchhhhhC-------CCCCC
Q 014117          238 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----------QNYIVSTRHYRAPEVILG-------LGWTY  299 (430)
Q Consensus       238 ~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----------~~~~~gt~~y~aPE~~~~-------~~~~~  299 (430)
                                            +.+||+|||++......           ....+||+.|+|||++.+       ..++.
T Consensus       157 ----------------------~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~  214 (336)
T 3g2f_A          157 ----------------------GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALK  214 (336)
T ss_dssp             ----------------------SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHH
T ss_pred             ----------------------CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccccc
Confidence                                  45566666655432211           123468999999999987       35678


Q ss_pred             cchHHHHHHHHHHHHhCCCCCC-CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhcc--CcccCCCCCCChhhHHhhc
Q 014117          300 PCDIWSVGCILVELCTGEALFQ-THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR--GRLDWPEGAASRESIKSVM  376 (430)
Q Consensus       300 ~~DvwslGv~l~el~tG~~Pf~-~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  376 (430)
                      ++|||||||++|||++|..||. +....+....+....+..|....  .    ......  .....++...         
T Consensus       215 ~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~---------  279 (336)
T 3g2f_A          215 QVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFED--M----QVLVSREKQRPKFPEAWK---------  279 (336)
T ss_dssp             HHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHH--H----HHHHTTSCCCCCCCTTCC---------
T ss_pred             ccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHH--H----HhhhcccccCCCCCcccc---------
Confidence            8999999999999999976653 32221111111222222221100  0    000000  0001111000         


Q ss_pred             CchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHH------hcCCCCCCC
Q 014117          377 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA------LRHPFFTRD  426 (430)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~el------L~hp~f~~~  426 (430)
                                 .....+.++.+||.+||+.||++|||++|+      +.++|-++.
T Consensus       280 -----------~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~  324 (336)
T 3g2f_A          280 -----------ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK  324 (336)
T ss_dssp             -----------CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred             -----------cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence                       011235579999999999999999999999      557887765

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.5e-43  Score=360.77  Aligned_cols=253  Identities=26%  Similarity=0.349  Sum_probs=203.5

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ...++|++.++||+|+||.||+|.+.. +..||||+++......+.+..|+++++++.     |+||+++++++.. +.+
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~~~~~~~~-~~~  336 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-----HEKLVQLYAVVSE-EPI  336 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCC-----CTTBCCEEEEECS-SSC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCC-----CCCEeeEEEEEee-ccc
Confidence            345689999999999999999999875 466999999865555677889999999984     4889999998876 778


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      ||||||+ +++|.++|.......+++..+..++.||+.||+|||++|||||||||+||||+.+                 
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-----------------  399 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-----------------  399 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-----------------
T ss_pred             eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCC-----------------
Confidence            9999999 8899999976443469999999999999999999999999999999999999544                 


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCC----CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCc
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE  324 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~  324 (430)
                                +.+||+|||+++.....    .....+|..|+|||++.+..++.++|||||||+||||++ |..||.+..
T Consensus       400 ----------~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~  469 (535)
T 2h8h_A          400 ----------LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV  469 (535)
T ss_dssp             ----------GCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred             ----------CcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence                      45666666666543221    112346788999999999999999999999999999999 999998877


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+....+.....                                                ...+..++.++.+||.+||
T Consensus       470 ~~~~~~~i~~~~~------------------------------------------------~~~~~~~~~~l~~li~~cl  501 (535)
T 2h8h_A          470 NREVLDQVERGYR------------------------------------------------MPCPPECPESLHDLMCQCW  501 (535)
T ss_dssp             HHHHHHHHHTTCC------------------------------------------------CCCCTTCCHHHHHHHHHHT
T ss_pred             HHHHHHHHHcCCC------------------------------------------------CCCCCCCCHHHHHHHHHHc
Confidence            6655544322110                                                0112356778999999999


Q ss_pred             hcCCCCCCCHHHHhcC--CCCCC
Q 014117          405 RYDPTDRLTAREALRH--PFFTR  425 (430)
Q Consensus       405 ~~dP~~R~ta~elL~h--p~f~~  425 (430)
                      +.||++|||+++|++.  .+|+.
T Consensus       502 ~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          502 RKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             CSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             CCChhHCcCHHHHHHHHHHHhhc
Confidence            9999999999998864  55553

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.1e-44  Score=348.61  Aligned_cols=210  Identities=21%  Similarity=0.292  Sum_probs=169.0

Q ss_pred             cCcEEEEeeeccccceEEEEE-----EECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           93 TSRYKIHSKMGEGTFGQVLEC-----WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~-----~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .++|.+.+.||+|+||+||+|     .+..+++.||+|+++..  ....+..|++++..+.+.  .+++++.+++.+...
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~--~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPS--MQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGG--GGGGBCCEEEEEECS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhh--hhhhhhhhheeeecC
Confidence            568999999999999999999     46778899999999743  345677788888888532  357899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKN---NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                      +..||||||+ +++|.+++...   ....+++..+..++.||+.||+|||++|||||||||+|||++.+....-      
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~------  213 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD------  213 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-------
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc------
Confidence            9999999999 89999999752   2357999999999999999999999999999999999999964210000      


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccC--CC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYER--PD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~--~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                ...+..+.+||+|||+++...  ..   ....+||+.|+|||++.+..|+.++|||||||++|||++|+.
T Consensus       214 ----------~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~  283 (365)
T 3e7e_A          214 ----------DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY  283 (365)
T ss_dssp             ---------------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred             ----------ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence                      000236788999999885432  11   133579999999999999999999999999999999999999


Q ss_pred             CCCC
Q 014117          319 LFQT  322 (430)
Q Consensus       319 Pf~~  322 (430)
                      ||..
T Consensus       284 pf~~  287 (365)
T 3e7e_A          284 MKVK  287 (365)
T ss_dssp             CCEE
T ss_pred             cccc
Confidence            9964

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.8e-44  Score=347.41  Aligned_cols=270  Identities=20%  Similarity=0.222  Sum_probs=197.2

Q ss_pred             CceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchh--hHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           89 GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        89 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      .+...++|++.+.||+|+||.||+|.+. +++.||||++.....  ....+..|++++..+     .|+||+++++++..
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~   98 (326)
T 3uim_A           25 LQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMA-----VHRNLLRLRGFCMT   98 (326)
T ss_dssp             HHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTC-----CCTTBCCCCEEECC
T ss_pred             HHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhc-----cCCCccceEEEEec
Confidence            3445678999999999999999999754 688899999874322  222467788887776     35889999999999


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeeccCCCCceEEeecCccccCCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNY--RSFPIDLVREIARQLLECIAFMHDL---CMIHTDLKPENVLLVSSEYIKVPDY  240 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlKp~NILl~~~~~~~i~df  240 (430)
                      .+..++||||+ +++|.+++.....  ..+++..+..++.||+.||.|||++   ||+||||||+|||++          
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~----------  168 (326)
T 3uim_A           99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD----------  168 (326)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC----------
T ss_pred             CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC----------
Confidence            99999999999 8899999986542  3499999999999999999999999   999999999999994          


Q ss_pred             cCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhC
Q 014117          241 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG  316 (430)
Q Consensus       241 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG  316 (430)
                                       .++.+||+|||++.......    ....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       169 -----------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  231 (326)
T 3uim_A          169 -----------------EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG  231 (326)
T ss_dssp             -----------------TTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHC
T ss_pred             -----------------CCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhC
Confidence                             45567777777776433222    224589999999999998999999999999999999999


Q ss_pred             CCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHH
Q 014117          317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL  396 (430)
Q Consensus       317 ~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (430)
                      ..||......          ..........+    ..............                .......+...+.++
T Consensus       232 ~~pf~~~~~~----------~~~~~~~~~~~----~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l  281 (326)
T 3uim_A          232 QRAFDLARLA----------NDDDVMLLDWV----KGLLKEKKLEALVD----------------VDLQGNYKDEEVEQL  281 (326)
T ss_dssp             CCSBCHHHHT----------TTSCSBHHHHH----TTTTSSCCSTTSSC----------------TTCTTSCCHHHHHHH
T ss_pred             CCcccccccc----------cccchhHHHHH----HHHhhchhhhhhcC----------------hhhccccCHHHHHHH
Confidence            9999621100          00000000000    00000000000000                000011223345679


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCC
Q 014117          397 THLLQGLLRYDPTDRLTAREALRHP  421 (430)
Q Consensus       397 ~~ll~~~L~~dP~~R~ta~elL~hp  421 (430)
                      .+|+.+||+.||.+|||+.||++|-
T Consensus       282 ~~li~~cl~~dP~~Rps~~ell~~L  306 (326)
T 3uim_A          282 IQVALLCTQSSPMERPKMSEVVRML  306 (326)
T ss_dssp             HHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred             HHHHHHHhCcCCccCCCHHHHHHHh
Confidence            9999999999999999999999873

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=359.81  Aligned_cols=251  Identities=24%  Similarity=0.334  Sum_probs=194.0

Q ss_pred             cCcEEEEe-eeccccceEEEEEEEC--CCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           93 TSRYKIHS-KMGEGTFGQVLECWDR--ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        93 ~~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .+++.+.+ .||+|+||.||+|.++  .++..||||+++..  ....+.+..|+++++++     .|+||+++++++.. 
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-----~hpniv~l~~~~~~-  407 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-----DNPYIVRLIGVCQA-  407 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-----CCTTBCCEEEEEES-
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-----CCCCEeeEEEEecc-
Confidence            34566666 8999999999999876  35667999999753  23456788899999888     35889999999876 


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +.+||||||+ +++|.+++.... ..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||++...
T Consensus       408 ~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          408 EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             SSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             CCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence            5699999999 889999997653 46999999999999999999999999999999999999977666555555555432


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCch
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN  325 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~  325 (430)
                      ......                     ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.
T Consensus       487 ~~~~~~---------------------~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~  545 (613)
T 2ozo_A          487 GADDSY---------------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG  545 (613)
T ss_dssp             C-----------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS
T ss_pred             cCCCce---------------------eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence            211000                     000011245789999999999999999999999999999998 9999998777


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+....+....                                                ....+..++.++.+||.+||+
T Consensus       546 ~~~~~~i~~~~------------------------------------------------~~~~p~~~~~~l~~li~~cl~  577 (613)
T 2ozo_A          546 PEVMAFIEQGK------------------------------------------------RMECPPECPPELYALMSDCWI  577 (613)
T ss_dssp             HHHHHHHHTTC------------------------------------------------CCCCCTTCCHHHHHHHHHTTC
T ss_pred             HHHHHHHHcCC------------------------------------------------CCCCCCcCCHHHHHHHHHHcC
Confidence            66554443211                                                011234567889999999999


Q ss_pred             cCCCCCCCHHHHhc
Q 014117          406 YDPTDRLTAREALR  419 (430)
Q Consensus       406 ~dP~~R~ta~elL~  419 (430)
                      .||++|||+.++++
T Consensus       578 ~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          578 YKWEDRPDFLTVEQ  591 (613)
T ss_dssp             SSTTTSCCHHHHHH
T ss_pred             CChhHCcCHHHHHH
Confidence            99999999998853

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.1e-43  Score=335.88  Aligned_cols=249  Identities=20%  Similarity=0.273  Sum_probs=191.3

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecC-chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee----cC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRG-IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD----YR  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~----~~  167 (430)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.. .......+..|+.+++.+     .|+||+++++++.    ..
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-----NHPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-----CCTTBCCCCEEEEEEETTE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-----CCCCeeeEEEEEEeccCCC
Confidence            3579999999999999999999999999999998853 234456677899988887     4588999999886    34


Q ss_pred             CeEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                      ...++||||+ +++|.+++...  ....+++..+..++.||+.||.|||++||+||||||+|||++              
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~--------------  168 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG--------------  168 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC--------------
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--------------
Confidence            5899999999 78999998762  235799999999999999999999999999999999999994              


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCC------------CeeeecCcccchhhhhCCC---CCCcchHHHHHHH
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------------NYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCI  309 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------------~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGv~  309 (430)
                                   .++.+||+|||++.......            ....||+.|+|||++.+..   ++.++|||||||+
T Consensus       169 -------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i  235 (317)
T 2buj_A          169 -------------DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV  235 (317)
T ss_dssp             -------------TTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHH
T ss_pred             -------------CCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHH
Confidence                         45567777777665432110            1135799999999987654   7899999999999


Q ss_pred             HHHHHhCCCCCCCCchHH-HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhh
Q 014117          310 LVELCTGEALFQTHENLE-HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH  388 (430)
Q Consensus       310 l~el~tG~~Pf~~~~~~~-~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (430)
                      +|+|++|..||....... ......                      .. ....                        ..
T Consensus       236 l~el~~g~~p~~~~~~~~~~~~~~~----------------------~~-~~~~------------------------~~  268 (317)
T 2buj_A          236 LYAMMFGEGPYDMVFQKGDSVALAV----------------------QN-QLSI------------------------PQ  268 (317)
T ss_dssp             HHHHHHSSCTTHHHHHTTSCHHHHH----------------------HC-C--C------------------------CC
T ss_pred             HHHHHhCCCChhhhhcccchhhHHh----------------------hc-cCCC------------------------Cc
Confidence            999999999995311000 000000                      00 0000                        01


Q ss_pred             cCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       389 ~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      ....+.++.+||.+||+.||.+|||+.+++++
T Consensus       269 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          269 SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            23456789999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.7e-42  Score=332.81  Aligned_cols=260  Identities=25%  Similarity=0.354  Sum_probs=194.6

Q ss_pred             ecCcE-EEEeeeccccceEEEEEE----ECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           92 LTSRY-KIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        92 ~~~~y-~~~~~lG~G~~g~V~~~~----~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      +.++| ++++.||+|+||+||+|.    +..+++.||||+++...  .....+..|+++++.+.     ++||+++++++
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~  102 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY-----HEHIIKYKGCC  102 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-----CTTBCCEEEEE
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCC-----CcchhhEEEEE
Confidence            44555 999999999999998875    34578999999997542  34566788999999984     48899999998


Q ss_pred             ec--CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          165 DY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       165 ~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      ..  ...+++||||+ +++|.+++...   .+++..+..++.||+.||.|||++||+||||||+|||++           
T Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~-----------  168 (318)
T 3lxp_A          103 EDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD-----------  168 (318)
T ss_dssp             EETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------
T ss_pred             ecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc-----------
Confidence            76  47899999999 88999999765   499999999999999999999999999999999999994           


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT  315 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t  315 (430)
                                      .++.+||+|||++.......      ....||..|+|||++.+..++.++|||||||++|+|++
T Consensus       169 ----------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~  232 (318)
T 3lxp_A          169 ----------------NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT  232 (318)
T ss_dssp             ----------------TTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred             ----------------CCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence                            44556677777665443322      22357888999999999999999999999999999999


Q ss_pred             CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhH
Q 014117          316 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD  395 (430)
Q Consensus       316 G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (430)
                      |..||.......     ....+........   .........+.                         ....+..++.+
T Consensus       233 g~~p~~~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~~-------------------------~~~~~~~~~~~  279 (318)
T 3lxp_A          233 HCDSSQSPPTKF-----LELIGIAQGQMTV---LRLTELLERGE-------------------------RLPRPDKCPAE  279 (318)
T ss_dssp             TTCGGGSHHHHH-----HHHHCSCCHHHHH---HHHHHHHHTTC-------------------------CCCCCTTCCHH
T ss_pred             CCCcccccchhh-----hhhhcccccchhH---HHHHHHHhccc-------------------------CCCCCccccHH
Confidence            999997532211     1111111110000   00001111100                         11123466788


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          396 LTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       396 ~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      +.+||.+||+.||.+|||++|+++
T Consensus       280 l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          280 VYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHH
Confidence            999999999999999999999985

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=9e-43  Score=329.79  Aligned_cols=246  Identities=21%  Similarity=0.278  Sum_probs=186.8

Q ss_pred             cCcEEEEeeeccccceEEEEEEECC-CC--eEEEEEEecCc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRE-RK--EMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~--~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .++|++.+.||+|+||+||+|.+.. ++  ..||+|+++..    ....+.+..|+++++.+     .|+||+++++++.
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~   91 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-----DHRNLIRLYGVVL   91 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEC
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-----CCCCcccEEEEEc
Confidence            4589999999999999999998643 33  36999988642    23445677899999888     3588999999988


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                      ... .++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+         
T Consensus        92 ~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~---------  160 (291)
T 1u46_A           92 TPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLV---------  160 (291)
T ss_dssp             SSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEE---------
T ss_pred             cCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCE---------
Confidence            765 88999999 889999998653 369999999999999999999999999999999999999765554         


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCC------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE  317 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~  317 (430)
                                        ||+|||++.......      ....+|..|+|||++.+..++.++|||||||++|+|++ |.
T Consensus       161 ------------------kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~  222 (291)
T 1u46_A          161 ------------------KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ  222 (291)
T ss_dssp             ------------------EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSC
T ss_pred             ------------------EEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence                              555555444332211      12356888999999999889999999999999999999 99


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      .||.+.+..+....+......++                                               .+...+.++.
T Consensus       223 ~p~~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~l~  255 (291)
T 1u46_A          223 EPWIGLNGSQILHKIDKEGERLP-----------------------------------------------RPEDCPQDIY  255 (291)
T ss_dssp             CTTTTCCHHHHHHHHHTSCCCCC-----------------------------------------------CCTTCCHHHH
T ss_pred             CCcccCCHHHHHHHHHccCCCCC-----------------------------------------------CCcCcCHHHH
Confidence            99988766555443322111111                                               1234567899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhc
Q 014117          398 HLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      ++|.+||+.||.+|||+.++++
T Consensus       256 ~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          256 NVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.8e-44  Score=369.50  Aligned_cols=280  Identities=24%  Similarity=0.315  Sum_probs=204.0

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---  166 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~---  166 (430)
                      ..++|++.+.||+|+||.||+|.+..+++.||||+++..  ......+..|+++++++.     |+||+.+++++..   
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-----HpnIV~l~~v~~~~~~   86 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN-----HPNVVSAREVPDGLQK   86 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCC-----BTTBCCEEECCTTTCC
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCC-----CCCCCceeeeeccccc
Confidence            347899999999999999999999999999999998643  334566788999999984     4789998887655   


Q ss_pred             ---CCeEEEEEecC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          167 ---RNHICIVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       167 ---~~~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                         .+..|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++        
T Consensus        87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g--------  158 (676)
T 3qa8_A           87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP--------  158 (676)
T ss_dssp             CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCS--------
T ss_pred             ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCC--------
Confidence               77889999999 8999999986432 3699999999999999999999999999999999999996543        


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL  319 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~P  319 (430)
                                      ....+||+|||++.......  ....||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       159 ----------------~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~P  222 (676)
T 3qa8_A          159 ----------------QRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP  222 (676)
T ss_dssp             ----------------SSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSS
T ss_pred             ----------------CceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCC
Confidence                            23347888888887544332  345799999999999999999999999999999999999999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |.........      ..........   .........+...+.....                .........+..+.+|
T Consensus       223 f~~~~~~~~~------~~~i~~~~~~---~~~~~~~l~g~~~~~~~lp----------------~p~~l~~~ls~~L~dL  277 (676)
T 3qa8_A          223 FLPNWQPVQW------HGKVREKSNE---HIVVYDDLTGAVKFSSVLP----------------TPNHLSGILAGKLERW  277 (676)
T ss_dssp             CCSSCHHHHS------STTCC---------CCSCCCCSSSCCCCSSSC----------------CSCCCCGGGHHHHHHH
T ss_pred             CCcccchhhh------hhhhhcccch---hhhhhhhhccccccccccC----------------CchhhchhhhHHHHHH
Confidence            9764332211      0000000000   0000000111111111100                0011233467889999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          400 LQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      |.+||+.||++|||++|+|+||||+.
T Consensus       278 I~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          278 LQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             HHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             HHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            99999999999999999999999963

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.3e-42  Score=359.68  Aligned_cols=242  Identities=23%  Similarity=0.347  Sum_probs=191.7

Q ss_pred             cEEEE-eeeccccceEEEEEEE--CCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           95 RYKIH-SKMGEGTFGQVLECWD--RERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        95 ~y~~~-~~lG~G~~g~V~~~~~--~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      .+.+. ++||+|+||.||+|.+  +.+++.||||+++...   ...+.+..|+++++++.     |+||++++++++. +
T Consensus       369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-----hpnIv~l~~~~~~-~  442 (635)
T 4fl3_A          369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-----NPYIVRMIGICEA-E  442 (635)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCC-----CTTBCCEEEEEES-S
T ss_pred             hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-----CCCEeeEEEEEec-C
Confidence            34443 4899999999999954  4567899999997432   23567889999999984     4889999999864 5


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .++|||||+ +++|.+++....  .+++..+..++.||+.||+|||++|||||||||+||||+.++.             
T Consensus       443 ~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~-------------  507 (635)
T 4fl3_A          443 SWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY-------------  507 (635)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE-------------
T ss_pred             CEEEEEEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC-------------
Confidence            689999999 889999998754  7999999999999999999999999999999999999976554             


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCC------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF  320 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf  320 (430)
                                    +||+|||+++......      ....||+.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus       508 --------------~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf  573 (635)
T 4fl3_A          508 --------------AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY  573 (635)
T ss_dssp             --------------EEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             --------------EEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                          5555555554332211      12356788999999999999999999999999999998 99999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .+.+..+....+.....                                                ...+..++.++.+||
T Consensus       574 ~~~~~~~~~~~i~~~~~------------------------------------------------~~~p~~~~~~l~~li  605 (635)
T 4fl3_A          574 RGMKGSEVTAMLEKGER------------------------------------------------MGCPAGCPREMYDLM  605 (635)
T ss_dssp             TTCCHHHHHHHHHTTCC------------------------------------------------CCCCTTCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCC------------------------------------------------CCCCCCCCHHHHHHH
Confidence            98777665544432110                                                012345677899999


Q ss_pred             HHhhhcCCCCCCCHHHHhc
Q 014117          401 QGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~  419 (430)
                      .+||+.||++|||+++|++
T Consensus       606 ~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          606 NLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHTCSSTTTSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=7.3e-43  Score=333.25  Aligned_cols=254  Identities=24%  Similarity=0.353  Sum_probs=191.7

Q ss_pred             EEeeeccccceEEEEEEECCCCeEEEEEEecCc-----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           98 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        98 ~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      ..+.||+|+||.||+|.+  +++.||+|++...     ....+.+..|+.+++.+.     |+||+++++++...+..++
T Consensus        35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~l  107 (307)
T 2nru_A           35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-----HENLVELLGFSSDGDDLCL  107 (307)
T ss_dssp             TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-----CTTBCCEEEEECSSSSCEE
T ss_pred             cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-----CCCeEEEEEEEecCCceEE
Confidence            348899999999999986  5788999998632     234566788999999984     4889999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          173 VFEKL-GSSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      ||||+ +++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++                    
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~--------------------  167 (307)
T 2nru_A          108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD--------------------  167 (307)
T ss_dssp             EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC--------------------
T ss_pred             EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc--------------------
Confidence            99999 899999997432 34699999999999999999999999999999999999994                    


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                             .++.+||+|||++.......     ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.....
T Consensus       168 -------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          168 -------EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             -------TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             -------CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence                   44566777777665433221     23478999999998876 589999999999999999999999987554


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+....+..........+        ..++...                          ....+...+..+.+++.+||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~--------~~~~~~~--------------------------~~~~~~~~~~~l~~li~~cl~  285 (307)
T 2nru_A          240 PQLLLDIKEEIEDEEKTI--------EDYIDKK--------------------------MNDADSTSVEAMYSVASQCLH  285 (307)
T ss_dssp             SSBTTHHHHHHHTTSCCH--------HHHSCSS--------------------------CSCCCHHHHHHHHHHHHHHTC
T ss_pred             hHHHHHHHHHhhhhhhhh--------hhhcccc--------------------------ccccchHHHHHHHHHHHHHcC
Confidence            332222222111110000        0000000                          000112345678999999999


Q ss_pred             cCCCCCCCHHHHhcC
Q 014117          406 YDPTDRLTAREALRH  420 (430)
Q Consensus       406 ~dP~~R~ta~elL~h  420 (430)
                      .||.+|||+.+++++
T Consensus       286 ~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          286 EKKNKRPDIKKVQQL  300 (307)
T ss_dssp             SSTTTSCCHHHHHHH
T ss_pred             CCcccCcCHHHHHHH
Confidence            999999999999864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.7e-42  Score=329.32  Aligned_cols=262  Identities=22%  Similarity=0.302  Sum_probs=193.8

Q ss_pred             cCcEEEEeeeccccceEEEEEE----ECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECW----DRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .++|++++.||+|+||.||+|.    +..+++.||+|++.... ...+.+..|+.+++.+.     ++||+++++++...
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-----HDNIVKYKGVCYSA  114 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCC-----CTTBCCEEEEECC-
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCC-----CCCeeeEEEEEEec
Confidence            4579999999999999999998    46789999999987533 34456788999998883     48899999887654


Q ss_pred             --CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          168 --NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       168 --~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                        ..+++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+         
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~---------  184 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV---------  184 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEE---------
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcE---------
Confidence              4789999999 889999998764 469999999999999999999999999999999999999766555         


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCC------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                        ||+|||++.......      ....+|..|+|||++.+..++.++|||||||++|+|++|..
T Consensus       185 ------------------kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~  246 (326)
T 2w1i_A          185 ------------------KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE  246 (326)
T ss_dssp             ------------------EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTC
T ss_pred             ------------------EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCC
Confidence                              455555444322221      12356778999999999889999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||..... +    +....+..+.....  .......+..+.                         ....+..++.++.+
T Consensus       247 ~~~~~~~-~----~~~~~~~~~~~~~~--~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~  294 (326)
T 2w1i_A          247 KSKSPPA-E----FMRMIGNDKQGQMI--VFHLIELLKNNG-------------------------RLPRPDGCPDEIYM  294 (326)
T ss_dssp             GGGSHHH-H----HHHHHCTTCCTHHH--HHHHHHHHHTTC-------------------------CCCCCTTCCHHHHH
T ss_pred             CCCCCHH-H----HHHhhccccchhhh--HHHHHHHhhcCC-------------------------CCCCCCcccHHHHH
Confidence            9864211 1    11111211110000  000000111100                         01123456788999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhc
Q 014117          399 LLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~  419 (430)
                      ||.+||+.||++|||+.|+++
T Consensus       295 li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          295 IMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999975

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.6e-42  Score=334.37  Aligned_cols=258  Identities=20%  Similarity=0.256  Sum_probs=193.5

Q ss_pred             eeecCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee
Q 014117           85 MFALGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF  164 (430)
Q Consensus        85 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~  164 (430)
                      ++..+..+.++|++.+.||+|+||.||+|.+  +++.||||++...  .......|.+++..+.   ..|+||+++++++
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~---l~h~ni~~~~~~~  105 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR--EERSWFREAEIYQTVM---LRHENILGFIAAD  105 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHSC---CCCTTBCCEEEEE
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch--hHHHHHHHHHHHHHhh---cCCCcEEEEEeee
Confidence            4445566678999999999999999999987  5889999999643  3355667888877742   2458899999998


Q ss_pred             ecCC----eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCeeeccCCCCceEEee
Q 014117          165 DYRN----HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH--------DLCMIHTDLKPENVLLVS  231 (430)
Q Consensus       165 ~~~~----~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH--------~~~ivHrDlKp~NILl~~  231 (430)
                      ....    .+|+||||+ +++|.+++...   .+++..+..++.||+.||.|||        +.||+||||||+|||++ 
T Consensus       106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~-  181 (342)
T 1b6c_B          106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-  181 (342)
T ss_dssp             ECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC-
T ss_pred             cccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC-
Confidence            8765    899999999 78999999764   5999999999999999999999        89999999999999994 


Q ss_pred             cCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-------CeeeecCcccchhhhhCCC------CC
Q 014117          232 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLG------WT  298 (430)
Q Consensus       232 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~------~~  298 (430)
                                                .++.+||+|||++.......       ....||+.|+|||++.+..      ++
T Consensus       182 --------------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~  235 (342)
T 1b6c_B          182 --------------------------KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF  235 (342)
T ss_dssp             --------------------------TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHH
T ss_pred             --------------------------CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccC
Confidence                                      44567777777665433322       2347899999999998763      33


Q ss_pred             CcchHHHHHHHHHHHHhC----------CCCCCCCch----HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCC
Q 014117          299 YPCDIWSVGCILVELCTG----------EALFQTHEN----LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPE  364 (430)
Q Consensus       299 ~~~DvwslGv~l~el~tG----------~~Pf~~~~~----~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  364 (430)
                      .++|||||||++|||++|          ..||.....    .+........ ....                   ...+.
T Consensus       236 ~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~-------------------~~~~~  295 (342)
T 1b6c_B          236 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE-QKLR-------------------PNIPN  295 (342)
T ss_dssp             HHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT-SCCC-------------------CCCCG
T ss_pred             CcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHH-HHhC-------------------CCCcc
Confidence            689999999999999999          778865321    1111110000 0000                   00000


Q ss_pred             CCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          365 GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      .                     ......+..+.+||.+||+.||++|||++|+++|
T Consensus       296 ~---------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          296 R---------------------WQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             G---------------------GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             c---------------------ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            0                     0012334578999999999999999999999875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.2e-43  Score=343.53  Aligned_cols=270  Identities=20%  Similarity=0.233  Sum_probs=191.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---------hhHHHHHHHHHHHHHHHh--------cCC---
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAK--------HDK---  152 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~E~~~l~~l~~--------~~~---  152 (430)
                      .++|++.+.||+|+||+||+|++  +++.||||+++...         ...+.+..|+.+++.+..        |.+   
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            35799999999999999999988  67999999987432         123667889999999873        111   


Q ss_pred             ----------CCCceEEecceeec-------------CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHH
Q 014117          153 ----------GGNRCVQIRNWFDY-------------RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC  208 (430)
Q Consensus       153 ----------~~~~i~~~~~~~~~-------------~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~a  208 (430)
                                .|+||+++++++..             .+.+||||||+ +|++.+.+.+   ..+++..++.++.||+.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence                      14666666666665             78999999999 7766555533   368999999999999999


Q ss_pred             HHHHH-hcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCccc
Q 014117          209 IAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR  287 (430)
Q Consensus       209 L~~lH-~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~  287 (430)
                      |.||| ++|||||||||+|||++.++... .+++...      ...........+||+|||+|+....  ...+||+.|+
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~-~~~~~~~------~~~~~~~~~~~vkL~DFG~a~~~~~--~~~~gt~~y~  244 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKK-LHYTLNG------KSSTIPSCGLQVSIIDYTLSRLERD--GIVVFCDVSM  244 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSE-EEEEETT------EEEEEECTTEEEEECCCTTCBEEET--TEEECCCCTT
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcc-eeeeccC------ccccccCCCceEEEeeccccEecCC--CcEEEeeccc
Confidence            99999 99999999999999998764210 1111100      0000001234789999999986543  3458999999


Q ss_pred             chhhhhCCCCCCcchHHHHHHH-HHHHHhCCCCCCCCchHH-HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCC
Q 014117          288 APEVILGLGWTYPCDIWSVGCI-LVELCTGEALFQTHENLE-HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEG  365 (430)
Q Consensus       288 aPE~~~~~~~~~~~DvwslGv~-l~el~tG~~Pf~~~~~~~-~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  365 (430)
                      |||++.+.. +.++|||||+++ .+++++|..||....... ....+...                      ....  ..
T Consensus       245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~----------------------~~~~--~~  299 (336)
T 2vuw_A          245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQ----------------------MTFK--TK  299 (336)
T ss_dssp             CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHT----------------------CCCS--SC
T ss_pred             ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhh----------------------hccC--cc
Confidence            999998876 899999998777 778889999995311100 11111100                      0000  00


Q ss_pred             CCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHh-cCCCCC
Q 014117          366 AASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL-RHPFFT  424 (430)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL-~hp~f~  424 (430)
                      .                  ....++..+.++.+||.+||++|     ||+|+| +||||+
T Consensus       300 ~------------------~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          300 C------------------NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             C------------------CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             c------------------chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            0                  00012345778999999999987     999999 999996

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.7e-41  Score=353.06  Aligned_cols=247  Identities=23%  Similarity=0.287  Sum_probs=196.2

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCC---CeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      ...++|++.+.||+|+||.||+|.+..+   +..||+|+++..  ....+.+..|+.+++++     .|+||+++++++.
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~  461 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-----DHPHIVKLIGVIT  461 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEC
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEe
Confidence            3457899999999999999999998653   567999998643  23446678899999988     4588999999885


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                       .+.+|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++ 
T Consensus       462 -~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a-  538 (656)
T 2j0j_A          462 -ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS-  538 (656)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCC-
T ss_pred             -cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCC-
Confidence             46789999999 899999998654 46899999999999999999999999999999999999976665555555544 


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL  319 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~P  319 (430)
                                                .......    ....+|+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus       539 --------------------------~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~P  592 (656)
T 2j0j_A          539 --------------------------RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP  592 (656)
T ss_dssp             --------------------------CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             --------------------------eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCC
Confidence                                      3322111    12356789999999999999999999999999999997 9999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |.+.+..+....+......                                                ..+..++.++.+|
T Consensus       593 f~~~~~~~~~~~i~~~~~~------------------------------------------------~~~~~~~~~l~~l  624 (656)
T 2j0j_A          593 FQGVKNNDVIGRIENGERL------------------------------------------------PMPPNCPPTLYSL  624 (656)
T ss_dssp             TTTCCHHHHHHHHHHTCCC------------------------------------------------CCCTTCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCCCC------------------------------------------------CCCccccHHHHHH
Confidence            9987766655444321100                                                1234567789999


Q ss_pred             HHHhhhcCCCCCCCHHHHhc
Q 014117          400 LQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~  419 (430)
                      |.+||+.||.+|||+.++++
T Consensus       625 i~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          625 MTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999975

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.1e-42  Score=329.72  Aligned_cols=245  Identities=21%  Similarity=0.274  Sum_probs=189.8

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      ...++|++.+.||+|+||.||+|.+...   ||+|+++...   ...+.+..|+.+++++     .|+||+++++++...
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~~---~avk~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQT-----RHENVVLFMGACMSP  101 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESSS---EEEEECCCCSCCCCCCCCCCTTGGGGTTC-----CCTTBCCCCEEEECS
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcCe---EEEEEeecCCCCHHHHHHHHHHHHHHhcC-----CCCCEeEEEEEEecC
Confidence            3356799999999999999999988643   9999986322   2223455677777776     458899999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +.+++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++             
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~-------------  166 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG-------------  166 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----------------
T ss_pred             CceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC-------------
Confidence            9999999999 789999997643 4699999999999999999999999999999999999995 33             


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccC--------CCCCeeeecCcccchhhhhC---------CCCCCcchHHHHHHH
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYER--------PDQNYIVSTRHYRAPEVILG---------LGWTYPCDIWSVGCI  309 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~--------~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslGv~  309 (430)
                                    .+||+|||++....        .......||+.|+|||++.+         ..++.++|||||||+
T Consensus       167 --------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~i  232 (319)
T 2y4i_B          167 --------------KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI  232 (319)
T ss_dssp             --------------CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHH
T ss_pred             --------------CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHH
Confidence                          45566666544321        11122468999999999975         357899999999999


Q ss_pred             HHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhc
Q 014117          310 LVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV  389 (430)
Q Consensus       310 l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (430)
                      +|+|++|..||...........+.....+..                                               ..
T Consensus       233 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~  265 (319)
T 2y4i_B          233 WYELHAREWPFKTQPAEAIIWQMGTGMKPNL-----------------------------------------------SQ  265 (319)
T ss_dssp             HHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC-----------------------------------------------CC
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHhccCCCCCC-----------------------------------------------Cc
Confidence            9999999999987766554433322111000                                               01


Q ss_pred             CCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          390 DHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       390 ~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      ...+.++.+||.+||+.||.+|||+.++++
T Consensus       266 ~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          266 IGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             SSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            234567999999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.6e-41  Score=321.16  Aligned_cols=229  Identities=14%  Similarity=0.031  Sum_probs=178.7

Q ss_pred             ecCc-eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEec
Q 014117           87 ALGE-NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIR  161 (430)
Q Consensus        87 ~~~~-~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~  161 (430)
                      ..|+ .+.++|++.+.||+|+||.||+|++..+++.||||++....    .....+..|+.++..+     .|+||++++
T Consensus        23 ~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~hp~iv~~~   97 (286)
T 3uqc_A           23 VPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-----DKPGVARVL   97 (286)
T ss_dssp             CTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-----CCTTBCCEE
T ss_pred             CCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-----CCCCcceee
Confidence            3455 56678999999999999999999999999999999997432    2335677788887776     458899999


Q ss_pred             ceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCC
Q 014117          162 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY  240 (430)
Q Consensus       162 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~df  240 (430)
                      +++...+..|+||||+ |++|.+++...    .....+..++.||+.||+|||++||+||||||+|||++.         
T Consensus        98 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~---------  164 (286)
T 3uqc_A           98 DVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSI---------  164 (286)
T ss_dssp             EEEEETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEET---------
T ss_pred             EEEEECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcC---------
Confidence            9999999999999999 78999998542    456678889999999999999999999999999999954         


Q ss_pred             cCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          241 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       241 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                        ++.+||+++                 .|++|       ++.++|||||||++|||++|+.||
T Consensus       165 ------------------~g~~kl~~~-----------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf  202 (286)
T 3uqc_A          165 ------------------DGDVVLAYP-----------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPL  202 (286)
T ss_dssp             ------------------TSCEEECSC-----------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECS
T ss_pred             ------------------CCCEEEEec-----------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCC
Confidence                              445665532                 34443       789999999999999999999999


Q ss_pred             CCCchHHHHHHH-HHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          321 QTHENLEHLAMM-ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       321 ~~~~~~~~~~~i-~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      .+.+..+.+... ....+.                                           ...........+.++.+|
T Consensus       203 ~~~~~~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~~~l~~l  239 (286)
T 3uqc_A          203 PEAGVRSGLAPAERDTAGQ-------------------------------------------PIEPADIDRDIPFQISAV  239 (286)
T ss_dssp             CCCSBCCCSEECCBCTTSC-------------------------------------------BCCHHHHCTTSCHHHHHH
T ss_pred             CcCCcchhhHHHHHHhccC-------------------------------------------CCChhhcccCCCHHHHHH
Confidence            875432100000 000000                                           000112345678889999


Q ss_pred             HHHhhhcCCCCCCCHHHHhc
Q 014117          400 LQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~  419 (430)
                      |.+||+.||++| |++|+++
T Consensus       240 i~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          240 AARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             HHHHHCTTSSCC-CHHHHHH
T ss_pred             HHHHcccCCccC-CHHHHHH
Confidence            999999999999 9999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.6e-41  Score=355.67  Aligned_cols=244  Identities=24%  Similarity=0.360  Sum_probs=194.2

Q ss_pred             eecCceecCcEEEEeeeccccceEEEEEEECC-CCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 014117           86 FALGENLTSRYKIHSKMGEGTFGQVLECWDRE-RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN  162 (430)
Q Consensus        86 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~  162 (430)
                      +..++.+.++|++.+.||+|+||.||+|.+.. +++.||||++...  ......+..|+.++.++     .|+||+++++
T Consensus        72 ~~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~  146 (681)
T 2pzi_A           72 LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-----VHPSIVQIFN  146 (681)
T ss_dssp             SCTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-----CCTTBCCEEE
T ss_pred             CCCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-----CCCCcCeEee
Confidence            44567888999999999999999999999986 7899999998633  23445667888888877     3588999999


Q ss_pred             eeecCCe-----EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccc
Q 014117          163 WFDYRNH-----ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK  236 (430)
Q Consensus       163 ~~~~~~~-----~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~  236 (430)
                      ++...+.     .||||||+ |++|.+++..    .+++..+..++.||+.||.|||++|||||||||+|||++      
T Consensus       147 ~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~------  216 (681)
T 2pzi_A          147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT------  216 (681)
T ss_dssp             EEEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC------
T ss_pred             eEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe------
Confidence            9887655     79999999 8899887653    699999999999999999999999999999999999994      


Q ss_pred             cCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhC
Q 014117          237 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG  316 (430)
Q Consensus       237 i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG  316 (430)
                                           . ..+||+|||++...... ...+||+.|+|||++.+. ++.++|||||||++|+|++|
T Consensus       217 ---------------------~-~~~kl~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g  272 (681)
T 2pzi_A          217 ---------------------E-EQLKLIDLGAVSRINSF-GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLD  272 (681)
T ss_dssp             ---------------------S-SCEEECCCTTCEETTCC-SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSC
T ss_pred             ---------------------C-CcEEEEecccchhcccC-CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhC
Confidence                                 2 26888888888765443 456799999999998775 48999999999999999999


Q ss_pred             CCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHH
Q 014117          317 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL  396 (430)
Q Consensus       317 ~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  396 (430)
                      .+||.+....           ..+..                           ..                 ....+..+
T Consensus       273 ~~~~~~~~~~-----------~~~~~---------------------------~~-----------------~~~~~~~l  297 (681)
T 2pzi_A          273 LPTRNGRYVD-----------GLPED---------------------------DP-----------------VLKTYDSY  297 (681)
T ss_dssp             CCEETTEECS-----------SCCTT---------------------------CH-----------------HHHHCHHH
T ss_pred             CCCCcccccc-----------ccccc---------------------------cc-----------------ccccCHHH
Confidence            9998742110           00000                           00                 00123568


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHhcCCCC
Q 014117          397 THLLQGLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       397 ~~ll~~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      .+||.+||+.||++||++.+++.|+|+
T Consensus       298 ~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          298 GRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             HHHHhhhccCChhhCCCHHHHHHHHHH
Confidence            999999999999999998888888765

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=2.6e-34  Score=296.05  Aligned_cols=183  Identities=19%  Similarity=0.122  Sum_probs=126.1

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCc-----------hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGI-----------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----------~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      ..++.|+.|.+..++....|+.||+|++.+.           ....+.+.+|+++|+++.    .++||+++++++++.+
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~----~~~~i~~~~~~~ed~~  315 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPP----AGFDAPAVLAHGENAQ  315 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCC----TTCCCCCEEEEEECSS
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcC----CCCCeeEEEEEEEECC
Confidence            4567788888888887788999999998532           223456778999988874    3478999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+||||||+ |++|.++|...+  .+++.   .|+.||+.||+|||++|||||||||+||||+                 
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~-----------------  373 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVD-----------------  373 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEEC-----------------
T ss_pred             EEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEEC-----------------
Confidence            999999999 899999998765  67654   5889999999999999999999999999994                 


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCC
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL  319 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~P  319 (430)
                                .++.+||+|||+|+.....   ....+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       374 ----------~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          374 ----------ARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ----------TTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             ----------CCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence                      4556777777777644332   234689999999999877 467889999999999888766443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=6.4e-28  Score=247.02  Aligned_cols=179  Identities=19%  Similarity=0.172  Sum_probs=137.0

Q ss_pred             EEEeeeccccceEEEEEEECCCCeEEEEEEecCch---------hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           97 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        97 ~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      ...+.||+|+||.||+|  ...++.+|+|......         ...+.+.+|+++++++.|     +||+.+..+....
T Consensus       339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-----~nIv~~~~~~~~~  411 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKD-----FGIPAPYIFDVDL  411 (540)
T ss_dssp             ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGG-----GTCCCCCEEEEET
T ss_pred             CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCC-----CCcCceEEEEEeC
Confidence            44578999999999999  3456788999864211         113446889999999955     6777544444566


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +..||||||+ +++|.+++..          +..++.||+.||+|||++||+||||||+|||+                 
T Consensus       412 ~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl-----------------  464 (540)
T 3en9_A          412 DNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF-----------------  464 (540)
T ss_dssp             TTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE-----------------
T ss_pred             CccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE-----------------
Confidence            7779999999 7999999865          56899999999999999999999999999999                 


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC----------CeeeecCcccchhhhhC--CCCCCcchHHHHHHHHHHHH
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELC  314 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~  314 (430)
                                +.  .+||+|||+++......          ...+||+.|||||++.+  ..|+..+|+||..+-..+.+
T Consensus       465 ----------~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v  532 (540)
T 3en9_A          465 ----------DK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDV  532 (540)
T ss_dssp             ----------SS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHH
T ss_pred             ----------CC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHH
Confidence                      33  78999999988665432          24689999999999987  56888999999999888888


Q ss_pred             hCCCCCC
Q 014117          315 TGEALFQ  321 (430)
Q Consensus       315 tG~~Pf~  321 (430)
                      .++.+|.
T Consensus       533 ~~r~rY~  539 (540)
T 3en9_A          533 ERRARYV  539 (540)
T ss_dssp             HTCSCCC
T ss_pred             HhccccC
Confidence            8777764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.6e-25  Score=210.82  Aligned_cols=154  Identities=23%  Similarity=0.300  Sum_probs=117.6

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-------------------hhHHHHHHHHHHHHHHHhcCCCCC
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------------------KYREAAMIEIEVLQQLAKHDKGGN  155 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------------------~~~~~~~~E~~~l~~l~~~~~~~~  155 (430)
                      .|.+.+.||+|+||.||+|.+ .+++.||+|+++...                   .....+..|+.+++++. +     
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~-----  163 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G-----  163 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T-----
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C-----
Confidence            466779999999999999999 889999999986321                   12456778999999985 1     


Q ss_pred             ceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCc
Q 014117          156 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY  234 (430)
Q Consensus       156 ~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~  234 (430)
                        +.+.++++. +..|+||||+ |++|.+ +.      .  .....++.||+.||.|||++|||||||||+|||++    
T Consensus       164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----  227 (282)
T 1zar_A          164 --LAVPKVYAW-EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----  227 (282)
T ss_dssp             --SSSCCEEEE-ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----
T ss_pred             --CCcCeEEec-cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----
Confidence              233333333 5569999999 779987 32      1  23457999999999999999999999999999994    


Q ss_pred             cccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC----------CCCCCcchHH
Q 014117          235 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG----------LGWTYPCDIW  304 (430)
Q Consensus       235 ~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dvw  304 (430)
                                              ++.+||+|||+++          .+..|+|||++..          ..|+..+|+|
T Consensus       228 ------------------------~~~vkl~DFG~a~----------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~  273 (282)
T 1zar_A          228 ------------------------EEGIWIIDFPQSV----------EVGEEGWREILERDVRNIITYFSRTYRTEKDIN  273 (282)
T ss_dssp             ------------------------TTEEEECCCTTCE----------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHH
T ss_pred             ------------------------CCcEEEEECCCCe----------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChH
Confidence                                    4567888888875          4667899999864          3455566666


Q ss_pred             H
Q 014117          305 S  305 (430)
Q Consensus       305 s  305 (430)
                      .
T Consensus       274 ~  274 (282)
T 1zar_A          274 S  274 (282)
T ss_dssp             H
T ss_pred             H
Confidence            5

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=3.3e-22  Score=185.74  Aligned_cols=137  Identities=16%  Similarity=0.131  Sum_probs=106.5

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeE--EEEEEecCchh-------------------------hHHHHHHHHHHHHHHH
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEM--VAIKIVRGIKK-------------------------YREAAMIEIEVLQQLA  148 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~--vAiK~~~~~~~-------------------------~~~~~~~E~~~l~~l~  148 (430)
                      |++.+.||+|+||.||+|.+..+|+.  ||||+++....                         ....+..|+.++.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78999999999999999998778988  99998753211                         1135678999999998


Q ss_pred             hcCCCCCceEEecceeecCCeEEEEEecCC--C----CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCeeecc
Q 014117          149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLG--S----SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTD  221 (430)
Q Consensus       149 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~--~----~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivHrD  221 (430)
                      +.....+.++..       +..+|||||++  |    +|.++...     .++..+..++.||+.||.||| +.||||||
T Consensus       129 ~~~i~~p~~~~~-------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrD  196 (258)
T 1zth_A          129 EAGVSVPQPYTY-------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHAD  196 (258)
T ss_dssp             HTTCCCCCEEEE-------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSS
T ss_pred             hCCCCCCeEEEc-------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence            764433443322       35689999994  3    67766432     235567889999999999999 99999999


Q ss_pred             CCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCcccc
Q 014117          222 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE  273 (430)
Q Consensus       222 lKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~  273 (430)
                      |||+|||+                           +.  .++|+|||+|...
T Consensus       197 lkp~NILl---------------------------~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMY---------------------------ID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEE---------------------------SS--SEEECCCTTCEET
T ss_pred             CCHHHEEE---------------------------cC--cEEEEECcccccC
Confidence            99999999                           33  7899999988643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=2.9e-18  Score=166.03  Aligned_cols=122  Identities=18%  Similarity=0.211  Sum_probs=88.2

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---------------h--------hHHHHHHHHHHHHHHHhcCC
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---------------K--------YREAAMIEIEVLQQLAKHDK  152 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---------------~--------~~~~~~~E~~~l~~l~~~~~  152 (430)
                      |++.+.||.|+||.||+|.+. +|+.||||+++...               .        .+.....|...|.++.+...
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999985 68899999875210               0        01122457778888865432


Q ss_pred             CCCceEEecceeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEee
Q 014117          153 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS  231 (430)
Q Consensus       153 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~  231 (430)
                      ..+   ..+..   . ..+|||||+ |.+|.++.        ....+..++.||+.+|.+||++|||||||||.|||++.
T Consensus       176 ~vp---~p~~~---~-~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          176 PVP---EPIAQ---S-RHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIRE  240 (397)
T ss_dssp             SCC---CEEEE---E-TTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEE
T ss_pred             CCC---eeeec---c-CceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeC
Confidence            222   22211   1 237999999 66764432        12345678899999999999999999999999999987


Q ss_pred             cC
Q 014117          232 SE  233 (430)
Q Consensus       232 ~~  233 (430)
                      +|
T Consensus       241 dg  242 (397)
T 4gyi_A          241 EK  242 (397)
T ss_dssp             EE
T ss_pred             CC
Confidence            66

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.36  E-value=3.1e-12  Score=118.34  Aligned_cols=108  Identities=11%  Similarity=0.095  Sum_probs=81.2

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      ..|++...++.|+.+.||++...  ++.+++|+..... ........|.++++.+..+    ..+++++.+....+..|+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~----~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGK----LPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTT----SCCCCEEEEEEETTEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcC----CCCCeEEEEEecCCceEE
Confidence            45888899999999999999743  5789999986421 2234577899999999652    346677777788889999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD  214 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~  214 (430)
                      |||++ |.+|.+.+.       +......++.+++.+|..||+
T Consensus        88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~  123 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHS  123 (263)
T ss_dssp             EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHH
T ss_pred             EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhC
Confidence            99999 778876521       122234678899999999998

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.22  E-value=3.1e-11  Score=110.98  Aligned_cols=105  Identities=12%  Similarity=0.101  Sum_probs=70.3

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      .|.+....+.|..+.||++.. .+|..+++|+....  .......|..+++.+.++.   ..+++++.+....+..++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~---~~vP~~~~~~~~~~~~~~v~   94 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTG---VPCAAVLDVVTEAGRDWLLL   94 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTT---CCBCCEEEEEECSSCEEEEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCC---CCCCeEEEeccCCCCCEEEE
Confidence            455544444666799999964 45677999997643  2245678999999997642   22556677777778899999


Q ss_pred             ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 014117          175 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL  215 (430)
Q Consensus       175 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~  215 (430)
                      |++ |.+|.  ..     ..+   ...++.+++..|..||+.
T Consensus        95 e~i~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~  126 (264)
T 1nd4_A           95 GEVPGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTL  126 (264)
T ss_dssp             ECCSSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTS
T ss_pred             EecCCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCC
Confidence            999 66663  11     122   125667777777777764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.11  E-value=8.8e-11  Score=111.05  Aligned_cols=184  Identities=18%  Similarity=0.238  Sum_probs=114.9

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC---eEEEEEec
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN---HICIVFEK  176 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~---~~~lv~e~  176 (430)
                      +.++.|.+..||++.     ..+++|+.... ........|.++++.+..+..  ..+..++......+   ..|+||++
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~--v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLP--LPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSS--SCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCC--CCCCceEeecCCCCCCCcceEEEcc
Confidence            458899999999863     34889986533 344567889999999855321  11333333333222   45889999


Q ss_pred             C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 014117          177 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-----------------------------------------  214 (430)
Q Consensus       177 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-----------------------------------------  214 (430)
                      + |.+|.+....    .++......++.|++..|..||+                                         
T Consensus        98 i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           98 IKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             cCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9 6666543322    46777778888888888888885                                         


Q ss_pred             -----------------cCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC
Q 014117          215 -----------------LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ  277 (430)
Q Consensus       215 -----------------~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~  277 (430)
                                       ..++|+|++|.|||++.+                         ....+.|+||+.+....+..
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-------------------------~~~~~~~iD~~~~~~~~~~~  228 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-------------------------KNTICGIIDFGDAAISDPDN  228 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-------------------------TTEEEEECCCTTCEEECTTH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-------------------------CCCEEEEEeCCCCccCChHH
Confidence                             237999999999999641                         02345677777665432211


Q ss_pred             CeeeecCcc---cchhhhhC--CC------------CCCcchHHHHHHHHHHHHhCCCCCC
Q 014117          278 NYIVSTRHY---RAPEVILG--LG------------WTYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       278 ~~~~gt~~y---~aPE~~~~--~~------------~~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                      . +.....+   ..|+....  ..            .....+.|+++.++|.+.+|..+|-
T Consensus       229 D-l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          229 D-FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             H-HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             H-HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            0 0001111   23332211  00            1223589999999999999987763

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.10  E-value=3.4e-10  Score=109.60  Aligned_cols=108  Identities=16%  Similarity=0.145  Sum_probs=74.4

Q ss_pred             EEeeeccccceEEEEEEECCCCeEEEEEEec--Cch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC---CeE
Q 014117           98 IHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---NHI  170 (430)
Q Consensus        98 ~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~--~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~---~~~  170 (430)
                      .++.|+.|.++.||++...  +..+++|+..  ...  ........|..+++.+....   ..+++++.++.+.   +..
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~---vpvP~~~~~~~~~~~~g~~  116 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTD---VPVAKMYALCEDESVIGRA  116 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSS---SCCCCEEEEECCTTTTSSC
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCC---CCCCcEEEECCCCCccCCe
Confidence            3577899999999998754  3568888775  322  12345677999999997633   3356666666555   568


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD  214 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~  214 (430)
                      |+|||++ |..+.+.    ....++......++.+++..|..||+
T Consensus       117 ~~vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~  157 (359)
T 3dxp_A          117 FYIMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHT  157 (359)
T ss_dssp             EEEEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhC
Confidence            9999999 5555331    11246788888999999999999997

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.67  E-value=2.1e-07  Score=87.80  Aligned_cols=103  Identities=17%  Similarity=0.103  Sum_probs=62.4

Q ss_pred             EeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee-ecCCeEEEEEecC
Q 014117           99 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-DYRNHICIVFEKL  177 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-~~~~~~~lv~e~~  177 (430)
                      ++.++.|....||+.     +..+++|+-.. .........|.++|+.+.++..  ..+...+.+. ...+..++|||++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~--v~VP~~~~~~~~~~g~~~~v~e~i   95 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVK--VNIPQYVYIGKRSDGNPFVGYRKV   95 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCS--SBCCCEEEEEECTTSCEEEEEECC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCC--CCCCCeEeecccCCCceEEEEecc
Confidence            345788888899987     34588998542 3344567889999999976421  1234444444 2456678999999


Q ss_pred             -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 014117          178 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH  213 (430)
Q Consensus       178 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH  213 (430)
                       |..|.+..-.    .++......++.++...|..||
T Consensus        96 ~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH  128 (306)
T 3tdw_A           96 QGQILGEDGMA----VLPDDAKDRLALQLAEFMNELS  128 (306)
T ss_dssp             CSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHh
Confidence             6566552211    2344444444444444444444

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.62  E-value=3.3e-07  Score=84.63  Aligned_cols=101  Identities=14%  Similarity=0.198  Sum_probs=66.0

Q ss_pred             eeccccce-EEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-C
Q 014117          101 KMGEGTFG-QVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G  178 (430)
Q Consensus       101 ~lG~G~~g-~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~  178 (430)
                      .+..|..+ .||+......+..+++|+-...  .......|..+|+.+....   | +.+++.+..+.+..++|||++ |
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~v---P-VP~v~~~~~~~~~~~lvme~l~G  104 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFM---P-LPTIKHFIRTPDDAWLLTTAIPG  104 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTS---C-CCCEEEEEEETTEEEEEEECCCS
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCC---C-cCeEEEEEEECCeEEEEEEeeCC
Confidence            34445555 6999887777778999986532  2345677999999986532   2 566777778889999999999 6


Q ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 014117          179 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH  213 (430)
Q Consensus       179 ~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH  213 (430)
                      .++.+.....      ......+..++...|.-||
T Consensus       105 ~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh  133 (272)
T 4gkh_A          105 KTAFQVLEEY------PDSGENIVDALAVFLRRLH  133 (272)
T ss_dssp             EEHHHHHHHC------GGGHHHHHHHHHHHHHHHH
T ss_pred             ccccccccCC------HHHHHHHHHHHHHHHHHhc
Confidence            6766654321      1122334455555555555

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.37  E-value=2.1e-06  Score=83.99  Aligned_cols=77  Identities=19%  Similarity=0.226  Sum_probs=48.5

Q ss_pred             EeeeccccceEEEEEEECCCCeEEEEEEecCch--------hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           99 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .+.||.|.++.||++.+..+++.|++|......        ........|.++++.+.....  ..++.++.+  +.+..
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~--~~vP~~~~~--d~~~~  110 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVP--HLVPRVFYS--DTEMA  110 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCG--GGSCCEEEE--ETTTT
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCC--CCcCeEEEE--cCCcc
Confidence            567899999999999776667789999864211        112345678999998865321  223444433  23445


Q ss_pred             EEEEecCCC
Q 014117          171 CIVFEKLGS  179 (430)
Q Consensus       171 ~lv~e~~~~  179 (430)
                      ++|||++.+
T Consensus       111 ~lvmE~l~g  119 (397)
T 2olc_A          111 VTVMEDLSH  119 (397)
T ss_dssp             EEEECCCTT
T ss_pred             EEEEEeCCC
Confidence            799999943

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.33  E-value=1.1e-05  Score=76.76  Aligned_cols=76  Identities=13%  Similarity=0.176  Sum_probs=44.1

Q ss_pred             EeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEec-c--eeecCCeEEEEEe
Q 014117           99 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR-N--WFDYRNHICIVFE  175 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~-~--~~~~~~~~~lv~e  175 (430)
                      ++.|+.|..+.||++...  +..+++|+.....   .....|..+++.+..+....|.++... +  +....+..++||+
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSCH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCCH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            355666778999998753  3359999987532   334457778888876543223333211 1  1234677899999


Q ss_pred             cC-CC
Q 014117          176 KL-GS  179 (430)
Q Consensus       176 ~~-~~  179 (430)
                      ++ |.
T Consensus       112 ~i~G~  116 (346)
T 2q83_A          112 WIEGR  116 (346)
T ss_dssp             CCCCB
T ss_pred             eecCc
Confidence            99 53

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.14  E-value=4.8e-06  Score=80.08  Aligned_cols=81  Identities=10%  Similarity=0.075  Sum_probs=52.8

Q ss_pred             EEEeee-ccccceEEEEEEECC------CCeEEEEEEecCch---h-hHHHHHHHHHHHHHHHhc-CCCCCceEEeccee
Q 014117           97 KIHSKM-GEGTFGQVLECWDRE------RKEMVAIKIVRGIK---K-YREAAMIEIEVLQQLAKH-DKGGNRCVQIRNWF  164 (430)
Q Consensus        97 ~~~~~l-G~G~~g~V~~~~~~~------~~~~vAiK~~~~~~---~-~~~~~~~E~~~l~~l~~~-~~~~~~i~~~~~~~  164 (430)
                      ...+.| +.|....+|+.....      ++..+++|+.....   . .......|..+++.+..+ ...   +.+++.+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vp---vP~v~~~~   99 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVP---VPRVRWIE   99 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSC---CCCEEEEE
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCC---CCcEEEEc
Confidence            345778 889899999886530      15678999865332   0 124567799999999875 322   44455544


Q ss_pred             ecC---CeEEEEEecC-CCC
Q 014117          165 DYR---NHICIVFEKL-GSS  180 (430)
Q Consensus       165 ~~~---~~~~lv~e~~-~~~  180 (430)
                      ...   +..++|||++ |..
T Consensus       100 ~~~~~~g~~~~v~e~l~G~~  119 (357)
T 3ats_A          100 TTGDVLGTPFFLMDYVEGVV  119 (357)
T ss_dssp             CSSTTTSSCEEEEECCCCBC
T ss_pred             cCCCccCCceEEEEecCCCC
Confidence            443   4568999999 433

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.80  E-value=7.9e-05  Score=73.29  Aligned_cols=75  Identities=16%  Similarity=0.169  Sum_probs=43.9

Q ss_pred             EeeeccccceEEEEEEECCCCeEEEEEEecC-----chh---hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           99 HSKMGEGTFGQVLECWDRERKEMVAIKIVRG-----IKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~---~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ++.||.|..+.||++..  +++.++||....     ...   .......|.+++..+....  ...+++++.+.  .+..
T Consensus        39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~--~~~vP~v~~~~--~~~~  112 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLS--PDHVPEVYHFD--RTMA  112 (420)
T ss_dssp             EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHS--GGGSCCEEEEE--TTTT
T ss_pred             EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhC--CCCCCeEEEEC--CCcc
Confidence            56789999999999954  456799994321     011   0122334555554443321  12344555443  4667


Q ss_pred             EEEEecC-CC
Q 014117          171 CIVFEKL-GS  179 (430)
Q Consensus       171 ~lv~e~~-~~  179 (430)
                      ++|||++ ++
T Consensus       113 ~lv~e~l~~g  122 (420)
T 2pyw_A          113 LIGMRYLEPP  122 (420)
T ss_dssp             EEEECCCCTT
T ss_pred             EEEEeecCCc
Confidence            8999999 76

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.77  E-value=0.00014  Score=68.11  Aligned_cols=69  Identities=12%  Similarity=-0.036  Sum_probs=43.3

Q ss_pred             EeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-
Q 014117           99 HSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-  177 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-  177 (430)
                      ++.|+.|....+|++      ..+++|+.............|..+++.+...... |.+   +...  .+.-++|+||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~-P~~---~~~~--~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVS-PEV---LHVD--PATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSS-CCE---EEEC--TTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCC-Cce---EEEE--CCCCEEEEeecC
Confidence            577888999999998      3488998753221111234688888888776543 333   3333  22346889998 


Q ss_pred             CC
Q 014117          178 GS  179 (430)
Q Consensus       178 ~~  179 (430)
                      +|
T Consensus        91 ~g   92 (301)
T 3dxq_A           91 GA   92 (301)
T ss_dssp             TC
T ss_pred             CC
Confidence            55

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.70  E-value=0.00031  Score=66.05  Aligned_cols=77  Identities=22%  Similarity=0.227  Sum_probs=57.3

Q ss_pred             EEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 014117           98 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL  177 (430)
Q Consensus        98 ~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~  177 (430)
                      -.+.|+.|.+..+|+...  .+..+++|+....  ....+..|.+.|+.+....  ...+++.+.+....+..++|||++
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~--~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTN--SINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTT--SSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhC--CCCcceEEEEeecCCceEEEEEec
Confidence            356789999999999874  4567889987532  3456778999999997642  234666677777778899999999


Q ss_pred             -CCC
Q 014117          178 -GSS  180 (430)
Q Consensus       178 -~~~  180 (430)
                       |..
T Consensus       114 ~G~~  117 (312)
T 3jr1_A          114 NKSK  117 (312)
T ss_dssp             CCCC
T ss_pred             cCCC
Confidence             443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.64  E-value=0.001  Score=62.66  Aligned_cols=78  Identities=15%  Similarity=0.181  Sum_probs=47.8

Q ss_pred             eeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecc--eeecCCeEEEEEecC
Q 014117          100 SKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN--WFDYRNHICIVFEKL  177 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~--~~~~~~~~~lv~e~~  177 (430)
                      ..|+ |....||++.. .+|+.+++|+.+...........|..+++.+.......+.++...+  .....+..++||+++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3455 78889998754 3455699999863322345566789999998765432222222111  122356778999999


Q ss_pred             CC
Q 014117          178 GS  179 (430)
Q Consensus       178 ~~  179 (430)
                      .|
T Consensus       110 ~G  111 (328)
T 1zyl_A          110 GG  111 (328)
T ss_dssp             CC
T ss_pred             CC
Confidence            44

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.61  E-value=0.00062  Score=64.04  Aligned_cols=79  Identities=8%  Similarity=0.013  Sum_probs=46.3

Q ss_pred             EEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEec-c--eeecCCeEEEE
Q 014117           97 KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR-N--WFDYRNHICIV  173 (430)
Q Consensus        97 ~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~-~--~~~~~~~~~lv  173 (430)
                      .-++.|+.|....||++... ++ .+++|+.... ........|..++..+..+....|.++... +  +....+..++|
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l  101 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL  101 (322)
T ss_dssp             EEEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred             eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence            34567888888999998754 33 5889988642 122345568889998887643333333211 1  11234677899


Q ss_pred             EecCC
Q 014117          174 FEKLG  178 (430)
Q Consensus       174 ~e~~~  178 (430)
                      |+++.
T Consensus       102 ~~~l~  106 (322)
T 2ppq_A          102 ISFLE  106 (322)
T ss_dssp             EECCC
T ss_pred             EEeCC
Confidence            99993

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.53  E-value=0.00045  Score=65.45  Aligned_cols=78  Identities=10%  Similarity=0.052  Sum_probs=38.7

Q ss_pred             eeeccccceE-EEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecCC
Q 014117          100 SKMGEGTFGQ-VLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG  178 (430)
Q Consensus       100 ~~lG~G~~g~-V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~  178 (430)
                      +.|+.|+... +|+... .++..+++|......  ......|+.+++.+......   +++++......+  ++|||+++
T Consensus        24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~---vP~v~~~d~~~g--~ll~e~l~   95 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDIS---APEIYAEEHARG--LLLIEDLG   95 (333)
T ss_dssp             CC--------CCEEEEC-TTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCB---CCCEEEEETTTT--EEEECCCC
T ss_pred             eECCCCCCCceEEEEEc-CCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCC---CCceeeecCCCC--EEEEeeCC
Confidence            4455554444 566643 225567777654321  12345578888888765432   344444333333  68999984


Q ss_pred             -CCHHHHH
Q 014117          179 -SSLYDFL  185 (430)
Q Consensus       179 -~~L~~~l  185 (430)
                       ..+.+++
T Consensus        96 ~~~l~~~l  103 (333)
T 3csv_A           96 DALFTEVI  103 (333)
T ss_dssp             SCBHHHHH
T ss_pred             CcchHHHh
Confidence             4555443

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.42  E-value=0.0011  Score=61.43  Aligned_cols=76  Identities=11%  Similarity=0.002  Sum_probs=51.2

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      ...-++.+|.|..+.||+... .+|+.|.+|+-.... .....+..|...|+.+.....  ..+++++.+.    .-++|
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~--vpvP~v~~~~----~~~lv   88 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFG--SPVPQVAGWD----DRTLA   88 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTT--CCSCCEEEEE----TTEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCC--CCcceEEecc----CceEE
Confidence            456678899999999999975 467889999865322 223446779999999965321  1233444332    23689


Q ss_pred             EecC
Q 014117          174 FEKL  177 (430)
Q Consensus       174 ~e~~  177 (430)
                      ||++
T Consensus        89 ~e~l   92 (288)
T 3f7w_A           89 MEWV   92 (288)
T ss_dssp             EECC
T ss_pred             EEee
Confidence            9998

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.10  E-value=0.0047  Score=54.18  Aligned_cols=97  Identities=12%  Similarity=0.008  Sum_probs=59.4

Q ss_pred             CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCC
Q 014117          180 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK  258 (430)
Q Consensus       180 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~  258 (430)
                      +|.+.|+..+ .++++++++.++.|.+.+|.-+- ...-..+=+-|..|++..+|.+                       
T Consensus        34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V-----------------------   89 (229)
T 2yle_A           34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAV-----------------------   89 (229)
T ss_dssp             EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCE-----------------------
T ss_pred             cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCce-----------------------
Confidence            7999998766 68999999999999999987762 1111233344688888655543                       


Q ss_pred             CCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh
Q 014117          259 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT  315 (430)
Q Consensus       259 ~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t  315 (430)
                          .+.+ ..+.         .....+.|||... ...+.+.=|||||+++|..+-
T Consensus        90 ----~f~~-~~s~---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           90 ----TLAP-AADD---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ----EECC-C---------------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             ----eccc-cccc---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence                3221 1000         1123466887653 234567789999999999874

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.08  E-value=0.0022  Score=61.99  Aligned_cols=70  Identities=14%  Similarity=0.171  Sum_probs=41.6

Q ss_pred             eeeccccceEEEEEEECC-------CCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117          100 SKMGEGTFGQVLECWDRE-------RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      +.|..|-...+|++....       .++.|++|+............+|..+++.+......    .+++..++.    .+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~----P~ll~~~~~----g~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLG----PQLYGVFPE----GR  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSS----CCEEEEETT----EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCC----CeEEEEcCC----cc
Confidence            567778888899987642       346799998633222234455799999999876542    344555543    28


Q ss_pred             EEecC
Q 014117          173 VFEKL  177 (430)
Q Consensus       173 v~e~~  177 (430)
                      ||||+
T Consensus       128 v~e~i  132 (379)
T 3feg_A          128 LEQYI  132 (379)
T ss_dssp             EEECC
T ss_pred             EEEEe
Confidence            99998

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.04  E-value=0.0071  Score=59.42  Aligned_cols=71  Identities=14%  Similarity=0.152  Sum_probs=47.3

Q ss_pred             EEeeeccccceEEEEEEECC-------CCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           98 IHSKMGEGTFGQVLECWDRE-------RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        98 ~~~~lG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      -++.|+.|....||++....       .++.+++|+.... ........|..+++.+..+.. .   +++++.+..    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~-~---P~l~~~~~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHL-G---PKLYGIFSG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTS-S---SCEEEEETT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCC-C---CcEEEEeCC----
Confidence            35678889899999997643       2567999988432 111344579999999977543 2   344444432    


Q ss_pred             EEEEecC
Q 014117          171 CIVFEKL  177 (430)
Q Consensus       171 ~lv~e~~  177 (430)
                      .+|+||+
T Consensus       148 g~v~e~l  154 (429)
T 1nw1_A          148 GRLEEYI  154 (429)
T ss_dssp             EEEECCC
T ss_pred             CEEEEEe
Confidence            2899998

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.03  E-value=0.0035  Score=60.19  Aligned_cols=72  Identities=21%  Similarity=0.128  Sum_probs=41.8

Q ss_pred             EeeeccccceEEEEEEECC--------CCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           99 HSKMGEGTFGQVLECWDRE--------RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~--------~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      +..|+.|....+|++....        .+..+++|+.............|..+++.+..+.. .|   +++...  .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~-~P---~~~~~~--~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKI-AP---QLLNTF--NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTS-SC---CEEEEE--TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCC-CC---ceEEec--CC--
Confidence            4567888888999987643        12578999875322211123568889998876543 23   333333  12  


Q ss_pred             EEEEecCC
Q 014117          171 CIVFEKLG  178 (430)
Q Consensus       171 ~lv~e~~~  178 (430)
                      ++|||++.
T Consensus       110 ~~v~e~i~  117 (369)
T 3c5i_A          110 GRIEEWLY  117 (369)
T ss_dssp             EEEEECCC
T ss_pred             cEEEEEec
Confidence            58999983

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.99  E-value=0.0082  Score=59.48  Aligned_cols=72  Identities=11%  Similarity=0.035  Sum_probs=44.9

Q ss_pred             EEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC
Q 014117           98 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL  177 (430)
Q Consensus        98 ~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~  177 (430)
                      -++.|+.|-...+|++.....+..+++|+........-....|..++..+.....    .+++++.+..    .+||||+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl----~P~ll~~~~~----G~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNI----AKKIYVFFTN----GRIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSS----BCCEEEEETT----EEEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCC----CCCEEEEeCC----eEEEEee
Confidence            3567888889999999876545789999874321111112468999999976442    2445555532    2599998

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.76  E-value=0.019  Score=54.39  Aligned_cols=69  Identities=13%  Similarity=0.143  Sum_probs=43.2

Q ss_pred             ccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecce------eecCCeEEEEEec
Q 014117          103 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW------FDYRNHICIVFEK  176 (430)
Q Consensus       103 G~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~------~~~~~~~~lv~e~  176 (430)
                      |.|....||++... ++ .+++|+......     ..|..+++.+.....  +.++..+..      ....+..++||++
T Consensus        32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~--~~vp~pi~~~~G~~~~~~~g~~~~l~~~  102 (339)
T 3i1a_A           32 GADTNAFAYQADSE-SK-SYFIKLKYGYHD-----EINLSIIRLLHDSGI--KEIIFPIHTLEAKLFQQLKHFKIIAYPF  102 (339)
T ss_dssp             TSCSSCEEEEEECS-SC-EEEEEEEECSSC-----CHHHHHHHHHHHTTC--CSSCCCCCCTTSCSSEECSSEEEEEEEC
T ss_pred             cCccccceEEEEeC-CC-CEEEEEecCccc-----hHHHHHHHHHHhcCC--cccccceecCCCCEEEEECCEEEEEEec
Confidence            34446899998643 34 799998764331     457788888876533  223333322      2345788999999


Q ss_pred             C-CCC
Q 014117          177 L-GSS  180 (430)
Q Consensus       177 ~-~~~  180 (430)
                      + |..
T Consensus       103 i~G~~  107 (339)
T 3i1a_A          103 IHAPN  107 (339)
T ss_dssp             CCCCB
T ss_pred             cCCCc
Confidence            9 443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.89  E-value=0.25  Score=48.19  Aligned_cols=71  Identities=13%  Similarity=0.051  Sum_probs=44.6

Q ss_pred             EeeeccccceEEEEEEECCC-------CeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           99 HSKMGEGTFGQVLECWDRER-------KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~-------~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      ++.|..|-...+|++.....       ++.|++|+........-....|..+++.+.....    ..++++.+.  +  +
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi----~P~l~~~~~--~--~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINI----APNIIADFP--E--G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTS----SCCEEEEET--T--E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCC----CCCEEEEcC--C--C
Confidence            45677788889999876521       5679999864322111123568899999876543    233333332  2  6


Q ss_pred             EEEecC
Q 014117          172 IVFEKL  177 (430)
Q Consensus       172 lv~e~~  177 (430)
                      +||+|+
T Consensus       147 ~I~efI  152 (424)
T 3mes_A          147 RIEEFI  152 (424)
T ss_dssp             EEEECC
T ss_pred             EEEEEe
Confidence            889998

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.21  E-value=0.22  Score=48.15  Aligned_cols=35  Identities=26%  Similarity=0.493  Sum_probs=25.7

Q ss_pred             eeeccCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccc
Q 014117          217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY  272 (430)
Q Consensus       217 ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~  272 (430)
                      ++|+|+.+.|||+..+..                     .+....+.++||-.|..
T Consensus       246 fcHnDl~~gNil~~~~~~---------------------~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRE---------------------NSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGG---------------------GCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcc---------------------cCcCCeEEEechHhccC
Confidence            689999999999954321                     03456789999987763

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	430
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-55
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-52
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-52
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-51
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-51
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-50
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-50
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-49
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-49
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-48
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-48
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-48
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-47
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-47
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-47
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-47
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-45
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-45
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-45
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-45
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-45
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-45
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-44
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-44
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-41
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-41
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-40
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-36
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-36
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-35
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-34
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-33
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-33
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-32
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-31
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-30
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-30
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-30
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-30
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-29
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-29
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-29
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-28
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-28
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-28
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-27
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-26
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-26
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-26
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-26
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-25
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-25
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-25
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-13
d1nw1a_	395	d.144.1.8 (A:) Choline kinase {Caenorhabditis eleg	9e-05

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 2e-55
 Identities = 68/338 (20%), Positives = 117/338 (34%), Gaps = 44/338 (13%)

Query: 93  TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKH 150
              ++  S++G G  G V +   +    ++A K++        R   + E++VL +    
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NS 63

Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
                  V     F     I I  E + G SL   L+K      P  ++ +++  +++ +
Sbjct: 64  P----YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGL 117

Query: 210 AFMHDLC-MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
            ++ +   ++H D+KP N+L+ S                              IK+ DFG
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNSRGE---------------------------IKLCDFG 150

Query: 269 -STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
            S        N  V TR Y +PE + G  ++   DIWS+G  LVE+  G       +  E
Sbjct: 151 VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
              M    +         R           G    P  A        V + P    L   
Sbjct: 211 LELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP--PKLPSG 268

Query: 388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                  D    +   L  +P +R   ++ + H F  R
Sbjct: 269 VFSLEFQD---FVNKCLIKNPAERADLKQLMVHAFIKR 303

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  177 bits (451), Expect = 1e-52
 Identities = 71/341 (20%), Positives = 130/341 (38%), Gaps = 80/341 (23%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAK 149
           ++   Y I  ++G G FG V  C ++    +   K +       +     EI ++ QL  
Sbjct: 26  SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-H 84

Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           H     + + + + F+ +  + ++ E L G  L+D +   +Y+      V    RQ  E 
Sbjct: 85  HP----KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEG 139

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +  MH+  ++H D+KPEN++                             K+S++K+IDFG
Sbjct: 140 LKHMHEHSIVHLDIKPENIMC-------------------------ETKKASSVKIIDFG 174

Query: 269 STTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
             T   PD+      +T  + APE++      +  D+W++G +   L +G + F   ++L
Sbjct: 175 LATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234

Query: 327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 386
           E L  ++R      +     V   A+                                  
Sbjct: 235 ETLQNVKRCDWEFDEDAFSSVSPEAK---------------------------------- 260

Query: 387 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                        ++ LL+ +P  RLT  +AL HP+   DH
Sbjct: 261 -----------DFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 8e-52
 Identities = 77/342 (22%), Positives = 147/342 (42%), Gaps = 45/342 (13%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKH 150
           S+Y+  +K+G+GTFG+V +   R+  + VA+K V      + +   A+ EI++LQ L   
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 151 DKGGNRCV---QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
           +      +   +   +   +  I +VF+     L   L  N    F +  ++ + + LL 
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLN 128

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   ++H D+K  NVL+     +K+ D+  +                   +    
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA-------------------RAFSL 169

Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
              +      N  V T  YR PE++LG   +  P D+W  GCI+ E+ T   + Q +   
Sbjct: 170 AKNSQPNRYTNR-VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 228

Query: 327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 386
             LA++ ++ G +   +   VD +  +   +  L   +    ++ +K+ ++ P   +LI 
Sbjct: 229 HQLALISQLCGSITPEVWPNVDNY--ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 286

Query: 387 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 428
           +               LL  DP  R+ + +AL H FF  D +
Sbjct: 287 K---------------LLVLDPAQRIDSDDALNHDFFWSDPM 313

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 1e-51
 Identities = 74/344 (21%), Positives = 139/344 (40%), Gaps = 81/344 (23%)

Query: 92  LTSRYKIHSKM-GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH 150
           +   YK+ S++ G G  G+VL+ +++  +E  A+K+++   K R     E+E+  + ++ 
Sbjct: 9   IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQC 64

Query: 151 DKGGNRCVQIRNWFDY----RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
                  V+I + ++     R  + IV E L G  L+  ++    ++F      EI + +
Sbjct: 65  P----HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 120

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
            E I ++H + + H D+KPEN+L  S                           ++ +K+ 
Sbjct: 121 GEAIQYLHSINIAHRDVKPENLLYTS------------------------KRPNAILKLT 156

Query: 266 DFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
           DFG         +      T +Y APEV+    +   CD+WS+G I+  L  G   F ++
Sbjct: 157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
             L     M+                     +R G+ ++P    S  S            
Sbjct: 217 HGLAISPGMKT-------------------RIRMGQYEFPNPEWSEVS------------ 245

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                      ++  L++ LL+ +PT R+T  E + HP+  +  
Sbjct: 246 ----------EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (443), Expect = 1e-51
 Identities = 84/340 (24%), Positives = 142/340 (41%), Gaps = 45/340 (13%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLA 148
           ++  RY   S +GEG +G V   +D   K  VAIK +   +   Y +  + EI++L +  
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64

Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
             +  G   +      +    + +V   +G+ LY  L+    +    D +     Q+L  
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRG 121

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           + ++H   ++H DLKP N+LL ++  +K+ D+  +     D  +   +            
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL------------ 169

Query: 269 STTYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                       V+TR YRAPE++L   G+T   DIWSVGCIL E+ +   +F     L+
Sbjct: 170 ---------TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220

Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  +  +LG   Q  L  +        R   L  P             K     N +  
Sbjct: 221 QLNHILGILGSPSQEDLNCIIN---LKARNYLLSLPH------------KNKVPWNRLFP 265

Query: 388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           + D  A D   LL  +L ++P  R+   +AL HP+  + +
Sbjct: 266 NADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQYY 302

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  174 bits (442), Expect = 2e-51
 Identities = 75/343 (21%), Positives = 130/343 (37%), Gaps = 80/343 (23%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLA 148
           +++   Y IH ++G G FG V    +R      A K V    +  +E    EI+ +  L 
Sbjct: 22  DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL- 80

Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
           +H       V + + F+  N + +++E + G  L++ +   + +    D   E  RQ+ +
Sbjct: 81  RHP----TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCK 135

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            +  MH+   +H DLKPEN++  +                          +S+ +K+IDF
Sbjct: 136 GLCHMHENNYVHLDLKPENIMFTT-------------------------KRSNELKLIDF 170

Query: 268 GSTTYERPDQNYIVST--RHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
           G T +  P Q+  V+T    + APEV  G    Y  D+WSVG +   L +G + F    +
Sbjct: 171 GLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 230

Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 385
            E L  ++     +       +                                      
Sbjct: 231 DETLRNVKSCDWNMDDSAFSGISE------------------------------------ 254

Query: 386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 428
                    D    ++ LL  DP  R+T  +AL HP+ T  + 
Sbjct: 255 ---------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  172 bits (437), Expect = 1e-50
 Identities = 105/355 (29%), Positives = 164/355 (46%), Gaps = 46/355 (12%)

Query: 88  LGENLT-SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ 146
            GE    +RY +  K+G G F  V    D      VA+KIVRG K Y EAA  EI++LQ+
Sbjct: 6   KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQR 65

Query: 147 LAKHDK------GGNRCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPID 196
           +   D       G N  +++ + F+++     H+ +VFE LG +L   ++K  +R  P+ 
Sbjct: 66  VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 125

Query: 197 LVREIARQLLECIAFMHDLCMI-HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 255
            V++I++QLL  + +MH  C I HTD+KPENVL+   +                      
Sbjct: 126 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS--------------------- 164

Query: 256 MPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 315
                 IK+ D G+  +        + TR YR+PEV+LG  W    DIWS  C++ EL T
Sbjct: 165 PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 224

Query: 316 GEALFQTHE------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASR 369
           G+ LF+  E      + +H+A +  +LG LP ++L+        +  RG L         
Sbjct: 225 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR-------N 277

Query: 370 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
            S      L  +     +     A +++  L  +L+ DP  R  A   + HP+  
Sbjct: 278 ISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 332

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (430), Expect = 4e-50
 Identities = 83/338 (24%), Positives = 140/338 (41%), Gaps = 54/338 (15%)

Query: 93  TSRYKIHSKMGEGTFGQVLECWDRE-RKEMVAIKIVR---GIKKYREAAMIEIEVLQQLA 148
             +Y+  +++GEG +G+V +  D +     VA+K VR   G +    + + E+ VL+ L 
Sbjct: 6   DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65

Query: 149 KHDKGGN---RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQL 205
             +         V   +  D    + +VFE +   L  +L K      P + ++++  QL
Sbjct: 66  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L  + F+H   ++H DLKP+N+L+ SS  IK+ D                          
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD-------------------------F 160

Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 325
                   +     +V T  YRAPEV+L   +  P D+WSVGCI  E+   + LF+   +
Sbjct: 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220

Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 385
           ++ L  +  V+G   +                   DWP   A             ++  +
Sbjct: 221 VDQLGKILDVIGLPGEE------------------DWPRDVALPRQAFHSKSAQPIEKFV 262

Query: 386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
              +D    D   LL   L ++P  R++A  AL HP+F
Sbjct: 263 -TDIDELGKD---LLLKCLTFNPAKRISAYSALSHPYF 296

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 4e-49
 Identities = 62/334 (18%), Positives = 121/334 (36%), Gaps = 79/334 (23%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG 153
             ++I   +G+G FG V    +++ K ++A+K++   +  +     ++    ++  H + 
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 154 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
            N  +++  +F     + ++ E     ++Y  L+K     F          +L   +++ 
Sbjct: 66  PN-ILRLYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYC 122

Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
           H   +IH D+KPEN+LL S+  +K+ D+  S+H P                         
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-------------------- 162

Query: 273 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 332
                  +  T  Y  PE+I G       D+WS+G +  E   G+  F+ +   E    +
Sbjct: 163 ------TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 216

Query: 333 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 392
            RV    P  + +                                               
Sbjct: 217 SRVEFTFPDFVTE----------------------------------------------- 229

Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                 L+  LL+++P+ R   RE L HP+ T +
Sbjct: 230 --GARDLISRLLKHNPSQRPMLREVLEHPWITAN 261

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 7e-49
 Identities = 60/343 (17%), Positives = 117/343 (34%), Gaps = 79/343 (23%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK 149
           + L  +Y I   +G G FG V  C +   K+    K V+     +     EI +L    +
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-R 59

Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
           H       + +   F+    + ++FE + G  +++ +  + +       +     Q+ E 
Sbjct: 60  HR----NILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEA 114

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           + F+H   + H D++PEN++  +     +                         K+I+FG
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTI-------------------------KIIEFG 149

Query: 269 STTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
                +P  N+  + +   Y APEV      +   D+WS+G ++  L +G   F    N 
Sbjct: 150 QARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209

Query: 327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 386
           + +  +        +   K +                                       
Sbjct: 210 QIIENIMNAEYTFDEEAFKEISI------------------------------------- 232

Query: 387 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 429
                   +    +  LL  +   R+TA EAL+HP+  +   R
Sbjct: 233 --------EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 1e-48
 Identities = 89/333 (26%), Positives = 146/333 (43%), Gaps = 53/333 (15%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHD 151
            ++   K+GEGT+G V +  ++   E+VA+K +R     +     A+ EI +L++L   +
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                 V++ +     N + +VFE L   L  F+  +     P+ L++    QLL+ +AF
Sbjct: 63  -----IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   ++H DLKP+N+L+ +   IK+ D+  +         +                  
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------------------ 159

Query: 272 YERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
                  + V T  YRAPE++LG   ++   DIWS+GCI  E+ T  ALF     ++ L 
Sbjct: 160 ------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 213

Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 390
            + R LG   + +                  WP   +  +   S  K  R      + V 
Sbjct: 214 RIFRTLGTPDEVV------------------WPGVTSMPDYKPSFPKWARQD--FSKVVP 253

Query: 391 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
               D   LL  +L YDP  R++A+ AL HPFF
Sbjct: 254 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  165 bits (418), Expect = 1e-48
 Identities = 69/342 (20%), Positives = 118/342 (34%), Gaps = 81/342 (23%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----------GIKKYREAAMIEIEVL 144
            Y+    +G G    V  C  +   +  A+KI+            +++ REA + E+++L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIAR 203
           ++++ H       +Q+++ ++      +VF+ +    L+D+L +    +      R+I R
Sbjct: 64  RKVSGHP----NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMR 117

Query: 204 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 263
            LLE I  +H L ++H DLKPEN+LL     IK+ D+  S                    
Sbjct: 118 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS-------------------C 158

Query: 264 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
            +D G    E       ++             G+    D+WS G I+  L  G   F   
Sbjct: 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
           + +  L M+                                                   
Sbjct: 219 KQMLMLRMIMSGNYQFGSPEWDDYSD---------------------------------- 244

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 425
                       +  L+   L   P  R TA EAL HPFF +
Sbjct: 245 -----------TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (416), Expect = 4e-48
 Identities = 67/343 (19%), Positives = 124/343 (36%), Gaps = 81/343 (23%)

Query: 89  GENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQ 146
            E++   Y     +G G F +V+   D+  +++VAIK +    ++    +   EI VL +
Sbjct: 4   AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK 63

Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL 205
           + KH       V + + ++   H+ ++ + + G  L+D + +  +  +       +  Q+
Sbjct: 64  I-KHP----NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQV 116

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L+ + ++HDL ++H DLKPEN+L  S                        + + S I + 
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYS------------------------LDEDSKIMIS 152

Query: 266 DFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 323
           DFG +  E P         T  Y APEV+    ++   D WS+G I   L  G   F   
Sbjct: 153 DFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
            + +    + +            +                                    
Sbjct: 213 NDAKLFEQILKAEYEFDSPYWDDISD---------------------------------- 238

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                           ++ L+  DP  R T  +AL+HP+   D
Sbjct: 239 -----------SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 1e-47
 Identities = 67/342 (19%), Positives = 124/342 (36%), Gaps = 81/342 (23%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAK 149
           N    ++I  ++G+G FG+V +  ++E   + A K++    ++  E  M+EI++L     
Sbjct: 9   NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-D 67

Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
           H       V++ + F Y N++ I+ E       D +     R      ++ + +Q L+ +
Sbjct: 68  HPN----IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL 123

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            ++HD  +IH DLK  N+L      IK+ D+  S    +                     
Sbjct: 124 NYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR---------------- 167

Query: 270 TTYERPDQNYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGCILVELCTGEALFQTHE 324
                   +  + T ++ APEV++        + Y  D+WS+G  L+E+   E       
Sbjct: 168 --------DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219

Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
            +  L  + +   P                     L  P   +S                
Sbjct: 220 PMRVLLKIAKSEPP--------------------TLAQPSRWSS---------------- 243

Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                     +    L+  L  +   R T  + L+HPF T D
Sbjct: 244 ----------NFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 1e-47
 Identities = 81/344 (23%), Positives = 146/344 (42%), Gaps = 65/344 (18%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
            Y     +G G+FG V +    +  E+VAIK V   K+++     E++++++L  H    
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-DHC--- 73

Query: 155 NRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLL 206
              V++R +F          ++ +V + +  ++Y   R      ++ P+  V+    QL 
Sbjct: 74  -NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             +A++H   + H D+KP+N+LL                           P ++ +K+ D
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLL--------------------------DPDTAVLKLCD 166

Query: 267 FGSTTYERPDQNY--IVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 323
           FGS       +     + +R+YRAPE+I G   +T   D+WS GC+L EL  G+ +F   
Sbjct: 167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
             ++ L  + +VLG   +  ++ ++ +  ++       +P+           +K      
Sbjct: 227 SGVDQLVEIIKVLGTPTREQIREMNPNYTEF------KFPQ-----------IKAHPWTK 269

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +        A     L   LL Y PT RLT  EA  H FF    
Sbjct: 270 VFRPRTPPEAIA---LCSRLLEYTPTARLTPLEACAHSFFDELR 310

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 5e-47
 Identities = 73/335 (21%), Positives = 138/335 (41%), Gaps = 58/335 (17%)

Query: 101 KMGEGTFGQVLECWDRERKEMVAIKIVRGIKK------YREAAMIEIEVLQQLAKHDKGG 154
            +GEG F  V +  D+   ++VAIK ++   +          A+ EI++LQ+L  H    
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHP--- 60

Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
              + + + F ++++I +VF+ + + L   ++ N+    P   ++      L+ + ++H 
Sbjct: 61  -NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP-SHIKAYMLMTLQGLEYLHQ 118

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 274
             ++H DLKP N+LL  +  +K+ D+  +      +  +                     
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--------------------- 157

Query: 275 PDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
               + V TR YRAPE++ G   +    D+W+VGCIL EL           +L+ L  + 
Sbjct: 158 ---THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214

Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 393
             LG   +                    WP+  +  + +          + I        
Sbjct: 215 ETLGTPTEE------------------QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDL 256

Query: 394 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 428
            DL   +QGL  ++P  R+TA +AL+  +F+    
Sbjct: 257 LDL---IQGLFLFNPCARITATQALKMKYFSNRPG 288

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  162 bits (410), Expect = 6e-47
 Identities = 71/337 (21%), Positives = 138/337 (40%), Gaps = 56/337 (16%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
            Y++  K+G G + +V E  +    E V +KI++     ++    EI++L+ L       
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--PVKKKKIKREIKILENLRGGP--- 90

Query: 155 NRCVQIRNWF--DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
              + + +           +VFE +  +      +           +R    ++L+ + +
Sbjct: 91  -NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDY 144

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H + ++H D+KP NV++                            +   +++ID+G   
Sbjct: 145 CHSMGIMHRDVKPHNVMIDH--------------------------EHRKLRLIDWGLAE 178

Query: 272 YERPDQ--NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGE-ALFQTHENLE 327
           +  P Q  N  V++R+++ PE+++    + Y  D+WS+GC+L  +   +   F  H+N +
Sbjct: 179 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238

Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L  + +VLG                Y+ +  ++            S  +  R  +   Q
Sbjct: 239 QLVRIAKVLGT----------EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQ 288

Query: 388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 424
           H+     +    L  LLRYD   RLTAREA+ HP+F 
Sbjct: 289 HLVSP--EALDFLDKLLRYDHQSRLTAREAMEHPYFY 323

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 2e-45
 Identities = 75/341 (21%), Positives = 132/341 (38%), Gaps = 40/341 (11%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQL 147
            +  RY+    +G G  G V   +D      VAIK +      + + + A  E+ +++ +
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73

Query: 148 AKHDKGGNR-CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
              +          +   +    + +V E + ++L   ++         + +  +  Q+L
Sbjct: 74  NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQML 129

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             I  +H   +IH DLKP N+++ S   +K+ D                           
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD-------------------------FG 164

Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 326
              T          V TR+YRAPEVILG+G+    DIWSVGCI+ E+   + LF   + +
Sbjct: 165 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224

Query: 327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 386
           +    +   LG      +K++      YV       P+ A           L    +   
Sbjct: 225 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN----RPKYAGLTFPKLFPDSLFPADSEHN 280

Query: 387 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
           +     A D   LL  +L  DP  R++  +AL+HP+    +
Sbjct: 281 KLKASQARD---LLSKMLVIDPAKRISVDDALQHPYINVWY 318

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 3e-45
 Identities = 84/356 (23%), Positives = 148/356 (41%), Gaps = 56/356 (15%)

Query: 80  KDGHYMFALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKY 133
           + G Y   + +    + + Y+    +G G +G V    D      VAIK +      + +
Sbjct: 1   RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60

Query: 134 REAAMIEIEVLQQLA-KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRS 192
            + A  E+ +L+ +  ++  G           D      +V   +G+ L   ++      
Sbjct: 61  AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH---EK 117

Query: 193 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 252
              D ++ +  Q+L+ + ++H   +IH DLKP N+ +                       
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----------------------- 154

Query: 253 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILV 311
                +   +K++DFG       +    V TR YRAPEVIL  + +T   DIWSVGCI+ 
Sbjct: 155 ----NEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 210

Query: 312 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRES 371
           E+ TG+ LF+  ++L+ L  + +V G  P   ++R+     K   +G  +  +   +   
Sbjct: 211 EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS-- 268

Query: 372 IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                        I+ +    A +   LL+ +L  D   R+TA EAL HP+F   H
Sbjct: 269 -------------ILTNASPLAVN---LLEKMLVLDAEQRVTAGEALAHPYFESLH 308

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  157 bits (397), Expect = 3e-45
 Identities = 68/345 (19%), Positives = 118/345 (34%), Gaps = 88/345 (25%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQ 145
           ++    +    ++G G+FG V    D    E+VAIK +        +  +  + E+  LQ
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 146 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQL 205
           +L +H       +Q R  +   +   +V E    S  D L  +  +      +  +    
Sbjct: 71  KL-RHP----NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGA 124

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           L+ +A++H   MIH D+K  N+LL                                +K+ 
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGL---------------------------VKLG 157

Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQT 322
           DFGS +   P  ++ V T ++ APEVIL +    +    D+WS+G   +EL   +     
Sbjct: 158 DFGSASIMAPANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216

Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 382
              +  L  + +   P  Q                    W E                  
Sbjct: 217 MNAMSALYHIAQNESPALQSG-----------------HWSE------------------ 241

Query: 383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                          + +   L+  P DR T+   L+H F  R+ 
Sbjct: 242 ------------YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 4e-45
 Identities = 67/340 (19%), Positives = 118/340 (34%), Gaps = 80/340 (23%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLA 148
            +   +Y    K+G+G  G V    D    + VAI+ +   +   +E  + EI V+++  
Sbjct: 16  GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN- 74

Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
           K+       V   + +   + + +V E L G SL D + +          +  + R+ L+
Sbjct: 75  KNP----NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQ 127

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + F+H   +IH D+K +N+LL     +K+ D+        + S    M           
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM----------- 176

Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                        V T ++ APEV+    +    DIWS+G + +E+  GE  +     L 
Sbjct: 177 -------------VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223

Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            L ++     P                     L  PE  ++                   
Sbjct: 224 ALYLIATNGTP--------------------ELQNPEKLSA------------------- 244

Query: 388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
                       L   L  D   R +A+E L+H F     
Sbjct: 245 -------IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 6e-45
 Identities = 59/336 (17%), Positives = 113/336 (33%), Gaps = 79/336 (23%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDK 152
            + +   +GEG +G+V    +R  +E VA+KIV         E    EI + + L  H+ 
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE- 63

Query: 153 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                V+        N   +  E   G  L+D +  +     P    +    QL+  + +
Sbjct: 64  ---NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVY 118

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H + + H D+KPEN+LL   + +K+ D+  +     ++                     
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN--------------------- 157

Query: 272 YERPDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
                 N +  T  Y APE++    +   P D+WS G +L  +  GE  +    +     
Sbjct: 158 -RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE- 215

Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 390
             +        +  K++D                                          
Sbjct: 216 YSDWKEKKTYLNPWKKIDSAPL-------------------------------------- 237

Query: 391 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 426
                   LL  +L  +P+ R+T  +  +  ++ + 
Sbjct: 238 -------ALLHKILVENPSARITIPDIKKDRWYNKP 266

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 8e-45
 Identities = 69/344 (20%), Positives = 123/344 (35%), Gaps = 85/344 (24%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIE 142
           EN+   Y    ++G G F  V +C ++      A K ++  +         RE    E+ 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 143 VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREI 201
           +L+++ +H       + +   ++ +  + ++ E + G  L+DFL +    S   +   E 
Sbjct: 66  ILKEI-QHP----NVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 118

Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
            +Q+L  + ++H L + H DLKPEN++L+                        R      
Sbjct: 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLD-----------------------RNVPKPR 155

Query: 262 IKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
           IK+IDFG             I  T  + APE++         D+WS+G I   L +G + 
Sbjct: 156 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

Query: 320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 379
           F      E LA +  V               A+                           
Sbjct: 216 FLGDTKQETLANVSAVNYEFEDEYFSNTSALAK--------------------------- 248

Query: 380 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                               ++ LL  DP  R+T +++L+HP+ 
Sbjct: 249 ------------------DFIRRLLVKDPKKRMTIQDSLQHPWI 274

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 1e-44
 Identities = 77/342 (22%), Positives = 146/342 (42%), Gaps = 53/342 (15%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQL 147
            +  RY+  S +G G +G V   +D +    VA+K +        + +    E+ +L+ +
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74

Query: 148 A-KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLL 206
             ++  G           +  N + +V   +G+ L + ++    +    D V+ +  Q+L
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQIL 131

Query: 207 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 266
             + ++H   +IH DLKP N+                            + +   +K++D
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLA---------------------------VNEDCELKILD 164

Query: 267 FGSTTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHEN 325
           FG   +   +    V+TR YRAPE++L    +    DIWSVGCI+ EL TG  LF   ++
Sbjct: 165 FGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224

Query: 326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 385
           ++ L ++ R++G     +LK++   + +   +     P+   +                +
Sbjct: 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN---------------V 269

Query: 386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
               +  A D   LL+ +L  D   R+TA +AL H +F + H
Sbjct: 270 FIGANPLAVD---LLEKMLVLDSDKRITAAQALAHAYFAQYH 308

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 7e-44
 Identities = 63/349 (18%), Positives = 129/349 (36%), Gaps = 92/349 (26%)

Query: 87  ALGENLTSRY-KIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIE 142
           A+G +   R+ K   ++G G+F  V +  D E    VA   ++     K  R+    E E
Sbjct: 1   AVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAE 60

Query: 143 VLQQLAKHDKGGNRCVQIRNWF----DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDL 197
           +L+ L +H       V+  + +      +  I +V E +   +L  +L++   +   I +
Sbjct: 61  MLKGL-QHP----NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKV 113

Query: 198 VREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 255
           +R   RQ+L+ + F+H     +IH DLK +N+ +                          
Sbjct: 114 LRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG------------------------ 149

Query: 256 MPKSSAIKVIDFGSTTYERPDQNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
              + ++K+ D G  T +R      ++ T  + APE+     +    D+++ G  ++E+ 
Sbjct: 150 --PTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMA 206

Query: 315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
           T E  +   +N   +                   R     V+    D             
Sbjct: 207 TSEYPYSECQNAAQIY------------------RRVTSGVKPASFD------------- 235

Query: 375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                            +  ++  +++G +R +  +R + ++ L H FF
Sbjct: 236 ---------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 8e-42
 Identities = 64/341 (18%), Positives = 116/341 (34%), Gaps = 93/341 (27%)

Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-------GIKKYREAAMIEIEVL 144
           L S+Y++   +G G FG V           VAIK V        G         +E+ +L
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61

Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 204
           ++++    G    +++ +WF+  +   ++ E+       F       +   +L R    Q
Sbjct: 62  KKVSSGFSG---VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +LE +   H+  ++H D+K EN+L+  +                             +K+
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGE--------------------------LKL 152

Query: 265 IDFG-STTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQT 322
           IDFG     +         TR Y  PE I           +WS+G +L ++  G+  F+ 
Sbjct: 153 IDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212

Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 382
            E                              + RG++ + +  +S              
Sbjct: 213 DEE-----------------------------IIRGQVFFRQRVSS-------------- 229

Query: 383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
                       +  HL++  L   P+DR T  E   HP+ 
Sbjct: 230 ------------ECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  146 bits (370), Expect = 1e-41
 Identities = 80/333 (24%), Positives = 132/333 (39%), Gaps = 55/333 (16%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHD 151
           +Y    K+GEGT+G V +  +    E  A+K +R  K         + EI +L++L   +
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                 V++ +    +  + +VFE L   L   L             +    QLL  IA+
Sbjct: 62  -----IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAY 115

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            HD  ++H DLKP+N+L+     +K+ D+  +         +                  
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY------------------ 157

Query: 272 YERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
                  + + T  YRAP+V++G   ++   DIWSVGCI  E+  G  LF      + L 
Sbjct: 158 ------THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211

Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 390
            + R+LG         V                     +      +  P      ++ +D
Sbjct: 212 RIFRILGTPNSKNWPNVTELP-----------------KYDPNFTVYEPLPWESFLKGLD 254

Query: 391 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 423
            S  DL   L  +L+ DP  R+TA++AL H +F
Sbjct: 255 ESGIDL---LSKMLKLDPNQRITAKQALEHAYF 284

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 2e-41
 Identities = 61/336 (18%), Positives = 110/336 (32%), Gaps = 81/336 (24%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
            +K    +GEG+F  V+   +       AIKI+      +E  +  +   + +       
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 155 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
              V++   F     +           L  ++RK    SF     R    +++  + ++H
Sbjct: 69  F-FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH 125

Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
              +IH DLKPEN+LL    +I++ D+ ++     +S   +                   
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA------------------ 167

Query: 274 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
               N  V T  Y +PE++         D+W++GCI+ +L  G   F+          + 
Sbjct: 168 ----NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 223

Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 393
           ++    P+                    +P+                             
Sbjct: 224 KLEYDFPEKF------------------FPK----------------------------- 236

Query: 394 GDLTHLLQGLLRYDPTDRLTAREA------LRHPFF 423
                L++ LL  D T RL   E         HPFF
Sbjct: 237 --ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (365), Expect = 8e-41
 Identities = 81/338 (23%), Positives = 143/338 (42%), Gaps = 55/338 (16%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHD 151
           +Y+   K+GEGT+G V +  +RE  E+VA+K VR     +    +A+ EI +L++L   +
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                 V++ +       + +VFE     L  +    N    P ++V+    QLL+ + F
Sbjct: 63  -----IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP-EIVKSFLFQLLKGLGF 116

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
            H   ++H DLKP+N+L+  +  +K+ ++  +         +                  
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY------------------ 158

Query: 272 YERPDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEA-LFQTHENLEHL 329
                 +  V T  YR P+V+ G    +   D+WS GCI  EL      LF  ++  + L
Sbjct: 159 ------SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212

Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
             + R+LG   +     + +  +                    K     P   +L+    
Sbjct: 213 KRIFRLLGTPTEEQWPSMTKLPD-------------------YKPYPMYPATTSLVNVVP 253

Query: 390 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 427
             +A     LLQ LL+ +P  R++A EAL+HP+F+   
Sbjct: 254 KLNA-TGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 3e-40
 Identities = 63/335 (18%), Positives = 113/335 (33%), Gaps = 85/335 (25%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKH 150
            + +H  +G+G+FG+V     ++  +  AIK ++     +    E  M+E  VL    +H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
                    +   F  + ++  V E L G  L   ++      F +      A +++  +
Sbjct: 63  P----FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGL 116

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 269
            F+H   +++ DLK +N+LL    +IK+ D+          +                  
Sbjct: 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---------------- 160

Query: 270 TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 329
                   N    T  Y APE++LG  + +  D WS G +L E+  G++ F   +  E  
Sbjct: 161 --------NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 212

Query: 330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 389
                                    +R     +P                          
Sbjct: 213 -----------------------HSIRMDNPFYPRWLEK--------------------- 228

Query: 390 DHSAGDLTHLLQGLLRYDPTDRLTAR-EALRHPFF 423
                +   LL  L   +P  RL  R +  +HP F
Sbjct: 229 -----EAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 5e-40
 Identities = 62/343 (18%), Positives = 111/343 (32%), Gaps = 96/343 (27%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDK 152
           Y++   +G G++G+  +   +   +++  K +      +  ++  + E+ +L++L KH  
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPN 64

Query: 153 GGNRCVQIRNWFDYR--NHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLE 207
                V+  +    R    + IV E   G  L   + K     +    + V  +  QL  
Sbjct: 65  ----IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 208 CIAFMHDL-----CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 262
            +   H        ++H DLKP NV L   +                            +
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---------------------------V 153

Query: 263 KVIDFGSTTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 319
           K+ DFG       D ++    V T +Y +PE +  + +    DIWS+GC+L ELC     
Sbjct: 154 KLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 213

Query: 320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 379
           F      E                           +R G+        S E         
Sbjct: 214 FTAFSQKELAGK-----------------------IREGKFRRIPYRYSDE--------- 241

Query: 380 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 422
                           L  ++  +L      R +  E L +P 
Sbjct: 242 ----------------LNEIITRMLNLKDYHRPSVEEILENPL 268

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (360), Expect = 5e-40
 Identities = 60/339 (17%), Positives = 110/339 (32%), Gaps = 64/339 (18%)

Query: 92  LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD 151
           + +RY++  K+G G+FG +    D    E VAIK+   +K       IE ++ + +    
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGG- 62

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                   IR      ++  +V E LG SL D     + R F +  V  +A Q++  I +
Sbjct: 63  ---VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEY 118

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H    IH D+KP+N L+   +   +           D    K+   +   + I +    
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYII-------DFGLAKKYRDARTHQHIPYRENK 171

Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                   +  T  Y +    LG+  +   D+ S+G +L+    G   +Q  +       
Sbjct: 172 N-------LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224

Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
            ER                                         +   ++   I      
Sbjct: 225 YER-----------------------------------------ISEKKMSTPIEVLCKG 243

Query: 392 SAGDLTHLLQGLLRYDPTDRLTA---REALRHPFFTRDH 427
              +    L         D+      R+  R+ F  +  
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  136 bits (344), Expect = 7e-38
 Identities = 50/252 (19%), Positives = 92/252 (36%), Gaps = 38/252 (15%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
            YK+  ++GEG+FG + E  +    + VAIK     +        E    + LA      
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-RRSDAPQLRDEYRTYKLLAGC---- 60

Query: 155 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 214
                +  +     H  +V + LG SL D L     R F +  V   A+Q+L  +  +H+
Sbjct: 61  TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE 119

Query: 215 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG------ 268
             +++ D+KP+N L+                             ++ I V+DFG      
Sbjct: 120 KSLVYRDIKPDNFLIGR----------------------PNSKNANMIYVVDFGMVKFYR 157

Query: 269 ----STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 324
                      ++  +  T  Y +    LG   +   D+ ++G + +    G   +Q  +
Sbjct: 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217

Query: 325 NLEHLAMMERVL 336
              +    ER+ 
Sbjct: 218 AATNKQKYERIG 229

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  134 bits (338), Expect = 3e-36
 Identities = 67/341 (19%), Positives = 128/341 (37%), Gaps = 89/341 (26%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKH 150
            + +H  +G G FG+V  C   +  +M A+K +      +K+    A+ E  +L  ++  
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 209
           D      V +   F   + +  + + + G  L+  L ++    F    +R  A +++  +
Sbjct: 65  DC--PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGL 120

Query: 210 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 268
             MH+  +++ DLKP N+LL    +                           +++ D G 
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGH---------------------------VRISDLGL 153

Query: 269 STTYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
           +  + +   +  V T  Y APEV+  G+ +    D +S+GC+L +L  G + F+ H+  +
Sbjct: 154 ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213

Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
              +    L                       ++ P+  +                    
Sbjct: 214 KHEIDRMTLTM--------------------AVELPDSFSP------------------- 234

Query: 388 HVDHSAGDLTHLLQGLLRYDPTDRLT-----AREALRHPFF 423
                  +L  LL+GLL+ D   RL      A+E    PFF
Sbjct: 235 -------ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  132 bits (334), Expect = 5e-36
 Identities = 62/337 (18%), Positives = 110/337 (32%), Gaps = 91/337 (27%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHD 151
           ++I   +G G+FG+V     R      A+K+++       K  E    E  +L  +  H 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THP 64

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
                 +++   F     I ++ + +       L + + R FP  + +  A ++   + +
Sbjct: 65  ----FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEY 119

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +H   +I+ DLKPEN+LL  + +                           IK+ DFG   
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGH---------------------------IKITDFGFAK 152

Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
           Y       +  T  Y APEV+    +    D WS G ++ E+  G   F           
Sbjct: 153 YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY---------- 202

Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
                        ++        +    L +P                            
Sbjct: 203 -----DSNTMKTYEK--------ILNAELRFPPFFNE----------------------- 226

Query: 392 SAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
              D+  LL  L+  D + RL        +   HP+F
Sbjct: 227 ---DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 1e-35
 Identities = 58/329 (17%), Positives = 108/329 (32%), Gaps = 84/329 (25%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG 153
              K+   +G+G FG V+    R  K  VA+K ++      +A + E  V+ QL +H   
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHS-- 60

Query: 154 GNRCVQIRNWF-DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 211
               VQ+     + +  + IV E +   SL D+LR         D + + +  + E + +
Sbjct: 61  --NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118

Query: 212 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 271
           +     +H DL   NVL+                            + +  KV DFG T 
Sbjct: 119 LEGNNFVHRDLAARNVLV---------------------------SEDNVAKVSDFGLTK 151

Query: 272 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 331
                Q+       + APE +    ++   D+WS G +L E+ +   +      L+ +  
Sbjct: 152 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-- 209

Query: 332 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 391
                                +  +  ++D P+G             P +  ++      
Sbjct: 210 -------------------VPRVEKGYKMDAPDGCP-----------PAVYEVMKN---- 235

Query: 392 SAGDLTHLLQGLLRYDPTDRLTAREALRH 420
                          D   R +  +    
Sbjct: 236 -----------CWHLDAAMRPSFLQLREQ 253

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 4e-35
 Identities = 62/338 (18%), Positives = 113/338 (33%), Gaps = 90/338 (26%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHD 151
           +     +G+GTFG+V+   ++      A+KI+R      K      + E  VLQ   +H 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RH- 64

Query: 152 KGGNRCVQIRNWFDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                   ++  F   + +C V E   G  L+  L +     F  +  R    +++  + 
Sbjct: 65  ---PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALE 119

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H   +++ D+K EN++L    +IK+ D+        D +                   
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM----------------- 162

Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
                       T  Y APEV+    +    D W +G ++ E+  G   F   ++     
Sbjct: 163 -------KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215

Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 390
           +                       +    + +P   +                       
Sbjct: 216 L-----------------------ILMEEIRFPRTLSP---------------------- 230

Query: 391 HSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
               +   LL GLL+ DP  RL      A+E + H FF
Sbjct: 231 ----EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  128 bits (322), Expect = 1e-34
 Identities = 51/276 (18%), Positives = 96/276 (34%), Gaps = 37/276 (13%)

Query: 91  NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQ 146
           +L+ RY++   +G G   +V    D      VA+K++R        +      E +    
Sbjct: 4   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63

Query: 147 LAKHDKGGNRCVQIRNWFDYRNH----ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREI 201
           L  H       V + +  +          IV E + G +L D +              E+
Sbjct: 64  L-NHP----AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEV 116

Query: 202 ARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 261
                + + F H   +IH D+KP N+++ ++  +KV D+  +       +   +      
Sbjct: 117 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT----- 171

Query: 262 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 321
                             ++ T  Y +PE   G       D++S+GC+L E+ TGE  F 
Sbjct: 172 ----------------AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 215

Query: 322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRR 357
               +       R     P    + +    +  V +
Sbjct: 216 GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLK 251

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 6e-34
 Identities = 62/336 (18%), Positives = 118/336 (35%), Gaps = 86/336 (25%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKH 150
            +  +  ++G G+FG V +    +    VA+K++       +  +A   E+ VL++    
Sbjct: 8   GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT--- 61

Query: 151 DKGGNRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
                R V I  +  Y     + IV +   GSSLY  L     + F +  + +IARQ  +
Sbjct: 62  -----RHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQ 115

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++H   +IH DLK  N+ L     +K+ D+  +    + S   +             
Sbjct: 116 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF------------ 163

Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHE 324
                       +  +  + APEVI       +++  D+++ G +L EL TG+  +    
Sbjct: 164 ----------EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

Query: 325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 384
           N + +  M                      V RG L                        
Sbjct: 214 NRDQIIFM----------------------VGRGYLSPD--------------------- 230

Query: 385 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
           + +   +    +  L+   L+    +R    + L  
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  126 bits (317), Expect = 2e-33
 Identities = 66/338 (19%), Positives = 111/338 (32%), Gaps = 91/338 (26%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKH 150
           ++     +G G+FG+V+    +E     A+KI+   K    K  E  + E  +LQ +   
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NF 100

Query: 151 DKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 210
                      ++ D  N   ++    G  ++  LR+     F     R  A Q++    
Sbjct: 101 P---FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFE 155

Query: 211 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 270
           ++H L +I+ DLKPEN+L+    Y                           I+V DFG  
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGY---------------------------IQVTDFGFA 188

Query: 271 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 330
              +     +  T    APE+IL  G+    D W++G ++ E+  G   F   + ++   
Sbjct: 189 KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248

Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 390
            +       P H                                                
Sbjct: 249 KIVSGKVRFPSHFSS--------------------------------------------- 263

Query: 391 HSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
               DL  LL+ LL+ D T R         +   H +F
Sbjct: 264 ----DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 4e-33
 Identities = 62/334 (18%), Positives = 115/334 (34%), Gaps = 80/334 (23%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG 153
              K+  ++G G FG+V   +     + VA+K ++      +A + E  +++QL +H   
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQL-QHQ-- 68

Query: 154 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
             R V++      +  I I+ E +   SL DFL+  +     I+ + ++A Q+ E +AF+
Sbjct: 69  --RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125

Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
            +   IH DL+  N+L+  +   K+ D+  +     +    +                  
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG---------------- 169

Query: 273 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 332
                        + APE I    +T   D+WS G +L E+ T   +         +   
Sbjct: 170 -------AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--- 219

Query: 333 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 392
                              +   R  R+  P+                            
Sbjct: 220 ------------------IQNLERGYRMVRPDNCPE------------------------ 237

Query: 393 AGDLTHLLQGLLRYDPTDRLTAREALR--HPFFT 424
             +L  L++   +  P DR T          FFT
Sbjct: 238 --ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 2e-32
 Identities = 60/333 (18%), Positives = 111/333 (33%), Gaps = 78/333 (23%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG 153
              ++  K+G+G FG+V           VAIK ++      EA + E +V+++L      
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHE--- 72

Query: 154 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
             + VQ+           +       SL DFL+    +   +  + ++A Q+   +A++ 
Sbjct: 73  --KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130

Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
            +  +H DL+  N+L+  +   KV D+  +     +    ++                  
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG----------------- 173

Query: 274 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
                       + APE  L   +T   D+WS G +L EL T   +              
Sbjct: 174 ------AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------- 219

Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 393
                  + +L +V+R         R+  P                 L +L+ Q      
Sbjct: 220 ------NREVLDQVERGY-------RMPCPPECP-----------ESLHDLMCQ------ 249

Query: 394 GDLTHLLQGLLRYDPTDRLTAREALR--HPFFT 424
                      R +P +R T          +FT
Sbjct: 250 ---------CWRKEPEERPTFEYLQAFLEDYFT 273

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 5e-31
 Identities = 58/327 (17%), Positives = 105/327 (32%), Gaps = 76/327 (23%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG 153
           S      ++G G FG V   +    K+ VAIK +R      E  + E EV+ +L  H   
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHP-- 60

Query: 154 GNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
             + VQ+      +  IC+VFE +         +     F  + +  +   + E +A++ 
Sbjct: 61  --KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 273
           + C+IH DL   N L+  ++ IKV D+  +     D                        
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG----------------- 161

Query: 274 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 333
                       + +PEV     ++   D+WS G ++ E+ +   +   + +   +    
Sbjct: 162 ------TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---- 211

Query: 334 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 393
                             E      RL  P  A++                         
Sbjct: 212 -----------------VEDISTGFRLYKPRLAST------------------------- 229

Query: 394 GDLTHLLQGLLRYDPTDRLTAREALRH 420
             +  ++    +  P DR      LR 
Sbjct: 230 -HVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  115 bits (290), Expect = 3e-30
 Identities = 51/297 (17%), Positives = 111/297 (37%), Gaps = 31/297 (10%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG 153
           +   +  K+G G +G+V E   ++    VA+K ++      E  + E  V++++ KH   
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP-- 73

Query: 154 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 212
               VQ+           I+ E +   +L D+LR+ N +     ++  +A Q+   + ++
Sbjct: 74  --NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131

Query: 213 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 272
                IH DL   N L+  +  +KV D+  S     D+                      
Sbjct: 132 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-------------------- 171

Query: 273 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL--A 330
                        + APE +    ++   D+W+ G +L E+ T         +L  +   
Sbjct: 172 ---AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 228

Query: 331 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
           + +      P+   ++V        +    D P  A   ++ +++ +   + + + +
Sbjct: 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 285

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 6e-30
 Identities = 57/358 (15%), Positives = 110/358 (30%), Gaps = 105/358 (29%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKE-----MVAIKIVR--GIKKYREAAMIEIEVLQQ 146
              +    +G G FG+V+        +      VA+K+++       REA M E++++ Q
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYR-------------- 191
           L  H+      V +         I ++FE      L ++LR    +              
Sbjct: 97  LGSHE----NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152

Query: 192 -------SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 244
                      + +   A Q+ + + F+     +H DL   NVL+   + +K+ D+  + 
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212

Query: 245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIW 304
               DS+Y  R                              + APE +    +T   D+W
Sbjct: 213 DIMSDSNYVVRG----------------------NARLPVKWMAPESLFEGIYTIKSDVW 250

Query: 305 SVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDW 362
           S G +L E+ + G   +       +                        K ++ G ++D 
Sbjct: 251 SYGILLWEIFSLGVNPYPGIPVDANF----------------------YKLIQNGFKMDQ 288

Query: 363 PEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
           P  A                            ++  ++Q    +D   R +       
Sbjct: 289 PFYATE--------------------------EIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 9e-30
 Identities = 57/346 (16%), Positives = 104/346 (30%), Gaps = 95/346 (27%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRE--RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAK 149
           +  K    +GEG FGQVL+   ++   +   AIK ++    K        E+EVL +L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 150 HDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY--------------RSFP 194
           H       + +    ++R ++ +  E     +L DFLRK+                 +  
Sbjct: 70  HP----NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 195 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 254
              +   A  +   + ++     IH DL   N+L+  +   K+ D+  S           
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--- 182

Query: 255 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 314
                                 +        + A E +    +T   D+WS G +L E+ 
Sbjct: 183 ----------------------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 220

Query: 315 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 374
           +             L                      EK  +  RL+ P           
Sbjct: 221 SLGGTPYCGMTCAEL---------------------YEKLPQGYRLEKPLNCDD------ 253

Query: 375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
                               ++  L++   R  P +R +  + L  
Sbjct: 254 --------------------EVYDLMRQCWREKPYERPSFAQILVS 279

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 9e-30
 Identities = 60/332 (18%), Positives = 119/332 (35%), Gaps = 85/332 (25%)

Query: 101 KMGEGTFGQVLECWDRERK--EMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGN 155
           ++G G FG V + + + +K  + VA+KI++        ++  + E  V+QQL  +     
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNP---- 68

Query: 156 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
             V++    +  + + ++       L  +L++N  R      + E+  Q+   + ++ + 
Sbjct: 69  YIVRMIGICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES 126

Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
             +H DL   NVLLV+  Y K+ D+  S     D +Y+K                     
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ------------------- 167

Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE-LCTGEALFQTHENLEHLAMMER 334
              +      + APE I    ++   D+WS G ++ E    G+  ++  +  E  AM+E+
Sbjct: 168 --THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225

Query: 335 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 394
                                   R+  P G                             
Sbjct: 226 GE----------------------RMGCPAGCPR-------------------------- 237

Query: 395 DLTHLLQGLLRYDPTDRLTARE---ALRHPFF 423
           ++  L+     YD  +R         LR+ ++
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 2e-29
 Identities = 58/337 (17%), Positives = 111/337 (32%), Gaps = 62/337 (18%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG 154
              +   +G+G FG+V     + R E VA+KI    ++       EI     L +H+   
Sbjct: 4   TIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVML-RHENIL 60

Query: 155 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY-----RSFPIDLVREIARQLLEC 208
                          + +V +     SL+D+L +            +     +A   +E 
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +       + H DLK +N+L+  +    + D                      + V    
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADL--------------------GLAVRHDS 160

Query: 269 STTYERPDQNYIVSTRHYRAPEVILG------LGWTYPCDIWSVGCILVELCTGEALFQT 322
           +T       N+ V T+ Y APEV+               DI+++G +  E+    ++   
Sbjct: 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220

Query: 323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 382
           HE+ +          P  + M K V        ++ R + P    S E+++ + K     
Sbjct: 221 HEDYQLPYYDLVPSDPSVEEMRKVVCE------QKLRPNIPNRWQSCEALRVMAK----- 269

Query: 383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 419
                           +++     +   RLTA    +
Sbjct: 270 ----------------IMRECWYANGAARLTALRIKK 290

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 2e-29
 Identities = 62/351 (17%), Positives = 116/351 (33%), Gaps = 98/351 (27%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVR--GIKKYREAAMIEIEVLQQ 146
           +R      +G G FG+V+E         +    VA+K+++       REA M E++VL  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRK----------------NN 189
           L  H       V +           ++ E      L +FLR+                ++
Sbjct: 83  LGNHM----NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 190 YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 249
             +  ++ +   + Q+ + +AF+     IH DL   N+LL      K+ D+  +     D
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 250 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI 309
           S+Y                        +        + APE I    +T+  D+WS G  
Sbjct: 199 SNYVV----------------------KGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236

Query: 310 LVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAAS 368
           L EL +  +       ++                         K ++ G R+  PE    
Sbjct: 237 LWELFSLGSSPYPGMPVDSKFY---------------------KMIKEGFRMLSPE---- 271

Query: 369 RESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 419
                                 H+  ++  +++     DP  R T ++ ++
Sbjct: 272 ----------------------HAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  114 bits (285), Expect = 2e-29
 Identities = 58/337 (17%), Positives = 110/337 (32%), Gaps = 78/337 (23%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDR---ERKEMVAIKIVRG--IKKYREAAMIEIEVL 144
           E   S  KI   +G G FG+V     +   +R+  VAIK ++    +K R   + E  ++
Sbjct: 22  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81

Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 204
            Q   H       + +         + I+ E + +   D   + N   F +  +  + R 
Sbjct: 82  GQF-DHPN----VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 136

Query: 205 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 264
           +   + ++ D+  +H DL   N+L+ S+   KV D+  S                   + 
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS-------------------RF 177

Query: 265 IDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 323
           ++  ++               + APE I    +T   D+WS G ++ E+ + GE  +   
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
            N + +  +E                      +  RL  P    S               
Sbjct: 238 TNQDVINAIE----------------------QDYRLPPPMDCPS--------------- 260

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
                       L  L+    + D   R    + +  
Sbjct: 261 -----------ALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 2e-28
 Identities = 51/326 (15%), Positives = 104/326 (31%), Gaps = 78/326 (23%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN 155
                ++G G FG V     R + + VAIK+++      +  + E +V+  L  H+    
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNL-SHE---- 59

Query: 156 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
           + VQ+      +  I I+ E + +       +     F    + E+ + + E + ++   
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119

Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
             +H DL   N L+     +KV D+  S +   D                          
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG------------------- 160

Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 334
                     +  PEV++   ++   DIW+ G ++ E+ + G+  ++   N E    + +
Sbjct: 161 ----SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216

Query: 335 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 394
            L                      RL  P  A+                           
Sbjct: 217 GL----------------------RLYRPHLASE-------------------------- 228

Query: 395 DLTHLLQGLLRYDPTDRLTAREALRH 420
            +  ++         +R T +  L +
Sbjct: 229 KVYTIMYSCWHEKADERPTFKILLSN 254

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 4e-28
 Identities = 62/345 (17%), Positives = 116/345 (33%), Gaps = 90/345 (26%)

Query: 95  RYKIHSKMGEGTFGQVLECWD---RERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQ 146
            +++   +G G +G+V         +  ++ A+K+++        K  E    E +VL+ 
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQL 205
           + +        V +   F     + ++ +   G  L+  L +     F    V+    ++
Sbjct: 85  IRQS----PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEI 138

Query: 206 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 265
           +  +  +H L +I+ D+K EN+LL S+ ++ + D+  S                      
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF------------------- 179

Query: 266 DFGSTTYERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTH 323
                  E         T  Y AP+++ G   G     D WS+G ++ EL TG + F   
Sbjct: 180 ----VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 235

Query: 324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 383
                 A + R                    + +    +P+  ++               
Sbjct: 236 GEKNSQAEISR-------------------RILKSEPPYPQEMSA--------------- 261

Query: 384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 423
                          L+Q LL  DP  RL      A E   H FF
Sbjct: 262 -----------LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 6e-28
 Identities = 67/333 (20%), Positives = 115/333 (34%), Gaps = 85/333 (25%)

Query: 101 KMGEGTFGQVLECWDRERKE--MVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           ++G G FG V +   R RK+   VAIK+++    K   E  M E +++ QL  +      
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNP----Y 70

Query: 157 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
            V++         + +V E   G  L+ FL        P+  V E+  Q+   + ++ + 
Sbjct: 71  IVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK 128

Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
             +H DL   NVLLV+  Y K+ D+  S     D SY+                      
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR------------------- 169

Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE-LCTGEALFQTHENLEHLAMMER 334
             +       + APE I    ++   D+WS G  + E L  G+  ++  +  E +A +E+
Sbjct: 170 --SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227

Query: 335 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 394
                                   R++ P               P L  L+         
Sbjct: 228 GK----------------------RMECPPECP-----------PELYALMSD------- 247

Query: 395 DLTHLLQGLLRYDPTDRLTARE---ALRHPFFT 424
                      Y   DR         +R  +++
Sbjct: 248 --------CWIYKWEDRPDFLTVEQRMRACYYS 272

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 1e-27
 Identities = 45/262 (17%), Positives = 93/262 (35%), Gaps = 34/262 (12%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDR----ERKEMVAIKIVRG--IKKYREAAMIEIEVLQQL 147
           S       +G G FG+V +   +    +++  VAIK ++    +K R   + E  ++ Q 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 148 AKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
           + H       +++         + I+ E + +   D   +     F +  +  + R +  
Sbjct: 67  SHH-----NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++ ++  +H DL   N+L+ S+   KV D+  S     D                  
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT----------- 170

Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                     +       + APE I    +T   D+WS G ++ E+ T         +  
Sbjct: 171 ----------SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 220

Query: 328 HL--AMMERVLGPLPQHMLKRV 347
            +  A+ +    P P      +
Sbjct: 221 EVMKAINDGFRLPTPMDCPSAI 242

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 1e-26
 Identities = 54/351 (15%), Positives = 106/351 (30%), Gaps = 97/351 (27%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDR-------ERKEMVAIKIVR--GIKKYREAAMIEIEVL 144
            R  +   +GEG FGQV+             R   VA+K+++    +K     + E+E++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 145 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLR--------------KNN 189
           + + KH       + +         + ++ E     +L ++L+               N 
Sbjct: 73  KMIGKH----KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 190 YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 249
                   +   A Q+   + ++     IH DL   NVL+     +K+ D+  +      
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 250 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI 309
             Y K                               + APE +    +T+  D+WS G +
Sbjct: 189 DYYKKTT----------------------NGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226

Query: 310 LVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASR 369
           L E+ T          +E L                      +      R+D P    + 
Sbjct: 227 LWEIFTLGGSPYPGVPVEEL---------------------FKLLKEGHRMDKPSNCTN- 264

Query: 370 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
                                    +L  +++      P+ R T ++ +  
Sbjct: 265 -------------------------ELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  105 bits (263), Expect = 3e-26
 Identities = 54/360 (15%), Positives = 101/360 (28%), Gaps = 104/360 (28%)

Query: 90  ENLTSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVR--GIKKYREAAMIEIE 142
           E   +  +    +GEG FG+V +         E   MVA+K+++       +     E  
Sbjct: 9   EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 68

Query: 143 VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS--------- 192
           ++ +           V++         +C++FE +    L +FLR  +  +         
Sbjct: 69  LMAEFDNP-----NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 193 -------------FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 239
                                IARQ+   +A++ +   +H DL   N L+  +  +K+ D
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 183

Query: 240 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTY 299
           +  S +      Y                                 +  PE I    +T 
Sbjct: 184 FGLSRNIYSADYYKADGN----------------------DAIPIRWMPPESIFYNRYTT 221

Query: 300 PCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGR 359
             D+W+ G +L E+ +           E +                              
Sbjct: 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEV---------------------IYYVRDGNI 260

Query: 360 LDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 419
           L  PE                              +L +L++      P DR +     R
Sbjct: 261 LACPENCPL--------------------------ELYNLMRLCWSKLPADRPSFCSIHR 294

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 3e-26
 Identities = 54/332 (16%), Positives = 92/332 (27%), Gaps = 81/332 (24%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRGI--KKYREAAMIEIEVLQQLA 148
            R ++   +GEG FG V +      +     VAIK  +       RE  + E   ++Q  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF- 65

Query: 149 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 208
            H       V++       N + I+ E           +    S  +  +   A QL   
Sbjct: 66  DHP----HIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120

Query: 209 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 268
           +A++     +H D+   NVL+ S++ +K+ D+  S +    + Y                
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK------------ 168

Query: 269 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 328
                            + APE I    +T   D+W  G  + E+               
Sbjct: 169 -----------GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217

Query: 329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 388
           +                       +     RL  P                         
Sbjct: 218 V---------------------IGRIENGERLPMPPNCPP-------------------- 236

Query: 389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
                  L  L+     YDP+ R    E    
Sbjct: 237 ------TLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 3e-26
 Identities = 44/325 (13%), Positives = 83/325 (25%), Gaps = 76/325 (23%)

Query: 101 KMGEGTFGQVLECWDRE---RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGN 155
            +G G FG V      +   +K   A+K +  I         + E  +++    H    N
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHP---N 89

Query: 156 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 215
               +           +V   +         +N   +  +  +     Q+ + + F+   
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149

Query: 216 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 275
             +H DL   N +L     +KV D+  +                +               
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA--------------- 194

Query: 276 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 335
                     + A E +    +T   D+WS G +L EL T  A      N   +      
Sbjct: 195 -----KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------ 243

Query: 336 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 395
                              ++  RL  PE                          +    
Sbjct: 244 ---------------TVYLLQGRRLLQPE--------------------------YCPDP 262

Query: 396 LTHLLQGLLRYDPTDRLTAREALRH 420
           L  ++          R +  E +  
Sbjct: 263 LYEVMLKCWHPKAEMRPSFSELVSR 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 1e-25
 Identities = 55/352 (15%), Positives = 111/352 (31%), Gaps = 96/352 (27%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVR--GIKKYREAAMIEIEVLQQ 146
            +  +  ++G+G+FG V E   +     E +  VAIK V      + R   + E  V+++
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 147 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS--------FPIDL 197
              H       V++           ++ E +    L  +LR                +  
Sbjct: 80  FNCH-----HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 198 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 257
           + ++A ++ + +A+++    +H DL   N ++     +K+ D+  +    +   Y K   
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 258 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 317
                                  +    + +PE +    +T   D+WS G +L E+ T  
Sbjct: 195 ----------------------GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232

Query: 318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 377
                  + E +                         +  G LD P              
Sbjct: 233 EQPYQGLSNEQV---------------------LRFVMEGGLLDKP-------------- 257

Query: 378 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR------HPFF 423
                       D+    L  L++   +Y+P  R +  E +        P F
Sbjct: 258 ------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 2e-25
 Identities = 42/255 (16%), Positives = 93/255 (36%), Gaps = 35/255 (13%)

Query: 95  RYKIHSKMGEGTFGQVLECWDRE---RKEMVAIKIVR----GIKKYREAAMIEIEVLQQL 147
             ++  K+G+G+FG V          +   VA+K ++       +  +  + E+  +  L
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 148 AKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
             H       +++         + +V E           + +   F +  +   A Q+ E
Sbjct: 69  -DHRN----LIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++     IH DL   N+LL + + +K+ D+      P++  ++              
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM------------ 170

Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 326
                    Q +      + APE +    +++  D W  G  L E+ T G+  +      
Sbjct: 171 ---------QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221

Query: 327 EHLAMMERVLGPLPQ 341
           + L  +++    LP+
Sbjct: 222 QILHKIDKEGERLPR 236

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 3e-25
 Identities = 50/333 (15%), Positives = 97/333 (29%), Gaps = 85/333 (25%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA--------MIEIEVLQQL 147
           +K    +G G FG V +       E V I +   IK+ REA         + E  V+  +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA--IKELREATSPKANKEILDEAYVMASV 68

Query: 148 AKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 207
             +        ++           I        L D++R++   +     +     Q+ +
Sbjct: 69  -DNP----HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 122

Query: 208 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 267
            + ++ D  ++H DL   NVL+ + +++K+ D+  +     +   +              
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------------ 170

Query: 268 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 327
                             + A E IL   +T+  D+WS G  + EL T  +         
Sbjct: 171 ----------EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220

Query: 328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 387
            +                     +    +  RL  P                        
Sbjct: 221 EI---------------------SSILEKGERLPQPPICTI------------------- 240

Query: 388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
                  D+  ++      D   R   RE +  
Sbjct: 241 -------DVYMIMVKCWMIDADSRPKFRELIIE 266

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.6 bits (247), Expect = 3e-24
 Identities = 56/350 (16%), Positives = 108/350 (30%), Gaps = 95/350 (27%)

Query: 94  SRYKIHSKMGEGTFGQVLECWDRERK-----EMVAIKIVR--GIKKYREAAMIEIEVLQQ 146
            R K+   +G G FGQV+E              VA+K+++         A M E+++L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 147 LAKHDKGGNRCVQIRN-WFDYRNHICIVFEKL-GSSLYDFLRKNNY-------------- 190
           +  H       V +          + ++ E     +L  +LR                  
Sbjct: 73  IGHH----LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128

Query: 191 RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 250
               ++ +   + Q+ + + F+     IH DL   N+LL     +K+ D+  +    KD 
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188

Query: 251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 310
            Y ++                              + APE I    +T   D+WS G +L
Sbjct: 189 DYVRK----------------------GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 226

Query: 311 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRE 370
            E+ +  A                    + +   +R+                       
Sbjct: 227 WEIFSLGASPYPGVK-------------IDEEFCRRLK---------------------- 251

Query: 371 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 420
                      +   M+  D++  ++   +      +P+ R T  E + H
Sbjct: 252 -----------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 66.7 bits (162), Expect = 2e-13
 Identities = 33/223 (14%), Positives = 63/223 (28%), Gaps = 39/223 (17%)

Query: 96  YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGG 154
             I   MGEG    V  C+  +  E   +K  + G   +++            +      
Sbjct: 2   DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 155 NR-CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 213
            R   +            +   +  + L + +         ++   E+   +LE +A  +
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 214 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTY 272
              ++H DL   NVL+                                I +IDF  S   
Sbjct: 121 HRGIVHGDLSQYNVLVSEEG----------------------------IWIIDFPQSVEV 152

Query: 273 ERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVE 312
                  I+     R    I+      +    DI S    +++
Sbjct: 153 GEEGWREIL----ERDVRNIITYFSRTYRTEKDINSAIDRILQ 191

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} Length = 395

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 42.1 bits (98), Expect = 9e-05
 Identities = 24/172 (13%), Positives = 49/172 (28%), Gaps = 10/172 (5%)

Query: 97  KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 156
           K++     G   + +        E+    +       + A  +      ++    +    
Sbjct: 109 KLYGIFSGGRLEEYIPSRPLSCHEISLAHMST-----KIAKRVAKVHQLEVPIWKEPDYL 163

Query: 157 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 216
           C  ++ W            +        +   N     +DL RE+             + 
Sbjct: 164 CEALQRWLKQLTGTVDAEHRFDLPEECGVSSVNC----LDLARELEFLRAHISLSKSPVT 219

Query: 217 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK-DSSYFKRMPKSSAIKVIDF 267
             H DL+  N+LL  +    +     S  T    +S     P    + +IDF
Sbjct: 220 FCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDF 271

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	430
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.38
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.11
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.9
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.76
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.24
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.92

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-60  Score=444.18  Aligned_cols=249  Identities=24%  Similarity=0.428  Sum_probs=213.0

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++.+..    .....+.+|+++++++     .|+||+++++++.+.+.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-----RHPNILRLYGYFHDATR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSSE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-----CCCCCCeEEEEEEECCE
Confidence            56999999999999999999999999999999986322    2345677899999888     45899999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +||||||| +|+|.+++...+  .+++..++.++.||+.||+|||++|||||||||+|||++                  
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~------------------  140 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG------------------  140 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC------------------
T ss_pred             EEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec------------------
Confidence            99999999 889999998765  799999999999999999999999999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC-CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                               .++.+||+|||+|...... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+
T Consensus       141 ---------~~~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~  211 (263)
T d2j4za1         141 ---------SAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE  211 (263)
T ss_dssp             ---------TTSCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             ---------CCCCEeecccceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH
Confidence                     4456677777777544332 244689999999999999999999999999999999999999999877766


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      .+..+.+....                                                 +++..++++.+||.+||+.|
T Consensus       212 ~~~~i~~~~~~-------------------------------------------------~p~~~s~~~~~li~~~L~~d  242 (263)
T d2j4za1         212 TYKRISRVEFT-------------------------------------------------FPDFVTEGARDLISRLLKHN  242 (263)
T ss_dssp             HHHHHHTTCCC-------------------------------------------------CCTTSCHHHHHHHHHHTCSS
T ss_pred             HHHHHHcCCCC-------------------------------------------------CCccCCHHHHHHHHHHccCC
Confidence            65554332111                                                 22346778999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTR  425 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~  425 (430)
                      |++|||++|+|+||||+.
T Consensus       243 p~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         243 PSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             GGGSCCHHHHHTCHHHHH
T ss_pred             HhHCcCHHHHHcCcCcCC
Confidence            999999999999999974

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-60  Score=445.69  Aligned_cols=254  Identities=24%  Similarity=0.366  Sum_probs=206.1

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .++|++++.||+|+||+||+|+++.+++.||||+++...  ...+.+.+|+++++++     .|+||+++++++.+.+.+
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-----~HpnIv~~~~~~~~~~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-----NHENVVKFYGHRREGNIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-----CCTTBCCEEEEEEETTEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-----CCCCEeeEeeeeccCcee
Confidence            357999999999999999999999999999999986432  2345678899999888     458999999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      ||||||| +|+|.+++....  .+++..++.++.||+.||+|||++|||||||||+|||++                   
T Consensus        79 ~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~-------------------  137 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD-------------------  137 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC-------------------
T ss_pred             EEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC-------------------
Confidence            9999999 889999987553  799999999999999999999999999999999999994                   


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCC-CCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                              .++.+||+|||+|+.....     ....+||+.|||||++.+..+ +.++|||||||++|||++|++||...
T Consensus       138 --------~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~  209 (271)
T d1nvra_         138 --------ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP  209 (271)
T ss_dssp             --------TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred             --------CCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCC
Confidence                    4456777777777643221     234689999999999998886 57899999999999999999999765


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      ++..............+                                              ..+...+.++.+||.+|
T Consensus       210 ~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~s~~~~~li~~~  243 (271)
T d1nvra_         210 SDSCQEYSDWKEKKTYL----------------------------------------------NPWKKIDSAPLALLHKI  243 (271)
T ss_dssp             STTSHHHHHHHTTCTTS----------------------------------------------TTGGGSCHHHHHHHHHH
T ss_pred             ChHHHHHHHHhcCCCCC----------------------------------------------CccccCCHHHHHHHHHH
Confidence            44322221111110000                                              01234567899999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      |+.||++|||++|+|+||||++.
T Consensus       244 L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         244 LVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             SCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             cCCChhHCcCHHHHhcCHhhCcC
Confidence            99999999999999999999865

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-60  Score=450.48  Aligned_cols=263  Identities=25%  Similarity=0.448  Sum_probs=209.4

Q ss_pred             cCceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           88 LGENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        88 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      ..+.+.+.|++.+.||+|+||+||+|+++.+++.||||++....  .....+.+|+.+++++     .||||+++++++.
T Consensus         3 ~~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~   77 (307)
T d1a06a_           3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-----KHPNIVALDDIYE   77 (307)
T ss_dssp             ECSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-----CCTTBCCEEEEEE
T ss_pred             CCCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-----CCCCCCcEEEEEE
Confidence            34567788999999999999999999999999999999986432  2334566799999888     4589999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                      +.+.+||||||| |++|.+++...+  .+++..++.++.||+.||+|||++|||||||||+|||+...            
T Consensus        78 ~~~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~------------  143 (307)
T d1a06a_          78 SGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL------------  143 (307)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS------------
T ss_pred             ECCEEEEEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeeccc------------
Confidence            999999999999 899999998754  79999999999999999999999999999999999999532            


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                  +.++.+||+|||+|+......  ...+||+.|||||++.+..|+.++|||||||++|||++|.+||.+
T Consensus       144 ------------~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  211 (307)
T d1a06a_         144 ------------DEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD  211 (307)
T ss_dssp             ------------STTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ------------CCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC
Confidence                        345678999999887554332  446899999999999999999999999999999999999999998


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      .+..+....+......++.                                             ..++..++++.+||.+
T Consensus       212 ~~~~~~~~~i~~~~~~~~~---------------------------------------------~~~~~~s~~~~~li~~  246 (307)
T d1a06a_         212 ENDAKLFEQILKAEYEFDS---------------------------------------------PYWDDISDSAKDFIRH  246 (307)
T ss_dssp             SSHHHHHHHHHTTCCCCCT---------------------------------------------TTTTTSCHHHHHHHHH
T ss_pred             CCHHHHHHHHhccCCCCCC---------------------------------------------ccccCCCHHHHHHHHH
Confidence            7777666655443222221                                             1234567889999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||++||++|||++|+|+||||++.
T Consensus       247 ~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         247 LMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HccCCHhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999854

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-60  Score=445.59  Aligned_cols=253  Identities=26%  Similarity=0.411  Sum_probs=214.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      .++|+++++||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+++++++     .|+||+++++++.+.+.+|
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-----KNPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-----CCCCEeeEeEEEEECCEEE
Confidence            357999999999999999999999999999999986433 3456688899999998     4589999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      |||||| |++|.+++.+.   .+++..++.++.||+.||+|||++|||||||||+|||++                    
T Consensus        94 ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~--------------------  150 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG--------------------  150 (293)
T ss_dssp             EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC--------------------
T ss_pred             EEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC--------------------
Confidence            999999 89999988764   699999999999999999999999999999999999994                    


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                             .++.+||+|||+|+.....   ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+
T Consensus       151 -------~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~  223 (293)
T d1yhwa1         151 -------MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR  223 (293)
T ss_dssp             -------TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             -------CCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH
Confidence                   4556777777777654322   234589999999999999999999999999999999999999999877766


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+.....+..                                              ..+..++.++++||.+||+.|
T Consensus       224 ~~~~~~~~~~~~~----------------------------------------------~~~~~~s~~~~~li~~~L~~d  257 (293)
T d1yhwa1         224 ALYLIATNGTPEL----------------------------------------------QNPEKLSAIFRDFLNRCLDMD  257 (293)
T ss_dssp             HHHHHHHHCSCCC----------------------------------------------SSGGGSCHHHHHHHHHHTCSS
T ss_pred             HHHHHHhCCCCCC----------------------------------------------CCcccCCHHHHHHHHHHccCC
Confidence            5554433211100                                              123456778999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~  426 (430)
                      |.+|||++|+|+||||+..
T Consensus       258 P~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         258 VEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             TTTSCCHHHHTTCGGGGGC
T ss_pred             hhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-59  Score=439.72  Aligned_cols=263  Identities=25%  Similarity=0.459  Sum_probs=224.8

Q ss_pred             ceecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-------hhHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 014117           90 ENLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRN  162 (430)
Q Consensus        90 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~  162 (430)
                      +++.++|++.+.||+|+||+||+|+++.+|+.||||++++..       ...+.+.+|+.+|+++.     |+||+++++
T Consensus         6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-----HpnIv~~~~   80 (293)
T d1jksa_           6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-----HPNVITLHE   80 (293)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-----CTTBCCEEE
T ss_pred             CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-----CCCCCcEEE
Confidence            456678999999999999999999999999999999986321       23467889999999984     489999999


Q ss_pred             eeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          163 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       163 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      ++.+.+.+||||||| +|+|.+++...+  .+++..++.++.||+.||+|||++|||||||||+|||++.++        
T Consensus        81 ~~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~--------  150 (293)
T d1jksa_          81 VYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN--------  150 (293)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS--------
T ss_pred             EEEECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCC--------
Confidence            999999999999999 899999998765  799999999999999999999999999999999999997654        


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL  319 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~P  319 (430)
                                     .....+||+|||+|......  .....||+.|+|||++.+..|+.++|||||||++|||++|..|
T Consensus       151 ---------------~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P  215 (293)
T d1jksa_         151 ---------------VPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP  215 (293)
T ss_dssp             ---------------SSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ---------------CcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCC
Confidence                           23456899999998765433  2446899999999999999999999999999999999999999


Q ss_pred             CCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          320 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       320 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      |.+.+..+.+..+......++..                                             .++..+.++.+|
T Consensus       216 f~~~~~~~~~~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~l  250 (293)
T d1jksa_         216 FLGDTKQETLANVSAVNYEFEDE---------------------------------------------YFSNTSALAKDF  250 (293)
T ss_dssp             SCCSSHHHHHHHHHTTCCCCCHH---------------------------------------------HHTTSCHHHHHH
T ss_pred             CCCCCHHHHHHHHHhcCCCCCch---------------------------------------------hcCCCCHHHHHH
Confidence            99888877776665543333322                                             234567789999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          400 LQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      |.+||+.||++|||++|+|+||||+..+
T Consensus       251 i~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         251 IRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             HHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999999998654

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-59  Score=441.02  Aligned_cols=254  Identities=25%  Similarity=0.456  Sum_probs=213.3

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc-hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      +.|++++.||+|+||+||+|+++.+++.||||+++.. ....+.+..|+++++++     .|+||+++++++.+.+.+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-----DHPNIVKLLDAFYYENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-----CCTTBCCEEEEEEETTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEeeCCeEEE
Confidence            4699999999999999999999999999999999643 34446778899999998     45899999999999999999


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||| +|+|.+++.+.. ..+++..++.++.||+.||.|||++|||||||||+|||+                      
T Consensus        87 vmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll----------------------  143 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF----------------------  143 (288)
T ss_dssp             EEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----------------------
T ss_pred             EEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE----------------------
Confidence            99999 889999987653 479999999999999999999999999999999999999                      


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhh-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                           +.++.+||+|||+|......   ....+||+.|||||++.     +..|+.++|||||||++|||++|++||.+.
T Consensus       144 -----~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~  218 (288)
T d2jfla1         144 -----TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL  218 (288)
T ss_dssp             -----CTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             -----CCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence                 44566788888877543221   13468999999999985     446899999999999999999999999987


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +..+.+..+.....+..                                              ..+...+.++.+||.+|
T Consensus       219 ~~~~~~~~i~~~~~~~~----------------------------------------------~~~~~~s~~~~~li~~~  252 (288)
T d2jfla1         219 NPMRVLLKIAKSEPPTL----------------------------------------------AQPSRWSSNFKDFLKKC  252 (288)
T ss_dssp             CGGGHHHHHHHSCCCCC----------------------------------------------SSGGGSCHHHHHHHHHH
T ss_pred             CHHHHHHHHHcCCCCCC----------------------------------------------CccccCCHHHHHHHHHH
Confidence            77666655543211100                                              11235577899999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      |+.||++|||++|+|+||||+.+
T Consensus       253 L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         253 LEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             SCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             ccCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999865

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.8e-59  Score=448.61  Aligned_cols=260  Identities=28%  Similarity=0.453  Sum_probs=222.8

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+++++.     |+||+++++++.+.+.+
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~-----HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-----HPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTC-----CTTBCCEEEEEEETTEE
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCC-----CCCCCcEEEEEEECCEE
Confidence            4568999999999999999999999999999999987443 34466778999999984     48899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      ||||||| ||+|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+|||++.                  
T Consensus        99 ~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~------------------  159 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT------------------  159 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS------------------
T ss_pred             EEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc------------------
Confidence            9999999 899999996543 36999999999999999999999999999999999999953                  


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                             +.++.+||+|||+|+......  ...+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+
T Consensus       160 -------~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~  232 (350)
T d1koaa2         160 -------KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE  232 (350)
T ss_dssp             -------TTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             -------CCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence                   234678999999887655443  34689999999999999999999999999999999999999999888877


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      .+..+......++..                                             .+...+.++++||.+||+.|
T Consensus       233 ~~~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li~~~L~~d  267 (350)
T d1koaa2         233 TLRNVKSCDWNMDDS---------------------------------------------AFSGISEDGKDFIRKLLLAD  267 (350)
T ss_dssp             HHHHHHHTCCCSCCG---------------------------------------------GGGGCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHhCCCCCCcc---------------------------------------------cccCCCHHHHHHHHHHccCC
Confidence            777766544333221                                             12345678999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~~  427 (430)
                      |++|||++|+|+||||+...
T Consensus       268 P~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         268 PNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             GGGSCCHHHHHHSTTTSCTT
T ss_pred             hhHCcCHHHHhcCcccCCCC
Confidence            99999999999999998653

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-59  Score=437.84  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=211.9

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||+|+||+||+|+++.+++.||||++++..    .....+.+|+++++++.     |+||+++++++.+.+.
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-----HpnIv~l~~~~~~~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-----HPFFVKLYFTFQDDEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-----STTBCCEEEEEECSSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-----CCCeeEEEEEEEECCE
Confidence            56999999999999999999999999999999986432    23356788999999983     4899999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +||||||| ||+|.+++...+  .+++..++.++.||+.||+|||++|||||||||+|||++                  
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~------------------  142 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN------------------  142 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred             EEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC------------------
Confidence            99999999 889999998765  799999999999999999999999999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                               .++.+||+|||+|+.....     ....+||+.|||||++.+..|+.++|||||||++|||++|..||.+.
T Consensus       143 ---------~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (288)
T d1uu3a_         143 ---------EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG  213 (288)
T ss_dssp             ---------TTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ---------CCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence                     4456777777777643321     13357999999999999999999999999999999999999999987


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +..+....|.+....                                                 ++..+++++++||.+|
T Consensus       214 ~~~~~~~~i~~~~~~-------------------------------------------------~p~~~s~~~~~li~~~  244 (288)
T d1uu3a_         214 NEYLIFQKIIKLEYD-------------------------------------------------FPEKFFPKARDLVEKL  244 (288)
T ss_dssp             SHHHHHHHHHTTCCC-------------------------------------------------CCTTCCHHHHHHHHTT
T ss_pred             CHHHHHHHHHcCCCC-------------------------------------------------CCccCCHHHHHHHHHH
Confidence            776666554332111                                                 2335677899999999


Q ss_pred             hhcCCCCCCCHHH------HhcCCCCCCCC
Q 014117          404 LRYDPTDRLTARE------ALRHPFFTRDH  427 (430)
Q Consensus       404 L~~dP~~R~ta~e------lL~hp~f~~~~  427 (430)
                      |+.||++|||++|      +++||||++-+
T Consensus       245 L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~  274 (288)
T d1uu3a_         245 LVLDATKRLGCEEMEGYGPLKAHPFFESVT  274 (288)
T ss_dssp             SCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             ccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence            9999999999987      58999998754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-59  Score=449.45  Aligned_cols=290  Identities=22%  Similarity=0.333  Sum_probs=210.9

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      ...++|+++++||+|+||+||+|+++.+|+.||+|+++..  ......+.+|+.+|+++     +||||+++++++.+.+
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~   77 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-----NSPYIVGFYGAFYSDG   77 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-----CCTTBCCEEEEEECSS
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECC
Confidence            3457899999999999999999999999999999998643  33456778899998887     4589999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      ++||||||+ |++|.+++.+.+  .+++..++.++.||+.||.|||+ +|||||||||+||||                 
T Consensus        78 ~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl-----------------  138 (322)
T d1s9ja_          78 EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV-----------------  138 (322)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE-----------------
T ss_pred             EEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE-----------------
Confidence            999999999 889999998765  79999999999999999999997 599999999999999                 


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCC-CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                                +.++.+||+|||+|+.... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus       139 ----------~~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~  208 (322)
T d1s9ja_         139 ----------NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA  208 (322)
T ss_dssp             ----------CTTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred             ----------CCCCCEEEeeCCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence                      4556788888888864322 23456899999999999999999999999999999999999999987654


Q ss_pred             HHHH-HHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhh-----cCCchhHHHHH
Q 014117          326 LEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH-----VDHSAGDLTHL  399 (430)
Q Consensus       326 ~~~~-~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l  399 (430)
                      .+.. ..+....+...... ..................+.  ....        ..........     ....+.++.+|
T Consensus       209 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~--~~~~--------~~~~~~~~~~~~~~~~~~~s~~~~dl  277 (322)
T d1s9ja_         209 KELELMFGCQVEGDAAETP-PRPRTPGRPLSSYGMDSRPP--MAIF--------ELLDYIVNEPPPKLPSGVFSLEFQDF  277 (322)
T ss_dssp             THHHHHC-------------------------------CC--CCHH--------HHHHHHHTSCCCCCCBTTBCHHHHHH
T ss_pred             HHHHHHHHHHhcCCcccCC-cccccccccccccccccccc--hhHH--------HHHhhhhccCCccCccccCCHHHHHH
Confidence            3322 22222222211100 00000000000000000000  0000        0000001111     12357889999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          400 LQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      |.+||++||.+||||+|+|+||||++
T Consensus       278 i~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         278 VNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHhhCHhhCc
Confidence            99999999999999999999999974

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.2e-58  Score=447.76  Aligned_cols=258  Identities=26%  Similarity=0.469  Sum_probs=222.1

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+|+.+|+++     .|+||+++++++.+.+.+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~~~~~~~~~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-----HHPKLINLHDAFEDKYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-----CSTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCEEE
Confidence            457999999999999999999999999999999987543 3345667899999888     3589999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      |||||| |++|.+++...+ .++++..++.++.||+.||+|||++|||||||||+||||+.                   
T Consensus       103 ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-------------------  162 (352)
T d1koba_         103 LILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-------------------  162 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-------------------
T ss_pred             EEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-------------------
Confidence            999999 899999876543 46999999999999999999999999999999999999953                   


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                            ...+.+||+|||+|.......  ....||+.|+|||++.+..|+.++|||||||++|+|+||++||.+.+..+.
T Consensus       163 ------~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~  236 (352)
T d1koba_         163 ------KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET  236 (352)
T ss_dssp             ------TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred             ------cCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                  245689999999988665543  346899999999999999999999999999999999999999999888877


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      +..+......+|..                                             .+...++++.+||.+||++||
T Consensus       237 ~~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li~~~L~~dp  271 (352)
T d1koba_         237 LQNVKRCDWEFDED---------------------------------------------AFSSVSPEAKDFIKNLLQKEP  271 (352)
T ss_dssp             HHHHHHCCCCCCSS---------------------------------------------TTTTSCHHHHHHHHTTSCSSG
T ss_pred             HHHHHhCCCCCCcc---------------------------------------------cccCCCHHHHHHHHHHccCCh
Confidence            77666544333321                                             224567889999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCC
Q 014117          409 TDRLTAREALRHPFFTRD  426 (430)
Q Consensus       409 ~~R~ta~elL~hp~f~~~  426 (430)
                      .+|||++|+|+||||+..
T Consensus       272 ~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         272 RKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             GGSCCHHHHHTSTTTSSC
T ss_pred             hHCcCHHHHhcCHhhCCC
Confidence            999999999999999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-58  Score=431.06  Aligned_cols=251  Identities=24%  Similarity=0.433  Sum_probs=205.8

Q ss_pred             cCcE-EEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--
Q 014117           93 TSRY-KIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--  166 (430)
Q Consensus        93 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--  166 (430)
                      .++| ++.++||+|+||+||+|.++.+++.||+|++...   ....+.+.+|+++++++     .|+||++++++++.  
T Consensus         7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~   81 (270)
T d1t4ha_           7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-----QHPNIVRFYDSWESTV   81 (270)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEEES
T ss_pred             CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEeecc
Confidence            3445 7788999999999999999999999999998643   23445677899999888     35899999998864  


Q ss_pred             --CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeeccCCCCceEEeecCccccCCCc
Q 014117          167 --RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       167 --~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                        ...+||||||+ +++|.+++.+..  .+++..++.++.||+.||+|||+++  ||||||||+|||++           
T Consensus        82 ~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~-----------  148 (270)
T d1t4ha_          82 KGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT-----------  148 (270)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES-----------
T ss_pred             ccCCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee-----------
Confidence              46789999999 889999998764  7999999999999999999999999  99999999999994           


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                     +.++.+||+|||+|+...... ...+||+.|||||++.+ .|+.++|||||||++|||++|+.||
T Consensus       149 ---------------~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf  212 (270)
T d1t4ha_         149 ---------------GPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY  212 (270)
T ss_dssp             ---------------STTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ---------------CCCCCEEEeecCcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCC
Confidence                           234578888888887544333 45689999999999876 6999999999999999999999999


Q ss_pred             CCCchHHHH-HHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHH
Q 014117          321 QTHENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL  399 (430)
Q Consensus       321 ~~~~~~~~~-~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  399 (430)
                      .+..+.... ..+..  +..|.                                             .++...++++.+|
T Consensus       213 ~~~~~~~~~~~~i~~--~~~~~---------------------------------------------~~~~~~~~~~~~l  245 (270)
T d1t4ha_         213 SECQNAAQIYRRVTS--GVKPA---------------------------------------------SFDKVAIPEVKEI  245 (270)
T ss_dssp             TTCSSHHHHHHHHTT--TCCCG---------------------------------------------GGGGCCCHHHHHH
T ss_pred             CCcccHHHHHHHHHc--CCCCc---------------------------------------------ccCccCCHHHHHH
Confidence            876544433 22211  11111                                             1234567789999


Q ss_pred             HHHhhhcCCCCCCCHHHHhcCCCCC
Q 014117          400 LQGLLRYDPTDRLTAREALRHPFFT  424 (430)
Q Consensus       400 l~~~L~~dP~~R~ta~elL~hp~f~  424 (430)
                      |.+||+.||++|||++|+|+||||+
T Consensus       246 i~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         246 IEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHccCCHhHCcCHHHHhCCcccC
Confidence            9999999999999999999999996

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-58  Score=440.67  Aligned_cols=250  Identities=25%  Similarity=0.414  Sum_probs=214.8

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++++.||+|+||.||+|+++.+++.||||++++..    ........|+.+|+++     .|+||+++++++.+.+.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~~~~~~~   79 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-----RHPFLTALKYAFQTHDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-----CCTTBCCEEEEEECSSE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-----CCCCEEEEEeeeccccc
Confidence            57999999999999999999999999999999997432    2345677899998887     45899999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|+||||| ||+|.+++...+  .+++..++.++.||+.||+|||++|||||||||+|||+                   
T Consensus        80 ~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl-------------------  138 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML-------------------  138 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE-------------------
T ss_pred             cccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe-------------------
Confidence            99999999 899999998865  79999999999999999999999999999999999999                   


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                              +.++.+||+|||+|+.....   ....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus       139 --------~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~  210 (337)
T d1o6la_         139 --------DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH  210 (337)
T ss_dssp             --------CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             --------cCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH
Confidence                    44556777777777643322   2346899999999999999999999999999999999999999998877


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+....+......                                                 ++...++++.+||.+||+
T Consensus       211 ~~~~~~i~~~~~~-------------------------------------------------~p~~~s~~~~dli~~~L~  241 (337)
T d1o6la_         211 ERLFELILMEEIR-------------------------------------------------FPRTLSPEAKSLLAGLLK  241 (337)
T ss_dssp             HHHHHHHHHCCCC-------------------------------------------------CCTTSCHHHHHHHHHHTC
T ss_pred             HHHHHHHhcCCCC-------------------------------------------------CCccCCHHHHHHHHhhcc
Confidence            6666554432211                                                 234567889999999999


Q ss_pred             cCCCCCC-----CHHHHhcCCCCCCC
Q 014117          406 YDPTDRL-----TAREALRHPFFTRD  426 (430)
Q Consensus       406 ~dP~~R~-----ta~elL~hp~f~~~  426 (430)
                      +||.+|+     |++|+++||||++-
T Consensus       242 ~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         242 KDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             SSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             CCchhhcccccccHHHHHcCcccccC
Confidence            9999999     49999999999764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-58  Score=440.42  Aligned_cols=260  Identities=23%  Similarity=0.402  Sum_probs=226.5

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .+.++|++++.||+|+||+||+|.++.+++.||+|+++........+.+|+++|+.+.     |+||+++++++++.+.+
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~-----HpnIv~~~~~~~~~~~~   76 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-----HRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSC-----CTTBCCEEEEEEETTEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCC-----CCCCCeEEEEEEECCEE
Confidence            3567899999999999999999999999999999999876666667789999999884     48899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      ||||||| |++|.+++...+ ..+++..++.|+.||+.||+|||++|||||||||+|||++.                  
T Consensus        77 ~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~------------------  137 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT------------------  137 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS------------------
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC------------------
Confidence            9999999 889999997654 36999999999999999999999999999999999999954                  


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC--CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                             +....+||+|||++.......  ...+||+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+..+
T Consensus       138 -------~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~  210 (321)
T d1tkia_         138 -------RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ  210 (321)
T ss_dssp             -------SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             -------CCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH
Confidence                   234578999999987654443  34578999999999999999999999999999999999999999988888


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      .+..|......+|...                                             +..++.++++||.+||+.|
T Consensus       211 ~~~~i~~~~~~~~~~~---------------------------------------------~~~~s~~~~~li~~~L~~d  245 (321)
T d1tkia_         211 IIENIMNAEYTFDEEA---------------------------------------------FKEISIEAMDFVDRLLVKE  245 (321)
T ss_dssp             HHHHHHHTCCCCCHHH---------------------------------------------HTTSCHHHHHHHHTTSCSS
T ss_pred             HHHHHHhCCCCCChhh---------------------------------------------ccCCCHHHHHHHHHHccCC
Confidence            7777766544444322                                             2356778999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~  426 (430)
                      |.+|||++|+|+||||++.
T Consensus       246 p~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         246 RKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             GGGSCCHHHHHHSHHHHSC
T ss_pred             hhHCcCHHHHhcCHhhccC
Confidence            9999999999999999753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8e-58  Score=435.88  Aligned_cols=250  Identities=25%  Similarity=0.409  Sum_probs=217.5

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++..    ...+.+..|+.+++++.     ||||+++++++.+.+.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-----HpnIv~~~~~~~~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-----HPFIIRMWGTFQDAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-----BTTBCCEEEEEECSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-----CcChhheeeeEeeCCe
Confidence            46999999999999999999999999999999996432    23456778999988884     4899999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +|+||||| |++|..++....  .+++..++.++.||+.||+|||++|||||||||+||||                   
T Consensus        79 ~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl-------------------  137 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL-------------------  137 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE-------------------
T ss_pred             eeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE-------------------
Confidence            99999999 889999988765  78999999999999999999999999999999999999                   


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                              +.++.+||+|||+|+.........+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.
T Consensus       138 --------~~~g~vkL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~  209 (316)
T d1fota_         138 --------DKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT  209 (316)
T ss_dssp             --------CTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             --------cCCCCEEEecCccceEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH
Confidence                    455678888888887766666677999999999999999999999999999999999999999998877776


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      ...+......                                                 +++..+.++.++|.+||++||
T Consensus       210 ~~~i~~~~~~-------------------------------------------------~p~~~s~~~~~li~~~L~~dp  240 (316)
T d1fota_         210 YEKILNAELR-------------------------------------------------FPPFFNEDVKDLLSRLITRDL  240 (316)
T ss_dssp             HHHHHHCCCC-------------------------------------------------CCTTSCHHHHHHHHHHTCSCT
T ss_pred             HHHHHcCCCC-------------------------------------------------CCCCCCHHHHHHHHHHhhhCH
Confidence            6655432221                                                 223567789999999999999


Q ss_pred             CCCC-----CHHHHhcCCCCCCC
Q 014117          409 TDRL-----TAREALRHPFFTRD  426 (430)
Q Consensus       409 ~~R~-----ta~elL~hp~f~~~  426 (430)
                      .+|+     |++++|+||||++-
T Consensus       241 ~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         241 SQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             TTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HhccccchhhHHHHHcCcccccC
Confidence            9996     99999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-58  Score=428.86  Aligned_cols=250  Identities=22%  Similarity=0.366  Sum_probs=198.5

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--CC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RN  168 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--~~  168 (430)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++...   ....+.+.+|+++++++     .||||+++++++.+  .+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~   78 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-----KHPNIVRYYDRIIDRTNT   78 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-----CCTTBCCEEEEEEC----
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-----CCCCEeeEEEEEEeCCCC
Confidence            5699999999999999999999999999999998643   23345677888888877     45899999998854  56


Q ss_pred             eEEEEEecC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcC-----eeeccCCCCceEEeecCccccCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLC-----MIHTDLKPENVLLVSSEYIKVPDY  240 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~-----ivHrDlKp~NILl~~~~~~~i~df  240 (430)
                      .+||||||| +|+|.+++.+.  ....+++..++.++.||+.||+|||++|     ||||||||+||||           
T Consensus        79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll-----------  147 (269)
T d2java1          79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL-----------  147 (269)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE-----------
T ss_pred             EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc-----------
Confidence            799999999 88999998642  2357999999999999999999999976     9999999999999           


Q ss_pred             cCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCC
Q 014117          241 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       241 g~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~  317 (430)
                                      +.++.+||+|||+|+......   ...+||+.|||||++.+..|+.++|||||||++|||+||.
T Consensus       148 ----------------~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~  211 (269)
T d2java1         148 ----------------DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM  211 (269)
T ss_dssp             ----------------CTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             ----------------CCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCC
Confidence                            445667777777776543322   3468999999999999999999999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      +||.+.+..+....+....  .+                                              ..+..+++++.
T Consensus       212 ~Pf~~~~~~~~~~~i~~~~--~~----------------------------------------------~~~~~~s~~l~  243 (269)
T d2java1         212 PPFTAFSQKELAGKIREGK--FR----------------------------------------------RIPYRYSDELN  243 (269)
T ss_dssp             CSCCCSSHHHHHHHHHHTC--CC----------------------------------------------CCCTTSCHHHH
T ss_pred             CCCCCCCHHHHHHHHHcCC--CC----------------------------------------------CCCcccCHHHH
Confidence            9999877766555543311  10                                              12235677899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCCCC
Q 014117          398 HLLQGLLRYDPTDRLTAREALRHPFF  423 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~hp~f  423 (430)
                      +||.+||+.||.+|||++|+|+|||+
T Consensus       244 ~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         244 EIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            99999999999999999999999996

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-57  Score=439.38  Aligned_cols=250  Identities=26%  Similarity=0.421  Sum_probs=218.0

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++++.||+|+||.||+|+++.+|+.||||++.+..    ...+.+.+|+.+|+.+     .|+||+++++++.....
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFLVKLEFSFKDNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-----CCCcEeecccccccccc
Confidence            57999999999999999999999999999999986322    2335677899998887     45899999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +++||||+ +++|.+++...+  .+++..++.|+.||+.||.|||++|||||||||+||||                   
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl-------------------  174 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI-------------------  174 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE-------------------
T ss_pred             cccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc-------------------
Confidence            99999999 899999998765  79999999999999999999999999999999999999                   


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH  328 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~~  328 (430)
                              +.++.+||+|||+|+.........+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+....
T Consensus       175 --------~~~g~ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~  246 (350)
T d1rdqe_         175 --------DQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI  246 (350)
T ss_dssp             --------CTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             --------CCCCCEEeeeceeeeecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH
Confidence                    455678888888887766666667999999999999999999999999999999999999999998777666


Q ss_pred             HHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCC
Q 014117          329 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP  408 (430)
Q Consensus       329 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP  408 (430)
                      +..+......                                                 .+..+++++.+||.+||++||
T Consensus       247 ~~~i~~~~~~-------------------------------------------------~p~~~s~~~~~li~~~L~~dP  277 (350)
T d1rdqe_         247 YEKIVSGKVR-------------------------------------------------FPSHFSSDLKDLLRNLLQVDL  277 (350)
T ss_dssp             HHHHHHCCCC-------------------------------------------------CCTTCCHHHHHHHHHHSCSCT
T ss_pred             HHHHhcCCCC-------------------------------------------------CCccCCHHHHHHHHHHhhhCH
Confidence            6655443222                                                 123567789999999999999


Q ss_pred             CCCC-----CHHHHhcCCCCCCC
Q 014117          409 TDRL-----TAREALRHPFFTRD  426 (430)
Q Consensus       409 ~~R~-----ta~elL~hp~f~~~  426 (430)
                      .+|+     |++|||+||||+..
T Consensus       278 ~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         278 TKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             TTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HhccccccccHHHHHcCccccCC
Confidence            9995     99999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-58  Score=436.53  Aligned_cols=252  Identities=26%  Similarity=0.370  Sum_probs=207.5

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      ...|+++++||+|+||+||+|+++.+++.||||+++...    ...+.+.+|+.+++++     .|+||+++++++.+.+
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~~~~~~~~~~   88 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-----RHPNTIQYRGCYLREH   88 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETT
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-----CCCCEeeEEEEEEECC
Confidence            456999999999999999999999999999999986432    2334577899999888     4589999999999999


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+||||||| +++|..++...  ..+++..++.++.||+.||.|||++|||||||||+|||++.+               
T Consensus        89 ~~~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~---------------  151 (309)
T d1u5ra_          89 TAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP---------------  151 (309)
T ss_dssp             EEEEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT---------------
T ss_pred             EEEEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC---------------
Confidence            999999999 67776666554  379999999999999999999999999999999999999544               


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCc
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEALFQTHE  324 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGv~l~el~tG~~Pf~~~~  324 (430)
                                  +.+||+|||+|..... ....+||+.|||||++.+   ..|+.++|||||||++|||++|..||.+.+
T Consensus       152 ------------~~~Kl~DFG~a~~~~~-~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~  218 (309)
T d1u5ra_         152 ------------GLVKLGDFGSASIMAP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  218 (309)
T ss_dssp             ------------TEEEECCCTTCBSSSS-BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             ------------CCEEEeecccccccCC-CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence                        4566666666654332 234579999999999975   358999999999999999999999998877


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+.+..+.....+.+                                               .+...++++.+||.+||
T Consensus       219 ~~~~~~~i~~~~~~~~-----------------------------------------------~~~~~s~~~~~li~~~L  251 (309)
T d1u5ra_         219 AMSALYHIAQNESPAL-----------------------------------------------QSGHWSEYFRNFVDSCL  251 (309)
T ss_dssp             HHHHHHHHHHSCCCCC-----------------------------------------------SCTTSCHHHHHHHHHHT
T ss_pred             HHHHHHHHHhCCCCCC-----------------------------------------------CCCCCCHHHHHHHHHHC
Confidence            7665554443211110                                               11345778999999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +.||++|||++|+|+||||++.
T Consensus       252 ~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         252 QKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             CSSGGGSCCHHHHTTCHHHHSC
T ss_pred             cCChhHCcCHHHHHhCHHhcCC
Confidence            9999999999999999999764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8.6e-57  Score=420.81  Aligned_cols=255  Identities=29%  Similarity=0.498  Sum_probs=214.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----------hhHHHHHHHHHHHHHHHhcCCCCCceEEecc
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRN  162 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~  162 (430)
                      .++|++.+.||+|+||+||+|+++.+++.||||++++..          ...+.+.+|+.+++++..    |+||+++++
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~----hpnIv~~~~   77 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG----HPNIIQLKD   77 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTT----CTTBCCEEE
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcC----CCCeEEEEe
Confidence            468999999999999999999999999999999986431          233457789999999953    478999999


Q ss_pred             eeecCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          163 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       163 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      ++.+++++||||||| +++|.++|..++  .+++..++.++.||+.||+|||++|||||||||+|||+            
T Consensus        78 ~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill------------  143 (277)
T d1phka_          78 TYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL------------  143 (277)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------
T ss_pred             ecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE------------
Confidence            999999999999999 889999998765  79999999999999999999999999999999999999            


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhC------CCCCCcchHHHHHHHHHHH
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILG------LGWTYPCDIWSVGCILVEL  313 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGv~l~el  313 (430)
                                     +.++.+||+|||++......  ....+||+.|+|||++.+      ..++.++||||+||++|||
T Consensus       144 ---------------~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyem  208 (277)
T d1phka_         144 ---------------DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL  208 (277)
T ss_dssp             ---------------CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHH
T ss_pred             ---------------cCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhh
Confidence                           45566777777777654332  234689999999999963      3478899999999999999


Q ss_pred             HhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCch
Q 014117          314 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA  393 (430)
Q Consensus       314 ~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (430)
                      ++|+.||.+.+..+....+......++.                                             ......+
T Consensus       209 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~---------------------------------------------~~~~~~s  243 (277)
T d1phka_         209 LAGSPPFWHRKQMLMLRMIMSGNYQFGS---------------------------------------------PEWDDYS  243 (277)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHTCCCCCT---------------------------------------------TTGGGSC
T ss_pred             ccCCCCCCCCCHHHHHHHHHhCCCCCCC---------------------------------------------cccccCC
Confidence            9999999988777766555443221111                                             0123567


Q ss_pred             hHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          394 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       394 ~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      +++.+||.+||+.||++|||++|||+||||++
T Consensus       244 ~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         244 DTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            88999999999999999999999999999975

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-57  Score=429.14  Aligned_cols=281  Identities=32%  Similarity=0.517  Sum_probs=226.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ++|+++++||+|+||+||+|.++.+++.||||+++...   .....+.+|+++++++     +|+||+++++++.+.+++
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-----~Hp~Iv~~~~~~~~~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHPNIVKLLDVIHTENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-----CCCcEEEeccccccccce
Confidence            47999999999999999999999999999999996432   2345678899999887     458999999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      |+||||+++++.+++.......+++..++.++.||+.||+|||++|||||||||+|||+                     
T Consensus        77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---------------------  135 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---------------------  135 (298)
T ss_dssp             EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---------------------
T ss_pred             eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---------------------
Confidence            99999998888888776666789999999999999999999999999999999999999                     


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                            +.+..+||+|||.|......   ....+||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..
T Consensus       136 ------~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~  209 (298)
T d1gz8a_         136 ------NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI  209 (298)
T ss_dssp             ------CTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ------cccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH
Confidence                  45567788888877654332   23458999999999988766 578999999999999999999999999988


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +.+..+....+.+++..+..+.....     ....++...               ...........+.++.+||.+||++
T Consensus       210 ~~~~~i~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~---------------~~~~~~~~~~~s~~~~dll~~mL~~  269 (298)
T d1gz8a_         210 DQLFRIFRTLGTPDEVVWPGVTSMPD-----YKPSFPKWA---------------RQDFSKVVPPLDEDGRSLLSQMLHY  269 (298)
T ss_dssp             HHHHHHHHHHCCCCTTTSTTGGGSTT-----CCTTSCCCC---------------CCCHHHHSTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHhcCCCchhhccccccccc-----ccccccccc---------------ccchhhhccCCCHHHHHHHHHHccC
Confidence            98988888888876543332111100     000011000               0111233456778999999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||++|||++|+|+||||++.
T Consensus       270 dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         270 DPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             STTTSCCHHHHHTSGGGTTC
T ss_pred             ChhHCcCHHHHhCCHhhccC
Confidence            99999999999999999864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=431.28  Aligned_cols=276  Identities=26%  Similarity=0.448  Sum_probs=214.3

Q ss_pred             EEeeeccccceEEEEEEECCCCeEEEEEEecCchh------hHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           98 IHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKK------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        98 ~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      .++.||+|+||+||+|+++.+|+.||||+++....      ....+.+|+.+++++.     |+||+++++++...+++|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~~~~~~~~~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-----HPNIIGLLDAFGHKSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-----CTTBCCEEEEECCTTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-----CCCEeEEEeeeccCCcee
Confidence            46889999999999999999999999999864322      1235778999999984     589999999999999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          172 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       172 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      |||||+.+++...+... ...+++..++.++.||+.||+|||++|||||||||+|||++                     
T Consensus        77 ivmE~~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~---------------------  134 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---------------------  134 (299)
T ss_dssp             EEEECCSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---------------------
T ss_pred             ehhhhhcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec---------------------
Confidence            99999955554544433 25799999999999999999999999999999999999994                     


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLE  327 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~~  327 (430)
                            ..+.+||+|||++......   ....+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.++.+
T Consensus       135 ------~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~  208 (299)
T d1ua2a_         135 ------ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD  208 (299)
T ss_dssp             ------TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ------CCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH
Confidence                  4556777777777543332   2335799999999998755 58999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ++..|.+.+|.++...+......      .....+..           ...    ..........+.++.+||.+||++|
T Consensus       209 ~l~~i~~~~~~~~~~~~~~~~~~------~~~~~~~~-----------~~~----~~~~~~~~~~s~~~~dll~~~L~~d  267 (299)
T d1ua2a_         209 QLTRIFETLGTPTEEQWPDMCSL------PDYVTFKS-----------FPG----IPLHHIFSAAGDDLLDLIQGLFLFN  267 (299)
T ss_dssp             HHHHHHHHHCCCCTTTSSSTTSS------TTCCCCCC-----------CCC----CCHHHHCTTCCHHHHHHHHHHHCSS
T ss_pred             HHHHHHHhcCCCChhhccchhcc------chhhhhcc-----------CCC----CChHHhcccCCHHHHHHHHHHccCC
Confidence            99999999988775422110000      00000000           000    0012234566789999999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCC
Q 014117          408 PTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       408 P~~R~ta~elL~hp~f~~~~  427 (430)
                      |++||||+|+|+||||++.+
T Consensus       268 P~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         268 PCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             TTTSCCHHHHHTSGGGTSSS
T ss_pred             hhhCcCHHHHhCCHhhCCCC
Confidence            99999999999999999764

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-56  Score=431.86  Aligned_cols=292  Identities=27%  Similarity=0.490  Sum_probs=231.8

Q ss_pred             CCceeecCce---ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCC
Q 014117           82 GHYMFALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGN  155 (430)
Q Consensus        82 ~~~~~~~~~~---~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~  155 (430)
                      |.+...+++.   +.++|+++++||+|+||+||+|.++.+|+.||||+++..   ....+.+.+|+++|+++.     |+
T Consensus         3 ~~~~~~~~~~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-----hp   77 (346)
T d1cm8a_           3 GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-----HE   77 (346)
T ss_dssp             SBCCEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-----BT
T ss_pred             CcEEEeccCceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcC-----CC
Confidence            4455555554   688999999999999999999999999999999999743   234456788999999984     47


Q ss_pred             ceEEecceeecCC------eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEE
Q 014117          156 RCVQIRNWFDYRN------HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLL  229 (430)
Q Consensus       156 ~i~~~~~~~~~~~------~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl  229 (430)
                      ||+++++++...+      ++||||||++.+|..++...   .+++..++.++.||+.||+|||++|||||||||+|||+
T Consensus        78 niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~  154 (346)
T d1cm8a_          78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV  154 (346)
T ss_dssp             TBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             CeeEEEEEeccCccccccceEEEEEecccccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc
Confidence            8999999987654      67999999988888887653   69999999999999999999999999999999999999


Q ss_pred             eecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCC-CCCCcchHHHHHH
Q 014117          230 VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGC  308 (430)
Q Consensus       230 ~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv  308 (430)
                                                 +.++.+|++|||+|..........+||+.|+|||++.+. .++.++||||+||
T Consensus       155 ---------------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGv  207 (346)
T d1cm8a_         155 ---------------------------NEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC  207 (346)
T ss_dssp             ---------------------------CTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHH
T ss_pred             ---------------------------ccccccccccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchH
Confidence                                       556678888888887766666667899999999999875 5789999999999


Q ss_pred             HHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhh
Q 014117          309 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH  388 (430)
Q Consensus       309 ~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (430)
                      ++|+|++|++||.+.+..+.+..+....+.+|.................+......                  ......
T Consensus       208 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~  269 (346)
T d1cm8a_         208 IMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEK------------------KDFASI  269 (346)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCC------------------CCGGGT
T ss_pred             HHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccc------------------cchHHh
Confidence            99999999999999999999999999999999877654432222111111100000                  001123


Q ss_pred             cCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       389 ~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ....++++.+||.+||++||++||||+|||+||||++.
T Consensus       270 ~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         270 LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             ccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence            35667889999999999999999999999999999863

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.5e-56  Score=435.14  Aligned_cols=256  Identities=25%  Similarity=0.410  Sum_probs=207.6

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch----hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++++.||+|+||.||+|+++.+|+.||||++.+..    ........|...+..+.+  ..||||+++++++.+.+.
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~--~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSS--SCCTTBCCEEEEEECSSE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhc--CCCCcEEEEEEEEEECCE
Confidence            57999999999999999999999999999999986322    223345556666666543  246999999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +||||||| |++|.++|....  .+++..++.++.||+.||+|||++|||||||||+|||++                  
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~------------------  141 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD------------------  141 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC------------------
T ss_pred             EEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc------------------
Confidence            99999999 899999998765  789999999999999999999999999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCC-CCCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                               ..+.+||+|||+|+.... .....+||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.+.+..
T Consensus       142 ---------~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~  212 (364)
T d1omwa3         142 ---------EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK  212 (364)
T ss_dssp             ---------SSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred             ---------CCCcEEEeeeceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH
Confidence                     455677777777764433 2344689999999999974 56999999999999999999999999875443


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +............                                              ...++.+++++.+||.+||++
T Consensus       213 ~~~~~~~~~~~~~----------------------------------------------~~~~~~~s~~~~~li~~~L~~  246 (364)
T d1omwa3         213 DKHEIDRMTLTMA----------------------------------------------VELPDSFSPELRSLLEGLLQR  246 (364)
T ss_dssp             CHHHHHHHSSSCC----------------------------------------------CCCCSSSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHhcccCC----------------------------------------------CCCCCCCCHHHHHHHHHHccc
Confidence            3222211111111                                              112456788999999999999


Q ss_pred             CCCCCCC-----HHHHhcCCCCCCC
Q 014117          407 DPTDRLT-----AREALRHPFFTRD  426 (430)
Q Consensus       407 dP~~R~t-----a~elL~hp~f~~~  426 (430)
                      ||.+|||     |+|+++||||++-
T Consensus       247 dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         247 DVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             STTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             CHHHhCCCcccCHHHHHcCccccCC
Confidence            9999999     8999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-56  Score=426.12  Aligned_cols=283  Identities=28%  Similarity=0.475  Sum_probs=221.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCC-CeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee---
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRER-KEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD---  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~---  165 (430)
                      .++|+++++||+|+||+||+|++..+ ++.||||+++..   ........+|+.+++.+...  .|+||+++++++.   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~--~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF--EHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT--CCTTBCCEEEEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhc--CCCCcceeeeeecccc
Confidence            46899999999999999999999765 678999998632   22234566788998888642  4588999998874   


Q ss_pred             --cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCC
Q 014117          166 --YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       166 --~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                        ....+|++||++.+++..+........+++..++.++.||+.||+|||++|||||||||+|||++.            
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~------------  151 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS------------  151 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT------------
T ss_pred             cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcC------------
Confidence              346899999999666655555555568999999999999999999999999999999999999954            


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                                     .+.+||+|||++......  ....+||+.|+|||++.+..|+.++|||||||++|||++|++||.
T Consensus       152 ---------------~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~  216 (305)
T d1blxa_         152 ---------------SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR  216 (305)
T ss_dssp             ---------------TCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ---------------CCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCC
Confidence                           455666666666543222  234689999999999999999999999999999999999999999


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      +.+..+.+..+...++.++...++                  .........    ...........++...++++.+||.
T Consensus       217 ~~~~~~~~~~i~~~~~~~~~~~~~------------------~~~~~~~~~----~~~~~~~~~~~~~~~~s~~~~dli~  274 (305)
T d1blxa_         217 GSSDVDQLGKILDVIGLPGEEDWP------------------RDVALPRQA----FHSKSAQPIEKFVTDIDELGKDLLL  274 (305)
T ss_dssp             CSSHHHHHHHHHHHHCCCCGGGSC------------------TTCSSCGGG----SCCCCCCCGGGTCCSCCHHHHHHHH
T ss_pred             CCCHHHHHHHHHHhhCCCchhccc------------------ccccchhhh----hccccccchhhccccCCHHHHHHHH
Confidence            999999999999998887654221                  111100000    0000001122345677889999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          402 GLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +||++||++||||+|+|+||||++-
T Consensus       275 ~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         275 KCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             HHCcCChhHCcCHHHHhcChhhcCc
Confidence            9999999999999999999999865

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=427.65  Aligned_cols=251  Identities=25%  Similarity=0.389  Sum_probs=210.2

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++++.||+|+||+||+|.++.+++.||||++++.    .........|..++.+..    +||||+++++++.+.+.
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~----~hp~Iv~~~~~~~~~~~   77 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW----EHPFLTHMFCTFQTKEN   77 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT----TCTTBCCEEEEEECSSE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhC----CCCcEEEEEEEEccCCc
Confidence            4699999999999999999999999999999999643    223345566766665432    45899999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      +||||||+ +|+|.+++....  .+++..++.++.||+.||+|||++|||||||||+|||++                  
T Consensus        78 ~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~------------------  137 (320)
T d1xjda_          78 LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD------------------  137 (320)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC------------------
T ss_pred             eeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec------------------
Confidence            99999999 899999998765  799999999999999999999999999999999999994                  


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN  325 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~~~~  325 (430)
                               ..+.+||+|||+++.....   ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus       138 ---------~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~  208 (320)
T d1xjda_         138 ---------KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE  208 (320)
T ss_dssp             ---------TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ---------CCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH
Confidence                     4556677777776543222   2335899999999999999999999999999999999999999998887


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+....+......                                                 ++...++++.+||.+||+
T Consensus       209 ~~~~~~i~~~~~~-------------------------------------------------~p~~~s~~~~dli~~~L~  239 (320)
T d1xjda_         209 EELFHSIRMDNPF-------------------------------------------------YPRWLEKEAKDLLVKLFV  239 (320)
T ss_dssp             HHHHHHHHHCCCC-------------------------------------------------CCTTSCHHHHHHHHHHSC
T ss_pred             HHHHHHHHcCCCC-------------------------------------------------CCccCCHHHHHHHHHhcc
Confidence            7766655432111                                                 223467789999999999


Q ss_pred             cCCCCCCCHH-HHhcCCCCCCC
Q 014117          406 YDPTDRLTAR-EALRHPFFTRD  426 (430)
Q Consensus       406 ~dP~~R~ta~-elL~hp~f~~~  426 (430)
                      +||.+|||+. |+++||||++-
T Consensus       240 ~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         240 REPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             SSGGGSBTTBSCGGGSGGGTTC
T ss_pred             cCCCCCcCHHHHHHhCchhccC
Confidence            9999999995 89999999864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-57  Score=432.09  Aligned_cols=263  Identities=27%  Similarity=0.478  Sum_probs=209.9

Q ss_pred             eecCcEEEEe-eeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 014117           91 NLTSRYKIHS-KMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---  166 (430)
Q Consensus        91 ~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~---  166 (430)
                      .+.++|+++. .||+|+||+||+|+++.+++.||||+++..    ....+|++++.++.    +|+||++++++|++   
T Consensus         8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~----~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1           8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS----QCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT----TSTTBCCEEEEEEEEET
T ss_pred             CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhc----CCCCCCeEEEEEeeccc
Confidence            3456899886 599999999999999999999999999754    34566888877664    34889999998865   


Q ss_pred             -CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          167 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       167 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                       ..++||||||| ||+|.++|...+...+++..++.|+.||+.||+|||++|||||||||+|||++..            
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~------------  147 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK------------  147 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCS------------
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccc------------
Confidence             57899999999 8899999988766789999999999999999999999999999999999999642            


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                  ...+.+||+|||+|+.....  ....+||+.|||||++.+..|+.++|||||||++|+|+||.+||.+
T Consensus       148 ------------~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~  215 (335)
T d2ozaa1         148 ------------RPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS  215 (335)
T ss_dssp             ------------STTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred             ------------cccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence                        23567899999998754433  2446899999999999999999999999999999999999999987


Q ss_pred             CchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHH
Q 014117          323 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG  402 (430)
Q Consensus       323 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~  402 (430)
                      .+..+....+..                   .+..+.+.+|..                      .+..+++++.+||++
T Consensus       216 ~~~~~~~~~~~~-------------------~i~~~~~~~~~~----------------------~~~~~s~~~~~li~~  254 (335)
T d2ozaa1         216 NHGLAISPGMKT-------------------RIRMGQYEFPNP----------------------EWSEVSEEVKMLIRN  254 (335)
T ss_dssp             TTCC---------------------------CCCSCSSSCCTT----------------------HHHHSCHHHHHHHHH
T ss_pred             CCHHHHHHHHHH-------------------HHhcCCCCCCCc----------------------ccccCCHHHHHHHHH
Confidence            554433322211                   111122222110                      112457789999999


Q ss_pred             hhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          403 LLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       403 ~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ||++||++|||+.|+|+||||.+.
T Consensus       255 ~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         255 LLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             HSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             HccCChhHCcCHHHHHcCHHhhCC
Confidence            999999999999999999999654

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-56  Score=418.59  Aligned_cols=248  Identities=26%  Similarity=0.472  Sum_probs=205.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-------hhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .++|++.+.||+|+||+||+|+++.+++.||||+++...       .....+..|+.+++++.+   .|+||+++++++.
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~---~h~nIv~~~~~~~   79 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS---GFSGVIRLLDWFE   79 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS---SSCSBCCEEEEEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhcc---CCCCccEEEEEEe
Confidence            568999999999999999999999999999999986422       112335679999999853   3588999999999


Q ss_pred             cCCeEEEEEecC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCC
Q 014117          166 YRNHICIVFEKL-G-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS  243 (430)
Q Consensus       166 ~~~~~~lv~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~  243 (430)
                      +.+.+|+||||+ + +++.+++....  .+++..++.++.||+.||+|||++|||||||||+|||++.            
T Consensus        80 ~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~------------  145 (273)
T d1xwsa_          80 RPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL------------  145 (273)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET------------
T ss_pred             eCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec------------
Confidence            999999999998 4 58888887764  7999999999999999999999999999999999999952            


Q ss_pred             CCCCCCCcccccCCCCCCeEEEeCCCccccCCC-CCeeeecCcccchhhhhCCCC-CCcchHHHHHHHHHHHHhCCCCCC
Q 014117          244 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                                    ..+.+||+|||+|+..... ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.
T Consensus       146 --------------~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~  211 (273)
T d1xwsa_         146 --------------NRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE  211 (273)
T ss_dssp             --------------TTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             --------------CCCeEEECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCC
Confidence                          2356788888887654333 244689999999999988775 577899999999999999999997


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      ..+.      +..                       +..                          .++...++++.+||.
T Consensus       212 ~~~~------i~~-----------------------~~~--------------------------~~~~~~s~~~~~li~  236 (273)
T d1xwsa_         212 HDEE------IIR-----------------------GQV--------------------------FFRQRVSSECQHLIR  236 (273)
T ss_dssp             SHHH------HHH-----------------------CCC--------------------------CCSSCCCHHHHHHHH
T ss_pred             CchH------Hhh-----------------------ccc--------------------------CCCCCCCHHHHHHHH
Confidence            5321      110                       111                          123456788999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          402 GLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +||+.||++|||++|+|+||||++.
T Consensus       237 ~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         237 WCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             HHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             HHccCCHhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.3e-55  Score=414.10  Aligned_cols=278  Identities=28%  Similarity=0.453  Sum_probs=219.1

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ++|+++++||+|+||+||+|+++ +++.||||+++...   .....+.+|+.+++++     .|+||+++++++...+..
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-----KHSNIVKLYDVIHTKKRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-----CCTTBCCEEEEEECSSCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-----CCCcEEeeeeecccCCce
Confidence            58999999999999999999986 77899999996432   2346788899999888     358899999999999999


Q ss_pred             EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          171 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       171 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      |+|||++++++...+.... ..+++..++.++.||+.||+|||++|||||||||+|||+                     
T Consensus        76 ~i~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---------------------  133 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---------------------  133 (286)
T ss_dssp             EEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---------------------
T ss_pred             eEEEEeehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---------------------
Confidence            9999999666666555433 579999999999999999999999999999999999999                     


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCC---CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL  326 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~~~~  326 (430)
                            +.++.+||+|||.+......   .....||+.|+|||.+.+. .++.++|||||||++|||++|++||.+.++.
T Consensus       134 ------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~  207 (286)
T d1ob3a_         134 ------NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA  207 (286)
T ss_dssp             ------CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ------cCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH
Confidence                  45567788888877654332   2334789999999999865 4689999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +++..+...++.++...+..........     ......  .             ...........+.++.|||.+||++
T Consensus       208 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~--~-------------~~~~~~~~~~~s~~~~dli~~~L~~  267 (286)
T d1ob3a_         208 DQLMRIFRILGTPNSKNWPNVTELPKYD-----PNFTVY--E-------------PLPWESFLKGLDESGIDLLSKMLKL  267 (286)
T ss_dssp             HHHHHHHHHHCCCCTTTSTTGGGSTTCC-----TTCCCC--C-------------CCCGGGTCCSCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHhhCCCChhhccchhhhhhcc-----cccccc--c-------------CcchhhhcccCCHHHHHHHHHHccC
Confidence            9999988888887755433221111000     000000  0             0011234566788999999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCC
Q 014117          407 DPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       407 dP~~R~ta~elL~hp~f~~  425 (430)
                      ||++|||++|+|+||||++
T Consensus       268 dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         268 DPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             STTTSCCHHHHHTSGGGGC
T ss_pred             ChhHCcCHHHHhcCcccCc
Confidence            9999999999999999974

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=420.24  Aligned_cols=300  Identities=26%  Similarity=0.435  Sum_probs=227.8

Q ss_pred             CceeecCce---ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCc
Q 014117           83 HYMFALGEN---LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNR  156 (430)
Q Consensus        83 ~~~~~~~~~---~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~  156 (430)
                      .|++..|+.   +.++|+++++||+|+||+||+|+++.+|+.||||+++..   ......+.+|+.+++++     +|+|
T Consensus         3 ~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-----~hpn   77 (355)
T d2b1pa1           3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKN   77 (355)
T ss_dssp             EEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-----CCTT
T ss_pred             CEEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-----CCCC
Confidence            467888884   458999999999999999999999999999999999743   23345677899999888     3488


Q ss_pred             eEEecceee------cCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEe
Q 014117          157 CVQIRNWFD------YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV  230 (430)
Q Consensus       157 i~~~~~~~~------~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~  230 (430)
                      |++++++|.      ...++|+|||||.+++.+.+.    ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus        78 Iv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~  153 (355)
T d2b1pa1          78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK  153 (355)
T ss_dssp             BCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             eeEEEEEEecccccccCceeEEEEeccchHHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc
Confidence            999999885      347999999999777777663    3689999999999999999999999999999999999995


Q ss_pred             ecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHH
Q 014117          231 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC  308 (430)
Q Consensus       231 ~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv  308 (430)
                      .                           ++.+|++|||+++.....  ....+||+.|+|||++.+..++.++||||+||
T Consensus       154 ~---------------------------~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~  206 (355)
T d2b1pa1         154 S---------------------------DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC  206 (355)
T ss_dssp             T---------------------------TCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHH
T ss_pred             c---------------------------ccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccc
Confidence            4                           445666666665533322  23457899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhh
Q 014117          309 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH  388 (430)
Q Consensus       309 ~l~el~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (430)
                      ++|+|++|++||.+.+.......+....+.++.+.+.........+........ .  ......   .. ..........
T Consensus       207 ~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~---~~-~~~~~~~~~~  279 (355)
T d2b1pa1         207 IMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYA-G--LTFPKL---FP-DSLFPADSEH  279 (355)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCC-C--CCHHHH---SC-GGGSCCSSHH
T ss_pred             hHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccc-c--cccccc---cc-cccccccccc
Confidence            999999999999999999999999999999888887776666555554322111 0  000000   00 0000001112


Q ss_pred             cCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCC
Q 014117          389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       389 ~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      ....+.++.+||++||++||++||||+|||+||||+.
T Consensus       280 ~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         280 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             HHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             cccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            2334678999999999999999999999999999975

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=420.05  Aligned_cols=277  Identities=28%  Similarity=0.514  Sum_probs=219.7

Q ss_pred             cEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee------cCC
Q 014117           95 RYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD------YRN  168 (430)
Q Consensus        95 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~------~~~  168 (430)
                      +|+.+++||+|+||+||+|+++.+++.||||+++.....   ..+|+++|+++     .|+||+++++++.      +..
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l-----~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKL-----DHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHC-----CCTTBCCEEEEEEEC--CCSCC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhc-----CCCCCCcEEEEEEecCccCCce
Confidence            599999999999999999999999999999999754332   34689999988     3488999988874      345


Q ss_pred             eEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          169 HICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       169 ~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      ++|||||||++++.+.+..  .....+++..++.++.||+.||+|||++|||||||||+|||++.+              
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~--------------  158 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD--------------  158 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT--------------
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecC--------------
Confidence            7899999997776665542  233579999999999999999999999999999999999999432              


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH  323 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~  323 (430)
                                  ...+||+|||++......  ....+||+.|+|||++.+. .|+.++||||+||++|||++|++||...
T Consensus       159 ------------~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~  226 (350)
T d1q5ka_         159 ------------TAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD  226 (350)
T ss_dssp             ------------TCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred             ------------CCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence                        246888888888654332  2446899999999998764 6899999999999999999999999999


Q ss_pred             chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          324 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       324 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      +..+++..+.+.+|.++.+.+..........      ..+....              ..+........++++.+||.+|
T Consensus       227 ~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~------~~~~~~~--------------~~~~~~~~~~~s~~~~dLl~~m  286 (350)
T d1q5ka_         227 SGVDQLVEIIKVLGTPTREQIREMNPNYTEF------KFPQIKA--------------HPWTKVFRPRTPPEAIALCSRL  286 (350)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHHCC---CC------CCCCCCC--------------CCGGGTSCTTSCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHhCCChHHhhhhhccchhhc------ccccccc--------------CchhhhcccCCCHHHHHHHHHH
Confidence            9999999999999999987766443221111      1111000              0001112345678899999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~~  425 (430)
                      |++||++||||+|+|+||||++
T Consensus       287 L~~dP~~R~ta~e~L~Hp~f~~  308 (350)
T d1q5ka_         287 LEYTPTARLTPLEACAHSFFDE  308 (350)
T ss_dssp             SCSSGGGSCCHHHHHTSGGGGG
T ss_pred             ccCChhHCcCHHHHhcCHhhcc
Confidence            9999999999999999999975

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-54  Score=407.36  Aligned_cols=254  Identities=20%  Similarity=0.298  Sum_probs=207.5

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      -.++|++.++||+|+||+||+|.++.+++.||||+++......+.+.+|+++++++.     |+||+++++++.+.+.+|
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~-----HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-----HPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCC-----CTTBCCEEEEECSSSSCE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCC-----CCCEecCCccEeeCCeeE
Confidence            356899999999999999999999999999999999866666778899999999984     489999999999999999


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      |||||| +|+|.+++.......+++..++.++.||+.||+|||++|||||||||+||||+.+                  
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~------------------  151 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN------------------  151 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG------------------
T ss_pred             EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC------------------
Confidence            999999 8999999988766789999999999999999999999999999999999999554                  


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCC-Cch
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT-HEN  325 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~-~~~  325 (430)
                               +.+||+|||+|+......    ....||+.|+|||++.+..|+.++|||||||++|||++|..||.. .+.
T Consensus       152 ---------~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~  222 (287)
T d1opja_         152 ---------HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL  222 (287)
T ss_dssp             ---------GCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ---------CcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH
Confidence                     456666666665433322    123589999999999999999999999999999999997666544 333


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR  405 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  405 (430)
                      .+....+....                                                ....++.++.++.+||.+||+
T Consensus       223 ~~~~~~i~~~~------------------------------------------------~~~~~~~~~~~l~~li~~cl~  254 (287)
T d1opja_         223 SQVYELLEKDY------------------------------------------------RMERPEGCPEKVYELMRACWQ  254 (287)
T ss_dssp             HHHHHHHHTTC------------------------------------------------CCCCCTTCCHHHHHHHHHHTC
T ss_pred             HHHHHHHhcCC------------------------------------------------CCCCCccchHHHHHHHHHHcC
Confidence            33222221100                                                011234667889999999999


Q ss_pred             cCCCCCCCHHHHhc--CCCCCC
Q 014117          406 YDPTDRLTAREALR--HPFFTR  425 (430)
Q Consensus       406 ~dP~~R~ta~elL~--hp~f~~  425 (430)
                      .||++|||++||++  ..++++
T Consensus       255 ~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         255 WNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             SSGGGSCCHHHHHHHHHHTTSS
T ss_pred             CCHhHCcCHHHHHHHHHHHHHh
Confidence            99999999999976  244443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-54  Score=409.75  Aligned_cols=284  Identities=27%  Similarity=0.455  Sum_probs=212.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec---
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY---  166 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~---  166 (430)
                      .++|+++++||+|+||+||+|+++.+|+.||||++...   ......+.+|+.+|+++.|     +|++.+++.+..   
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h-----~nii~~~~~~~~~~~   83 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH-----ENVVNLIEICRTKAS   83 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCC-----TTBCCEEEEEEC---
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcC-----CCccceEeeeecccc
Confidence            47899999999999999999999999999999998533   2344667889999999843     778888877644   


Q ss_pred             -----CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          167 -----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       167 -----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                           .+++|+||||+++.+....... ...+++..++.++.||+.||.|||++|||||||||+|||++.++        
T Consensus        84 ~~~~~~~~~~iv~e~~~~~~~~~~~~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~--------  154 (318)
T d3blha1          84 PYNRCKGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--------  154 (318)
T ss_dssp             -------CEEEEEECCCEEHHHHHTCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--------
T ss_pred             cccccCceEEEEEeccCCCccchhhhc-ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC--------
Confidence                 4578999999966666555433 35799999999999999999999999999999999999995554        


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCC-------CCCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHH
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-------DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVEL  313 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el  313 (430)
                                         .+||+|||++.....       .....+||+.|+|||++.+. .|+.++|||||||++|||
T Consensus       155 -------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el  215 (318)
T d3blha1         155 -------------------VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM  215 (318)
T ss_dssp             -------------------CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             -------------------cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeH
Confidence                               455555555532221       11235799999999999876 689999999999999999


Q ss_pred             HhCCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcC-chhHHHHHhhhcCCc
Q 014117          314 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK-LPRLQNLIMQHVDHS  392 (430)
Q Consensus       314 ~tG~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  392 (430)
                      ++|++||.+.++.+....+....+.++.............                ..+..... .........  ....
T Consensus       216 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~--~~~~  277 (318)
T d3blha1         216 WTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELY----------------EKLELVKGQKRKVKDRLK--AYVR  277 (318)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-----------------------CCSSCCBCHHHHHH--HHHC
T ss_pred             hhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhh----------------hhhcccccccccchhhhc--cccC
Confidence            9999999999999999999999998876532211100000                00000000 000111111  1123


Q ss_pred             hhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCCC
Q 014117          393 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH  427 (430)
Q Consensus       393 ~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~~  427 (430)
                      ++++.|||.+||++||++||||+|+|+||||+..+
T Consensus       278 ~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p  312 (318)
T d3blha1         278 DPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  312 (318)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence            56789999999999999999999999999999754

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=411.51  Aligned_cols=282  Identities=29%  Similarity=0.517  Sum_probs=214.8

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC--
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--  167 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~--  167 (430)
                      +.++|+++++||+|+||+||+|.++.+|+.||||+++...  ...+.+..|+++|+++.     |++|+++++.+...  
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~-----hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-----HENIIGINDIIRAPTI   80 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCC-----CTTBCCCCEEECCSST
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcC-----CCCCCcEEEEEeeccc
Confidence            4578999999999999999999999999999999997432  34457788999999984     47888888887653  


Q ss_pred             ---CeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          168 ---NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       168 ---~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                         .++|++|++++++|.+++...   .+++..++.++.||+.||+|||++|||||||||+|||++.+            
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~------------  145 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT------------  145 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT------------
T ss_pred             cccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCC------------
Confidence               357788777799999999764   69999999999999999999999999999999999999544            


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCC------CCeeeecCcccchhhhhC-CCCCCcchHHHHHHHHHHHHhCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGE  317 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~tG~  317 (430)
                                     +.+||+|||++......      ....+||+.|+|||++.. ..++.++||||+||++|+|++|+
T Consensus       146 ---------------~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~  210 (345)
T d1pmea_         146 ---------------CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR  210 (345)
T ss_dssp             ---------------CCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred             ---------------CCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCC
Confidence                           45666666665432211      233579999999999854 46789999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      +||.+.+..+....+...++.++.............   ......+...               ........+..+.++.
T Consensus       211 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~---------------~~~~~~~~~~~s~~~~  272 (345)
T d1pmea_         211 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR---NYLLSLPHKN---------------KVPWNRLFPNADSKAL  272 (345)
T ss_dssp             CSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHH---HHHHTSCCCC---------------CCCHHHHCTTSCHHHH
T ss_pred             CCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhh---cccccCCccC---------------CCCHHHhCCCCCHHHH
Confidence            999998888888888888887776543211000000   0000000000               0001123456678899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          398 HLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +||.+||++||++||||+|+|+||||+..
T Consensus       273 ~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         273 DLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            99999999999999999999999999853

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-54  Score=414.47  Aligned_cols=282  Identities=26%  Similarity=0.463  Sum_probs=222.2

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--  166 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--  166 (430)
                      +.++|+++++||+|+||+||+|+++.+|+.||||++++..   ...+.+.+|+++|+.+.     |+|++++++++..  
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-----h~~iv~~~~~~~~~~   90 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-----HENVIGLLDVFTPAR   90 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC-----CTTBCCCSEEECSCS
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcC-----CCCeeeEEEEEeecc
Confidence            4678999999999999999999999999999999997432   33456778999999984     4789999888753  


Q ss_pred             ----CCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcC
Q 014117          167 ----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS  242 (430)
Q Consensus       167 ----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~  242 (430)
                          ...+++++++++++|.+++...   ++++..++.++.||+.||+|||++|||||||||+|||+             
T Consensus        91 ~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi-------------  154 (348)
T d2gfsa1          91 SLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-------------  154 (348)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-------------
T ss_pred             ccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc-------------
Confidence                3446666666699999998643   69999999999999999999999999999999999999             


Q ss_pred             CCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCC-CCCcchHHHHHHHHHHHHhCCCCCC
Q 014117          243 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                                    +.++.+|++|||++...........||+.|+|||++.+.. ++.++|||||||++|+|++|++||.
T Consensus       155 --------------~~~~~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~  220 (348)
T d2gfsa1         155 --------------NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP  220 (348)
T ss_dssp             --------------CTTCCEEECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             --------------cccccccccccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence                          4556677888887766555555668999999999987764 6899999999999999999999999


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      +.+.......+....+..+.+....................+..                  .........++++.+||.
T Consensus       221 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~s~~~~dli~  282 (348)
T d2gfsa1         221 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKM------------------NFANVFIGANPLAVDLLE  282 (348)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCC------------------CHHHHSTTCCHHHHHHHH
T ss_pred             CCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCc------------------chhhhcCCCCHHHHHHHH
Confidence            99999999999999998887665433222221111111111110                  011223567888999999


Q ss_pred             HhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          402 GLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      +||++||.+||||+|+|+||||++-
T Consensus       283 ~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         283 KMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHCcCChhhCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999853

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=397.31  Aligned_cols=245  Identities=26%  Similarity=0.389  Sum_probs=197.3

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      ++|++.+.||+|+||+||+|+++ +++.||||+++......+.+.+|+++++++.     |+||+++++++...+.+++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~-----HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-----HPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCC-----CTTBCCEEEEECSSSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcC-----CCCcccccceeccCCceEEE
Confidence            56999999999999999999986 5678999999876666678899999999984     48999999999999999999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      |||+ +|+|.+++.... ..+++..+..++.||+.||+|||+++||||||||+|||++.++                   
T Consensus        79 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~-------------------  138 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-------------------  138 (263)
T ss_dssp             EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG-------------------
T ss_pred             EEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC-------------------
Confidence            9999 899999987654 5789999999999999999999999999999999999995544                   


Q ss_pred             cccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHH
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE  327 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~  327 (430)
                              .+||+|||+++......    ....||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+
T Consensus       139 --------~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~  210 (263)
T d1sm2a_         139 --------VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE  210 (263)
T ss_dssp             --------CEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH
T ss_pred             --------CeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH
Confidence                    55555666554332221    22478999999999999999999999999999999999 577777766665


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+......                                                ..+...+.++.+||.+||+.|
T Consensus       211 ~~~~i~~~~~~------------------------------------------------~~p~~~~~~l~~li~~cl~~~  242 (263)
T d1sm2a_         211 VVEDISTGFRL------------------------------------------------YKPRLASTHVYQIMNHCWKER  242 (263)
T ss_dssp             HHHHHHHTCCC------------------------------------------------CCCTTSCHHHHHHHHHHTCSS
T ss_pred             HHHHHHhcCCC------------------------------------------------CCccccCHHHHHHHHHHccCC
Confidence            55544332111                                                112345678999999999999


Q ss_pred             CCCCCCHHHHhcC
Q 014117          408 PTDRLTAREALRH  420 (430)
Q Consensus       408 P~~R~ta~elL~h  420 (430)
                      |++|||++|+++|
T Consensus       243 p~~Rps~~~il~~  255 (263)
T d1sm2a_         243 PEDRPAFSRLLRQ  255 (263)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             HhHCcCHHHHHHH
Confidence            9999999999975

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.8e-54  Score=403.02  Aligned_cols=253  Identities=24%  Similarity=0.337  Sum_probs=198.2

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      .+.++|++.+.||+|+||+||+|+++.+++.||||+++..    ......+.+|+++++.+     +|+||+++++++..
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-----~hpniv~~~~~~~~   78 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-----NHPAIVAVYDTGEA   78 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEE
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-----CCCCCCcccceeee
Confidence            4678899999999999999999999999999999999643    22345677899988877     45889999998875


Q ss_pred             CC----eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCc
Q 014117          167 RN----HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK  241 (430)
Q Consensus       167 ~~----~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg  241 (430)
                      .+    .+||||||+ |++|.+++...+  .+++..++.++.||+.||+|||++|||||||||+|||++.++.       
T Consensus        79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~-------  149 (277)
T d1o6ya_          79 ETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA-------  149 (277)
T ss_dssp             ECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC-------
T ss_pred             ccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc-------
Confidence            43    589999999 889999988765  7999999999999999999999999999999999999965554       


Q ss_pred             CCCCCCCCCcccccCCCCCCeEEEeCCCccccCC------CCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh
Q 014117          242 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP------DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT  315 (430)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t  315 (430)
                                          ++|+|||.+.....      .....+||+.|||||++.+..|+.++|||||||++|||+|
T Consensus       150 --------------------~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyellt  209 (277)
T d1o6ya_         150 --------------------VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT  209 (277)
T ss_dssp             --------------------EEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             --------------------ceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHh
Confidence                                45555554432211      1233589999999999999999999999999999999999


Q ss_pred             CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhH
Q 014117          316 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD  395 (430)
Q Consensus       316 G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (430)
                      |.+||.+.+..+....+......+|.                                             ..++..+.+
T Consensus       210 G~~Pf~~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~s~~  244 (277)
T d1o6ya_         210 GEPPFTGDSPVSVAYQHVREDPIPPS---------------------------------------------ARHEGLSAD  244 (277)
T ss_dssp             SSCSCCCSSHHHHHHHHHHCCCCCGG---------------------------------------------GTSSSCCHH
T ss_pred             CCCCCCCcCHHHHHHHHHhcCCCCCc---------------------------------------------hhccCCCHH
Confidence            99999988777665554432221111                                             123567788


Q ss_pred             HHHHHHHhhhcCCCCCC-CHHHHhcCCCC
Q 014117          396 LTHLLQGLLRYDPTDRL-TAREALRHPFF  423 (430)
Q Consensus       396 ~~~ll~~~L~~dP~~R~-ta~elL~hp~f  423 (430)
                      +.+||.+||++||++|| |++++ .|+|.
T Consensus       245 l~~li~~~L~~dp~~R~~sa~~l-~~~l~  272 (277)
T d1o6ya_         245 LDAVVLKALAKNPENRYQTAAEM-RADLV  272 (277)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHH-HHHHH
T ss_pred             HHHHHHHHccCCHhHCHhHHHHH-HHHHH
Confidence            99999999999999999 55555 45554

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-54  Score=403.35  Aligned_cols=251  Identities=26%  Similarity=0.375  Sum_probs=204.5

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      .++|++.+.||+|+||+||+|+++ +++.||||+++......+.+.+|++++.++.     |+||+++++++.. +.+||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~-----HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ-----HQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCC-----CTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCC-----CCCEeEEEeeecc-CCeEE
Confidence            468999999999999999999976 5778999999866666678899999999984     4889999998754 56799


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+ +|+|.+++.......+++..+..++.||+.||.|||+++||||||||+||||+                     
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~---------------------  143 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---------------------  143 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------------
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeee---------------------
Confidence            99999 89999987655445699999999999999999999999999999999999994                     


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCchH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG-EALFQTHENL  326 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG-~~Pf~~~~~~  326 (430)
                            .++.+||+|||+|+......    ....||+.|||||++.+..|+.++|||||||++|||+|| .+||...+..
T Consensus       144 ------~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~  217 (272)
T d1qpca_         144 ------DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP  217 (272)
T ss_dssp             ------TTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             ------cccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH
Confidence                  45566677777665443222    234789999999999998999999999999999999995 5666665555


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +....+.....                                                ...++.++.++.+||.+||+.
T Consensus       218 ~~~~~i~~~~~------------------------------------------------~~~p~~~~~~l~~li~~cl~~  249 (272)
T d1qpca_         218 EVIQNLERGYR------------------------------------------------MVRPDNCPEELYQLMRLCWKE  249 (272)
T ss_dssp             HHHHHHHTTCC------------------------------------------------CCCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHhcCC------------------------------------------------CCCcccChHHHHHHHHHHcCC
Confidence            54444322110                                                012345677899999999999


Q ss_pred             CCCCCCCHHHHhc--CCCCCC
Q 014117          407 DPTDRLTAREALR--HPFFTR  425 (430)
Q Consensus       407 dP~~R~ta~elL~--hp~f~~  425 (430)
                      ||++|||++||++  |+||+.
T Consensus       250 ~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         250 RPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             SGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHhHCcCHHHHHHHhhhhhhc
Confidence            9999999999998  788864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-53  Score=400.42  Aligned_cols=278  Identities=28%  Similarity=0.454  Sum_probs=218.6

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch---hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      ++|+++++||+|+||+||+|+++.+++.||||+++...   .....+.+|+.+++.+.     |+||+++++++......
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-----h~niv~~~~~~~~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-----HKNIVRLHDVLHSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-----CTTBCCEEEEEECSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcC-----cCCEEeeccccccccce
Confidence            57999999999999999999999999999999986432   34567788999988873     47899999999999999


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      ++||+++ +++|..++...  ..+++..++.++.|++.||+|||++|||||||||+|||+                    
T Consensus        77 ~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli--------------------  134 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI--------------------  134 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE--------------------
T ss_pred             eEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc--------------------
Confidence            9999999 66777766654  478999999999999999999999999999999999999                    


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCCC---CeeeecCcccchhhhhCCC-CCCcchHHHHHHHHHHHHhCCCCC-CCCc
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALF-QTHE  324 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~tG~~Pf-~~~~  324 (430)
                             +.+..+||+|||.+.......   ....+++.|+|||++.+.. ++.++|||||||++|||++|..|| .+.+
T Consensus       135 -------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  207 (292)
T d1unla_         135 -------NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND  207 (292)
T ss_dssp             -------CTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS
T ss_pred             -------ccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC
Confidence                   445567888888776543322   2346788999999998765 689999999999999999999885 5566


Q ss_pred             hHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhh
Q 014117          325 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL  404 (430)
Q Consensus       325 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  404 (430)
                      ..+.+..+....+.++...++.......    ........                ............++++.+||.+||
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~----------------~~~~~~~~~~~~s~~~~dll~~mL  267 (292)
T d1unla_         208 VDDQLKRIFRLLGTPTEEQWPSMTKLPD----YKPYPMYP----------------ATTSLVNVVPKLNATGRDLLQNLL  267 (292)
T ss_dssp             HHHHHHHHHHHHCCCCTTTCTTGGGSTT----CCCCCCCC----------------TTCCCTTTSTTCCHHHHHHHHHHS
T ss_pred             HHHHHHHHHhhcCCCChhhhhhhhhccc----cccccccc----------------ccchhhhccccCCHHHHHHHHHHc
Confidence            6777888888888776543221111000    00000000                001112234566788999999999


Q ss_pred             hcCCCCCCCHHHHhcCCCCCC
Q 014117          405 RYDPTDRLTAREALRHPFFTR  425 (430)
Q Consensus       405 ~~dP~~R~ta~elL~hp~f~~  425 (430)
                      ++||.+||||+|||+||||++
T Consensus       268 ~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         268 KCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             CSSGGGSCCHHHHTTSGGGSS
T ss_pred             cCChhHCcCHHHHhcChhhcC
Confidence            999999999999999999975

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.6e-53  Score=407.74  Aligned_cols=283  Identities=25%  Similarity=0.485  Sum_probs=212.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec--CCeE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHI  170 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~--~~~~  170 (430)
                      .++|+++++||+|+||+||+|+++.+++.||||+++...  .+...+|+++|+.+.+    |+||+++++++..  ...+
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~----hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRG----GPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTT----STTBCCEEEEEECTTTCSE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccC----CCCCcEEEEEEEecCCCce
Confidence            368999999999999999999999999999999997533  4567889999999853    4789999998874  4679


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      |+||||| +++|..+.     +.+++..++.++.||+.||+|||++|||||||||+||||+.+                 
T Consensus       108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~-----------------  165 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE-----------------  165 (328)
T ss_dssp             EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-----------------
T ss_pred             eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCC-----------------
Confidence            9999999 77876542     469999999999999999999999999999999999999632                 


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCC-CCCCcchHHHHHHHHHHHHhCCCCCCCC-ch
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH-EN  325 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~tG~~Pf~~~-~~  325 (430)
                               +..+||+|||+|+.....  ....+||+.|+|||.+.+. .|+.++||||+||++|+|++|..||... +.
T Consensus       166 ---------~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~  236 (328)
T d3bqca1         166 ---------HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN  236 (328)
T ss_dssp             ---------TTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred             ---------CCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh
Confidence                     335788888887654432  3446789999999998875 4899999999999999999999999654 45


Q ss_pred             HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccC--CCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHh
Q 014117          326 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW--PEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL  403 (430)
Q Consensus       326 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  403 (430)
                      .++...+...+|.+......  .    .........+  ............        ..........++++.|||++|
T Consensus       237 ~~~~~~i~~~~g~~~~~~~~--~----~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~s~~~~dli~~m  302 (328)
T d3bqca1         237 YDQLVRIAKVLGTEDLYDYI--D----KYNIELDPRFNDILGRHSRKRWER--------FVHSENQHLVSPEALDFLDKL  302 (328)
T ss_dssp             HHHHHHHHHHHCHHHHHHHH--H----HTTCCCCGGGGGTCCCCCCCCGGG--------GCCTTTGGGCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCchhhhhh--h----hcccccCcccchhcccccccchhh--------cccccccccCCHHHHHHHHHH
Confidence            56666777777643221111  0    0000000000  000000000000        001112234677899999999


Q ss_pred             hhcCCCCCCCHHHHhcCCCCCCC
Q 014117          404 LRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       404 L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      |++||++||||+|||+||||++-
T Consensus       303 L~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         303 LRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             SCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             ccCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-53  Score=406.00  Aligned_cols=250  Identities=20%  Similarity=0.290  Sum_probs=199.9

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCe-----EEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKE-----MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .++|++.+.||+|+||+||+|+++.+++     .||+|++...  ......+..|+.++.++.    +|+||+++++++.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~HpnIv~l~~~~~  111 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG----SHENIVNLLGACT  111 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC----CCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhc----CCCcEeEEEEEEe
Confidence            4689999999999999999999876543     6999998533  234456788999998884    3488999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNNY---------------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLK  223 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlK  223 (430)
                      +.+.+||||||| +|+|.++|.....                     ..+++..++.++.||+.||+|||++||||||||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK  191 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  191 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence            999999999999 9999999976432                     358999999999999999999999999999999


Q ss_pred             CCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCC
Q 014117          224 PENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWT  298 (430)
Q Consensus       224 p~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~  298 (430)
                      |+|||++.++                           .+||+|||+|+......     ....||+.|||||++.+..|+
T Consensus       192 p~Nill~~~~---------------------------~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~  244 (325)
T d1rjba_         192 ARNVLVTHGK---------------------------VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT  244 (325)
T ss_dssp             GGGEEEETTT---------------------------EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred             hhccccccCC---------------------------eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC
Confidence            9999996544                           55666666654332222     234689999999999999999


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcC
Q 014117          299 YPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK  377 (430)
Q Consensus       299 ~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (430)
                      .++|||||||++|||+| |.+||.+.+..+.+..+......+                                      
T Consensus       245 ~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~--------------------------------------  286 (325)
T d1rjba_         245 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM--------------------------------------  286 (325)
T ss_dssp             HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC--------------------------------------
T ss_pred             cceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC--------------------------------------
Confidence            99999999999999998 899998866555444333211111                                      


Q ss_pred             chhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          378 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                               ..+...+.++.+||.+||+.||++|||++||++|
T Consensus       287 ---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         287 ---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                     1234567789999999999999999999999975

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=398.48  Aligned_cols=248  Identities=23%  Similarity=0.327  Sum_probs=194.6

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      .++|++.+.||+|+||+||+|..+   ..||||+++..   ....+.+.+|+.++.++     .|+||+++++++. .+.
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~~~~~-~~~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-----RHVNILLFMGYST-APQ   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-----CCTTBCCEEEEEC-SSS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCCCEeeeeEEEe-ccE
Confidence            467999999999999999999754   35999998632   33456778899999888     3588999999765 467


Q ss_pred             EEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCC
Q 014117          170 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK  248 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~  248 (430)
                      ++|||||| +|+|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.++               
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~---------------  141 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL---------------  141 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS---------------
T ss_pred             EEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC---------------
Confidence            89999999 789999997654 4699999999999999999999999999999999999996544               


Q ss_pred             CCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCC---CCCCcchHHHHHHHHHHHHhCCCCC
Q 014117          249 DSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALF  320 (430)
Q Consensus       249 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGv~l~el~tG~~Pf  320 (430)
                                  .+||+|||+|+.....     .....||+.|||||++.+.   .|+.++|||||||++|||+||+.||
T Consensus       142 ------------~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf  209 (276)
T d1uwha_         142 ------------TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY  209 (276)
T ss_dssp             ------------SEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ------------CEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCC
Confidence                        5566666655433221     1335799999999999753   4899999999999999999999999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .+.+.......+.......|.                                           ....+..++.++.+||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~p~-------------------------------------------~~~~~~~~~~~l~~li  246 (276)
T d1uwha_         210 SNINNRDQIIFMVGRGYLSPD-------------------------------------------LSKVRSNCPKAMKRLM  246 (276)
T ss_dssp             TTCCCHHHHHHHHHHTSCCCC-------------------------------------------GGGSCTTCCHHHHHHH
T ss_pred             CCCChHHHHHHHHhcCCCCCc-------------------------------------------chhccccchHHHHHHH
Confidence            987666555443332211110                                           1123456678899999


Q ss_pred             HHhhhcCCCCCCCHHHHhcC
Q 014117          401 QGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~h  420 (430)
                      .+||+.||++|||++|+++|
T Consensus       247 ~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         247 AECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999876

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7e-53  Score=398.85  Aligned_cols=247  Identities=23%  Similarity=0.329  Sum_probs=194.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCe---EEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKE---MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .++|++.+.||+|+||+||+|+++.+++   .||||.+...  ....+.+.+|+++|+++     .|+||+++++++...
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~g~~~~~   99 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-----DHPNVIHLEGVVTKS   99 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECSS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-----CCCCCccEEEEEeeC
Confidence            4679999999999999999999987654   6899988632  34456788999999888     358999999999999


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +.+|+||||| +|+|.+++.... ..+++..+..++.||+.||+|||++|||||||||+||||+.+              
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~--------------  164 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN--------------  164 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT--------------
T ss_pred             CEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCC--------------
Confidence            9999999999 889999887654 469999999999999999999999999999999999999554              


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC--------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE  317 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~  317 (430)
                                   +.+||+|||+++......        ....||+.|||||++.+..|+.++|||||||++|||+| |.
T Consensus       165 -------------~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~  231 (299)
T d1jpaa_         165 -------------LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE  231 (299)
T ss_dssp             -------------CCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             -------------CcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCC
Confidence                         455555555554332211        11357999999999999999999999999999999998 89


Q ss_pred             CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHH
Q 014117          318 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT  397 (430)
Q Consensus       318 ~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (430)
                      +||.+.+..+....+......                                                ..+...+.++.
T Consensus       232 ~Pf~~~~~~~~~~~i~~~~~~------------------------------------------------~~~~~~~~~l~  263 (299)
T d1jpaa_         232 RPYWDMTNQDVINAIEQDYRL------------------------------------------------PPPMDCPSALH  263 (299)
T ss_dssp             CTTTTCCHHHHHHHHHTTCCC------------------------------------------------CCCTTCCHHHH
T ss_pred             CCCCCCCHHHHHHHHHcCCCC------------------------------------------------CCCccchHHHH
Confidence            999987776665544321111                                                01235677899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHhcC
Q 014117          398 HLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       398 ~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      +||.+||+.||++|||++||+++
T Consensus       264 ~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         264 QLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999988764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-53  Score=391.08  Aligned_cols=245  Identities=21%  Similarity=0.326  Sum_probs=205.4

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV  173 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv  173 (430)
                      ++|+++++||+|+||+||+|+++ +++.||||+++......+.+.+|+.++.++.     |+||+++++++.+.+.+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~-----HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-----HEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCC-----CTTBCCEEEEECCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcC-----CCceeeEEEEEeeCCceEEE
Confidence            46889999999999999999985 7788999999876666778899999999884     48999999999999999999


Q ss_pred             EecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCcc
Q 014117          174 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY  252 (430)
Q Consensus       174 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~  252 (430)
                      |||+ +|+|.+++.... ..+++..+..++.||++||.|||+.||+||||||+|||+++                     
T Consensus        78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~---------------------  135 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND---------------------  135 (258)
T ss_dssp             EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECT---------------------
T ss_pred             EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcC---------------------
Confidence            9999 789999876544 46899999999999999999999999999999999999954                     


Q ss_pred             cccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHH
Q 014117          253 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE  327 (430)
Q Consensus       253 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~  327 (430)
                            ++.+||+|||+++......    ....||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..+
T Consensus       136 ------~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~  209 (258)
T d1k2pa_         136 ------QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE  209 (258)
T ss_dssp             ------TCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred             ------CCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence                  4556666666665332221    22468999999999999999999999999999999998 899999888777


Q ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcC
Q 014117          328 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD  407 (430)
Q Consensus       328 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  407 (430)
                      ....+.+....                                                ..+...+.++.+||.+||+.|
T Consensus       210 ~~~~i~~~~~~------------------------------------------------~~p~~~~~~l~~li~~cl~~d  241 (258)
T d1k2pa_         210 TAEHIAQGLRL------------------------------------------------YRPHLASEKVYTIMYSCWHEK  241 (258)
T ss_dssp             HHHHHHTTCCC------------------------------------------------CCCTTCCHHHHHHHHHTTCSS
T ss_pred             HHHHHHhCCCC------------------------------------------------CCcccccHHHHHHHHHHccCC
Confidence            66555432111                                                113355678999999999999


Q ss_pred             CCCCCCHHHHhcC
Q 014117          408 PTDRLTAREALRH  420 (430)
Q Consensus       408 P~~R~ta~elL~h  420 (430)
                      |++|||++++|+|
T Consensus       242 P~~RPt~~eil~~  254 (258)
T d1k2pa_         242 ADERPTFKILLSN  254 (258)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             HhHCcCHHHHHHH
Confidence            9999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=394.39  Aligned_cols=254  Identities=24%  Similarity=0.335  Sum_probs=199.4

Q ss_pred             CcEEEEe-eeccccceEEEEEEECC--CCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           94 SRYKIHS-KMGEGTFGQVLECWDRE--RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        94 ~~y~~~~-~lG~G~~g~V~~~~~~~--~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      ++|.+.+ +||+|+||+||+|.++.  ++..||||+++..  ....+.+.+|++++.++.     |+||+++++++.. +
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~-----HpnIv~l~g~~~~-~   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-----NPYIVRLIGVCQA-E   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC-----CTTBCCEEEEEES-S
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCC-----CCCEeeEeeeecc-C
Confidence            5688888 49999999999998764  4557999998643  334567889999999983     4889999999875 4


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP  247 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~  247 (430)
                      .+||||||| +|+|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||++....
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             eEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence            689999999 889999986543 479999999999999999999999999999999999999766655555555443222


Q ss_pred             CCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchH
Q 014117          248 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL  326 (430)
Q Consensus       248 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~  326 (430)
                      ....                     .........||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+..
T Consensus       161 ~~~~---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~  219 (285)
T d1u59a_         161 ADDS---------------------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP  219 (285)
T ss_dssp             TCSC---------------------EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred             cccc---------------------ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH
Confidence            1110                     0001122468999999999999999999999999999999998 99999987776


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +....+.+..  .                                              ...++.++.++.+||.+||+.
T Consensus       220 ~~~~~i~~~~--~----------------------------------------------~~~p~~~~~~l~~li~~cl~~  251 (285)
T d1u59a_         220 EVMAFIEQGK--R----------------------------------------------MECPPECPPELYALMSDCWIY  251 (285)
T ss_dssp             HHHHHHHTTC--C----------------------------------------------CCCCTTCCHHHHHHHHHTTCS
T ss_pred             HHHHHHHcCC--C----------------------------------------------CCCCCcCCHHHHHHHHHHcCC
Confidence            6555443211  0                                              012346678899999999999


Q ss_pred             CCCCCCCHHHH---hcCCCC
Q 014117          407 DPTDRLTAREA---LRHPFF  423 (430)
Q Consensus       407 dP~~R~ta~el---L~hp~f  423 (430)
                      ||++|||+.+|   |+|+|+
T Consensus       252 ~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         252 KWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             SGGGSCCHHHHHHHHHHHHH
T ss_pred             CHhHCcCHHHHHHHHHHHHH
Confidence            99999999877   677776

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=393.34  Aligned_cols=247  Identities=23%  Similarity=0.361  Sum_probs=192.4

Q ss_pred             eeeccccceEEEEEEEC--CCCeEEEEEEecCc---hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEE
Q 014117          100 SKMGEGTFGQVLECWDR--ERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF  174 (430)
Q Consensus       100 ~~lG~G~~g~V~~~~~~--~~~~~vAiK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~  174 (430)
                      ++||+|+||+||+|.++  .+++.||||+++..   ....+.+.+|+++++++     .|+||++++++++. +..||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~g~~~~-~~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-----DNPYIVRMIGICEA-ESWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEES-SSEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-----CCCCCceEEEEecc-CCEEEEE
Confidence            46999999999999864  45678999998632   23346688899999888     45899999999865 4578999


Q ss_pred             ecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCccc
Q 014117          175 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF  253 (430)
Q Consensus       175 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~  253 (430)
                      ||+ +|+|.+++....  .+++..+..++.||+.||+|||++|||||||||+|||++.++.+|++|||++......... 
T Consensus        87 E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~-  163 (277)
T d1xbba_          87 EMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-  163 (277)
T ss_dssp             ECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-
T ss_pred             EcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc-
Confidence            999 889999998764  7999999999999999999999999999999999999976665555555544322111000 


Q ss_pred             ccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHHHHH
Q 014117          254 KRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMM  332 (430)
Q Consensus       254 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~~~i  332 (430)
                                          ........||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..+....+
T Consensus       164 --------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i  223 (277)
T d1xbba_         164 --------------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML  223 (277)
T ss_dssp             --------------------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred             --------------------cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH
Confidence                                001122468999999999999999999999999999999998 89999987766655444


Q ss_pred             HHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCC
Q 014117          333 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL  412 (430)
Q Consensus       333 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~  412 (430)
                      .+.  ..                                              ...+..++.++.+||.+||+.||++||
T Consensus       224 ~~~--~~----------------------------------------------~~~p~~~~~~~~~li~~cl~~dp~~RP  255 (277)
T d1xbba_         224 EKG--ER----------------------------------------------MGCPAGCPREMYDLMNLCWTYDVENRP  255 (277)
T ss_dssp             HTT--CC----------------------------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSC
T ss_pred             HcC--CC----------------------------------------------CCCCcccCHHHHHHHHHHcCCCHhHCc
Confidence            321  10                                              112345678899999999999999999


Q ss_pred             CHHHH---hcCCCC
Q 014117          413 TAREA---LRHPFF  423 (430)
Q Consensus       413 ta~el---L~hp~f  423 (430)
                      |+++|   |+|+|+
T Consensus       256 s~~~i~~~L~~~~~  269 (277)
T d1xbba_         256 GFAAVELRLRNYYY  269 (277)
T ss_dssp             CHHHHHHHHHHHHH
T ss_pred             CHHHHHHHhhCHHh
Confidence            99998   566665

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-52  Score=389.72  Aligned_cols=252  Identities=26%  Similarity=0.346  Sum_probs=200.9

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      .++|++.+.||+|+||+||+|+++.+ +.||||+++......+.+.+|+.++.++.     |+||+++++++.+ +.+++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~-----h~nIv~~~g~~~~-~~~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR-----HEKLVQLYAVVSE-EPIYI   88 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCC-----CTTBCCEEEEECS-SSCEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcc-----cCCEeEEEEEEec-CCeEE
Confidence            46799999999999999999998765 56999999866666678899999999984     4789999998854 56789


Q ss_pred             EEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          173 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       173 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      ||||+ +|+|..++.......+++..++.++.||+.||+|||++||+||||||+||||+.++                  
T Consensus        89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~------------------  150 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL------------------  150 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG------------------
T ss_pred             EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC------------------
Confidence            99999 88999988765445799999999999999999999999999999999999995544                  


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCCC----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCchH
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG-EALFQTHENL  326 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG-~~Pf~~~~~~  326 (430)
                               .+||+|||+++......    ....||+.|+|||++.+..++.++|||||||++|||++| .+||......
T Consensus       151 ---------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~  221 (285)
T d1fmka3         151 ---------VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR  221 (285)
T ss_dssp             ---------CEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             ---------cEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH
Confidence                     55666666554332221    224689999999999999999999999999999999995 5555655555


Q ss_pred             HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhc
Q 014117          327 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY  406 (430)
Q Consensus       327 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  406 (430)
                      +.+..+.....                                                ...+...+.++.+||.+||+.
T Consensus       222 ~~~~~i~~~~~------------------------------------------------~~~~~~~~~~l~~li~~cl~~  253 (285)
T d1fmka3         222 EVLDQVERGYR------------------------------------------------MPCPPECPESLHDLMCQCWRK  253 (285)
T ss_dssp             HHHHHHHTTCC------------------------------------------------CCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHhcCC------------------------------------------------CCCCcccCHHHHHHHHHHccc
Confidence            55544432111                                                012345677899999999999


Q ss_pred             CCCCCCCHHHHhc--CCCCCCC
Q 014117          407 DPTDRLTAREALR--HPFFTRD  426 (430)
Q Consensus       407 dP~~R~ta~elL~--hp~f~~~  426 (430)
                      ||++|||+++|+.  |+||+..
T Consensus       254 dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         254 EPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             SGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CHhHCcCHHHHHHHHhhhhcCC
Confidence            9999999999998  8999754

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.2e-51  Score=396.40  Aligned_cols=315  Identities=31%  Similarity=0.503  Sum_probs=240.1

Q ss_pred             ceeecCceec-CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCC------CCCc
Q 014117           84 YMFALGENLT-SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK------GGNR  156 (430)
Q Consensus        84 ~~~~~~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~------~~~~  156 (430)
                      +++.+|+.+. ++|+++++||+|+||+||+|+++.+|+.||||+++......+...+|+.+++.+.+...      .++|
T Consensus         2 ~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~   81 (362)
T d1q8ya_           2 HPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANH   81 (362)
T ss_dssp             CCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             CCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence            4567788876 57999999999999999999999999999999998776666778889999999977542      2478


Q ss_pred             eEEecceeec--CCeEEEEEecC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeeccCCCCceEEee
Q 014117          157 CVQIRNWFDY--RNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVS  231 (430)
Q Consensus       157 i~~~~~~~~~--~~~~~lv~e~~--~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlKp~NILl~~  231 (430)
                      |+++++++..  ....++||+++  +++............+++..++.++.||+.||+|||+ .||+||||||+||||+.
T Consensus        82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~  161 (362)
T d1q8ya_          82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI  161 (362)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred             eEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeec
Confidence            9999887754  45667777766  5566666666666789999999999999999999997 89999999999999976


Q ss_pred             cCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHH
Q 014117          232 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILV  311 (430)
Q Consensus       232 ~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~  311 (430)
                      ++..                     .....++++|||.+..........+||+.|+|||++.+..|+.++||||+||+++
T Consensus       162 ~~~~---------------------~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  220 (362)
T d1q8ya_         162 VDSP---------------------ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIF  220 (362)
T ss_dssp             EETT---------------------TTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHH
T ss_pred             cCcc---------------------cccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHH
Confidence            5420                     1223589999999887666666778999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCC------chHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHH
Q 014117          312 ELCTGEALFQTH------ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI  385 (430)
Q Consensus       312 el~tG~~Pf~~~------~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (430)
                      +|++|+.||...      ...+....+...+|.+|.++..........+...+....-.... ...      ........
T Consensus       221 el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~------~~~~~~~~  293 (362)
T d1q8ya_         221 ELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK-FWP------LEDVLTEK  293 (362)
T ss_dssp             HHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCC-BCC------HHHHHHHT
T ss_pred             HHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhcccccc-CCc------hhhhcccc
Confidence            999999999753      24556777888999999887665444333332222111111100 000      01111122


Q ss_pred             hhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcCCCCCCC
Q 014117          386 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD  426 (430)
Q Consensus       386 ~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~hp~f~~~  426 (430)
                      ...+...+.++.|||.+||++||.+||||+|||+||||++.
T Consensus       294 ~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         294 YKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT  334 (362)
T ss_dssp             TCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred             cccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence            23344567889999999999999999999999999999854

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-52  Score=398.55  Aligned_cols=256  Identities=24%  Similarity=0.393  Sum_probs=206.2

Q ss_pred             CcEEEEeeeccccceEEEEEEE---CCCCeEEEEEEecCc-----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           94 SRYKIHSKMGEGTFGQVLECWD---RERKEMVAIKIVRGI-----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~---~~~~~~vAiK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      ++|++++.||+|+||+||+|++   +.+|+.||||+++..     ....+.+..|+++++++.|+    +||++++++++
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~----pnIv~~~~~~~   99 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS----PFLVTLHYAFQ   99 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTC----TTBCCEEEEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCC----CeEEEeeeeec
Confidence            6799999999999999999987   447899999998632     12345677899999999763    67999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCC
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL  244 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~  244 (430)
                      +...+++||||+ +++|.+++...+  .+++..++.++.||+.||+|||++|||||||||+|||++              
T Consensus       100 ~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~--------------  163 (322)
T d1vzoa_         100 TETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD--------------  163 (322)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC--------------
T ss_pred             cCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeec--------------
Confidence            999999999999 899999998775  788999999999999999999999999999999999994              


Q ss_pred             CCCCCCcccccCCCCCCeEEEeCCCccccCCC----CCeeeecCcccchhhhhCC--CCCCcchHHHHHHHHHHHHhCCC
Q 014117          245 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEA  318 (430)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~tG~~  318 (430)
                                   .++.+||+|||++......    .....||+.|+|||.+.+.  .++.++|||||||+||+|++|..
T Consensus       164 -------------~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~  230 (322)
T d1vzoa_         164 -------------SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS  230 (322)
T ss_dssp             -------------TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSC
T ss_pred             -------------CCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCC
Confidence                         4556777777776543221    1335789999999999865  47889999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||.+.+..+....+.+....                                             .....+...+.++.+
T Consensus       231 PF~~~~~~~~~~~i~~~~~~---------------------------------------------~~~~~~~~~s~~~~~  265 (322)
T d1vzoa_         231 PFTVDGEKNSQAEISRRILK---------------------------------------------SEPPYPQEMSALAKD  265 (322)
T ss_dssp             TTSCTTSCCCHHHHHHHHHH---------------------------------------------CCCCCCTTSCHHHHH
T ss_pred             CCCCCCHHHHHHHHHHhccc---------------------------------------------CCCCCcccCCHHHHH
Confidence            99876544333332221100                                             001123456788999


Q ss_pred             HHHHhhhcCCCCCC-----CHHHHhcCCCCCCCC
Q 014117          399 LLQGLLRYDPTDRL-----TAREALRHPFFTRDH  427 (430)
Q Consensus       399 ll~~~L~~dP~~R~-----ta~elL~hp~f~~~~  427 (430)
                      ||.+||++||++||     ||+|+|+||||++.+
T Consensus       266 li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         266 LIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             HHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence            99999999999999     589999999998743

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-51  Score=387.62  Aligned_cols=250  Identities=22%  Similarity=0.293  Sum_probs=190.0

Q ss_pred             cCcEEEEeeeccccceEEEEEEECC-----CCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .++|++.++||+|+||.||+|.+..     +++.||||+++..  ......+..|..++.++.+    |++|+.+++.+.
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~----h~~iv~~~~~~~   87 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH----HLNVVNLLGACT   87 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCC----CTTBCCEEEEEC
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcC----CCeEEEeeeeec
Confidence            4679999999999999999999754     4578999998643  2344566778888888754    367888877754


Q ss_pred             -cCCeEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEE
Q 014117          166 -YRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLL  229 (430)
Q Consensus       166 -~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl  229 (430)
                       ....+++||||| +|+|.+++....              ...+++..+..++.||+.||+|||++|||||||||+||||
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl  167 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  167 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence             456799999999 899999997542              2358999999999999999999999999999999999999


Q ss_pred             eecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchHH
Q 014117          230 VSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIW  304 (430)
Q Consensus       230 ~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dvw  304 (430)
                      +.++                           .+||+|||+|+.....     ....+||+.|+|||++.+..|+.++|||
T Consensus       168 ~~~~---------------------------~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiw  220 (299)
T d1ywna1         168 SEKN---------------------------VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW  220 (299)
T ss_dssp             CGGG---------------------------CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHH
T ss_pred             CCCC---------------------------cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCccccee
Confidence            6555                           4555555555432211     1235799999999999999999999999


Q ss_pred             HHHHHHHHHHhC-CCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHH
Q 014117          305 SVGCILVELCTG-EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN  383 (430)
Q Consensus       305 slGv~l~el~tG-~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (430)
                      ||||++|||+|| .+||.+.+..+.+..+......                                             
T Consensus       221 S~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~---------------------------------------------  255 (299)
T d1ywna1         221 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR---------------------------------------------  255 (299)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC---------------------------------------------
T ss_pred             ehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---------------------------------------------
Confidence            999999999986 5788776554443322221100                                             


Q ss_pred             HHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          384 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       384 ~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                        ...++..++++.+||.+||+.||++|||++|+++|
T Consensus       256 --~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         256 --MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence              11234567789999999999999999999999986

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=380.23  Aligned_cols=246  Identities=20%  Similarity=0.283  Sum_probs=191.3

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCC----eEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERK----EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      .+.|++.+.||+|+||.||+|.++.++    ..||||+++..  ......+.+|++++.++.     |+||+++++++..
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~-----H~nIv~~~g~~~~   80 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-----HHNIIRLEGVISK   80 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC-----CTTBCCEEEEECS
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcC-----CCCEeeeeEEEec
Confidence            457999999999999999999987654    47999998643  334456788999999883     4889999999999


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                      .+.+++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+++||||||||+||||+.              
T Consensus        81 ~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~--------------  145 (283)
T d1mqba_          81 YKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS--------------  145 (283)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--------------
T ss_pred             CCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECC--------------
Confidence            99999999999 888888877654 47999999999999999999999999999999999999954              


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCC------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCC-C
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE-A  318 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~-~  318 (430)
                                   ++.+||+|||+++......      ....||+.|||||++.+..|+.++|||||||++|||++|. +
T Consensus       146 -------------~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~  212 (283)
T d1mqba_         146 -------------NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER  212 (283)
T ss_dssp             -------------TCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             -------------CCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCC
Confidence                         4556666666665432211      1236899999999999999999999999999999999965 5


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||...+..+.+..+.....                                                ...+...+.++.+
T Consensus       213 ~~~~~~~~~~~~~i~~~~~------------------------------------------------~~~~~~~~~~l~~  244 (283)
T d1mqba_         213 PYWELSNHEVMKAINDGFR------------------------------------------------LPTPMDCPSAIYQ  244 (283)
T ss_dssp             TTTTCCHHHHHHHHHTTCC------------------------------------------------CCCCTTCBHHHHH
T ss_pred             ccccCCHHHHHHHHhccCC------------------------------------------------CCCchhhHHHHHH
Confidence            5555555444433321110                                                0123456778999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhc
Q 014117          399 LLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~  419 (430)
                      ||.+||+.||++|||+.||++
T Consensus       245 li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         245 LMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHCcCCHhHCcCHHHHHH
Confidence            999999999999999999876

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-51  Score=382.85  Aligned_cols=246  Identities=24%  Similarity=0.309  Sum_probs=193.7

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCC---CeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      .++|++.+.||+|+||.||+|++..+   +..||||.++..  ....+.+.+|+.+++++     .||||+++++++. .
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~-~   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-----DHPHIVKLIGVIT-E   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEC-S
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEe-c
Confidence            46899999999999999999998754   356899988643  33456678899999888     4589999999986 4


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      +.+|+||||+ +|+|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+|+         
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl---------  149 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL---------  149 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEE---------
T ss_pred             CeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEE---------
Confidence            6789999999 889999877654 47999999999999999999999999999999999999976655554         


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCC----CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQ  321 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~  321 (430)
                                        +|||+|+.....    .....||+.|+|||++.+..|+.++|||||||++|||++ |.+||.
T Consensus       150 ------------------~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~  211 (273)
T d1mp8a_         150 ------------------GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ  211 (273)
T ss_dssp             ------------------CC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ------------------ccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCC
Confidence                              555544432211    123468999999999999999999999999999999998 899998


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      +.+..+....+....  .                                              ...++.++.++.+||.
T Consensus       212 ~~~~~~~~~~i~~~~--~----------------------------------------------~~~~~~~~~~~~~li~  243 (273)
T d1mp8a_         212 GVKNNDVIGRIENGE--R----------------------------------------------LPMPPNCPPTLYSLMT  243 (273)
T ss_dssp             TCCGGGHHHHHHTTC--C----------------------------------------------CCCCTTCCHHHHHHHH
T ss_pred             CCCHHHHHHHHHcCC--C----------------------------------------------CCCCCCCCHHHHHHHH
Confidence            877766555443211  0                                              0123466788999999


Q ss_pred             HhhhcCCCCCCCHHHHhcC
Q 014117          402 GLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~h  420 (430)
                      +||+.||++|||++||++|
T Consensus       244 ~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         244 KCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.7e-50  Score=380.68  Aligned_cols=261  Identities=24%  Similarity=0.309  Sum_probs=203.6

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +.++|++.+.||+|+||.||+|+++.+++.||||++..... ...+..|+++++.+.++    ++|+.+..++...+..+
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~----~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGG----VGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTS----TTCCCEEEEEEETTEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCC----CcccEEEEEEecCCEEE
Confidence            44689999999999999999999999999999999874332 34577899999988653    45777777888899999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          172 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       172 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      +||||++++|.+.+.... ..+++..+..++.||+.||+|||++|||||||||+|||++..                   
T Consensus        80 ivme~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~-------------------  139 (299)
T d1ckia_          80 MVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG-------------------  139 (299)
T ss_dssp             EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG-------------------
T ss_pred             EEEEEcCCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccccc-------------------
Confidence            999999999988876654 579999999999999999999999999999999999998543                   


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCC----------CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                           +.+..+||+|||+|+.....          ....+||+.|||||++.+..|+.++|||||||++|||++|..||.
T Consensus       140 -----~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~  214 (299)
T d1ckia_         140 -----KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ  214 (299)
T ss_dssp             -----GGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             -----CCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccc
Confidence                 23456788888877654321          234589999999999999999999999999999999999999998


Q ss_pred             CCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          322 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       322 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      .....+....+.....                                         .............++.++.+||.
T Consensus       215 ~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~p~~~~~li~  253 (299)
T d1ckia_         215 GLKAATKRQKYERISE-----------------------------------------KKMSTPIEVLCKGYPSEFATYLN  253 (299)
T ss_dssp             CCC-------HHHHHH-----------------------------------------HHHHSCHHHHTTTSCHHHHHHHH
T ss_pred             ccchHHHHHHHHHhhc-----------------------------------------ccCCCChhHhccCCCHHHHHHHH
Confidence            7655443322211100                                         00000112234567889999999


Q ss_pred             HhhhcCCCCCCCHH---HHhcCCCC
Q 014117          402 GLLRYDPTDRLTAR---EALRHPFF  423 (430)
Q Consensus       402 ~~L~~dP~~R~ta~---elL~hp~f  423 (430)
                      .||+.||++||+++   ++|+|+|.
T Consensus       254 ~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         254 FCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHccCChhHCcCHHHHHHHHHHHHH
Confidence            99999999999986   55677654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-50  Score=384.78  Aligned_cols=245  Identities=20%  Similarity=0.270  Sum_probs=192.6

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCe----EEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecC
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKE----MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR  167 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~  167 (430)
                      ++|++++.||+|+||+||+|.+..+|+    .||+|.++..  ....+.+.+|+.+++++.     |+||+++++++.++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----HpnIv~l~g~~~~~   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-----NPHVCRLLGICLTS   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCC-----CTTBCCEEEEEESS
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCC-----CCCEeeEEEEEecC
Confidence            459999999999999999999988876    4788887532  334567889999999984     48899999999875


Q ss_pred             CeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCC
Q 014117          168 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT  246 (430)
Q Consensus       168 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~  246 (430)
                      + .+++||++ +++|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++.++.            
T Consensus        84 ~-~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~------------  149 (317)
T d1xkka_          84 T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH------------  149 (317)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE------------
T ss_pred             C-eeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC------------
Confidence            5 55666666 899999887654 57999999999999999999999999999999999999966554            


Q ss_pred             CCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 014117          247 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALF  320 (430)
Q Consensus       247 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf  320 (430)
                                     +||+|||+|+......     ....||+.|+|||++.+..|+.++|||||||++|||+| |.+||
T Consensus       150 ---------------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~  214 (317)
T d1xkka_         150 ---------------VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY  214 (317)
T ss_dssp             ---------------EEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ---------------eEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCC
Confidence                           5555555554332211     22368999999999999999999999999999999998 89999


Q ss_pred             CCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHH
Q 014117          321 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL  400 (430)
Q Consensus       321 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  400 (430)
                      .+.+..+....+.....                                                ...++.++.++.+||
T Consensus       215 ~~~~~~~~~~~i~~~~~------------------------------------------------~~~p~~~~~~~~~li  246 (317)
T d1xkka_         215 DGIPASEISSILEKGER------------------------------------------------LPQPPICTIDVYMIM  246 (317)
T ss_dssp             TTSCGGGHHHHHHHTCC------------------------------------------------CCCCTTBCHHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCC------------------------------------------------CCCCcccCHHHHHHH
Confidence            88766555444432110                                                012345677899999


Q ss_pred             HHhhhcCCCCCCCHHHHhcC
Q 014117          401 QGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       401 ~~~L~~dP~~R~ta~elL~h  420 (430)
                      .+||+.||.+|||+.|+++|
T Consensus       247 ~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         247 VKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhCCCChhhCcCHHHHHHH
Confidence            99999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-51  Score=380.29  Aligned_cols=245  Identities=22%  Similarity=0.317  Sum_probs=194.2

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEeccee-ecCCeEE
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-DYRNHIC  171 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~-~~~~~~~  171 (430)
                      .++|++.+.||+|+||.||+|.++  |..||||+++.. ...+.+.+|++++++++     |+||+++++++ +..+.+|
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~-----HpnIv~~~g~~~~~~~~~~   77 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLR-----HSNLVQLLGVIVEEKGGLY   77 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCC-----CTTBCCEEEEECCC--CCE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCC-----CCCEeeEEEEEEecCCcEE
Confidence            357999999999999999999874  678999999754 34466888999988873     58999999987 4557789


Q ss_pred             EEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCC
Q 014117          172 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS  250 (430)
Q Consensus       172 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~  250 (430)
                      +||||+ +|+|.++|.+.....+++..++.++.||+.||.|||+.+||||||||+|||+                     
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---------------------  136 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---------------------  136 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---------------------
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---------------------
Confidence            999999 9999999977654469999999999999999999999999999999999999                     


Q ss_pred             cccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHH
Q 014117          251 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHL  329 (430)
Q Consensus       251 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~Pf~~~~~~~~~  329 (430)
                            +.++.+||+|||+++..........+|..|+|||++.+..++.++|||||||++|||+| |++||...+..+..
T Consensus       137 ------~~~~~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~  210 (262)
T d1byga_         137 ------SEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV  210 (262)
T ss_dssp             ------CTTSCEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH
T ss_pred             ------cCCCCEeecccccceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH
Confidence                  55667788888888766555566688999999999999999999999999999999998 78999876655544


Q ss_pred             HHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCC
Q 014117          330 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT  409 (430)
Q Consensus       330 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~  409 (430)
                      ..+...  .                                              ....+...++++.+||.+||+.||.
T Consensus       211 ~~i~~~--~----------------------------------------------~~~~~~~~~~~~~~li~~cl~~dP~  242 (262)
T d1byga_         211 PRVEKG--Y----------------------------------------------KMDAPDGCPPAVYEVMKNCWHLDAA  242 (262)
T ss_dssp             HHHTTT--C----------------------------------------------CCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHcC--C----------------------------------------------CCCCCccCCHHHHHHHHHHcccCHh
Confidence            433210  0                                              1123445677899999999999999


Q ss_pred             CCCCHHHHhcC
Q 014117          410 DRLTAREALRH  420 (430)
Q Consensus       410 ~R~ta~elL~h  420 (430)
                      +|||+.+++++
T Consensus       243 ~Rps~~~l~~~  253 (262)
T d1byga_         243 MRPSFLQLREQ  253 (262)
T ss_dssp             GSCCHHHHHHH
T ss_pred             HCcCHHHHHHH
Confidence            99999999874

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.2e-49  Score=372.06  Aligned_cols=255  Identities=20%  Similarity=0.256  Sum_probs=203.0

Q ss_pred             ecCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEE
Q 014117           92 LTSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC  171 (430)
Q Consensus        92 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~  171 (430)
                      +.++|++.+.||+|+||+||+|++..+|+.||||+++... .......|+++++.+.++    ++++.++.++......+
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~----~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGC----TGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTC----TTCCCEEEEEEETTEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCC----CCCCEEEEEeecCCccE
Confidence            4578999999999999999999999999999999986433 234567788888888653    56778888899999999


Q ss_pred             EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCCCc
Q 014117          172 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS  251 (430)
Q Consensus       172 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~~~  251 (430)
                      +||||++++|.+++...+ ..+++..+..++.|++.||+|||++|||||||||+|||++....                 
T Consensus        78 ~vme~~~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~-----------------  139 (293)
T d1csna_          78 LVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS-----------------  139 (293)
T ss_dssp             EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS-----------------
T ss_pred             EEEEecCCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCccc-----------------
Confidence            999999999999987654 57999999999999999999999999999999999999964321                 


Q ss_pred             ccccCCCCCCeEEEeCCCccccCCC----------CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 014117          252 YFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ  321 (430)
Q Consensus       252 ~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~  321 (430)
                           ...+.+||+|||+|+.....          ....+||+.|||||++.+..++.++|||||||++|||++|..||.
T Consensus       140 -----~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~  214 (293)
T d1csna_         140 -----KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ  214 (293)
T ss_dssp             -----TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             -----ccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence                 23457888888888653321          234589999999999999999999999999999999999999997


Q ss_pred             CCchH---HHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          322 THENL---EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       322 ~~~~~---~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      +....   +....+....-..+                                            ..+....+++++.+
T Consensus       215 ~~~~~~~~~~~~~i~~~~~~~~--------------------------------------------~~~l~~~~p~~l~~  250 (293)
T d1csna_         215 GLKAATNKQKYERIGEKKQSTP--------------------------------------------LRELCAGFPEEFYK  250 (293)
T ss_dssp             SCCSCCHHHHHHHHHHHHHHSC--------------------------------------------HHHHTTTSCHHHHH
T ss_pred             CccchhHHHHHHHHHhccCCCC--------------------------------------------hHHhcCCCCHHHHH
Confidence            64332   22222211110000                                            11223456788999


Q ss_pred             HHHHhhhcCCCCCCCHHHHh
Q 014117          399 LLQGLLRYDPTDRLTAREAL  418 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL  418 (430)
                      ++..|+..+|++||+.+.+.
T Consensus       251 ii~~~~~~~~~~rP~y~~l~  270 (293)
T d1csna_         251 YMHYARNLAFDATPDYDYLQ  270 (293)
T ss_dssp             HHHHHHHCCTTCCCCHHHHH
T ss_pred             HHHHHhcCCcccCcCHHHHH
Confidence            99999999999999876553

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-50  Score=374.63  Aligned_cols=245  Identities=21%  Similarity=0.267  Sum_probs=189.0

Q ss_pred             CcEEEEeeeccccceEEEEEEECCC-C--eEEEEEEecCc----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeec
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRER-K--EMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY  166 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~-~--~~vAiK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~  166 (430)
                      ++|++.+.||+|+||.||+|+.... +  ..||||+++..    ....+.+.+|+.+++++.     |+||+++++++.+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-----H~nIv~~~g~~~~   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-----HRNLIRLYGVVLT   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-----CTTBCCEEEEECS
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-----CCCEEEEEEEEee
Confidence            5699999999999999999986533 2  46899988642    233456789999999983     4889999999976


Q ss_pred             CCeEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCC
Q 014117          167 RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH  245 (430)
Q Consensus       167 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~  245 (430)
                       +.+++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.           
T Consensus        83 -~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~-----------  149 (273)
T d1u46a_          83 -PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL-----------  149 (273)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE-----------
T ss_pred             -cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc-----------
Confidence             4678999999 889998877654 36999999999999999999999999999999999999976554           


Q ss_pred             CCCCCcccccCCCCCCeEEEeCCCccccCCCC------CeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHh-CCC
Q 014117          246 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA  318 (430)
Q Consensus       246 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~t-G~~  318 (430)
                                      +||+|||+++......      ....||..|+|||++.+..++.++|||||||++|||+| |..
T Consensus       150 ----------------vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~  213 (273)
T d1u46a_         150 ----------------VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE  213 (273)
T ss_dssp             ----------------EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ----------------eeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCC
Confidence                            5555555554332221      22467889999999999999999999999999999998 899


Q ss_pred             CCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHH
Q 014117          319 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH  398 (430)
Q Consensus       319 Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  398 (430)
                      ||.+.+..+....+......+                                               ..++..+.++.+
T Consensus       214 Pf~~~~~~~~~~~i~~~~~~~-----------------------------------------------~~~~~~~~~l~~  246 (273)
T d1u46a_         214 PWIGLNGSQILHKIDKEGERL-----------------------------------------------PRPEDCPQDIYN  246 (273)
T ss_dssp             TTTTCCHHHHHHHHHTSCCCC-----------------------------------------------CCCTTCCHHHHH
T ss_pred             CCCCcCHHHHHHHHHhCCCCC-----------------------------------------------CCcccccHHHHH
Confidence            999888777665544321111                                               123456778999


Q ss_pred             HHHHhhhcCCCCCCCHHHHhc
Q 014117          399 LLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       399 ll~~~L~~dP~~R~ta~elL~  419 (430)
                      ||.+||+.||++|||++||++
T Consensus       247 li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         247 VMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=375.32  Aligned_cols=248  Identities=19%  Similarity=0.284  Sum_probs=195.4

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCC-------eEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERK-------EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW  163 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~  163 (430)
                      .++|++.+.||+|+||.||+|++..++       ..||||+++...  .....+..|...+.++.    .|+||++++++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~----~HpnIv~~~~~   87 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG----KHKNIINLLGA   87 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEE
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhc----CCCeEEecccc
Confidence            468999999999999999999976554       479999986433  34456777888888874    34889999999


Q ss_pred             eecCCeEEEEEecC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceE
Q 014117          164 FDYRNHICIVFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL  228 (430)
Q Consensus       164 ~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NIL  228 (430)
                      +.+.+.+++||||+ +|+|.++|....              ...+++..+..++.||+.||+|||+++||||||||+|||
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  167 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence            99999999999999 999999997553              245899999999999999999999999999999999999


Q ss_pred             EeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCCCCCCcchH
Q 014117          229 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDI  303 (430)
Q Consensus       229 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dv  303 (430)
                      ++.                           ++.+||+|||++......     .....||+.|+|||++.+..|+.++||
T Consensus       168 l~~---------------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~Di  220 (299)
T d1fgka_         168 VTE---------------------------DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV  220 (299)
T ss_dssp             ECT---------------------------TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHH
T ss_pred             ecC---------------------------CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhh
Confidence            954                           445666666665533221     123578999999999999999999999


Q ss_pred             HHHHHHHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHH
Q 014117          304 WSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ  382 (430)
Q Consensus       304 wslGv~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (430)
                      |||||++|||++ |.+||.+.+..+....+...  ..+                                          
T Consensus       221 wS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~--~~~------------------------------------------  256 (299)
T d1fgka_         221 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG--HRM------------------------------------------  256 (299)
T ss_dssp             HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT--CCC------------------------------------------
T ss_pred             HHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcC--CCC------------------------------------------
Confidence            999999999998 79999877766554433221  111                                          


Q ss_pred             HHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          383 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       383 ~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                          ..+..++.++.+||.+||+.||++|||+.||++
T Consensus       257 ----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         257 ----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             ----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence                123456778999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-49  Score=377.02  Aligned_cols=249  Identities=20%  Similarity=0.289  Sum_probs=201.5

Q ss_pred             eecCcEEEEeeeccccceEEEEEEEC-----CCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW  163 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~  163 (430)
                      ...++|++++.||+|+||+||+|+.+     .+++.||||+++..  ......+.+|+++++++.     |+|++.++++
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~-----h~niv~~~~~   84 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-----NPNIVKLLGV   84 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC-----CTTBCCEEEE
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcC-----CCCcccceee
Confidence            34578999999999999999999875     35678999998643  234566889999999884     4889999999


Q ss_pred             eecCCeEEEEEecC-CCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeec
Q 014117          164 FDYRNHICIVFEKL-GSSLYDFLRKNN----------------------YRSFPIDLVREIARQLLECIAFMHDLCMIHT  220 (430)
Q Consensus       164 ~~~~~~~~lv~e~~-~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHr  220 (430)
                      +...+..++||||+ +++|.+++....                      ...+++..+..++.||+.||+|||+++||||
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr  164 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR  164 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence            99999999999999 899999997532                      1348899999999999999999999999999


Q ss_pred             cCCCCceEEeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-----CCeeeecCcccchhhhhCC
Q 014117          221 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGL  295 (430)
Q Consensus       221 DlKp~NILl~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~  295 (430)
                      ||||+|||++.                           ++.+||+|||+|+.....     .....||+.|+|||++.+.
T Consensus       165 DlKp~NILld~---------------------------~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  217 (301)
T d1lufa_         165 DLATRNCLVGE---------------------------NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN  217 (301)
T ss_dssp             CCSGGGEEECG---------------------------GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC
T ss_pred             EEcccceEECC---------------------------CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC
Confidence            99999999954                           455677777766532221     1235789999999999999


Q ss_pred             CCCCcchHHHHHHHHHHHHhCC-CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHh
Q 014117          296 GWTYPCDIWSVGCILVELCTGE-ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS  374 (430)
Q Consensus       296 ~~~~~~DvwslGv~l~el~tG~-~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (430)
                      .|+.++|||||||++|||++|. +||.+.+..+....+...  ..+                                  
T Consensus       218 ~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~--~~~----------------------------------  261 (301)
T d1lufa_         218 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG--NIL----------------------------------  261 (301)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT--CCC----------------------------------
T ss_pred             CCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcC--CCC----------------------------------
Confidence            9999999999999999999985 788887776665544321  111                                  


Q ss_pred             hcCchhHHHHHhhhcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          375 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                                  ..+..++.++.+||.+||+.||++|||+.||++
T Consensus       262 ------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         262 ------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                        123456778999999999999999999999965

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=378.23  Aligned_cols=248  Identities=21%  Similarity=0.265  Sum_probs=197.9

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeE--EEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCe
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEM--VAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH  169 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~  169 (430)
                      ++|++.+.||+|+||.||+|.++.++..  ||||.++..  ....+.+.+|+++|.++.    .|+||+++++++...+.
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~----~HpnIv~~~~~~~~~~~   85 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG----HHPNIINLLGACEHRGY   85 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC----CCTTBCCEEEEEEETTE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhcc----CCCCEeeEEEEEecCCe
Confidence            5799999999999999999999988874  677776532  234456788999988873    34889999999999999


Q ss_pred             EEEEEecC-CCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCc
Q 014117          170 ICIVFEKL-GSSLYDFLRKN--------------NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY  234 (430)
Q Consensus       170 ~~lv~e~~-~~~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~  234 (430)
                      +++||||+ +|+|.++|+..              ....+++..+..++.||+.||.|||+++||||||||+|||++.   
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~---  162 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE---  162 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG---
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC---
Confidence            99999999 89999999754              2357999999999999999999999999999999999999954   


Q ss_pred             cccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC--CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHH
Q 014117          235 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE  312 (430)
Q Consensus       235 ~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~e  312 (430)
                                              +..+||+|||+++.....  .....||..|+|||.+.+..|+.++|||||||++||
T Consensus       163 ------------------------~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~e  218 (309)
T d1fvra_         163 ------------------------NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE  218 (309)
T ss_dssp             ------------------------GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred             ------------------------CCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHH
Confidence                                    456677777766543322  223468999999999999999999999999999999


Q ss_pred             HHhCC-CCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCC
Q 014117          313 LCTGE-ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH  391 (430)
Q Consensus       313 l~tG~-~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (430)
                      |++|. +||.+.+..+....+.+.  ..                                              ...+..
T Consensus       219 ll~~~~~p~~~~~~~~~~~~i~~~--~~----------------------------------------------~~~~~~  250 (309)
T d1fvra_         219 IVSLGGTPYCGMTCAELYEKLPQG--YR----------------------------------------------LEKPLN  250 (309)
T ss_dssp             HHTTSCCTTTTCCHHHHHHHGGGT--CC----------------------------------------------CCCCTT
T ss_pred             HHhcCCCCCCCCCHHHHHHHHHhc--CC----------------------------------------------CCCCcc
Confidence            99965 678877666554433211  00                                              112345


Q ss_pred             chhHHHHHHHHhhhcCCCCCCCHHHHhcC
Q 014117          392 SAGDLTHLLQGLLRYDPTDRLTAREALRH  420 (430)
Q Consensus       392 ~~~~~~~ll~~~L~~dP~~R~ta~elL~h  420 (430)
                      .++++.+||.+||+.||++|||++||++|
T Consensus       251 ~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         251 CDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            67889999999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=371.38  Aligned_cols=254  Identities=23%  Similarity=0.334  Sum_probs=198.9

Q ss_pred             cCcEEEEeeeccccceEEEEEEEC-----CCCeEEEEEEecCc--hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDR-----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD  165 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~  165 (430)
                      .++|++.++||+|+||.||+|..+     .+++.||||+++..  ......+..|+.++.++.    +|+||+++++++.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~----~HpnIv~~~g~~~   97 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG----NHMNIVNLLGACT   97 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhcc----CCCCEEEEEEEEe
Confidence            468999999999999999999863     46778999999743  234456778999999884    3588999999999


Q ss_pred             cCCeEEEEEecC-CCCHHHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceE
Q 014117          166 YRNHICIVFEKL-GSSLYDFLRKNN----------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL  228 (430)
Q Consensus       166 ~~~~~~lv~e~~-~~~L~~~l~~~~----------------~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NIL  228 (430)
                      ..+.+||||||| +++|.+++....                ...+++..+..++.||+.||+|||++|||||||||+|||
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl  177 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL  177 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence            999999999999 889999997643                236899999999999999999999999999999999999


Q ss_pred             EeecCccccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccchhhhhCCCCCCcchHHHHHH
Q 014117          229 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC  308 (430)
Q Consensus       229 l~~~~~~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv  308 (430)
                      ++..+.++++|||++.........                      ......+||+.|+|||++.+..++.++|||||||
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~  235 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNY----------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI  235 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTS----------------------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred             ccccCcccccccchheeccCCCcc----------------------eEeeecccChHHcCHHHhcCCCCCCcccccchHH
Confidence            966555555555544332211100                      0012247899999999999999999999999999


Q ss_pred             HHHHHHh-CCCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhh
Q 014117          309 ILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ  387 (430)
Q Consensus       309 ~l~el~t-G~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (430)
                      ++|||+| |.+||...+..+.+..+...--.+                                               .
T Consensus       236 ~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~-----------------------------------------------~  268 (311)
T d1t46a_         236 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM-----------------------------------------------L  268 (311)
T ss_dssp             HHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC-----------------------------------------------C
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-----------------------------------------------C
Confidence            9999998 677777766555444333211110                                               1


Q ss_pred             hcCCchhHHHHHHHHhhhcCCCCCCCHHHHhc
Q 014117          388 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALR  419 (430)
Q Consensus       388 ~~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~  419 (430)
                      .+...+.++.+||.+||+.||++|||++|||+
T Consensus       269 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         269 SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            12345778999999999999999999999985

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=369.89  Aligned_cols=255  Identities=21%  Similarity=0.303  Sum_probs=206.0

Q ss_pred             eecCcEEEEeeeccccceEEEEEEECC-----CCeEEEEEEecCch--hhHHHHHHHHHHHHHHHhcCCCCCceEEecce
Q 014117           91 NLTSRYKIHSKMGEGTFGQVLECWDRE-----RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW  163 (430)
Q Consensus        91 ~~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vAiK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~  163 (430)
                      ...++|++.++||+|+||+||+|.++.     +++.||||+++...  .....+.+|+++++++     +|+||+++++.
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-----~h~nIv~~~~~   91 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-----NCHHVVRLLGV   91 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-----CCTTBCCEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-----CCCCEeeeeeE
Confidence            345789999999999999999998753     35789999997432  3334577899888887     45889999999


Q ss_pred             eecCCeEEEEEecC-CCCHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCc
Q 014117          164 FDYRNHICIVFEKL-GSSLYDFLRKN--------NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY  234 (430)
Q Consensus       164 ~~~~~~~~lv~e~~-~~~L~~~l~~~--------~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~  234 (430)
                      +...+..++||||+ +|+|.+++...        ....+++..+..++.||+.||.|||+++||||||||+||||     
T Consensus        92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl-----  166 (308)
T d1p4oa_          92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV-----  166 (308)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE-----
T ss_pred             EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee-----
Confidence            99999999999999 89999988642        12357899999999999999999999999999999999999     


Q ss_pred             cccCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCC-----CeeeecCcccchhhhhCCCCCCcchHHHHHHH
Q 014117          235 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI  309 (430)
Q Consensus       235 ~~i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~  309 (430)
                                            +.+..+||+|||+++......     ....||+.|+|||.+.+..++.++|||||||+
T Consensus       167 ----------------------d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~i  224 (308)
T d1p4oa_         167 ----------------------AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV  224 (308)
T ss_dssp             ----------------------CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred             ----------------------cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHH
Confidence                                  455667777777776433221     22478999999999999999999999999999


Q ss_pred             HHHHHhC-CCCCCCCchHHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhh
Q 014117          310 LVELCTG-EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH  388 (430)
Q Consensus       310 l~el~tG-~~Pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  388 (430)
                      +|||+|| .+||.+.+..+.+..+.+..  .+                                              ..
T Consensus       225 l~El~t~~~~p~~~~~~~~~~~~i~~~~--~~----------------------------------------------~~  256 (308)
T d1p4oa_         225 LWEIATLAEQPYQGLSNEQVLRFVMEGG--LL----------------------------------------------DK  256 (308)
T ss_dssp             HHHHHHTSCCTTTTSCHHHHHHHHHTTC--CC----------------------------------------------CC
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHHhCC--CC----------------------------------------------CC
Confidence            9999998 58888877766655443211  00                                              12


Q ss_pred             cCCchhHHHHHHHHhhhcCCCCCCCHHHHhc------CCCCCC
Q 014117          389 VDHSAGDLTHLLQGLLRYDPTDRLTAREALR------HPFFTR  425 (430)
Q Consensus       389 ~~~~~~~~~~ll~~~L~~dP~~R~ta~elL~------hp~f~~  425 (430)
                      +..++.++.+||.+||+.||++|||++||++      +|+|++
T Consensus       257 p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         257 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            3456778999999999999999999999998      777754

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-47  Score=361.97  Aligned_cols=249  Identities=17%  Similarity=0.201  Sum_probs=190.2

Q ss_pred             EEEeeeccccceEEEEEEECCCC---eEEEEEEecC--chhhHHHHHHHHHHHHHHHhcCCCCCceEEecceee-cCCeE
Q 014117           97 KIHSKMGEGTFGQVLECWDRERK---EMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-YRNHI  170 (430)
Q Consensus        97 ~~~~~lG~G~~g~V~~~~~~~~~---~~vAiK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~-~~~~~  170 (430)
                      .+.++||+|+||+||+|++..++   ..||||.++.  .....+.+.+|++++.++.     |+||+++++++. .++.+
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-----HpnIv~~~g~~~~~~~~~  104 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-----HPNVLSLLGICLRSEGSP  104 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCC-----CTTBCCCCEEEEETTTEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC-----CCCEeEEeEEEEecCCce
Confidence            33578999999999999986643   3699999863  3344567889999999884     489999999865 46789


Q ss_pred             EEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccccCCCcCCCCCCCC
Q 014117          171 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD  249 (430)
Q Consensus       171 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~i~dfg~~~~~~~~  249 (430)
                      ++||||| +++|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+||||++++.               
T Consensus       105 ~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~---------------  168 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---------------  168 (311)
T ss_dssp             EEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC---------------
T ss_pred             EEEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC---------------
Confidence            9999999 889999887654 46888899999999999999999999999999999999965554               


Q ss_pred             CcccccCCCCCCeEEEeCCCccccCCC-------CCeeeecCcccchhhhhCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 014117          250 SSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT  322 (430)
Q Consensus       250 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el~tG~~Pf~~  322 (430)
                                  +||+|||+++.....       .....||+.|+|||.+.+..++.++||||||+++|||+||..||..
T Consensus       169 ------------~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~  236 (311)
T d1r0pa_         169 ------------VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP  236 (311)
T ss_dssp             ------------EEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred             ------------EEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence                        555555554432211       1224689999999999999999999999999999999998777764


Q ss_pred             Cch-HHHHHHHHHHhCCCCHHHHHHHHhhhhhhhccCcccCCCCCCChhhHHhhcCchhHHHHHhhhcCCchhHHHHHHH
Q 014117          323 HEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ  401 (430)
Q Consensus       323 ~~~-~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  401 (430)
                      ... .+....+.                       +|.                         ....++..+.++.+||.
T Consensus       237 ~~~~~~~~~~i~-----------------------~g~-------------------------~~~~p~~~~~~l~~li~  268 (311)
T d1r0pa_         237 DVNTFDITVYLL-----------------------QGR-------------------------RLLQPEYCPDPLYEVML  268 (311)
T ss_dssp             ------CHHHHH-----------------------TTC-------------------------CCCCCTTCCHHHHHHHH
T ss_pred             CCCHHHHHHHHH-----------------------cCC-------------------------CCCCcccCcHHHHHHHH
Confidence            322 22222111                       110                         00123455678999999


Q ss_pred             HhhhcCCCCCCCHHHHhcC------CCCCCC
Q 014117          402 GLLRYDPTDRLTAREALRH------PFFTRD  426 (430)
Q Consensus       402 ~~L~~dP~~R~ta~elL~h------p~f~~~  426 (430)
                      +||+.||++|||+.||++|      .|..+.
T Consensus       269 ~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~  299 (311)
T d1r0pa_         269 KCWHPKAEMRPSFSELVSRISAIFSTFIGEH  299 (311)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred             HHcCCCHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence            9999999999999999998      666544

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=361.09  Aligned_cols=193  Identities=23%  Similarity=0.301  Sum_probs=153.1

Q ss_pred             cCcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC----
Q 014117           93 TSRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----  168 (430)
Q Consensus        93 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~----  168 (430)
                      ..+|.+.+.||+|+||.||+|+.  +|+.||||+++....  .....|.+++...   ..+|+||+++++++...+    
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~--~~~~~e~ei~~~~---~~~HpnIv~~~~~~~~~~~~~~   74 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTV---MLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTST---TCCCTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hHHHHHHHHHHHh---hCCCCcCcceEEEEEeCCCcce
Confidence            35689999999999999999985  688999999974432  3344454443221   125699999999886543    


Q ss_pred             eEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------cCeeeccCCCCceEEeecCccccCC
Q 014117          169 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD--------LCMIHTDLKPENVLLVSSEYIKVPD  239 (430)
Q Consensus       169 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--------~~ivHrDlKp~NILl~~~~~~~i~d  239 (430)
                      .+|+||||+ +|+|.++|++.   .+++..+..++.|++.||.|||+        +|||||||||+||||+         
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~---------  142 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---------  142 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC---------
T ss_pred             EEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc---------
Confidence            789999999 88999999875   59999999999999999999996        5999999999999994         


Q ss_pred             CcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCC-------CCeeeecCcccchhhhhCCC------CCCcchHHHH
Q 014117          240 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGLG------WTYPCDIWSV  306 (430)
Q Consensus       240 fg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~------~~~~~Dvwsl  306 (430)
                                        .++.+||+|||+++.....       ....+||+.|+|||++.+..      ++.++|||||
T Consensus       143 ------------------~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~  204 (303)
T d1vjya_         143 ------------------KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM  204 (303)
T ss_dssp             ------------------TTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred             ------------------CCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhh
Confidence                              4556666777766543222       12357999999999987653      6778999999


Q ss_pred             HHHHHHHHhCCCCCCC
Q 014117          307 GCILVELCTGEALFQT  322 (430)
Q Consensus       307 Gv~l~el~tG~~Pf~~  322 (430)
                      ||+||||+||..||..
T Consensus       205 Gvvl~el~tg~~~~~~  220 (303)
T d1vjya_         205 GLVFWEIARRCSIGGI  220 (303)
T ss_dssp             HHHHHHHHHTBCBTTB
T ss_pred             HHHHHHHhhCCCCCCc
Confidence            9999999999988854

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=5.3e-25  Score=193.01  Aligned_cols=164  Identities=20%  Similarity=0.211  Sum_probs=110.0

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-------------------hhHHHHHHHHHHHHHHHhcCCCCCc
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-------------------KYREAAMIEIEVLQQLAKHDKGGNR  156 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-------------------~~~~~~~~E~~~l~~l~~~~~~~~~  156 (430)
                      +.+.++||+|+||+||+|.+. +|+.||||+++...                   ........|...+.++.+     .+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-----~~   75 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG-----LA   75 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-----SS
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccC-----CC
Confidence            457899999999999999985 68899999875211                   011223346666666633     34


Q ss_pred             eEEecceeecCCeEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccCCCCceEEeecCccc
Q 014117          157 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK  236 (430)
Q Consensus       157 i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlKp~NILl~~~~~~~  236 (430)
                      ++..+++..    .++||||+++...        ..++...+..++.|++.||.|||++||+||||||+|||+++     
T Consensus        76 v~~~~~~~~----~~lvme~~~~~~~--------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~-----  138 (191)
T d1zara2          76 VPKVYAWEG----NAVLMELIDAKEL--------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE-----  138 (191)
T ss_dssp             SCCEEEEET----TEEEEECCCCEEG--------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET-----
T ss_pred             cceEEEecC----CEEEEEeeccccc--------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC-----
Confidence            554443321    2799999954311        13556667789999999999999999999999999999953     


Q ss_pred             cCCCcCCCCCCCCCcccccCCCCCCeEEEeCCCccccCCCCCeeeecCcccch--hh---hhCCCCCCcchHHHHHHHH
Q 014117          237 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAP--EV---ILGLGWTYPCDIWSVGCIL  310 (430)
Q Consensus       237 i~dfg~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aP--E~---~~~~~~~~~~DvwslGv~l  310 (430)
                                             ..++|+|||.|........     ..|...  +.   .....|+.++|+||+.--+
T Consensus       139 -----------------------~~~~liDFG~a~~~~~~~~-----~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         139 -----------------------EGIWIIDFPQSVEVGEEGW-----REILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             -----------------------TEEEECCCTTCEETTSTTH-----HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             -----------------------CCEEEEECCCcccCCCCCc-----HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence                                   2378889998865432221     111111  10   1134689999999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.38  E-value=9.2e-07  Score=78.90  Aligned_cols=84  Identities=8%  Similarity=0.031  Sum_probs=56.0

Q ss_pred             CcEEEEeeeccccceEEEEEEECCCCeEEEEEEecCch-hhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEE
Q 014117           94 SRYKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI  172 (430)
Q Consensus        94 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~l  172 (430)
                      ..|++++..+-++.+.||+..  ..++.+.+|+..... ........|...+..+..+.    .+.+++.+.+.++..++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~v----pvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKL----PVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTS----CCCCEEEEEEETTEEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccC----CCCcEEEEEecCCceEE
Confidence            457777765545557899875  345567888875332 22334567888888885432    25566777778889999


Q ss_pred             EEecC-CCCHHH
Q 014117          173 VFEKL-GSSLYD  183 (430)
Q Consensus       173 v~e~~-~~~L~~  183 (430)
                      ||+++ |.++.+
T Consensus        88 v~~~l~G~~~~~   99 (263)
T d1j7la_          88 LMSEADGVLCSE   99 (263)
T ss_dssp             EEECCSSEEHHH
T ss_pred             EEEecccccccc
Confidence            99999 556544

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.11  E-value=8.1e-06  Score=77.37  Aligned_cols=76  Identities=20%  Similarity=0.239  Sum_probs=47.5

Q ss_pred             EeeeccccceEEEEEEECCCCeEEEEEEecC----c----hhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeE
Q 014117           99 HSKMGEGTFGQVLECWDRERKEMVAIKIVRG----I----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI  170 (430)
Q Consensus        99 ~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~----~----~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~  170 (430)
                      .+.||.|....||++.+..+++.|+||.-..    .    .....+...|.+.|+.+.....  ..+++++.+.  +...
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p--~~vP~v~~~d--~~~~  106 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVP--HLVPRVFYSD--TEMA  106 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCG--GGSCCEEEEE--TTTT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCC--CCcceEEEEc--CCCC
Confidence            4578999999999999888888899997431    1    1122345568888888765421  2345555443  3445


Q ss_pred             EEEEecCC
Q 014117          171 CIVFEKLG  178 (430)
Q Consensus       171 ~lv~e~~~  178 (430)
                      ++|||+++
T Consensus       107 ~lvmE~L~  114 (392)
T d2pula1         107 VTVMEDLS  114 (392)
T ss_dssp             EEEECCCT
T ss_pred             EEEEeccC
Confidence            78999994

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.90  E-value=1.3e-05  Score=70.84  Aligned_cols=74  Identities=12%  Similarity=0.096  Sum_probs=50.3

Q ss_pred             eeccccc-eEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCCeEEEEEecC-C
Q 014117          101 KMGEGTF-GQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G  178 (430)
Q Consensus       101 ~lG~G~~-g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~  178 (430)
                      .+..|.. +.||+... .++..+++|......  ......|...++.+.....   .+.+++.+..+.+..++||+++ |
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gv---pvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGV---PCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTC---CBCCEEEEEECSSCEEEEEECCSS
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCC---CCCceeeecccccceEEEEEeeec
Confidence            3444543 67898865 455668899875432  2346678899988876543   2556666677788899999999 4


Q ss_pred             CC
Q 014117          179 SS  180 (430)
Q Consensus       179 ~~  180 (430)
                      .+
T Consensus        91 ~~   92 (255)
T d1nd4a_          91 QD   92 (255)
T ss_dssp             EE
T ss_pred             cc
Confidence            34

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.76  E-value=0.00012  Score=67.01  Aligned_cols=71  Identities=17%  Similarity=0.205  Sum_probs=47.7

Q ss_pred             eEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEec--ceeecCCeEEEEEecCCC
Q 014117          108 GQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR--NWFDYRNHICIVFEKLGS  179 (430)
Q Consensus       108 g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~--~~~~~~~~~~lv~e~~~~  179 (430)
                      -.||++.. .+|..|++|+.+......++...|...+..|.......+..+...  ..+...+..+.|+++++|
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            57999865 467779999987544445667789999999987654322222221  233456788899999843

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.24  E-value=0.00076  Score=63.29  Aligned_cols=72  Identities=13%  Similarity=0.128  Sum_probs=48.1

Q ss_pred             EEEEeeeccccceEEEEEEECC-------CCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecceeecCC
Q 014117           96 YKIHSKMGEGTFGQVLECWDRE-------RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN  168 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~-------~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~~~~~~~  168 (430)
                      ++ ++.|+.|-.-.+|++....       ..+.|.+++.-..... .....|..+++.+..+..    .+++++++..  
T Consensus        45 l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~-idr~~E~~i~~~ls~~gl----~Pkll~~~~~--  116 (395)
T d1nw1a_          45 LR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-SHLVAESVIFTLLSERHL----GPKLYGIFSG--  116 (395)
T ss_dssp             EE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-HHHHHHHHHHHHHHHTTS----SSCEEEEETT--
T ss_pred             eE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh-hHHHHHHHHHHHHHhCCC----CCeEEEEcCC--
Confidence            44 4678888899999998653       3456778876533222 334578999999877543    3455665543  


Q ss_pred             eEEEEEecC
Q 014117          169 HICIVFEKL  177 (430)
Q Consensus       169 ~~~lv~e~~  177 (430)
                        .+||||+
T Consensus       117 --g~I~efi  123 (395)
T d1nw1a_         117 --GRLEEYI  123 (395)
T ss_dssp             --EEEECCC
T ss_pred             --ceEEEEe
Confidence              5889998

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.92  E-value=0.0041  Score=55.97  Aligned_cols=79  Identities=8%  Similarity=0.017  Sum_probs=42.9

Q ss_pred             EEEEeeeccccceEEEEEEECCCCeEEEEEEecCchhhHHHHHHHHHHHHHHHhcCCCCCceEEecc---eeecCCeEEE
Q 014117           96 YKIHSKMGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN---WFDYRNHICI  172 (430)
Q Consensus        96 y~~~~~lG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~i~~~~~---~~~~~~~~~l  172 (430)
                      ..-.+.|..|---+.|+..... | .|++|++.... .......|++++..+..+....|..+....   .....+....
T Consensus        20 ~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~   96 (316)
T d2ppqa1          20 LTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA   96 (316)
T ss_dssp             EEEEEEECC---EEEEEEEESS-C-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred             ceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccce
Confidence            3444567777778899987543 4 39999986432 223455578888888876544443322211   1122445556


Q ss_pred             EEecC
Q 014117          173 VFEKL  177 (430)
Q Consensus       173 v~e~~  177 (430)
                      ++.+.
T Consensus        97 ~~~~~  101 (316)
T d2ppqa1          97 LISFL  101 (316)
T ss_dssp             EEECC
T ss_pred             eeeec
Confidence            66655